PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lam, TTY; Zhou, BP; Wang, J; Chai, YJ; Shen, YY; Chen, XC; Ma, C; Hong, WS; Chen, Y; Zhang, YJ; Duan, L; Chen, PW; Jiang, JF; Zhang, Y; Li, LF; Poon, LLM; Webby, RJ; Smith, DK; Leung, GM; Peiris, JSM; Holmes, EC; Guan, Y; Zhu, HC				Lam, Tommy Tsan-Yuk; Zhou, Boping; Wang, Jia; Chai, Yujuan; Shen, Yongyi; Chen, Xinchun; Ma, Chi; Hong, Wenshan; Chen, Yin; Zhang, Yanjun; Duan, Lian; Chen, Peiwen; Jiang, Junfei; Zhang, Yu; Li, Lifeng; Poon, Leo Lit Man; Webby, Richard J.; Smith, David K.; Leung, Gabriel M.; Peiris, Joseph S. M.; Holmes, Edward C.; Guan, Yi; Zhu, Huachen			Dissemination, divergence and establishment of H7N9 influenza viruses in China	NATURE			English	Article							MAXIMUM-LIKELIHOOD PHYLOGENIES; HUMAN INFECTIONS; A VIRUS; POULTRY; DIVERSITY; EVOLUTION; GENESIS; GENOME; PHYML; HOST	Since 2013 the occurrence of human infections by a novel avian H7N9 influenza virus in China has demonstrated the continuing threat posed by zoonotic pathogens(1,2). Although the first outbreak wave that was centred on eastern China was seemingly averted, human infections recurred in October 2013 (refs 3-7). It is unclear how the H7N9 virus re-emerged and how it will develop further; potentially it may become a long-term threat to public health. Here we show that H7N9 viruses have spread from eastern to southern China and become persistent in chickens, which has led to the establishment of multiple regionally distinct lineages with different reassortant genotypes. Repeated introductions of viruses from Zhejiang to other provinces and the presence of H7N9 viruses at live poultry markets have fuelled the recurrence of human infections. This rapid expansion of the geographical distribution and genetic diversity of the H7N9 viruses poses a direct challenge to current disease control systems. Our results also suggest that H7N9 viruses have become enzootic in China and may spread beyond the region, following the pattern previously observed with H5N1 and H9N2 influenza viruses(8,9).	[Lam, Tommy Tsan-Yuk; Zhou, Boping; Chen, Xinchun; Duan, Lian; Chen, Peiwen; Jiang, Junfei; Poon, Leo Lit Man; Peiris, Joseph S. M.; Guan, Yi; Zhu, Huachen] Shenzhen Third Peoples Hosp, HKU Shenzhen Branch, State Key Lab Emerging Infect Dis, Shenzhen 518112, Peoples R China; [Lam, Tommy Tsan-Yuk; Wang, Jia; Chai, Yujuan; Shen, Yongyi; Ma, Chi; Hong, Wenshan; Duan, Lian; Chen, Peiwen; Zhang, Yu; Li, Lifeng; Smith, David K.; Guan, Yi; Zhu, Huachen] SUMC, Joint Influenza Res Ctr SUMC HKU, Shantou 515041, Peoples R China; [Lam, Tommy Tsan-Yuk; Wang, Jia; Chai, Yujuan; Shen, Yongyi; Ma, Chi; Duan, Lian; Jiang, Junfei; Zhang, Yu; Li, Lifeng; Poon, Leo Lit Man; Smith, David K.; Leung, Gabriel M.; Peiris, Joseph S. M.; Guan, Yi; Zhu, Huachen] Univ Hong Kong, Sch Publ Hlth, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China; [Chen, Yin; Zhang, Yanjun] Zhejiang Prov Ctr Dis Control & Prevent, Key Lab Emergency Detect Publ Hlth Zhejiang Prov, Hangzhou 310051, Zhejiang, Peoples R China; [Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Hong Kong; Zhejiang Provincial Center for Disease Control & Prevention; St Jude Children's Research Hospital; University of Sydney; University of Sydney	Guan, Y (corresponding author), Shenzhen Third Peoples Hosp, HKU Shenzhen Branch, State Key Lab Emerging Infect Dis, Shenzhen 518112, Peoples R China.	yguan@hku.hk; zhuhch@hku.hk	Zhu, Huachen/A-8252-2017; Poon, Leo/AAP-6887-2020; Webby, Richard J/N-5657-2018; Poon, Leo Lit Man/C-4382-2009; Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; Peiris, Joseph Sriyal Malik/C-4380-2009; Lam, Tsan Yuk/D-4837-2012	Zhu, Huachen/0000-0003-2711-0501; Poon, Leo Lit Man/0000-0002-9101-7953; Holmes, Edward/0000-0001-9596-3552; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Shen, Yongyi/0000-0001-7660-5522; Smith, David/0000-0003-3608-0586; Lam, Tsan Yuk/0000-0002-9769-1527; Leung, Gabriel/0000-0002-2503-6283; Guan, Yi/0000-0001-6057-9243	Shenzhen Peacock Plan High-End Talents Program [KQTD201203]; Hong Kong Government [RRG-10, RRG-14]; University Grants Committee of Hong Kong [AoE/M-12/06]; National Institute of Allergy and Infectious Diseases [HHSN272201400006C]; Li Ka Shing Foundation; NHMRC [AF30]	Shenzhen Peacock Plan High-End Talents Program; Hong Kong Government; University Grants Committee of Hong Kong; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Li Ka Shing Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank C. L. Cheung, H. Y. Liang and G. C. Yu for their assistance in data processing; Z. H. Ou, Z. Y. Jin, T. Y. Leung, K. K. Chan, Y. R. Qiu, J. Z. Xie, N. Qi, J. Zhou, P. Y. Huang and all staff members at the Joint Influenza Research Centre (SUMC/HKU) for technical support, the four collaborative hospitals in Shenzhen for human sample collection, and P. Lemey for his advice on phylogeographic analysis. This study was supported by the Shenzhen Peacock Plan High-End Talents Program (KQTD201203), the Health and Medical Research Fund of the Hong Kong Government (RRG-10 and RRG-14), the University Grants Committee of Hong Kong (Area of Excellence Scheme grant AoE/M-12/06), the National Institute of Allergy and Infectious Diseases (contract HHSN272201400006C), and the Li Ka Shing Foundation. E.C.H. is supported by an NHMRC Australia Fellowship (AF30).	Chen E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.43.20616; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chen ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107266; Chen ZQ, 2014, EMERG INFECT DIS, V20, P1535, DOI 10.3201/eid2009.140424; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, VIRUS RES, V178, P35, DOI 10.1016/j.virusres.2013.05.012; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Lam TTY, 2013, INFECT GENET EVOL, V18, P367, DOI 10.1016/j.meegid.2013.03.015; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lu J, 2014, J VIROL, V88, P8297, DOI 10.1128/JVI.00630-14; Ma C., 2015, J VIROL; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Okamatsu M, 2013, VIRUS GENES, V47, P317, DOI 10.1007/s11262-013-0954-7; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Qi X, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00706-14; Rambaut A., 2007, TRACER V1 5; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Wang D, 2014, EUROSURVEILLANCE, V2013, P19, DOI DOI 10.2807/1560-7917.ES2014.19.25.20836; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, SIT UPD AV INFL; World Health Organization (WHO), 2014, WHO INF MOL DIAGN IN; Wu AP, 2013, CELL HOST MICROBE, V14, P446, DOI 10.1016/j.chom.2013.09.001; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhao KK, 2013, VET MICROBIOL, V163, P351, DOI 10.1016/j.vetmic.2012.12.025	38	168	175	3	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					102	U265		10.1038/nature14348	http://dx.doi.org/10.1038/nature14348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25762140				2022-12-24	WOS:000355543400038
J	Barraclough, K; Gale, CP; Hall, R				Barraclough, Kevin; Gale, Chris P.; Hall, Roger			UNCERTAINTIES Assessment of chest pain in a low risk patient: is the exercise tolerance test obsolete?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-ARTERY-DISEASE; PROGNOSTIC VALUE; DIAGNOSIS; PROBABILITY; ANGIOGRAPHY; TOMOGRAPHY; GUIDELINES; MANAGEMENT		[Barraclough, Kevin] Hoyland House, Painswick GL6 6TY, Glos, England; [Gale, Chris P.] Univ Leeds, Ctr Epidemiol & Biostat, Leeds LS2 9JT, W Yorkshire, England; [Hall, Roger] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of Leeds; University of East Anglia	Barraclough, K (corresponding author), Hoyland House, Painswick GL6 6TY, Glos, England.	k.barraclough@btinternet.com		Gale, Chris/0000-0003-4732-382X	Medical Research Council [MR/L01629X/1] Funding Source: researchfish; MRC [MR/L01629X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsterdam EA, 2014, JAMA INTERN MED, V174, P553, DOI 10.1001/jamainternmed.2013.13415; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Douglas PS, 2014, AM HEART J, V167, P796, DOI 10.1016/j.ahj.2014.03.003; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Hulten E, 2013, J AM COLL CARDIOL, V61, P880, DOI 10.1016/j.jacc.2012.11.061; Jelinek M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4117; Lauer MS, 2007, ANN INTERN MED, V147, P821, DOI 10.7326/0003-4819-147-12-200712180-00001; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; McKavanagh P, 2015, EUR HEART J-CARD IMG, V16, P441, DOI 10.1093/ehjci/jeu284; Montalescot G, 2014, TURK KARDIYOL DERN A, V42, P73, DOI 10.1093/eurheartj/eht296; National Institute for Health and Care Excellence, 2011, MAN STABL ANG; National Institute for Health and Care Excellence, 2010, CHEST PAIN REC ONS A; Nilsson S, 2003, BRIT J GEN PRACT, V53, P378; Office for National Statistics, 2014, DEATH REG SUMM TABL; Safavi KC, 2014, JAMA INTERN MED, V74, P553; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Sekhri N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2240; SOX HC, 1990, AM J MED, V89, P7, DOI 10.1016/0002-9343(90)90090-Z	23	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2015	350								h1905	10.1136/bmj.h1905	http://dx.doi.org/10.1136/bmj.h1905			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GD	25948490				2022-12-24	WOS:000354414000002
J	Marzi, A; Halfmann, P; Hill-Batorski, L; Feldmann, F; Shupert, WL; Neumann, G; Feldmann, H; Kawaoka, Y				Marzi, Andrea; Halfmann, Peter; Hill-Batorski, Lindsay; Feldmann, Friederike; Shupert, W. Lesley; Neumann, Gabriele; Feldmann, Heinz; Kawaoka, Yoshihiro			An Ebola whole-virus vaccine is protective in nonhuman primates	SCIENCE			English	Article							I CLINICAL-TRIAL; CELLULAR-IMMUNITY; MARBURG VIRUSES; INFECTION; CHALLENGE; IMMUNOGENICITY; INFLUENZA; RESPONSES; MACAQUES	Zaire ebolavirus is the causative agent of the current outbreak of hemorrhagic fever disease in West Africa. Previously, we showed that a whole Ebola virus (EBOV) vaccine based on a replication-defective EBOV (EBOV Delta VP30) protects immunized mice and guinea pigs against lethal challenge with rodent-adapted EBOV. Here, we demonstrate that EBOV Delta VP30 protects nonhuman primates against lethal infection with EBOV. Although EBOV Delta VP30 is replication-incompetent, we additionally inactivated the vaccine with hydrogen peroxide; the chemically inactivated vaccine remained antigenic and protective in nonhuman primates. EBOV Delta VP30 thus represents a safe, efficacious, whole-EBOV vaccine candidate that differs from other EBOV vaccine platforms in that it presents all viral proteins and the viral RNA to the host immune system, which might contribute to protective immune responses.	[Marzi, Andrea; Shupert, W. Lesley; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Halfmann, Peter; Hill-Batorski, Lindsay; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA; [Feldmann, Friederike] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT USA; [Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Dept Microbiol & Immunol,Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Tokyo; Japan Science & Technology Agency (JST)	Kawaoka, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu	Halfmann, Peter/W-8084-2019; Marzi, Andrea/AAF-4617-2020	Marzi, Andrea/0000-0003-0186-9587	Region V "Great Lakes" Regional Center of Excellence (GLRCE) [U54 AI 57153]; Health and Labour Sciences Research Grants, Japan; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089, ZIAAI001163, U54AI057153] Funding Source: NIH RePORTER	Region V "Great Lakes" Regional Center of Excellence (GLRCE); Health and Labour Sciences Research Grants, Japan; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Ollmann-Saphire (Scripps Research Institute, La Jolla, CA) for purified EBOV NP. We also thank S. Watson for editing the manuscript, T. Armbrust for excellent technical assistance, and staff of the Rocky Mountain Veterinary Branch for assistance with animal work. Y.K. and G.N. are inventors on a patent (held by the University of Wisconsin Alumni Research Foundation) for EBOV reverse genetics; therefore, a Material Transfer Agreement (MTA) is required to obtain this system. Funding for this research was provided by the Region V "Great Lakes" Regional Center of Excellence (GLRCE; U54 AI 57153) and by Health and Labour Sciences Research Grants, Japan. The study was partially funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH. Raw data can be found at https://docs.google.com/spreadsheets/d/1dBgzt5_z4rp-qOuxXcI_FbUz8wNqMvHy6kVP_tpW0MY/edit?usp=sharing.	Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763; Amanna IJ, 2009, ANTIVIR RES, V84, P119, DOI 10.1016/j.antiviral.2009.08.008; Blaney JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003389; Brining DL, 2010, COMPARATIVE MED, V60, P389; Dembinski JL, 2014, J VIROL METHODS, V207, P232, DOI 10.1016/j.jviromet.2014.07.003; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Halfmann P, 2008, P NATL ACAD SCI USA, V105, P1129, DOI 10.1073/pnas.0708057105; Halfmann P, 2009, J VIROL, V83, P3810, DOI 10.1128/JVI.00074-09; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kempner ES, 2001, J PHARM SCI, V90, P1637, DOI 10.1002/jps.1114; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Swenson DL, 2005, VACCINE, V23, P3033, DOI 10.1016/j.vaccine.2004.11.070; Takada A, 2003, J VIROL, V77, P1069, DOI 10.1128/JVI.77.2.1069-1074.2003; Walker JM, 2012, J VIROL, V86, P13735, DOI 10.1128/JVI.02178-12; Warfield KL, 2007, J INFECT DIS, V196, pS421, DOI 10.1086/520612; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184	27	60	69	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					439	442		10.1126/science.aaa4919	http://dx.doi.org/10.1126/science.aaa4919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25814063	Green Accepted			2022-12-24	WOS:000353338000035
J	Bass, JIF; Sahni, N; Shrestha, S; Garcia-Gonzalez, A; Mori, A; Bhat, N; Yi, S; Hill, DE; Vidal, M; Walhout, AJM				Bass, Juan I. Fuxman; Sahni, Nidhi; Shrestha, Shaleen; Garcia-Gonzalez, Aurian; Mori, Akihiro; Bhat, Numana; Yi, Song; Hill, David E.; Vidal, Marc; Walhout, Albertha J. M.			Human Gene-Centered Transcription Factor Networks for Enhancers and Disease Variants	CELL			English	Article							ONE-HYBRID ASSAYS; REGULATORY NETWORK; PROTEIN-DNA; LHX4 GENE; MUTATIONS; PROMOTER; BINDING; MOUSE	Gene regulatory networks (GRNs) comprising interactions between transcription factors (TFs) and regulatory loci control development and physiology. Numerous disease-associated mutations have been identified, the vast majority residing in non-coding regions of the genome. As current GRN mapping methods test one TF at a time and require the use of cells harboring the mutation(s) of interest, they are not suitable to identify TFs that bind to wildtype and mutant loci. Here, we use gene-centered yeast one-hybrid (eY1H) assays to interrogate binding of 1,086 human TFs to 246 enhancers, as well as to 109 non-coding disease mutations. We detect both loss and gain of TF interactions with mutant loci that are concordant with target gene expression changes. This work establishes eY1H assays as a powerful addition to the toolkit of mapping human GRNs and for the high-throughput characterization of genomic variants that are rapidly being identified by genome-wide association studies.	[Bass, Juan I. Fuxman; Shrestha, Shaleen; Garcia-Gonzalez, Aurian; Mori, Akihiro; Bhat, Numana; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA; [Bass, Juan I. Fuxman; Shrestha, Shaleen; Garcia-Gonzalez, Aurian; Mori, Akihiro; Bhat, Numana; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Sahni, Nidhi; Yi, Song; Hill, David E.; Vidal, Marc; Walhout, Albertha J. M.] Dana Farber Canc Inst, Dept Canc Biol, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Sahni, Nidhi; Yi, Song; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Walhout, AJM (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	walhout@umassmed.edu	Yi, Song/ABG-6526-2020	Yi, Song/0000-0003-0047-8103; Walhout, Marian/0000-0001-5587-3608; Sahni, Nidhi/0000-0002-9155-5882; Garcia Gonzalez, Aurian P./0000-0003-4120-4408	US NIH [GM082971, HG004233, HG006066]; Pew Latin American Fellows Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC4HG006066, P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM107000, R01GM082971] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Latin American Fellows Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the A.J.M.W. laboratory, R. McCord, N. Kaplan, and J. Dekker for discussions and critical reading of the manuscript. We thank J. Gibcus for the pGL4 plasmid and expression vectors and advice on the luciferase assays. We thank N. Beittel and B. Parmentier for technical assistance. This work was supported by US NIH grants GM082971 to A.J.M.W., HG004233 to M.V., and HG006066 to M.V. and D.E.H. J.I.F.B. was partially supported by a postdoctoral fellowship from the Pew Latin American Fellows Program.	Alhashem YN, 2011, J BIOL CHEM, V286, P24819, DOI 10.1074/jbc.M111.247536; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arda HE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.23; Arda HE, 2010, BRIEF FUNCT GENOMICS, V9, P4, DOI 10.1093/bfgp/elp049; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bass JIF, 2014, NUCLEIC ACIDS RES, V42, P153, DOI 10.1093/nar/gkt858; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brady SM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.114; Brickman JM, 2001, DEVELOPMENT, V128, P5189; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Gardiner MR, 2007, MECH DEVELOP, V124, P762, DOI 10.1016/j.mod.2007.06.005; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luo W, 1996, J BIOL CHEM, V271, P23445, DOI 10.1074/jbc.271.38.23445; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Reece-Hoyes JS, 2013, MOL CELL, V51, P116, DOI 10.1016/j.molcel.2013.05.018; Reece-Hoyes JS, 2012, METHODS MOL BIOL, V812, P189, DOI 10.1007/978-1-61779-455-1_11; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Sharpe J, 1999, CURR BIOL, V9, P97, DOI 10.1016/S0960-9822(99)80022-0; Tajima T, 2007, ENDOCR J, V54, P637, DOI 10.1507/endocrj.K06-200; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Walhout AJM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-109; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009	39	65	65	4	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					661	673		10.1016/j.cell.2015.03.003	http://dx.doi.org/10.1016/j.cell.2015.03.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910213	Green Accepted, Bronze			2022-12-24	WOS:000353553600023
J	MacNeil, MA; Graham, NAJ; Cinner, JE; Wilson, SK; Williams, ID; Maina, J; Newman, S; Friedlander, AM; Jupiter, S; Polunin, NVC; McClanahan, TR				MacNeil, M. Aaron; Graham, Nicholas A. J.; Cinner, Joshua E.; Wilson, Shaun K.; Williams, Ivor D.; Maina, Joseph; Newman, Steven; Friedlander, Alan M.; Jupiter, Stacy; Polunin, Nicholas V. C.; McClanahan, Tim R.			Recovery potential of the world's coral reef fishes	NATURE			English	Article							MARINE PROTECTED AREAS; UNDERWATER VISUAL CENSUS; OCEAN; RESILIENCE; BIOMASS; RATES; COMMUNITIES; FUTURE	Continuing degradation of coral reef ecosystems has generated substantial interest in how management can support reef resilience(1,2). Fishing is the primary source of diminished reef function globally(3-5), leading to widespread calls for additional marine reserves to recover fish biomass and restore key ecosystem functions(6). Yet there are no established baselines for determining when these conservation objectives have been met or whether alternative management strategies provide similar ecosystem benefits. Here we establish empirical conservation benchmarks and fish biomass recovery timelines against which coral reefs can be assessed and managed by studying the recovery potential of more than 800 coral reefs along an exploitation gradient. We show that resident reef fish biomass in the absence of fishing (B-0) averages similar to 1,000 kg ha(-1), and that the vast majority (83%) of fished reefs are missing more than half their expected biomass, with severe consequences for key ecosystem functions such as predation. Given protection from fishing, reef fish biomass has the potential to recover within 35 years on average and less than 60 years when heavily depleted. Notably, alternative fisheries restrictions are largely (64%) successful at maintaining biomass above 50% of B-0, sustaining key functions such as herbivory. Our results demonstrate that crucial ecosystem functions can be maintained through a range of fisheries restrictions, allowing coral reef managers to develop recovery plans that meet conservation and livelihood objectives in areas where marine reserves are not socially or politically feasible solutions.	[MacNeil, M. Aaron] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [MacNeil, M. Aaron] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada; [MacNeil, M. Aaron; Graham, Nicholas A. J.; Cinner, Joshua E.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Wilson, Shaun K.] Dept Pk & Wildlife, Perth, WA 6151, Australia; [Wilson, Shaun K.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia; [Williams, Ivor D.] NOAA, Coral Reef Ecosyst Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96818 USA; [Maina, Joseph] Univ Queensland, Australian Res Council, CEED, St Lucia, Qld 4074, Australia; [Maina, Joseph; Jupiter, Stacy; McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY 10460 USA; [Newman, Steven; Polunin, Nicholas V. C.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Friedlander, Alan M.] Pristine Seas Natl Geog, Washington, DC 20036 USA	Australian Institute of Marine Science; Dalhousie University; James Cook University; University of Western Australia; National Oceanic Atmospheric Admin (NOAA) - USA; University of Queensland; Wildlife Conservation Society; Newcastle University - UK; University of Hawaii System; National Geographic Society	MacNeil, MA (corresponding author), Australian Inst Marine Sci, PMB 3 Townsville MC, Townsville, Qld 4810, Australia.	a.macneil@aims.gov.au	Graham, Nicholas AJ/C-8360-2014; MacNeil, Aaron/E-8196-2017; Cinner, Joshua e/E-8966-2011; Cinner, Joshua/AAA-6823-2021; McClanahan, Tim/K-4998-2019; MacNeil, M. Aaron/ABD-6444-2021	Graham, Nicholas AJ/0000-0002-0304-7467; MacNeil, Aaron/0000-0001-8406-325X; Cinner, Joshua e/0000-0003-2675-9317; MacNeil, M. Aaron/0000-0001-8406-325X; Jupiter, Stacy/0000-0001-9742-1677; Williams, Ivor/0000-0002-9444-1020; Wilson, Shaun/0000-0002-4590-0948; McClanahan, Timothy/0000-0001-5821-3584; Polunin, Nick/0000-0002-1480-8794; Maina, Joseph/0000-0003-1268-6137	Australian Institute of Marine Science; ARC Centre of Excellence for Coral Reef Studies; John D. and Catherine T. MacArthur Foundation	Australian Institute of Marine Science; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); John D. and Catherine T. MacArthur Foundation	We thank M. Emslie, A. Cheal, J. Wetherall, C. Hutchery and K. Anthony for comments on early drafts of the manuscript. The Australian Institute of Marine Science, the ARC Centre of Excellence for Coral Reef Studies, and the John D. and Catherine T. MacArthur Foundation supported this research.	Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brooks SP, 2000, STAT SCI, V15, P357; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Hamner WM, 2007, MAR ECOL PROG SER, V334, P83, DOI 10.3354/meps334083; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Lambert GI, 2014, J APPL ECOL, V51, P1326, DOI 10.1111/1365-2664.12277; MacNeil M. A., 2015, ECOLOGY FISHES CORAL; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2012, ENVIRON CONSERV, V39, P357, DOI 10.1017/S0376892912000197; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Patil A, 2010, J STAT SOFTW, V35, P1; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Watson RA, 1997, ECOL MODEL, V104, P103, DOI 10.1016/S0304-3800(97)00117-8; Westberry T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003078; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	40	224	229	15	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					341	+		10.1038/nature14358	http://dx.doi.org/10.1038/nature14358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855298	Green Submitted			2022-12-24	WOS:000352974200037
J	Tanabe, H; Fujii, Y; Okada-Iwabu, M; Iwabu, M; Nakamura, Y; Hosaka, T; Motoyama, K; Ikeda, M; Wakiyama, M; Terada, T; Ohsawa, N; Hato, M; Ogasawara, S; Hino, T; Murata, T; Iwata, S; Hirata, K; Kawano, Y; Yamamoto, M; Kimura-Someya, T; Shirouzu, M; Yamauchi, T; Kadowaki, T; Yokoyama, S				Tanabe, Hiroaki; Fujii, Yoshifumi; Okada-Iwabu, Miki; Iwabu, Masato; Nakamura, Yoshihiro; Hosaka, Toshiaki; Motoyama, Kanna; Ikeda, Mariko; Wakiyama, Motoaki; Terada, Takaho; Ohsawa, Noboru; Hato, Masakatsu; Ogasawara, Satoshi; Hino, Tomoya; Murata, Takeshi; Iwata, So; Hirata, Kunio; Kawano, Yoshiaki; Yamamoto, Masaki; Kimura-Someya, Tomomi; Shirouzu, Mikako; Yamauchi, Toshimasa; Kadowaki, Takashi; Yokoyama, Shigeyuki			Crystal structures of the human adiponectin receptors	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; COMPLEMENT-RELATED PROTEIN; GLUCOSE-TRANSPORT; ADIPOSE; CRYSTALLIZATION; EXPRESSION; RHODOPSIN; FEATURES; AGONIST	Adiponectin stimulation of its receptors, AdipoR1 and AdipoR2, increases the activities of 59AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR), respectively, thereby contributing to healthy longevity as key anti-diabetic molecules. AdipoR1 and AdipoR2 were predicted to contain seven transmembrane helices with the opposite topology to G-protein-coupled receptors. Here we report the crystal structures of human AdipoR1 and AdipoR2 at 2.9 and 2.4 angstrom resolution, respectively, which represent a novel class of receptor structure. The seven-transmembrane helices, conformationally distinct from those of G-protein-coupled receptors, enclose a large cavity where three conserved histidine residues coordinate a zinc ion. The zinc-binding structure may have a role in the adiponectin-stimulated AMPK phosphorylation and UCP2 upregulation. Adiponectin may broadly interact with the extracellular face, rather than the carboxy-terminal tail, of the receptors. The present information will facilitate the understanding of novel structure-function relationships and the development and optimization of AdipoR agonists for the treatment of obesity-related diseases, such as type 2 diabetes.	[Tanabe, Hiroaki; Fujii, Yoshifumi; Nakamura, Yoshihiro; Hosaka, Toshiaki; Motoyama, Kanna; Ikeda, Mariko; Wakiyama, Motoaki; Terada, Takaho; Ohsawa, Noboru; Hato, Masakatsu; Murata, Takeshi; Iwata, So; Kimura-Someya, Tomomi; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Tanabe, Hiroaki; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Tanabe, Hiroaki; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Tanabe, Hiroaki; Nakamura, Yoshihiro; Hosaka, Toshiaki; Ikeda, Mariko; Wakiyama, Motoaki; Ohsawa, Noboru; Hato, Masakatsu; Kimura-Someya, Tomomi; Shirouzu, Mikako] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Tanabe, Hiroaki; Fujii, Yoshifumi; Nakamura, Yoshihiro; Terada, Takaho; Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Okada-Iwabu, Miki; Iwabu, Masato; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Bunkyo Ku, Tokyo 1130033, Japan; [Okada-Iwabu, Miki; Iwabu, Masato; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, Century Med & Res Ctr 22, Bunkyo Ku, Tokyo 1130033, Japan; [Iwabu, Masato] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ogasawara, Satoshi; Hino, Tomoya; Murata, Takeshi; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Hino, Tomoya; Murata, Takeshi; Iwata, So] JST, Res Accelerat Program, Membrane Prot Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Iwata, So] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Iwata, So; Hirata, Kunio; Kawano, Yoshiaki; Yamamoto, Masaki] RIKEN, SPring Ctr 8, Harima Inst, Sayo, Hyogo 6795148, Japan; [Yamauchi, Toshimasa] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; University of Tokyo; RIKEN; RIKEN; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; Japan Science & Technology Agency (JST); Chiba University; Imperial College London; Diamond Light Source; RIKEN; Japan Science & Technology Agency (JST)	Yokoyama, S (corresponding author), RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	tyamau-tky@umin.net; kadowaki-3im@h.u-tokyo.ac.jp; yokoyama@riken.jp	Shirouzu, Mikako/A-6521-2016; Kawano, Yoshiaki/C-7585-2017; Wakiyama, Motoaki/N-6928-2015; Kimura-Someya, Tomomi/C-4169-2017; Yokoyama, Shigeyuki/N-6911-2015; Murata, Takeshi/J-6181-2017; Yamamoto, Masaki/B-7844-2015	Wakiyama, Motoaki/0000-0002-8029-4795; Kimura-Someya, Tomomi/0000-0003-2232-1801; Yokoyama, Shigeyuki/0000-0003-3133-7338; Murata, Takeshi/0000-0002-5748-4670; Yamamoto, Masaki/0000-0002-1311-1768; Hirata, Kunio/0000-0002-1491-6509	Targeted Proteins Research Program; Platform for Drug Discovery, Informatics and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [26000012, 20229008, 25221307, 26293216, 30557236]; Japan Science and Technology Agency; BBSRC [BB/G02325/1]; Wellcome Trust [062164/Z/00/Z]; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; BBSRC [BB/G023425/1] Funding Source: UKRI	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to the staffs of BL32XU at SPring-8 (proposals 2012A1332, 201281453, 2013A1008, 2013A1008, 201381034, 201381007, 2014A1007, 2014A1008 and 2014A1186), beamline X06SA at Diamond Light Source, and beamline X06SA at the Swiss Light Source for their assistance in data collection. We thank R. Akasaka for protein analysis, M. Toyama, M. Inoue, M. Goto, M. Aoki and K. Ishii for expression plasmid preparation, M. Nishimoto, Y. Tomabechi and Y. Terazawa for technical assistance with protein expression and purification, and Y. Nishibaba, M. Yuasa and A. Hayashi for technical assistance and support with the activity assays of the mutants. This work was supported by grants from the Targeted Proteins Research Program (S.Y., T.K., S.I. and M.Y.), the Platform for Drug Discovery, Informatics and Structural Life Science (S.Y. and M.Y.), a Grant-in-Aid for Specially Promoted Research (26000012) (T.K.), Grants-in-Aid for Scientific Research (S) (20229008, 25221307) (T.K.), a Grant-in-Aid for Scientific Research (B) (26293216) (M.O.-I.), a Grant-in-Aid for Young Scientists (A) (30557236) (M. Iwabu), and the Translational Research Network Program (M.O.-I.), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the research acceleration program of the Japan Science and Technology Agency (S.I.), and by the BBSRC (BB/G02325/1) (S.I.). The authors are grateful for the use of the Membrane Protein Laboratory funded bythe Wellcome Trust(grant062164/Z/00/Z)(S.I.)atthe Diamond Light Source Limited.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; de Graaf C, 2011, J MED CHEM, V54, P8195, DOI 10.1021/jm2011589; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hato Masakatsu, 2014, Journal of Structural and Functional Genomics, V15, P165, DOI 10.1007/s10969-014-9187-9; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lyons TJ, 2004, P NATL ACAD SCI USA, V101, P5506, DOI 10.1073/pnas.0306324101; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Murakami I, 2012, J GYNECOL ONCOL, V23, P153, DOI 10.3802/jgo.2012.23.3.153; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Tanabe Hiroaki, 2015, Journal of Structural and Functional Genomics, V16, P11, DOI 10.1007/s10969-014-9192-z; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Ueno G, 2005, J SYNCHROTRON RADIAT, V12, P380, DOI 10.1107/S0909049505004735; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	58	130	137	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					312	+		10.1038/nature14301	http://dx.doi.org/10.1038/nature14301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855295	Green Accepted			2022-12-24	WOS:000352974200030
J	Twyman-Saint Victor, C; Rech, AJ; Maity, A; Rengan, R; Pauken, KE; Stelekati, E; Benci, JL; Xu, BH; Dada, H; Odorizzi, PM; Herati, RS; Mansfield, KD; Patsch, D; Amaravadi, RK; Schuchter, LM; Ishwaran, H; Mick, R; Pryma, DA; Xu, XW; Feldman, MD; Gangadhar, TC; Hahn, SM; Wherry, EJ; Vonderheide, RH; Minn, AJ				Twyman-Saint Victor, Christina; Rech, Andrew J.; Maity, Amit; Rengan, Ramesh; Pauken, Kristen E.; Stelekati, Erietta; Benci, Joseph L.; Xu, Bihui; Dada, Hannah; Odorizzi, Pamela M.; Herati, Ramin S.; Mansfield, Kathleen D.; Patsch, Dana; Amaravadi, Ravi K.; Schuchter, Lynn M.; Ishwaran, Hemant; Mick, Rosemarie; Pryma, Daniel A.; Xu, Xiaowei; Feldman, Michael D.; Gangadhar, Tara C.; Hahn, Stephen M.; Wherry, E. John; Vonderheide, Robert H.; Minn, Andy J.			Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer	NATURE			English	Article							T-CELLS; EXPRESSION; SAFETY; REPERTOIRE; ANTI-PD-1; ANTIBODY; PD-1	Immune checkpoint inhibitors(1) result in impressive clinical responses(2-5), but optimal results will require combination with each other(6) and other therapies. This raises fundamental questions about mechanisms of non-redundancy and resistance. Here we report major tumour regressions in a subset of patients with metastatic melanoma treated with an anti-CTLA4 antibody (anti-CTLA4) and radiation, and reproduced this effect in mouse models. Although combined treatment improved responses in irradiated and unirradiated tumours, resistance was common. Unbiased analyses of mice revealed that resistance was due to upregulation of PD-L1 on melanoma cells and associated with T-cell exhaustion. Accordingly, optimal response in melanoma and other cancer types requires radiation, anti-CTLA4 and anti-PD-L1/PD-1. Anti-CTLA4 predominantly inhibits T-regulatory cells (T-reg cells), thereby increasing theCD8T-cell to T-reg (CD8/T-reg) ratio. Radiation enhances the diversity of the T-cell receptor (TCR) repertoire of intratumoral T cells. Together, anti-CTLA4 promotes expansion of T cells, while radiation shapes the TCR repertoire of the expanded peripheral clones. Addition of PD-L1 blockade reverses T-cell exhaustion to mitigate depression in the CD8/T-reg ratio and further encourages oligoclonal T-cell expansion. Similarly to results from mice, patients on our clinical trial with melanoma showing high PD-L1 did not respond to radiation plus anti-CTLA4, demonstrated persistent T-cell exhaustion, and rapidly progressed. Thus, PD-L1 on melanoma cells allows tumours to escape anti-CTLA4-based therapy, and the combination of radiation, anti-CTLA4 and anti-PD-L1 promotes response and immunity through distinct mechanisms.	[Twyman-Saint Victor, Christina; Herati, Ramin S.; Amaravadi, Ravi K.; Schuchter, Lynn M.; Gangadhar, Tara C.; Vonderheide, Robert H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Twyman-Saint Victor, Christina; Rech, Andrew J.; Benci, Joseph L.; Xu, Bihui; Dada, Hannah; Vonderheide, Robert H.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Maity, Amit; Rengan, Ramesh; Benci, Joseph L.; Xu, Bihui; Dada, Hannah; Patsch, Dana; Hahn, Stephen M.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Maity, Amit; Rengan, Ramesh; Amaravadi, Ravi K.; Schuchter, Lynn M.; Mick, Rosemarie; Pryma, Daniel A.; Xu, Xiaowei; Feldman, Michael D.; Gangadhar, Tara C.; Hahn, Stephen M.; Wherry, E. John; Vonderheide, Robert H.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Pauken, Kristen E.; Stelekati, Erietta; Odorizzi, Pamela M.; Mansfield, Kathleen D.; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Pauken, Kristen E.; Stelekati, Erietta; Odorizzi, Pamela M.; Herati, Ramin S.; Mansfield, Kathleen D.; Wherry, E. John; Vonderheide, Robert H.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Ishwaran, Hemant] Univ Miami, Dept Publ Hlth Sci, Div Biostat, Miami, FL 33136 USA; [Mick, Rosemarie] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Pryma, Daniel A.] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Xu, Xiaowei; Feldman, Michael D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Miami; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	andyminn@exchange.upenn.edu	Wherry, John/ABI-1280-2020; Rengan, Ramesh/L-4700-2019	Rengan, Ramesh/0000-0001-5379-536X; Minn, Andy/0000-0003-1418-0906; Benci, Joseph/0000-0002-1759-4621; Sedaghat Herati, Ramin/0000-0001-7713-2587; Ishwaran, Hemant/0000-0003-2758-9647; Maity, Amit/0000-0001-7151-2845; Twyman-Saint Victor, Christina/0000-0001-7253-6179; Herati, Ramin/0000-0003-2613-4050	NIH training grant and career development award [T32DK007066, KL2TR000139]; Robertson Foundation/Cancer Research Institute Irvington Fellowship; Melanoma Research Alliance; NIH [P50CA174523, R01CA163739, R01CA158186, P30CA016520, U19AI082630, R01AI105343, U01AI095608, P01AI112521]; Basser Research Center for BRCA; NIH/NCI [R01CA172651]; Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer; Institute for Translational Medicine and Therapeutics' Transdisciplinary Program in Translational Medicine and Therapeutics; National Center for Research Resources [UL1RR024134]; NATIONAL CANCER INSTITUTE [P50CA174523, R01CA169123, R01CA158186, R01CA169134, R01CA163739, R01CA172651, P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000139] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, P01AI112521, R01AI105343, U01AI095608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066] Funding Source: NIH RePORTER	NIH training grant and career development award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Foundation/Cancer Research Institute Irvington Fellowship; Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basser Research Center for BRCA; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer; Institute for Translational Medicine and Therapeutics' Transdisciplinary Program in Translational Medicine and Therapeutics; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.T. was supported by an NIH training grant and career development award (T32DK007066, KL2TR000139). K.E.P. was supported by a Robertson Foundation/Cancer Research Institute Irvington Fellowship, T.C.G. and R.R. by the Melanoma Research Alliance, and X.X. and M.D.F by a grant from the NIH (P50CA174523). B.X. and A.J.M. were supported by the Basser Research Center for BRCA. A.J.M. is a Department of Defense Era of Hope Scholar (W81XWH-09-1-0339) and was supported by funding from the NIH/NCI (R01CA172651). H.I. and A.J.M. were supported by a grant from the NIH (R01CA163739). R.H.V. was supported by grants from the NIH (R01CA158186, P30CA016520) and by the Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer. E.J.W. was supported by funding from the NIH (U19AI082630, R01AI105343, U01AI095608 and P01AI112521). The project was supported in part by the Institute for Translational Medicine and Therapeutics' Transdisciplinary Program in Translational Medicine and Therapeutics, and the National Center for Research Resources (UL1RR024134).	Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holets LM, 2006, BIOL REPROD, V74, P352, DOI 10.1095/biolreprod.105.046581; Ishwaran Hemant, 2011, Statistical Analysis and Data Mining, V4, P115, DOI 10.1002/sam.10103; Ishwaran H., 2013, RANDOM FORESTS SURVI; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Rempala GA, 2013, J MATH BIOL, V67, P1339, DOI 10.1007/s00285-012-0589-7; Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thomas N, 2014, BIOINFORMATICS, V30, P3181, DOI 10.1093/bioinformatics/btu523; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	33	1535	1585	20	356	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					373	+		10.1038/nature14292	http://dx.doi.org/10.1038/nature14292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25754329	Green Accepted			2022-12-24	WOS:000352974200044
J	Schechter, MT				Schechter, Martin T.			PERSONAL VIEW Drug users should be able to get heroin from the health system	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; OPIOID DEPENDENCE; PRESCRIBED HEROIN; ORAL METHADONE; ADDICTS; DIACETYLMORPHINE; TRIAL		Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia	Schechter, MT (corresponding author), Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	martin.schechter@ubc.ca		Schechter, Martin/0000-0001-6063-2155				Byford S, 2013, BRIT J PSYCHIAT, V203, P341, DOI 10.1192/bjp.bp.112.111583; Dijkgraaf MGW, 2005, BMJ-BRIT MED J, V330, P1297, DOI 10.1136/bmj.330.7503.1297; Ferri M, 2011, COCHRANE DB SYST REV, V8; Haasen C, 2007, BRIT J PSYCHIAT, V191, P55, DOI 10.1192/bjp.bp.106.026112; March JC, 2006, J SUBST ABUSE TREAT, V31, P203, DOI 10.1016/j.jsat.2006.04.007; Nosyk B, 2012, CAN MED ASSOC J, V184, pE317, DOI 10.1503/cmaj.110669; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; Perneger TV, 1998, BMJ-BRIT MED J, V317, P13, DOI 10.1136/bmj.317.7150.13; Spittal PM, 2006, AIDS CARE, V18, P101, DOI 10.1080/09540120500159292; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310	11	1	1	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2015	350								h1753	10.1136/bmj.h1753	http://dx.doi.org/10.1136/bmj.h1753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG5JL	25873413				2022-12-24	WOS:000353327500002
J	Clarkson, MO; Kasemann, SA; Wood, RA; Lenton, TM; Daines, SJ; Richoz, S; Ohnemueller, F; Meixner, A; Poulton, SW; Tipper, ET				Clarkson, M. O.; Kasemann, S. A.; Wood, R. A.; Lenton, T. M.; Daines, S. J.; Richoz, S.; Ohnemueller, F.; Meixner, A.; Poulton, S. W.; Tipper, E. T.			Ocean acidification and the Permo-Triassic mass extinction	SCIENCE			English	Article							SHALLOW-MARINE CARBONATES; EROSIONAL TRUNCATION; BOUNDARY; GEOCHEMISTRY; SULFUR; FACIES; RECORD	Ocean acidification triggered by Siberian Trap volcanism was a possible kill mechanism for the Permo-Triassic Boundary mass extinction, but direct evidence for an acidification event is lacking. We present a high-resolution seawater pH record across this interval, using boron isotope data combined with a quantitative modeling approach. In the latest Permian, increased ocean alkalinity primed the Earth system with a low level of atmospheric CO2 and a high ocean buffering capacity. The first phase of extinction was coincident with a slow injection of carbon into the atmosphere, and ocean pH remained stable. During the second extinction pulse, however, a rapid and large injection of carbon caused an abrupt acidification event that drove the preferential loss of heavily calcified marine biota.	[Clarkson, M. O.; Wood, R. A.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3FE, Midlothian, Scotland; [Kasemann, S. A.; Ohnemueller, F.; Meixner, A.] Univ Bremen, Fac Geosci, D-28334 Bremen, Germany; [Kasemann, S. A.; Ohnemueller, F.; Meixner, A.] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28334 Bremen, Germany; [Lenton, T. M.; Daines, S. J.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QE, Devon, England; [Richoz, S.] Graz Univ, NAWI Graz, Inst Earth Sci, A-8010 Graz, Austria; [Poulton, S. W.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Tipper, E. T.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Edinburgh; University of Bremen; University of Bremen; University of Exeter; University of Graz; University of Leeds; University of Cambridge	Clarkson, MO (corresponding author), Univ Otago, Dept Chem, Union St,POB 56, Dunedin 9016, New Zealand.	matthew.clarkson@otago.ac.nz	Lenton, Tim M/X-1893-2018; Richoz, Sylvain/D-4079-2009; /AAL-3738-2021	Lenton, Tim M/0000-0002-6725-7498; Richoz, Sylvain/0000-0001-5424-3540; Clarkson, Matthew/0000-0002-2527-4556; Tipper, Edward/0000-0003-3540-3558; Poulton, Simon/0000-0001-7621-189X; Kasemann, Simone Antonia/0000-0002-6913-7748	Edinburgh University Principal's Career Development Scholarship; International Centre for Carbonate Reservoirs; Marsden Fund [U001314]; Natural Environment Research Council [NE/I005978]; Leverhulme Trust [RPG-2013-106]; German Research Foundation (Deutsche Forschungsgemeinschaft) Major Research Instrumentation Program INST [144/307-1]; Austrian National Committee (Austrian Academy of Sciences); NERC [NE/I005978/2, NE/I005978/1, NE/I005935/1, NE/K000705/2, NE/I005862/2] Funding Source: UKRI; Natural Environment Research Council [NE/I005862/2, NE/I005978/2, NE/I005978/1, NE/K000705/2, NE/I005935/1] Funding Source: researchfish	Edinburgh University Principal's Career Development Scholarship; International Centre for Carbonate Reservoirs; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); German Research Foundation (Deutsche Forschungsgemeinschaft) Major Research Instrumentation Program INST(German Research Foundation (DFG)); Austrian National Committee (Austrian Academy of Sciences); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	M.O.C. acknowledges funding from the Edinburgh University Principal's Career Development Scholarship, the International Centre for Carbonate Reservoirs, and The Marsden Fund (U001314). R.A.W., T.M.L., and S.W.P. acknowledge support from the Natural Environment Research Council through the "Co-evolution of Life and the Planet" scheme (NE/I005978). T.M.L. and S.J.D. were supported by the Leverhulme Trust (RPG-2013-106). S.A.K. and A.M. acknowledge support from the German Research Foundation (Deutsche Forschungsgemeinschaft) Major Research Instrumentation Program INST 144/307-1. This is a contribution to IGCP 572, with S.R. sponsored for fieldwork by the Austrian National Committee (Austrian Academy of Sciences) for the International Geoscience Programme (IGCP). We are grateful to R. Newton and A. Thomas for helpful discussions, L. Krystyn for field assistance, F. Maurer for discussions on stratigraphy and providing photomicrographs, and B. Mills for assisting with model studies. Data are available online in the supplementary materials and at www.pangaea.de.	Algeo TJ, 2011, PALAEOGEOGR PALAEOCL, V308, P1, DOI 10.1016/j.palaeo.2011.01.011; Baud A, 2007, GLOBAL PLANET CHANGE, V55, P81, DOI 10.1016/j.gloplacha.2006.06.008; Berner RA, 2002, P NATL ACAD SCI USA, V99, P4172, DOI 10.1073/pnas.032095199; Black BA, 2014, GEOLOGY, V42, P67, DOI 10.1130/G34875.1; Black BA, 2012, EARTH PLANET SC LETT, V317, P363, DOI 10.1016/j.epsl.2011.12.001; Blattler CL, 2011, EARTH PLANET SC LETT, V309, P77, DOI 10.1016/j.epsl.2011.06.029; Broecker WS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1167, DOI 10.1029/1999GB900066; Burgess SD, 2014, P NATL ACAD SCI USA, V111, P3316, DOI 10.1073/pnas.1317692111; Clarkson MO, 2013, GONDWANA RES, V24, P233, DOI 10.1016/j.gr.2012.10.002; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Grice K, 2005, SCIENCE, V307, P706, DOI 10.1126/science.1104323; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Joachimski MM, 2012, GEOLOGY, V40, P195, DOI 10.1130/G32707.1; Joachimski MM, 2005, GEOCHIM COSMOCHIM AC, V69, P4035, DOI 10.1016/j.gca.2004.11.017; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Koehrer B, 2010, GEOARABIA, V15, P91; Korte C, 2004, INT J EARTH SCI, V93, P565, DOI 10.1007/s00531-004-0406-7; Korte C, 2010, J ASIAN EARTH SCI, V39, P215, DOI 10.1016/j.jseaes.2010.01.005; Korte C, 2010, J ASIAN EARTH SCI, V37, P293, DOI 10.1016/j.jseaes.2009.08.012; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; Maurer F, 2009, GEOARABIA, V14, P125; Payne JL, 2007, GEOL SOC AM BULL, V119, P771, DOI 10.1130/B26091.1; Payne JL, 2010, P NATL ACAD SCI USA, V107, P8543, DOI 10.1073/pnas.0914065107; Rampino MR, 2005, TERRA NOVA, V17, P554, DOI 10.1111/j.1365-3121.2005.00648.x; Richoz S, 2010, J ASIAN EARTH SCI, V39, P236, DOI 10.1016/j.jseaes.2009.12.014; Shen SZ, 2013, EARTH PLANET SC LETT, V375, P156, DOI 10.1016/j.epsl.2013.05.020; Song HJ, 2013, NAT GEOSCI, V6, P52, DOI [10.1038/NGEO1649, 10.1038/ngeo1649]; Stampfli GM, 2002, EARTH PLANET SC LETT, V196, P17, DOI 10.1016/S0012-821X(01)00588-X; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Wignall PB, 2009, GEOL SOC AM BULL, V121, P954, DOI 10.1130/B26424.1; Wignall PB, 2002, GEOL SOC AM SPEC PAP, V356, P395, DOI 10.1130/0-8137-2356-6.395; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155; Woods AD, 2014, EARTH-SCI REV, V137, P6, DOI 10.1016/j.earscirev.2013.08.015; Yin HF, 2014, EARTH-SCI REV, V137, P19, DOI 10.1016/j.earscirev.2013.06.003	35	221	232	20	377	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					229	232		10.1126/science.aaa0193	http://dx.doi.org/10.1126/science.aaa0193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859043	Green Accepted, Green Submitted			2022-12-24	WOS:000352613700044
J	Chu, BB; Liao, YC; Qi, W; Xie, C; Du, XM; Wang, J; Yang, HY; Miao, HH; Li, BL; Song, BL				Chu, Bei-Bei; Liao, Ya-Cheng; Qi, Wei; Xie, Chang; Du, Ximing; Wang, Jiang; Yang, Hongyuan; Miao, Hong-Hua; Li, Bo-Liang; Song, Bao-Liang			Cholesterol Transport through Lysosome-Peroxisome Membrane Contacts	CELL			English	Article							SYNAPTOTAGMIN-VII; BILE-ACID; ADRENOLEUKODYSTROPHY; CELLS; GENE; MICE; HOMEOSTASIS; ENDOCYTOSIS; EXOCYTOSIS; PATHWAY	Cholesterol is dynamically transported among organelles, which is essential for multiple cellular functions. However, the mechanism underlying intracellular cholesterol transport has remained largely unknown. We established an amphotericin B-based assay enabling a genome-wide shRNA screen for delayed LDL-cholesterol transport and identified 341 hits with particular enrichment of peroxisome genes, suggesting a previously unappreciated pathway for cholesterol transport. We show dynamic membrane contacts between peroxisome and lysosome, which are mediated by lysosomal Synaptotagmin VII binding to the lipid PI(4,5)P-2 on peroxisomal membrane. LDL-cholesterol enhances such contacts, and cholesterol is transported from lysosome to peroxisome. Disruption of critical peroxisome genes leads to cholesterol accumulation in lysosome. Together, these findings reveal an unexpected role of peroxisome in intracellular cholesterol transport. We further demonstrate massive cholesterol accumulation in human patient cells and mouse model of peroxisomal disorders, suggesting a contribution of abnormal cholesterol accumulation to these diseases.	[Chu, Bei-Bei; Liao, Ya-Cheng; Xie, Chang; Miao, Hong-Hua; Li, Bo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Chu, Bei-Bei; Song, Bao-Liang] Wuhan Univ, Inst Adv Studies, Coll Life Sci, Wuhan 430072, Peoples R China; [Chu, Bei-Bei; Wang, Jiang] Henan Agr Univ, Col Anim Sci & Vet Med, Zhengzhou 4500026, Henan Province, Peoples R China; [Du, Ximing; Yang, Hongyuan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Wuhan University; Henan Agricultural University; University of New South Wales Sydney	Song, BL (corresponding author), Wuhan Univ, Inst Adv Studies, Coll Life Sci, Wuhan 430072, Peoples R China.	blsong@whu.edu.cn	Chu, Beibei/ABD-9819-2021; Xie, Chang/V-7099-2019; Yang, Hongyuan/AAR-1326-2020; Xie, Chang/O-8270-2016	Yang, Hongyuan/0000-0002-8482-6031; Xie, Chang/0000-0002-7643-5321; Song, Bao-Liang/0000-0002-6397-5935; Qi, Wei/0000-0003-0813-5316	National Natural Science Foundation (NNSF) of China [31430044, 31230020, 91413112]; Ministry of Science and Technology (MOST) of China [2011CB910900, 2012CB524900]; Shanghai Science and Technology Committee [13XD1404100]; 10,000 Talents Plan; National Health and Medical Research Council (NHMRC), Australia [APP1041301]	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); 10,000 Talents Plan; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Yu-Xiu Qu, Jie Xu, and Jie Qin for technical assistance. We thank Dr. Dawei Zhang (University of Alberta) for measuring ABCD1 activity, Dr. Fei Sun (Institute of Biophysics, Chinese Academy of Sciences) for helping with EM, Dr. TY Chang (Dartmouth Medical School) for CT43 cells, and Dr. Xiangdong Fu (Wuhan University) for helpful discussion and critical reading the manuscript. This work was supported by the grants from the National Natural Science Foundation (NNSF) of China (31430044, 31230020, and 91413112), the Ministry of Science and Technology (MOST) of China (2011CB910900 and 2012CB524900), Shanghai Science and Technology Committee (13XD1404100) and the 10,000 Talents Plan. X.D. and H.Y. were supported by grant APP1041301 from the National Health and Medical Research Council (NHMRC), Australia. H.Y. is a Senior Research Fellow of the NHMRC.	ANDREOLI TE, 1973, KIDNEY INT, V4, P337, DOI 10.1038/ki.1973.126; Andrews NW, 2005, TRENDS CELL BIOL, V15, P626, DOI 10.1016/j.tcb.2005.09.001; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; Fukuda M, 2001, J BIOL CHEM, V276, P27670, DOI 10.1074/jbc.M100851200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HARDEMAN D, 1990, BIOCHIM BIOPHYS ACTA, V1027, P149, DOI 10.1016/0005-2736(90)90078-3; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Jeynov B, 2006, FEBS LETT, V580, P5917, DOI 10.1016/j.febslet.2006.09.058; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lange Y, 1999, J LIPID RES, V40, P2264; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Moser HW, 2005, JAMA-J AM MED ASSOC, V294, P3131, DOI 10.1001/jama.294.24.3131; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Woudenberg J, 2010, HEPATOLOGY, V52, P623, DOI 10.1002/hep.23684	29	216	228	6	132	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					291	306		10.1016/j.cell.2015.02.019	http://dx.doi.org/10.1016/j.cell.2015.02.019			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860611	Bronze			2022-12-24	WOS:000352708300022
J	Raiborg, C; Wenzel, EM; Pedersen, NM; Olsvik, H; Schink, KO; Schultz, SW; Vietri, M; Nisi, V; Bucci, C; Brech, A; Johansen, T; Stenmark, H				Raiborg, Camilla; Wenzel, Eva M.; Pedersen, Nina M.; Olsvik, Hallvard; Schink, Kay O.; Schultz, Sebastian W.; Vietri, Marina; Nisi, Veronica; Bucci, Cecilia; Brech, Andreas; Johansen, Terje; Stenmark, Harald			Repeated ER-endosome contacts promote endosome translocation and neurite outgrowth	NATURE			English	Article							ENDOPLASMIC-RETICULUM; RAB7 EFFECTOR; PROTEINS; PROTRUDIN; LOCALIZATION; TRANSPORT; SITES; BINDS; PHOSPHOINOSITIDES; CHOLESTEROL	The main organelles of the secretory and endocytic pathways-the endoplasmic reticulum(ER) and endosomes, respectively-are connected through contact sites whose numbers increase as endosomes mature(1-3). One function of such sites is to enable dephosphorylation of the cytosolic tails of endosomal signalling receptors by an ER-associated phosphatase(4), whereas others serve to negatively control the association of endosomes with the minus-end-directed microtubule motor dynein(5) or mediate endosome fission(6). Cholesterol transfer and Ca2+ exchange have been proposed as additional functions of such sites(2,3). However, the compositions, activities and regulations of ER-endosome contact sites remain incompletely understood. Here we show in human and rat cell lines that protrudin, an ER protein that promotes protrusion and neurite outgrowth(7), forms contact sites with late endosomes (LEs) via coincident detection of the small GTPase RAB7 and phosphatidylinositol 3-phosphate (PtdIns(3)P). These contact sites mediate transfer of the microtubule motor kinesin 1 fromprotrudin to the motor adaptor FYCO1 on LEs. Repeated LE-ER contacts promote microtubule-dependent translocation of LEs to the cell periphery and subsequent synaptotagmin-VII-dependent fusion with the plasma membrane. Such fusion induces outgrowth of protrusions and neurites, which requires the abilities of protrudin and FYCO1 to interact with LEs and kinesin 1. Thus, protrudin-containing ER-LE contact sites are platforms for kinesin-1 loading onto LEs, and kinesin-1-mediated translocation of LEs to the plasma membrane, fuelled by repeated ER contacts, promotes protrusion and neurite outgrowth.	[Raiborg, Camilla; Wenzel, Eva M.; Pedersen, Nina M.; Schink, Kay O.; Schultz, Sebastian W.; Vietri, Marina; Brech, Andreas; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0379 Oslo, Norway; [Raiborg, Camilla; Wenzel, Eva M.; Pedersen, Nina M.; Schink, Kay O.; Schultz, Sebastian W.; Vietri, Marina; Brech, Andreas; Stenmark, Harald] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0379 Oslo, Norway; [Olsvik, Hallvard; Johansen, Terje] Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway; [Nisi, Veronica; Bucci, Cecilia] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, I-73100 Lecce, Italy	University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Salento	Raiborg, C (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, N-0379 Oslo, Norway.	camilla.raiborg@rr-research.no; stenmark@ulrik.uio.no	Stenmark, Harald/B-8868-2008; Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021; Bucci, Cecilia/F-6699-2012	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Bucci, Cecilia/0000-0002-6232-6183; Schink, Kay Oliver/0000-0002-5903-4059; Olsvik, Hallvard/0000-0003-3489-7461; Vietri, Marina/0000-0002-5859-322X; Wenzel, Eva Maria/0000-0002-5561-3344; Brech, Andreas/0000-0002-9803-1774	Associazione Italiana per la Ricerca sul Cancro [14709]; Telethon-Italy [GGP09145]; MIUR (PRIN); Norwegian Research Council [196898]; Norwegian Cancer Society [71043-PR-2006-0320]; European Research Council; Research Council of Norway through its Centres of Excellence funding scheme [179571]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); European Research Council(European Research Council (ERC)European Commission); Research Council of Norway through its Centres of Excellence funding scheme	We thank A. Sagona and K.-W. Tan for assistance with plasmid constructs, E. Ronning for yeast two-hybrid analyses and protein purifications, Y. Zhen for advice on RAB7 knockdowns, and A. Engen for expert help with cell cultures. We are grateful to W. Do Heo for providing mCitrine-protrudin and the protrudin(FYVE4A) mutant. The Core Facilities for Advanced Light Microscopy and Electron Microscopy at Oslo University Hospital are acknowledged for providing access to relevant microscopes. C.R. and E.M.W. are senior research fellows of the Norwegian Cancer Society and South-Eastern Norway Regional Health Authority, respectively. C.B. was supported by the Associazione Italiana per la Ricerca sul Cancro (Investigator Grant 14709), Telethon-Italy (grant GGP09145) and MIUR (PRIN2010-2011). T.J. was supported by grant 196898 from the Norwegian Research Council and grant 71043-PR-2006-0320 from the Norwegian Cancer Society. H.S. was supported by grants from the Norwegian Cancer Society and an Advanced Grant from the European Research Council. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; BLACK MM, 1982, J CELL BIOL, V95, P379, DOI 10.1083/jcb.95.2.379; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Catimel B, 2013, J PROTEOMICS, V82, P35, DOI 10.1016/j.jprot.2013.01.031; Chang J, 2013, P NATL ACAD SCI USA, V110, P14954, DOI 10.1073/pnas.1307391110; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Gil JE, 2012, J BIOL CHEM, V287, P41268, DOI 10.1074/jbc.M112.419127; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Honscher C, 2014, CRIT REV BIOCHEM MOL, V49, P262, DOI 10.3109/10409238.2013.875512; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pantakani DVK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029584; Pedersen NM, 2012, TRAFFIC, V13, P1547, DOI 10.1111/j.1600-0854.2012.01400.x; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; van der Kant R, 2014, J CELL SCI, V127, P929, DOI 10.1242/jcs.137539; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang CL, 2012, J CELL BIOCHEM, V113, P2296, DOI 10.1002/jcb.24100	40	255	256	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					234	+		10.1038/nature14359	http://dx.doi.org/10.1038/nature14359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25855459				2022-12-24	WOS:000352454600042
J	Baltimore, D; Berg, P; Botchan, M; Carroll, D; Charo, RA; Church, G; Corn, JE; Daley, GQ; Doudna, JA; Fenner, M; Greely, HT; Jinek, M; Martin, GS; Penhoet, E; Puck, J; Sternberg, SH; Weissman, JS; Yamamoto, KR				Baltimore, David; Berg, Paul; Botchan, Michael; Carroll, Dana; Charo, R. Alta; Church, George; Corn, Jacob E.; Daley, George Q.; Doudna, Jennifer A.; Fenner, Marsha; Greely, Henry T.; Jinek, Martin; Martin, G. Steven; Penhoet, Edward; Puck, Jennifer; Sternberg, Samuel H.; Weissman, Jonathan S.; Yamamoto, Keith R.			A prudent path forward for genomic engineering and germline gene modification	SCIENCE			English	Editorial Material							GENERATION		[Baltimore, David] CALTECH, Pasadena, CA 91125 USA; [Berg, Paul] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Botchan, Michael] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Botchan, Michael; Corn, Jacob E.; Doudna, Jennifer A.; Fenner, Marsha; Weissman, Jonathan S.; Yamamoto, Keith R.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Carroll, Dana] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Charo, R. Alta] Univ Wisconsin, Sch Law, Sch Med & Publ Hlth, Dept Med Hist & Bioeth, Madison, WI 53706 USA; [Church, George] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Daley, George Q.] Boston Childrens Hosp, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Greely, Henry T.] Ctr Law & Biosci, Stanford, CA 94305 USA; [Jinek, Martin] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Martin, G. Steven] Univ Calif Berkeley, Coll Letters & Sci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Penhoet, Edward] Alta Partners, Embarcadero Ctr 1, San Francisco, CA 94111 USA; [Puck, Jennifer] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Sternberg, Samuel H.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Yamamoto, Keith R.] UCSF Sch Med, San Francisco, CA 94158 USA	California Institute of Technology; Stanford University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Zurich; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Berg, P (corresponding author), Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA.	doudna@berkeley.edu	Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X; Weissman, Jonathan/0000-0003-2445-670X; Sternberg, Samuel/0000-0001-8240-9114; church, george/0000-0001-6232-9969; Charo, Robin Alta/0000-0003-3710-1043	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [P50 HG005550] Funding Source: Medline; NIGMS NIH HHS [T32 GM066698, R01 GM078571] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2015, IGI FOR BIOETH NAP C; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; U.S. Food and Drug Administration, CELL TISS GEN THER A; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8	9	413	431	6	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					36	38		10.1126/science.aab1028	http://dx.doi.org/10.1126/science.aab1028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25791083	Green Accepted			2022-12-24	WOS:000352079500016
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Diabetes team award	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2015	350									10.1136/bmj.h1553	http://dx.doi.org/10.1136/bmj.h1553			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OC	25812978				2022-12-24	WOS:000352030200008
J	Karimi-Shah, BA; Chowdhury, BA				Karimi-Shah, Banu A.; Chowdhury, Badrul A.			Forced Vital Capacity in Idiopathic Pulmonary Fibrosis - FDA Review of Pirfenidone and Nintedanib	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Karimi-Shah, Banu A.; Chowdhury, Badrul A.] US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Karimi-Shah, BA (corresponding author), US FDA, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; FDA, DRUGS FDA FDA APPR D; Karimi-Shah BA, 2010, PULM ALL DRUGS ADV C; Raghu G, 2012, AM J RESP CRIT CARE, V185, P1044, DOI 10.1164/rccm.201201-0006PP	4	184	187	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2015	372	13					1189	1191		10.1056/NEJMp1500526	http://dx.doi.org/10.1056/NEJMp1500526			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1QD	25806913				2022-12-24	WOS:000351585900004
J	Lee, DI; Zhu, GS; Sasaki, T; Cho, GS; Hamdani, N; Holewinski, R; Jo, SH; Danner, T; Zhang, ML; Rainer, PP; Bedja, D; Kirk, JA; Ranek, MJ; Dostmann, WR; Kwon, C; Margulies, KB; Van Eyk, JE; Paulus, WJ; Takimoto, E; Kass, DA				Lee, Dong I.; Zhu, Guangshuo; Sasaki, Takashi; Cho, Gun-Sik; Hamdani, Nazha; Holewinski, Ronald; Jo, Su-Hyun; Danner, Thomas; Zhang, Manling; Rainer, Peter P.; Bedja, Djahida; Kirk, Jonathan A.; Ranek, Mark J.; Dostmann, Wolfgang R.; Kwon, Chulan; Margulies, Kenneth B.; Van Eyk, Jennifer E.; Paulus, Walter J.; Takimoto, Eiki; Kass, David A.			Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease	NATURE			English	Article							PRESERVED EJECTION FRACTION; NATRIURETIC PEPTIDES; CYCLIC-GMP; INHIBITION; FAILURE; DELETION	Cyclic guanosine monophosphate (cGMP) is a second messenger molecule that transduces nitric-oxide-and natriuretic-peptide-coupled signalling, stimulating phosphorylation changes by protein kinase G. Enhancing cGMP synthesis or blocking its degradation by phosphodiesterase type 5A (PDE5A) protects against cardiovascular disease(1,2). However, cGMP stimulation alone is limited by counter-adaptions including PDE upregulation(3). Furthermore, although PDE5A regulates nitric-oxide-generated cGMP(4,5), nitric oxide signalling is often depressed by heart disease(6). PDEs controlling natriuretic-peptide-coupled cGMP remain uncertain. Here we show that cGMP-selective PDE9A (refs 7, 8) is expressed in the mammalian heart, including humans, and is upregulated by hypertrophy and cardiac failure. PDE9A regulates natriuretic-peptide-rather than nitric-oxide-stimulated cGMP in heart myocytes and muscle, and its genetic or selective pharmacological inhibition protects against pathological responses to neurohormones, and sustained pressure-overload stress. PDE9A inhibition reverses pre-established heart disease independent of nitric oxide synthase (NOS) activity, whereas PDE5A inhibition requires active NOS. Transcription factor activation and phosphoproteome analyses of myocytes with each PDE selectively inhibited reveals substantial differential targeting, with phosphorylation changes from PDE5A inhibition being more sensitive to NOS activation. Thus, unlike PDE5A, PDE9A can regulate cGMP signalling independent of the nitric oxide pathway, and its role in stress-induced heart disease suggests potential as a therapeutic target.	[Lee, Dong I.; Zhu, Guangshuo; Cho, Gun-Sik; Holewinski, Ronald; Danner, Thomas; Zhang, Manling; Rainer, Peter P.; Bedja, Djahida; Kirk, Jonathan A.; Ranek, Mark J.; Kwon, Chulan; Van Eyk, Jennifer E.; Takimoto, Eiki; Kass, David A.] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Sasaki, Takashi] Mitsubishi Tanabe Pharma Corp, Div Res, Adv Med Res Labs, Yokohama, Kanagawa 2270033, Japan; [Hamdani, Nazha; Paulus, Walter J.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Physiol, NL-1081 BT Amsterdam, Netherlands; [Holewinski, Ronald; Van Eyk, Jennifer E.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Holewinski, Ronald; Van Eyk, Jennifer E.] Cedars Sinai Med Ctr, Adv Clin Biosyst Res Inst, Los Angeles, CA 90048 USA; [Jo, Su-Hyun] Kangwon Natl Univ, Inst Biosci & Biotechnol, Plus Grad Program BK21, Dept Physiol,Coll Med, Chunchon 200701, South Korea; [Dostmann, Wolfgang R.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Margulies, Kenneth B.] Univ Penn, Dept Med, Perelman Sch Med, Div Cardiovasc Med,Cardiovasc Inst, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Mitsubishi Tanabe Pharma Corporation; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Kangwon National University; University of Vermont; University of Pennsylvania; Pennsylvania Medicine	Kass, DA (corresponding author), Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	dkass@jhmi.edu	Kirk, Jonathan/N-3878-2019; Takimoto, Eiki/AAC-5100-2021; Ranek, Mark/GYA-1420-2022; Kirk, Jonathan A/Q-2522-2015; Rainer, Peter P/M-2145-2016	Kirk, Jonathan/0000-0002-5192-2860; Kirk, Jonathan A/0000-0002-5192-2860; Rainer, Peter P/0000-0002-2840-6454	National Institutes of Health (NIH) [HL-119012, HL-089297, HL-07227]; Fondation Leducq TransAtlantic Network of Excellence; Peter Belfer Foundation; Abraham and Virginia Weiss Professorship; American Heart Association; Austrian Academy of Sciences; National Institutes of Health [HL089847, HL105993]; European Commission [261409]; Johns Hopkins Innovation Proteomics Center in Heart Failure [NHLBI-HV-10-05 (2), HHSN268201000032C]; NIH [HL68891]; Totman Trust for Biomedical Research;  [HL-093432]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093432, R01HL111198, T32HL007227, R01HL089847, R01HL105993, P01HL107153, R01HL119012, R01HL089297, R01HL068891] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq TransAtlantic Network of Excellence(Leducq Foundation); Peter Belfer Foundation; Abraham and Virginia Weiss Professorship; American Heart Association(American Heart Association); Austrian Academy of Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Johns Hopkins Innovation Proteomics Center in Heart Failure; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Totman Trust for Biomedical Research; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank students R. D. Wardlow and X. Hu for their assistance with some of the assays and studies. This research was supported by: the National Institutes of Health (NIH) (HL-119012, HL-089297, HL-07227), Fondation Leducq TransAtlantic Network of Excellence, The Peter Belfer Foundation, Abraham and Virginia Weiss Professorship (D.A.K.); HL-093432 (E.T.), American Heart Association (D.I.L.) and Max Kade Fellowship of the Austrian Academy of Sciences (P.P.R). Procurement of human heart tissue was enabled by grants from the National Institutes of Health (HL089847 and HL105993) to K.B.M. N.H. and W.J.P. were supported by the European Commission FP7 project 2010 Health (MEDIA; 261409). R.H. and J.E.V.E. were supported by The Johns Hopkins Innovation Proteomics Center in Heart Failure (NHLBI-HV-10-05 (2) and HHSN268201000032C). W.R.D. was supported by NIH grant HL68891 and the Totman Trust for Biomedical Research. We thank Pfizer and in particular C. Schmidt and R. Kleiman for providing the Pde9a<SUP>-/-</SUP> mouse and PF-04449613, and L. Jaffe at the University of Connecticut Health Center for providing the PDE9A antibody.	Carnicer R, 2013, ANTIOXID REDOX SIGN, V18, P1078, DOI 10.1089/ars.2012.4824; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Greene SJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000536; Heckman PRA, 2015, CURR PHARM DESIGN, V21, P317; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Kirk JA, 2014, J CLIN INVEST, V124, P129, DOI 10.1172/JCI69253; Kleiman RJ, 2012, J PHARMACOL EXP THER, V341, P396, DOI 10.1124/jpet.111.191353; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kukreja RC, 2012, J AM COLL CARDIOL, V59, P1921, DOI 10.1016/j.jacc.2011.09.086; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mullershausen F, 2004, MOL BIOL CELL, V15, P4023, DOI 10.1091/mbc.E03-12-0890; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Sharma K, 2014, CIRC RES, V115, P79, DOI 10.1161/CIRCRESAHA.115.302922; Singh G, 2006, CIRC RES, V99, P183, DOI 10.1161/01.RES.0000232322.06633.d3; Soderling SH, 1998, J BIOL CHEM, V273, P15553, DOI 10.1074/jbc.273.25.15553; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2007, CIRCULATION, V115, P2159, DOI 10.1161/CIRCULATIONAHA.106.643536; van Heerebeek L, 2012, CIRCULATION, V126, P830, DOI 10.1161/CIRCULATIONAHA.111.076075; Verhoest PR, 2012, J MED CHEM, V55, P9045, DOI 10.1021/jm3007799; Zakeri R, 2011, CAN J PHYSIOL PHARM, V89, P593, DOI [10.1139/Y11-048, 10.1139/y11-048]; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	30	222	232	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					472	+		10.1038/nature14332	http://dx.doi.org/10.1038/nature14332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799991	Green Accepted			2022-12-24	WOS:000351602800056
J	Gluckman, P; Nishtar, S; Armstrong, T				Gluckman, Peter; Nishtar, Sania; Armstrong, Timothy			Ending childhood obesity: a multidimensional challenge	LANCET			English	Editorial Material									[Gluckman, Peter] Off Prime Ministers Chief Sci Advisor, Auckland 1150, New Zealand; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Armstrong, Timothy] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Gluckman, P (corresponding author), Off Prime Ministers Chief Sci Advisor, Auckland 1150, New Zealand.	peter.gluckman@pmcsa.org.nz			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Lobstein T, 2015, LANCET; WHO, 2010, GLOB STAT REP NONC D; WHO Commission on Ending Childhood Obesity, 2015, INT REP COMM END CHI; World Health Organization, 2014, WORLD HLTH STAT 2014	4	27	29	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1048	1050		10.1016/S0140-6736(15)60509-8	http://dx.doi.org/10.1016/S0140-6736(15)60509-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD7KX	25797547				2022-12-24	WOS:000351270400006
J	Wang, XC; Gong, W; Fang, LZ; Zhu, RY; Li, SH; Engle, KM; Yu, JQ				Wang, Xiao-Chen; Gong, Wei; Fang, Li-Zhen; Zhu, Ru-Yi; Li, Suhua; Engle, Keary M.; Yu, Jin-Quan			Ligand-enabled meta-C-H activation using a transient mediator	NATURE			English	Article							U-SHAPED TEMPLATE; ASYMMETRIC-SYNTHESIS; BOND ACTIVATION; PALLADIUM; ARYLATION; OLEFINATION; FUNCTIONALIZATION; 2-ALKYLATION; ALKYLATION; C(SP(3))-H	Achieving site selectivity in C-H functionalization reactions is a significant challenge, especially when the target C-H bond is distant from existing functional groups(1-5). Coordination of a functional group to a metal is often a key driving force and control element in many important reactions including asymmetric hydrogenation(6), epoxidation(7,8) and lithiation(9). Exploitation of this effect has led to the development of a broad range of directed C-H activation reactions(10-14). However, these C-H activation methods are limited to proximal C-H bonds, which are spatially and geometrically accessible from the directing functional group. The development of meta-selective C-H functionalizations remains a significant challenges(1-5,15-17). We recently developed a U-shaped template that can be used to overcome this constraint and have shown that it can be used to selectively activate remote meta-C-H bonds(1,2). Although this approach has proved to be applicable to various substrates and catalytic transformations(3-5), the need for a covalently attached, complex template is a substantial drawback for synthetic applications. Here we report an alternative approach employing norbornene as a transient mediator to achieve meta-selective C-H activation with a simple and common orthodirecting group. The use of a newly developed pyridine-based ligand is crucial for relaying the palladium catalyst to the meta position by norbornene after initial ortho-C-H activation. This catalytic reaction demonstrates the feasibility of switching ortho-selectivity to metaselectivity in C-H activation of the same substrate by catalyst control.	[Wang, Xiao-Chen; Gong, Wei; Fang, Li-Zhen; Zhu, Ru-Yi; Li, Suhua; Engle, Keary M.; Yu, Jin-Quan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Zhu, Ruyi/AAO-4630-2021; Engle, Keary/A-9223-2015	Engle, Keary/0000-0003-2767-6556	Scripps Research Institute; National Institutes of Health (NIGMS) [1R01 GM102265]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102265] Funding Source: NIH RePORTER	Scripps Research Institute; National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Spangler and A. Homs for constructive suggestions. We thank the Scripps Research Institute and the National Institutes of Health (NIGMS, 1R01 GM102265) for financial support. L.-Z.F. is a visiting scholar from School of Pharmacy, Xinxiang Medical University and is sponsored by the China Scholarship Council.	BROWN JM, 1993, CHEM SOC REV, V22, P25, DOI 10.1039/cs9932200025; Cardenas DJ, 2006, J AM CHEM SOC, V128, P5033, DOI 10.1021/ja056661j; Catellani M, 1996, SYNTHESIS-STUTTGART, P769; Catellani M, 1997, ANGEW CHEM INT EDIT, V36, P119, DOI 10.1002/anie.199701191; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Dong Z, 2013, J AM CHEM SOC, V135, P18350, DOI 10.1021/ja410823e; Duong HA, 2011, ANGEW CHEM INT EDIT, V50, P463, DOI 10.1002/anie.201004704; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Faccini F, 2004, J AM CHEM SOC, V126, P78, DOI 10.1021/ja039043g; Hartung C. G., 2004, MODERN ARENE CHEM, P330, DOI DOI 10.1002/3527601767.CH10; He J, 2014, SCIENCE, V343, P1216, DOI 10.1126/science.1249198; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Jiao L, 2012, J AM CHEM SOC, V134, P14563, DOI 10.1021/ja3058138; Jiao L, 2011, J AM CHEM SOC, V133, P12990, DOI 10.1021/ja2055066; Lee S, 2013, J AM CHEM SOC, V135, P18778, DOI 10.1021/ja4107034; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Li SH, 2014, J AM CHEM SOC, V136, P5267, DOI 10.1021/ja501689j; Li Z, 2013, ACCOUNTS CHEM RES, V46, P506, DOI 10.1021/ar300216r; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Martins A, 2010, ORG LETT, V12, P5186, DOI 10.1021/ol1019037; Martins A, 2010, TOP CURR CHEM, V292, P1, DOI 10.1007/128_2009_13; Ojima, 2005, CATALYTIC ASYMMETRIC, P231; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Tang RY, 2014, NATURE, V507, P215, DOI 10.1038/nature12963; Wan L, 2013, J AM CHEM SOC, V135, P18056, DOI 10.1021/ja410760f; Wang XC, 2013, J AM CHEM SOC, V135, P10326, DOI 10.1021/ja4055492; Wencel-Delord J, 2011, CHEM SOC REV, V40, P4740, DOI 10.1039/c1cs15083a; Yang GQ, 2014, J AM CHEM SOC, V136, P10807, DOI 10.1021/ja505737x; Zhu RY, 2014, J AM CHEM SOC, V136, P13194, DOI 10.1021/ja508165a	30	389	391	17	374	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					334	338		10.1038/nature14214	http://dx.doi.org/10.1038/nature14214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25754328	Green Accepted			2022-12-24	WOS:000351171900037
J	Alper, BS; Malone-Moses, M; McLellan, JS; Prasad, K; Manheimer, E				Alper, Brian S.; Malone-Moses, Meghan; McLellan, James S.; Prasad, Kameshwar; Manheimer, Eric			Thrombolysis in acute ischaemic stroke: time for a rethink?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; POOLED ANALYSIS; ALTEPLASE; TRIAL; GUIDELINES; ATLANTIS; THERAPY; TREAT; NINDS; ECASS		[Alper, Brian S.; Malone-Moses, Meghan; McLellan, James S.] EBSCO Hlth, EBSCO Informat Serv, DynaMed, Ipswich, MA 01938 USA; [Prasad, Kameshwar] All India Inst Med Sci, Dept Neurol, New Delhi, India; [Manheimer, Eric] Cochrane Collaborat, Bahrain Branch, Awali, Bahrain	All India Institute of Medical Sciences (AIIMS) New Delhi	Alper, BS (corresponding author), EBSCO Hlth, EBSCO Informat Serv, DynaMed, Ipswich, MA 01938 USA.	balper@EBSCO.com						Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Altman Douglas G, 2002, BMC Med Res Methodol, V2, P3, DOI 10.1186/1471-2288-2-3; American Academy of Emergency Medicine Work Group on Thrombolytic Therapy in Stroke, 2002, POS STAT US INTR THR; American College of Emergency Physicians, 2013, Ann Emerg Med, V61, P225, DOI 10.1016/j.annemergmed.2012.11.005; American College of Emergency Physicians, 2015, CLIN POL US INTR TPA; Australasian College for Emergency Medicine, 2014, STAT INTR THROMB ISC; Australian Government Department of Health Therapeutic goods administration, PROD CONS MED INF AC; Bryer Alan, 2010, S Afr Med J, V100, P747; Canadian Association of Emergency Physicians, 2014, POS STAT AC ISCH STR; Canadian Association of Emergency Physicians Committee on Thrombolytic Therapy for Acute Ischemic Stroke, THROMB THER AC ISCH; Electronic Medicines Compendium, SUMM PROD CHAR ACT; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Genentech, ACT ALT; Gilhus NE, 2011, EUROPEAN HDB NEUROLO, V1, P101; Hacke W, 2004, LANCET, V363, P768; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Haute Autorite de Sante, 2009, TREATING TOBACCO USE; Hudson I, 2014, LANCET, V384, P662, DOI 10.1016/S0140-6736(14)61388-X; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Lansberg MG, 2012, CHEST, V141, pE601S, DOI 10.1378/chest.11-2302; Lees Kennedy R, 2010, Lancet, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lindsay MP, 2013, CANADIAN BEST PRACTI; Minematsu K, 2013, J STROKE CEREBROVASC, V22, P571, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.001; National Institute for Health and Care Excellence, 2012, REV TECHN APPR GUID; National Stroke Foundation, 2010, CLIN GUID STROK MAN; New Zealand Faculty of the Australasian College for Emergency Medicine, 2013, CONS STAT THROMB AC; Newcombe RG, 1999, STAT MED, V18, P1293, DOI 10.1002/(SICI)1097-0258(19990530)18:10<1293::AID-SIM175>3.0.CO;2-7; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sandercock P, 2012, INT J STROKE, V7, P186, DOI 10.1111/j.1747-4949.2012.00782.x; Shy BD, 2014, J EMERG MED, V46, P385, DOI 10.1016/j.jemermed.2012.05.014; Stroke Thrombolysis Trialists' Collaborative Group, 2013, STROKE, V8, P278; van Zuuren EJ, J EVID BASE IN PRESS; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Xu AD, 2013, CNS NEUROSCI THER, V19, P543, DOI 10.1111/cns.12126	35	38	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2015	350								h1075	10.1136/bmj.h1075	http://dx.doi.org/10.1136/bmj.h1075			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KO	25786912				2022-12-24	WOS:000351570700002
J	Najafzadeh, M; Andersson, K; Shrank, WH; Krumme, AA; Matlin, OS; Brennan, T; Avorn, J; Choudhry, NK				Najafzadeh, Mehdi; Andersson, Karin; Shrank, William H.; Krumme, Alexis A.; Matlin, Olga S.; Brennan, Troyen; Avorn, Jerry; Choudhry, Niteesh K.			Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus	ANNALS OF INTERNAL MEDICINE			English	Article							DISCRETE-EVENT SIMULATION; ACTING ANTIVIRAL THERAPY; TREATMENT-NAIVE PATIENTS; GENOTYPE 1 INFECTION; CHRONIC HCV; UNITED-STATES; FIBROSIS PROGRESSION; PLUS SOFOSBUVIR; ALCOHOL-USE; RIBAVIRIN	Background: New regimens for hepatitis C virus (HCV) have shorter treatment durations and increased rates of sustained virologic response compared with existing therapies but are extremely expensive. Objective: To evaluate the cost-effectiveness of these treatments under different assumptions about their price and efficacy. Design: Discrete-event simulation. Data Sources: Published literature. Target Population: Treatment-naive patents infected with chronic HCV genotype 1, 2, or 3. Time Horizon: Lifetime. Perspective: Societal. Intervention: Usual care (boceprevir-ribavirin-pegylated interferon [PEG]) was compared with sofosbuvir-ribavirin-PEG and 3 PEG-free regimens: sofosbuvir-simeprevir, sofosbuvir-daclatasvir, and sofosbuvir-ledipasvir. For genotypes 2 and 3, usual care (ribavirin-PEG) was compared with sofosbuvir-ribavirin, sofosbuvir-daclatasvir, and sofosbuvir-ledipasvir-ribavirin (genotype 3 only). Outcome Measures: Discounted costs (in 2014 U.S. dollars), quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Assuming sofosbuvir, simeprevir, daclatasvir, and ledipasvir cost $7000, $5500, $5500, and $875 per week, respectively, sofosbuvir-ledipasvir was cost-effective for genotype 1 and cost $12 825 more per OALY than usual care. For genotype 2, sofosbuvir-ribavirin and sofosbuvir-daclatasvir cost $110000 and $691 000 per QALY, respectively. For genotype 3, sofosbuvir-ledipasvir-ribavirin cost $73 000 per QALY, sofosbuvir-ribavirin was more costly and less effective than usual care, and sofosbuvir-daclatasvir cost more than $396 000 per QALY at assumed prices. Results of Sensitivity Analysis: Sofosbuvir-ledipasvir was the optimal strategy in most simulations for genotype 1 and would be cost-saving if sofosbuvir cost less than $5500. For genotype 2, sofosbuvir-ribavirin-PEG would be cost-saving if sofosbuvir cost less than $2250 per week. For genotype 3, sofosbuvir-ledipasvir-ribavirin would be cost-saving if sofosbuvir cost less than $1500 per week. Limitation: Data are lacking on real-world effectiveness of new treatments and some prices. Conclusion: From a societal perspective, novel treatments for HCV are cost-effective compared with usual care for genotype 1 and probably genotype 3 but not for genotype 2.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; CVS Hlth, Woonsocket, RI USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Choudhry, NK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	mnajafzadeh@partners.org; nchoudhry@partners.org		Andersson, Karin/0000-0002-8497-1335	CVS Health	CVS Health	CVS Health.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Anand BS, 2006, GASTROENTEROLOGY, V130, P1607, DOI 10.1053/j.gastro.2006.02.023; [Anonymous], 2014, FDA APPR VIEK PAK TR; [Anonymous], 2014, GIL ANN PHAS 2 RES 2; Arias E., 2012, NATL VITAL STAT REPO, V61; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BLS, 2014, CPI INFL CALC; Brennan T, 2014, JAMA-J AM MED ASSOC, V312, P593, DOI 10.1001/jama.2014.8897; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; Caro JJ, 2010, VALUE HEALTH, V13, P1056, DOI 10.1111/j.1524-4733.2010.00775.x; Chan K, 2013, CLIN GASTROENTEROL H, V11, P1503, DOI 10.1016/j.cgh.2013.05.014; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Ferrante SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-190; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gold MR, 1996, COST EFFECTIVENESS H; Gordon SC, 2012, HEPATOLOGY, V56, P1651, DOI 10.1002/hep.25842; Holmes JA, 2012, J VIRAL HEPATITIS, V19, P677, DOI 10.1111/jvh.12003; Jacobson I., 2013, 64 ANN M AM ASS STUD; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Karnon J, 2012, MED DECIS MAKING, V32, P701, DOI 10.1177/0272989X12455462; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; McCombs JS, 2011, CLIN THER, V33, P1268, DOI 10.1016/j.clinthera.2011.07.008; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Owens GM., 2014, AM J MANAG CARE; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Russell M, 2012, HEPATOLOGY, V56, P1223, DOI 10.1002/hep.25755; Ryan B., 2014, HEP MAGAZINE    1010; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Solomon M, 2011, DIGEST DIS SCI, V56, P3024, DOI 10.1007/s10620-011-1802-z; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Yee HS, 2012, AM J GASTROENTEROL, V107, P669, DOI 10.1038/ajg.2012.48; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	52	171	174	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					407	U136		10.7326/M14-1152	http://dx.doi.org/10.7326/M14-1152			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775313				2022-12-24	WOS:000351279600014
J	Maxwell, SL; Milner-Gulland, EJ; Jones, JPG; Knight, AT; Bunnefeld, N; Nuno, A; Bal, P; Earle, S; Watson, JEM; Rhodes, JR				Maxwell, S. L.; Milner-Gulland, E. J.; Jones, J. P. G.; Knight, A. T.; Bunnefeld, N.; Nuno, A.; Bal, P.; Earle, S.; Watson, J. E. M.; Rhodes, J. R.			Being smart about SMART environmental targets	SCIENCE			English	Editorial Material									[Maxwell, S. L.; Bal, P.; Watson, J. E. M.; Rhodes, J. R.] Univ Queensland, Sch Geog Planning & Environm Management, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia; [Milner-Gulland, E. J.; Knight, A. T.; Earle, S.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Jones, J. P. G.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor LL57 2DG, Gwynedd, Wales; [Bunnefeld, N.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Nuno, A.] Univ Exeter, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England; [Watson, J. E. M.] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY 10460 USA	University of Queensland; Imperial College London; Bangor University; University of Stirling; University of Exeter; Wildlife Conservation Society	Maxwell, SL (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia.	smaxwell@uq.edu.au	Knight, Andrew Thomas/C-8394-2009; Jones, Julia P G/A-3031-2011; Watson, James Edward Maxwell/D-8779-2013; Jones, Julia P G/ABD-5629-2021; Nuno, Ana/H-9497-2019; Rhodes, Jonathan/C-4841-2008	Knight, Andrew Thomas/0000-0002-6563-0500; Jones, Julia P G/0000-0002-5199-3335; Watson, James Edward Maxwell/0000-0003-4942-1984; Jones, Julia P G/0000-0002-5199-3335; Bunnefeld, Nils/0000-0002-1349-4463; Rhodes, Jonathan/0000-0001-6746-7412; Bal, Payal/0000-0002-8759-6964; Nuno, Ana/0000-0003-4680-2378				Bull JW, 2014, BIOL CONSERV, V178, P2, DOI 10.1016/j.biocon.2014.07.006; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Campbell LM, 2014, GLOBAL ENVIRON POLIT, V14, P41, DOI 10.1162/GLEP_a_00238; Daniels S.E., 2001, WORKING ENV CONFLICT; Dubash NK, 2014, SCIENCE, V345, P36, DOI 10.1126/science.1255734; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Pouwels R, 2011, ECOL SOC, V16, DOI 10.5751/ES-04191-160417; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; SKJAERSETH JB, 1992, GLOBAL ENVIRON CHANG, V2, P292, DOI 10.1016/0959-3780(92)90046-A; Smead R, 2014, NAT CLIM CHANGE, V4, P442, DOI [10.1038/NCLIMATE2229, 10.1038/nclimate2229]; Stafford-Smith M, 2014, NATURE, V513, P281, DOI 10.1038/513281a; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484	13	63	64	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1075	1076		10.1126/science.aaa1451	http://dx.doi.org/10.1126/science.aaa1451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4WB	25745152				2022-12-24	WOS:000350354200024
J	Wang, Q				Wang, Qiang			China's scientists must engage the public on GM	NATURE			English	Editorial Material									Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	qiangwang7@outlook.com	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093					0	22	22	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					7	7		10.1038/519007a	http://dx.doi.org/10.1038/519007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC4EQ	25739594	Bronze			2022-12-24	WOS:000350304000004
J	Agenor, M; Peitzmeier, S; Gordon, AR; Haneuse, S; Potter, JE; Austin, SB				Agenor, Madina; Peitzmeier, Sarah; Gordon, Allegra R.; Haneuse, Sebastien; Potter, Jennifer E.; Austin, S. Bryn			Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine Among US Women and Girls A National Survey	ANNALS OF INTERNAL MEDICINE			English	Article							GENITAL HUMAN-PAPILLOMAVIRUS; LESBIAN HEALTH; SAME-SEX; TRANSMITTED INFECTIONS; HPV VACCINATION; CANCER; RISK; ADOLESCENT; BEHAVIORS; INSURANCE	Background: Lesbians and bisexual women are at risk for human papillomavirus (HPV) infection from female and male sexual partners. Objective: To examine the association between sexual orientation identity and HPV vaccination among U.S. women and girls. Design: Cross-sectional, using 2006-2010 National Survey of Family Growth data. Setting: U.S.civilian noninstitutionalized population. Participants: The 2006-2010 National Survey of Family Growth used stratified cluster sampling to establish a national probability sample of 12 279 U.S. women and girls aged 15 to 44 years. Analyses were restricted to 3253 women and girls aged 15 to 25 years who were asked about HPV vaccination. Measurements: Multivariable logistic regression was used to obtain prevalence estimates of HPV vaccine awareness and initiation adjusted for sociodemographic and health care factors for each sexual orientation identity group. Results: Among U.S. women and girls aged 15 to 25 years, 84.4% reported having heard of the HPV vaccine; of these, 28.5% had initiated HPV vaccination. The adjusted prevalence of vaccine awareness was similar among heterosexual, bisexual, and lesbian respondents. After adjustment for covariates, 8.5% (P = 0.007) of lesbians and 33.2% (P = 0.33) of bisexual women and girls who had heard of the vaccine had initiated vaccination compared with 28.4% of their heterosexual counterparts. Limitation: Self-reported, cross-sectional data, and findings may not be generalizable to periods after 2006 to 2010 or all U. S. lesbians aged 15 to 25 years (because of the small sample size for this group). Conclusion: Adolescent and young adult lesbians may be less likely to initiate HPV vaccination than their heterosexual counterparts. Programs should facilitate access to HPV vaccination services among young lesbians.	Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dana Farber Canc Inst, Fenway Hlth,Beth Israel Deaconess Med Ctr,Med Sch, Boston, MA 02115 USA; Boston Childrens Hosp, Boston, MA USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Agenor, M (corresponding author), Harvard Univ, Dept Social & Behav Sci, TH Chan Sch Publ Hlth, Kresge Bldg,7th Floor,677 Huntington Ave, Boston, MA 02115 USA.	magenor@mail.harvard.edu		Peitzmeier, Sarah/0000-0003-4552-1099	National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA075308, R25CA057711] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute.	Aaron DJ, 2001, AM J PUBLIC HEALTH, V91, P972, DOI 10.2105/AJPH.91.6.972; Agenor M, 2014, AM J PUBLIC HEALTH, V104, pE68, DOI 10.2105/AJPH.2013.301548; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Bauer GR, 2001, AM J PUBLIC HEALTH, V91, P1282, DOI 10.2105/AJPH.91.8.1282; Bednarczyk RA, 2011, VACCINE, V29, P3138, DOI 10.1016/j.vaccine.2011.02.045; Ben-Natan M, 2014, INT J STD AIDS, V25, P800, DOI 10.1177/0956462414521167; Boehmer U, 2007, AM J PUBLIC HEALTH, V97, P1134, DOI 10.2105/AJPH.2006.088419; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Buchmueller T, 2010, AM J PUBLIC HEALTH, V100, P489, DOI 10.2105/AJPH.2009.160804; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carroll N, 1997, J GAY LESBIAN MED AS, V1, P15, DOI DOI 10.1023/B:JOLA.0000007008.17392.2D; Caskey R, 2009, J ADOLESCENT HEALTH, V45, P453, DOI 10.1016/j.jadohealth.2009.04.021; Charlton BM, 2011, J ADOLESCENT HEALTH, V49, P505, DOI 10.1016/j.jadohealth.2011.03.013; Clark MA, 2003, WOMEN HEALTH, V38, P19, DOI 10.1300/J013v38n02_02; Cochran SD, 2001, AM J PUBLIC HEALTH, V91, P591, DOI 10.2105/AJPH.91.4.591; Cochran SD, 2013, AM J PUBLIC HEALTH, V103, P1837, DOI 10.2105/AJPH.2013.301423; Committee on Infectious Diseases, 2012, Pediatrics, V129, P602, DOI 10.1542/peds.2011-3865; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Diamant AL, 1999, ARCH INTERN MED, V159, P2730, DOI 10.1001/archinte.159.22.2730; Diamant AL, 2000, ARCH FAM MED, V9, P1043, DOI 10.1001/archfami.9.10.1043; Eliason MJ., 2001, J GAY LESBIAN MED AS, V5, P125, DOI [DOI 10.1023/A:1014257910462, 10.1023/A:1014257910462]; Everett BG, 2013, ARCH SEX BEHAV, V42, P225, DOI 10.1007/s10508-012-9902-1; Ferris DG, 1996, J FAM PRACTICE, V43, P581; Fish J., 2009, CERVICAL SCREENING L, P51; Gonzales G, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301577; Goodenow C, 2008, AM J PUBLIC HEALTH, V98, P1051, DOI 10.2105/AJPH.2005.080531; Gorgos LM, 2011, CLIN INFECT DIS, V53, pS84, DOI 10.1093/cid/cir697; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Korn E. L., 1999, ANAL HLTH SURVEYS; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Krieger N, 2001, J EPIDEMIOL COMMUN H, V55, P693, DOI 10.1136/jech.55.10.693; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krieger N., 2014, CURR EPIDEMIOL REP, V1, P45, DOI [DOI 10.1007/S40471-013-0001-1, 10.1007/s40471-013-0001-1]; Krieger N., 2011, EPIDEMIOLOGY PEOPLES, DOI [DOI 10.1093/ACPROF:OSO/9780195383874.001.0001, DOI 10.1007/s10803-010-0982-2]; Lepkowski James M, 2006, Vital Health Stat 2, P1; Lepkowski James M, 2010, Vital Health Stat 2, P1; Marrazzo JM, 1998, J INFECT DIS, V178, P1604, DOI 10.1086/314494; Marrazzo JM, 2005, SEX TRANSM DIS, V32, P570, DOI 10.1097/01.olq.0000175368.82940.61; Marrazzo JM, 2001, AM J PUBLIC HEALTH, V91, P947, DOI 10.2105/AJPH.91.6.947; Marrazzo JM, 2000, AM J OBSTET GYNECOL, V183, P770, DOI 10.1067/mob.2000.106681; Matthews AK, 2004, PREV MED, V38, P105, DOI 10.1016/j.ypmed.2003.09.034; McNair R, 2003, WOMEN HEALTH, V37, P89, DOI 10.1300/J013v37n04_07; McNair RP, 2003, MED J AUSTRALIA, V178, P643, DOI 10.5694/j.1326-5377.2003.tb05394.x; McNair R, 2009, AUST NZ J PUBL HEAL, V33, P87, DOI 10.1111/j.1753-6405.2009.00345.x; McNair Ruth, 2005, Sex Health, V2, P209, DOI 10.1071/SH04046; McNair RP, 2010, ANN FAM MED, V8, P533, DOI 10.1370/afm.1173; Mcree AL, 2014, VACCINE, V32, P4736, DOI 10.1016/j.vaccine.2014.07.001; Miller MK, 2014, J COMMUN HEALTH, V39, P835, DOI 10.1007/s10900-014-9858-2; OHanlan KA, 1996, OBSTET GYNECOL, V88, P702, DOI 10.1016/0029-7844(96)00206-2; Polek Carolee, 2010, Oncol Nurs Forum, V37, pE191, DOI 10.1188/10.ONF.E191-E197; Polonijo AN, 2013, SOC SCI MED, V82, P115, DOI 10.1016/j.socscimed.2012.12.020; Ponce NA, 2010, HEALTH AFFAIR, V29, P1539, DOI 10.1377/hlthaff.2009.0583; Power J, 2009, CULT HEALTH SEX, V11, P67, DOI 10.1080/13691050802541674; Price JH, 1996, J COMMUN HEALTH, V21, P89, DOI 10.1007/BF01682301; Roberts ME, 2010, PEDIATRICS, V125, P982, DOI 10.1542/peds.2009-2888; Roberts SJ, 2004, WOMEN HEALTH, V39, P41, DOI 10.1300/J013v39n04_03; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; RUST PC, 1992, SOC PROBL, V39, P366, DOI 10.1525/sp.1992.39.4.03x0044r; Ryan JM., 2011, DESIGN DEV TESTING N; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Singh D., 2009, OPEN INFECT DIS J, V3, P128, DOI DOI 10.2174/187427930; Valanis BG, 2000, ARCH FAM MED, V9, P843, DOI 10.1001/archfami.9.9.843; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Williams WW, 2014, MMWR-MORBID MORTAL W, V63, P95; Xu FJ, 2010, SEX TRANSM DIS, V37, P407, DOI 10.1097/OLQ.0b013e3181db2e18	66	45	44	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					99	+		10.7326/M14-2108	http://dx.doi.org/10.7326/M14-2108			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN4NS	25961737	Green Accepted			2022-12-24	WOS:000358407500017
J	Novas, FE; Salgado, L; Suarez, M; Agnolin, FL; Ezcurra, MD; Chimento, NR; de la Cruz, R; Isasi, MP; Vargas, AO; Rubilar-Rogers, D				Novas, Fernando E.; Salgado, Leonardo; Suarez, Manuel; Agnolin, Federico L.; Ezcurra, Martin D.; Chimento, Nicolas R.; de la Cruz, Rita; Isasi, Marcelo P.; Vargas, Alexander O.; Rubilar-Rogers, David			An enigmatic plant-eating theropod from the Late Jurassic period of Chile	NATURE			English	Article							DINOSAUR; EVOLUTION; ANATOMY; OSTEOLOGY; TETANURAE	Theropod dinosaurs were the dominant predators inmost Mesozoic era terrestrial ecosystems(1). Early theropod evolution is currently interpreted as the diversification of various carnivorous and cursorial taxa, whereas the acquisition of herbivorism, together with the secondary loss of cursorial adaptations, occurred much later among advanced coelurosaurian theropods(1,2). A new, bizarre herbivorous basal tetanuran from the Upper Jurassic of Chile challenges this conception. The new dinosaur was discovered at Aysen, a fossil locality in the Upper Jurassic Toqui Formation of southern Chile (General Carrera Lake)(3,4). The site yielded abundant and exquisitely preserved three-dimensional skeletons of small archosaurs. Several articulated individuals of Chilesaurus at different ontogenetic stages have been collected, as well as less abundant basal crocodyliforms, and fragmentary remains of sauropod dinosaurs (diplodocids and titanosaurians).	[Novas, Fernando E.; Salgado, Leonardo; Isasi, Marcelo P.] Museo Argentino Ciencias Nat Bernardino Rivadavia, CONICET, Buenos Aires, DF, Argentina; [Novas, Fernando E.; Agnolin, Federico L.; Chimento, Nicolas R.; Isasi, Marcelo P.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Salgado, Leonardo] Univ Nacl Rio Negro, Inst Invest Paleobiol & Geol, CONICET, RA-8332 Gen Roca, Rio Negro, Argentina; [Salgado, Leonardo] Univ Nacl Rio Negro, Inst Invest Paleobiol & Geol, RA-8332 Gen Roca, Rio Negro, Argentina; [Suarez, Manuel] Univ Andres Bello, Geol, Fac Ingn, Santiago, Chile; [Suarez, Manuel] Univ Maimonides, Fdn Hist Nat Felix de Azara, Buenos Aires, DF, Argentina; [Ezcurra, Martin D.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [de la Cruz, Rita] Serv Nacl Geol & Mineria, Santiago 8330177, Chile; [Vargas, Alexander O.; Rubilar-Rogers, David] Univ Chile, Dept Biol, Lab Ontogenia & Filogenia, Red Paleontol U Chile, Santiago 7800003, Chile; [Rubilar-Rogers, David] Museo Nacl Hist Nat Chile, Area Paleontol, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Andres Bello; University of Birmingham; Universidad de Chile	Novas, FE (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, CONICET, Ave Angel Gallardo 470 C1405DJR, Buenos Aires, DF, Argentina.	fernovas@yahoo.com.ar	Vargas, Alexander O/L-3788-2017	Vargas, Alexander/0000-0002-2009-7116; Chimento, Nicolas/0000-0002-6340-4358	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-066]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1121140, 1030162]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	We thank P. Barrett, A. Milner and R. Butler for comments on early versions of this manuscript. We are grateful to C. Alsina, M. Milani, R. Stoll and M. Aranciaga for field assistance and technical preparation of Chilesaurus specimens. G. Lio executed the silhouette of Chilesaurus in Fig. 1. C. Burke offered support to conduct fieldwork and technical preparation of the specimens. We are indebted to the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-066 to F.E.N.) and the Fondo Nacional de Desarrollo Cientifico y Tecnologico (no. 1121140 and 1030162 to M.S.) for continuing financial assistance.	Barrett PM, 2014, ANNU REV EARTH PL SC, V42, P207, DOI 10.1146/annurev-earth-042711-105515; Barrett PM, 2005, PALAEONTOLOGY, V48, P347, DOI 10.1111/j.1475-4983.2005.00448.x; Bonaparte J.F., 1991, Historical Biology, V5, P1; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Lautenschlager S., 2014, P ROY SOC LOND B BIO, V281, P1471; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; NOVAS FE, 1989, J PALEONTOL, V63, P677, DOI 10.1017/S0022336000041317; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Novas Fernando E., 1996, Memoirs of the Queensland Museum, V39, P675; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Paul GS., 1984, J VERTEBR PALEONTOL, V4, P507, DOI DOI 10.1080/02724634.1984.10012026; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Sadleir Rudyard W., 2008, Monograph of the Palaeontographical Society, P1; Salgado L, 2008, J VERTEBR PALEONTOL, V28, P529, DOI 10.1671/0272-4634(2008)28[529:FLJDBF]2.0.CO;2; Smith ND, 2008, P ROY SOC B-BIOL SCI, V275, P2085, DOI 10.1098/rspb.2008.0504; Weishampel DB., 2004, DINOSAURIA; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029	27	51	51	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					331	+		10.1038/nature14307	http://dx.doi.org/10.1038/nature14307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25915021				2022-12-24	WOS:000356425400051
J	Washam, JB; Stevens, SR; Lokhnygina, Y; Halperin, JL; Breithardt, G; Singer, DE; Mahaffey, KW; Hankey, GJ; Berkowitz, SD; Nessel, CC; Fox, KAA; Califf, RM; Piccini, JP; Patel, MR				Washam, Jeffrey B.; Stevens, Susanna R.; Lokhnygina, Yuliya; Halperin, Jonathan L.; Breithardt, Guenter; Singer, Daniel E.; Mahaffey, Kenneth W.; Hankey, Graeme J.; Berkowitz, Scott D.; Nessel, Christopher C.; Fox, Keith A. A.; Califf, Robert M.; Piccini, Jonathan P.; Patel, Manesh R.		ROCKET AF Steering Comm Investigat	Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)	LANCET			English	Article							INCREASED MORTALITY; MANAGEMENT; EPIDEMIOLOGY; ASSOCIATION; DEATH; RISK	Background Digoxin is a widely used drug for ventricular rate control in patients with atrial fibrillation (AF), despite a scarcity of randomised trial data. We studied the use and outcomes of digoxin in patients in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Methods For this retrospective analysis, we included and classified patients from ROCKET AF on the basis of digoxin use at baseline and during the study. Patients in ROCKET AF were recruited from 45 countries and had AF and risk factors putting them at moderate-to-high risk of stroke, with or without heart failure. We used Cox proportional hazards regression models adjusted for baseline characteristics and drugs to investigate the association of digoxin with all-cause mortality, vascular death, and sudden death. ROCKET AF was registered with ClinicalTrials.gov, number NCT00403767. Findings In 14 171 randomly assigned patients, digoxin was used at baseline in 5239 (37%). Patients given digoxin were more likely to be female (42% vs 38%) and have a history of heart failure (73% vs 56%), diabetes (43% vs 38%), and persistent AF (88% vs 77%; p<0.0001 for each comparison). After adjustment, digoxin was associated with increased all-cause mortality (5.41 vs 4.30 events per 100 patients-years; hazard ratio 1.17; 95% CI 1.04-1.32; p=0.0093), vascular death (3.55 vs 2.69 per 100 patient-years; 1.19; 1.03-1.39, p=0.0201), and sudden death (1.68 vs 1.12 events per 100 patient-years; 1.36; 1.08-1.70, p=0.0076). Interpretation Digoxin treatment was associated with a significant increase in all-cause mortality, vascular death, and sudden death in patients with AF. This association was independent of other measured prognostic factors, and although residual confounding could account for these results, these data show the possibility of digoxin having these effects. A randomised trial of digoxin in treatment of AF patients with and without heart failure is needed.	[Washam, Jeffrey B.] Duke Univ, Med Ctr, Duke Heart Ctr, Durham, NC 27705 USA; [Stevens, Susanna R.; Lokhnygina, Yuliya; Piccini, Jonathan P.; Patel, Manesh R.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA; [Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27705 USA; [Halperin, Jonathan L.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Breithardt, Guenter] Hops Univ Munster, Munster, Germany; [Singer, Daniel E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Singer, Daniel E.] Harvard Univ, Sch Med, Boston, MA USA; [Mahaffey, Kenneth W.] Stanford Sch Med, Stanford, CA USA; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Berkowitz, Scott D.] Bayer HealthCare Pharmaceut, Whippany, NJ USA; [Nessel, Christopher C.] Janssen Res & Dev, Raritan, NJ USA; [Fox, Keith A. A.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Fox, Keith A. A.] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland	Duke University; Duke University; Duke University; Icahn School of Medicine at Mount Sinai; University of Munster; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University; University of Western Australia; Bayer AG; Bayer Healthcare Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA.	manesh.patel@duke.edu	Fox, keith A A/I-3742-2013; Berkowitz, Scott Darrell/AAS-9397-2021; Hankey, Graeme J/H-4968-2014; Halperin, Jonathan/AAJ-4721-2020; Patel, Manesh/AAC-5385-2019	Berkowitz, Scott Darrell/0000-0002-9428-4408; Hankey, Graeme J/0000-0002-6044-7328; Halperin, Jonathan/0000-0002-8318-5471; Fox, Keith/0000-0002-0140-2752	Janssen Research Development; Bayer HealthCare AG	Janssen Research Development; Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals)	Janssen Research & Development and Bayer HealthCare AG.	Al-Khatib SM, 2013, TREATMENT ATRIAL FIB; Camm AJ, 2007, HEART, V93, P35, DOI 10.1136/hrt.2006.099903; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Friberg L, 2010, HEART, V96, P275, DOI 10.1136/hrt.2009.175786; Gheorghiade M, 2013, EUR HEART J, V34, P1489, DOI 10.1093/eurheartj/eht120; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hallberg P, 2007, EUR J CLIN PHARMACOL, V63, P959, DOI 10.1007/s00228-007-0346-9; Hersi AS, 2012, J SAUDI HEART ASSOC, V24, P243, DOI 10.1016/j.jsha.2012.08.001; January CT, 2014, CIRCULATION; Lane DA, 2011, CLIN EVID; Magnani JW, 2011, CIRCULATION, V124, P1982, DOI 10.1161/CIRCULATIONAHA.111.039677; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; Mulder BA, 2014, HEART RHYTHM, V11, P1543, DOI 10.1016/j.hrthm.2014.06.007; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Patel MR, 2010, AM HEART J, V159, P340, DOI 10.1016/j.ahj.2009.11.025; Perry G, 1997, NEW ENGL J MED, V336, P525; Piccini JP, 2012, HEART RHYTHM, V9, P1403, DOI 10.1016/j.hrthm.2012.04.031; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Reinier K, 2014, JACC-HEART FAIL, V2, P221, DOI 10.1016/j.jchf.2013.12.006; Shah M, 2014, AM J CARDIOL, V114, P401, DOI 10.1016/j.amjcard.2014.05.013; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yusuf S, 2011, NEW ENGL J MED, V364, P928, DOI 10.1056/NEJMoa1008816	24	92	95	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 13	2015	385	9985					2363	2370		10.1016/S0140-6736(14)61836-5	http://dx.doi.org/10.1016/S0140-6736(14)61836-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1XV	25749644				2022-12-24	WOS:000356003700029
J	Boersma, V; Moatti, N; Segura-Bayona, S; Peuscher, MH; van der Torre, J; Wevers, BA; Orthwein, A; Durocher, D; Jacobs, JJL				Boersma, Vera; Moatti, Nathalie; Segura-Bayona, Sandra; Peuscher, Marieke H.; van der Torre, Jaco; Wevers, Brigitte A.; Orthwein, Alexandre; Durocher, Daniel; Jacobs, Jacqueline J. L.			MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5 ' end resection	NATURE			English	Article							DAMAGE RESPONSE; POLYMERASE-ZETA; PROTECTION; HALLMARKS; MUTATION; ROLES; RIF1; REV7; TRF2; NHEJ	Appropriate repair of DNA lesions and the inhibition of DNA repair activities at telomeres are crucial to prevent genomic instability. By fuelling the generation of genetic alterations and by compromising cell viability, genomic instability is a driving force in cancer and ageing(1,2). Here we identify MAD2L2 (also known as MAD2B or REV7) through functional genetic screening as a novel factor controlling DNA repair activities at mammalian telomeres. We show that MAD2L2 accumulates at uncapped telomeres and promotes non-homologous end-joining (NHEJ)-mediated fusion of deprotected chromosome ends and genomic instability. MAD2L2 depletion causes elongated 39 telomeric overhangs, indicating that MAD2L2 inhibits 59 end resection. End resection blocks NHEJ while committing to homology-directed repair, and is under the control of 53BP1, RIF1 and PTIP3. Consistent with MAD2L2 promoting NHEJ-mediated telomere fusion by inhibiting 5' end resection, knockdown of the nucleases CTIP or EXO1 partially restores telomere-driven genomic instability in MAD2L2-depleted cells. Control of DNA repair by MAD2L2 is not limited to telomeres. MAD2L2 also accumulates and inhibits end resection at irradiation-induced DNA double-strand breaks and promotes end-joining of DNA double-strand breaks in several settings, including during immunoglobulin class switch recombination. These activities of MAD2L2 depend on ATM kinase activity, RNF8, RNF168, 53BP1 and RIF1, but not on PTIP, REV1 and REV3, the latter two acting with MAD2L2 in translesion synthesis(4). Together, our data establish MAD2L2 as a crucial contributor to the control of DNA repair activity by 53BP1 that promotes NHEJ by inhibiting 5' end resection downstream of RIF1.	[Boersma, Vera; Moatti, Nathalie; Segura-Bayona, Sandra; Peuscher, Marieke H.; van der Torre, Jaco; Wevers, Brigitte A.; Jacobs, Jacqueline J. L.] Netherlands Canc Inst, Div Mol Oncol, NL-1066 CX Amsterdam, Netherlands; [Orthwein, Alexandre; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	Netherlands Cancer Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Jacobs, JJL (corresponding author), Netherlands Canc Inst, Div Mol Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.jacobs@nki.nl	Durocher, Daniel/A-7733-2010; Jacobs, Jacqueline/ABA-5652-2020; Segura-Bayona, Sandra/W-8156-2019	Durocher, Daniel/0000-0003-3863-8635; Jacobs, Jacqueline/0000-0002-7704-4795; Segura-Bayona, Sandra/0000-0001-7788-9889; Peuscher, Marieke/0000-0001-9410-4350; van der Torre, Jaco/0000-0002-5405-3824; Orthwein, Alexandre/0000-0002-7350-3413	European Research Council [ERCStG 311565]; Dutch Cancer Society [KWF-NKI2007-3907]; Canadian Institutes for Health Research [CIHR MOP89754]; La Caixa fellowship; CIHR	European Research Council(European Research Council (ERC)European Commission); Dutch Cancer Society(KWF Kankerbestrijding); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); La Caixa fellowship(La Caixa Foundation); CIHR(Canadian Institutes of Health Research (CIHR))	We thank A. Konishi, G. Celli and T. de Lange for TRF2(Ile468Ala), Trf2<SUP>flox/-</SUP> p53<SUP>-/-</SUP> MEFs and Trf2<SUP>flox/-</SUP> p53<SUP>-/-</SUP> Lig4<SUP>-/-</SUP> MEFs, P. Bouwman, M. Pieterse, T. Halazonetis, O. Kallioniemi, B. Gerritsen, B. Morris and P. Halonen for composing and providing the DDR TRC shRNA sub-library, members of the NKI Genomics Core Facility for technical support, A. van Kessel for MAD2L2 cDNA, E. Hendrickson for repair plasmids, R. Chapman and S. Boulton for mRIF1 antibody, 53bp1<SUP>-/-</SUP> and Rif1<SUP>-/-</SUP> MEFs, E. Callen and A. Nussenzweig for 53BP1 and PTIP expression vectors and for Ptip<SUP>-/-</SUP> MEFs, N. de Wind for Rev1<SUP>-/-</SUP> and Rev3<SUP>-/-</SUP> MEFs, B. van den Broek for help with telomere mobility analysis, I. de Krijger, Z. Yalcin and M. Simonetta from the Jacobs group for contributing to end resection and interaction analysis and members of the R. Medema laboratory for discussion. This work was supported by grants from the European Research Council (ERCStG 311565) and Dutch Cancer Society (KWF-NKI2007-3907) to J.J.L.J., a grant from the Canadian Institutes for Health Research (CIHR MOP89754) to D.D., a La Caixa fellowship to S. S. B. and a CIHR post-doctoral fellowship to A.O. D.D. is a Canada Research Chair (tier 1) in the Molecular Mechanisms of Genome Integrity and J.J.L.J. is an EMBO Young Investigator.	Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Daniel JA, 2013, MOL CELL, V50, P309, DOI 10.1016/j.molcel.2013.04.017; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Kato H, 1997, DEVELOPMENT, V124, P4133; Khalaj M, 2014, J BIOL CHEM, V289, P3811, DOI 10.1074/jbc.M113.514752; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Murnane JP, 2012, MUTAT RES-FUND MOL M, V730, P28, DOI 10.1016/j.mrfmmm.2011.04.008; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Peuscher MH, 2011, NAT CELL BIOL, V13, P1139, DOI 10.1038/ncb2326; Rimkus C, 2007, INT J CANCER, V120, P207, DOI 10.1002/ijc.22155; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	32	197	200	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					537	U291		10.1038/nature14216	http://dx.doi.org/10.1038/nature14216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25799990	Green Accepted			2022-12-24	WOS:000355286600047
J	Park, SY; Yang, JS; Schmider, AB; Soberman, RJ; Hsu, VW				Park, Seung-Yeol; Yang, Jia-Shu; Schmider, Angela B.; Soberman, Roy J.; Hsu, Victor W.			Coordinated regulation of bidirectional COPI transport at the Golgi by CDC42	NATURE			English	Article							CISTERNAL MATURATION; MEMBRANE CURVATURE; VESICLE FORMATION; ARFGAP1 PROMOTES; APPARATUS; COMPLEX; YEAST	The Golgi complex has a central role in the intracellular sorting of secretory proteins(1,2). Anterograde transport through the Golgi has been explained by the movement of Golgi cisternae, known as cisternal maturation(3-5). Because this explanation is now appreciated to be incomplete(6), interest has developed in understanding tubules that connect the Golgi cisternae(7-9). Here we show that the coat protein (COPI) complex sorts anterograde cargoes into these tubules in human cells. Moreover, the small GTPase CDC42 regulates bidirectional Golgi transport by targeting the dual functions of COPI in cargo sorting and carrier formation. CDC42 also directly imparts membrane curvature to promote COPI tubule formation. Our findings further reveal that COPI tubular transport complements cisternal maturation in explaining how anterograde Golgi transport is achieved, and that bidirectional COPI transport is modulated by environmental cues through CDC42.	[Park, Seung-Yeol; Yang, Jia-Shu; Hsu, Victor W.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Park, Seung-Yeol; Yang, Jia-Shu; Schmider, Angela B.; Soberman, Roy J.; Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Schmider, Angela B.; Soberman, Roy J.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA 02129 USA; [Schmider, Angela B.; Soberman, Roy J.] Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; [Soberman, Roy J.] Massachusetts Gen Hosp, Mol Imaging Core, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hsu, VW (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	vhsu@research.bwh.harvard.edu		Park, Seung-Yeol/0000-0001-5061-4535	National Institutes of Health [R01GM058615, R01AI068871, R01AR065538, 1S10RR027931-01, K01DK089145]; National Research Foundation of Korea [2014R1A6A3A03056673]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Li, M. Bai, X. Michelet and C. Alves for discussions, and M. Ericsson for electron microscopy technical advice. This work was funded by grants from the National Institutes of Health to V.W.H. (R01GM058615), R.J.S. (R01AI068871, R01AR065538 and 1S10RR027931-01), A.B.S. (K01DK089145), and also by the Basic Science Research Program of the National Research Foundation of Korea to S.-Y.P. (2014R1A6A3A03056673).	Azcutia V, 2013, MOL BIOL CELL, V24, P3358, DOI 10.1091/mbc.E13-01-0063; Bai M, 2011, NAT CELL BIOL, V13, P559, DOI 10.1038/ncb2221; Bair AM, 2012, MOL BIOL CELL, V23, P4456, DOI 10.1091/mbc.E12-06-0489; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Nakano A, 2010, CURR OPIN CELL BIOL, V22, P471, DOI 10.1016/j.ceb.2010.05.003; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	24	60	62	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					529	U257		10.1038/nature14457	http://dx.doi.org/10.1038/nature14457			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25945738	Green Accepted, Green Submitted			2022-12-24	WOS:000355286600045
J	Chen, ZS; Shojaee, S; Buchner, M; Geng, HM; Lee, J; Klemm, L; Titz, B; Graeber, TG; Park, E; Tan, YX; Satterthwaite, A; Paietta, E; Hunger, SP; Willman, CL; Melnick, A; Loh, ML; Jung, JU; Coligan, JE; Bolland, S; Mak, TW; Limnander, A; Jumaa, H; Reth, M; Weiss, A; Lowell, CA; Muschen, M				Chen, Zhengshan; Shojaee, Seyedmehdi; Buchner, Maike; Geng, Huimin; Lee, JaeWoong; Klemm, Lars; Titz, Boern; Graeber, Thomas G.; Park, Eugene; Tan, Ying Xim; Satterthwaite, Anne; Paietta, Elisabeth; Hunger, Stephen P.; Willman, Cheryl L.; Melnick, Ari; Loh, Mignon L.; Jung, Jae U.; Coligan, John E.; Bolland, Silvia; Mak, Tak W.; Limnander, Andre; Jumaa, Hassan; Reth, Michael; Weiss, Arthur; Lowell, Clifford A.; Mueschen, Markus			Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia	NATURE			English	Article							IN-VIVO; RECEPTOR; DELETION; ACTIVATION; MOTIFS	B cells are selected for an intermediate level of B-cell antigen receptor (BCR) signalling strength: attenuation below minimum(for example, non-functional BCR)(1) or hyperactivation above maximum (for example, self-reactive BCR)(2,3) thresholds of signalling strength causes negative selection. In similar to 25% of cases, acute lymphoblastic leukaemia (ALL) cells carry the oncogenic BCR-ABL1 tyrosine kinase (Philadelphia chromosome positive), which mimics constitutively active pre-BCR signalling(4,5). Current therapeutic approaches are largely focused on the development of more potent tyrosine kinase inhibitors to suppress oncogenic signalling below a minimum threshold for survival(6). We tested the hypothesis that targeted hyperactivation-above a maximum threshold-will engage a deletional checkpoint for removal of self-reactive B cells and selectively kill ALL cells. Here we find, by testing various components of proximal pre-BCR signalling in mouse BCR-ABL1 cells, that an incremental increase of Syk tyrosine kinase activity was required and sufficient to induce cell death. Hyperactive Syk was functionally equivalent to acute activation of a self-reactive BCR on ALL cells. Despite oncogenic transformation, this basic mechanism of negative selection was still functional in ALL cells. Unlike normal pre-B cells, patient-derived ALL cells express the inhibitory receptors PECAM1, CD300A and LAIR1 at high levels. Genetic studies revealed that Pecam1, Cd300a and Lair1 are critical to calibrate oncogenic signalling strength through recruitment of the inhibitory phosphatases Ptpn6 (ref. 7) and Inpp5d (ref. 8). Using a novel small-molecule inhibitor of INPP5D (also known as SHIP1)(9), we demonstrated that pharmacological hyperactivation of SYK and engagement of negative B-cell selection represents a promising new strategy to overcome drug resistance in human ALL.	[Chen, Zhengshan; Shojaee, Seyedmehdi; Buchner, Maike; Geng, Huimin; Lee, JaeWoong; Klemm, Lars; Park, Eugene; Lowell, Clifford A.; Mueschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Titz, Boern; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Tan, Ying Xim; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med,Div Rheumatol, Rosalind Russell Ephraim P Engleman Med Res Ctr A, San Francisco, CA 94143 USA; [Satterthwaite, Anne] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Paietta, Elisabeth] Albert Einstein Coll Med, Dept Med, Bronx, NY 10466 USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Div Pediat Oncol, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87102 USA; [Melnick, Ari] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Melnick, Ari] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Loh, Mignon L.] Univ Calif San Francisco, Pediat Hematol Oncol, San Francisco, CA 94143 USA; [Jung, Jae U.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Coligan, John E.] NIAID, Receptor Cell Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Bolland, Silvia] NIAID, Autoimmun & Funct Genom Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; [Limnander, Andre] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Jumaa, Hassan] Univ Clin Ulm, Inst Immunol, D-89081 Ulm, Germany; [Reth, Michael] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Reth, Michael] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Reth, Michael] MPI Immunbiol & Epigenet, D-79104 Freiburg, Germany	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of New Mexico; Cornell University; Cornell University; University of California System; University of California San Francisco; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Francisco; Ulm University; University of Freiburg; University of Freiburg	Muschen, M (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	markus.muschen@ucsf.edu	Melnick, Ari/AAA-5763-2020; Titz, Bjoern/G-6317-2017	Titz, Bjoern/0000-0003-4414-4105; Loh, Mignon/0000-0003-4099-4700; Graeber, Thomas/0000-0001-8574-9181; Lee, Jaewoong/0000-0001-7952-5544	National Institutes of Health/National Cancer Institute [R01CA137060, R01CA139032, R01CA169458, R01CA172558, R01CA157644]; ECOG-ACRIN [CA180820, CA180794]; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine [TR02-1816]; William Lawrence and Blanche Hughes Foundation; DFG [EXC294, TRR130, SFB746]; NATIONAL CANCER INSTITUTE [U01CA157937, R01CA137060, R01CA157644, U10CA180886, R01CA139032, R01CA172558, U10CA180820, U10CA180827, R01CA169458, U10CA021115, U24CA114737, U24CA196172, U10CA180794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000912, ZIAAI000964, R01AI068150, R01AI113272] Funding Source: NIH RePORTER; Cancer Research UK [18131] Funding Source: researchfish	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ECOG-ACRIN; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); William Lawrence and Blanche Hughes Foundation; DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK)	We thank R. W. Hendriks for encouragement and critical discussions, A. Park and C. Lin and all the members of the Muschen laboratory, L. Tian and B. Scott for their support. This work is supported by grants from the National Institutes of Health/National Cancer Institute through R01CA137060, R01CA139032, R01CA169458, R01CA172558 and R01CA157644 (to M.M.), ECOG-ACRIN grants CA180820 and CA180794 (to E.P.), grants from the Leukemia and Lymphoma Society (to M.M.), the California Institute for Regenerative Medicine through TR02-1816 (M.M.), and the William Lawrence and Blanche Hughes Foundation. M.M. is a Scholar of The Leukemia and Lymphoma Society and a Senior Investigator of the Wellcome Trust. M.R. is supported by the DFG through EXC294, TRR130 and SFB746.	Anderson LJ, 2008, J GEN VIROL, V89, P1563, DOI 10.1099/vir.0.2008/001461-0; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Brooks R, 2010, J IMMUNOL, V184, P3582, DOI 10.4049/jimmunol.0902844; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Feldhahn N, 2005, J EXP MED, V201, P1837, DOI 10.1084/jem.20042101; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; Klein F, 2004, J EXP MED, V199, P673, DOI 10.1084/jem.20031637; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Staub E, 2004, CELL SIGNAL, V16, P435, DOI 10.1016/j.cellsig.2003.08.013; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	22	88	89	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					357	+		10.1038/nature14231	http://dx.doi.org/10.1038/nature14231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25799995	Green Accepted, Green Submitted			2022-12-24	WOS:000354816500057
J	Ardlie, KG; DeLuca, DS; Segre, AV; Sullivan, TJ; Young, TR; Gelfand, ET; Trowbridge, CA; Maller, JB; Tukiainen, T; Lek, M; Ward, LD; Kheradpour, P; Iriarte, B; Meng, Y; Palmer, CD; Esko, T; Winckler, W; Hirschhorn, JN; Kellis, M; MacArthur, DG; Getz, G; Shabalin, AA; Li, G; Zhou, YH; Nobel, AB; Rusyn, I; Wright, FA; Lappalainen, T; Ferreira, PG; Ongen, H; Rivas, MA; Battle, A; Mostafavi, S; Monlong, J; Sammeth, M; Mele, M; Reverter, F; Goldmann, JM; Koller, D; Guigo, R; McCarthy, MI; Dermitzakis, ET; Gamazon, ER; Im, HK; Konkashbaev, A; Nicolae, DL; Cox, NJ; Flutre, T; Wen, XQ; Stephens, M; Pritchard, JK; Tu, ZD; Zhang, B; Huang, T; Long, Q; Lin, L; Yang, JL; Zhu, J; Liu, J; Brown, A; Mestichelli, B; Tidwell, D; Lo, E; Salvatore, M; Shad, S; Thomas, JA; Lonsdale, JT; Moser, MT; Gillard, BM; Karasik, E; Ramsey, K; Choi, C; Foster, BA; Syron, J; Fleming, J; Magazine, H; Hasz, R; Walters, GD; Bridge, JP; Miklos, M; Sullivan, S; Barker, LK; Traino, HM; Mosavel, M; Siminoff, LA; Valley, DR; Rohrer, DC; Jewell, SD; Branton, PA; Sobin, LH; Barcus, M; Qi, LQ; McLean, J; Hariharan, P; Um, KS; Wu, SP; Tabor, D; Shive, C; Smith, AM; Buia, SA; Undale, AH; Robinson, KL; Roche, N; Valentino, KM; Britton, A; Burges, R; Bradbury, D; Hambright, KW; Seleski, J; Korzeniewski, GE; Erickson, K; Marcus, Y; Tejada, J; Taherian, M; Lu, CR; Basile, M; Mash, DC; Volpi, S; Struewing, JP; Temple, GF; Boyer, J; Colantuoni, D; Little, R; Koester, S; Carithers, LJ; Moore, HM; Guan, P; Compton, C; Sawyer, SJ; Demchok, JP; Vaught, JB; Rabiner, CA; Lockhart, NC; Ardlie, KG; Getz, G; Wright, FA; Kellis, M; Volpi, S; Dermitzakis, ET				Ardlie, Kristin G.; DeLuca, David S.; Segre, Ayellet V.; Sullivan, Timothy J.; Young, Taylor R.; Gelfand, Ellen T.; Trowbridge, Casandra A.; Maller, Julian B.; Tukiainen, Taru; Lek, Monkol; Ward, Lucas D.; Kheradpour, Pouya; Iriarte, Benjamin; Meng, Yan; Palmer, Cameron D.; Esko, Tonu; Winckler, Wendy; Hirschhorn, Joel N.; Kellis, Manolis; MacArthur, Daniel G.; Getz, Gad; Shabalin, Andrey A.; Li, Gen; Zhou, Yi-Hui; Nobel, Andrew B.; Rusyn, Ivan; Wright, Fred A.; Lappalainen, Tuuli; Ferreira, Pedro G.; Ongen, Halit; Rivas, Manuel A.; Battle, Alexis; Mostafavi, Sara; Monlong, Jean; Sammeth, Michael; Mele, Marta; Reverter, Ferran; Goldmann, Jakob M.; Koller, Daphne; Guigo, Roderic; McCarthy, Mark I.; Dermitzakis, Emmanouil T.; Gamazon, Eric R.; Im, Hae Kyung; Konkashbaev, Anuar; Nicolae, Dan L.; Cox, Nancy J.; Flutre, Timothee; Wen, Xiaoquan; Stephens, Matthew; Pritchard, Jonathan K.; Tu, Zhidong; Zhang, Bin; Huang, Tao; Long, Quan; Lin, Luan; Yang, Jialiang; Zhu, Jun; Liu, Jun; Brown, Amanda; Mestichelli, Bernadette; Tidwell, Denee; Lo, Edmund; Salvatore, Michael; Shad, Saboor; Thomas, Jeffrey A.; Lonsdale, John T.; Moser, Michael T.; Gillard, Bryan M.; Karasik, Ellen; Ramsey, Kimberly; Choi, Christopher; Foster, Barbara A.; Syron, John; Fleming, Johnell; Magazine, Harold; Hasz, Rick; Walters, Gary D.; Bridge, Jason P.; Miklos, Mark; Sullivan, Susan; Barker, Laura K.; Traino, Heather M.; Mosavel, Maghboeba; Siminoff, Laura A.; Valley, Dana R.; Rohrer, Daniel C.; Jewell, Scott D.; Branton, Philip A.; Sobin, Leslie H.; Barcus, Mary; Qi, Liqun; McLean, Jeffrey; Hariharan, Pushpa; Um, Ki Sung; Wu, Shenpei; Tabor, David; Shive, Charles; Smith, Anna M.; Buia, Stephen A.; Undale, Anita H.; Robinson, Karna L.; Roche, Nancy; Valentino, Kimberly M.; Britton, Angela; Burges, Robin; Bradbury, Debra; Hambright, Kenneth W.; Seleski, John; Korzeniewski, Greg E.; Erickson, Kenyon; Marcus, Yvonne; Tejada, Jorge; Taherian, Mehran; Lu, Chunrong; Basile, Margaret; Mash, Deborah C.; Volpi, Simona; Struewing, Jeffery P.; Temple, Gary F.; Boyer, Joy; Colantuoni, Deborah; Little, Roger; Koester, Susan; Carithers, Latarsha J.; Moore, Helen M.; Guan, Ping; Compton, Carolyn; Sawyer, Sherilyn J.; Demchok, Joanne P.; Vaught, Jimmie B.; Rabiner, Chana A.; Lockhart, Nicole C.; Ardlie, Kristin G.; Getz, Gad; Wright, Fred A.; Kellis, Manolis; Volpi, Simona; Dermitzakis, Emmanouil T.		GTEx Consortium	The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; IDENTIFICATION; TRANSCRIPTOME; LOCI; ARCHITECTURE; RESOURCE; SYSTEMS	Understanding the functional consequences of genetic variation, and how it affects complex human disease and quantitative traits, remains a critical challenge for biomedicine. We present an analysis of RNA sequencing data from 1641 samples across 43 tissues from 175 individuals, generated as part of the pilot phase of the Genotype-Tissue Expression (GTEx) project. We describe the landscape of gene expression across tissues, catalog thousands of tissue-specific and shared regulatory expression quantitative trait loci (eQTL) variants, describe complex network relationships, and identify signals from genome-wide association studies explained by eQTLs. These findings provide a systematic understanding of the cellular and biological consequences of human genetic variation and of the heterogeneity of such effects among a diverse set of human tissues.	[DeLuca, David S.; Segre, Ayellet V.; Sullivan, Timothy J.; Young, Taylor R.; Gelfand, Ellen T.; Trowbridge, Casandra A.; Maller, Julian B.; Tukiainen, Taru; Lek, Monkol; Ward, Lucas D.; Kheradpour, Pouya; Meng, Yan; Palmer, Cameron D.; Esko, Tonu; Winckler, Wendy; Hirschhorn, Joel N.; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Maller, Julian B.; Tukiainen, Taru; Lek, Monkol; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ward, Lucas D.; Kheradpour, Pouya; Iriarte, Benjamin] MIT, MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Palmer, Cameron D.; Esko, Tonu; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Palmer, Cameron D.; Esko, Tonu; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shabalin, Andrey A.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA 23298 USA; [Li, Gen; Nobel, Andrew B.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27599 USA; [Li, Gen; Nobel, Andrew B.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Zhou, Yi-Hui] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Zhou, Yi-Hui] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Zhou, Yi-Hui] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Rusyn, Ivan] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Rusyn, Ivan] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Lappalainen, Tuuli; Ferreira, Pedro G.; Ongen, Halit] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Ferreira, Pedro G.; Ongen, Halit] Univ Geneva, Inst Genet & Genom Geneva iG3, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Ferreira, Pedro G.; Ongen, Halit] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY 10011 USA; [Lappalainen, Tuuli] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Rivas, Manuel A.; McCarthy, Mark I.] Univ Oxford, Nuffield Dept Clin Med, Wellcome Trust Ctr Human Genet Res, Oxford OX3 7BN, England; [Battle, Alexis; Mostafavi, Sara; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Monlong, Jean; Sammeth, Michael; Mele, Marta; Reverter, Ferran; Goldmann, Jakob M.; Guigo, Roderic] CRG, Barcelona 08003, Catalonia, Spain; [Monlong, Jean; Sammeth, Michael; Mele, Marta; Guigo, Roderic] Univ Pompeu Fabra, Barcelona 08003, Catalonia, Spain; [Monlong, Jean] McGill Univ, Human Genet Dept, Montreal, PQ H3A 0G1, Canada; [Sammeth, Michael] Natl Inst Sci Comp, BR-25651075 Rio De Janeiro, Brazil; [Mele, Marta] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Reverter, Ferran] Univ Barcelona, E-08028 Barcelona, Spain; [Goldmann, Jakob M.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Guigo, Roderic] Inst Hosp Mar Invest Med IMIM, Barcelona 08003, Spain; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Gamazon, Eric R.; Im, Hae Kyung; Konkashbaev, Anuar; Nicolae, Dan L.; Cox, Nancy J.] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Gamazon, Eric R.; Im, Hae Kyung; Konkashbaev, Anuar; Nicolae, Dan L.; Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gamazon, Eric R.; Konkashbaev, Anuar; Cox, Nancy J.] Vanderbilt Univ, Dept Med, Div Genet Med, Nashville, TN 37232 USA; [Flutre, Timothee; Stephens, Matthew; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Flutre, Timothee] INRA, Dept Plant Biol & Breeding, UMR 1334, AGAP, F-34060 Montpellier, France; [Wen, Xiaoquan] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Genet & Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Tu, Zhidong; Zhang, Bin; Huang, Tao; Long, Quan; Lin, Luan; Yang, Jialiang; Zhu, Jun] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Tu, Zhidong; Zhang, Bin; Huang, Tao; Long, Quan; Lin, Luan; Yang, Jialiang; Zhu, Jun] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Liu, Jun] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Brown, Amanda; Mestichelli, Bernadette; Tidwell, Denee; Lo, Edmund; Salvatore, Michael; Shad, Saboor; Thomas, Jeffrey A.; Lonsdale, John T.] Natl Dis Res Interchange, Philadelphia, PA 19103 USA; [Moser, Michael T.; Gillard, Bryan M.; Karasik, Ellen; Ramsey, Kimberly; Choi, Christopher; Foster, Barbara A.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Syron, John; Fleming, Johnell; Magazine, Harold] Sci Care Inc, Phoenix, AZ USA; [Hasz, Rick] Gift Life Donor Program, Philadelphia, PA 19103 USA; [Walters, Gary D.] LifeNet Hlth, Virginia Beach, VA 23453 USA; [Bridge, Jason P.; Miklos, Mark; Sullivan, Susan] UNYTS, Buffalo, NY 14203 USA; [Barker, Laura K.; Traino, Heather M.; Mosavel, Maghboeba; Siminoff, Laura A.] Virginia Commonwealth Univ, Richmond, VA 23298 USA; [Traino, Heather M.; Siminoff, Laura A.] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA; [Valley, Dana R.; Rohrer, Daniel C.; Jewell, Scott D.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Branton, Philip A.; Carithers, Latarsha J.; Moore, Helen M.; Guan, Ping; Compton, Carolyn; Sawyer, Sherilyn J.; Vaught, Jimmie B.; Rabiner, Chana A.; Lockhart, Nicole C.] NCI, Biorepositories & Biospecimen Res Branch, Bethesda, MD 20892 USA; [Sobin, Leslie H.; Barcus, Mary; Qi, Liqun; McLean, Jeffrey; Hariharan, Pushpa; Um, Ki Sung; Wu, Shenpei; Tabor, David; Shive, Charles; Smith, Anna M.; Buia, Stephen A.; Undale, Anita H.; Robinson, Karna L.; Roche, Nancy; Valentino, Kimberly M.; Britton, Angela; Burges, Robin; Bradbury, Debra; Hambright, Kenneth W.; Korzeniewski, Greg E.] Leidos Biomed Res Inc, Clin Res Directorate, Biospecimen Res Grp, Rockville, MD 20852 USA; [Seleski, John] iDoxSolutions Inc, Bethesda, MD 20814 USA; [Erickson, Kenyon] Sapient Govt Serv, Arlington, VA 22201 USA; [Marcus, Yvonne; Tejada, Jorge; Taherian, Mehran; Lu, Chunrong; Basile, Margaret; Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Neurol, Brain Endowment Bank, Miami, FL 33136 USA; [Struewing, Jeffery P.; Temple, Gary F.; Colantuoni, Deborah] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Boyer, Joy; Lockhart, Nicole C.] NHGRI, Div Genom & Soc, Bethesda, MD 20892 USA; [Little, Roger] NIMH, Off Sci Policy Planning & Commun, Bethesda, MD 20892 USA; [Koester, Susan] NIMH, Div Neurosci & Basic Behav Sci, Bethesda, MD 20892 USA; [Demchok, Joanne P.] NCI, Canc Diag Program, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Tartu; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Stanford University; Columbia University; University of Oxford; Wellcome Centre for Human Genetics; Stanford University; Johns Hopkins University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; McGill University; Harvard University; University of Barcelona; Radboud University Nijmegen; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Oxford; University of Oxford; University of Chicago; University of Chicago; Vanderbilt University; University of Chicago; INRAE; Universite de Montpellier; University of Michigan System; University of Michigan; University of Chicago; Stanford University; Howard Hughes Medical Institute; University of Chicago; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Roswell Park Cancer Institute; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ardlie, KG (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	kardlie@broadinstitute.org; emmanouil.dermitzakis@unige.ch	Guigo, Roderic/D-1303-2010; Monlong, Jean/AAZ-8589-2020; Ferreira, Pedro G/J-6379-2013; Rivas, Manuel/ABE-8173-2020; Gamazon, Eric/I-6873-2018; Qi, LI/AAF-3389-2019; reverter, ferran/I-1547-2015; Rusyn, Ivan/S-2426-2016; Ferreira, Pedro/HDO-1346-2022; Kellis, Manolis/ABE-7385-2020; Lappalainen, Tuuli/AAE-6532-2020; Goldmann, Jakob M/K-5948-2013; Sammeth, Michael/C-1157-2014; McCarthy, Mark/M-3763-2015	Guigo, Roderic/0000-0002-5738-4477; Monlong, Jean/0000-0002-9737-5516; Ferreira, Pedro G/0000-0003-3838-8664; Rivas, Manuel/0000-0003-1457-9925; Gamazon, Eric/0000-0003-4204-8734; reverter, ferran/0000-0002-9489-3350; Kellis, Manolis/0000-0001-7113-9630; Lappalainen, Tuuli/0000-0002-7746-8109; Goldmann, Jakob M/0000-0002-8514-573X; Sammeth, Michael/0000-0002-6528-9883; Shabalin, Andrey/0000-0003-0309-6821; Tukiainen, Taru/0000-0002-5404-8398; MacArthur, Daniel/0000-0002-5771-2290; Rusyn, Ivan/0000-0001-9340-7384; Ongen, Halit/0000-0002-4197-5790; mele, marta/0000-0001-8874-6453; Ward, Lucas/0000-0002-8017-809X; Nicolae, Dan/0000-0002-0918-4630; McCarthy, Mark/0000-0002-4393-0510; Wen, Xiaoquan/0000-0001-8990-2737; Flutre, Timothee/0000-0003-4489-4782; Esko, Tonu/0000-0003-1982-6569	Common Fund of the Office of the Director, U.S. National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NIA; NIAID; NINDS through NIH [HHSN261200800001E, 10XS170, 10XS171, 12ST1039, 10ST1035, HHSN268201000029C]; European Research Council; Swiss National Science Foundation; Louis-Jeantet Foundation; Wellcome Trust [098381]; Clarendon Scholarship; NDM Studentship; Univ. of Oxford Green Templeton College Award; NIH [R01 DA006227-17, R01 MH090941, R01 MH090951, R01 MH090937, R01 MH090936, R01 MH090948, R01 GM104371, R01AG046170, R01CA163772, U01AI111598-01]; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA163772, K12CA139160, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI111598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090937, R01MH101819, R01MH101820, R01MH090951, R01MH090941, R01MH090948, R01MH090936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG046170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER	Common Fund of the Office of the Director, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS through NIH; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis-Jeantet Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Clarendon Scholarship; NDM Studentship; Univ. of Oxford Green Templeton College Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the donors and their families for their generous gifts of organ donation for transplantation and tissue donations for the GTEx research study; the Genomics Platform at the Broad Institute for data generation; J. Nedzel, K. Huang, and K. Hadley for work on the GTEx Portal; L. Gaffney for help with figures; and members of the Analysis Working Group for scientific editing and feedback. The primary and processed data used to generate the analyses presented here are available in the following locations: all primary sequence and clinical data files, and any other protected data, are deposited in and available from dbGaP (www.ncbi.nlm.nih.gov/gap) (phs000424.v3.p1, except for whole-exome sequencing data, which are part of phs000424.v5.p1); derived analysis files are available on the GTEx Portal (www.gtexportal.org). Biospecimens remaining from the study may be requested for research studies. The sample request form, biospecimen access policy, and material transfer agreement (MTA) are available on the GTEx Portal (www.gtexportal.org/home/samplesPage). Supported by the Common Fund of the Office of the Director, U.S. National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, NIA, NIAID, and NINDS through NIH contracts HHSN261200800001E (Leidos Prime contract with NCI), 10XS170 (NDRI), 10XS171 (Roswell Park Cancer Institute), 10X172 (Science Care Inc.), 12ST1039 (IDOX), 10ST1035 (Van Andel Institute), and HHSN268201000029C (Broad Institute) and through NIH grants R01 DA006227-17 (Univ. of Miami Brain Bank), R01 MH090941 (Univ. of Geneva), R01 MH090951 and R01 MH090937 (Univ. of Chicago), R01 MH090936 (Univ. of North Carolina-Chapel Hill), R01 MH090948 (Harvard Univ.), R01 GM104371 (Massachusetts General Hospital), and R01AG046170, R01CA163772, and U01AI111598-01 (Icahn School of Medicine, Mount Sinai). Additional support: European Research Council, Swiss National Science Foundation, and Louis-Jeantet Foundation (E.T.D.); Wellcome Trust grant 098381 (M.I.M.); Clarendon Scholarship, a NDM Studentship, and a Univ. of Oxford Green Templeton College Award (M.A.R.). J.K.P. is compensated for his work on the scientific advisory board for 23andMe and computational advisory board for DNANexus; W.W. is an employee and shareholder of Novartis Inc.; A. Battle is a shareholder of Google, Inc.; J. Fleming is executive director of the American Medical and Research Association; and J.B.V. and R. Little serve on the board of NDRI. Author contributions: The GTEx Consortium contributed collectively to this study. Biospecimens were provided by the Biospecimen source sites and the brain bank operations, and processed by the LDACC and comprehensive biospecimen resource. Pathological review of specimens was conducted by the pathology resource center, and all donor data entry and review by the comprehensive data resource. Data generation was undertaken by the Laboratory, Data Analysis and Coordinating Center (LDACC), and analyses were performed by all members of the Analysis Working Group. Project activities were coordinated by caHUB operations and overseen by the NHGRI, NIMH, and NCI project teams. We acknowledge the following investigators of the Analysis Working Group who contributed substantially to analyses presented here. Transcriptome variation: D.S.D., P.G.F. Single-tissue eQTL analysis: A.A.S., D.S.D., A.V.S. Multitissue eQTL analysis: T.F., X.W., A.A.S., G.L. Allele-specific expression: T.L. Splice QTLs: J.M., H.O. Functional annotation: L.D.W., P.K. Network Analyses: A. Battle, S.M., Z.T., T.H., B.I. Protein-truncating analyses: M.A.R., M.; L. GWAS analysis: E.R.G., A.V.S., L.D.W.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Monlong J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5698; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wen XQ, 2014, BIOMETRICS, V70, P73, DOI 10.1111/biom.12112; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	45	3025	3056	15	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					648	660		10.1126/science.1262110	http://dx.doi.org/10.1126/science.1262110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954001	Green Published, Green Accepted			2022-12-24	WOS:000354045700036
J	Greer, EL; Blanco, MA; Gu, L; Sendinc, E; Liu, JZ; Aristizabal-Corrales, D; Hsu, CH; Aravind, L; He, C; Shi, Y				Greer, Eric Lieberman; Blanco, Mario Andres; Gu, Lei; Sendinc, Erdem; Liu, Jianzhao; Aristizabal-Corrales, David; Hsu, Chih-Hung; Aravind, L.; He, Chuan; Shi, Yang			DNA Methylation on N-6-Adenine in C-elegans	CELL			English	Article							EPIGENETIC INHERITANCE; CAENORHABDITIS-ELEGANS; HISTONE METHYLATION; MOUSE; RNA; MECHANISMS; MEMORY; INACTIVATION; GENERATIONS; DEMETHYLASE	In mammalian cells, DNA methylation on the fifth position of cytosine (5mC) plays an important role as an epigenetic mark. However, DNA methylation was considered to be absent in C. elegans because of the lack of detectable 5mC, as well as homologs of the cytosine DNA methyltransferases. Here, using multiple approaches, we demonstrate the presence of adenine N-6-methylation (6mA) in C. elegans DNA. We further demonstrate that this modification increases trans-generationally in a paradigm of epigenetic inheritance. Importantly, we identify a DNA demethylase, NMAD-1, and a potential DNA methyltransferase, DAMT-1, which regulate 6mA levels and crosstalk between methylations of histone H3K4 and adenines and control the epigenetic inheritance of phenotypes associated with the loss of the H3K4me2 demethylase spr-5. Together, these data identify a DNA modification in C. elegans and raise the exciting possibility that 6mA may be a carrier of heritable epigenetic information in eukaryotes.	[Greer, Eric Lieberman; Blanco, Mario Andres; Gu, Lei; Sendinc, Erdem; Aristizabal-Corrales, David; Hsu, Chih-Hung; Shi, Yang] Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Greer, Eric Lieberman; Blanco, Mario Andres; Gu, Lei; Sendinc, Erdem; Aristizabal-Corrales, David; Hsu, Chih-Hung; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Liu, Jianzhao; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Dept Chem, Chicago, IL 60637 USA; [Liu, Jianzhao; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, Chicago, IL 60637 USA; [Aravind, L.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Chicago; Howard Hughes Medical Institute; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Greer, EL (corresponding author), Childrens Hosp, Div Newborn Med, 300 Longwood Ave, Boston, MA 02115 USA.	eric.greer@childrens.harvard.edu; yshi@hms.harvard.edu	Liu, Jianzhao/AAO-2359-2020; Gu, Lei/GWQ-6785-2022; Hsu, Chih-Hung/AEM-8298-2022; Liu, Jianzhao/E-9165-2011	Liu, Jianzhao/0000-0001-9465-6075; Hsu, Chih-Hung/0000-0001-8071-0122; Liu, Jianzhao/0000-0001-9465-6075; Aravind, L/0000-0003-0771-253X; Greer, Eric/0000-0002-7501-7371; Blanco, M. Andres/0000-0003-4404-2301	NIH Office of Research Infrastructure Programs [P40OD010440]; Tufts University Core Facility Genomics Core; University of Massachusetts Medical School Deep Sequencing Core; Helen Hay Whitney postdoctoral fellowship; National Institute on Aging of the NIH [K99AG043550]; NIH NRSA postdoctoral fellowship [1F32CA180450-01]; Leukemia & Lymphoma Society [3353-15]; National Library of Health, NIH; U.S. department of Health and Human Services; NIH [K99AG043550, GM058012, CA118487, MH096066]; Ellison Foundation; Samual Waxman Cancer Research Foundation [SWCRF-1856]; NATIONAL CANCER INSTITUTE [F32CA180450, R01CA118487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG043550, K99AG043550] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University Core Facility Genomics Core; University of Massachusetts Medical School Deep Sequencing Core; Helen Hay Whitney postdoctoral fellowship; National Institute on Aging of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Library of Health, NIH; U.S. department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); Samual Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Shi lab for helpful discussions, Elizabeth Pollina for feedback on the manuscript, and Madeline Schuck and LaVondea Elow for technical and administrative support. We thank the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40OD010440) for C. elegans strains, and the Tufts University Core Facility Genomics Core and the University of Massachusetts Medical School Deep Sequencing Core for MeDIP-seq and SMRT sequencing, respectively. E.L.G. was supported by a Helen Hay Whitney postdoctoral fellowship and a National Institute on Aging of the NIH grant (K99AG043550). M.A.B. was supported by an NIH NRSA postdoctoral fellowship (1F32CA180450-01) and is currently supported by a Special Fellow award from the Leukemia & Lymphoma Society (3353-15). L.A. was supported by funds of the Intramural Research Program of the National Library of Health, NIH, and U.S. department of Health and Human Services. C.H. is a Howard Hughes Medical Institute investigator. This work was supported by NIH grants to Y.S. (GM058012, CA118487, and MH096066) and E.L.G. (K99AG043550), by an Ellison Foundation Senior Scholar Award to Y.S, and by a Samual Waxman Cancer Research Foundation grant to Y.S. (SWCRF-1856). Y.S. is an American Cancer Society Research Professor. Y.S. is also a cofounder of Constellation Pharmaceuticals Inc. and is a member of its scientific advisory board.	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gao F, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r100; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Greer EL, 2014, CELL REP, V7, P113, DOI 10.1016/j.celrep.2014.02.044; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Gutierrez Juan C., 2000, International Microbiology, V3, P139; Han JS, 2004, J BIOL CHEM, V279, P30236, DOI 10.1074/jbc.M402612200; Iyer LM, 2014, P NATL ACAD SCI USA, V111, P1676, DOI 10.1073/pnas.1321818111; Iyer LM, 2013, NUCLEIC ACIDS RES, V41, P7635, DOI 10.1093/nar/gkt573; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kerr SC, 2014, P NATL ACAD SCI USA, V111, P9509, DOI 10.1073/pnas.1321843111; Koh KP, 2013, CURR OPIN CELL BIOL, V25, P152, DOI 10.1016/j.ceb.2013.02.014; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nottke AC, 2011, P NATL ACAD SCI USA, V108, P12805, DOI 10.1073/pnas.1102298108; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Saksouk N, 2014, MOL CELL, V56, P580, DOI 10.1016/j.molcel.2014.10.001; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P3418, DOI 10.1073/pnas.79.11.3418; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wenzel D, 2011, GENESIS, V49, P647, DOI 10.1002/dvg.20762; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Yi CQ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012575; Zemach A, 2010, CURR BIOL, V20, pR780, DOI 10.1016/j.cub.2010.07.007; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	46	401	425	9	164	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					868	878		10.1016/j.cell.2015.04.005	http://dx.doi.org/10.1016/j.cell.2015.04.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25936839	Green Accepted, Bronze			2022-12-24	WOS:000354175200019
J	Ma, DKG; Stolte, C; Krycer, JR; James, DE; O'Donoghue, SI				Ma, David K.G.; Stolte, Christian; Krycer, James R.; James, David E.; O'Donoghue, Sean I.			SnapShot: Insulin/IGF1 Signaling	CELL			English	Editorial Material							PHOSPHODIESTERASE 3B; PHOSPHORYLATION; ACTIVATION; PROTEIN; AKT		[Ma, David K.G.; O'Donoghue, Sean I.] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Ma, David K.G.] UNSW, Sch Comp Sci & Engn, Sydney, NSW 2052, Australia; [Stolte, Christian; O'Donoghue, Sean I.] CSIRO, N Ryde, NSW 1670, Australia; [Krycer, James R.; James, David E.] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; University of Sydney	Ma, DKG (corresponding author), Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia.		; O'Donoghue, Sean/A-9522-2012	Stolte, Christian/0000-0002-8228-4195; O'Donoghue, Sean/0000-0001-9520-6623; James, David/0000-0001-5946-5257; Krycer, James/0000-0003-1536-7270				Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Ma DKG, 2013, AIP CONF PROC, V1559, P185, DOI 10.1063/1.4825010; Onuma H, 2002, DIABETES, V51, P3362, DOI 10.2337/diabetes.51.12.3362; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Ziv E, 2011, AGEING RES REV, V10, P201, DOI 10.1016/j.arr.2010.09.002	10	14	14	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4							948.e1	10.1016/j.cell.2015.04.041	http://dx.doi.org/10.1016/j.cell.2015.04.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957692	Bronze			2022-12-24	WOS:000354175200026
J	Venkatesh, HS; Johung, TB; Caretti, V; Noll, A; Tang, YJ; Nagaraja, S; Gibson, EM; Mount, CW; Polepalli, J; Mitra, SS; Woo, PJ; Malenka, RC; Vogel, H; Bredel, M; Mallick, P; Monje, M				Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Polepalli, Jai; Mitra, Siddhartha S.; Woo, Pamelyn J.; Malenka, Robert C.; Vogel, Hannes; Bredel, Markus; Mallick, Parag; Monje, Michelle			Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion	CELL			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; OLIGODENDROCYTE PRECURSOR CELLS; MALIGNANT GLIOMA; C-FOS; HUMAN GLIOBLASTOMA; TRANSGENIC MICE; HISTONE H3.3; BRAIN; ACTIVATION; EXPRESSION	Active neurons exert a mitogenic effect on normal neural precursor and oligodendroglial precursor cells, the putative cellular origins of high-grade glioma (HGG). By using optogenetic control of cortical neuronal activity in a patient-derived pediatric glioblastoma xenograft model, we demonstrate that active neurons similarly promote HGG proliferation and growth in vivo. Conditioned medium from opto-genetically stimulated cortical slices promoted proliferation of pediatric and adult patient-derived HGG cultures, indicating secretion of activity-regulated mitogen(s). The synaptic protein neuroligin-3 (NLGN3) was identified as the leading candidate mitogen, and soluble NLGN3 was sufficient and necessary to promote robust HGG cell proliferation. NLGN3 induced PI3K-mTOR pathway activity and feedforward expression of NLGN3 in glioma cells. NLGN3 expression levels in human HGG negatively correlated with patient overall survival. These findings indicate the important role of active neurons in the brain tumor microenvironment and identify secreted NLGN3 as an unexpected mechanism promoting neuronal activity-regulated cancer growth.	[Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Venkatesh, Humsa S.; Johung, Tessa B.; Caretti, Viola; Noll, Alyssa; Tang, Yujie; Nagaraja, Surya; Gibson, Erin M.; Mount, Christopher W.; Mitra, Siddhartha S.; Woo, Pamelyn J.; Monje, Michelle] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Polepalli, Jai; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Bredel, Markus] Univ Alabama Birmingham, Sch Med, Dept Radiat Oncol, Birmingham, AL 35233 USA; [Mallick, Parag] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Alabama System; University of Alabama Birmingham; Stanford University	Monje, M (corresponding author), Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA.	mmonje@stanford.edu		Monje, Michelle/0000-0002-3547-237X; Venkatesh, Humsa/0000-0003-1194-3015; Vogel, Otto Hannes/0000-0002-0960-3508; Mount, Christopher/0000-0003-1635-2492; Gibson, Erin/0000-0001-9749-3814; Polepalli, Jai/0000-0003-2004-2163	Matthew Larson Foundation; Godfrey Family Fund in Memory of Fiona Penelope; National Institute of Neurological Disorders and Stroke (NINDS) [K08NS070926]; McKenna Claire Foundation; National Science Foundation Graduate Research Fellowship Program; California Institute for Regenerative Medicine [CIRM RB4-06093, RN3-06510]; Alex's Lemonade Stand Foundation; Cure Starts Now Foundation; Lyla Nsouli Foundation; Unravel Pediatric Cancer; Wayland Villars DIPG Foundation; Jennifer Kranz Memorial Fund, virginia; D.K. Ludwig Fund for Cancer Research; Bear Necessities Pediatric Cancer Foundation; Lucile Packard Foundation for Children's Health; Stanford University School of Medicine Dean's Fellowship; Child Health Research Institute at Stanford Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; National Cancer Institute [PSOC-MCSTART U54CA143907]; Canary Foundation; Ben and Catherine Ivy Foundation; Sujal and Meera Patel Foundation; Dylan Jewett Memorial Fund, Virginia; Connor Johnson Memorial Fund, Virginia; Zoey Ganesh Memorial Fund, Virginia; Dylan Frick Memorial Fund, Virginia; Abigail Jensen Memorial Fund, Virginia; NATIONAL CANCER INSTITUTE [U54CA143907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070926] Funding Source: NIH RePORTER	Matthew Larson Foundation; Godfrey Family Fund in Memory of Fiona Penelope; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McKenna Claire Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Alex's Lemonade Stand Foundation; Cure Starts Now Foundation; Lyla Nsouli Foundation; Unravel Pediatric Cancer; Wayland Villars DIPG Foundation; Jennifer Kranz Memorial Fund, virginia; D.K. Ludwig Fund for Cancer Research; Bear Necessities Pediatric Cancer Foundation; Lucile Packard Foundation for Children's Health; Stanford University School of Medicine Dean's Fellowship; Child Health Research Institute at Stanford Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation; Ben and Catherine Ivy Foundation; Sujal and Meera Patel Foundation; Dylan Jewett Memorial Fund, Virginia; Connor Johnson Memorial Fund, Virginia; Zoey Ganesh Memorial Fund, Virginia; Dylan Frick Memorial Fund, Virginia; Abigail Jensen Memorial Fund, Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge support from the Matthew Larson Foundation, Godfrey Family Fund in Memory of Fiona Penelope, National Institute of Neurological Disorders and Stroke (NINDS K08NS070926), McKenna Claire Foundation, National Science Foundation Graduate Research Fellowship Program, California Institute for Regenerative Medicine (CIRM RB4-06093 and RN3-06510), Alex's Lemonade Stand Foundation, The Cure Starts Now Foundation, Lyla Nsouli Foundation, Unravel Pediatric Cancer, the Wayland Villars DIPG Foundation, the Dylan Jewett, Connor Johnson, Zoey Ganesh, Dylan Frick, Abigail Jensen, and Jennifer Kranz Memorial Funds, Virginia and D.K. Ludwig Fund for Cancer Research, the Bear Necessities Pediatric Cancer Foundation, Lucile Packard Foundation for Children's Health, Stanford University School of Medicine Dean's Fellowship, Child Health Research Institute at Stanford Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases, National Cancer Institute (PSOC-MCSTART U54CA143907), Canary Foundation, Ben and Catherine Ivy Foundation, and the Sujal and Meera Patel Foundation. Special thanks to Sarah Chen for illustrations, to Elizabeth Hoyte for assistance with figures, to Eric Raabe for use of the JHH-DIPGI cell line, and to Tom Sudhof for helpful discussions.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Campbell SL, 2012, EPILEPSIA, V53, P1360, DOI 10.1111/j.1528-1167.2012.03557.x; Chen DB, 2003, MOL CELL ENDOCRINOL, V200, P141, DOI 10.1016/S0303-7207(02)00379-9; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Galvao RP, 2014, P NATL ACAD SCI USA, V111, pE4214, DOI 10.1073/pnas.1414389111; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Gjorlund MD, 2012, FASEB J, V26, P4174, DOI 10.1096/fj.11-202242; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Glasgow SM, 2014, NAT NEUROSCI, V17, P1322, DOI 10.1038/nn.3790; Gonzales M, 2002, ONCOGENE, V21, P2721, DOI 10.1038/sj.onc.1205366; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Samarelli AV, 2014, J BIOL CHEM, V289, P19466, DOI 10.1074/jbc.M113.530972; Scherer H., 1938, AM J CANC, V34, P333, DOI [DOI 10.1158/AJC.1938.333, 10.1158/ajc.1938.333]; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seifert S, 2014, J PHYSIOL-LONDON, V592, P5109, DOI 10.1113/jphysiol.2014.274498; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Stopczynski RE, 2014, CANCER RES, V74, P1718, DOI 10.1158/0008-5472.CAN-13-2050; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Synowitz M, 2001, EUR J NEUROSCI, V14, P1294, DOI 10.1046/j.0953-816x.2001.01764.x; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	57	324	336	3	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					803	816		10.1016/j.cell.2015.04.012	http://dx.doi.org/10.1016/j.cell.2015.04.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25913192	Bronze, Green Accepted			2022-12-24	WOS:000354175200014
J	Kreiter, S; Vormehr, M; van de Roemer, N; Diken, M; Lower, M; Diekmann, J; Boegel, S; Schrors, B; Vascotto, F; Castle, JC; Tadmor, AD; Schoenberger, SP; Huber, C; Tureci, O; Sahin, U				Kreiter, Sebastian; Vormehr, Mathias; van de Roemer, Niels; Diken, Mustafa; Loewer, Martin; Diekmann, Jan; Boegel, Sebastian; Schroers, Barbara; Vascotto, Fulvia; Castle, John C.; Tadmor, Arbel D.; Schoenberger, Stephen P.; Huber, Christoph; Tuereci, Oezlem; Sahin, Ugur			Mutant MHC class II epitopes drive therapeutic immune responses to cancer	NATURE			English	Article							EXOME ANALYSIS REVEALS; CD4(+) T-CELLS; PD-1 BLOCKADE; ANTIGENS; LYMPHOCYTES; EFFICIENCY; LANDSCAPE; STABILITY; PATIENT	Tumour-specific mutations are ideal targets for cancer immunotherapy as they lack expression in healthy tissues and can potentially be recognized as neo-antigens by the mature T-cell repertoire. Their systematic targeting by vaccine approaches, however, has been hampered by the fact that every patient's tumour possesses a unique set of mutations (the mutanome') that must first be identified. Recently, we proposed a personalized immunotherapy approach to target the full spectrum of a patient's individual tumour-specific mutationsl. Here we show in three independent murine tumour models that a considerable fraction of non-synonymous cancer mutations is immunogenic and that, unexpectedly, the majority of the immunogenic mutanome is recognized by Cal+ T cells. Vaccination with such Cal+ immunogenic mutations confers strong antitumour activity. Encouraged by these findings, we established a process by which mutations identified by exome sequencing could be selected as vaccine targets solely through bioinformatic prioritization on the basis of their expression levels and major histocompatibility complex (MHC) class II-binding capacity for rapid production as synthetic poly-neo-epitope messenger RNA vaccines. We show that vaccination with such polytope mRNA vaccines induces potent tumour control and complete rejection of established aggressively growing tumours in mice. Moreover, we demonstrate that Cal+ T cell neo-epitope vaccination reshapes the tumour microenvironment and induces cytotoxic T lymphocyte responses against an independent immunodominant antigen in mice, indicating orchestration of antigen spread. Finally, we demonstrate an abundance of mutations predicted to bind to MHC class II in human cancers as well by employing the same predictive algorithm on corresponding human cancer types. Thus, the tailored immunotherapy approach introduced here may be regarded as a universally applicable blueprint for comprehensive exploitation of the substantial neo-epitope target repertoire of cancers, enabling the effective targeting of every patient's tumour with vaccines produced 'just in time'.	[Kreiter, Sebastian; Diken, Mustafa; Loewer, Martin; Diekmann, Jan; Boegel, Sebastian; Schroers, Barbara; Vascotto, Fulvia; Castle, John C.; Tadmor, Arbel D.; Tuereci, Oezlem; Sahin, Ugur] Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, D-55131 Mainz, Germany; [Vormehr, Mathias; van de Roemer, Niels; Huber, Christoph; Sahin, Ugur] Res Ctr Immunotherapy FZI, D-55131 Mainz, Germany; [Diekmann, Jan; Sahin, Ugur] Biopharmaceut New Technol BioNTech Corp, D-55131 Mainz, Germany; [Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	Johannes Gutenberg University of Mainz; BioNTech SE; La Jolla Institute for Immunology	Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, TRON Translat Oncol, Freiligrathstr 12, D-55131 Mainz, Germany.	sahin@uni-mainz.de	Sahin, Ugur/L-4818-2017; Boegel, Sebastian/AAH-8171-2019; Vormehr, Mathias/AAJ-7808-2021	Sahin, Ugur/0000-0003-0363-1564; Vormehr, Mathias/0000-0001-7788-3380; Schrors, Barbara/0000-0001-9758-250X; Vascotto, Fulvia/0000-0002-9839-3484; Roth, Rene/0000-0002-4333-695X; Boegel, Sebastian/0000-0001-5425-8304	CI3 excellence cluster program of the Federal Ministry of Education and Research (BMBF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107010] Funding Source: NIH RePORTER	CI3 excellence cluster program of the Federal Ministry of Education and Research (BMBF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Holzmann, A. Konig, U. Schmitt, R. Roth, C. Worm and N. Krause for technical assistance; L. Ralla, J. Gross, A. Spruss, M. Erdeljan, S. Woll and C. Rohde for immunohistochemical staining and analysis; C. Paret for sequence validation of mutations; M. Brkic for immunofluorescence staining; S. Witzel and Bodo Tillmann, S. Wurzel and Z. Yildiz for cloning of constructs; S. Kind, M. Mechler, F. Wille, B. Otte and S. Petri for RNA production as well as L. Kranz and colleagues involved in RNA formulation development. We are grateful to B. Kloke, S. Heesch, A. Kuhn, J. Buck, C. Britten and H. Haas for conceptual and technical discussions. Moreover, we would like to thank V. Bukur, J. de Graf and C. Albrecht who supported the next-generation sequencing of samples. Furthermore we like to acknowledge A. Kong for critical reading and A. Orlandini for help with graphic design. The results shown here are in part based on data generated by the TCGA Research Network http://cancergenome.nih.gov/. The study was supported by the CI3 excellence cluster program of the Federal Ministry of Education and Research (BMBF).	Arnold PY, 2002, J IMMUNOL, V169, P739, DOI 10.4049/jimmunol.169.2.739; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Boegel S, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.954893; Britten CM, 2013, NAT BIOTECHNOL, V31, P880, DOI 10.1038/nbt.2708; Castle JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04743; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kreiter S, 2008, J IMMUNOL, V180, P309, DOI 10.4049/jimmunol.180.1.309; Kreiter S, 2010, CANCER RES, V70, P9031, DOI 10.1158/0008-5472.CAN-10-0699; Kuhn AN, 2010, GENE THER, V17, P961, DOI 10.1038/gt.2010.52; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lower M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002714; Lu YC, 2013, J IMMUNOL, V190, P6034, DOI 10.4049/jimmunol.1202830; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Shen ZH, 1997, J IMMUNOL, V158, P2723; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	30	715	787	9	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					692	U269		10.1038/nature14426	http://dx.doi.org/10.1038/nature14426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25901682	Green Accepted			2022-12-24	WOS:000353689700053
J	Urnavicius, L; Zhang, K; Diamant, AG; Motz, C; Schlager, MA; Yu, MM; Patel, NA; Robinson, CV; Carter, AP				Urnavicius, Linas; Zhang, Kai; Diamant, Aristides G.; Motz, Carina; Schlager, Max A.; Yu, Minmin; Patel, Nisha A.; Robinson, Carol V.; Carter, Andrew P.			The structure of the dynactin complex and its interaction with dynein	SCIENCE			English	Article							ACTIN-RELATED PROTEIN; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; HEAVY-CHAIN; BARBED-END; BICAUDAL-D; IN-VITRO; RECRUITMENT; COMPONENT; FILAMENT	Dynactin is an essential cofactor for the microtubule motor cytoplasmic dynein-1. We report the structure of the 23-subunit dynactin complex by cryo-electronmicroscopy to 4.0 angstroms. Our reconstruction reveals how dynactin is built around a filament containing eight copies of the actin-related protein Arp1 and one of beta-actin. The filament is capped at each end by distinct protein complexes, and its length is defined by elongated peptides that emerge from the a-helical shoulder domain. A further 8.2 angstrom structure of the complex between dynein, dynactin, and the motility-inducing cargo adaptor Bicaudal-D2 shows how the translational symmetry of the dynein tail matches that of the dynactin filament. The Bicaudal-D2 coiled coil runs between dynein and dynactin to stabilize the mutually dependent interactions between all three components.	[Urnavicius, Linas; Zhang, Kai; Diamant, Aristides G.; Motz, Carina; Schlager, Max A.; Yu, Minmin; Carter, Andrew P.] MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 0QH, England; [Patel, Nisha A.; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	MRC Laboratory Molecular Biology; University of Oxford	Carter, AP (corresponding author), MRC, Mol Biol Lab, Div Struct Studies, Francis Crick Ave, Cambridge CB2 0QH, England.	cartera@mrc-lmb.cam.ac.uk		robinson, carol/0000-0001-7829-5505; Carter, Andrew/0000-0001-7292-5430; Zhang, Kai/0000-0001-8617-2855	Medical Research Council, UK [MC_UP_A025_1011]; Wellcome Trust New Investigator Award [WT100387]; Medical Research Council [MC_UP_A025_1011, 1352465] Funding Source: researchfish; MRC [MC_UP_A025_1011] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust New Investigator Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Scheres and X. Bai for cryo-EM advice; G. McMullan, C. Savva, J. Grimmett, and T. Darling for technical support; S. Leech for fresh pig brains; V. Beilsten-Edmands for assistance with proteomic analyses; S. Bullock, R. McKenney, and J. Pennell for comments on the manuscript; and Y. Toyoshima for sharing her unpublished negative-stain EM model of the p150<SUP>Glued</SUP> projection, which helped us to interpret our observations. This work was funded by the Medical Research Council, UK (MC_UP_A025_1011), and a Wellcome Trust New Investigator Award (WT100387). Cryo-EM maps are deposited with the Electron Microscopy Data Bank (EMD-2854, EMD-2855, EMD-2856, EMD-2857, EMD-2860, EMD-2861, and EMD-2862), and coordinates are deposited with the Protein Data Bank (5AFT, 5AFU, and 5AFR). Author contributions: L.U. prepared dynactin and determined the TDB structure. K.Z. determined the structure of dynactin. A.G.D. and M.Y. determined the crystal structure of the DHC N terminus. C.M. and M.A.S. prepared the dynein tail complex. N.A.P. and C. V. R performed MS. A.P.C. initiated the project and designed the experiments.	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Bingham JB, 1999, CURR BIOL, V9, P223, DOI 10.1016/S0960-9822(99)80095-5; Cheong FKY, 2014, MOL BIOL CELL, V25, P2171, DOI 10.1091/mbc.E14-03-0842; Dienstbier M, 2009, BIOCHEM SOC T, V37, P1066, DOI 10.1042/BST0371066; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Hammesfahr B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-95; Hodgkinson JL, 2005, P NATL ACAD SCI USA, V102, P3667, DOI 10.1073/pnas.0409506102; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Imai H, 2014, J MOL BIOL, V426, P3262, DOI 10.1016/j.jmb.2014.07.010; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; LEESMILLER JP, 1992, NATURE, V359, P244, DOI 10.1038/359244a0; Liu Y, 2013, GENE DEV, V27, P1233, DOI 10.1101/gad.212381.112; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Pfister KK, 1998, CELL MOTIL CYTOSKEL, V41, P154, DOI 10.1002/(SICI)1097-0169(1998)41:2<154::AID-CM6>3.0.CO;2-E; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schiavo G, 2013, TRENDS NEUROSCI, V36, P641, DOI 10.1016/j.tins.2013.08.001; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Siglin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059453; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Tripathy SK, 2014, NAT CELL BIOL, V16, P1192, DOI 10.1038/ncb3063; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yeh TY, 2013, EMBO J, V32, P1023, DOI 10.1038/emboj.2013.30; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496	39	223	224	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1441	1446		10.1126/science.aaa4080	http://dx.doi.org/10.1126/science.aaa4080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814576	Green Accepted			2022-12-24	WOS:000352136400032
J	Wang, JH; Cao, JL; Dickson, AL; Poss, KD				Wang, Jinhu; Cao, Jingli; Dickson, Amy L.; Poss, Kenneth D.			Epicardial regeneration is guided by cardiac outflow tract and Hedgehog signalling	NATURE			English	Article							ZEBRAFISH HEART REGENERATION; MOTOR-NEURON INDUCTION; SONIC-HEDGEHOG; IN-VIVO; TRANSCRIPTION FACTORS; FLOOR PLATE; CELLS; INJURY; CARDIOMYOCYTES; NOTOCHORD	In response to cardiac damage, a mesothelial tissue layer enveloping the heart called the epicardium is activated to proliferate and accumulate at the injury site. Recent studies have implicated the epicardium in multiple aspects of cardiac repair: as a source of paracrine signals for cardiomyocyte survival or proliferation; a supply of perivascular cells and possibly other cell types such as cardiomyocytes; and as a mediator of inflammation1-9. However, the biology and dynamism of the adult epicardium is poorly understood. To investigate this, we created a transgenic line to ablate the epicardial cell population in adult zebrafish. Here we find that genetic depletion of the epicardium after myocardial loss inhibits cardiomyocyte proliferation and delays muscle regeneration. The epicardium vigorously regenerates after its ablation, through proliferation and migration of spared epicardial cells as a sheet to cover the exposed ventricular surface in a wave from the chamber base towards its apex. By reconstituting epicardial regeneration ex vivo, we show that extirpation of the bulbous arteriosus-a distinct, smooth-muscle-rich tissue structure that distributes outflow from the ventricle-prevents epicardial regeneration. Conversely, experimental repositioning of the bulbous arteriosus by tissue recombination initiates epicardial regeneration and can govern its direction. Hedgehog (Hh) ligand is expressed in the bulbous arteriosus, and treatment with a Hh signalling antagonist arrests epicardial regeneration and blunts the epicardial response to muscle injury. Transplantation of Sonic hedgehog (Shh)-soaked beads at the ventricular base stimulates epicardial regeneration after bulbous arteriosus removal, indicating that Hh signalling can substitute for the influence of the outflow tract. Thus, the ventricular epicardium has pronounced regenerative capacity, regulated by the neighbouring cardiac outflow tract and Hh signalling. These findings extend our understanding of tissue interactions during regeneration and have implications for mobilizing epicardial cells for therapeutic heart repair.	[Wang, Jinhu; Cao, Jingli; Dickson, Amy L.; Poss, Kenneth D.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Wang, Jinhu; Cao, Jingli; Dickson, Amy L.; Poss, Kenneth D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	kenneth.poss@duke.edu		Cao, Jingli/0000-0001-5938-6604; Wang, Jinhu/0000-0001-9477-0310; Poss, Kenneth/0000-0002-6743-5709	American Heart Association; National Institutes of Health [HL081674]; American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081674] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Burris, N. Lee, A. Dunlap and S. Davies for fish care, and M. Bagnat, B. Hogan, J. Kang and R. Karra for comments on the manuscript. This work was funded by postdoctoral fellowships from the American Heart Association to J.W. and J.C., and grants from the National Institutes of Health (HL081674) and American Federation for Aging Research to K.D.P.	Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Guerrero I, 2014, SEMIN CELL DEV BIOL, V33, P52, DOI 10.1016/j.semcdb.2014.06.016; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kim J, 2012, NAT PROTOC, V7, P247, DOI 10.1038/nprot.2011.440; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Singh SP, 2012, DEV CELL, V22, P879, DOI 10.1016/j.devcel.2012.03.006; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Zhou B, 2012, METHODS MOL BIOL, V843, P155, DOI 10.1007/978-1-61779-523-7_15; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	29	131	134	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					226	+		10.1038/nature14325	http://dx.doi.org/10.1038/nature14325			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25938716	Green Accepted			2022-12-24	WOS:000356016700041
J	Bosch, FH; Fleming, DA				Bosch, Frank H.; Fleming, David A.			Moving to High-Value Care: More Thoughtful Use of Cardiopulmonary Resuscitation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HOSPITAL CARDIAC-ARREST; SURVIVAL; TRENDS		[Bosch, Frank H.] Rijnstate Hosp, Dept Internal Med, NL-6800 TA Arnhem, Netherlands; Univ Missouri, Sch Med, Columbia, MO USA	Rijnstate Hospital; University of Missouri System; University of Missouri Columbia	Bosch, FH (corresponding author), Rijnstate Hosp, Dept Internal Med, POB 9555, NL-6800 TA Arnhem, Netherlands.	fhbosch@gmail.com	Bosch, Frank/AAW-6704-2020					Alahmar AE, 2014, HEART, V100, P1125, DOI 10.1136/heartjnl-2014-305696; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Green Michael J, 2015, Ann Intern Med, V162, pW74, DOI 10.7326/G14-0009; Institute of Medicine, 2014, DYING AM IMPR QUAL H; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Pizzo PA, 2015, ANN INTERN MED, V162, P228, DOI 10.7326/M14-2399; SAFAR P, 1958, NEW ENGL J MED, V258, P671, DOI 10.1056/NEJM195804032581401; Smith CD, 2012, ANN INTERN MED, V157, P284, DOI 10.7326/0003-4819-157-4-201208210-00496; Stapleton RD, 2014, CHEST, V146, P1214, DOI 10.1378/chest.13-2110	10	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					790	791		10.7326/M15-0492	http://dx.doi.org/10.7326/M15-0492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	25844884				2022-12-24	WOS:000355572300008
J	Wu, J; Okamura, D; Li, M; Suzuki, K; Luo, CY; Ma, L; He, YP; Li, ZW; Benner, C; Tamura, I; Krause, MN; Nery, JR; Du, TT; Zhang, ZZ; Hishida, T; Takahashi, Y; Aizawa, E; Kim, NY; Lajara, J; Guillen, P; Campistol, JM; Esteban, CR; Ross, PJ; Saghatelian, A; Ren, B; Ecker, JR; Belmonte, JCI				Wu, Jun; Okamura, Daiji; Li, Mo; Suzuki, Keiichiro; Luo, Chongyuan; Ma, Li; He, Yupeng; Li, Zhongwei; Benner, Chris; Tamura, Isao; Krause, Marie N.; Nery, Joseph R.; Du, Tingting; Zhang, Zhuzhu; Hishida, Tomoaki; Takahashi, Yuta; Aizawa, Emi; Kim, Na Young; Lajara, Jeronimo; Guillen, Pedro; Campistol, Josep M.; Esteban, Concepcion Rodriguez; Ross, Pablo J.; Saghatelian, Alan; Ren, Bing; Ecker, Joseph R.; Belmonte, Juan Carlos Izpisua			An alternative pluripotent state confers interspecies chimaeric competency	NATURE			English	Article							EMBRYONIC STEM-CELLS; PRIMITIVE STREAK; MOUSE EMBRYOS; HOMOLOGOUS RECOMBINATION; REGULATORY REGIONS; SELF-RENEWAL; CULTURE; EMBRYOGENESIS; SPECIFICATION; TRANSCRIPTION	Pluripotency, the ability to generate any cell type of the body, is an evanescent attribute of embryonic cells. Transitory pluripotent cells can be captured at different time points during embryogenesis and maintained as embryonic stem cells or epiblast stem cells in culture. Since ontogenesis is a dynamic process in both space and time, it seems counterintuitive that these two temporal states represent the full spectrum of organismal pluripotency. Here we show that by modulating culture parameters, a stem-cell type with unique spatial characteristics and distinct molecular and functional features, designated as region-selective pluripotent stem cells (rsPSCs), can be efficiently obtained from mouse embryos and primate pluripotent stem cells, including humans. The ease of culturing and editing the genome of human rsPSCs offers advantages for regenerative medicine applications. The unique ability of human rsPSCs to generate post-implantation interspecies chimaeric embryos may facilitate our understanding of early human development and evolution.	[Wu, Jun; Okamura, Daiji; Li, Mo; Suzuki, Keiichiro; Ma, Li; Li, Zhongwei; Tamura, Isao; Krause, Marie N.; Hishida, Tomoaki; Takahashi, Yuta; Aizawa, Emi; Kim, Na Young; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Luo, Chongyuan; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Luo, Chongyuan; He, Yupeng; Nery, Joseph R.; Zhang, Zhuzhu; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Benner, Chris] Salk Inst Biol Studies, Integrated Genom, La Jolla, CA 92037 USA; [Du, Tingting; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hishida, Tomoaki] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058577, Japan; [Lajara, Jeronimo; Guillen, Pedro] Univ Catolica, Med, Guadalupe 30107, Spain; [Guillen, Pedro] Fdn Pedro Guillen, Clin Cemtro, Madrid 28035, Spain; [Campistol, Josep M.] Hosp Clin Barcelona, E-08036 Barcelona, Spain; [Ross, Pablo J.] Univ Calif Davis, Davis, CA 95616 USA; [Saghatelian, Alan] Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Tsukuba; Universidad Catolica de Valencia San Vicente Martir; University of Barcelona; Hospital Clinic de Barcelona; University of California System; University of California Davis; Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Li, Mo/AAM-8266-2021; Wu, Jun/AAF-1830-2019; Ecker, Joseph R/B-9144-2008; Nery, Joseph/AAE-8422-2019	Li, Mo/0000-0003-0827-8907; Wu, Jun/0000-0001-9863-1668; Ecker, Joseph R/0000-0001-5799-5895; Nery, Joseph/0000-0003-0153-5659; Suzuki, Keiichiro/0000-0001-5603-9105; Benner, Christopher/0000-0002-4618-0719; Lajara Blesa, Jeronimo/0000-0003-1859-8998; Josep M, Campistol/0000-0001-6244-0253	California Institute for Regenerative Medicine Training Grant; UCAM; Fundacion Pedro Guillen; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation	California Institute for Regenerative Medicine Training Grant; UCAM; Fundacion Pedro Guillen; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation	We would like to thank S. Mitalipov and J. Thomson for providing rhesus ESCs and iPSCs, respectively, F. Gage for providing chimpanzee iPSCs, K. Zhang for assistance with cell line derivation, M. Ku of the H. A. and Mary K. Chapman Charitable Foundations Genomic Sequencing Core for performing RNA-seq and mouse ChIP-seq experiments, M. Chang of the Integrative Genomic and Bioinformatics Core for bioinformatics analysis, W. T. Berggren and the staff of the Salk STEM Core for preparation of custom-mTeSR1 base medium and supply of validated stem culture materials, G. Pao and K. Hasegawa for discussions, Y. Dayn from transgenic core facility and J. Luo for blastocyst injections, Y. Tsunekawa for providing the mutante GFP human ESCs reporter line, E. O'Connor and K. Marquez of Human Embryonic Stem Cell Core Facility of Sanford Consortium for Regenerative Medicine for FACS sorting, R. H. Benitez, A. Goebl, R. D. Soligalia for assistance with genome editing, M. F. Pera for critical reading of the manuscript, and M. Schwarz, and P. Schwarz for administrative help. M. L. and K. S. are supported by a California Institute for Regenerative Medicine Training Grant. We thank J. L. Mendoza for his support on this project. This work was funded in part by UCAM (mouse studies). J. R. E. is an Investigator of the Howard Hughes Medical Institute. P. G. was supported by Fundacion Pedro Guillen. Work in the laboratory of J.C.I.B. was supported by G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust and The Moxie Foundation.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Alev C, 2010, DEVELOPMENT, V137, P2863, DOI 10.1242/dev.053462; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Berge D., 2011, NATURE CELL BIOL, V13, P1; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fooksman DR, 2014, J IMMUNOL, V192, P1004, DOI 10.4049/jimmunol.1300977; Fossat N, 2007, DEV CELL, V13, P761, DOI 10.1016/j.devcel.2007.11.011; Glanville-Jones HC, 2013, INT J DEV BIOL, V57, P61, DOI 10.1387/ijdb.120098ra; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hayashi K, 2013, NAT PROTOC, V8, P1513, DOI 10.1038/nprot.2013.090; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Kim H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3403; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okamura D, 2005, MOL REPROD DEV, V70, P20, DOI 10.1002/mrd.20136; Okamura D, 2003, DEVELOPMENT, V130, P6423, DOI 10.1242/dev.00870; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Pera MF, 2014, CELL STEM CELL, V15, P543, DOI 10.1016/j.stem.2014.10.013; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sumi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063378; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tonge PD, 2014, NATURE, V516, P192, DOI 10.1038/nature14047; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu J, 2014, NATURE, V516, P172, DOI 10.1038/516172a; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	57	163	170	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					316	+		10.1038/nature14413	http://dx.doi.org/10.1038/nature14413			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25945737	Green Accepted			2022-12-24	WOS:000354816500048
J	Cosentino, C; Alberio, L; Gazzarrini, S; Aquila, M; Romano, E; Cermenati, S; Zuccolini, P; Petersen, J; Beltrame, M; Van Etten, JL; Christie, JM; Thiel, G; Moroni, A				Cosentino, Cristian; Alberio, Laura; Gazzarrini, Sabrina; Aquila, Marco; Romano, Edoardo; Cermenati, Solei; Zuccolini, Paolo; Petersen, Jan; Beltrame, Monica; Van Etten, James L.; Christie, John M.; Thiel, Gerhard; Moroni, Anna			Engineering of a light-gated potassium channel	SCIENCE			English	Article							CHLORIDE CHANNEL; ION CHANNELS; K+ CHANNEL; CHANNELRHODOPSIN; DOMAIN; LOV	The present palette of opsin-based optogenetic tools lacks a light-gated potassium (K+) channel desirable for silencing of excitable cells. Here, we describe the construction of a blue-light-induced K+ channel 1 (BLINK1) engineered by fusing the plant LOV2-J alpha photosensory module to the small viral K+ channel Kcv. BLINK1 exhibits biophysical features of Kcv, including K+ selectivity and high single-channel conductance, but reversibly photoactivates in blue light. Opening of BLINK1 channels hyperpolarizes the cell to the K+ equilibrium potential. Ectopic expression of BLINK1 reversibly inhibits the escape response in light-exposed zebrafish larvae. BLINK1 therefore provides a single-component optogenetic tool that can establish prolonged, physiological hyperpolarization of cells at low light intensities.	[Cosentino, Cristian; Alberio, Laura; Gazzarrini, Sabrina; Aquila, Marco; Romano, Edoardo; Cermenati, Solei; Zuccolini, Paolo; Beltrame, Monica; Moroni, Anna] Univ Milan, Dept Biosci, I-20122 Milan, Italy; [Petersen, Jan; Christie, John M.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Van Etten, James L.] Univ Nebraska Lincoln, Dept Plant Pathol, Lincoln, NE 68583 USA; [Van Etten, James L.] Univ Nebraska Lincoln, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Thiel, Gerhard] Tech Univ Darmstadt, Membrane Biophys, Darmstadt, Germany	University of Milan; University of Glasgow; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Technical University of Darmstadt	Moroni, A (corresponding author), Univ Milan, Dept Biosci, I-20122 Milan, Italy.	anna.moroni@unimi.it	; moroni, anna/H-2097-2014	gazzarrini, sabrina/0000-0003-3062-7536; moroni, anna/0000-0002-1860-406X; Petersen, Jan/0000-0002-8469-6679; Alberio, Laura Silvia/0000-0002-2887-3343; Christie, John/0000-0002-9976-0055; Cosentino, Cristian/0000-0002-2784-0048; Beltrame, Monica/0000-0001-5094-3494; Thiel, Gerhard/0000-0002-2335-1351	Fondazione Cariplo grant [2009-3519]; PRIN (Programmi di Ricerca di Rilevante Interesse Nazionale) [2010CSJX4F]; MAE (Ministero Affari Esteri) [01467532013-06-27]; UK Biotechnology and Biological Sciences Research Council [BB/J016047/1, BB/M002128]; Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) initiative Soft Control; Biotechnology and Biological Sciences Research Council [BB/M002128/1, BB/J016047/1] Funding Source: researchfish; BBSRC [BB/J016047/1, BB/M002128/1] Funding Source: UKRI	Fondazione Cariplo grant(Fondazione Cariplo); PRIN (Programmi di Ricerca di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); MAE (Ministero Affari Esteri); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) initiative Soft Control; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank G. Romani for providing the antibody to Kcv; D. Minor for the Saccharomyces cerevisiae SGY1528 strain; U. P. Hansen, I. Schroeder, and A. Bertl for helpful discussion; and M. Ascagni for technical help with confocal microscopy. This work was supported by Fondazione Cariplo grant 2009-3519, PRIN (Programmi di Ricerca di Rilevante Interesse Nazionale) 2010CSJX4F, and MAE (Ministero Affari Esteri) 01467532013-06-27 to A. M.; by the UK Biotechnology and Biological Sciences Research Council (BB/J016047/1 and BB/M002128) to J.M.C.; and by the Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) initiative Soft Control to G.T.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Arrigoni C, 2013, J GEN PHYSIOL, V141, P389, DOI 10.1085/jgp.201210940; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Banghart MR, 2006, BIOCHEMISTRY-US, V45, P15129, DOI 10.1021/bi0618058; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Chatelain FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007496; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, MOL PLANT, V5, P533, DOI 10.1093/mp/sss020; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hertel B, 2010, EUR BIOPHYS J BIOPHY, V39, P1057, DOI 10.1007/s00249-009-0451-z; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Kang JY, 2013, NEURON, V80, P358, DOI 10.1016/j.neuron.2013.08.016; Latorre R, 2010, J PHYSIOL-LONDON, V588, P3141, DOI 10.1113/jphysiol.2010.191999; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Ohndorf UM, 2005, J MOL BIOL, V350, P857, DOI 10.1016/j.jmb.2005.05.050; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Schmidt D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4019; Strickland D, 2010, NAT METHODS, V7, P623, DOI [10.1038/NMETH.1473, 10.1038/nmeth.1473]; Tayefeh S, 2009, BIOPHYS J, V96, P485, DOI 10.1016/j.bpj.2008.09.050; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	23	89	92	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					707	710		10.1126/science.aaa2787	http://dx.doi.org/10.1126/science.aaa2787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954011	Green Submitted			2022-12-24	WOS:000354045700049
J	Ait-Ali, N; Fridlich, R; Millet-Puel, G; Clerin, E; Delalande, F; Jaillard, C; Blond, F; Perrocheau, L; Reichman, S; Byrne, LC; Olivier-Bandini, A; Bellalou, J; Moyse, E; Bouillaud, F; Nicol, X; Dalkara, D; van Dorsselaer, A; Sahel, JA; Leveillard, T				Ait-Ali, Najate; Fridlich, Ram; Millet-Puel, Geraldine; Clerin, Emmanuelle; Delalande, Francois; Jaillard, Celine; Blond, Frederic; Perrocheau, Ludivine; Reichman, Sacha; Byrne, Leah C.; Olivier-Bandini, Anne; Bellalou, Jacques; Moyse, Emmanuel; Bouillaud, Frederic; Nicol, Xavier; Dalkara, Deniz; van Dorsselaer, Alain; Sahel, Jose-Alain; Leveillard, Thierry			Rod-Derived Cone Viability Factor Promotes Cone Survival by Stimulating Aerobic Glycolysis	CELL			English	Article							THIOREDOXIN-LIKE PROTEIN; PYRUVATE-KINASE; RDCVF; EXPRESSION; CD147; PHOTORECEPTORS; DYSFUNCTION; SECRETION; RESCUE; MODEL	Rod-derived cone viability factor (RdCVF) is an inactive thioredoxin secreted by rod photoreceptors that protects cones from degeneration. Because the secondary loss of cones in retinitis pigmentosa (RP) leads to blindness, the administration of RdCVF is a promising therapy for this untreatable neurodegenerative disease. Here, we investigated the mechanism underlying the protective role of RdCVF in RP. We show that RdCVF acts through binding to Basigin-1 (BSG1), a transmembrane protein expressed specifically by photoreceptors. BSG1 binds to the glucose transporter GLUT1, resulting in increased glucose entry into cones. Increased glucose promotes cone survival by stimulation of aerobic glycolysis. Moreover, a missense mutation of RdCVF results in its inability to bind to BSG1, stimulate glucose uptake, and prevent secondary cone death in a model of RP. Our data uncover an entirely novel mechanism of neuroprotection through the stimulation of glucose metabolism.	[Ait-Ali, Najate; Fridlich, Ram; Millet-Puel, Geraldine; Clerin, Emmanuelle; Jaillard, Celine; Blond, Frederic; Perrocheau, Ludivine; Reichman, Sacha; Nicol, Xavier; Dalkara, Deniz; Sahel, Jose-Alain; Leveillard, Thierry] INSERM, U968, F-75012 Paris, France; [Ait-Ali, Najate; Fridlich, Ram; Millet-Puel, Geraldine; Clerin, Emmanuelle; Jaillard, Celine; Blond, Frederic; Perrocheau, Ludivine; Reichman, Sacha; Nicol, Xavier; Dalkara, Deniz; Sahel, Jose-Alain; Leveillard, Thierry] Univ Paris 06, Sorbonne Univ, UMR S 968, Inst Vis, F-75012 Paris, France; [Ait-Ali, Najate; Fridlich, Ram; Millet-Puel, Geraldine; Clerin, Emmanuelle; Jaillard, Celine; Blond, Frederic; Perrocheau, Ludivine; Reichman, Sacha; Nicol, Xavier; Dalkara, Deniz; Sahel, Jose-Alain; Leveillard, Thierry] CNRS, UMR 7210, F-75012 Paris, France; [Delalande, Francois; van Dorsselaer, Alain] Univ Strasbourg, IPHC, BioOrgan Mass Spectrometry Lab LSMBO, F-67087 Strasbourg, France; [Delalande, Francois; van Dorsselaer, Alain] CNRS, IPHC, UMR7178, F-67087 Strasbourg, France; [Byrne, Leah C.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Olivier-Bandini, Anne] Sanofi R&D, F-91385 Chilly Mazarin, France; [Bellalou, Jacques] Inst Pasteur, Platform Prod Recombinant Prot & Antibodies 5, F-75724 Paris 15, France; [Moyse, Emmanuel] Univ Francois Rabelais Tours, Ctr INRA Tours, Unite Physiol Reprod & Comportements PRC, UMR INRA 85, F-37380 Nouzilly, France; [Bouillaud, Frederic] INSERM, U1016, Inst Cochin, F-75014 Paris, France; [Bouillaud, Frederic] CNRS, UMR8104, F-75014 Paris, France; [Bouillaud, Frederic] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Berkeley; Sanofi-Aventis; Sanofi France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Leveillard, T (corresponding author), INSERM, U968, F-75012 Paris, France.	thierry.leveillard@inserm.fr	Dalkara, Deniz/D-5057-2017; Sahel, Jose-Alain/F-3172-2017; Bouillaud, Frédéric R/L-3238-2017; Reichman, Sacha/R-7581-2017; MOYSE, Emmanuel/ABE-1819-2021; Nicol, Xavier/D-6087-2012; Léveillard, Thierry/AAR-1804-2020; Aït-Ali, Najate/B-7988-2016	Dalkara, Deniz/0000-0003-4112-9321; Sahel, Jose-Alain/0000-0002-4831-1153; Bouillaud, Frédéric R/0000-0002-7518-9237; Reichman, Sacha/0000-0003-1776-6339; Nicol, Xavier/0000-0002-0310-8047; Léveillard, Thierry/0000-0001-5692-8770; Aït-Ali, Najate/0000-0003-1323-4087; Delalande, Francois/0000-0003-3590-9874; Puel, Geraldine/0000-0003-2387-538X; Byrne, Leah/0000-0002-3229-4993; Clerin, Emmanuelle/0000-0003-1451-6051; Najate, AIT-ALI/0000-0002-7626-8746; Blond, Frederic/0000-0002-2314-0570; MOYSE, Emmanuel/0000-0002-9590-1367	Sanofi; UPMC; Inserm; CNRS; EC; FFB; ANR	Sanofi; UPMC; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); EC(European CommissionEuropean Commission Joint Research Centre); FFB; ANR(French National Research Agency (ANR))	We thank C. Petit, J. Kaplan, J. Ochrietor, D.J. Zack, M. Canto-Soler, A. Chedotal, D. Hicks, R. Goument, N. Berdugo, V. Ferracane, Y. Zagar, M.L. Niepon, G. Lucchi, V. and M. Fradot, M. Desrosiers, G. Tarlet, S. Fouquet, NDRI, cornea bank of Beverwijk, and MIRCEN for scientific advice and/or biological materials. This work was supported by Sanofi, UPMC, Inserm, CNRS, EC, FFB, and ANR. J-A.S., and T.L. are patent holders on the use of RdCVF to treat inherited retinal degenerations. A.v.D, J-A.S., and T.L. are patent holders on the use of BSG1 RdCVF to treat inherited retinal degenerations.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bai Y, 2014, INT J MOL SCI, V15, P6356, DOI 10.3390/ijms15046356; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Casson RJ, 2013, CLIN EXP OPHTHALMOL, V41, P517, DOI 10.1111/ceo.12050; Chalmel F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-74; Chen Y, 2015, J MOL NEUROSCI, V55, P126, DOI 10.1007/s12031-014-0385-5; Clerin E, 2014, JOVE-J VIS EXP, DOI 10.3791/51954; Clerin E, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-38; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; Delyfer MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028791; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Elachouri G, 2015, FREE RADICAL BIO MED, V81, P22, DOI 10.1016/j.freeradbiomed.2015.01.003; Fridlich R, 2009, MOL CELL PROTEOMICS, V8, P1206, DOI 10.1074/mcp.M800406-MCP200; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Hanein S, 2006, ADV EXP MED BIOL, V572, P9; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Jaillard C, 2012, HUM MOL GENET, V21, P2298, DOI 10.1093/hmg/dds050; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Matsuo Y, 2013, CYTOKINE GROWTH F R, V24, P345, DOI 10.1016/j.cytogfr.2013.01.001; Mitamura Y, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/518170; Ochrietor JD, 2003, INVEST OPHTH VIS SCI, V44, P4086, DOI 10.1167/iovs.02-0995; Pekkari K, 2003, FEBS LETT, V539, P143, DOI 10.1016/S0014-5793(03)00214-X; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Redzic JS, 2011, J MOL BIOL, V411, P68, DOI 10.1016/j.jmb.2011.04.060; Reichman S, 2010, HUM MOL GENET, V19, P250, DOI 10.1093/hmg/ddp484; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Sahaf B, 2000, ANTIOXID REDOX SIGN, V2, P717, DOI 10.1089/ars.2000.2.4-717; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wright AF, 1997, NAT GENET, V17, P132, DOI 10.1038/ng1097-132; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu XLL, 2014, NATURE, V514, P385, DOI 10.1038/nature13813; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	44	229	236	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					817	832		10.1016/j.cell.2015.03.023	http://dx.doi.org/10.1016/j.cell.2015.03.023			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957687	Bronze			2022-12-24	WOS:000354175200015
J	Shalapour, S; Font-Burgada, J; Di Caro, G; Zhong, ZY; Sanchez-Lopez, E; Dhar, D; Willimsky, G; Ammirante, M; Strasner, A; Hansel, DE; Jamieson, C; Kane, CJ; Klatte, T; Birner, P; Kenner, L; Karin, M				Shalapour, Shabnam; Font-Burgada, Joan; Di Caro, Giuseppe; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Dhar, Debanjan; Willimsky, Gerald; Ammirante, Massimo; Strasner, Amy; Hansel, Donna E.; Jamieson, Christina; Kane, Christopher J.; Klatte, Tobias; Birner, Peter; Kenner, Lukas; Karin, Michael			Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy	NATURE			English	Article							GENE-EXPRESSION ANALYSIS; INFILTRATING B-CELLS; PROSTATE-CANCER; TARGETED DELETION; MICE; AUTOIMMUNITY; METASTASIS; MECHANISMS; IMMUNITY; THERAPY	Cancer-associated genetic alterations induce expression of tumour antigens that can activate CD8(+) cytotoxic T cells (CTLs), but the microenvironment of established tumours promotes immune tolerance through poorly understood mechanisms(1,2). Recently developed therapeutics that overcome tolerogenic mechanisms activate tumour-directed CTLs and are effective in some human cancers(1). Immune mechanisms also affect treatment outcome, and certain chemotherapeutic drugs stimulate cancer-specific immune responses by inducing immunogenic cell death and other effector mechanisms(3,4). Our previous studies revealed that B cells recruited by the chemokine CXCL13 into prostate cancer tumours promote the progression of castrate-resistant prostate cancer by producing lymphotoxin, which activates an IkB kinase a (IKK alpha)-BMI1 module in prostate cancer stem cells(5,6). Because castrate-resistant prostate cancer is refractory to most therapies, we examined B cell involvement in the acquisition of chemotherapy resistance. Here we focus on oxaliplatin, an immunogenic chemotherapeutic agent(3,4) that is effective in aggressive prostate cancer(7). We show that mouse B cells modulate the response to low-dose oxaliplatin, which promotes tumour-directed CTL activation by inducing immunogenic cell death. Three different mouse prostate cancer models were refractory to oxaliplatin unless genetically or pharmacologically depleted of B cells. The crucial immunosuppressive B cells are plasmocytes that express IgA, interleukin (IL)-10 and programmed death ligand 1 (PD-L1), the appearance of which depends on TGF beta receptor signalling. Elimination of these cells, which also infiltrate human-therapy-resistant prostate cancer, allows CTL-dependent eradication of oxaliplatin-treated tumours.	[Shalapour, Shabnam; Font-Burgada, Joan; Di Caro, Giuseppe; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Dhar, Debanjan; Ammirante, Massimo; Strasner, Amy; Karin, Michael] UCSD, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Shalapour, Shabnam; Font-Burgada, Joan; Di Caro, Giuseppe; Zhong, Zhenyu; Sanchez-Lopez, Elsa; Dhar, Debanjan; Ammirante, Massimo; Strasner, Amy; Hansel, Donna E.; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Willimsky, Gerald] Charite Campus Buch, Inst Immunol, D-13125 Berlin, Germany; [Jamieson, Christina; Kane, Christopher J.] Univ Calif San Diego, Div Urol, Dept Surg, San Diego, CA 92093 USA; [Klatte, Tobias] Med Univ Vienna, Dept Urol, A-1090 Vienna, Austria; [Birner, Peter; Kenner, Lukas] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria; [Kenner, Lukas] Univ Vet Med Vienna, Med Univ Vienna, Ludwig Boltzmann Inst Canc Res, Clin Inst Pathol,UPLA, A-1210 Vienna, Austria	University of California System; University of California San Diego; University of California System; University of California San Diego; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; University of Veterinary Medicine Vienna	Karin, M (corresponding author), UCSD, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Dhar, Debanjan/P-3072-2015; Willimsky, Gerald/AAA-2445-2021; Sanchez-Lopez, Elsa/A-7131-2017; Zhong, Zhenyu/A-8339-2017	Willimsky, Gerald/0000-0002-9693-948X; Sanchez-Lopez, Elsa/0000-0002-4236-1985; Kenner, Lukas/0000-0003-2184-1338; Shalapour, Shabnam/0000-0002-4743-3706; Zhong, Zhenyu/0000-0002-9441-7645	National Institutes of Health (NIH) [CA127923, AI043477]; DFG; German Cancer Consortium [TR36, DKTK]; Genome Research-Austria project 'Inflammobiota' (FWF) [P26011]; Cure Search Foundation; German Research Foundation (DFG) [SH721/1-1]; Irvington-CRI; CIRM [TG2-01154]; FIRC/AIRC; NATIONAL CANCER INSTITUTE [R01CA127923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); German Cancer Consortium; Genome Research-Austria project 'Inflammobiota' (FWF); Cure Search Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Irvington-CRI; CIRM(California Institute for Regenerative Medicine); FIRC/AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Bastian, K. Wang, A. Umemura, M. K. Kim, M. Susani, E. Gurnhofer and F. Grizzi for discussions and research materials. Antibodies and MACS-beads were gifts from eBioscience, Biolegends and Miltenyi Biotec. Anti-PD-L1 and Pdl1/2<SUP>-/-</SUP> mice were from I. Mellman (Genentech). Research was supported by the National Institutes of Health (NIH) (CA127923 and AI043477), DFG and German Cancer Consortium (TR36, DKTK to G.W.), the Genome Research-Austria project 'Inflammobiota' (FWF and P26011 to L.K.), the Cure Search Foundation (to D.D.) and postdoctoral research fellowships from the German Research Foundation (DFG, SH721/1-1 to S.S.); Irvington-CRI (to S.S. and Z.Z.); CIRM (TG2-01154 to J.F.-B.) and FIRC/AIRC (to G.D.C.). M.K. is an ACS Research Professor and holds the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Ammirante M, 2014, P NATL ACAD SCI USA, V111, P14776, DOI 10.1073/pnas.1416498111; Ammirante M, 2013, GENE DEV, V27, P1435, DOI 10.1101/gad.220202.113; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Czeh M, 2010, ONCOGENE, V29, P6591, DOI 10.1038/onc.2010.388; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590; Doi T, 2012, BIOCHEM BIOPH RES CO, V425, P918, DOI 10.1016/j.bbrc.2012.08.010; Feng T, 2011, INT IMMUNOPHARMACOL, V11, P589, DOI 10.1016/j.intimp.2010.11.016; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Foster BA, 1997, CANCER RES, V57, P3325; Fremd C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25443; Gingrich JR, 1996, CANCER RES, V56, P4096; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Harriman GR, 1999, J IMMUNOL, V162, P2521; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Keren Z, 2011, BLOOD, V117, P3104, DOI 10.1182/blood-2010-09-307983; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee JL, 2014, BRIT J CANCER, V110, P2472, DOI 10.1038/bjc.2014.204; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Magee JA, 2001, CANCER RES, V61, P5692; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Porichis F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6641; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schumacher TN, 2015, CANCER CELL, V27, P12, DOI 10.1016/j.ccell.2014.12.004; SHAH N, 1976, Urology, V8, P270, DOI 10.1016/0090-4295(76)90384-8; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Welsh JB, 2001, CANCER RES, V61, P5974; Woo JR, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-30; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	57	329	362	11	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					94	U235		10.1038/nature14395	http://dx.doi.org/10.1038/nature14395			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924065	Green Accepted, Green Submitted			2022-12-24	WOS:000354040900040
J	Lambertucci, SA; Shepard, ELC; Wilson, RP				Lambertucci, Sergio A.; Shepard, Emily L. C.; Wilson, Rory P.			Human-wildlife conflicts in a crowded airspace	SCIENCE			English	Editorial Material							COLLISIONS; ECOLOGY; BIRDS		[Lambertucci, Sergio A.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Shepard, Emily L. C.; Wilson, Rory P.] Swansea Univ, Swansea Lab Anim Movement, Biosci, Swansea, W Glam, Wales	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Swansea University	Lambertucci, SA (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	slambertucci@comahue-conicet.gob.ar		LAMBERTUCCI, SERGIO/0000-0002-2624-2185; Shepard, Emily/0000-0001-7325-6398	PIP [0095]; CONICET; Swansea University;  [PICT1156/2010]	PIP; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Swansea University; 	The authors thank PICT1156/2010, PIP 0095, CONICET, and Swansea University for funding; reviewers for comments; and F. Ballejo for help with the figure.	Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Creamean JM, 2013, SCIENCE, V339, P1572, DOI 10.1126/science.1227279; Dai KS, 2015, RENEW ENERG, V75, P911, DOI 10.1016/j.renene.2014.10.074; Diehl RH, 2013, TRENDS ECOL EVOL, V28, P377, DOI 10.1016/j.tree.2013.02.015; Dolbeer R., 2014, WILDLIFE STRIKES CIV; Dolbeer RA, 2006, J WILDLIFE MANAGE, V70, P1345, DOI 10.2193/0022-541X(2006)70[1345:HDOBRB]2.0.CO;2; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Kunz TH, 2008, INTEGR COMP BIOL, V48, P1, DOI [10.1093/icb/icn030, 10.1093/icb/icn037]; Lambertucci SA, 2014, BIOL CONSERV, V170, P145, DOI 10.1016/j.biocon.2013.12.041; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; Polymenakou PN, 2012, ATMOSPHERE-BASEL, V3, P87, DOI 10.3390/atmos3010087; Satheesan S. M., 2000, SERIOUS VULTURE HITS; Vas E, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0754	14	45	47	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					502	504		10.1126/science.aaa6743	http://dx.doi.org/10.1126/science.aaa6743			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH1JR	25931541				2022-12-24	WOS:000353778100022
J	Khatter, H; Myasnikov, AG; Natchiar, SK; Klaholz, BP				Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.			Structure of the human 80S ribosome	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; TRANSFER-RNA BINDING; O HYDROGEN-BONDS; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; EUKARYOTIC RIBOSOME; TRANSLATION INITIATION; BACTERIAL RIBOSOME; MESSENGER-RNA; L1 STALK	Ribosomes are translational machineries that catalyse protein synthesis. Ribosome structures from various species are known at the atomic level, but obtaining the structure of the human ribosome has remained a challenge; efforts to address this would be highly relevant with regard to human diseases. Here we report the near-atomic structure of the human ribosome derived from high-resolution single-particle cryo-eiecfron microscopy and atomic model, building. The structure has an average resolution of 3.6 angstrom, reaching 2.9 angstrom resolution in the most stable regions. It provides unprecedented insights into ribosomal RNA entities and amino acid side chains, notably of the transfer RNA binding sites and specific molecular interactions with the exit site tRINA. It reveals atomic details of the subunit interface, which is seen to remodel strongly upon rotational movements of the ribosomal submits. Furthermore, the structure paves the way for analysing antibiotic side effects and diseases associated with deregulated protein synthesis.	[Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.] IGBMC Inst Genet & Mol & Cellular Biol, Dept Integrated Struct Biol, Ctr Integrat Biol CBI, F-67404 Illkirch Graffenstaden, France; [Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.] CNRS, UMR 7104, F-67404 Illkirch Graffenstaden, France; [Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.] INSERM, U964, F-67404 Illkirch Graffenstaden, France; [Khatter, Heena; Myasnikov, Alexander G.; Natchiar, S. Kundhavai; Klaholz, Bruno P.] Univ Strasbourg, F-67081 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Klaholz, BP (corresponding author), IGBMC Inst Genet & Mol & Cellular Biol, Dept Integrated Struct Biol, Ctr Integrat Biol CBI, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	klaholz@igbmc.fr	Myasnikov, Alexander/T-4654-2018; Khatter, Heena/U-3668-2017		Equipex Equip@Meso project; CNRS; European Research Council (ERC) [N_243296]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI)	Equipex Equip@Meso project; CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council (ERC)(European Research Council (ERC)European Commission); French Infrastructure for Integrated Structural Biology (FRISBI); Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI)	We thank A. Urzhumtsev and P. Afonine for discussions on FEM maps; R. Fritz and J. Michalon for IT support; R. Druifor constant high-quality engineers support; J.-F. Menetret for technical support; H. Stark for discussions on Cs-correction; D. Moras and J.-C. Thierry for continuous encouragement in pushing structural biology frontiers; the IGBMC cell culture facilities for HeLa cell production; and the High Performance Computing Center of the University of Strasbourg funded by the Equipex Equip@Meso project. This long-term project (since 2003) was supported by the CNRS and the European Research Council (ERC Starting Grant N_243296 TRANSLATION MACHINERY), and the electron microscope facility was supported by the Alsace Region, the FRM, the I BiSA platform program, INSERM, CNRS and the Association pour la Recherche sur le Cancer (ARC) and by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01, and Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI).	Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Budkevich TV, 2014, CELL, V158, P121, DOI 10.1016/j.cell.2014.04.044; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; de Loubresse NG, 2014, NATURE, V513, P517, DOI 10.1038/nature13737; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Delano W.L, 2002, PYMOL USERS MANUAL; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Feng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058829; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Jiang L, 2002, J BIOL CHEM, V277, P37732, DOI 10.1074/jbc.M204514200; Khatter H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1404; Klaholz BP, 2002, STRUCTURE, V10, P1197, DOI 10.1016/S0969-2126(02)00828-6; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu AZ, 2008, J AM CHEM SOC, V130, P2428, DOI 10.1021/ja710114r; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOORE MN, 1985, BIOCHEMISTRY-US, V24, P191, DOI 10.1021/bi00322a027; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rhodin MHJ, 2010, NUCLEIC ACIDS RES, V38, P8377, DOI 10.1093/nar/gkq711; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; SPERRAZZA JM, 1980, BIOCHEMISTRY-US, V19, P1053, DOI 10.1021/bi00547a001; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Yamamoto H, 2014, NAT STRUCT MOL BIOL, V21, P721, DOI 10.1038/nsmb.2859; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	59	272	288	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					640	U338		10.1038/nature14427	http://dx.doi.org/10.1038/nature14427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25901680				2022-12-24	WOS:000353689700042
J	Manupriya				Manupriya			PAEDIATRICS Will new Indian growth charts help stem the rise in childhood obesity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN					manupriya9@gmail.com						Bhatia V, 2012, INDIAN J PEDIATR, V79, P943, DOI 10.1007/s12098-012-0745-5; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2009, INDIAN PEDIATR, V46, P463; Kar Sitanshu Sekhar, 2015, J Nat Sci Biol Med, V6, P12, DOI 10.4103/0976-9668.149071; Khadilkar V, 2015, INDIAN PEDIATR, V52, P47, DOI 10.1007/s13312-015-0566-5; Khadilkar Vaman, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS166, DOI 10.4103/2230-8210.84854	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2015	350								h2013	10.1136/bmj.h2013	http://dx.doi.org/10.1136/bmj.h2013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UB	25918353				2022-12-24	WOS:000353954800003
J	Kim, SJ; Yoon, JS; Shishido, H; Yang, ZY; Rooney, LA; Barral, JM; Skach, WR				Kim, Soo Jung; Yoon, Jae Seok; Shishido, Hideki; Yang, Zhongying; Rooney, LeeAnn A.; Barral, Jose M.; Skach, William R.			Translational tuning optimizes nascent protein folding in cells	SCIENCE			English	Article							CYSTIC-FIBROSIS; NMR-SPECTROSCOPY; DELTA-F508 CFTR; IN-VIVO; RIBOSOME; REVEALS; NBD1	In cells, biosynthetic machinery coordinates protein synthesis and folding to optimize efficiency and minimize off-pathway outcomes. However, it has been difficult to delineate experimentally the mechanisms responsible. Using fluorescence resonance energy transfer, we studied cotranslational folding of the first nucleotide-binding domain from the cystic fibrosis transmembrane conductance regulator. During synthesis, folding occurred discretely via sequential compaction of N-terminal, alpha-helical, and alpha/beta-core subdomains. Moreover, the timing of these events was critical; premature alpha-subdomain folding prevented subsequent core formation. This process was facilitated by modulating intrinsic folding propensity in three distinct ways: delaying alpha-subdomain compaction, facilitating b-strand intercalation, and optimizing translation kinetics via codon usage. Thus, de novo folding is translationally tuned by an integrated cellular response that shapes the cotranslational folding landscape at critical stages of synthesis.	[Kim, Soo Jung; Yoon, Jae Seok; Shishido, Hideki; Yang, Zhongying; Rooney, LeeAnn A.; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Barral, Jose M.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77550 USA; [Barral, Jose M.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77550 USA; [Skach, William R.] Cyst Fibrosis Fdn Therapeut, Bethesda, MD 20814 USA	Oregon Health & Science University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Cystic Fibrosis Foundation	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	skachw@ohsu.edu		Shishido, Hideki/0000-0002-2622-0664	NIH [R01GM53457, R01DK51818]; Cystic Fibrosis Foundation [KIM10F0, SKACH05X0];  [P30EYE010572];  [P30CA069533];  [S10OD012246];  [S10RR025571]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012246] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. David, B. Conti, and members of the Skach laboratory for helpful discussions; CFTR Folding Consortium for providing 3G11 CFTR antibody. This research was funded by NIH grants R01GM53457 and R01DK51818 (to W.R.S.) and Cystic Fibrosis Foundation Therapeutics grants KIM10F0 (to S.J.K.) and SKACH05X0 (to W.R.S.). Mass spectrometric analysis was performed by the OHSU Proteomics Shared Resource with support from P30EYE010572, P30CA069533, S10OD012246, and S10RR025571. U.S. patent application 13/664,252 covers the methodology to assess and redesign the NBD1 coding sequences, claiming priority to provisional application 61/553,861, filed on 31 October 2011. No other counterpart applications have been filed.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Chartier M, 2012, BIOINFORMATICS, V28, P1438, DOI 10.1093/bioinformatics/bts149; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Gloge F, 2014, CURR OPIN STRUC BIOL, V24, P24, DOI 10.1016/j.sbi.2013.11.004; Hingorani KS, 2014, CURR OPIN STRUC BIOL, V24, P81, DOI 10.1016/j.sbi.2013.11.007; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kelkar DA, 2012, J BIOL CHEM, V287, P2568, DOI 10.1074/jbc.M111.318766; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kosolapov A, 2009, NAT STRUCT MOL BIOL, V16, P405, DOI 10.1038/nsmb.1571; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; O'Brien EP, 2011, J AM CHEM SOC, V133, P513, DOI 10.1021/ja107863z; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Ugrinov KG, 2010, BIOPHYS J, V98, P1312, DOI 10.1016/j.bpj.2009.12.4291; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	32	136	138	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					444	448		10.1126/science.aaa3974	http://dx.doi.org/10.1126/science.aaa3974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908822				2022-12-24	WOS:000353338000037
J	Sahni, N; Yi, S; Taipale, M; Bass, JIF; Coulombe-Huntington, J; Yang, F; Peng, J; Weile, J; Karras, GI; Wang, Y; Kovacs, IA; Kamburov, A; Krykbaeva, I; Lam, MH; Tucker, G; Khurana, V; Sharma, A; Liu, YY; Yachie, N; Zhong, Q; Shen, Y; Palagi, A; San-Miguel, A; Fan, CY; Balcha, D; Dricot, A; Jordan, DM; Walsh, JM; Shah, AA; Yang, XP; Stoyanova, AK; Leighton, A; Calderwood, MA; Jacob, Y; Cusick, ME; Salehi-Ashtiani, K; Whitesell, LJ; Sunyaev, S; Berger, B; Barabasi, AL; Charloteaux, B; Hill, DE; Hao, T; Roth, FP; Xia, Y; Walhout, AJM; Lindquist, S; Vidal, M				Sahni, Nidhi; Yi, Song; Taipale, Mikko; Bass, Juan I. Fuxman; Coulombe-Huntington, Jasmin; Yang, Fan; Peng, Jian; Weile, Jochen; Karras, Georgios I.; Wang, Yang; Kovacs, Istvan A.; Kamburov, Atanas; Krykbaeva, Irina; Lam, Mandy H.; Tucker, George; Khurana, Vikram; Sharma, Amitabh; Liu, Yang-Yu; Yachie, Nozomu; Zhong, Quan; Shen, Yun; Palagi, Alexandre; San-Miguel, Adriana; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Jordan, Daniel M.; Walsh, Jennifer M.; Shah, Akash A.; Yang, Xinping; Stoyanova, Ani K.; Leighton, Alex; Calderwood, Michael A.; Jacob, Yves; Cusick, Michael E.; Salehi-Ashtiani, Kourosh; Whitesell, Luke J.; Sunyaev, Shamil; Berger, Bonnie; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Roth, Frederick P.; Xia, Yu; Walhout, Albertha J. M.; Lindquist, Susan; Vidal, Marc			Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders	CELL			English	Article							ONE-HYBRID ASSAYS; SEQUENCE VARIATION; PROTEIN COMPLEXES; HUMAN-DISEASE; MUTATIONS; NETWORK; CANCER; EXPRESSION; CHAPERONE; GENOME	How disease-associated mutations impair protein activities in the context of biological networks remains mostly undetermined. Although a few renowned alleles are well characterized, functional information is missing for over 100,000 disease-associated variants. Here we functionally profile several thousand missense mutations across a spectrum of Mendelian disorders using various interaction assays. The majority of disease-associated alleles exhibit wild-type chaperone binding profiles, suggesting they preserve protein folding or stability. While common variants from healthy individuals rarely affect interactions, two-thirds of disease-associated alleles perturb protein-protein interactions, with half corresponding to "edgetic" alleles affecting only a subset of interactions while leaving most other interactions unperturbed. With transcription factors, many alleles that leave protein-protein interactions intact affect DNA binding. Different mutations in the same gene leading to different interaction profiles often result in distinct disease phenotypes. Thus disease-associated alleles that perturb distinct protein activities rather than grossly affecting folding and stability are relatively widespread.	[Sahni, Nidhi; Yi, Song; Yang, Fan; Weile, Jochen; Wang, Yang; Kovacs, Istvan A.; Sharma, Amitabh; Yachie, Nozomu; Shen, Yun; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Calderwood, Michael A.; Cusick, Michael E.; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, Genom Anal Network, Perturbat Ctr Excellence Genom Sci CEGS, Boston, MA 02215 USA; [Sahni, Nidhi; Yi, Song; Yang, Fan; Weile, Jochen; Wang, Yang; Kovacs, Istvan A.; Kamburov, Atanas; Sharma, Amitabh; Liu, Yang-Yu; Yachie, Nozomu; Zhong, Quan; Shen, Yun; Palagi, Alexandre; San-Miguel, Adriana; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Walsh, Jennifer M.; Shah, Akash A.; Yang, Xinping; Stoyanova, Ani K.; Calderwood, Michael A.; Jacob, Yves; Cusick, Michael E.; Salehi-Ashtiani, Kourosh; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Roth, Frederick P.; Xia, Yu; Walhout, Albertha J. M.; Vidal, Marc] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Sahni, Nidhi; Yi, Song; Yang, Fan; Weile, Jochen; Wang, Yang; Kovacs, Istvan A.; Kamburov, Atanas; Sharma, Amitabh; Liu, Yang-Yu; Yachie, Nozomu; Zhong, Quan; Shen, Yun; Palagi, Alexandre; San-Miguel, Adriana; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Walsh, Jennifer M.; Shah, Akash A.; Yang, Xinping; Stoyanova, Ani K.; Calderwood, Michael A.; Jacob, Yves; Cusick, Michael E.; Salehi-Ashtiani, Kourosh; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Roth, Frederick P.; Xia, Yu; Walhout, Albertha J. M.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Sahni, Nidhi; Yi, Song; Wang, Yang; Kamburov, Atanas; Zhong, Quan; Shen, Yun; Palagi, Alexandre; San-Miguel, Adriana; Fan, Changyu; Balcha, Dawit; Dricot, Amelie; Walsh, Jennifer M.; Shah, Akash A.; Yang, Xinping; Stoyanova, Ani K.; Calderwood, Michael A.; Jacob, Yves; Cusick, Michael E.; Salehi-Ashtiani, Kourosh; Charloteaux, Benoit; Hill, David E.; Hao, Tong; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Taipale, Mikko; Karras, Georgios I.; Krykbaeva, Irina; Khurana, Vikram; Whitesell, Luke J.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bass, Juan I. Fuxman; Walhout, Albertha J. M.] Univ Massachusetts, Sch Med, Program Mol Med, Program Syst Biol, Worcester, MA 01605 USA; [Coulombe-Huntington, Jasmin; Xia, Yu] McGill Univ, Fac Engn, Dept Bioengn, Montreal, PQ H3A 0C3, Canada; [Yang, Fan; Weile, Jochen; Yachie, Nozomu; Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Yang, Fan; Weile, Jochen; Yachie, Nozomu; Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3E1, Canada; [Yang, Fan; Weile, Jochen; Lam, Mandy H.; Walhout, Albertha J. M.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Yang, Fan; Weile, Jochen; Yachie, Nozomu; Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Peng, Jian; Tucker, George; Leighton, Alex; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kovacs, Istvan A.; Sharma, Amitabh; Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res CCNR, Boston, MA 02115 USA; [Kovacs, Istvan A.; Sharma, Amitabh; Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Kovacs, Istvan A.; Sharma, Amitabh; Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Kovacs, Istvan A.; Sharma, Amitabh; Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Comp Sci, Boston, MA 02115 USA; [Jordan, Daniel M.; Sunyaev, Shamil] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Jordan, Daniel M.] Harvard Univ, Program Biophys, Cambridge, MA 02139 USA; [Jacob, Yves] CNRS, Dept Virol, Unite Genet Mol Virus ARN GMVR, Inst Pasteur,UMR3569, Paris, France; [Jacob, Yves] Univ Paris Diderot, Paris, France; [Whitesell, Luke J.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Whitesell, Luke J.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Sunyaev, Shamil] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Berger, Bonnie] MIT, Dept Math & Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Massachusetts System; University of Massachusetts Worcester; McGill University; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Massachusetts Institute of Technology (MIT); Northeastern University; Northeastern University; Northeastern University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Canadian Institute for Advanced Research (CIFAR); Howard Hughes Medical Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	lindquist@wi.mit.edu; marc_vidal@dfci.harvard.edu	Jordan, Daniel/M-6842-2019; zhong, quan/AAE-8893-2021; Roth, Frederick P/H-6308-2011; Barabasi, Albert-Laszlo/S-6474-2017; Calderwood, Mike/B-2475-2014; Kovacs, Istvan/A-8447-2013; Liu, Yang-Yu/G-8885-2011; Yang, Fan/V-6555-2019; Yang, Xinping/HGA-6104-2022; Yi, Song/ABG-6526-2020; Xia, Yu/W-6150-2019; Wang, Yang/AAN-7740-2020; San Miguel, Adriana/C-3937-2017	Jordan, Daniel/0000-0002-5318-8225; Calderwood, Mike/0000-0001-6475-1418; Kovacs, Istvan/0000-0002-6890-6277; Liu, Yang-Yu/0000-0003-2728-4907; Yang, Fan/0000-0003-4821-6583; Yi, Song/0000-0003-0047-8103; Xia, Yu/0000-0002-5596-5518; San Miguel, Adriana/0000-0003-0172-2163; Karras, Georgios/0000-0003-2933-1535; Jacob, Yves/0000-0001-9125-2374; Salehi-Ashtiani, Kourosh/0000-0002-6521-5243; Peng, Jian/0000-0002-1736-2978; Stoyanova, Ani/0000-0002-0804-7837; Krykbaeva, Irina/0000-0003-1380-7607; Kamburov, Atanas/0000-0002-0580-0619; Weile, Jochen/0000-0003-1628-9390; Khurana, Vikram/0000-0002-4018-5527; Taipale, Mikko/0000-0003-3811-1761; Walhout, Marian/0000-0001-5587-3608; Barabasi, Albert/0000-0002-4028-3522; Zhong, Quan/0000-0003-2910-5597; Roth, Frederick/0000-0002-6628-649X; Sahni, Nidhi/0000-0002-9155-5882; Yang, Xinping/0000-0003-4086-4180	NHGRI [P50HG004233, RC4HG006066, R01HG001715]; NIGMS [GM082971]; NSF [CCF-1219007]; NSERC [RGPIN-2014-03892]; Krembil Foundation; Canada Excellence Research Chair; Ontario Research Fund-Research Excellence Award; Pew Latin American Fellowship; EMBO Long-Term Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715, P50HG004233, RC4HG006066, U41HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871, R01GM082971] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [1219007] Funding Source: National Science Foundation	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Krembil Foundation; Canada Excellence Research Chair; Ontario Research Fund-Research Excellence Award; Pew Latin American Fellowship; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank the members of the DFCI Center for Cancer Systems Biology (CCSB) for valuable discussions and acknowledge A.A. Chen, M. Koeva, and E. Guney for helpful suggestions. This work was supported by NHGRI (P50HG004233 to M.V., F.P.R. and A.-L.B.; RC4HG006066 to M.V., T.H., D.E.H., K.S.-A., L.J.W., and S.L.; and R01HG001715 to M.V., D.E.H., and F.P.R.), NIGMS (GM082971 to A.J.M.W.), NSF (CCF-1219007 to Y.X.), NSERC (RGPIN-2014-03892 to Y.X.), and the Krembil Foundation, a Canada Excellence Research Chair, an Ontario Research Fund-Research Excellence Award awarded to F.P.R. J.I.F.B. is supported by a Pew Latin American Fellowship. A.K. is supported by an EMBO Long-Term Fellowship. S.L. is an investigator of the Howard Hughes Medical Institute. M.V. is a Chercheur Qualifie Honoraire from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia-Brussels Federation).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Balasubramanian S, 2005, NUCLEIC ACIDS RES, V33, P1710, DOI 10.1093/nar/gki311; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Clarke NF, 2008, ANN NEUROL, V63, P329, DOI 10.1002/ana.21308; De Nooy W., 2005, EXPLORATORY SOCIAL N; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; GUNNING P, 1990, DEV BIOL, V138, P443, DOI 10.1016/0012-1606(90)90210-A; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; McArdle A, 2006, EXP GERONTOL, V41, P497, DOI 10.1016/j.exger.2006.02.002; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1050, DOI [10.1038/NMETH.1764, 10.1038/nmeth.1764]; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Sahni N, 2013, CURR OPIN GENET DEV, V23, P649, DOI 10.1016/j.gde.2013.11.002; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Sorgjerd K, 2006, J MOL BIOL, V356, P469, DOI 10.1016/j.jmb.2005.11.051; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Subramanian S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-306; Sunyaev SR, 2012, HUM MOL GENET, V21, pR10, DOI 10.1093/hmg/dds385; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tervaniemi MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049920; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yamashita D, 2007, MOL CELL BIOL, V27, P2003, DOI 10.1128/MCB.01462-06; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	47	316	316	1	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					647	660		10.1016/j.cell.2015.04.013	http://dx.doi.org/10.1016/j.cell.2015.04.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910212	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000353553600022
J	Shyer, AE; Huycke, TR; Lee, CH; Mahadevan, L; Tabin, CJ				Shyer, Amy E.; Huycke, Tyler R.; Lee, ChangHee; Mahadevan, L.; Tabin, Clifford J.			Bending Gradients: How the Intestinal Stem Cell Gets Its Home	CELL			English	Article							SONIC-HEDGEHOG; BMP; MUCOSA; GROWTH; VILLI; MORPHOGENESIS; MORPHOLOGY; RENEWAL; SIGNALS; LIMB	We address the mechanism by which adult intestinal stem cells (ISCs) become localized to the base of each villus during embryonic development. We find that, early in gut development, proliferating progenitors expressing ISC markers are evenly distributed throughout the epithelium, in both the chick and mouse. However, as the villi form, the putative stem cells become restricted to the base of the villi. This shift in the localization is driven by mechanically influenced reciprocal signaling between the epithelium and underlying mesenchyme. Buckling forces physically distort the shape of the morphogenic field, causing local maxima of epithelial signals, in particular Shh, at the tip of each villus. This induces a suite of high-threshold response genes in the underlying mesenchyme to form a signaling center called the "villus cluster.'' Villus cluster signals, notably Bmp4, feed back on the overlying epithelium to ultimately restrict the stem cells to the base of each villus.	[Shyer, Amy E.; Huycke, Tyler R.; Lee, ChangHee; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Kavli Inst Nanobio Sci & Technol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Lee, ChangHee/0000-0002-9994-3142; Huycke, Tyler/0000-0001-8328-5061	NIH [HD047360]; MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK103563] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Alan Rodrigues and Sandy Klemm for assistance with single-molecule FISH probe design and experiments, Jessica Lehoczky for help with mice, Maxwell Heiman for the use of his microscope, and Jinhyun Choo for help with the simulation. We also thank D. Gumucio and K. Walton for discussions and for sharing data prior to publication. This work was supported by grants from the NIH (HD047360) to C.J.T. and the MacArthur Foundation to L.M.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batts LE, 2006, DEV DYNAM, V235, P1563, DOI 10.1002/dvdy.20741; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; COULOMBRE AJ, 1958, J EMBRYOL EXP MORPH, V6, P403; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Durdu S, 2014, NATURE, V515, P120, DOI 10.1038/nature13852; FERRI S, 1976, J ANAT, V121, P291; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Fukuda K, 1998, DEVELOPMENT, V125, P3535; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hilton WA, 1902, AM J ANAT, V1, P459, DOI 10.1002/aja.1000010406; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Knezevic V, 1997, DEVELOPMENT, V124, P4523; KOTZE SH, 1995, J MORPHOL, V225, P169, DOI 10.1002/jmor.1052250203; KRAUSE WJ, 1975, ANAT RECORD, V181, P251, DOI 10.1002/ar.1091810207; LACROIX B, 1984, GUT, V25, P925, DOI 10.1136/gut.25.9.925; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; MCAVOY JW, 1978, J ANAT, V125, P155; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Salazar-Ciudad I, 2012, CURR OPIN GENET DEV, V22, P585, DOI 10.1016/j.gde.2012.10.006; SBARBATI R, 1982, J ANAT, V135, P477; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Spence JR, 2011, DEV DYNAM, V240, P501, DOI 10.1002/dvdy.22540; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tian Q, 2005, CELL CYCLE, V4, P215; Walker RL, 2004, CAN J PHYSIOL PHARM, V82, P951, DOI 10.1139/Y04-103; Walton KD, 2012, P NATL ACAD SCI USA, V109, P15817, DOI 10.1073/pnas.1205669109; Winkler F, 1998, ANAT HISTOL EMBRYOL, V27, P335, DOI 10.1111/j.1439-0264.1998.tb00204.x	38	164	170	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					569	580		10.1016/j.cell.2015.03.041	http://dx.doi.org/10.1016/j.cell.2015.03.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25865482	Green Accepted, Bronze			2022-12-24	WOS:000353553600016
J	Rewers, A; Dong, F; Slover, RH; Klingensmith, GJ; Rewers, M				Rewers, Arleta; Dong, Fran; Slover, Robert H.; Klingensmith, Georgeanna J.; Rewers, Marian			Incidence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Colorado Youth, 1998-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHILDREN		[Rewers, Arleta] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Dong, Fran; Slover, Robert H.; Klingensmith, Georgeanna J.; Rewers, Marian] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rewers, A (corresponding author), Univ Colorado, Sch Med, Dept Pediat, 13123 E 16th Ave, Aurora, CO 80045 USA.	arleta.rewers@childrenscolorado.org	Rewers, Arleta/AAE-2484-2019		NIDDK NIH HHS [P30 DK57156] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Hekkala A, 2007, DIABETES CARE, V30, P861, DOI 10.2337/dc06-2281; Limenis Elizaveta, 2012, Diabetes Care, V35, pe5, DOI 10.2337/dc11-1980; Usher-Smith JA, 2012, DIABETOLOGIA, V55, P2878, DOI 10.1007/s00125-012-2690-2; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x	4	44	44	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1570	1572		10.1001/jama.2015.1414	http://dx.doi.org/10.1001/jama.2015.1414			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898057	Bronze			2022-12-24	WOS:000353198700024
J	Arrieta, JM; Mayol, E; Hansman, RL; Herndl, GJ; Dittmar, T; Duarte, CM				Arrieta, Jesus M.; Mayol, Eva; Hansman, Roberta L.; Herndl, Gerhard J.; Dittmar, Thorsten; Duarte, Carlos M.			Dilution limits dissolved organic carbon utilization in the deep ocean	SCIENCE			English	Article							MATTER; GROWTH; DEGRADATION; BACTERIA; ATLANTIC; SEAWATER; IMPACT; SEA; DOM	Oceanic dissolved organic carbon (DOC) is the second largest reservoir of organic carbon in the biosphere. About 72% of the global DOC inventory is stored in deep oceanic layers for years to centuries, supporting the current view that it consists of materials resistant to microbial degradation. An alternative hypothesis is that deep-water DOC consists of many different, intrinsically labile compounds at concentrations too low to compensate for the metabolic costs associated to their utilization. Here, we present experimental evidence showing that low concentrations rather than recalcitrance preclude consumption of a substantial fraction of DOC, leading to slow microbial growth in the deep ocean. These findings demonstrate an alternative mechanism for the long-term storage of labile DOC in the deep ocean, which has been hitherto largely ignored.	[Arrieta, Jesus M.; Mayol, Eva; Duarte, Carlos M.] UIB, CSIC, Inst Mediterrani Estudis Avancats IMEDEA, Dept Global Change Res, Esporles 07190, Spain; [Arrieta, Jesus M.; Duarte, Carlos M.] KAUST, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia; [Hansman, Roberta L.; Herndl, Gerhard J.] Univ Vienna, Div Biooceanog, Dept Limnol & Biooceanog, A-1090 Vienna, Austria; [Herndl, Gerhard J.] Royal Netherlands Inst Sea Res NIOZ, Dept Biol Oceanog, NL-1790 AB Den Burg, Netherlands; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Res Grp Marine Geochem, ICBM MPI Bridging Grp, Inst Chem & Biol Marine Environm ICBM, Bremen, Germany; [Dittmar, Thorsten] Max Planck Inst Marine Microbiol MPI, Bremen, Germany; [Duarte, Carlos M.] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; King Abdullah University of Science & Technology; University of Vienna; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Carl von Ossietzky Universitat Oldenburg; University of Western Australia	Arrieta, JM (corresponding author), UIB, CSIC, Inst Mediterrani Estudis Avancats IMEDEA, Dept Global Change Res, Esporles 07190, Spain.	txetxu@mail.com	Duarte Quesada, Carlos Manuel/ABD-6208-2021; Herndl, Gerhard J./B-1513-2013; Arrieta, Jesus M/B-1226-2008; Duarte, Carlos M/A-7670-2013; Herndl, Gerhard J./S-3011-2019; Dittmar, Thorsten/L-7796-2013	Herndl, Gerhard J./0000-0002-2223-2852; Arrieta, Jesus M/0000-0002-0190-6950; Duarte, Carlos M/0000-0002-1213-1361; Herndl, Gerhard J./0000-0002-2223-2852; Dittmar, Thorsten/0000-0002-3462-0107; Hansman, Roberta/0000-0003-1525-8509	Spanish Ministry of Economy and Competitiveness [CSD2008-00077]; Junta para la Ampliacion de Estudios program of CSIC; Austrian Science Fund (FWF) [I486-B09, P23234-B11]; European Research Council (ERC) under the European Community [268595]; Austrian Science Fund (FWF) [Z 194] Funding Source: researchfish	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta para la Ampliacion de Estudios program of CSIC; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC) under the European Community(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This is a contribution to the Malaspina 2010 Expedition project, funded by the CONSOLIDER-Ingenio 2010 program of the from the Spanish Ministry of Economy and Competitiveness (Ref. CSD2008-00077). J. M. A. was supported by a "Ramon y Cajal" research fellowship from the Spanish Ministry of Economy and Competitiveness. E.M. was supported by a fellowship from the Junta para la Ampliacion de Estudios program of CSIC. G.J.H. and R.L.H. were supported by the Austrian Science Fund (FWF) projects I486-B09 and P23234-B11 and by the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 268595 (MEDEA project). We thank A. Dorsett for assistance with DOC analyses, participants in the Malaspina Expedition and the crews of the BIO Hesperides, and RV Pelagia and the personnel of the Marine Technology Unit of CSIC for their invaluable support. Original data sets are available online at http://digital.csic.es/handle/10261/111563. J. M. A. designed the experimental setup, carried out part of the experiments, measured prokaryotic abundance, analyzed the data, and wrote the manuscript. E.M. carried out part of the experiments and data analysis. C.M.D. designed the Malaspina 2010 Expedition, was responsible for DOC analyses, and together with G.J.H. contributed to the design of the experiments and discussion of results. R.L.H. and T.D. analyzed the FT-ICR-MS samples. All authors discussed the results and contributed to the manuscript.	BARBER RT, 1968, NATURE, V220, P274, DOI 10.1038/220274a0; Bauer JE., 2002, BIOGEOCHEMISTRY MARI, P405, DOI [10.1016/B978-012323841-2/50010-5, DOI 10.1016/B978-012323841-2/50010-5]; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; Copley SD, 2000, TRENDS BIOCHEM SCI, V25, P261, DOI 10.1016/S0968-0004(00)01562-0; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Flerus R, 2012, BIOGEOSCIENCES, V9, P1935, DOI 10.5194/bg-9-1935-2012; Follett CL, 2014, P NATL ACAD SCI USA, V111, P16706, DOI 10.1073/pnas.1407445111; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; JANNASCH HW, 1994, GLOBAL PLANET CHANGE, V9, P289, DOI 10.1016/0921-8181(94)90022-1; JANNASCH HW, 1967, LIMNOL OCEANOGR, V12, P264, DOI 10.4319/lo.1967.12.2.0264; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kattner G, 2011, MICROBIAL CARBON PUM, P60, DOI DOI 10.1126/SCIENCE.OPMS.SB0001; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Konopka A, 2000, CURR OPIN MICROBIOL, V3, P244, DOI 10.1016/S1369-5274(00)00083-7; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Lechtenfeld OJ, 2014, GEOCHIM COSMOCHIM AC, V126, P321, DOI 10.1016/j.gca.2013.11.009; Maharjan RP, 2007, J BACTERIOL, V189, P2350, DOI 10.1128/JB.01414-06; Nebbioso A, 2013, ANAL BIOANAL CHEM, V405, P109, DOI 10.1007/s00216-012-6363-2; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; Sharp JH, 2009, ESTUAR COAST, V32, P1023, DOI 10.1007/s12237-009-9210-8; Stone R, 2010, SCIENCE, V328, P1476, DOI 10.1126/science.328.5985.1476; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0; Zubkov M, 2007, J PLANKTON RES, V29, P79	26	171	180	19	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					331	333		10.1126/science.1258955	http://dx.doi.org/10.1126/science.1258955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883355				2022-12-24	WOS:000352999000043
J	Gundem, G; Van Loo, P; Kremeyer, B; Alexandrov, LB; Tubio, JMC; Papaemmanuil, E; Brewer, DS; Kallio, HML; Hoegnas, G; Annala, M; Kivinummi, K; Goody, V; Latimer, C; O'Meara, S; Dawson, KJ; Isaacs, W; Emmert-Buck, MR; Nykter, M; Foster, C; Kote-Jarai, Z; Easton, D; Whitaker, HC; Neal, DE; Cooper, CS; Eeles, RA; Visakorpi, T; Campbell, PJ; McDermott, U; Wedge, DC; Bova, GS				Gundem, Gunes; Van Loo, Peter; Kremeyer, Barbara; Alexandrov, Ludmil B.; Tubio, Jose M. C.; Papaemmanuil, Elli; Brewer, Daniel S.; Kallio, Heini M. L.; Hoegnas, Gunilla; Annala, Matti; Kivinummi, Kati; Goody, Victoria; Latimer, Calli; O'Meara, Sarah; Dawson, Kevin J.; Isaacs, William; Emmert-Buck, Michael R.; Nykter, Matti; Foster, Christopher; Kote-Jarai, Zsofia; Easton, Douglas; Whitaker, Hayley C.; Neal, David E.; Cooper, Colin S.; Eeles, Rosalind A.; Visakorpi, Tapio; Campbell, Peter J.; McDermott, Ultan; Wedge, David C.; Bova, G. Steven		ICGC Prostate UK Grp	The evolutionary history of lethal metastatic prostate cancer	NATURE			English	Article							ANDROGEN DEPRIVATION THERAPY; PANCREATIC-CANCER; CLONAL EVOLUTION; HETEROGENEITY; PROGRESSION; RESISTANCE; PATHOGENESIS; MUTATIONS; SIGNATURE; PATTERNS	Cancers emerge from an ongoing Darwinian evolutionary process, often leading to multiple competing subdones within a single primary tumour(1-4). This evolutionary process culminates in the formation of metastases, which is the cause of 90% of cancer-related deaths(5). However, despite its clinical importance, little is known about the principles governing the dissemination of cancer cells to distant organs. Although the hypothesis that each metastasis originates from a single tumour cell is generally supported(6-8), recent studies using mouse models of cancer demonstrated the existence of polyclonal seeding from and interclonal cooperation between multiple subdonee(9,10). Here we sought definitive evidence for the existence of polydonal seeding in human malignancy and to establish the clonal relationship among different metastases in the context of androgendeprived metastatic prostate cancer. Using whole-genome sequencing, we characterized multiple metastases arising from prostate tumours in ten patients. Integrated analyses of subdonal architecture revealed the patterns of metastatic spread in unprecedented detail. Metastasis-to-metastasis spread was found to be common, either through de novo monoclonal seeding of daughter metastases or, in five cases, through the transfer of multiple tumour clones between metastatic sites. Lesions affecting tumour suppressor genes usually occur as single events, whereas mutations in genes involved in androgen receptor signalling commonly involve multiple, convergent events in different metastases. Our results elucidate in detail the complex patterns of metastatic spread and further our understanding of the development of resistance to androgen-deprivation therapy in prostate cancer.	[Gundem, Gunes; Van Loo, Peter; Kremeyer, Barbara; Alexandrov, Ludmil B.; Tubio, Jose M. C.; Papaemmanuil, Elli; Goody, Victoria; Latimer, Calli; O'Meara, Sarah; Dawson, Kevin J.; Campbell, Peter J.; McDermott, Ultan; Wedge, David C.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Van Loo, Peter] Canc Res UK London Res Inst, London WC2A 3LY, England; [Brewer, Daniel S.; Cooper, Colin S.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Brewer, Daniel S.; Cooper, Colin S.] Univ E Anglia, Dept Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Brewer, Daniel S.] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Kallio, Heini M. L.; Hoegnas, Gunilla; Annala, Matti; Kivinummi, Kati; Nykter, Matti; Visakorpi, Tapio; Bova, G. Steven] Univ Tampere, BioMediTech, Inst Biosci & Med Technol, FI-33520 Tampere, Finland; [Kallio, Heini M. L.; Hoegnas, Gunilla; Annala, Matti; Kivinummi, Kati; Nykter, Matti; Visakorpi, Tapio; Bova, G. Steven] Tampere Univ Hosp, Fimlab Labs, FI-33520 Tampere, Finland; [Isaacs, William] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; [Emmert-Buck, Michael R.] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA; [Foster, Christopher] Univ Liverpool, London WC1E 6JA, England; [Foster, Christopher] HCA Pathol Labs, London WC1E 6JA, England; [Kote-Jarai, Zsofia; Cooper, Colin S.; Eeles, Rosalind A.] Inst Canc Res, Div Genet & Epidemiol, London SW7 3RP, England; [Easton, Douglas] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Whitaker, Hayley C.; Neal, David E.] Canc Res UK Cambridge Inst, Urooncol Res Grp, Cambridge CB2 0RE, England; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge CB2 0QQ, England; [Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, London SW3 6JJ, England; [Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England	Wellcome Trust Sanger Institute; KU Leuven; Cancer Research UK; University of East Anglia; University of East Anglia; The Genome Analysis Centre (TGAC); Tampere University; Tampere University; Tampere University Hospital; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Liverpool; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Bova, GS (corresponding author), Univ Tampere, BioMediTech, Inst Biosci & Med Technol, FI-33520 Tampere, Finland.	um1@sanger.ac.uk; dw9@sanger.ac.uk; g.steven.bova@uta.fi	Brewer, Daniel S/D-6201-2018; Tubio, Jose M.C./H-5076-2015; Alexandrov, Ludmil/AAS-1454-2021; Tubio, Jose/AAG-7345-2019; Wedge, David/AAC-4977-2021	Brewer, Daniel S/0000-0003-4753-9794; Tubio, Jose M.C./0000-0003-3540-2459; Alexandrov, Ludmil/0000-0003-3596-4515; Tubio, Jose/0000-0003-3540-2459; Kallio, Heini M.L./0000-0003-4345-1787; Lynch, Andy/0000-0002-7876-7338; Neal, David/0000-0002-6033-5086; Van Loo, Peter/0000-0003-0292-1949; Bova, George/0000-0003-1639-3104; Nykter, Matti/0000-0001-6956-2843; Wedge, David/0000-0002-7572-3196; Massie, Charlie/0000-0003-2314-4843; Berney, Daniel/0000-0001-5474-8696; McDermott, Ultan/0000-0001-9032-4700; Dudderidge, Tim/0000-0001-6373-3613; Eeles, Rosalind/0000-0002-3698-6241; Visakorpi, Tapio/0000-0002-5004-0364	Cancer Research UK; NIH NCI Intramural Program; Academy of Finland; Cancer Society of Finland; PELICAN Autopsy Study family members and friends; John and Kathe Dyson; US National Cancer Institute [CA92234]; American Cancer Society; Johns Hopkins University Department of Pathology; Women's Board of Johns Hopkins Hospital; Grove Foundation; Association for the Cure of Cancer of the Prostate; American Foundation for Urologic Disease; Bob Champion Cancer Trust; Research Foundation - Flanders (FWO) [FWO-G.0687.12]; Cancer Research UK [15007, 17528] Funding Source: researchfish; Versus Arthritis [20406] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA092234] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NIH NCI Intramural Program; Academy of Finland(Academy of Finland); Cancer Society of Finland; PELICAN Autopsy Study family members and friends; John and Kathe Dyson; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Johns Hopkins University Department of Pathology; Women's Board of Johns Hopkins Hospital; Grove Foundation; Association for the Cure of Cancer of the Prostate; American Foundation for Urologic Disease; Bob Champion Cancer Trust; Research Foundation - Flanders (FWO)(FWO); Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the men and their families who participated in the PELICAN (Project to ELIminate lethal CANcer) integrated clinical-molecular autopsy study of prostate cancer. We thank M. A. Eisenberger, M. A. Carducci, V. Sinibaldi, T. B. Smyth and G. J. Mamo for oncologic and urologic clinical support; T. Tolonen for uropathology support; P. Martikainen, M. Vaha-Jaakkola, M. Vakkuri, K. Leinonen, T. Vormisto, M. Rohrer, A. Koskenalho, J. Silander, T. Lahtinen, C. Hardy, G. Hutchins, B. Crain,S. Jhavar, C. Talbot, L. Kasch, M. Penno, A. Warner and Y. Golubeva for technical support; and M. R. Stratton and P.A. Futreal for their comments on the manuscript. This is an ICGC Prostate Cancer study funded by: Cancer Research UK(2011-present); NIH NCI Intramural Program (2013-2014); Academy of Finland (2011-present); Cancer Society of Finland (2013-present); PELICAN Autopsy Study family members and friends (1998-2004); John and Kathe Dyson (2000); US National Cancer Institute CA92234 (2000-2005); American Cancer Society (1998-2000); Johns Hopkins University Department of Pathology (1997-2011); Women's Board of Johns Hopkins Hospital (1998); The Grove Foundation (1998); Association for the Cure of Cancer of the Prostate (1994-1998); American Foundation for Urologic Disease (1991-1994); Bob Champion Cancer Trust (2013-present); Research Foundation - Flanders (FWO) [FWO-G.0687.12] (2012-present). E.P. is a European Hematology Association Research Fellow.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bernard D, 2003, J CLIN INVEST, V112, P1724; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Karantanos T, 2013, CANCER CELL, V24, P11, DOI 10.1016/j.ccr.2013.06.007; Lee YF, 2004, CANCER RES, V64, P7201, DOI 10.1158/0008-5472.CAN-04-1673; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Maley CC, 2004, CANCER RES, V64, P3414, DOI 10.1158/0008-5472.CAN-03-3249; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	29	883	901	4	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					353	+		10.1038/nature14347	http://dx.doi.org/10.1038/nature14347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25830880	Green Submitted, Green Accepted			2022-12-24	WOS:000352974200040
J	Attenello, FJ; Wen, T; Cen, SY; Ng, A; Kim-Tenser, M; Sanossian, N; Amar, AP; Mack, WJ				Attenello, Frank J.; Wen, Timothy; Cen, Steven Y.; Ng, Alvin; Kim-Tenser, May; Sanossian, Nerses; Amar, Arun P.; Mack, William J.			Incidence of "never events" among weekend admissions versus weekday admissions to US hospitals: national analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LENGTH-OF-STAY; INPATIENT SAMPLE DATABASE; PATIENT SAFETY; MORTALITY; CARE; IMPACT; COMPLICATIONS; PERFORMANCE; SERVICES; MEDICARE	OBJECTIVE To evaluate the association between weekend admission to hospital and 14 hospital acquired conditions recently considered by the Centers for Medicare and Medicaid as "never events," serious, costly, and preventable medical errors, for which resulting healthcare costs are not reimbursed. DESIGN National analysis. SETTING US Nationwide Inpatient Sample discharge database. PARTICIPANTS 351 million patients discharged from US hospitals, 2002-10. MAIN OUTCOME MEASURES Univariate rates and multivariable likelihood of hospital acquired conditions among patients admitted on weekdays versus weekends, as well as the impacts of these events on prolonged length of stay and total inpatient charges. RESULTS From 2002 to 2010, 351 170 803 patients were admitted to hospital, with 19% admitted on a weekend. Hospital acquired conditions occurred at an overall frequency of 4.1% (5.7% among weekend admissions versus 3.7% among weekday admissions). Adjusting for patient and hospital cofactors the probability of having one or more hospital acquired conditions was more than 20% higher in weekend admissions compared with weekday admissions (odds ratio 1.25, 95% confidence interval 1.24 to 1.26, P < 0.01). Hospital acquired conditions have a negative impact on both hospital charges and length of stay. At least one hospital acquired condition was associated with an 83% (1.83, 1.77 to 1.90, P < 0.01) likelihood of increased charges and 38% likelihood of prolonged length of stay (1.38, 1.36 to 1.41, P < 0.01). CONCLUSION Weekend admission to hospital is associated with an increased likelihood of hospital acquired condition, cost, and length of stay. Future protocols and staffing regulations must be tailored to the requirements of this high risk subgroup.	[Attenello, Frank J.; Amar, Arun P.; Mack, William J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Wen, Timothy] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA; [Cen, Steven Y.; Kim-Tenser, May; Sanossian, Nerses] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90089 USA; [Cen, Steven Y.] Univ So Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA 90089 USA; [Ng, Alvin] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Wen, T (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA.	wentimot@usc.edu						Agency for Healthcare Research and Quality, 2014, HEALTHC COST UT PROJ; Allareddy V, 2013, OR SURG OR MED OR PA, V115, P710, DOI 10.1016/j.oooo.2012.09.004; Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Attenello FJ, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.053; Aujesky D, 2009, CIRCULATION, V119, P962, DOI 10.1161/CIRCULATIONAHA.108.824292; Barba R, 2006, EUR J INTERN MED, V17, P322, DOI 10.1016/j.ejim.2006.01.003; Bejanyan N, 2010, CANCER-AM CANCER SOC, V116, P3614, DOI 10.1002/cncr.25086; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Blegen MA, 1998, NURS ECON, V16, P196; Brown Sarah B, 2008, Hosp Health Netw, V82, P72; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Champaneria MC, 2013, ANN PLASTIC SURG; CMS, 2014, HOSP ACQ COND HAC AC; CMS, 2014, EFF IMPR PAT SAF RES; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Crowley RW, 2009, STROKE, V40, P2387, DOI 10.1161/STROKEAHA.108.546572; Czaplinski C, 1998, MED CARE, V36, P1626, DOI 10.1097/00005650-199812000-00002; Dasenbrock HH, 2012, NEUROSURGERY, V70, P586, DOI 10.1227/NEU.0b013e318232d1ee; Fakih MG, 2013, INFECT CONT HOSP EP, V34, P1048, DOI 10.1086/673149; Fargen KM, 2013, J NEUROSURG, V119, P966, DOI 10.3171/2013.5.JNS122378; Gosbee J, 2002, QUAL SAF HEALTH CARE, V11, P352, DOI 10.1136/qhc.11.4.352; Hanks N, 2014, WEST J EMERG MED, V15, P499, DOI 10.5811/westjem.2014.2.20388; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Hennessey P, 2012, LARYNGOSCOPE, V122, P2199, DOI 10.1002/lary.23459; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Horst MA, 2012, AM J MED QUAL, V27, P16, DOI 10.1177/1062860611409199; Houchens R, 2001, 20032 HCUP; Joice GA, 2013, UROLOGY, V81, P527, DOI 10.1016/j.urology.2012.09.050; Kaiman J., 2014, GUARDIAN; Karsh BT, 2006, QUAL SAF HEALTH CARE, V15, pI59, DOI 10.1136/qshc.2005.015974; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Lee MK, 2013, OR SURG OR MED OR PA, V116, P147, DOI 10.1016/j.oooo.2013.02.006; Mehtsun WT, 2013, SURGERY, V153, P465, DOI 10.1016/j.surg.2012.10.005; Milstein A, 2009, NEW ENGL J MED, V360, P2388, DOI 10.1056/NEJMp0809125; Morse BC, 2010, AM SURGEON, V76, P841; Naessens JM, 2012, AM J MED QUAL, V27, P48, DOI 10.1177/1062860611413456; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Panaich SS, 2014, AM J CARDIOL, V114, P1390, DOI 10.1016/j.amjcard.2014.07.075; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; SAS, 2010, SAS GLOB FOR P; Shaheen AAM, 2009, CLIN GASTROENTEROL H, V7, P303, DOI 10.1016/j.cgh.2008.08.033; Sharp AL, 2013, AM J EMERG MED, V31, P835, DOI 10.1016/j.ajem.2013.01.006; Teufack SG, 2010, J NEUROSURG, V112, P249, DOI 10.3171/2009.7.JNS09753; Turin TC, 2009, EUR J EPIDEMIOL, V24, P93, DOI 10.1007/s10654-008-9308-5; Wen T, 2014, J NEUROSURG, V121, P580, DOI 10.3171/2014.4.JNS131253; Wen T, 2014, NEUROSURGERY, V75, P43, DOI 10.1227/NEU.0000000000000352; Wen T, 2014, J ENDOUROL, V28, P660, DOI 10.1089/end.2013.0623; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	51	60	61	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2015	350								h1460	10.1136/bmj.h1460	http://dx.doi.org/10.1136/bmj.h1460			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JP	25876878	Green Published, hybrid			2022-12-24	WOS:000353328000001
J	Xiang, AH; Wang, XH; Martinez, MP; Walthall, JC; Curry, ES; Page, K; Buchanan, TA; Coleman, KJ; Getahun, D				Xiang, Anny H.; Wang, Xinhui; Martinez, Maya P.; Walthall, Johanna C.; Curry, Edward S.; Page, Kathleen; Buchanan, Thomas A.; Coleman, Karen J.; Getahun, Darios			Association of Maternal Diabetes With Autism in Offspring	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPECTRUM DISORDERS; ETHNIC DISPARITIES; GLUCOSE-TOLERANCE; RISK-FACTORS; PREGNANCY; OBESITY; ADIPOSITY; MELLITUS	IMPORTANCE Information about the association of maternal diabetes and autism spectrum disorders (ASDs) in offspring is limited, with no report on the importance of timing of exposure during gestation. OBJECTIVE To assess ASD risk associated with intrauterine exposure to preexisting type 2 diabetes and gestational diabetes mellitus (GDM) by gestational age at GDM diagnosis. DESIGN, SETTING, AND PATIENTS Retrospective longitudinal cohort study including 322 323 singleton children born in 1995-2009 at Kaiser Permanente Southern California (KPSC) hospitals. Children were tracked from birth until the first of the following: date of clinical diagnosis of ASD, last date of continuous KPSC health plan membership, death due to any cause, or December 31, 2012. Relative risks of ASD were estimated by hazard ratios (HRs) using Cox regression models adjusted for birth year. EXPOSURES Maternal preexisting type 2 diabetes (n = 6496), GDM diagnosed at 26 weeks' gestation or earlier (n = 7456) or after 26 weeks' gestation (n = 17 579), or no diabetes (n = 290 792) during the index pregnancy. MAIN OUTCOMES AND MEASURES Clinical diagnosis of ASD in offspring. RESULTS During follow-up, 3388 children were diagnosed as having ASD (115 exposed to preexisting type 2 diabetes, 130 exposed to GDM at <= 26 weeks, 180 exposed to GDM at >26 weeks, and 2963 unexposed). Unadjusted annual ASD incidences were 3.26, 3.02, 1.77, and 1.77 per 1000 among children of mothers with preexisting type 2 diabetes, GDM diagnosed at 26 weeks or earlier, GDM diagnosed after 26 weeks, and no diabetes, respectively. The birth year-adjusted HRs were 1.59(95% Cl, 1.29-1.95) for preexisting type 2 diabetes, 1.63(95% Cl, 1.35-1.97) for GDM diagnosed at 26 weeks or earlier, and 0.98 (95% Cl, 0.84-1.15) for GDM diagnosed after 26 weeks relative to no exposure. After adjustment for maternal age, parity, education, household income, race/ethnicity, history of comorbidity, and sex of the child, maternal preexisting type 2 diabetes was not significantly associated with risk of ASD in offspring (HR, 1.21; 95% Cl, 0.97-1.52), but GDM diagnosed at 26 weeks or earlier remained so (HR, 1.42; 95% Cl, 1.15-1.74). Antidiabetic medication exposure was not independently associated with ASD risk. Adjustment for a mother or older sibling with ASD in the full cohort and for maternal smoking, prepregnancy body mass index, and gestational weight gain in the subset with available data (n = 68 512) did not affect the results. CONCLUSIONS AND RELEVANCE In this large, multiethnic clinical cohort of singleton children born at 28 to 44 weeks' gestation, exposure to maternal GDM diagnosed by 26 weeks' gestation was associated with risk of ASD in offspring.	[Xiang, Anny H.; Wang, Xinhui; Martinez, Maya P.; Coleman, Karen J.; Getahun, Darios] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Walthall, Johanna C.] Kaiser Permanente So Calif, Dept Psychiat, Pasadena, CA 91101 USA; [Curry, Edward S.] Kaiser Permanente So Calif, Dept Pediat, Pasadena, CA 91101 USA; [Page, Kathleen; Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Div Endocrinol & Diabet, Los Angeles, CA 90033 USA; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA; [Getahun, Darios] Rutgers Robert Wood Johnson Med Sch, Dept Obstet & Gynecol, New Brunswick, NJ USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; University of Southern California; University of Southern California; Rutgers State University New Brunswick; Rutgers State University Medical Center	Xiang, AH (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, 100 S Los Robles Ave,Fifth Floor, Pasadena, CA 91101 USA.	anny.h.xiang@kp.org		Xiang, Anny/0000-0003-2786-1268; Martinez, Mayra/0000-0002-6134-606X	Kaiser Permanente Southern California Direct Community Benefit Funds	Kaiser Permanente Southern California Direct Community Benefit Funds	This work was supported by Kaiser Permanente Southern California Direct Community Benefit Funds.	American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Baron-Cohen S, 2000, J ROY SOC MED, V93, P521, DOI 10.1177/014107680009301007; Black MH, 2010, DIABETES CARE, V33, P2524, DOI 10.2337/dc10-1445; Burstyn I, 2010, CHRONIC DIS CAN, V30, P125; Burstyn I, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-2; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Coleman KJ, 2015, J AUTISM DEV DISORD, V45, P1989, DOI 10.1007/s10803-015-2358-0; Committee on Practice Bulletins-obstetrics, 2013, OBSTET GYNECOL, V131, P49, DOI DOI 10.1097/01.AOG.0000433006.09219.F1; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; Crume TL, 2011, J PEDIATR-US, V158, P941, DOI 10.1016/j.jpeds.2010.12.007; Davenport MH, 2013, OBSTET GYNECOL, V122, P255, DOI 10.1097/AOG.0b013e31829a3b86; Dodds L, 2011, J AUTISM DEV DISORD, V41, P891, DOI 10.1007/s10803-010-1114-8; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Koebnick Corinna, 2012, Perm J, V16, P37; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Page KA, 2014, J PEDIATR-US, V164, P807, DOI 10.1016/j.jpeds.2013.11.063; Reynolds LC, 2014, J PERINATOL, V34, P688, DOI 10.1038/jp.2014.80; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Suren P, 2014, PEDIATRICS, V133, pE1128, DOI 10.1542/peds.2013-3664; Suren P, 2013, JAMA-J AM MED ASSOC, V309, P570, DOI 10.1001/jama.2012.155925; von Ehrenstein OS, 2014, EPIDEMIOLOGY, V25, P851, DOI 10.1097/EDE.0000000000000150; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Xiang AH, 2011, DIABETOLOGIA, V54, P3016, DOI 10.1007/s00125-011-2330-2; Xiang AH, 2015, DIABETOLOGIA, V58, P272, DOI 10.1007/s00125-014-3420-8; Xu GF, 2014, J AUTISM DEV DISORD, V44, P766, DOI 10.1007/s10803-013-1928-2; Yao YM, 2006, ARCH NEUROL-CHICAGO, V63, P1161, DOI 10.1001/archneur.63.8.1161	32	200	211	1	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1425	1434		10.1001/jama.2015.2707	http://dx.doi.org/10.1001/jama.2015.2707			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871668	Bronze			2022-12-24	WOS:000352821200017
J	Kravtsova-Ivantsiv, Y; Shomer, I; Cohen-Kaplan, V; Snijder, B; Superti-Furga, G; Gonen, H; Sommer, T; Ziv, T; Admon, A; Naroditsky, I; Jbara, M; Brik, A; Pikarsky, E; Kwon, YT; Doweck, I; Ciechanover, A				Kravtsova-Ivantsiv, Yelena; Shomer, Inna; Cohen-Kaplan, Victoria; Snijder, Berend; Superti-Furga, Giulio; Gonen, Hedva; Sommer, Thomas; Ziv, Tamar; Admon, Arie; Naroditsky, Inna; Jbara, Muhammad; Brik, Ashraf; Pikarsky, Eli; Kwon, Yong Tae; Doweck, Ilana; Ciechanover, Aaron			KPC1-Mediated Ubiquitination and Proteasomal Processing of NF-kappa B1 p105 to p50 Restricts Tumor Growth	CELL			English	Article							NF-KAPPA-B; ACTIVATION; PROTEIN; PHOSPHORYLATION; DEGRADATION; SUBUNIT; PATHWAY; GLIOBLASTOMA; SUPPRESSOR; EXPRESSION	NF-kappa B is a key transcriptional regulator involved in inflammation and cell proliferation, survival, and transformation. Several key steps in its activation are mediated by the ubiquitin (Ub) system. One uncharacterized step is limited proteasomal processing of the NF-kappa B1 precursor p105 to the p50 active subunit. Here, we identify KPC1 as the Ub ligase (E3) that binds to the ankyrin repeats domain of p105, ubiquitinates it, and mediates its processing both under basal conditions and following signaling. Overexpression of KPC1 inhibits tumor growth likely mediated via excessive generation of p50. Also, overabundance of p50 downregulates p65, suggesting that a p50-p50 homodimer may modulate transcription in place of the tumorigenic p50-p65. Transcript analysis reveals increased expression of genes associated with tumor-suppressive signals. Overall, KPC1 regulation of NF-kappa B1 processing appears to constitute an important balancing step among the stimulatory and inhibitory activities of the transcription factor in cell growth control.	[Kravtsova-Ivantsiv, Yelena; Shomer, Inna; Cohen-Kaplan, Victoria; Gonen, Hedva; Ciechanover, Aaron] Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, David & Janet Polak Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Snijder, Berend; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Sommer, Thomas] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Ziv, Tamar; Admon, Arie] Technion Israel Inst Technol, Fac Biol, Smoler Prote Ctr, IL-32000 Haifa, Israel; [Naroditsky, Inna] Rambam Hlth Care Campus, Dept Pathol, IL-31096 Haifa, Israel; [Jbara, Muhammad; Brik, Ashraf] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; [Brik, Ashraf] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Immunol & Canc Res, IL-91120 Jerusalem, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Pathol, IL-91120 Jerusalem, Israel; [Kwon, Yong Tae; Ciechanover, Aaron] Seoul Natl Univ, Prot Metab Med Res Ctr, Seoul 110799, South Korea; [Kwon, Yong Tae; Ciechanover, Aaron] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Doweck, Ilana] Carmel Hosp, Dept Otolaryngol Head & Neck Surg, IL-34367 Haifa, Israel	Technion Israel Institute of Technology; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus; Ben Gurion University; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Seoul National University (SNU); Seoul National University (SNU); Clalit Health Services; Carmel Medical Center	Ciechanover, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, David & Janet Polak Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel.	aaroncie@tx.technion.ac.il	pikarsky, eli/GXV-7099-2022; Ciechanover, Aaron J/C-9166-2017; Snijder, Berend/O-9206-2019; Snijder, Berend/M-2998-2017; Superti-Furga, Giulio/AAE-5681-2019	Snijder, Berend/0000-0003-3386-6583; Ziv, Tamar/0000-0003-4299-7454; pikarsky, eli/0000-0003-4186-7105; Admon, Arie/0000-0003-0504-3950; Jbara, Muhammad/0000-0002-4206-5908; Doweck, Ilana/0000-0002-1065-0299	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation (ISF); I-CORE Program of the Planning and Budgeting Committee; ISF [1775/12]; EU Treat PolyQ Network; Nobel Laureates Invitation Program of Seoul National University; Deutsch-Israelische Projektkooperation (DIP); Program for Targeting Cancer by Modulating Protein Dynamics - Albert Sweet (Malibu, CA); Swiss National Science Foundation; Basic Science Research Programs of the National Research Foundation of Korea [NRF-2013R1A2A2A01014170]	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation (ISF)(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; ISF(Israel Science Foundation); EU Treat PolyQ Network; Nobel Laureates Invitation Program of Seoul National University; Deutsch-Israelische Projektkooperation (DIP); Program for Targeting Cancer by Modulating Protein Dynamics - Albert Sweet (Malibu, CA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Basic Science Research Programs of the National Research Foundation of Korea(National Research Foundation of Korea)	Research in the laboratory of A.C. is supported by grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF), the Israel Science Foundation (ISF), the I-CORE Program of the Planning and Budgeting Committee and the ISF (Grant1775/12), the EU Treat PolyQ Network, the Nobel Laureates Invitation Program of Seoul National University, the Deutsch-Israelische Projektkooperation (DIP), and the Program for Targeting Cancer by Modulating Protein Dynamics supported by Albert Sweet (Malibu, CA). We thank Dr. Kazuhiro Iwai (Department of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan) for providing us with some cDNAs. RNA-seq and mapping to the human genome was done by the Technion Genome Center. B.S. is supported by a fellowship from the Swiss National Science Foundation. Y.T.K. is supported by The Basic Science Research Programs of the National Research Foundation of Korea (NRF-2013R1A2A2A01014170). A.C. is an Israel Cancer Research Fund (ICRF) USA Professor.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Betts JC, 1996, MOL CELL BIOL, V16, P6363; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Cohen S, 2004, MOL CELL BIOL, V24, P475, DOI 10.1128/MCB.24.1.475-486.2004; Cohen S, 2006, BIOCHEM BIOPH RES CO, V345, P7, DOI 10.1016/j.bbrc.2006.04.036; Deng WG, 2003, J IMMUNOL, V171, P6581, DOI 10.4049/jimmunol.171.12.6581; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gao J, 2009, GLIA, V57, P989, DOI 10.1002/glia.20823; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Ivanov VN, 1997, ONCOGENE, V14, P2455, DOI 10.1038/sj.onc.1201088; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacKichan ML, 1996, J BIOL CHEM, V271, P6084, DOI 10.1074/jbc.271.11.6084; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Voce D. J., 2014, ONCOGENE; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	44	71	76	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					333	347		10.1016/j.cell.2015.03.001	http://dx.doi.org/10.1016/j.cell.2015.03.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860612	Bronze			2022-12-24	WOS:000352708300025
J	Jiang, L; Kon, N; Li, TY; Wang, SJ; Su, T; Hibshoosh, H; Baer, R; Gu, W				Jiang, Le; Kon, Ning; Li, Tongyuan; Wang, Shang-Jui; Su, Tao; Hibshoosh, Hanina; Baer, Richard; Gu, Wei			Ferroptosis as a p53-mediated activity during tumour suppression	NATURE			English	Article							CELL-DEATH; CYSTINE/GLUTAMATE ANTIPORTER; P53-INDUCIBLE REGULATOR; METABOLIC-REGULATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; REACTIVE OXYGEN; SYSTEM X(C)(-); P53 FUNCTION; CANCER	Although p53-mediated cell-cycle arrest, senescence and apoptosis serve as critical barriers to cancer development, emerging evidence suggests that the metabolic activities of p53 are also important. Here we show that p53 inhibits cystine uptake and sensitizes cells to ferroptosis, a non-apoptotic form of cell death, by repressing expression of SLC7A11, a key component of the cystine/glutamate antiporter. Notably, p53(3KR), an acetylation-defective mutant that fails to induce cell-cycle arrest, senescence and apoptosis, fully retains the ability to regulate SLC7A11 expression and induce ferroptosis upon reactive oxygen species (ROS)-induced stress. Analysis of mutant mice shows that these non-canonical p53 activities contribute to embryonic development and the lethality associated with loss of Mdm2. Moreover, SLC7A11 is highly expressed in human tumours, and its overexpression inhibits ROS-induced ferroptosis and abrogates p53(3KR)-mediated tumour growth suppression in xenograft models. Our findings uncover a new mode of tumour suppression based on p53 regulation of cystine metabolism, ROS responses and ferroptosis.	[Jiang, Le; Kon, Ning; Li, Tongyuan; Wang, Shang-Jui; Baer, Richard; Gu, Wei] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Baer, Richard; Gu, Wei] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Baer, Richard; Gu, Wei] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu			National Cancer Institute of the National Institutes of Health [5R01CA172023, 5RO1CA166294, 5RO1CA169246, 5RO1CA085533, 2P01CA080058]; National Cancer Institute [2P01CA097403]; NIH cancer biology training grant [T32-CA09503]; NATIONAL CANCER INSTITUTE [R01CA085533, R01CA172272, R01CA172023, R01CA169246, R01CA166294, P01CA097403, T32CA009503, P01CA080058] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH cancer biology training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health under awards 5R01CA172023, 5RO1CA166294, 5RO1CA169246, 5RO1CA085533 and 2P01CA080058 to W.G. It was also supported by the National Cancer Institute under award 2P01CA097403 to R.B. and W.G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. L.J. and S.-J.W. were supported by NIH cancer biology training grant T32-CA09503. We thank S. Mendrysa for Mdm2 mutant mice.	Aylon Y, 2011, CURR OPIN GENET DEV, V21, P86, DOI 10.1016/j.gde.2010.10.002; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chavez-Reyes A, 2003, CANCER RES, V63, P8664; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gannon Hugh S, 2012, Genes Cancer, V3, P209, DOI 10.1177/1947601912455324; Guo WJ, 2011, CANCER LETT, V312, P55, DOI 10.1016/j.canlet.2011.07.024; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Hughes RH, 2014, BRAIN RES, V1543, P308, DOI 10.1016/j.brainres.2013.11.020; Jackson JG, 2013, ONCOGENE, V32, P4325, DOI 10.1038/onc.2012.610; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liang YJ, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-9; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; Vu BT, 2011, CURR TOP MICROBIOL, V348, P151, DOI 10.1007/82_2010_110; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Wang PY, 2013, NEW ENGL J MED, V368, P1027, DOI 10.1056/NEJMoa1214091; Wang SJ, 2014, CURR OPIN ONCOL, V26, P78, DOI 10.1097/CCO.0000000000000024; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zheng H, 2013, MOL CELL, V50, P699, DOI 10.1016/j.molcel.2013.04.013	40	1221	1283	81	797	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					57	+		10.1038/nature14344	http://dx.doi.org/10.1038/nature14344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25799988	Green Accepted			2022-12-24	WOS:000352027700035
J	Roth, GA; Forouzanfar, MH; Moran, AE; Barber, R; Nguyen, G; Feigin, VL; Naghavi, M; Mensah, GA; Murray, CJL				Roth, Gregory A.; Forouzanfar, Mohammad H.; Moran, Andrew E.; Barber, Ryan; Nguyen, Grant; Feigin, Valery L.; Naghavi, Mohsen; Mensah, George A.; Murray, Christopher J. L.			Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; DEATH; COUNTRIES; BURDEN	BACKGROUND Global deaths from cardiovascular disease are increasing as a result of population growth, the aging of populations, and epidemiologic changes in disease. Disentangling the effects of these three drivers on trends in mortality is important for planning the future of the health care system and benchmarking progress toward the reduction of cardiovascular disease. METHODS We used mortality data from the Global Burden of Disease Study 2013, which includes data on 188 countries grouped into 21 world regions. We developed three counterfactual scenarios to represent the principal drivers of change in cardiovascular deaths (population growth alone, population growth and aging, and epidemiologic changes in disease) from 1990 to 2013. Secular trends and correlations with changes in national income were examined. RESULTS Global deaths from cardiovascular disease increased by 41% between 1990 and 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase in mortality due to the aging of populations and a 25% increase due to population growth. The relative contributions of these drivers varied by region; only in Central Europe and Western Europe did the annual number of deaths from cardiovascular disease actually decline. Change in gross domestic product per capita was correlated with change in age-specific death rates only among upper-middle income countries, and this correlation was weak; there was no significant correlation elsewhere. CONCLUSIONS The aging and growth of the population resulted in an increase in global cardiovascular deaths between 1990 and 2013, despite a decrease in age-specific death rates in most regions. Only Central and Western Europe had gains in cardiovascular health that were sufficient to offset these demographic forces.	[Roth, Gregory A.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98121 USA; [Roth, Gregory A.; Forouzanfar, Mohammad H.; Barber, Ryan; Nguyen, Grant; Naghavi, Mohsen; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Moran, Andrew E.] Columbia Univ, Dept Med, Div Gen Med, New York, NY USA; [Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Sci, Auckland, New Zealand; [Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bethesda, MD 20892 USA	University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Columbia University; Auckland University of Technology; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roth, GA (corresponding author), Univ Washington, Dept Med, Div Cardiol, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	rothg@uw.edu	Feigin, Valery/AAF-2313-2019	Feigin, Valery L./0000-0002-6372-1740	Bill and Melinda Gates Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Bill and Melinda Gates Foundation and others.	Beaglehole R, 2012, LANCET, V380, P1283, DOI 10.1016/S0140-6736(12)61692-4; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Reddy KS, 1998, CIRCULATION, V97, P596; Shorrocks AF, 2013, J ECON INEQUAL, V11, P99, DOI 10.1007/s10888-011-9214-z; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	13	639	667	2	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1333	1341		10.1056/NEJMoa1406656	http://dx.doi.org/10.1056/NEJMoa1406656			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830423	Green Accepted			2022-12-24	WOS:000352028500008
J	Zabow, G; Dodd, SJ; Koretsky, AP				Zabow, G.; Dodd, S. J.; Koretsky, A. P.			Shape-changing magnetic assemblies as high-sensitivity NMR-readable nanoprobes	NATURE			English	Article							INTRACELLULAR PH; RESPONSIVE HYDROGEL; MULTISPECTRAL MRI; CONTRAST AGENTS; PARACEST AGENTS; RESONANCE; COMPLEXES; BIOLOGY; PROBES	Fluorescent and plasmonic labels and sensors have revolutionized molecular biology, helping visualize cellular and biomolecular processes(1-3). Increasingly, such probes are now being designed to respond to wavelengths in the near-infrared region, where reduced tissue autofluorescence and photon attenuation enable subsurface in vivo sensing(4). But even in the near-infrared region, optical resolution and sensitivity decrease rapidly with increasing depth. Here we present a sensor design that obviates the need for optical addressability by operating in the nuclear magnetic resonance (NMR) radio-frequency spectrum, where signal attenuation and distortion by tissue and biological media are negligible, where background interferences vanish, and where sensors can be spatially located using standard magnetic resonance imaging(MRI) equipment. The radio-frequency-addressable sensor assemblies presented here comprise pairs of magnetic disks spaced by swellable hydrogel material; they reversibly reconfigure in rapid response to chosen stimuli, to give geometry-dependent, dynamic NMR spectral signatures. The sensors can be made from biocompatible materials, are themselves detectable down to low concentrations, and offer potential responsive NMR spectral shifts that are close to a million times greater than those of traditional magnetic resonance spectroscopies. Inherent adaptability should allow such shape-changing systems to measure numerous different environmental and physiological indicators, thus providing broadly generalizable, MRI-compatible, radio-frequency analogues to optically based probes for use in basic chemical, biological, medical and engineering research.	[Zabow, G.; Dodd, S. J.; Koretsky, A. P.] NINDS, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Zabow, G.] NIST, Electromagnet Div, Phys Measurements Lab, Boulder, CO 80305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Standards & Technology (NIST) - USA	Zabow, G (corresponding author), NINDS, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA.	gary.zabow@nist.gov	Koretsky, Alan P/C-7940-2015	Koretsky, Alan P/0000-0002-8085-4756; Zabow, Gary/0000-0002-1421-8540	NIH NINDS Intramural Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003047] Funding Source: NIH RePORTER	NIH NINDS Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the NIH NINDS Intramural Research Program. We thank the NIH Mouse Imaging Facility for use of their 14 T MRI, Y. Chen for providing the MDCK cells, and J. Moreland for discussion and NIST Boulder cleanroom access.	Aime S, 2003, ANGEW CHEM INT EDIT, V42, P4527, DOI 10.1002/anie.200352132; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0; DECKER C, 1985, MACROMOLECULES, V18, P1241, DOI 10.1021/ma00148a034; FISCHELGHODSIAN F, 1988, P NATL ACAD SCI USA, V85, P2403, DOI 10.1073/pnas.85.7.2403; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; GRAD J, 1990, J MAGN RESON, V90, P1, DOI 10.1016/0022-2364(90)90361-C; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Jindal AK, 2010, J AM CHEM SOC, V132, P1784, DOI 10.1021/ja910278e; Jorjani P, 1999, BIOTECHNOL BIOENG, V64, P349, DOI 10.1002/(SICI)1097-0290(19990805)64:3<349::AID-BIT11>3.0.CO;2-V; Kabiri K, 2008, J APPL POLYM SCI, V110, P3420, DOI 10.1002/app.28148; Madou M. J, 2002, FUNDAMENTALS MICROFA, V2nd; Martinez GV, 2011, NMR BIOMED, V24, P1380, DOI 10.1002/nbm.1701; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619; MOON RB, 1973, J BIOL CHEM, V248, P7276; PAN JW, 1988, P NATL ACAD SCI USA, V85, P7836, DOI 10.1073/pnas.85.21.7836; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Plunkett KN, 2005, BIOMACROMOLECULES, V6, P632, DOI 10.1021/bm049349v; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; TAYLOR JS, 1983, BIOPHYS J, V43, P261, DOI 10.1016/S0006-3495(83)84349-5; Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4; Wang CS, 2014, SENSOR ACTUAT B-CHEM, V196, P670, DOI 10.1016/j.snb.2014.01.096; Wang XF, 2013, CARDIOLOGY, V126, P110; Ward KM, 2000, MAGN RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; Woods M, 2006, CHEM SOC REV, V35, P500, DOI 10.1039/b509907m; Wu YK, 2008, J AM CHEM SOC, V130, P13854, DOI 10.1021/ja805775u; Wu YK, 2010, J AM CHEM SOC, V132, P14002, DOI 10.1021/ja106018n; Yoo B, 2008, FRONT BIOSCI-LANDMRK, V13, P1733, DOI 10.2741/2796; Yoon JW, 2010, SOFT MATTER, V6, P6004, DOI 10.1039/c0sm00434k; Zabow G, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385301; Zabow G, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/2/025020; Zabow G, 2008, NATURE, V453, P1058, DOI 10.1038/nature07048; Zabow G, 2014, SMALL, V10, P1902, DOI 10.1002/smll.201303045; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang J., 2003, NAT REV MOL CELL BIO, V4, P80	39	42	47	5	289	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					73	U157		10.1038/nature14294	http://dx.doi.org/10.1038/nature14294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25778701	Green Accepted			2022-12-24	WOS:000352027700039
J	Holmes, J; Angus, C; Meier, PS				Holmes, John; Angus, Colin; Meier, Petra S.			UK alcohol industry's "billion units pledge": interim evaluation flawed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Holmes, John; Angus, Colin] Univ Sheffield, Sch Hlth & Related Res, Sheffield Alcohol Res Grp, Sheffield S1 4DA, S Yorkshire, England; [Meier, Petra S.] Univ Sheffield, Sch Hlth & Related Res, Sheffield Alcohol Res Grp, Publ Hlth, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield	Angus, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield Alcohol Res Grp, Sheffield S1 4DA, S Yorkshire, England.	c.r.angus@sheffield.ac.uk	Meier, Petra/P-7504-2019; Angus, Colin/AAT-2786-2020; Meier, Petra S/L-7387-2017	Meier, Petra/0000-0001-5354-1933; Angus, Colin/0000-0003-0529-4135; Meier, Petra S/0000-0001-5354-1933; Holmes, John/0000-0001-9283-2151	Medical Research Council [MR/K023195/1B, G1000043, MR/K023195/1] Funding Source: researchfish; MRC [G1000043] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2012, GUARDIAN; British Beer and Pub Association, 2014, STATISTICAL HANDBOOK; Department of Health, 2014, LIVING WELL FOR LONG; Department of Health, 2014, RESPONSIBILITY DEAL; Department of Health, 2011, THE PUBLIC HEALTH RE; Department of Health, 2014, ALCOHOL UNIT REDUCTI; Department of Health, 2015, ALCOHOL UNIT REDUCTI; Department of Health, 2014, FIRST INTERIM MONITO; HM Government, 2012, THE GOVERNMENTS ALCO; HMRC, 2012, ALCOHOL FACT SHEET 2; HMRC, 2014, ALCOHOL DUTY; HMRC, ALCOHOL FACTSHEET 20; Home Office, 2013, NEXT STEPS FOLLOWING; Jones L, 2012, CAN PROMOTION OF LOW; Meng Y, 2014, ADDICTION, V109, P206, DOI 10.1111/add.12330; NHS Health Scotland, 2012, MONITORING AND EVALU; Patrick AO, 2008, WALL STREET JOURNAL	17	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2015	350								h1301	10.1136/bmj.h1301	http://dx.doi.org/10.1136/bmj.h1301			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NO	25810497	Green Accepted			2022-12-24	WOS:000352028800004
J	Sada, N; Lee, S; Katsu, T; Otsuki, T; Inoue, T				Sada, Nagisa; Lee, Suni; Katsu, Takashi; Otsuki, Takemi; Inoue, Tsuyoshi			Targeting LDH enzymes with a stiripentol analog to treat epilepsy	SCIENCE			English	Article							KETOGENIC DIET; ANTIEPILEPTIC DRUG; BRAIN; NEURONS; METABOLISM; TRANSPORT; GLUCOSE	Neuronal excitation is regulated by energy metabolism, and drug-resistant epilepsy can be suppressed by special diets. Here, we report that seizures and epileptiform activity are reduced by inhibition of the metabolic pathway via lactate dehydrogenase (LDH), a component of the astrocyte-neuron lactate shuttle. Inhibition of the enzyme LDH hyperpolarized neurons, which was reversed by the downstream metabolite pyruvate. LDH inhibition also suppressed seizures in vivo in a mouse model of epilepsy. We further found that stiripentol, a clinically used antiepileptic drug, is an LDH inhibitor. By modifying its chemical structure, we identified a previously unknown LDH inhibitor, which potently suppressed seizures in vivo. We conclude that LDH inhibitors are a promising new group of antiepileptic drugs.	[Sada, Nagisa; Katsu, Takashi; Inoue, Tsuyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biophys Chem, Okayama 7008530, Japan; [Lee, Suni; Otsuki, Takemi] Kawasaki Med Sch, Dept Hyg, Kurashiki, Okayama 7010192, Japan	Okayama University; Kawasaki Medical School	Inoue, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biophys Chem, Okayama 7008530, Japan.	tinoue@pharm.okayama-u.ac.jp	INOUE, Tsuyoshi/B-1604-2011		Japan Society for the Promotion of Science [24590114]; Takeda Science Foundation; Ryobi-Teien Memory Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ryobi-Teien Memory Foundation(Ryobi Teien Memory Foundation)	We thank K. Imoto for comments on this manuscript, D. Kase for technical advice on in vivo recordings at the initial stage, and A. Wakasa and K. Urakawa for their technical support on the intrahippocampal kainate model. N.S., S.L., T.O., and T.I. are inventors on a patent (World Intellectual Property Organization WO2014/115764) related to clinical use of stiripentol as LDH inhibitors, and N.S. and T.I. are also inventors on a patent (Japan JP2015-023572) related to isosafrole as antiepileptic compounds. These patent applications have been filed by Okayama University. All data described in the paper are presented in this report and supplementary materials. This work was supported by grants from the Japan Society for the Promotion of Science (24590114) and by research grants from Takeda Science Foundation and Ryobi-Teien Memory Foundation.	Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Caraballo RH, 2005, EPILEPSIA, V46, P1539, DOI 10.1111/j.1528-1167.2005.05705.x; Chiron C, 2000, LANCET, V356, P1638, DOI 10.1016/S0140-6736(00)03157-3; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; Deck LM, 1998, J MED CHEM, V41, P3879, DOI 10.1021/jm980334n; Dybdal D, 2000, J NEUROSCI, V20, P6728, DOI 10.1523/JNEUROSCI.20-17-06728.2000; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Granchi C, 2011, J MED CHEM, V54, P1599, DOI 10.1021/jm101007q; IADAROLA MJ, 1982, SCIENCE, V218, P1237, DOI 10.1126/science.7146907; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lutas A, 2013, TRENDS NEUROSCI, V36, P32, DOI 10.1016/j.tins.2012.11.005; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Parsons MP, 2010, J NEUROSCI, V30, P8061, DOI 10.1523/JNEUROSCI.5741-09.2010; Quilichini PP, 2006, EPILEPSIA, V47, P704, DOI 10.1111/j.1528-1167.2006.00497.x; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Samala R, 2011, NEUROCHEM INT, V58, P5, DOI 10.1016/j.neuint.2010.10.011; Shimizu H, 2007, NEURON, V54, P59, DOI 10.1016/j.neuron.2007.03.014; SILVER IA, 1994, J NEUROSCI, V14, P5068; Song ZT, 2001, DIABETES, V50, P2673, DOI 10.2337/diabetes.50.12.2673; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Trojnar MK, 2005, PHARMACOL REP, V57, P154	30	224	230	9	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1362	1367		10.1126/science.aaa1299	http://dx.doi.org/10.1126/science.aaa1299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792327				2022-12-24	WOS:000351219600042
J	Liu, WW; Mazor, O; Wilson, RI				Liu, Wendy W.; Mazor, Ofer; Wilson, Rachel I.			Thermosensory processing in the Drosophila brain	NATURE			English	Article							ANTENNAL LOBE; CENTRAL NEURONS; TEMPERATURE; MELANOGASTER; EXPRESSION; AVOIDANCE; LARVAL; TOOLS	In Drosophila, just as in vertebrates, changes in external temperature are encoded by bidirectional opponent thermoreceptor cells: some cells are excited by warming and inhibited by cooling, whereas others are excited by cooling and inhibited by warming(1,2). The central circuits that process these signals are not understood. In Drosophila, a specific brain region receives input from thermoreceptor cells(2,3). Here we show that distinct genetically identified projection neurons (PNs) in this brain region are excited by cooling, warming, or both. The PNs excited by cooling receive mainly feed-forward excitation from cool thermoreceptors. In contrast, the PNs excited by warming ('warm-PNs') receive both excitation from warm thermoreceptors and crossover inhibition from cool thermoreceptors through inhibitory interneurons. Notably, this crossover inhibition elicits warming-evoked excitation, because warming suppresses tonic activity in cool thermoreceptors. This in turn disinhibits warm-PNs and sums with feed-forward excitation evoked by warming. Crossover inhibition could cancel non-thermal activity (noise) that is positively correlated among warm and cool thermoreceptor cells, while reinforcing thermal activity which is anti-correlated. Our results show how central circuits can combine signals from bidirectional opponent neurons to construct sensitive and robust neural codes.	[Liu, Wendy W.; Mazor, Ofer; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mazor, Ofer] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Liu, Wendy/0000-0002-1648-4068; Mazor, Ofer/0000-0002-6860-7242; Wilson, Rachel/0000-0001-8573-9266	NIH [R01 DC008174]; HHMI International Research Fellowship; MD-PhD Program at Harvard Medical School; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI International Research Fellowship; MD-PhD Program at Harvard Medical School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to C. -H. Lee for the gift of LexAOp-HA-Ort flies, P. Garrity for Gr28b.d-Gal4, and A. Rajan for Gad1-Gal4 (line 2B). A. DiAntonio kindly supplied the anti-dVGluT antibody. We thank the Wilson laboratory, A. Samuel, P. Garrity, L. Griffith and D. Ginty for comments on the manuscript. D. Rogulja's laboratory and M. Y. Wong shared reagents and expertise. A portion of this work was supported by NIH grant R01 DC008174. W.W.L. is supported by an HHMI International Research Fellowship and a Presidential Scholarship from the MD-PhD Program at Harvard Medical School. R.I.W. is a Howard Hughes Investigator.	Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Enell L, 2007, J COMP NEUROL, V505, P18, DOI 10.1002/cne.21472; Fischer H, 2002, J COMP PHYSIOL A, V188, P643, DOI 10.1007/s00359-002-0339-1; Fisek M, 2014, NAT NEUROSCI, V17, P280, DOI 10.1038/nn.3613; FOELIX RF, 1989, CELL TISSUE RES, V258, P277, DOI 10.1007/BF00239448; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Green BG, 2004, J NEUROBIOL, V61, P13, DOI 10.1002/neu.20081; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Laissue PP, 1999, J COMP NEUROL, V405, P543; Liu WW, 2013, CURR BIOL, V23, P1202, DOI 10.1016/j.cub.2013.05.016; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; Mehren JE, 2006, LEARN MEMORY, V13, P686, DOI 10.1101/lm.317806; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Prescott SA, 2012, CURR OPIN NEUROBIOL, V22, P631, DOI 10.1016/j.conb.2012.02.010; Ruchty M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00174; Sachs F., 1998, REV PHYSL BIOCH PHAR, V132; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schepers RJ, 2010, NEUROSCI BIOBEHAV R, V34, P177, DOI 10.1016/j.neubiorev.2009.10.003; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Tang X, 2013, J NEUROSCI, V33, P894, DOI 10.1523/JNEUROSCI.1894-12.2013; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	36	51	52	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					353	+		10.1038/nature14170	http://dx.doi.org/10.1038/nature14170			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25739502	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000351171900041
J	Powell, JR				Powell, J. Robert			Are New Oral Anticoagulant Dosing Recommendations Optimal for All Patients?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ATRIAL-FIBRILLATION; DABIGATRAN		Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Powell, JR (corresponding author), Univ N Carolina, Eshelman Sch Pharm, 301 Pharm Ln, Chapel Hill, NC 27599 USA.	bob.powell49@gmail.com						Beasley BN, 2011, NEW ENGL J MED, V364, P1788, DOI 10.1056/NEJMp1103050; Cohen D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4670; Girgis IG, 2014, J CLIN PHARMACOL, V54, P917, DOI 10.1002/jcph.288; Hellriegel ET, 1996, CLIN PHARMACOL THER, V60, P601, DOI 10.1016/S0009-9236(96)90208-8; Ingelheim Boehringer, ID MID LONG TERM STR; Kowalsk K, 2014, J PHARMACOKINET PHAR, V41, pS19; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee, ED NDA 206314 STAT C	9	23	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1013	1014		10.1001/jama.2015.59	http://dx.doi.org/10.1001/jama.2015.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756434				2022-12-24	WOS:000350643100013
J	Burg, JS; Ingram, JR; Venkatakrishnan, AJ; Jude, KM; Dukkipati, A; Feinberg, EN; Angelini, A; Waghray, D; Dror, RO; Ploegh, HL; Garcia, KC				Burg, John S.; Ingram, Jessica R.; Venkatakrishnan, A. J.; Jude, Kevin M.; Dukkipati, Abhiram; Feinberg, Evan N.; Angelini, Alessandro; Waghray, Deepa; Dror, Ron O.; Ploegh, Hidde L.; Garcia, K. Christopher			Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor	SCIENCE			English	Article							SULFOTYROSINE RECOGNITION; SIGNALING NETWORKS; CRYSTAL-STRUCTURE; IDENTIFICATION; COMPLEX; BINDING; DOMAIN	Chemokines are small proteins that function as immune modulators through activation of chemokine G protein-coupled receptors (GPCRs). Several viruses also encode chemokines and chemokine receptors to subvert the host immune response. How protein ligands activate GPCRs remains unknown. We report the crystal structure at 2.9 angstrom resolution of the human cytomegalovirus GPCR US28 in complex with the chemokine domain of human CX3CL1 (fractalkine). The globular body of CX3CL1 is perched on top of the US28 extracellular vestibule, whereas its amino terminus projects into the central core of US28. The transmembrane helices of US28 adopt an active-state-like conformation. Atomic-level simulations suggest that the agonist-independent activity of US28 may be due to an amino acid network evolved in the viral GPCR to destabilize the receptor's inactive state.	[Burg, John S.; Jude, Kevin M.; Dukkipati, Abhiram; Waghray, Deepa; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Burg, John S.; Jude, Kevin M.; Dukkipati, Abhiram; Waghray, Deepa; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Burg, John S.; Venkatakrishnan, A. J.; Jude, Kevin M.; Dukkipati, Abhiram; Feinberg, Evan N.; Waghray, Deepa; Dror, Ron O.; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Ingram, Jessica R.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Venkatakrishnan, A. J.; Feinberg, Evan N.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.; Feinberg, Evan N.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Angelini, Alessandro] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT)	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Angelini, Alessandro/AAB-3682-2019	/0000-0001-5923-3843; Jude, Kevin/0000-0002-3675-5136; Dror, Ron/0000-0002-6418-2793; Feinberg, Evan/0000-0002-7989-8751	Cancer Research Institute; Howard Hughes Medical Institute; Keck Foundation Medical Scholars Program; NIH [RO1 GM097015]; Terman Faculty Fellowship; Swiss National Science Foundation; NIH Pioneer award; Ludwig Foundation for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097015, DP1GM106409] Funding Source: NIH RePORTER	Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Keck Foundation Medical Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terman Faculty Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Foundation for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Kobilka and members of the Kobilka lab for advice and discussions; S. Kim, N. Lotorraca, and A. Sanborn for assistance with MD simulations and analysis; J. Spangler for helpful discussions; E. Ozkan for assistance with data collection; and H. Axelrod for advice on refinement strategies. We also acknowledge beamline resources and staff of Advanced Photon Source GM/CA beamlines 23-ID-B and 23-ID-D and Stanford. Synchrotron Radiation Lightsource beamline 12-2. The data in this paper are tabulated in the main manuscript and in the supplementary materials. Structure factors and coordinates have been deposited in the Protein Data Bank with identification (ID) numbers 4XT1 and 4XT3. We acknowledge support from the Cancer Research Institute (J.S.B.), Howard Hughes Medical Institute (K.C.G.) the Keck Foundation Medical Scholars Program (K.C.G.), NIH RO1 GM097015 (K.C.G.), a Terman Faculty Fellowship (R.O.D.), Swiss National Science Foundation (A.A.), NIH Pioneer award (H.L.P.), and Ludwig Foundation for Cancer Research (A.A.).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Casarosa P, 2003, J BIOL CHEM, V278, P5172, DOI 10.1074/jbc.M210033200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; Han Xinbing, 2014, Adv Pharmacol, V70, P265, DOI 10.1016/B978-0-12-417197-8.00009-2; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Millard CJ, 2014, STRUCTURE, V22, P1571, DOI 10.1016/j.str.2014.08.023; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2014, CURR MED CHEM, V21, P3594, DOI 10.2174/0929867321666140716093155; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Vischer HF, 2006, TRENDS PHARMACOL SCI, V27, P56, DOI 10.1016/j.tips.2005.11.006; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	30	212	216	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1113	1117		10.1126/science.aaa5026	http://dx.doi.org/10.1126/science.aaa5026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745166	Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000350354200046
J	Sekine, Y; Zyryanova, A; Crespillo-Casado, A; Fischer, PM; Harding, HP; Ron, D				Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Fischer, Peter M.; Harding, Heather P.; Ron, David			Mutations in a translation initiation factor identify the target of a memory-enhancing compound	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; GUANINE-NUCLEOTIDE EXCHANGE; EIF2-ALPHA KINASE; PHOSPHORYLATION; GCN2; METABOLISM; INHIBITOR; INSIGHTS; EIF2B; PERK	The integrated stress response (ISR) modulates messenger RNA translation to regulate the mammalian unfolded protein response (UPR), immunity, and memory formation. A chemical ISR inhibitor, ISRIB, enhances cognitive function and modulates the UPR in vivo. To explore mechanisms involved in ISRIB action, we screened cultured mammalian cells for somatic mutations that reversed its effect on the ISR. Clustered missense mutations were found at the amino-terminal portion of the delta subunit of guanine nucleotide exchange factor (GEF) eIF2B. When reintroduced by CRISPR-Cas9 gene editing of wild-type cells, these mutations reversed both ISRIB-mediated inhibition of the ISR and its stimulatory effect on eIF2B GEF activity toward its substrate, the translation initiation factor eIF2, in vitro. Thus, ISRIB targets an interaction between eIF2 and eIF2B that lies at the core of the ISR.	[Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Harding, Heather P.; Ron, David] Univ Cambridge, Cambridge Inst Med Res CIMR, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 0XY, England; [Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Harding, Heather P.; Ron, David] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0XY, England; [Fischer, Peter M.] Univ Nottingham, Div Med Chem & Struct Biol, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Cambridge; University of Cambridge; University of Nottingham	Sekine, Y (corresponding author), Univ Cambridge, Cambridge Inst Med Res CIMR, Wellcome Trust MRC Inst Metab Sci, Cambridge CB2 0XY, England.	ys412@cam.ac.uk; dr360@medschl.cam.ac.uk	Sekine, Yusuke/AHI-8340-2022; Fischer, Peter/E-5657-2010	Fischer, Peter/0000-0002-5866-9271; Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636; Sekine, Yusuke/0000-0003-0345-1416	Wellcome Trust [084812/Z/08/Z, 100140]; Daiichi Sankyo Foundation of Life Science; Japan Society for the Promotion of Science	Wellcome Trust(Wellcome TrustEuropean Commission); Daiichi Sankyo Foundation of Life Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank P. Walter and C. Sidrauski (University of California, San Francisco) for their gift of ISRIB (used to confirm their observations), R. Schulte from the flow cytometery core, and R. Antrobus from the mass spectrometry core at the CIMR for their technical assistance. Supported by grants from the Wellcome Trust (Wellcome 084812/Z/08/Z and a strategic award Wellcome 100140), and by fellowships to Y.S. from the Daiichi Sankyo Foundation of Life Science and the Japan Society for the Promotion of Science for research abroad. D.R. is a Wellcome Trust Principal Research Fellow.	Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bogorad AM, 2014, BIOCHEMISTRY-US, V53, P3432, DOI 10.1021/bi500346u; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; DEHARO C, 1979, P NATL ACAD SCI USA, V76, P1741, DOI 10.1073/pnas.76.4.1741; Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754; Gordiyenko Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4902; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; KIMBALL SR, 1989, AM J PHYSIOL, V256, pC28, DOI 10.1152/ajpcell.1989.256.1.C28; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; RANU RS, 1979, P NATL ACAD SCI USA, V76, P1079, DOI 10.1073/pnas.76.3.1079; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Wortham NC, 2014, FASEB J, V28, P2225, DOI 10.1096/fj.13-243329; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	20	146	150	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1027	1030		10.1126/science.aaa6986	http://dx.doi.org/10.1126/science.aaa6986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	25858979	Green Accepted			2022-12-24	WOS:000355276600047
J	Adam, RC; Yang, H; Rockowitz, S; Larsen, SB; Nikolova, M; Oristian, DS; Polak, L; Kadaja, M; Asare, A; Zheng, DY; Fuchs, E				Adam, Rene C.; Yang, Hanseul; Rockowitz, Shira; Larsen, Samantha B.; Nikolova, Maria; Oristian, Daniel S.; Polak, Lisa; Kadaja, Meelis; Asare, Amma; Zheng, Deyou; Fuchs, Elaine			Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice	NATURE			English	Article							IDENTITY GENES; SELF-RENEWAL; NICHE; SKIN; GENOME; DIFFERENTIATION; REGENERATION; INHIBITION	Adult stem cells occur in niches that balance self-renewal with lineage selection and progression during tissue homeostasis. Following injury, culture or transplantation, stem cells outside their niche often display fate flexibility(1-4). Here we show that super-enhancers(5) underlie the identity, lineage commitment and plasticity of adult stem cells in vivo. Using hair follicle as a model, we map the global chromatin domains of hair follicle stem cells and their committed progenitors in their native microenvironments. We show that super-enhancers and their dense clusters ('epicentres') of transcription factor binding sites undergo remodelling upon lineage progression. New fate is acquired by decommissioning old and establishing new super-enhancers and/or epicentres, an auto-regulatory process that abates one master regulator subset while enhancing another. We further show that when outside their niche, either in vitro or in wound-repair, hair follicle stem cells dynamically remodel super-enhancers in response to changes in their microenvironment. Intriguingly, some key super-enhancers shift epicentres, enabling their genes to remain active and maintain a transitional state in an ever-changing transcriptional landscape. Finally, we identify SOX9 as a crucial chromatin rheostat of hair follicle stem cell super-enhancers, and provide functional evidence that super-enhancers are dynamic, dense transcription-factor-binding platforms which are acutely sensitive to pioneer master regulators whose levels define not only spatial and temporal features of lineage-status but also stemness, plasticity in transitional states and differentiation.	[Adam, Rene C.; Yang, Hanseul; Larsen, Samantha B.; Nikolova, Maria; Oristian, Daniel S.; Polak, Lisa; Kadaja, Meelis; Asare, Amma; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Rockowitz, Shira; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Larsen, Samantha/0000-0001-6392-2350; Asare, Amma/0000-0002-4865-6864; Zheng, Deyou/0000-0003-4354-5337	Anderson Cancer Center Graduate Student Fellowship; National Institutes of Health [R01-AR31737, R21MH099452]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699, T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099452] Funding Source: NIH RePORTER	Anderson Cancer Center Graduate Student Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Mazel, L. Li, S. Semova, and S. Tadesse for FACS sorting (Rockefeller University FACS facility); and C. Lai for assistance in high-throughput sequencing (Rockefeller University Genomics Resource Center). We thank E.F. laboratory members A. Aldeguer, S. Hacker, M. Sribour and J. Levorse for assistance in mouse research; I. Matos for advice on image acquisition; J. Racelis, S. Chai, and E. Wong for technical assistance; and Y. Ge, S. Naik, A. Kulukian, and N. Oshimori for discussions. R.C.A. was supported by the Anderson Cancer Center Graduate Student Fellowship. E.F. is an HHMI Investigator. This work was supported by grants from the National Institutes of Health (R01-AR31737 to E.F. and R21MH099452 to D.Z.).	Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu ZJ, 2014, CELL, V159, P358, DOI 10.1016/j.cell.2014.08.027; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Luyten A, 2014, GENE DEV, V28, P1827, DOI 10.1101/gad.240101.114; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	37	256	259	4	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					366	+		10.1038/nature14289	http://dx.doi.org/10.1038/nature14289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25799994	Green Accepted			2022-12-24	WOS:000354816500059
J	Sampson, GS; Sanchirico, JN; Roheim, CA; Bush, SR; Taylor, JE; Allison, EH; Anderson, JL; Ban, NC; Fujita, R; Jupiter, S; Wilson, JR				Sampson, Gabriel S.; Sanchirico, James N.; Roheim, Cathy A.; Bush, Simon R.; Taylor, J. Edward; Allison, Edward H.; Anderson, James L.; Ban, Natalie C.; Fujita, Rod; Jupiter, Stacy; Wilson, Jono R.			Secure sustainable seafood from developing countries	SCIENCE			English	Editorial Material							MSC CERTIFICATION; STEWARDSHIP		[Sampson, Gabriel S.; Sanchirico, James N.; Taylor, J. Edward] Univ Calif Davis, Davis, CA 95616 USA; [Sanchirico, James N.] Resources Future Inc, Washington, DC 20036 USA; [Roheim, Cathy A.] Univ Idaho, Moscow, ID 83844 USA; [Bush, Simon R.] Wageningen Univ, NL-6708 LX Wageningen, Netherlands; [Allison, Edward H.] Univ Washington, Seattle, WA 98105 USA; [Anderson, James L.] Univ Florida, Gainesville, FL 32611 USA; [Ban, Natalie C.] Univ Victoria, Victoria, BC V8W 2Y2, Canada; [Fujita, Rod] Environm Def Fund, San Francisco, CA 94105 USA; [Jupiter, Stacy] Wildlife Conservat Soc, Suva, Fiji; [Wilson, Jono R.] Nature Conservancy, Santa Barbara, CA 93106 USA	University of California System; University of California Davis; Resources for the Future; Idaho; University of Idaho; Wageningen University & Research; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; University of Victoria; Environmental Defense Fund; Nature Conservancy	Sampson, GS (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	jsanchirico@ucdavis.edu	Allison, Edward Hugh/B-8615-2009	Allison, Edward/0000-0003-4663-1396; Bush, Simon/0000-0002-6689-2246; Jupiter, Stacy/0000-0001-9742-1677	David and Lucile Packard Foundation [9072]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This research is an output of a workshop hosted by the University of California Davis Coastal and Marine Science Institute (J. N. S.) and funded by the David and Lucile Packard Foundation in June of 2014 (grant no. 9072). We thank K. Lee, W. Reid, R. Cudney, J. Claussen, S. Hogan, H. Ludemann, M. Weber, and M. Levine for comments.	[Anonymous], 2013, COMM FISH IMPR PROJ; Asche F, 2015, WORLD DEV, V67, P151, DOI 10.1016/j.worlddev.2014.10.013; Borit M, 2012, MAR POLICY, V36, P96, DOI 10.1016/j.marpol.2011.03.012; Bush SR, 2015, SUSTAINABILITY-BASEL, V7, P1861, DOI 10.3390/su7021861; Bush SR, 2013, MAR POLICY, V37, P288, DOI 10.1016/j.marpol.2012.05.011; Christian C, 2013, BIOL CONSERV, V161, P10, DOI 10.1016/j.biocon.2013.01.002; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; Deighan LK, 2015, MAR POLICY, V51, P476, DOI 10.1016/j.marpol.2014.10.009; Goyert W, 2010, MAR POLICY, V34, P1103, DOI 10.1016/j.marpol.2010.03.010; Helyar SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098691; Jacquet J, 2010, NATURE, V467, P28, DOI 10.1038/467028a; Micheli F, 2014, FRONT ECOL ENVIRON, V12, P297, DOI 10.1890/110257; Mills M, 2013, CONSERV LETT, V6, P418, DOI 10.1111/conl.12025; MSC, 2013, GLOB IMP REP 2013 MO; MSC, 2014, ANN REP 2013 2014 MS; Perez-Ramirez M, 2012, OCEAN COAST MANAGE, V63, P24, DOI 10.1016/j.ocecoaman.2012.03.009; Perez-Ramirez M, 2012, MAR POLICY, V36, P297, DOI 10.1016/j.marpol.2011.06.013; Ruddle Kenneth, 2008, Environment Development and Sustainability, V10, P565, DOI 10.1007/s10668-008-9152-5; Trumble R. J., 2013, EC MAH MAH FIP REV M	19	77	77	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					504	506		10.1126/science.aaa4639	http://dx.doi.org/10.1126/science.aaa4639			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH1JR	25931542				2022-12-24	WOS:000353778100023
J	Yang, SY; Fujikado, N; Kolodin, D; Benoist, C; Mathis, D				Yang, Siyoung; Fujikado, Noriyuki; Kolodin, Dmitriy; Benoist, Christophe; Mathis, Diane			Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance	SCIENCE			English	Article							AIRE CONTROL; HLA-DO; ANTIGEN; AUTOIMMUNITY; EXPRESSION; DISEASE; THYMUS; WINDOW; MICE	Aire is an important regulator of immunological tolerance, operating in a minute subset of thymic stromal cells to induce transcripts encoding peptides that guide T cell selection. Expression of Aire during a perinatal age window is necessary and sufficient to prevent the multiorgan autoimmunity characteristic of Aire-deficient mice. We report that Aire promotes the perinatal generation of a distinct compartment of Foxp3(+)CD4(+) regulatory T (T-reg) cells, which stably persists in adult mice. This population has a role in maintaining self-tolerance, a transcriptome and an activation profile distinguishable from those of T-regs produced in adults. Underlying the distinct T-reg populations are age-dependent, Aire-independent differences in the processing and presentation of thymic stromal-cell peptides, resulting in different Tcell receptor repertoires. Our findings expand the notion of a developmentally layered immune system.	[Yang, Siyoung; Fujikado, Noriyuki; Kolodin, Dmitriy; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA; [Yang, Siyoung] Korea Res Inst Biosci & Biotechnol KRIBB, Aging Intervent Res Ctr, Taejon 305806, South Korea; [Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Harvard University; Harvard Medical School	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu	Yang, Siyoung/ACC-8755-2022	Yang, Siyoung/0000-0002-6374-0140; Fujikado, Noriyuki/0000-0002-0415-5929; Fujikado, Noriyuki/0000-0002-3183-5866	NIH [R01 DK060027]; National Research Foundation of Korea [NRF-2013M3A9B6076413]; Japan Society for the Promotion of Science; National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Rudensky, M. Anderson, and A. Lichtman for providing valuable mouse strains; F. Depis and H.-K. Kwon for insightful discussions; and A. Ortiz-Lopez, L. Denu, and K. Hattori for technical assistance. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Microarray data can be found at Gene Expression Omnibus under accession numbers GSE66332 and GSE66402. This work was supported by NIH grant R01 DK060027 (to D.M.). S.Y., N.F., and D.K. were supported by fellowships from the National Research Foundation of Korea (NRF-2013M3A9B6076413), Japan Society for the Promotion of Science, and National Science Foundation, respectively.	Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; BOGUE M, 1992, P NATL ACAD SCI USA, V89, P11011, DOI 10.1073/pnas.89.22.11011; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dujardin HC, 2004, P NATL ACAD SCI USA, V101, P14473, DOI 10.1073/pnas.0403303101; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; HERZENBERG LA, 1989, CELL, V59, P953, DOI 10.1016/0092-8674(89)90748-4; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; JOTEREAU F, 1987, J IMMUNOL, V138, P1026; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kisand K, 2011, ANN NY ACAD SCI, V1246, P77, DOI 10.1111/j.1749-6632.2011.06308.x; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Polanczyk MJ, 2007, INT IMMUNOL, V19, P337, DOI 10.1093/intimm/dxl151; Poluektov YO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00260; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samy ET, 2008, J IMMUNOL, V180, P4366, DOI 10.4049/jimmunol.180.7.4366; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Tung KSK, 2005, CURR TOP MICROBIOL, V293, P209; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822	30	271	282	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					589	594		10.1126/science.aaa7017	http://dx.doi.org/10.1126/science.aaa7017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25791085	Green Accepted			2022-12-24	WOS:000353778100046
J	Mire, CE; Matassov, D; Geisbert, JB; Latham, TE; Agans, KN; Xu, R; Ota-Setlik, A; Egan, MA; Fenton, KA; Clarke, DK; Eldridge, JH; Geisbert, TW				Mire, Chad E.; Matassov, Demetrius; Geisbert, Joan B.; Latham, Theresa E.; Agans, Krystle N.; Xu, Rong; Ota-Setlik, Ayuko; Egan, Michael A.; Fenton, Karla A.; Clarke, David K.; Eldridge, John H.; Geisbert, Thomas W.			Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus	NATURE			English	Article							STOMATITIS-VIRUS; NEUROVIRULENCE; IMMUNOGENICITY; VECTORS	The family Filoviridae contains three genera, Ebolavirus, Marburgvirus, and Cuevavirusl. Some members of the genus, including Zaire ebolavirus (ZEBOV), can cause lethal haemorrhagic fever in humans. During 2014 an unprecedented ZEBOV outbreak occurred in West Africa and is still ongoing, resulting in over 10,000 deaths, and causing global concern of uncontrolled disease. To meet this challenge a rapid-acting vaccine is needed. Many vaccine approaches have shown promise in being able to protect nonhuman primates against ZEBOV2. In response to the current ZEBOV outbreak several of these vaccines have been fast tracked for human use. However, it is not known whether any of these vaccines can provide protection against the new outbreak Makona strain of ZEBOV. One of these approaches is a first-generation recombinant vesicular stomatitis virus (rVSV)-based vaccine expressing the ZEBOV glycoprotein (GP) (rVSV/ZEBOV). To address safety concerns associated with this vector, we developed two candidate, further-attenuated rVSV/ZEBOV vaccines. Both attenuated vaccines produced an approximately tenfold lower vaccine-associated viraemia compared to the first-generation vaccine and both provided complete, single-dose protection of macaques from lethal challenge with the Makona outbreak strain of ZEBOV.	[Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA; [Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Matassov, Demetrius; Latham, Theresa E.; Clarke, David K.; Eldridge, John H.] Profectus BioSci Inc, Dept Virol & Vaccine Vectors, Tarrytown, NY 10591 USA; [Xu, Rong; Ota-Setlik, Ayuko; Egan, Michael A.; Eldridge, John H.] Profectus BioSci Inc, Dept Immunol, Tarrytown, NY 10591 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA.	twgeisbe@utmb.edu	Mire, Chad/Z-6338-2019	Mire, Chad/0000-0001-7596-1808	Department of Microbiology and Immunology at UTMB; Department of Health and Human Services, National Institutes of Health [R01AI09881701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098817, U19AI109711] Funding Source: NIH RePORTER	Department of Microbiology and Immunology at UTMB; Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Borisevich and D. Deer for assistance with clinical pathology assays performed in the GNL BSL-4 laboratory, and the staff of the UTMB Animal Resources Center for animal care. This study was supported by the funds from the Department of Microbiology and Immunology at UTMB to T.W.G. and in part by the Department of Health and Human Services, National Institutes of Health grant R01A109881701 to J.H.E. and T.W.G.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Clarke DK, 2007, J VIROL, V81, P2056, DOI 10.1128/JVI.01911-06; Clarke DK, 2014, J VIROL, V88, P6690, DOI 10.1128/JVI.03441-13; Cooper D, 2008, J VIROL, V82, P207, DOI 10.1128/JVI.01515-07; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert T. W., 2013, FIELDS VIROLOGY; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hirschberg R, 2014, VIRUSES-BASEL, V6, P2673, DOI 10.3390/v6072673; Hoenen T., 2015, SCIENCE; Johnson JE, 2009, VACCINE, V27, P2930, DOI 10.1016/j.vaccine.2009.03.006; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Mire C. E., 2014, BIOL PATHOLOGY RHABD; Mire CE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001567; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Thi EP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009706; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Witko SE, 2006, J VIROL METHODS, V135, P91, DOI 10.1016/j.jviromet.2006.02.006	21	65	67	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					688	U253		10.1038/nature14428	http://dx.doi.org/10.1038/nature14428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25853476	Green Accepted			2022-12-24	WOS:000353689700052
J	Chang, RB; Strochlic, DE; Williams, EK; Umans, BD; Liberles, SD				Chang, Rui B.; Strochlic, David E.; Williams, Erika K.; Umans, Benjamin D.; Liberles, Stephen D.			Vagal Sensory Neuron Subtypes that Differentially Control Breathing	CELL			English	Article							CHEMOSENSORY RECEPTORS; RESPIRATORY GROUPS; NERVE-STIMULATION; AFFERENT NERVES; VAGUS NERVE; C-FIBERS; CAT; PULMONARY; MEDULLA; MOUSE	Breathing is essential for survival and under precise neural control. The vagus nerve is a major conduit between lung and brain required for normal respiration. Here, we identify two populations of mouse vagus nerve afferents (P2ry1, Npy2r), each a few hundred neurons, that exert powerful and opposing effects on breathing. Genetically guided anatomical mapping revealed that these neurons densely innervate the lung and send long-range projections to different brainstem targets. Npy2r neurons are largely slow-conducting C fibers, while P2ry1 neurons are largely fast-conducting A fibers that contact pulmonary endocrine cells (neuroepithelial bodies). Optogenetic stimulation of P2ry1 neurons acutely silences respiration, trapping animals in exhalation, while stimulating Npy2r neurons causes rapid, shallow breathing. Activating P2ry1 neurons did not impact heart rate or gastric pressure, other autonomic functions under vagal control. Thus, the vagus nerve contains intermingled sensory neurons constituting genetically definable labeled lines with different anatomical connections and physiological roles.	[Chang, Rui B.; Strochlic, David E.; Williams, Erika K.; Umans, Benjamin D.; Liberles, Stephen D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Liberles, SD (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	stephen_liberles@hms.harvard.edu		Umans, Benjamin/0000-0002-8209-9731; Liberles, Stephen/0000-0002-2177-9741	NSF; F30 NIH training grant; Harvard-MIT Joint Research Grants Program in Basic Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); F30 NIH training grant; Harvard-MIT Joint Research Grants Program in Basic Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bradford Lowell for providing Vglut2-ires-Cre and Lox-L10-GFP mice and for advice on AAV infection, Edward Fox and Jessica Biddinger for technical advice related to nodose/jugular complex injections, Wayne Silver for technical advice on whole nerve electrophysiology, Bernardo Sabatini and Ian Oldenburg for advice on channelrhodopsin studies, Jonathan Tilliss for help with illustrations, and the Nikon Imaging Center at Harvard Medical Center for assistance with microscopy. Genetically modified mice were generated by the Boston Nutrition Obesity Research Center/Boston Area Diabetes Endocrinology Research Center Transgenic Core. We thank Clifford Woolf, Susan Dymecki, and Clifford Saper for valuable comments on the manuscript. Support was from a NSF pre-doctoral fellowship (D.E.S.), an F30 NIH training grant (E.K.W.), and the Harvard-MIT Joint Research Grants Program in Basic Neuroscience (S.D.L.).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Andresen MC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00191; Bailey TW, 2006, J NEUROSCI, V26, P11893, DOI 10.1523/JNEUROSCI.2044-06.2006; Barretto RPJ, 2015, NATURE, V517, P373, DOI 10.1038/nature13873; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Canning BJ, 2006, RESP PHYSIOL NEUROBI, V152, P223, DOI 10.1016/j.resp.2006.03.001; Carr MJ, 2003, RESPIROLOGY, V8, P291, DOI 10.1046/j.1440-1843.2003.00473.x; COLERIDGE HM, 1983, J PHYSIOL-LONDON, V340, P415, DOI 10.1113/jphysiol.1983.sp014770; Coleridge JCG, 2011, COMPR PHYSIOL, P395; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Ferrero DM, 2013, NATURE, V502, P368, DOI 10.1038/nature12579; Foley JO, 1937, J COMP NEUROL, V67, P49, DOI 10.1002/cne.900670104; Fox EA, 2001, J NEUROSCI, V21, P8602, DOI 10.1523/JNEUROSCI.21-21-08602.2001; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hellekant G, 1998, PHYSIOL BEHAV, V65, P191, DOI 10.1016/S0031-9384(97)00532-5; KALIA M, 1980, J COMP NEUROL, V193, P467, DOI 10.1002/cne.901930211; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; KIM DG, 1992, MOL CELL BIOL, V12, P3636, DOI 10.1128/MCB.12.8.3636; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; KUBIN L, 1991, J PHYSIOL-LONDON, V435, P207, DOI 10.1113/jphysiol.1991.sp018506; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; PAINTAL AS, 1973, PHYSIOL REV, V53, P159, DOI 10.1152/physrev.1973.53.1.159; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; SAETHER K, 1987, BRAIN RES, V419, P87, DOI 10.1016/0006-8993(87)90571-3; Schachter SC, 1998, EPILEPSIA, V39, P677, DOI 10.1111/j.1528-1157.1998.tb01151.x; Schelegle ES, 2001, RESP PHYSIOL, V125, P17, DOI 10.1016/S0034-5687(00)00202-4; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; SPECK DF, 1982, J NEUROSCI, V2, P744; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Widdicombe J, 2001, RESP PHYSIOL, V125, P3, DOI 10.1016/S0034-5687(00)00201-2; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yu J, 2007, RESP PHYSIOL NEUROBI, V156, P116, DOI 10.1016/j.resp.2006.11.005	44	195	197	4	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					622	633		10.1016/j.cell.2015.03.022	http://dx.doi.org/10.1016/j.cell.2015.03.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892222	Bronze, Green Accepted			2022-12-24	WOS:000353553600020
J	Yutzey, KE				Yutzey, Katherine E.			REGENERATIVE BIOLOGY Neuregulin 1 makes heart muscle	NATURE			English	Editorial Material							RENEWAL	Three studies reveal that augmentation of a signalling pathway involving the growth factor neuregulin 1 and its receptor protein ERBB2 can promote the generation of muscle cells in zebrafish, mice and infant heart tissue.	Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yutzey, KE (corresponding author), Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA.	katherine.yutzey@cchmc.org		Yutzey, Katherine/0000-0002-1444-7124				Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Cote GM, 2012, NEW ENGL J MED, V367, P2150, DOI 10.1056/NEJMcibr1203156; D'Uva G., 2015, NATURE CELL BIOL; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Reuter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115871; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15	10	19	21	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					445	446		10.1038/520445a	http://dx.doi.org/10.1038/520445a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903623				2022-12-24	WOS:000353334500026
J	Ruschel, J; Hellal, F; Flynn, KC; Dupraz, S; Elliott, DA; Tedeschi, A; Bates, M; Sliwinski, C; Brook, G; Dobrindt, K; Peitz, M; Brustle, O; Norenberg, MD; Blesch, A; Weidner, N; Bunge, MB; Bixby, JL; Bradke, F				Ruschel, Joerg; Hellal, Farida; Flynn, Kevin C.; Dupraz, Sebastian; Elliott, David A.; Tedeschi, Andrea; Bates, Margaret; Sliwinski, Christopher; Brook, Gary; Dobrindt, Kristina; Peitz, Michael; Bruestle, Oliver; Norenberg, Michael D.; Blesch, Armin; Weidner, Norbert; Bunge, Mary Bartlett; Bixby, John L.; Bradke, Frank			Systemic administration of epothilone B promotes axon regeneration after spinal cord injury	SCIENCE			English	Article							FUNCTIONAL RECOVERY; IN-VIVO; RAT; GROWTH; ADULT; BRAIN; TAU; STABILIZATION; NEURONS; CANCER	After central nervous system (CNS) injury, inhibitory factors in the lesion scar and poor axon growth potential prevent axon regeneration. Microtubule stabilization reduces scarring and promotes axon growth. However, the cellular mechanisms of this dual effect remain unclear. Here, delayed systemic administration of a blood-brain barrier-permeable microtubule-stabilizing drug, epothilone B (epoB), decreased scarring after rodent spinal cord injury (SCI) by abrogating polarization and directed migration of scar-forming fibroblasts. Conversely, epothilone B reactivated neuronal polarization by inducing concerted microtubule polymerization into the axon tip, which propelled axon growth through an inhibitory environment. Together, these drug-elicited effects promoted axon regeneration and improved motor function after SCI. With recent clinical approval, epothilones hold promise for clinical use after CNS injury.	[Ruschel, Joerg; Hellal, Farida; Flynn, Kevin C.; Dupraz, Sebastian; Elliott, David A.; Tedeschi, Andrea; Bradke, Frank] German Ctr Neurodegenerat Dis, Axonal Growth & Regenerat, D-53175 Bonn, Germany; [Bates, Margaret; Bunge, Mary Bartlett; Bixby, John L.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Sliwinski, Christopher; Blesch, Armin; Weidner, Norbert] Univ Heidelberg Hosp, Spinal Cord Injury Ctr, D-69118 Heidelberg, Germany; [Brook, Gary] Rhein Westfal TH Aachen, Inst Neuropathol, D-52074 Aachen, Germany; [Brook, Gary] Univ Bonn, Julich Aachen Res Alliance Translat Brain Med, D-53127 Bonn, Germany; [Dobrindt, Kristina; Peitz, Michael; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life&Brain Ctr, D-53127 Bonn, Germany; [Dobrindt, Kristina; Peitz, Michael; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33101 USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Biochem, Miami, FL 33101 USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Mol Pathol, Miami, FL 33101 USA	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Miami; Ruprecht Karls University Heidelberg; RWTH Aachen University; University of Bonn; University of Bonn; University of Miami; University of Miami; University of Miami	Bradke, F (corresponding author), German Ctr Neurodegenerat Dis, Axonal Growth & Regenerat, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	frank.bradke@dzne.de	Hellal, Farida/D-1834-2015; Peitz, Michael/AHB-0741-2022; Hellal, Farida/AHC-2588-2022	Hellal, Farida/0000-0002-9344-1846; Hellal, Farida/0000-0002-9344-1846; Ruschel, Joerg/0000-0002-4782-9786; Bradke, Frank/0000-0002-0345-3772	NIH; International Foundation for Research in Paraplegia; Wings for Life; Deutsche Forschungsgemeinschaft; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Foundation for Research in Paraplegia; Wings for Life; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Materials and methods and other supporting materials are available on Science Online. We thank L. Meyn, K. Weisheit, D. Fleischer, and N. Thielen for technical assistance and animal care and C. Hill for teaching the spinal cord contusion injury model. We also thank C. Laskowski, C. H. Coles, A. Kania, M. Hubener, W. Jackson, and G. Tavosanis for critically reading and discussing the manuscript. We are grateful for support from the Human Spinal Cord Tissue Bank and the electron microscopy core at the Miami Project, as well as to B. Kakulas (University of Western Australia and Royal Perth) for providing anonymized postmortem sections after human spinal cord injury. This work was supported by NIH, International Foundation for Research in Paraplegia, Wings for Life, and Deutsche Forschungsgemeinschaft. H. Witte, A. Erturk, F. H., and F. B. filed a patent on the use of microtubule-stabilizing compounds for the treatment of lesions of CNS axons (European Patent no. 1858498; European patent application EP 11 00 9155.0; U.S. patent application 11/908,118). The authors declare no competing financial interests.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Ballatore C, 2012, J MED CHEM, V55, P8979, DOI 10.1021/jm301079z; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; CARBONELL AL, 1988, BRAIN RES, V439, P337, DOI 10.1016/0006-8993(88)91491-6; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fellner S, 2002, J CLIN INVEST, V110, P1309, DOI 10.1172/JCI200215451; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Laskowski CJ, 2013, EXP NEUROL, V242, P11, DOI 10.1016/j.expneurol.2012.07.007; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Slawinska U, 2013, EXP NEUROL, V247, P572, DOI 10.1016/j.expneurol.2013.02.008; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207	29	283	291	12	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					347	352		10.1126/science.aaa2958	http://dx.doi.org/10.1126/science.aaa2958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25765066	Green Accepted			2022-12-24	WOS:000352999000048
J	Upton, KR; Gerhardt, DJ; Jesuadian, JS; Richardson, SR; Sanchez-Luque, FJ; Bodea, GO; Ewing, AD; Salvador-Palomeque, C; van der Knaap, MS; Brennan, PM; Vanderver, A; Faulkner, GJ				Upton, Kyle R.; Gerhardt, Daniel J.; Jesuadian, J. Samuel; Richardson, Sandra R.; Sanchez-Luque, Francisco J.; Bodea, Gabriela O.; Ewing, Adam D.; Salvador-Palomeque, Carmen; van der Knaap, Marjo S.; Brennan, Paul M.; Vanderver, Adeline; Faulkner, Geoffrey J.			Ubiquitous L1 Mosaicism in Hippocampal Neurons	CELL			English	Article							SOMATIC MOSAICISM; HUMAN BRAIN; LINE-1 RETROTRANSPOSITION; HUMAN GENOMES; STEM-CELLS; ELEMENTS; HUMANS; ATLAS; TRANSCRIPTION; TRANSDUCTION	Somatic LINE-1 (L1) retrotransposition during neurogenesis is a potential source of genotypic variation among neurons. As a neurogenic niche, the hippocampus supports pronounced L1 activity. However, the basal parameters and biological impact of L1-driven mosaicism remain unclear. Here, we performed single-cell retrotransposon capture sequencing (RC-seq) on individual human hippocampal neurons and glia, as well as cortical neurons. An estimated 13.7 somatic L1 insertions occurred per hippocampal neuron and carried the sequence hallmarks of target-primed reverse transcription. Notably, hippocampal neuron L1 insertions were specifically enriched in transcribed neuronal stem cell enhancers and hippocampus genes, increasing their probability of functional relevance. In addition, bias against intronic L1 insertions sense oriented relative to their host gene was observed, perhaps indicating moderate selection against this configuration in vivo. These experiments demonstrate pervasive L1 mosaicism at genomic loci expressed in hippocampal neurons.	[Upton, Kyle R.; Gerhardt, Daniel J.; Jesuadian, J. Samuel; Richardson, Sandra R.; Sanchez-Luque, Francisco J.; Bodea, Gabriela O.; Ewing, Adam D.; Salvador-Palomeque, Carmen; Faulkner, Geoffrey J.] Univ Queensland, Mater Res Inst, Woolloongabba, Qld 4102, Australia; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1081 HV Amsterdam, Netherlands; [Brennan, Paul M.] Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Vanderver, Adeline] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Faulkner, Geoffrey J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	Mater Research; University of Queensland; Vrije Universiteit Amsterdam; University of Edinburgh; Children's National Health System; University of Queensland	Faulkner, GJ (corresponding author), Univ Queensland, Mater Res Inst, TRI Bldg, Woolloongabba, Qld 4102, Australia.	faulknergj@gmail.com	Upton, Kyle R./M-4772-2014; Sanchez-Luque, Francisco J/B-5682-2017; Richardson, Sandra/O-8908-2016; Faulkner, Geoffrey J/M-3168-2014; Ewing, Adam D/M-3164-2014; Vanderver, Adeline/CAG-5072-2022; Bodea, Gabriela Oana/I-6011-2014	Upton, Kyle R./0000-0003-1101-8081; Sanchez-Luque, Francisco J/0000-0003-1138-6124; Richardson, Sandra/0000-0001-5706-3393; Faulkner, Geoffrey J/0000-0001-5769-4494; Ewing, Adam D/0000-0002-4544-994X; Bodea, Gabriela Oana/0000-0002-9670-5237; van der Knaap, Marjo/0000-0001-8912-0954; Brennan, Paul/0000-0002-7347-830X	NHMRC [GNT1045237, GNT1042449, GNT1045991, GNT1067983, GNT1068789]; EU FP7 under MODHEP consortium [259743]; Alfonso Martin Escudero Foundation; Wellcome Trust Clinical Fellowship [090386/Z/09/Z]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); EU FP7 under MODHEP consortium; Alfonso Martin Escudero Foundation; Wellcome Trust Clinical Fellowship(Wellcome Trust)	We thank Haig Kazazian and Ryan Lister for critical reading of the manuscript. We also thank Marianna Bugiani for her work in the autopsy of AGS-1. G.J.F. acknowledges the support of an NHMRC Career Development Fellowship (GNT1045237), NHMRC Project Grants (GNT1042449, GNT1045991, GNT1067983 and GNT1068789), and the EU FP7 under grant agreement No. 259743 underpinning the MODHEP consortium. F.J.S-L. was supported by the Alfonso Martin Escudero Foundation. P.M.B. was supported by a Wellcome Trust Clinical Fellowship (090386/Z/09/Z).	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2011, HUM MOL GENET, V20, P3386, DOI 10.1093/hmg/ddr245; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Li WH, 2013, NAT NEUROSCI, V16, P529, DOI 10.1038/nn.3368; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Macfarlane CM, 2013, HUM MUTAT, V34, P974, DOI 10.1002/humu.22327; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Perrat PN, 2013, SCIENCE, V340, P91, DOI 10.1126/science.1231965; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Richardson SR, 2014, ANNU REV GENET, V48, P1, DOI 10.1146/annurev-genet-120213-092412; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019	40	208	215	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					228	239		10.1016/j.cell.2015.03.026	http://dx.doi.org/10.1016/j.cell.2015.03.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860606	Green Published, hybrid			2022-12-24	WOS:000352708300017
J	Genders, TSS; Petersen, SE; Pugliese, F; Dastidar, AG; Fleischmann, KE; Nieman, K; Hunink, MGM				Genders, Tessa S. S.; Petersen, Steffen E.; Pugliese, Francesca; Dastidar, Amardeep G.; Fleischmann, Kirsten E.; Nieman, Koen; Hunink, M. G. Myriam			The Optimal Imaging Strategy for Patients With Stable Chest Pain A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; QUALITY-OF-LIFE; AMERICAN-HEART-ASSOCIATION; FRACTIONAL FLOW RESERVE; DIAGNOSTIC PERFORMANCE; CT ANGIOGRAPHY; PROGNOSTIC VALUE; TASK-FORCE	Background: The optimal imaging strategy for patients with stable chest pain is uncertain. Objective: To determine the cost-effectiveness of different imaging strategies for patients with stable chest pain. Design: Microsimulation state-transition model. Data Sources: Published literature. Target Population: 60-year-old patients with a low to intermediate probability of coronary artery disease (CAD). Time Horizon: Lifetime. Perspective: The United States, the United Kingdom, and the Netherlands. Intervention: Coronary computed tomography (CT) angiography, cardiac stress magnetic resonance imaging, stress single-photon emission CT, and stress echocardiography. Outcome Measures: Lifetime costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: The strategy that maximized QALYs and was cost-effective in the United States and the Netherlands began with coronary CT angiography, continued with cardiac stress imaging if angiography found at least 50% stenosis in at least 1 coronary artery, and ended with catheter-based coronary angiography if stress imaging induced ischemia of any severity. For U. K. men, the preferred strategy was optimal medical therapy without catheter-based coronary angiography if coronary CT angiography found only moderate CAD or stress imaging induced only mild ischemia. In these strategies, stress echocardiography was consistently more effective and less expensive than other stress imaging tests. For U. K. women, the optimal strategy was stress echocardiography followed by catheter-based coronary angiography if echocardiography induced mild or moderate ischemia. Results of Sensitivity Analysis: Results were sensitive to changes in the probability of CAD and assumptions about false-positive results. Limitations: All cardiac stress imaging tests were assumed to be available. Exercise electrocardiography was included only in a sensitivity analysis. Differences in QALYs among strategies were small. Conclusion: Coronary CT angiography is a cost-effective triage test for 60-year-old patients who have nonacute chest pain and a low to intermediate probability of CAD.	Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Univ London, London, England; UCSF, Med Ctr, San Francisco, CA USA; Harvard Univ, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; University of London; University of California System; University of California San Francisco; UCSF Medical Center; Harvard University	Hunink, MGM (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.hunink@erasmusmc.nl	Dastidar, Amardeep/Y-1083-2019; Petersen, Steffen E/A-8389-2011	Dastidar, Amardeep/0000-0002-8688-5326; Petersen, Steffen E/0000-0003-4622-5160	Erasmus University Medical Center; National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts; Barts and The London Charity [437/1412]; National Institutes of Health (National Heart, Lung, and Blood Institute) [R21HL112255]	Erasmus University Medical Center; National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts; Barts and The London Charity; National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By a Health Care Efficiency grant from the Erasmus University Medical Center. Drs. Petersen and Pugliese were directly funded by the National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts. Dr. Dastidar received direct funding from Barts and The London Charity (437/1412). Dr. Fleischmann was directly funded by a grant from the National Institutes of Health (National Heart, Lung, and Blood Institute award R21HL112255).	Ara R, 2008, VALUE HEALTH, V11, P1131, DOI 10.1111/j.1524-4733.2008.00352.x; Arias E., 2007, US LIFE TABLES; Berger JS, 2008, AM J MED, V121, P43, DOI 10.1016/j.amjmed.2007.10.002; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Budoff MJ, 2008, INT J CARDIOL, V129, P32, DOI 10.1016/j.ijcard.2007.06.062; Cohen DJ, 2011, NEW ENGL J MED, V364, P1016, DOI 10.1056/NEJMoa1001508; Cooper A, 2010, CHEST PAIN RECENT ON, P9; Council of Europe, 2006, SG INF, P5; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Daly CA, 2005, EUR HEART J, V26, P1011, DOI 10.1093/eurheartj/ehi109; de Jong MC, 2012, EUR RADIOL, V22, P1881, DOI 10.1007/s00330-012-2434-1; Deckers JW, 2006, EUR HEART J, V27, P796, DOI 10.1093/eurheartj/ehi809; Dedic A, 2011, RADIOLOGY, V261, P428, DOI 10.1148/radiol.11110744; Dutch Central Bureau of Statistics, 2010, LIF TABL 2010; Dutch National Authority of Health Care, 2008, DUTCH TAR HLTH CAR P; Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Genders TSS, 2013, INT J CARDIOL, V167, P1268, DOI 10.1016/j.ijcard.2012.03.151; Genders TSS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3485; Genders TSS, 2009, RADIOLOGY, V253, P734, DOI 10.1148/radiol.2533090507; Gold MR, 1996, COST EFFECTIVENESS H; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Groothuis JGJ, 2010, RADIOLOGY, V254, P384, DOI 10.1148/radiol.09090802; Hachamovitch R, 2002, CIRCULATION, V105, P823, DOI 10.1161/hc0702.103973; Hakkaart-van Roijen L, 2010, DUTCH MANUAL COST AN, V17, P87; Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Heijenbrok-Kal MH, 2007, AM HEART J, V154, P415, DOI 10.1016/j.ahj.2007.04.061; Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011; Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040; Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213; KATAYAMA H, 1990, RADIOLOGY, V175, P621, DOI 10.1148/radiology.175.3.2343107; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; MacHaalany J, 2009, J AM COLL CARDIOL, V54, P1533, DOI 10.1016/j.jacc.2009.06.026; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Min JK, 2010, RADIOLOGY, V254, P801, DOI 10.1148/radiol.09090349; Moschetti K, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-35; Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292; Mudrick DW, 2012, AM HEART J, V163, P454, DOI 10.1016/j.ahj.2011.11.022; National Health Service, 2011, EL DRUG TAR; National Institute for Health and Care Excellence, 2008, GUID METH TECHN APPR, V41, P57; Nieman K, 2009, HEART, V95, P1669, DOI 10.1136/hrt.2009.169441; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Office for National Statistics, 2010, UK INT LIF TABL; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Van Loenen A, 2011, PHARMACOTHERAPEUTIC; Voko Z, 2011, EUR J EPIDEMIOL, V26, P375, DOI 10.1007/s10654-011-9558-5; von Ballmoos MW, 2011, ANN INTERN MED, V154, P413, DOI 10.7326/0003-4819-154-6-201103150-00007; Walker S, 2013, HEART, V99, P873, DOI 10.1136/heartjnl-2013-303624; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Wolk MJ, 2014, J AM COLL CARDIOL, V63, P380, DOI 10.1016/j.jacc.2013.11.009	63	49	49	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2015	162	7					474	U145		10.7326/M14-0027	http://dx.doi.org/10.7326/M14-0027			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4UT	25844996				2022-12-24	WOS:000353283400002
J	Rizvi, NA; Hellmann, MD; Snyder, A; Kvistborg, P; Makarov, V; Havel, JJ; Lee, W; Yuan, JD; Wong, P; Ho, TS; Miller, ML; Rekhtman, N; Moreira, AL; Ibrahim, F; Bruggeman, C; Gasmi, B; Zappasodi, R; Maeda, Y; Sander, C; Garon, EB; Merghoub, T; Wolchok, JD; Schumacher, TN; Chan, TA				Rizvi, Naiyer A.; Hellmann, Matthew D.; Snyder, Alexandra; Kvistborg, Pia; Makarov, Vladimir; Havel, Jonathan J.; Lee, William; Yuan, Jianda; Wong, Phillip; Ho, Teresa S.; Miller, Martin L.; Rekhtman, Natasha; Moreira, Andre L.; Ibrahim, Fawzia; Bruggeman, Cameron; Gasmi, Billel; Zappasodi, Roberta; Maeda, Yuka; Sander, Chris; Garon, Edward B.; Merghoub, Taha; Wolchok, Jedd D.; Schumacher, Ton N.; Chan, Timothy A.			Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer	SCIENCE			English	Article							EXOME ANALYSIS REVEALS; TUMOR; IPILIMUMAB; NIVOLUMAB; MPDL3280A; RESPONSES; ANTIGENS; ANTIBODY; EPITOPE	Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants of response to this therapy, we used whole-exome sequencing of non-small cell lung cancers treated with pembrolizumab, an antibody targeting programmed cell death-1 (PD-1). In two independent cohorts, higher nonsynonymous mutation burden in tumors was associated with improved objective response, durable clinical benefit, and progression-free survival. Efficacy also correlated with the molecular smoking signature, higher neoantigen burden, and DNA repair pathway mutations; each factor was also associated with mutation burden. In one responder, neoantigen-specific CD8+ T cell responses paralleled tumor regression, suggesting that anti-PD-1 therapy enhances neoantigen-specific T cell reactivity. Our results suggest that the genomic landscape of lung cancers shapes response to anti-PD-1 therapy.	[Rizvi, Naiyer A.; Hellmann, Matthew D.; Snyder, Alexandra; Ibrahim, Fawzia; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Rizvi, Naiyer A.; Hellmann, Matthew D.; Snyder, Alexandra; Wolchok, Jedd D.; Chan, Timothy A.] Weill Cornell Med Coll, New York, NY 10065 USA; [Snyder, Alexandra; Makarov, Vladimir; Havel, Jonathan J.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Kvistborg, Pia; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Lee, William; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Yuan, Jianda; Wong, Phillip; Ho, Teresa S.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, Immune Monitoring Core, New York, NY 10065 USA; [Miller, Martin L.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Rekhtman, Natasha; Moreira, Andre L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Bruggeman, Cameron] Columbia Univ, Dept Math, New York, NY 10027 USA; [Gasmi, Billel; Zappasodi, Roberta; Maeda, Yuka; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat Lab, New York, NY 10065 USA; [Garon, Edward B.] Univ Calif Los Angeles, David Geffen Sch Med, Santa Monica, CA 90404 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Netherlands Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chan, TA (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	chant@mskcc.org	Schumacher, Ton/Y-2432-2019; Merghoub, Taha/ABD-8362-2021; Chan, Timothy A/ABD-5850-2021	Schumacher, Ton/0000-0003-0517-8804; Miller, Martin L/0000-0003-3161-8690; Havel, Jonathan/0000-0003-0951-510X; Snyder Charen, Alexandra/0000-0002-2606-3523; Wong, Phillip/0000-0002-6360-849X; Zappasodi, Roberta/0000-0002-7031-6671	Geoffrey Beene Cancer Research Center; Society for Memorial Sloan Kettering Cancer Center; Lung Cancer Research Foundation; Frederick Adler Chair Fund; One Ball Matt Memorial Golf Tournament; Queen Wilhelmina Cancer Research Award; STARR Foundation; Ludwig Trust; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; Versus Arthritis [21141] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748, K23CA149079] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Center; Society for Memorial Sloan Kettering Cancer Center; Lung Cancer Research Foundation; Frederick Adler Chair Fund; One Ball Matt Memorial Golf Tournament; Queen Wilhelmina Cancer Research Award; STARR Foundation; Ludwig Trust; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant; Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Thoracic Oncology Service and the Chan and Wolchok laboratories at Memorial Sloan Kettering Cancer Center (MSKCC) for helpful discussions. We thank the Immune Monitoring Core at MSKCC, including L. Caro, R. Ramsawak, and Z. Mu, for exceptional support with processing and banking peripheral blood lymphocytes. We thank P. Worrell and E. Brzostowski for help in identifying tumor specimens for analysis. We thank A. Viale for superb technical assistance. We thank D. Philips, M. van Buuren, and M. Toebes for help performing the combinatorial coding screens. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Data are publicly available at the Cancer Genome Atlas (TCGA) cBio portal and database (www.cbioportal.org; study ID: Rizvi lung cancer). T.A.C. is the inventor on a patent (provisional application number 62/083,088). The application is directed toward methods for identifying patients who will benefit from treatment with immunotherapy. This work was supported by the Geoffrey Beene Cancer Research Center (M.D.H., N.A.R., T.A.C., J.D.W., and A.S.), the Society for Memorial Sloan Kettering Cancer Center (M.D.H.), Lung Cancer Research Foundation (W.L.), Frederick Adler Chair Fund (T.A.C.), The One Ball Matt Memorial Golf Tournament (E.B.G.), Queen Wilhelmina Cancer Research Award (T.N.S.), The STARR Foundation (T.A.C. and J.D.W.), the Ludwig Trust (J.D.W.), and a Stand Up To Cancer-Cancer Research Institute Cancer Immunology Translational Cancer Research Grant (J.D.W., T.N.S., and T.A.C.). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Andersen RS, 2012, NAT PROTOC, V7, P891, DOI 10.1038/nprot.2012.037; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Garon EB, 2014, ANN ONCOL, V25; Goodwin JF, 2014, CANCER DISCOV, V4, P1126, DOI 10.1158/2159-8290.CD-14-0358; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hindges R, 1997, BIOL CHEM, V378, P345; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Matsutake T, 2001, P NATL ACAD SCI USA, V98, P3992, DOI 10.1073/pnas.071523398; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	45	5265	5489	45	990	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					124	128		10.1126/science.aaa1348	http://dx.doi.org/10.1126/science.aaa1348			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25765070	Green Accepted			2022-12-24	WOS:000352079500041
J	Turner, TN; Sharma, K; Oh, EC; Liu, YFP; Collins, RL; Sosa, MX; Auer, DR; Brand, H; Sanders, SJ; Moreno-De-Luca, D; Pihur, V; Plona, T; Pike, K; Soppet, DR; Smith, MW; Cheung, SW; Martin, CL; State, MW; Talkowski, ME; Cook, E; Huganir, R; Katsanis, N; Chakravarti, A				Turner, Tychele N.; Sharma, Kamal; Oh, Edwin C.; Liu, Yangfan P.; Collins, Ryan L.; Sosa, Maria X.; Auer, Dallas R.; Brand, Harrison; Sanders, Stephan J.; Moreno-De-Luca, Daniel; Pihur, Vasyl; Plona, Teri; Pike, Kristen; Soppet, Daniel R.; Smith, Michael W.; Cheung, Sau Wai; Martin, Christa Lese; State, Matthew W.; Talkowski, Michael E.; Cook, Edwin; Huganir, Richard; Katsanis, Nicholas; Chakravarti, Aravinda			Loss of delta-catenin function in severe autism	NATURE			English	Article							STRUCTURAL VARIATION; SPECTRUM DISORDER; PROTEIN; MORPHOGENESIS; GENETICS; COMPLEX; SYNAPSE; SPINE; KAISO; RARE	Autism is a multifactorial neurodevelopmental disorder affecting more males than females; consequently, under a multifactorial genetic hypothesis, females are affected only when they cross a higher biological threshold. We hypothesize that deleterious variants at conserved residues are enriched in severely affected patients arising from female-enriched multiplex families with severe disease, enhancing the detection of key autism genes in modest numbers of cases. Here we show the use of this strategy by identifying missense and dosage sequence variants in the gene encoding the adhesive junction-associated delta-catenin protein (CTNND2) in female-enriched multiplex families and demonstrating their loss-of-function effect by functional analyses in zebrafish embryos and cultured hippocampal neurons from wild-type and Ctnnd2 null mouse embryos. Finally, through gene expression and network analyses, we highlight a critical role for CTNND2 in neuronal development and an intimate connection to chromatin biology. Our data contribute to the understanding of the genetic architecture of autism and suggest that genetic analyses of phenotypic extremes, such as female-enriched multiplex families, are of innate value in multifactorial disorders.	[Turner, Tychele N.; Sosa, Maria X.; Auer, Dallas R.; Pihur, Vasyl; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Turner, Tychele N.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD 21205 USA; [Turner, Tychele N.; Sosa, Maria X.; Auer, Dallas R.; Sanders, Stephan J.; Moreno-De-Luca, Daniel; Pihur, Vasyl; Martin, Christa Lese; State, Matthew W.; Chakravarti, Aravinda] Univ Calif Los Angeles, NIMH, Autism Ctr Excellence ACE Genet Consortium, Los Angeles, CA 90095 USA; [Sharma, Kamal; Huganir, Richard] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Oh, Edwin C.; Liu, Yangfan P.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Collins, Ryan L.; Brand, Harrison; Talkowski, Michael E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Collins, Ryan L.; Brand, Harrison; Talkowski, Michael E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Brand, Harrison; Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sanders, Stephan J.; State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Moreno-De-Luca, Daniel] Yale Univ, Dept Psychiat, New Haven, CT 06511 USA; [Plona, Teri; Pike, Kristen; Soppet, Daniel R.] Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Smith, Michael W.] NHGRI, Bethesda, MD 20892 USA; [Cheung, Sau Wai] Baylor Coll Med, Houston, TX 77030 USA; [Martin, Christa Lese] Geisinger Hlth Syst, Autism & Dev Med Inst, Lewisburg, PA 17837 USA; [Cook, Edwin] Univ Illinois, Chicago, IL 60608 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California Los Angeles; Johns Hopkins University; Duke University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine; Geisinger Health System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA.	aravinda@jhmi.edu	State, Matthew/W-2256-2019; Sanders, Stephan/S-8645-2019; /AAD-2060-2020	/0000-0003-4651-0084; State, Matthew/0000-0003-1624-8302; Collins, Ryan/0000-0003-1268-9995; Turner, Tychele/0000-0001-8246-6477; Collins, Rachel/0000-0002-1559-8135; Talkowski, Michael/0000-0003-2889-0992; Katsanis, Nicholas/0000-0002-2480-0171; Sanders, Stephan/0000-0001-9112-5148; Auer, Dallas/0000-0003-4466-4135	National Institute of Mental Health [1U24MH081810]; Simons Foundation; NIMH [MH095867, 5R25MH071584-07, MH19961-14, R01MH081754]; National Institutes of Health [RO1MH074090]; Autism Speaks Dennis Weatherstone pre-doctoral fellowship [7863]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060007, K99MH095867, R01MH074090, T32MH019961, R00MH095867, R01MH081754, R25MH071584, U24MH081810] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks Dennis Weatherstone pre-doctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge the participation of all of the families in the AGRE, NIMH and SSC studies that have been amodel of public participatory research. The AGRE is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health. The SSC used here was developed by the following principal investigators: A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, E. Wijsman. We thank the Allen Brain Atlas for use of their publicly available developing human brain expression data. Finally, we thank V. Kustanovich (AGRE) for helping with access to Autism Diagnostic Observation Schedule severity score data, D. Arking for sharing DNA from the SSC for Taqman genotyping, S. Maragh for zebrafish complementary DNA (cDNA) libraries and eef1a1l1 primers, A. Kapoor for discussions, Q. Jiang for the translation of ref. 43, and J. A. Rosenfeld, L. G. Shaffer, Y. Shenand B.-L. Wufor sharing CNV data sets. Sequencing services were provided by the Johns Hopkins University Next Generation Sequencing Center, Sidney Kimmel Comprehensive Cancer Center, Illumina Sequencing Services and the Johns Hopkins University Genetic Resources Core Facility. E. C. O. is a National Alliance for Research on Schizophrenia and Depression young investigator. N.K. is a Distinguished George W. Brumley Professor. This work was funded by grants from the Simons Foundation to A. C. and to N.K., NIMH grant MH095867 to M.E.T., NIMH grants 5R25MH071584-07 and MH19961-14 to D. M. D. L. (Malison), National Institutes of Health grant RO1MH074090 to C. L. M., NIMH grant R01MH081754 to A. C. and an Autism Speaks Dennis Weatherstone pre-doctoral fellowship (number 7863) to T.T.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Bareiss S, 2010, J NEUROSCI RES, V88, P2350, DOI 10.1002/jnr.22414; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; Chakravarti A, 2014, AM J HUM GENET, V94, P326, DOI 10.1016/j.ajhg.2013.11.014; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Fujita T, 2004, BIOCHEM J, V382, P717, DOI 10.1042/BJ20040141; Gai X, 2012, MOL PSYCHIATR, V17, P402, DOI 10.1038/mp.2011.10; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Harvard C, 2005, CLIN GENET, V67, P341, DOI 10.1111/j.1399-0004.2005.00406.x; He Wen-zhi, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P266, DOI 10.3760/cma.j.issn.1003-9406.2012.03.004; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Itoh K, 1997, MECH DEVELOP, V61, P113, DOI 10.1016/S0925-4773(96)00627-2; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Koutras C, 2011, J ALZHEIMERS DIS, V27, P307, DOI 10.3233/JAD-2011-110536; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Qiao Y, 2009, J MED GENET, V46, P680, DOI 10.1136/jmg.2009.066795; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang MH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-514; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Zhang J, 2010, EXP CELL RES, V316, P1070, DOI 10.1016/j.yexcr.2010.01.006; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	54	103	109	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					51	+		10.1038/nature14186	http://dx.doi.org/10.1038/nature14186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25807484	Green Submitted, Green Accepted			2022-12-24	WOS:000352027700034
J	Eisenstein, M				Eisenstein, Michael			ARTIFICIAL ORGANS Honey, I shrunk the lungs	NATURE			English	Editorial Material																		Huh D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004249; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Stevens KR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2853; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k	4	16	17	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S16	S18		10.1038/519S16a	http://dx.doi.org/10.1038/519S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806493	Bronze			2022-12-24	WOS:000351602800006
J	Bernstein, R				Bernstein, Rachel			Into the wilderness	SCIENCE			English	Editorial Material												SciCareerEditor@aaas.org							0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1282	1282		10.1126/science.347.6227.1282	http://dx.doi.org/10.1126/science.347.6227.1282			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766239				2022-12-24	WOS:000350824300043
J	Li, JQ; Ballmer, SG; Gillis, EP; Fujii, S; Schmidt, MJ; Palazzolo, AME; Lehmann, JW; Morehouse, GF; Burke, MD				Li, Junqi; Ballmer, Steven G.; Gillis, Eric P.; Fujii, Seiko; Schmidt, Michael J.; Palazzolo, Andrea M. E.; Lehmann, Jonathan W.; Morehouse, Greg F.; Burke, Martin D.			Synthesis of many different types of organic small molecules using one automated process	SCIENCE			English	Article							SOLID-PHASE SYNTHESIS; COUPLING REACTIONS; POLYKETIDE; CHEMISTRY; STRATEGY	Small-molecule synthesis usually relies on procedures that are highly customized for each target. A broadly applicable automated process could greatly increase the accessibility of this class of compounds to enable investigations of their practical potential. Here we report the synthesis of 14 distinct classes of small molecules using the same fully automated process. This was achieved by strategically expanding the scope of a building block-based synthesis platform to include even Csp3-rich polycyclic natural product frameworks and discovering a catch-and-release chromatographic purification protocol applicable to all of the corresponding intermediates. With thousands of compatible building blocks already commercially available, many small molecules are now accessible with this platform. More broadly, these findings illuminate an actionable roadmap to a more general and automated approach for small-molecule synthesis.	[Li, Junqi; Ballmer, Steven G.; Gillis, Eric P.; Fujii, Seiko; Schmidt, Michael J.; Palazzolo, Andrea M. E.; Lehmann, Jonathan W.; Morehouse, Greg F.; Burke, Martin D.] Univ Illinois, Howard Hughes Med Inst, Dept Chem, Urbana, IL 61801 USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Burke, MD (corresponding author), Univ Illinois, Howard Hughes Med Inst, Dept Chem, Urbana, IL 61801 USA.	mdburke@illinois.edu	Morehouse, Gregory/AGE-5989-2022	Morehouse, Gregory/0000-0001-9614-8808; Li, Junqi/0000-0003-0336-2544; Gillis, Eric/0000-0003-4294-6147; Palazzolo Ray, Andrea/0000-0002-2359-6690	NIH [GM080436, GM090153]; NSF [0747778]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080436, R01GM090153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the NIH (grants GM080436 and GM090153), the NSF (grant 0747778), HHMI, and Bristol-Myers Squibb for funding. M.D.B. is an HHMI Early Career Scientist, J.L. was an HHMI International Student Research Fellow, and J.L. and E.P.G. were Bristol-Myers Squibb Graduate Fellows. We thank D. Gray for performing the x-ray analysis on N-bromoacyl-14. The University of Illinois has filed patent applications on MIDA boronate chemistry and the automated synthesis platform reported herein. These inventions have been licensed to REVOLUTION Medicines, a company for which M.D.B. is a founder. Metrical parameters for the structure of N-bromoacyl-14 are available free of charge from the Cambridge Cyrstallographic Data Centre under reference CCDC-1045844.	Bracher F, 2003, NAT PROD RES, V17, P293, DOI 10.1080/1478641031000137004; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; Corey E. J., 2010, ENANTIOSELECTIVE CHE, P121; Dewick P.M., 2009, MED NATURAL PRODUCTS; Elliott EL, 2006, J ORG CHEM, V71, P5282, DOI 10.1021/jo0607212; Fujita K, 2012, ANGEW CHEM INT EDIT, V51, P7271, DOI 10.1002/anie.201203093; Fuse S., 2012, NEW STRATEGIES CHEM; Gillis EP, 2008, J AM CHEM SOC, V130, P14084, DOI 10.1021/ja8063759; Gillis EP, 2007, J AM CHEM SOC, V129, P6716, DOI 10.1021/ja0716204; Gillis EP, 2009, ALDRICHIM ACTA, V42, P17; Godfrey AG, 2013, DRUG DISCOV TODAY, V18, P795, DOI 10.1016/j.drudis.2013.03.001; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Grob JE, 2012, ORG LETT, V14, P5578, DOI 10.1021/ol302702q; Hall D, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, pXV; HEATHCOCK CH, 1992, J ORG CHEM, V57, P2554, DOI 10.1021/jo00035a009; Kinzel T, 2010, J AM CHEM SOC, V132, P14073, DOI 10.1021/ja1073799; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; Ley SV, 2015, ANGEW CHEM INT EDIT, V54, P3449, DOI 10.1002/anie.201410744; Maechling S, 2010, J COMB CHEM, V12, P818, DOI 10.1021/cc1001617; Mentel M, 2007, TOP CURR CHEM, V278, P209, DOI 10.1007/128_2006_107; MERRIFIELD RB, 1965, SCIENCE, V150, P178, DOI 10.1126/science.150.3693.178; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Newton S, 2014, ANGEW CHEM INT EDIT, V53, P4915, DOI 10.1002/anie.201402056; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; SHING TKM, 1995, J ORG CHEM, V60, P5785, DOI 10.1021/jo00123a011; Snyder SA, 2010, TETRAHEDRON, V66, P4796, DOI 10.1016/j.tet.2010.03.037; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Wilson RM, 2005, J AM CHEM SOC, V127, P11616, DOI 10.1021/ja054008q; Woerly EM, 2014, NAT CHEM, V6, P484, DOI 10.1038/NCHEM.1947; Woerly EM, 2010, J AM CHEM SOC, V132, P6941, DOI 10.1021/ja102721p; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l	32	316	318	20	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1221	1226		10.1126/science.aaa5414	http://dx.doi.org/10.1126/science.aaa5414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766227	Green Accepted			2022-12-24	WOS:000350824300030
J	Ghosh, TS; Van Dyke, M; Maffey, A; Whitley, E; Erpelding, D; Wolk, L				Ghosh, Tista S.; Van Dyke, Michael; Maffey, Ali; Whitley, Elizabeth; Erpelding, Dana; Wolk, Larry			Medical Marijuana's Public Health Lessons - Implications for Retail Marijuana in Colorado	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXPOSURES		[Ghosh, Tista S.; Van Dyke, Michael; Maffey, Ali; Whitley, Elizabeth; Erpelding, Dana; Wolk, Larry] Colorado Dept Publ Hlth & Environm, Denver, CO 80246 USA	Colorado Department of Public Health & Environment	Ghosh, TS (corresponding author), Colorado Dept Publ Hlth & Environm, Denver, CO 80246 USA.							Colorado Department of Public Health and Environment, 2013, HLTH KIDS COL SURV H; Colorado Department of Public Health and Environment, 2014, MON HLTH REL MAR COL; Salomonsen-Sautel S, 2014, DRUG ALCOHOL DEPEN, V140, P137, DOI 10.1016/j.drugalcdep.2014.04.008; Wang GS, 2014, ANN EMERG MED, V63, P684, DOI 10.1016/j.annemergmed.2014.01.017; Wang GS, 2013, JAMA PEDIATR, V167, P630, DOI 10.1001/jamapediatrics.2013.140	5	61	61	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					991	993		10.1056/NEJMp1500043	http://dx.doi.org/10.1056/NEJMp1500043			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD0XK	25760352				2022-12-24	WOS:000350797300002
J	Cui, GL; Staron, MM; Gray, SM; Ho, PC; Amezquita, RA; Wu, JX; Kaech, SM				Cui, Guoliang; Staron, Matthew M.; Gray, Simon M.; Ho, Ping-Chih; Amezquita, Robert A.; Wu, Jingxia; Kaech, Susan M.			IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8(+) T Cell Longevity	CELL			English	Article							BASAL HOMEOSTATIC PROLIFERATION; INTERLEUKIN (IL)-7; IL-7; NAIVE; GENERATION; EXPRESSION; EXPANSION; SURVIVAL; BCL-2; REQUIREMENTS	Memory T cells are critical for long-term immunity against reinfection and require interleukin-7 (IL-7), but the mechanisms by which IL-7 controls memory T cell survival, particularly metabolic fitness, remain elusive. We discover that IL-7 induces expression of the glycerol channel aquaporin 9 (AQP9) in virus-specific memory CD8+ T cells, but not naive cells, and that AQP9 is vitally required for their long-term survival. AQP9 deficiency impairs glycerol import into memory CD8+ T cells for fatty acid esterification and triglyceride (TAG) synthesis and storage. These defects can be rescued by ectopic expression of TAG synthases, which restores lipid stores and memory T cell survival. Finally, we find that TAG synthesis is a central component of IL-7-mediated survival of human and mouse memory CD8+ T cells. This study uncovers the metabolic mechanisms by which IL-7 tailors the metabolism of memory T cells to promote their longevity and fast response to rechallenge.	[Cui, Guoliang; Staron, Matthew M.; Gray, Simon M.; Ho, Ping-Chih; Amezquita, Robert A.; Kaech, Susan M.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Amezquita, Robert A.; Kaech, Susan M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wu, Jingxia] Yale Univ, Dept Internal Med, Sch Med, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Kaech, SM (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.	susan.kaech@yale.edu	wu, Jingxia/AFR-6587-2022	Ho, Ping-Chih/0000-0003-3078-3774; Cui, Guoliang/0000-0001-5559-7957	NIH [R37AI066232/R01AI074699, T32GM07205, U19AI089992]; Howard Hughes Medical Institute; Trudeau Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066232, U19AI089992, R01AI066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Trudeau Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Aleksandra Rojek, Soren Nielsen, and Peter Agre for providing Aqp9<SUP>-/-</SUP> mice. We thank Drs. Gerald Shulman and Rachel Perry for their discussion. We thank Barbara Siconolfi for collecting human samples. Drs. Huajin Wang and Tobias Walther provided generous help with TLC assay. This study is supported by grants from the NIH R37AI066232/R01AI074699 (S.M.K.), T32GM07205 (S.M.G.), U19AI089992 (D. Hafler, Yale University), Howard Hughes Medical Institute (S.M.K.), and a Trudeau Fellowship (G.C.).	Abrami L, 1996, PFLUG ARCH EUR J PHY, V431, P408, DOI 10.1007/BF02207279; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Beura LK, 2014, CELL, V157, P1488, DOI 10.1016/j.cell.2014.05.026; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Dow RL, 2011, ACS MED CHEM LETT, V2, P407, DOI 10.1021/ml200051p; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Ge Q, 2004, P NATL ACAD SCI USA, V101, P3041, DOI 10.1073/pnas.0307339101; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Khaled AR, 2002, IMMUNITY, V17, P561, DOI 10.1016/S1074-7613(02)00450-8; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Liu XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5244; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nanjappa SG, 2008, J CLIN INVEST, V118, P1027, DOI 10.1172/JCI32020; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pearson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033998; Pellegrini M, 2004, J EXP MED, V200, P1189, DOI 10.1084/jem.20041328; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Prlic M, 2002, J EXP MED, V195, pF49, DOI 10.1084/jem.20020767; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rodriguez A, 2011, CELL CYCLE, V10, P1548, DOI 10.4161/cc.10.10.15672; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Sportes C, 2010, CLIN CANCER RES, V16, P727, DOI 10.1158/1078-0432.CCR-09-1303; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297	48	199	208	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					750	761		10.1016/j.cell.2015.03.021	http://dx.doi.org/10.1016/j.cell.2015.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957683	Green Accepted, Bronze			2022-12-24	WOS:000354175200010
J	Zheng, SM; Vuong, BQ; Vaidyanathan, B; Lin, JY; Huang, FT; Chaudhuri, J				Zheng, Simin; Vuong, Bao Q.; Vaidyanathan, Bharat; Lin, Jia-Yu; Huang, Feng-Ting; Chaudhuri, Jayanta			Non-coding RNA Generated following Lariat Debranching Mediates Targeting of AID to DNA	CELL			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; TETRAMOLECULAR QUADRUPLEX G4-DNA; GENOME-REARRANGEMENT; RESOLVING ACTIVITY; SUPER-ENHANCERS; MAJOR SOURCE; RECRUIT AID; TRANSCRIPTION; GENE	Transcription through immunoglobulin switch (S) regions is essential for class switch recombination (CSR), but no molecular function of the transcripts has been described. Likewise, recruitment of activation-induced cytidine deaminase (AID) to S regions is critical for CSR; however, the underlying mechanism has not been fully elucidated. Here, we demonstrate that intronic switch RNA acts in trans to target AID to S region DNA. AID binds directly to switch RNA through G-quadruplexes formed by the RNA molecules. Disruption of this interaction by mutation of a key residue in the putative RNA-binding domain of AID impairs recruitment of AID to S region DNA, thereby abolishing CSR. Additionally, inhibition of RNA lariat processing leads to loss of AID localization to S regions and compromises CSR; both defects can be rescued by exogenous expression of switch transcripts in a sequence-specific manner. These studies uncover an RNA-mediated mechanism of targeting AID to DNA.	[Zheng, Simin; Vuong, Bao Q.; Vaidyanathan, Bharat; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Zheng, Simin; Vaidyanathan, Bharat; Chaudhuri, Jayanta] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Vuong, Bao Q.] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Lin, Jia-Yu; Huang, Feng-Ting] Natl Taiwan Univ, Dept Biochem Sci & Technol, Coll Life Sci, Taipei 106, Taiwan	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; City University of New York (CUNY) System; City College of New York (CUNY); National Taiwan University	Chaudhuri, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	chaudhuj@mskcc.org	Hsiao, Wei-Hung/B-9931-2013	Zheng, Simin/0000-0002-3442-1255; Vuong, Bao/0000-0001-5416-9635	NIH [1RO1AI072194]; Starr Cancer Foundation [I4-A447, I7-A767]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072194] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors wish to thank T. Honjo for AID<SUP>-/-</SUP> mice and CH12 cells, S. Kabir (Rockefeller University) for telomere-specific probes, and S. Vasudevan (Harvard University) and T. Agarwal for their helpful technical advice. We thank members of J.C.'s laboratory for their comments and discussion. This work was supported by grants from the NIH (1RO1AI072194) and the Starr Cancer Foundation (I4-A447 and I7-A767) to J.C.	ARENAS J, 1987, J BIOL CHEM, V262, P4274; Azzalin CM, 2007, NATURE, V448, P1001, DOI 10.1038/4481001a; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Kao YP, 2013, MOL IMMUNOL, V54, P208, DOI 10.1016/j.molimm.2012.11.009; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Li HL, 2013, BIOSENS BIOELECTRON, V41, P563, DOI 10.1016/j.bios.2012.09.024; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Mahdaviani SA, 2012, EXPERT REV CLIN IMMU, V8, P539, DOI 10.1586/ECI.12.46; Matthews AJ, 2014, ADV IMMUNOL, V122, P1, DOI 10.1016/B978-0-12-800267-4.00001-8; Maul RW, 2011, NAT IMMUNOL, V12, P70, DOI 10.1038/ni.1970; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Muller JR, 1998, J IMMUNOL, V161, P1354; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Perlot T, 2008, P NATL ACAD SCI USA, V105, P3843, DOI 10.1073/pnas.0712291105; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; RUSKIN B, 1985, SCIENCE, V229, P135, DOI 10.1126/science.2990042; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Taylor BJM, 2014, ELIFE, V3, DOI 10.7554/eLife.03553; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Xu Yan, 2008, Nucleic Acids Symp Ser (Oxf), P175, DOI 10.1093/nass/nrn089; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	53	121	122	4	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					762	773		10.1016/j.cell.2015.03.020	http://dx.doi.org/10.1016/j.cell.2015.03.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957684	Green Accepted, Bronze			2022-12-24	WOS:000354175200011
J	Mbengue, A; Bhattacharjee, S; Pandharkar, T; Liu, HN; Estiu, G; Stahelin, RV; Rizk, SS; Njimoh, DL; Ryan, Y; Chotivanich, K; Nguon, C; Ghorbal, M; Lopez-Rubio, JJ; Pfrender, M; Emrich, S; Mohandas, N; Dondorp, AM; Wiest, O; Haldar, K				Mbengue, Alassane; Bhattacharjee, Souvik; Pandharkar, Trupti; Liu, Haining; Estiu, Guillermina; Stahelin, Robert V.; Rizk, Shahir S.; Njimoh, Dieudonne L.; Ryan, Yana; Chotivanich, Kesinee; Nguon, Chea; Ghorbal, Mehdi; Lopez-Rubio, Jose-Juan; Pfrender, Michael; Emrich, Scott; Mohandas, Narla; Dondorp, Arjen M.; Wiest, Olaf; Haldar, Kasturi			A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria	NATURE			English	Article							I-TASSER; PROTEIN; UBIQUITIN; DYNAMICS; ARTESUNATE; ACCURACY; WELL	Artemisinins are the cornerstone of anti-malarial drugs'. Emergence and spread of resistance to them' raises risk of wiping out recent gains achieved in reducing worldwide malaria burden and threatens future malaria control and elimination on a global level. Genome-wide association studies (GWAS) have revealed parasite genetic loci associated with artemisinin resistance'''. However, there is no consensus on biochemical targets of artemisinin. Whether and how these targets interact with genes identified by GWAS, remains unknown. Here we provide biochemical and cellular evidence that artemisinins are potent inhibitors of Plasmodium falciparum phosphatidylinosito1-3-kinase (PfPI3K), revealing an unexpected mechanism of action. In resistant clinical strains, increased PfPI3K was associated with the C580Y mutation in P. falciparum Kelch13 (PfKelch13), a primary marker of artemisinin resistance. Polyubiquitination of PfPI3K and its binding to PfKelch13 were reduced by the PfKelch13 mutation, which limited proteolysis of PfPI3K and thus increased levels of the kinase, as well as its lipid product phosphatidylinosito1-3-phosphate (PI3P). We find PI3P levels to be predictive of artemisinin resistance in both clinical and engineered laboratory parasites as well as across non-isogenic strains. Elevated PI3P induced artemisinin resistance in absence of PfKelch13 mutations, but remained responsive to regulation by PfKelch13. Evidence is presented for PI3P-dependent signalling in which transgenic expression of an additional kinase confers resistance. Together these data present PI3P as the key mediator of artemisinin resistance and the sole PfPI3K as an important target for malaria elimination.	[Mbengue, Alassane; Bhattacharjee, Souvik; Pandharkar, Trupti; Liu, Haining; Estiu, Guillermina; Stahelin, Robert V.; Rizk, Shahir S.; Njimoh, Dieudonne L.; Ryan, Yana; Wiest, Olaf; Haldar, Kasturi] Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Mbengue, Alassane; Bhattacharjee, Souvik; Pandharkar, Trupti; Rizk, Shahir S.; Njimoh, Dieudonne L.; Ryan, Yana; Pfrender, Michael; Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Liu, Haining; Estiu, Guillermina; Stahelin, Robert V.; Wiest, Olaf] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Njimoh, Dieudonne L.] Univ Buea, Fac Sci, Dept Biochem & Mol Biol, Buea, Southwest Regio, Cameroon; [Chotivanich, Kesinee; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; [Nguon, Chea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh 12302, Cambodia; [Ghorbal, Mehdi; Lopez-Rubio, Jose-Juan] Univ Montpellier 1&2 MiVEGEC, CNRS 5290, IRD 224, Montpellier, France; [Emrich, Scott] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10032 USA; [Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7BN, England; [Wiest, Olaf] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen 518055, Peoples R China	University of Notre Dame; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend; Mahidol University; National Center Parasitology, Entomology & Malaria Control; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Notre Dame; New York Blood Center; University of Oxford; Peking University; University Town of Shenzhen	Haldar, K (corresponding author), Univ Notre Dame, Boler Parseghian Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Hua, QX/HGE-3640-2022; Stahelin, Robert/L-3567-2019; Pfrender, Micheal E./C-5065-2019; lopez-rubio, jose juan/A-4509-2014	Stahelin, Robert/0000-0001-5443-7863; mbengue, Alassane/0000-0002-4210-6167; lopez-rubio, jose juan/0000-0002-0555-1122; Ghorbal, Mehdi/0000-0002-8896-2786	NIH [HL069630, AI039071, HL078826, AI081077, DK26263]; Notre Dame International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826, R01HL069630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071, R01AI081077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants HL069630, AI039071, HL078826 (K.H.); AI081077 (R.V.S.); DK26263 (N.M.) and a grant from Notre Dame International. All parasite gene/protein sequences were obtained from PlasmoDB (http://www.plasmodb.org). This study is dedicated to the memory of Dr. Martin John Rogers, NIAID for his leadership in antimalarial drug research.	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Case DA, 2012, AMBER 12; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020932; Cheng Q, 2012, INT J PARASITOL-DRUG, V2, P249, DOI 10.1016/j.ijpddr.2012.01.001; Chotivanich K, 2014, ANTIMICROB AGENTS CH, V58, P3157, DOI 10.1128/AAC.01924-13; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Efferth T, 2002, J MOL MED-JMM, V80, P233, DOI 10.1007/s00109-001-0300-8; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fox T, 1996, PROTEINS, V25, P315, DOI 10.1002/(SICI)1097-0134(199607)25:3<315::AID-PROT4>3.0.CO;2-E; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jorgensen W L, 1986, Ann N Y Acad Sci, V482, P198, DOI 10.1111/j.1749-6632.1986.tb20951.x; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mi-Ichi F, 2007, PARASITOLOGY, V134, P1671, DOI 10.1017/S0031182007003137; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Osborne AR, 2010, MOL BIOCHEM PARASIT, V171, P25, DOI 10.1016/j.molbiopara.2010.01.003; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; PETERSEN HG, 1995, J CHEM PHYS, V103, P3668, DOI 10.1063/1.470043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; van Ooij C, 2013, J BIOL CHEM, V288, P31971, DOI 10.1074/jbc.M113.474189; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; World Health Organization, WORLD MALARIA REPORT; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	47	358	380	2	255	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					683	U246		10.1038/nature14412	http://dx.doi.org/10.1038/nature14412			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25874676	Green Submitted, Green Accepted			2022-12-24	WOS:000353689700051
J	Carson-Stevens, A; Edwards, A; Panesar, S; Parry, G; Rees, P; Sheikh, A; Donaldson, L				Carson-Stevens, Andrew; Edwards, Adrian; Panesar, Sukhmeet; Parry, Gareth; Rees, Philippa; Sheikh, Aziz; Donaldson, Liam			Reducing the burden of iatrogenic harm in children	LANCET			English	Editorial Material									[Carson-Stevens, Andrew; Edwards, Adrian; Rees, Philippa] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF14 4YS, S Glam, Wales; [Carson-Stevens, Andrew] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; [Carson-Stevens, Andrew; Panesar, Sukhmeet; Sheikh, Aziz] Univ Edinburgh, Med Informat Ctr, Edinburgh, Midlothian, Scotland; [Parry, Gareth] Inst Healthcare Improvement, Cambridge, MA USA; [Parry, Gareth; Sheikh, Aziz] Harvard Univ, Sch Med, Boston, MA USA; [Sheikh, Aziz] Brigham & Womens Hosp, Boston, MA 02115 USA; [Donaldson, Liam] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Cardiff University; University of British Columbia; University of Edinburgh; Institute for Healthcare Improvement; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Imperial College London	Carson-Stevens, A (corresponding author), Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF14 4YS, S Glam, Wales.	carson-stevensap@cardiff.ac.uk	Parry, Gareth/CAF-6975-2022	Sheikh, Aziz/0000-0001-7022-3056; Rees, Philippa/0000-0002-1074-5837; Carson-Stevens, Andrew/0000-0002-7580-7699	Department of Health [12/64/118] Funding Source: Medline; National Institute for Health Research [12/64/118] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Department for Education, 2013, CHILD DEATH REV YEAR; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Modi N, 2013, LANCET, V381, P73, DOI 10.1016/S0140-6736(12)61818-2; Parry G, 2012, JAMA-J AM MED ASSOC, V307, P2155, DOI 10.1001/jama.2012.3649; PEARSON GEE, 2008, WHY CHILDREN DIE PIL; Walsh KE, 2014, JAMA-J AM MED ASSOC, V311, P1731, DOI 10.1001/jama.2014.2038; Wang H, 2014, LANCET; WHO, REP PAT SAF INC; Wolfe I, 2013, LANCET, V381, P1224, DOI 10.1016/S0140-6736(12)62085-6	9	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1593	1594		10.1016/S0140-6736(14)61739-6	http://dx.doi.org/10.1016/S0140-6736(14)61739-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25943799				2022-12-24	WOS:000353418000007
J	Levy, A; Goren, MG; Yosef, I; Auster, O; Manor, M; Amitai, G; Edgar, R; Qimron, U; Sorek, R				Levy, Asaf; Goren, Moran G.; Yosef, Ido; Auster, Oren; Manor, Miriam; Amitai, Gil; Edgar, Rotem; Qimron, Udi; Sorek, Rotem			CRISPR adaptation biases explain preference for acquisition of foreign DNA	NATURE			English	Article							ADAPTIVE IMMUNE-SYSTEMS; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; SPACER ACQUISITION; RECBCD ENZYME; CAS SYSTEM; REPLICATION; PROKARYOTES; PLASMIDS; BACTERIA	CRISPR-Cas (clustered, regularly interspaced short palindromic repeats coupled with CRISPR-associated proteins) is a bacterial immunity system that protects against invading phages or plasmids. In the process of CRISPR adaptation, short pieces of DNA ('spacers') are acquired from foreign elements and integrated into the CRISPR array. So far, it has remained a mystery how spacers are preferentially acquired from the foreign DNA while the self chromosome is avoided. Here we show that spacer acquisition is replication-dependent, and that DNA breaks formed at stalled replication forks promote spacer acquisition. Chromosomal hotspots of spacer acquisition were confined by Chi sites, which are sequence octamers highly enriched on the bacterial chromosome, suggesting that these sites limit spacer acquisition from self DNA. We further show that the avoidance of self is mediated by the RecBCD double-stranded DNA break repair complex. Our results suggest that, in Escherichia coli, acquisition of new spacers largely depends on RecBCD-mediated processing of double-stranded DNA breaks occurring primarily at replication forks, and that the preference for foreign DNA is achieved through the higher density of Chi sites on the self chromosome, in combination with the higher number of forks on the foreign DNA. This model explains the strong preference to acquire spacers both from high copy plasmids and from phages.	[Levy, Asaf; Amitai, Gil; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Goren, Moran G.; Yosef, Ido; Auster, Oren; Manor, Miriam; Edgar, Rotem; Qimron, Udi] Tel Aviv Univ, Sackler Sch Med, Dep Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Qimron, U (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dep Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	ehudq@post.tau.ac.il; rotem.sorek@weizmann.ac.il	Gazit, Ehud/AHE-9332-2022; Levy, Asaf/ABA-2623-2020	Qimron, Udi/0000-0003-2169-5270	Israel Science Foundation [1303/12, 1796, 268/14]; European Research Council [260432, 336079]; Human Frontier Science Program [RGP0011/2013]; Abisch-Frenkel foundation; Pasteur-Weizmann Council; Minerva Foundation; Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft; Israeli Ministry of Health [9988-3]; Azrieli Foundation	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); Abisch-Frenkel foundation; Pasteur-Weizmann Council; Minerva Foundation; Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israeli Ministry of Health; Azrieli Foundation	We thank N. Barkai, A. Tanay, E. Mick, S. Doron, A. Stern, T. Dagan and M. Shamir for discussion. We also thank the Skarstad group for providing the MG1655dnaC2 strain, the Michel group for providing the JJC1819 strain and D. Dar for assistance in Illumina sequencing. R.S. was supported, in part, by the Israel Science Foundation (personal grant 1303/12 and I-CORE grant 1796), the European Research Council Starting Grant programme (grant 260432), Human Frontier Science Program (grant RGP0011/2013), the Abisch-Frenkel foundation, the Pasteur-Weizmann Council, the Minerva Foundation, and by a Deutsch-Israelische Projektkooperation grant from the Deutsche Forschungsgemeinschaft. U.Q. was supported, in part, by the European Research Council Starting Grant programme (grant 336079), the Israel Science Foundation (grant 268/14) and the Israeli Ministry of Health (grant 9988-3). A.L. is grateful to the Azrieli Foundation for the award of an Azrieli Fellowship.	Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Erdmann S, 2014, MOL MICROBIOL, V91, P900, DOI 10.1111/mmi.12503; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lin L., 1992, THESIS STATE U NEW Y; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Shee C, 2013, ELIFE, V2, DOI 10.7554/eLife.01222; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Smith GR, 2012, MICROBIOL MOL BIOL R, V76, P217, DOI 10.1128/MMBR.05026-11; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Waldminghaus T, 2012, NUCLEIC ACIDS RES, V40, P5465, DOI 10.1093/nar/gks187; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	37	252	263	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					505	+		10.1038/nature14302	http://dx.doi.org/10.1038/nature14302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25874675	Green Accepted			2022-12-24	WOS:000353334500035
J	Marlin, BJ; Mitre, M; D'amour, JA; Chao, MV; Froemke, RC				Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Chao, Moses V.; Froemke, Robert C.			Oxytocin enables maternal behaviour by balancing cortical inhibition	NATURE			English	Article							MOUSE AUDITORY-CORTEX; ULTRASONIC COMMUNICATION; CENTRAL AMYGDALA; SOCIAL-BEHAVIOR; MICE; VASOPRESSIN; RECOGNITION; PARTURITION; NEURONS; HYPOTHALAMUS	Oxytocin is important for social interactions and maternal behaviour. However, little is known about when, where and how oxytocin modulates neural circuits to improve social cognition. Here we show how oxytocin enables pup retrieval behaviour in female mice by enhancing auditory cortical pup call responses. Retrieval behaviour required the left but not right auditory cortex, was accelerated by oxytocin in the left auditory cortex, and oxytocin receptors were preferentially expressed in the left auditory cortex. Neural responses to pup calls were lateralized, with co-tuned and temporally precise excitatory and inhibitory responses in the left cortex of maternal but not pup-naive adults. Finally, pairing calls with oxytocin enhanced responses by balancing the magnitude and timing of inhibition with excitation. Our results describe fundamental synaptic mechanisms by which oxytocin increases the salience of acoustic social stimuli. Furthermore, oxytocin-induced plasticity provides a biological basis for lateralization of auditory cortical processing.	[Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Chao, Moses V.; Froemke, Robert C.] NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; [Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Chao, Moses V.; Froemke, Robert C.] NYU, Sch Med, Neurosci Inst, New York, NY 10016 USA; [Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Froemke, Robert C.] NYU, Sch Med, Dept Otolaryngol, New York, NY 10016 USA; [Marlin, Bianca J.; Mitre, Mariela; D'amour, James A.; Chao, Moses V.; Froemke, Robert C.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Mitre, Mariela; Chao, Moses V.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Mitre, Mariela; Chao, Moses V.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Chao, Moses V.; Froemke, Robert C.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University; New York University; New York University; New York University; New York University; New York University	Froemke, RC (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	robert.froemke@med.nyu.edu		Froemke, Robert/0000-0002-1230-6811; Chao, Moses/0000-0002-6969-3744	NIDCD [DC009635, DC12557]; Klingenstein Fellowship; McKnight Scholarship; Pew Scholarship; Sloan Research Fellowship; Whitehead Foundation; Skirball Institute Collaborative Research Award; NIMH [T32]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS021072, T32NS086750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012557, K99DC009635, R00DC009635] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Klingenstein Fellowship(Klingenstein Philanthropies); McKnight Scholarship; Pew Scholarship; Sloan Research Fellowship(Alfred P. Sloan Foundation); Whitehead Foundation; Skirball Institute Collaborative Research Award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank V. Azzara, R. Alicka, H. Bernstein, G. Buzsaki, I. Carcea, C. Grosso, M. Insanally, M. Jin, K. Kuchibhotla, B. Y. B. Lau, D. Lin, M. A. Long, N. Lopez, J. Marlin, C. McFarlane, E. Morina, S. Norden, D. Okobi, K. Peng, R. Priya, W. Rashid, L. Rubin, S. Shea, R. M. Sullivan, R. W. Tsien, D. Vallentin, L. J. Young and N. Zaika for comments, discussions and technical assistance, A. Mar and the NYU School of Medicine Behavioral Core for assistance with behavioural analysis, and C. A. Loomis and the NYU School of Medicine Histology Core for assistance with anatomical studies. Oxytocin-IRES-Cre mice were obtained from D. Olson and B. Lowell. Oxytocin receptor knockout mice were obtained from R. W. Tsien. Oxytocin receptor plasmid (pAAV-OXTR) was obtained from L. J. Young. Adeno-associated virus was obtained from the U. Penn Vector Core. S. E. Ross created artwork in Fig. 1a. This work was funded by NIDCD (DC009635, DC12557), a Klingenstein Fellowship, a McKnight Scholarship, a Pew Scholarship, a Sloan Research Fellowship, and a Whitehead Foundation Fellowship (R.C.F.); a Skirball Institute Collaborative Research Award (M. V. C. and R.C.F.); and NIMH (T32; B.J.M.).	Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bennur S, 2013, HEARING RES, V305, P3, DOI 10.1016/j.heares.2013.08.008; Bishop DVM, 2013, SCIENCE, V340, DOI 10.1126/science.1230531; Chang SWC, 2014, BRAIN RES, V1580, P57, DOI 10.1016/j.brainres.2013.11.006; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; Cohen L, 2011, NEURON, V72, P357, DOI 10.1016/j.neuron.2011.08.019; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Fichtel I, 1999, NEUROREPORT, V10, P2341, DOI 10.1097/00001756-199908020-00022; Fraser EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090368; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; HOFSTETTER KM, 1992, J COMP NEUROL, V323, P370, DOI 10.1002/cne.903230306; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Irani BG, 2010, NEUROSCIENCE, V170, P1065, DOI 10.1016/j.neuroscience.2010.07.064; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; KOCH M, 1989, PHYSIOL BEHAV, V45, P771, DOI 10.1016/0031-9384(89)90293-X; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; LORING DW, 1990, NEUROPSYCHOLOGIA, V28, P831, DOI 10.1016/0028-3932(90)90007-B; Nakajima M, 2014, CELL, V159, P295, DOI 10.1016/j.cell.2014.09.020; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Owen SF, 2013, NATURE, V500, P458, DOI 10.1038/nature12330; PEDERSEN CA, 1982, SCIENCE, V216, P648, DOI 10.1126/science.7071605; RICHARD P, 1991, PHYSIOL REV, V71, P331, DOI 10.1152/physrev.1991.71.2.331; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; Rothschild G, 2013, J NEUROSCI, V33, P12851, DOI 10.1523/JNEUROSCI.4656-12.2013; Rudick CN, 2001, J NEUROSCI, V21, P6532, DOI 10.1523/JNEUROSCI.21-17-06532.2001; SEWELL GD, 1970, NATURE, V227, P410, DOI 10.1038/227410a0; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Tan AYY, 2009, NEUROSCIENCE, V163, P1302, DOI 10.1016/j.neuroscience.2009.07.032; Wacker DW, 2012, HORM BEHAV, V61, P259, DOI 10.1016/j.yhbeh.2011.08.014; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WINSLOW JT, 1991, J NEUROSCI, V11, P2032; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045167; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	56	368	376	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					499	+		10.1038/nature14402	http://dx.doi.org/10.1038/nature14402			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25874674	Green Accepted			2022-12-24	WOS:000353334500034
J	Arie, S				Arie, Sophie			Can mobile phones transform healthcare in low and middle income countries?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Mobile technology has the potential to put rural populations in touch with formal health services for the first time, but is the buzz around mobile health justified, asks Sophie Arie				sarie@bmj.com						Agarwal S, 2014, JAMA-J AM MED ASSOC, V312, P229, DOI 10.1001/jama.2014.6371; [Anonymous], 2015, BIG DAT SEL MAK BIG; [Anonymous], 2014, IT NEWS AFR     1212; GSMA, PAN AFR MHEALTH IN; Linda Jamii, MWISHO WA MAWAZO; Minges M, KEY TRENDS DEV MOBIL; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Unicef Zambia, 2012, PROJECT MWANA USING; Vital Wave Consulting, MHEALTH ETH STRAT NE; World Bank, 2012, INF COMM DEV MAX MOB	10	21	22	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2015	350								h1975	10.1136/bmj.h1975	http://dx.doi.org/10.1136/bmj.h1975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QZ	25902967				2022-12-24	WOS:000353576700005
J	Shen, MM				Shen, Michael M.			The complex seeds of metastasis	NATURE			English	News Item							TUMOR-CELL HETEROGENEITY; CANCER METASTASIS; PROSTATE-CANCER; MOUSE MODEL	Analyses of prostate-cancer metastases reveal a complex cellular architecture, and show that secondary sites can be seeded by multiple cell populations derived from both the primary tumour and other metastases.	[Shen, Michael M.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Dept Urol, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Shen, Michael M.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Shen, MM (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA.	mshen@columbia.edu	Shen, Michael M/C-7546-2009	Shen, Michael M/0000-0002-4042-1657; Shen, Mouquan/0000-0001-6448-4866	NATIONAL CANCER INSTITUTE [P01CA154293] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA154293] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Aytes A, 2013, P NATL ACAD SCI USA, V110, pE3506, DOI 10.1073/pnas.1303558110; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hong M. K. H., 2015, NATURE COMMUN; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125	12	13	13	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					298	299		10.1038/nature14377	http://dx.doi.org/10.1038/nature14377			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25830892				2022-12-24	WOS:000352974200023
J	Zhang, DD; Gao, ZG; Zhang, KH; Kiselev, E; Crane, S; Wang, J; Paoletta, S; Yi, CY; Ma, LM; Zhang, WR; Han, GW; Liu, H; Cherezov, V; Katritch, V; Jiang, HL; Stevens, RC; Jacobson, KA; Zhao, Q; Wu, BL				Zhang, Dandan; Gao, Zhan-Guo; Zhang, Kaihua; Kiselev, Evgeny; Crane, Steven; Wang, Jiang; Paoletta, Silvia; Yi, Cuiying; Ma, Limin; Zhang, Wenru; Han, Gye Won; Liu, Hong; Cherezov, Vadim; Katritch, Vsevolod; Jiang, Hualiang; Stevens, Raymond C.; Jacobson, Kenneth A.; Zhao, Qiang; Wu, Beili			Two disparate ligand-binding sites in the human P2Y(1) receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; NUCLEOTIDE RECEPTORS; PURINERGIC RECEPTORS; SMALL-MOLECULE; ANTAGONISTS; AGONIST; DISCOVERY; COMPLEX; RECOGNITION	In response to adenosine 59-diphosphate, the P2Y(1) receptor (P2Y(1)R) facilitates platelet aggregation, and thus serves as an important antithrombotic drug target. Here we report the crystal structures of the human P2Y(1)R in complex with a nucleotide antagonist MRS2500 at 2.7 angstrom resolution, and with a non-nucleotide antagonist BPTU at 2.2 angstrom resolution. The structures reveal two distinct ligand-binding sites, providing atomic details of P2Y(1)R's unique ligand-binding modes. MRS2500 recognizes a binding site within the seven transmembrane bundle of P2Y(1)R, which is different in shape and location from the nucleotide binding site in the previously determined structure of P2Y(12)R, representative of another P2YR subfamily. BPTU binds to an allosteric pocket on the external receptor interface with the lipid bilayer, making it the first structurally characterized selective G-protein-coupled receptor (GPCR) ligand located entirely outside of the helical bundle. These high-resolutioninsights into P2Y(1)R should enable discovery of new orthosteric and allosteric antithrombotic drugs with reduced adverse effects.	[Zhang, Dandan; Zhang, Kaihua; Wang, Jiang; Yi, Cuiying; Ma, Limin; Zhang, Wenru; Liu, Hong; Zhao, Qiang; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Gao, Zhan-Guo; Kiselev, Evgeny; Crane, Steven; Paoletta, Silvia; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Univ So Calif, Dept Chem, Bridge Inst, Los Angeles, CA 90089 USA; [Katritch, Vsevolod] Univ So Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Southern California; University of Southern California; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	zhaoq@simm.ac.cn; beiliwu@simm.ac.cn	Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLT-1531-2022; Zhang, Kaihua/AAD-7882-2022; Katritch, Vsevolod/Q-8357-2016; Jacobson, Kenneth Alan/A-1530-2009; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8673-2022	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Zhang, Kaihua/0000-0003-3734-3624; Katritch, Vsevolod/0000-0003-3883-4505; Jacobson, Kenneth Alan/0000-0001-8104-1493; Cherezov, Vadim/0000-0002-5265-3914; Zhang, Dandan/0000-0002-8863-5806	National Basic Research Program of China [2012CB518000, 2014CB910400, 2012CB910400]; CAS Strategic Priority Research Program [XDB08020300]; National Science Foundation of China [31422017, 31370729, 91313000]; National Science and Technology Major Project [2013ZX09507001]; NIDDK; NIH Intramural Research Program [Z01 DK031116-26]; National Institutes of Health [U54 GM094618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031126, Z01DK031116, ZIADK031116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); CAS Strategic Priority Research Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Basic Research Program of China grants 2012CB518000, 2014CB910400 and 2012CB910400 (Q.Z., B.W.), CAS Strategic Priority Research Program XDB08020300 (B.W.), the National Science Foundation of China grants 31422017 (B.W.), 31370729 (Q.Z.) and 91313000 (H.J.), the National Science and Technology Major Project 2013ZX09507001 (H.J., Q.Z., B.W.), NIDDK, NIH Intramural Research Program grant Z01 DK031116-26 (K.A.J.), and the National Institutes of Health grant U54 GM094618 (V.C., V.K., R.C.S.). The authors thank A. Walker for assistance with manuscript preparation and S. M. Moss for technical assistance. The synchrotron radiation experiments were performed at the BL41XU of Spring-8 with approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2014A1094 and 2014B1056). We thank the beamline staff members of the BL41XU for help with X-ray data collection.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chao HG, 2013, J MED CHEM, V56, P1704, DOI 10.1021/jm301708u; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fam SR, 2000, J NEUROSCI, V20, P2800; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Guo DP, 2002, DRUG DEVELOP RES, V57, P173, DOI 10.1002/ddr.10145; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hechler B, 2006, J PHARMACOL EXP THER, V316, P556, DOI 10.1124/jpet.105.094037; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Jacobson KA, 2011, PURINERG SIGNAL, V7, P305, DOI 10.1007/s11302-011-9216-0; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HS, 2003, J MED CHEM, V46, P4974, DOI 10.1021/jm030127+; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moro S, 1998, J MED CHEM, V41, P1456, DOI 10.1021/jm970684u; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Qiao JX, 2013, J MED CHEM, V56, P9275, DOI 10.1021/jm4013906; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Wang TC, 2013, BIOORG MED CHEM LETT, V23, P3239, DOI 10.1016/j.bmcl.2013.03.125; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yang W, 2014, J MED CHEM, V57, P6150, DOI 10.1021/jm5006226; Zerr M, 2011, CIRCULATION, V123, P2404, DOI 10.1161/CIRCULATIONAHA.110.002139; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	37	238	241	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					317	+		10.1038/nature14287	http://dx.doi.org/10.1038/nature14287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25822790	Green Accepted			2022-12-24	WOS:000352974200031
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Palliative care team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2015	350								h1861	10.1136/bmj.h1861	http://dx.doi.org/10.1136/bmj.h1861			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JP	25876989				2022-12-24	WOS:000353328000006
J	Shore, S; Ho, PM; Lambert-Kerzner, A; Glorioso, TJ; Carey, EP; Cunningham, F; Longo, L; JackeviciusPharmD, C; Rose, A; Turakhia, MP				Shore, Supriya; Ho, P. Michael; Lambert-Kerzner, Anne; Glorioso, Thomas J.; Carey, Evan P.; Cunningham, Fran; Longo, Lisa; Jackevicius, Cynthia; Rose, Adam; Turakhia, Mintu P.			Site-Level Variation in and Practices Associated With Dabigatran Adherence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL-FIBRILLATION; MEDICATION ADHERENCE; STROKE PREVENTION; PHARMACY RECORDS; PATIENT-OUTCOMES; HEALTH; ANTICOAGULATION; WARFARIN; CARE; INSIGHTS	IMPORTANCE Unlike warfarin, which requires routine laboratory testing and dose adjustment, target-specific oral anticoagulants like dabigatran do not. However, optimal follow-up infrastructure and modifiable site-level factors associated with improved adherence to dabigatran are unknown. OBJECTIVES To assess site-level variation in dabigatran adherence and to identify site-level practices associated with higher dabigatran adherence. DESIGN, SETTING, AND PARTICIPANTS Mixed-methods study involving retrospective quantitative and cross-sectional qualitative data. A total of 67 Veterans Health Administration sites with 20 or more patients filling dabigatran prescriptions between 2010 and 2012 for nonvalvular atrial fibrillation were sampled (4863 total patients; median, 51 patients per site). Forty-seven pharmacists from 41 eligible sites participated in the qualitative inquiry. EXPOSURE Site-level practices identified included appropriate patient selection, pharmacist-driven patient education, and pharmacist-led adverse event and adherence monitoring. MAIN OUTCOMES AND MEASURES Dabigatran adherence (intensity of drug use during therapy) defined by proportion of days covered (ratio of days supplied by prescription to follow-up duration) of 80% or more. RESULTS The median proportion of patients adherent to dabigatran was 74% (interquartile range [IQR], 66%-80%). After multivariable adjustment, dabigatran adherence across sites varied by a median odds ratio of 1.57. Review of practices across participating sites showed that appropriate patient selection was performed at 31 sites, pharmacist-led education was provided at 30 sites, and pharmacist-led monitoring at 28 sites. The proportion of adherent patients was higher at sites performing appropriate selection (75% vs 69%), education (76% vs 66%), and monitoring (77% vs 65%). Following multivariable adjustment, association between pharmacist-led education and dabigatran adherence was not statistically significant (relative risk [RR], 0.94; 95% Cl, 0.83-1.06). Appropriate patient selection (RR, 1.14; 95% Cl, 1.05-1.25), and provision of pharmacist-led monitoring (RR, 1.25; 95% Cl, 1.11-1.40 were associated with better patient adherence. Additionally, longer duration of monitoring and providing more intensive care to nonadherent patients in collaboration with the clinician improved adherence. CONCLUSIONS AND RELEVANCE Among nonvalvular atrial fibrillation patients treated with dabigatran, there was variability in patient medication adherence across Veterans Health Administration sites. Specific pharmacist-based activities were associated with greater patient adherence to dabigatran.	[Shore, Supriya] Emory Univ, Sch Med, Atlanta, GA USA; [Ho, P. Michael; Lambert-Kerzner, Anne; Glorioso, Thomas J.; Carey, Evan P.] Vet Affairs Eastern Colorado Hlth Care Syst, Denver, CO USA; [Ho, P. Michael; Glorioso, Thomas J.; Carey, Evan P.] Univ Colorado, Aurora, CO USA; [Ho, P. Michael; Lambert-Kerzner, Anne; Glorioso, Thomas J.; Carey, Evan P.] Colorado Cardiovasc Outcomes Res Consortium, Denver, CO USA; [Cunningham, Fran; Longo, Lisa] Pharm Benefits Management Serv, Vet Affairs, Hines, IL USA; [Cunningham, Fran; Longo, Lisa] Ctr Medicat Safety, Hines, IL USA; [Jackevicius, Cynthia] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; [Jackevicius, Cynthia] Western Univ Hlth Sci, Pomona, CA USA; [Rose, Adam] Bedford Veterabs Affairs Med Ctr, Bedford, MA USA; [Rose, Adam] Boston Univ, Boston, MA 02215 USA; [Turakhia, Mintu P.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Turakhia, Mintu P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Western University of Health Sciences; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Turakhia, MP (corresponding author), VA Palo Alto Hlth Care Syst, Dept Cardiol, 3801 Miranda Ave,Ste 111C, Palo Alto, CA 94304 USA.	mintu@stanford.edu	Rose, Adam/HHY-9078-2022	Rose, Adam/0000-0001-8681-6155; Turakhia, Minang/0000-0001-8025-0904	Career Development Award from VA Health Services Research Development; American Heart Association National Scientist Development Grant; Gilead Sciences Cardiovascular Research Scholars Program award	Career Development Award from VA Health Services Research Development; American Heart Association National Scientist Development Grant(American Heart Association); Gilead Sciences Cardiovascular Research Scholars Program award	Dr Turakhia is supported by a Career Development Award from VA Health Services Research & Development, an American Heart Association National Scientist Development Grant, and a Gilead Sciences Cardiovascular Research Scholars Program award.	Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Carrero JJ, 2014, JAMA-J AM MED ASSOC, V311, P919, DOI 10.1001/jama.2014.1334; Chiquette E, 1998, ARCH INTERN MED, V158, P1641, DOI 10.1001/archinte.158.15.1641; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Davis EM, 2014, J MANAG CARE SPEC PH, V20, P741, DOI 10.18553/jmcp.2014.20.7.741; Ho PM, 2014, JAMA INTERN MED, V174, P186, DOI 10.1001/jamainternmed.2013.12944; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Hojsgaard S, 2006, J STAT SOFTW, V15; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.021, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142]; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Rose AJ, 2013, CHEST, V143, P751, DOI 10.1378/chest.12-1119; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tsai K, 2013, AM J MANAG CARE, V19; Turakhia MP, 2014, J AM COLL CARDIOL, V64, P660, DOI 10.1016/j.jacc.2014.03.060; Turakhia MP, 2013, AM HEART J, V165, P93, DOI 10.1016/j.ahj.2012.10.010; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2, P12; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183	24	100	101	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1443	1450		10.1001/jama.2015.2761	http://dx.doi.org/10.1001/jama.2015.2761			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871670	Bronze			2022-12-24	WOS:000352821200020
J	Lu, Y; Wang, WP; Kirschner, MW				Lu, Ying; Wang, Weiping; Kirschner, Marc W.			Specificity of the anaphase-promoting complex: A single-molecule study	SCIENCE			English	Article							SUBSTRATE DEGRADATION; MECHANISM; PROTEOLYSIS; CYCLIN; POLYUBIQUITINATION; PROCESSIVITY; DESTRUCTION; CASCADES; INSIGHTS; RECEPTOR	Biological processes require specific enzymatic reactions, paradoxically involving short recognition sequences. As an example, cell-cycle timing depends on a sequence of ubiquitylation events mediated by the anaphase-promoting complex (APC) based on short redundant motifs. To understand the origin of specificity, we designed single-molecule fluorescence assays that capture transient ubiquitylation reactions. We find that the APC-mediated ubiquitylation involves a highly processive initial reaction on the substrate, followed by multiple encounters and reactions at a slower rate. The initial ubiquitylation greatly enhances the substrate's binding affinity in subsequent reactions, by both increasing the on-rate and decreasing the off-rate. We postulate that these cycles of positive feedback enable high specificity for substrates with short recognition motifs in a complex cellular environment.	[Lu, Ying; Wang, Weiping; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	marc@hms.harvard.edu			National Institute of General Medical Sciences [5R01GM039023-26]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039023] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. King for providing plasmids and W. Ma, L. Bai, M. Rape, and R. King for commenting on the manuscript. We are grateful to the Nikon imaging center at Harvard Medical School and in particular to J. Waters for technical support; Y.L. is a Damon Runyon Cancer Research Fellow and a Lallage Feazel Wall Fellow. We acknowledge the continuing support of the National Institute of General Medical Sciences (grant no. 5R01GM039023-26).	Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; BESSMAN MJ, 1974, J MOL BIOL, V88, P409, DOI 10.1016/0022-2836(74)90491-4; BOHMAN K, 1984, MOL GEN GENET, V198, P90, DOI 10.1007/BF00328706; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Highbarger LA, 1996, BIOCHEMISTRY-US, V35, P41, DOI 10.1021/bi9518306; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kelly A., 2014, SCIENCE, V56, P232, DOI DOI 10.1016/J.M0LCEL.2014.09.010;PMID:25306918; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034370; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Meyer HJ, 2011, SEMIN CELL DEV BIOL, V22, P544, DOI 10.1016/j.semcdb.2011.03.009; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670	29	49	50	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231							1248737	10.1126/science.1248737	http://dx.doi.org/10.1126/science.1248737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859049	Green Accepted			2022-12-24	WOS:000352613700034
J	Soltwisch, J; Kettling, H; Vens-Cappell, S; Wiegelmann, M; Muthing, J; Dreisewerd, K				Soltwisch, Jens; Kettling, Hans; Vens-Cappell, Simeon; Wiegelmann, Marcel; Muething, Johannes; Dreisewerd, Klaus			Mass spectrometry imaging with laser-induced postionization	SCIENCE			English	Article							SINGLE CELLS; ION YIELDS; MALDI; IONIZATION; DESORPTION; MOLECULES; PRESSURE; TISSUE; RESOLUTION; SPECTRA	Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) can simultaneously record the lateral distribution of numerous biomolecules in tissue slices, but its sensitivity is restricted by limited ionization. We used a wavelength-tunable postionization laser to initiate secondary MALDI-like ionization processes in the gas phase. In this way, we could increase the ion yields for numerous lipid classes, liposoluble vitamins, and saccharides, imaged in animal and plant tissue with a 5-micrometer-wide laser spot, by up to two orders of magnitude. Critical parameters for initiation of the secondary ionization processes are pressure of the cooling gas in the ion source, laser wavelength, pulse energy, and delay between the two laser pulses. The technology could enable sensitive MALDI-MS imaging with a lateral resolution in the low micrometer range.	[Soltwisch, Jens; Kettling, Hans; Vens-Cappell, Simeon; Wiegelmann, Marcel; Muething, Johannes; Dreisewerd, Klaus] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Kettling, Hans; Vens-Cappell, Simeon; Dreisewerd, Klaus] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany	University of Munster; University of Munster	Dreisewerd, K (corresponding author), Univ Munster, Inst Hyg, Robert Koch Str 41, D-48149 Munster, Germany.	klaus.dreisewerd@uni-muenster.de	Soltwisch, Jens/N-8141-2015; Dreisewerd, Klaus/K-3884-2015	Soltwisch, Jens/0000-0002-0258-1561; Dreisewerd, Klaus/0000-0002-7619-808X; Niehaus, Marcel/0000-0002-4876-6190; Vens-Cappell, Simeon/0000-0003-4773-4653	German Science Foundation [DR416/8-2, DR416/9-1, SO976/2-1, GRK 1409, MU845/4-2]; Interdisciplinary Center for Clinical Research (IZKF) Munster [Z03]	German Science Foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Munster	We thank Waters Corp. and GWU Lasertechnik for technical support; F. Spieker and J. Haier for animal tissue; J. Klingauf for scanning electron microscopy images; W. Kramer for Fig. 1; and S. Albrecht, H. Karch, T. Kuhlmann, G. Pohlentz, and J. Y. Yew for helpful discussions. Financial support by the German Science Foundation (grants DR416/8-2 and DR416/9-1 to K.D., SO976/2-1 to J. S., GRK 1409 and MU845/4-2 to J.M.) and the Interdisciplinary Center for Clinical Research (IZKF) Munster (Z03 to K.D.) is gratefully acknowledged. We dedicate this work to the memory of Dr. Franz Hillenkamp in recognition of his lifetime achievements in the field of MALDI mass spectrometry.	BECKER CH, 1995, J AM SOC MASS SPECTR, V6, P883, DOI 10.1016/1044-0305(95)00472-P; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; DREISEWERD K, 1995, INT J MASS SPECTROM, V141, P127, DOI 10.1016/0168-1176(94)04108-J; Dreisewerd K, 2003, CHEM REV, V103, P395, DOI 10.1021/cr010375i; Dreisewerd K, 2014, ANAL BIOANAL CHEM, V406, P2261, DOI 10.1007/s00216-014-7646-6; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; Hanley L, 2009, ANAL CHEM, V81, P4174, DOI 10.1021/ac8013675; Hillenkamp F., 2013, MALDI MS PRACTICAL G; Jaskolla TW, 2011, J AM SOC MASS SPECTR, V22, P976, DOI 10.1007/s13361-011-0093-0; Kettling H, 2014, ANAL CHEM, V86, P7798, DOI 10.1021/ac5017248; Knochenmuss R, 2003, CHEM REV, V103, P441, DOI 10.1021/cr0103773; Knochenmuss R, 2012, ANAL BIOANAL CHEM, V402, P2511, DOI 10.1007/s00216-011-5194-x; Krutchinsky AN, 2002, J AM SOC MASS SPECTR, V13, P129, DOI 10.1016/S1044-0305(01)00336-1; Lanni EJ, 2012, J PROTEOMICS, V75, P5036, DOI 10.1016/j.jprot.2012.03.017; Lin Q, 2001, RAPID COMMUN MASS SP, V15, P1422, DOI 10.1002/rcm.380; Nemes P, 2007, ANAL CHEM, V79, P8098, DOI 10.1021/ac071181r; Norris JL, 2013, CHEM REV, V113, P2309, DOI 10.1021/cr3004295; Rompp A, 2010, ANGEW CHEM INT EDIT, V49, P3834, DOI 10.1002/anie.200905559; Rohlfing A, 2010, J PHYS CHEM C, V114, P5367, DOI 10.1021/jp905251r; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; Soltwisch J, 2012, ANAL CHEM, V84, P6567, DOI 10.1021/ac3008434; Soltwisch J, 2009, ANAL CHEM, V81, P2921, DOI 10.1021/ac802301s; Spengler B, 2015, ANAL CHEM, V87, P64, DOI 10.1021/ac504543v; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Zavalin A, 2012, J MASS SPECTROM, V47, P1473, DOI 10.1002/jms.3108; ZemskiBerry K. A., 2011, CHEM REV, V111, P6491; ZHANG JY, 1991, ANAL CHEM, V63, P2995, DOI 10.1021/ac00024a039	28	186	188	14	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					211	215		10.1126/science.aaa1051	http://dx.doi.org/10.1126/science.aaa1051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25745064				2022-12-24	WOS:000352613700039
J	Davis, JR; Luchici, A; Mosis, F; Thackery, J; Salazar, JA; Mao, YL; Dunn, GA; Betz, T; Miodownik, M; Stramer, BM				Davis, John R.; Luchici, Andrei; Mosis, Fuad; Thackery, James; Salazar, Jesus A.; Mao, Yanlan; Dunn, Graham A.; Betz, Timo; Miodownik, Mark; Stramer, Brian M.			Inter-Cellular Forces Orchestrate Contact Inhibition of Locomotion	CELL			English	Article							MICROTUBULE DYNAMICS; ACTIN CYTOSKELETON; RETROGRADE FLOW; STRESS FIBERS; CELLS; MECHANISMS; ADHESION; REORGANIZATION; FIBROBLASTS; REPULSION	Contact inhibition of locomotion (CIL) is a multifaceted process that causes many cell types to repel each other upon collision. During development, this seemingly uncoordinated reaction is a critical driver of cellular dispersion within embryonic tissues. Here, we show that Drosophila hemocytes require a precisely orchestrated CIL response for their developmental dispersal. Hemocyte collision and subsequent repulsion involves a stereotyped sequence of kinematic stages that are modulated by global changes in cytoskeletal dynamics. Tracking actin retrograde flow within hemocytes in vivo reveals synchronous reorganization of colliding actin networks through engagement of an inter-cellular adhesion. This inter-cellular actin-clutch leads to a subsequent build-up in lamellar tension, triggering the development of a transient stress fiber, which orchestrates cellular repulsion. Our findings reveal that the physical coupling of the flowing actin networks during CIL acts as a mechanotransducer, allowing cells to haptically sense each other and coordinate their behaviors.	[Davis, John R.; Luchici, Andrei; Mosis, Fuad; Thackery, James; Salazar, Jesus A.; Dunn, Graham A.; Stramer, Brian M.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Luchici, Andrei; Miodownik, Mark] UCL, Dept Mech Engn, London WC2R 2LS, England; [Mao, Yanlan] UCL, Mol Cell Biol Lab, London WC1E 6BT, England; [Betz, Timo] Inst Curie, Ctr Rech, UMR168, Paris, France	University of London; King's College London; University of London; University College London; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Miodownik, M (corresponding author), UCL, Dept Mech Engn, London WC2R 2LS, England.	m.miodownik@ucl.ac.uk; brian.m.stramer@kcl.ac.uk	Betz, Timo/ABF-9946-2021	Betz, Timo/0000-0002-1548-0655; Davis, John Robert/0000-0002-6022-0369; Stramer, Brian/0000-0001-7034-3269	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F020635/1]; French Agence Nationale de la Recherche (ANR) [ANR-11-JSV5-0002]; Medical Research Council (MRC); BBSRC; CMCBI at KCL; BBSRC [BB/F020635/2] Funding Source: UKRI; MRC [MR/L009056/1, G0401026] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020635/2, BBS/B/02495, 1112060] Funding Source: researchfish; Medical Research Council [MR/L009056/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CMCBI at KCL; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank M. Peifer and D. Kiehart for fly lines. We appreciate comments on the manuscript from B. Baum, G. Charras, N. Davis, M. Dionne, P. Martin, E. Paluch, and W. Razzell. We also would like to thank N. Tapon, and P. Jordan and D. Alibhai from LRI Light Microscopy for help with laser ablations. B.M.S. was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) project grant BB/F020635/1. T.B. was supported by French Agence Nationale de la Recherche (ANR) grant ANR-11-JSV5-0002. J.R.D. was funded by the Medical Research Council (MRC). A.L. was funded by the BBSRC. We also thank the CMCBI at KCL for their support.	ABERCROMBIE M, 1970, EUR J CANCER, V6, P7, DOI 10.1016/0014-2964(70)90048-4; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; Betz T, 2009, BIOPHYS J, V96, P5130, DOI 10.1016/j.bpj.2009.03.045; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Davis JR, 2012, DEVELOPMENT, V139, P4555, DOI 10.1242/dev.082248; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; DUNN GA, 1982, PHILOS T ROY SOC B, V299, P147, DOI 10.1098/rstb.1982.0121; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; HEAYSMAN JE, 1973, EXP CELL RES, V78, P71, DOI 10.1016/0014-4827(73)90039-6; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Peglion F, 2014, NAT CELL BIOL, V16, P639, DOI 10.1038/ncb2985; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Sandbo N, 2013, J BIOL CHEM, V288, P15466, DOI 10.1074/jbc.M113.464461; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Stramer BM, 2013, J MICROSC-OXFORD, V251, P206, DOI 10.1111/jmi.12045; Stramer B, 2010, J CELL BIOL, V189, P681, DOI 10.1083/jcb.200912134; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; VESELY P, 1973, INT J CANCER, V11, P64, DOI 10.1002/ijc.2910110108; Villar-Cervino V, 2013, NEURON, V77, P457, DOI 10.1016/j.neuron.2012.11.023; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	42	73	73	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					361	373		10.1016/j.cell.2015.02.015	http://dx.doi.org/10.1016/j.cell.2015.02.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25799385	Green Published, hybrid			2022-12-24	WOS:000352708300027
J	Schoors, S; Bruning, U; Missiaen, R; Queiroz, KCS; Borgers, G; Elia, I; Zecchin, A; Cantelmo, AR; Christen, S; Goveia, J; Heggermont, W; Godde, L; Vinckier, S; Van Veldhoven, PP; Eelen, G; Schoonjans, L; Gerhardt, H; Dewerchin, M; Baes, M; De Bock, K; Ghesquiere, B; Lunt, SY; Fendt, SM; Carmeliet, P				Schoors, Sandra; Bruning, Ulrike; Missiaen, Rindert; Queiroz, Karla C. S.; Borgers, Gitte; Elia, Ilaria; Zecchin, Annalisa; Cantelmo, Anna Rita; Christen, Stefan; Goveia, Jermaine; Heggermont, Ward; Godde, Lucica; Vinckier, Stefan; Van Veldhoven, Paul P.; Eelen, Guy; Schoonjans, Luc; Gerhardt, Holger; Dewerchin, Mieke; Baes, Myriam; De Bock, Katrien; Ghesquiere, Bart; Lunt, Sophia Y.; Fendt, Sarah-Maria; Carmeliet, Peter			Fatty acid carbon is essential for dNTP synthesis in endothelial cells	NATURE			English	Article							GROWTH-FACTOR; METABOLISM; OXIDATION; TUMOR; ANGIOGENESIS; GLYCOLYSIS; CULTURE; KINASE; POOLS	The metabolism of endothelial cells during vessel sprouting remains poorly studied. Here we report that endothelial loss of CFT1A, a rate-limiting enzyme of fatty acid oxidation (FAO), causes vascular sprouting defects due to impaired proliferation, not migration, of human and murine endothelial cells. Reduction of FAO in endothelial cells did not cause energy depletion or disturb redox homeostasis, but impaired de novo nucleotide synthesis for DNA replication. Isotope labelling studies in control endothelial cells showed that fatty acid carbons substantially replenished the Krebs cycle, and were incorporated into aspartate (a nucleotide precursor), uridine monophosphate (a precursor of pyrimidine nucleoside triphosphates) and DNA. CPT1A silencing reduced these processes and depleted endothelial cell stores of aspartate and deoxyribonucleoside triphosphates. Acetate (metabolized to acetyl-CoA, thereby substituting for the depleted FAO-derived acetyl-CoA) or a nucleoside mix rescued the phenotype of CPT1A-silenceil endothelial cells. Finally, CPT1 blockade inhibited pathological ocular angiogenesis in mice, suggesting a novel strategy for blocking angiogenesis.	[Schoors, Sandra; Bruning, Ulrike; Missiaen, Rindert; Queiroz, Karla C. S.; Borgers, Gitte; Zecchin, Annalisa; Cantelmo, Anna Rita; Goveia, Jermaine; Godde, Lucica; Vinckier, Stefan; Eelen, Guy; Schoonjans, Luc; Dewerchin, Mieke; De Bock, Katrien; Ghesquiere, Bart; Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium; [Schoors, Sandra; Bruning, Ulrike; Missiaen, Rindert; Queiroz, Karla C. S.; Borgers, Gitte; Zecchin, Annalisa; Cantelmo, Anna Rita; Goveia, Jermaine; Godde, Lucica; Vinckier, Stefan; Eelen, Guy; Schoonjans, Luc; Dewerchin, Mieke; De Bock, Katrien; Ghesquiere, Bart; Carmeliet, Peter] VIB, Lab Angiogenesis & Neurovasc Link, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Elia, Ilaria; Christen, Stefan; Fendt, Sarah-Maria] Katholieke Univ Leuven, Dept Oncol, Lab Cellular Metab & Metab Regulat, B-3000 Leuven, Belgium; [Elia, Ilaria; Christen, Stefan; Fendt, Sarah-Maria] VIB, Lab Cellular Metab & Metab Regulat, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Heggermont, Ward] Katholieke Univ Leuven, Dept Cardiovasc Res, Ctr Mol & Vasc Biol, B-3000 Leuven, Belgium; [Heggermont, Ward] UZ Leuven, Div Clin Cardiol, B-3000 Leuven, Belgium; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Lab Lipid Biochem & Prot Interact, B-3000 Leuven, Belgium; [Gerhardt, Holger] Katholieke Univ Leuven, Dept Oncol, Vasc Patterning Lab, B-3000 Leuven, Belgium; [Gerhardt, Holger] VIB, Vesalius Res Ctr, Vasc Patterning Lab, B-3000 Leuven, Belgium; [Gerhardt, Holger] Max Delbruck Ctr Mol Med, Integrat Vasc Biol Lab, D-13125 Berlin, Germany; [Baes, Myriam] Katholieke Univ Leuven, Lab Cell Metab, Dept Pharmaceut & Pharmacol Sci, B-3000 Leuven, Belgium; [De Bock, Katrien] Katholieke Univ Leuven, Exercise Physiol Res Grp, Dept Kinesiol, B-3000 Leuven, Belgium; [Lunt, Sophia Y.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Helmholtz Association; Max Delbruck Center for Molecular Medicine; KU Leuven; KU Leuven; Michigan State University	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium.	sarah-maria.fendt@vib-kuleuven.be; peter.carmeliet@vib-kuleuven.be	Carmeliet, Peter/AAQ-5140-2020; , Van Veldhoven Paul/U-6359-2019; Cantelmo, Anna Rita/G-6766-2018; Gerhardt, Holger/G-4610-2011; De Bock, Katrien/L-2273-2013; Ghesquiere, Bart/HGU-8736-2022	Carmeliet, Peter/0000-0001-7961-1821; , Van Veldhoven Paul/0000-0002-4478-2564; Cantelmo, Anna Rita/0000-0002-2748-264X; Gerhardt, Holger/0000-0002-3030-0384; De Bock, Katrien/0000-0001-8232-4663; Ghesquiere, Bart/0000-0003-1547-1705; Lunt, Sophia/0000-0003-4522-6065; Elia, Ilaria/0000-0003-0922-9429; Fendt, Sarah-Maria/0000-0001-6018-9296; Baes, Myriam/0000-0002-2525-2269	Institution of Research/Innovation (IWT); Research Foundation Flanders (FWO); Marie Curie-IEF Fellowship; CAPES (Brazil); KU Leuven; Marie Curie CIG; FWO-Odysseusll; Concern Foundation; Bayer Healthcare Pharmaceuticals; Methusalem funding (Flemish Government); FWO; Foundation Leducq Transatlantic Network (ARTEMIS); Foundation against Cancer; European Research Council (ERC) Advanced Research Grant [EU-ERC269073]; AXA Research grant; Department of Defense CDMRP Visionary Postdoctoral Award [W81XWH-12-1-0466];  [IUAP7/03]	Institution of Research/Innovation (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); Marie Curie-IEF Fellowship(European Commission); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); KU Leuven(KU Leuven); Marie Curie CIG; FWO-Odysseusll; Concern Foundation; Bayer Healthcare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Methusalem funding (Flemish Government); FWO(FWO); Foundation Leducq Transatlantic Network (ARTEMIS); Foundation against Cancer; European Research Council (ERC) Advanced Research Grant(European Research Council (ERC)); AXA Research grant(AXA Research Fund); Department of Defense CDMRP Visionary Postdoctoral Award(United States Department of Defense); 	We thank M. Vander Heiden and D. Tollervey for discussion, R. Adams for providing VE-cadherin(PAC)-Cre<SUP>ERT2</SUP> mice, and S. Rodriguez-Aristegui for synthesis of etomoxir. S.S. is funded by the Institution of Research/Innovation (IWT); R.M., B.G., A.R.C. and J.G. by the Research Foundation Flanders (FWO); U.B. by a Marie Curie-IEF Fellowship; K.C.S.Q. by CAPES (Brazil) and G.B. by KU Leuven. The work of S.-M.F. is supported by Marie Curie CIG, FWO-Odysseusll, Concern Foundation, Bayer Healthcare Pharmaceuticals. The work of P.C. is supported by IUAP7/03, Methusalem funding (Flemish Government), FWO grants, Foundation Leducq Transatlantic Network (ARTEMIS), Foundation against Cancer, European Research Council (ERC) Advanced Research Grant (EU-ERC269073) and AXA Research grant S.Y.L. was supported by the Department of Defense CDMRP Visionary Postdoctoral Award (W81XWH-12-1-0466). Views and opinions of, and endorsements by, the authors do not reflect those of the US Army or the Department of Defense. The authors thank the MSU LC-MS Core.	Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Fendt SM, 2013, CANCER RES, V73, P4429, DOI 10.1158/0008-5472.CAN-13-0080; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Geudens I, 2010, ARTERIOSCL THROM VAS, V30, P1695, DOI 10.1161/ATVBAHA.110.203034; Henry TD, 2014, NAT REV CARDIOL, V11, P78, DOI 10.1038/nrcardio.2013.200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Korff T, 2004, EXP CELL RES, V297, P415, DOI 10.1016/j.yexcr.2004.03.043; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Thompson CB, 2014, EMBO J, V33, P1420, DOI 10.15252/embj.201488785; Vander Heiden MG, 2013, J CLIN INVEST, V123, P3648, DOI 10.1172/JCI72391; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350	35	355	361	5	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					192	U113		10.1038/nature14362	http://dx.doi.org/10.1038/nature14362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830893	Green Accepted			2022-12-24	WOS:000352454600032
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Innovation team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2015	350								h1749	10.1136/bmj.h1749	http://dx.doi.org/10.1136/bmj.h1749			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SR	25855656				2022-12-24	WOS:000352907500002
J	Jain, Y				Jain, Yogesh			PERSONAL VIEW India should screen all tuberculosis patients for drug resistant disease at diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Jan Swasthya Sahyog Peoples Hlth Support Grp, Bilaspur 495112, India		Jain, Y (corresponding author), Jan Swasthya Sahyog Peoples Hlth Support Grp, Village & PO Ganiyari, Bilaspur 495112, India.	yogeshjain.jssbilaspur@gmail.com						Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare, 2012, GUID PROGR MAN DRUG; Chang KC, 2011, THORAX, V66, P997, DOI 10.1136/thx.2010.148585; Denkinger CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084197; Farmer P., 1999, INFECT INEQUALITIES, P244; Government of India, 2018, GUIDELINES CLIN OPER; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Srivastava K., 2015, DNA; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, GLOB TUB REP 2014; World Health Organization, TUB COUNTR PROF IND; World Health Organization, TB DIAGN LAB STRENGT; World Health Organization, MAPS IND DIAGN NOT T; World Health Organization, GUID PROGR MAN DRUG, P11	14	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2015	350								h1235	10.1136/bmj.h1235	http://dx.doi.org/10.1136/bmj.h1235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NK	25805835				2022-12-24	WOS:000352028400002
J	Stupple, A				Stupple, Aaron			PERSONAL VIEW Training in communication skills should be integrated with mandatory resuscitation training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Stupple, A (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	astupple@gmail.com						Institute of Medicine, 2014, DYING IN AMERICA IMP	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2015	350								h1405	10.1136/bmj.h1405	http://dx.doi.org/10.1136/bmj.h1405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KV	25791831				2022-12-24	WOS:000351571400003
J	Chhatwal, J; Kanwal, F; Roberts, MS; Dunn, MA				Chhatwal, Jagpreet; Kanwal, Fasiha; Roberts, Mark S.; Dunn, Michael A.			Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							GENOTYPE 1 INFECTION; SUSTAINED VIROLOGICAL RESPONSE; QUALITY-OF-LIFE; PLUS RIBAVIRIN; CHRONIC HCV; HEPATOCELLULAR-CARCINOMA; INITIAL TREATMENT; NATIONAL-HEALTH; ALL-CAUSE; BOCEPREVIR	Background: Sofosbuvir and ledipasvir, which have recently been approved for treatment of chronic hepatitis C virus (HCV) infection, are more efficacious and safer than the old standard of care (oSOC) but are substantially more expensive. Whether and in which patients their improved efficacy justifies their increased cost is unclear. Objective: To evaluate the cost-effectiveness and budget impact of sofosbuvir and ledipasvir. Design: Microsimulat on model of the natural history of HCV infection. Data Sources: Published literature. Target Population: Treatment-naive and treatment-experienced HCV population defined on the basis of HCV genotype, age, and fibrosis distribution in the United States. Time Horizon: Lifetime. Perspective: Third-party payer. Intervention: Simulation of sofosbuvir-ledipasvir compared with the oSOC (interferon-based therapies). Outcome Measures: Quality-adjusted life-years (QALYs), incremental cost-effectiveness ratios (ICERs), and 5-year spending on antiviral drugs. Results of Base-Case Analysis: Sofosbuvir-based therapies added 0.56 (DALY relative to the oSOC at an ICER of $55 400 per additional OALY. The ICERs ranged from $9700 to $284 300 per QALY depending on the patient's status with respect to treatment history, HCV genotype, and presence of cirrhosis. At a willingness-to-pay threshold of $100 000 per (DALY, sofosbuvir-based therapies were cost-effective in 83% of treatment-naive and 81% of treatment-experienced patients. Compared with the oSOC, treating eligible HCV-infected persons in the United States with the new drugs would cost an additional $65 billion in the next 5 years, whereas the resulting cost offsets would be $16 billion. Results of Sensitivity Analysis: Results were sensitive to drug price, drug efficacy, and quality of life after successful treatment. Limitation: Data on real-world effectiveness of new antivirals are lacking. Conclusion: Treatment of HCV is cost-effective in most patients, but additional resources and value-based patient prioritization are needed to manage patients with HCV.	[Chhatwal, Jagpreet] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Unit 1444, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; [Kanwal, Fasiha] Houston Vet Affairs Hlth Serv Res & Dev Ctr Innov, Houston, TX 77021 USA; Michael E DeBakey VA Med Ctr, Houston, TX USA; [Roberts, Mark S.] Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Dunn, Michael A.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chhatwal, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Unit 1444, 1515 Holcombe Blvd, Houston, TX 77030 USA.	JChhatwal@mdanderson.org			National Institutes of Health; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000146]; Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety [CIN 13-413]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Institutes of Health.; This study was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number KL2TR000146. Dr. Kanwal was supported in part by the Veterans Affairs Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety (#CIN 13-413).	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society, 2014, REC TEST MAN TREAT H; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Bronowicki JP, 2012, J HEPATOL, V56, pS6, DOI 10.1016/S0168-8278(12)60025-7; Bureau of Labor Statistics, 2015, CONS PRIC IND ALL UR; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chambers JD, 2010, MED DECIS MAKING, V30, pE14, DOI 10.1177/0272989X10371134; Chhatwal J, 2013, VALUE HEALTH, V16, P973, DOI 10.1016/j.jval.2013.07.006; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Drenth JPH, 2013, NEW ENGL J MED, V368, P1931, DOI 10.1056/NEJMe1303818; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Ferrante SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-190; First Databank, 2014, DRUG PRIC POL; Frakt AB, 2012, HEALTH ECON, V21, P485, DOI 10.1002/hec.1733; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hagan LM, 2013, J VIRAL HEPATITIS, V20, P847, DOI 10.1111/jvh.12111; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Japsen B., 2014, FORBES; Kabiri M, 2014, ANN INTERN MED, V161, P170, DOI 10.7326/M14-0095; Kantarjian HM, 2013, J CLIN ONCOL, V31, P3600, DOI 10.1200/JCO.2013.49.1845; Kanwal F, 2014, CLIN GASTROENTEROL H, V12, P1381, DOI 10.1016/j.cgh.2014.02.031; Kelly RJ, 2014, J CLIN ONCOL, V32, P983, DOI 10.1200/JCO.2013.54.6002; Khuroo MS, 2004, ALIMENT PHARM THER, V20, P931, DOI 10.1111/j.1365-2036.2004.02208.x; Knox Richard., 2013, NATL PUBLIC RADIO; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058975; Martin AB, 2014, HEALTH AFFAIR, V33, P67, DOI 10.1377/hlthaff.2013.1254; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Neumann PJ, 2005, USING COST EFFECTIVE; Ngo-Metzger Q, 2013, ANN INTERN MED, V159, P364, DOI 10.7326/0003-4819-159-5-201309030-00675; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Ruane PJ, 2013, HEPATOLOGY, V58, p736A; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Silverman Ed, 2014, WALL STREET J; Stepanova M, 2011, HEPATOLOGY, V53, P737, DOI 10.1002/hep.24131; Sussman NL, 2014, CLIN GASTROENTEROL H, V12, P533, DOI 10.1016/j.cgh.2014.01.025; Talal AH, 2013, ALIMENT PHARM THER, V37, P473, DOI 10.1111/apt.12200; Terhune Chad, 2014, LOS ANGELES TIMES; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Tice JA, 2014, COMP CLIN EFFECTIVEN; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Wilson J, 2007, HEALTH TECHNOL ASSES, V11, P1; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; Younossi ZM, 2014, J HEPATOL, V60, P530, DOI 10.1016/j.jhep.2013.11.009; Zeuzem S, 2013, HEPATOLOGY, V58, p733A; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	70	267	274	3	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					397	U114		10.7326/M14-1336	http://dx.doi.org/10.7326/M14-1336			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775312	Green Accepted			2022-12-24	WOS:000351279600013
J	Nan, HM; Hutter, CM; Lin, Y; Jacobs, EJ; Ulrich, CM; White, E; Baron, JA; Berndt, SI; Brenner, H; Butterbach, K; Caan, BJ; Campbell, PT; Carlson, CS; Casey, G; Chang-Claude, J; Chanock, SJ; Cotterchio, M; Duggan, D; Figueiredo, JC; Fuchs, CS; Giovannucci, EL; Gong, J; Haile, RW; Harrison, TA; Hayes, RB; Hoffmeister, M; Hopper, JL; Hudson, TJ; Jenkins, MA; Jiao, S; Lindor, NM; Lemire, M; Le Marchand, L; Newcomb, PA; Ogino, S; Pflugeisen, BM; Potter, JD; Qu, CH; Rosse, SA; Rudolph, A; Schoen, RE; Schumacher, FR; Seminara, D; Slattery, ML; Thibodeau, SN; Thomas, F; Thornquist, M; Warnick, GS; Zanke, BW; Gauderman, WJ; Peters, U; Hsu, L; Chan, AT				Nan, Hongmei; Hutter, Carolyn M.; Lin, Yi; Jacobs, Eric J.; Ulrich, Cornelia M.; White, Emily; Baron, John A.; Berndt, Sonja I.; Brenner, Hermann; Butterbach, Katja; Caan, Bette J.; Campbell, Peter T.; Carlson, Christopher S.; Casey, Graham; Chang-Claude, Jenny; Chanock, Stephen J.; Cotterchio, Michelle; Duggan, David; Figueiredo, Jane C.; Fuchs, Charles S.; Giovannucci, Edward L.; Gong, Jian; Haile, Robert W.; Harrison, Tabitha A.; Hayes, Richard B.; Hoffmeister, Michael; Hopper, John L.; Hudson, Thomas J.; Jenkins, Mark A.; Jiao, Shuo; Lindor, Noralane M.; Lemire, Mathieu; Le Marchand, Loic; Newcomb, Polly A.; Ogino, Shuji; Pflugeisen, Bethann M.; Potter, John D.; Qu, Conghui; Rosse, Stephanie A.; Rudolph, Anja; Schoen, Robert E.; Schumacher, Fredrick R.; Seminara, Daniela; Slattery, Martha L.; Thibodeau, Stephen N.; Thomas, Fridtjof; Thornquist, Mark; Warnick, Greg S.; Zanke, Brent W.; Gauderman, W. James; Peters, Ulrike; Hsu, Li; Chan, Andrew T.		CCFR; GECCO	Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN E-2 BIOSYNTHESIS; COLON-CANCER; PIK3CA MUTATION; METAANALYSIS; CYCLOOXYGENASE-2; CHEMOPREVENTION; INTERLEUKIN-16; POLYMORPHISMS	IMPORTANCE Use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with lower risk of colorectal cancer. OBJECTIVE To identify common genetic markers that may confer differential benefit from aspirin or NSAID chemoprevention, we tested gene x environment interactions between regular use of aspirin and/or NSAIDs and single-nucleotide polymorphisms (SNPs) in relation to risk of colorectal cancer. DESIGN, SETTING, AND PARTICIPANTS Case-control study using data from 5 case-control and 5 cohort studies initiated between 1976 and 2003 across the United States, Canada, Australia, and Germany and including colorectal cancer cases (n=8634) and matched controls (n=8553) ascertained between 1976 and 2011. Participants were all of European descent. EXPOSURES Genome-wide SNP data and information on regular use of aspirin and/or NSAIDs and other risk factors. MAIN OUTCOMES AND MEASURES Colorectal cancer. RESULTS Regular use of aspirin and/or NSAIDs was associated with lower risk of colorectal cancer (prevalence, 28% vs 38%; odds ratio [OR], 0.69 [95% Cl, 0.64-0.74]; P = 6.2 x 10(-28)) compared with nonregular use. In the conventional logistic regression analysis, the SNP rs2965667 at chromosome 12p12.3 near the MGST1 gene showed a genome-wide significant interaction with aspirin and/or NSAID use (P = 4.6 x 10(-9) for interaction). Aspirin and/or NSAID use was associated with a lower risk of colorectal cancer among individuals with rs2965667-TT genotype (prevalence, 28% vs 38%; OR, 0.66 [95% CI, 0.61-0.70]; P =7.7 x 10(-33)) but with a higher risk among those with rare (4%) TA or AA genotypes (prevalence, 35% vs 29%; OR, 1.89 [95% Cl, 1.27-2.81]; P = .002). In case-only interaction analysis, the SNP rs16973225 at chromosome 15q25.2 near the IL16 gene showed a genome-wide significant interaction with use of aspirin and/or NSAIDs (P = 8.2 x 10(-9) for interaction). Regular use was associated with a lower risk of colorectal cancer among individuals with rs16973225-AA genotype (prevalence, 28% vs 38%; OR, 0.66 [95% CI, 0.62-0.71]; P = 1.9 x 10(-30)) but was not associated with risk of colorectal cancer among those with less common (9%) AC or CC genotypes (prevalence, 36% vs 39%; OR, 0.97 [95% Cl, 0.78-1.20]; P = .76). CONCLUSIONS AND RELEVANCE In this genome-wide investigation of gene x environment interactions, use of aspirin and/or NSAIDs was associated with lower risk of colorectal cancer, and this association differed according to genetic variation at 2 SNPs at chromosomes 12 and 15. Validation of these findings in additional populations may facilitate targeted colorectal cancer prevention strategies.	[Nan, Hongmei] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA; [Nan, Hongmei] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Hutter, Carolyn M.; Seminara, Daniela] NHGRI, NIH, Bethesda, MD 20892 USA; [Lin, Yi; Ulrich, Cornelia M.; White, Emily; Carlson, Christopher S.; Gong, Jian; Harrison, Tabitha A.; Jiao, Shuo; Newcomb, Polly A.; Pflugeisen, Bethann M.; Potter, John D.; Qu, Conghui; Rosse, Stephanie A.; Thornquist, Mark; Warnick, Greg S.; Peters, Ulrike; Hsu, Li] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Jacobs, Eric J.; Campbell, Peter T.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Ulrich, Cornelia M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [White, Emily; Peters, Ulrike] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Baron, John A.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Berndt, Sonja I.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Brenner, Hermann; Butterbach, Katja; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Consortium DKTK, Heidelberg, Germany; [Caan, Bette J.] Kaiser Permanente Med Care Program No Calif, Div Res, Oakland, CA USA; [Casey, Graham; Figueiredo, Jane C.; Haile, Robert W.; Schumacher, Fredrick R.; Gauderman, W. James] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Cotterchio, Michelle] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Duggan, David] Translat Genom Res Inst TGen, Genet Basis Human Dis Div, Phoenix, AZ USA; [Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Giovannucci, Edward L.; Chan, Andrew T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Div Network Med, Boston, MA 02115 USA; [Hayes, Richard B.] NYU, Sch Med, Dept Populat Hlth, Div Epidemiol, New York, NY USA; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Hudson, Thomas J.; Lemire, Mathieu] Ontario Inst Canc Res, Toronto, ON, Canada; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Thibodeau, Stephen N.] Mayo Clin, Dept Med Genet, Rochester, MN USA; [Thomas, Fridtjof] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Div Biostat & Epidemiol, Memphis, TN 38163 USA; [Zanke, Brent W.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Hsu, Li] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Chan, Andrew T.] Harvard Univ, Sch Med, Boston, MA USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fred Hutchinson Cancer Center; American Cancer Society; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Kaiser Permanente; University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Care Ontario; Translational Genomics Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; New York University; University of Melbourne; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Mayo Clinic; Mayo Clinic Phoenix; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Massey University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Mayo Clinic; Mayo Clinic; University of Tennessee System; University of Tennessee Health Science Center; University of Ottawa; Ottawa Hospital Research Institute; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hsu, L (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave North,M2-B500, Seattle, WA 98109 USA.	lih@fredhutch.org; achan@mgh.harvard.edu	Jenkins, Mark/P-7803-2015; Hoffmeister, Michael/AAB-2321-2022; Umar, Asad/AAI-4560-2020; Hoffmeister, Michael/B-5745-2012; Brenner, Hermann/B-4627-2017; Hoffmeister, Michael/T-7187-2019; Schumacher, Fredrick/R-6043-2019; Brenner, Hermann/ABE-6383-2020; Berndt, Sonja I/J-8423-2016	Jenkins, Mark/0000-0002-8964-6160; Hoffmeister, Michael/0000-0002-8307-3197; Umar, Asad/0000-0002-6239-8494; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Schumacher, Fredrick/0000-0002-3073-7463; Brenner, Hermann/0000-0002-6129-1572; Thomas, Fridtjof/0000-0003-1325-4870; Potter, John/0000-0001-5439-1500; Harrison, Tabitha/0000-0002-4173-7530; Cotterchio, Michelle/0000-0003-2862-7895; Ogino, Shuji/0000-0002-3909-2323; Hayes, Richard/0000-0002-0918-661X; Caan, Bette/0000-0002-5803-310X	National Cancer Institute (NCI), National Institutes of Health (NIH), US Department of Health and Human Services [U01 CA137088, RO1 CA059045]; NIH [RFA CA-95-011, R01 CA48998, P01 CA 055075, UM1 CA167552, R01137178, R01 CA137178, P01 CA 087969, RO1 CA151993, P50 CA 127003, U01 CA074783, R01 CA076366, K05 CA154337]; NCI, NIH [U01 CA122839]; NIH: Australasian Colorectal Cancer Family Registry [U01 CA097735]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; Seattle Colorectal Cancer Family Registry [U01 CA074794]; German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704163, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; Ontario Research Fund [GL2]; Canadian Institutes of Health Research; Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research through Ontario Ministry of Research and Innovation; Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, NCI, NIH, Department of Health and Human Services; National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services [HHSN268201100046C, HH5N268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C];  [K24 DK098311]; NATIONAL CANCER INSTITUTE [P30CA015083, UM1CA167551, U01CA074794, R01CA151993, P01CA087969, U01CA074783, R01CA059045, R01CA076366, U01CA097735, U01CA137088, P30CA071789, U01CA122839, U01CA164930, P50CA127003, K05CA154337, U24CA097735, R01CA137178, U24CA074783, P01CA053996, UM1CA167552, P01CA055075, R01CA048998, U24CA074794, K22CA095011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH), US Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH: Australasian Colorectal Cancer Family Registry; Ontario Registry for Studies of Familial Colorectal Cancer; Seattle Colorectal Cancer Family Registry; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research through Ontario Ministry of Research and Innovation; Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, NCI, NIH, Department of Health and Human Services; National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GECCO (Genetics and Epidemiology of Colorectal Cancer Consortium) was supported by the National Cancer Institute (NCI), National Institutes of Health (NIH), US Department of Health and Human Services (U01 CA137088; RO1 CA059045). CCFR (Colon Cancer Family Registry) was supported by the NIH (RFA CA-95-011) and through cooperative agreements with members of the Colon Cancer Family Registry and prinicipal investigators. This genome wide scan was supported by the NCI, NIH, by U01 CA122839. The following Colon CFR centers contributed data to this manuscript and were supported by NIH: Australasian Colorectal Cancer Family Registry (U01 CA097735), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), and Seattle Colorectal Cancer Family Registry (U01 CA074794). DACHS (Darmkrebs: Chancen der Verhutung durch Screening Study) is supported by the German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704163, BR 1704/6-4 and CH 117/1-1) and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS (Diet, Activity and Lifestyle Study) is suported by the NIH (R01 CA48998 to Dr Slattery). HPFS (Health Professionals Follow-up Study) is supported by the NIH (P01 CA 055075, UM1 CA167552, R01137178, RO1 CA151993, and P50 CA 127003) and the NHS (Nurses Health Study) by the NIH (R01 CA137178, P01 CA 087969, RO1 CA151993, and P50 CA 127003). Dr Chan is also supported by K24 DK098311 and is a Damon Runyon Clinical Investigator. OFCCR (Ontario Familial Colorectal Cancer Registry) is supported by the NIH through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783) (see CCFR section above). As subset of ARCTIC, OFCCR is supported by a GL2 grant from the Ontario Research Fund, the Canadian Institutes of Health Research, and the Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute. Dr Hudson and Dr Zanke are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. PLCO (Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, NCI, NIH, Department of Health and Human Services. PMH-CCFR (Postmenopausal Hormone Study-Colon Cancer Family Registry) is suported by the NIH (R01 CA076366 to Dr Newcomb). VITAL (VITamins And Lifestyle) is supported by the NIH (K05 CA154337). WHI (Women's Health Initiative) is supported by the National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services, through contracts HHSN268201100046C, HH5N268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C.	Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Azimzadeh P, 2011, J GASTROINTEST LIVER, V20, P371; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; Castellone MD, 2006, CANCER RES, V66, P11085, DOI 10.1158/0008-5472.CAN-06-2233; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757, DOI 10.1002/jlb.67.6.757; Dihlmann S, 2001, ONCOGENE, V20, P645, DOI 10.1038/sj.onc.1204123; Domingo E, 2013, J CLIN ONCOL, V31, P4297, DOI 10.1200/JCO.2013.50.0322; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7; Gala MK, 2015, CLIN CANCER RES, V21, P1543, DOI 10.1158/1078-0432.CCR-14-0877; Gerhard R, 2011, N-S ARCH PHARMACOL, V383, P285, DOI 10.1007/s00210-010-0592-8; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; Kamei D, 2003, J BIOL CHEM, V278, P19396, DOI 10.1074/jbc.M213290200; Kaur J, 2010, TUMOR BIOL, V31, P623, DOI 10.1007/s13277-010-0078-9; Klampfer L, 2011, CURR CANCER DRUG TAR, V11, P451, DOI 10.2174/156800911795538066; Kwon YJ, 2012, J THORAC ONCOL, V7, P20, DOI 10.1097/JTO.0b013e3182307f62; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Makar KW, 2013, CANCER CAUSE CONTROL, V24, P2059, DOI 10.1007/s10552-013-0282-1; Morgenstern R, 2011, DRUG METAB REV, V43, P300, DOI 10.3109/03602532.2011.558511; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakanishi M, 2010, BIOCHIMIE, V92, P660, DOI 10.1016/j.biochi.2010.02.006; Nan H, 2013, JNCI-J NATL CANCER I, V105, P1852, DOI 10.1093/jnci/djt331; Pearce CL, 2013, CANCER EPIDEM BIOMAR, V22, P880, DOI 10.1158/1055-9965.EPI-12-1030-T; Pfeiffer RM, 2009, STAT SCI, V24, P547, DOI 10.1214/09-STS286; Prage EB, 2011, BIOCHEMISTRY-US, V50, P7684, DOI 10.1021/bi2010448; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P376, DOI 10.1097/00001648-200007000-00003; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seufert BL, 2013, CARCINOGENESIS, V34, P79, DOI 10.1093/carcin/bgs296; Sherratt PJ, 2003, BIOCHEM PHARMACOL, V66, P51, DOI 10.1016/S0006-2952(03)00206-5; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007	40	132	136	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1133	1142		10.1001/jama.2015.1815	http://dx.doi.org/10.1001/jama.2015.1815			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781442	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000351102500015
J	Ricci, MA; Manzo, C; Garcia-Parajo, MF; Lakadamyali, M; Cosma, MP				Aurelia Ricci, Maria; Manzo, Carlo; Filomena Garcia-Parajo, Maria; Lakadamyali, Melike; Pia Cosma, Maria			Chromatin Fibers Are Formed by Heterogeneous Groups of Nucleosomes In Vivo	CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; GENE-REGULATION; HISTONE; STATE; TCF3; TRANSCRIPTION; PLURIPOTENCY; DETERMINANTS; CHROMOSOMES	Nucleosomes help structure chromosomes by compacting DNA into fibers. To gain insight into how nucleosomes are arranged in vivo, we combined quantitative super-resolution nanoscopy with computer simulations to visualize and count nucleosomes along the chromatin fiber in single nuclei. Nucleosomes assembled in heterogeneous groups of varying sizes, here termed "clutches,'' and these were interspersed with nucleosome-depleted regions. The median number of nucleosomes inside clutches and their compaction defined as nucleosome density were cell-type-specific. Ground-state pluripotent stem cells had, on average, less dense clutches containing fewer nucleosomes and clutch size strongly correlated with the pluripotency potential of induced pluripotent stem cells. RNA polymerase II preferentially associated with the smallest clutches while linker histone H1 and heterochromatin were enriched in the largest ones. Our results reveal how the chromatin fiber is formed at nanoscale level and link chromatin fiber architecture to stem cell state.	[Aurelia Ricci, Maria; Pia Cosma, Maria] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Aurelia Ricci, Maria; Pia Cosma, Maria] UPF, Barcelona 08003, Spain; [Manzo, Carlo; Filomena Garcia-Parajo, Maria; Lakadamyali, Melike] ICFO, Inst Ciencies Foton, Barcelona 08860, Spain; [Filomena Garcia-Parajo, Maria; Pia Cosma, Maria] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA	Lakadamyali, M (corresponding author), ICFO, Inst Ciencies Foton, Mediterranean Technol Pk, Barcelona 08860, Spain.	melike.lakadamyali@icfo.es; pia.cosma@crg.es	Manzo, Carlo/B-9745-2012; Cosma, Maria Pia/E-8731-2015; Garcia-Parajo, Maria F./I-4610-2015	Manzo, Carlo/0000-0002-8625-0996; Cosma, Maria Pia/0000-0003-4207-5097; Garcia-Parajo, Maria F./0000-0001-6618-3944	Fundacio Cellex Barcelona; System's Microscopy Network of Excellence consortium [FP-7-HEALTH.2010.2.1.2.2]; European Union under the European Research Council [337191-MOTOS, 242630-RERE]; Human Frontier Science Program (HFSP);  [MAT2011-22887]; ICREA Funding Source: Custom	Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission); System's Microscopy Network of Excellence consortium; European Union under the European Research Council; Human Frontier Science Program (HFSP)(Human Frontier Science Program); ; ICREA(ICREA)	We thank A. Skoultchi (Albert Einstein College of Medicine), S. Grigoryev (Penn State Hershey Cancer Institute), T. Misgeld (TUM, Munich), X. Zhuang (Harvard University) and J. Ries (European Molecular Biology Laboratory [EMBL], Heidelberg) for providing reagents and cell lines, B. Huang (University of California, San Francisco [UCSF]) for Insight3 STORM analysis software, L. Batlle Morera (Center for Genomic Regulation [CRG], Barcelona) for helping in hiPSC generation, J. Font Mateu (CRG, Barcelona) for technical suggestions on in vitro polynucleosome, F. Sottile (CRG, Barcelona) for cloning the H2B-mEos2 plasmid. We thank M. Beato, C. di Vona, G. Filion, T. Graf, B. Lehner, M. Marti-Renom, M. Mendoza, J. Sharpe, J. Solon and J. Valcarcel (CRG, Barcelona), E. Meshorer (Hebrew University of Jerusalem), A. Oddone and J. Otterstrom (Institute of Photonic Sciences [ICFO], Barcelona), and X. Zhuang (Harvard University) for critical reading of the manuscript and helpful discussions. We acknowledge the ICFO Super-resolution Light Nanoscopy (SLN) facility, the ICFO Nikon Center of Excellence in STORM, the CRG microscopy facility and the EMBL electron microscopy core facility. We thank E. Sahagun Alonso (Scixel) and A. Hirschmann (ICFO) for help with the graphical abstract. The research leading to these results was supported in part by the Fundacio Cellex Barcelona (M. L.), the System's Microscopy Network of Excellence consortium (call identifier FP-7-HEALTH.2010.2.1.2.2 to M. L.), by the European Union Seventh Framework Programme under the European Research Council grants 337191-MOTOS to M. L. and 242630-RERE to M.P.C., a Human Frontier Science Program (HFSP) grant (M.P.C.), and MAT2011-22887 (M.F.G.-P). This article reflects only the author's views and the Union is not liable for any use that may be made of the information contained therein.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Bohn M, 2010, BIOPHYS J, V99, P1358, DOI 10.1016/j.bpj.2010.05.043; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Durisic N, 2014, CURR OPIN CHEM BIOL, V20, P22, DOI 10.1016/j.cbpa.2014.04.005; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lluis F, 2013, CELL MOL LIFE SCI, V70, P1413, DOI 10.1007/s00018-012-1137-8; Lluis F, 2011, P NATL ACAD SCI USA, V108, P11912, DOI 10.1073/pnas.1017402108; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; Meister P, 2013, CURR OPIN GENET DEV, V23, P96, DOI 10.1016/j.gde.2012.12.001; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Wendt KS, 2014, CURR OPIN GENET DEV, V25, P62, DOI 10.1016/j.gde.2013.11.020; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	41	365	374	4	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1145	1158		10.1016/j.cell.2015.01.054	http://dx.doi.org/10.1016/j.cell.2015.01.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768910	Green Published, Bronze			2022-12-24	WOS:000351951800014
J	Blythe, SA; Wieschaus, EF				Blythe, Shelby A.; Wieschaus, Eric F.			Zygotic Genome Activation Triggers the DNA Replication Checkpoint at the Midblastula Transition	CELL			English	Article							RNA-POLYMERASE-II; EARLY DROSOPHILA EMBRYO; CELL-CYCLE PROGRAM; DEVELOPMENTAL CONTROL; GAGA FACTOR; BINDING; TRANSCRIPTION; NUCLEAR; GENES; ONSET	A conserved feature of the midblastula transition (MBT) is a requirement for a functional DNA replication checkpoint to coordinate cell-cycle remodeling and zygotic genome activation (ZGA). We have investigated what triggers this checkpoint during Drosophila embryogenesis. We find that the magnitude of the checkpoint scales with the quantity of transcriptionally engaged DNA. Measuring RNA polymerase II (Pol II) binding at 20 min intervals over the course of ZGA reveals that the checkpoint coincides with widespread de novo recruitment of Pol II that precedes and does not require a functional checkpoint. This recruitment drives slowing or stalling of DNA replication at transcriptionally engaged loci. Reducing Pol II recruitment in zelda mutants both reduces replication stalling and bypasses the requirement for a functional checkpoint. This suggests a model where the checkpoint functions as a feedback mechanism to remodel the cell cycle in response to nascent ZGA.	[Blythe, Shelby A.; Wieschaus, Eric F.] Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University	Wieschaus, EF (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.	efw@princeton.edu		Blythe, Shelby/0000-0003-4986-2579	National Institute of Child Health and Human Development (NICHD) [5R37HD15587]; Ruth Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship from NICHD [1F32HD072653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587, F32HD072653] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ruth Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship from NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the Bloomington Drosophila Stock Center for fly stocks. We thank C. Hannon, A. Roknabadi, and B. Pelham-Webb for help with experiments, all members of the E.F.W. and Schupbach laboratories, especially S. Little and B. He for lively discussion. We thank R. Kadzik, P. Klein, T. Schupbach, J. Lieb, M. Harrison, J. Zeitlinger, T. Orr-Weaver, W. Sullivan, and P. O'Farrell for helpful comments and C. Rushlow, P. Schedl, and J. Sekelsky for fly stocks. We are indebted to the staff of the Sequencing Core Facility of the Lewis Sigler Institute and to L. Parsons for support for the ChIP-seq studies. We thank S. Di Talia for comments on the manuscript. This work was supported in part by grant 5R37HD15587 from the National Institute of Child Health and Human Development (NICHD) to E.F.W. and Ruth Kirschstein National Research Service Award (NRSA) Postdoctoral Fellowship 1F32HD072653 from NICHD to S.A.B. E.F.W. is an investigator with the Howard Hughes Medical Institute.	Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Benoit B, 2009, DEVELOPMENT, V136, P923, DOI 10.1242/dev.031815; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bhat KM, 1996, DEVELOPMENT, V122, P1113; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Chen K, 2013, ELIFE, V2, DOI 10.7554/eLife.00861; Collart C, 2013, SCIENCE, V341, P893, DOI 10.1126/science.1241530; Conn CW, 2004, DEV CELL, V7, P275, DOI 10.1016/j.devcel.2004.07.003; Crest J, 2007, GENETICS, V175, P567, DOI 10.1534/genetics.106.065219; Di Talia S, 2013, CURR BIOL, V23, P127, DOI 10.1016/j.cub.2012.11.029; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Farrell JA, 2013, CURR BIOL, V23, P118, DOI 10.1016/j.cub.2012.11.036; Farrell JA, 2012, GENE DEV, V26, P714, DOI 10.1101/gad.186429.111; Fasulo B, 2012, MOL BIOL CELL, V23, P1047, DOI 10.1091/mbc.E11-10-0832; FOE VE, 1983, J CELL SCI, V61, P31; FOGARTY P, 1994, DEVELOPMENT, V120, P2131; Fujimoto M, 2012, MOL CELL, V48, P182, DOI 10.1016/j.molcel.2012.07.026; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Ji JY, 2004, DEVELOPMENT, V131, P401, DOI 10.1242/dev.00944; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaRocque JR, 2007, GENETICS, V176, P1441, DOI 10.1534/genetics.107.073635; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li BY, 1996, MOL CELL BIOL, V16, P5433; Li XY, 2014, ELIFE, V3, DOI 10.7554/eLife.03737; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perez-Montero S, 2013, DEV CELL, V26, P578, DOI 10.1016/j.devcel.2013.08.011; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sung HW, 2013, CURR BIOL, V23, P133, DOI 10.1016/j.cub.2012.12.013; Tadros W, 2003, GENETICS, V164, P989; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	104	104	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1169	1181		10.1016/j.cell.2015.01.050	http://dx.doi.org/10.1016/j.cell.2015.01.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25748651	Green Accepted, Bronze			2022-12-24	WOS:000351951800016
J	Luna, JM; Scheel, TKH; Danino, T; Shaw, KS; Mele, A; Fak, JJ; Nishiuchi, E; Takacs, CN; Catanese, MT; de Jong, YP; Jacobson, IM; Rice, CM; Darnell, RB				Luna, Joseph M.; Scheel, Troels K. H.; Danino, Tal; Shaw, Katharina S.; Mele, Aldo; Fak, John J.; Nishiuchi, Eiko; Takacs, Constantin N.; Catanese, Maria Teresa; de Jong, Ype P.; Jacobson, Ira M.; Rice, Charles M.; Darnell, Robert B.			Hepatitis C Virus RNA Functionally Sequesters miR-122	CELL			English	Article							SINGLE-NUCLEOTIDE RESOLUTION; HITS-CLIP; CERNA HYPOTHESIS; BINDING PROTEIN; MICRORNA; IDENTIFICATION; ARGONAUTE; INFECTION; GENES; SITES	Hepatitis C virus (HCV) uniquely requires the liver-specific microRNA-122 for replication, yet global effects on endogenous miRNA targets during infection are unexplored. Here, high-throughput sequencing and crosslinking immunoprecipitation (HITS-CLIP) experiments of human Argonaute (AGO) during HCV infection showed robust AGO binding on the HCV 5'UTR at known and predicted miR-122 sites. On the human transcriptome, we observed reduced AGO binding and functional mRNA de-repression of miR-122 targets during virus infection. This miR-122 "sponge'' effect was relieved and redirected to miR-15 targets by swapping the miRNA tropism of the virus. Single-cell expression data from reporters containing miR-122 sites showed significant derepression during HCV infection depending on expression level and site number. We describe a quantitative mathematical model of HCV-induced miR-122 sequestration and propose that such miR-122 inhibition by HCV RNA may result in global derepression of host miR-122 targets, providing an environment fertile for the long-term oncogenic potential of HCV.	[Luna, Joseph M.; Scheel, Troels K. H.; Danino, Tal; Shaw, Katharina S.; Nishiuchi, Eiko; Takacs, Constantin N.; Catanese, Maria Teresa; de Jong, Ype P.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA; [Luna, Joseph M.; Mele, Aldo; Fak, John J.; Darnell, Robert B.] Rockefeller Univ, Lab Mol Neurooncol, New York, NY 10065 USA; [Luna, Joseph M.; Mele, Aldo; Fak, John J.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Scheel, Troels K. H.] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen Hepatitis C Program CO HEP, Hvidovre, Denmark; [Scheel, Troels K. H.] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Scheel, Troels K. H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen N, Denmark; [Danino, Tal] MIT, Hlth Sci & Technol, Cambridge, MA 02139 USA; [Takacs, Constantin N.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA; [de Jong, Ype P.; Jacobson, Ira M.] Weill Cornell Med Coll, Div Gastroenterol & Hepatol, Ctr Study Hepatitis C, New York, NY 10065 USA; [Darnell, Robert B.] New York Genome Ctr, New York, NY 10013 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Copenhagen; University of Copenhagen; University of Copenhagen; Massachusetts Institute of Technology (MIT); Rockefeller University; Cornell University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA.	ricec@rockefeller.edu; darnelr@rockefeller.edu	; Darnell, Robert/B-9022-2008	Luna, Joseph/0000-0003-2415-9203; Scheel, Troels/0000-0003-1545-4067; Darnell, Robert/0000-0002-5134-8088	Public Health Service; NIH, NIAID [AI099284, AI072613, AI075099, AI091707, AI090055]; NINDS [NS034389, NS081706]; Office of the Director through the NIH Roadmap for Medical Research [DK085713]; NCI [CA057973]; Rockefeller University Center for Clinical and Translational Science [UL1RR024143]; Center for Basic and Translational Research on Disorders of the Digestive System; Greenberg Medical Research Institute; Starr Foundation; David Rockefeller Graduate Student Fellowship; Danish Council for Independent Research; HHMI International Predoctoral Fellowship; Rockefeller University Women and Science Fellowship; Novo Nordisk Fonden [NNF12OC0002037, NNF14OC0012533] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091707, R01AI099284, R01AI072613, R01AI075099, R01AI090055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090576, R01DK085713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081706, R56NS034389, R01NS034389] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of the Director through the NIH Roadmap for Medical Research; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rockefeller University Center for Clinical and Translational Science; Center for Basic and Translational Research on Disorders of the Digestive System; Greenberg Medical Research Institute; Starr Foundation; David Rockefeller Graduate Student Fellowship; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); HHMI International Predoctoral Fellowship; Rockefeller University Women and Science Fellowship; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Zhang for bioinformatics support; M. Moore for flow cytometry assistance; the Rockefeller Genomics Resource Center; and M.E. Castillo, S.M. Pecoraro Di Vittorio, J. Palarca, J. Sable, B. Hough-Loomis, and J. Smith for excellent technical and administrative assistance. Lastly, we thank members of the Darnell and Rice labs for invaluable advice. This study was supported by grants from the Public Health Service, NIH, NIAID (AI099284, AI072613, AI075099, AI091707, AI090055), NINDS (NS034389, NS081706), Office of the Director through the NIH Roadmap for Medical Research (DK085713), NCI (CA057973), The Rockefeller University Center for Clinical and Translational Science (UL1RR024143), the Center for Basic and Translational Research on Disorders of the Digestive System through the generosity of the Leona M. and Harry B. Helmsley Charitable Trust, the Greenberg Medical Research Institute, and the Starr Foundation. J.M.L. was supported by a David Rockefeller Graduate Student Fellowship. T.K.H.S. was supported by a Postdoctoral Fellowship and a Sapere Aude Research Talent Award from The Danish Council for Independent Research. C.N.T. was supported by an HHMI International Predoctoral Fellowship. M.T.C. was supported by the Rockefeller University Women and Science Fellowship. R.B.D. is an investigator of the Howard Hughes Medical Institute.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Catanese MT, 2013, J VIROL, V87, P8282, DOI 10.1128/JVI.01102-13; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Horwitz JA, 2013, VIROLOGY, V439, P23, DOI [10.1016/j.virol.2013.01.019, 10.1016/j.virol.201]; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kandathil AJ, 2013, GASTROENTEROLOGY, V145, P1404, DOI 10.1053/j.gastro.2013.08.034; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lee S, 2013, CELL HOST MICROBE, V13, P678, DOI 10.1016/j.chom.2013.05.007; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Li YP, 2011, P NATL ACAD SCI USA, V108, P4991, DOI 10.1073/pnas.1016606108; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nasheri N, 2011, VIROLOGY, V410, P336, DOI 10.1016/j.virol.2010.11.015; Pal S, 2006, J VIROL, V80, P2280, DOI 10.1128/JVI.80.5.2280-2290.2006; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Saeed A, 2013, CLIN EXP IMMUNOL, V174, P265, DOI 10.1111/cei.12174; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007; Singaravelu R, 2014, CURR OPIN VIROL, V7, P1, DOI 10.1016/j.coviro.2014.03.004; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Yamane D, 2013, CURR TOP MICROBIOL, V369, P263, DOI 10.1007/978-3-642-27340-7_11; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263	44	240	243	3	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1099	1110		10.1016/j.cell.2015.02.025	http://dx.doi.org/10.1016/j.cell.2015.02.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768906	Bronze, Green Accepted			2022-12-24	WOS:000351951800010
J	Dumbreck, S; Flynn, A; Nairn, M; Wilson, M; Treweek, S; Mercer, SW; Alderson, P; Thompson, A; Payne, K; Guthrie, B				Dumbreck, Siobhan; Flynn, Angela; Nairn, Moray; Wilson, Martin; Treweek, Shaun; Mercer, Stewart W.; Alderson, Phil; Thompson, Alex; Payne, Katherine; Guthrie, Bruce			Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE; EVENTS; PEOPLE	OBJECTIVE To identify the number of drug-disease and drug-drug interactions for exemplar index conditions within National Institute of Health and Care Excellence (NICE) clinical guidelines. DESIGN Systematic identification, quantification, and classification of potentially serious drug-disease and drug-drug interactions for drugs recommended by NICE clinical guidelines for type 2 diabetes, heart failure, and depression in relation to 11 other common conditions and drugs recommended by NICE guidelines for those conditions. SETTING NICE clinical guidelines for type 2 diabetes, heart failure, and depression. MAIN OUTCOME MEASURES Potentially serious drug-disease and drug-drug interactions. RESULTS Following recommendations for prescription in 12 national clinical guidelines would result in several potentially serious drug interactions. There were 32 potentially serious drug-disease interactions between drugs recommended in the guideline for type 2 diabetes and the 11 other conditions compared with six for drugs recommended in the guideline for depression and 10 for drugs recommended in the guideline for heart failure. Of these drug-disease interactions, 27 (84%) in the type 2 diabetes guideline and all of those in the two other guidelines were between the recommended drug and chronic kidney disease. More potentially serious drug-drug interactions were identified between drugs recommended by guidelines for each of the three index conditions and drugs recommended by the guidelines for the 11 other conditions: 133 drug-drug interactions for drugs recommended in the type 2 diabetes guideline, 89 for depression, and 111 for heart failure. Few of these drug-disease or drug-drug interactions were highlighted in the guidelines for the three index conditions. CONCLUSIONS Drug-disease interactions were relatively uncommon with the exception of interactions when a patient also has chronic kidney disease. Guideline developers could consider a more systematic approach regarding the potential for drug-disease interactions, based on epidemiological knowledge of the comorbidities of people with the disease the guideline is focused on, and should particularly consider whether chronic kidney disease is common in the target population. In contrast, potentially serious drug-drug interactions between recommended drugs for different conditions were common. The extensive number of potentially serious interactions requires innovative interactive approaches to the production and dissemination of guidelines to allow clinicians and patients with multimorbidity to make informed decisions about drug selection.	[Dumbreck, Siobhan; Flynn, Angela; Guthrie, Bruce] Univ Dundee, Dundee DD2 4BF, Scotland; [Nairn, Moray] Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland, Edinburgh EH12 9EB, Midlothian, Scotland; [Wilson, Martin] Raigmore Hosp, Inverness IV2 3UJ, Scotland; [Treweek, Shaun] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Mercer, Stewart W.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 9LX, Lanark, Scotland; [Alderson, Phil] Natl Inst Hlth & Care Excellence, Ctr Clin Practice, Manchester M1 4BD, Lancs, England; [Thompson, Alex; Payne, Katherine] Univ Manchester, Manchester Ctr Hlth Econ, Manchester M13 9PL, Lancs, England	University of Dundee; University of Aberdeen; University of Glasgow; National Institute for Health & Care Excellence; University of Manchester	Guthrie, B (corresponding author), Univ Dundee, Mackenzie Bldg, Dundee DD2 4BF, Scotland.	B.Guthrie@dundee.ac.uk	Treweek, Shaun/AAE-8006-2019; Guthrie, Bruce/HHM-9696-2022; Payne, Katherine/AAJ-3728-2020	Treweek, Shaun/0000-0002-7239-7241; Payne, Katherine/0000-0002-3938-4350; Guthrie, Bruce/0000-0003-4191-4880; Nairn, Moray/0000-0001-6474-4410; Dumbreck, Siobhan/0000-0001-8300-096X; Thompson, Alexander/0000-0003-4930-5107; Mercer, Stewart William/0000-0002-1703-3664	National Institutes for Health Services and Delivery Research Programme [NIHR HSDR 11/2003/27]; National Institute for Health Research [11/2003/27] Funding Source: researchfish; Chief Scientist Office [HSRU2] Funding Source: researchfish	National Institutes for Health Services and Delivery Research Programme; National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The study was funded by the National Institutes for Health Services and Delivery Research Programme (NIHR HS&DR 11/2003/27). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HS&DR Programme, NIHR, NHS or the Department of Health. The funder had no role in study design, study conduct, or the decision to publish.	Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2013, BRIT NATL FORMULARY; [Anonymous], 2010, CHRON HEART FAIL MAN; [Anonymous], 2011, CLIN MAN PRIM HYP AD; [Anonymous], 2009, MAN RHEUM ARTHR AD; [Anonymous], 2009, TREATM MAN DEPR AD; [Anonymous], 2008, CAR MAN OST AD; [Anonymous], 2006, SUPP PEOPL DEM THEIR; [Anonymous], 2006, MAN ATR FIBR; [Anonymous], 2008, EARL ID MAN CHRON KI; [Anonymous], 2006, BIP DIS MAN BIP DIS; [Anonymous], 2010, MAN TYP 2 DIAB; [Anonymous], 2010, MAN CHRON OBSTR PULM; [Anonymous], 2007, SEC PREV PRIM SEC CA; [Anonymous], 2010, PHARM MAN NEUR PAIN; [Anonymous], 2011, AM BP TABL 10MG SUMM; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2014, J GEN INTERN MED, V29, P552, DOI 10.1007/s11606-013-2658-z; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Guthrie Bruce, 2011, BMJ, V342, pd3514, DOI 10.1136/bmj.d3514; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; House of Commons Health Committee, 2014, MAN CAR PEOPL LONG T, P222; Hovstadius Bo, 2010, BMC Clin Pharmacol, V10, P16, DOI 10.1186/1472-6904-10-16; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Lorgunpai SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089447; Marengoni A, 2014, EUR J INTERN MED, V25, P843, DOI 10.1016/j.ejim.2014.10.001; National Institute for Health and Care Excellence, 2009, DEPR AD CHRON PHYS H; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Pronovost PJ, 2013, JAMA-J AM MED ASSOC, V310, P2501, DOI 10.1001/jama.2013.281334; Ruscitto A, 2015, EUR J PAIN, V19, P59, DOI 10.1002/ejp.520; Schedlbauer A, 2009, J AM MED INFORM ASSN, V16, P531, DOI 10.1197/jamia.M2910; Tan K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5019; Uhlig K, 2014, J GEN INTERN MED, V29, P670, DOI 10.1007/s11606-013-2659-y; Van Spall H, 2007, JAMA-J AM MED ASSOC, V297, P8; Vandvik PO, 2013, CHEST, V144, P381, DOI 10.1378/chest.13-0746; Zhang Min, 2009, BMJ, V338, pa2752, DOI 10.1136/bmj.a2752	41	173	176	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2015	350								h949	10.1136/bmj.h949	http://dx.doi.org/10.1136/bmj.h949			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EL	25762567	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000351182200016
J	Gauderman, WJ; Urman, R; Avol, E; Berhane, K; McConnell, R; Rappaport, E; Chang, R; Lurmann, F; Gilliland, F				Gauderman, W. James; Urman, Robert; Avol, Edward; Berhane, Kiros; McConnell, Rob; Rappaport, Edward; Chang, Roger; Lurmann, Fred; Gilliland, Frank			Association of Improved Air Quality with Lung Development in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTHERN CALIFORNIA COMMUNITIES; PULMONARY-FUNCTION; FUNCTION GROWTH; DIFFERING LEVELS; FOLLOW-UP; POLLUTION; MORTALITY; RISK; POPULATION; DECLINE	BACKGROUND Air-pollution levels have been trending downward progressively over the past several decades in southern California, as a result of the implementation of air quality-control policies. We assessed whether long-term reductions in pollution were associated with improvements in respiratory health among children. METHODS As part of the Children's Health Study, we measured lung function annually in 2120 children from three separate cohorts corresponding to three separate calendar periods: 1994-1998, 1997-2001, and 2007-2011. Mean ages of the children within each cohort were 11 years at the beginning of the period and 15 years at the end. Linear-regression models were used to examine the relationship between declining pollution levels over time and lung-function development from 11 to 15 years of age, measured as the increases in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) during that period (referred to as 4-year growth in FEV1 and FVC). RESULTS Over the 13 years spanned by the three cohorts, improvements in 4-year growth of both FEV1 and FVC were associated with declining levels of nitrogen dioxide (P<0.001 for FEV1 and FVC) and of particulate matter with an aerodynamic diameter of less than 2.5 mu m (P = 0.008 for FEV1 and P<0.001 for FVC) and less than 10 mu m (P<0.001 for FEV1 and FVC). These associations persisted after adjustment for several potential confounders. Significant improvements in lung-function development were observed in both boys and girls and in children with asthma and children without asthma. The proportions of children with clinically low FEV1 (defined as <80% of the predicted value) at 15 years of age declined significantly, from 7.9% to 6.3% to 3.6% across the three periods, as the air quality improved (P = 0.001). CONCLUSIONS We found that long-term improvements in air quality were associated with statistically and clinically significant positive effects on lung-function growth in children. (Funded by the Health Effects Institute and others.)	[Gauderman, W. James; Urman, Robert; Avol, Edward; Berhane, Kiros; McConnell, Rob; Rappaport, Edward; Chang, Roger; Gilliland, Frank] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90032 USA; [Lurmann, Fred] Sonoma Technol, Petaluma, CA USA	University of Southern California	Gauderman, WJ (corresponding author), Univ So Calif, Dept Prevent Med, 2001 Soto St,202-K, Los Angeles, CA 90032 USA.	jimg@usc.edu			Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011627, P30ES007048, R03ES022719, R21ES024844] Funding Source: NIH RePORTER	Health Effects Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the Health Effects Institute and others.	ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; BURROWS B, 1983, CHEST, V83, P717, DOI 10.1378/chest.83.5.717; Department of Commerce Economics and Statistics Administration U.S. Census Bureau, 2012, CAL 2010 SUMM POP HO; FRIEDMAN GD, 1976, NEW ENGL J MED, V294, P1071, DOI 10.1056/NEJM197605132942001; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021; Gehring U, 2013, ENVIRON HEALTH PERSP, V121, P1357, DOI 10.1289/ehp.1306770; Georgiopoulou VV, 2011, AM J MED, V124, P334, DOI 10.1016/j.amjmed.2010.12.006; Gotschi T, 2008, INT J EPIDEMIOL, V37, P1349, DOI 10.1093/ije/dyn136; Hole DJ, 1996, BRIT MED J, V313, P711; Islam T, 2007, THORAX, V62, P957, DOI 10.1136/thx.2007.078964; KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X; Knuiman MW, 1999, ANN EPIDEMIOL, V9, P297, DOI 10.1016/S1047-2797(98)00066-0; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lepeule J, 2014, AM J RESP CRIT CARE, V190, P542, DOI 10.1164/rccm.201402-0350OC; Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; McDonald BC, 2012, J GEOPHYS RES-ATMOS, V117, DOI [10.1029/2012JD018304, 10.1029/2011JD016715]; Mckean MC, 2001, EUR RESPIR J, V18, P23, DOI 10.1183/09031936.01.00073101; Molter A, 2013, ENVIRON HEALTH PERSP, V121, P1232, DOI 10.1289/ehp.1205961; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Peters JM, 1999, AM J RESP CRIT CARE, V159, P768, DOI 10.1164/ajrccm.159.3.9804144; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Ryan G, 1999, J EPIDEMIOL COMMUN H, V53, P230, DOI 10.1136/jech.53.4.230; Sarder SB, 2005, J GEOPHYS RES-ATMOS, V110, P1; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Tager IB, 1999, AM J RESP CRIT CARE, V160, P387; U. S. Census Bureau, 2000, PROF GEN DEM CHAR; Urman R, 2014, THORAX, V69, P540, DOI 10.1136/thoraxjnl-2012-203159; WANG XB, 1993, AM REV RESPIR DIS, V148, P1502, DOI 10.1164/ajrccm/148.6_Pt_1.1502	34	396	411	2	137	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					905	913		10.1056/NEJMoa1414123	http://dx.doi.org/10.1056/NEJMoa1414123			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC4EU	25738666	Green Accepted			2022-12-24	WOS:000350304500006
J	Bartesaghi, A; Merk, A; Banerjee, S; Matthies, D; Wu, XW; Milne, JLS; Subramaniam, S				Bartesaghi, Alberto; Merk, Alan; Banerjee, Soojay; Matthies, Doreen; Wu, Xiongwu; Milne, Jacqueline L. S.; Subramaniam, Sriram			2.2 angstrom resolution cryo-EM structure of beta-galactosidase in complex with a cell-permeant inhibitor	SCIENCE			English	Article							ATOMIC MODEL; SUBUNIT; MICROSCOPY; MECHANISM; RIBOSOME; REVEALS; VIRUS	Cryo-electron microscopy (cryo-EM) is rapidly emerging as a powerful tool for protein structure determination at high resolution. Here we report the structure of a complex between Escherichia coli beta-galactosidase and the cell-permeant inhibitor phenylethyl beta-D-thiogalactopyranoside (PETG), determined by cryo-EM at an average resolution of similar to 2.2 angstroms (angstrom). Besides the PETG ligand, we identified densities in the map for similar to 800 water molecules and for magnesium and sodium ions. Although it is likely that continued advances in detector technology may further enhance resolution, our findings demonstrate that preparation of specimens of adequate quality and intrinsic protein flexibility, rather than imaging or image-processing technologies, now represent the major bottlenecks to routinely achieving resolutions close to 2 angstrom using single-particle cryo-EM.	[Bartesaghi, Alberto; Merk, Alan; Banerjee, Soojay; Matthies, Doreen; Milne, Jacqueline L. S.; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wu, Xiongwu] NHLBI, Lab Computat Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	ss1@nih.gov		Subramaniam, Sriram/0000-0003-4231-4115; Matthies, Doreen/0000-0001-9221-4484	NIH, Center for Cancer Research, National Cancer Institute; Intramural AIDS Targeted Antiviral Program; NATIONAL CANCER INSTITUTE [ZIABC010826, ZIABC010824, ZIABC010412] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001027] Funding Source: NIH RePORTER	NIH, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by funds from the Intramural Research Program of the NIH, Center for Cancer Research, National Cancer Institute, and the Intramural AIDS Targeted Antiviral Program. We thank R. Mueller and J. Cometa for technical assistance with electron microscopy, P. Mooney and F. Ulmer for advice and assistance with optimizing detector performance, K. Podolsky for assistance with data collection, J.-J. Fernandez for providing the code to run the TOMOCTFFIND program, and V. Falconieri for assistance in preparation of the figures and the supplementary movie. This study used the high-performance computational capabilities of the Biowulf Linux cluster at NIH (http://biowulf.nih.gov). The density map and refined atomic model have been deposited with the Electron Microscopy Data Bank (accession number EMD-2984) and the Protein Data Bank (entry code 5a1a), respectively.	Agard D., 2014, ADV IMAG ELECT PHYS, P113; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Campbell MG, 2015, ELIFE, V4, DOI 10.7554/eLife.06380; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008; Guo F, 2014, P NATL ACAD SCI USA, V111, pE4606, DOI 10.1073/pnas.1407020111; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Jiang JS, 2015, NATURE, V521, P545, DOI 10.1038/nature14247; Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Yu XK, 2011, STRUCTURE, V19, P652, DOI 10.1016/j.str.2011.03.003; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	25	340	347	1	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1147	1151		10.1126/science.aab1576	http://dx.doi.org/10.1126/science.aab1576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25953817	Green Accepted			2022-12-24	WOS:000355590500051
J	Lee, ASY; Kranzusch, PJ; Cate, JHD				Lee, Amy S. Y.; Kranzusch, Philip J.; Cate, Jamie H. D.			eIF3 targets cell-proliferation messenger RNAs for translational activation or repression	NATURE			English	Article							C-JUN; PREINITIATION COMPLEX; VIRAL TRANSLATION; BINDING PROTEIN; PAR-CLIP; INITIATION; SITES; IDENTIFICATION; TRANSFORMATION; SPECIFICITY	Regulation of protein synthesis is fundamental for all aspects of eukaryotic biology by controlling development, homeostasis and stress responses(1,2). The 13-subunit, 800-kilodalton eukaryotic initiation factor 3 (eIF3) organizes initiation factor and ribosome interactions required for productive translation(3). However, current understanding of eIF3 function does not explain genetic evidence correlating eIF3 deregulation with tissue-specific cancers and developmental defects(4). Here we report the genome-wide discovery of human transcripts that interact with eIF3 using photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP)(5). eIF3 binds to a highly specific program of messenger RNAs involved in cell growth control processes, including cell cycling, differentiation and apoptosis, via them RNA 5' untranslated region. Surprisingly, functional analysis of the interaction between eIF3 and two mRNAs encoding the cell proliferation regulators c-JUN and BTG1 reveals that eIF3 uses different modes of RNA stem-loop binding to exert either translational activation or repression. Our findings illuminate a new role for eIF3 in governing a specialized repertoire of gene expression and suggest that binding of eIF3 to specific mRNAs could be targeted to control carcinogenesis.	[Lee, Amy S. Y.; Kranzusch, Philip J.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lee, Amy S. Y.; Cate, Jamie H. D.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Kranzusch, Philip J.] Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jcate@lbl.gov			National Institutes of Health (NIH) [S10RR029668, S10RR027303]; NIH [S10RR025622]; National Institute of General Medical Sciences Center for RNA Systems Biology; American Cancer Society [PF-14-108-01-RMC]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303, S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences Center for RNA Systems Biology; American Cancer Society(American Cancer Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Doudna, D. Ruggero, D. Black, M. Truitt, A. Tambe, Y. Bai and K. Chat for discussions. HeLa cytoplasm was a gift from J. Fang. This work used the Vincent J. Coates Genomics Sequencing Laboratory at University of California, Berkeley, supported by National Institutes of Health (NIH) S10 Instrumentation Grants S10RR029668 and S10RR027303; and the Vincent J. Proteomics/Mass Spectrometry Laboratory at University of California, Berkeley, supported in part by NIH S10 Instrumentation Grant S10RR025622. This work was funded by the National Institute of General Medical Sciences Center for RNA Systems Biology (A.S.Y.L. and J.H.D.C.). A.S.Y.L is supported as an American Cancer Society Postdoctoral Fellow (PF-14-108-01-RMC) and P.J.K. is supported as a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation.	Andaya A, 2014, INT J MOL SCI, V15, P11523, DOI 10.3390/ijms150711523; Bai Y, 2013, NUCLEIC ACIDS RES, V41, P7861, DOI 10.1093/nar/gkt543; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Blau L, 2012, P NATL ACAD SCI USA, V109, pE2875, DOI 10.1073/pnas.1203659109; Carlsten JOP, 2013, TRENDS BIOCHEM SCI, V38, P531, DOI 10.1016/j.tibs.2013.08.007; Choudhuri A, 2013, P NATL ACAD SCI USA, V110, P9818, DOI 10.1073/pnas.1302934110; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hershey JWB, 2010, BRAZ J MED BIOL RES, V43, P920, DOI 10.1590/S0100-879X2010001000002; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rakotondrafara AM, 2011, NAT PROTOC, V6, P563, DOI 10.1038/nprot.2011.314; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	42	231	241	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					111	U292		10.1038/nature14267	http://dx.doi.org/10.1038/nature14267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25849773	Green Accepted			2022-12-24	WOS:000355543400040
J	Goodarzi, H; Liu, XH; Nguyen, HCB; Zhang, S; Fish, L; Tavazoie, SF				Goodarzi, Hani; Liu, Xuhang; Nguyen, Hoang C. B.; Zhang, Steven; Fish, Lisa; Tavazoie, Sohail F.			Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement	CELL			English	Article							TARGETING HYPOXIA; YB-1; METASTASIS; BIOGENESIS; SURVIVAL; THERAPY; CLIP	Upon exposure to stress, tRNAs are enzymatically cleaved, yielding distinct classes of tRNA-derived fragments (tRFs), yielding distinct classes of tRFs. We identify a novel class of tRFs derived from tRNA(Glu), tRNA(Asp), tRNA(Gly), and tRNA(Tyr) that, upon induction, suppress the stability of multiple oncogenic transcripts in breast cancer cells by displacing their 30 untranslated regions (UTRs) from the RNA-binding protein YBX1. This mode of post-transcriptional silencing is sequence specific, as these fragments all share a common motif that matches the YBX1 recognition sequence. Loss-of-function and gain-of-function studies, using anti-sense locked-nucleic acids (LNAs) and synthetic RNA mimetics, respectively, revealed that these fragments suppress growth under serum-starvation, cancer cell invasion, and metastasis by breast cancer cells. Highly metastatic cells evade this tumor-suppressive pathway by attenuating the induction of these tRFs. Our findings reveal a tumor-suppressive role for specific tRNA-derived fragments and describe a molecular mechanism for their action. This transcript displacement-based mechanism may generalize to other tRNA, ribosomal-RNA, and sno-RNA fragments.	[Goodarzi, Hani; Liu, Xuhang; Nguyen, Hoang C. B.; Zhang, Steven; Fish, Lisa; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA	Rockefeller University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu		Goodarzi, Hani/0000-0002-9648-8949; Fish, Lisa/0000-0001-9184-0512; Bui Nguyen, Hoang/0000-0001-6975-3084	Ruth L. Kirschstein National Research Service Award from the NIH [T32CA009673-36A1]; Department of Defense; NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award from the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Saeed Tavazoie, Claudio Alarcon, and Alexander Nguyen for their thoughtful comments on this manuscript. We thank Nora Pencheva for insightful discussions on YBX1. We thank C. Zhao, W. Zhang, C. Lai, and S. Dewell of the Rockefeller Genomics Resource Center for assistance with next-generation RNA sequencing and microarray profiling. We also thank H. Molina at Rockefeller Proteomics Resource Center. H.G. was previously supported by an Anderson Cancer Center Fellowship and is currently the recipient of a Ruth L. Kirschstein National Research Service Award from the NIH (T32CA009673-36A1). S.F.T. is a Department of Defense Era of Hope Scholar and a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient.	BOREK E, 1977, CANCER RES, V37, P3362; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jurchott K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001231; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lasham A, 2012, JNCI-J NATL CANCER I, V104, P133, DOI 10.1093/jnci/djr512; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Matsumoto Ken, 2005, J Mol Genet Med, V1, P11; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moyer MW, 2012, NAT MED, V18, P636, DOI 10.1038/nm0512-636b; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; SPEER J, 1979, CANCER, V44, P2120, DOI 10.1002/1097-0142(197912)44:6<2120::AID-CNCR2820440623>3.0.CO;2-6; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu Y, 2012, J SURG ONCOL, V105, P724, DOI 10.1002/jso.23030; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	27	442	471	8	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					790	802		10.1016/j.cell.2015.02.053	http://dx.doi.org/10.1016/j.cell.2015.02.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957686	Bronze, Green Accepted			2022-12-24	WOS:000354175200013
J	Pefanis, E; Wang, JG; Rothschild, G; Lim, J; Kazadi, D; Sun, JB; Federation, A; Chao, J; Elliott, O; Liu, ZP; Economides, AN; Bradner, JE; Rabadan, R; Basu, U				Pefanis, Evangelos; Wang, Jiguang; Rothschild, Gerson; Lim, Junghyun; Kazadi, David; Sun, Jianbo; Federation, Alexander; Chao, Jaime; Elliott, Oliver; Liu, Zhi-Ping; Economides, Aris N.; Bradner, James E.; Rabadan, Raul; Basu, Uttiya			RNA Exosome-Regulated Long Non-Coding RNA Transcription Controls Super-Enhancer Activity	CELL			English	Article							POLYMERASE-II; DIVERGENT TRANSCRIPTION; SEQUENCING REVEALS; CELL IDENTITY; TARGETS AID; TERMINATION; CHROMATIN; ACCUMULATION; GENERATION; INITIATION	We have ablated the cellular RNA degradation machinery in differentiated B cells and pluripotent embryonic stem cells (ESCs) by conditional mutagenesis of core (Exosc3) and nuclear RNase (Exosc10) components of RNA exosome and identified a vast number of long non-coding RNAs (lncRNAs) and enhancer RNAs (eRNAs) with emergent functionality. Unexpectedly, eRNA-expressing regions accumulate R-loop structures upon RNA exosome ablation, thus demonstrating the role of RNA exosome in resolving deleterious DNA/RNA hybrids arising from active enhancers. We have uncovered a distal divergent eRNA-expressing element (lncRNA-CSR) engaged in long-range DNA interactions and regulating IgH 30 regulatory region super-enhancer function. CRISPR-Cas9-mediated ablation of lncRNA-CSR transcription decreases its chromosomal looping-mediated association with the IgH 30 regulatory region super-enhancer and leads to decreased class switch recombination efficiency. We propose that the RNA exosome protects divergently transcribed lncRNA expressing enhancers by resolving deleterious transcription-coupled secondary DNA structures, while also regulating long-range super-enhancer chromosomal interactions important for cellular function.	[Pefanis, Evangelos; Rothschild, Gerson; Lim, Junghyun; Kazadi, David; Sun, Jianbo; Chao, Jaime; Basu, Uttiya] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Wang, Jiguang; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA; [Wang, Jiguang; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Syst Biol, New York, NY 10032 USA; [Liu, Zhi-Ping] Shandong Univ, Sch Control Sci & Engn, Dept Biomed Engn, Jinan 250061, Shandong, Peoples R China; [Pefanis, Evangelos; Economides, Aris N.] Regeneron Pharmaceut & Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Federation, Alexander; Bradner, James E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Federation, Alexander; Bradner, James E.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Columbia University; Columbia University; Columbia University; Shandong University; Regeneron; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Rabadan, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA.	rr2579@cumc.columbia.edu; ub2121@cumc.columbia.edu	Rabadan, Raul/AAZ-7367-2020; Sun, Jianbo/E-2316-2013; Lim, Junghyun/AAX-3678-2021; Sun, Jianbo/ACQ-1702-2022; Liu, Zhi-Ping/C-9846-2010; Wang, Jiguang/B-2717-2012	Sun, Jianbo/0000-0001-8153-1847; Lim, Junghyun/0000-0002-5292-7487; Sun, Jianbo/0000-0001-8153-1847; Liu, Zhi-Ping/0000-0001-7742-9161; Rabadan, Raul/0000-0001-7946-9255; Federation, Alexander/0000-0002-7771-1148; Wang, Jiguang/0000-0002-6923-4097; Economides, Aris/0000-0002-6508-8942; Kazadi, David/0000-0001-5117-2900	NIH [1DP2OD008651-01, 1R01CA185486-01, 1R01CA179044-01A1, 1U54CA121852-05, F31AI098411-01A1]; NIAID [1R01AI099195-01A1]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA185486, R01CA179044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099195, F31AI098411] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008651] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Christopher Lima (MSKCC, New York), Frederic Chedin (University of California, Davis), Saul Silverstein, Stephen Goff, Sankar Ghosh, Lorraine Symington, and members of the Basu lab for critical input and reagents. We thank Olivier Courrone of Columbia University genome center for RNA sequencing and Victor Lin of Herbert Irving Cancer Center Transgenic facility for targeting and generation of Exosc3<SUP>COIN</SUP> and Exosc10<SUP>COIN</SUP> allele ESCs and mouse models. This work was supported by grants from NIH (1DP2OD008651-01) and NIAID (1R01AI099195-01A1) to U.B.; NIH (1R01CA185486-01; 1R01CA179044-01A1; 1U54CA121852-05) to R.R.; and F31AI098411-01A1 to D.K. U.B. is a scholar of the Irma Hirschl Charitable Trust and the Leukemia and Lymphoma Society.	Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; Birshtein BK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00163; Bonasio R, 2014, ANNU REV GENET, V48, P433, DOI 10.1146/annurev-genet-120213-092323; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Colin J, 2014, MOL CELL, V56, P667, DOI 10.1016/j.molcel.2014.10.026; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Flynn RA, 2012, CURR OPIN GENET DEV, V22, P172, DOI 10.1016/j.gde.2011.11.002; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hazelbaker DZ, 2013, MOL CELL, V49, P55, DOI 10.1016/j.molcel.2012.10.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Januszyk K, 2010, ADV EXP MED BIOL, V702, P9, DOI 10.1007/978-1-4419-7841-7_2; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lemay JF, 2014, NAT STRUCT MOL BIOL, V21, P919, DOI 10.1038/nsmb.2893; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Manfrini N, 2015, EMBO REP, V16, P221, DOI 10.15252/embr.201439458; Marin-Vicente C, 2015, J CELL SCI, V128, P1097, DOI 10.1242/jcs.158733; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schaeffer D, 2011, P NATL ACAD SCI USA, V108, P2366, DOI 10.1073/pnas.1013180108; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shah S, 2014, GENE DEV, V28, P231, DOI 10.1101/gad.230177.113; Shin JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003411; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Sun JB, 2013, TRANSCR-AUSTIN, V4, P127, DOI 10.4161/trns.24556; Sun JB, 2013, GENE DEV, V27, P1821, DOI 10.1101/gad.210211.112; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006	58	284	297	6	176	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					774	789		10.1016/j.cell.2015.04.034	http://dx.doi.org/10.1016/j.cell.2015.04.034			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957685	Green Accepted, Bronze			2022-12-24	WOS:000354175200012
J	Chen, S; Itoh, Y; Masuda, T; Shimizu, S; Zhao, J; Ma, J; Nakamura, S; Okuro, K; Noguchi, H; Uosaki, K; Aida, T				Chen, Shuo; Itoh, Yoshimitsu; Masuda, Takuya; Shimizu, Seishi; Zhao, Jun; Ma, Jing; Nakamura, Shugo; Okuro, Kou; Noguchi, Hidenori; Uosaki, Kohei; Aida, Takuzo			Subnanoscale hydrophobic modulation of salt bridges in aqueous media	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; AIR/WATER INTERFACE; WATER; SURFACE; FLUORESCENCE; VOLTAGE; ENERGY; FORCE; PH	Polar interactions such as electrostatic forces and hydrogen bonds play an essential role in biological molecular recognition. On a protein surface, polar interactions occur mostly in a hydrophobic environment because nonpolar amino acid residues cover similar to 75% of the protein surface. We report that ionic interactions on a hydrophobic surface are modulated by their subnanoscale distance to the surface. We developed a series of ionic head groups-appended self-assembled monolayers with C2, C6, C8, and C12 space-filling alkyl chains, which capture a dendritic guest via the formation of multiple salt bridges. The guest release upon protonolysis is progressively suppressed when its distance from the background hydrophobe changes from 1.2 (C2) to 0.2 (C12) nanometers, with an increase in salt bridge strength of similar to 3.9 kilocalories per mole.	[Chen, Shuo; Itoh, Yoshimitsu; Okuro, Kou; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Masuda, Takuya; Noguchi, Hidenori; Uosaki, Kohei] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan; [Shimizu, Seishi] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Zhao, Jun; Ma, Jing] Nanjing Univ, Sch Chem & Chem Engn, Collaborat Innovat Ctr Chem Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Nakamura, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Noguchi, Hidenori; Uosaki, Kohei] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Noguchi, Hidenori; Uosaki, Kohei] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0600810, Japan; [Aida, Takuzo] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	University of Tokyo; National Institute for Materials Science; University of York - UK; Nanjing University; University of Tokyo; National Institute for Materials Science; Hokkaido University; RIKEN	Itoh, Y (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	itoh@macro.t.u-tokyo.ac.jp; aida@macro.t.u-tokyo.ac.jp	Itoh, Yoshimitsu/G-8162-2012; Ma, Jing/K-3359-2013; Zhao, Jun/J-9087-2015; Masuda, Takuya/H-2540-2011; Aida, Takuzo/I-9117-2012; Uosaki, Kohei/A-8217-2008; NOGUCHI, Hidenori/H-2534-2011	Itoh, Yoshimitsu/0000-0002-8356-7605; Ma, Jing/0000-0001-5848-9775; Zhao, Jun/0000-0001-7118-4992; Uosaki, Kohei/0000-0001-8886-3270; NOGUCHI, Hidenori/0000-0001-9643-1689; Chen, Shuo/0000-0003-3581-0997; Okuro, Kou/0000-0003-0445-6358; Shimizu, Seishi/0000-0002-7853-1683	Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan; National Natural Science Foundation of China [21273102]	Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank N. Matubayashi from Division of Chemical Engineering, Graduate School of Engineering Science, Osaka University for valuable discussion. We also thank E. Silver for generous discussion. This work was supported by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). Y. I. acknowledges the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Grant-in-Aid for Young Scientists B. S.N. is partly supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan. K.U. and H.N. thank the World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics from MEXT, Japan. J.M. is supported by the National Natural Science Foundation of China (no. 21273102).	ALIVISATOS AP, 1987, J CHEM PHYS, V86, P6540, DOI 10.1063/1.452396; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Bard A. J., 2001, ELECTROCHEMICAL METH; Ben-Naim AY., 1992, STAT THERMODYNAMICS, V1st ed.; Burgess I, 2006, LANGMUIR, V22, P4420, DOI 10.1021/la052767g; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chorny I, 2005, J PHYS CHEM B, V109, P24056, DOI 10.1021/jp055043m; DIEHL H, 1985, TALANTA, V32, P159, DOI 10.1016/0039-9140(85)80049-7; DIETRICH B, 1979, HELV CHIM ACTA, V62, P2763, DOI 10.1002/hlca.19790620827; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Han Y, 2011, LANGMUIR, V27, P11951, DOI 10.1021/la2020995; Jungwirth P, 2006, CHEM REV, V106, P1259, DOI 10.1021/cr0403741; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Luo MX, 2012, J PHYS CHEM C, V116, P13964, DOI 10.1021/jp3020996; Ma CD, 2015, NATURE, V517, P347, DOI 10.1038/nature14018; MARTIN MM, 1975, J LUMIN, V10, P381, DOI 10.1016/0022-2313(75)90003-4; McArthur EA, 2004, J AM CHEM SOC, V126, P2260, DOI 10.1021/ja038062n; Morrow R, 2012, P ROY SOC A-MATH PHY, V468, P18, DOI 10.1098/rspa.2011.0323; Ng CCA, 2012, ANGEW CHEM INT EDIT, V51, P7706, DOI 10.1002/anie.201202118; Nihonyanagi S, 2011, J AM CHEM SOC, V133, P16875, DOI 10.1021/ja2053754; Onclin S, 2005, ANGEW CHEM INT EDIT, V44, P6282, DOI 10.1002/anie.200500633; Presiado I, 2011, J PHYS CHEM C, V115, P10245, DOI 10.1021/jp2008094; Rant U, 2007, P NATL ACAD SCI USA, V104, P17364, DOI 10.1073/pnas.0703974104; Schaefer M, 1996, J PHYS CHEM-US, V100, P1578, DOI 10.1021/jp9521621; SCHELLMAN JA, 1953, J PHYS CHEM-US, V57, P472, DOI 10.1021/j150505a020; Shen YR, 2006, CHEM REV, V106, P1140, DOI 10.1021/cr040377d; Snyder PW, 2014, EUR PHYS J-SPEC TOP, V223, P853, DOI 10.1140/epjst/e2013-01818-y; Teschke O, 2003, APPL PHYS LETT, V82, P1126, DOI 10.1063/1.1542945; Valtiner M, 2012, J AM CHEM SOC, V134, P1746, DOI 10.1021/ja209653n; Venkateshwaran V, 2014, P NATL ACAD SCI USA, V111, P8729, DOI 10.1073/pnas.1403294111; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Yeung CL, 2010, ADV FUNCT MATER, V20, P2657, DOI 10.1002/adfm.201000411	33	41	41	4	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					555	559		10.1126/science.aaa7532	http://dx.doi.org/10.1126/science.aaa7532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931555				2022-12-24	WOS:000353778100037
J	Cole, TJ				Cole, T. J.			Setting number of decimal places for reporting risk ratios: rule of four	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EFFICACY; THERAPY; SAFETY	The Summary statistics are often reported to too many or, less often, too few decimal places. The rule of four provides a simple framework to guide authors in the appropriate number of decimal places to use when reporting risk ratios	UCL Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England	University of London; University College London	Cole, TJ (corresponding author), UCL Inst Child Hlth, Populat Policy & Practice Programme, London WC1N 1EH, England.	tim.cole@ucl.ac.uk	Cole, Tim J/B-7883-2008	Cole, Tim J/0000-0001-5711-8200	Medical Research Council [MR/M012069/1]; MRC [MR/M012069/1, MR/J004839/1] Funding Source: UKRI; Medical Research Council [MR/J004839/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	TJC is funded by Medical Research Council grant no MR/M012069/1.	Altman DG, 1996, BRIT MED J, V312, P572, DOI 10.1136/bmj.312.7030.572; American Psychological Association, 2020, PUBL MAN AM PSYCH AS, V7th; Banzi R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5856; Barone-Adesi F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5414; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d195; Bowen A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4407; Cochrane Collaboration, 2010, COCHR STYL GUID; Cole TJ, 2015, ARCH DIS CHILD; Esmail A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5662; European Association of Science Editors, 2014, EASE GUID AUTH TRANS; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Gerstman BB, 2000, DATA ANAL EPI INFO; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Hopkins WG, 2011, SCAND J MED SCI SPOR, V21, P867, DOI 10.1111/j.1600-0838.2011.01393.x; Lang TA, 2013, SCI EDITORS HDB; Llor C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5762; Nielsen SF, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5244	17	19	19	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2015	350								h1845	10.1136/bmj.h1845	http://dx.doi.org/10.1136/bmj.h1845			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UB	25918351	Green Published, hybrid			2022-12-24	WOS:000353954800002
J	Paulsen, CE; Armache, JP; Gao, Y; Cheng, YF; Julius, D				Paulsen, Candice E.; Armache, Jean-Paul; Gao, Yuan; Cheng, Yifan; Julius, David			Structure of the TRPA1 ion channel suggests regulatory mechanisms	NATURE			English	Article							RECEPTOR POTENTIAL A1; MOLECULAR DETERMINANTS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ACTIVATION; PROTEIN; COLD; PAIN; IDENTIFICATION; VISUALIZATION	The TRPA1 ion channel (also known as the wasabi receptor) is a detector of noxious chemical agents encountered in our environment or produced endogenously during tissue injury or drug metabolism. These include a broad class of electrophiles that activate the channel through covalent protein modification. TRPA1 antagonists hold potential for treating neurogenic inflammatory conditions provoked or exacerbated by irritant exposure. Despite compelling reasons to understand TRPA1 function, structural mechanisms underlying channel regulation remain obscure. Here we use single-particle electron cryomicroscopy to determine the structure of full-length human TRPA1 to similar to 4 angstrom resolution in the presence of pharmacophores, including a potent antagonist. Several unexpected features are revealed, including an extensive coiled-coil assembly domain stabilized by polyphosphate co-factors and a highly integrated nexus that converges on an unpredicted transient receptor potential (TRP)-like allosteric domain. These findings provide new insights into the mechanisms of TRPA1 regulation, and establish a blueprint for structure-based design of analgesic and anti-inflammatory agents.	[Paulsen, Candice E.; Gao, Yuan; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Armache, Jean-Paul; Gao, Yuan; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, Keck Adv Microscopy Lab, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	ycheng@ucsf.edu; david.julius@ucsf.edu	Armache, Jean-Paul/U-3113-2019	Armache, Jean-Paul/0000-0001-9195-2282; Gao, Yuan/0000-0003-1248-1828; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01NS055299, R01GM098672]; UCSF Program for Breakthrough Biomedical Research; UCSF CVRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672, T32GM008284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; UCSF CVRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Liao for initial electron microscopy analysis of vampire bat TRPA1, and S. Wu and M. Zhao for help with refining the atomic model. This work was supported by grants from the National Institutes of Health (R01NS055299 to D.J. and R01GM098672 to Y.C.) and the UCSF Program for Breakthrough Biomedical Research (Y.C.). C.E.P. was supported by a T32 Postdoctoral Training Grant from the UCSF CVRI, and is currently a HHMI Fellow of the Helen Hay Whitney Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Andrade EL, 2012, PHARMACOL THERAPEUT, V133, P189, DOI 10.1016/j.pharmthera.2011.10.008; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Banzawa N, 2014, J BIOL CHEM, V289, P31927, DOI 10.1074/jbc.M114.586891; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen J, 2008, J NEUROSCI, V28, P5063, DOI 10.1523/JNEUROSCI.0047-08.2008; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Klement G, 2013, BIOPHYS J, V104, P798, DOI 10.1016/j.bpj.2013.01.008; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McGaraughty S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-14; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Nakatsuka K, 2013, J MOL NEUROSCI, V51, P754, DOI 10.1007/s12031-013-0060-2; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Penczek P, 1999, J STRUCT BIOL, V128, P44, DOI 10.1006/jsbi.1999.4157; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohacs T, 2014, HANDB EXP PHARMACOL, V223, P1143, DOI 10.1007/978-3-319-05161-1_18; Samad A, 2011, BIOCHEM J, V433, P197, DOI 10.1042/BJ20101256; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zayats V, 2013, J MOL MODEL, V19, P4689, DOI 10.1007/s00894-012-1505-1; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002	72	418	428	7	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					511	+		10.1038/nature14367	http://dx.doi.org/10.1038/nature14367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25855297	Green Accepted, Green Submitted			2022-12-24	WOS:000353334500036
J	Greber, BJ; Bieri, P; Leibundgut, M; Leitner, A; Aebersold, R; Boehringer, D; Ban, N				Greber, Basil J.; Bieri, Philipp; Leibundgut, Marc; Leitner, Alexander; Aebersold, Ruedi; Boehringer, Daniel; Ban, Nenad			The complete structure of the 55S mammalian mitochondrial ribosome	SCIENCE			English	Article							MESSENGER-RNAS; PROTEINS; SUBUNIT; IDENTIFICATION; MUTATION; ANTIBIOTICS; OTOTOXICITY; APOPTOSIS; INSIGHTS; SITES	Mammalian mitochondrial ribosomes (mitoribosomes) synthesize mitochondrially encoded membrane proteins that are critical for mitochondrial function. Here we present the complete atomic structure of the porcine 55S mitoribosome at 3.8 angstrom resolution by cryo-electron microscopy and chemical cross-linking/mass spectrometry. The structure of the 28S subunit in the complex was resolved at 3.6 angstrom resolution by focused alignment, which allowed building of a detailed atomic structure including all of its 15 mitoribosomal-specific proteins. The structure reveals the intersubunit contacts in the 55S mitoribosome, the molecular architecture of the mitoribosomal messenger RNA (mRNA) binding channel and its interaction with transfer RNAs, and provides insight into the highly specialized mechanism of mRNA recruitment to the 28S subunit. Furthermore, the structure contributes to a mechanistic understanding of aminoglycoside ototoxicity.	[Greber, Basil J.; Bieri, Philipp; Leibundgut, Marc; Boehringer, Daniel; Ban, Nenad] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Leitner, Alexander; Aebersold, Ruedi] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Ban, N (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Otto Stern Weg 5, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Leitner, Alexander/U-1601-2019	Leitner, Alexander/0000-0003-4126-0725; Greber, Basil/0000-0001-9379-7159; Bieri, Philipp/0000-0001-9031-2945	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) Structural Biology and RNA & Disease programs of the SNSF; European Research Council under the European Community [250071]; Commission of the European Communities through the PROSPECTS consortium (European Union) [201648, 233226]; European Research Council [ERC-2008-AdG 233226]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) Structural Biology and RNA & Disease programs of the SNSF; European Research Council under the European Community(European Research Council (ERC)); Commission of the European Communities through the PROSPECTS consortium (European Union); European Research Council(European Research Council (ERC)European Commission)	EM data were collected at the ScopeM facility of ETH Zurich. We thank P. Tittmann (ScopeM) for support and J. Erzberger for discussions. This work was supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology and RNA & Disease programs of the SNSF, European Research Council grant 250071 under the European Community's Seventh Framework Programme (to N.B.), the Commission of the European Communities through the PROSPECTS consortium (European Union FP7 projects 201648 and 233226) (R.A.), and the European Research Council (grant ERC-2008-AdG 233226) (R.A.). The 3.6 angstrom cryo-EM map of the 28S mitoribosomal subunit and the 3.8 angstrom cryo-EM map of the 55S mitoribosome have been deposited at the Electron Microscopy Data Bank (EMDB) with accession codes EMD-2913 and EMD-2914. Coordinates of the refined 28S subunit and the 55S mitoribosome in the canonical state have been deposited in the Protein Data Bank (PDB) with PDB codes 5AJ3 (28S) and 5AJ4 (55S). A PyMol script for display of the 55S mitoribosome is available from the Ban Lab website (www.mol.biol.ethz.ch/groups/ban_group/). ETH Zurich has filed a patent application to use the coordinates of the porcine mitoribosome structure for development of compounds that can (i) specifically interfere with mitochondrial translation by binding to mitoribosomes or (ii) specifically inhibit translation in pathogenic organisms without interfering with mitoribosomes.	Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; Desmond E, 2011, RES MICROBIOL, V162, P53, DOI 10.1016/j.resmic.2010.10.004; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Filipovska A, 2013, RNA BIOL, V10, P1426, DOI 10.4161/rna.24769; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Haque ME, 2008, MITOCHONDRION, V8, P254, DOI 10.1016/j.mito.2008.04.004; Jones CN, 2008, RNA, V14, P862, DOI 10.1261/rna.909208; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Longen S, 2014, DEV CELL, V28, P30, DOI 10.1016/j.devcel.2013.11.007; Matt T, 2012, P NATL ACAD SCI USA, V109, P10984, DOI 10.1073/pnas.1204073109; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Miller JL, 2008, PROTEIN SCI, V17, P251, DOI 10.1110/ps.073185608; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; OBRIEN TW, 1971, J BIOL CHEM, V246, P3409; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Rotig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	40	261	268	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					303	308		10.1126/science.aaa3872	http://dx.doi.org/10.1126/science.aaa3872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25837512	Green Submitted			2022-12-24	WOS:000352999000035
J	Price, WN; Rai, AK				Price, W. Nicholson, II; Rai, Arti K.			Are trade secrets delaying biosimilars?	SCIENCE			English	Editorial Material									[Price, W. Nicholson, II] Univ New Hampshire, Sch Law, Concord, NH 03301 USA; [Rai, Arti K.] Duke Law Sch, Durham, NC 27705 USA	University System Of New Hampshire; University of New Hampshire; Duke University	Price, WN (corresponding author), Univ New Hampshire, Sch Law, Concord, NH 03301 USA.	nicholson.price@law.unh.edu; rai@law.duke.edu		Price, Nicholson/0000-0003-0729-290X				Falit BP, 2015, HEALTH AFFAIR, V34, P294, DOI 10.1377/hlthaff.2014.0482; Grabowski HG, 2014, HEALTH AFFAIR, V33, P1048, DOI 10.1377/hlthaff.2013.0862; IMS Institute for Healthcare Informatics, 2012, GLOB US MED OUTL 201; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; McCamish M., 2015, GLOBAL HLTH BIOPHARM; McCamish M, 2012, CLIN PHARMACOL THER, V91, P405, DOI 10.1038/clpt.2011.343; Ozturk S., 2005, CELL CULTURE TECHNOL; Sharma B, 2007, BIOTECHNOL ADV, V25, P325, DOI 10.1016/j.biotechadv.2007.01.007; Tavernise Sabrina, 2015, NY TIMES, V20; Teece D.J., 1998, EC PERFORMANCE THEOR; U. S. Food and Drug Administration, 2012, SCI CONS DEM BIOS RE; U. S. Food and Drug Administration, 2012, QUAL CONS DEM BIOS R	12	22	22	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					188	189		10.1126/science.aab1684	http://dx.doi.org/10.1126/science.aab1684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859034				2022-12-24	WOS:000352613700026
J	Villanueva, GL; Mumma, MJ; Novak, RE; Kaufl, HU; Hartogh, P; Encrenaz, T; Tokunaga, A; Khayat, A; Smith, MD				Villanueva, G. L.; Mumma, M. J.; Novak, R. E.; Kaeufl, H. U.; Hartogh, P.; Encrenaz, T.; Tokunaga, A.; Khayat, A.; Smith, M. D.			Strong water isotopic anomalies in the martian atmosphere: Probing current and ancient reservoirs	SCIENCE			English	Article							ANNUAL CYCLE; MARS; DEUTERIUM; EVOLUTION; HYDROGEN; VAPOR; SURFACE; H2O; HDO	We measured maps of atmospheric water (H2O) and its deuterated form (HDO) across the martian globe, showing strong isotopic anomalies and a significant high deuterium/hydrogen (D/H) enrichment indicative of great water loss. The maps sample the evolution of sublimation from the north polar cap, revealing that the released water has a representative D/H value enriched by a factor of about 7 relative to Earth's ocean [Vienna standard mean ocean water (VSMOW)]. Certain basins and orographic depressions show even higher enrichment, whereas high-altitude regions show much lower values (1 to 3 VSMOW). Our atmospheric maps indicate that water ice in the polar reservoirs is enriched in deuterium to at least 8 VSMOW, which would mean that early Mars (4.5 billion years ago) had a global equivalent water layer at least 137 meters deep.	[Villanueva, G. L.; Mumma, M. J.; Smith, M. D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Villanueva, G. L.] Catholic Univ Amer, Washington, DC 20064 USA; [Novak, R. E.] Iona Coll, New Rochelle, NY 10801 USA; [Kaeufl, H. U.] European So Observ, Munich, Germany; [Hartogh, P.] Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; [Encrenaz, T.] Observ Paris, F-92195 Meudon, France; [Tokunaga, A.; Khayat, A.] Univ Hawaii Manoa, Honolulu, HI 96822 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Catholic University of America; Iona College; European Southern Observatory; Max Planck Society; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Hawaii System; University of Hawaii Manoa	Villanueva, GL (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	geronimo.villanueva@nasa.gov	mumma, michael j/I-2764-2013	mumma, michael j/0000-0003-4627-750X; Tokunaga, Alan/0000-0001-8136-9704	NASA's Planetary Astronomy Program [08 PAST08 0034, RTOP 344 32 07]; NASA's Planetary Atmospheres Program [08 PATM08 0031]; NASA's Astrobiology Program [RTOP 344 53 51]; NSF Research in Undergraduate Institutions [AST 0805540]; NASA Keck PI Data Award	NASA's Planetary Astronomy Program(National Aeronautics & Space Administration (NASA)); NASA's Planetary Atmospheres Program(National Aeronautics & Space Administration (NASA)); NASA's Astrobiology Program(National Aeronautics & Space Administration (NASA)); NSF Research in Undergraduate Institutions(National Science Foundation (NSF)); NASA Keck PI Data Award	We thank the staff of the Very Large Telescope (runs 83.C-0538 and 92.C-0436), the NASA InfraRed Telescope Facility, and the W. M. Keck Observatory for their exceptional support throughout our long Mars observing Programs. G.L.V. acknowledges support from NASA's Planetary Astronomy Program (08 PAST08 0034) and NASA's Planetary Atmospheres Program (08 PATM08 0031). NASA's Planetary Astronomy Program (RTOP 344 32 07) and NASA's Astrobiology Program (RTOP 344 53 51) supported M.J.M. and G.L.V. NSF Research in Undergraduate Institutions supported R.E.N. through grant AST 0805540. This work was also supported by a NASA Keck PI Data Award. The authors recognize and acknowledge the very important cultural role and reverence that the summit of MaunaKea has always had within the indigenous Hawaiian community. We are most fortunate to have the opportunity to conduct observations from this mountain.	[Anonymous], [No title captured]; Aoki S., 2013, EUR PLAN SCI C 2013, P8; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bjoraker G. L., 1989, B AM ASTRON SOC, V21, P991; Boctor NZ, 2003, GEOCHIM COSMOCHIM AC, V67, P3971, DOI 10.1016/S0016-7037(03)00234-5; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Carr MH, 1999, J GEOPHYS RES-PLANET, V104, P21897, DOI 10.1029/1999JE001048; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; Fouchet T, 2007, ICARUS, V190, P32, DOI 10.1016/j.icarus.2007.03.003; Fouchet T, 2000, ICARUS, V144, P114, DOI 10.1006/icar.1999.6264; Fouchet T, 2011, PLANET SPACE SCI, V59, P683, DOI 10.1016/j.pss.2011.01.017; Greenwood JP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032721; Grotzinger JP, 2013, SCIENCE, V341, P1475, DOI 10.1126/science.1244258; JOUZEL J, 1984, J GEOPHYS RES-ATMOS, V89, P1749, DOI 10.1029/JD089iD07p11749; Krasnopolsky VA, 1998, SCIENCE, V280, P1576, DOI 10.1126/science.280.5369.1576; Kurokawa H, 2014, EARTH PLANET SC LETT, V394, P179, DOI 10.1016/j.epsl.2014.03.027; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Lasue J, 2013, SPACE SCI REV, V174, P155, DOI 10.1007/s11214-012-9946-5; Mahaffy PR, 2015, SCIENCE, V347, P412, DOI 10.1126/science.1260291; Montmessin F, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002357; Mouginot J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050286; Mumma M. J., 2003, 6 INT C MARS LUN PLA, P3186; Murray JB, 2005, NATURE, V434, P352, DOI 10.1038/nature03379; Novak RE, 2011, PLANET SPACE SCI, V59, P163, DOI 10.1016/j.pss.2010.06.017; Novak R. E., 2007, 7 INT C MARS PAS CA, P3283; Novak RE, 2002, ICARUS, V158, P14, DOI 10.1006/icar.2002.6863; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; Page DP, 2009, ICARUS, V203, P376, DOI 10.1016/j.icarus.2009.05.012; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001522; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; Tschimmel A, 2008, ICARUS, V195, P557, DOI 10.1016/j.icarus.2008.01.018; Usui T., 2012, 43 LUN PLAN SCI C WO, P1341; Villanueva GL, 2013, ICARUS, V223, P11, DOI 10.1016/j.icarus.2012.11.013; Villanueva GL, 2012, J QUANT SPECTROSC RA, V113, P202, DOI 10.1016/j.jqsrt.2011.11.001; Villanueva G. L., 2008, MARS ATMOSPHERE MODE, P9101; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Zuber MT, 1998, SCIENCE, V282, P2053, DOI 10.1126/science.282.5396.2053	42	174	177	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					218	221		10.1126/science.aaa3630	http://dx.doi.org/10.1126/science.aaa3630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25745065	Green Submitted			2022-12-24	WOS:000352613700041
J	Arias, CA; Murray, BE				Arias, Cesar A.; Murray, Barbara E.			A New Antibiotic and the Evolution of Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DRUGS		[Arias, Cesar A.; Murray, Barbara E.] Univ Texas Med Sch Houston, Div Infect Dis, Dept Internal Med, Houston, TX 77030 USA; [Arias, Cesar A.; Murray, Barbara E.] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX USA; [Arias, Cesar A.] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Bogota, Colombia; [Arias, Cesar A.] Univ El Bosque, Int Ctr Microbial Genom, Bogota, Colombia	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Universidad El Bosque; Universidad El Bosque	Arias, CA (corresponding author), Univ Texas Med Sch Houston, Div Infect Dis, Dept Internal Med, Houston, TX 77030 USA.				NIAID NIH HHS [R01 AI093749] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093749] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; O'Neill J, 2014, ANTIMICROBIAL RESIST; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201	5	79	82	0	294	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1168	1170		10.1056/NEJMcibr1500292	http://dx.doi.org/10.1056/NEJMcibr1500292			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD6EZ	25785976	Green Accepted			2022-12-24	WOS:000351183600015
J	Wolfe, S				Wolfe, Sidney			Rosuvastatin: winner in the statin wars, patients' health notwithstanding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA		Wolfe, S (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA.	swolfe@citizen.org						[Anonymous], 2003, LANCET, V362, P1341; Anzalone DA, 2015, LANCET DIABETES 0204; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Brault M, 2014, METABOLISM, V63, P735, DOI 10.1016/j.metabol.2014.02.014; FDA, COMMUNICATION; FDA Advisory Committee, 2009, COMM RIDK REAS INCL; FDA Center for Drug Evaluation and Research, END MET DRUGS ADV CO; Food and Drug Administration, DRUG LAB; Freeman DJ, 2001, CIRCULATION, V103, P357; IMS Health, 2013, TOP GLOB PROD 2013; IMS Health, 2014, 1 OCT 2013 30 SEPT 2; Kaufman M, 2004, WASHINGTON POST; Koh KK, 2013, INT J CARDIOL, V166, P509, DOI 10.1016/j.ijcard.2011.11.028; McKillop T, 2003, LANCET, V362, P1498, DOI 10.1016/S0140-6736(03)14698-3; MCKILLOP T, 2003, LANCET          OCT; Morrissey RP, 2011, CURR ATHEROSCLER REP, V13, P413, DOI 10.1007/s11883-011-0197-9; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; Public Citizen's Health Research Group, PET BAN CHOL LOW DRU; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; van Staa TP, 2014, BRIT J CLIN PHARMACO, V78, P649, DOI 10.1111/bcp.12367; Zaharan NL, 2013, BRIT J CLIN PHARMACO, V75, P1118, DOI 10.1111/j.1365-2125.2012.04403.x	21	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2015	350								h1388	10.1136/bmj.h1388	http://dx.doi.org/10.1136/bmj.h1388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KO	25787130	Bronze			2022-12-24	WOS:000351570700007
J	Hewitt, RJ; Francis, M; Singanayagam, A; Kon, OM				Hewitt, Richard J.; Francis, Marie; Singanayagam, Aran; Kon, Onn Min			RATIONAL TESTING Screening tests for tuberculosis before starting biological therapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GAMMA RELEASE ASSAYS; INFLAMMATORY-BOWEL-DISEASE; LATENT TUBERCULOSIS; SKIN-TEST; RHEUMATOID-ARTHRITIS; INFECTION; PERFORMANCE; RISK		[Hewitt, Richard J.; Francis, Marie; Singanayagam, Aran; Kon, Onn Min] Imperial Coll NHS Trust, St Marys Hosp, Chest & Allergy Dept, London W2 1NY, England; [Kon, Onn Min] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London; Imperial College London	Kon, OM (corresponding author), Imperial Coll NHS Trust, St Marys Hosp, Chest & Allergy Dept, London W2 1NY, England.	onn.kon@imperial.nhs.uk		Kon, Onn Min/0000-0003-2647-4688; Singanayagam, Aran/0000-0001-9849-0033				Bartalesi F, 2009, EUR RESPIR J, V33, P586, DOI 10.1183/09031936.00107608; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Costantino F, 2013, J RHEUMATOL, V40, P1986, DOI 10.3899/jrheum.130303; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; European Centre for Disease Prevention and Control, 2011, US INT GAMM REL ASS; Greveson K, 2013, J CROHNS COLITIS, V7, P412, DOI 10.1016/j.crohns.2012.08.010; Hsia EC, 2012, ARTHRITIS RHEUM-US, V64, P2068, DOI 10.1002/art.34382; Kleinert S, 2012, ANN RHEUM DIS, V71, P1791, DOI 10.1136/annrheumdis-2011-200941; Kourbeti IS, 2014, CLIN INFECT DIS, V58, P1649, DOI 10.1093/cid/ciu185; Mariette X, 2012, ANN RHEUM DIS, V71, P1783, DOI 10.1136/annrheumdis-2011-200408; Martyn-Simmons CL, 2013, BRIT J DERMATOL, V168, P1012, DOI 10.1111/bjd.12176; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Munoz L, 2015, CLIN INFECT DIS, V60, P349, DOI 10.1093/cid/ciu796; National Institute for Health and Care Excellence, 2011, TUB CLIN DIAGN MAN, V117; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Ruan Q, 2014, CLIN RHEUMATOL; Shahidi N, 2012, INFLAMM BOWEL DIS, V18, P2034, DOI 10.1002/ibd.22901; Singanayagam A, 2013, THORAX, V68, P955, DOI 10.1136/thoraxjnl-2013-203436; Soborg B, 2009, J RHEUMATOL, V36, P1876, DOI 10.3899/jrheum.081292; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	21	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2015	350								h1060	10.1136/bmj.h1060	http://dx.doi.org/10.1136/bmj.h1060			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DP	25742884				2022-12-24	WOS:000351180000001
J	Torjesen, I				Torjesen, Ingrid			Crowdfunding sought for study that will provide first images of human brain on LSD	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2015	350								h1215	10.1136/bmj.h1215	http://dx.doi.org/10.1136/bmj.h1215			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6DP	25742689				2022-12-24	WOS:000351180000005
J	Bharat, TAM; Murshudov, GN; Sachse, C; Lowe, J				Bharat, Tanmay A. M.; Murshudov, Garib N.; Sachse, Carsten; Loewe, Jan			Structures of actin-like ParM filaments show architecture of plasmid-segregating spindles	NATURE			English	Article							BACTERIAL ACTIN; F-ACTIN; DNA SEGREGATION; R1; VISUALIZATION; REPLICATION; RECONSTRUCTION; REFINEMENT; RESOLUTION; MECHANISM	Active segregation of Escherichia coli low-copy-number plasmid R1 involves formation of a bipolar spindle made of left-handed double-helical actin-like ParM filaments(1-6). ParR links the filaments with centromeric parC plasmid DNA, while facilitating the addition of subunits to ParM filaments(3,7-9). Growing ParMRC spindles push sister plasmids to the cell poles(9,10). Here, using modern electron cryomicroscopy methods, we investigate the structures and arrangements of ParM filaments in vitro and in cells, revealing at near-atomic resolution how subunits and filaments come together to produce the simplest known mitotic machinery. To understand the mechanism of dynamic instability, we determine structures of ParM filaments in different nucleotide states. The structure of filaments bound to the ATP analogue AMPPNP is determined at 4.3 angstrom resolution and refined. The ParM filament structure shows strong longitudinal interfaces and weaker lateral interactions. Also using electron cryomicroscopy, we reconstruct ParM doublets forming antiparallel spindles. Finally, with whole-cell electron cryotomography, we show that doublets are abundant in bacterial cells containing low-copy-number plasmids with the ParMRC locus, leading to an asynchronous model of R1 plasmid segregation.	[Bharat, Tanmay A. M.; Murshudov, Garib N.; Loewe, Jan] MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 0QH, England; [Sachse, Carsten] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	MRC Laboratory Molecular Biology; European Molecular Biology Laboratory (EMBL)	Lowe, J (corresponding author), MRC, Mol Biol Lab, Struct Studies Div, Francis Crick Ave, Cambridge CB2 0QH, England.	jyl@mrc-lmb.cam.ac.uk	Löwe, Jan/X-6998-2019; Sachse, Carsten/H-2727-2012; Sachse, Carsten/AAY-9384-2020	Sachse, Carsten/0000-0002-1168-5143; Sachse, Carsten/0000-0002-1168-5143; Bharat, Tanmay/0000-0002-0168-0277; Lowe, Jan/0000-0002-5218-6615	Medical Research Council [U105184326, MC-UP-A025-1012]; Wellcome Trust [095514/Z/11/Z]; Federation of European Biochemical Societies (FEBS); European Molecular Biology Organization (EMBO) [ALTF 3-2013]; Medical Research Council [MC_U105184326] Funding Source: researchfish; MRC [MC_U105184326] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Federation of European Biochemical Societies (FEBS); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. van den Ent, K. Gerdes and P. Gayathri for help with sample preparation, and C. Johnson, C. Savva and F. de Haas for help with data collection. This work was supported by the Medical Research Council (U105184326) and the Wellcome Trust (095514/Z/11/Z). T.A.M.B. is the recipient of Federation of European Biochemical Societies (FEBS) and European Molecular Biology Organization (EMBO) (ALTF 3-2013) long-termfellowships. G.N.M. was funded by Medical Research Council grant MC-UP-A025-1012.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Breuner A, 1996, MOL MICROBIOL, V20, P581, DOI 10.1046/j.1365-2958.1996.5351063.x; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gayathri P, 2012, SCIENCE, V338, P1334, DOI 10.1126/science.1229091; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; GUSTAFSSON P, 1980, J BACTERIOL, V141, P106, DOI 10.1128/JB.141.1.106-110.1980; Izore T, 2014, FEBS LETT, V588, P776, DOI 10.1016/j.febslet.2014.01.029; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Ozyamak E, 2013, BIOCHEMISTRY-US, V52, P6928, DOI 10.1021/bi4010792; Ozyamak E, 2013, J BIOL CHEM, V288, P4265, DOI 10.1074/jbc.M112.417030; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2010, BIOCHEM BIOPH RES CO, V391, P1598, DOI 10.1016/j.bbrc.2009.12.078; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Salje J, 2009, SCIENCE, V323, P509, DOI 10.1126/science.1164346; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Turk D, 2013, ACTA CRYSTALLOGR D, V69, P1342, DOI 10.1107/S0907444913008408; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033	39	49	51	6	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					106	+		10.1038/nature14356	http://dx.doi.org/10.1038/nature14356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	25915019	Green Accepted			2022-12-24	WOS:000357169500041
J	Collins, SH; Wiggin, MB; Sawicki, GS				Collins, Steven H.; Wiggin, M. Bruce; Sawicki, Gregory S.			Reducing the energy cost of human walking using an unpowered exoskeleton	NATURE			English	Article							WORK; EXPENDITURE; ENERGETICS; MECHANICS; BIOMECHANICS; GAIT; MASS	With efficiencies derived from evolution, growth and learning, humans are very well-tuned for locomotion(1). Metabolic energy used during walking can be partly replaced by power input from an exoskeleton(2), but is it possible to reduce metabolic rate without providing an additional energy source? This would require an improvement in the efficiency of the human-machine system as a whole, and would be remarkable given the apparent optimality of human gait. Here we show that the metabolic rate of human walking can be reduced by an unpowered ankle exoskeleton. We built a lightweight elastic device that acts in parallel with the user's calf muscles, off-loading muscle force and thereby reducing the metabolic energy consumed in contractions. The device uses a mechanical clutch to hold a spring as it is stretched and relaxed by ankle movements when the foot is on the ground, helping to fulfil one function of the calf muscles and Achilles tendon. Unlike muscles, however, the clutch sustains force passively. The exoskeleton consumes no chemical or electrical energy and delivers no net positive mechanical work, yet reduces the metabolic cost of walking by 7.2 +/- 2.6% for healthy human users under natural conditions, comparable to savings with powered devices. Improving upon walking economy in this way is analogous to altering the structure of the body such that it is more energy-effective at walking. While strong natural pressures have already shaped human locomotion, improvements in efficiency are still possible. Much remains to be learned about this seemingly simple behaviour.	[Collins, Steven H.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Wiggin, M. Bruce; Sawicki, Gregory S.] N Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA; [Wiggin, M. Bruce; Sawicki, Gregory S.] Univ North Carolina Chapel Hill, Raleigh, NC 27695 USA	Carnegie Mellon University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Collins, SH (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	stevecollins@cmu.edu; greg_sawicki@ncsu.edu		Collins, Steve/0000-0002-3997-3374	North Carolina State Faculty Research and Professional Development Fund; North Carolina State Chancellors Innovation Fund; United States - Israel Binational Science Foundation [2011152]; National Institute of Nursing Research of the National Institutes of Health [R01NR014756]; National Science Foundation [IIS-1355716]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014756] Funding Source: NIH RePORTER	North Carolina State Faculty Research and Professional Development Fund; North Carolina State Chancellors Innovation Fund; United States - Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	We thank A. Westbrook for data collection, K. Takahashi and R. Nuckols for stiffness characterizations, B. Reich for discussions on statistical analysis, R. Jackson for data collection and manuscript editing, and J. Caputo, P. Collins, S. Diller, N. Donahue, A. Kuo, I. Lau, L. Lau, C. Majidi, J. Malen, T. Roberts, A. Robinson, A. Ruina, P. Taggart, K. Witte, M. Wu and others for editorial suggestions. The photograph in Fig. 1b is by S. Thrift. Funding for this research was provided by grants to G.S.S. from the North Carolina State Faculty Research and Professional Development Fund; the North Carolina State Chancellors Innovation Fund; grant number 2011152 from the United States - Israel Binational Science Foundation; and award number R01NR014756 from the National Institute of Nursing Research of the National Institutes of Health. This material is based upon work supported by the National Science Foundation under grant number IIS-1355716 to S.H.C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding agencies listed.	Alexander RM., 2003, PRINCIPLES ANIMAL LO; Bregman DJJ, 2011, CLIN BIOMECH, V26, P955, DOI 10.1016/j.clinbiomech.2011.05.007; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Collins SH, 2009, P ROY SOC B-BIOL SCI, V276, P3679, DOI 10.1098/rspb.2009.0664; Davidson PR, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S11; Dietz V, 2003, CLIN NEUROPHYSIOL, V114, P1379, DOI 10.1016/S1388-2457(03)00120-2; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; ERICSSON KA, 1994, AM PSYCHOL, V49, P725, DOI 10.1037/0003-066X.49.8.725; Farris DJ, 2013, J APPL PHYSIOL, V115, P579, DOI 10.1152/japplphysiol.00253.2013; Farris DJ, 2012, J APPL PHYSIOL, V113, P1862, DOI 10.1152/japplphysiol.00802.2012; FORSSBERG H, 1985, EXP BRAIN RES, V57, P480; Galle S, 2013, GAIT POSTURE, V38, P495, DOI 10.1016/j.gaitpost.2013.01.029; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; Grabowski AM, 2009, J APPL PHYSIOL, V107, P670, DOI 10.1152/japplphysiol.91609.2008; HEGLUND NC, 1995, NATURE, V375, P52, DOI 10.1038/375052a0; Holt NC, 2014, J EXP BIOL, V217, P4365, DOI 10.1242/jeb.112813; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Kao PC, 2010, J BIOMECH, V43, P203, DOI 10.1016/j.jbiomech.2009.09.030; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; Roberts TJ, 2002, COMP BIOCHEM PHYS A, V133, P1087, DOI 10.1016/S1095-6433(02)00244-1; Rome LC, 2006, NATURE, V444, P1023, DOI 10.1038/4441023a; Ryschon TW, 1997, J APPL PHYSIOL, V83, P867, DOI 10.1152/jappl.1997.83.3.867; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; TUCKER VA, 1975, AM SCI, V63, P413; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; Umberger BR, 2011, EXERC SPORT SCI REV, V39, P59, DOI 10.1097/JES.0b013e31820d7bc5; van Dijk W., 2011, IEEE INT C REHABIL R, V2011, P5975470; Westerterp KR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00090; Yagn N., 1890, U.S. Patent, Patent No. [420,179, 420179, 4 201 79]; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237; Zelik KE, 2014, J THEOR BIOL, V346, P75, DOI 10.1016/j.jtbi.2013.12.014; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zoss A, 2006, ADV ROBOTICS, V20, P967, DOI 10.1163/156855306778394030	38	500	532	65	606	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					212	+		10.1038/nature14288	http://dx.doi.org/10.1038/nature14288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25830889	Green Submitted, Green Accepted			2022-12-24	WOS:000356016700038
J	Davies, K				Davies, Kay			Keep the directive that protects research animals	NATURE			English	Editorial Material									Univ Oxford, MRC Funct Genom Unit, Oxford OX1 2JD, England	University of Oxford	Davies, K (corresponding author), Univ Oxford, MRC Funct Genom Unit, Oxford OX1 2JD, England.	kay.davies@dpag.ox.ac.uk							0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					7	7		10.1038/521007a	http://dx.doi.org/10.1038/521007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH4YS	25951248	Bronze			2022-12-24	WOS:000354040900004
J	Kardon, JR; Yien, YY; Huston, NC; Branco, DS; Hildick-Smith, GJ; Rhee, KY; Paw, BH; Baker, TA				Kardon, Julia R.; Yien, Yvette Y.; Huston, Nicholas C.; Branco, Diana S.; Hildick-Smith, Gordon J.; Rhee, Kyu Y.; Paw, Barry H.; Baker, Tania A.			Mitochondrial ClpX Activates a Key Enzyme for Heme Biosynthesis and Erythropoiesis	CELL			English	Article							5-AMINOLEVULINATE SYNTHASE; PYRIDOXAL KINASE; PORE LOOPS; PROTEIN; DEGRADATION; GENE; ORGANIZATION; RECOGNITION; HYDROLYSIS; DIAGNOSIS	The mitochondrion maintains and regulates its proteome with chaperones primarily inherited from its bacterial endosymbiont ancestor. Among these chaperones is the AAA+ unfoldase ClpX, an important regulator of prokaryotic physiology with poorly defined function in the eukaryotic mitochondrion. We observed phenotypic similarity in S. cerevisiae genetic interaction data between mitochondrial ClpX (mtClpX) and genes contributing to heme biosynthesis, an essential mitochondrial function. Metabolomic analysis revealed that 5-aminolevulinic acid (ALA), the first heme precursor, is 5-fold reduced in yeast lacking mtClpX activity and that total heme is reduced by half. mtClpX directly stimulates ALA synthase in vitro by catalyzing incorporation of its cofactor, pyridoxal phosphate. This activity is conserved in mammalian homologs; additionally, mtClpX depletion impairs vertebrate erythropoiesis, which requires massive upregulation of heme biosynthesis to supply hemoglobin. mtClpX, therefore, is a widely conserved stimulator of an essential biosynthetic pathway and uses a previously unrecognized mechanism for AAA+ unfoldases.	[Kardon, Julia R.; Baker, Tania A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yien, Yvette Y.; Huston, Nicholas C.; Branco, Diana S.; Hildick-Smith, Gordon J.; Paw, Barry H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol,Dept Med, Boston, MA 02115 USA; [Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, Div Infect Dis, New York, NY 10065 USA; [Paw, Barry H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol,Dept Med, Boston, MA 02115 USA; [Paw, Barry H.] Dana Farber Canc Inst, Dept Pediat, Boston, MA 02115 USA; [Kardon, Julia R.; Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University; Cornell University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tabaker@mit.edu		Paw, Barry/0000-0002-0492-1419; Kardon, Julia/0000-0002-6621-4461	NIH [RO1 GM049224, F32DK095726, T32HL007574, F32DK098866, R01DK070838, P01HL032262]; March of Dimes Foundation [6-FY09-289]; Brazilian CAPES Foundation; Brazilian FAPESP Foundation; Burroughs Wellcome Career Award in the Biomedical Sciences; William Randolph Hearst Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007574, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095726, F32DK098866, R01DK070838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Brazilian CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian FAPESP Foundation; Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); William Randolph Hearst Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Bell, J. Weissman, R. Vale, J. Nunnari, and N. Bradshaw for critical reading of the manuscript; L. Zon for the Tg(globin-LCR:eGFP) transgenic line; K. Hoffmeister for fluorescence-activated cell sorting (FACS) machine use; and C. Lawrence and his team for zebrafish husbandry. This work was supported by grants from the NIH (RO1 GM049224 to T.A.B., F32DK095726 to J. R. K., T32HL007574 and F32DK098866 to Y.Y.Y., and R01DK070838 and P01HL032262 to B.H.P.), the March of Dimes Foundation (6-FY09-289 to B.H.P.), and the Brazilian CAPES and FAPESP Foundations (to D.S.B.). K.Y.R. is the recipient of a Burroughs Wellcome Career Award in the Biomedical Sciences and of support from the William Randolph Hearst Foundation. T.A.B. is an employee of the Howard Hughes Medical Institute.	Al-Furoukh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103141; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; ARESE M, 1983, CURR GENET, V7, P175, DOI 10.1007/BF00434887; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001; Cheung PY, 2003, J BIOCHEM, V134, P731, DOI 10.1093/jb/mvg201; Cooney JD, 2013, DEV BIOL, V373, P431, DOI 10.1016/j.ydbio.2012.08.015; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; HAMFELT A, 1967, CLIN CHIM ACTA, V16, P19, DOI 10.1016/0009-8981(67)90264-1; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kasashima K, 2012, EXP CELL RES, V318, P2335, DOI 10.1016/j.yexcr.2012.07.012; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; KIM YT, 1988, J BIOL CHEM, V263, P13712; Konieczny I, 1997, P NATL ACAD SCI USA, V94, P14378, DOI 10.1073/pnas.94.26.14378; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Lawrence JM, 2003, COMP BIOCHEM PHYS A, V134, P71; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Rottgers K, 2002, J BIOL CHEM, V277, P45829, DOI 10.1074/jbc.M207152200; Russell R, 2014, CELL, V158, P479, DOI 10.1016/j.cell.2014.07.009; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sassa S, 2006, BRIT J HAEMATOL, V135, P281, DOI 10.1111/j.1365-2141.2006.06289.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; van Dyck L, 1998, FEBS LETT, V438, P250, DOI 10.1016/S0014-5793(98)01310-6; Vass RH, 2013, P NATL ACAD SCI USA, V110, P18138, DOI 10.1073/pnas.1311302110; VOLLAND C, 1984, EUR J BIOCHEM, V142, P551, DOI 10.1111/j.1432-1033.1984.tb08321.x; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; WANG ZY, 1992, PLANT PHYSIOL, V99, P1348, DOI 10.1104/pp.99.4.1348; Wintrobe MM, 2004, WINTROBES CLIN HEMAT, V11th; Wu TH, 2003, BBA-PROTEINS PROTEOM, V1647, P315, DOI 10.1016/S1570-9639(03)00081-5	57	72	77	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					858	867		10.1016/j.cell.2015.04.017	http://dx.doi.org/10.1016/j.cell.2015.04.017			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957689	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000354175200018
J	Liao, KP; Cai, TX; Savova, GK; Murphy, SN; Karlson, EW; Ananthakrishnan, AN; Gainer, VS; Shaw, SY; Xia, ZQ; Szolovits, P; Churchill, S; Kohane, I				Liao, Katherine P.; Cai, Tianxi; Savova, Guergana K.; Murphy, Shawn N.; Karlson, Elizabeth W.; Ananthakrishnan, Ashwin N.; Gainer, Vivian S.; Shaw, Stanley Y.; Xia, Zongqi; Szolovits, Peter; Churchill, Susanne; Kohane, Isaac			Development of phenotype algorithms using electronic medical records and incorporating natural language processing	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; DISCOVERY RESEARCH; CROHNS-DISEASE; NORMALIZATION; RISK; IDENTIFICATION; PREVALENCE; SYSTEM		[Liao, Katherine P.; Karlson, Elizabeth W.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Liao, Katherine P.; Karlson, Elizabeth W.; Shaw, Stanley Y.; Xia, Zongqi; Churchill, Susanne; Kohane, Isaac] Harvard Univ, Sch Med, Boston, MA USA; [Cai, Tianxi] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Savova, Guergana K.] Childrens Hosp Boston, Dept Pediat, Boston, MA USA; [Murphy, Shawn N.; Kohane, Isaac] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Ananthakrishnan, Ashwin N.] Massachusetts Gen Hosp, Dept Gastroenterol, MGH Crohns & Colitis Ctr, Boston, MA 02114 USA; [Gainer, Vivian S.] Partners HealthCare Syst, Partners Res Comp, Boston, MA USA; [Shaw, Stanley Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Xia, Zongqi] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Szolovits, Peter] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Liao, KP (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	kliao@partners.org	Xia, Zongqi/AAX-3091-2020; Xia, Zongqi/AAB-1565-2022	Xia, Zongqi/0000-0003-1500-2589; Xia, Zongqi/0000-0003-1500-2589; Szolovits, Peter/0000-0001-8411-6403	US National Institutes of Health [U54LM008748, AR 060257, K08 K23 DK097142]; Harold and Duval Bowen Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR060257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS079493] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harold and Duval Bowen Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by grants from the US National Institutes of Health (U54LM008748, AR 060257, K08 K23 DK097142), and the Harold and Duval Bowen Fund.	Ananthakrishnan AN, 2014, CLIN GASTROENTEROL H, V12, P1905, DOI 10.1016/j.cgh.2014.02.034; Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P1411, DOI 10.1097/MIB.0b013e31828133fd; Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P37, DOI [10.1002/ibd.22951, 10.1097/MIB.0b013e3182902ad9]; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Bodenreider O, 2003, J BIOMED INFORM, V36, P414, DOI 10.1016/j.jbi.2003.11.002; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; Carrell DS, 2014, AM J EPIDEMIOL, V179, P749, DOI 10.1093/aje/kwt441; Carroll RJ, 2012, J AM MED INFORM ASSN, V19, pE162, DOI 10.1136/amiajnl-2011-000583; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Endicott M, 2012, J AHIMA, V82, P60; Garla VN, 2013, J AM MED INFORM ASSN, V20, P882, DOI 10.1136/amiajnl-2012-001350; Jurafsky D., 2009, SPEECH LANGUAGE PROC; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Leaman R, 2013, BIOINFORMATICS, V29, P2909, DOI 10.1093/bioinformatics/btt474; Liao KP, 2014, ANN RHEUM DIS, V73, P1170, DOI 10.1136/annrheumdis-2012-203202; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Liao KP, 2011, RHEUMATOLOGY, P823; McCormick Patrick J, 2008, AMIA Annu Symp Proc, P450; Murff HJ, 2011, JAMA-J AM MED ASSOC, V306, P848, DOI 10.1001/jama.2011.1204; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; Perlis RH, 2012, PSYCHOL MED, V42, P41, DOI 10.1017/S0033291711000997; Pradhan S, 2015, J AM MED INFORM ASSN, V22, P143, DOI 10.1136/amiajnl-2013-002544; Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]; Rasmussen LV, 2014, J BIOMED INFORM, V51, P280, DOI 10.1016/j.jbi.2014.06.007; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; US National Library of Medicine, 2014, UN MED LANG SYST TER; Xia ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078927; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	35	157	159	2	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2015	350								h1885	10.1136/bmj.h1885	http://dx.doi.org/10.1136/bmj.h1885			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG8RC	25911572	Bronze, Green Published			2022-12-24	WOS:000353577000004
J	Reddy, P; Ocampo, A; Suzuki, K; Luo, J; Bacman, SR; Williams, SL; Sugawara, A; Okamura, D; Tsunekawa, Y; Wu, J; Lam, D; Xiong, X; Montserrat, N; Esteban, CR; Liu, GH; Sancho-Martinez, I; Manau, D; Civico, S; Cardellach, F; O'Callaghan, MD; Campistol, J; Zhao, H; Campistol, JM; Moraes, CT; Belmonte, JCI				Reddy, Pradeep; Ocampo, Alejandro; Suzuki, Keiichiro; Luo, Jinping; Bacman, Sandra R.; Williams, Sion L.; Sugawara, Atsushi; Okamura, Daiji; Tsunekawa, Yuji; Wu, Jun; Lam, David; Xiong, Xiong; Montserrat, Nuria; Esteban, Concepcion Rodriguez; Liu, Guang-Hui; Sancho-Martinez, Ignacio; Manau, Dolors; Civico, Salva; Cardellach, Francesc; O'Callaghan, Maria del Mar; Campistol, Jaime; Zhao, Huimin; Campistol, Josep M.; Moraes, Carlos T.; Belmonte, Juan Carlos Izpisua			Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing	CELL			English	Article							DNA MUTATIONS; DISEASE; TRANSMISSION; HETEROPLASMY; DEGRADATION; SEQUENCE; EMBRYOS; DRIFT	Mitochondrial diseases include a group of maternally inherited genetic disorders caused by mutations in mtDNA. In most of these patients, mutated mtDNA coexists with wild-type mtDNA, a situation known as mtDNA heteroplasmy. Here, we report on a strategy toward preventing germline transmission of mitochondrial diseases by inducing mtDNA heteroplasmy shift through the selective elimination of mutated mtDNA. As a proof of concept, we took advantage of NZB/BALB heteroplasmic mice, which contain two mtDNA haplotypes, BALB and NZB, and selectively prevented their germline transmission using either mitochondria-targeted restriction endonucleases or TALENs. In addition, we successfully reduced human mutated mtDNA levels responsible for Leber's hereditary optic neuropathy (LHOND), and neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in mammalian oocytes using mitochondria-targeted TALEN (mito-TALENs). Our approaches represent a potential therapeutic avenue for preventing the trans-generational transmission of human mitochondrial diseases caused by mutations in mtDNA.	[Reddy, Pradeep; Ocampo, Alejandro; Suzuki, Keiichiro; Luo, Jinping; Sugawara, Atsushi; Okamura, Daiji; Wu, Jun; Lam, David; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Bacman, Sandra R.; Williams, Sion L.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Tsunekawa, Yuji] RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Kobe, Hyogo 6500047, Japan; [Xiong, Xiong; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Montserrat, Nuria] Inst Bioengn Catalonia IBEC, Pluripotent Stem Cells & Organ Regenerat, Barcelona 08028, Spain; [Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Liu, Guang-Hui] Ctr Mol & Translat Med CMTM, Beijing 100101, Peoples R China; [Liu, Guang-Hui] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China; [Manau, Dolors; Civico, Salva] Univ Barcelona, Hosp Clin, Inst Clin Gynecol Obstet & Neonatol ICGON, E-08036 Barcelona, Spain; [Cardellach, Francesc] Univ Barcelona, IDIBAPS CIBER Rare Dis, Mitochondrial Res Lab, E-08036 Barcelona, Spain; [Cardellach, Francesc] Univ Barcelona, Dept Internal Med, Hosp Clin, E-08036 Barcelona, Spain; [O'Callaghan, Maria del Mar; Campistol, Jaime] Hosp Univ St Joan de Deu, Neuropediat Dept CIBERER, Esplugas de Llobregat 08950, Spain; [Campistol, Josep M.] Univ Barcelona, IDIBAPS, Hosp Clin, Renal Div, E-08036 Barcelona, Spain; [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	Salk Institute; University of Miami; RIKEN; University of Illinois System; University of Illinois Urbana-Champaign; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Miami	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	belmonte@salk.edu	Montserrat, Nuria/F-3136-2016; Manau, Dolors M/D-8977-2019; Wu, Jun/AAF-1830-2019; Reddy, Pradeep/G-1770-2014; Moraes, Carlos/AAT-3818-2021	Montserrat, Nuria/0000-0002-1603-1755; Manau, Dolors M/0000-0002-1377-9565; Wu, Jun/0000-0001-9863-1668; Reddy, Pradeep/0000-0002-9173-3845; Josep M, Campistol/0000-0001-6244-0253; Suzuki, Keiichiro/0000-0001-5603-9105; Ocampo, Alejandro/0000-0002-3731-3647	Leona M. and Harry B. Helmsley Charitable Trust; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship; National Basic Research Program of China (973 Program) [2015CB964800, 2014CB964600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; National Natural Science Foundation of China (NSFC) [81271266, 31222039, 31201111, 81371342]; NIH [5R01EY010804, 1R01AG036871]; JDM Fund; Muscular Dystrophy Association; United Mitochondrial Disease Foundation; Florida Department of Health [3KN09]; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036871, F32AG047770] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDM Fund; Muscular Dystrophy Association(Muscular Dystrophy Association); United Mitochondrial Disease Foundation; Florida Department of Health; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Financial support: M.M. Ku and S. Heinz are supported by the Leona M. and Harry B. Helmsley Charitable Trust. A.O. was partially supported by an NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship. G.-H.L. was supported by National Basic Research Program of China (973 Program, 2015CB964800; 2014CB964600), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), National Natural Science Foundation of China (NSFC: 81271266; 31222039; 31201111; 81371342). C.T.M. was supported by NIH grants 5R01EY010804, 1R01AG036871, the JDM Fund, the Muscular Dystrophy Association and the United Mitochondrial Disease Foundation. S.L.W. is supported by Florida Department of Health Grant 3KN09. Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation and the Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002).	Alexeyev M., 2013, COLD SPRING HARB PER, V5; Alexeyev MF, 2008, GENE THER, V15, P516, DOI [10.1038/gt.2008.11, 10.1038/sj.gt.2008.11]; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2009, BBA-MOL BASIS DIS, V1792, P1097, DOI 10.1016/j.bbadis.2009.03.002; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; Hayden EC, 2013, NATURE, V502, P284, DOI 10.1038/502284a; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; JUN AS, 1994, P NATL ACAD SCI USA, V91, P6206, DOI 10.1073/pnas.91.13.6206; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313; Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Russell O, 2014, EXP CELL RES, V325, P38, DOI 10.1016/j.yexcr.2014.03.012; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Vogel G, 2014, SCIENCE, V343, P827, DOI 10.1126/science.343.6173.827; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wang T, 2014, CELL, V157, P1591, DOI 10.1016/j.cell.2014.04.042	32	184	193	2	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					459	469		10.1016/j.cell.2015.03.051	http://dx.doi.org/10.1016/j.cell.2015.03.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910206	Bronze, Green Accepted			2022-12-24	WOS:000353553600008
J	Soufi, A; Garcia, MF; Jaroszewicz, A; Osman, N; Pellegrini, M; Zaret, KS				Soufi, Abdenour; Garcia, Meilin Fernandez; Jaroszewicz, Artur; Osman, Nebiyu; Pellegrini, Matteo; Zaret, Kenneth S.			Pioneer Transcription Factors Target Partial DNA Motifs on Nucleosomes to Initiate Reprogramming	CELL			English	Article							CRYSTAL-STRUCTURE; STEM-CELLS; MYC-MAX; COMPLEX; BINDING; RECOGNITION; DOMAIN; OCT4; SPECIFICITY; MECHANISMS	Pioneer transcription factors (TFs) access silent chromatin and initiate cell-fate changes, using diverse types of DNA binding domains (DBDs). FoxA, the paradigm pioneer TF, has a winged helix DBD that resembles linker histone and thereby binds its target sites on nucleosomes and in compacted chromatin. Herein, we compare the nucleosome and chromatin targeting activities of Oct4 (POU DBD), Sox2 (HMG box DBD), Klf4 (zinc finger DBD), and c-Myc (bHLH DBD), which together reprogram somatic cells to pluripotency. Purified Oct4, Sox2, and Klf4 proteins can bind nucleosomes in vitro, and in vivo they preferentially target silent sites enriched for nucleosomes. Pioneer activity relates simply to the ability of a given DBD to target partial motifs displayed on the nucleosome surface. Such partial motif recognition can occur by coordinate binding between factors. Our findings provide insight into how pioneer factors can target naive chromatin sites.	[Soufi, Abdenour; Garcia, Meilin Fernandez; Osman, Nebiyu; Zaret, Kenneth S.] Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Soufi, Abdenour; Garcia, Meilin Fernandez; Osman, Nebiyu; Zaret, Kenneth S.] Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res, Epigenet Program,Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Jaroszewicz, Artur; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles	Zaret, KS (corresponding author), Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res, Inst Regenerat Med, Bldg 421,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu		Soufi, Abdenour/0000-0002-3666-3266; Fernandez Garcia, Meilin/0000-0002-8745-9775; Pellegrini, Matteo/0000-0001-9355-9564	NIH [P01GM099134]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Donahue for advice and G. Blobel, R. Marmorstein, M. Iwafuchi-Doi, and D. Nicetto for comments on the manuscript. The work was supported by NIH grant P01GM099134 to K.S.Z.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Budry L, 2012, GENE DEV, V26, P2299, DOI 10.1101/gad.200436.112; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; DAVIS RL, 1992, SCIENCE, V256, P1027, DOI 10.1126/science.1317057; El Omari K, 2013, CELL REP, V4, P135, DOI 10.1016/j.celrep.2013.06.008; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Farina A, 2004, PROTEIN EXPRES PURIF, V34, P215, DOI 10.1016/j.pep.2003.11.021; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Longo A, 2008, BIOCHEMISTRY-US, V47, P218, DOI 10.1021/bi701527r; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Pogenberg V, 2012, GENE DEV, V26, P2647, DOI 10.1101/gad.198192.112; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Privalov PL, 2009, TRENDS BIOCHEM SCI, V34, P464, DOI 10.1016/j.tibs.2009.05.005; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Sauve S, 2004, J MOL BIOL, V342, P813, DOI 10.1016/j.jmb.2004.07.058; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Soufi A, 2014, CURR OPIN GENET DEV, V25, P101, DOI 10.1016/j.gde.2013.12.007; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; VERRIJZER CP, 1992, EMBO J, V11, P4993, DOI 10.1002/j.1460-2075.1992.tb05606.x; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zheng RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083723	60	412	418	8	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					555	568		10.1016/j.cell.2015.03.017	http://dx.doi.org/10.1016/j.cell.2015.03.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892221	Green Accepted, Bronze			2022-12-24	WOS:000353553600015
J	Nagasawa, M; Mitsui, S; En, S; Ohtani, N; Ohta, M; Sakuma, Y; Onaka, T; Mogi, K; Kikusui, T				Nagasawa, Miho; Mitsui, Shouhei; En, Shiori; Ohtani, Nobuyo; Ohta, Mitsuaki; Sakuma, Yasuo; Onaka, Tatsushi; Mogi, Kazutaka; Kikusui, Takefumi			Oxytocin-gaze positive loop and the coevolution of human-dog bonds	SCIENCE			English	Article							SOCIAL-INTERACTION; URINARY OXYTOCIN; BRAIN OXYTOCIN; ATTACHMENT; WOLVES; NEOTENY	Human-like modes of communication, including mutual gaze, in dogs may have been acquired during domestication with humans. We show that gazing behavior from dogs, but not wolves, increased urinary oxytocin concentrations in owners, which consequently facilitated owners' affiliation and increased oxytocin concentration in dogs. Further, nasally administered oxytocin increased gazing behavior in dogs, which in turn increased urinary oxytocin concentrations in owners. These findings support the existence of an interspecies oxytocin-mediated positive loop facilitated and modulated by gazing, which may have supported the coevolution of human-dog bonding by engaging common modes of communicating social attachment.	[Nagasawa, Miho; Mitsui, Shouhei; En, Shiori; Ohtani, Nobuyo; Ohta, Mitsuaki; Mogi, Kazutaka; Kikusui, Takefumi] Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan; [Nagasawa, Miho; Onaka, Tatsushi] Jichi Med Univ, Dept Physiol, Shimotsuke, Tochigi, Japan; [Sakuma, Yasuo] Univ Tokyo Hlth Sci, Tokyo, Japan	Azabu University; Jichi Medical University	Kikusui, T (corresponding author), Azabu Univ, Dept Anim Sci & Biotechnol, Sagamihara, Kanagawa, Japan.	kikusui@azabu-u.ac.jp	Sakuma, Yasuo/C-5604-2011	Sakuma, Yasuo/0000-0001-6816-3779; Onaka, Tatsushi/0000-0001-5666-9035; Mogi, Kazutaka/0000-0002-0689-9761	Japan Society for the Promotion of Science, in Japan [4501]; Grants-in-Aid for Scientific Research [25118008, 26450433] Funding Source: KAKEN	Japan Society for the Promotion of Science, in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Grant-in-Aid for Scientific Research on Innovative Areas (No. 4501) from the Japan Society for the Promotion of Science, in Japan. We thank all human and canine participants, Howlin' Ks Nature School, U.S. Kennel, R. Ooyama and N. Yoshida-Tsuchihashi from Azabu University, and Drs. Kato and Takeda from University of Tokyo Health Sciences. We are also grateful to Cody and Charley for their significant contributions. The analyzed data are included in the supplementary materials.	COPPINGER R, 1987, ETHOLOGY, V75, P89; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; DICKSTEIN S, 1984, INFANT BEHAV DEV, V7, P507, DOI 10.1016/S0163-6383(84)80009-0; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Fox M. W., 1997, THE SOUL OF THE WOLF; Gacsi M, 2013, APPL ANIM BEHAV SCI, V145, P109, DOI 10.1016/j.applanim.2013.02.007; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Kim S, 2014, BRAIN RES, V1580, P133, DOI 10.1016/j.brainres.2013.10.050; Meins E., 1997, SECURITY ATTACHMENT; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Mitsui S, 2011, HORM BEHAV, V60, P239, DOI 10.1016/j.yhbeh.2011.05.012; Nagasawa M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00031; Nagasawa M, 2009, JPN PSYCHOL RES, V51, P209, DOI 10.1111/j.1468-5884.2009.00402.x; Nagasawa M, 2009, HORM BEHAV, V55, P434, DOI 10.1016/j.yhbeh.2008.12.002; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Neumann ID, 2002, PROG BRAIN RES, V139, P147; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; Shinozaki J, 2007, NEUROREPORT, V18, P993, DOI 10.1097/WNR.0b013e3281ac2161; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Tuber DS, 1996, J COMP PSYCHOL, V110, P103, DOI 10.1037/0735-7036.110.1.103; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	26	357	368	14	386	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					333	336		10.1126/science.1261022	http://dx.doi.org/10.1126/science.1261022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883356				2022-12-24	WOS:000352999000044
J	Tsubogo, T; Oyamada, H; Kobayashi, S				Tsubogo, Tetsu; Oyamada, Hidekazu; Kobayashi, Shu			Multistep continuous-flow synthesis of (R) - and (S) -rolipram using heterogeneous catalysts	NATURE			English	Article							CARBON BOND FORMATION; HYDROGENATION; CHEMISTRY; MECHANISM; REACTORS; TOOLS	Chemical manufacturing is conducted using either batch systems or continuous-flow systems. Flow systems have several advantages over batch systems, particularly in terms of productivity, heat and mixing efficiency, safety, and reproducibility'. However, for over half a century, pharmaceutical manufacturing has used batch systems because the synthesis of complex molecules such as drugs has been difficult to achieve with continuous-flow systems'''. Here we describe the continuous-flow synthesis of drugs using only columns packed with heterogeneous catalysts. Commercially available starting materials were successively passed through four columns containing achiral and chiral heterogeneous catalysts to produce (R)-rolipram', an anti-inflammatory drug and one of the family of y-aminobutyric acid (GABA) derivatives'. In addition, simply by replacing a column packed with a chiral heterogeneous catalyst with another column packed with the opposing enantiomer, we obtained antipole (S)-rolipram. Similarly, we also synthesized (R)-phenibut, another drug belonging to the GABA family. These flow systems are simple and stable with no leaching of metal catalysts. Our results demonstrate that multistep (eight steps in this case) chemical transformations for drug synthesis can proceed smoothly under flow conditions using only heterogeneous catalysts, without the isolation of any intermediates and without the separation of any catalysts, co-products, by-products, and excess reagents. We anticipate that such syntheses will be useful in pharmaceutical manufacturing.	[Tsubogo, Tetsu; Oyamada, Hidekazu; Kobayashi, Shu] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Tsubogo, Tetsu; Oyamada, Hidekazu; Kobayashi, Shu] Univ Tokyo, Sch Sci, Green & Sustainable Chem Social Cooperat Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Kobayashi, S (corresponding author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Tsubogo, Tetsu/P-8292-2019; Kobayashi, Shu/E-9214-2012	Tsubogo, Tetsu/0000-0003-2615-7287; 	Global COE Program, The University of Tokyo, MEXT, Japan; ACT-C; Center of Innovation (COI) Program; Japan Science and Technology Agency (JST)	Global COE Program, The University of Tokyo, MEXT, Japan; ACT-C; Center of Innovation (COI) Program; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was partially supported by a Grant-in-Aid for Science Research from the Japan Society for the Promotion of Science (JSPS), Global COE Program, The University of Tokyo, MEXT, Japan, the ACT-C and Center of Innovation (COI) Program, and the Japan Science and Technology Agency (JST).	Anastas P. T., 1998, GREEN CHEM THEORY PR; Barnes DM, 2002, J AM CHEM SOC, V124, P13097, DOI 10.1021/ja026788y; Battilocchio C, 2013, ORG LETT, V15, P2278, DOI 10.1021/ol400856g; Day JP, 2011, J MED CHEM, V54, P3331, DOI 10.1021/jm200070e; Frost CG, 2010, GREEN CHEM, V12, P1687, DOI 10.1039/c0gc00133c; Geyer K, 2006, CHEM-EUR J, V12, P8434, DOI 10.1002/chem.200600596; Hartman RL, 2011, ANGEW CHEM INT EDIT, V50, P7502, DOI 10.1002/anie.201004637; Hartwig J, 2013, ANGEW CHEM INT EDIT, V52, P9813, DOI 10.1002/anie.201302239; Hopkin MD, 2013, ORG BIOMOL CHEM, V11, P1822, DOI 10.1039/c2ob27002a; Hynes PS, 2008, ORG LETT, V10, P1389, DOI 10.1021/ol800108u; Kirschning A, 2006, CHEM-EUR J, V12, P5972, DOI 10.1002/chem.200600236; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Ley SV, 2002, NAT REV DRUG DISCOV, V1, P573, DOI 10.1038/nrd871; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Malykh AG, 2010, DRUGS, V70, P287, DOI 10.2165/11319230-000000000-00000; Maxwell CR, 2004, NEUROSCIENCE, V129, P101, DOI 10.1016/j.neuroscience.2004.07.038; Motokura K, 2009, J AM CHEM SOC, V131, P7944, DOI 10.1021/ja9012003; O'Brien M, 2011, CHEM SCI, V2, P1250, DOI 10.1039/c1sc00055a; Ojima I., 2010, CATALYTIC ASYMMETRIC; Oyamada H, 2011, BEILSTEIN J ORG CHEM, V7, P735, DOI 10.3762/bjoc.7.83; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Poechlauer P, 2012, ORG PROCESS RES DEV, V16, P1586, DOI 10.1021/op300159y; Soldi L, 2008, J CATAL, V258, P289, DOI 10.1016/j.jcat.2008.07.005; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; Tsubogo T, 2013, ANGEW CHEM INT EDIT, V52, P6590, DOI 10.1002/anie.201210066; Tsubogo T, 2012, CHEM-EUR J, V18, P13624, DOI 10.1002/chem.201202896; VANARNUM P, 2013, PHARM TECHNOL, V37, P78; Webb D, 2010, CHEM SCI, V1, P675, DOI 10.1039/c0sc00381f; Wiles C, 2012, GREEN CHEM, V14, P38, DOI 10.1039/c1gc16022b; Worrall DL, 1929, ORG SYNTH, V9, P66	30	262	264	15	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					329	332		10.1038/nature14343	http://dx.doi.org/10.1038/nature14343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877201				2022-12-24	WOS:000352974200034
J	Mccoy, RC; Demko, Z; Ryan, A; Banjevic, M; Hill, M; Sigurjonsson, S; Rabinowitz, M; Fraser, HB; Petrov, DA				McCoy, Rajiv C.; Demko, Zachary; Ryan, Allison; Banjevic, Milena; Hill, Matthew; Sigurjonsson, Styrmir; Rabinowitz, Matthew; Fraser, Hunter B.; Petrov, Dmitri A.			Common variants spanning PLK4 are associated with mitotic-origin aneuploidy in human embryos	SCIENCE			English	Article							PREIMPLANTATION EMBRYOS; CHROMOSOMAL MOSAICISM; BLASTOMERES; SINGLE; RATES	Aneuploidy, the inheritance of an atypical chromosome complement, is common in early human development and is the primary cause of pregnancy loss. By screening day-3 embryos during in vitro fertilization cycles, we identified an association between aneuploidy of putative mitotic origin and linked genetic variants on chromosome 4 of maternal genomes. This associated region contains a candidate gene, Polo-like kinase 4 (PLK4), that plays a well-characterized role in centriole duplication and has the ability to alter mitotic fidelity upon minor dysregulation. Mothers with the high-risk genotypes contributed fewer embryos for testing at day 5, suggesting that their embryos are less likely to survive to blastocyst formation. The associated region coincides with a signature of a selective sweep in ancient humans, suggesting that the causal variant was either the target of selection or hitchhiked to substantial frequency.	[McCoy, Rajiv C.; Fraser, Hunter B.; Petrov, Dmitri A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Demko, Zachary; Ryan, Allison; Banjevic, Milena; Hill, Matthew; Sigurjonsson, Styrmir; Rabinowitz, Matthew] Natera Inc, San Carlos, CA 94070 USA	Stanford University	Demko, Z (corresponding author), Natera Inc, San Carlos, CA 94070 USA.	rmccoy@stanford.edu; zdemko@natera.com; dpetrov@stanford.edu	McCoy, Rajiv/AEW-9951-2022	McCoy, Rajiv/0000-0003-0615-146X; Petrov, Dmitri/0000-0002-3664-9130	 [R01 GM100366];  [R01 GM097415];  [R01 GM089926]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100366, R01GM097415, R01GM089926] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to C. Hin and J. Layne for computing support; E. Sharon for advice regarding analyses; R. Taylor and other members of the Petrov lab for helpful input; J. Sage, J. Arand, T. Stearns, and O. Cormier for advice regarding functional annotation; and C. Boggs for comments on the manuscript. D.A.P. devised the project. D.A.P., H.B.F., and Z.D. provided guidance throughout the project. R.C.M. performed analyses and wrote the manuscript. Z.D., A. R., M.B., M.H., S.S., and M.R. helped generate the data and design the algorithm by which aneuploidies are detected. All authors read the manuscript and provided comments. D.A.P. has received stock options in Natera, Inc., as consulting fees. Z.D., A.R., M.B., M.H., S.S., and M. R. are full-time employees of and hold stock or options to hold stock in Natera, Inc. De-identified aneuploidy outcome data for all blastomeres are uploaded as supplemental material, as are genome-wide association study summary statistics. Patient genotype data for the associated region are archived at Natera, which will cooperate with qualified researchers attempting to replicate the findings of this study, conditional on institutional research board approval and adherence to a materials transfer agreement. Stanford University filed a provisional patent related to this work with the U.S. Patent and Trademark Office on 14 November 2014 (USSN 62/080,251). This work was partly supported by grants R01 GM100366, R01 GM097415, and R01 GM089926 to D.A.P. Correspondence regarding the data should be addressed to Z.D. (zdemko@natera.com); other correspondence should be addressed to R.C.M. (rmccoy@stanford.edu) or D.A.P. (dpetrov@stanford.edu).	Alexander R.D., 1979, EVOLUTIONARY BIOL HU, P436; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Coelho PA, 2013, DEV CELL, V27, P586, DOI 10.1016/j.devcel.2013.09.029; Coonen E, 2004, HUM REPROD, V19, P316, DOI 10.1093/humrep/deh077; Daphnis DD, 2005, HUM REPROD, V20, P129, DOI 10.1093/humrep/deh554; Delhanty JDA, 1997, HUM GENET, V99, P755, DOI 10.1007/s004390050443; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Johnson DS, 2010, HUM REPROD, V25, P1066, DOI 10.1093/humrep/dep452; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Sillibourne JE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-25; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Templado C, 2011, CYTOGENET GENOME RES, V133, P91, DOI 10.1159/000323795; Vega M, 2014, FERTIL STERIL, V102, P394, DOI 10.1016/j.fertnstert.2014.04.026; Voullaire L, 2000, HUM GENET, V106, P210, DOI 10.1007/s004390051030; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	25	74	78	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					235	238		10.1126/science.aaa3337	http://dx.doi.org/10.1126/science.aaa3337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859044	Green Accepted			2022-12-24	WOS:000352613700046
J	Spitale, RC; Flynn, RA; Zhang, QC; Crisalli, P; Lee, B; Jung, JW; Kuchelmeister, HY; Batista, PJ; Torre, EA; Kool, ET; Chang, HY				Spitale, Robert C.; Flynn, Ryan A.; Zhang, Qiangfeng Cliff; Crisalli, Pete; Lee, Byron; Jung, Jong-Wha; Kuchelmeister, Hannes Y.; Batista, Pedro J.; Torre, Eduardo A.; Kool, Eric T.; Chang, Howard Y.			Structural imprints in vivo decode RNA regulatory mechanisms	NATURE			English	Article							GENOME-WIDE MEASUREMENT; SECONDARY STRUCTURE; REVEALS; METHYLATION; SEQUENCES; RECOGNITION; EXPRESSION; VERTEBRATE; PROTEINS	Visualizing the physical basis for molecular behaviour inside living cells is a great challenge for biology. RNAs are central to biological regulation, and the ability of RNA to adopt specific structures intimately controls every step of the gene expression program(1). However, our understanding of physiological RNA structures is limited; current in vivo RNA structure profiles include only two of the four nucleotides that make up RNA(2,3). Here we present a novel biochemical approach, in vivo click selective 2'-hydroxyl acylation and profiling experiment (icSHAPE), which enables the first global view, to our knowledge, of RNA secondary structures in living cells for all four bases. icSHAPE of the mouse embryonic stem cell transcriptome versus purified RNA folded in vitro shows that the structural dynamics of RNA in the cellular environment distinguish different classes of RNAs and regulatory elements. Structural signatures at translational start sites and ribosome pause sites are conserved from in vitro conditions, suggesting that these RNA elements are programmed by sequence. In contrast, focal structural rearrangements in vivo reveal precise interfaces of RNA with RNA-binding proteins or RNA-modification sites that are consistent with atomic-resolution structural data. Such dynamic structural footprints enable accurate prediction of RNA-protein interactions and N-6-methyladenosine (m(6)A) modification genome wide. These results open the door for structural genomics of RNA in living cells and reveal key physiological structures controlling gene expression.	[Spitale, Robert C.; Flynn, Ryan A.; Zhang, Qiangfeng Cliff; Lee, Byron; Batista, Pedro J.; Torre, Eduardo A.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Spitale, Robert C.; Flynn, Ryan A.; Zhang, Qiangfeng Cliff; Lee, Byron; Batista, Pedro J.; Torre, Eduardo A.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Crisalli, Pete; Jung, Jong-Wha; Kuchelmeister, Hannes Y.; Kool, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kool@stanford.edu; howchang@stanford.edu	Zhang, Qiangfeng/C-2902-2011; Batista, Pedro J/K-5303-2012	Flynn, Ryan/0000-0001-5013-0442; Kool, Eric/0000-0002-7310-2935; Lee, Byron/0000-0001-7132-2662	National Institutes of Health (NIH) [R01HG004361, P50HG007735]; California Institute for Regenerative Medicine; NIH [R01068122, T32AR007422, F30CA189514]; A.P. Giannini Foundation; Stanford Dean's Fellowship; Stanford Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [T32CA009302, F30CA189514] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068122] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A.P. Giannini Foundation; Stanford Dean's Fellowship; Stanford Medical Scientist Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Chang laboratory, J. Weissman and J. Doudna for comments. This work was supported by National Institutes of Health (NIH) R01HG004361 and P50HG007735, and the California Institute for Regenerative Medicine (H.Y.C.), NIH R01068122 (E.T.K.), the A.P. Giannini Foundation (R.C.S.), a Stanford Dean's Fellowship (Q.C.Z.), NIH T32AR007422 (P.J.B.), and the Stanford Medical Scientist Training Program and NIH F30CA189514 (R.A.F.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dvir S, 2013, P NATL ACAD SCI USA, V110, pE2792, DOI 10.1073/pnas.1222534110; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Gherghe C, 2010, P NATL ACAD SCI USA, V107, P19248, DOI 10.1073/pnas.1006897107; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jangi M, 2014, GENE DEV, V28, P637, DOI 10.1101/gad.235770.113; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4472, DOI 10.1093/nar/gkg633; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; McGinnis JL, 2014, BIOCHEMISTRY-US, V53, P3237, DOI 10.1021/bi500198b; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Schroeder R, 2002, CURR OPIN STRUC BIOL, V12, P296, DOI 10.1016/S0959-440X(02)00325-1; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]; Vandivier LE, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24301; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weeks KM, 2011, ACCOUNTS CHEM RES, V44, P1280, DOI 10.1021/ar200051h; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	438	467	11	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					486	+		10.1038/nature14263	http://dx.doi.org/10.1038/nature14263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799993	Green Submitted, Green Accepted			2022-12-24	WOS:000351602800059
J	Fei, JY; Singh, D; Zhang, QC; Park, S; Balasubramanian, D; Golding, I; Vanderpool, CK; Ha, T				Fei, Jingyi; Singh, Digvijay; Zhang, Qiucen; Park, Seongjin; Balasubramanian, Divya; Golding, Ido; Vanderpool, Carin K.; Ha, Taekjip			Determination of in vivo target search kinetics of regulatory noncoding RNA	SCIENCE			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; POSTTRANSCRIPTIONAL REGULATION; HFQ; SGRS; CELL; COMPETITION; EXPRESSION; BACTERIA; SYSTEMS	Base-pairing interactions between nucleic acids mediate target recognition in many biological processes. We developed a super-resolution imaging and modeling platform that enabled the in vivo determination of base pairing-mediated target recognition kinetics. We examined a stress-induced bacterial small RNA, SgrS, which induces the degradation of target messenger RNAs (mRNAs). SgrS binds to a primary target mRNA in a reversible and dynamic fashion, and formation of SgrS-mRNA complexes is rate-limiting, dictating the overall regulation efficiency in vivo. Examination of a secondary target indicated that differences in the target search kinetics contribute to setting the regulation priority among different target mRNAs. This super-resolution imaging and analysis approach provides a conceptual framework that can be generalized to other small RNA systems and other target search processes.	[Fei, Jingyi; Zhang, Qiucen; Park, Seongjin; Golding, Ido; Ha, Taekjip] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Singh, Digvijay; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Balasubramanian, Divya; Vanderpool, Carin K.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ha, Taekjip] Howard Hughes Med Inst, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Vanderpool, CK (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	cvanderp@life.uiuc.edu; tjha@illinois.edu	Singh, Digvijay/J-3091-2019; Ha, Taekjip/B-9506-2009; Park, Seongjin/AAU-9963-2020	Singh, Digvijay/0000-0002-7411-4436; Ha, Taekjip/0000-0003-2195-6258; Vanderpool, Carin/0000-0002-2850-5532	National Science Foundation [PHY 082265, PHY 1147498]; National Institutes of Health [GM 112659, GM065367, GM082837, GM092830]; Welch Foundation [Q-1759]; Jane Coffin Childs Memorial Fund for Medical Research; Division Of Physics [1430124, 1147498] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837, R01GM065367, R01GM092830, R01GM112659] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Jane Coffin Childs Memorial Fund for Medical Research; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. A. Sepulveda, L. H. So, M. Bates, X. Zhuang, Y. Liu, J. E. Stone, K. Schulten, H. Aiba, Z. Luthey-Schulten, T. E. Kuhlman, Y. Wang, and T. Lu for discussion, reagents, and software (12). This work was supported by grants from the National Science Foundation (PHY 082265 and PHY 1147498), the National Institutes of Health (GM 112659, GM065367, GM082837, and GM092830), the Welch Foundation (Q-1759), and the Jane Coffin Childs Memorial Fund for Medical Research.	Arluison V, 2007, NUCLEIC ACIDS RES, V35, P999, DOI 10.1093/nar/gkl1124; Bobrovskyy M, 2013, ANNU REV GENET, V47, P209, DOI 10.1146/annurev-genet-111212-133445; Daszykowski M, 2001, CHEMOMETR INTELL LAB, V56, P83, DOI 10.1016/S0169-7439(01)00111-3; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Ester M., 1996, P 2 INT C KNOWL DISC, V1996, P226, DOI DOI 10.1023/A:1009745219419; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hussein R, 2011, P NATL ACAD SCI USA, V108, P1110, DOI 10.1073/pnas.1010082108; Hwang W, 2011, NUCLEIC ACIDS RES, V39, P5131, DOI 10.1093/nar/gkr075; Jost D, 2013, BIOPHYS J, V104, P1773, DOI 10.1016/j.bpj.2013.02.020; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kimata K, 2001, EMBO J, V20, P3587, DOI 10.1093/emboj/20.13.3587; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/nmeth.2069, 10.1038/NMETH.2069]; Malkova A, 2013, CURR OPIN GENET DEV, V23, P271, DOI 10.1016/j.gde.2013.05.007; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rice JB, 2011, NUCLEIC ACIDS RES, V39, P3806, DOI 10.1093/nar/gkq1219; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sun Y, 2013, J BACTERIOL, V195, P4804, DOI 10.1128/JB.00722-13; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wadler CS, 2009, NUCLEIC ACIDS RES, V37, P5477, DOI 10.1093/nar/gkp591; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	28	84	86	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1371	1374		10.1126/science.1258849	http://dx.doi.org/10.1126/science.1258849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792329	Green Accepted			2022-12-24	WOS:000351219600044
J	Zimmerman, JB; Anastas, PT				Zimmerman, Julie B.; Anastas, Paul T.			Toward substitution with no regrets	SCIENCE			English	Editorial Material							BISPHENOL-A; FRAMEWORK; EXPOSURE; RISK		[Zimmerman, Julie B.; Anastas, Paul T.] Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06511 USA	Yale University	Zimmerman, JB (corresponding author), Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06511 USA.	julie.zimmerman@yale.edu	Anastas, Paul/L-3258-2013; Zimmerman, Julie B/K-9572-2013	Anastas, Paul/0000-0003-4777-5172; Zimmerman, Julie/0000-0002-5392-312X				Anastas P. T., 1998, GREEN CHEM THEORY PR; Anderson SE, 2013, FOOD CHEM TOXICOL, V62, P373, DOI 10.1016/j.fct.2013.08.053; Boethling RS, 2007, CHEM REV, V107, P2207, DOI 10.1021/cr050952t; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Eladak S, 2015, FERTIL STERIL, V103, P11, DOI 10.1016/j.fertnstert.2014.11.005; Hoque J, 2012, LANGMUIR, V28, P12225, DOI 10.1021/la302303d; Hubbs AF, 2012, AM J PATHOL, V181, P829, DOI 10.1016/j.ajpath.2012.05.021; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P257, DOI 10.1289/ehp.6115; National Research Council, 2014, FRAM GUID SEL CHEM A; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sudakin DL, 2003, J TOXICOL-CLIN TOXIC, V41, P831, DOI 10.1081/CLT-120025348; U.S. Environmental Protection Agency, 2012, EPAS DFE STAND SAF P; Velleux M, 2012, ENVIRON SCI TECHNOL, V46, P6723, DOI 10.1021/es204452w; Voutchkova AM, 2010, CHEM REV, V110, P5845, DOI 10.1021/cr9003105	15	77	78	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1198	1199		10.1126/science.aaa0812	http://dx.doi.org/10.1126/science.aaa0812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766217				2022-12-24	WOS:000350824300018
J	Adachi, M; Motohashi, M				Adachi, Makoto; Motohashi, Masayuki			Passage of a Sialolith	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adachi, Makoto; Motohashi, Masayuki] Asahi Univ Murakami Mem Hosp, Gifu, Japan		Adachi, M (corresponding author), Asahi Univ Murakami Mem Hosp, Gifu, Japan.	madachi_dds_phd@yahoo.co.jp	Adachi, Makoto/K-8113-2019	Adachi, Makoto/0000-0002-9382-7052					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11							e15	10.1056/NEJMicm1407548	http://dx.doi.org/10.1056/NEJMicm1407548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760374				2022-12-24	WOS:000350797300011
J	Buitrago-Delgado, E; Nordin, K; Rao, A; Geary, L; LaBonne, C				Buitrago-Delgado, Elsy; Nordin, Kara; Rao, Anjali; Geary, Lauren; LaBonne, Carole			Shared regulatory programs suggest retention of blastula-stage potential in neural crest cells	SCIENCE			English	Article							SELF-RENEWAL; STEM-CELLS; ES CELLS; XENOPUS; PLURIPOTENCY; INDUCTION; EXPRESSION; PAX3; MYC; DIFFERENTIATION	Neural crest cells, which are specific to vertebrates, arise in the ectoderm but can generate cell types that are typically categorized as mesodermal. This broad developmental potential persists past the time when most ectoderm-derived cells become lineage-restricted. The ability of neural crest to contribute mesodermal derivatives to the bauplan has raised questions about how this apparent gain in potential is achieved. Here, we describe shared molecular underpinnings of potency in neural crest and blastula cells. We show that in Xenopus, key neural crest regulatory factors are also expressed in blastula animal pole cells and promote pluripotency in both cell types. We suggest that neural crest cells may have evolved as a consequence of a subset of blastula cells retaining activity of the regulatory network underlying pluripotency.	[Buitrago-Delgado, Elsy; Nordin, Kara; Rao, Anjali; Geary, Lauren; LaBonne, Carole] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [LaBonne, Carole] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	LaBonne, C (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	clabonne@northwestern.edu	Rao, Anjali/AGQ-5949-2022; Rao, Anjali/AAT-8123-2020	Rao, Anjali/0000-0001-8815-9865	 [F31DE021922];  [T32CA009560-24];  [T32GM008061];  [R01GM114058]; NATIONAL CANCER INSTITUTE [T32CA009560, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, R01GM077288] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010997] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Nguyen for technical assistance, S. Sokol for providing activin, and R. Carthew and X. Wang for helpful discussions. K.N. was supported by grants F31DE021922 and T32CA009560-24. L.G was supported by grant T32GM008061. This work was supported by grant R01GM114058 to C.L. The supplementary materials contain additional data.	Abitua PB, 2012, NATURE, V492, P104, DOI 10.1038/nature11589; ANDERSON DJ, 1989, TRENDS GENET, V5, P174, DOI 10.1016/0168-9525(89)90072-3; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Frankenberg SR, 2014, DEVELOPMENT, V141, P2921, DOI 10.1242/dev.108407; Furue M., 2004, HDB STEM CELLS, V1; GRAINGER RM, 1989, P NATL ACAD SCI USA, V86, P1900, DOI 10.1073/pnas.86.6.1900; Hall BK, 1999, NEURAL CREST DEV EVO; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; JONES EA, 1987, DEVELOPMENT, V101, P557; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 1999, NEURAL CREST, V2; Light W, 2005, DEVELOPMENT, V132, P1831, DOI 10.1242/dev.01734; Lin YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4070; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; NIEUWKOOP PD, 1969, ROUX ARCH DEV BIOL, V163, P298; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nordin K, 2014, DEV CELL, V31, P374, DOI 10.1016/j.devcel.2014.10.003; Rogers CD, 2008, DEV BIOL, V313, P307, DOI 10.1016/j.ydbio.2007.10.023; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Scerbo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036855; Taylor KM, 2007, CURR OPIN GENET DEV, V17, P326, DOI 10.1016/j.gde.2007.05.012; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	33	94	96	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1332	1335		10.1126/science.aaa3655	http://dx.doi.org/10.1126/science.aaa3655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	25931449	Green Accepted			2022-12-24	WOS:000356449500043
J	Liu, Y; Holmstrom, E; Zhang, JW; Yu, P; Wang, JB; Dyba, MA; Chen, D; Ying, JF; Lockett, S; Nesbitt, DJ; Ferre-D'Amare, AR; Sousa, R; Stagno, JR; Wang, YX				Liu, Yu; Holmstrom, Erik; Zhang, Jinwei; Yu, Ping; Wang, Jinbu; Dyba, Marzena A.; Chen, De; Ying, Jinfa; Lockett, Stephen; Nesbitt, David J.; Ferre-D'Amare, Adrian R.; Sousa, Rui; Stagno, Jason R.; Wang, Yun-Xing			Synthesis and applications of RNAs with position-selective labelling and mosaic composition	NATURE			English	Article							SINGLE-MOLECULE; TRANSCRIPTION INITIATION; MESSENGER-RNAS; DNA TEMPLATES; POLYMERASE; RIBOSWITCH; STABILITY; LIGAND; DISSOCIATION; SPECIFICITY	Knowledge of the structure and dynamics of RNA molecules is critical to understanding their many biological functions. Furthermore, synthetic RNAs have applications as therapeutics and molecular sensors. Both research and technological applications of RNA would be dramatically enhanced by methods that enable incorporation of modified or labelled nucleotides into specifically designated positions or regions of RNA. However, the synthesis of tens of milligrams of such RNAs using existing methods has been impossible. Here we develop a hybrid solid-liquid phase transcription method and automated robotic platform for the synthesis of RNAs with position-selective labelling. We demonstrate its use by successfully preparing various isotope- or fluorescently labelled versions of the 71-nucleotide aptamer domain of an adenine riboswitch(1) for nuclear magnetic resonance spectroscopy or single-molecule Forster resonance energy transfer, respectively. Those RNAs includemolecules that were selectively isotope-labelled in specific loops, linkers, a helix, several discrete positions, or a single internal position, as well as RNA molecules that were fluorescently labelled in and near kissing loops. These selectively labelled RNAs have the same fold as those transcribed using conventional methods, but they greatly simplify the interpretation of NMR spectra. The single-position isotope-and fluorescently labelled RNA samples reveal multiple conformational states of the adenine riboswitch. Lastly, we describe a robotic platform- and the operation that automates this technology. Our selective labelling method may be useful for studying RNA structure and dynamics and for making RNA sensors for a variety of applications including cell-biological studies, substance detection(2), and disease diagnostics(3,4).	[Liu, Yu; Wang, Jinbu; Stagno, Jason R.; Wang, Yun-Xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Holmstrom, Erik; Nesbitt, David J.] Univ Colorado, NIST, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Holmstrom, Erik; Nesbitt, David J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Zhang, Jinwei; Ferre-D'Amare, Adrian R.] NHLBI, Biochem & Biophys Ctr, Bethesda, MD 20892 USA; [Yu, Ping; Dyba, Marzena A.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Basic Sci Program, Struct Biophys Lab, Frederick, MD 21702 USA; [Chen, De; Lockett, Stephen] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Opt Microscopy & Anal Lab, Frederick, MD 21702 USA; [Ying, Jinfa] NIDDK, Lab Chem Phys, NIH, Bethesda, MD 20892 USA; [Sousa, Rui] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Health San Antonio	Wang, YX (corresponding author), NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA.	wangyunx@mail.nih.gov	Zhang, Jinwei/AAU-9195-2020; Stagno, Jason/AAP-2159-2020	Zhang, Jinwei/0000-0002-2114-173X; Stagno, Jason/0000-0002-6464-7829; Sousa, Rui/0000-0003-4314-121X	National Cancer Institute, the National Institute of Diabetes, Digestive and Kidney Diseases, the National Heart, Lung and Blood Institute; Intramural Antiviral Target Program (IATAP) of the Office of the Director, National Institutes of Health; National Institutes of Health; National Cancer Institute [HHSN261200800001E]; National Science Foundation [CHE1266416, PHYS1125844]; National Institutes of Health Molecular Biophysics Training Program [T32 GM-065103]; W. M. Keck Foundation; National Institute of Standards and Technology; NATIONAL CANCER INSTITUTE [ZICBC011535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052522, T32GM065103] Funding Source: NIH RePORTER	National Cancer Institute, the National Institute of Diabetes, Digestive and Kidney Diseases, the National Heart, Lung and Blood Institute; Intramural Antiviral Target Program (IATAP) of the Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Molecular Biophysics Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. E. Draper, A. Bax, A. Byrd, M. Summers, A. Rein, and J. Strathern for discussions. This work was supported in part by the Intramural Research Programs of the National Cancer Institute, the National Institute of Diabetes, Digestive and Kidney Diseases, the National Heart, Lung and Blood Institute; by the Intramural Antiviral Target Program (IATAP) of the Office of the Director, National Institutes of Health; by the 2013 Director's Challenge Innovation Award of the National Institutes of Health; by the fund from the National Cancer Institute under contract number HHSN261200800001E; by the National Science Foundation (CHE1266416, PHYS1125844); by the National Institutes of Health Molecular Biophysics Training Program (T32 GM-065103); and by the W. M. Keck Foundation, and the National Institute of Standards and Technology. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dalgarno PA, 2013, NUCLEIC ACIDS RES, V41, P4253, DOI 10.1093/nar/gkt128; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferre-D'Amare A. R., 1996, NUCLEIC ACIDS RES, V24, P977; Fiore JL, 2008, BIOPHYS J, V95, P3892, DOI 10.1529/biophysj.108.134346; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Holmstrom ED, 2014, J PHYS CHEM B, V118, P3853, DOI 10.1021/jp501893c; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lee MK, 2010, P NATL ACAD SCI USA, V107, P9192, DOI 10.1073/pnas.1001195107; Leipply D, 2011, BIOCHEMISTRY-US, V50, P2790, DOI 10.1021/bi101948k; Leipply D, 2010, BIOCHEMISTRY-US, V49, P1843, DOI 10.1021/bi902036j; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lu K, 2010, J BIOMOL NMR, V46, P113, DOI 10.1007/s10858-009-9375-2; Lyakhov DL, 1998, J MOL BIOL, V280, P201, DOI 10.1006/jmbi.1998.1854; Mairal T, 2008, ANAL BIOANAL CHEM, V390, P989, DOI 10.1007/s00216-007-1346-4; Makarova OV, 1995, P NATL ACAD SCI USA, V92, P12250, DOI 10.1073/pnas.92.26.12250; MARBLE HA, 1995, BIOTECHNOL PROGR, V11, P393, DOI 10.1021/bp00034a005; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Pavlov MY, 1997, BIOCHIMIE, V79, P415, DOI 10.1016/S0300-9084(97)86151-2; Pinheiro VB, 2014, TRENDS BIOTECHNOL, V32, P321, DOI 10.1016/j.tibtech.2014.03.010; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Scaringe SA, 1998, J AM CHEM SOC, V120, P11820, DOI 10.1021/ja980730v; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Sohn YH, 2003, METHOD ENZYMOL, V371, P170; Steinberg G, 2004, BIOPOLYMERS, V73, P597, DOI 10.1002/bip.20006; USMAN N, 1987, J AM CHEM SOC, V109, P7845, DOI 10.1021/ja00259a037; Wilson C, 2006, CURR OPIN CHEM BIOL, V10, P607, DOI 10.1016/j.cbpa.2006.10.001; Ying JF, 2011, J BIOMOL NMR, V51, P89, DOI 10.1007/s10858-011-9544-y; Zhang JW, 2014, STRUCTURE, V22, P1363, DOI 10.1016/j.str.2014.07.011; Zuo XB, 2010, P NATL ACAD SCI USA, V107, P1385, DOI 10.1073/pnas.0908140107	45	72	74	1	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					368	+		10.1038/nature14352	http://dx.doi.org/10.1038/nature14352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25938715	Green Accepted			2022-12-24	WOS:000356425400059
J	Elsasser, SJ; Noh, KM; Diaz, N; Allis, CD; Banaszynski, LA				Elsasser, Simon J.; Noh, Kyung-Min; Diaz, Nichole; Allis, C. David; Banaszynski, Laura A.			Histone H3.3 is required for endogenous retroviral element silencing in embryonic stem cells	NATURE			English	Article							DNA; RETROTRANSPOSONS; CHROMATIN; DISTINCT; CHAPERONE; GENOME; GENES; DAXX; TRANSCRIPTION; REPRESSION	Transposable elements comprise roughly 40% of mammalian genomes(1). They have an active role in genetic variation, adaptation and evolution through the duplication or deletion of genes or their regulatory elements(2-4), and transposable elements themselves can act as alternative promoters for nearby genes, resulting in noncanonical regulation of transcription(5,6). However, transposable element activity can lead to detrimental genome instability(7), and hosts have evolved mechanisms to silence transposable element mobility appropriately(8,9). Recent studies have demonstrated that a subset of transposable elements, endogenous retroviral elements (ERVs) containing long terminal repeats (LTRs), are silenced through trimethylation of histone H3 on lysine 9 (H3K9me3) by ESET (also known as SETDB1 or KMT1E)(10) and a co-repressor complex containing KRAB-associated protein 1 (KAP1; also known as TRIM28)(11) in mouse embryonic stem cells. Here we show that the replacement histone variant H3.3 is enriched at class I and class II ERVs, notably those of the early transposon (ETn)/MusD family and intracisternal A-type particles (IAPs). Deposition at a subset of these elements is dependent upon the H3.3 chaperone complex containing alpha-thalassaemia/mental retardation syndrome X-linked (ATRX) 12 and death-domain-associated protein (DAXX)(12-14). We demonstrate that recruitment of DAXX, H3.3 and KAP1 to ERVs is co-dependent and occurs upstream of ESET, linking H3.3 to ERV-associated H3K9me3. Importantly, H3K9me3 is reduced at ERVs upon H3.3 deletion, resulting in derepression and dysregulation of adjacent, endogenous genes, along with increased retrotransposition of IAPs. Our study identifies a unique heterochromatin state marked by the presence of both H3.3 and H3K9me3, and establishes an important role for H3.3 in control of ERV retrotransposition in embryonic stem cells.	[Elsasser, Simon J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Elsasser, Simon J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden; [Noh, Kyung-Min; Diaz, Nichole; Allis, C. David; Banaszynski, Laura A.] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Banaszynski, Laura A.] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Banaszynski, Laura A.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA	MRC Laboratory Molecular Biology; Karolinska Institutet; Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Elsasser, SJ (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	simon.elsasser@scilifelab.se; alliscd@rockefeller.edu; laura.banaszynski@utsouthwestern.edu	Elsässer, Simon/AAM-3986-2020	Elsässer, Simon/0000-0001-8724-4849; Noh, Kyung-Min/0000-0002-0708-787X	Rockefeller University Fund; Tri-Institutional Stem Cell Initiative; EMBO ALTF [1232-2011]; Cambridge University Herchel Smith Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER	Rockefeller University Fund; Tri-Institutional Stem Cell Initiative; EMBO ALTF; Cambridge University Herchel Smith Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Rockefeller University Fund and the Tri-Institutional Stem Cell Initiative. S.J.E. acknowledges funding from EMBO ALTF 1232-2011 and the Cambridge University Herchel Smith Fund. We thank D. Pickett, D. Trono and D. Shinkai for cell lines. We thank A. Goldberg and C. Li for technical assistance and members of the Allis laboratory for helpful discussions.	Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Chen P, 2013, GENE DEV, V27, P2109, DOI 10.1101/gad.222174.113; Das PP, 2014, MOL CELL, V53, P32, DOI 10.1016/j.molcel.2013.11.011; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; DeNizio JE, 2014, NUCLEIC ACIDS RES, V42, P4318, DOI 10.1093/nar/gku090; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Frey A, 2014, CURR BIOL, V24, P2195, DOI 10.1016/j.cub.2014.07.077; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Jurka J, 2005, CYTOGENET GENOME RES, V110, P117, DOI 10.1159/000084943; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004047; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; Longo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-334; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Rebollo R, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R89, 10.1186/gb-2012-13-10-r89]; Ribet D, 2008, GENOME RES, V18, P597, DOI 10.1101/gr.073486.107; Robberecht C, 2013, GENOME RES, V23, P411, DOI 10.1101/gr.145631.112; Rowe HM, 2013, GENOME RES, V23, P452, DOI 10.1101/gr.147678.112; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Yildirim O, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004515; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	40	218	225	6	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					240	U323		10.1038/nature14345	http://dx.doi.org/10.1038/nature14345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25938714	Green Accepted			2022-12-24	WOS:000356016700044
J	Wong, YL; Anzola, JV; Davis, RL; Yoon, M; Motamedi, A; Kroll, A; Seo, CP; Hsia, JE; Kim, SK; Mitchell, JW; Mitchell, BJ; Desai, A; Gahman, TC; Shiau, AK; Oegema, K				Wong, Yao Liang; Anzola, John V.; Davis, Robert L.; Yoon, Michelle; Motamedi, Amir; Kroll, Ashley; Seo, Chanmee P.; Hsia, Judy E.; Kim, Sun K.; Mitchell, Jennifer W.; Mitchell, Brian J.; Desai, Arshad; Gahman, Timothy C.; Shiau, Andrew K.; Oegema, Karen			Reversible centriole depletion with an inhibitor of Polo-like kinase 4	SCIENCE			English	Article							CENTROSOME DUPLICATION; CYCLE; P53; CYTOKINESIS; CFI-400945; PATHWAY	Centrioles are ancient organelles that build centrosomes, the major microtubule-organizing centers of animal cells. Extra centrosomes are a common feature of cancer cells. To investigate the importance of centrosomes in the proliferation of normal and cancer cells, we developed centrinone, a reversible inhibitor of Polo-like kinase 4 (Plk4), a serine-threonine protein kinase that initiates centriole assembly. Centrinone treatment caused centrosome depletion in human and other vertebrate cells. Centrosome loss irreversibly arrested normal cells in a senescence-like G(1) state by a p53-dependent mechanism that was independent of DNA damage, stress, Hippo signaling, extended mitotic duration, or segregation errors. In contrast, cancer cell lines with normal or amplified centrosome numbers could proliferate indefinitely after centrosome loss. Upon centrinone washout, each cancer cell line returned to an intrinsic centrosome number "set point." Thus, cells with cancer-associated mutations fundamentally differ from normal cells in their response to centrosome loss.	[Wong, Yao Liang; Kroll, Ashley; Desai, Arshad; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Anzola, John V.; Davis, Robert L.; Yoon, Michelle; Motamedi, Amir; Seo, Chanmee P.; Hsia, Judy E.; Gahman, Timothy C.; Shiau, Andrew K.] Ludwig Inst Canc Res, Small Mol Discovery Program, La Jolla, CA 92093 USA; [Kim, Sun K.; Mitchell, Jennifer W.; Mitchell, Brian J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Northwestern University; Feinberg School of Medicine	Oegema, K (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	ashiau@ucsd.edu; koegema@ucsd.edu		Wong, Yao Liang/0000-0003-0298-8510; Mitchell, Brian/0000-0001-6281-1536; Kim, Sun/0000-0002-6033-6142	NIH [GM103403, GM074207, GM089970]; Hilton Ludwig Cancer Prevention Initiative; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074207, R01GM089970, P41GM103403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hilton Ludwig Cancer Prevention Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Li for leading the Sundia Meditech chemistry team, Advanced Photon Source NE-CAT (supported by NIH GM103403) for assistance with x-ray data collection, Q. Zhu and I. Verma for the p53 and Glu4 shRNA lentiviruses, A. Holland and D. Cleveland for the Plk4-YFP DLD-1 cell line, R. Gassmann for help with initial cell-based assays, M. Kaulich for technical advice on CRISPR/Cas9, and A. Dammermann for generation of the Sas6 and Cep192 antibodies. J.V.A, R.L.D., M.Y., A.M., C.P.S., J.E.H., A.D., T.C.G., A.K.S., and K.O. receive salary and other support from the Ludwig Institute for Cancer Research. This work was supported by NIH grants to K.O. (GM074207) and B.J.M. (GM089970), and with funds from the Hilton Ludwig Cancer Prevention Initiative to A.K.S. and T.C.G. The data described here are tabulated in the main paper and Supplementary Materials. The structure of the centrinone-bound Plk4 kinase domain complex has been deposited in the Protein Data Bank (4YUR). The Ludwig Institute for Cancer Research has filed a patent application (62/149,292) related to the structures, syntheses, and uses of centrinone, centrinone B, and chemically related Plk4 inhibitors. Requests for the centrinones should be directed to A.K.S. (ashiau@ucsd.edu).	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bazzi H, 2014, P NATL ACAD SCI USA, V111, pE1491, DOI 10.1073/pnas.1400568111; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; Brito DA, 2012, CURR OPIN CELL BIOL, V24, P4, DOI 10.1016/j.ceb.2012.01.003; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Izquierdo D, 2014, CELL REP, V8, P957, DOI 10.1016/j.celrep.2014.07.022; Jenkins LMM, 2012, CARCINOGENESIS, V33, P1441, DOI 10.1093/carcin/bgs145; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Mason JM, 2014, CANCER CELL, V26, P163, DOI 10.1016/j.ccr.2014.05.006; Nigg EA, 2014, FEBS LETT, V588, P2366, DOI 10.1016/j.febslet.2014.06.030; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Rios RM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0462; Sampson PB, 2015, J MED CHEM, V58, P147, DOI 10.1021/jm5005336; Schatten H, 2008, HISTOCHEM CELL BIOL, V129, P667, DOI 10.1007/s00418-008-0427-6; Shen H, 2011, CURR PHARM DESIGN, V17, P560, DOI 10.2174/138161211795222603; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Sir JH, 2013, J CELL BIOL, V203, P747, DOI 10.1083/jcb.201309038; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Sumigray Kaelyn D, 2011, Bioarchitecture, V1, P221; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018	35	258	261	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1155	1160		10.1126/science.aaa5111	http://dx.doi.org/10.1126/science.aaa5111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25931445	Green Accepted, Green Submitted			2022-12-24	WOS:000355590500053
J	Zhou, XX; Halladin, DK; Rojas, ER; Koslover, EF; Lee, TK; Huang, KC; Theriot, JA				Zhou, Xiaoxue; Halladin, David K.; Rojas, Enrique R.; Koslover, Elena F.; Lee, Timothy K.; Huang, Kerwyn Casey; Theriot, Julie A.			Mechanical crack propagation drives millisecond daughter cell separation in Staphylococcus aureus	SCIENCE			English	Article							CRYOELECTRON MICROSCOPY; DIVISION; GROWTH; PEPTIDOGLYCAN; RING; AUTOLYSIN; BACTERIA; GEOMETRY; ENZYMES; WALLS	When Staphylococcus aureus undergoes cytokinesis, it builds a septum, generating two hemispherical daughters whose cell walls are only connected via a narrow peripheral ring. We found that resolution of this ring occurred within milliseconds ("popping"), without detectable changes in cell volume. The likelihood of popping depended on cell-wall stress, and the separating cells split open asymmetrically, leaving the daughters connected by a hinge. An elastostatic model of the wall indicated high circumferential stress in the peripheral ring before popping. Last, we observed small perforations in the peripheral ring that are likely initial points of mechanical failure. Thus, the ultrafast daughter cell separation in S. aureus appears to be driven by accumulation of stress in the peripheral ring and exhibits hallmarks of mechanical crack propagation.	[Zhou, Xiaoxue] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Zhou, Xiaoxue; Halladin, David K.; Rojas, Enrique R.; Koslover, Elena F.; Theriot, Julie A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Zhou, Xiaoxue; Halladin, David K.; Rojas, Enrique R.; Koslover, Elena F.; Theriot, Julie A.] Stanford Univ, Howard Hughes Med Inst HHMI, Sch Med, Stanford, CA 94305 USA; [Rojas, Enrique R.; Huang, Kerwyn Casey; Theriot, Julie A.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Rojas, Enrique R.; Lee, Timothy K.; Huang, Kerwyn Casey] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Theriot, JA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	theriot@stanford.edu	Koslover, Elena/K-4548-2017; Theriot, Julie/HHN-2034-2022	Koslover, Elena/0000-0003-4139-9209; Zhou, Xiaoxue/0000-0002-4551-0608; Theriot, Julie/0000-0002-2334-2535	National Center for Research Resources [1S10OD01227601]; Stanford Interdisciplinary Graduate Fellowship; Stanford Cell and Molecular Biology Training Grant [T32-GM007276]; NIH Center for Biomedical Computation [U54-GM072970]; James S. McDonnell Foundation; Siebel Scholars Graduate Fellowship; NIH Biotechnology Training Grant; NIH Director's New Innovator Award [DP2OD006466]; HHMI; National Institute of Allergy and Infectious Diseases [R01-AI36929]; Stanford Center for Systems Biology [P50-GM107615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036929, R01AI036929, R01AI067712, T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, U54GM072970, T32GM007276] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006466] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Stanford Interdisciplinary Graduate Fellowship; Stanford Cell and Molecular Biology Training Grant; NIH Center for Biomedical Computation; James S. McDonnell Foundation; Siebel Scholars Graduate Fellowship; NIH Biotechnology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Center for Systems Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. A. Levin for strain Newman; A. Cheung for RN6390 Delta spa; W. M. Nauseef for plasmid pCM29; J. Bose and K. W. Bayles for UAMS-1 and UAMS-1 Delta atl; J. Mulholland and L. Joubert in the Cell Sciences Imaging Facility at Stanford for technical assistance with 3D SIM (funded by National Center for Research Resources award number 1S10OD01227601) and SEM; S. Lou and L. Harris for help with the blind SEM analysis; M. Pinho, F. Chang, and L. Cegelski for discussions; and J. Shaevitz, D. Fisher, L. Harris, and the anonymous reviewers for helpful comments on the manuscript. X.Z. was supported by a Stanford Interdisciplinary Graduate Fellowship; D.K.H. was supported by the Stanford Cell and Molecular Biology Training Grant (T32-GM007276); E.R.R. was supported by a Distinguished Postdoctoral Fellowship from the Simbios NIH Center for Biomedical Computation (U54-GM072970); E.F.K. was supported by the James S. McDonnell Foundation Postdoctoral Fellowship Award in Studying Complex Systems; T.K.L. was supported by a Siebel Scholars Graduate Fellowship and an NIH Biotechnology Training Grant; K.C.H. was funded by a NIH Director's New Innovator Award (DP2OD006466); and J.A.T. was funded by HHMI, the National Institute of Allergy and Infectious Diseases (R01-AI36929) and the Stanford Center for Systems Biology (P50-GM107615).	AMAKO K, 1977, J ULTRA MOL STRUCT R, V58, P34, DOI 10.1016/S0022-5320(77)80005-1; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baumberger T, 2006, NAT MATER, V5, P552, DOI 10.1038/nmat1666; Baumberger T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078267; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Dill E. H., 2007, CONTINUUM MECH ELAST, P239; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Griffith AA., 1921, PHILOS T R SOC LON A, V221, P163; KOYAMA T, 1977, J BACTERIOL, V129, P1518, DOI 10.1128/JB.129.3.1518-1523.1977; Matias VRF, 2007, MOL MICROBIOL, V64, P195, DOI 10.1111/j.1365-2958.2007.05634.x; Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; PREVIC EP, 1970, J THEOR BIOL, V27, P471, DOI 10.1016/S0022-5193(70)80010-8; Rojas E, 2014, P NATL ACAD SCI USA, V111, P7807, DOI 10.1073/pnas.1402591111; Schijve J., 2009, FATIGUE STRUCTURES M, DOI [DOI 10.1007/978-1-4020-6808-9, 10.1007/978-1-4020-6808-9_17]; SELIGMAN SJ, 1987, J THEOR BIOL, V124, P275, DOI 10.1016/S0022-5193(87)80116-9; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Touhami A, 2004, J BACTERIOL, V186, P3286, DOI 10.1128/JB.186.11.3286-3295.2004; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; TZAGOLOFF H, 1977, J BACTERIOL, V129, P343, DOI 10.1128/JB.129.1.343-350.1977; WAGNER M, 1979, Z IMMUNITATSFORSCH, V156, P57; WALSH JM, 1984, J APPL PHYS, V56, P1997, DOI 10.1063/1.334234; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Zhou F, 2006, INT J IMPACT ENG, V33, P880, DOI 10.1016/j.ijimpeng.2006.09.070	31	63	63	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					574	578		10.1126/science.aaa1511	http://dx.doi.org/10.1126/science.aaa1511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931560	Green Accepted			2022-12-24	WOS:000353778100042
J	Rosenberg, OS; Dovala, D; Li, XM; Connolly, L; Bendebury, A; Finer-Moore, J; Holton, J; Cheng, YF; Stroud, RM; Cox, JS				Rosenberg, Oren S.; Dovala, Dustin; Li, Xueming; Connolly, Lynn; Bendebury, Anastasia; Finer-Moore, Janet; Holton, James; Cheng, Yifan; Stroud, Robert M.; Cox, Jeffery S.			Substrates Control Multimerization and Activation of the Multi-Domain ATPase Motor of Type VII Secretion	CELL			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DNA TRANSLOCATION; VIRULENCE; ESAT-6; SECA; MECHANISM; SYSTEM; SIGNAL; PATHOGENESIS; RECOGNITION	Mycobacterium tuberculosis and Staphylococcus aureus secrete virulence factors via type VII protein secretion (T7S), a system that intriguingly requires all of its secretion substrates for activity. To gain insights into T7S function, we used structural approaches to guide studies of the putative translocase EccC, a unique enzyme with three ATPase domains, and its secretion substrate EsxB. The crystal structure of EccC revealed that the ATPase domains are joined by linker/pocket interactions that modulate its enzymatic activity. EsxB binds via its signal sequence to an empty pocket on the C-terminal ATPase domain, which is accompanied by an increase in ATPase activity. Surprisingly, substrate binding does not activate EccC allosterically but, rather, by stimulating its multimerization. Thus, the EsxB substrate is also an integral T7S component, illuminating a mechanism that helps to explain interdependence of substrates, and suggests a model in which binding of substrates modulates their coordinate release from the bacterium.	[Rosenberg, Oren S.; Connolly, Lynn] Univ Calif San Francisco, Div Infect Dis, Dept Med, UCSF Med Ctr, San Francisco, CA 94143 USA; [Dovala, Dustin; Bendebury, Anastasia; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA; [Li, Xueming] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Finer-Moore, Janet; Holton, James; Cheng, Yifan; Stroud, Robert M.] Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94158 USA; [Connolly, Lynn] Achaogen Inc, San Francisco, CA 94080 USA; [Holton, James] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; UCSF Medical Center; University of California System; University of California San Francisco; Tsinghua University; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA.	jeffery.cox@ucsf.edu		Cheng, Yifan/0000-0001-9535-0369	NIH [K08AI091656, R01AI081727, P01AI063302, U54GM094625]; NSF [1144247]; U.S. DOE [DE-AC02-06CH11357, DE-AC02-05CH11231]; U.S. DOE Office of Biological and Environmental Research; NIH-GMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI091656, R01AI081727, T32AI007641, P01AI063302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM094625, R37GM024485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. DOE(United States Department of Energy (DOE)); U.S. DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH-GMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the NIH (K08AI091656 to O.S.R., R01AI081727 and P01AI063302 to J.S.C., and U54GM094625 to R.M.S.) and the NSF (grant no. 1144247 to D.D.). For technical assistance, we thank Rebecca Robbins, Peter Bieling, Jenifer Du Mond, Lara Koehler, R. Stefan Isaac, Yaneth Robles, Diana Romero, Spenser Alexander, and Andrew Rodriguez. For helpful discussions, we thank Ron Vale, John Kuriyan, James Berger, Bennett Penn, Matt Lohse, and Damian Ekiert. We thank R. Rajashankar at the APS beamline NE-CAT 24ID; George Meigs and Jane Tanamachi at ALS BL 8.3.1; and Tzanko Doukov and Lisa Dunn at SSRL. APS is supported by the U.S. DOE Contract DE-AC02-06CH11357. ALS is supported by the U.S. DOE Contract DE-AC02-05CH11231. The SSRL Structural Molecular Biology Program is supported by the U.S. DOE Office of Biological and Environmental Research and by the NIH-GMS (including P41GM103393).	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Besprozvannaya M, 2013, J BIOL CHEM, V288, P28962, DOI 10.1074/jbc.M113.484055; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Chatzi KE, 2014, BBA-MOL CELL RES, V1843, P1466, DOI 10.1016/j.bbamcr.2014.02.014; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Guglielmini J, 2013, MOL BIOL EVOL, V30, P315, DOI 10.1093/molbev/mss221; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Huppert LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096267; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pena A, 2011, J BIOL CHEM, V286, P17376, DOI 10.1074/jbc.M110.208942; Poulsen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089313; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Ramsdell TL, 2015, J MOL BIOL, V427, P1119, DOI 10.1016/j.jmb.2014.06.013; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Senior AE, 2012, J BIOL CHEM, V287, P30049, DOI 10.1074/jbc.X112.402313; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Sysoeva TA, 2014, P NATL ACAD SCI USA, V111, P7653, DOI 10.1073/pnas.1322200111; Trokter M, 2014, CURR OPIN STRUC BIOL, V27, P16, DOI 10.1016/j.sbi.2014.02.006; Waksman G, 2012, PHILOS T R SOC B, V367, P1014, DOI 10.1098/rstb.2011.0200; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014	46	82	90	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					501	512		10.1016/j.cell.2015.03.040	http://dx.doi.org/10.1016/j.cell.2015.03.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25865481	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000353553600011
J	Hautier, Y; Tilman, D; Isbell, F; Seabloom, EW; Borer, ET; Reich, PB				Hautier, Yann; Tilman, David; Isbell, Forest; Seabloom, Eric W.; Borer, Elizabeth T.; Reich, Peter B.			Anthropogenic environmental changes affect ecosystem stability via biodiversity	SCIENCE			English	Article							PLANT DIVERSITY; GRASSLAND EXPERIMENT; PRODUCTIVITY; EUTROPHICATION; DISTURBANCE; POPULATION	Human-driven environmental changes may simultaneously affect the biodiversity, productivity, and stability of Earth's ecosystems, but there is no consensus on the causal relationships linking these variables. Data from 12 multiyear experiments that manipulate important anthropogenic drivers, including plant diversity, nitrogen, carbon dioxide, fire, herbivory, and water, show that each driver influences ecosystem productivity. However, the stability of ecosystem productivity is only changed by those drivers that alter biodiversity, with a given decrease in plant species numbers leading to a quantitatively similar decrease in ecosystem stability regardless of which driver caused the biodiversity loss. These results suggest that changes in biodiversity caused by drivers of environmental change may be a major factor determining how global environmental changes affect ecosystem stability.	[Hautier, Yann] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Hautier, Yann; Tilman, David; Isbell, Forest; Seabloom, Eric W.; Borer, Elizabeth T.] Univ Minnesota Twin Cities, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hautier, Yann] Univ Utrecht, Dept Biol, Ecol & Biodivers Grp, NL-3584 CH Utrecht, Netherlands; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm, Santa Barbara, CA 93106 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia	University of Oxford; University of Minnesota System; University of Minnesota Twin Cities; Utrecht University; University of California System; University of California Santa Barbara; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University	Hautier, Y (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	yann.hautier@plants.ox.ac.uk	Hautier, Yann/D-5426-2015; Tilman, David/ABD-5309-2021; Hautier, Yann/I-2526-2019; Isbell, Forest/C-6915-2012	Hautier, Yann/0000-0003-4347-7741; Hautier, Yann/0000-0003-4347-7741; Isbell, Forest/0000-0001-9689-769X; Seabloom, Eric/0000-0001-6780-9259; Borer, Elizabeth/0000-0003-2259-5853; Reich, Peter/0000-0003-4424-662X	European Union Seventh Framework Programme [298935]; U.S. National Science Foundation (NSF) Long-Term Ecological Research (LTER) Program at Cedar Creek [DEB-8811884, DEB-9411972, DEB-0080382, DEB-0620652, DEB-1234162]; Biocomplexity Coupled Biogeochemical Cycles [DEB-0322057]; Long-Term Research in Environmental Biology [DEB-0716587, DEB-1242531]; Ecosystem Sciences [NSF DEB-1120064]; U.S. Department of Energy (DOE) Program for Ecosystem Research [DE-FG02-96ER62291]; U.S. DOE National Institute for Climatic Change Research [DE-FC02-06ER64158]; Division Of Environmental Biology [1120064] Funding Source: National Science Foundation	European Union Seventh Framework Programme(European Commission); U.S. National Science Foundation (NSF) Long-Term Ecological Research (LTER) Program at Cedar Creek(National Science Foundation (NSF)); Biocomplexity Coupled Biogeochemical Cycles; Long-Term Research in Environmental Biology; Ecosystem Sciences; U.S. Department of Energy (DOE) Program for Ecosystem Research(United States Department of Energy (DOE)); U.S. DOE National Institute for Climatic Change Research; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 298935 to Y.H. and has been supported by the U.S. National Science Foundation (NSF) Long-Term Ecological Research (LTER) Program at Cedar Creek (DEB-8811884, DEB-9411972, DEB-0080382, DEB-0620652, and DEB-1234162), Biocomplexity Coupled Biogeochemical Cycles (DEB-0322057), Long-Term Research in Environmental Biology (DEB-0716587, DEB-1242531), and Ecosystem Sciences (NSF DEB-1120064) Programs, as well as the U.S. Department of Energy (DOE) Program for Ecosystem Research (DE-FG02-96ER62291) and the U.S. DOE National Institute for Climatic Change Research (DE-FC02-06ER64158). We thank T. Mielke, D. Bahauddin, K. Worm, S. Barrott, E. Lind, and many summer interns for their assistance with this research. We also thank R. S. L. Veiga, W. S. Harpole, T. Zust, and M. Tanadini for suggestions that improved the manuscript. For detailed methods and original data, see www.cedarcreek.umn.edu/research/data. See table S1 for links to data for each experiment and supplementary materials for guidance on data access. The authors declare no conflict of interests. Author contributions: Y.H. and D. T. developed and framed the research question; D. T., F.I., E. W. S., E.T.B., and P.B.R. designed research; D. T., E. W. S., E.T.B., and P.B.R. performed research; Y.H. and F.I. analyzed data; and Y.H. wrote the paper with inputs from all coauthors.	Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Cardinale BJ, 2012, NATURE, V489, P326, DOI 10.1038/nature11373; Collins SL, 2012, J VEG SCI, V23, P563, DOI 10.1111/j.1654-1103.2011.01369.x; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Hautier Y, 2014, NATURE, V508, P521, DOI 10.1038/nature13014; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Leps J, 2004, OIKOS, V107, P64, DOI 10.1111/j.0030-1299.2004.13023.x; MacDougall AS, 2013, NATURE, V494, P86, DOI 10.1038/nature11869; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Yang ZL, 2011, PLANT SOIL, V345, P315, DOI 10.1007/s11104-011-0784-0	30	358	376	82	859	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					336	340		10.1126/science.aaa1788	http://dx.doi.org/10.1126/science.aaa1788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883357				2022-12-24	WOS:000352999000045
J	Denning, DW; Bromley, MJ				Denning, David W.; Bromley, Michael J.			How to bolster the antifungal pipeline	SCIENCE			English	Editorial Material							INVASIVE ASPERGILLOSIS; VORICONAZOLE; THERAPY; DRUG		[Denning, David W.; Bromley, Michael J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Denning, David W.] Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester M20 8LR, Lancs, England; [Bromley, Michael J.] Univ Manchester, Manchester Fungal Infect Grp, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester	Denning, DW (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	ddenning@manchester.ac.uk	Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251; Bromley, Michael/0000-0002-7611-0201	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashbee HR, 2014, J ANTIMICROB CHEMOTH, V69, P1162, DOI 10.1093/jac/dkt508; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cadranel J, 2012, EUR J CLIN MICROBIOL, V31, P3231, DOI 10.1007/s10096-012-1690-y; Denning DW, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-14; Denning DW, 2002, CLIN INFECT DIS, V34, P563, DOI 10.1086/324620; European Crop Protection Association, ASS EC IMP AZ EUR AG; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Perkhofer S, 2010, INT J ANTIMICROB AG, V36, P531, DOI 10.1016/j.ijantimicag.2010.08.010; Rex JH, 2013, LANCET INFECT DIS, V13, P269, DOI 10.1016/S1473-3099(12)70293-1; Roemer T, 2013, NAT CHEM BIOL, V9, P222, DOI [10.1038/NCHEMBIO.1205, 10.1038/nchembio.1205]; Slavin M, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.021; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Valdez JM, 2011, CLIN INFECT DIS, V52, P726, DOI 10.1093/cid/ciq245; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	14	309	323	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1414	1416		10.1126/science.aaa6097	http://dx.doi.org/10.1126/science.aaa6097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814567				2022-12-24	WOS:000352136400020
J	Skelton, E; Howlett, D				Skelton, Emily; Howlett, David			ANATOMY QUIZ Axial T2 weighted magnetic resonance image at the level of the lateral ventricles	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Skelton, Emily; Howlett, David] Eastbourne Dist Gen Hosp, Eastbourne BN1 2UD, E Sussex, England		Skelton, E (corresponding author), Eastbourne Dist Gen Hosp, Eastbourne BN1 2UD, E Sussex, England.	e.skelton@nhs.net		Skelton, Emily/0000-0003-0132-7948					0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2015	350								h1609	10.1136/bmj.h1609	http://dx.doi.org/10.1136/bmj.h1609			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NV	25810506				2022-12-24	WOS:000352029500004
J	Dietrich, MO; Zimmer, MR; Bober, J; Horvath, TL				Dietrich, Marcelo O.; Zimmer, Marcelo R.; Bober, Jeremy; Horvath, Tamas L.			Hypothalamic Agrp Neurons Drive Stereotypic Behaviors beyond Feeding	CELL			English	Article							AGOUTI-RELATED PROTEIN; OBSESSIVE-COMPULSIVE DISORDER; NEUROPEPTIDE-Y; ANOREXIA-NERVOSA; FOOD-INTAKE; IN-VIVO; CAPSAICIN RECEPTOR; BRAIN CIRCUITRY; NEURAL CIRCUIT; MICE	The nervous system evolved to coordinate flexible goal-directed behaviors by integrating interoceptive and sensory information. Hypothalamic Agrp neurons are known to be crucial for feeding behavior. Here, however, we show that these neurons also orchestrate other complex behaviors in adult mice. Activation of Agrp neurons in the absence of food triggers foraging and repetitive behaviors, which are reverted by food consumption. These stereotypic behaviors that are triggered by Agrp neurons are coupled with decreased anxiety. NPY5 receptor signaling is necessary to mediate the repetitive behaviors after Agrp neuron activation while having minor effects on feeding. Thus, we have unmasked a functional role for Agrp neurons in controlling repetitive behaviors mediated, at least in part, by neuropeptidergic signaling. The findings reveal a new set of behaviors coupled to the energy homeostasis circuit and suggest potential therapeutic avenues for diseases with stereotypic behaviors.	[Dietrich, Marcelo O.; Zimmer, Marcelo R.; Bober, Jeremy; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Dietrich, Marcelo O.; Zimmer, Marcelo R.] Univ Fed Rio Grande do Sul, Grad Program Biochem, BR-90035 Porto Alegre, RS, Brazil; [Horvath, Tamas L.] Yale Univ, Kavli Inst Neurosci, New Haven, CT 06520 USA	Yale University; Yale University; Universidade Federal do Rio Grande do Sul; Yale University	Dietrich, MO (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.	marcelo.dietrich@yale.edu	Zimmer, Marcelo Rigon/ABB-7993-2020; Dietrich, Marcelo/A-9928-2009	Zimmer, Marcelo Rigon/0000-0001-9628-8915; Dietrich, Marcelo/0000-0001-9781-2221	NIH [DP1 DK006850, R01AG040236, P01NS062686]; American Diabetes Association; Helmholtz Society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [CNPq: 401476/2012-0]; Brain and Behavior Research Foundation; NCATS [UL1 TR000142]; CNPq, Brazil [487096/2013-4]; Science Without Borders fellowship from CNPq/Brazil; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040236] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Helmholtz Society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brain and Behavior Research Foundation; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science Without Borders fellowship from CNPq/Brazil; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Zhong-Wu Liu for electrophysiological recordings. We thank Marya Shanabrough for assistance. T.L.H. was supported by NIH (DP1 DK006850, R01AG040236, and P01NS062686), the American Diabetes Association, the Helmholtz Society (ICEMED), and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: 401476/2012-0, Brazil). M.O.D. received support from Brain and Behavior Research Foundation, NCATS (UL1 TR000142), and CNPq (487096/2013-4, Brazil). M.R.Z. was partially supported by a Science Without Borders fellowship from CNPq/Brazil.	Adamah-Biassi EB, 2013, BEHAV BRAIN RES, V243, P306, DOI 10.1016/j.bbr.2013.01.003; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Amodeo DA, 2012, BEHAV BRAIN RES, V227, P64, DOI 10.1016/j.bbr.2011.10.032; Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; BARNETT S.A, 1956, BEHAVIOUR, V9, P24, DOI 10.1163/156853956X00237; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; Dube MG, 2000, PEPTIDES, V21, P1557, DOI 10.1016/S0196-9781(00)00311-9; Erondu N, 2006, CELL METAB, V4, P275, DOI 10.1016/j.cmet.2006.08.002; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Grove KL, 2001, ENDOCRINOLOGY, V142, P4771, DOI 10.1210/en.142.11.4771; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Halmi KA, 2003, INT J EAT DISORDER, V33, P308, DOI 10.1002/eat.10138; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Horvath TL, 1999, J NEUROSCI, V19, P1072; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Kanatani A, 2000, ENDOCRINOLOGY, V141, P1011, DOI 10.1210/en.141.3.1011; Karvat G, 2012, BEHAV BRAIN RES, V233, P405, DOI 10.1016/j.bbr.2012.05.028; Kheifets A, 2012, P NATL ACAD SCI USA, V109, P8776, DOI 10.1073/pnas.1205131109; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kyzar EJ, 2012, BRAIN RES BULL, V89, P168, DOI 10.1016/j.brainresbull.2012.08.004; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Londei T, 1998, BEHAV BRAIN RES, V94, P249, DOI 10.1016/S0166-4328(97)00162-9; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Matsunaga H, 1999, PSYCHOL MED, V29, P407, DOI 10.1017/S003329179800796X; Merle JV, 2011, PSYCHOL MED, V41, P2183, DOI 10.1017/S0033291711000365; Moriya J, 2006, PSYCHONEUROENDOCRINO, V31, P1057, DOI 10.1016/j.psyneuen.2006.06.006; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Sarrar L, 2011, PSYCHONEUROENDOCRINO, V36, P1396, DOI 10.1016/j.psyneuen.2011.03.014; STANLEY BG, 1986, PEPTIDES, V7, P1189; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; THIEL A, 1995, AM J PSYCHIAT, V152, P72; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Witkin J. M., 2008, NEUROSCI; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	59	149	152	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1222	1232		10.1016/j.cell.2015.02.024	http://dx.doi.org/10.1016/j.cell.2015.02.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25748653	Green Accepted, Bronze			2022-12-24	WOS:000351951800020
J	Prescott, HC; Langa, KM; Iwashyna, TJ				Prescott, Hallie C.; Langa, Kenneth M.; Iwashyna, Theodore J.			Readmission Diagnoses After Hospitalization for Severe Sepsis and Other Acute Medical Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEALTH		[Prescott, Hallie C.; Langa, Kenneth M.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] Hlth Serv Res & Dev Serv Ctr Innovat, VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Prescott, HC (corresponding author), Univ Michigan, Dept Med, 2800 Plymouth Rd,North Campus Res Ctr, Ann Arbor, MI 48109 USA.	hprescot@med.umich.edu		Prescott, Hallie/0000-0002-8442-6724; Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030155, P30AG024824, U01AG009740, R21AG044752] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007749] Funding Source: Medline; NIA NIH HHS [U01 AG09740, P30 AG024824, R01 AG030155, U01 AG009740, R21 AG044752, R01 AG0030155] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agency for Healthcare Research and Quality, GUID PREV QUAL IND; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Prescott HC, 2014, AM J RESP CRIT CARE, V190, P62, DOI 10.1164/rccm.201403-0471OC; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067	6	141	147	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1055	1057		10.1001/jama.2015.1410	http://dx.doi.org/10.1001/jama.2015.1410			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756444	Green Accepted, Bronze			2022-12-24	WOS:000350643100023
J	Haussecker, D; Kay, MA				Haussecker, Dirk; Kay, Mark A.			Drugging RNAi	SCIENCE			English	Editorial Material							THERAPEUTICS; DELIVERY; MICE		[Haussecker, Dirk] RNAi Therapeut Consulting, Rastatt, Germany; [Kay, Mark A.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Haussecker, D (corresponding author), RNAi Therapeut Consulting, Rastatt, Germany.	dirk.haussecker@gmail.com; markay@stanford.edu		Kay, Mark/0000-0002-2799-2615	NIAID NIH HHS [R01 AI071068, R37 AI071068] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071068] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Haussecker D, 2014, J CONTROL RELEASE, V195, P49, DOI 10.1016/j.jconrel.2014.07.056; Haussecker D, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.9; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Maraganore J, 2014, NATURE, V510, P35, DOI 10.1038/510035b; Mueller C, 2012, MOL THER, V20, P590, DOI 10.1038/mt.2011.292; Prakash TP, 2014, NUCLEIC ACIDS RES, V42, P8796, DOI 10.1093/nar/gku531; Samakoglu S, 2006, NAT BIOTECHNOL, V24, P89, DOI 10.1038/nbt1176; Vaish N, 2011, NUCLEIC ACIDS RES, V39, P1823, DOI 10.1093/nar/gkq961; Wooddell CI, 2013, MOL THER, V21, P973, DOI 10.1038/mt.2013.31	12	68	72	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1069	1070		10.1126/science.1252967	http://dx.doi.org/10.1126/science.1252967			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745148	Green Accepted			2022-12-24	WOS:000350354200020
J	Lori, C; Ozaki, S; Steiner, S; Bohm, R; Abel, S; Dubey, BN; Schirmer, T; Hiller, S; Jenal, U				Lori, C.; Ozaki, S.; Steiner, S.; Boehm, R.; Abel, S.; Dubey, B. N.; Schirmer, T.; Hiller, S.; Jenal, U.			Cyclic di-GMP acts as a cell cycle oscillator to drive chromosome replication	NATURE			English	Article							BACTERIAL-DNA REPLICATION; CAULOBACTER-CRESCENTUS; DEPENDENT KINASES; DIGUANYLATE CYCLASE; RESPONSE REGULATOR; POLAR LOCALIZATION; HISTIDINE KINASES; PROTEIN; PHOSPHORYLATION; PROGRESSION	Fundamental to all living organisms is the capacity to coordinate cell division and cell differentiation to generate appropriate numbers of specialized cells. Whereas eukaryotes use cyclins and cyclin-dependent kinases to balance division with cell fate decisions(1), equivalent regulatory systems have not been described in bacteria. Moreover, the mechanisms used by bacteria to tune division in line with developmental programs are poorly understood. Here we show that Caulobacter crescentus, a bacterium with an asymmetric division cycle, uses oscillating levels of the second messenger cyclic diguanylate (c-di-GMP) to drive its cell cycle. We demonstrate that c-diGMP directly binds to the essential cell cycle kinase CckA to inhibit kinase activity and stimulate phosphatase activity. An upshift of c-di-GMP during the G1-S transition switches CckA from the kinase to the phosphatase mode, thereby allowing replication initiation and cell cycle progression. Finally, we show that during division, c-di-GMP imposes spatial control on CckA to install the replication asymmetry of future daughter cells. These studies reveal c-di-GMP to be a cyclin-like molecule in bacteria that coordinates chromosome replication with cell morphogenesis in Caulobacter. The observation that c-di-GMP-mediated control is conserved in the plant pathogen Agrobacterium tumefaciens suggests a general mechanism through which this global regulator of bacterial virulence and persistence coordinates behaviour and cell proliferation.	[Lori, C.; Ozaki, S.; Steiner, S.; Abel, S.; Jenal, U.] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland; [Boehm, R.; Dubey, B. N.; Schirmer, T.; Hiller, S.] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland	University of Basel; University of Basel	Jenal, U (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.	urs.jenal@unibas.ch	Hiller, Sebastian/B-3573-2008	Hiller, Sebastian/0000-0002-6709-4684; Dubey, Badri Nath/0000-0002-8626-8918; Ozaki, Shogo/0000-0002-4384-1366; Abel, Soren/0000-0002-4041-6989	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships; Swiss National Science Foundation [310030B_147090]; ERC Advanced Research Grant	Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERC Advanced Research Grant	We thank T. Sharp for help with protein analysis and F. Hamburger for plasmid constructions. S.O. is a recipient of a Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for research abroad. This work was supported by Swiss National Science Foundation grant 310030B_147090 to U.J. and an ERC Advanced Research Grant to U.J.	Abel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003744; Angelastro PS, 2010, J BACTERIOL, V192, P539, DOI 10.1128/JB.00985-09; Arellano BH, 2010, APPL ENVIRON MICROB, V76, P3004, DOI 10.1128/AEM.02085-09; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Chen YE, 2011, P NATL ACAD SCI USA, V108, P1052, DOI 10.1073/pnas.1015397108; Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09; Childers WS, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001979; Choi YJ, 2014, ONCOGENE, V33, P1890, DOI 10.1038/onc.2013.137; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; ELY B, 1991, METHOD ENZYMOL, V204, P372; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Ishidate T, 2014, CELL CYCLE, V13, P1384, DOI 10.4161/cc.28656; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; KIM J, 2013, NATL GEOGR, V224, P8; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Taylor JA, 2011, MOL MICROBIOL, V82, P312, DOI 10.1111/j.1365-2958.2011.07785.x; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Zahringer F, 2013, STRUCTURE, V21, P1149, DOI 10.1016/j.str.2013.04.026; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	46	120	123	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					236	U278		10.1038/nature14473	http://dx.doi.org/10.1038/nature14473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	25945741	Green Accepted			2022-12-24	WOS:000357695900040
J	Dirlikov, E; Raviglione, M; Scano, F				Dirlikov, Emilio; Raviglione, Mario; Scano, Fabio			Global Tuberculosis Control: Toward the 2015 Targets and Beyond	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-RESISTANT TUBERCULOSIS; TRENDS; PROSPECTS; PROGRESS; TIME; CARE	Since 1990, progress has been made toward global tuberculosis (TB) control, as measured by targets set for 2015. However, TB remains a major threat to health around the world. In 2013, there were an estimated 11 million prevalent cases, and an estimated 9.0 million incident cases occurred globally. Approximately 1.5 million deaths were caused by TB, including 360 000 among people living with HIV. Substantial challenges threaten future control efforts. These include multidrug-resistant forms and coinfection with HIV, as well as other factors, such as the increased prominence of noncommunicable diseases and adverse socioeconomic conditions. Beyond 2015, TB control must be seen as both a public health imperative unto itself and a vital component of economic development plans. To that end, control strategies should exploit technical and operational innovations to improve TB control and care and should promote universal health coverage and social protection mechanisms to expand access to essential prevention, diagnostics, and treatment services while avoiding catastrophic costs incurred by patients.	McGill Univ, Montreal, PQ H3A 2T7, Canada; Univ Turin, Turin, Italy; Univ Padua, Padua, Italy	McGill University; University of Turin; University of Padua	Dirlikov, E (corresponding author), McGill Univ, Dept Anthropol, 7th Floor,Leacock Bldg,855 Sherbrooke St West, Montreal, PQ H3A 2T7, Canada.	emilio.dirlikov@mail.mcgill.ca		Dirlikov, Emilio/0000-0003-4631-2643; RAVIGLIONE, Mario/0000-0002-9331-2067	Programme bourses d'excellence pour etudiants etrangers from the Fonds Quebecois de la recherche sur la nature et les technologies [Dossier 136663]	Programme bourses d'excellence pour etudiants etrangers from the Fonds Quebecois de la recherche sur la nature et les technologies	Mr. Dirlikov's doctoral studies are supported by the Programme bourses d'excellence pour etudiants etrangers from the Fonds Quebecois de la recherche sur la nature et les technologies (Dossier 136663). No additional external funding was provided for this research.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; [Anonymous], 1993, World Health Forum, V14, P438; [Anonymous], 1993, WORLD DEV REP 1993; [Anonymous], 2015, MIN C TUB SUST DEV A; [Anonymous], 2015, WHO MON XP MTB RIF R; [Anonymous], 2014, MILL DEV GOALS REP 2, P34; Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; CHIANG CY, 2013, INT J TUBERC LUNG D, V17, P714, DOI [DOI 10.5588/IJT1D.12.0989, DOI 10.5588/IJTLD.12.0989]; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Daley CL, 2013, SEMIN RESP CRIT CARE, V34, P44, DOI 10.1055/s-0032-1333546; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Falzon Dennis, 2013, Lancet Respir Med, V1, pe9, DOI 10.1016/S2213-2600(12)70056-5; Floyd K, 2013, LANCET GLOB HEALTH, V1, pE105, DOI 10.1016/S2214-109X(13)70032-9; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X; Mnyani CN, 2011, BJOG-INT J OBSTET GY, V118, P226, DOI 10.1111/j.1471-0528.2010.02771.x; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Ogden J, 2003, SOC SCI MED, V57, P179, DOI 10.1016/S0277-9536(02)00373-8; Oxlade O, 2009, INT J TUBERC LUNG D, V13, P1238; Pai M, 2014, LANCET RESP MED, V2, P25, DOI 10.1016/S2213-2600(13)70256-X; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; PHILLIPS PPJ, 2013, INT J TUBERC LUNG D, V17, P807, DOI DOI 10.5588/IFID.12.0725; Raviglione M, 2012, LANCET, V379, P1077, DOI 10.1016/S0140-6736(12)60373-0; Raviglione Mario, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P6, DOI 10.5588/ijtld.11.0158; Raviglione MC, 2013, NAT MED, V19, P263, DOI 10.1038/nm.3129; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Raviglione MC, 2002, LANCET, V359, P775, DOI 10.1016/S0140-6736(02)07880-7; Reichman LB, 2013, INT J TUBERC LUNG D, V17, P711, DOI 10.5588/ijtld.13.0299; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Warsame A, 2014, INT J TUBERC LUNG D, V18, P61, DOI 10.5588/ijtld.13.0324; WHO, 1998, WHOTB98245; World Economic Forum, 2014, GLOB RISKS 2014; World Health Organization, 2006, STOP TB STRATEGY BUI; World Health Organization, 1991, 44 WORLD HLTH ASS GE; World Health Organization, 2012, WHOHTMTB20121; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2009, 62 WORLD HLTH ASS RE, P25; World Health Organization, 2014, 67 WORLD HLTH ASS GE; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zignol M, 2013, EUR RESPIR J, V42, P701, DOI 10.1183/09031936.00175812	61	48	51	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 7	2015	163	1					52	58		10.7326/M14-2210	http://dx.doi.org/10.7326/M14-2210			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1LI	25915859				2022-12-24	WOS:000357442000006
J	Palikaras, K; Lionaki, E; Tavernarakis, N				Palikaras, Konstantinos; Lionaki, Eirini; Tavernarakis, Nektarios			Coordination of mitophagy and mitochondrial biogenesis during ageing in C-elegans	NATURE			English	Article							EXTENDS LIFE-SPAN; CELL-DEATH; NIX; METABOLISM; CLEARANCE; LONGEVITY; AUTOPHAGY; DIAPAUSE; PROTEIN; GENES	Impaired mitochondrial maintenance in disparate cell types is a shared hallmark of many human pathologies and ageing(1-8). How mitochondrial biogenesis coordinates with the removal of damaged or superfluous mitochondria to maintain cellular homeostasis is not well understood. Here we show that mitophagy, a selective type of autophagy targeting mitochondria for degradation, interfaces with mitochondrial biogenesis to regulate mitochondrial content and longevity in Caenorhabditis elegans. We find that DCT-1 is a key mediator of mitophagy and longevity assurance under conditions of stress in C. elegans. Impairment of mitophagy compromises stress resistance and triggers mitochondrial retrograde signalling through the SKN-1 transcription factor that regulates both mitochondrial biogenesis genes and mitophagy by enhancing DCT-1 expression. Our findings reveal a homeostatic feedback loop that integrates metabolic signals to coordinate the biogenesis and turnover of mitochondria. Uncoupling of these two processes during ageing contributes to overproliferation of damaged mitochondria and decline of cellular function.	[Palikaras, Konstantinos; Lionaki, Eirini; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece; [Palikaras, Konstantinos] Univ Crete, Dept Biol, Iraklion 70013, Crete, Greece; [Tavernarakis, Nektarios] Univ Crete, Fac Med, Dept Basic Sci, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete; University of Crete	Tavernarakis, N (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Nikolaou Plastira 100, Iraklion 70013, Crete, Greece.	tavernarakis@imbb.forth.gr	Palikaras, Konstantinos/AAI-1300-2020; Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466; LIONAKI, EIRINI/0000-0002-7689-0463; Palikaras, Konstantinos/0000-0001-6992-5560	National Center for Research Resources of the National Institutes of Health; National Bioresource Project in Japan; European Research Council; European Commission; Greek General Secretariat for Research and Technology	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Greek General Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	We thank A. Pasparaki for technical support with experiments, N. Kourtis for the GCaMP2.0-expressing C. elegans strain, N. Charmpilas for the neuronal CTS-1::mCherry-expressing C. elegans strain and the unc-43 RNA interference (RNAi) plasmid, and K. Kounakis for the rpn-6 RNAi plasmid. We thank B. P. Braeckman for the Hyper-expressing C. elegans strain and D. Sieburth for the INVOM::RFP-expressing C. elegans strain. We thank R. Devenish for providing the pAS1NB-CS-Rosella plasmid. Mass spectrometry analysis was performed at the Institute of Molecular Biology and Biotechnology Proteomics Facility. We are grateful to M. Aivaliotis for the characterization and relative quantification of DCT-1 tryptic peptides by nanoflow liquid chromatography with tandem mass spectrometry. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources of the National Institutes of Health, and S. Mitani (National Bioresource Project) in Japan. We thank A. Fire for plasmid vectors. This work was funded by grants from the European Research Council, the European Commission 7th Framework Programme and the Greek General Secretariat for Research and Technology.	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Back P, 2012, FREE RADICAL BIO MED, V52, P850, DOI 10.1016/j.freeradbiomed.2011.11.037; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; BRENNER S, 1974, GENETICS, V77, P71; Campbell GR, 2012, CURR OPIN NEUROL, V25, P221, DOI 10.1097/WCO.0b013e3283533a25; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Ghose P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004063; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Malpass K, 2013, NAT REV NEUROL, V9, P179, DOI [10.1038/nrneurol.2012.35, 10.1038/nrneurol.2013.55, 10.1038/nrneurol.2013.158, 10.1038/nrneurol.2013.119, 10.1038/nrneurol.2013.138, 10.1038/nrneurol.2013.77, 10.1038/nrneurol.2013.64, 10.1038/nrneurol.2013.35, 10.1038/nrneurol.2012.245]; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mijaljica D, 2011, JOVE-J VIS EXP, DOI 10.3791/2779; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/nchembio.1352, 10.1038/NCHEMBIO.1352]; Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Staab TA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004100; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Xue D, 1997, NATURE, V390, P305, DOI 10.1038/36889; Yasuda M, 1998, ONCOGENE, V17, P2525, DOI 10.1038/sj.onc.1202467; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang J, 2012, AUTOPHAGY, V8, P1325, DOI 10.4161/auto.20764; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	38	412	427	27	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					525	U241		10.1038/nature14300	http://dx.doi.org/10.1038/nature14300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25896323				2022-12-24	WOS:000355286600044
J	McHugh, CA; Chen, CK; Chow, A; Surka, CF; Tran, C; McDonel, P; Pandya-Jones, A; Blanco, M; Burghard, C; Moradian, A; Sweredoski, MJ; Shishkin, AA; Su, JL; Lander, ES; Hess, S; Plath, K; Guttman, M				McHugh, Colleen A.; Chen, Chun-Kan; Chow, Amy; Surka, Christine F.; Tran, Christina; McDonel, Patrick; Pandya-Jones, Amy; Blanco, Mario; Burghard, Christina; Moradian, Annie; Sweredoski, Michael J.; Shishkin, Alexander A.; Su, Julia; Lander, Eric S.; Hess, Sonja; Plath, Kathrin; Guttman, Mitchell			The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3	NATURE			English	Article							IDENTIFICATION RATES; MATRIX PROTEIN; X-INACTIVATION; RNA; BINDING; REPRESSION; PRC2; DNA; LOCALIZATION; RECRUITMENT	Many long non-coding RNAs (lncRNAs) affect gene expression(1), but the mechanisms by which they act are still largely unknown(2). One of the best-studied lncRNAs is Xist, which is required for transcriptional silencing of one X chromosome during development in female mammals(3,4). Despite extensive efforts to define the mechanism of Xist-mediated transcriptional silencing, we still do not know any proteins required for this role(3). The main challenge is that there are currently no methods to comprehensively define the proteins that directly interact with a lncRNA in the cell(5). Here we develop a method to purify a lncRNA from cells and identify proteins interacting with it directly using quantitative mass spectrometry. We identify ten proteins that specifically associate with Xist, three of these proteins-SHARP, SAF-A and LBR-are required for Xist-mediated transcriptional silencing. We show that SHARP, which interacts with the SMRT co-repressor(6) that activates HDAC3(7), is not only essential for silencing, but is also required for the exclusion of RNA polymerase II (Pol II) from the inactive X. Both SMRT and HDAC3 are also required for silencing and Pol II exclusion. In addition to silencing transcription, SHARP and HDAC3 are required for Xist-mediated recruitment of the polycomb repressive complex 2 (PRC2) across the X chromosome. Our results suggest that Xist silences transcription by directly interacting with SHARP, recruiting SMRT, activating HDAC3, and deacetylating histones to exclude Pol II across the X chromosome.	[McHugh, Colleen A.; Chen, Chun-Kan; Chow, Amy; Surka, Christine F.; Tran, Christina; Blanco, Mario; Burghard, Christina; Shishkin, Alexander A.; Su, Julia; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [McDonel, Patrick; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Pandya-Jones, Amy; Plath, Kathrin] Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Pandya-Jones, Amy; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja] CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA	California Institute of Technology; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu		Plath, Kathrin/0000-0001-7796-3372; Pandya-Jones, Amy/0000-0001-5519-4613	Caltech; NIH NRSA [T32GM07616]; Caltech Beckman Institute; Arnold and Mabel Beckman Foundation; Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; NIH [1S10RR029591-01A1, DP5OD012190]; Rose Hills Foundation; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115233, T32GM007616] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012190, DP2OD001686] Funding Source: NIH RePORTER	Caltech; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Beckman Institute; Arnold and Mabel Beckman Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rose Hills Foundation; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Engreitz for extensive discussions, help in adapting the RAP method, and critical comments on the manuscript; A. Gnirke, S. Carr, J. Jaffe and M. Schenone for initial discussions about the RAP-MS method; A. Collazo, E. Lubek, and L. Cai for microscopy help; A. Wutz for providing transgenic cell lines; R. Eggleston-Rangel for assistance with mass spectrometry; S. Grossman, I. Amit, M. Garber and J. Rinn for comments on the manuscript and helpful suggestions; and S. Knemeyer for illustrations. C.A.M. is supported by a post-doctoral fellowship from Caltech. C.-K.C. is supported by an NIH NRSA training grant (T32GM07616). Imaging was performed in the Biological Imaging Facility, with the support of the Caltech Beckman Institute and the Arnold and Mabel Beckman Foundation. This work was funded by the Gordon and Betty Moore Foundation (GBMF775), the Beckman Institute, and NIH (1S10RR029591-01A1 to S.H.), an NIH Director's Early Independence Award (DP5OD012190), the Rose Hills Foundation, Edward Mallinckrodt Foundation, Sontag Foundation, Searle Scholars Program, and funds from the California Institute of Technology.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Arieti F, 2014, NUCLEIC ACIDS RES, V42, P6742, DOI 10.1093/nar/gku277; Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Brown CJ, 1996, SOMAT CELL MOLEC GEN, V22, P403, DOI 10.1007/BF02369896; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McHugh CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4152; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Raffel GD, 2007, P NATL ACAD SCI USA, V104, P6001, DOI 10.1073/pnas.0609041104; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Royce-Tolland ME, 2010, NAT STRUCT MOL BIOL, V17, P948, DOI 10.1038/nsmb.1877; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Theodosiou Z, 2007, CYTOM PART A, V71A, P439, DOI 10.1002/cyto.a.20409; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	45	696	723	9	208	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					232	+		10.1038/nature14443	http://dx.doi.org/10.1038/nature14443			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25915022	Green Submitted, Green Accepted			2022-12-24	WOS:000354377800061
J	Mele, M; Ferreira, PG; Reverter, F; DeLuca, DS; Monlong, J; Sammeth, M; Young, TR; Goldmann, JM; Pervouchine, DD; Sullivan, TJ; Johnson, R; Segre, AV; Djebali, S; Niarchou, A; Wright, FA; Lappalainen, T; Calvo, M; Getz, G; Dermitzakis, ET; Ardlie, KG; Guigo, R				Mele, Marta; Ferreira, Pedro G.; Reverter, Ferran; DeLuca, David S.; Monlong, Jean; Sammeth, Michael; Young, Taylor R.; Goldmann, Jakob M.; Pervouchine, Dmitri D.; Sullivan, Timothy J.; Johnson, Rory; Segre, Ayellet V.; Djebali, Sarah; Niarchou, Anastasia; Wright, Fred A.; Lappalainen, Tuuli; Calvo, Miquel; Getz, Gad; Dermitzakis, Emmanouil T.; Ardlie, Kristin G.; Guigo, Roderic		GTEx Consortium	The human transcriptome across tissues and individuals	SCIENCE			English	Article							REVEALS; DISCOVERY	Transcriptional regulation and posttranscriptional processing underlie many cellular and organismal phenotypes. We used RNA sequence data generated by Genotype-Tissue Expression (GTEx) project to investigate the patterns of transcriptome variation across individuals and tissues. Tissues exhibit characteristic transcriptional signatures that show stability in postmortem samples. These signatures are dominated by a relatively small number of genes-which is most clearly seen in blood-though few are exclusive to a particular tissue and vary more across tissues than individuals. Genes exhibiting high interindividual expression variation include disease candidates associated with sex, ethnicity, and age. Primary transcription is the major driver of cellular specificity, with splicing playing mostly a complementary role; except for the brain, which exhibits a more divergent splicing program. Variation in splicing, despite its stochasticity, may play in contrast a comparatively greater role in defining individual phenotypes.	[Mele, Marta; Ferreira, Pedro G.; Reverter, Ferran; Monlong, Jean; Sammeth, Michael; Goldmann, Jakob M.; Pervouchine, Dmitri D.; Johnson, Rory; Djebali, Sarah; Guigo, Roderic] CRG, Barcelona, Catalonia, Spain; [Mele, Marta] Harvard Univ, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ferreira, Pedro G.; Niarchou, Anastasia; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Ferreira, Pedro G.; Niarchou, Anastasia; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet, Geneva, Switzerland; [Ferreira, Pedro G.; Niarchou, Anastasia; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, Genom Geneva iGE3, Geneva, Switzerland; [Ferreira, Pedro G.; Niarchou, Anastasia; Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Geneva, Switzerland; [Reverter, Ferran; Calvo, Miquel] UB, Fac Biol, Barcelona, Catalonia, Spain; [Reverter, Ferran; Monlong, Jean; Sammeth, Michael; Goldmann, Jakob M.; Pervouchine, Dmitri D.; Johnson, Rory; Djebali, Sarah; Guigo, Roderic] UPF, Barcelona, Catalonia, Spain; [DeLuca, David S.; Young, Taylor R.; Sullivan, Timothy J.; Segre, Ayellet V.; Getz, Gad; Ardlie, Kristin G.] Broad Inst & Harvard, Cambridge, MA USA; [Monlong, Jean] McGill Univ, Montreal, PQ, Canada; [Sammeth, Michael] Natl Inst Sci Comp LNCC, Rio De Janeiro, Brazil; [Goldmann, Jakob M.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Pervouchine, Dmitri D.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119992, Russia; [Wright, Fred A.] N Carolina State Univ, Raleigh, NC 27695 USA; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY USA; [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY USA; [Getz, Gad] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Guigo, Roderic] Inst Hosp Mar Invest Med IMIM, Barcelona, Catalonia, Spain; [Guigo, Roderic] IRB, Joint CRG Barcelona Super Comp Ctr BSC, Program Computat Biol, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Harvard University; University of Geneva; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; University of Barcelona; Pompeu Fabra University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McGill University; Laboratorio Nacional de Computacao Cientifica (LNCC); Radboud University Nijmegen; Lomonosov Moscow State University; University of North Carolina; North Carolina State University; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Ardlie, KG (corresponding author), CRG, Barcelona, Catalonia, Spain.	kardlie@broadinstitute.org; roderic.guigo@crg.cat	Ferreira, Pedro G/J-6379-2013; Goldmann, Jakob M/K-5948-2013; Djebali, Sarah/O-9817-2014; Monlong, Jean/AAZ-8589-2020; Pervouchine, Dmitri/H-5252-2015; Guigo, Roderic/D-1303-2010; reverter, ferran/I-1547-2015; Lappalainen, Tuuli/AAE-6532-2020; Pervouchine, Dmitri/AAU-5399-2021; Pervouchine, Dmitri/AAE-2178-2020; Johnson, Rory/ABE-2503-2021; Ferreira, Pedro/HDO-1346-2022; Sammeth, Michael/C-1157-2014; Little, Roger/O-6191-2014	Ferreira, Pedro G/0000-0003-3838-8664; Goldmann, Jakob M/0000-0002-8514-573X; Djebali, Sarah/0000-0002-0599-1267; Monlong, Jean/0000-0002-9737-5516; Pervouchine, Dmitri/0000-0003-0543-9760; Guigo, Roderic/0000-0002-5738-4477; reverter, ferran/0000-0002-9489-3350; Lappalainen, Tuuli/0000-0002-7746-8109; Pervouchine, Dmitri/0000-0003-0543-9760; Johnson, Rory/0000-0003-4607-2782; Sammeth, Michael/0000-0002-6528-9883; mele, marta/0000-0001-8874-6453; Little, Roger/0000-0001-6831-0177; Calvo LLorca, Miguel/0000-0002-4016-3336	Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute (NCI); National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; United States National Institutes of Health [HHSN261200800001E, 10XS170, 10XS171, 10X172, 12ST1039, 10ST1035, HHSN268201000029C, R01 DA006227-17, R01 MH090941]; European Research Council; Swiss National Science Foundation; Louis-Jeantet Foundation [R01 MH090936]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BIO2011-26205]; Generalitat de Catalunya [2014 SGR 464, 2014 SGR 1319]; European Research Council-European Commission [294653]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101819, R01MH090941, R01MH090936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER	Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis-Jeantet Foundation; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Research Council-European Commission(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We acknowledge and thank the donors and their families for their generous gifts of organ donation for transplantation and tissue donations for the GTEx research study. We thank the Genomics Platform at the Broad Institute for data generation; L. Gaffney for help with figures; E. Gelfand and C. Trowbridge for project support and members of the Analysis Working Group for feedback; and D. MacArthur, J. Maller, and B. Neale for critical reading of the manuscript. The primary and processed data used to generate the analyses presented here are available in the following locations: All primary sequence files are deposited in and available from dbGaP (phs000424.v3.p1); gene and transcript quantifications are available on the GTEx Portal (www.gtexportal.org). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health (http://commonfund.nih.gov/GTEx). Additional funds were provided by the National Cancer Institute (NCI); National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; National Institute of Mental Health; and National Institute of Neurological Disorders and Stroke. This work was supported by the following grants and contracts from the United States National Institutes of Health: contract HHSN261200800001E (Leidos Prime contract with NCI); contracts 10XS170 [National Disease Research Interchange (NDRI)], 10XS171 (Roswell Park Cancer Institute), 10X172 (Science Care Inc.), and 12ST1039 (IDOX); contract 10ST1035 (Van Andel Institute); contract HHSN268201000029C (Broad Institute); R01 DA006227-17 (University of Miami Brain Bank); R01 MH090941 (University of Geneva), European Research Council, Swiss National Science Foundation, and Louis-Jeantet Foundation to E.T.D.; R01 MH090936 (University of North Carolina-Chapel Hill); and grants BIO2011-26205 from the Spanish Ministerio de Ciencia e Innovacion (MICINN), 2014 SGR 464 and 2014 SGR 1319 from the Generalitat de Catalunya, and 294653 from the European Research Council-European Commission.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Birdsill AC, 2011, CELL TISSUE BANK, V12, P311, DOI 10.1007/s10561-010-9210-8; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gonzalez-Porta M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r70; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Regitz-Zagrosek V, 2011, WIEN MED WOCHENSCHR, V161, P109, DOI 10.1007/s10354-011-0892-8; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74	22	732	743	8	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					660	665		10.1126/science.aaa0355	http://dx.doi.org/10.1126/science.aaa0355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954002	Green Accepted			2022-12-24	WOS:000354045700037
J	Kessler, SC; Tiedeken, EJ; Simcock, KL; Derveau, S; Mitchell, J; Softley, S; Stout, JC; Wright, GA				Kessler, Sebastien C.; Tiedeken, Erin Jo; Simcock, Kerry L.; Derveau, Sophie; Mitchell, Jessica; Softley, Samantha; Stout, Jane C.; Wright, Geraldine A.			Bees prefer foods containing neonicotinoid pesticides	NATURE			English	Article							BITTER TASTE; EXPOSURE; INSECTICIDES; HONEYBEES; RESIDUES; POLLEN; NECTAR; MEMORY	The impact of neonicotinoid insecticides on insect pollinators is highly controversial. Sublethal concentrations alter the behaviour of social bees and reduce survival of entire colonies(1-3). However, critics argue that the reported negative effects only arise from neonicotinoid concentrations that are greater than those found in the nectar and pollen of pesticide-treated plants(4). Furthermore, it has been suggested that bees could choose to forage on other available flowers and hence avoid or dilute exposure(4,5). Here, using a two-choice feeding assay, we show that the honeybee, Apis mellifera, and the buff-tailed bumblebee, Bombus terrestris, do not avoid nectar-relevant concentrations of three of the most commonly used neonicotinoids, imidacloprid (IMD), thiamethoxam (TMX), and clothianidin (CLO), in food. Moreover, bees of both species prefer to eat more of sucrose solutions laced with IMD or TMX than sucrose alone. Stimulation with IMD, TMX and CLO neither elicited spiking responses from gustatory neurons in the bees' mouthparts, nor inhibited the responses of sucrose-sensitive neurons. Our data indicate that bees cannot taste neonicotinoids and are not repelled by them. Instead, bees preferred solutions containing IMD or TMX, even though the consumption of these pesticides caused them to eat less food overall. This work shows that bees cannot control their exposure to neonicotinoids in food and implies that treating flowering crops with IMD and TMX presents a sizeable hazard to foraging bees.	[Kessler, Sebastien C.; Simcock, Kerry L.; Softley, Samantha; Wright, Geraldine A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Tiedeken, Erin Jo; Stout, Jane C.] Trinity Coll Dublin, Dept Bot, Dublin 2, Ireland; [Derveau, Sophie] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mitchell, Jessica] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England	Newcastle University - UK; Trinity College Dublin; Newcastle University - UK; University of Oxford	Wright, GA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jeri.wright@ncl.ac.uk	Stout, Jane/AAS-8867-2020; Serrano, Jose/A-2854-2009; Stout, Jane C/B-1631-2010	Stout, Jane/0000-0002-2027-0863; Serrano, Jose/0000-0002-1565-5216; Stout, Jane C/0000-0002-2027-0863	BBSRC; NERC; Wellcome Trust; Defra; Scottish Government under the Insect Pollinators Initiative [BB/I000143/1]; Leverhulme Trust [RPG-2012-708]; Science Foundation Ireland [10/RFP/EOB2842]; US National Science Foundation [2010097514]; Irish Research Council's EMBARK Postgraduate Scholarship Scheme grant [RS/2010/2147]; BBSRC [BB/I000143/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000143/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government under the Insect Pollinators Initiative; Leverhulme Trust(Leverhulme Trust); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); US National Science Foundation(National Science Foundation (NSF)); Irish Research Council's EMBARK Postgraduate Scholarship Scheme grant(Irish Research Council for Science, Engineering and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Thompson for beekeeping, A. Radcliffe for help with experiments, and C. Rowe, S. Waddell, M. Palmer and N. Millar for comments. This work was funded jointly by a grant from the BBSRC, NERC, the Wellcome Trust, Defra, and the Scottish Government under the Insect Pollinators Initiative (BB/I000143/1) to G.A.W., a Leverhulme Trust research project grant (RPG-2012-708) to G.A.W., a Science Foundation Ireland grant (10/RFP/EOB2842) to J.C.S., a US National Science Foundation Graduate Research Fellowship awarded to E.J.T. (Grant No. 2010097514), and an Irish Research Council's EMBARK Postgraduate Scholarship Scheme grant (RS/2010/2147) to E.J.T.	BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brown LA, 2006, J NEUROCHEM, V99, P608, DOI 10.1111/j.1471-4159.2006.04084.x; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; Carreck NL, 2014, J APICULT RES, V53, P607, DOI 10.3896/IBRA.1.53.5.08; CHAPMAN RF, 1991, J EXP BIOL, V158, P241; de Brito Sanchez MG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00025; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Department for Environment Food and Rural Affairs, 2013, ASS KEY EV NEON BEES; Dethier V., 1976, THE HUNGRY FLY; DETHIER VG, 1989, PHYSIOL ENTOMOL, V14, P127, DOI 10.1111/j.1365-3032.1989.tb00944.x; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Dupuis JP, 2011, J NEUROPHYSIOL, V106, P1604, DOI 10.1152/jn.00126.2011; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; MarionPoll F, 1996, ENTOMOL EXP APPL, V80, P113, DOI 10.1007/BF00194738; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Paoli PP, 2014, AMINO ACIDS, V46, P1449, DOI 10.1007/s00726-014-1706-2; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Stoner KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077550; The Food and Environment Research Agency, 2013, EFF NEON SEED TREATM; Thompson HM, 2015, PEST MANAG SCI, V71, P946, DOI 10.1002/ps.3868; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WHITEHEAD A T, 1976, International Journal of Insect Morphology and Embryology, V5, P301, DOI 10.1016/0020-7322(76)90030-1; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2014, ECOTOXICOLOGY, V23, P1409, DOI 10.1007/s10646-014-1283-x; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040	43	271	287	40	683	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					74	U145		10.1038/nature14414	http://dx.doi.org/10.1038/nature14414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25901684	Green Accepted			2022-12-24	WOS:000354040900035
J	Maruyama, D; Volz, R; Takeuchi, H; Mori, T; Igawa, T; Kurihara, D; Kawashima, T; Ueda, M; Ito, M; Umeda, M; Nishikawa, S; Gross-Hardt, R; Higashiyama, T				Maruyama, Daisuke; Voelz, Ronny; Takeuchi, Hidenori; Mori, Toshiyuki; Igawa, Tomoko; Kurihara, Daisuke; Kawashima, Tomokazu; Ueda, Minako; Ito, Masaki; Umeda, Masaaki; Nishikawa, Shuh-ichi; Gross-Hardt, Rita; Higashiyama, Tetsuya			Rapid Elimination of the Persistent Synergid through a Cell Fusion Mechanism	CELL			English	Article							PREMATURE CHROMOSOME CONDENSATION; MULTIPLE POLLEN TUBES; DOUBLE FERTILIZATION; ARABIDOPSIS-THALIANA; BLOCK; SPERM; POLYSPERMY; ENDOSPERM; PLANTS; DNA	In flowering plants, fertilization-dependent degeneration of the persistent synergid cell ensures one-on-one pairings of male and female gametes. Here, we report that the fusion of the persistent synergid cell and the endosperm selectively inactivates the persistent synergid cell in Arabidopsis thaliana. The synergid-endosperm fusion causes rapid dilution of pre-secreted pollen tube attractant in the persistent synergid cell and selective disorganization of the synergid nucleus during the endosperm proliferation, preventing attractions of excess number of pollen tubes (polytubey). The synergid-endosperm fusion is induced by fertilization of the central cell, while the egg cell fertilization predominantly activates ethylene signaling, an inducer of the synergid nuclear disorganization. Therefore, two female gametes (the egg and the central cell) control independent pathways yet coordinately accomplish the elimination of the persistent synergid cell by double fertilization.	[Maruyama, Daisuke; Ueda, Minako; Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Maruyama, Daisuke] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Maruyama, Daisuke] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Maruyama, Daisuke; Kawashima, Tomokazu] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Maruyama, Daisuke; Kawashima, Tomokazu] Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore; [Voelz, Ronny; Gross-Hardt, Rita] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Voelz, Ronny] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal 239556900, Saudi Arabia; [Takeuchi, Hidenori; Kurihara, Daisuke; Higashiyama, Tetsuya] Nagoya Univ, JST ERATO Higashiyama Live Holon Project, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Mori, Toshiyuki] Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, Tokyo 1698050, Japan; [Igawa, Tomoko] Chiba Univ, Graduate Sch Hort, Matsudo, Chiba 2718510, Japan; [Kawashima, Tomokazu] Gregor Mendel Inst, A-1030 Vienna, Austria; [Ito, Masaki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Ito, Masaki] Nagoya Univ, Sch Agr Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Umeda, Masaaki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Umeda, Masaaki] CREST, JST, Nara 6300192, Japan; [Nishikawa, Shuh-ichi] Niigata Univ, Grad Sch Sci, Dept Life & Food Sci, Nishi Ku, Niigata 9502181, Japan; [Gross-Hardt, Rita] Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany	Nagoya University; Nagoya University; Nagoya University; National University of Singapore; National University of Singapore; Eberhard Karls University of Tubingen; King Abdullah University of Science & Technology; Nagoya University; Waseda University; Chiba University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Nagoya University; Nagoya University; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Niigata University; University of Bremen	Maruyama, D (corresponding author), Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	maruyama.daisuke@f.mbox.nagoya-u.ac.jp	Kawashima, Tomo/AAM-9411-2021; Takeuchi, Hidenori/AFG-8500-2022; Ueda, Minako/I-6130-2014; kurihara, daisuke/I-7206-2014; Higashiyama, Tetsuya/C-2882-2012; Mori, Toshiyuki/F-8488-2013; Takeuchi, Hidenori/AAF-1988-2022; Igawa, Tomoko/N-1578-2015; Ito, Masaki/G-4252-2013	Kawashima, Tomo/0000-0003-3803-3070; Takeuchi, Hidenori/0000-0002-0719-3736; kurihara, daisuke/0000-0003-2703-0405; Higashiyama, Tetsuya/0000-0002-7346-360X; Takeuchi, Hidenori/0000-0002-0719-3736; Igawa, Tomoko/0000-0003-1829-6076; Ueda, Minako/0000-0002-6892-2744; Ito, Masaki/0000-0002-9635-9709; Gross-Hardt, Rita/0000-0003-1998-0507	Global Center of Excellence program (Nagoya University); Japan Society for the Promotion of Science [6526, 5834]; Japan Advanced Plant Science Network; Japan Science and Technology Agency (ERATO project); Grants-in-Aid for Scientific Research [26113509, 25840113, 26660290] Funding Source: KAKEN	Global Center of Excellence program (Nagoya University); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Advanced Plant Science Network; Japan Science and Technology Agency (ERATO project); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kinoshita, S. McCormick, F. Berger, G.N. Drews, and T. Naka-gawa for the materials, N. Iwata, T. Nishii, and T.M. Vu for assistance in preparing materials, S. Tiedemann for genetic analysis, and A. Schnittger for discussions. F. Berger also provided useful comments on the manuscript. D.M. was supported by the Global Center of Excellence program (Nagoya University). D.M. and H.T. were supported by grants 6526 and 5834 from the Japan Society for the Promotion of Science Fellowships, respectively. This work was supported in part by Japan Advanced Plant Science Network and by a grant from the Japan Science and Technology Agency (ERATO project to T.H.).	Adachi S, 2011, P NATL ACAD SCI USA, V108, P10004, DOI 10.1073/pnas.1103584108; Beale KM, 2013, CURR OPIN PLANT BIOL, V16, P590, DOI 10.1016/j.pbi.2013.08.005; Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; CASS DD, 1970, AM J BOT, V57, P62, DOI 10.2307/2440380; Denninger P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5645; ENGELL K, 1989, NORD J BOT, V9, P265, DOI 10.1111/j.1756-1051.1989.tb01002.x; Furuta KM, 2014, SCIENCE, V345, P933, DOI 10.1126/science.1253736; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Guignard M.L., 1899, REV G N BOT, V11, P129; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Igawa T, 2013, J PLANT RES, V126, P387, DOI 10.1007/s10265-012-0528-0; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Ito J, 2002, PLANT CELL, V14, P3201, DOI 10.1105/tpc.006411; Kang IH, 2008, PLANT CELL, V20, P635, DOI 10.1105/tpc.107.055137; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kohler C, 2012, ANNU REV PLANT BIOL, V63, P331, DOI 10.1146/annurev-arplant-042811-105514; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; Maruyama D, 2013, DEV CELL, V25, P317, DOI 10.1016/j.devcel.2013.03.013; Milligan CE, 1997, BRIT MED BULL, V53, P570; Mori T., 2014, SEXUAL REPROD ANIMAL, P329; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; RAO PN, 1972, J CELL SCI, V10, P495; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; SCHULZ P, 1977, AM J BOT, V64, P384, DOI 10.2307/2441767; Schulz S.R., 1968, AM J BOT, V55, P541; Scott RJ, 2008, MOL PLANT, V1, P611, DOI 10.1093/mp/ssn016; Strasburger E., 1884, NEUE UNTERSUCHUNGEN; SZABADOS L, 1980, EXP CELL RES, V127, P442, DOI 10.1016/0014-4827(80)90450-4; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Takeuchi H, 2011, CURR OPIN PLANT BIOL, V14, P614, DOI 10.1016/j.pbi.2011.07.010; Tsaadon A, 2006, MOL CELL ENDOCRINOL, V252, P107, DOI 10.1016/j.mce.2006.03.037; Volz R, 2013, DEV CELL, V25, P310, DOI 10.1016/j.devcel.2013.04.001; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Yin K, 2014, PLANT J, V80, P541, DOI 10.1111/tpj.12652	37	71	74	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					907	918		10.1016/j.cell.2015.03.018	http://dx.doi.org/10.1016/j.cell.2015.03.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25913191	Bronze			2022-12-24	WOS:000354175200022
J	Linas, BP; Barter, DM; Morgan, JR; Pho, MT; Leff, JA; Schackman, BR; Horsburgh, CR; Assoumou, SA; Salomon, JA; Weinstein, MC; Freedberg, KA; Kim, AY				Linas, Benjamin P.; Barter, Devra M.; Morgan, Jake R.; Pho, Mai T.; Leff, Jared A.; Schackman, Bruce R.; Horsburgh, C. Robert; Assoumou, Sabrina A.; Salomon, Joshua A.; Weinstein, Milton C.; Freedberg, Kenneth A.; Kim, Arthur Y.			The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; SUSTAINED VIROLOGICAL RESPONSE; FIBROSIS PROGRESSION; NATURAL-HISTORY; UNITED-STATES; ALL-CAUSE; RIBAVIRIN; CIRRHOSIS; THERAPY; PEGINTERFERON	Background: Chronic infection with hepatitis C virus (HCV) genotype 2 or 3 can be treated with sofosbuvir without interferon. Because sofosbuvir is costly, its benefits should be compared with the additional resources used. Objective: To estimate the cost-effectiveness of sofosbuvir-based treatments for HCV genotype 2 or 3 infection in the United States. Design: Monte Carlo simulation, including deterministic and probabilistic sensitivity analyses. Data Sources: Randomized trials, observational cohorts, and national health care spending surveys. Target Population: 8 patient types defined by HCV genotype (2 vs. 3), treatment history (naive vs. experienced), and cirrhosis status (noncirrhotic vs. cirrhotic). Time Horizon: Lifetime. Perspective: Payer. Intervention: Sofosbuvir-based therapies, pegylated interferon-ribavirin, and no therapy. Outcome Measures: Discounted quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: The ICER of sofosbuvir-based treatment was less than $100 000 per QALY in cirrhotic patients (genotype 2 or 3 and treatment-naive or treatment-experienced) and in treatment-experienced noncirrhotic patients but was greater than $200 000 per QALY in treatment-naive noncirrhotic patients. Results of Sensitivity Analysis: The ICER of sofosbuvir-based therapy for treatment-naive noncirrhotic patients with genotype 2 or 3 infection was less than $100 000 per QALY when the cost of sofosbuvir was reduced by approximately 40% and 60%, respectively. In probabilistic sensitivity analyses, cost-effectiveness conclusions were robust to uncertainty in treatment efficacy. Limitation: The analysis did not consider possible benefits of preventing HCV transmission. Conclusion: Sofosbuvir provides good value for money for treatment-experienced patients with HCV genotype 2 or 3 infection and those with cirrhosis. At their current cost, sofosbuvir-based regimens for treatment-naive noncirrhotic patients exceed willingness-to-pay thresholds commonly cited in the United States.	Boston Univ, Harvard Univ, Sch Publ Hlth, Boston Med Ctr, Boston, MA 02118 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Chicago, Chicago, IL 60637 USA; Weill Cornell Med Coll, New York, NY USA	Boston Medical Center; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University of Chicago; Cornell University	Linas, BP (corresponding author), Boston Med Ctr, HIV Epidemiol & Outcomes Res Unit, 850 Harrison Ave,Dowling 3N,Room 3205, Boston, MA 02118 USA.	Benjamin.Linas@BMC.org	Salomon, Joshua A/D-3898-2009; Leff, Jared A./B-7631-2014; Morgan, Jake R/H-3487-2019; Assoumou, Sabrina/AAF-2087-2021; Schackman, Bruce R./J-8208-2019; Salomon, Joshua/S-1929-2019	Salomon, Joshua A/0000-0003-3929-5515; Leff, Jared A./0000-0001-6995-6009; Morgan, Jake R/0000-0002-1559-3983; Assoumou, Sabrina/0000-0002-5169-620X; Schackman, Bruce R./0000-0002-1132-2932; Salomon, Joshua/0000-0003-3929-5515; Horsburgh, C./0000-0001-6838-7895	National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042006, R37AI042006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027379, R01DA031059] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse and National Institute of Allergy and Infectious Diseases.	Agency for Healthcare Research and Quality, 2013, TOT HLTH SERV MEAN M; American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society-USA, 2015, REC TEST MAN TREAT H; [Anonymous], 2013, MICR 2 0 DRUG TOP RE; Armstrong D, 2014, BLOOMBERG BUSIN 0305; Barnett PG, 2001, ADDICTION, V96, P1267, DOI 10.1046/j.1360-0443.2001.96912676.x; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Bruno S, 2009, AM J GASTROENTEROL, V104, P1147, DOI 10.1038/ajg.2009.31; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Center for Medicare and Medicaid Services, 2013, CLIN LAB FEE SCHED; Centers for Medicare and Medicaid Services, 2013, PHYS FEE SCHED; Chaiwat O, 2009, ANESTHESIOLOGY, V110, P351, DOI 10.1097/ALN.0b013e3181948a97; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Daltron-Oliveira R, 2013, ANN HEPATOL, V12, P399, DOI 10.1016/S1665-2681(19)31002-6; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; Dias PT, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-208; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold MR, 1996, COST EFFECTIVENESS H; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kim Arthur Y, 2013, F1000Prime Rep, V5, P24, DOI 10.12703/P5-24; Lawitz E, 2015, HEPATOLOGY, V61, P769, DOI 10.1002/hep.27567; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Linas BP, 2011, J VIRAL HEPATITIS, V18, P506, DOI 10.1111/j.1365-2893.2010.01325.x; Linas BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097317; Linas BP, 2014, AIDS, V28, P365, DOI 10.1097/QAD.0000000000000093; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Pianko S, 2014, AM ASS STUD LIV DIS; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Quest Diagnostics, 2013, HEP C VIR HCV FIBROS; Reau NS, 2014, HEPATOLOGY, V59, P1246, DOI 10.1002/hep.27039; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Schackman BR, 2008, MED DECIS MAKING, V28, P233, DOI 10.1177/0272989X07311753; Sherman K, 2013, J HEPATOL, V58, pS372, DOI 10.1016/S0168-8278(13)60906-X; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Stein K, 2002, Health Technol Assess, V6, P1; Stepanova M, 2014, ALIMENT PHARM THER, V40, P676, DOI 10.1111/apt.12880; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; US Food and Drug Administration, 2013, APPR SOV SOF TABL TR; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vera-Llonch M, 2013, ALIMENT PHARM THER, V38, P124, DOI 10.1111/apt.12354; Whitaker B., 2005, 2005 NATIONWIDE BLOO, P1; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	55	81	82	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					619	U220		10.7326/M14-1313	http://dx.doi.org/10.7326/M14-1313			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25820703	Green Accepted			2022-12-24	WOS:000354119100006
J	Das, I; Krzyzosiak, A; Schneider, K; Wrabetz, L; D'Antonio, M; Barry, N; Sigurdardottir, A; Bertolotti, A				Das, Indrajit; Krzyzosiak, Agnieszka; Schneider, Kim; Wrabetz, Lawrence; D'Antonio, Maurizio; Barry, Nicholas; Sigurdardottir, Anna; Bertolotti, Anne			Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit	SCIENCE			English	Article							INDUCED GENE-EXPRESSION; PROTEIN-SYNTHESIS; GUANABENZ; PHOSPHORYLATION; DEATH; MICE; ALS	Protein phosphorylation regulates virtually all biological processes. Although protein kinases are popular drug targets, targeting protein phosphatases remains a challenge. Here, we describe Sephin1 (selective inhibitor of a holophosphatase), a small molecule that safely and selectively inhibited a regulatory subunit of protein phosphatase 1 in vivo. Sephin1 selectively bound and inhibited the stress-induced PPP1R15A, but not the related and constitutive PPP1R15B, to prolong the benefit of an adaptive phospho-signaling pathway, protecting cells from otherwise lethal protein misfolding stress. In vivo, Sephin1 safely prevented the motor, morphological, and molecular defects of two otherwise unrelated protein-misfolding diseases in mice, Charcot-Marie-Tooth 1B, and amyotrophic lateral sclerosis. Thus, regulatory subunits of phosphatases are drug targets, a property exploited here to safely prevent two protein misfolding diseases.	[Das, Indrajit; Krzyzosiak, Agnieszka; Schneider, Kim; Barry, Nicholas; Sigurdardottir, Anna; Bertolotti, Anne] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Wrabetz, Lawrence; D'Antonio, Maurizio] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy	MRC Laboratory Molecular Biology; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bertolotti, A (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	aberto@mrc-lmb.cam.ac.uk	Krzyżosiak, Agnieszka/AAW-3711-2021; D'Antonio, Maurizio/AHI-1781-2022; Sigurdardottir, Anna G/J-1562-2015	D'Antonio, Maurizio/0000-0003-0637-8971; Sigurdardottir, Anna G/0000-0002-5225-397X; Das, Indrajit/0000-0001-8407-9796; Krzyzosiak, Agnieszka/0000-0002-4330-3189	Medical Research Council (UK); European Research Council (ERC) under the European Union/ERC [309516]; European Molecular Biology Organization and Human Frontier Science Program; Swiss National Science Foundation; Italian Ministry of Health [GR-2011-02642791]; NIH [R01-NS55256]; Medical Research Council [MC_U105185860] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055256] Funding Source: NIH RePORTER; MRC [MC_U105185860] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC) under the European Union/ERC(European Research Council (ERC)); European Molecular Biology Organization and Human Frontier Science Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Italian Ministry of Health(Ministry of Health, Italy); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Tsaytler for some initial experiments on Sephin1; H. Meziane for the studies on memory; E. Fisher for SOD1<SUP>G93A</SUP> mice; E. Pettinato and C. Ferri for technical assistance; R. Roberts for discussions on CMT; A. Segonds-Pichon for statistical analysis; and members of the Bertolotti laboratory, M. Goedert, M. Hastings, and S. Munro for discussions. A.B. is an honorary fellow of the Clinical Neurosciences Department of Cambridge University. This work was supported by the Medical Research Council (UK) and the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant 309516. A.K. was supported by the European Molecular Biology Organization and Human Frontier Science Program, K.S. by the Swiss National Science Foundation, M.D. by the Italian Ministry of Health (GR-2011-02642791), and L.W. by NIH R01-NS55256. A.B. is a co-inventor on Great Britain patent WO 2014108520, covering benzylideneguanidine derivatives inhibitors of PPP1R15A. The data presented in this paper are tabulated in the main paper and the supplementary materials.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BROSTROM MA, 1989, J BIOL CHEM, V264, P1638; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALL AH, 1985, ANN INTERN MED, V102, P787, DOI 10.7326/0003-4819-102-6-787; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MEACHAM RH, 1980, J PHARMACOL EXP THER, V214, P594; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Nordlund A, 2008, HFSP J, V2, P354, DOI 10.2976/1.2995726; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Wrabetz L, 2006, J NEUROSCI, V26, P2358, DOI 10.1523/JNEUROSCI.3819-05.2006	25	262	271	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					239	242		10.1126/science.aaa4484	http://dx.doi.org/10.1126/science.aaa4484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859045	Green Accepted			2022-12-24	WOS:000352613700047
J	Bush, A; Kleinert, S; Pavord, ID				Bush, Andrew; Kleinert, Sabine; Pavord, Ian D.			The asthmas in 2015 and beyond: a Lancet Commission	LANCET			English	Editorial Material							EOSINOPHILIC ASTHMA; PERSISTENT ASTHMA; MEPOLIZUMAB		[Bush, Andrew] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bush, Andrew] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Kleinert, Sabine] The Lancet, London, England; [Pavord, Ian D.] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford OX3 7FZ, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; University of Oxford	Pavord, ID (corresponding author), Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford OX3 7FZ, England.	ian.pavord@ndm.ox.ac.uk		Pavord, Ian/0000-0002-4288-5973	National Institute for Health Research [NF-SI-0510-10192] Funding Source: researchfish; Asthma UK [AUK-AC-2012-01, 10/058] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK		[Anonymous], 1990, BMJ, V301, P651; Bush A, 2014, ARCH DIS CHILD, V99, P191, DOI 10.1136/archdischild-2012-303105; Bush A, 2011, THORAX, V66, P367, DOI 10.1136/thx.2011.160861; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Han MLK, 2014, AM J RESP CRIT CARE, V189, P1503, DOI 10.1164/rccm.201402-0207OC; Hargreave FE, 2009, CLIN EXP ALLERGY, V39, P1652, DOI 10.1111/j.1365-2222.2009.03321.x; Levy M, 2014, WHY ASTHMA STILL KIL; Pavord ID, 2008, LANCET, V372, P1017, DOI 10.1016/S0140-6736(08)61421-X; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Rosenthal M, 2015, THORAX, V70, P112, DOI 10.1136/thoraxjnl-2014-206010; Sabroe I, 2013, THORAX, V68, P1085, DOI 10.1136/thoraxjnl-2013-203773; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048	15	25	25	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1273	1275		10.1016/S0140-6736(15)60654-7	http://dx.doi.org/10.1016/S0140-6736(15)60654-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25890896				2022-12-24	WOS:000352272400015
J	Macilwain, C				Macilwain, Colin			Change the cancer conversation	NATURE			English	Editorial Material												cfnworldview@googlemail.com							0	7	7	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					7	7		10.1038/520007a	http://dx.doi.org/10.1038/520007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE7NE	25832371	Bronze			2022-12-24	WOS:000352027700010
J	Loxterkamp, D				Loxterkamp, David			LETTER FROM NEW ENGLAND An inconvenient truth: urgent care is not primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Community Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com						Japsen B., 2013, FORBES MAGAZINE; PR Newswire, 2014, PR NEWSWIRE     1103; Ziobro P., 2014, WALL STREET J	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2015	350									10.1136/bmj.h1657	http://dx.doi.org/10.1136/bmj.h1657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OC	25813141				2022-12-24	WOS:000352030200012
J	Scheffer, M; Barrett, S; Carpenter, SR; Folke, C; Green, AJ; Holmgren, M; Hughes, TP; Kosten, S; van de Leemput, IA; Nepstad, DC; van Nes, EH; Peeters, ETHM; Walker, B				Scheffer, M.; Barrett, S.; Carpenter, S. R.; Folke, C.; Green, A. J.; Holmgren, M.; Hughes, T. P.; Kosten, S.; van de Leemput, I. A.; Nepstad, D. C.; van Nes, E. H.; Peeters, E. T. H. M.; Walker, B.			Creating a safe operating space for iconic ecosystems	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; CORAL-REEFS; DEFORESTATION; RESILIENCE; IMPACTS; AMAZON; SHIFTS; FIRE		[Scheffer, M.; van de Leemput, I. A.; van Nes, E. H.; Peeters, E. T. H. M.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands; [Barrett, S.] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Carpenter, S. R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Folke, C.] Stockholm Univ, Royal Swedish Acad Sci, Beijer Inst Ecol Econ, SE-10405 Stockholm, Sweden; [Folke, C.] Stockholm Univ, Stockholm Resilience Ctr, SE-10405 Stockholm, Sweden; [Green, A. J.] CSIC, EBD, E-41080 Seville, Spain; [Holmgren, M.] Wageningen Univ, Resource Ecol Grp, NL-6700 AA Wageningen, Netherlands; [Hughes, T. P.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Kosten, S.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Aquat Ecol & Environm Biol, NL-6525 AJ Nijmegen, Netherlands; [Nepstad, D. C.] Earth Innovat Inst, San Francisco, CA 94110 USA; [Walker, B.] CSIRO Land & Water, Canberra, ACT 2601, Australia	Wageningen University & Research; Columbia University; University of Wisconsin System; University of Wisconsin Madison; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; Stockholm University; Stockholm University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Wageningen University & Research; James Cook University; Radboud University Nijmegen; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Scheffer, M (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands.	marten.scheffer@wur.nl	Folke, Carl/Z-1545-2019; Green, Andy J/A-5189-2008; Carpenter, Stephen/AAQ-6404-2020; van Nes, Egbert H/F-2681-2011; Kosten, Sarian/D-7550-2011; Hughes, Terry/L-4721-2013	Green, Andy J/0000-0002-1268-4951; Kosten, Sarian/0000-0003-2031-0965; Hughes, Terry/0000-0002-5257-5063; van Nes, Egbert/0000-0002-6345-104X; Folke, Carl/0000-0002-4050-3281; Carpenter, Stephen/0000-0001-8097-8700; Peeters, Edwin T.H.M./0000-0003-2541-1829	European Research Council; Spinoza award; Stellenbosch Institute for Advanced Study; NSF; WIMEK research fellowship; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [86312012]	European Research Council(European Research Council (ERC)European Commission); Spinoza award; Stellenbosch Institute for Advanced Study; NSF(National Science Foundation (NSF)); WIMEK research fellowship; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	M.S. is supported by a European Research Council advanced grant and Spinoza award. C.F. is supported by the Stellenbosch Institute for Advanced Study. S.R.C.'s research is supported by NSF. A.J.G. was supported by a WIMEK research fellowship and S.K. by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Veni grant 86312012. M.S., C.F., and S.R.C. are also at the South American Institute for Resilience and Sustainability Studies. This work was carried out under the program of the Netherlands Earth System Science Centre (NESSC).	[Anonymous], 2014, GREAT BARR REET MAR; Barrett S, 2014, NAT CLIM CHANGE, V4, P36, DOI [10.1038/nclimate2059, 10.1038/NCLIMATE2059]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Guardiola-Albert C, 2011, WETLANDS, V31, P907, DOI 10.1007/s13157-011-0205-4; Holmgren M, 2013, NAT CLIM CHANGE, V3, P755, DOI [10.1038/nclimate1906, 10.1038/NCLIMATE1906]; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kelly RP, 2011, SCIENCE, V332, P1036, DOI 10.1126/science.1203815; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Moss B, 2011, INLAND WATERS, V1, P101, DOI 10.5268/IW-1.2.359; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Normile D, 2014, SCIENCE, V346, P683, DOI 10.1126/science.346.6210.683; Oreskes Naomi, 2010, MERCHANTS DOUBT; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Rockstrom J, 2009, ECOL SOC, V14; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000	21	162	167	1	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1317	1319		10.1126/science.aaa3769	http://dx.doi.org/10.1126/science.aaa3769			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792318	Green Submitted			2022-12-24	WOS:000351219600023
J	Seydel, KB; Kampondeni, SD; Valim, C; Potchen, MJ; Milner, DA; Muwalo, FW; Birbeck, GL; Bradley, WG; Fox, LL; Glover, SJ; Hammond, CA; Heyderman, RS; Chilingulo, CA; Molyneux, ME; Taylor, TE				Seydel, Karl B.; Kampondeni, Samuel D.; Valim, Clarissa; Potchen, Michael J.; Milner, Danny A.; Muwalo, Francis W.; Birbeck, Gretchen L.; Bradley, William G.; Fox, Lindsay L.; Glover, Simon J.; Hammond, Colleen A.; Heyderman, Robert S.; Chilingulo, Cowles A.; Molyneux, Malcolm E.; Taylor, Terrie E.			Brain Swelling and Death in Children with Cerebral Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FALCIPARUM-MALARIA; CONTINUOUS EEG; ACTIVATION; COAGULATION; SEQUESTRATION; INFLAMMATION; PATTERNS	BACKGROUND Case fatality rates among African children with cerebral malaria remain in the range of 15 to 25%. The key pathogenetic processes and causes of death are unknown, but a combination of clinical observations and pathological findings suggests that increased brain volume leading to raised intracranial pressure may play a role. Magnetic resonance imaging (MRI) became available in Malawi in 2009, and we used it to investigate the role of brain swelling in the pathogenesis of fatal cerebral malaria in African children. METHODS We enrolled children who met a stringent definition of cerebral malaria (one that included the presence of retinopathy), characterized them in detail clinically, and obtained MRI scans on admission and daily thereafter while coma persisted. RESULTS Of 348 children admitted with cerebral malaria (as defined by the World Health Organization), 168 met the inclusion criteria, underwent all investigations, and were included in the analysis. A total of 25 children (15%) died, 21 of whom (84%) had evidence of severe brain swelling on MRI at admission. In contrast, evidence of severe brain swelling was seen on MRI in 39 of 143 survivors (27%). Serial MRI scans showed evidence of decreasing brain volume in the survivors who had had brain swelling initially. CONCLUSIONS Increased brain volume was seen in children who died from cerebral malaria but was uncommon in those who did not die from the disease, a finding that suggests that raised intracranial pressure may contribute to a fatal outcome. The natural history indicates that increased intracranial pressure is transient in survivors.	[Seydel, Karl B.; Fox, Lindsay L.; Taylor, Terrie E.] Michigan State Univ, Dept Osteopath Med Specialties, Coll Osteopath Med, E Lansing, MI 48824 USA; [Potchen, Michael J.; Hammond, Colleen A.] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA; [Birbeck, Gretchen L.] Michigan State Univ, Dept Neurol & Ophthal, Int Neurol & Psychiat Epidemiol Program, E Lansing, MI 48824 USA; [Seydel, Karl B.; Kampondeni, Samuel D.; Milner, Danny A.; Muwalo, Francis W.; Fox, Lindsay L.; Taylor, Terrie E.] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Heyderman, Robert S.; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Kampondeni, Samuel D.; Chilingulo, Cowles A.] Univ Malawi, Coll Med, Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Glover, Simon J.] Univ Malawi, Coll Med, Dept Anat, Blantyre, Malawi; [Valim, Clarissa; Milner, Danny A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Milner, Danny A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bradley, William G.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University; Michigan State University; University of Malawi; University of Malawi; University of Malawi; University of Malawi; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Diego; Liverpool School of Tropical Medicine; University of Liverpool	Taylor, TE (corresponding author), Michigan State Univ, W Fee Hall,909 Fee Rd,Rm B305-B, E Lansing, MI 48824 USA.	ttmalawi@msu.edu	Milner, Danny/K-3568-2019	Potchen, Michael/0000-0002-2603-9355; Heyderman, Robert/0000-0003-4573-449X; Milner, Jr, Danny Arnold/0000-0002-6685-8208	National Institutes of Health; Wellcome Trust U.K.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust U.K.(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and Wellcome Trust U.K.	Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; Bauer G, 2013, J CLIN NEUROPHYSIOL, V30, P477, DOI 10.1097/WNP.0b013e3182a73e47; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2011, FUTURE MICROBIOL, V6, P349, DOI [10.2217/fmb.11.3, 10.2217/FMB.11.3]; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; CLARK IA, 1995, J INFECT DIS, V171, P1068, DOI 10.1093/infdis/171.4.1068; CLARK IA, 1993, Q J MED, V86, P217; CLEMENS R, 1994, BRIT J HAEMATOL, V87, P100, DOI 10.1111/j.1365-2141.1994.tb04877.x; Crepeau AZ, 2013, NEUROLOGY, V80, P339, DOI 10.1212/WNL.0b013e31827f089d; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; ELHASSAN IM, 1994, AM J TROP MED HYG, V51, P372, DOI 10.4269/ajtmh.1994.51.372; Enwere G, 2005, TROP MED INT HEALTH, V10, P1171, DOI 10.1111/j.1365-3156.2005.01505.x; Faiz MA, 2005, LANCET, V366, P717; Fingelkurts AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025967; Hawkes M, 2013, VIRULENCE, V4, P543, DOI 10.4161/viru.25949; HEMMER CJ, 1991, AM J MED, V91, P37, DOI 10.1016/0002-9343(91)90071-5; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Jimmy EO, 2003, ANN TROP MED PARASIT, V97, P879, DOI 10.1179/000349803225002426; Lewallen S, 2008, T ROY SOC TROP MED H, V102, P1089, DOI 10.1016/j.trstmh.2008.06.014; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MEDER JF, 1994, J NEURORADIOLOGY, V21, P118; Milner DA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00104; Mohanty D, 1997, AM J HEMATOL, V54, P23, DOI 10.1002/(SICI)1096-8652(199701)54:1&lt;23::AID-AJH4&gt;3.0.CO;2-6; Moxon CA, 2013, BLOOD, V122, P842, DOI 10.1182/blood-2013-03-490219; NEWTON CRJC, 1994, ARCH DIS CHILD, V70, P281, DOI 10.1136/adc.70.4.281; NEWTON CRJC, 1991, LANCET, V337, P573, DOI 10.1016/0140-6736(91)91638-B; Newton CRJC, 1997, ARCH DIS CHILD, V76, P219, DOI 10.1136/adc.76.3.219; Oemichem M, 2006, FORENSIC NEUROPATHOL; Ponsford MJ, 2012, J INFECT DIS, V205, P663, DOI 10.1093/infdis/jir812; Potchen MJ, 2012, AM J NEURORADIOL, V33, P1740, DOI 10.3174/ajnr.A3035; Potchen MJ, 2013, NEUROLOGY, V81, P585, DOI 10.1212/WNL.0b013e31829e6ed5; PROHOVNIK I, 1989, NEUROLOGY, V39, P344, DOI 10.1212/WNL.39.3.344; RDCT, 2011, R LANG ENV STAT COMP; Romano Andrea, 2003, Radiol Med, V106, P521; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Taylor Terrie E, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS6, DOI 10.1016/j.trstmh.2008.10.049; Teksam M, 2008, AM J NEURORADIOL, V29, P1961, DOI 10.3174/ajnr.A1246; Turner GDH, 1998, AM J PATHOL, V152, P1477; WHITE NJ, 1985, LANCET, V1, P776; WHO, 2013, WORLD MALARIA REPORT 2013, P1	42	213	215	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2015	372	12					1126	1137		10.1056/NEJMoa1400116	http://dx.doi.org/10.1056/NEJMoa1400116			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EZ	25785970	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000351183600007
J	Zhang, WQ; Li, JY; Suzuki, K; Qu, J; Wang, P; Zhou, JZ; Liu, XM; Ren, RT; Xu, XL; Ocampo, A; Yuan, TT; Yang, JP; Li, Y; Shi, L; Guan, D; Pan, HZ; Duan, SL; Ding, ZC; Li, M; Yi, F; Bai, RJ; Wang, YY; Chen, C; Yang, FQ; Li, XY; Wang, ZM; Aizawa, E; Goebl, A; Soligalla, RD; Reddy, P; Esteban, CR; Tang, FC; Liu, GH; Belmonte, JCI				Zhang, Weiqi; Li, Jingyi; Suzuki, Keiichiro; Qu, Jing; Wang, Ping; Zhou, Junzhi; Liu, Xiaomeng; Ren, Ruotong; Xu, Xiuling; Ocampo, Alejandro; Yuan, Tingting; Yang, Jiping; Li, Ying; Shi, Liang; Guan, Dee; Pan, Huize; Duan, Shunlei; Ding, Zhichao; Li, Mo; Yi, Fei; Bai, Ruijun; Wang, Yayu; Chen, Chang; Yang, Fuquan; Li, Xiaoyu; Wang, Zimei; Aizawa, Emi; Goebl, April; Soligalla, Rupa Devi; Reddy, Pradeep; Esteban, Concepcion Rodriguez; Tang, Fuchou; Liu, Guang-Hui; Belmonte, Juan Carlos Izpisua			A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging	SCIENCE			English	Article							GENE; DEFECTS; DISEASE; WRN	Werner syndrome (WS) is a premature aging disorder caused by WRN protein deficiency. Here, we report on the generation of a human WS model in human embryonic stem cells (ESCs). Differentiation of WRN-null ESCs to mesenchymal stem cells (MSCs) recapitulates features of premature cellular aging, a global loss of H3K9me3, and changes in heterochromatin architecture. We show that WRN associates with heterochromatin proteins SUV39H1 and HP1 alpha and nuclear lamina-heterochromatin anchoring protein LAP2 beta. Targeted knock-in of catalytically inactive SUV39H1 in wild-type MSCs recapitulates accelerated cellular senescence, resembling WRN-deficient MSCs. Moreover, decrease in WRN and heterochromatin marks are detected in MSCs from older individuals. Our observations uncover a role for WRN in maintaining heterochromatin stability and highlight heterochromatin disorganization as a potential determinant of human aging.	[Zhang, Weiqi; Wang, Ping; Zhou, Junzhi; Ren, Ruotong; Xu, Xiuling; Yuan, Tingting; Yang, Jiping; Li, Ying; Guan, Dee; Pan, Huize; Duan, Shunlei; Ding, Zhichao; Chen, Chang; Yang, Fuquan; Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Li, Jingyi; Liu, Xiaomeng; Tang, Fuchou] Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Suzuki, Keiichiro; Ocampo, Alejandro; Li, Mo; Aizawa, Emi; Goebl, April; Soligalla, Rupa Devi; Reddy, Pradeep; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Qu, Jing; Bai, Ruijun] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Shi, Liang; Wang, Yayu] PLA, Hosp 306, Diagnosis & Treatment Ctr Oral Dis, Beijing, Peoples R China; [Yi, Fei] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Li, Xiaoyu] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Wang, Zimei; Liu, Guang-Hui] Shenzhen Univ, Ctr Antiaging & Regenerat Med, Shenzhen 518060, Peoples R China; [Goebl, April] Univ Catolica San Antonio Murcia, Murcia 30107, Spain; [Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Tang, Fuchou; Liu, Guang-Hui] Ctr Mol & Translat Med CMTM, Beijing 100101, Peoples R China; [Tang, Fuchou] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Liu, Guang-Hui] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University; Salk Institute; Chinese Academy of Sciences; Institute of Zoology, CAS; Stanford University; Peking University; Shenzhen University; Universidad Catolica de Murcia; Peking University	Liu, GH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	tangfuchou@pku.edu.cn; ghliu@ibp.ac.cn; belmonte@salk.edu	Li, Mo/AAM-8266-2021; Ren, Ruotong/AAF-4046-2020; Reddy, Pradeep/G-1770-2014; Qu, Jing/ABB-9088-2020; Pan, Huize/ACM-3473-2022; Liu, Xiaomeng/GNM-9778-2022	Li, Mo/0000-0003-0827-8907; Reddy, Pradeep/0000-0002-9173-3845; Pan, Huize/0000-0002-3478-6799; Liu, Xiaomeng/0000-0002-3288-212X; Tas, Sadik Taskin/0000-0002-4732-4761; Suzuki, Keiichiro/0000-0001-5603-9105; Zhang, Weiqi/0000-0002-8885-5104; Duan, Shunlei/0000-0003-0548-5150; Ocampo, Alejandro/0000-0002-3731-3647; chen, chang/0000-0003-1008-1062; qu, jing/0000-0002-3988-5067	National Natural Science Foundation of China [NSFC: 81330008]; National Basic Research Program of China (973 Program) [2015CB964800, 2014CB910500, 2014CB964600, 2012CB966704]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; NSFC [31222039, 31201111, 81371342, 81300261, 81300677, 81271266, 81471414, 81422017, 81401159, 31322037, 81471407]; National High Technology Research and Development Program of China (863 program) [2015AA020307]; Beijing Natural Science Foundation [7141005, 5142016]; Chinese Academy of Sciences [KJZDEW-TZ-L05]; Thousand Young Talents program of China; National Laboratory of Biomacromolecules [012kf02, 2013kf05, 2013kf11, 2014kf02, 2015kf10]; State Key Laboratory of Drug Research [SIMM1302KF-17]; China Postdoctoral Science Foundation [2013M530751]; California Institute for Regenerative Medicine Training Grant; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship; UCAM; Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; NATIONAL INSTITUTE ON AGING [F32AG047770] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Thousand Young Talents program of China(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; State Key Laboratory of Drug Research; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); California Institute for Regenerative Medicine Training Grant; NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCAM; Glenn Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to W. G. Zhu, L. Comai, K. Mitani, P. Ng, and A. Lieber for sharing experimental materials; L. Sun, W. Ding, G. Yuan, and X. Zhu from Center for Biological Imaging for technical assistance; and M. Schwarz and L. Zhao for administrative help. This work was supported by National Natural Science Foundation of China (NSFC: 81330008), National Basic Research Program of China (973 Program, 2015CB964800; 2014CB910500; 2014CB964600; 2012CB966704), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01020312), NSFC (31222039; 31201111; 81371342; 81300261; 81300677; 81271266; 81471414; 81422017; 81401159; 31322037; 81471407), National High Technology Research and Development Program of China (863 program: 2015AA020307), Beijing Natural Science Foundation (7141005; 5142016), Key Research Program of the Chinese Academy of Sciences (KJZDEW-TZ-L05), the Thousand Young Talents program of China, National Laboratory of Biomacromolecules (012kf02;2013kf05;2013kf11;2014kf02;2015kf10) and State Key Laboratory of Drug Research (SIMM1302KF-17), and China Postdoctoral Science Foundation Grant (2013M530751). K. Sand M. L. are supported by a California Institute for Regenerative Medicine Training Grant. A.O. was partially supported by an NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship. The physiological human cell aging studies were supported by UCAM. The J.C.I.B. laboratory was supported by The Glenn Foundation, The G. Harold and Leila Y. Mathers Charitable Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002). All materials are available from the G.-H.L., F.T., and J.C.I.B. laboratories under a material transfer agreement with Institute of Biophysics (CAS), Peking University, or The Salk Institute for Biological Studies. Myc-HP1 alpha plasmid can be obtained from W. G. Zhu under a material transfer agreement with Peking University.	Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Liu GH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5330; Liu GH, 2012, CURR OPIN CELL BIOL, V24, P765, DOI 10.1016/j.ceb.2012.08.014; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Tomar GB, 2010, BIOCHEM BIOPH RES CO, V393, P377, DOI 10.1016/j.bbrc.2010.01.126; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Zhang WQ, 2013, TRENDS CELL BIOL, V23, P587, DOI 10.1016/j.tcb.2013.07.001	20	307	321	9	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1160	1168		10.1126/science.aaa1356	http://dx.doi.org/10.1126/science.aaa1356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	25931448	Green Accepted			2022-12-24	WOS:000355590500054
J	Abraham, NS; Singh, S; Alexander, GC; Heien, H; Haas, LR; Crown, W; Shah, ND				Abraham, Neena S.; Singh, Sonal; Alexander, G. Caleb; Heien, Herbert; Haas, Lindsey R.; Crown, William; Shah, Nilay D.			Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; ANTITHROMBOTIC THERAPY; STROKE PREVENTION; METAANALYSIS; EFFICACY; SAFETY; MANAGEMENT; OLDER	OBJECTIVE To determine the real world risk of gastrointestinal bleeding associated with the use of the novel oral anticoagulants dabigatran and rivaroxaban compared with warfarin. DESIGN Retrospective, propensity matched cohort study. SETTING: Optum Labs Data Warehouse, a large database including administrative claims data on privately insured and Medicare Advantage enrollees. PARTICIPANTS New users of dabigatran, rivaroxaban, and warfarin from 1 November 2010 to 30 September 2013. MAIN OUTCOME MEASURES Incidence rates (events/100 patient years) and propensity score matched Cox proportional hazards models were used to estimate rates of total gastrointestinal bleeds, upper gastrointestinal bleeds, and lower gastrointestinal bleeds for the novel oral anticoagulants compared with warfarin in patients with and without atrial fibrillation. Heterogeneity of treatment effect related to age was examined using a marginal effects model. RESULTS The incidence of gastrointestinal bleeding associated with dabigatran was 2.29 (95% confidence interval 1.88 to 2.79) per 100 patient years and that associated with warfarin was 2.87 (2.41 to 3.41) per 100 patient years in patients with atrial fibrillation. In non-atrial fibrillation patients, the incidence of gastrointestinal bleeding was 4.10 (2.47 to 6.80) per 100 patient years with dabigatran and 3.71 (2.16 to 6.40) per 100 patient years with warfarin. With rivaroxaban, 2.84 (2.30 to 3.52) gastrointestinal bleeding events per 100 patient years occurred in atrial fibrillation patients (warfarin 3.06 (2.49 to 3.77)/100 patient years) and 1.66 (1.23 to 2.24) per 100 patient years in non-atrial fibrillation patients (warfarin 1.57 (1.25 to 1.99)/100 patient years). In propensity score matched models, the risk of gastrointestinal bleeding with novel oral anticoagulants was similar to that with warfarin in atrial fibrillation patients (dabigatran v warfarin, hazard ratio 0.79 (0.61 to 1.03); rivaroxaban v warfarin, 0.93 (0.69 to 1.25)) and in non-AF patients (dabigatran v warfarin, hazard ratio 1.14 (0.54 to 2.39); rivaroxaban v warfarin, 0.89 (0.60 to 1.32)). The risk of gastrointestinal bleeding increased after age 65, such that by age 76 the risk exceeded that with warfarin among atrial fibrillation patients taking dabigatran (hazard ratio 2.49 (1.61 to 3.83)) and patients with and without atrial fibrillation taking rivaroxaban (2.91 (1.65 to 4.81) and 4.58 (2.40 to 8.72), respectively). CONCLUSIONS: The risk of gastrointestinal bleeding related to novel oral anticoagulants was similar to that for warfarin. Caution should be used when prescribing novel oral anticoagulants to older people, particularly those over 75 years of age.	[Abraham, Neena S.] Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, Scottsdale, AZ 85259 USA; [Abraham, Neena S.; Shah, Nilay D.] Mayo Clin, Dept Hlth Serv Res, Div Hlth Care Policy & Res, Rochester, MN USA; [Abraham, Neena S.; Heien, Herbert; Haas, Lindsey R.; Shah, Nilay D.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Singh, Sonal; Alexander, G. Caleb] Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD USA; [Singh, Sonal; Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Singh, Sonal; Alexander, G. Caleb] Ctr Drug Safety & Effectiveness, Baltimore, MD USA; [Crown, William] Optum Labs, Cambridge, MA USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Optum	Abraham, NS (corresponding author), Mayo Clin, Dept Med, Div Gastroenterol & Hepatol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	abraham.neena@mayo.edu	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X	Mayo Clinic Robert D and Patricia E Kern Center for the Science of Health Care Delivery	Mayo Clinic Robert D and Patricia E Kern Center for the Science of Health Care Delivery	This study was funded by the Mayo Clinic Robert D and Patricia E Kern Center for the Science of Health Care Delivery.	Abraham NS, 2013, CIRCULATION, V128, P1869, DOI 10.1161/CIRCULATIONAHA.113.004747; Abraham NS, 2013, CURR OPIN GASTROEN, V29, P676, DOI 10.1097/MOG.0b013e328365d415; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Freedman JE, 2014, CIRCULATION, V130, P129, DOI 10.1161/CIRCULATIONAHA.114.010873; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goodman SG, 2014, J AM COLL CARDIOL, V63, P891, DOI 10.1016/j.jacc.2013.11.013; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hernandez I, 2015, JAMA INTERN MED, V175, P18, DOI 10.1001/jamainternmed.2014.5398; Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Komocsi A, 2012, ARCH INTERN MED, V172, P1537, DOI 10.1001/archinternmed.2012.4026; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Wallace PJ, 2014, HEALTH AFFAIR, V33, P1187, DOI 10.1377/hlthaff.2014.0038; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	25	250	257	2	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2015	350								h1857	10.1136/bmj.h1857	http://dx.doi.org/10.1136/bmj.h1857			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RC	25910928	Green Published, hybrid			2022-12-24	WOS:000353577000003
J	Bekerman, E; Einav, S				Bekerman, Elena; Einav, Shirit			Combating emerging viral threats	SCIENCE			English	Editorial Material							DISEASES; ANALOG; HOST		[Bekerman, Elena] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Bekerman, E (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.	seinav@stanford.edu			Doris Duke Charitable Foundation [2013100] Funding Source: Medline; NIAID NIH HHS [T32 AI007502, U19 AI109662] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109662, T32AI007502] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011; Coolidge A., 2014, CINCINNATI ENQUIRER; Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14; Florescu DF, 2014, EXPERT REV ANTI-INFE, V12, P1171, DOI 10.1586/14787210.2014.948847; Friedman RM, 2008, BRIT J CLIN PHARMACO, V65, P158, DOI 10.1111/j.1365-2125.2007.03055.x; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Haqqani AA, 2013, ANTIVIR RES, V98, P158, DOI 10.1016/j.antiviral.2013.03.017; Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020; Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845; Pollock S, 2010, P NATL ACAD SCI USA, V107, P17176, DOI 10.1073/pnas.1009445107; Rolain JM, 2007, INT J ANTIMICROB AG, V30, P297, DOI 10.1016/j.ijantimicag.2007.05.015; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Vela E, 2012, VIRUSES-BASEL, V4, P1802, DOI 10.3390/v4091802; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027	15	119	121	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					282	283		10.1126/science.aaa3778	http://dx.doi.org/10.1126/science.aaa3778			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883340	Green Accepted			2022-12-24	WOS:000352999000019
J	Lee, DF; Su, J; Kim, HS; Chang, B; Papatsenko, D; Zhao, RY; Yuan, Y; Gingold, J; Xia, WY; Darr, H; Mirzayans, R; Hung, MC; Schaniel, C; Lemischka, IR				Lee, Dung-Fang; Su, Jie; Kim, Huen Suk; Chang, Betty; Papatsenko, Dmitri; Zhao, Ruiying; Yuan, Ye; Gingold, Julian; Xia, Weiya; Darr, Henia; Mirzayans, Razmik; Hung, Mien-Chie; Schaniel, Christoph; Lemischka, Ihor R.			Modeling Familial Cancer with Induced Pluripotent Stem Cells	CELL			English	Article							MOUSE MODELS; P53; OSTEOSARCOMA; EXPRESSION; GAIN; H19; DIFFERENTIATION; DERIVATION; MUTATIONS; INDUCTION	In vitro modeling of human disease has recently become feasible with induced pluripotent stem cell (iPSC) technology. Here, we established patient-derived iPSCs from a Li-Fraumeni syndrome (LFS) family and investigated the role of mutant p53 in the development of osteosarcoma (OS). LFS iPSC-derived osteoblasts (OBs) recapitulated OS features including defective osteoblastic differentiation as well as tumorigenic ability. Systematic analyses revealed that the expression of genes enriched in LFS-derived OBs strongly correlated with decreased time to tumor recurrence and poor patient survival. Furthermore, LFS OBs exhibited impaired upregulation of the imprinted gene H19 during osteogenesis. Restoration of H19 expression in LFS OBs facilitated osteoblastic differentiation and repressed tumorigenic potential. By integrating human imprinted gene network (IGN) into functional genomic analyses, we found that H19 mediates suppression of LFS-associated OS through the IGN component DECORIN (DCN). In summary, these findings demonstrate the feasibility of studying inherited human cancer syndromes with iPSCs.	[Lee, Dung-Fang; Su, Jie; Kim, Huen Suk; Chang, Betty; Papatsenko, Dmitri; Yuan, Ye; Gingold, Julian; Darr, Henia; Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Lee, Dung-Fang; Su, Jie; Kim, Huen Suk; Chang, Betty; Papatsenko, Dmitri; Yuan, Ye; Gingold, Julian; Darr, Henia; Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Su, Jie; Kim, Huen Suk; Chang, Betty; Yuan, Ye; Gingold, Julian; Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Zhao, Ruiying; Xia, Weiya; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Schaniel, Christoph; Lemischka, Ihor R.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Mirzayans, Razmik] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Texas System; UTMD Anderson Cancer Center; Icahn School of Medicine at Mount Sinai; University of Alberta; China Medical University Taiwan; China Medical University Taiwan	Lee, DF (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	dung-fang.lee@mssm.edu; ihor.lemischka@mssm.edu	Schaniel, Christoph/P-3836-2019; Schaniel, Chrisoph/C-9655-2012; Hung, Mien-Chie/ABD-5911-2021; Gingold, Julian/AAD-7321-2020; Papatsenko, Dmitri/G-7375-2016	Schaniel, Christoph/0000-0002-1343-4858; Hung, Mien-Chie/0000-0003-4317-4740; Gingold, Julian/0000-0002-0354-5933; Papatsenko, Dmitri/0000-0002-4390-5446; Su, Jie/0000-0002-3071-7139; Lee, Dung-Fang/0000-0003-2387-597X	NIH [5R01GM078465, K99CA181496]; Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) [C024176, C024410]; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; National Breast Cancer Foundation Inc.; Program for Stem Cell and Regenerative Medicine Frontier Research [Taiwan] [NSC 102-2321-B-039-001]; Canadian Breast Cancer Foundation-Prairies/NWT region; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD075735] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R00CA181496, K99CA181496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through New York State Department of Health (NYSTEM); University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; National Breast Cancer Foundation Inc.; Program for Stem Cell and Regenerative Medicine Frontier Research [Taiwan]; Canadian Breast Cancer Foundation-Prairies/NWT region; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Yang, X. Wei, C.-K. Chou, C. F. Pereira, Y. Liu, and X. Niu, for experimental assistance. We also thank E. Lopez-Rivera and M. Li for CAM assay assistance, the Mount Sinai Genomic Core Facility and Columbia Genome Center for mRNA-seq analysis, as well as Mount Sinai's Flow Cytometry Core for sorting MSCs. We gratefully acknowledge K.A. Moore, and A. Waghray for discussions. This research was funded by grants from the NIH (5R01GM078465), the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM; C024176 and C024410) to I.R.L.; The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund, The National Breast Cancer Foundation Inc., the Program for Stem Cell and Regenerative Medicine Frontier Research (NSC 102-2321-B-039-001 [Taiwan]) to M.-C.H.; the Canadian Breast Cancer Foundation-Prairies/NWT region to R.M.; and NIH Pathway to Independence Award (K99CA181496) to D.-F.L. B.C. is a trainee in NIDCR-Interdisciplinary Training in Systems and Developmental Biology and Birth Defects (T32HD075735).	Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barley RDC, 1998, ONCOGENE, V17, P533, DOI 10.1038/sj.onc.1202271; BRIDGE JA, 1993, CANCER GENET CYTOGEN, V69, P79, DOI 10.1016/0165-4608(93)90080-6; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Eggermann T, 2010, AM J MED GENET C, V154C, P355, DOI 10.1002/ajmg.c.30274; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; Joyce JA, 1998, J CLIN PATHOL-MOL PA, V51, P185, DOI 10.1136/mp.51.4.185; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; LI FP, 1969, J NATL CANCER I, V43, P1365; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; LustigYariv O, 1997, ONCOGENE, V15, P169, DOI 10.1038/sj.onc.1201175; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mirzayans R, 2010, J CELL PHYSIOL, V223, P57, DOI 10.1002/jcp.22002; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; PORTER DE, 1992, J BONE JOINT SURG BR, V74, P883; Sosa-Garcia B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013954; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Varley JM, 2003, HUM MUTAT, V21, P313, DOI 10.1002/humu.10185; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Verkerk AJMH, 1997, ONCOGENE, V14, P95, DOI 10.1038/sj.onc.1200802; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Yi L, 2012, CANCER RES, V72, P5635, DOI 10.1158/0008-5472.CAN-12-1451; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	37	127	131	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					240	254		10.1016/j.cell.2015.02.045	http://dx.doi.org/10.1016/j.cell.2015.02.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860607	Green Accepted, Bronze			2022-12-24	WOS:000352708300018
J	Lock, D				Lock, David			BRIEFING Avastin and Lucentis: a guide through the legal maze	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Queens Counsel, London, England		Lock, D (corresponding author), Queens Counsel, London, England.	DLock@landmarkchambers.co.uk						NICE, 2008, RAN PEG TREATM AG RE, P155	1	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1377	10.1136/bmj.h1377	http://dx.doi.org/10.1136/bmj.h1377			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25834023				2022-12-24	WOS:000352439300002
J	Gerling, T; Wagenbauer, KF; Neuner, AM; Dietz, H				Gerling, Thomas; Wagenbauer, Klaus F.; Neuner, Andrea M.; Dietz, Hendrik			Dynamic DNA devices and assemblies formed by shape-complementary, non-base pairing 3D components	SCIENCE			English	Article							NANOSCALE SHAPES; RIBONUCLEASE-P; STRAND DISPLACEMENT; TRANSFER-RNA; FOLDING DNA; NANOSTRUCTURES; COMPLEX; HOLOENZYME; NETWORK; SYSTEM	We demonstrate that discrete three-dimensional (3D) DNA components can specifically self-assemble in solution on the basis of shape-complementarity and without base pairing. Using this principle, we produced homo-and heteromultimeric objects, including micrometer-scale one- and two-stranded filaments and lattices, as well as reconfigurable devices, including an actuator, a switchable gear, an unfoldable nanobook, and a nanorobot. These multidomain assemblies were stabilized via short-ranged nucleobase stacking bonds that compete against electrostatic repulsion between the components' interfaces. Using imaging by electron microscopy, ensemble and single-molecule fluorescence resonance energy transfer spectroscopy, and electrophoretic mobility analysis, we show that the balance between attractive and repulsive interactions, and thus the conformation of the assemblies, may be finely controlled by global parameters such as cation concentration or temperature and by an allosteric mechanism based on strand-displacement reactions.	[Gerling, Thomas; Wagenbauer, Klaus F.; Neuner, Andrea M.; Dietz, Hendrik] Tech Univ Munich, Walter Schottky Inst, Dept Phys, D-85748 Garching, Germany	Technical University of Munich	Dietz, H (corresponding author), Tech Univ Munich, Walter Schottky Inst, Dept Phys, Coulombwall 4a, D-85748 Garching, Germany.	dietz@tum.de		Dietz, Hendrik/0000-0003-1270-3662	European Research Council [256270]; Deutsche Forschungsgemeinschaft; NIM (Nanosystems Initiative Munich); Technische Universitat Munchen (TUM) Institute for Advanced Study; TUM International Graduate School of Science and Engineering (IGSSE);  [Sonderforschungsbereich SFB863]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIM (Nanosystems Initiative Munich); Technische Universitat Munchen (TUM) Institute for Advanced Study; TUM International Graduate School of Science and Engineering (IGSSE); 	We thank E. Stahl, T. Martin, J. Funke, M. Schickinger, F. Kilchherr, C. Wachauf, L. Meregalli, and V. Hechtl for technical assistance. F. Praetorius is acknowledged for scaffold DNA preparations. This work was supported by a European Research Council Starting Grant to H.D. (GA no. 256270) and the Deutsche Forschungsgemeinschaft through grants provided within the Excellence Clusters CIPSM (Center for Integrated Protein Science Munich), NIM (Nanosystems Initiative Munich), the Sonderforschungsbereich SFB863, the Technische Universitat Munchen (TUM) Institute for Advanced Study, and the TUM International Graduate School of Science and Engineering (IGSSE). K.F.W. and H.D. are grateful for additional support from the Hans L. Merkle Foundation. T.G., K.F.W., and A.N. performed research. H.D. designed research and wrote the manuscript. T.G., K.F.W., and H.D. prepared figures. T.G., K.F.W., and H.D. analyzed and discussed data and edited the manuscript. We confirm no competing financial interests. The data reported in this paper are tabulated in the supplementary materials.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Endo M, 2010, CHEM-EUR J, V16, P5362, DOI 10.1002/chem.200903057; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Goodman RP, 2008, NAT NANOTECHNOL, V3, P93, DOI 10.1038/nnano.2008.3; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hsieh J, 2009, RNA, V15, P1565, DOI 10.1261/rna.1639409; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Krishnan Y, 2011, ANGEW CHEM INT EDIT, V50, P3124, DOI 10.1002/anie.200907223; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SMITH D, 1992, J BIOL CHEM, V267, P2429; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Srinivas N, 2013, NUCLEIC ACIDS RES, V41, P10641, DOI 10.1093/nar/gkt801; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang F, 2014, CHEM REV, V114, P2881, DOI 10.1021/cr400354z; Wang RS, 2010, CHEM COMMUN, V46, P4905, DOI 10.1039/c0cc01167c; Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532	29	395	401	18	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1446	1452		10.1126/science.aaa5372	http://dx.doi.org/10.1126/science.aaa5372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814577				2022-12-24	WOS:000352136400033
J	Tan, J; Jakob, C; Rossow, WB; Tselioudis, G				Tan, Jackson; Jakob, Christian; Rossow, William B.; Tselioudis, George			Increases in tropical rainfall driven by changes in frequency of organized deep convection	NATURE			English	Article							PACIFIC CLOUD REGIMES; WESTERN PACIFIC; WEATHER STATES; GLOBAL PRECIPITATION; HYDROLOGICAL CYCLE; ISCCP; IDENTIFICATION; PATTERNS; RICHER	Increasing global precipitation has been associated with a warming climate resulting from a strengthening of the hydrological cycle(1). This increase, however, is not spatially uniform. Observations and models have found that changes in rainfall show patterns characterized as 'wet-gets-wetter'(1-7) and 'warmer-gets-wetter'(5,8,9). These changes in precipitation are largely located in the tropics and hence are probably associated with convection. However, the underlying physical processes for the observed changes are not entirely clear. Here we show from observations that most of the regional increase in tropical precipitation is associated with changes in the frequency of organized deep convection. By assessing the contributions of various convective regimes to precipitation, we find that the spatial patterns of change in the frequency of organized deep convection are strongly correlated with observed change in rainfall, both positive and negative (correlation of 0.69), and can explain most of the patterns of increase in rainfall. In contrast, changes in less organized forms of deep convection or changes in precipitation within organized deep convection contribute less to changes in precipitation. Our results identify organized deep convection as the link between changes in rainfall and in the dynamics of the tropical atmosphere, thus providing a framework for obtaining a better understanding of changes in rainfall. Given the lack of a distinction between the different degrees of organization of convection in climate models(10), our results highlight an area of priority for future climate model development in order to achieve accurate rainfall projections in a warming climate.	[Tan, Jackson; Jakob, Christian] Monash Univ, Sch Earth Atmosphere & Environm, ARC Ctr Excellence Climate Syst Sci, Clayton, Vic 3800, Australia; [Rossow, William B.] CUNY City Coll, CREST Inst, New York, NY 10031 USA; [Tselioudis, George] NASA, Goddard Inst Space Studies, New York, NY 10027 USA	Monash University; City University of New York (CUNY) System; City College of New York (CUNY); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Tan, J (corresponding author), Monash Univ, Sch Earth Atmosphere & Environm, ARC Ctr Excellence Climate Syst Sci, Clayton, Vic 3800, Australia.	jackson.tan@nasa.gov	Rossow, William B/F-3138-2015; Tan, Jackson/H-5640-2019; Jakob, Christian/A-1082-2010	Tan, Jackson/0000-0001-7085-3074; Jakob, Christian/0000-0002-5012-3207	Australian Research Council Centre of Excellence for Climate System Science [CE110001028]; NASA [NNX13AO39G]; NASA; Monash University	Australian Research Council Centre of Excellence for Climate System Science(Australian Research Council); NASA(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Monash University(Monash University)	We thank S. Sherwood and B. Stevens for comments on the study. The GPCP combined precipitation data were developed and computed by the NASA/Goddard Space Flight Centre's Mesoscale Atmospheric Processes Laboratory as a contribution to the GEWEX Global Precipitation Climatology Project, and provided by National Oceanic and Atmospheric Administration (NOAA) Office of Oceanic and Atmospheric Research and Earth System Research Laboratory Physical Sciences Division (PSD) at http://www.esrl.noaa.gov/psd/. The TRMM 3B42 and 3A25 data were provided by the NASA/Goddard Space Flight Center's Mesoscale Atmospheric Processes Laboratory and Precipitation Processing System as a contribution to TRMM, and archived at the NASA Goddard Earth Sciences Data and Information Services Center. J.T. and C.J. are funded under the Australian Research Council Centre of Excellence for Climate System Science (CE110001028). W.B.R. is supported by NASA grant NNX13AO39G. G.T. acknowledges the support of the NASA Modeling Analysis and Prediction (MAP) programme managed by D. Considine. J.T. acknowledges support from the Monash University Postgraduate Publication Award.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Allan RP, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025205; Chadwick R, 2013, J CLIMATE, V26, P3803, DOI 10.1175/JCLI-D-12-00543.1; Chou C, 2013, NAT GEOSCI, V6, P263, DOI [10.1038/NGEO1744, 10.1038/ngeo1744]; Chou C, 2009, J CLIMATE, V22, P1982, DOI 10.1175/2008JCLI2471.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Handlos ZJ, 2014, J CLIMATE, V27, P7667, DOI 10.1175/JCLI-D-13-00602.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Huang P, 2013, NAT GEOSCI, V6, P357, DOI [10.1038/ngeo1792, 10.1038/NGEO1792]; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huffman GJ, 2001, J HYDROMETEOROL, V2, P36, DOI 10.1175/1525-7541(2001)002<0036:GPAODD>2.0.CO;2; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Jakob C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018367; Jakob C, 2005, J CLIMATE, V18, P1203, DOI 10.1175/JCLI3326.1; Jakob C, 2008, J CLIMATE, V21, P4348, DOI 10.1175/2008JCLI2122.1; Laing AG, 1997, Q J ROY METEOR SOC, V123, P389, DOI 10.1002/qj.49712353807; Lee D, 2013, J CLIMATE, V26, P772, DOI 10.1175/JCLI-D-11-00718.1; Li W, 2013, J GEOPHYS RES-ATMOS, V118, P592, DOI 10.1002/jgrd.50114; Liu CL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016568; Mapes B, 2011, J ADV MODEL EARTH SY, V3, DOI 10.1029/2011MS000042; Oreopoulos L, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015472; Rossow WB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024584; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; ROSSOW WB, 1993, J CLIMATE, V6, P2394, DOI 10.1175/1520-0442(1993)006<2394:COIAOC>2.0.CO;2; Rossow WB, 2013, J CLIMATE, V26, P1457, DOI 10.1175/JCLI-D-11-00725.1; Seager R, 2010, J CLIMATE, V23, P4651, DOI 10.1175/2010JCLI3655.1; Stachnik JP, 2013, J CLIMATE, V26, P7097, DOI 10.1175/JCLI-D-12-00673.1; Tan J, 2013, J CLIMATE, V26, P6618, DOI 10.1175/JCLI-D-12-00624.1; Tselioudis G, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044092; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1	30	106	107	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					451	+		10.1038/nature14339	http://dx.doi.org/10.1038/nature14339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25810207				2022-12-24	WOS:000351602800052
J	McDonald, TM; Mason, JA; Kong, XQ; Bloch, ED; Gygi, D; Dani, A; Crocella, V; Giordanino, F; Odoh, SO; Drisdell, WS; Vlaisavljevich, B; Dzubak, AL; Poloni, R; Schnell, SK; Planas, N; Lee, K; Pascal, T; Wan, LWF; Prendergast, D; Neaton, JB; Smit, B; Kortright, JB; Gagliardi, L; Bordiga, S; Reimer, JA; Long, JR				McDonald, Thomas M.; Mason, Jarad A.; Kong, Xueqian; Bloch, Eric D.; Gygi, David; Dani, Alessandro; Crocella, Valentina; Giordanino, Filippo; Odoh, Samuel O.; Drisdell, Walter S.; Vlaisavljevich, Bess; Dzubak, Allison L.; Poloni, Roberta; Schnell, Sondre K.; Planas, Nora; Lee, Kyuho; Pascal, Tod; Wan, Liwen F.; Prendergast, David; Neaton, Jeffrey B.; Smit, Berend; Kortright, Jeffrey B.; Gagliardi, Laura; Bordiga, Silvia; Reimer, Jeffrey A.; Long, Jeffrey R.			Cooperative insertion of CO2 in diamine-appended metal-organic frameworks	NATURE			English	Article							CARBON-DIOXIDE CAPTURE; TOTAL-ENERGY CALCULATIONS; COORDINATION POLYMER; CRYSTAL-STRUCTURE; ADSORPTION; PSEUDOPOTENTIALS; TRANSITIONS; ISOTHERMS; SOLVENTS; BINDING	The process of carbon capture and sequestration has been proposed as a method of mitigating the build-up of greenhouse gases in the atmosphere. If implemented, the cost of electricity generated by a fossil fuel-burning power plant would rise substantially, owing to the expense of removing CO2 from the effluent stream. There is therefore an urgent need for more efficient gas separation technologies, such as those potentially offered by advanced solid adsorbents. Here we show that diamine-appended metal-organic frameworks can behave as 'phase-change' adsorbents, with unusual step-shaped CO2 adsorption isotherms that shift markedly with temperature. Results from spectroscopic, diffraction and computational studies show that the origin of the sharp adsorption step is an unprecedented cooperative process in which, above a metal-dependent threshold pressure, CO2 molecules insert into metal-amine bonds, inducing a reorganization of the amines into well-ordered chains of ammonium carbamate. As a consequence, large CO2 separation capacities can be achieved with small temperature swings, and regeneration energies appreciably lower than achievable withstate-of-the-art aqueous amine solutions become feasible. The results provide a mechanistic framework for designing highly efficient adsorbents for removing CO2 from various gas mixtures, and yield insights into the conservation of Mg2+ within the ribulose-1,5-bisphosphate carboxylase/oxygenase family of enzymes.	[McDonald, Thomas M.; Mason, Jarad A.; Bloch, Eric D.; Gygi, David; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kong, Xueqian; Vlaisavljevich, Bess; Schnell, Sondre K.; Lee, Kyuho; Smit, Berend; Reimer, Jeffrey A.] Univ Calif Berkeley, Dept Chem & Biol Engn, Berkeley, CA 94720 USA; [Kong, Xueqian] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China; [Dani, Alessandro; Crocella, Valentina; Giordanino, Filippo; Bordiga, Silvia] Univ Turin, NIS & INSTM Ctr Reference, Dept Chem, I-10135 Turin, Italy; [Odoh, Samuel O.; Dzubak, Allison L.; Planas, Nora; Gagliardi, Laura] Univ Minnesota, Dept Chem, Chem Theory Ctr, Minneapolis, MN 55455 USA; [Odoh, Samuel O.; Dzubak, Allison L.; Planas, Nora; Gagliardi, Laura] Univ Minnesota, Supercomp Inst, Minneapolis, MN 55455 USA; [Drisdell, Walter S.; Smit, Berend; Kortright, Jeffrey B.; Reimer, Jeffrey A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Poloni, Roberta] Univ Grenoble Alpes, F-38000 Grenoble, France; [Poloni, Roberta] Sci & Ingn Mat & Proc SIMAP, F-38000 Grenoble, France; [Poloni, Roberta] CNRS, SIMAP, F-38000 Grenoble, France; [Schnell, Sondre K.] Norwegian Univ Sci & Technol, Dept Chem, N-7491 Trondheim, Norway; [Pascal, Tod; Wan, Liwen F.; Prendergast, David; Neaton, Jeffrey B.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Neaton, Jeffrey B.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Neaton, Jeffrey B.] Univ Calif Berkeley, Kavli Energy Nanosci Inst, Berkeley, CA 94720 USA; [Smit, Berend] EPFL, Inst Sci & Ingn Chim, Valais, CH-1950 Sion, Switzerland	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Zhejiang University; University of Turin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Norwegian University of Science & Technology (NTNU); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jrlong@berkeley.edu	Poloni, Roberta/AAC-8743-2020; Neaton, Jeffrey/F-8578-2015; Lee, Kyuho/B-9370-2008; Vlaisavljevich, Bess/AGH-3580-2022; LEE, KYUHO/O-5868-2019; Kong, Xueqian/P-3152-2018; Bordiga, Silvia/M-3875-2014; Prendergast, David/E-4437-2010; Smit, Berend/B-7580-2009; Crocellà, Valentina/E-5203-2016; Schnell, Sondre K/H-4934-2016; Gagliardi, Laura/S-3023-2017	Neaton, Jeffrey/0000-0001-7585-6135; Lee, Kyuho/0000-0001-9325-3717; Vlaisavljevich, Bess/0000-0001-6065-0732; LEE, KYUHO/0000-0001-9325-3717; Kong, Xueqian/0000-0002-1901-9073; Bordiga, Silvia/0000-0003-2371-4156; Prendergast, David/0000-0003-0598-1453; Smit, Berend/0000-0003-4653-8562; Crocellà, Valentina/0000-0002-3606-8424; Schnell, Sondre K/0000-0002-0664-6756; Gagliardi, Laura/0000-0001-5227-1396; Dzubak, Allison/0000-0001-9967-0263; Drisdell, Walter/0000-0002-8693-4562; Wan, Liwen/0000-0002-5391-0804	Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy (DOE) [DE-AR0000103, DE-AR0000402]; DOE, Office of Science, Office of Basic Energy Sciences [DE-SC0001015]; GENCI (CINES) [2014-c2015097211]; Nanoporous Materials Genome Center of the DOE, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG02-12ER16362]; DOE Office of Science [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences of the DOE [DE-AC02-05CH11231]; National Science Foundation; Research Council of Norway [230534];  [MIUR-PRIN 2010-2011]	Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy (DOE)(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); GENCI (CINES); Nanoporous Materials Genome Center of the DOE, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences; DOE Office of Science(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences of the DOE(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Research Council of Norway(Research Council of Norway); 	We thank A. S. Bhown and A. H. Berger of EPRI, H. Krutka, C. M. Brown and. K. S. Suslick for discussions, and L. Ribaud and the 11-BM staff at the Advanced Photon Source at Argonne National Laboratory for assisting with powder X-ray diffraction experiments. The work presented here pertaining to the synthesis and gas adsorption properties of metal-organic frameworks was funded by the Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy (DOE), under award numbers DE-AR0000103 and DE-AR0000402. Funding pertaining to the characterization of materials by spectroscopy and X-ray diffraction and the computational work performed by W.S.D., B.V., R.P., S.K.S., K.L., J.B.N., B.S. and J.B.K. was provided by the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center funded by the DOE, Office of Science, Office of Basic Energy Sciences under award DE-SC0001015. Experiments performed in Turin were supported by grant MIUR-PRIN 2010-2011. Work at SIMAP was performed using computer resources from GENCI (CINES grant 2014-c2015097211). The computational work performed by S.O.O., A.L.D., N.P. and L.G. was supported through the Nanoporous Materials Genome Center of the DOE, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, under award number DE-FG02-12ER16362. This research used resources of the Advanced Photon Source, a DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. Portions of this work (use of beamline 6.3.2 at the Advanced Light Source; a user project at The Molecular Foundry, facilitated by T.P., L.F.W. and D.P., and use of its computer cluster vulcan, managed by the High Performance Computing Services Group; use of the National Energy Research Scientific Computing Center) were performed at Lawrence Berkeley National Laboratory, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract no. DE-AC02-05CH11231. For fellowship support, we further thank the National Science Foundation (J.A.M.), Gerald K. Branch and Arkema (E.D.B.) and the Research Council of Norway (grant 230534 to S.K.S.).	Allen MP., 1989, COMPUTER SIMULATION; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Boot-Handford ME, 2014, ENERG ENVIRON SCI, V7, P130, DOI 10.1039/c3ee42350f; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Choi S, 2012, J PHYS CHEM LETT, V3, P1136, DOI 10.1021/jz300328j; Choi S, 2009, CHEMSUSCHEM, V2, P796, DOI 10.1002/cssc.200900036; Coelho A., 2007, TOPAS ACAD VERSION 4; Coelho AA, 2000, J APPL CRYSTALLOGR, V33, P899, DOI 10.1107/S002188980000248X; Coelho AA, 2003, J APPL CRYSTALLOGR, V36, P86, DOI 10.1107/S0021889802019878; Demessence A, 2009, J AM CHEM SOC, V131, P8784, DOI 10.1021/ja903411w; Dietzel PDC, 2006, CHEM COMMUN, P959, DOI 10.1039/b515434k; Drisdell WS, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890816; Drisdell WS, 2013, J AM CHEM SOC, V135, P18183, DOI 10.1021/ja408972f; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Haszeldine RS, 2009, SCIENCE, V325, P1647, DOI 10.1126/science.1172246; Henke S, 2011, CRYSTENGCOMM, V13, P6399, DOI 10.1039/c1ce05446e; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/NCHEM.444, 10.1038/nchem.444]; International Energy Agency, 2013, CO2 EM FUEL COMB HIG; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Jessop PG, 2012, ENERG ENVIRON SCI, V5, P7240, DOI 10.1039/c2ee02912j; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081101; Lee WR, 2014, ENERG ENVIRON SCI, V7, P744, DOI 10.1039/c3ee42328j; Liebenthal U, 2013, ENRGY PROCED, V37, P1844, DOI 10.1016/j.egypro.2013.06.064; LIECHTENSTEIN AI, 1995, PHYS REV B, V52, pR5467, DOI 10.1103/PhysRevB.52.R5467; Lin LC, 2012, NAT MATER, V11, P633, DOI [10.1038/NMAT3336, 10.1038/nmat3336]; LORIMER GH, 1981, ANNU REV PLANT PHYS, V32, P349, DOI 10.1146/annurev.pp.32.060181.002025; Ma'mun S, 2013, ENRGY PROCED, V37, P331, DOI 10.1016/j.egypro.2013.05.119; Mason JA, 2011, ENERG ENVIRON SCI, V4, P3030, DOI 10.1039/c1ee01720a; McDonald TM, 2012, J AM CHEM SOC, V134, P7056, DOI 10.1021/ja300034j; McDonald TM, 2011, CHEM SCI, V2, P2022, DOI 10.1039/c1sc00354b; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Planas N, 2013, J AM CHEM SOC, V135, P7402, DOI 10.1021/ja4004766; Prendergast D, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235126; Rochelle G, 2011, CHEM ENG J, V171, P725, DOI 10.1016/j.cej.2011.02.011; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Sayari A, 2010, J AM CHEM SOC, V132, P6312, DOI 10.1021/ja1013773; Seo J, 2009, J AM CHEM SOC, V131, P12792, DOI 10.1021/ja904363b; Serre C, 2002, J AM CHEM SOC, V124, P13519, DOI 10.1021/ja0276974; Shirley EL, 1996, PHYS REV B, V54, P16464, DOI 10.1103/PhysRevB.54.16464; Stephens PW, 1999, J APPL CRYSTALLOGR, V32, P281, DOI 10.1107/S0021889898006001; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Taillefumier M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.195107; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; THOMY A, 1994, SURF SCI, V299, P415; Tiritiris I, 2011, Z NATURFORSCH B, V66, P164, DOI 10.5560/ZNB.2011.66b0164; van Lare C. E. J., 1991, THESIS TECH U EINDHO, P141; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Walton KS, 2008, J AM CHEM SOC, V130, P406, DOI 10.1021/ja076595g; Wang L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014431; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993; Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x	62	806	820	43	1148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					303	+		10.1038/nature14327	http://dx.doi.org/10.1038/nature14327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762144	Green Published, Green Accepted			2022-12-24	WOS:000351171900031
J	Bird, AN; Davis, AM				Bird, Amber-Nicole; Davis, Andrew M.			Screening for Abdominal Aortic Aneurysm	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bird, Amber-Nicole; Davis, Andrew M.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Bird, AN (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 7082, Chicago, IL 60637 USA.	amber-nicole.bird@uchospitals.edu						Abdominal aortic aneurysm: screening, 2014, ABD AORT AN SCREEN; Bjorck M, 2015, EUR J VASC ENDOVASC, V49, P113, DOI 10.1016/j.ejvs.2014.08.015; Dua A, 2014, J VASC SURG, V59, P1512, DOI 10.1016/j.jvs.2014.01.007; Greco G, 2010, ANN SURG, V252, P675, DOI 10.1097/SLA.0b013e3181f621c8; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Guirguis-Blake JM, 2014, PRIMARY CARE SCREENI, P1; Hye RJ, 2014, J VASC SURG, V59, P1535, DOI 10.1016/j.jvs.2013.12.016; LeFevre ML, 2014, ANN INTERN MED, V161, P281, DOI 10.7326/M14-1204; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897	10	13	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1156	1157		10.1001/jama.2015.0996	http://dx.doi.org/10.1001/jama.2015.0996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781445				2022-12-24	WOS:000351102500018
J	Rosemond, AD; Benstead, JP; Bumpers, PM; Gulis, V; Kominoski, JS; Manning, DWP; Suberkropp, K; Wallace, JB				Rosemond, Amy D.; Benstead, Jonathan P.; Bumpers, Phillip M.; Gulis, Vladislav; Kominoski, John S.; Manning, David W. P.; Suberkropp, Keller; Wallace, J. Bruce			Experimental nutrient additions accelerate terrestrial carbon loss from stream ecosystems	SCIENCE			English	Article							LITTER DECOMPOSITION; DETRITUS; ENRICHMENT; NITROGEN; EUTROPHICATION; RESPONSES; BREAKDOWN; ECOLOGY; FLUXES	Nutrient pollution of freshwater ecosystems results in predictable increases in carbon (C) sequestration by algae. Tests of nutrient enrichment on the fates of terrestrial organic C, which supports riverine food webs and is a source of CO2, are lacking. Using whole-stream nitrogen (N) and phosphorus (P) additions spanning the equivalent of 27 years, we found that average terrestrial organic C residence time was reduced by similar to 50% as compared to reference conditions as a result of nutrient pollution. Annual inputs of terrestrial organic C were rapidly depleted via release of detrital food webs from N and P co-limitation. This magnitude of terrestrial C loss can potentially exceed predicted algal C gains with nutrient enrichment across large parts of river networks, diminishing associated ecosystem services.	[Rosemond, Amy D.; Bumpers, Phillip M.; Kominoski, John S.; Manning, David W. P.; Wallace, J. Bruce] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Benstead, Jonathan P.; Suberkropp, Keller] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Gulis, Vladislav] Coastal Carolina Univ, Dept Biol, Conway, SC 29528 USA	University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Tuscaloosa; Coastal Carolina University	Rosemond, AD (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	rosemond@uga.edu	Kominoski, John Stephen/A-5907-2008; Rosemond, Amy D./I-2688-2018	Kominoski, John Stephen/0000-0002-0978-3326; Rosemond, Amy D./0000-0003-4299-9353; Bumpers, Phillip M/0000-0003-1298-0571	National Science Foundation Division Environmental Biology (NSF DEB) [0823293]; NSF from the Ecosystem Studies Program [DEB-9806610, 0318063, 0918894, 0918904, 0919054]; Direct For Biological Sciences [0823293] Funding Source: National Science Foundation; Division Of Environmental Biology [1440485] Funding Source: National Science Foundation	National Science Foundation Division Environmental Biology (NSF DEB); NSF from the Ecosystem Studies Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank H. Weyers, N. Taylor, R. Hilten, S. Dye, J. Coombs, and K. Norris or their assistance in maintaining the enrichments and associated data collection and analyses; C. Tant and J. Greenwood for conducting the N+P litterbag studies; and S. Eggert for assisting in data collection and analysis and helping develop sampling protocols. T. Mccallister illustrated Fig. 1 (photo credit: PMB). The manuscript was improved by comments from R. Hall, E. Rosi-Marshall, F. Ballantyne, S. Altizer, A. Helton, A. Huryn, M. Paul, J. Davis, R. Sponseller, C. Song; and anonymous reviewers. J. Maerz contributed ideas and logistical help associated with the NxP experiment; S. Wenger, R. Hall, C. Song, and D. Hall provided statistical advice; D. Leigh and J. Hepinstall-Cymerman provided spatial data; and J. Webster provided site information. We are grateful to A. Helton for conducting the network-scale extrapolation. Data are available in the supplementary materials in Science Online. This research leveraged logistical support from the Coweeta Long Term Ecological Research Program at the University of Georgia, which is supported by the National Science Foundation Division Environmental Biology (NSF DEB grant 0823293). The order of authors after the first author is alphabetical; funding for these experiments was provided in NSF grants DEB-9806610, 0318063, 0918894, 0918904, and 0919054 from the Ecosystem Studies Program to A.D.R., J.P.B., V.G., K.S., J.B.W., and others (J. Maerz, above; M. Black, University of Georgia; and P. Mulholland, Oak Ridge National Laboratory).	Alexander RB, 2006, LIMNOL OCEANOGR, V51, P639, DOI 10.4319/lo.2006.51.1_part_2.0639; Allgeier JE, 2011, J APPL ECOL, V48, P96, DOI 10.1111/j.1365-2664.2010.01894.x; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benstead JP, 2009, ECOLOGY, V90, P2556, DOI 10.1890/08-0862.1; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dodds WK, 2007, TRENDS ECOL EVOL, V22, P669, DOI 10.1016/j.tree.2007.07.010; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Ferreira V, 2015, BIOL REV, V90, P669, DOI 10.1111/brv.12125; Finlay JC, 2013, SCIENCE, V342, P247, DOI 10.1126/science.1242575; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Gessner MO, 2002, ECOL APPL, V12, P498, DOI 10.1890/1051-0761(2002)012[0498:ACFULB]2.0.CO;2; Greenwood JL, 2007, OECOLOGIA, V151, P637, DOI 10.1007/s00442-006-0609-7; Griffiths NA, 2009, ECOL APPL, V19, P133, DOI 10.1890/07-1876.1; Gulis V, 2003, FRESHWATER BIOL, V48, P123, DOI 10.1046/j.1365-2427.2003.00985.x; Pacheco FS, 2014, INLAND WATERS, V4, P41, DOI 10.5268/IW-4.1.614; Suberkropp K, 2010, LIMNOL OCEANOGR, V55, P149, DOI 10.4319/lo.2010.55.1.0149; Tant CJ, 2013, FRESHW SCI, V32, P1111, DOI 10.1899/12-049.1; Thomas SA, 2001, LIMNOL OCEANOGR, V46, P1415, DOI 10.4319/lo.2001.46.6.1415; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; WALLACE JB, 1982, OECOLOGIA, V53, P197, DOI 10.1007/BF00545663; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; WALLACE JB, 1991, INT VER THEOR ANGEW, V24, P1676; Walther DA, 2011, J N AM BENTHOL SOC, V30, P357, DOI 10.1899/10-006.1; Webster J.R., 2000, VERHANDLUNGEN INT VE, V27, P1337, DOI DOI 10.1080/03680770.1998.11901453; Webster JR, 2007, J N AM BENTHOL SOC, V26, P375, DOI 10.1899/06-095.1; Webster JR, 1999, FRESHWATER BIOL, V41, P687, DOI 10.1046/j.1365-2427.1999.00409.x; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534	29	158	164	15	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1142	1145		10.1126/science.aaa1958	http://dx.doi.org/10.1126/science.aaa1958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745171				2022-12-24	WOS:000350354200054
J	Jolly, SS; Mehta, SR				Jolly, Sanjit S.; Mehta, Shamir R.			Coronary intervention: radial artery access comes of age	LANCET			English	Editorial Material							ST-SEGMENT ELEVATION; ACUTE MYOCARDIAL-INFARCTION; FEMORAL ACCESS; ANGIOGRAPHY; CLOPIDOGREL; OUTCOMES; IMPACT		[Jolly, Sanjit S.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; Population Health Research Institute	Jolly, SS (corresponding author), McMaster Univ, Hamilton, ON L8L 2X2, Canada.	sanjit.jollly@phri.ca	Jolly, Sanjit/O-2534-2015					Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Feldman DN, 2013, CIRCULATION, V127, P2295, DOI 10.1161/CIRCULATIONAHA.112.000536; Jolly SS, 2014, J AM COLL CARDIOL, V63, P954, DOI 10.1016/j.jacc.2013.10.052; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; Levine GN, 2012, CATHETER CARDIO INTE, V79, P453, DOI 10.1002/ccd.23438; Mehta SR, 2012, J AM COLL CARDIOL, V60, P2490, DOI 10.1016/j.jacc.2012.07.050; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Valgimigli M, 2015, LANCET; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	13	8	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 20	2015	385	9986					2437	2439		10.1016/S0140-6736(15)60507-4	http://dx.doi.org/10.1016/S0140-6736(15)60507-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK9AR	25791213				2022-12-24	WOS:000356532500005
J	Blazer, DG; Yaffe, K; Karlawish, J				Blazer, Dan G.; Yaffe, Kristine; Karlawish, Jason			Cognitive Aging A Report From the Institute of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Blazer, Dan G.] Duke Univ, Sch Med, Durham, NC 27710 USA; [Yaffe, Kristine] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Karlawish, Jason] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Duke University; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine	Blazer, DG (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Div Community & Family Med, 3521 Hosp S,POB 3003, Durham, NC 27710 USA.	blaze001@mc.duke.edu						AARP, 2013, 2012 MEMB OP SURV IS; Inst Med, 2015, COGNITIVE AGING: PROGRESS IN UNDERSTANDING AND OPPORTUNITIES FOR ACTION, P1; MetLife Mature Market Institute National Committee for the Prevention of Elder Abuse and Virginia Tech, 2011, METLIFE STUD ELD FIN	3	62	64	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2121	2122		10.1001/jama.2015.4380	http://dx.doi.org/10.1001/jama.2015.4380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	25875498				2022-12-24	WOS:000355430900007
J	Harris, RP				Harris, Russell P.			Incidental Findings in the Pancreas (and Elsewhere): Putting Our Patients (and Ourselves) in a Difficult Situation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERNATIONAL CONSENSUS GUIDELINES; PREVALENCE; MANAGEMENT; CYSTS; CARE		[Harris, Russell P.] Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Harris, RP (corresponding author), Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Blvd,CB 7590, Chapel Hill, NC 27599 USA.	rharris@med.unc.edu						Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; de Jong K, 2010, CLIN GASTROENTEROL H, V8, P806, DOI 10.1016/j.cgh.2010.05.017; Harris RP, 2015, ANN INTERN MED, V162, P712, DOI 10.7326/M14-2327; Laffan TA, 2008, AM J ROENTGENOL, V191, P802, DOI 10.2214/AJR.07.3340; Scheiman JM, 2015, GASTROENTER IN PRESS; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Vege SS, 2015, GASTROENTER IN PRESS	9	7	9	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					787	789		10.7326/M15-0590	http://dx.doi.org/10.7326/M15-0590			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	25807075				2022-12-24	WOS:000355572300007
J	Dzau, VJ; Ginsburg, GS; Van Nuys, K; Agus, D; Goldman, D				Dzau, Victor J.; Ginsburg, Geoffrey S.; Van Nuys, Karen; Agus, David; Goldman, Dana			Aligning incentives to fulfil the promise of personalised medicine	LANCET			English	Editorial Material									[Dzau, Victor J.] Inst Med, Washington, DC 20001 USA; [Ginsburg, Geoffrey S.] Duke Ctr Appl Genom & Precis Med, Durham, NC USA; [Van Nuys, Karen] Precis Hlth Econ, Los Angeles, CA USA; [Agus, David] Univ So Calif, Keck Sch Med, Beverly Hills, CA USA; [Agus, David] Univ So Calif, Viterbi Sch Engn, Beverly Hills, CA USA; [Goldman, Dana] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Dzau, VJ (corresponding author), Inst Med, Washington, DC 20001 USA.	vdzau@nas.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396; Agus, David B./0000-0002-7499-7822	NIA NIH HHS [P30 AG024968] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Goldman Dana P, 2013, Forum Health Econ Policy, V16, pS87, DOI 10.1515/fhep-2013-0023; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Michaud PC, 2011, SOC SCI MED, V73, P254, DOI 10.1016/j.socscimed.2011.05.027	4	54	55	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2118	2119		10.1016/S0140-6736(15)60722-X	http://dx.doi.org/10.1016/S0140-6736(15)60722-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI7XK	25957453	Green Accepted			2022-12-24	WOS:000354979100031
J	van de Wetering, M; Francies, HE; Francis, JM; Bounova, G; Iorio, F; Pronk, A; van Houdt, W; van Gorp, J; Taylor-Weiner, A; Kester, L; McLaren-Douglas, A; Blokker, J; Jaksani, S; Bartfeld, S; Volckman, R; van Sluis, P; Li, VSW; Seepo, S; Pedamallu, CS; Cibulskis, K; Carter, SL; McKenna, A; Lawrence, MS; Lichtenstein, L; Stewart, C; Koster, J; Versteeg, R; van Oudenaarden, A; Saez-Rodriguez, J; Vries, RGJ; Getz, G; Wessels, L; Stratton, MR; McDermott, U; Meyerson, M; Garnett, MJ; Clevers, H				van de Wetering, Marc; Francies, Hayley E.; Francis, Joshua M.; Bounova, Gergana; Iorio, Francesco; Pronk, Apollo; van Houdt, Winan; van Gorp, Joost; Taylor-Weiner, Amaro; Kester, Lennart; McLaren-Douglas, Anne; Blokker, Joyce; Jaksani, Sridevi; Bartfeld, Sina; Volckman, Richard; van Sluis, Peter; Li, Vivian S. W.; Seepo, Sara; Pedamallu, Chandra Sekhar; Cibulskis, Kristian; Carter, Scott L.; McKenna, Aaron; Lawrence, Michael S.; Lichtenstein, Lee; Stewart, Chip; Koster, Jan; Versteeg, Rogier; van Oudenaarden, Alexander; Saez-Rodriguez, Julio; Vries, Robert G. J.; Getz, Gad; Wessels, Lodewyk; Stratton, Michael R.; McDermott, Ultan; Meyerson, Matthew; Garnett, Mathew J.; Clevers, Hans			Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients	CELL			English	Article							SMALL-INTESTINE; DRUG-SENSITIVITY; WNT RECEPTORS; COLON-CANCER; STEM-CELLS; GENE; LGR5; EPITHELIUM; MUTATIONS; GENOME	In Rspondin-based 3D cultures, Lgr5 stem cells from multiple organs form ever-expanding epithelial organoids that retain their tissue identity. We report the establishment of tumor organoid cultures from 20 consecutive colorectal carcinoma (CRC) patients. For most, organoids were also generated from adjacent normal tissue. Organoids closely recapitulate several properties of the original tumor. The spectrum of genetic changes within the "living biobank'' agrees well with previous large-scale mutational analyses of CRC. Gene expression analysis indicates that the major CRC molecular subtypes are represented. Tumor organoids are amenable to high-throughput drug screens allowing detection of gene-drug associations. As an example, a single organoid culture was exquisitely sensitive to Wnt secretion (porcupine) inhibitors and carried a mutation in the negative Wnt feedback regulator RNF43, rather than in APC. Organoid technology may fill the gap between cancer genetics and patient trials, complement cell-line- and xenograft-based drug studies, and allow personalized therapy design.	[van de Wetering, Marc; Kester, Lennart; Blokker, Joyce; Jaksani, Sridevi; Bartfeld, Sina; van Oudenaarden, Alexander; Vries, Robert G. J.; Clevers, Hans] Canc Genom & Univ Med Ctr, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van de Wetering, Marc; Blokker, Joyce; Jaksani, Sridevi; Vries, Robert G. J.; Clevers, Hans] Fdn Hubrecht Organoid Technol HUB, NL-3584 CT Utrecht, Netherlands; [Francies, Hayley E.; McLaren-Douglas, Anne; Stratton, Michael R.; McDermott, Ultan; Garnett, Mathew J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Francis, Joshua M.; Taylor-Weiner, Amaro; Seepo, Sara; Pedamallu, Chandra Sekhar; Cibulskis, Kristian; Carter, Scott L.; McKenna, Aaron; Lawrence, Michael S.; Lichtenstein, Lee; Getz, Gad; Meyerson, Matthew] MIT, Broad Inst, Cambridge, MA 02142 USA; [Francis, Joshua M.; Taylor-Weiner, Amaro; Seepo, Sara; Pedamallu, Chandra Sekhar; Cibulskis, Kristian; Carter, Scott L.; McKenna, Aaron; Lawrence, Michael S.; Lichtenstein, Lee; Stewart, Chip; Getz, Gad; Meyerson, Matthew] Harvard Univ, Cambridge, MA 02142 USA; [Francis, Joshua M.; Pedamallu, Chandra Sekhar; Carter, Scott L.; Getz, Gad; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bounova, Gergana; Wessels, Lodewyk] Netherlands Canc Inst, Computat Canc Biol, NL-1066 CX Amsterdam, Netherlands; [Iorio, Francesco; Saez-Rodriguez, Julio] European Bioinformat Inst, European Mol Biol, Cambridge CB10 1SA, England; [Pronk, Apollo; van Houdt, Winan] Diakonessen Hosp, Dept Surg, NL-3582 KE Utrecht, Netherlands; [van Gorp, Joost] Diakonessen Hosp, Dept Pathol, NL-3582 KE Utrecht, Netherlands; [Volckman, Richard; van Sluis, Peter; Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogenom, NL-1105 AZ Amsterdam, Netherlands; [Li, Vivian S. W.] MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Netherlands Cancer Institute; European Molecular Biology Laboratory (EMBL); Diakonessenhuis; Diakonessenhuis; University of Amsterdam; Academic Medical Center Amsterdam; MRC National Institute for Medical Research	Garnett, MJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	mg12@sanger.ac.uk; h.clevers@hubrecht.eu	Versteeg, Rogier/AAQ-1765-2020; Cibulskis, Kristian/AAC-7380-2019; Iorio, Francesco/H-3282-2019; Pedamallu, Chandra Sekhar/AAV-6723-2020; Lawrence, Michael/AAC-8202-2020; Pedamallu, Chandra Sekhar/AAV-6745-2020; van Oudenaarden, Alexander/AAA-1705-2019; van Houdt, Winan/AAH-6108-2019; Saez-Rodriguez, Julio/H-7114-2019; Koster, Jan/C-5934-2008; Iorio, Francesco/H-3284-2019	van Houdt, Winan/0000-0002-2303-3468; Saez-Rodriguez, Julio/0000-0002-8552-8976; Koster, Jan/0000-0002-0890-7585; Iorio, Francesco/0000-0001-7063-8913; Cibulskis, Kristian/0000-0003-1343-1582; Kester, Lennart/0000-0002-8259-9971; Versteeg, Rogier/0000-0001-7172-0388; Meyerson, Matthew/0000-0002-9133-8108; Li, Vivian/0000-0003-2041-0085; Bartfeld, Sina/0000-0003-2493-8282; McDermott, Ultan/0000-0001-9032-4700	Stichting Virtutis Opus; Alpe dHuzes/KWF; Dutch Cancer Society [H1/2014-6919]; Stichting Vrienden van het Hubrecht; The Francis Crick Institute [10105] Funding Source: researchfish	Stichting Virtutis Opus; Alpe dHuzes/KWF; Dutch Cancer Society(KWF Kankerbestrijding); Stichting Vrienden van het Hubrecht; The Francis Crick Institute	Thanks to the Broad Institute Genomics Platform for processing and generating the sequence data, the cell line screening, and analysis team at the Sanger Institute, Liliane Wijnaendts and Joost Oudejans for help with tumor dissections, Harry Begthel and Jeroen Korving for histology, Sepideh Darakhshan for help with organoids, and the members of the M.M., M.J.G., and H.C. laboratories for support. M.v.d.W. is supported by Stichting Virtutis Opus and Stichting Vrienden van het Hubrecht. R.G.J.V., S.J., and J.B. are supported by a Grant from Alpe dHuzes/KWF. This work was supported with a grant from the Dutch Cancer Society to M.S. (H1/2014-6919). The organoids are available for academic research upon evaluation of a research proposal by the Medical Ethical Comity. M.M. received a commercial research grant from Bayer and has ownership interest (including patents) in and is a consultant/advisory board member for Foundation Medicine.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Centenera MM, 2013, NAT REV UROL, V10, P483, DOI 10.1038/nrurol.2013.126; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Ryland GL, 2013, J PATHOL, V229, P469, DOI 10.1002/path.4134; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Takahashi M, 2002, CANCER RES, V62, P5651; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vecchione L, 2014, CURR COLORECT CANC R, V10, P263, DOI 10.1007/s11888-014-0232-7; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	54	1238	1255	34	293	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					933	945		10.1016/j.cell.2015.03.053	http://dx.doi.org/10.1016/j.cell.2015.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957691	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000354175200024
J	Taylor, DW; Zhu, YF; Staals, RHJ; Kornfeld, JE; Shinkai, A; van der Oost, J; Nogales, E; Doudna, JA				Taylor, David W.; Zhu, Yifan; Staals, Raymond H. J.; Kornfeld, Jack E.; Shinkai, Akeo; van der Oost, John; Nogales, Eva; Doudna, Jennifer A.			Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning	SCIENCE			English	Article							GUIDED SURVEILLANCE COMPLEX; CRYSTAL-STRUCTURE; DNA RECOGNITION; CLEAVAGE; ENDONUCLEASE; PROKARYOTES; SYSTEM; CAS9	Adaptive immunity in bacteria involves RNA-guided surveillance complexes that use CRISPR (clustered regularly interspaced short palindromic repeats)-associated (Cas) proteins together with CRISPR RNAs (crRNAs) to target invasive nucleic acids for degradation. Whereas type I and type II CRISPR-Cas surveillance complexes target double-stranded DNA, type III complexes target single-stranded RNA. Near-atomic resolution cryo-electron microscopy reconstructions of native type III Cmr (CRISPR RAMP module) complexes in the absence and presence of target RNA reveal a helical protein arrangement that positions the crRNA for substrate binding. Thumblike b hairpins intercalate between segments of duplexed crRNA: target RNA to facilitate cleavage of the target at 6-nucleotide intervals. The Cmr complex is architecturally similar to the type I CRISPR-Cascade complex, suggesting divergent evolution of these immune systems from a common ancestor.	[Taylor, David W.; Kornfeld, Jack E.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Taylor, David W.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Zhu, Yifan; Staals, Raymond H. J.; van der Oost, John] Wageningen Univ, Lab Microbiol, Dept Agrotechnol & Food Sci, NL-6703 HB Wageningen, Netherlands; [Shinkai, Akeo] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Shinkai, Akeo] RIKEN Struct Biol, Yokohama, Kanagawa 2300045, Japan; [Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Wageningen University & Research; RIKEN; RIKEN; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	enogales@lbl.gov; doudna@berkeley.edu	Shinkai, Akeo/E-8354-2013; van+der+Oost, John/Y-2548-2019; Staals, Raymond/AAD-6871-2020	Shinkai, Akeo/0000-0002-9867-0832; Staals, Raymond/0000-0002-5741-9457; Taylor, David/0000-0002-6198-1194; Zhu, Yifan/0000-0002-8403-7833	Damon Runyon Cancer Research Foundation [DRG-2218-15]; University of Otago's Division of Health Sciences Career Development postdoctoral fellowship; Netherlands Organisation for Scientific Research (NWO) [024.002.002, 854.10.003]; Japan Society for the Promotion of Science [25440013]	Damon Runyon Cancer Research Foundation; University of Otago's Division of Health Sciences Career Development postdoctoral fellowship; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The structures of intact apo-Cmr, smaller apo-Cmr, and target-bound Cmr have been deposited into the EMDataBank with accession codes EMD-2898, EMD-2899, and EMD-2900, respectively. We thank R. Louder, S. Howes, E. Kellogg, R. Zhang, P. Grob, Y. He, T. Houweling, Z. Yu, and M. J. de la Cruz for expert electron microscopy assistance. D.W.T is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2218-15). R.H.J.S. was supported by the University of Otago's Division of Health Sciences Career Development postdoctoral fellowship. Y. Z. and J.v.d.O. received financial support from the Netherlands Organisation for Scientific Research (NWO), via a Gravitation grant to the Soehngen Institute for Anaerobic Microbiology (024.002.002) and an ALW-TOP project (854.10.003), respectively. This work was supported in part by Japan Society for the Promotion of Science KAKENHI grant 25440013 (to A. S.). J. A. D and E.N. are Howard Hughes Medical Institute Investigators. The T. thermophilus Cmr complex and T. thermophilus strain-producing Cmr6-His protein are available from A. S. under a material transfer agreement with RIKEN.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402	22	92	95	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					581	585		10.1126/science.aaa4535	http://dx.doi.org/10.1126/science.aaa4535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25837515	Green Accepted			2022-12-24	WOS:000353778100044
J	Wang, DT; Gruen, DS; Lollar, BS; Hinrichs, KU; Stewart, LC; Holden, JF; Hristov, AN; Pohlman, JW; Morrill, PL; Konneke, M; Delwiche, KB; Reeves, EP; Sutcliffe, CN; Ritter, DJ; Seewald, JS; McIntosh, JC; Hemond, HF; Kubo, MD; Cardace, D; Hoehler, TM; Ono, S				Wang, David T.; Gruen, Danielle S.; Lollar, Barbara Sherwood; Hinrichs, Kai-Uwe; Stewart, Lucy C.; Holden, James F.; Hristov, Alexander N.; Pohlman, John W.; Morrill, Penny L.; Koenneke, Martin; Delwiche, Kyle B.; Reeves, Eoghan P.; Sutcliffe, Chelsea N.; Ritter, Daniel J.; Seewald, Jeffrey S.; McIntosh, Jennifer C.; Hemond, Harold F.; Kubo, Michael D.; Cardace, Dawn; Hoehler, Tori M.; Ono, Shuhei			Nonequilibrium clumped isotope signals in microbial methane	SCIENCE			English	Article							HYDROGEN; FRACTIONATION; CARBON; BASIN; GAS; REDUCTION; OXIDATION; FLUIDS; WATER; D/H	Methane is a key component in the global carbon cycle, with a wide range of anthropogenic and natural sources. Although isotopic compositions of methane have traditionally aided source identification, the abundance of its multiply substituted "clumped" isotopologues (for example, (CH3D)-C-13) has recently emerged as a proxy for determining methane-formation temperatures. However, the effect of biological processes on methane's clumped isotopologue signature is poorly constrained. We show that methanogenesis proceeding at relatively high rates in cattle, surface environments, and laboratory cultures exerts kinetic control on (CH3D)-C-13 abundances and results in anomalously elevated formation-temperature estimates. We demonstrate quantitatively that H-2 availability accounts for this effect. Clumped methane thermometry can therefore provide constraints on the generation of methane in diverse settings, including continental serpentinization sites and ancient, deep groundwaters.	[Wang, David T.; Gruen, Danielle S.; Reeves, Eoghan P.; Ono, Shuhei] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Wang, David T.; Gruen, Danielle S.; Seewald, Jeffrey S.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; [Lollar, Barbara Sherwood; Sutcliffe, Chelsea N.] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada; [Hinrichs, Kai-Uwe; Koenneke, Martin] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Hinrichs, Kai-Uwe; Koenneke, Martin] Univ Bremen, Dept Geosci, D-28359 Bremen, Germany; [Stewart, Lucy C.; Holden, James F.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Hristov, Alexander N.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Pohlman, John W.] US Geol Survey, Woods Hole Coastal & Marine Sci Ctr, Woods Hole, MA 02543 USA; [Morrill, Penny L.] Mem Univ Newfoundland, Dept Earth Sci, St John, NF A1B 3X5, Canada; [Delwiche, Kyle B.; Hemond, Harold F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Ritter, Daniel J.; McIntosh, Jennifer C.] Univ Arizona, Det Hydrol & Water Resources, Tucson, AZ 85721 USA; [Kubo, Michael D.; Hoehler, Tori M.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Cardace, Dawn] Univ Rhode Isl, Dept Geosci, Kingston, RI 02881 USA	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; University of Toronto; University of Bremen; University of Bremen; University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; Memorial University Newfoundland; Massachusetts Institute of Technology (MIT); University of Arizona; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Rhode Island	Ono, S (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	sono@mit.edu	Holden, James F/E-6815-2013; Reeves, Eoghan P./M-3542-2013; Hinrichs, Kai-Uwe/C-7675-2009; Koenneke, Martin/E-6893-2013	Reeves, Eoghan P./0000-0003-0146-0714; Hinrichs, Kai-Uwe/0000-0002-0739-9291; Koenneke, Martin/0000-0001-6770-414X; Gruen, Danielle/0000-0003-1019-4390; Stewart, Lucy/0000-0001-7352-3329; Holden, James/0000-0002-4343-2378; Wang, David/0000-0002-2656-8951	NSF [EAR-1250394, EAR-1322805]; N. R. Braunsdorf and D. J. H. Smit of Shell PTI/EG; Deep Carbon Observatory; Natural Sciences and Engineering Research Council of Canada; Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft [HI 616-14-1]; National Defense Science and Engineering Graduate Fellowship; Neil a nd Anna Rasmussen Foundation Fund; Grayce B. Kerr Fellowship; Shell-MITEI Graduate Fellowship; Directorate For Geosciences [1322805] Funding Source: National Science Foundation; Division Of Earth Sciences [1250394] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); N. R. Braunsdorf and D. J. H. Smit of Shell PTI/EG; Deep Carbon Observatory; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Defense Science and Engineering Graduate Fellowship; Neil a nd Anna Rasmussen Foundation Fund; Grayce B. Kerr Fellowship; Shell-MITEI Graduate Fellowship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank J. Hayes, R. Summons, A. Whitehill, S. Zaarur, C. Ruppel, L. T. Bryndzia, N. Blair, D. Vinson, K. Nealson, and M. Schrenk for discussions; W. Olszewski, D. Nelson, G. Lacrampe-Couloume, and B. Topcuoglu for technical assistance; A. Whitehill, G. Luo, A. Apprill, K. Twing, W. Brazelton, A. Wray, J. Oh, A. Rowe, G. Chadwick, and A. Rietze for assistance in the field; R. Michener for the delta D<INF>water</INF> analyses; L. T. Bryndzia (Shell) for providing the shale gas samples; R. Dias (USGS) for sharing the NGS samples; and R. Raiche, D. McCrory, S. Moore (HomestakeMining Co.), the staff of the McLaughlin Natural Reserve, and the well operators for access to samples. Grants from the NSF (EAR-1250394 to S.O. and EAR-1322805 to J.C.M.), N. R. Braunsdorf and D. J. H. Smit of Shell PTI/EG (to S.O.), the Deep Carbon Observatory (to S.O., B. S. L., M.K., and K.-U.H.), the Natural Sciences and Engineering Research Council of Canada (to B. S. L.), and the Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft (HI 616-14-1 to K.-U.H. and M.K.) supported this study. D. T. W. was supported by a National Defense Science and Engineering Graduate Fellowship. D. S. G. was supported by the Neil a nd Anna Rasmussen Foundation Fund, the Grayce B. Kerr Fellowship, and a Shell-MITEI Graduate Fellowship. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. government. All data used to support the conclusions in this manuscript are provided in the supplementary materials. Author contributions: D. T. W. and S.O. developed the methods, analyzed data, and performed modeling. D. T. W. and D. S. G. performed isotopic analyses. D. S. G., L.C.S., J.F.H., M.K., K.-U.H., and S.O. designed and/or conducted microbiological experiments. D. T. W., D. S. G., B. S. L., P.L.M., K. B. D., A. N. H., C.N.S., M.D.K., D. J. R., J.C.M., D.C., and S.O. designed and/or executed the field-sampling campaigns. D.T.W. and S.O. wrote the manuscript with input from all authors.	BALABANE M, 1987, ORG GEOCHEM, V11, P115, DOI 10.1016/0146-6380(87)90033-7; Baldassare FJ, 2014, AAPG BULL, V98, P341, DOI 10.1306/06111312178; Bates BL, 2011, CHEM GEOL, V284, P45, DOI 10.1016/j.chemgeo.2011.02.004; BURKE RA, 1993, CHEMOSPHERE, V26, P55, DOI 10.1016/0045-6535(93)90412-X; BURKE RA, 1988, NATURE, V332, P829, DOI 10.1038/332829a0; Burruss RC, 2010, ORG GEOCHEM, V41, P1285, DOI 10.1016/j.orggeochem.2010.09.008; Cardace D, 2013, SCI DRILL, V16, P45, DOI 10.5194/sd-16-45-2013; Etiope G, 2013, REV GEOPHYS, V51, P276, DOI 10.1002/rog.20011; Flores RM, 2008, INT J COAL GEOL, V76, P52, DOI 10.1016/j.coal.2008.02.005; Holland G, 2013, NATURE, V497, P357, DOI 10.1038/nature12127; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Horibe Y, 1995, GEOCHIM COSMOCHIM AC, V59, P5209, DOI 10.1016/0016-7037(95)00391-6; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Lollar BS, 2008, GEOCHIM COSMOCHIM AC, V72, P4778, DOI 10.1016/j.gca.2008.07.004; Lollar BS, 2014, NATURE, V516, P379, DOI 10.1038/nature14017; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; McCalley CK, 2014, NATURE, V514, P478, DOI 10.1038/nature13798; Morrill PL, 2013, GEOCHIM COSMOCHIM AC, V109, P222, DOI 10.1016/j.gca.2013.01.043; Ono S, 2014, ANAL CHEM, V86, P6487, DOI 10.1021/ac5010579; Pohlman JW, 2009, EARTH PLANET SC LETT, V287, P504, DOI 10.1016/j.epsl.2009.08.037; REES CE, 1973, GEOCHIM COSMOCHIM AC, V37, P1141, DOI 10.1016/0016-7037(73)90052-5; Reeves EP, 2014, P NATL ACAD SCI USA, V111, P5474, DOI 10.1073/pnas.1400643111; Reeves EP, 2012, GEOCHIM COSMOCHIM AC, V77, P582, DOI 10.1016/j.gca.2011.10.008; SCHOELL M, 1988, CHEM GEOL, V71, P1, DOI 10.1016/0009-2541(88)90101-5; Stolper DA, 2014, SCIENCE, V344, P1500, DOI 10.1126/science.1254509; Stolper DA, 2014, GEOCHIM COSMOCHIM AC, V126, P169, DOI 10.1016/j.gca.2013.10.045; Takai K, 2008, P NATL ACAD SCI USA, V105, P10949, DOI 10.1073/pnas.0712334105; Valentine DL, 2004, GEOCHIM COSMOCHIM AC, V68, P1571, DOI 10.1016/j.gca.2003.10.012; Varadharajan C, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001866; WELHAN JA, 1987, AAPG BULL, V71, P215; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; WHITICAR MJ, 1990, ORG GEOCHEM, V16, P531, DOI 10.1016/0146-6380(90)90068-B; Wing BA, 2014, P NATL ACAD SCI USA, V111, P18116, DOI 10.1073/pnas.1407502111	34	146	155	4	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					428	431		10.1126/science.aaa4326	http://dx.doi.org/10.1126/science.aaa4326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25745067	Green Submitted			2022-12-24	WOS:000353338000032
J	D'Astolfo, DS; Pagliero, RJ; Pras, A; Karthaus, WR; Clevers, H; Prasad, V; Lebbink, RJ; Rehmann, H; Geijsen, N				D'Astolfo, Diego S.; Pagliero, Romina J.; Pras, Anita; Karthaus, Wouter R.; Clevers, Hans; Prasad, Vikram; Lebbink, Robert Jan; Rehmann, Holger; Geijsen, Niels			Efficient Intracellular Delivery of Native Proteins	CELL			English	Article							MEDIATED DELIVERY; HOST FACTORS; HUMAN-CELLS; STEM-CELLS; IN-VITRO; GENOME; TRANSDUCTION; PATHOGENS; GROWTH; LYSIS	Modulation of protein function is used to intervene in cellular processes but is often done indirectly by means of introducing DNA or mRNA encoding the effector protein. Thus far, direct intracellular delivery of proteins has remained challenging. We developed a method termed iTOP, for induced transduction by osmocytosis and propanebetaine, in which a combination of NaCl hypertonicity-induced macropinocytosis and a transduction compound (propanebetaine) induces the highly efficient transduction of proteins into a wide variety of primary cells. We demonstrate that iTOP is a useful tool in systems in which transient cell manipulation drives permanent cellular changes. As an example, we demonstrate that iTOP can mediate the delivery of recombinant Cas9 protein and short guide RNA, driving efficient gene targeting in a non-integrative manner.	[D'Astolfo, Diego S.; Pras, Anita; Karthaus, Wouter R.; Clevers, Hans; Geijsen, Niels] KNAW Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [D'Astolfo, Diego S.; Pagliero, Romina J.; Karthaus, Wouter R.; Clevers, Hans; Lebbink, Robert Jan; Rehmann, Holger; Geijsen, Niels] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands; [Prasad, Vikram] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Geijsen, Niels] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, NL-3584 CM Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University System of Ohio; University of Cincinnati; Utrecht University	Geijsen, N (corresponding author), KNAW Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	n.geijsen@hubrecht.eu	Lebbink, Robert Jan/GNH-5209-2022	Lebbink, Robert Jan/0000-0002-1981-0420; Karthaus, Wouter R./0000-0002-9234-9044	Netherlands Organization for Scientific Research (NWO) [91796323, 91610138]; Netherlands Organization for Scientific Research (American Heart Association) [11BGIA7720005]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (American Heart Association)	The authors thank Sarah Opitz for critically reading the manuscript; Nune Schelling for technical support; Stefan van der Elst of the Hubrecht Institute FACS facility for help with cell sorting; Anko de Graaf of the Hubrecht Institute imaging facility; David Egan of the Cell Screening facility at the UMCU; Gustavo Mostoslavsky for providing lentiviral vectors; Saravanan Manikam and Antoinette Killian for help with NDSB analysis; Thijn Brummelkamp for providing the KBM7 cells; Liqun Luo and Paul Krimpenfort for providing mTmG reporter mice; and Bart van Steen and Jack den Hartog for help with compound synthesis. This work was funded in part by The Netherlands Organization for Scientific Research (NWO, project 91796323 and 91610138, and American Heart Association 11BGIA7720005). D.S.D. and N.G. are co-inventors on a patent application describing the transduction technology PCT/IB2014/064127 and co-founders of NTrans technologies.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; Commisso C, 2014, NAT PROTOC, V9, P182, DOI 10.1038/nprot.2014.004; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kultz D, 1998, J BIOL CHEM, V273, P13645, DOI 10.1074/jbc.273.22.13645; Louis Sharon A, 2005, Methods Mol Biol, V290, P265; Lundberg M, 2001, NAT BIOTECHNOL, V19, P713, DOI 10.1038/90741; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; OKADA CY, 1982, CELL, V29, P33, DOI 10.1016/0092-8674(82)90087-3; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ray K, 2010, CELL MICROBIOL, V12, P545, DOI 10.1111/j.1462-5822.2010.01428.x; Redon CE, 2011, P NATL ACAD SCI USA, V108, P20281, DOI 10.1073/pnas.1117713109; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; Zhou J, 2006, CANCER RES, V66, P8954, DOI 10.1158/0008-5472.CAN-06-1726; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	20	207	220	3	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					674	690		10.1016/j.cell.2015.03.028	http://dx.doi.org/10.1016/j.cell.2015.03.028			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910214	Bronze			2022-12-24	WOS:000353553600024
J	Ticau, S; Friedman, LJ; Ivica, NA; Gelles, J; Bell, SP				Ticau, Simina; Friedman, Larry J.; Ivica, Nikola A.; Gelles, Jeff; Bell, Stephen P.			Single-Molecule Studies of Origin Licensing Reveal Mechanisms Ensuring Bidirectional Helicase Loading	CELL			English	Article							DNA-REPLICATION; MCM2-7 HELICASE; ATP-HYDROLYSIS; COMPLEX; ACTIVATION; MICROSCOPY; INITIATION	Loading of the ring-shaped Mcm2-7 replicative helicase around DNA licenses eukaryotic origins of replication. During loading, Cdc6, Cdt1, and the origin-recognition complex (ORC) assemble two heterohexameric Mcm2-7 complexes into a head-to-head double hexamer that facilitates bidirectional replication initiation. Using multi-wavelength single-molecule fluorescence to monitor the events of helicase loading, we demonstrate that double-hexamer formation is the result of sequential loading of individual Mcm2-7 complexes. Loading of each Mcm2-7 molecule involves the ordered association and dissociation of distinct Cdc6 and Cdt1 proteins. In contrast, one ORC molecule directs loading of both helicases in each double hexamer. Based on single-molecule FRET, arrival of the second Mcm2-7 results in rapid double-hexamer formation that anticipates Cdc6 and Cdt1 release, suggesting that Mcm-Mcm interactions recruit the second helicase. Our findings reveal the complex protein dynamics that coordinate helicase loading and indicate that distinct mechanisms load the oppositely oriented helicases that are central to bidirectional replication initiation.	[Ticau, Simina; Ivica, Nikola A.; Bell, Stephen P.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Friedman, Larry J.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Brandeis University	Gelles, J (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	gelles@brandeis.edu; spbell@mit.edu		/0000-0002-0124-0087; Bell, Stephen/0000-0002-2876-610X; Friedman, Larry/0000-0003-4946-8731	NIH [GM52339, R01 GM81648]; G. Harold and Leila Y. Mathers Foundation; NIH Pre-Doctoral Training Grant [GM007287]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081648, R01GM052339, T32GM007287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Foundation; NIH Pre-Doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Bell laboratory for useful discussions. We thank Daniel Duzdevich and Eric C. Greene for comments on the manuscript and helpful discussions. We thank Jonathan B. Grimm and Luke D. Lavis for graciously providing the Janelia Fluors. This work was supported by NIH grants GM52339 (S.P.B.) and R01 GM81648 (J.G.) and a grant from the G. Harold and Leila Y. Mathers Foundation (J.G.). S.T. was supported in part by an NIH Pre-Doctoral Training Grant (GM007287). S.P.B. is an investigator with the Howard Hughes Medical Institute.	Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Crawford DJ, 2013, P NATL ACAD SCI USA, V110, P6783, DOI 10.1073/pnas.1219305110; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duzdevich D., 2015, MOL CELL, V58; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Gendreizig S, 2003, J AM CHEM SOC, V125, P14970, DOI 10.1021/ja037883p; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Siddiqui K, 2013, COLD SPRING HARB PER, V5; Stratmann SA, 2014, CHEM SOC REV, V43, P1201, DOI 10.1039/c3cs60391a; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Sun JC, 2012, STRUCTURE, V20, P534, DOI 10.1016/j.str.2012.01.011; Takara TJ, 2011, EMBO J, V30, P4885, DOI 10.1038/emboj.2011.394; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738	28	125	128	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					513	525		10.1016/j.cell.2015.03.012	http://dx.doi.org/10.1016/j.cell.2015.03.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892223	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000353553600012
J	Wu, XL; Zhang, ZH; Schramm, CA; Joyce, MG; Do Kwon, Y; Zhou, TQ; Sheng, ZZ; Zhang, BS; O'Dell, S; Mckee, K; Georgiev, IS; Chuang, GY; Longo, NS; Lynch, RM; Saunders, KO; Soto, C; Srivatsan, S; Yang, YP; Bailer, RT; Louder, MK; Mullikin, JC; Connors, M; Kwong, PD; Mascola, JR; Shapiro, L				Wu, Xueling; Zhang, Zhenhai; Schramm, Chaim A.; Joyce, M. Gordon; Do Kwon, Young; Zhou, Tongqing; Sheng, Zizhang; Zhang, Baoshan; O'Dell, Sijy; Mckee, Krisha; Georgiev, Ivelin S.; Chuang, Gwo-Yu; Longo, Nancy S.; Lynch, Rebecca M.; Saunders, Kevin O.; Soto, Cinque; Srivatsan, Sanjay; Yang, Yongping; Bailer, Robert T.; Louder, Mark K.; Mullikin, James C.; Connors, Mark; Kwong, Peter D.; Mascola, John R.; Shapiro, Lawrence		Program, NCS	Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection	CELL			English	Article							BROADLY NEUTRALIZING ANTIBODIES; B-CELL RECEPTORS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; POTENT NEUTRALIZATION; CD4-BINDING SITE; RATIONAL DESIGN; ENVELOPE TRIMER; BINDING-SITE; GENE USAGE	HIV-1-neutralizing antibodies develop in most HIV-1-infected individuals, although highly effective antibodies are generally observed only after years of chronic infection. Here, we characterize the rate of maturation and extent of diversity for the lineage that produced the broadly neutralizing antibody VRC01 through longitudinal sampling of peripheral B cell transcripts over 15 years and co-crystal structures of lineage members. Next-generation sequencing identified VRC01-lineage transcripts, which encompassed diverse antibodies organized into distinct phylogenetic clades. Prevalent clades maintained characteristic features of antigen recognition, though each evolved binding loops and disulfides that formed distinct recognition surfaces. Over the course of the study period, VRC01-lineage clades showed continuous evolution, with rates of similar to 2 substitutions per 100 nucleotides per year, comparable to that of HIV-1 evolution. This high rate of antibody evolution provides a mechanism by which antibody lineages can achieve extraordinary diversity and, over years of chronic infection, develop effective HIV-1 neutralization.	[Wu, Xueling; Zhang, Zhenhai; Joyce, M. Gordon; Do Kwon, Young; Zhou, Tongqing; Zhang, Baoshan; O'Dell, Sijy; Mckee, Krisha; Georgiev, Ivelin S.; Chuang, Gwo-Yu; Longo, Nancy S.; Lynch, Rebecca M.; Saunders, Kevin O.; Soto, Cinque; Srivatsan, Sanjay; Yang, Yongping; Bailer, Robert T.; Louder, Mark K.; Kwong, Peter D.; Mascola, John R.; Shapiro, Lawrence] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Wu, Xueling] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Zhang, Zhenhai; Schramm, Chaim A.; Sheng, Zizhang; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zhang, Zhenhai; Schramm, Chaim A.; Sheng, Zizhang; Shapiro, Lawrence] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Zhang, Zhenhai] Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Zhenhai] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Guangzhou 510515, Guangdong, Peoples R China; [Mullikin, James C.; Program, NCS] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rockefeller University; Columbia University; Columbia University; Southern Medical University - China; Southern Medical University - China; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov; jmascola@nih.gov; lss8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019; Mascola, John/AAI-7193-2021; Do Kwon, Young/A-6957-2010; Sheng, Zizhang/AFR-8049-2022; Zhang, Zhenhai/GRX-5887-2022; Zhou, Tongqing/A-6880-2010	Do Kwon, Young/0000-0002-1188-7458; Sheng, Zizhang/0000-0002-3253-3309; Zhang, Zhenhai/0000-0002-4310-0525; Zhou, Tongqing/0000-0002-3935-4637	Intramural Research Program of the VRC; NHGRI; NIH [P01-AI104722]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZIAAI005022, P01AI104722, ZICAI005113, ZIAAI005095, ZICAI005111] Funding Source: NIH RePORTER	Intramural Research Program of the VRC; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Turk and C.-L. Lin for technical assistance with large neutralization panels. We thank members of the Structural Biology Section, Structural Bioinformatics Core Section, and Humoral Immunology Core Section, Vaccine Research Center (VRC), NIAID, NIH, for comments and suggestions on the manuscript. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 Envelope plasmids used in our neutralization panel. The sequences of NIH45-177 and NIH45-243 were kindly provided by J. Scheid and M. Nussenzweig. We thank F. Alt for helpful discussions on antibody lineage development and rates. Support for this work was provided by the Intramural Research Program of the VRC and the NHGRI and by NIH grant P01-AI104722. Use of sector 22 at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chaillon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044163; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Vrancken B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003505; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu L, 2006, VACCINE, V24, P4995, DOI 10.1016/j.vaccine.2006.03.083; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu JXX, 2013, SCI CHINA CHEM, V56, P1, DOI 10.1007/s11426-012-4811-7	49	160	164	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					470	485		10.1016/j.cell.2015.03.004	http://dx.doi.org/10.1016/j.cell.2015.03.004			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25865483	Green Accepted, Bronze			2022-12-24	WOS:000353553600009
J	Furu, K; Kieler, H; Haglund, B; Engeland, A; Selmer, R; Stephansson, O; Valdimarsdottir, UA; Zoega, H; Artama, M; Gissler, M; Malm, H; Norgaard, M				Furu, Kari; Kieler, Helle; Haglund, Bengt; Engeland, Anders; Selmer, Randi; Stephansson, Olof; Valdimarsdottir, Unnur Anna; Zoega, Helga; Artama, Miia; Gissler, Mika; Malm, Heli; Norgaard, Mette			Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL USE; ANTIDEPRESSANT USE; 1ST-TRIMESTER USE; HEART-DEFECTS; MALFORMATIONS; DEPRESSION; PAROXETINE; EXPOSURE; DRUGS; 1ST	OBJECTIVE To assess whether use of specific selective serotonin reuptake inhibitors (SSRIs) or venlafaxine in early pregnancy is associated with an increased risk of birth defects, with emphasis on cardiovascular birth defects even when accounting for lifestyle or other familial confounding. DESIGN Multicountry population based cohort study, including sibling controlled design. SETTING Nordic population (Denmark, Finland, Iceland, Norway, and Sweden) identified from nationwide health registers at different periods in 1996-2010. POPULATION The full study cohort included women giving birth to 2.3 million live singletons. The sibling cohort included 2288 singleton live births. The sibling controlled analyses included sibling pairs who were discordant for exposure to SSRIs or venlafaxine and birth defects. MAIN OUTCOME MEASURE Prevalence of birth defects, including subtypes of cardiac defects. Odds ratio of birth defects from logistic and conditional logistic regression. RESULTS Among 36 772 infants exposed to any SSRI in early pregnancy, 3.7% (n=1357) had a birth defect compared with 3.1% of 2 266 875 unexposed infants, yielding a covariate adjusted odds ratio of 1.13 (95% confidence interval 1.06 to 1.20). In the sibling controlled analysis the adjusted odds ratio decreased to 1.06 (0.91 to 1.24). The odds ratios for any cardiac birth defect with use of any SSRI or venlafaxine were 1.15 (95% confidence interval 1.05 to 1.26) in the covariate adjusted analysis and 0.92 (0.72 to 1.17) in the sibling controlled analysis. For atrial and ventricular septal defects the covariate adjusted odds ratio was 1.17 (1.05 to 1.31). Exposure to any SSRI or venlafaxine increased the prevalence of right ventricular outflow tract obstruction defects, with a covariate adjusted odds ratio of 1.48 (1.15 to 1.89). In the sibling controlled analysis the adjusted odds ratio decreased to 0.56 (0.21 to 1.49) for any exposure to SSRIs or venlafaxine and right ventricular outflow tract obstruction defects. CONCLUSIONS In this large Nordic study no substantial increase was found in prevalence of overall cardiac birth defects among infants exposed to SSRIs or venlafaxine in utero. Although the prevalence of septal defects and right ventricular outflow tract defects was higher in exposed infants, the lack of an association in the sibling controlled analyses points against a teratogenic effect of these drugs.	[Furu, Kari; Engeland, Anders; Selmer, Randi] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Pharmacoepidemiol, NO-0403 Oslo, Norway; [Kieler, Helle; Haglund, Bengt; Stephansson, Olof] Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Engeland, Anders] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Stephansson, Olof] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Valdimarsdottir, Unnur Anna; Zoega, Helga] Univ Iceland, Fac Med, Sch Hlth Sci, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Valdimarsdottir, Unnur Anna] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Artama, Miia] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Artama, Miia] Univ Turku, Dept Child Psychiat, Turku, Finland; [Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Malm, Heli] HUSLAB, Teratol Informat Serv, Helsinki, Finland; [Malm, Heli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Malm, Heli] Univ Helsinki, Dept Clin Pharmacol, SF-00250 Helsinki, Finland; [Norgaard, Mette] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	Norwegian Institute of Public Health (NIPH); Karolinska Institutet; University of Bergen; Karolinska Institutet; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; University of Helsinki; University of Turku; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Aarhus University	Furu, K (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Dept Pharmacoepidemiol, PB 4404 Nydalen, NO-0403 Oslo, Norway.	kari.furu@fhi.no	Zoega, Helga/M-1968-2015; Engeland, Anders/AAG-7437-2021	Valdimarsdottir, Unnur/0000-0001-5382-946X; Kieler, Helle/0000-0001-9338-7133; Gissler, Mika/0000-0001-8254-7525; Stephansson, Olof/0000-0003-1528-4563	Swedish pharmacy company Apoteksbolaget	Swedish pharmacy company Apoteksbolaget	This study was funded by the authors' affiliations and the Swedish pharmacy company Apoteksbolaget. Apoteksbolaget had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Bakker MK, 2010, BIRTH DEFECTS RES A, V88, P94, DOI 10.1002/bdra.20641; Ban L, 2014, BJOG-INT J OBSTET GY, V121, P1471, DOI 10.1111/1471-0528.12682; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Jepsen P, 2006, INT J RISK SAF MED, V18, P77; Kallen BAJ, 2007, BIRTH DEFECTS RES A, V79, P301, DOI 10.1002/bdra.20327; Kieler H, 2015, BJOG-INT J OBSTET GY, V122, P1618, DOI 10.1111/1471-0528.13164; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Kieler Helle, 2010, Clin Epidemiol, V2, P205, DOI 10.2147/CLEP.S10426; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kornum Jette B, 2010, Clin Epidemiol, V2, P29; Laugesen K, 2013, BMJ OPEN, V3; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P942, DOI 10.1002/pds.3462; Mitchell AA, 2012, PHARMACOEPIDEM DR S, P487, DOI DOI 10.1002/9781119959946.CH28; Nebigil CG, 2003, CIRCULATION, V108, P902, DOI 10.1161/01.CIR.0000081520.25714.D9; Nordeng H, 2012, J CLIN PSYCHOPHARM, V32, P186, DOI 10.1097/JCP.0b013e3182490eaf; O'Keane V, 2007, BMJ-BRIT MED J, V334, P1003, DOI 10.1136/bmj.39189.662581.55; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Polen KND, 2013, BIRTH DEFECTS RES A, V97, P28, DOI 10.1002/bdra.23096; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Reis M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002166; Rothman KJ, 2014, J GEN INTERN MED, V29, P1060, DOI 10.1007/s11606-013-2755-z; Sadler TW, 2011, REPROD TOXICOL, V32, P484, DOI 10.1016/j.reprotox.2011.09.004; Sari Y, 2003, INT J DEV NEUROSCI, V21, P417, DOI 10.1016/j.ijdevneu.2003.10.002; Skurtveit S, 2013, J CLIN EPIDEMIOL, V66, P964, DOI 10.1016/j.jclinepi.2013.02.011; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Tuccori M, 2010, POSTGRAD MED, V122, P49, DOI 10.3810/pgm.2010.07.2175; Vasilakis-Scaramozza C, 2013, PHARMACOTHERAPY, V33, P693, DOI 10.1002/phar.1211; WHO Collaborating Centre for Drug Statistics Methodology, 2009, GUID ATC CLASS DDD A; Wogelius P, 2006, EPIDEMIOLOGY, V17, P701, DOI 10.1097/01.ede.0000239581.76793.ae; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627	44	110	115	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2015	350								h1798	10.1136/bmj.h1798	http://dx.doi.org/10.1136/bmj.h1798			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JZ	25888213	Green Published, hybrid			2022-12-24	WOS:000353329100001
J	Gamerdinger, M; Hanebuth, MA; Frickey, T; Deuerling, E				Gamerdinger, Martin; Hanebuth, Marie Anne; Frickey, Tancred; Deuerling, Elke			The principle of antagonism ensures protein targeting specificity at the endoplasmic reticulum	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; POLYPEPTIDE-ASSOCIATED COMPLEX; CAENORHABDITIS-ELEGANS; MEMBRANE INTERACTION; NASCENT CHAINS; BETA-NAC; TRANSLOCATION; RIBOSOMES; BINDING; SEQUENCE	The sorting of proteins to the appropriate compartment is one of the most fundamental cellular processes. We found that in the model organism Caenorhabditis elegans, correct cotranslational endoplasmic reticulum (ER) transport required the suppressor activity of the nascent polypeptide-associated complex (NAC). NAC did not affect the accurate targeting of ribosomes to ER translocons mediated by the signal recognition particle (SRP) pathway but inhibited additional unspecific contacts between ribosomes and translocons by blocking their autonomous binding affinity. NAC depletion shortened the life span of Caenorhabditis elegans, caused global mistargeting of translating ribosomes to the ER, and provoked incorrect import of mitochondrial proteins into the ER lumen, resulting in a strong impairment of protein homeostasis in both compartments. Thus, the antagonistic targeting activity of NAC is important in vivo to preserve the robustness and specificity of cellular protein-sorting routes.	[Gamerdinger, Martin; Hanebuth, Marie Anne; Deuerling, Elke] Univ Konstanz, Inst Mol Microbiol, Dept Biol, D-78457 Constance, Germany; [Frickey, Tancred] Univ Konstanz, Appl Bioinformat Lab, Dept Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz	Deuerling, E (corresponding author), Univ Konstanz, Inst Mol Microbiol, Dept Biol, D-78457 Constance, Germany.	elke.deuerling@uni-konstanz.de		Gamerdinger, Martin/0000-0003-1483-8181	German Science Foundation (DFG) [SFB969/A01]; Human Frontier in Science Program (HFSP) [RGP025]	German Science Foundation (DFG)(German Research Foundation (DFG)); Human Frontier in Science Program (HFSP)	We gratefully acknowledge the help of A. Dillin and K. Steffen to get started with this C. elegans project. We thank the Caenorhabditis Genetics Center for strains and E. Schulze for the microinjection training. We also thank A. Page, W. Neupert, and C. Bargmann for providing reagents. We thank R. Schloemer, K. Turgay, C. Schlatterer, S. Zboron, and E. Oberer-Bley for their critical discussions and valuable help with the manuscript. This work was supported by research grants from the German Science Foundation (DFG; SFB969/A01) and from Human Frontier in Science Program (HFSP; RGP025) to E.D. Data are deposited in Gene Expression Omnibus under accession no. GSE63928.	ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; BORGESE N, 1974, J MOL BIOL, V88, P559, DOI 10.1016/0022-2836(74)90408-2; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Hotokezaka Y, 2009, CELL DEATH DIFFER, V16, P1505, DOI 10.1038/cdd.2009.90; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; LAURING B, 1995, P NATL ACAD SCI USA, V92, P5411, DOI 10.1073/pnas.92.12.5411; Markesich DC, 2000, DEVELOPMENT, V127, P559; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Pech Markus, 2010, J Biol Chem, V285, P19679, DOI 10.1074/jbc.M109.092536; Powers T, 1996, CURR BIOL, V6, P331, DOI 10.1016/S0960-9822(02)00484-0; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Raden D, 1998, MOL BIOL CELL, V9, P117, DOI 10.1091/mbc.9.1.117; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhang Y, 2012, MOL BIOL CELL, V23, P3027, DOI 10.1091/mbc.E12-02-0112	42	82	83	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					201	207		10.1126/science.aaa5335	http://dx.doi.org/10.1126/science.aaa5335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859040	Green Submitted			2022-12-24	WOS:000352613700037
J	Karreth, FA; Reschke, M; Ruocco, A; Ng, C; Chapuy, B; Leopold, V; Sjoberg, M; Keane, TM; Verma, A; Ala, U; Tay, Y; Wu, D; Seitzer, N; Velasco-Herrera, MD; Bothmer, A; Fung, J; Langellotto, F; Rodig, SJ; Elemento, O; Shipp, MA; Adams, DJ; Chiarle, R; Pandolfi, PP				Karreth, Florian A.; Reschke, Markus; Ruocco, Anna; Ng, Christopher; Chapuy, Bjoern; Leopold, Valentine; Sjoberg, Marcela; Keane, Thomas M.; Verma, Akanksha; Ala, Ugo; Tay, Yvonne; Wu, David; Seitzer, Nina; Velasco-Herrera, Martin Del Castillo; Bothmer, Anne; Fung, Jacqueline; Langellotto, Fernanda; Rodig, Scott J.; Elemento, Olivier; Shipp, Margaret A.; Adams, David J.; Chiarle, Roberto; Pandolfi, Pier Paolo			The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo	CELL			English	Article							B-CELL LYMPHOMA; X-CHROMOSOME; CERNA HYPOTHESIS; GENE-EXPRESSION; MICRORNA; PTEN; MALIGNANCIES; IDIC(X)(Q13); ACTIVATION; ABSENCE	Research over the past decade has suggested important roles for pseudogenes in physiology and disease. In vitro experiments demonstrated that pseudogenes contribute to cell transformation through several mechanisms. However, in vivo evidence for a causal role of pseudogenes in cancer development is lacking. Here, we report that mice engineered to overexpress either the full-length murine B-Raf pseudogene Braf-rs1 or its pseudo "CDS'' or "3' UTR'' develop an aggressive malignancy resembling human diffuse large B cell lymphoma. We show that Braf-rs1 and its human ortholog, BRAFP1, elicit their oncogenic activity, at least in part, as competitive endogenous RNAs (ceRNAs) that elevate BRAF expression and MAPK activation in vitro and in vivo. Notably, we find that transcriptional or genomic aberrations of BRAFP1 occur frequently in multiple human cancers, including B cell lymphomas. Our engineered mouse models demonstrate the oncogenic potential of pseudogenes and indicate that ceRNA-mediated microRNA sequestration may contribute to the development of cancer.	[Karreth, Florian A.; Reschke, Markus; Ruocco, Anna; Ng, Christopher; Leopold, Valentine; Ala, Ugo; Tay, Yvonne; Seitzer, Nina; Bothmer, Anne; Fung, Jacqueline; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Res Inst,Dept Med & Pathol,Med Sch, Boston, MA 02215 USA; [Chapuy, Bjoern; Shipp, Margaret A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sjoberg, Marcela; Keane, Thomas M.; Velasco-Herrera, Martin Del Castillo; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Hinxton CB10 1HH, England; [Verma, Akanksha; Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY 10021 USA; [Wu, David] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10021 USA; [Langellotto, Fernanda; Chiarle, Roberto] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Langellotto, Fernanda; Chiarle, Roberto] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chiarle, Roberto] Univ Torino, Dept Mol Biotechnol & Hlth Sci, I-10124 Turin, Italy	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Wellcome Trust Sanger Institute; Cornell University; Cornell University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Turin	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Res Inst,Dept Med & Pathol,Med Sch, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Verma, Akanksha/HGT-9212-2022; Verma, Akanksha/W-1810-2019; Ala, Ugo/K-2029-2016; Rodig, Scott/Y-3889-2019	Verma, Akanksha/0000-0001-6121-801X; Ala, Ugo/0000-0001-5408-6397; Pandolfi, Pier Paolo/0000-0002-5352-5295; Leopold, Valentine/0000-0002-2131-5760; Wu, David/0000-0003-4513-2739; Sjoberg Herrera, Marcela K./0000-0001-7173-048X; Adams, David/0000-0001-9490-0306; Keane, Thomas/0000-0001-7532-6898; Del Castillo Velasco Herrera, Martin/0000-0001-5956-0211; CHIARLE, Roberto/0000-0003-1564-8531; Ng, Christopher/0000-0001-8815-7958	Department of Defense Prostate Cancer Research Program; American Cancer Society; German Academy of Sciences Leopoldina; CHB-MIT fellowship; Italian Association for Cancer Research (AIRC) [IG-9408]; Cancer Research UK; Wellcome Trust; FP7 ERC-StG grant [242965]; AIRC [IG-12023]; International Association for Cancer Research (AICR) [12-0216]; NIH [CA170158-01]; Cancer Research UK [13031] Funding Source: researchfish; Worldwide Cancer Research [12-0216] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA170158] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); German Academy of Sciences Leopoldina; CHB-MIT fellowship; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); FP7 ERC-StG grant; AIRC(Fondazione AIRC per la ricerca sul cancro); International Association for Cancer Research (AICR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to L. Cantley for hosting F.A.K. in his lab for part of this study. We thank S. Lowe for CAG-rtTA3 mice; L. Cantley, B. Vogelstein, and P. Sharp for cell lines; G. DeNicola for helpful discussions; and the Nikon Imaging Center at Harvard Medical School for help with light microscopy, the Dana Farber/Harvard Cancer Center Specialized Histopathology Core for help with immunohistochemistry, J. Clohessy and B. Padmani for help with ultrasound imaging, and S. Annunziato, A. Nyein, A. Bester, and K Berry for technical assistance. F.A.K. was supported by fellowships from the Department of Defense Prostate Cancer Research Program and the American Cancer Society. M.R. was supported by the German Academy of Sciences Leopoldina, F.L. received a CHB-MIT fellowship, and U.A. acknowledges support from the Italian Association for Cancer Research (AIRC) under grant IG-9408. M.S., T.M.K., M.D.C.V.-H., and D.J.A. are funded by Cancer Research UK and the Wellcome Trust. R.C. was supported by a FP7 ERC-2009-StG grant (Proposal No. 242965, "Lunely''), AIRC grant IG-12023, and an International Association for Cancer Research (AICR) grant 12-0216. P.P.P. was supported by NIH grant CA170158-01.	Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bier A, 2009, MOL CANCER THER, V8, P786, DOI 10.1158/1535-7163.MCT-08-0930; Bosia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066609; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Chiu HS, 2015, GENOME RES, V25, P257, DOI 10.1101/gr.178194.114; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; DEWALD GW, 1989, CANCER GENET CYTOGEN, V42, P173, DOI 10.1016/0165-4608(89)90085-X; DIERLAMM J, 1995, BRIT J HAEMATOL, V91, P885, DOI 10.1111/j.1365-2141.1995.tb05405.x; Figliuzzi M, 2013, BIOPHYS J, V104, P1203, DOI 10.1016/j.bpj.2013.01.012; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Heinonen K, 1999, MED PEDIATR ONCOL, V32, P360, DOI 10.1002/(SICI)1096-911X(199905)32:5<360::AID-MPO9>3.0.CO;2-7; Jens M, 2015, NAT REV GENET, V16, P113, DOI 10.1038/nrg3853; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Libri V, 2012, P NATL ACAD SCI USA, V109, P279, DOI 10.1073/pnas.1114204109; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Monni O, 1996, BLOOD, V87, P5269, DOI 10.1182/blood.V87.12.5269.bloodjournal87125269; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Paulsson K, 2010, HUM MOL GENET, V19, P1507, DOI 10.1093/hmg/ddq024; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; RACK KA, 1994, HUM MOL GENET, V3, P1053, DOI 10.1093/hmg/3.7.1053; Ravi A, 2012, CANCER CELL, V21, P848, DOI 10.1016/j.ccr.2012.04.037; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yamamoto K, 2002, CANCER GENET CYTOGEN, V134, P84, DOI 10.1016/S0165-4608(01)00603-3; Zou MJ, 2009, NEOPLASIA, V11, P57, DOI 10.1593/neo.81044	44	242	250	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					319	332		10.1016/j.cell.2015.02.043	http://dx.doi.org/10.1016/j.cell.2015.02.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25843629	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000352708300024
J	Jakes, AD; Phillips, R; Scales, M				Jakes, Adam D.; Phillips, Robert; Scales, Michael			10-MINUTE CONSULTATION Teenagers with back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jakes, Adam D.] Leeds Teaching Hosp NHS Trust, St Jamess Univ Hosp, Leeds L59 7TF, W Yorkshire, England; [Phillips, Robert] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Phillips, Robert] Leeds Gen Infirm, Leeds, W Yorkshire, England; [Scales, Michael] Univ Leeds, Acad Unit Primary Care, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; University of York - UK; Leeds General Infirmary; University of Leeds; University of Leeds	Jakes, AD (corresponding author), Leeds Teaching Hosp NHS Trust, St Jamess Univ Hosp, Leeds L59 7TF, W Yorkshire, England.	adam.jakes@hyms.ac.uk			MRC [G0800472] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		American Academy of Pediatrics HealthyChildren.org., 2013, BACKP SAF; Arthritis Research UK, 2011, BACK PAIN; Bhatia NN, 2008, J PEDIATR ORTHOPED, V28, P230, DOI 10.1097/BPO.0b013e3181651bc8; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; d'Hemecourt PA, 2000, CLIN SPORT MED, V19, P663, DOI 10.1016/S0278-5919(05)70231-3; Davis PJC, 2008, ARCH DIS CHILDHOOD-E, V93, P73, DOI 10.1136/adc.2006.115535; Michaleff ZA, 2014, EUR SPINE J, V23, P2046, DOI 10.1007/s00586-014-3461-1; National Institute of Health and Clinical Excellence, 2005, REF GUID SUSP CANC C	8	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2015	350								h1275	10.1136/bmj.h1275	http://dx.doi.org/10.1136/bmj.h1275			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3IB	25838410				2022-12-24	WOS:000352440700001
J	Scott, AR				Scott, Andrew R.			POLYMERS Secrets from the deep sea	NATURE			English	Editorial Material																		Fathi A, 2014, EUR POLYM J, V59, P161, DOI 10.1016/j.eurpolymj.2014.07.011; Jorfi M, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/011001; Lim HL, 2014, BIOMATER SCI-UK, V2, P603, DOI 10.1039/c3bm60288e; Meredith HJ, 2014, ADV FUNCT MATER, V24, P3259, DOI 10.1002/adfm.201303536; Nguyen JK, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056014; Shubhra QTH, 2014, POLYM REV, V54, P112, DOI 10.1080/15583724.2013.862544	6	14	16	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S12	S13		10.1038/519S12a	http://dx.doi.org/10.1038/519S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806491	Bronze			2022-12-24	WOS:000351602800004
J	Weber, GF; Chousterman, BG; He, S; Fenn, AM; Nairz, M; Anzai, A; Brenner, T; Uhle, F; Iwamoto, Y; Robbins, CS; Noiret, L; Maier, SL; Zonnchen, T; Rahbari, NN; Scholch, S; Ameln, AKV; Chavakis, T; Weitz, J; Hofer, S; Weigand, MA; Nahrendorf, M; Weissleder, R; Swirski, FK				Weber, Georg F.; Chousterman, Benjamin G.; He, Shun; Fenn, Ashley M.; Nairz, Manfred; Anzai, Atsushi; Brenner, Thorsten; Uhle, Florian; Iwamoto, Yoshiko; Robbins, Clinton S.; Noiret, Lorette; Maier, Sarah L.; Zoennchen, Tina; Rahbari, Nuh N.; Schoelch, Sebastian; Ameln, Anne Klotzsche-von; Chavakis, Triantafyllos; Weitz, Juergen; Hofer, Stefan; Weigand, Markus A.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.			Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis	SCIENCE			English	Article							B-CELLS PROTECT; IN-VITRO; IMMUNOSUPPRESSION; BIOLOGY; TRIAL; CSF	Sepsis is a frequently fatal condition characterized by an uncontrolled and harmful host reaction to microbial infection. Despite the prevalence and severity of sepsis, we lack a fundamental grasp of its pathophysiology. Here we report that the cytokine interleukin-3 (IL-3) potentiates inflammation in sepsis. Using a mouse model of abdominal sepsis, we showed that innate response activator B cells produce IL-3, which induces myelopoiesis of Ly-6C(high) monocytes and neutrophils and fuels a cytokine storm. IL-3 deficiency protects mice against sepsis. In humans with sepsis, high plasma IL-3 levels are associated with high mortality even after adjusting for prognostic indicators. This study deepens our understanding of immune activation, identifies IL-3 as an orchestrator of emergency myelopoiesis, and reveals a new therapeutic target for treating sepsis.	[Weber, Georg F.; Chousterman, Benjamin G.; He, Shun; Fenn, Ashley M.; Nairz, Manfred; Anzai, Atsushi; Iwamoto, Yoshiko; Robbins, Clinton S.; Noiret, Lorette; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02163 USA; [Weber, Georg F.; Maier, Sarah L.; Zoennchen, Tina; Rahbari, Nuh N.; Schoelch, Sebastian; Weitz, Juergen] Tech Univ Dresden, Dept Visceral Thorac & Vasc Surg, D-01062 Dresden, Germany; [Brenner, Thorsten; Uhle, Florian; Hofer, Stefan; Weigand, Markus A.] Heidelberg Univ, Dept Anesthesiol, Heidelberg, Germany; [Ameln, Anne Klotzsche-von; Chavakis, Triantafyllos] Tech Univ Dresden, Dept Clin Pathobiochem, D-01062 Dresden, Germany; [Ameln, Anne Klotzsche-von; Chavakis, Triantafyllos] Tech Univ Dresden, Inst Clin Chem & Lab Med, D-01062 Dresden, Germany; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Technische Universitat Dresden; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Technische Universitat Dresden; Harvard University; Harvard Medical School	Weber, GF (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02163 USA.	georg.weber@uniklinikum-dresden.de; fswirski@mgh.harvard.edu	Swirski, Filip/AAF-1340-2019; Uhle, Florian/Q-6191-2019; Schoelch, Sebastian/W-4314-2019; Chavakis, Triantafyllos/ABE-8845-2020; Weitz, Juergen/L-7136-2018	Schoelch, Sebastian/0000-0003-0012-3177; Swirski, Filip/0000-0002-3163-9152; /0000-0003-0828-4143; Chousterman, Benjamin Glenn/0000-0002-9592-7014; Nairz, Manfred/0000-0001-9103-7041; Robbins, Clinton/0000-0001-9848-1495	NIH [5R01HL095612, R56-AI104695]; Massachusetts General Hospital Howard M. Goodman Fellowship; German Research Foundation [WE4892/1-2, WE4892/3-1]; Societe Francaise d'Anesthesie-Reanimation (SFAR); Institut Servier; Fondation Groupe Pasteur Mutualite; Fulbright Scholarships (Monahan Foundation); Fulbright Scholarships (Harvard French Scholarship Fund); Erwin Schrodinger Fellowship of the Austrian Science Fund FWF [J3486-B13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI104695] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [J 3486] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Howard M. Goodman Fellowship; German Research Foundation(German Research Foundation (DFG)); Societe Francaise d'Anesthesie-Reanimation (SFAR); Institut Servier; Fondation Groupe Pasteur Mutualite; Fulbright Scholarships (Monahan Foundation); Fulbright Scholarships (Harvard French Scholarship Fund); Erwin Schrodinger Fellowship of the Austrian Science Fund FWF(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank M. Greene for secretarial assistance, M. Waring and A. Chicoine for sorting cells, and K. Joyes for editing the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The General Hospital Corporation has filed a patent application (61/973,458) with the U.S. Patent and Trademark Office entitled "Agents and Methods for Diagnosing and Treating Sepsis," which names F.K.S. and G.F.W. as inventors. Il3<SUP>-/-</SUP> mice are available from Riken, Japan, under a materials transfer agreement. This work was supported by NIH grants 5R01HL095612 and R56-AI104695 and the Massachusetts General Hospital Howard M. Goodman Fellowship (F.K.S.). G.F.W. was supported by the German Research Foundation (WE4892/1-2 and 3-1). B.G.C. was supported by the Societe Francaise d'Anesthesie-Reanimation (SFAR), Institut Servier, Fondation Groupe Pasteur Mutualite, and Fulbright Scholarships (Monahan Foundation and Harvard French Scholarship Fund). M.N. was supported by an Erwin Schrodinger Fellowship of the Austrian Science Fund FWF (J3486-B13). The authors declare no conflicts of interest.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004; Brenner T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0683-x; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Coopersmith CM, 2012, CRIT CARE MED, V40, P1072, DOI 10.1097/CCM.0b013e31823c8d03; DALLOUL AH, 1991, BLOOD, V77, P69; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Dolgin E, 2012, NAT MED, V18, P1000, DOI 10.1038/nm0712-1000; GROOPMAN JE, 1989, NEW ENGL J MED, V321, P1449, DOI 10.1056/NEJM198911233212106; Ha SA, 2006, J EXP MED, V203, P2541, DOI 10.1084/jem.20061041; HAPEL AJ, 1981, CELL, V25, P179, DOI 10.1016/0092-8674(81)90242-7; Hilgendorf I, 2014, CIRCULATION, V129, P1677, DOI 10.1161/CIRCULATIONAHA.113.006381; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; IHLE JN, 1981, J IMMUNOL, V126, P2184; Jamur Maria Celia, 2011, Front Biosci (Schol Ed), V3, P1390; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Ronnberg E, 2014, IMMUNOLOGY, V143, P155, DOI 10.1111/imm.12297; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Voehringer D, 2012, EUR J IMMUNOL, V42, P2544, DOI 10.1002/eji.201142318; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Ward PA, 2011, JAMA-J AM MED ASSOC, V306, P2618, DOI 10.1001/jama.2011.1831; Weber GF, 2014, J EXP MED, V211, P1243, DOI 10.1084/jem.20131471; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0	32	186	199	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1260	1265		10.1126/science.aaa4268	http://dx.doi.org/10.1126/science.aaa4268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766237	Green Accepted			2022-12-24	WOS:000350824300041
J	MacCoun, RJ; Mello, MM				MacCoun, Robert J.; Mello, Michelle M.			Half-Baked - The Retail Promotion of Marijuana Edibles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[MacCoun, Robert J.; Mello, Michelle M.] Stanford Law Sch, Stanford, CA 94305 USA; [MacCoun, Robert J.] Freeman Spogli Inst, Stanford, CA USA; [Mello, Michelle M.] Stanford Univ Sch Med, Stanford, CA USA	Stanford University; Stanford University	MacCoun, RJ (corresponding author), Stanford Law Sch, Stanford, CA 94305 USA.		MacCoun, Robert/N-1765-2019	MacCoun, Robert/0000-0003-0929-4423; Mello, Michelle/0000-0003-2877-4270				Appelboam A, 2006, EUR J EMERG MED, V13, P177, DOI 10.1097/01.mej.0000194405.38206.f2; Grotenhermen F, 2003, CLIN PHARMACOKINET, V42, P327, DOI 10.2165/00003088-200342040-00003; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; Richter KP, 2014, NEW ENGL J MED, V371, P399, DOI 10.1056/NEJMp1406074; Wang GS, 2013, JAMA PEDIATR, V167, P630, DOI 10.1001/jamapediatrics.2013.140	5	83	83	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					989	991		10.1056/NEJMp1416014	http://dx.doi.org/10.1056/NEJMp1416014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD0XK	25760351				2022-12-24	WOS:000350797300001
J	Ganda, OP				Ganda, Om P.			Deciphering Cholesterol Treatment Guidelines A Clinician's Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Med Sch, Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Ganda, OP (corresponding author), Harvard Univ, Med Sch, Joslin Diabet Ctr, 1 Joslin Pl,Ste 242, Boston, MA 02215 USA.	om.ganda@joslin.harvard.edu			NIDDK NIH HHS [DK036836, P30 DK036836] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2015, DIABETES CARE, V38, pS49, DOI 10.2337/dc15-S011; Ginsberg HN, 2014, CIRC RES, V114, P761, DOI 10.1161/CIRCRESAHA.114.303398; Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007; National Institute for Health and Care Excellence, 2014, LIPID MODIFICATION C; Nissen SE, 2014, JAMA INTERN MED, V174, P1972, DOI 10.1001/jamainternmed.2014.3278; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	6	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1009	1010		10.1001/jama.2015.216	http://dx.doi.org/10.1001/jama.2015.216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756432	Green Accepted			2022-12-24	WOS:000350643100011
J	Mesa, KR; Rompolas, P; Zito, G; Myung, P; Sun, TY; Brown, S; Gonzalez, DG; Blagoev, KB; Haberman, AM; Greco, V				Mesa, Kailin R.; Rompolas, Panteleimon; Zito, Giovanni; Myung, Peggy; Sun, Thomas Y.; Brown, Samara; Gonzalez, David G.; Blagoev, Krastan B.; Haberman, Ann M.; Greco, Valentina			Niche-induced cell death and epithelial phagocytosis regulate hair follicle stem cell pool	NATURE			English	Article							DERMAL PAPILLA; REGRESSION; CATENIN; ACTIVATION; APOPTOSIS; DYNAMICS; PROGENY; GROWTH	Tissue homeostasis is achieved through a balance of cell production (growth) and elimination (regression)(1,2). In contrast to tissue growth, the cells and molecular signals required for tissue regression remain unknown. To investigate physiological tissue regression, we use the mouse hair follicle, which cycles stereotypically between phases of growth and regression while maintaining a pool of stem cells to perpetuate tissue regeneration(3). Here we show by intravital microscopy in live mice(4-6) that the regression phase eliminates the majority of the epithelial cells by two distinct mechanisms: terminal differentiation of suprabasal cells and a spatial gradient of apoptosis of basal cells. Furthermore, we demonstrate that basal epithelial cells collectively act as phagocytes to clear dying epithelial neighbours. Through cellular and genetic ablation we show that epithelial cell death is extrinsically induced through transforming growth factor (TGF)-beta activation and mesenchymal crosstalk. Strikingly, our data show that regression acts to reduce the stem cell pool, as inhibition of regression results in excess basal epithelial cells with regenerative abilities. This study identifies the cellular behaviours and molecular mechanisms of regression that counterbalance growth to maintain tissue homeostasis.	[Mesa, Kailin R.; Rompolas, Panteleimon; Myung, Peggy; Sun, Thomas Y.; Brown, Samara; Greco, Valentina] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Zito, Giovanni] Univ Palermo, Dept Biopathol & Med Biotechnol, I-90100 Palermo, Italy; [Myung, Peggy; Greco, Valentina] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Gonzalez, David G.; Haberman, Ann M.] Yale Univ, Sch Med, Dept Immunobiol, Dept Lab Med, New Haven, CT 06510 USA; [Blagoev, Krastan B.] Natl Sci Fdn, Arlington, VA 22230 USA; [Blagoev, Krastan B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging,Dept Radiol, Boston, MA 02114 USA; [Greco, Valentina] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Greco, Valentina] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Yale University; University of Palermo; Yale University; Yale University; National Science Foundation (NSF); Harvard University; Harvard Medical School; Massachusetts General Hospital; Yale University; Yale University	Greco, V (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	valentina.greco@yale.edu	Zito, Giovanni/AAC-3639-2022; Zito, Giovanni/J-7238-2016; , Zito/O-3836-2019; Sun, Thomas/AAG-4824-2020	Zito, Giovanni/0000-0002-0482-6729; , Zito/0000-0002-0482-6729; Rompolas, Panteleimon/0000-0001-9135-7651; Sun, Thomas Yang/0000-0001-7436-0138; Mesa, Kailin/0000-0003-4452-9048	National Institutes of Health (NIH) [5T32 GM007223]; American Cancer Society [RSG-12-059-02]; National Cancer Institute, NIH [2P50CA121974]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH [1R01AR063663-01]; New York Stem Cell Foundation; NIAMS Rheumatic Diseases Research Core Centers [5 P30 AR053495-07]; NSF; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR066790, R01AR063663, P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York Stem Cell Foundation; NIAMS Rheumatic Diseases Research Core Centers; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Fuchs for the K14-H2BGFP, Lef1-RFP and K14-GFPActin mice; M. Taketo for the Cttnb1<SUP>fl(Ex3)/+</SUP> mice; A. Horwich and A. Mesa for critical feedback; M. Rendl for technical advice; M. Graham and X. Liu for technical support with electron microscopy; D. Egli for the H2BmCherry construct; and T. Nottoli for generating the K14-H2BmCherry mouse line. K.R.M. and S.B. were supported by the National Institutes of Health (NIH) Predoctoral Program in Cellular and Molecular Biology, grant no. 5T32 GM007223. K.R.M. is currently a National Science Foundation (NSF) Graduate Research Fellow. This work is supported by the American Cancer Society, grant no. RSG-12-059-02; Yale Spore Grant National Cancer Institute, NIH, grant no. 2P50CA121974; the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, grant no. 1R01AR063663-01; and by The New York Stem Cell Foundation. V.G. is a New York Stem Cell Foundation-Robertson Investigator. P.R. is a New York Stem Cell Foundation-Druckenmiller Fellow. A.M.H. is supported by NIAMS Rheumatic Diseases Research Core Centers grant no. 5 P30 AR053495-07. K.B.B. was supported by the NSF. The NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented here are not those of the NSF and represent solely the views of the authors.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clavel C, 2012, DEV CELL, V23, P981, DOI 10.1016/j.devcel.2012.10.013; Deschene ER, 2014, SCIENCE, V343, P1353, DOI 10.1126/science.1248373; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Lindner G, 1997, AM J PATHOL, V151, P1601; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Poon I. K., 2014, NATURE REV IMMUNOL; Rahmani W, 2014, DEV CELL, V31, P543, DOI 10.1016/j.devcel.2014.10.022; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; Rompolas P., 2013, NATURE; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Zito G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4543	28	82	85	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					94	U236		10.1038/nature14306	http://dx.doi.org/10.1038/nature14306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25849774	Green Submitted, Green Accepted			2022-12-24	WOS:000355543400036
J	Porazinski, S; Wang, HJ; Asaoka, Y; Behrndt, M; Miyamoto, T; Morita, H; Hata, S; Sasaki, T; Krens, SFG; Osada, Y; Asaka, S; Momoi, A; Linton, S; Miesfeld, JB; Link, BA; Senga, T; Castillo-Morales, A; Urrutia, AO; Shimizu, N; Nagase, H; Matsuura, S; Bagby, S; Kondoh, H; Nishina, H; Heisenberg, CP; Furutani-Seiki, M				Porazinski, Sean; Wang, Huijia; Asaoka, Yoichi; Behrndt, Martin; Miyamoto, Tatsuo; Morita, Hitoshi; Hata, Shoji; Sasaki, Takashi; Krens, S. F. Gabriel; Osada, Yumi; Asaka, Satoshi; Momoi, Akihiro; Linton, Sarah; Miesfeld, Joel B.; Link, Brian A.; Senga, Takeshi; Castillo-Morales, Atahualpa; Urrutia, Araxi O.; Shimizu, Nobuyoshi; Nagase, Hideaki; Matsuura, Shinya; Bagby, Stefan; Kondoh, Hisato; Nishina, Hiroshi; Heisenberg, Carl-Philipp; Furutani-Seiki, Makoto			YAP is essential for tissue tension to ensure vertebrate 3D body shape	NATURE			English	Article							EXTRACELLULAR-MATRIX; CELL-ADHESION; ZEBRAFISH; MEDAKA; ORGANIZATION; DYNAMICS; PATHWAY; YAP/TAZ; PROTEIN; FORCES	Vertebrates have a unique 3D body shape in which correct tissue and organ shape and alignment are essential for function. For example, vision requires the lens to be centred in the eye cup which must in turn be correctly positioned in the head(1). Tissue morphogenesis depends on force generation, force transmission through the tissue, and response of tissues and extracellular matrix to force(2,3). Although a century ago D'Arcy Thompson postulated that terrestrial animal body shapes are conditioned by gravity(4), there has been no animal model directly demonstrating how the aforementioned mechano-morphogenetic processes are coordinated to generate a body shape that withstands gravity. Here we report a unique medaka fish (Oryzias latipes) mutant, hirame (hir), which is sensitive to deformation by gravity. hir embryos display a markedly flattened body caused by mutation of YAP, a nuclear executor of Hippo signalling that regulates organ size. We show that actomyosin-mediated tissue tension is reduced in hir embryos, leading to tissue flattening and tissue misalignment, both of which contribute to body flattening. By analysing YAP function in 3D spheroids of human cells, we identify the Rho GTPase activating protein ARHGAP18 as an effector of YAP in controlling tissue tension. Together, these findings reveal a previously unrecognised function of YAP in regulating tissue shape and alignment required for proper 3D body shape. Understanding this morphogenetic function of YAP could facilitate the use of embryonic stem cells to generate complex organs requiring correct alignment of multiple tissues.	[Porazinski, Sean; Wang, Huijia; Linton, Sarah; Castillo-Morales, Atahualpa; Urrutia, Araxi O.; Bagby, Stefan; Furutani-Seiki, Makoto] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Asaoka, Yoichi; Hata, Shoji; Asaka, Satoshi; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan; [Behrndt, Martin; Morita, Hitoshi; Krens, S. F. Gabriel; Heisenberg, Carl-Philipp] IST Austria, A-3400 Klosterneuburg, Austria; [Miyamoto, Tatsuo; Matsuura, Shinya] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Genet & Cell Biol, Hiroshima 7348553, Japan; [Sasaki, Takashi; Shimizu, Nobuyoshi] Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; [Osada, Yumi; Momoi, Akihiro; Kondoh, Hisato; Furutani-Seiki, Makoto] Japan Sci & Technol Agcy JST, ERATO SORST Kondoh Differentiat Signaling Project, Kyoto 6068305, Japan; [Miesfeld, Joel B.; Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Senga, Takeshi] Nagoya Univ, Grad Sch Med, Div Canc Biol, Nagoya, Aichi 4668550, Japan; [Nagase, Hideaki] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Kondoh, Hisato] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Kondoh, Hisato] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6038555, Japan	University of Bath; Tokyo Medical & Dental University (TMDU); Institute of Science & Technology - Austria; Hiroshima University; Keio University; Japan Science & Technology Agency (JST); Medical College of Wisconsin; Nagoya University; University of Oxford; Osaka University; Kyoto Sangyo University	Heisenberg, CP (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	nishina.dbio@mri.tmd.ac.jp; heisenberg@ist.ac.at; furutaniseiki@gmail.com	Matsuura, Shinya/U-4182-2017; Miyamoto, Tatsuo/J-5187-2014; Sasaki, Takashi/AAD-1461-2019; Porazinski, Sean/M-6973-2015; Krens, Gabriel/U-6760-2017; Miyamoto, Tatsuo/ABG-8292-2021	Matsuura, Shinya/0000-0001-5294-081X; Miyamoto, Tatsuo/0000-0002-1097-0647; Porazinski, Sean/0000-0003-3804-1150; Krens, Gabriel/0000-0003-4761-5996; Miyamoto, Tatsuo/0000-0002-1097-0647; Urrutia, Araxi/0000-0001-9011-8675; Sasaki, Takashi/0000-0002-6275-046X; Heisenberg, Carl-Philipp/0000-0002-0912-4566; Castillo Morales, Atahualpa/0000-0001-9733-6923; Bagby, Stefan/0000-0003-2302-9511; Morita, Hitoshi/0000-0002-9073-2664	ERATO/SORST projects of JST, Japan; National Institutes of Health [R01EY014167]; Medical Research Council, UK; NATIONAL EYE INSTITUTE [R01EY016060, R01EY014167, T32EY014537, P30EY001931] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [I 930] Funding Source: researchfish; Medical Research Council [G117/563] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26114005, 25460358] Funding Source: KAKEN; MRC [G117/563] Funding Source: UKRI	ERATO/SORST projects of JST, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Raff, T. Perry, A. Ward, M. Wills, J. Caunt, J. Clarke, L. Hurst and C. Tickle for critical reading and comments. We thank M. Tada, M. Furuse, N. Wada, Y. Nakai, J. Robinson and R. Kelsh for contributions to the paper and University of Bath for fish and bioimaging facilities. This work was funded by the ERATO/SORST projects of JST, Japan (H.K.), National Institutes of Health R01EY014167 (B.A.L.) and Medical Research Council, UK (M.F.-S.).	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Chauhan BK, 2009, DEVELOPMENT, V136, P3657, DOI 10.1242/dev.042242; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Guevorkian K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218101; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hirose Y, 2004, DEVELOPMENT, V131, P2553, DOI 10.1242/dev.01140; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Iwanami N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000171; Iwasaki T, 2001, CELL STRUCT FUNCT, V26, P677, DOI 10.1247/csf.26.677; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; MCDONALD JA, 1987, J BIOL CHEM, V262, P2957; Miesfeld JB, 2014, MECH DEVELOP, V133, P177, DOI 10.1016/j.mod.2014.02.003; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pinto IM, 2012, DEV CELL, V22, P1247, DOI 10.1016/j.devcel.2012.04.015; Porazinski SR, 2011, METHODS MOL BIOL, V770, P211, DOI 10.1007/978-1-61779-210-6_8; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Thompson D.W, 1917, GROWTH FORM; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	38	159	166	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					217	+		10.1038/nature14215	http://dx.doi.org/10.1038/nature14215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25778702	Green Accepted			2022-12-24	WOS:000354377800058
J	Saunders, A; Oldenburg, IA; Berezovskii, VK; Johnson, CA; Kingery, ND; Elliott, HL; Xie, T; Gerfen, CR; Sabatini, BL				Saunders, Arpiar; Oldenburg, Ian A.; Berezovskii, Vladimir K.; Johnson, Caroline A.; Kingery, Nathan D.; Elliott, Hunter L.; Xie, Tiao; Gerfen, Charles R.; Sabatini, Bernardo L.			A direct GABAergic output from the basal ganglia to frontal cortex	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; GLOBUS-PALLIDUS; CHOLINERGIC NEURONS; INDIRECT PATHWAYS; CRE-RECOMBINASE; NUCLEUS BASALIS; DRIVER LINES; SCHIZOPHRENIA; FOREBRAIN; RAT	The basal ganglia are phylogenetically conserved subcortical nuclei necessary for coordinated motor action and reward learning(1). Current models postulate that the basal ganglia modulate cerebral cortex indirectly via an inhibitory output to thalamus, bidirectionally controlled by direct-and indirect-pathway striatal projection neurons (dSPNs and iSPNs, respectively)(2-4). The basal ganglia thalamic output sculpts cortical activity by interacting with signals from sensory and motor systems(5). Here we describe a direct projection from the globus pallidus externus (GP), a central nucleus of the basal ganglia, to frontal regions of the cerebral cortex (FC). Two cell types make up the GP-FC projection, distinguished by their electrophysiological properties, cortical projections and expression of choline acetyltransferase (ChAT), a synthetic enzyme for the neurotransmitter acetylcholine (ACh). Despite these differences, ChAT(+) cells, which have been historically identified as an extension of the nucleus basalis, as well asChAT(-) cells, release the inhibitory neurotransmitter GABA (c-aminobutyric acid) and are inhibited by iSPNs and dSPNs of dorsal striatum. Thus, GP-FC cells comprise a direct GABAergic/cholinergic projection under the control of striatum that activates frontal cortex in vivo. Furthermore, iSPN inhibition of GP-FC cells is sensitive to dopamine 2 receptor signalling, revealing a pathway by which drugs that target dopamine receptors for the treatment of neuropsychiatric disorders can act in the basal ganglia to modulate frontal cortices.	[Saunders, Arpiar; Oldenburg, Ian A.; Berezovskii, Vladimir K.; Johnson, Caroline A.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Kingery, Nathan D.] Harvard Univ, Sch Med, Dept Neurobiol, Neurobiol Imaging Facil, Boston, MA 02115 USA; [Elliott, Hunter L.; Xie, Tiao] Harvard Univ, Sch Med, Image & Data Anal Core, Boston, MA 02115 USA; [Gerfen, Charles R.] NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu	Berezovskii, Vladimir/B-9866-2013; soler, martha maricel m gomez/L-6025-2014; Berezovskii, Vladimir/AAB-5253-2022	Berezovskii, Vladimir/0000-0003-4077-3940; soler, martha maricel m gomez/0000-0002-4412-8108; Johnson, Caroline/0000-0001-5770-6176	National Institutes of Health [F31 NS074842, F31-MH093026-01A1, P30 EY12196]; NINDS P30 Core Center grant [NS072030]; NIH [R01 NS046579]; NATIONAL EYE INSTITUTE [P30EY012196, P30EY002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH093026, ZIAMH002497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072030, R01NS046579, F31NS074842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS P30 Core Center grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Lowell laboratory at Beth Israel Deaconess Medical Center for the gift of the DIO-synaptophysin-mCherry and DIO-synaptophysin-GFP rAAVs, R. Pemberton for technical support and F. Krienen, N. Duggan, P. Kaeser and members of the Sabatini laboratory for helpful discussions. This work was supported by grants from the National Institutes of Health (F31 NS074842) to A.S., (F31-MH093026-01A1) to I.A.O., (P30 EY12196) to the Vision Core and NINDS P30 Core Center grant (#NS072030) to the Neural Imaging Center and Neurobiology Imaging Center in the Department of Neurobiology at Harvard Medical School and a NIH grant (R01 NS046579) to B.L.S.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Beurrier C, 2006, NEUROSCIENCE, V140, P77, DOI 10.1016/j.neuroscience.2006.02.029; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; Blum BP, 2002, INT J NEUROPSYCHOPH, V5, P159, DOI 10.1017/S1461145702002894; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CHANG HT, 1987, BRAIN RES, V426, P197, DOI 10.1016/0006-8993(87)90443-4; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Eberly D., 1994, Journal of Mathematical Imaging and Vision, V4, P353, DOI 10.1007/BF01262402; Freeze BS, 2013, J NEUROSCI, V33, P18531, DOI 10.1523/JNEUROSCI.1278-13.2013; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Goldberg JH, 2013, TRENDS NEUROSCI, V36, P695, DOI 10.1016/j.tins.2013.09.001; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GROVE EA, 1986, BRAIN RES, V367, P379, DOI 10.1016/0006-8993(86)91623-9; Henderson Z, 1997, NEUROSCIENCE, V78, P943, DOI 10.1016/S0306-4522(96)00636-7; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Kita H, 2007, PROG BRAIN RES, V160, P111, DOI 10.1016/S0079-6123(06)60007-1; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; LAPLANE D, 1989, BRAIN, V112, P699, DOI 10.1093/brain/112.3.699; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Madisen L., 2012, NAT NEUROSCI, V15, P1; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Marx M, 2012, NAT PROTOC, V7, P394, DOI 10.1038/nprot.2011.449; MCKINNEY M, 1983, J COMP NEUROL, V217, P103, DOI 10.1002/cne.902170109; MESULAM MM, 1984, NEUROSCIENCE, V12, P669, DOI 10.1016/0306-4522(84)90163-5; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sarter M, 2002, EUR J NEUROSCI, V15, P1867, DOI 10.1046/j.1460-9568.2002.02004.x; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Scarr E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00055; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Smith Y, 1998, NEUROSCIENCE, V86, P353; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Tohen M, 2009, BIPOLAR DISORD, V11, P45, DOI 10.1111/j.1399-5618.2009.00710.x; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	44	169	171	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					85	U193		10.1038/nature14179	http://dx.doi.org/10.1038/nature14179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25739505	Green Accepted, Green Submitted			2022-12-24	WOS:000354040900038
J	Goldman, DH; Kaiser, CM; Milin, A; Righini, M; Tinoco, I; Bustamante, C				Goldman, Daniel H.; Kaiser, Christian M.; Milin, Anthony; Righini, Maurizio; Tinoco, Ignacio, Jr.; Bustamante, Carlos			Mechanical force releases nascent chain-mediated ribosome arrest in vitro and in vivo	SCIENCE			English	Article							EXIT TUNNEL; EF-P; TRANSLATION; TRANSLOCATION; PEPTIDES	Protein synthesis rates can affect gene expression and the folding and activity of the translation product. Interactions between the nascent polypeptide and the ribosome exit tunnel represent one mode of regulating synthesis rates. The SecM protein arrests its own translation, and release of arrest at the translocon has been proposed to occur by mechanical force. Using optical tweezers, we demonstrate that arrest of SecM-stalled ribosomes can indeed be rescued by force alone and that the force needed to release stalling can be generated in vivo by a nascent chain folding near the ribosome tunnel exit. We formulate a kinetic model describing how a protein can regulate its own synthesis by the force generated during folding, tuning ribosome activity to structure acquisition by a nascent polypeptide.	[Goldman, Daniel H.; Milin, Anthony; Tinoco, Ignacio, Jr.; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kaiser, Christian M.; Righini, Maurizio; Bustamante, Carlos] Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Kaiser, Christian M.; Milin, Anthony] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Kavli Energy Nanosci Inst Berkeley, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Johns Hopkins University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	kaiser@jhu.edu; carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; Milin, Anthony/0000-0002-1923-7441; Righini, Maurizio/0000-0002-8454-8887	NSF's Graduate Research Fellowship; NIH [5K99GM086516, 5R01GM32543, GM10840]; QB3 Institute, Berkeley (Distinguished Postdoctoral Fellowship); Damon Runyon Cancer Research Foundation [DRG-2096-11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840, R01GM032543, R37GM010840, K99GM086516] Funding Source: NIH RePORTER	NSF's Graduate Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3 Institute, Berkeley (Distinguished Postdoctoral Fellowship); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Chistol and L. Alexander for guidance regarding data analysis and the kinetic model, and members of the Bustamante and Tinoco laboratories for helpful discussions on the manuscript. D.H.G acknowledges the NSF's Graduate Research Fellowship; C.M.K acknowledges support from the NIH K99 Award 5K99GM086516 and the QB3 Institute, Berkeley (Distinguished Postdoctoral Fellowship); M.R. acknowledges support from the Damon Runyon Cancer Research Foundation (DRG-2096-11). C.B. acknowledges support from NIH grant 5R01GM32543; I.T. acknowledges support from NIH grant GM10840.	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Deutsch, 2014, REGULATORY NASCENT P, P61; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Gumbart J, 2012, BIOPHYS J, V103, P331, DOI 10.1016/j.bpj.2012.06.005; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakamori K, 2014, FEBS LETT, V588, P3098, DOI 10.1016/j.febslet.2014.06.038; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nathans P., 1964, NATL ACAD SCI US, V51, P585; Nissley DA, 2014, J AM CHEM SOC, V136, P17892, DOI 10.1021/ja510082j; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Tsai A, 2014, CELL REP, V7, P1521, DOI 10.1016/j.celrep.2014.04.033; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yap MN, 2011, MOL MICROBIOL, V81, P540, DOI 10.1111/j.1365-2958.2011.07713.x	27	139	139	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					457	460		10.1126/science.1261909	http://dx.doi.org/10.1126/science.1261909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908824	Green Accepted			2022-12-24	WOS:000353338000040
J	Kim, D; Fiske, BP; Birsoy, K; Freinkman, E; Kami, K; Possemato, RL; Chudnovsky, Y; Pacold, ME; Chen, WW; Cantor, JR; Shelton, LM; Gui, DY; Kwon, M; Ramkissoon, SH; Ligon, KL; Kang, SW; Snuderl, M; Vander Heiden, MG; Sabatini, DM				Kim, Dohoon; Fiske, Brian P.; Birsoy, Kivanc; Freinkman, Elizaveta; Kami, Kenjiro; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Shelton, Laura M.; Gui, Dan Y.; Kwon, Manjae; Ramkissoon, Shakti H.; Ligon, Keith L.; Kang, Seong Woo; Snuderl, Matija; Vander Heiden, Matthew G.; Sabatini, David M.			SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance	NATURE			English	Article							PYRUVATE-KINASE M2; TUMOR HYPOXIA; STEM-CELLS; CANCER; METABOLISM; SERINE; METHYLGLYOXAL; AMINOACETONE; CATABOLISM; THREONINE	Cancer cells adapt their metabolic processes to support rapid proliferation, but less is known about how cancer cells alter metabolism to promote cell survival in a poorly vascularized tumour microenvironment(1-3). Here we identify a key role for serine and glycine metabolism in the survival of brain cancer cells within the ischaemic zones of gliomas. Inhuman glioblastoma multiforme, mitochondrial serine hydroxymethyltransferase (SHMT2) and glycine decarboxylase (GLDC) are highly expressed in the pseudopalisading cells that surround necrotic foci. We find that SHMT2 activity limits that of pyruvate kinase (PKM2) and reduces oxygen consumption, eliciting a metabolic state that confers a profound survival advantage to cells in poorly vascularized tumour regions. GLDC inhibition impairs cells with high SHMT2 levels as the excess glycine not metabolized by GLDC can be converted to the toxic molecules aminoacetone and methylglyoxal. Thus, SHMT2 is required for cancer cells to adapt to the tumour environment, but also renders these cells sensitive to glycine cleavage system inhibition.	[Kim, Dohoon; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Kwon, Manjae; Kang, Seong Woo; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kim, Dohoon; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Kang, Seong Woo; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Kim, Dohoon; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Kwon, Manjae; Kang, Seong Woo; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Kim, Dohoon; Fiske, Brian P.; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Gui, Dan Y.; Kang, Seong Woo; Vander Heiden, Matthew G.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kim, Dohoon; Fiske, Brian P.; Birsoy, Kivanc; Freinkman, Elizaveta; Possemato, Richard L.; Chudnovsky, Yakov; Pacold, Michael E.; Chen, Walter W.; Cantor, Jason R.; Gui, Dan Y.; Kang, Seong Woo; Vander Heiden, Matthew G.; Sabatini, David M.] Broad Inst Harvard & MIT, Seven Cambridge Ctr, Cambridge, MA 02142 USA; [Kami, Kenjiro] Human Metabolome Technol Inc, Tsuruoka, Yamagata 9970052, Japan; [Pacold, Michael E.; Ramkissoon, Shakti H.; Ligon, Keith L.; Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Shelton, Laura M.] Human Metabolome Technol Ameri Inc, Boston, MA 02134 USA; [Ramkissoon, Shakti H.; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti H.; Ligon, Keith L.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Snuderl, Matija] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Snuderl, Matija] NYU, Sch Med, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; New York University; NYU Langone Medical Center; New York University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		Chen, Walter/0000-0002-7752-9581; Fiske, Brian/0000-0001-5891-4268; Snuderl, Matija/0000-0003-0752-0917; /0000-0002-1446-7256; Possemato, Richard/0000-0002-2401-0030	Basic Research Fellowship from the American Brain Tumor Association; MIT School of Science Fellowship in Cancer Research; National Institutes of Health (NIH) [T32GM007287, K99 CA168940, K08-NS087118, R01CA168653, 5P30CA14051]; Jane Coffin Childs Memorial Fund; Leukemia and Lymphoma Society; American Cancer Society; American Brain Tumor Association Discovery Grant; US National Institute of Aging; Smith Family Foundation; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; Stern family; DOD CDMRP Discovery Award; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust Fund; NIH [CA103866, CA129105, AI07389]; NATIONAL CANCER INSTITUTE [R01CA168653, P30CA014051, R01CA103866, K99CA168940, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS087118] Funding Source: NIH RePORTER	Basic Research Fellowship from the American Brain Tumor Association; MIT School of Science Fellowship in Cancer Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); American Brain Tumor Association Discovery Grant; US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Smith Family Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; Stern family; DOD CDMRP Discovery Award; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Sabatini laboratory for assistance and feedback, in particular Y. Shaul, T. Wang, S. Wang and O. Yilmaz. Authors would like to thank J. Taylor for GBM sample collection, and T. DiCesare for illustrations. This work was supported by a Basic Research Fellowship from the American Brain Tumor Association to D.K.; MIT School of Science Fellowship in Cancer Research and National Institutes of Health (NIH) T32GM007287 to B.P.F., fellowships from the Jane Coffin Childs Memorial Fund and Leukemia and Lymphoma Society to K.B.; a grant from the NIH (K99 CA168940) to R.P.; an American Cancer Society fellowship and an American Brain Tumor Association Discovery Grant to Y.C.; a fellowship from the US National Institute of Aging to W.W.C.; NIH (K08-NS087118) to S.H.R.; support from NIH (R01CA168653, 5P30CA14051), the Smith Family Foundation, the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, and the Stern family to M.G.V.H.; DOD CDMRP Discovery Award, grants from the David H. Koch Institute for Integrative Cancer Research at MIT, The Alexander and Margaret Stewart Trust Fund, and NIH (CA103866, CA129105, and AI07389) to D.M.S.; D.M.S. is an investigator of the Howard Hughes Medical Institute.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Brat DJ, 2004, LAB INVEST, V84, P397, DOI 10.1038/labinvest.3700070; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; DALE RA, 1978, BIOCHIM BIOPHYS ACTA, V544, P496, DOI 10.1016/0304-4165(78)90324-0; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; JOIS M, 1989, J BIOL CHEM, V264, P3347; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kazachkov M, 2005, J CHROMATOGR B, V824, P116, DOI 10.1016/j.jchromb.2005.07.006; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Narkewicz MR, 1996, BIOCHEM J, V313, P991, DOI 10.1042/bj3130991; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ptolemy AS, 2011, CLIN CHEM, V57, P545, DOI 10.1373/clinchem.2010.144899; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rotem R, 2005, CANCER RES, V65, P1984, DOI 10.1158/0008-5472.CAN-04-3091; Sartori A, 2008, CHEM RES TOXICOL, V21, P1841, DOI 10.1021/tx8001753; Saudubray JM, INBORN METABOLIC DIS, V7th; Shikano N, 2010, NUCL MED BIOL, V37, P189, DOI 10.1016/j.nucmedbio.2009.10.003; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; TRESSEL T, 1986, J BIOL CHEM, V261, P6428; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	39	228	238	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					363	+		10.1038/nature14363	http://dx.doi.org/10.1038/nature14363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855294	Green Submitted, Green Accepted			2022-12-24	WOS:000352974200042
J	Rupnik, M				Rupnik, Maja			Toward a True Bacteriotherapy for Clostridium difficile Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICROBIOTA		[Rupnik, Maja] Univ Maribor, Natl Lab Hlth Environm & Food, SLO-2000 Maribor, Slovenia; [Rupnik, Maja] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; [Rupnik, Maja] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Maribor; University of Maribor	Rupnik, M (corresponding author), Univ Maribor, Natl Lab Hlth Environm & Food, SLO-2000 Maribor, Slovenia.							Adamu BO, 2013, CURR OPIN MICROBIOL, V16, P596, DOI 10.1016/j.mib.2013.06.009; Brandt LJ, 2013, GASTROINTEST ENDOSC, V78, P240, DOI 10.1016/j.gie.2013.03.1329; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828	4	15	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1566	1568		10.1056/NEJMcibr1500270	http://dx.doi.org/10.1056/NEJMcibr1500270			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9BL	25875262				2022-12-24	WOS:000352856500014
J	Rusbridger, A				Rusbridger, Alan			Scientists must speak up on fossil-fuel divestment	NATURE			English	Editorial Material												alan.rusbridger@theguardian.com							0	1	1	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					265	265		10.1038/520265a	http://dx.doi.org/10.1038/520265a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG0RI	25877168	Bronze			2022-12-24	WOS:000352974200005
J	Wagenblast, E; Soto, M; Gutierrez-Angel, S; Hartl, CA; Gable, AL; Maceli, AR; Erard, N; Williams, AM; Kim, SY; Dickopf, S; Harrell, JC; Smith, AD; Perou, CM; Wilkinson, JE; Hannon, GJ; Knott, SRV				Wagenblast, Elvin; Soto, Mar; Gutierrez-Angel, Sara; Hartl, Christina A.; Gable, Annika L.; Maceli, Ashley R.; Erard, Nicolas; Williams, Alissa M.; Kim, Sun Y.; Dickopf, Steffen; Harrell, J. Chuck; Smith, Andrew D.; Perou, Charles M.; Wilkinson, John E.; Hannon, Gregory J.; Knott, Simon R. V.			A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis	NATURE			English	Article							VASCULOGENIC MIMICRY; GENOMIC ANALYSIS; TUMOR; MAMMARY; CELLS; EXPRESSION; MELANOMA; SURVIVAL; ORIGINS; BRAIN	Cancer metastasis requires that primary tumour cells evolve the capacity to intravasate into the lymphatic system or vasculature, and extravasate into and colonize secondary sites(1). Others have demonstrated that individual cells within complex populations show heterogeneity in their capacity to form secondary lesions(2-5). Here we develop a polyclonal mouse model of breast tumour heterogeneity, and show that distinct clones within a mixed population display specialization, for example, dominating the primary tumour, contributing to metastatic populations, or showing tropism for entering the lymphatic or vasculature systems. We correlate these stable properties to distinct gene expression profiles. Those clones that efficiently enter the vasculature express two secreted proteins, Serpine2 and Slpi, which were necessary and sufficient to program these cells for vascular mimicry. Our data indicate that these proteins not only drive the formation of extravascular networks but also ensure their perfusion by acting as anticoagulants. We propose that vascular mimicry drives the ability of some breast tumour cells to contribute to distant metastases while simultaneously satisfying a critical need of the primary tumour to be fed by the vasculature. Enforced expression of SERPINE2 and SLPI in human breast cancer cell lines also programmed them for vascular mimicry, and SERPINE2 and SLPI were overexpressed preferentially in human patients that had lung-metastatic relapse. Thus, these two secreted proteins, and the phenotype they promote, may be broadly relevant as drivers of metastatic progression in human cancer.	[Wagenblast, Elvin; Soto, Mar; Gutierrez-Angel, Sara; Hartl, Christina A.; Gable, Annika L.; Maceli, Ashley R.; Erard, Nicolas; Williams, Alissa M.; Kim, Sun Y.; Dickopf, Steffen; Hannon, Gregory J.; Knott, Simon R. V.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Erard, Nicolas; Hannon, Gregory J.; Knott, Simon R. V.] Univ Cambridge, Li Ka Shing Ctr, CRUK Cambridge Inst, Cambridge CB2 0RE, England; [Harrell, J. Chuck; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet & Pathol, Chapel Hill, NC 27599 USA; [Smith, Andrew D.] Univ So Calif, Mol & Computat Biol, Los Angeles, CA 90089 USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; CRUK Cambridge Institute; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; University of Michigan System; University of Michigan	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Perou, Charles M/H-9934-2014; Smith, Andrew D./G-4104-2013; Hannon, Gregory/AAB-3568-2019	Perou, Charles M/0000-0001-9827-2247; Smith, Andrew D./0000-0002-3337-1970; Harrell, J. Chuck/0000-0003-3541-8418; Wagenblast, Elvin/0000-0002-0709-2759; Gable, Annika Lisa/0000-0002-8965-0848; Kim, Sun/0000-0001-8133-865X	Howard Hughes Medical Institute; NIH; Cancer Center [5P30CA045508]; Boehringer Ingelheim Fonds; NCI Breast SPORE program [P50-CA58223-09A1]; Breast Cancer Research Foundation; Triple Negative Breast Cancer Foundation; Hope Funds For Cancer Research; Cancer Research UK [21143] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA045508, P50CA058223, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534, R37GM062534] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; Boehringer Ingelheim Fonds(Boehringer Ingelheim); NCI Breast SPORE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Triple Negative Breast Cancer Foundation; Hope Funds For Cancer Research; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute as well as grants from the NIH (G.J.H.). This work was performed with assistance from CSHL Shared Resources, which are funded, in part, by the Cancer Center Support Grant 5P30CA045508. We thank M. Mosquera, M. Cahn, J. Coblentz, L. Bianco for support with mouse work; J. Ratcliff and P. Moody for assistance with flow cytometry; D. Hoppe, A. Nourjanova, R. Puzis for histology support and S. Hearn for microscopy assistance. We thank E. Hodges and E. Lee for support with next-generation sequencing; K. Chang for the lentiviral barcode library; E. Mardis and C. Sawyers for comments on the manuscript. E.W. is a Starr Centennial Scholar and is supported by a fellowship from the Boehringer Ingelheim Fonds. J.C.H. and C. M. P. were supported by funds from the NCI Breast SPORE program (P50-CA58223-09A1), the Breast Cancer Research Foundation and the Triple Negative Breast Cancer Foundation. S.R.V.K. is supported by a fellowship from The Hope Funds For Cancer Research.	Amiano NO, 2013, J CELL PHYSIOL, V228, P469, DOI 10.1002/jcp.24153; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Cao ZF, 2013, EUR J CANCER, V49, P3914, DOI 10.1016/j.ejca.2013.07.148; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; FIDLER IJ, 1978, CANCER RES, V38, P2651; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; MILLER BE, 1988, CANCER RES, V48, P5747; MILLER FR, 1983, INVAS METAST, V3, P22; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Rosso M, 2014, BIOL CELL, V106, P308, DOI 10.1111/boc.201300075; Ruf W, 2003, CANCER RES, V63, P5381; Sayers KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104223; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007	26	246	263	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					358	+		10.1038/nature14403	http://dx.doi.org/10.1038/nature14403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25855289	Green Accepted, Green Submitted			2022-12-24	WOS:000352974200041
J	Branch, WT				Branch, William T., Jr.			The Ethics of Patient Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOCTOR		Emory Univ, Sch Med, Dept Med, Div Gen Internal Med & Geriatr, Atlanta, GA 30303 USA	Emory University	Branch, WT (corresponding author), Emory Univ, Sch Med, Dept Med, Div Gen Internal Med & Geriatr, Atlanta, GA 30303 USA.	wbranch@emory.edu						[Anonymous], PHILOS MED REBORN PE; [Anonymous], 1983, DIFFERENT VOICE PSYC; [Anonymous], WHAT MATTERS; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Beauchamp T.L., 2012, PRINCIPLES BIOMEDICA, V7th; Branch WT, 2014, HASTINGS CENT REP, V44, P15, DOI 10.1002/hast.250; Branch WT, 2014, MED EDUC, V48, P67, DOI 10.1111/medu.12369; Branch WT, 2000, ACAD MED, V75, P127, DOI 10.1097/00001888-200002000-00006; Noddings N., 1984, CARING FEMININE APPR	9	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1421	1422		10.1001/jama.2015.1080	http://dx.doi.org/10.1001/jama.2015.1080			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25871666				2022-12-24	WOS:000352821200014
J	Metzger, MJ; Reinisch, C; Sherry, J; Goff, SP				Metzger, Michael J.; Reinisch, Carol; Sherry, James; Goff, Stephen P.			Horizontal Transmission of Clonal Cancer Cells Causes Leukemia in Soft-Shell Clams	CELL			English	Article							FACIAL-TUMOR DISEASE; MOLLUSK MYA-ARENARIA; HEMIC NEOPLASIA; HEMATOPOIETIC NEOPLASIA; SOFTSHELL CLAMS; FLOW-CYTOMETRY; POPULATIONS; INDUCTION; PREVALENCE; ACTIVATION	Outbreaks of fatal leukemia-like cancers of marine bivalves throughout the world have led to massive population loss. The cause of the disease is unknown. We recently identified a retrotransposon, Steamer, that is highly expressed and amplified to high copy number in neoplastic cells of soft-shell clams (Mya arenaria). Through analysis of Steamer integration sites, mitochondrial DNA single-nucleotide polymorphisms (SNPs), and polymorphic microsatellite alleles, we show that the genotypes of neoplastic cells do not match those of the host animal. Instead, neoplastic cells from dispersed locations in New York, Maine, and Prince Edward Island (PEI), Canada, all have nearly identical genotypes that differ from those of the host. These results indicate that the cancer is spreading between animals in the marine environment as a clonal transmissible cell derived from a single original clam. Our findings suggest that horizontal transmission of cancer cells is more widespread in nature than previously supposed.	[Metzger, Michael J.; Goff, Stephen P.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Reinisch, Carol; Sherry, James] Environm Canada, Water Sci & Technol Directorate, Burlington, ON L7R 4A6, Canada	Columbia University; Howard Hughes Medical Institute; Environment & Climate Change Canada	Goff, SP (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	spg1@columbia.edu	Goff, Stephen P/K-6337-2014; Metzger, Michael/AAA-3635-2022	Goff, Stephen P/0000-0003-0693-5547; Metzger, Michael/0000-0001-7855-1388	Howard Hughes Medical Institute; National Institutes of Health (NIH) [T32 CA009503]; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Gloria Arriagada for work on the Steamer element, Brian Beal (University of Maine at Machias) for M. arenaria samples from Maine, Annette Murray for help in collection and diagnosis of M. arenaria from PEI, and Charles Walker and Sarah Mercier (University of New Hampshire) for help in acquisition of leukemic sample ME-HL01. We also thank Anne Gifford for putting the laboratories in contact to initiate the studies. This work was supported by the Howard Hughes Medical Institute and by the National Institutes of Health (NIH) Training Grant T32 CA009503 (to M.J.M.).	AboElkhair M, 2012, J INVERTEBR PATHOL, V109, P97, DOI 10.1016/j.jip.2011.10.008; Arriagada G, 2014, P NATL ACAD SCI USA, V111, P14175, DOI 10.1073/pnas.1409945111; Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; Beal BF, 2002, AQUACULTURE, V208, P81, DOI 10.1016/S0044-8486(01)00900-0; Brown R.S, 1977, Annals NY Acad Sci, V298, P522, DOI 10.1111/j.1749-6632.1977.tb19287.x; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; COOPER KR, 1982, J INVERTEBR PATHOL, V39, P149, DOI 10.1016/0022-2011(82)90004-0; da Silva PM, 2005, DIS AQUAT ORGAN, V67, P133, DOI 10.3354/dao067133; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Delaporte M, 2008, J INVERTEBR PATHOL, V98, P190, DOI 10.1016/j.jip.2007.12.005; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KATZIR N, 1985, P NATL ACAD SCI USA, V82, P1054, DOI 10.1073/pnas.82.4.1054; Kopelman NM, 2015, MOL ECOL RESOUR; Krapal AM, 2012, INT J MOL SCI, V13, P2515, DOI 10.3390/ijms13022515; MCLAUGHLIN S M, 1992, In Vivo (Attiki), V6, P367; MIOSKY DL, 1989, J INVERTEBR PATHOL, V53, P32, DOI 10.1016/0022-2011(89)90071-2; MOORE JD, 1991, J INVERTEBR PATHOL, V58, P231, DOI 10.1016/0022-2011(91)90067-Z; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Murchison EP, 2014, SCIENCE, V343, P437, DOI 10.1126/science.1247167; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Muttray A, 2012, SCI TOTAL ENVIRON, V424, P130, DOI 10.1016/j.scitotenv.2012.02.029; OPRANDY JJ, 1981, J INVERTEBR PATHOL, V38, P45, DOI 10.1016/0022-2011(81)90033-1; OPRANDY JJ, 1983, J INVERTEBR PATHOL, V42, P196, DOI 10.1016/0022-2011(83)90062-9; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pritchard JK, 2000, GENETICS, V155, P945; RENO PW, 1994, J INVERTEBR PATHOL, V64, P163, DOI 10.1016/S0022-2011(94)90025-6; Rodzen JA, 2002, GENOME, V45, P1064, DOI [10.1139/g02-083, 10.1139/G02-083]; Siah A, 2011, DEV COMP IMMUNOL, V35, P151, DOI 10.1016/j.dci.2010.09.012; Siddle HV, 2015, IMMUNOLOGY, V144, P11, DOI 10.1111/imm.12377; Siddle HV, 2013, P NATL ACAD SCI USA, V110, P5103, DOI 10.1073/pnas.1219920110; SMOLOWITZ RM, 1989, J INVERTEBR PATHOL, V53, P41, DOI 10.1016/0022-2011(89)90072-4; St-Onge P, 2013, MAR BIOL, V160, P1065, DOI 10.1007/s00227-012-2157-5; Strasser CA, 2009, CONSERV GENET, V10, P803, DOI 10.1007/s10592-008-9641-y; SUNILA I, 1989, DIS AQUAT ORGAN, V7, P111, DOI 10.3354/dao007111; Taraska NG, 2013, J INVERTEBR PATHOL, V112, P94, DOI 10.1016/j.jip.2012.10.001; Vassilenko E, 2014, J INVERTEBR PATHOL, V117, P68, DOI 10.1016/j.jip.2014.02.002; Vassilenko EI, 2010, MUTAT RES-GEN TOX EN, V701, P145, DOI 10.1016/j.mrgentox.2010.06.001; Voskoboynik A, 2013, SCIENCE, V341, P384, DOI 10.1126/science.1238036; Walker C, 2009, BIOL BULL-US, V216, P23; Weinberg JR, 1997, J INVERTEBR PATHOL, V69, P183, DOI 10.1006/jipa.1996.4641; YANG TJ, 1987, BRIT J CANCER, V55, P131, DOI 10.1038/bjc.1987.27; Yevich P.P, 1977, Annals NY Acad Sci, V298, P409, DOI 10.1111/j.1749-6632.1977.tb19281.x	43	120	125	3	78	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					255	263		10.1016/j.cell.2015.02.042	http://dx.doi.org/10.1016/j.cell.2015.02.042			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860608	Green Accepted, Bronze			2022-12-24	WOS:000352708300019
J	Ran, FA; Cong, L; Yan, WX; Scott, DA; Gootenberg, JS; Kriz, AJ; Zetsche, B; Shalem, O; Wu, XB; Makarova, KS; Koonin, EV; Sharp, PA; Zhang, F				Ran, F. Ann; Cong, Le; Yan, Winston X.; Scott, David A.; Gootenberg, Jonathan S.; Kriz, Andrea J.; Zetsche, Bernd; Shalem, Ophir; Wu, Xuebing; Makarova, Kira S.; Koonin, Eugene V.; Sharp, Phillip A.; Zhang, Feng			In vivo genome editing using Staphylococcus aureus Cas9	NATURE			English	Article							OFF-TARGET SITES; GUIDE RNA; NUCLEASE SPECIFICITY; DNA CLEAVAGE; CRISPR RNA; GENE; IMMUNITY; SYSTEMS; ENDONUCLEASE; SEQUENCE	The RNA-guided endonuclease Cas9 has emerged as a versatile genom-editing platform. However, the size of the commonly used Cas9 from Streptococcus pyogenes (SpCas9) limits its utility for basic research and therapeutic applications that use the highly versatileaderio-assolated virus (AAV) delivery vehicle. Here, we we characterize six smaller Cas9 ortholocgues and show that Cas9 from Staphylococcus aureus (SaCas9) can edit the genome with efficiencies similar to those of spcas9, while being more than 1 kilobase shorter. We packaged SaCas9 and its single guide RNA expression cassette into a single AAV vector and targeted the cholesterol regulatory gene Pcsk9 in the mouse liver. Within one week of injection we observed >40%. gene modification, accompanied by significant reductions in serum Pcsk9 and total cholesterol le; Is We further assess the genome -wide targeting specificity of SaCas9 and SpCas9 using BLESS, and demonstrate that SaCas9-mediated in vivo genome editing has the potential to be efficient and specific.	[Ran, F. Ann; Cong, Le; Yan, Winston X.; Scott, David A.; Gootenberg, Jonathan S.; Zetsche, Bernd; Shalem, Ophir; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ran, F. Ann] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Cong, Le; Kriz, Andrea J.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yan, Winston X.] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA; [Yan, Winston X.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Scott, David A.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Scott, David A.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Wu, Xuebing; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wu, Xuebing] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Makarova, Kira S.; Koonin, Eugene V.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Massachusetts Institute of Technology (MIT)	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Wilson, Matthew H/K-3193-2013; Cong, Le/M-9981-2013; Wu, Xuebing/C-9152-2013; Huang, ZhiXin/H-5123-2017; Gootenberg, Jonathan/AAY-8174-2021; Macrae, Rhiannon/AAX-1536-2020	Cong, Le/0000-0003-4725-8714; Wu, Xuebing/0000-0003-0369-5269; Huang, ZhiXin/0000-0003-0705-1970; Gootenberg, Jonathan/0000-0003-2757-2175; Shalem, Ophir/0000-0002-2267-0801	National Institute of General Medical Sciences [T32GM007753]; Paul and Daisy Soros Fellowship; US Department of Energy Computational Science Graduate Fellowship; United States Public Health Service from the National Institutes of Health [RO1-GM34277, R01-CA133404]; United States Public Health Service from the National Cancer Institute [PO1-CA42063]; Cancer Center from the National Cancer Institute [P30-CA14051]; National Institutes of Health through NIMH [5DP1-MH100706]; National Institutes of Health through NIDDK [5R01DK097768-03]; Waterman Award from the National Science Foundation; Keck Foundation; New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; NIH core grant [5P30EY012196-17]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA133404, P01CA042063] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024259, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, R01GM034277, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Paul and Daisy Soros Fellowship; US Department of Energy Computational Science Graduate Fellowship(United States Department of Energy (DOE)); United States Public Health Service from the National Institutes of Health; United States Public Health Service from the National Cancer Institute; Cancer Center from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through NIMH; National Institutes of Health through NIDDK; Waterman Award from the National Science Foundation; Keck Foundation(W.M. Keck Foundation); New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; NIH core grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Charpentier, I. Fonfara and K. Chylinski for discussions; A. Scherer-Hoock, B. Clear and the MIT Division of Comparative Medicine for assistance with animal experiments; Boston Children's Hospital Viral Core and R. Xiao for assistance with AAV production; N. Crosetto for advice on BLESS; C.-Y. Lin and I. Slaymaker for experimental assistance; and the entire Zhang laboratory for support and advice. F.A.R. is a Junior Fellow at the Harvard Society of Fellows. W.X.Y. is supported by T32GM007753 from the National Institute of General Medical Sciences and a Paul and Daisy Soros Fellowship. J.S.G. is supported by a US Department of Energy Computational Science Graduate Fellowship. X.W. is a Howard Hughes Medical Institute International Student Research Fellow. P.A.S. is supported by United States Public Health Service grants RO1-GM34277, R01-CA133404 from the National Institutes of Health, and PO1-CA42063 from the National Cancer Institute, and partially by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. F.Z. is supported by the National Institutes of Health through NIMH (5DP1-MH100706) and NIDDK (5R01DK097768-03), a Waterman Award from the National Science Foundation, the Keck, New York Stem Cell, Damon Runyon, Searle Scholars, Merkin, and Vallee Foundations, and B. Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. The Children's Hospital virus core is supported by an NIH core grant (5P30EY012196-17). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. CRISPR reagents are available to the academic community through Addgene, and information about the protocols, plasmids, and reagents can be found at the Zhang laboratory website http://www.genome-engineering.org.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gaudet D, 2010, ATHEROSCLEROSIS SUPP, V11, P55, DOI 10.1016/j.atherosclerosissup.2010.03.004; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Rozema DB, 2007, P NATL ACAD SCI USA, V104, P12982, DOI 10.1073/pnas.0703778104; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Veldwijk MR, 2002, MOL THER, V6, P272, DOI 10.1006/mthe.2002.0569; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	1632	1954	26	690	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					186	U98		10.1038/nature14299	http://dx.doi.org/10.1038/nature14299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830891	Green Submitted, Green Accepted			2022-12-24	WOS:000352454600031
J	Zhang, XY; Zhu, Y; Liu, XD; Hong, XY; Xu, Y; Zhu, P; Shen, Y; Wu, HH; Ji, YS; Wen, X; Zhang, C; Zhao, Q; Wang, YC; Lu, J; Guo, HW				Zhang, Xinyan; Zhu, Ying; Liu, Xiaodan; Hong, Xinyu; Xu, Yang; Zhu, Ping; Shen, Yang; Wu, Huihui; Ji, Yusi; Wen, Xing; Zhang, Chen; Zhao, Qiong; Wang, Yichuan; Lu, Jian; Guo, Hongwei			Suppression of endogenous gene silencing by bidirectional cytoplasmic RNA decay in Arabidopsis	SCIENCE			English	Article							ETHYLENE GAS; TRANSCRIPTION; ETHYLENE-INSENSITIVE3; BIOGENESIS; RESPONSES; TURNOVER	Plant immunity against foreign gene invasion takes advantage of posttranscriptional gene silencing (PTGS). How plants elaborately avert inappropriate PTGS of endogenous coding genes remains unclear. We demonstrate in Arabidopsis that both 5'-3' and 3'-5' cytoplasmic RNA decay pathways act as repressors of transgene and endogenous PTGS. Disruption of bidirectional cytoplasmic RNA decay leads to pleiotropic developmental defects and drastic transcriptomic alterations, which are substantially rescued by PTGS mutants. Upon dysfunction of bidirectional RNA decay, a large number of 21- to 22-nucleotide endogenous small interfering RNAs are produced from coding transcripts, including multiple microRNA targets, which could interfere with their cognate gene expression and functions. This study highlights the risk of unwanted PTGS and identifies cytoplasmic RNA decay pathways as safeguards of plant transcriptome and development.	[Zhang, Xinyan; Zhu, Ying; Liu, Xiaodan; Hong, Xinyu; Wu, Huihui; Ji, Yusi; Wen, Xing; Zhang, Chen; Zhao, Qiong; Wang, Yichuan; Lu, Jian; Guo, Hongwei] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Xu, Yang; Zhu, Ping] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Shen, Yang; Lu, Jian; Guo, Hongwei] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Guo, HW (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	hongweig@pku.edu.cn	Wen, Xing/ABI-5408-2020; zhao, qiong/AAB-4655-2020; Zhang, Xinyan/O-3442-2016	Wen, Xing/0000-0002-9322-2272; Zhu, Ping/0000-0002-4521-7524	National Basic Research Program of China (973 Program) [2012CB910902]; National Natural Science Foundation of China [91217305, 91017010]; 111 Project of Peking University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project of Peking University	We thank Y. Qi (Tsinghua University) and F. Tang and Y. Li (Peking University) for assistance in RNA sequencing experiments. We also thank J. Olson (Peking University) for assistance in English editing. This work is supported by the National Basic Research Program of China (973 Program; grant 2012CB910902) and the National Natural Science Foundation of China (grants 91217305 and 91017010 to H.G.). The publication fee is covered by the 111 Project of Peking University. Data have been deposited in the Gene Expression Omnibus under accession numbers GSE52407 and GSE57936. The supplementary materials contain additional data.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; Dorcey E, 2012, PLOS GENET, V8, P395, DOI 10.1371/journal.pgen.1002652; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hwang CF, 1997, PLANT PHYSIOL, V113, P853, DOI 10.1104/pp.113.3.853; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Moreno AB, 2013, NUCLEIC ACIDS RES, V41, P4699, DOI 10.1093/nar/gkt152; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Vazquez F, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/783253; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang XY, 2013, MOL PLANT, V6, P1661, DOI 10.1093/mp/sst071	25	103	108	3	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					120	123		10.1126/science.aaa2618	http://dx.doi.org/10.1126/science.aaa2618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838384				2022-12-24	WOS:000352079500040
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2015 Dementia team award	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2015	350									10.1136/bmj.h1556	http://dx.doi.org/10.1136/bmj.h1556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7OC	25812566				2022-12-24	WOS:000352030200009
J	Lieberman, J; Sharp, PA				Lieberman, Judy; Sharp, Philip A.			Harnessing RNA Interference for Therapy The Silent Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Sharp, Philip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, 200 Longwood Ave, Boston, MA 02115 USA.	judy.lieberman@childrens.harvard.edu	Lieberman, Judy/A-2717-2015					Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828	6	10	10	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1207	1208		10.1001/jama.2015.1241	http://dx.doi.org/10.1001/jama.2015.1241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803342				2022-12-24	WOS:000351435500013
J	Coleman, MP; Allemani, C				Coleman, Michel P.; Allemani, Claudia			Cancer: the elephant in the room	LANCET			English	Editorial Material									[Coleman, Michel P.; Allemani, Claudia] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine	Coleman, MP (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England.	michel.coleman@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807	Cancer Research UK [11700, 16148] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Ahmad AS, 2015, BRIT J CANCER, V112, P943, DOI 10.1038/bjc.2014.606; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; [Anonymous], 2013, LANCET, V381, P426, DOI 10.1016/S0140-6736(13)60060-4; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cavalli F, 2013, LANCET, V381, P425, DOI 10.1016/S0140-6736(13)60059-8; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Department of Health, 2011, IMPR OUTC STRAT CANC; Department of Health, 2000, NHS CANC PLAN PLAN I; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Knaul FM, 2011, CLOSING CANC DIVIDE, P71; NHS England, 2015, NHS LAUNCH NEW BID B; Office for National Statistics, 2014, OFF NAT STAT SER MB1, V43; Pui CH, 2013, SEMIN HEMATOL, V50, P185, DOI 10.1053/j.seminhematol.2013.06.007; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9	14	10	10	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1047	1048		10.1016/S0140-6736(15)60571-2	http://dx.doi.org/10.1016/S0140-6736(15)60571-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD7KX	25797546				2022-12-24	WOS:000351270400005
J	Hakala, A; Kimmelman, J; Carlisle, B; Freeman, G; Fergusson, D				Hakala, Amanda; Kimmelman, Jonathan; Carlisle, Benjamin; Freeman, Georgina; Fergusson, Dean			Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PUBLICATION	Objective To quantify the proportion of trials for unsuccessfully licensed drugs that are not published. Design A systematic assessment of the availability of published research reports for publicly registered trials testing drugs stalling in clinical development ("stalled drugs") and drugs receiving regulatory licensure in the same time period ("licensed drugs"). Data sources Searches of clinicaltrials.gov, Google Scholar, PubMed, Embase, and electronic query of contacts in registries to identify trials and assess publication status. Eligibility criteria The cohort of licensed drugs consisted of all disease modifying drugs in cancer, cardiovascular disease, or neurological disorders that received Food and Drug Administration licensure during 2005 to 2009 inclusive. The cohort of stalled drugs included unlicensed drugs in the same disease areas that had at least one completed phase III trial before 2009 and no evidence of any clinical trial activity after 31 December 2009. Inclusion criteria for registered trials advanced into publication searching were an intervention tested in a disease modifying, phase II, III, or IV trial registered on clinicaltrials. gov, with enrolment of at least one patient, that reported primary outcome collection end date between 1 January 2006 and 31 December 2008. Results The unadjusted publication proportion for registered trials of licensed drugs was 75% (72/96) versus 37% (30/81) for stalled drugs. The adjusted hazard ratio for publication was 2.7 (95% confidence interval 1.7 to 4.3) in favour of licensed drug trials. Higher publication rates for licensed drug trials were observed regardless of disease type, sponsorship, trial phase, and geography. The rate of non-publication of stalled drug trials was significantly higher for studies that did not complete enrolment compared with licensed drug trials. A total of 20 135 patients participated in trials of stalled drugs that were never published. Conclusions Much of the information collected in unsuccessful drug trials is inaccessible to the broader research and practice communities. These findings provide an evidence base and rationale for policy reforms aimed at promoting transparency, ethics, and accountability in clinical research.	[Hakala, Amanda; Kimmelman, Jonathan; Carlisle, Benjamin; Freeman, Georgina] McGill Univ, Dept Social Studies Med, Biomed Eth Unit, Studies Translat Eth & Med STREAM, Montreal, PQ H3A 1X1, Canada; [Fergusson, Dean] Univ Ottawa, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON K1H 8L6, Canada	McGill University; University of Ottawa; Ottawa Hospital Research Institute	Kimmelman, J (corresponding author), McGill Univ, Dept Social Studies Med, Biomed Eth Unit, Studies Translat Eth & Med STREAM, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmelman@mcgill.ca	Carlisle, Benjamin/AAD-6332-2020	Carlisle, Benjamin/0000-0001-8975-0649; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research [EOG111391]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes of Health Research (EOG111391). The study sponsor played no role in study design; collection, analysis, or interpretation of data; writing of the article; or the decision to submit the manuscript for publication. All researchers are independent from the funder.	Allarakhia M, 2013, DRUG DES DEV THER, V7, P753, DOI 10.2147/DDDT.S46289; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; [Anonymous], FED REG; Burton TM, 2012, WALL STREET J; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2010, TRI COUNC POL STAT E; Deftereos SN, 2011, WIRES SYST BIOL MED, V3, P323, DOI 10.1002/wsbm.147; Doshi P, 2013, JAMA INTERN MED, V173, P380, DOI 10.1001/jamainternmed.2013.3838; Goodyear M, 2006, BRIT MED J, V332, P677, DOI 10.1136/bmj.38797.635012.47; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hudson KL, 2015, JAMA-J AM MED ASSOC, V313, P355, DOI 10.1001/jama.2014.10716; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Karve S, 2012, P NATL ACAD SCI USA, V109, P8230, DOI 10.1073/pnas.1120508109; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; NIH Office of Science Policy, 2011, NIH IND ROUNDT EXPL; Peart KN, 2014, YALE NEWS       0130; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Rogawski MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002939; US National Institutes of Health, FDAAA 801 REQ AR THE; Wadman M, 2013, NAT NEWS BLOG   0618	20	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2015	350								h1116	10.1136/bmj.h1116	http://dx.doi.org/10.1136/bmj.h1116			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EA	25752879	hybrid			2022-12-24	WOS:000351181100001
J	Jovanovic, M; Rooney, MS; Mertins, P; Przybylski, D; Chevrier, N; Satija, R; Rodriguez, EH; Fields, AP; Schwartz, S; Raychowdhury, R; Mumbach, MR; Eisenhaure, T; Rabani, M; Gennert, D; Lu, DN; Delorey, T; Weissman, JS; Carr, SA; Hacohen, N; Regev, A				Jovanovic, Marko; Rooney, Michael S.; Mertins, Philipp; Przybylski, Dariusz; Chevrier, Nicolas; Satija, Rahul; Rodriguez, Edwin H.; Fields, Alexander P.; Schwartz, Schraga; Raychowdhury, Raktima; Mumbach, Maxwell R.; Eisenhaure, Thomas; Rabani, Michal; Gennert, Dave; Lu, Diana; Delorey, Toni; Weissman, Jonathan S.; Carr, Steven A.; Hacohen, Nir; Regev, Aviv			Dynamic profiling of the protein life cycle in response to pathogens	SCIENCE			English	Article							MESSENGER-RNA; TEMPORAL DYNAMICS; DENDRITIC CELLS; REVEALS; EXPRESSION; TRANSLATION; PRINCIPLES; ABUNDANCE; TLR; QUANTIFICATION	Protein expression is regulated by the production and degradation of messenger RNAs (mRNAs) and proteins, but their specific relationships remain unknown. We combine measurements of protein production and degradation and mRNA dynamics so as to build a quantitative genomic model of the differential regulation of gene expression in lipopolysaccharide-stimulated mouse dendritic cells. Changes in mRNA abundance play a dominant role in determining most dynamic fold changes in protein levels. Conversely, the preexisting proteome of proteins performing basic cellular functions is remodeled primarily through changes in protein production or degradation, accounting for more than half of the absolute change in protein molecules in the cell. Thus, the proteome is regulated by transcriptional induction for newly activated cellular functions and by protein life-cycle changes for remodeling of preexisting functions.	[Jovanovic, Marko; Rooney, Michael S.; Mertins, Philipp; Przybylski, Dariusz; Chevrier, Nicolas; Satija, Rahul; Schwartz, Schraga; Raychowdhury, Raktima; Mumbach, Maxwell R.; Eisenhaure, Thomas; Rabani, Michal; Gennert, Dave; Lu, Diana; Delorey, Toni; Carr, Steven A.; Hacohen, Nir; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rooney, Michael S.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Chevrier, Nicolas] Harvard Univ, Harvard Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Rodriguez, Edwin H.; Fields, Alexander P.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Eisenhaure, Thomas; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [Regev, Aviv] MIT, Dept Biol, HHMI, Cambridge, MA 02140 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	nhacohen@mgh.harvard.edu; aregev@broad.mit.edu	Carr, Steven A./AAH-8366-2019; Satija, Rahul/AAF-9564-2019	Weissman, Jonathan/0000-0003-2445-670X; Mumbach, Maxwell/0000-0002-5570-6663; Schwartz, Schraga/0000-0002-3671-9709; Delorey, Toni/0000-0001-6614-3803	National Human Genome Research Institute Centers of Excellence in Genomics Science [P50 HG006193]; Broad Institute Funds; NIH Pioneer Award; Klarman Cell Observatory; HHMI; Swiss National Science Foundation (SNF); Marie Sklodowska-Curie International Outgoing Fellowships; NIH Training Program in Bioinformatics and Integrative Genomics training grant; Rothschild Fellowship; European Molecular Biology Organization fellowship; Human Frontier Science Program fellowships; Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER	National Human Genome Research Institute Centers of Excellence in Genomics Science; Broad Institute Funds; NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; HHMI(Howard Hughes Medical Institute); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Marie Sklodowska-Curie International Outgoing Fellowships; NIH Training Program in Bioinformatics and Integrative Genomics training grant; Rothschild Fellowship; European Molecular Biology Organization fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program fellowships; Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Regev, Hacohen, and Carr groups, as well as G. Brar, N. Slavov, and E. Airoldi for constant input and discussions. We thank L. Gaffney for help with the figures and K. Lage and A. Kashani for help with some of the analyses. This work was supported by National Human Genome Research Institute Centers of Excellence in Genomics Science P50 HG006193 (A.R, N.H., S.A.C.) and Broad Institute Funds. A.R. was supported by an NIH Pioneer Award, the Klarman Cell Observatory, and HHMI. M.J. was supported by fellowships of the Swiss National Science Foundation for advanced researchers (SNF) and the Marie Sklodowska-Curie International Outgoing Fellowships. M.S.R. was supported by the NIH Training Program in Bioinformatics and Integrative Genomics training grant. S.S. was supported by a Rothschild Fellowship, a European Molecular Biology Organization fellowship, and Human Frontier Science Program fellowships. E.H.R. was supported by the Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study. Data have been deposited in the Gene Expression Omnibus under accession number GSE59793. The original mass spectra, may be downloaded from MassIVE (http://massive.ucsd.edu) using the identifier MSV000078994. The data are accessible at ftp://MSV000078994:a@massive.ucsd.edu. DogmaQuant is distributed under open source (BSD) license.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Albert FW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004692; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aviner R, 2013, GENE DEV, V27, P1834, DOI 10.1101/gad.219105.113; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bell C, 2013, MOL CELL PROTEOMICS, V12, P2394, DOI 10.1074/mcp.M112.025775; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Eichelbaum K, 2014, MOL CELL PROTEOMICS, V13, P792, DOI 10.1074/mcp.M113.030916; Eichelbaum K, 2012, NAT BIOTECHNOL, V30, P984, DOI 10.1038/nbt.2356; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Geiger T, 2013, MOL CELL PROTEOMICS, V12, P1709, DOI 10.1074/mcp.M112.024919; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kuan AP, 1999, IMMUNOGENETICS, V49, P79, DOI 10.1007/s002510050466; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Lelouard H, 2007, J CELL BIOL, V179, P1427, DOI 10.1083/jcb.200707166; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Rabani M, 2014, CELL, V159, P1698, DOI 10.1016/j.cell.2014.11.015; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Sanada T, 2008, J BIOL CHEM, V283, P33858, DOI 10.1074/jbc.M806923200; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Weiss M, 2010, PROTEOMICS, V10, P1297, DOI 10.1002/pmic.200900414; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015	56	281	281	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226							1259038	10.1126/science.1259038	http://dx.doi.org/10.1126/science.1259038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745177	Green Submitted, Green Accepted			2022-12-24	WOS:000350354200045
J	Heath, I				Heath, Iona			ESSAY Role of fear in overdiagnosis and overtreatment-an essay by Iona Heath	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk						Bakewell Sarah, 2010, LIVE LIFE MONTAIGNE, P123; BARNARD D, 1988, J MED PHILOS, V13, P393, DOI 10.1093/jmp/13.4.393; Bauman Z, 1994, ALONE AGAIN ETHICS U; Larkin Philip, 1988, COLLECTED POEMS, p[208, 208]; McCormick J, 1975, J R Coll Gen Pract, V25, P9; Nussbaum M., 1986, FRAGILITY GOODNESS L; Skrabanek P., 1991, HLTH LIFESTYLE ENV, P47; Sontag Susan, 1978, ILLNESS METAPHOR; Toulmin Stephen, 1990, COSMOPOLIS HIDDEN AG	9	37	38	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2014	349								g6123	10.1136/bmj.g6123	http://dx.doi.org/10.1136/bmj.g6123			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR7OI	25954986				2022-12-24	WOS:000343768700003
J	Andersen, DS; Colombani, J; Palmerini, V; Chakrabandhu, K; Boone, E; Rothlisberger, M; Toggweiler, J; Basler, K; Mapelli, M; Hueber, AO; Leopold, P				Andersen, Ditte S.; Colombani, Julien; Palmerini, Valentina; Chakrabandhu, Krittalak; Boone, Emilie; Roethlisberger, Michael; Toggweiler, Janine; Basler, Konrad; Mapelli, Marina; Hueber, Anne-Odile; Leopold, Pierre			The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth	NATURE			English	Article							TUMOR-SUPPRESSOR; RETINAL DEGENERATION; GENETIC SCREEN; CRUMBS COMPLEX; ONCOGENIC RAS; EIGER; SUPERFAMILY; MELANOGASTER; ACTIVATION; MECHANISM	Disruption of epithelial polarity is a key event in the acquisition of neoplastic growth. JNK signalling is known to play an important part in driving the malignant progression of many epithelial tumours, although the link between loss of polarity and JNK signalling remains elusive. In a Drosophila genome-wide genetic screen designed to identify molecules implicated in neoplastic growth(1), we identified grindelwald (grnd), a gene encoding a transmembrane protein with homology to members of the tumour necrosis factor receptor (TNFR) superfamily. Here we show that Grnd mediates the pro-apoptotic functions of Eiger (Egr), the unique Drosophila TNF, and that overexpression of an active form of Grnd lacking the extracellular domain is sufficient to activate JNK signalling in vivo. Grnd also promotes the invasiveness of Ras(V12)/scrib(-/-) tumours through Egr-dependent Matrix metallo-protease-1 (Mmp1) expression. Grnd localizes to the subapical membrane domain with the cell polarity determinant Crumbs (Crb) and couples Crb-induced loss of polarity with JNK activation and neoplastic growth through physical interaction with Veli (also known as Lin-7). Therefore, Grnd represents the first example of a TNFR that integrates signals from both Egr and apical polarity determinants to induce JNK-dependent cell death or tumour growth.	[Andersen, Ditte S.; Colombani, Julien; Chakrabandhu, Krittalak; Boone, Emilie; Hueber, Anne-Odile; Leopold, Pierre] Univ Nice Sophia Antipolis, Inst Biol Valrose, F-06108 Nice, France; [Andersen, Ditte S.; Colombani, Julien; Chakrabandhu, Krittalak; Boone, Emilie; Hueber, Anne-Odile; Leopold, Pierre] CNRS, Inst Biol Valrose, F-06108 Nice, France; [Andersen, Ditte S.; Colombani, Julien; Chakrabandhu, Krittalak; Boone, Emilie; Hueber, Anne-Odile; Leopold, Pierre] INSERM, Inst Biol Valrose, F-06108 Nice, France; [Andersen, Ditte S.; Colombani, Julien; Boone, Emilie; Leopold, Pierre] Inst Biol Valrose, Genet & Physiol Growth Lab, F-06108 Nice, France; [Palmerini, Valentina; Mapelli, Marina] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Chakrabandhu, Krittalak; Hueber, Anne-Odile] Inst Biol Valrose, Death Receptors Signalling & Canc Therapy Lab, F-06108 Nice, France; [Roethlisberger, Michael; Toggweiler, Janine; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; IRCCS European Institute of Oncology (IEO); UDICE-French Research Universities; Universite Cote d'Azur; University of Zurich	Colombani, J (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, Parc Valrose, F-06108 Nice, France.	julien.colombani@unice.fr; leopold@unice.fr	Mapelli, Marina/AAC-7346-2022; Palmerini, Valentina/AAQ-1639-2020; Anne-Odile, Hueber/G-4352-2013; Anne-Odile, Hueber/P-9860-2019	Mapelli, Marina/0000-0001-8502-0649; Anne-Odile, Hueber/0000-0003-3816-2446; Anne-Odile, Hueber/0000-0003-3816-2446; Colombani, Julien/0000-0002-8250-4899; Andersen, Ditte/0000-0003-1209-6102; Basler, Konrad/0000-0003-3534-1529	CNRS; INSERM; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Association pour la Recherche contre le Cancer [PJA20131200042]; European Research Council [268813]; Marie Curie Life Long Training grant [252373]; Labex Signalife program [ANR-11-LABX-0028-01]; Italian Association for Cancer Research (AIRC) [IG-12877]; Italian Ministry of Health [GR-2008-1134103]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); European Research Council(European Research Council (ERC)European Commission); Marie Curie Life Long Training grant; Labex Signalife program; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	We thank G. Jarretou for technical assistance, the Vienna Drosophila RNAi Centers, the Drosophila Genetics Resource Center, the Bloomington Stock Center, N. Caridi and S. Pasqualato for technical assistance and P.L. laboratory members for comments on the manuscript This work was supported by the CNRS, INSERM, Agence Nationale de la Recherche, Fondation pour la Recherche Medicale, Association pour la Recherche contre le Cancer (grant no. PJA20131200042 to J.C.), European Research Council (Advanced grant no. 268813 to P.L.), Marie Curie Life Long Training (grant no. 252373 to D.S.A.), the Labex Signalife program (grant ANR-11-LABX-0028-01 to P.L.), the Italian Association for Cancer Research (AIRC IG-12877) and the Italian Ministry of Health (GR-2008-1134103) to M.M.	Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Bachmann A, 2008, EUR J CELL BIOL, V87, P123, DOI 10.1016/j.ejcb.2007.11.002; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Chakrabandhu K, 2008, CELL DEATH DIFFER, V15, P1824, DOI 10.1038/cdd.2008.115; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Geuking P, 2005, GENETICS, V171, P1683, DOI 10.1534/genetics.105.045534; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Karp CM, 2008, CANCER RES, V68, P4105, DOI 10.1158/0008-5472.CAN-07-6814; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Narasimamurthy R, 2009, CELL RES, V19, P392, DOI 10.1038/cr.2009.16; Olsen O, 2007, J CELL BIOL, V179, P151, DOI 10.1083/jcb.200702054; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vidal M, 2010, CELL CYCLE, V9, P3851, DOI 10.4161/cc.9.19.13280; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006	33	98	101	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					482	+		10.1038/nature14298	http://dx.doi.org/10.1038/nature14298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	25874673				2022-12-24	WOS:000356782900051
J	Samai, P; Pyenson, N; Jiang, WY; Goldberg, GW; Hatoum-Aslan, A; Marraffini, LA				Samai, Poulami; Pyenson, Nora; Jiang, Wenyan; Goldberg, Gregory W.; Hatoum-Aslan, Asma; Marraffini, Luciano A.			Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity	CELL			English	Article							STREPTOCOCCUS-THERMOPHILUS; NUCLEOTIDE-SEQUENCE; ANTIVIRAL DEFENSE; ESCHERICHIA-COLI; FUNCTIONAL MAP; SYSTEM; PROKARYOTES; RESISTANCE; COMPLEX; INTERFERENCE	Immune systems must recognize and destroy different pathogens that threaten the host. CRISPR-Cas immune systems protect prokaryotes from viral and plasmid infection utilizing small CRISPR RNAs that are complementary to the invader's genome and specify the targets of RNA-guided Cas nucleases. Type III CRISPR-Cas immunity requires target transcription, and whereas genetic studies demonstrated DNA targeting, in vitro data have shown crRNA-guided RNA cleavage. The molecular mechanism behind these disparate activities is not known. Here, we show that transcription across the targets of the Staphylococcus epidermidis type III-A CRISPR-Cas system results in the cleavage of the target DNA and its transcripts, mediated by independent active sites within the Cas10-Csm ribonucleoprotein effector complex. Immunity against plasmids and DNA viruses requires DNA, but not RNA, cleavage activity. Our studies reveal a highly versatile mechanism of CRISPR immunity that can defend microorganisms against diverse DNA and RNA invaders.	[Samai, Poulami; Pyenson, Nora; Jiang, Wenyan; Goldberg, Gregory W.; Hatoum-Aslan, Asma; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Rockefeller University	Marraffini, LA (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA.	marraffini@rockefeller.edu		Goldberg, Gregory/0000-0002-5022-9976	Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award [1DP2AI104556-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER	Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Seth Darst, Arkady Mustaev, and Brian Bae for providing CBR703 and help with transcription inhibition assays. We also like to thank Andrew Varble for critical reading of the manuscript. P.S. is supported by a Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University. L.A.M. is supported by the Searle Scholars Program, Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award and a NIH Director's New Innovator Award (1DP2AI104556-01).	Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-43; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Heitman J, 1999, MOL MICROBIOL, V33, P1141, DOI 10.1046/j.1365-2958.1999.01556.x; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; HORINOUCHI S, 1982, J BACTERIOL, V150, P804, DOI 10.1128/JB.150.2.804-814.1982; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Ramia NF, 2014, NUCLEIC ACIDS RES, V42, P1129, DOI 10.1093/nar/gkt914; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	35	248	272	7	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1164	1174		10.1016/j.cell.2015.04.027	http://dx.doi.org/10.1016/j.cell.2015.04.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25959775	Green Accepted, Bronze			2022-12-24	WOS:000355152600022
J	Rivas, MA; Pirinen, M; Conrad, DF; Lek, M; Tsang, EK; Karczewski, KJ; Maller, JB; Kukurba, KR; DeLuca, DS; Fromer, M; Ferreira, PG; Smith, KS; Zhang, R; Zhao, FM; Banks, E; Poplin, R; Ruderfer, DM; Purcell, SM; Tukiainen, T; Minikel, EV; Stenson, PD; Cooper, DN; Huang, KH; Sullivan, TJ; Nedzel, J; Bustamante, CD; Li, JB; Daly, MJ; Guigo, R; Donnelly, P; Ardlie, K; Sammeth, M; Dermitzakis, ET; McCarthy, MI; Montgomery, SB; Lappalainen, T; MacArthur, DG				Rivas, Manuel A.; Pirinen, Matti; Conrad, Donald F.; Lek, Monkol; Tsang, Emily K.; Karczewski, Konrad J.; Maller, Julian B.; Kukurba, Kimberly R.; DeLuca, David S.; Fromer, Menachem; Ferreira, Pedro G.; Smith, Kevin S.; Zhang, Rui; Zhao, Fengmei; Banks, Eric; Poplin, Ryan; Ruderfer, Douglas M.; Purcell, Shaun M.; Tukiainen, Taru; Minikel, Eric V.; Stenson, Peter D.; Cooper, David N.; Huang, Katharine H.; Sullivan, Timothy J.; Nedzel, Jared; Bustamante, Carlos D.; Li, Jin Billy; Daly, Mark J.; Guigo, Roderic; Donnelly, Peter; Ardlie, Kristin; Sammeth, Michael; Dermitzakis, Emmanouil T.; McCarthy, Mark I.; Montgomery, Stephen B.; Lappalainen, Tuuli; MacArthur, Daniel G.		GTEx Consortium; Geuvadis Consortium	Effect of predicted protein-truncating genetic variants on the human transcriptome	SCIENCE			English	Article							EXPRESSION; DOSAGE	Accurate prediction of the functional effect of genetic variation is critical for clinical genome interpretation. We systematically characterized the transcriptome effects of protein-truncating variants, a class of variants expected to have profound effects on gene function, using data from the Genotype-Tissue Expression (GTEx) and Geuvadis projects. We quantitated tissue-specific and positional effects on nonsense-mediated transcript decay and present an improved predictive model for this decay. We directly measured the effect of variants both proximal and distal to splice junctions. Furthermore, we found that robustness to heterozygous gene inactivation is not due to dosage compensation. Our results illustrate the value of transcriptome data in the functional interpretation of genetic variants.	[Rivas, Manuel A.; Donnelly, Peter; McCarthy, Mark I.] Univ Oxford, Nuffield Dept Clin Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Pirinen, Matti] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Conrad, Donald F.] Washington Univ, St Louis, MO USA; [Lek, Monkol; Karczewski, Konrad J.; Maller, Julian B.; DeLuca, David S.; Fromer, Menachem; Zhao, Fengmei; Banks, Eric; Poplin, Ryan; Purcell, Shaun M.; Tukiainen, Taru; Minikel, Eric V.; Huang, Katharine H.; Sullivan, Timothy J.; Nedzel, Jared; Daly, Mark J.; Ardlie, Kristin; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Lek, Monkol; Karczewski, Konrad J.; Maller, Julian B.; Fromer, Menachem; Zhao, Fengmei; Purcell, Shaun M.; Tukiainen, Taru; Minikel, Eric V.; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Tsang, Emily K.; Kukurba, Kimberly R.; Smith, Kevin S.; Zhang, Rui; Bustamante, Carlos D.; Li, Jin Billy; Montgomery, Stephen B.; Lappalainen, Tuuli] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Tsang, Emily K.; Kukurba, Kimberly R.; Smith, Kevin S.; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Tsang, Emily K.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.] Mt Sinai Hosp, Dept Psychiat, New York, NY USA; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Ferreira, Pedro G.; Dermitzakis, Emmanouil T.; Lappalainen, Tuuli] Swiss Inst Bioinformat, Geneva, Switzerland; [Ruderfer, Douglas M.; Purcell, Shaun M.] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Stenson, Peter D.; Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales; [Guigo, Roderic; Sammeth, Michael] UPF, CRG, Barcelona, Catalonia, Spain; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Sammeth, Michael] Natl Inst Sci Comp LNCC, Rio De Janeiro, Brazil; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY USA; [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY USA; [MacArthur, Daniel G.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	University of Oxford; Wellcome Centre for Human Genetics; University of Helsinki; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Stanford University; Stanford University; Stanford University; Icahn School of Medicine at Mount Sinai; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Icahn School of Medicine at Mount Sinai; Cardiff University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Oxford; Laboratorio Nacional de Computacao Cientifica (LNCC); University of Oxford; Columbia University; Harvard University; Harvard Medical School	Rivas, MA (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Wellcome Trust Ctr Human Genet, Oxford, England.	rivas@well.ox.ac.uk; tlappalainen@nygenome.org; macarthur@atgu.mgh.harvard.edu	Antonarakis, Stylianos E/N-8866-2014; Ruderfer, Douglas M/M-5795-2016; Guigo, Roderic/D-1303-2010; Beltran, Sergi/I-3408-2015; Daly, Mark J/B-2453-2017; Meitinger, Thomas/O-1318-2015; Rivas, Manuel/ABE-8173-2020; Stegle, Oliver/AAU-9177-2020; Ferreira, Pedro/HDO-1346-2022; Gamazon, Eric/I-6873-2018; Kellis, Manolis/ABE-7385-2020; Cooper, David N/H-4384-2011; Häsler, Robert/A-4908-2009; Lappalainen, Tuuli/AAE-6532-2020; Esser, Daniela/ABB-9383-2020; Ferreira, Pedro G/J-6379-2013; Sammeth, Michael/C-1157-2014; Little, Roger/O-6191-2014; McCarthy, Mark/M-3763-2015; Karczewski, Jakub/L-7326-2018; Estivill, Xavier/A-3125-2013	Antonarakis, Stylianos E/0000-0001-8907-5823; Ruderfer, Douglas M/0000-0002-2365-386X; Guigo, Roderic/0000-0002-5738-4477; Beltran, Sergi/0000-0002-2810-3445; Daly, Mark J/0000-0002-0949-8752; Rivas, Manuel/0000-0003-1457-9925; Stegle, Oliver/0000-0002-8818-7193; Gamazon, Eric/0000-0003-4204-8734; Kellis, Manolis/0000-0001-7113-9630; Cooper, David N/0000-0002-8943-8484; Häsler, Robert/0000-0003-4174-8229; Lappalainen, Tuuli/0000-0002-7746-8109; Ferreira, Pedro G/0000-0003-3838-8664; Sammeth, Michael/0000-0002-6528-9883; Little, Roger/0000-0001-6831-0177; Friedlander, Marc/0000-0001-6577-4363; Esko, Tonu/0000-0003-1982-6569; Minikel, Eric Vallabh/0000-0003-2206-1608; Zhou, Yi-Hui/0000-0002-4092-7463; Meitinger, Thomas/0000-0002-8838-8403; mele, marta/0000-0001-8874-6453; Carracedo, Angel/0000-0003-1085-8986; Montgomery, Stephen/0000-0002-5200-3903; Brazma, Alvis/0000-0001-5988-7409; Tukiainen, Taru/0000-0002-5404-8398; McCarthy, Mark/0000-0002-4393-0510; Zhang, Rui/0000-0001-9000-5021; Bustamante, Carlos D./0000-0002-4187-7920; Karczewski, Jakub/0000-0001-9322-7842; Pirinen, Matti/0000-0002-1664-1350; Kilpinen, Helena/0000-0001-6692-6154; Estivill, Xavier/0000-0002-0723-2256; Ongen, Halit/0000-0002-4197-5790; MacArthur, Daniel/0000-0002-5771-2290; Karczewski, Konrad/0000-0003-2878-4671	National Institutes of Health [NIGMS R01GM104371, NIMH R01MH101814, R01MH090941, U01HG007593, R01MH101810]; Academy of Finland [257654]; Hewlett-Packard Stanford Graduate Fellowship; Natural Science and Engineering Research Council of Canada; National Defense Science and Engineering Graduate Fellowship (NDSEG) from the United States Department of Defense (DoD); European Research Council; Swiss National Science Foundation; Louis-Jeantet Foundation; Wellcome Trust [095552/Z/11/Z, 090532/Z/09/Z, 098381]; University of Oxford; Common Fund of the Office of the Director of NIH; NCI/SAIC-Frederick, Inc. (SAIC-F) [X10S172]; University of Geneva [MH090941]; University of Chicago [MH090951, MH090937]; University of North Carolina-Chapel Hill [MH090936]; Harvard University [MH090948];  [HHSN268201000029C];  [10ST1035];  [DA006227]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371, T32GM007790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101820, R01MH101810, R01MH101814, R01MH090941, R01MH090948, R01MH090936, R01MH101819, R01MH090937, R01MH090951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001942] Funding Source: researchfish; BBSRC [BBS/E/I/00001942] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Hewlett-Packard Stanford Graduate Fellowship; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Defense Science and Engineering Graduate Fellowship (NDSEG) from the United States Department of Defense (DoD); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis-Jeantet Foundation; Wellcome Trust(Wellcome Trust); University of Oxford; Common Fund of the Office of the Director of NIH; NCI/SAIC-Frederick, Inc. (SAIC-F); University of Geneva; University of Chicago(University of Chicago); University of North Carolina-Chapel Hill; Harvard University; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all the members of the GTEx and Geuvadis consortia and L. Solomon for assistance with the figures. This work was supported by the National Institutes of Health (NIGMS R01GM104371 to D.G.M.; NIMH R01MH101814 to E.T.D, C.D.B., S.B.M., R.G., T.L., and M.I.M.; R01MH090941 to E.T.D. and M.I.M.; U01HG007593 to J.B.L. and S.B.M.; and R01MH101810 to D.F.C.); Academy of Finland (257654 to M.P.); a Hewlett-Packard Stanford Graduate Fellowship and a doctoral fellowship from the Natural Science and Engineering Research Council of Canada to E.K.T.; a National Defense Science and Engineering Graduate Fellowship (NDSEG) from the United States Department of Defense (DoD) to K.R.K.; European Research Council, Swiss National Science Foundation, and Louis-Jeantet Foundation to E.T.D.; Wellcome Trust (095552/Z/11/Z and 090532/Z/09/Z to P.D. and 098381 to M.I.M.); and a Clarendon Scholarship, NDM Studentship, and Green Templeton College Award from University of Oxford to M.A.R. The Genotype-Tissue Expression (GTEx) project was supported by the Common Fund of the Office of the Director of NIH. Additional funds were enrolled at Biospecimen Source sites funded by NCI/SAIC-Frederick, Inc. (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171), and Science Care, Inc. (X10S172). The Laboratory, Data Analysis, and Coordinating Center (LDACC) was funded through a contract (HHSN268201000029C) to the Broad Institute, Inc. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by a supplement to University of Miami grant DA006227. Statistical methods development grants were made to the University of Geneva (MH090941), the University of Chicago (MH090951 and MH090937), the University of North Carolina-Chapel Hill (MH090936), and Harvard University (MH090948). The primary and processed data used to generate the analyses presented here are available in the following locations: All primary sequence and clinical data files, and any other protected data, are deposited in and available from the database of Genotypes and Phenotypes (www.ncbi.nlm.nih.gov/gap) (phs000424.v3.p1, except for whole-exome sequencing data in phs000424.v5.p1 and mmPCR-seq data and processed ASE data in phs000424.v6.p1); derived analysis files are available on the GTEx Portal (www.gtexportal.org). Biospecimens remaining from the study may be requested for research studies. The sample request form, biospecimen access policy, and material transfer agreement are available on the GTEx Portal (www.gtexportal.org/home/samplesPage). The Geuvadis data are available in ArrayExpress accession E-GEUV-1. Further details and links to data and software are available in www.well.ox.ac.uk/similar to rivas/ptv2015. C.D.B. is a paid member of the Scientific Advisory Boards of Personalis, InVitae, and Ancestry.com; he is founder and chair of the SAB of Identify Genomics, LLC; he also owns stock options in Personalis, Invitae, and Identify Genomics, LLC.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Burge CB, 1999, RNA WORLD, P525; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; KACSER H, 1981, GENETICS, V97, P639; Kukurba KR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004304; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McAnally AA, 2010, GENOME BIOL EVOL, V2, P44, DOI 10.1093/gbe/evp054; McCarthy DJ, 2014, GENOME MED, V6, DOI 10.1186/gm543; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pirinen M., 2015, BIOINFORMATICS; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736; Zhou J, 2011, GENOME BIOL EVOL, V3, P1014, DOI 10.1093/gbe/evr023	27	148	153	6	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					666	669		10.1126/science.1261877	http://dx.doi.org/10.1126/science.1261877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954003	Green Accepted			2022-12-24	WOS:000354045700038
J	Prezioso, M; Merrikh-Bayat, F; Hoskins, BD; Adam, GC; Likharev, KK; Strukov, DB				Prezioso, M.; Merrikh-Bayat, F.; Hoskins, B. D.; Adam, G. C.; Likharev, K. K.; Strukov, D. B.			Training andoperation of an integrated neuromorphic network based on metal-oxide memristors	NATURE			English	Article							CIRCUITS; DEVICE; MEMORY	Despite much progress in semiconductor integrated circuit technology, the extreme complexity of the human cerebral cortex(1), with its approximately 10(14) synapses, makes the hardware implementation of neuromorphic networks with a comparable number of devices exceptionally challenging. To provide comparable complexity while operating much faster and with manageable power dissipation, networks(2) based on circuits(3,4) combining complementary metaloxide-semiconductors (CMOSs) and adjustable two-terminal resistive devices (memristors) have been developed. In such circuits, the usual CMOS stack is augmented with one(3) or several(4) crossbar layers, with memristors at each crosspoint. There have recently been notable improvements in the fabrication of such memristive crossbars and their integration with CMOS circuits(5-12), including first demonstrations(5,6,12) of their vertical integration. Separately, discrete memristors have been used as artificial synapses in neuromorphic networks(13-18). Very recently, such experiments have been extended(19) to crossbar arrays of phase-change memristive devices. The adjustment of such devices, however, requires an additional transistor at each crosspoint, and hence these devices are much harder to scale than metal-oxide memristors(11,20,21), whose nonlinear current-voltage curves enable transistor-free operation. Here we report the experimental implementation of transistor-free metal-oxide memristor crossbars, with device variability sufficiently low to allow operation of integrated neural networks, in a simple network: a single-layer perceptron (an algorithm for linear classification). The network can be taught in situ using a coarse-grain variety of the delta rule algorithm(22) to perform the perfect classification of 3 3 3-pixel black/white images into three classes (representing letters). This demonstration is an important step towards much larger and more complex memristive neuromorphic networks.	[Prezioso, M.; Merrikh-Bayat, F.; Hoskins, B. D.; Adam, G. C.; Strukov, D. B.] Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA; [Likharev, K. K.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA	University of California System; University of California Santa Barbara; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Prezioso, M (corresponding author), Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA.	mprezioso@ece.ucsb.edu; strukov@ece.ucsb.edu	Prezioso, Mirko/D-7518-2011	Prezioso, Mirko/0000-0002-3318-9132; Adam, Gina/0000-0003-0027-1145; , Dmitri/0000-0002-4526-4347; Hoskins, Brian/0000-0002-9418-9291	AFOSR under the MURI [FA9550-12-1-0038]; DARPA via BAE Systems [HR0011-13-C-0051UPSIDE]; DENSO Corporation, Japan	AFOSR under the MURI; DARPA via BAE Systems; DENSO Corporation, Japan	We acknowledge useful discussions with F. Alibart, I. Kataeva, W. Lu, L. Sengupta, S. Stemmer, and E. Zamanidoost. This work was supported by the AFOSR under the MURI grant FA9550-12-1-0038, by DARPA under contract number HR0011-13-C-0051UPSIDE via BAE Systems, and by the DENSO Corporation, Japan.	Alibart F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3072; Chanthbouala A, 2012, NAT MATER, V11, P860, DOI [10.1038/NMAT3415, 10.1038/nmat3415]; Chevallier C. J., 2010, INT SOLID STATE CIRC, V10, P260; Eryilmaz SB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00205; Govoreanu B., 2013, ELECT DEVICES M IEDM, V13, P256, DOI DOI 10.1109/IEDM.2013.6724599; Hasler J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00118; Hertz JA, 2018, INTRO THEORY NEURAL; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Kaneko Y, 2014, IEEE T ELECTRON DEV, V61, P2827, DOI 10.1109/TED.2014.2331707; Kawahara A., 2012, 2012 IEEE International Solid-State Circuits Conference (ISSCC), P432, DOI 10.1109/ISSCC.2012.6177078; Kim GH, 2013, ADV FUNCT MATER, V23, P1440, DOI 10.1002/adfm.201202170; Kim KH, 2012, NANO LETT, V12, P389, DOI 10.1021/nl203687n; Krizhevsky A, 2012, COMMUN, V25, P1097, DOI DOI 10.1145/3065386; LeCun Y, 2012, LECT NOTES COMPUT SC, V7700, P9, DOI DOI 10.1007/3-540-49430-8_; Likharev KK, 2011, SCI ADV MATER, V3, P322, DOI 10.1166/sam.2011.1177; Likharev KK, 2008, J NANOELECTRON OPTOE, V3, P203, DOI 10.1166/jno.2008.301; Liu TY, 2013, ISSCC DIG TECH PAP I, V56, P210, DOI 10.1109/ISSCC.2013.6487703; Miyamura M., 2011, 2011 IEEE International Solid-State Circuits Conference (ISSCC 2011), P228, DOI 10.1109/ISSCC.2011.5746296; Mountcastle V. B., 1998, CEREBRAL CORTEX; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Pershin YV, 2010, NEURAL NETWORKS, V23, P881, DOI 10.1016/j.neunet.2010.05.001; Pi S, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4827021; Schiffmann W, 1994, TECHNICAL REPORT; Seo K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254023; Strukov DB, 2009, P NATL ACAD SCI USA, V106, P20155, DOI 10.1073/pnas.0906949106; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Wong HSP, 2012, P IEEE, V100, P1951, DOI 10.1109/JPROC.2012.2190369; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]; Ziegler M, 2012, ADV FUNCT MATER, V22, P2744, DOI 10.1002/adfm.201200244	30	1678	1702	117	1246	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					61	64		10.1038/nature14441	http://dx.doi.org/10.1038/nature14441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951284	Green Submitted			2022-12-24	WOS:000354040900032
J	Zhang, HT; Unal, H; Gati, C; Han, GW; Liu, W; Zatsepin, NA; James, D; Wang, DJ; Nelson, G; Weierstall, U; Sawaya, MR; Xu, QP; Messerschmidt, M; Williams, GJ; Boutet, S; Yefanov, OM; White, TA; Wang, C; Ishchenko, A; Tirupula, KC; Desnoyer, R; Coe, J; Conrad, CE; Fromme, P; Stevens, RC; Katritch, V; Karnik, SS; Cherezov, V				Zhang, Haitao; Unal, Hamiyet; Gati, Cornelius; Han, Gye Won; Liu, Wei; Zatsepin, Nadia A.; James, Daniel; Wang, Dingjie; Nelson, Garrett; Weierstall, Uwe; Sawaya, Michael R.; Xu, Qingping; Messerschmidt, Marc; Williams, Garth J.; Boutet, Sebastien; Yefanov, Oleksandr M.; White, Thomas A.; Wang, Chong; Ishchenko, Andrii; Tirupula, Kalyan C.; Desnoyer, Russell; Coe, Jesse; Conrad, Chelsie E.; Fromme, Petra; Stevens, Raymond C.; Katritch, Vsevolod; Karnik, Sadashiva S.; Cherezov, Vadim			Structure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography	CELL			English	Article							II TYPE-1 RECEPTOR; AT(1A) CARBOXYL-TERMINUS; LIPIDIC CUBIC PHASE; AGONISTIC AUTOANTIBODIES; PROXIMAL REGION; OPIOID RECEPTOR; BINDING; GPCR; ACTIVATION; MANAGEMENT	Angiotensin II type 1 receptor (AT(1)R) is a G protein-coupled receptor that serves as a primary regulator for blood pressure maintenance. Although several anti-hypertensive drugs have been developed as AT(1)R blockers (ARBs), the structural basis for AT(1)R ligand-binding and regulation has remained elusive, mostly due to the difficulties of growing high-quality crystals for structure determination using synchrotron radiation. By applying the recently developed method of serial femtosecond crystallography at an X-ray free-electron laser, we successfully determined the room-temperature crystal structure of the human AT(1)R in complex with its selective antagonist ZD7155 at 2.9-angstrom resolution. The AT(1)R-ZD7155 complex structure revealed key structural features of AT(1)R and critical interactions for ZD7155 binding. Docking simulations of the clinically used ARBs into the AT(1)R structure further elucidated both the common and distinct binding modes for these antihypertensive drugs. Our results thereby provide fundamental insights into AT(1)R structure-function relationship and structure-based drug design.	[Zhang, Haitao; Stevens, Raymond C.; Katritch, Vsevolod] Univ So Calif, Dept Biol Sci, Bridge Inst, Los Angeles, CA 90089 USA; [Unal, Hamiyet; Tirupula, Kalyan C.; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Gati, Cornelius; Yefanov, Oleksandr M.; White, Thomas A.] DESY, Ctr Free Elect Laser Sci, D-22607 Hamburg, Germany; [Han, Gye Won; Ishchenko, Andrii; Stevens, Raymond C.; Cherezov, Vadim] Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Liu, Wei; Coe, Jesse; Conrad, Chelsie E.; Fromme, Petra] Arizona State Univ, Ctr Appl Struct Discovery, Biodesign Inst, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Zatsepin, Nadia A.; James, Daniel; Wang, Dingjie; Nelson, Garrett; Weierstall, Uwe] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Xu, Qingping] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Light Source, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Messerschmidt, Marc] BioXFEL Sci & Technol Ctr, Buffalo, NY 14203 USA; [Williams, Garth J.; Boutet, Sebastien] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Wang, Chong] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China	University of Southern California; Cleveland Clinic Foundation; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Southern California; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Harvard University; ShanghaiTech University	Cherezov, V (corresponding author), Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA.	cherezov@usc.edu	Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8673-2022; Messerschmidt, Marc/Y-8929-2019; Han, Gye Won/GLQ-8724-2022; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019; Zatsepin, Nadia/AAF-2451-2019; Messerschmidt, Marc/F-3796-2010; Liu, Wei/F-1820-2011; Karnik, Sadashiva/Y-2477-2019; Cherezov, Vadim/L-9812-2013; Zhang, Haitao/L-7612-2015; Stevens, Raymond/K-7272-2015	Messerschmidt, Marc/0000-0002-8641-3302; Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Messerschmidt, Marc/0000-0002-8641-3302; Karnik, Sadashiva/0000-0003-0746-2753; Cherezov, Vadim/0000-0002-5265-3914; Zhang, Haitao/0000-0003-4879-2951; Stevens, Raymond/0000-0002-4522-8725; Zatsepin, Nadia/0000-0003-1757-0205; Sawaya, Michael/0000-0003-0874-9043; James, Daniel/0000-0002-8348-6661; Yefanov, Oleksandr/0000-0001-8676-0091	NIH [R01 GM108635, U54 GM094618, P41 GM103393, R01 HL57470, R01 HL115964, U54 GM094599, R01 GM095583, U54 GM094586]; National Research Service [HL007914]; NSF BioXFEL Science and Technology center [1231306]; Helmholtz Gemeinschaft; BMBF [FKZ 05K12CH1]; PIER Helmholtz Graduate School; Helmholtz Association; Chinese 1000 Talent Program; DFG Cluster of Excellence "Center for Ultrafast Imaging''; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115964, T32HL007914, R01HL057470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583, P41GM103393, U54GM094599, R01GM108635, U54GM094586, U54GM094618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service; NSF BioXFEL Science and Technology center; Helmholtz Gemeinschaft(Helmholtz Association); BMBF(Federal Ministry of Education & Research (BMBF)); PIER Helmholtz Graduate School; Helmholtz Association(Helmholtz Association); Chinese 1000 Talent Program; DFG Cluster of Excellence "Center for Ultrafast Imaging''(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in parts by the NIH grants R01 GM108635 (V.C.), U54 GM094618 (target GPCR-11) (V.K., V.C., R.C.S.), P41 GM103393 (S.B.), R01 HL57470 (S.S.K.), R01 HL115964 (S.S.K.), U54 GM094599 (P.F.), R01 GM095583 (P.F.), U54 GM094586 (Q.X.), and National Research Service award HL007914 (H.U.). Further support was provided by the NSF BioXFEL Science and Technology center grant 1231306 (P.F., U.W, G.N.); the Helmholtz Gemeinschaft, the DFG Cluster of Excellence "Center for Ultrafast Imaging''; the BMBF project FKZ 05K12CH1 (C.G., O.M.Y., T.A.W.); the PIER Helmholtz Graduate School and the Helmholtz Association (C.G.); and the Chinese 1000 Talent Program (R.C.S.). Parts of this research were carried out at the LCLS, a National User Facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences, and at the GM/CA CAT of the Argonne Photon Source, Argonne National Laboratory. We thank J. Velasquez for help with molecular biology; T. Trinh and M. Chu for help with baculovirus expression; M. Metz, D. Oberthuer, A. Barty, S. Basu, and R. Fromme for help with the XFEL data collection and analysis, and R. Miller, K. Kadyshevskaya, and A. Walker for assistance with manuscript preparation. We are grateful to J. Spence and H. Chapman for their encouragement and support.	Akazawa H, 2013, CURR PHARM DESIGN, V19, P2988; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Balakumar P, 2012, CURR DIABETES REV, V8, P183, DOI 10.2174/157339912800563972; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Bricogne G, 2009, BUSTER VERSION 2 8 0; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Fu MLX, 2000, J HYPERTENS, V18, P945, DOI 10.1097/00004872-200018070-00017; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hart P., 2012, NUCL SCI S MED IM C; Imaizumi S, 2013, CURR PHARM DESIGN, V19, P3002; Junggren IL, 1996, J PHARM PHARMACOL, V48, P829, DOI 10.1111/j.2042-7158.1996.tb03983.x; Kamimori H, 2005, ANAL SCI, V21, P171, DOI 10.2116/analsci.21.171; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Liu W, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0314; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miura S, 2003, J BIOL CHEM, V278, P3720, DOI 10.1074/jbc.M211338200; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Miura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079914; Miura S, 2013, HYPERTENS RES, V36, P134, DOI 10.1038/hr.2012.147; Miura S, 2011, J RENIN-ANGIO-ALDO S, V12, P1, DOI 10.1177/1470320310370852; Mozsolits H, 2002, BIOCHEMISTRY-US, V41, P7830, DOI 10.1021/bi0121813; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Ramanath VS, 2009, MAYO CLIN PROC, V84, P465, DOI 10.1016/S0025-6196(11)60566-1; Ramchandran R, 2006, P NATL ACAD SCI USA, V103, P19087, DOI 10.1073/pnas.0602715103; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Shenoy S.K., 2005, SCI STKE 2005, V2005, pcm14; Takezako T, 2004, J BIOL CHEM, V279, P15248, DOI 10.1074/jbc.M312728200; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; THOMAS WG, 1995, J BIOL CHEM, V270, P22153, DOI 10.1074/jbc.270.38.22153; Thomas WG, 1999, FEBS LETT, V455, P367, DOI 10.1016/S0014-5793(99)00904-7; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Unal H, 2014, J FINANC SERV RES, V45, P1, DOI 10.1007/s10693-014-0191-9; Unal H, 2012, ADV EXP MED BIOL, V749, P187, DOI 10.1007/978-1-4614-3381-1_13; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xia Y, 2013, CIRC RES, V113, P78, DOI 10.1161/CIRCRESAHA.113.300752; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	55	253	256	2	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					833	844		10.1016/j.cell.2015.04.011	http://dx.doi.org/10.1016/j.cell.2015.04.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25913193	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-24	WOS:000354175200016
J	Raschle, M; Smeenk, G; Hansen, RK; Temu, T; Oka, Y; Hein, MY; Nagaraj, N; Long, DT; Walter, JC; Hofmann, K; Storchova, Z; Cox, J; Bekker-Jensen, S; Mailand, N; Mann, M				Raeschle, Markus; Smeenk, Godelieve; Hansen, Rebecca K.; Temu, Tikira; Oka, Yasuyoshi; Hein, Marco Y.; Nagaraj, Nagarjuna; Long, David T.; Walter, Johannes C.; Hofmann, Kay; Storchova, Zuzana; Cox, Juergen; Bekker-Jensen, Simon; Mailand, Niels; Mann, Matthias			Proteomics reveals dynamic assembly of repair complexes during bypass of DNA cross-links	SCIENCE			English	Article							STRAND-BREAK REPAIR; REPLICATION STRESS; SMC5/6; DAMAGE; IDENTIFICATION; KIAA1018/FAN1; RECRUITMENT; DEFICIENCY; MECHANISM; CELLS	DNA interstrand cross-links (ICLs) block replication fork progression by inhibiting DNA strand separation. Repair of ICLs requires sequential incisions, translesion DNA synthesis, and homologous recombination, but the full set of factors involved in these transactions remains unknown. We devised a technique called chromatin mass spectrometry (CHROMASS) to study protein recruitment dynamics during perturbed DNA replication in Xenopus egg extracts. Using CHROMASS, we systematically monitored protein assembly and disassembly on ICL-containing chromatin. Among numerous prospective DNA repair factors, we identified SLF1 and SLF2, which form a complex with RAD18 and together define a pathway that suppresses genome instability by recruiting the SMC5/6 cohesion complex to DNA lesions. Our study provides a global analysis of an entire DNA repair pathway and reveals the mechanism of SMC5/6 relocalization to damaged DNA in vertebrate cells. Copyright 2015, American Association for the Advancement of Science.	[Raeschle, Markus; Temu, Tikira; Hein, Marco Y.; Nagaraj, Nagarjuna; Cox, Juergen; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Smeenk, Godelieve; Hansen, Rebecca K.; Oka, Yasuyoshi; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Ubiquitin Signaling Grp, Dept Dis Biol, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Long, David T.; Walter, Johannes C.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Long, David T.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Storchova, Zuzana] Max Planck Inst Biochem, Maintenance Genome Stabil Grp, D-82152 Martinsried, Germany; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Mann, Matthias] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Prote Program, DK-2200 Copenhagen, Denmark	Max Planck Society; University of Copenhagen; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Max Planck Society; University of Cologne; University of Copenhagen	Bekker-Jensen, S (corresponding author), Univ Copenhagen, Ubiquitin Signaling Grp, Dept Dis Biol, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark.	simon.bekker-jensen@cpr.ku.dk; niels.mailand@cpr.ku.dk; mmann@biochem.mpg.de	Cox, Jurgen/B-9481-2008; Hein, Marco/C-2994-2014	Cox, Jurgen/0000-0001-8597-205X; Hein, Marco/0000-0002-9490-2261; Walter, Johannes/0000-0002-4186-7570; Long, David/0000-0001-9232-0316; Storchova, Zuzana/0000-0003-2376-7047	Center for Integrated Protein Research Munich (CIPSM); Novo Nordisk Foundation; Danish Medical Research Council; Danish Cancer Society; Lundbeck Foundation; Bundesministerium fur Bildung und Forschung [FKZ01GS0861]; European Committees Marie Sklodowska-Curie actions [PIEF-GA-2012-330675]; 7th Framework Program PROSPECTS [HEALTH-F4-2008-201648]; NIH [HL098316]; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM102325] Funding Source: NIH RePORTER	Center for Integrated Protein Research Munich (CIPSM); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Committees Marie Sklodowska-Curie actions; 7th Framework Program PROSPECTS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation Center for Protein Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hyman and I. Poser for providing BAC cell lines; I. Hickson for providing BLM-deficient and -corrected cells; J. Huang for reagents; J. Cox, F. Gnad, M. Oroshi, R. Scheltema, and C. Schaab for bioinformatics support; S. Schmalbrock, A. Sewo Pires de Campos, C. Kuffer, and A. Kutznetsova for help with microscopy; K. Mayr, I. Paron, G. Sowa, S. Kroiss, B. Splettstosser, and people from the Max Planck animal facility for support; and S. Gruber, B. Pfander, M. Steger, M. Wierer, and F. Coscia for discussion and reading the manuscript. Supported by the Center for Integrated Protein Research Munich (CIPSM), the Novo Nordisk Foundation, the Danish Medical Research Council, the Danish Cancer Society, the Lundbeck Foundation, the Bundesministerium fur Bildung und Forschung (grant FKZ01GS0861, DiGtoP consortium) and the European Committees Marie Sklodowska-Curie actions (grant PIEF-GA-2012-330675) and 7th Framework Program PROSPECTS (HEALTH-F4-2008-201648). J.C.W. was supported by NIH grant HL098316. J.C.W. is an investigator of the Howard Hughes Medical Institute. The mass spectrometry data have been deposited at Proteome Exchange: http://proteomecentral.proteomexchange.org.	Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bustard DE, 2012, J BIOL CHEM, V287, P11374, DOI 10.1074/jbc.M111.336263; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Helchowski CM, 2013, CELL CYCLE, V12, P3749, DOI 10.4161/cc.26640; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lee KM, 2007, GENETICS, V175, P1585, DOI 10.1534/genetics.106.067801; Leung GP, 2011, J BIOL CHEM, V286, P26250, DOI 10.1074/jbc.M111.235200; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Liu T, 2012, DNA REPAIR, V11, P131, DOI 10.1016/j.dnarep.2011.10.012; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sale JE, 2012, J CELL SCI, V125, P1633, DOI 10.1242/jcs.094748; Sheedy DM, 2005, GENETICS, V171, P457, DOI 10.1534/genetics.105.044966; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	38	121	122	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234							1253671	10.1126/science.1253671	http://dx.doi.org/10.1126/science.1253671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931565	Green Accepted			2022-12-24	WOS:000353778100032
J	Allred, BW; Smith, WK; Twidwell, D; Haggerty, JH; Running, SW; Naugle, DE; Fuhlendorf, SD				Allred, Brady W.; Smith, W. Kolby; Twidwell, Dirac; Haggerty, Julia H.; Running, Steven W.; Naugle, David E.; Fuhlendorf, Samuel D.			Ecosystem services lost to oil and gas in North America	SCIENCE			English	Editorial Material							ENERGY DEVELOPMENT; FRAMEWORK; FRACKING; RISKS		[Allred, Brady W.; Smith, W. Kolby; Running, Steven W.; Naugle, David E.] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Smith, W. Kolby] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Twidwell, Dirac] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA; [Haggerty, Julia H.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Fuhlendorf, Samuel D.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	University of Montana System; University of Montana; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Lincoln; Montana State University System; Montana State University Bozeman; Oklahoma State University System; Oklahoma State University - Stillwater	Allred, BW (corresponding author), Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA.	brady.allred@umontana.edu	Noojipady, Praveen/B-2511-2010; Fuhlendorf, Samuel/A-2931-2011	Twidwell, Dirac/0000-0002-0280-3339; Fuhlendorf, Samuel/0000-0002-8726-9402; Smith, William/0000-0002-5785-6489; Haggerty, Julia/0000-0003-2073-4063	Office of Integrative Activities [1443108] Funding Source: National Science Foundation	Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))		Butt N, 2013, SCIENCE, V342, P425, DOI 10.1126/science.1237261; Drummond M. A., 2012, LAND COVER TRENDS US; Food and Agriculture Organization of the United Nations, 2014, WAT EN FOOD NEX; Gassert F., 2013, WORKING PAPER; International Energy Agency, 2013, WORLD EN OUTL 2013; Jackson RB, 2014, ANNU REV ENV RESOUR, V39, P327, DOI 10.1146/annurev-environ-031113-144051; Jacquet JB, 2014, ENVIRON SCI TECHNOL, V48, P8321, DOI 10.1021/es404647x; Jones NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081391; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; Mitchell AL, 2011, ENVIRON SCI TECHNOL, V45, P9506, DOI 10.1021/es2021796; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Peters DPC, 2008, FRONT ECOL ENVIRON, V6, P229, DOI 10.1890/070098; Rabe BG, 2014, ENVIRON SCI TECHNOL, V48, P8369, DOI 10.1021/es4051132; Smith WK, 2012, ENVIRON SCI TECHNOL, V46, P3536, DOI 10.1021/es203935d; Sontag D, 2014, NEW YORK TIMES; US Energy Information Administration, 2013, INT EN OUTL; Vengosh A, 2014, ENVIRON SCI TECHNOL, V48, P8334, DOI 10.1021/es405118y; Warner B, 2013, PUBLIUS J FEDERALISM, V43, P474, DOI 10.1093/publius/pjt014; Weber JG, 2012, ENERG ECON, V34, P1580, DOI 10.1016/j.eneco.2011.11.013; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	20	176	184	2	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					401	402		10.1126/science.aaa4785	http://dx.doi.org/10.1126/science.aaa4785			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG5NF	25908812				2022-12-24	WOS:000353338000021
J	Kiers, ET; West, SA				Kiers, E. Toby; West, Stuart A.			Evolving new organisms via symbiosis	SCIENCE			English	Editorial Material							TRANSMISSION		[Kiers, E. Toby] Vrije Univ, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Vrije Universiteit Amsterdam; University of Oxford	Kiers, ET (corresponding author), Vrije Univ, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands.	toby.kiers@vu.nl	Toby, Kiers/H-4819-2017; West, Stuart/M-3608-2014	Toby, Kiers/0000-0002-0597-1653; West, Stuart/0000-0003-2152-3153				Archibald J, 2014, ONE PLUS ONE EQUALS; Bennett GM, 2013, GENOME BIOL EVOL, V5, P1675, DOI 10.1093/gbe/evt118; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Gruber-Vodicka HR, 2011, P NATL ACAD SCI USA, V108, P12078, DOI 10.1073/pnas.1105347108; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; McCutcheon JP, 2014, CURR BIOL, V24, pR654, DOI 10.1016/j.cub.2014.05.073; McFall-Ngai M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001783; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Porter SS, 2014, ECOL LETT, V17, P1121, DOI 10.1111/ele.12318; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Szathmary E, 1995, MAJOR TRANSITIONS EV; Van Leuven JT, 2014, CELL, V158, P1270, DOI 10.1016/j.cell.2014.07.047	15	48	48	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					392	394		10.1126/science.aaa9605	http://dx.doi.org/10.1126/science.aaa9605			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908807				2022-12-24	WOS:000353338000016
J	Marx, V				Marx, Vivien			A MOST EXCEPTIONAL RESPONSE	NATURE			English	Editorial Material							EVEROLIMUS											Costello J. C., 2015, NAT BIOTECHNOL, V32, P1202; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Friend SH, 2014, SCIENCE, V344, P970, DOI 10.1126/science.1255648; Gorry PR, 2002, LANCET, V359, P1832, DOI 10.1016/S0140-6736(02)08681-6; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352	6	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					389	393		10.1038/520389a	http://dx.doi.org/10.1038/520389a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877204				2022-12-24	WOS:000352974200050
J	Lauressergues, D; Couzigou, JM; Clemente, HS; Martinez, Y; Dunand, C; Becard, G; Combier, JP				Lauressergues, Dominique; Couzigou, Jean-Malo; Clemente, Helene San; Martinez, Yves; Dunand, Christophe; Becard, Guillaume; Combier, Jean-Philippe			Primary transcripts of microRNAs encode regulatory peptidesPrimary transcripts of microRNAs encode regulatory peptides	NATURE			English	Article							EXPRESSION	MicroRNAs (miRNAs) are small regulatory RNA molecules that inhibit the expression of specific target genes by binding to and cleaving their messenger RNAs or otherwise inhibiting their translation into proteins(1). miRNAs are transcribed as much larger primary transcripts (pri-miRNAs), the function of which is not fully understood. Here we show that plant pri-miRNAs contain short open reading frame sequences that encode regulatory peptides. The pri-miR171b of Medicago truncatula and the pri-miR165a of Arabid-opsis thaliana produce peptides, which we term miPEP171b and miPEP165a, respectively, that enhance the accumulation of their corresponding mature miRNAs, resulting in downregulation of target genes involved in root development. The mechanism of miRNA-encoded peptide (miPEP) action involves increasing transcription of the pri-miRNA. Five other pri-miRNAs of A. thaliana and M. truncatula encode active miPEPs, suggesting that miPEPs are widespread throughout the plant kingdom. Synthetic miPEP171b and miPEP165a peptides applied to plants specifically trigger the accumulation of miR171b and miR165a, leading to reduction of lateral root development and stimulation of mainroot growth, respectively, suggesting that miPEPs might have agronomical applications.	[Lauressergues, Dominique; Couzigou, Jean-Malo; Clemente, Helene San; Dunand, Christophe; Becard, Guillaume; Combier, Jean-Philippe] Univ Toulouse, UPS, UMR5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Lauressergues, Dominique; Couzigou, Jean-Malo; Clemente, Helene San; Dunand, Christophe; Becard, Guillaume; Combier, Jean-Philippe] CNRS, UMR5546, F-31326 Castanet Tolosan, France; [Martinez, Yves] Federat Rech FR3450 CNRS, F-31326 Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Combier, JP (corresponding author), Univ Toulouse, UPS, UMR5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France.	combier@lrsv.ups-tlse.fr	Dunand, Christophe/I-6424-2012	Dunand, Christophe/0000-0003-1637-4042; Couzigou, Jean-Malo/0000-0002-1362-6286	French ANR project miRcorrhiza [ANR-12-JSV7-0002-01]; CNRS; Paul Sabatier University Toulouse; Toulouse Tech Transfer	French ANR project miRcorrhiza(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Paul Sabatier University Toulouse; Toulouse Tech Transfer	This work was funded by the French ANR project miRcorrhiza (ANR-12-JSV7-0002-01), the CNRS, Paul Sabatier University Toulouse. This work is also supported by Toulouse Tech Transfer (http://www.toulouse-tech-transfer.com) for valorization and transfer. It was carried out in the LRSV which belongs to the Laboratoire d'Excellence entitled TULIP (ANR-10-LABX-41). We thank the GenoToul bioinformatics facility for providing computing and storage resources. We also thank J.-M. Prosperi (UMR AGAP 1334, Montpellier, France) for M. truncatula seeds, X. Chen (University of California, USA) for nrpb2-3 seeds, V. Cotelle (LRSV) for help with protein analyses, C. Rosenberg (LIPM, Castanet Tolosan, France) for providing modified pCAMBIA 2200, and F. Payre and S. Plaza (CBD CNRS, Toulouse), J. Cavaille (LBME CNRS, Toulouse) and C. Featherstone for critical reading of the manuscript.	Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fliegmann J, 2013, ACS CHEM BIOL, V8, P1900, DOI 10.1021/cb400369u; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Juntawong P, 2014, P NATL ACAD SCI USA, V111, pE203, DOI 10.1073/pnas.1317811111; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Lauressergues D, 2012, PLANT J, V72, P512, DOI 10.1111/j.1365-313X.2012.05099.x; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009	13	254	291	4	300	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					90	U205		10.1038/nature14346	http://dx.doi.org/10.1038/nature14346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25807486				2022-12-24	WOS:000352027700043
J	Fares, S; Mugnozza, GS; Corona, P; Palahi, M				Fares, Silvano; Mugnozza, Giuseppe Scarascia; Corona, Piermaria; Palahi, Marc			Five steps for managing Europe's forests	NATURE			English	Editorial Material									[Fares, Silvano] Council Agr Res & Econ, Res Ctr Soil Plant Syst, Rome, Italy; [Mugnozza, Giuseppe Scarascia] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, Viterbo, Italy; [Corona, Piermaria] Council Agr Res & Econ, Forestry Res Ctr, Arezzo, Italy; [Palahi, Marc] European Forest Inst, Joensuu, Finland	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Tuscia University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Fares, S (corresponding author), Council Agr Res & Econ, Res Ctr Soil Plant Syst, Rome, Italy.	silvano.fares@entecra.it	Corona, Piermaria/G-1565-2011; Fares, Silvano/H-4322-2011	Corona, Piermaria/0000-0002-8105-0792; Fares, Silvano/0000-0002-1990-0928				Bellassen V, 2014, NATURE, V506, P153, DOI 10.1038/506153a; Birot Y., 2009, LIVING WITH WILDFIRE; Forest Europe UNECE and FAO, 2011, STATE OF EUROPES FOR; Hardiman BS, 2013, FOREST ECOL MANAG, V298, P111, DOI 10.1016/j.foreco.2013.02.031; Hetemaki L., 2014, THINKFOREST FOREST B; Kolstrom M, 2011, FORESTS, V2, P961, DOI 10.3390/f2040961; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Nabuurs GJ, 2013, NAT CLIM CHANGE, V3, P792, DOI [10.1038/NCLIMATE1853, 10.1038/nclimate1853]; Prokofieva I., 2012, PAYMENTS FOR ENVIRON; Stocker T. F., 2013, CLIMATE CHANGE 2013	10	58	61	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					407	409		10.1038/519407a	http://dx.doi.org/10.1038/519407a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25810187	Bronze			2022-12-24	WOS:000351602800029
J	Yanovski, SZ; Yanovski, JA				Yanovski, Susan Z.; Yanovski, Jack A.			Naltrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OVERWEIGHT; WEIGHT		[Yanovski, Susan Z.] NIDDK, Div Digest Dis & Nutr, Bethesda, MD 20892 USA; [Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Obes, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yanovski, SZ (corresponding author), NIDDK, Off Obes Res, 6707 Democracy Blvd,Room 675, Bethesda, MD 20892 USA.	sy29f@nih.gov		Yanovski, Jack/0000-0001-8542-1637	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HD999999, ZIA HD000641-21, ZIA HD000641] Funding Source: Medline; PHS HHS [1ZIAHD000641] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2014, CONTRAVE NALTREXONE; [Anonymous], FDA BRIEFING DOCUMEN; Apovian CM, 2013, OBESITY, V21, P935, DOI 10.1002/oby.20309; Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4; Hollander P, 2013, DIABETES CARE, V36, P4022, DOI 10.2337/dc13-0234; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; Wadden TA, 2011, OBESITY, V19, P110, DOI 10.1038/oby.2010.147; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	9	43	43	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2015	313	12					1213	1214		10.1001/jama.2015.1617	http://dx.doi.org/10.1001/jama.2015.1617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD9RJ	25803343	Green Accepted			2022-12-24	WOS:000351435500016
J	Frick, M; von Delft, D; Kumar, B				Frick, Mike; von Delft, Dalene; Kumar, Blessina			PERSONAL VIEW End stigmatizing language in tuberculosis research and practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATHWAYS; CARE; HIV		[Frick, Mike] Treatment Act GrpN, New York, NY 10016 USA; [von Delft, Dalene] TB Proof, Cape Town, South Africa; [Kumar, Blessina] Global Coalit TB Activists, New Delhi, India		Frick, M (corresponding author), Treatment Act GrpN, New York, NY 10016 USA.	mike.frick@treatmentactiongroup.org						[Anonymous], 2011, SUGG LANG US TUB CAR; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Daftary A, 2015, AIDS, V29, P1, DOI 10.1097/QAD.0000000000000515; DeLuca A, 2014, LANCET RESP MED, V2, P258, DOI 10.1016/S2213-2600(14)70035-9; Ditiu L, 2012, INT J TUBERC LUNG D, V16, P711, DOI 10.5588/ijtld.12.0297; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Harrington M, 2010, CLIN INFECT DIS, V50, pS260, DOI 10.1086/651500; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Naidoo P, 2009, QUAL HEALTH RES, V19, P55, DOI 10.1177/1049732308327893; Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447; Shaw Dorothy, 2015, COMMUNICATION; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Watkins RE, 2004, QUAL HEALTH RES, V14, P691, DOI 10.1177/1049732304263628; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	14	14	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2015	350								h1479	10.1136/bmj.h1479	http://dx.doi.org/10.1136/bmj.h1479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NK	25805838				2022-12-24	WOS:000352028400005
J	Frank, DD; Jouandet, GC; Kearney, PJ; Macpherson, LJ; Gallio, M				Frank, Dominic D.; Jouandet, Genevieve C.; Kearney, Patrick J.; Macpherson, Lindsey J.; Gallio, Marco			Temperature representation in the Drosophila brain	NATURE			English	Article							FLUORESCENT PROTEINS; ANTENNAL LOBE; CIRCUIT; NEURONS; MELANOGASTER; NEUROBIOLOGY; MARKER; GFP	In Drosophila, rapid temperature changes are detected at the periphery by dedicated receptors forming a simple sensory map for hot and cold in the brain(1). However, flies show a host of complex innate and learned responses to temperature, indicating that they are able to extract a range of information from this simple input. Here we define the anatomical and physiological repertoire for temperature representation in the Drosophila brain. First, we use a photolabelling strategy(2) to trace the connections that relay peripheral thermosensory information to higher brain centres, and show that they largely converge onto three target regions: the mushroom body, the lateral horn (both of which are well known centres for sensory processing) and the posterior lateral protocerebrum, a region we now define as a major site of thermosensory representation. Next, using in vivo calcium imaging(3), we describe the thermosensory projection neurons selectively activated by hot or cold stimuli. Fast-adapting neurons display transient ON and OFF responses and track rapid temperature shifts remarkably well, while slow-adapting cell responses better reflect the magnitude of simple thermal changes. Unexpectedly, we also find a population of broadly tuned cells that respond to both heating and cooling, and show that they are required for normal behavioural avoidance of both hot and cold in a simple two-choice temperature preference assay. Taken together, our results uncover a coordinated ensemble of neural responses to temperature in the Drosophila brain, demonstrate that a broadly tuned thermal line contributes to rapid avoidance behaviour, and illustrate how stimulus quality, temporal structure, and intensity can be extracted from a simple glomerular map at a single synaptic station.	[Frank, Dominic D.; Jouandet, Genevieve C.; Kearney, Patrick J.; Gallio, Marco] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Macpherson, Lindsey J.] Columbia Univ, Dept Biochem, New York, NY 10032 USA; [Macpherson, Lindsey J.] Columbia Univ, Dept Mol Biophys, New York, NY 10032 USA	Northwestern University; Columbia University; Columbia University	Gallio, M (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	marco.gallio@northwestern.edu		Gallio, Marco/0000-0003-2132-0639; Kearney, Patrick/0000-0002-7145-5964; Macpherson, Lindsey/0000-0002-1089-3733	NIH [1R01NS086859-01];  [2T32MH067564]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076774, R01NS086859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Ruta and B. Noro for providing PA-GFP flies and reagents, and especially G. Rubin for providing access to the FlyLight collection before publication. We are grateful to N. Ryba, D. Yarmolinsky, C. Zuker and members of the Gallio laboratory for critical comments on the manuscript. Z. Turan and A. Kuang provided technical assistance and we thank C. Ulmer and a number of undergraduate students for fly husbandry. This work was supported by NIH grant 1R01NS086859-01 (to M.G.) and by training grant 2T32MH067564 (to D.D.F.).	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bruckner S, 2009, IEEE T VIS COMPUT GR, V15, P1497, DOI 10.1109/TVCG.2009.121; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Karuppudurai T, 2014, NEURON, V81, P603, DOI 10.1016/j.neuron.2013.12.010; Lai JSY, 2012, P NATL ACAD SCI USA, V109, P2607, DOI 10.1073/pnas.1117307109; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	22	90	91	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					358	+		10.1038/nature14284	http://dx.doi.org/10.1038/nature14284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25739506	Green Accepted			2022-12-24	WOS:000351171900042
J	Kimsey, IJ; Petzold, K; Sathyamoorthy, B; Stein, ZW; Al-Hashimi, HM				Kimsey, Isaac J.; Petzold, Katja; Sathyamoorthy, Bharathwaj; Stein, Zachary W.; Al-Hashimi, Hashim M.			Visualizing transient Watson-Crick-like mispairs in DNA and RNA duplexes	NATURE			English	Article							RARE TAUTOMER HYPOTHESIS; STRUCTURAL BASIS; ROTATING-FRAME; NUCLEIC-ACIDS; BASE-PAIR; N-15 NMR; RELAXATION DISPERSION; CHEMICAL-EXCHANGE; POLYMERASE-I; REPLICATION	Rare tautomeric and anionic nucleobases are believed to have fundamental biological roles, but their prevalence and functional importance has remained elusive because they exist transiently, in low abundance, and involve subtle movements of protons that are difficult to visualize. Using NMR relaxation dispersion, we show here that wobble dG.dT and rG.rU mispairs in DNA and RNA duplexes exist in dynamic equilibrium with short-lived, low-populated Watson-Crick-like mispairs that are stabilized by rare enolic or anionic bases. These mispairs can evade Watson-Crick fidelity checkpoints and form with probabilities (10(-3) to 10(-5)) that strongly imply a universal role in replication and translation errors. Our results indicate that rare tautomeric and anionic bases are widespread in nucleic acids, expanding their structural and functional complexity beyond that attainable with canonical bases.	[Kimsey, Isaac J.; Sathyamoorthy, Bharathwaj; Al-Hashimi, Hashim M.] Duke Univ Med Ctr, Dept Biochem & Chem, Durham, NC 27710 USA; [Petzold, Katja] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Stein, Zachary W.] Univ Michigan, Ann Arbor, MI 48109 USA	Duke University; Karolinska Institutet; University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Duke Univ Med Ctr, Dept Biochem & Chem, Durham, NC 27710 USA.	hashim.al.hashimi@duke.edu	Petzold, Katja/M-7298-2015; Petzold, Katja/E-9816-2011; Sathyamoorthy, Bharathwaj/ABG-2715-2020	Petzold, Katja/0000-0001-9470-0347; Petzold, Katja/0000-0001-9470-0347; Sathyamoorthy, Bharathwaj/0000-0002-1568-2599	NIH [R01GM089846]; Agilent Thought Leader Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agilent Thought Leader Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Horowitz, H. Zhou, J. Lee, A. M. Mustoe, and E. N. Nikolova for assistance and critical comments. We are grateful for technical support and resources from the Duke Magnetic Resonance Spectroscopy Center and University of Michigan Flux HPC Cluster. This work was supported by an NIH grant (R01GM089846) and an Agilent Thought Leader Award given to H.M.A.	[Anonymous], 2009, GAUSSIAN 09; Bebenek K, 2011, P NATL ACAD SCI USA, V108, P1862, DOI 10.1073/pnas.1012825108; Bevilacqua PC, 2006, CURR OPIN CHEM BIOL, V10, P455, DOI 10.1016/j.cbpa.2006.08.014; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Bothe JR, 2014, J MAGN RESON, V244, P18, DOI 10.1016/j.jmr.2014.04.010; Brovarets O. O., 2010, Biopolymers and Cell, V26, P398; Brovarets O. O., 2013, REP NATL ACAD SCI UK, V4, P154; Brovarets O.O., 2009, UKRAIN BIOORG ACTA 2, V8, P12; Brovarets' OO, 2014, J BIOMOL STRUCT DYN, V32, P993, DOI 10.1080/07391102.2013.799439; Cantara WA, 2013, P NATL ACAD SCI USA, V110, P10964, DOI 10.1073/pnas.1222641110; Cavanagh J., 1995, PROTEIN NMR SPECTROS; CHO BP, 1990, CHEM RES TOXICOL, V3, P445, DOI 10.1021/tx00017a010; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Czernek J, 2000, J MAGN RESON, V145, P142, DOI 10.1006/jmre.2000.2091; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dethoff EA, 2012, NATURE, V491, P724, DOI 10.1038/nature11498; DOSANJH MK, 1991, BIOCHEMISTRY-US, V30, P11595, DOI 10.1021/bi00113a015; DOSANJH MK, 1990, BIOCHEMISTRY-US, V29, P4698, DOI 10.1021/bi00471a026; DRIGGERS PH, 1988, BIOCHEMISTRY-US, V27, P1729, DOI 10.1021/bi00405a052; DUTHALER RO, 1978, J AM CHEM SOC, V100, P4969, DOI 10.1021/ja00484a008; ECKERT KA, 1993, J BIOL CHEM, V268, P13462; Farjon J, 2009, J AM CHEM SOC, V131, P8571, DOI 10.1021/ja901633y; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Gilbert SD, 2009, STRUCTURE, V17, P857, DOI 10.1016/j.str.2009.04.009; GOSWAMI B, 1993, J AM CHEM SOC, V115, P3832, DOI 10.1021/ja00062a082; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Hansen AL, 2014, P NATL ACAD SCI USA, V111, pE1705, DOI 10.1073/pnas.1400577111; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Harris VH, 2003, J MOL BIOL, V326, P1389, DOI 10.1016/S0022-2836(03)00051-2; Hoogstraten CG, 2000, BIOCHEMISTRY-US, V39, P9951, DOI 10.1021/bi0007627; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P11233, DOI 10.1093/nar/gku789; Kochina O. S., 2008, REP NATL ACAD SCI UK, V1, P181; Korzhnev DM, 2005, J AM CHEM SOC, V127, P713, DOI 10.1021/ja0446855; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; Li DY, 2014, P NATL ACAD SCI USA, V111, pE3252, DOI 10.1073/pnas.1405635111; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Miloushev VZ, 2005, J MAGN RESON, V177, P221, DOI 10.1016/j.jmr.2005.07.023; Nikolova EN, 2012, J AM CHEM SOC, V134, P3667, DOI 10.1021/ja2117816; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; Nomura K., 2013, J MOD PHYS, V4, P422, DOI DOI 10.4236/JMP.2013.43A059; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Orozco M, 1998, J PHYS CHEM B, V102, P5228, DOI 10.1021/jp981005+; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Palmer AG, 2014, J MAGN RESON, V241, P3, DOI 10.1016/j.jmr.2014.01.008; Sathyamoorthy B, 2014, J BIOMOL NMR, V60, P77, DOI 10.1007/s10858-014-9856-9; Satpati P, 2014, NUCLEIC ACIDS RES, V42, P12876, DOI 10.1093/nar/gku1044; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; SINGER B, 1989, P NATL ACAD SCI USA, V86, P8271, DOI 10.1073/pnas.86.21.8271; SINGER B, 1990, MUTAT RES, V233, P45, DOI 10.1016/0027-5107(90)90150-3; Singh V, 2014, ACS CHEM BIOL, V9, P227, DOI 10.1021/cb400581f; SOWERS LC, 1989, J MOL BIOL, V205, P437, DOI 10.1016/0022-2836(89)90353-7; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0; TOPAL MD, 1976, NATURE, V263, P285, DOI 10.1038/263285a0; Trott O, 2004, J MAGN RESON, V170, P104, DOI 10.1016/j.jmr.2004.06.005; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wang WN, 2011, P NATL ACAD SCI USA, V108, P17644, DOI 10.1073/pnas.1114496108; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P498, DOI 10.1038/nsmb1242; Wijmenga SS, 1998, PROG NUCL MAG RES SP, V32, P287, DOI 10.1016/S0079-6565(97)00023-X; Xia SL, 2014, BIOCHEMISTRY-US, V53, P2752, DOI 10.1021/bi4014215; Xia SL, 2014, PROTEIN SCI, V23, P508, DOI 10.1002/pro.2434; Xu XP, 2000, J PHYS CHEM B, V104, P5641, DOI 10.1021/jp0007538; YU H, 1993, J BIOL CHEM, V268, P15935; Zhang ZQ, 2013, BIOCHEMISTRY-US, V52, P8165, DOI 10.1021/bi401002c; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; ZIMMER DP, 1995, P NATL ACAD SCI USA, V92, P3091, DOI 10.1073/pnas.92.8.3091	77	157	157	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					315	+		10.1038/nature14227	http://dx.doi.org/10.1038/nature14227			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762137	Green Accepted			2022-12-24	WOS:000351171900033
J	Kandala, NB; Connock, M; Pulikottil-Jacob, R; Sutcliffe, P; Crowther, MJ; Grove, A; Mistry, H; Clarke, A				Kandala, Ngianga-Bakwin; Connock, Martin; Pulikottil-Jacob, Ruth; Sutcliffe, Paul; Crowther, Michael J.; Grove, Amy; Mistry, Hema; Clarke, Aileen			Setting benchmark revision rates for total hip replacement: analysis of registry evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL DEVICES; FAILURE; JOINT; PROSTHESES; MODELS	Objective To compare 10 year revision rates for frequently used types of primary total hip replacement to inform setting of a new benchmark rate in England and Wales that will be of international relevance. Design Retrospective cohort study. Setting National Joint Registry. Participants 239 000 patient records. Main outcome measures Revision rates for five frequently used types of total hip replacement that differed according to bearing surface and fixation mode, encompassing 62% of all primary total hip replacements in the National Joint Registry for England and Wales. Revision rates were compared using Kaplan-Meier and competing risks analyses, and five and 10 year rates were estimated using well fitting parametric models. Results Estimated revision rates at 10 years were 4% or below for four of the five types of total hip replacement investigated. Rates differed little according to Kaplan-Meier or competing risks analysis, but differences between prosthesis types were more substantial. Cemented prostheses with ceramic-on-polyethylene bearing surfaces had the lowest revision rates (1.88-2.11% at 10 years depending on the method used), and cementless prostheses with ceramic-on-ceramic bearing surfaces had the highest revision rates (3.93-4.33%). Men were more likely to receive revision of total hip replacement than were women, and this difference was statistically significant for four of the five prosthesis types. Conclusions Ten year revision rate estimates were all less than 5%, and in some instances considerably less. The results suggest that the current revision rate benchmark should be at least halved from 10% to less than 5% at 10 years. This has implications for benchmarks internationally.	[Kandala, Ngianga-Bakwin; Connock, Martin; Pulikottil-Jacob, Ruth; Sutcliffe, Paul; Grove, Amy; Mistry, Hema; Clarke, Aileen] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick Evidence, Coventry CV4 7AL, W Midlands, England; [Crowther, Michael J.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England	University of Warwick; University of Leicester	Clarke, A (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick Evidence, Coventry CV4 7AL, W Midlands, England.	Aileen.Clarke@warwick.ac.uk	Clarke, Aileen/I-5679-2012; Crowther, Michael/AAL-9932-2021; Sutcliffe, Paul/AAB-7325-2020	Clarke, Aileen/0000-0001-8299-3146; Grove, Prof Amy/0000-0002-8027-7274; Mistry, Hema/0000-0002-5023-1160; Crowther, Michael/0000-0001-8378-8259; Pulikottil-Jacob, Ruth/0000-0003-0630-960X	Health Technology Assessment programme [11/118]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust; NIHR [DRF-2013-06-064, DRF-2012-05-409]; National Institute for Health Research [DRF-2012-05-409] Funding Source: researchfish	Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the Health Technology Assessment programme (project number 11/118). Further information is available at www.nets.nihr.ac.uk/programmes/hta. N-BK and AC are also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at University Hospitals Birmingham NHS Foundation Trust. AG is supported by the NIHR Doctoral Fellowship Programme (project number DRF-2013-06-064), and MJC is funded by an NIHR doctoral research fellowship (DRF-2012-05-409). This report presents independent research commissioned by the NIHR) to support the work of the National Institute for Health and Care Excellence (NICE). The views and opinions expressed in this publication are those of the authors and do not necessarily reflect those of the NHS, NICE, NIHR, MRC, CCF, NETSCC, Health Technology Assessment programme, or Department of Health.	American Joint Replacement Registry, 2013, AB US; [Anonymous], 2013, DEPUY ASR HIP REC GU; [Anonymous], 2011, INTRO NEW PROSTH WEB; Australian Orthopaedic Association National Joint Replacement Registry, 2012, ANN REP 2012; Briggs Andrew, 2004, Appl Health Econ Health Policy, V3, P79, DOI 10.2165/00148365-200403020-00004; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Centers for Disease Control and Prevention, 2010, NUMB ALL LIST PROC D; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; Coviello E, STCOMPADJ STATA MODU; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Crowther MJ, 2013, J STAT SOFTW, V53, P1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garellick G, 2011, SWEDISH HIP ARTHROPL; Gillam MH, 2011, ACTA ORTHOP, V82, P513, DOI 10.3109/17453674.2011.618918; Higashi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025403; Hinchliffe SR, 2013, STATA J, V13, P344, DOI 10.1177/1536867X1301300209; Konan S, 2013, BONE JOINT J, V95B, P1585, DOI 10.1302/0301-620X.95B12.33353; Kynaston-Pearson F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6956; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Makela KT, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7592; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; National Audit Office, 2000, HIP REPL GETT IT RIG; National Institute for Health and Care Excellence, 2014, REV TECHN APPR GUID; National Institute for Health and Clinical Excellence, 2002, GUID US MET MET HIP; National Institute for Health and Clinical Excellence, 2003, GUID SEL PROSTH PRIM; National Joint Registry, 2012, NAT JOINT REG ENGL W; National Joint Registry, 2013, NAT JOINT REG ENGL W; NHS Supply Chain, 2013, ORTH DEV EV PAN; Norton MR, 2002, J BONE JOINT SURG BR, V84B, P631, DOI 10.1302/0301-620X.84B5.12679; Norwegian Arthroplasty Register, NORW ARTHR REG REP 2; Pennington M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1026; Royal College of Surgeons 3M Capital Hip System Steering Group, 2001, 3M CAP HIP SYST LESS; Sedrakyan A, 2012, LANCET, V379, P1174, DOI 10.1016/S0140-6736(12)60372-9; Smith AJ, 2012, LANCET, V380, P1759, DOI 10.1016/S0140-6736(12)60989-1; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Tucker K, 2012, DESIGN METHODOLOGY P	37	46	47	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2015	350								h756	10.1136/bmj.h756	http://dx.doi.org/10.1136/bmj.h756			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EA	25752749	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000351181100007
J	Doughty, CE; Metcalfe, DB; Girardin, CAJ; Amezquita, FF; Cabrera, DG; Huasco, WH; Silva-Espejo, JE; Araujo-Murakami, A; da Costa, MC; Rocha, W; Feldpausch, TR; Mendoza, ALM; da Costa, ACL; Meir, P; Phillips, OL; Malhi, Y				Doughty, Christopher E.; Metcalfe, D. B.; Girardin, C. A. J.; Farfan Amezquita, F.; Galiano Cabrera, D.; Huaraca Huasco, W.; Silva-Espejo, J. E.; Araujo-Murakami, A.; da Costa, M. C.; Rocha, W.; Feldpausch, T. R.; Mendoza, A. L. M.; da Costa, A. C. L.; Meir, P.; Phillips, O. L.; Malhi, Y.			Drought impact on forest carbon dynamics and fluxes in Amazonia	NATURE			English	Article							NET PRIMARY PRODUCTIVITY; TROPICAL FOREST; THROUGHFALL EXCLUSION; RAIN-FOREST; ALLOCATION; ECOSYSTEM; RESPIRATION; BALANCE; SENSITIVITY; BIOMASS	In 2005 and 2010 the Amazon basin experienced two strong droughts', driven by shifts in the tropical hydrological regime(2) possibly associated with global climate change(3), as predicted by some global models'. Tree mortality increased after the 2005 drought(4), and regional atmospheric inversion modelling showed basin-wide decreases in CO2 uptake in 2010 compared with 2011 (ref. 5). But the response of tropical forest carbon cycling to these droughts is not fully understood and there has been no detailed multi-site investigation in situ. Here we use several years of data from a network of thirteen 1-ha forest plots spread throughout South America, where each component of net primary production (NPP), autotrophic respiration and heterotrophic respiration is measured separately, to develop a better mechanistic understanding of the impact of the 2010 drought on the Amazon forest. We find that total NPP remained constant throughout the drought. However, towards the end of the drought, autotrophic respiration, especially in roots and stems, declined significantly compared with measurements in 2009 made in the absence of drought, with extended decreases in autotrophic respiration in the three driest plots. In the year after the drought, total NPP remained constant but the allocation of carbon shifted towards canopy NPP and away from fine-root NPP. Both leaf-level and plot-level measurements indicate that severe drought suppresses photosynthesis. Scaling these measurements to the entire Amazon basin with rainfall data, we estimate that drought suppressed Amazon-wide photosynthesis in 2010 by 0.38 petagrams of carbon (0.23-0.53 petagrams of carbon). Overall, we find that during this drought, instead of reducing total NPP, trees prioritized growth by reducing autotrophic respiration that was unrelated to growth. This suggests that trees decrease investment in tissue maintenance and defence, in line with eco-evolutionary theories that trees are competitively disadvantaged in the absence of growth(6). We propose that weakened maintenance and defence investment may, in turn, cause the increase in post-drought tree mortality observed at our plots.	[Doughty, Christopher E.; Girardin, C. A. J.; Malhi, Y.] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford OX1 3QY, England; [Metcalfe, D. B.] Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22362 Lund, Sweden; [Farfan Amezquita, F.; Galiano Cabrera, D.; Huaraca Huasco, W.; Silva-Espejo, J. E.; Mendoza, A. L. M.] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Araujo-Murakami, A.] Univ Autonoma Gabriel Rene Moreno, Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [da Costa, M. C.; da Costa, A. C. L.] Fed Univ Para, Inst Geociencias, Fac Meteorol, BR-66075110 Belem, Para, Brazil; [Rocha, W.] IPAM Inst Pesquisa Ambiental Amazonia, BR-78640000 Canarana, Mato Grosso, Brazil; [Feldpausch, T. R.] Univ Exeter, Coll Life & Environm Sci, Dept Geog, Exeter EX4 4RJ, Devon, England; [Meir, P.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3FF, Midlothian, Scotland; [Meir, P.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Phillips, O. L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of Oxford; Lund University; Universidad Nacional de San Antonio Abad del Cusco; Universidade Federal do Para; University of Exeter; University of Edinburgh; Australian National University; University of Leeds	Doughty, CE (corresponding author), Univ Oxford, Sch Geog & Environm, Environm Change Inst, S Parks Rd, Oxford OX1 3QY, England.	chris.doughty@ouce.ox.ac.uk	Phillips, Oliver/A-1523-2011; Feldpausch, Ted/D-3436-2009; Meir, Patrick/J-8344-2012; Feldpausch, Ted/ABH-3123-2020; Silva Espejo, Javier Eduardo/U-2962-2017	Phillips, Oliver/0000-0002-8993-6168; Feldpausch, Ted/0000-0002-6631-7962; Feldpausch, Ted/0000-0002-6631-7962; Silva Espejo, Javier Eduardo/0000-0003-1954-3817; Huaraca Huasco, Walter/0000-0001-5300-4986; Doughty, Christopher/0000-0003-3985-7960	Gordon and Betty Moore Foundation; Andes Biodiversity and Ecosystems Research Group (ABERG); UK Natural Environment Research Council [NE/D01025X/1, NE/D014174/1, NE/F002149/1, NE/J011002/1]; NERC AMAZONICA consortium grant [NE/F005776/1]; EU [282664, 283080]; National Council for Scientific and Technological Development (CNPq, Brazil); ARC [FT110100457]; ERC Advanced Investigator Award; Royal Society Wolfson Research Merit Award; Jackson Foundation; John Fell Fund; Natural Environment Research Council [NE/D011191/1, NE/D01185X/1, NE/J011002/1, NE/D010306/1, NE/B504630/1, NER/A/S/2003/00608/2, NE/F005776/1, NE/D014174/1, NE/J023418/1, NE/I02982X/1, NE/D01025X/1] Funding Source: researchfish; NERC [NE/J011002/1, NE/F005776/1, NE/D01185X/1, NE/I02982X/1, NE/D014174/1, NE/D010306/1, NE/J023418/1, NE/D011191/1, NE/D01025X/1] Funding Source: UKRI	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Andes Biodiversity and Ecosystems Research Group (ABERG); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC AMAZONICA consortium grant; EU(European Commission); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ARC(Australian Research Council); ERC Advanced Investigator Award; Royal Society Wolfson Research Merit Award(Royal Society of London); Jackson Foundation; John Fell Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank P. Brando and Tanguro partners for logistical support and advice. This work is a product of the Global Ecosystems Monitoring (GEM) network (http://gem.tropicalforests.ox.ac.uk) and the RAIN FOR and ABERG research consortia, and was funded by grants to Y.M. and O.L.P. from the Gordon and Betty Moore Foundation to the Amazon Forest Inventory Network (RAINFOR) and the Andes Biodiversity and Ecosystems Research Group (ABERG), and grants from the UK Natural Environment Research Council (NE/D01025X/1, NE/D014174/1, NE/F002149/1 and NE/J011002/1), the NERC AMAZONICA consortium grant (NE/F005776/1) and the EU FP7 Amazalert (282664) GEOCARBON (283080) projects. Some data in this publication were provided by the Tropical Ecology Assessment and Monitoring (TEAM) Network, a collaboration between Conservation International, the Missouri Botanical Garden, the Smithsonian Institution and the Wildlife Conservation Society, and partly funded by these institutions, the Gordon and Betty Moore Foundation, and other donors. T.R.F. is supported by a National Council for Scientific and Technological Development (CNPq, Brazil) award. P.M. is supported by an ARC fellowship award FT110100457; O.L.P. is supported by an ERC Advanced Investigator Award and a Royal Society Wolfson Research Merit Award; Y.M. is supported by an ERC Advanced Investigator Award and by the Jackson Foundation. C.E.D. acknowledges funding from the John Fell Fund.	Araujo-Murakami A, 2014, PLANT ECOL DIVERS, V7, P55, DOI 10.1080/17550874.2013.798364; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Chambers JQ, 2004, ECOL APPL, V14, pS72; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; da Costa ACL, 2014, PLANT ECOL DIVERS, V7, P7, DOI 10.1080/17550874.2013.798366; da Rocha HR, 2004, ECOL APPL, V14, pS22; Dietze MC, 2014, ANNU REV PLANT BIOL, V65, P667, DOI 10.1146/annurev-arplant-050213-040054; Doughty CE, 2014, ECOLOGY, V95, P2192, DOI 10.1890/13-1507.1; Doughty CE, 2014, PLANT ECOL DIVERS, V7, P41, DOI 10.1080/17550874.2013.798367; Doughty CE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI [10.1029/2007JG000632, 10.1029/2007JG000590]; Doughty CE, 2011, BIOTROPICA, V43, P658, DOI 10.1111/j.1744-7429.2010.00746.x; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fenn K., 2014, ECOSYSTEMS; Fisher RA, 2007, GLOBAL CHANGE BIOL, V13, P2361, DOI 10.1111/j.1365-2486.2007.01417.x; Franklin O, 2012, TREE PHYSIOL, V32, P648, DOI 10.1093/treephys/tpr138; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P107, DOI 10.1080/17550874.2013.820222; Gloor M, 2013, GEOPHYS RES LETT, V40, P1729, DOI 10.1002/grl.50377; Hikosaka K, 2012, FUNCT ECOL, V26, P1024, DOI 10.1111/j.1365-2435.2012.02042.x; Huasco WH, 2014, PLANT ECOL DIVERS, V7, P125, DOI 10.1080/17550874.2013.819042; KING DA, 1993, TREE PHYSIOL, V12, P119, DOI 10.1093/treephys/12.2.119; LEHMANN J, 2003, AMAZONIAN DARK EARTH; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Malhi Y, 2015, GLOBAL CHANGE BIOL, V21, P2283, DOI 10.1111/gcb.12859; Malhi Y, 2014, PLANT ECOL DIVERS, V7, P85, DOI 10.1080/17550874.2013.820805; Malhi Y, 2011, PHILOS T R SOC B, V366, P3225, DOI 10.1098/rstb.2011.0062; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Malhi Y, 2009, GLOBAL CHANGE BIOL, V15, P1255, DOI 10.1111/j.1365-2486.2008.01780.x; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Meir P, 2008, PHILOS T R SOC B, V363, P1849, DOI 10.1098/rstb.2007.0021; Metcalfe DB, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000443; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; Rocha W, 2014, PLANT ECOL DIVERS, V7, P25, DOI 10.1080/17550874.2013.798368; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Sala A, 2012, TREE PHYSIOL, V32, P764, DOI 10.1093/treephys/tpr143; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Townsend AR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013454; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; Xu LA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046824	48	359	378	41	536	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					78	U140		10.1038/nature14213	http://dx.doi.org/10.1038/nature14213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739631	Green Submitted			2022-12-24	WOS:000350304000039
J	Granger, DE; Gibbon, RJ; Kuman, K; Clarke, RJ; Bruxelles, L; Caffee, MW				Granger, Darryl E.; Gibbon, Ryan J.; Kuman, Kathleen; Clarke, Ronald J.; Bruxelles, Laurent; Caffee, Marc W.			New cosmogenic burial ages for Sterkfontein Member 2 Australopithecus and Member 5 Oldowan	NATURE			English	Article							SOUTH-AFRICA; HOMINID; SKELETON; STRATIGRAPHY	The cave infills at Sterkfontein contain one of the richest assemblages of Australopithecus fossils in the world, including the nearly complete skeleton StW 573 ('Little Foot')(1-4) in its lower section, as well as early stone tools(5-7) in higher sections. However, the chronology of the site remains controversial(8-14) owing to the complex history of cave infilling. Much of the existing chronology based on uranium-lead dating(10,11) and palaeomagnetic stratigraphy(8,12) has recently been called into question by the recognition that dated flowstones fill cavities formed within previously cemented breccias and therefore do not form a stratigraphic sequence(4,14). Earlier dating with cosmogenic nuclides(9) suffered a high degree of uncertainty and has been questioned on grounds of sediment reworking(10,11,13). Here we use isochron burial dating with cosmogenic aluminium-26 and beryllium-10 to show that the breccia containing StW 573 did not undergo significant reworking, and that it was deposited 3.67 +/- 0.16 million years ago, far earlier than the 2.2 million year flowstones found within it(10,11). The skeleton is thus coeval with early Australopithecus afar-ensis in eastern Africa(15,16). We also date the earliest stone tools at Sterkfontein to 2.18 +/- 0.21 million years ago, placing them in the Oldowan at a time similar to that found elsewhere in South Africa at Swartkans(17) and Wonderwerk(18).	[Granger, Darryl E.; Caffee, Marc W.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Gibbon, Ryan J.] Univ New Brunswick, Dept Anthropol, Fredericton, NB E3B 5A3, Canada; [Kuman, Kathleen; Clarke, Ronald J.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Kuman, Kathleen; Bruxelles, Laurent] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, ZA-2050 Johannesburg, South Africa; [Bruxelles, Laurent] French Natl Inst Prevent Archaeol Res Inrap, F-30900 Nimes, France; [Bruxelles, Laurent] Univ Toulouse Jean Jaures, UMR 5608, CNRS, TRACES,Maison Rech, F-31058 Toulouse, France; [Caffee, Marc W.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of New Brunswick; University of Witwatersrand; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Granger, DE (corresponding author), Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA.	dgranger@purdue.edu		Bruxelles, Laurent/0000-0002-7174-2111; Kuman, Kathleen/0000-0003-1252-9895	National Science Foundation [EAR1153689, EAR0844151]; Palaeontological Scientific Trust (PAST); National Research Foundation (NRF) of South Africa; NRF (SA) [AOP1207112551-82611, AOP1207173196-82591]	National Science Foundation(National Science Foundation (NSF)); Palaeontological Scientific Trust (PAST); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); NRF (SA)	This work results from a collaboration begun with T. C. Partridge (deceased). AMS development and measurements were funded by National Science Foundation EAR1153689 to M.W.C. and D.E.G. and National Science Foundation EAR0844151 to D.E.G. Major funding to R.J.G., K.K. and R.J.C. was received from the Palaeontological Scientific Trust (PAST), which has supported research at Sterkfontein for 20 years. R.J.G. received bursary support from the National Research Foundation (NRF) of South Africa. K.K. thanks the NRF (SA) for substantial funding (AOP1207112551-82611 and AOP1207173196-82591) and Prof. Bruce Rubidge of the Evolutionary Studies Institute for additional support. Figure 1 includes modified material from J. Hum Evol. vol. 70, Bruxelles L. et al., Stratigraphic analysis of the Sterkfontein StW 573 Australopithecus skeleton and implications for its age, 36-48 (2014), with permission from Elsevier.	Balco G, 2013, QUAT GEOCHRONOL, V18, P149, DOI 10.1016/j.quageo.2013.02.002; Balco G, 2008, AM J SCI, V308, P1083, DOI 10.2475/10.2008.02; Bruxelles L, 2014, J HUM EVOL, V70, P36, DOI 10.1016/j.jhevol.2014.02.014; Chazan M, 2012, J HUM EVOL, V63, P859, DOI 10.1016/j.jhevol.2012.08.008; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; Clarke R. J., 2006, Transactions of the Royal Society of South Africa, V61, P111; CLARKE RJ, 1995, SCIENCE, V269, P521, DOI 10.1126/science.7624772; Clarke RJ, 2002, S AFR J SCI, V98, P523; Clarke RJ, 1998, S AFR J SCI, V94, P460; Clarke RJ, 1994, INTEGRATIVE PATHS ES, P205; Dart RA, 1948, AM J PHYS ANTHROP-NE, V6, P259, DOI 10.1002/ajpa.1330060304; Drake R., 1987, LAETOLI PLIOCENE SIT, P48; Erlanger ED, 2012, GEOLOGY, V40, P1019, DOI 10.1130/G33172.1; Gibbon RJ, 2014, QUAT GEOCHRONOL, V24, P10, DOI 10.1016/j.quageo.2014.07.004; Granger D. E., 2014, TREATISE GEOCHEMISTR, P81; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Herries Andy I.R., 2013, P21; Herries AIR, 2011, J HUM EVOL, V60, P523, DOI 10.1016/j.jhevol.2010.09.001; KUMAN K, 1994, J HUM EVOL, V27, P471, DOI 10.1006/jhev.1994.1065; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; Kuman K., 2009, CUTTING EDGE NEW APP, P151; Nishiizumi K, 2004, NUCL INSTRUM METH B, V223, P388, DOI 10.1016/j.nimb.2004.04.075; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; PARTRIDGE T C, 1991, Palaeontologia Africana, V28, P35; PARTRIDGE TC, 1978, NATURE, V275, P282, DOI 10.1038/275282a0; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Partridge TC, 1999, J QUATERNARY SCI, V14, P293, DOI 10.1002/(SICI)1099-1417(199907)14:4<293::AID-JQS471>3.0.CO;2-X; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Pickering TR, 2004, J HUM EVOL, V46, P279, DOI 10.1016/j.jhevol.2003.12.001; Walker J, 2006, SCIENCE, V314, P1592, DOI 10.1126/science.1132916	30	134	141	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					85	U200		10.1038/nature14268	http://dx.doi.org/10.1038/nature14268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25830884				2022-12-24	WOS:000355543400034
J	Jiang, JS; Pentelute, BL; Collier, RJ; Zhou, ZH				Jiang, Jiansen; Pentelute, Bradley L.; Collier, R. John; Zhou, Z. Hong			Atomic structure of anthrax protective antigen pore elucidates toxin translocation	NATURE			English	Article							PROTEIN TRANSLOCATION; PHENYLALANINE CLAMP; CRYSTAL-STRUCTURE; RECEPTOR; BINDING; SYSTEM; VISUALIZATION; MUTATIONS; SOFTWARE; DRIVEN	Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Protective antigen forms oligomeric prepores that undergo conversion to membrane-spanning pores by endosomal acidification, and these pores translocate the enzymes lethal factor and oedema factor into the cytosol of target cells(1). Protective antigen is not only a vaccine component and therapeutic target for anthrax infections but also an excellent model system for understanding the mechanism of protein translocation. On the basis of biochemical and electrophysiological results, researchers have proposed that a phi (Phi)-clamp composed of phenylalanine (Phe)427 residues of protective antigen catalyses protein translocation via a charge-state-dependent Brownian ratchet(2-9). Although atomic structures of protective antigen prepores are available(10-14), how protective antigen senses low pH, converts to active pore, and translocates lethal factor and oedema factor are not well defined without an atomic model of its pore. Here, by cryoelectron microscopy with direct electron counting, we determine the protective antigen pore structure at 2.9-angstrom resolution. The structure reveals the long-sought-after catalytic Phi-clamp and the membrane-spanning translocation channel, and supports the Brownian ratchet model for protein translocation. Comparisons of four structures reveal conformational changes in prepore to pore conversion that support a multi-step mechanism by which low pH is sensed and the membrane-spanning channel is formed.	[Jiang, Jiansen; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Jiang, Jiansen; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Pentelute, Bradley L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Collier, R. John] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	Hong.Zhou@ucla.edu	Jiang, Jiansen/J-2057-2015; Zhou, Z Hong/HDN-0747-2022	Jiang, Jiansen/0000-0002-1692-7906; 	National Institutes of Health [AI094386/AI046420, GM071940, AI022021, AI057159, 1S10RR23057, 1S10OD018111]; American Heart Association [14POST18870059]; Damon Runyon Cancer Research Foundation; National Science Foundation (CAREER) [CHE-1351807]; National Science Foundation [DBI-1338135]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046420, R01AI094386, U54AI057159, R01AI022021, R37AI022021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1338135] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Damon Runyon Cancer Research Foundation; National Science Foundation (CAREER)(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by grants from the National Institutes of Health (AI094386/AI046420 and GM071940 to Z.H.Z., and AI022021 to R.J.C.), the American Heart Association (Postdoctoral Fellowship 14POST18870059 to J.J.), Damon Runyon Cancer Research Foundation Innovation Award (B.L.P.), and National Science Foundation (CAREER Award CHE-1351807 to B.L.P.). We thank the NERCE facility (the National Institutes of Health grant AI057159) for expression of toxin proteins. We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines supported by University of California, Los Angeles, and by instrumentation grants from the National Institutes of Health (1S10RR23057, 1S10OD018111) and National Science Foundation (DBI-1338135). We thank L. Jin for initial efforts on this project and J. Feigon for discussion.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ballester P., 2012, IMPORTANCE PI INTERA, P79, DOI DOI 10.1002/9781119945888; Basilio D, 2011, J GEN PHYSIOL, V137, P343, DOI 10.1085/jgp.201010578; Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; Brown MJ, 2011, J BIOL CHEM, V286, P23189, DOI 10.1074/jbc.M111.231167; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Finkelstein A, 2009, PHILOS T R SOC B, V364, P209, DOI 10.1098/rstb.2008.0126; Goyal P, 2014, NATURE, V516, P250, DOI 10.1038/nature13768; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Janowiak BE, 2010, J BIOL CHEM, V285, P8130, DOI 10.1074/jbc.M109.093195; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kintzer AF, 2012, P NATL ACAD SCI USA, V109, P18378, DOI 10.1073/pnas.1208280109; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; The PyMOL, 2014, PYMOL MOL GRAPH SYST; Vernier G, 2009, PROTEIN SCI, V18, P1882, DOI 10.1002/pro.199; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006280; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wynia-Smith SL, 2012, J BIOL CHEM, V287, P43753, DOI 10.1074/jbc.M112.419598; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Ziv G, 2005, P NATL ACAD SCI USA, V102, P18956, DOI 10.1073/pnas.0508234102	49	161	165	0	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					545	U323		10.1038/nature14247	http://dx.doi.org/10.1038/nature14247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25778700	Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000355286600049
J	Drost, J; van Jaarsveld, RH; Ponsioen, B; Zimberlin, C; van Boxtel, R; Buijs, A; Sachs, N; Overmeer, RM; Offerhaus, GJ; Begthel, H; Korving, J; van de Wetering, M; Schwank, G; Logtenberg, M; Cuppen, E; Snippert, HJ; Medema, JP; Kops, GJPL; Clevers, H				Drost, Jarno; van Jaarsveld, Richard H.; Ponsioen, Bas; Zimberlin, Cheryl; van Boxtel, Ruben; Buijs, Arjan; Sachs, Norman; Overmeer, Rene M.; Offerhaus, G. Johan; Begthel, Harry; Korving, Jeroen; van de Wetering, Marc; Schwank, Gerald; Logtenberg, Meike; Cuppen, Edwin; Snippert, Hugo J.; Medema, Jan Paul; Kops, Geert J. P. L.; Clevers, Hans			Sequential cancer mutations in cultured human intestinal stem cells	NATURE			English	Article							IN-VITRO EXPANSION; STRUCTURAL BASIS; ORGANOIDS; ADENOMAS; REVEALS; COLON	Crypt stem cells represent the cells of origin for intestinal neoplasia. Both mouse and human intestinal stem cells can be cultured in medium containing the stem-cell-niche factors WNT, R-spondin, epidermal growth factor (EGF) and noggin over long time periods as epithelial organoids that remain genetically and phenotypically stable. Here we utilize CRISPR/Cas9 technology for targeted gene modification of four of the most commonly mutated colorectal cancer genes (APC, P53 (also known as TP53), KRAS and SMAD4) in cultured human intestinal stem cells. Mutant organoids can be selected by removing individual growth factors from the culture medium. Quadruple mutants grow independently of all stem-cell-niche factors and tolerate the presence of the P53 stabilizer nutlin-3. Upon xenotransplantation into mice, quadruple mutants grow as tumours with features of invasive carcinoma. Finally, combined loss of APC and P53 is sufficient for the appearance of extensive aneuploidy, a hallmark of tumour progression.	[Drost, Jarno; van Boxtel, Ruben; Sachs, Norman; Begthel, Harry; Korving, Jeroen; van de Wetering, Marc; Schwank, Gerald; Logtenberg, Meike; Cuppen, Edwin; Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Drost, Jarno; van Boxtel, Ruben; Sachs, Norman; Begthel, Harry; Korving, Jeroen; van de Wetering, Marc; Schwank, Gerald; Logtenberg, Meike; Cuppen, Edwin; Clevers, Hans] UMC Utrecht, NL-3584 CT Utrecht, Netherlands; [Drost, Jarno; van Jaarsveld, Richard H.; Ponsioen, Bas; Zimberlin, Cheryl; van Boxtel, Ruben; Sachs, Norman; Overmeer, Rene M.; Begthel, Harry; Korving, Jeroen; van de Wetering, Marc; Schwank, Gerald; Logtenberg, Meike; Cuppen, Edwin; Snippert, Hugo J.; Medema, Jan Paul; Kops, Geert J. P. L.; Clevers, Hans] UMC Utrecht, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands; [van Jaarsveld, Richard H.; Ponsioen, Bas; Overmeer, Rene M.; Snippert, Hugo J.; Kops, Geert J. P. L.] UMC Utrecht, Ctr Mol Med, Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Zimberlin, Cheryl; Medema, Jan Paul] AMC, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands; [Buijs, Arjan] UMC Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [Offerhaus, G. Johan] UMC Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [van de Wetering, Marc] Fdn Hubrecht Organoid Technol HUB, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Overmeer, René M/E-5698-2011; Drost, Jarno/J-9758-2012; Drost, Jarno/M-6964-2017; Schwank, Gerald/A-8586-2018; Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; Schwank, Gerald/AAE-6640-2020	Drost, Jarno/0000-0002-2941-6179; Drost, Jarno/0000-0002-2941-6179; Schwank, Gerald/0000-0003-0767-2953; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Schwank, Gerald/0000-0003-0767-2953; van Jaarsveld, Richard H/0000-0001-5247-6965; Logtenberg, Meike/0000-0002-8981-1189; van Boxtel, Ruben/0000-0003-1285-2836; Medema, Jan Paul/0000-0003-3045-2924; Kops, Geert/0000-0003-3555-5295	Netherlands Organisation for Scientific Research (NWO-ZonMw) VENI grant [91614138]; University of Amsterdam [2012-5735]; Dutch Digestive Diseases Foundation (MLDS) [FP13-07]; Netherlands Institute of Regenerative Medicine; Dutch Cancer Society (KWF) [KWF/PF-HUBR 2007-3956, UU2013-6070]; Stand Up to Cancer/Stichting Vrienden van het Hubrecht; NWO-ZonMw [116.005.002]; CancerGenomics.nl (NWO Gravitation) program	Netherlands Organisation for Scientific Research (NWO-ZonMw) VENI grant(Netherlands Organization for Scientific Research (NWO)); University of Amsterdam; Dutch Digestive Diseases Foundation (MLDS); Netherlands Institute of Regenerative Medicine; Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Stand Up to Cancer/Stichting Vrienden van het Hubrecht; NWO-ZonMw(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); CancerGenomics.nl (NWO Gravitation) program	We would like to thank H. M. Rodermond for help with in vivo transplantation assays and members of the contributing laboratories for support. We thank A. Pronk, W. van Houdt and J. van Gorp for facilitating human colon tissue. We are grateful for support from the following: The Netherlands Organisation for Scientific Research (NWO-ZonMw) VENI grant to J.D. (91614138); University of Amsterdam (2012-5735) and The Dutch Digestive Diseases Foundation (MLDS) (FP13-07) to C.Z. and J.P.M.; Netherlands Institute of Regenerative Medicine (N.S. and G.S.); Dutch Cancer Society (KWF) (KWF/PF-HUBR 2007-3956 for H.B.; KWF Fellowship UU2013-6070 for H.J.S.); Stand Up to Cancer/Stichting Vrienden van het Hubrecht (M.v.d.W.); NWO-ZonMw (116.005.002 for R.v.B.); and the CancerGenomics.nl (NWO Gravitation) program.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; HERBERGS J, 1994, INT J CANCER, V57, P781, DOI 10.1002/ijc.2910570604; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Van de Wetering M., CELL IN PRESS; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	32	608	630	20	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					43	U329		10.1038/nature14415	http://dx.doi.org/10.1038/nature14415			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924068				2022-12-24	WOS:000354040900028
J	Stock, S				Stock, Stephanie			INTERNATIONAL HEALTH CARE SYSTEMS Integrated Ambulatory Specialist Care - Germany's New Health Care Sector	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Inst Hlth Econ & Clin Epidemiol, Cologne, Germany		Stock, S (corresponding author), Inst Hlth Econ & Clin Epidemiol, Cologne, Germany.							[Anonymous], 2012, EARL EV PAT CENT MED; [Anonymous], 2013, HLTH INF TECHN US BE; Nolte E, 2012, HEALTH ECON POLICY L, V7, P125, DOI 10.1017/S1744133111000338; Stock S, 2010, HEALTH AFFAIR, V29, P2197, DOI 10.1377/hlthaff.2009.0799	4	6	6	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1781	1785		10.1056/NEJMp1413625	http://dx.doi.org/10.1056/NEJMp1413625			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH4BB	25946277				2022-12-24	WOS:000353974700001
J	Arndt, EM; Moore, W; Lee, WK; Ortiz, C				Arndt, Eric M.; Moore, Wendy; Lee, Wah-Keat; Ortiz, Christine			Mechanistic origins of bombardier beetle (Brachinini) explosion-induced defensive spray pulsation	SCIENCE			English	Article							INSECT CUTICLE; BIOCHEMISTRY; ARTHROPODS	Bombardier beetles (Brachinini) use a rapid series of discrete explosions inside their pygidial gland reaction chambers to produce a hot, pulsed, quinone-based defensive spray. The mechanism of brachinines' spray pulsation was explored using anatomical studies and direct observation of explosions inside living beetles using synchrotron x-ray imaging. Quantification of the dynamics of vapor inside the reaction chamber indicates that spray pulsation is controlled by specialized, contiguous cuticular structures located at the junction between the reservoir (reactant) and reaction chambers. Kinematics models suggest passive mediation of spray pulsation by mechanical feedback from the explosion, causing displacement of these structures.	[Arndt, Eric M.; Ortiz, Christine] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Moore, Wendy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Lee, Wah-Keat] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA	Massachusetts Institute of Technology (MIT); University of Arizona; United States Department of Energy (DOE); Brookhaven National Laboratory	Ortiz, C (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	cortiz@mit.edu	Lee, Wah-Keat/GRR-9734-2022	Moore, Wendy/0000-0003-4441-6203; Arndt, Emily/0000-0003-0099-743X	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, DE-SC0012704]; U.S. Army Research Laboratory; U.S. Army Research Office through the MIT Institute of Soldier Nanotechnologies [W911NF-13-D-0001]; National Science Foundation through the MIT Center for Materials Science and Engineering [DMR-08-19762]; U.S. Department of Defense, Office of the Director, Defense Research and Engineering, through the National Security Science and Engineering Faculty Fellowship [N00244-09-1-0064]; National Science Foundation [DEB-0908187]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office through the MIT Institute of Soldier Nanotechnologies; National Science Foundation through the MIT Center for Materials Science and Engineering; U.S. Department of Defense, Office of the Director, Defense Research and Engineering, through the National Security Science and Engineering Faculty Fellowship(United States Department of Defense); National Science Foundation(National Science Foundation (NSF))	Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. This work was supported in part by the U.S. Army Research Laboratory and the U.S. Army Research Office through the MIT Institute of Soldier Nanotechnologies under contract W911NF-13-D-0001 and in part by the National Science Foundation through the MIT Center for Materials Science and Engineering under contract DMR-08-19762. This research was funded in part by the U.S. Department of Defense, Office of the Director, Defense Research and Engineering, through the National Security Science and Engineering Faculty Fellowship awarded to C.O. under contract N00244-09-1-0064; in part by the National Science Foundation through funding awarded to W.M. under contract DEB-0908187; and in part by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-SC0012704. Experiment data are available for download from DSpace@MIT (https://dspace.mit.edu); please cite this collection using the handle hdl.handle.net/1721.1/96123.	ANDERSEN SO, 1979, ANNU REV ENTOMOL, V24, P29, DOI 10.1146/annurev.en.24.010179.000333; ANESHANSLEY DJ, 1969, SCIENCE, V165, P61, DOI 10.1126/science.165.3888.61; [Anonymous], 1981, CHEM DEFENSES ARTHRO; Beheshti N, 2007, BIOINSPIR BIOMIM, V2, P57, DOI 10.1088/1748-3182/2/4/001; DEAN J, 1990, SCIENCE, V248, P1219, DOI 10.1126/science.2349480; Eisner T, 1999, P NATL ACAD SCI USA, V96, P9705, DOI 10.1073/pnas.96.17.9705; EISNER T, 1958, J INSECT PHYSIOL, V2, P215, DOI 10.1016/0022-1910(58)90006-4; EISNER T, 1977, J INSECT PHYSIOL, V23, P1383, DOI 10.1016/0022-1910(77)90162-7; James A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0801; Lee Wah-Keat, 2009, BMC Physiology, V9, P2, DOI 10.1186/1472-6793-9-2; SCHILDKNECHT H, 1970, Angewandte Chemie International Edition in English, V9, P1, DOI 10.1002/anie.197000011; SCHILDKNECHT H, 1964, ANGEW CHEM INT EDIT, V3, P73, DOI 10.1002/anie.196400731; Socha JJ, 2008, J EXP BIOL, V211, P3409, DOI 10.1242/jeb.019877; Socha JJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-6; SOTAVALTA O, 1953, BIOL BULL, V104, P439, DOI 10.2307/1538496; VINCENT JFV, 1979, J INSECT PHYSIOL, V25, P653, DOI 10.1016/0022-1910(79)90115-X; VINCENT JFV, 1975, PROC R SOC SER B-BIO, V188, P189, DOI 10.1098/rspb.1975.0012; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008	20	40	41	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					563	567		10.1126/science.1261166	http://dx.doi.org/10.1126/science.1261166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931557	Green Submitted			2022-12-24	WOS:000353778100039
J	Bridier-Nahmias, A; Tchalikian-Cosson, A; Baller, JA; Menouni, R; Fayol, H; Flores, A; Saib, A; Werner, M; Voytas, DF; Lesage, P				Bridier-Nahmias, Antoine; Tchalikian-Cosson, Aurelie; Baller, Joshua A.; Menouni, Rachid; Fayol, Helene; Flores, Amando; Saib, Ali; Werner, Michel; Voytas, Daniel F.; Lesage, Pascale			An RNA polymerase III subunit determines sites of retrotransposon integration	SCIENCE			English	Article							LEUKEMIA-VIRUS INTEGRATION; POSITION-SPECIFIC INTEGRATION; NUCLEAR-LOCALIZATION SIGNAL; TRANSCRIPTION START SITES; SACCHAROMYCES-CEREVISIAE; TRANSPOSABLE ELEMENTS; TY1 RETROTRANSPOSON; CHROMATIN; YEAST; GENES	Mobile genetic elements are ubiquitous. Their integration site influences genome stability and gene expression. The Ty1 retrotransposon of the yeast Saccharomyces cerevisiae integrates upstream of RNA polymerase III (Pol III)-transcribed genes, yet the primary determinant of target specificity has remained elusive. Here we describe an interaction between Ty1 integrase and the AC40 subunit of Pol III and demonstrate that AC40 is the predominant determinant targeting Ty1 integration upstream of Pol III-transcribed genes. Lack of an integrase-AC40 interaction dramatically alters target site choice, leading to a redistribution of Ty1 insertions in the genome, mainly to chromosome ends. The mechanism of target specificity allows Ty1 to proliferate and yet minimizes genetic damage to its host.	[Bridier-Nahmias, Antoine; Tchalikian-Cosson, Aurelie; Menouni, Rachid; Fayol, Helene; Saib, Ali; Lesage, Pascale] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, Inst Univ Hematol,Hop St Louis,CNRS,U944,UMR 7212, F-75010 Paris, France; [Bridier-Nahmias, Antoine] Dept CASER Conservatoire Natl Arts & Metie, F-75003 Paris, France; [Baller, Joshua A.] Univ Minnesota, Dept enet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Baller, Joshua A.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Baller, Joshua A.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN 55455 USA; [Flores, Amando; Werner, Michel] Univ Paris Sud, CEA Saclay, Commissariat Energie Atom & Energies Alternat CEA, IBiTec S,Inst Biol Integrat Cellule I2BC,CNRS, F-91191 Gif Sur Yvette, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lesage, P (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, Inst Univ Hematol,Hop St Louis,CNRS,U944,UMR 7212, F-75010 Paris, France.	pascale.lesage@inserm.fr	Flores, Amando/K-9283-2017; LESAGE, Pascale/AAQ-8821-2021	Flores, Amando/0000-0002-1887-0659; Bridier-Nahmias, Antoine/0000-0002-0376-6840; Baller, Joshua/0000-0003-3936-7953; Voytas, Daniel/0000-0002-4944-1224; LESAGE, Pascale/0000-0002-4221-8038	CNRS; INSERM; Universite Paris Diderot Sorbonne Paris Cite; Agence nationale de recherches sur le sida et les hepatites virales [AO 2008-01]; Agence Nationale de la Recherche [13-BSV3-0012-01]; European Union through the FP7 project HIVINNOV [305137]; European Molecular Biology Organization Short-Term Fellowship [ASTF 17-2013]; Ministere de l'Enseignement Superieur et de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Diderot Sorbonne Paris Cite; Agence nationale de recherches sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union through the FP7 project HIVINNOV; European Molecular Biology Organization Short-Term Fellowship; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	We thank J. Boeke, S. Moore, and M. Riva for reagents; C. Conesa, J. Curcio, O. Lefebvre, and members of the laboratory for stimulating discussions; M. Bazin, D. Davoine, M. Saunier, and M. Zitouni for contributions during their training; and E. Fabre, H. de The, and J. Recht for critical reading of the manuscript. This work was supported by CNRS, INSERM, Universite Paris Diderot Sorbonne Paris Cite, Agence nationale de recherches sur le sida et les hepatites virales (grant AO 2008-01), Agence Nationale de la Recherche (grant 13-BSV3-0012-01), and the European Union through the FP7 project HIVINNOV (grant 305137). A.B.-N. was supported by a CNRS Ph.D. fellowship and a European Molecular Biology Organization Short-Term Fellowship (ASTF 17-2013) (to work in D.F.V.'s lab) and A. T.-C. by a Ph.D. fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Bachman N, 2005, GENE DEV, V19, P955, DOI 10.1101/gad.1299105; Bachman N, 2004, GENOME RES, V14, P1232, DOI 10.1101/gr.2052904; Baller JA, 2012, GENOME RES, V22, P704, DOI 10.1101/gr.129585.111; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Chung T, 2007, MOL CELL BIOL, V27, P8492, DOI 10.1128/MCB.01173-07; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Gupta SS, 2013, J VIROL, V87, P12721, DOI 10.1128/JVI.01942-13; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kenna MA, 1998, MOL CELL BIOL, V18, P1115, DOI 10.1128/MCB.18.2.1115; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; Kumar Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-402; Leem YE, 2008, MOL CELL, V30, P98, DOI 10.1016/j.molcel.2008.02.016; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; Rattray AJ, 2000, GENETICS, V154, P543; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; SHARON G, 1994, MOL CELL BIOL, V14, P6540, DOI 10.1128/MCB.14.10.6540; Shpakovski GV, 1999, CURR GENET, V36, P208, DOI 10.1007/s002940050492; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yieh L, 2000, J BIOL CHEM, V275, P29800, DOI 10.1074/jbc.M003149200	30	46	47	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					585	588		10.1126/science.1259114	http://dx.doi.org/10.1126/science.1259114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931562				2022-12-24	WOS:000353778100045
J	Ciocchi, S; Passecker, J; Malagon-Vina, H; Mikus, N; Klausberger, T				Ciocchi, S.; Passecker, J.; Malagon-Vina, H.; Mikus, N.; Klausberger, T.			Selective information routing by ventral hippocampal CA1 projection neurons	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; PYRAMIDAL CELLS; SPATIAL MEMORY; ANXIETY; DORSAL; AMYGDALA; ORGANIZATION; BEHAVIORS; UNITS; FEAR	The hippocampus computes diverse information involving spatial memory, anxiety, or reward and directly projects to several brain areas. Are different computations transmitted to all downstream targets uniformly, or does the hippocampus selectively route information according to content and target region? By recording from ventral hippocampal CA1 neurons in rats during different behavioral tasks and determining axonal projections with optogenetics, we observed subsets of neurons changing firing at places of elevated anxiety or changing activity during goal approach. Anxiety-related firing was selectively increased in neurons projecting to the prefrontal cortex. Goal-directed firing was most prominent in neurons targeting the nucleus accumbens; and triple-projecting neurons, targeting the prefrontal cortex, amygdala, and nucleus accumbens, were most active during tasks and sharp wave/ripples. Thus, hippocampal neurons route distinct behavior-contingent information selectively to different target areas.	[Ciocchi, S.; Passecker, J.; Malagon-Vina, H.; Mikus, N.; Klausberger, T.] Med Univ Vienna, Ctr Brain Res, Dept Cognit Neurobiol, A-1090 Vienna, Austria; [Klausberger, T.] Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	Medical University of Vienna; University of Oxford	Ciocchi, S (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Cognit Neurobiol, Spitalgasse 4, A-1090 Vienna, Austria.	stephane.ciocchi@meduniwien.ac.at; thomas.klausberger@meduniwien.ac.at	Passecker, Johannes/AAW-4357-2021	Passecker, Johannes/0000-0002-4366-2691; Malagon-Vina, Hugo/0000-0001-5029-8464; Ciocchi, Stephane/0000-0002-5701-9250; Mikus, Nace/0000-0002-3445-9464	European Research Council [242689]; Vienna Science and Technology Fund [SCIC03]; Medical Research Council [MC_UU_12020/6] Funding Source: researchfish; MRC [MC_UU_12020/6] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Vienna Science and Technology Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Schonenberger [Institute of Science and Technology (IST), Klosterneuburg, Austria] and S. Wolff (Harvard Medical School, Boston, USA) for helpful discussions on the optogenetic strategy; T. Asenov (IST) for three-dimensional printing of microdrives; R. Tomioka (Kumamoto University, Japan) for help in setting up the behavioral and electrophysiological experiments; E. Borok and R. Hauer for technical help with histology; all the members of the Klausberger lab for insightful discussions; and P. Somogyi, T. Viney, and M. Lagler for commenting on an earlier version of the manuscript. We thank Penn Vector Core from the University of Pennsylvania for the adeno-associated virus (AAV). The use of the AAV is disclosed by an materials transfer agreement between the University of Pennsylvania and the Medical University of Vienna. This work was supported in part by grant 242689 of the European Research Council and grant SCIC03 of the Vienna Science and Technology Fund. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Some of the original data are shown in the supplementary materials; all other data are available upon request from the corresponding authors.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Arszovszki A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00053; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; CARR GD, 1983, LIFE SCI, V33, P2551, DOI 10.1016/0024-3205(83)90165-0; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; Hussaini SA, 2011, NEURON, V72, P643, DOI 10.1016/j.neuron.2011.09.007; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; JUNG MW, 1994, J NEUROSCI, V14, P7347; Keinath AT, 2014, HIPPOCAMPUS, V24, P1533, DOI 10.1002/hipo.22333; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Komorowski RW, 2013, J NEUROSCI, V33, P8079, DOI 10.1523/JNEUROSCI.5458-12.2013; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Orsini CA, 2011, J NEUROSCI, V31, P17269, DOI 10.1523/JNEUROSCI.4095-11.2011; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Ruediger S, 2012, NAT NEUROSCI, V15, P1563, DOI 10.1038/nn.3224; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	30	171	172	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					560	563		10.1126/science.aaa3245	http://dx.doi.org/10.1126/science.aaa3245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931556				2022-12-24	WOS:000353778100038
J	Lewandowski, JR; Halse, ME; Blackledge, M; Emsley, L				Lewandowski, Jozef R.; Halse, Meghan E.; Blackledge, Martin; Emsley, Lyndon			Direct observation of hierarchical protein dynamics	SCIENCE			English	Article							GLASS-TRANSITION; HEAT-CAPACITY; MOTIONS; RELAXATION; MYOGLOBIN; SOLVENT; NMR	One of the fundamental challenges of physical biology is to understand the relationship between protein dynamics and function. At physiological temperatures, functional motions arise from the complex interplay of thermal motions of proteins and their environments. Here, we determine the hierarchy in the protein conformational energy landscape that underlies these motions, based on a series of temperature-dependent magic-angle spinning multinuclear nuclear-magnetic-resonance relaxation measurements in a hydrated nanocrystalline protein. The results support strong coupling between protein and solvent dynamics above 160 kelvin, with fast solvent motions, slow protein side-chain motions, and fast protein backbone motions being activated consecutively. Low activation energy, small-amplitude local motions dominate at low temperatures, with larger-amplitude, anisotropic, and functionally relevant motions involving entire peptide units becoming dominant at temperatures above 220 kelvin.	[Lewandowski, Jozef R.; Halse, Meghan E.; Emsley, Lyndon] UCB Lyon 1, Inst Sci Analyt, CNRS, ENS Lyon, F-69100 Villeurbanne, France; [Blackledge, Martin] Univ Grenoble Alpes, Inst Biol Struct IBS, F-38044 Grenoble, France; [Blackledge, Martin] CEA, IBS, F-38044 Grenoble, France; [Emsley, Lyndon] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lewandowski, JR (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	j.r.lewandowski@warwick.ac.uk; martin.blackledge@ibs.fr; lyndon.emsley@epfl.ch	Emsley, Lyndon/AAS-6384-2020; Emsley, Lyndon/C-6108-2008; Halse, Meghan/AAA-9131-2020; Lewandowski, Józef/F-3480-2011	Emsley, Lyndon/0000-0003-1360-2572; Emsley, Lyndon/0000-0003-1360-2572; Halse, Meghan/0000-0002-3605-5551; Lewandowski, Józef/0000-0001-6525-7083	Agence Nationale de la Recherche (ANR); European Commission [BioNMR 261863]; Swiss National Science Foundation [31-132857]; European Union [PIRG03-GA-2008-231026]; University of Warwick; BBSRC [BB/L022761/1] Funding Source: UKRI; EPSRC [EP/L025906/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L022761/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L025906/1] Funding Source: researchfish	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); University of Warwick; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Grzesiek and H. J. Sass for providing [U-<SUP>13</SUP>C,<SUP>15</SUP>N]GB1. We acknowledge support from Agence Nationale de la Recherche (ANR PCV 2007 Protein Motion, ComplexDynamics ANR Blanc 2012 SIMI7), the Access to Research Infrastructures Activity in the Seventh Framework Program of the European Commission (BioNMR 261863), and Swiss National Science Foundation grant 31-132857. J.R.L. acknowledges support from the European Union International Reintegration Grant (PIRG03-GA-2008-231026) and startup funds from University of Warwick. All data used to support conclusions in this manuscript are provided in the supplementary materials.	ANDREW ER, 1978, BIOPOLYMERS, V17, P1913, DOI 10.1002/bip.1978.360170808; Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102; Daniel RM, 1998, BIOPHYS J, V75, P2504, DOI 10.1016/S0006-3495(98)77694-5; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Doster W, 2008, EUR BIOPHYS J BIOPHY, V37, P591, DOI 10.1007/s00249-008-0274-3; Fenimore PW, 2013, CHEM PHYS, V424, P2, DOI 10.1016/j.chemphys.2013.06.023; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Giraud N, 2005, J AM CHEM SOC, V127, P18190, DOI 10.1021/ja055182h; Idiyatullin D, 2003, J MOL BIOL, V325, P149, DOI 10.1016/S0022-2836(02)01155-5; Jansson H, 2011, J PHYS CHEM B, V115, P4099, DOI 10.1021/jp1089867; Knab JR, 2007, P IEEE, V95, P1605, DOI 10.1109/JPROC.2007.898906; Lee AL, 2001, NATURE, V411, P501, DOI 10.1038/35078119; Lewandowski JR, 2011, J AM CHEM SOC, V133, P16762, DOI 10.1021/ja206815h; Lewandowski JR, 2013, ACCOUNTS CHEM RES, V46, P2018, DOI 10.1021/ar300334g; Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668; Mollica L, 2012, J PHYS CHEM LETT, V3, P3657, DOI 10.1021/jz3016233; PARAK F, 1971, ACTA CRYSTALL A-CRYS, VA 27, P573, DOI 10.1107/S0567739471001281; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Tarek M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138101; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Weik M, 2010, ACTA CRYSTALLOGR D, V66, P437, DOI 10.1107/S0907444910002702; Wood K, 2008, J AM CHEM SOC, V130, P4586, DOI 10.1021/ja710526r	24	172	174	6	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					578	581		10.1126/science.aaa6111	http://dx.doi.org/10.1126/science.aaa6111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931561	Green Accepted			2022-12-24	WOS:000353778100043
J	Nelson, B				Nelson, Bryn			Behind a vaccine	NATURE			English	Editorial Material																			0	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					711	713		10.1038/nj7549-711a	http://dx.doi.org/10.1038/nj7549-711a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25932490				2022-12-24	WOS:000353689700059
J	Yeung, LY; Ash, JL; Young, ED				Yeung, Laurence Y.; Ash, Jeanine L.; Young, Edward D.			Biological signatures in clumped isotopes of O-2	SCIENCE			English	Article							WATER GAS TRANSFER; O BOND FORMATION; PHOTOSYSTEM-II; OXYGEN ISOTOPES; FRACTIONATION; OXIDATION; EXCHANGE; COMPLEX; METHANE; PRECIPITATION	The abundances of molecules containing more than one rare isotope have been applied broadly to determine formation temperatures of natural materials. These applications of "clumped" isotopes rely on the assumption that isotope-exchange equilibrium is reached, or at least approached, during the formation of those materials. In a closed-system terrarium experiment, we demonstrate that biological oxygen (O-2) cycling drives the clumped-isotope composition of O-2 away from isotopic equilibrium. Our model of the system suggests that unique biological signatures are present in clumped isotopes of O-2-and not formation temperatures. Photosynthetic O-2 is depleted in (OO)-O-18-O-18 and (OO)-O-17-O-18 relative to a stochastic distribution of isotopes, unlike at equilibrium, where heavy-isotope pairs are enriched. Similar signatures may be widespread in nature, offering new tracers of biological and geochemical cycling.	[Yeung, Laurence Y.; Ash, Jeanine L.; Young, Edward D.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [Yeung, Laurence Y.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA	University of California System; University of California Los Angeles; Rice University	Yeung, LY (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA.	lyeung@rice.edu; jlash@ucla.edu	Yeung, Laurence Y/D-4574-2009	Yeung, Laurence Y/0000-0001-9901-2607; Young, Edward/0000-0002-1299-0801; Ash, Jeanine/0000-0003-4062-3942	National Science Foundation [EAR-1049655, DGE-1144087]; National Aeronautics and Space Administration Cosmochemistry program; Deep Carbon Observatory	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration Cosmochemistry program; Deep Carbon Observatory	We thank H. Hu and N. Levin for performing oxygen triple-isotope analyses of the terrarium water at Johns Hopkins University, and E. Schauble for helpful discussions during the course of this work. This research was supported in part by the National Science Foundation (EAR-1049655 and DGE-1144087), the National Aeronautics and Space Administration Cosmochemistry program, and the Deep Carbon Observatory. The data and model parameters used in this study are available in the supplementary materials (tables S1 to S3).	Affek HP, 2014, GEOCHIM COSMOCHIM AC, V143, P319, DOI 10.1016/j.gca.2014.08.005; Affek HP, 2013, AM J SCI, V313, P309, DOI 10.2475/04.2013.02; Angeles-Boza AM, 2014, CHEM SCI, V5, P1141, DOI 10.1039/c3sc51919h; Angeles-Boza AM, 2012, INORG CHEM, V51, P4722, DOI 10.1021/ic202745n; Angert A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001933; Cheah MH, 2014, ANAL CHEM, V86, P5171, DOI 10.1021/ac501086n; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Guo WF, 2009, GEOCHIM COSMOCHIM AC, V73, P7203, DOI 10.1016/j.gca.2009.05.071; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; Helman Y, 2005, PLANT PHYSIOL, V138, P2292, DOI 10.1104/pp.105.063768; Hillier W, 2008, COORDIN CHEM REV, V252, P306, DOI 10.1016/j.ccr.2007.09.004; Hoffman BM, 2013, ACCOUNTS CHEM RES, V46, P587, DOI 10.1021/ar300267m; Juranek LW, 2013, ANNU REV MAR SCI, V5, P503, DOI 10.1146/annurev-marine-121211-172430; KNOX M, 1992, J GEOPHYS RES-OCEANS, V97, P20335, DOI 10.1029/92JC00949; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Luz B, 2005, GEOCHIM COSMOCHIM AC, V69, P1099, DOI 10.1016/j.gca.2004.09.001; Luz B, 1999, NATURE, V400, P547, DOI 10.1038/22987; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Ono S, 2014, ANAL CHEM, V86, P6487, DOI 10.1021/ac5010579; Passey BH, 2012, EARTH PLANET SC LETT, V351, P223, DOI 10.1016/j.epsl.2012.07.021; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; RICHET P, 1977, ANNU REV EARTH PL SC, V5, P65, DOI 10.1146/annurev.ea.05.050177.000433; STEVENS CLR, 1975, PLANT PHYSIOL, V56, P126, DOI 10.1104/pp.56.1.126; Stolper DA, 2014, SCIENCE, V344, P1500, DOI 10.1126/science.1254509; Stolper DA, 2014, GEOCHIM COSMOCHIM AC, V126, P169, DOI 10.1016/j.gca.2013.10.045; Tang JW, 2014, GEOCHIM COSMOCHIM AC, V134, P120, DOI 10.1016/j.gca.2014.03.005; Tempest KE, 2013, MAR CHEM, V153, P39, DOI 10.1016/j.marchem.2013.04.002; Thurston RS, 2010, CHEM GEOL, V269, P252, DOI 10.1016/j.chemgeo.2009.10.001; Urey HC, 1935, J AM CHEM SOC, V57, P321, DOI 10.1021/ja01305a026; Wang ZG, 2004, GEOCHIM COSMOCHIM AC, V68, P4779, DOI 10.1016/j.gca.2004.05.039; Yeung LY, 2014, J GEOPHYS RES-ATMOS, V119, P10552, DOI 10.1002/2014JD021909; Yeung LY, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017992	33	40	43	3	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					431	434		10.1126/science.aaa6284	http://dx.doi.org/10.1126/science.aaa6284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908819				2022-12-24	WOS:000353338000033
J	Abe, N; Dror, I; Yang, L; Slattery, M; Zhou, TY; Bussemaker, HJ; Rohs, R; Mann, RS				Abe, Namiko; Dror, Iris; Yang, Lin; Slattery, Matthew; Zhou, Tianyin; Bussemaker, Harmen J.; Rohs, Remo; Mann, Richard S.			Deconvolving the Recognition of DNA Shape from Sequence	CELL			English	Article							TRANSCRIPTION-FACTOR-BINDING; HOX SPECIFICITY; GENOMIC SCALE; SITES; FEATURES; PREDICTION; COMPLEXES; PROTEINS; DATABASE	Protein-DNA binding is mediated by the recognition of the chemical signatures of the DNA bases and the 3D shape of the DNA molecule. Because DNA shape is a consequence of sequence, it is difficult to dissociate these modes of recognition. Here, we tease them apart in the context of Hox-DNA binding by mutating residues that, in a co-crystal structure, only recognize DNA shape. Complexes made with these mutants lose the preference to bind sequences with specific DNA shape features. Introducing shape-recognizing residues from one Hox protein to another swapped binding specificities in vitro and gene regulation in vivo. Statistical machine learning revealed that the accuracy of binding specificity predictions improves by adding shape features to a model that only depends on sequence, and feature selection identified shape features important for recognition. Thus, shape readout is a direct and independent component of binding site selection by Hox proteins.	[Abe, Namiko; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Abe, Namiko; Mann, Richard S.] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Dror, Iris; Yang, Lin; Zhou, Tianyin; Rohs, Remo] Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA; [Rohs, Remo] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Rohs, Remo] Univ So Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA; [Rohs, Remo] Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA; [Dror, Iris] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Slattery, Matthew] Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth, MN 55812 USA; [Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	Columbia University; Columbia University; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Technion Israel Institute of Technology; University of Minnesota System; University of Minnesota Duluth; Columbia University	Rohs, R (corresponding author), Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA.	rohs@usc.edu; rsm10@columbia.edu			NIH [R01GM058575, F32GM099160, R01GM106056, U01GM103804, R01HG003008]; USC-Technion Visiting Fellows Program; Alfred P. Sloan Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM103804, R01GM054510, F32GM099160, R01GM106056, R35GM118336, R01GM058575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC-Technion Visiting Fellows Program; Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Barry Honig, David Stern, and members of the R.R., H.J.B., and R.S.M. laboratories for feedback and comments on this project, and Vince FitzPatrick, Gabriella Martini, Todd Riley, and Roumen Voutev for technical assistance. This work was supported by the NIH (grants R01GM058575 to R.S.M., F32GM099160 to N.A., R01GM106056 and U01GM103804 to R.R., and R01HG003008 to H.J.B. and R.R.), the USC-Technion Visiting Fellows Program, and an Alfred P. Sloan Research Fellowship (to R.R.).	Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Chang YP, 2013, CELL REP, V3, P1117, DOI 10.1016/j.celrep.2013.03.002; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Dror I, 2014, NUCLEIC ACIDS RES, V42, P430, DOI 10.1093/nar/gkt862; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Hooghe B, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks283; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Maienschein-Cline M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks771; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Meysman P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1071; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Riley TR, 2014, METHODS MOL BIOL, V1196, P255, DOI 10.1007/978-1-4939-1242-1_16; Rohs R, 2009, CURR OPIN STRUC BIOL, V19, P171, DOI 10.1016/j.sbi.2009.03.002; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Zhou T., 2015, P NATL ACAD SCI US; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	29	115	115	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					307	318		10.1016/j.cell.2015.02.008	http://dx.doi.org/10.1016/j.cell.2015.02.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25843630	Green Accepted, Bronze			2022-12-24	WOS:000352708300023
J	Brewer, C; Irwin, M				Brewer, Colin; Irwin, Michael			END OF LIFE CARE In support of assisted dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												CBrewerbrewerismo@gmail.com	Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431					0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1828	10.1136/bmj.h1828	http://dx.doi.org/10.1136/bmj.h1828			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25857306				2022-12-24	WOS:000352914700012
J	Miller, LS				Miller, Lloyd S.			Adipocytes Armed against Staphylococcus aureus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTIOUS-DISEASES SOCIETY; PRACTICE GUIDELINES; SKIN		Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Johns Hopkins University	Miller, LS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.			Miller, Lloyd/0000-0002-8332-2210				DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972	5	6	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14					1368	1370		10.1056/NEJMcibr1500271	http://dx.doi.org/10.1056/NEJMcibr1500271			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830428				2022-12-24	WOS:000352028500015
J	Sanderson, K				Sanderson, Katharine			STRUCTURE Artificial armour	NATURE			English	Editorial Material																		Barber A. H., 2015, R SOC INTERFACE; Libanori R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2281; Mirkhalaf M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4166	3	15	16	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S14	S15		10.1038/519S14a	http://dx.doi.org/10.1038/519S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806492	Bronze			2022-12-24	WOS:000351602800005
J	Xu, HJ; Xue, J; Lu, B; Zhang, XC; Zhuo, JC; He, SF; Ma, XF; Jiang, YQ; Fan, HW; Xu, JY; Ye, YX; Pan, PL; Li, Q; Bao, YY; Nijhout, HF; Zhang, CX				Xu, Hai-Jun; Xue, Jian; Lu, Bo; Zhang, Xue-Chao; Zhuo, Ji-Chong; He, Shu-Fang; Ma, Xiao-Fang; Jiang, Ya-Qin; Fan, Hai-Wei; Xu, Ji-Yu; Ye, Yu-Xuan; Pan, Peng-Lu; Li, Qiao; Bao, Yan-Yuan; Nijhout, H. Frederik; Zhang, Chuan-Xi			Two insulin receptors determine alternative wing morphs in planthoppers	NATURE			English	Article							NILAPARVATA-LUGENS; BROWN PLANTHOPPER; JUVENILE-HORMONE; GROWTH-CONTROL; DROSOPHILA; INSECTS; POLYMORPHISM; PATHWAY; FORM; POLYPHENISM	Wing polyphenism is an evolutionarily successful feature found in a wide range of insects(1). Long-winged morphs can fly, which allows them to escape adverse habitats and track changing resources, whereas short-winged morphs are flightless, but usually possess higher fecundity than the winged morphs(1-3). Studies on aphids, crickets and planthoppers have revealed that alternative wing morphs develop in response to various environmental cues(1,2,4-8), and that the response to these cuesmay be mediated by developmental hormones, although research in this area has yielded equivocal and conflicting results about exactly which hormones are involved(4,8-10). As it stands, the molecular mechanism underlying wing morph determination in insects has remained elusive. Here we show that two insulin receptors in the migratory brown planthopper Nilaparvata lugens, InR1 and InR2, have opposing roles in controlling long wing versus short wing development by regulating the activity of the forkhead transcription factor Foxo. InR1, acting via the phosphatidylinositol-3-OH kinase (PI(3)K)-protein kinase B (Akt) signalling cascade, leads to the long-winged morph if active and the short-winged morph if inactive. InR2, by contrast, functions as a negative regulator of the InR1-PI(3)K-Akt pathway: suppression of InR2 results in development of the long-winged morph. The brain-secreted ligand Ilp3 triggers development of long-winged morphs. Our findings provide the first evidence of a molecular basis for the regulation of wing polyphenism in insects, and they are also the first demonstration-to our knowledge-of binary control over alternative developmental outcomes, and thus deepen our understanding of the development and evolution of phenotypic plasticity.	[Xu, Hai-Jun; Xue, Jian; Lu, Bo; Zhang, Xue-Chao; Zhuo, Ji-Chong; He, Shu-Fang; Ma, Xiao-Fang; Jiang, Ya-Qin; Fan, Hai-Wei; Xu, Ji-Yu; Ye, Yu-Xuan; Pan, Peng-Lu; Li, Qiao; Bao, Yan-Yuan; Zhang, Chuan-Xi] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Hai-Jun; Xue, Jian; Lu, Bo; Zhang, Xue-Chao; Zhuo, Ji-Chong; He, Shu-Fang; Ma, Xiao-Fang; Jiang, Ya-Qin; Fan, Hai-Wei; Xu, Ji-Yu; Ye, Yu-Xuan; Pan, Peng-Lu; Li, Qiao; Bao, Yan-Yuan; Zhang, Chuan-Xi] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Agr Entomol, Hangzhou 310058, Zhejiang, Peoples R China; [Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC 27708 USA	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Duke University	Zhang, CX (corresponding author), Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China.	haijunxu@zju.edu.cn; chxzhang@zju.edu.cn	卓, 继冲/HCH-4822-2022; Jian, Xue/M-2381-2019; Zhang, Chuan-Xi/K-7978-2019	卓, 继冲/0000-0001-9956-8621; Zhang, Chuan-Xi/0000-0002-7784-1188; Xu, Hai-Jun/0000-0002-7314-377X	National Basic Research Program of China (973 Program) [2010CB126205]; National Science Foundation of China [31201509, 31471765]; Division Of Integrative Organismal Systems [1121065] Funding Source: National Science Foundation	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R.-Z. Zhang for help with BPH imaging (Fig. 1a). This work was supported by the National Basic Research Program of China (973 Program, no. 2010CB126205) and by the National Science Foundation of China (no. 31201509 and no. 31471765).	Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Braendle C, 2005, P ROY SOC B-BIOL SCI, V272, P657, DOI 10.1098/rspb.2004.2995; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; DENNO RF, 1985, ECOLOGY, V66, P1588, DOI 10.2307/1938021; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Geminard C., 2009, CELL METAB, V10, P199; Hartfelder K., 2012, INSECT ENDOCRINOLOGY, P464, DOI [10.1016/B978-0-12-384749-2.10011-1, DOI 10.1016/B978-0-12-384749-2.10011-1]; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hirumi H., 1971, INVERTEBRATE TISSUE, P307; IWANAGA K, 1986, J INSECT PHYSIOL, V32, P585, DOI 10.1016/0022-1910(86)90076-4; IWANAGA K, 1985, ENTOMOL EXP APPL, V38, P101, DOI 10.1007/BF00361919; KISIMOTO R, 1956, NATURE, V178, P641, DOI 10.1038/178641a0; LEES AD, 1977, NATURE, V267, P46, DOI 10.1038/267046a0; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Marshall L, 2012, EMBO J, V31, P1916, DOI 10.1038/emboj.2012.33; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Roff DA, 2007, BIOSCIENCE, V57, P155, DOI 10.1641/B570210; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Syobu S, 2002, JPN J APPL ENTOMOL Z, V46, P135, DOI 10.1303/jjaez.2002.135; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu HJ, 2013, INSECT MOL BIOL, V22, P635, DOI 10.1111/imb.12051; Xue J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0521-0; Xue J, 2013, INSECT BIOCHEM MOLEC, V43, P433, DOI 10.1016/j.ibmb.2013.02.006; Zera A. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P609; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhao ZW, 2002, P NATL ACAD SCI USA, V99, P16829, DOI 10.1073/pnas.262533999	37	267	304	15	369	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					464	+		10.1038/nature14286	http://dx.doi.org/10.1038/nature14286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799997				2022-12-24	WOS:000351602800055
J	Halstead, JM; Lionnet, T; Wilbertz, JH; Wippich, F; Ephrussi, A; Singer, RH; Chao, JA				Halstead, James M.; Lionnet, Timothee; Wilbertz, Johannes H.; Wippich, Frank; Ephrussi, Anne; Singer, Robert H.; Chao, Jeffrey A.			An RNA biosensor for imaging the first round of translation from single cells to living animals	SCIENCE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; STRESS GRANULES; PROCESSING BODIES; OSKAR; ELONGATION; DYNAMICS; PROTEIN; YEAST; DECAY	Analysis of single molecules in living cells has provided quantitative insights into the kinetics of fundamental biological processes; however, the dynamics of messenger RNA (mRNA) translation have yet to be addressed. We have developed a fluorescence microscopy technique that reports on the first translation events of individual mRNA molecules. This allowed us to examine the spatiotemporal regulation of translation during normal growth and stress and during Drosophila oocyte development. We have shown that mRNAs are not translated in the nucleus but translate within minutes after export, that sequestration within P-bodies regulates translation, and that oskar mRNA is not translated until it reaches the posterior pole of the oocyte. This methodology provides a framework for studying initiation of protein synthesis on single mRNAs in living cells.	[Halstead, James M.; Wilbertz, Johannes H.; Chao, Jeffrey A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Lionnet, Timothee; Singer, Robert H.; Chao, Jeffrey A.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Lionnet, Timothee; Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Lionnet, Timothee; Singer, Robert H.] Howard Hughes Med Inst, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Wilbertz, Johannes H.] Univ Basel, CH-4003 Basel, Switzerland; [Wippich, Frank; Ephrussi, Anne] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	Friedrich Miescher Institute for Biomedical Research; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of Basel; European Molecular Biology Laboratory (EMBL)	Ephrussi, A (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	ephrussi@embl.de; robert.singer@einstein.yu.edu; jeffrey.chao@fmi.ch	Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021; Lemke, Henrik Till/N-7419-2016	Ephrussi, Anne/0000-0002-5061-4620; Wilbertz, Johannes/0000-0002-0002-6847; Lionnet, Timothee/0000-0003-1508-0202; Wippich, Frank/0000-0003-2633-9777; Halstead, James/0000-0002-8321-2927; Chao, Jeffrey/0000-0002-5895-9156; Lemke, Henrik Till/0000-0003-1577-8643	Novartis Research Foundation; NIH [NS83085, EB013571, GM57071]; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	Novartis Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Molecular Biology Laboratory (EMBL); EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This was work supported by the Novartis Research Foundation (J.A.C); NIH grants NS83085, EB013571, and GM57071 (R.H.S); Howard Hughes Medical Institute (R.H.S and T.L.); European Molecular Biology Laboratory (EMBL) (A.E.); and a postdoctoral fellowship from the EMBL Interdisciplinary Postdoc Program (EIPOD) under Marie Curie COFUND actions (F.W.). We thank C. Damgaard (University of Aarhus) for providing the rpL32-beta-globin plasmid; S. Shenoy (Albert Einstein College of Medicine), L. Gelman and S. Bourke (Friedrich Miescher Institute), and EMBL Advanced Light Microscopy Facility for microscopy support; D. Ciepielewski (Nikon) for providing access to NIS tracking software; C. Eliscovich (Albert Einstein College of Medicine) for advice on IF-FISH; L. Lavis (Janelia Farm) for providing JF549 dye; M. Beal (Biosearch Technologies) for Stellaris FISH probes;	Al-Jubran K, 2013, RNA, V19, P1669, DOI 10.1261/rna.038356.113; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chao JA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012310; Colak D, 2013, CELL, V153, P1252, DOI 10.1016/j.cell.2013.04.056; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lin MD, 2008, DEV BIOL, V322, P276, DOI 10.1016/j.ydbio.2008.07.033; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Morais-de-Sa E, 2013, DEV CELL, V26, P303, DOI 10.1016/j.devcel.2013.06.011; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; STANNERS CP, 1966, BIOCHEM BIOPH RES CO, V24, P758, DOI 10.1016/0006-291X(66)90390-1; Tanenbaum M.E., 2014, SCIENCE, V159, P635; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112	27	174	177	9	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1367	1371		10.1126/science.aaa3380	http://dx.doi.org/10.1126/science.aaa3380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792328	Green Accepted			2022-12-24	WOS:000351219600043
J	Head, S				Head, Stephen			We need a drug formulary for obese people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Nottinghamshire Healthcare Trust, Edwinstowe Hlth Ctr, Mansfield NG21 9QS, Notts, England		Head, S (corresponding author), Nottinghamshire Healthcare Trust, Edwinstowe Hlth Ctr, Mansfield NG21 9QS, Notts, England.	shead@doctors.org.uk						Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000; Martin JH, 2012, BRIT J CLIN PHARMACO, V73, P685, DOI 10.1111/j.1365-2125.2011.04159.x; UK Medicines Information (UKMi), 2013, Q A 378 1 SHOULD ANT	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1356	10.1136/bmj.h1356	http://dx.doi.org/10.1136/bmj.h1356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25779677				2022-12-24	WOS:000351570500005
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Drugs with anticholinergic side effects and cognitive decline-cause or effect?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICATION USE; POPULATION; MORTALITY; BURDEN; DEMENTIA; RISK					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Ellett LMK, 2014, J AM GERIATR SOC, V62, P1916, DOI 10.1111/jgs.13054; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Gray SL, 2015, JAMA INTERN MED, V175, P401, DOI 10.1001/jamainternmed.2014.7663; Han L, 2008, J AM GERIATR SOC, V56, P2203, DOI 10.1111/j.1532-5415.2008.02009.x; Kersten H, 2013, J GERONTOL A-BIOL, V68, P271, DOI 10.1093/gerona/gls176; Kumpula EK, 2011, J CLIN PHARMACOL, V51, P256, DOI 10.1177/0091270010368410; Myint PK, 2015, AGE AGEING, V44, P219, DOI 10.1093/ageing/afu185; Nishtala PS, 2014, PHARMACOEPIDEM DR S, V23, P753, DOI 10.1002/pds.3624; Tjia J, 2013, DRUG AGING, V30, P285, DOI 10.1007/s40266-013-0064-1	10	1	1	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1428	10.1136/bmj.h1428	http://dx.doi.org/10.1136/bmj.h1428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25775913	Bronze			2022-12-24	WOS:000351570500006
J	Welker, F; Collins, MJ; Thomas, JA; Wadsley, M; Brace, S; Cappellini, E; Turvey, ST; Reguero, M; Gelfo, JN; Kramarz, A; Burger, J; Thomas-Oates, J; Ashford, DA; Ashton, PD; Rowsell, K; Porter, DM; Kessler, B; Fischer, R; Baessmann, C; Kaspar, S; Olsen, JV; Kiley, P; Elliott, JA; Kelstrup, CD; Mullin, V; Hofreiter, M; Willerslev, E; Hublin, JJ; Orlando, L; Barnes, I; MacPhee, RDE				Welker, Frido; Collins, Matthew J.; Thomas, Jessica A.; Wadsley, Marc; Brace, Selina; Cappellini, Enrico; Turvey, Samuel T.; Reguero, Marcelo; Gelfo, Javier N.; Kramarz, Alejandro; Burger, Joachim; Thomas-Oates, Jane; Ashford, David A.; Ashton, Peter D.; Rowsell, Keri; Porter, Duncan M.; Kessler, Benedikt; Fischer, Roman; Baessmann, Carsten; Kaspar, Stephanie; Olsen, Jesper V.; Kiley, Patrick; Elliott, James A.; Kelstrup, Christian D.; Mullin, Victoria; Hofreiter, Michael; Willerslev, Eske; Hublin, Jean-Jacques; Orlando, Ludovic; Barnes, Ian; MacPhee, Ross D. E.			Ancient proteins resolve the evolutionary history of Darwin's South American ungulates	NATURE			English	Article							DENTAL ERUPTION; DNA; SOFTWARE; SEQUENCE; MODEL	No large group of recently extinct placental mammals remains as evolutionarily cryptic as the approximately 280 genera grouped as 'South American native ungulates'. To Charles Darwin(1,)2, who first collected their remains, they included perhaps the 'strangest animal[s] ever discovered'. Today, much like 180 years ago, it is no clearer whether they had one origin or several, arose before or after the Cretaceous/Palaeogene transition 66.2 million years ago(3), or are more likely to belong with the elephants and sirenians of superorder Afrotheria than with the euungulates (cattle, horses, and allies) of superorder Laurasiatheria(4-6). Morphology-based analyses have proved unconvincing because convergences are pervasive among unrelated ungulate-like placentals. Approaches using ancient DNA have also been unsuccessful, probably because of rapid DNA degradation in semitropical and temperate deposits. Here we apply proteomic analysis to screen bone samples of the Late Quaternary South American native ungulate taxa Toxodon (Notoungulata) and Macrauchenia (Litopterna) for phylogenetically informative protein sequences. For each ungulate, we obtain approximately 90% direct sequence coverage of type I collagen alpha 1-and alpha 2-chains, representing approximately 900 of 1,140 amino-acid residues for each subunit. A phylogeny is estimated from an alignment of these fossil sequences with collagen (I) gene transcripts from available mammalian genomes or mass spectrometrically derived sequence data obtained for this study. The resulting consensus tree agrees well with recent higher-level mammalian phylogenies(7-9). Toxodon and Macrauchenia form a monophyletic group whose sister taxon is not Afrotheria or any of its constituent clades as recently claimed(5,6), but instead crown Perissodactyla (horses, tapirs, and rhinoceroses). These results are consistent with the origin of at least some South American native ungulates(4,6) from 'condylarths', a paraphyletic assembly of archaic placentals. With ongoing improvements in instrumentation and analytical procedures, proteomics may produce a revolution in systematics such as that achieved by genomics, but with the possibility of reaching much further back in time.	[Welker, Frido; Collins, Matthew J.; Thomas, Jessica A.; Wadsley, Marc; Rowsell, Keri; Hofreiter, Michael] Univ York, BioArCh, York YO10 5DD, N Yorkshire, England; [Welker, Frido; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Brace, Selina; Barnes, Ian] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Cappellini, Enrico; Willerslev, Eske; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Turvey, Samuel T.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Reguero, Marcelo; Gelfo, Javier N.] Univ Nacl La Plata, Fac Ciencias Nat & Museo La Plata, CONICET, Div Paleontol Vertebrados,Museo La Plata, RA-1900 La Plata, Buenos Aires, Argentina; [Kramarz, Alejandro] Museo Argentino Ciencias Nat Bernardino Rivadavia, Secc Paleontol Vertebrados, Buenos Aires, DF, Argentina; [Burger, Joachim] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55128 Mainz, Germany; [Thomas-Oates, Jane] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Ashford, David A.; Ashton, Peter D.] Univ York, Dept Biol, Biosci Technol Facil, York YO10 5DD, N Yorkshire, England; [Porter, Duncan M.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Kessler, Benedikt; Fischer, Roman] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Oxford OX3 7FZ, England; [Baessmann, Carsten; Kaspar, Stephanie] Bruker Daltonik GmbH, Applicat Dev, D-28359 Bremen, Germany; [Olsen, Jesper V.; Kelstrup, Christian D.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Kiley, Patrick; Elliott, James A.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0FS, England; [Mullin, Victoria] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Hofreiter, Michael] Inst Biochem & Biol, D-14476 Potsdam Ot Golm, Germany; [MacPhee, Ross D. E.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA	University of York - UK; Max Planck Society; Natural History Museum London; University of Copenhagen; Zoological Society of London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Johannes Gutenberg University of Mainz; University of York - UK; University of York - UK; Virginia Polytechnic Institute & State University; University of Oxford; Bruker Corporation; Bruker Daltonik GmbH; University of Copenhagen; University of Cambridge; Trinity College Dublin; American Museum of Natural History (AMNH)	Barnes, I (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England.	frido.welker@palaeo.eu; matthew.collins@york.ac.uk; i.barnes@nhm.ac.uk; macphee@amnh.org	Gelfo, Javier N./AAW-1905-2021; Elliott, James A/A-4135-2009; Fischer, Roman/N-4408-2017; Kessler, Benedikt/AAY-8614-2021; Barnes, Ian C/B-8081-2008; Cappellini, Enrico/F-9346-2013; Willerslev, Eske/A-9619-2011; Elliott, James/M-9821-2019; Collins, Matthew J/A-7534-2008; Olsen, Jesper/ABH-4638-2020; Collins, Matthew James/O-1095-2019; Willerslev, Eske/AAA-5686-2019; Orlando, Ludovic/A-8932-2013; Hofreiter, Michael/A-3996-2017	Gelfo, Javier N./0000-0002-9989-5902; Elliott, James A/0000-0002-4887-6250; Fischer, Roman/0000-0002-9715-5951; Kessler, Benedikt/0000-0002-8160-2446; Barnes, Ian C/0000-0001-8322-6918; Cappellini, Enrico/0000-0001-7885-7811; Willerslev, Eske/0000-0002-7081-6748; Elliott, James/0000-0002-4887-6250; Collins, Matthew J/0000-0003-4226-5501; Olsen, Jesper/0000-0002-4747-4938; Collins, Matthew James/0000-0003-4226-5501; Orlando, Ludovic/0000-0003-3936-1850; Kelstrup, Christian Dahl/0000-0003-4647-1425; Ashton, Peter/0000-0002-7446-5009; Hofreiter, Michael/0000-0003-0441-4705	SYNTAX award "Barcode of Death"; European Research Council (ERC); ERC; Engineering and Physical Sciences Research Council [NE/G012237/1]; National Science Foundation [OPP 1142052]; Northern Way Initiative; SYNTHESYS FP7 grant [226506]; Directorate For Geosciences [1142104] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1142129, 1142052] Funding Source: National Science Foundation; NERC [NE/J009342/1] Funding Source: UKRI; Natural Environment Research Council [NE/J009342/1] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Jesper Velgaard Olsen] Funding Source: researchfish	SYNTAX award "Barcode of Death"; European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); Northern Way Initiative; SYNTHESYS FP7 grant; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Novo Nordisk Foundation Center for Protein Research	We thank the Museo Argentino de Ciencias Naturales "Bernardino Rivadavia", Buenos Aires (MACN), the Museo de La Plata (MLP), and the Natural History Museum of Denmark, Copenhagen (ZMK), for allowing us to sample fossil specimens in their collections for this project. The American Museum of Natural History and the Copenhagen Zoo provided samples of extant mammals suitable for collagen extraction. Mogens Andersen and Kristian Gregersen of ZMK provided information on specimens in their care. This work was partly supported by SYNTAX award "Barcode of Death", European Research Council (ERC) Advanced Award CodeX, ERC Consolidator Award GeneFlow, SYNTHESYS FP7 grant agreement 226506, Engineering and Physical Sciences Research Council NE/G012237/1 and National Science Foundation OPP 1142052. J.T.-O. and D.A.A. are members of the York Centre of Excellence in Mass Spectrometry, created thanks to a major capital investment through Science City York, supported by Yorkshire Forward with funds from the Northern Way Initiative.	Agnolin FL, 2011, MAMM BIOL, V76, P101, DOI 10.1016/j.mambio.2010.12.001; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Asher RJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-14; Benton Michael J., 2009, P35; Billet G, 2011, NATURWISSENSCHAFTEN, V98, P509, DOI 10.1007/s00114-011-0795-y; Brace S, 2012, MOL ECOL, V21, P2239, DOI 10.1111/j.1365-294X.2012.05514.x; Buckley M., 2011, ANTIQUA, V1, P1, DOI [DOI 10.4081/ANTIQUA.2011.E1, DOI 10.4081/ANTIQUA.2011.E1.-E1]; Buckley M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059614; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; CIFELLI RL, 1993, MAMMAL PHYLOGENY : PLACENTALS, P195; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Darwin Charles R., 1839, J RESEARCHES GEOLOGY; De Muizon C., 2000, GEODIVERSITAS, V22, P1; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Drummond A., 2007, BEAUTI V 1 4 2 BAYES; Drummond A. J., 2010, GENEIOUS V4 7; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Hamza VM, 2011, CLIMATE CHANGE - GEOPHYSICAL FOUNDATIONS AND ECOLOGICAL EFFECTS, P113; Horovitz Ines, 2004, Bulletin of Carnegie Museum of Natural History, V36, P63, DOI 10.2992/0145-9058(2004)36[63:EMSATO]2.0.CO;2; Hudson DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093467; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Husson D, 2011, EARTH PLANET SC LETT, V305, P328, DOI 10.1016/j.epsl.2011.03.008; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kramarz A, 2014, MAMM BIOL, V79, P170, DOI 10.1016/j.mambio.2013.11.001; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; McKenna MC, 1997, CLASSIFICATION MAMMA; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meyer M., 2010, COLD SPRING HARB PRO; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Owen R., 1838, ZOOLOGY VOYAGE HMS 1; PATTERSON B, 1968, Q REV BIOL, V43, P409, DOI 10.1086/405916; Rambaut A., 2013, TRACER V16; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanchez-Villagra MR, 2007, SYST BIODIVERS, V5, P1, DOI 10.1017/S1477200006002258; SARICH VM, 1967, P NATL ACAD SCI USA, V58, P142, DOI 10.1073/pnas.58.1.142; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Simpson GG., 1967, B AM MUS NAT HIST, V137, P1; Song S, 2012, P NATL ACAD SCI USA, V109, P14942, DOI 10.1073/pnas.1211733109; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Terajima M., 2014, J BIOL CHEM; US. Central Intelligence Agency, 2013, WORLD FACTB 2013 14; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; van Doorn N. L., 2014, ENCY GLOBAL ARCHAEOL, P7998, DOI DOI 10.1007/978-1-4419-0465-2_2418; van Doorn NL, 2012, RAPID COMMUN MASS SP, V26, P2319, DOI 10.1002/rcm.6351; van Valen L.M., 1988, Evolutionary Monographs, V10, P1; Vizcaino M, 2010, CLIM DYNAM, V34, P301, DOI 10.1007/s00382-009-0591-y; Wilf P, 2013, ANNU REV EARTH PL SC, V41, P561, DOI 10.1146/annurev-earth-050212-124217; ZUCKERKANDL E, 1960, P NATL ACAD SCI USA, V46, P1349, DOI 10.1073/pnas.46.10.1349	58	208	227	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					81	U192		10.1038/nature14249	http://dx.doi.org/10.1038/nature14249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25799987	Green Published, Green Accepted			2022-12-24	WOS:000355543400033
J	Hultman, J; Waldrop, MP; Mackelprang, R; David, MM; McFarland, J; Blazewicz, SJ; Harden, J; Turetsky, MR; McGuire, AD; Shah, MB; VerBerkmoes, NC; Lee, LH; Mavrommatis, K; Jansson, JK				Hultman, Jenni; Waldrop, Mark P.; Mackelprang, Rachel; David, Maude M.; McFarland, Jack; Blazewicz, Steven J.; Harden, Jennifer; Turetsky, Merritt R.; McGuire, A. David; Shah, Manesh B.; VerBerkmoes, Nathan C.; Lee, Lang Ho; Mavrommatis, Kostas; Jansson, Janet K.			Multi-omics of permafrost, active layer and thermokarst bog soil microbiomes	NATURE			English	Article							THAW; BACTERIAL; CLIMATE; CARBON	Over 20% of Earth's terrestrial surface is underlain by permafrost with vast stores of carbon that, once thawed, may represent the largest future transfer of carbon from the biosphere to the atmosphere(1). This process is largely dependent on microbial responses, but we know little about microbial activity in intact, let alone in thawing, permafrost. Molecular approaches have recently revealed the identities and functional gene composition of microorganismsin some permafrost soils(2-4) and a rapid shift in functional gene composition during short-term thaw experiments(3). However, the fate of permafrost carbon depends on climatic, hydrological and microbial responses to thaw at decadal scales(5,6). Here we use the combination of several molecular 'omics' approaches to determine the phylogenetic composition of the microbial communities, including several draft genomes of novel species, their functional potential and activity in soils representing different states of thaw: intact permafrost, seasonally thawed active layer and thermokarst bog. The multi-omics strategy reveals a good correlation of process rates to omics data for dominant processes, such as methanogenesis in the bog, as well as novel survival strategies for potentially active microbes in permafrost.	[Hultman, Jenni; David, Maude M.; Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Waldrop, Mark P.; McFarland, Jack; Blazewicz, Steven J.; Harden, Jennifer] US Geol Survey, Menlo Pk, CA 94025 USA; [Mackelprang, Rachel] Calif State Univ Northridge, Biol Dept, Northridge, CA 91330 USA; [Mackelprang, Rachel; Mavrommatis, Kostas; Jansson, Janet K.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Turetsky, Merritt R.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [McGuire, A. David] Univ Alaska Fairbanks, Alaska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Fairbanks, AK 99775 USA; [Shah, Manesh B.; VerBerkmoes, Nathan C.] Oak Ridge Natl Lab, Chem Sci Div, Oak Ridge, TN 37831 USA; [Lee, Lang Ho] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Lee, Lang Ho] Oak Ridge Natl Lab, Knoxville, TN 37996 USA; [Jansson, Janet K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Jansson, Janet K.] Univ Copenhagen, Dept Biol, Ctr Permafrost Res CENPERM, DK-2100 Copenhagen, Denmark	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey; California State University System; California State University Northridge; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Guelph; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Berkeley; University of Copenhagen	Jansson, JK (corresponding author), Pacific NW Natl Lab, Div Biol Sci, 902 Battelle Blvd, Richland, WA 99352 USA.	janet.jansson@pnnl.gov	Jansson, Janet/H-5478-2018; Hultman, Jenni/K-1990-2015	Jansson, Janet/0000-0002-5487-4315; Hultman, Jenni/0000-0002-3431-1785; Blazewicz, Steven/0000-0001-7517-1750; Mavrommatis, Konstantinos/0000-0003-4549-385X; David, Maude/0000-0003-1561-418X; Harden, Jennifer W/0000-0002-6570-8259; Waldrop, Mark/0000-0003-1829-7140	Office of Science, Office of Biological and Environmental Research, Climate and Environmental [JGI CSP - 152]; Lawrence Berkeley National Laboratory Laboratory Directed Research & Development (LDRD) grant [DE-AC02-05CH11231]; Pacific Northwest National Laboratory [DE-AC05-76RL01830]; Danish National Research Foundation [CENPERM DNRF100]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Bonanza Creek Long-Term Ecological Research Program - National Science Foundation [DEB 1026415]; US Department of Agriculture Forest Service, Pacific Northwest Research Station [PNW01-JV112619320-16]; US Geological Survey Climate RD Program; Alaska Climate Science Center; Academy of Finland [135669]; Division Of Environmental Biology [1026415] Funding Source: National Science Foundation	Office of Science, Office of Biological and Environmental Research, Climate and Environmental; Lawrence Berkeley National Laboratory Laboratory Directed Research & Development (LDRD) grant; Pacific Northwest National Laboratory(United States Department of Energy (DOE)); Danish National Research Foundation(Danmarks Grundforskningsfond); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Bonanza Creek Long-Term Ecological Research Program - National Science Foundation; US Department of Agriculture Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); US Geological Survey Climate RD Program; Alaska Climate Science Center; Academy of Finland(Academy of Finland); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Hettich and the Organic and Biological Mass Spectrometry group at Oak Ridge National Laboratory for access to mass spectrometry instrumentation. M. Haw, K. Li, K. Chavarria and R. Lamendella are acknowledged for help with pre-processing frozen samples. We thank K. Billis for help with RNA sequence preprocessing. This work was partly supported by the Director, Office of Science, Office of Biological and Environmental Research, Climate and Environmental Science Division, of the US Department of Energy, Terrestrial Ecosystem Science-Scientific Focus Area (TES-SFA), through a Community Sequencing Project at the DOE Joint Genome Institute (JGI CSP - 152) and by a Lawrence Berkeley National Laboratory Laboratory Directed Research & Development (LDRD) grant, all under contract number DE-AC02-05CH11231; by the Pacific Northwest National Laboratory under contract number DE-AC05-76RL01830; and by the Danish National Research Foundation (CENPERM DNRF100). The work conducted by the US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, is supported by the Office of Science of the US Department of Energy under contract number DE-AC02-05CH11231. Additional funding and considerable logistic support were provided by the Bonanza Creek Long-Term Ecological Research Program, which is jointly funded by National Science Foundation (DEB 1026415) and the US Department of Agriculture Forest Service, Pacific Northwest Research Station (PNW01-JV112619320-16). Support was also received from the US Geological Survey Climate R&D Program and Alaska Climate Science Center. J.Hu. was supported by Academy of Finland grant number 135669.	Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; BALDERSTON WL, 1976, APPL ENVIRON MICROB, V31, P504, DOI 10.1128/AEM.31.4.504-508.1976; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chourey K, 2010, J PROTEOME RES, V9, P6615, DOI 10.1021/pr100787q; Florens Laurence, 2006, V328, P159; Giannone RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022942; Jansson J. K., 2012, MICROBE, V6, P309; Jorgenson MT, 2001, CLIMATIC CHANGE, V48, P551, DOI 10.1023/A:1005667424292; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Kunin V, 2010, OPEN J, V1, P1; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; MACY JM, 1972, AM J CLIN NUTR, V25, P1318; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McCalley CK, 2014, NATURE, V514, P478, DOI 10.1038/nature13798; Meyer D., 2012, VCD VISUALIZING CATE; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mondav R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4212; Nicora CD, 2013, PROTEOMICS, V13, P2776, DOI 10.1002/pmic.201300003; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Parks DH, 2014, PEERJ PREPRINTS, V2, DOI DOI 10.7287/PEERJ.PREPRINTS.554V1; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Schuur EAG, 2011, NATURE, V480, P32, DOI 10.1038/480032a; Waldrop MP, 2010, GLOBAL CHANGE BIOL, V16, P2543, DOI 10.1111/j.1365-2486.2009.02141.x; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; ZEHNDER AJB, 1980, APPL ENVIRON MICROB, V39, P194, DOI 10.1128/AEM.39.1.194-204.1980	30	283	294	32	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					208	+		10.1038/nature14238	http://dx.doi.org/10.1038/nature14238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25739499				2022-12-24	WOS:000354377800056
J	Spang, A; Saw, JH; Jorgensen, SL; Zaremba-Niedzwiedzka, K; Martijn, J; Lind, AE; van Eijk, R; Schleper, C; Guy, L; Ettema, TJG				Spang, Anja; Saw, Jimmy H.; Jorgensen, Steffen L.; Zaremba-Niedzwiedzka, Katarzyna; Martijn, Joran; Lind, Anders E.; van Eijk, Roel; Schleper, Christa; Guy, Lionel; Ettema, Thijs J. G.			Complex archaea that bridge the gap between prokaryotes and eukaryotes	NATURE			English	Article							PHYLOGENETIC TREE SELECTION; MULTIPLE SEQUENCE ALIGNMENT; ARCTIC MIDOCEAN RIDGE; RIBOSOMAL-RNA GENES; GENOME ANNOTATION; ESCRT MACHINERY; COMMON ANCESTOR; CELL-DIVISION; ORIGIN; EVOLUTION	The origin of the eukaryotic cell remains one of the most contentious puzzles in modern biology. Recent studies have provided support for the emergence of the eukaryotic host cell from within the archaeal domain of life, but the identity and nature of the putative archaeal ancestor remain a subject of debate. Here we describe the discovery of 'Lokiarchaeota', a novel candidate archaeal phylum, which forms a monophyletic group with eukaryotes in phylogenomic analyses, and whose genomes encode an expanded repertoire of eukaryotic signature proteins that are suggestive of sophisticated membrane remodelling capabilities. Our results provide strong support for hypotheses in which the eukaryotic host evolved from a bona fide archaeon, and demonstrate that many components that underpin eukaryote-specific features were already present in that ancestor. This provided the host with a rich genomic 'starter-kit' to support the increase in the cellular and genomic complexity that is characteristic of eukaryotes.	[Spang, Anja; Saw, Jimmy H.; Zaremba-Niedzwiedzka, Katarzyna; Martijn, Joran; Lind, Anders E.; van Eijk, Roel; Guy, Lionel; Ettema, Thijs J. G.] Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden; [Saw, Jimmy H.; Schleper, Christa] Univ Bergen, Dept Biol, Ctr Geobiol, N-5020 Bergen, Norway; [Schleper, Christa] Univ Vienna, Div Archaea Biol & Ecogen, Dept Ecogen & Syst Biol, A-1090 Vienna, Austria; [Guy, Lionel] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University; University of Bergen; University of Vienna; Uppsala University	Ettema, TJG (corresponding author), Uppsala Univ, Sci Life Lab, Dept Cell & Mol Biol, SE-75123 Uppsala, Sweden.	lionel.guy@imbim.uu.se; thijs.ettema@icm.uu.se	Guy, Lionel/B-4501-2008; Jørgensen, Steffen Leth/ABB-7303-2021; Saw, Jimmy/J-1360-2019; Jørgensen, Steffen Leth/N-4599-2015; Schleper, Christa M/C-2567-2013	Guy, Lionel/0000-0001-8354-2398; Jørgensen, Steffen Leth/0000-0003-0240-7907; Saw, Jimmy/0000-0001-8353-3854; Jørgensen, Steffen Leth/0000-0003-0240-7907; Zaremba-Niedzwiedzka, Katarzyna/0000-0003-1030-8212; Martijn, Joran/0000-0001-7651-5252; Schleper, Christa/0000-0002-1918-2735; Spang, Anja/0000-0002-6518-8556	Swedish Research Council (VR) [621-2009-4813]; European Research Council (ERC) [310039-PUZZLE_CELL]; Swedish Foundation for Strategic Research [SSF-FFL5]; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Wenner-Gren Stiftelserna; Marie Curie IIF [331291]; IEF by the European Union [625521]; H2DEEP project through the EuroMARC program; Research Council of Norway through the Centre for Geobiology, University of Bergen; Austrian Science Fund (FWF) [P27017]	Swedish Research Council (VR)(Swedish Research Council); European Research Council (ERC)(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Tryggers Stiftelse for Vetenskaplig Forskning; Wenner-Gren Stiftelserna; Marie Curie IIF(European Commission); IEF by the European Union; H2DEEP project through the EuroMARC program; Research Council of Norway through the Centre for Geobiology, University of Bergen; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We dedicate this paper to the memory of Rolf Bernander. We thank P. Offre and I. de Bruijn for technical advice and useful discussions, and A. Denny for image processing. We also acknowledge the help from chief scientist R.B. Pedersen, the scientific party and the entire crew on board the Norwegian research vessel G.O. Sars during the summer 2010 expedition. All sequencing was performed by the National Genomics Infrastructure sequencing platforms at the Science for Life Laboratory at Uppsala University, a national infrastructure supported by the Swedish Research Council (VR-RFI) and the Knut and Alice Wallenberg Foundation. We thank the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) at Uppsala University and the Swedish National Infrastructure for Computing (SNIC) at the PDC Center for High-Performance Computing for providing computational resources. This work was supported by grants of the Swedish Research Council (VR grant 621-2009-4813), the European Research Council (ERC Starting grant 310039-PUZZLE_CELL) and the Swedish Foundation for Strategic Research (SSF-FFL5) to T.J.G.E., and by grants of the Carl Tryggers Stiftelse for Vetenskaplig Forskning (to A.S.), the Wenner-Gren Stiftelserna (to J.H.S.), and by Marie Curie IIF (331291 to J.H.S.) and IEF (625521 to A.S.) grants by the European Union. S.L.J received financial support from the H2DEEP project through the EuroMARC program, and by the Research Council of Norway through the Centre for Geobiology, University of Bergen. C.S. is supported by the Austrian Science Fund (FWF grant P27017).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bernander Rolf, 2011, Commun Integr Biol, V4, P664; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Deschamps P, 2014, GENOME BIOL EVOL, V6, P1549, DOI 10.1093/gbe/evu127; Dong JH, 2007, GENE, V396, P116, DOI 10.1016/j.gene.2007.03.001; Durbin AM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00168; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Ettema TJG, 2011, MOL MICROBIOL, V80, P1052, DOI 10.1111/j.1365-2958.2011.07635.x; Field MC, 2009, CURR OPIN CELL BIOL, V21, P4, DOI 10.1016/j.ceb.2008.12.004; Foster PG, 2009, PHILOS T R SOC B, V364, P2197, DOI 10.1098/rstb.2009.0034; Goodson HV, 2002, J CELL SCI, V115, P2619; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; Guy L, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016022; Guy L, 2014, ISME J, V8, P1353, DOI 10.1038/ismej.2014.6; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; HENDERSON E, 1984, SCIENCE, V225, P510, DOI 10.1126/science.6429855; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Jorgensen SL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00299; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawai M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00080; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koonin EV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016188; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kostelansky MS, 2006, CELL, V125, P113, DOI 10.1016/j.cell.2006.01.049; Koumandou VL, 2013, CRIT REV BIOCHEM MOL, V48, P373, DOI 10.3109/10409238.2013.821444; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Lasek-Nesselquist E, 2013, MOL PHYLOGENET EVOL, V69, P17, DOI 10.1016/j.ympev.2013.05.006; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Martijn J, 2013, BIOCHEM SOC T, V41, P451, DOI 10.1042/BST20120292; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Morono Y, 2014, APPL ENVIRON MICROB, V80, P1985, DOI 10.1128/AEM.04150-13; Nelson-Sathi S, 2015, NATURE, V517, P77, DOI 10.1038/nature13805; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Poole AM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015990; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; R Core Team, 2014, R LANG ENV STAT COMP; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Rochette NC, 2014, MOL BIOL EVOL, V31, P832, DOI 10.1093/molbev/mst272; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sugahara Junichi, 2006, In Silico Biology, V6, P411; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thiergart T, 2012, GENOME BIOL EVOL, V4, P466, DOI 10.1093/gbe/evs018; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Von Schnurbein S., 2000, HIST RELIGIONS, V40, P109, DOI DOI 10.1086/463618; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Williams TA, 2012, P ROY SOC B-BIOL SCI, V279, P4870, DOI 10.1098/rspb.2012.1795; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972; Yutin N, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-10; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	98	638	664	22	514	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					173	+		10.1038/nature14447	http://dx.doi.org/10.1038/nature14447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25945739	Green Accepted			2022-12-24	WOS:000354377800049
J	Rundlof, M; Andersson, GKS; Bommarco, R; Fries, I; Hederstrom, V; Herbertsson, L; Jonsson, O; Klatt, BK; Pedersen, TR; Yourstone, J; Smith, HG				Rundlof, Maj; Andersson, Georg K. S.; Bommarco, Riccardo; Fries, Ingemar; Hederstrom, Veronica; Herbertsson, Lina; Jonsson, Ove; Klatt, Bjorn K.; Pedersen, Thorsten R.; Yourstone, Johanna; Smith, Henrik G.			Seed coating with a neonicotinoid insecticide negatively affects wild bees	NATURE			English	Article							BOMBUS-IMPATIENS HYMENOPTERA; COMBINED PESTICIDE; TREATED CANOLA; COLONY HEALTH; POLLINATORS; EXPOSURE; CLOTHIANIDIN; MEGACHILIDAE; TRAITS; IMPACT	Understanding the effects of neonicotinoid insecticides on bees is vital because of reported declines in bee diversity and distribution(1-3) and the crucial role bees have as pollinators in ecosystems and agriculture(4). Neonicotinoids are suspected to pose an unacceptable risk to bees, partly because of their systemic uptake in plants(5), and the European Union has therefore introduced a moratorium on three neonicotinoids as seed coatings in flowering crops that attract bees(6). The moratorium has been criticized for being based on weak evidence(7), particularly because effects have mostly been measured on bees that have been artificially fed neonicotinoids(8-11). Thus, the key question is how neonicotinoids influence bees, and wild bees in particular, in real-world agricultural landscapes(11-13). Here we show that a commonly used insecticide seed coating in a flowering crop can have serious consequences for wild bees. In a study with replicated and matched landscapes, we found that seed coating with Elado, an insecticide containing a combination of the neonicotinoid clothianidin and the non-systemic pyrethroid beta-cyfluthrin, applied to oilseed rape seeds, reduced wild bee density, solitary bee nesting, and bumblebee colony growth and reproduction under field conditions. Hence, such insecticidal use can pose a substantial risk to wild bees in agricultural landscapes, and the contribution of pesticides to the global decline of wild bees(1-3) may have been underestimated. The lack of a significant response in honeybee colonies suggests that reported pesticide effects on honeybees cannot always be extrapolated to wild bees.	[Rundlof, Maj; Andersson, Georg K. S.; Hederstrom, Veronica; Yourstone, Johanna; Smith, Henrik G.] Lund Univ, Dept Biol, S-22362 Lund, Sweden; [Andersson, Georg K. S.; Herbertsson, Lina; Klatt, Bjorn K.; Smith, Henrik G.] Lund Univ, Ctr Environm & Climate Res, S-22362 Lund, Sweden; [Bommarco, Riccardo; Fries, Ingemar] Swedish Univ Agr Sci, Dept Ecol, S-75007 Uppsala, Sweden; [Jonsson, Ove] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, S-75007 Uppsala, Sweden; [Jonsson, Ove] Swedish Univ Agr Sci, Ctr Chem Pesticides, S-75007 Uppsala, Sweden; [Pedersen, Thorsten R.] Swedish Board Agr, S-55182 Jonkoping, Sweden	Lund University; Lund University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Rundlof, M (corresponding author), Lund Univ, Dept Biol, S-22362 Lund, Sweden.	maj.rundlof@biol.lu.se	Hederstrom, Veronica/E-5205-2016; Andersson, Georg/AAD-5985-2021; Yourstone, Johanna/N-3841-2017; Hederström, Veronica/ABB-8862-2021; Rundlöf, Maj/AAB-7401-2022; Bommarco, Riccardo/E-7109-2016	Hederstrom, Veronica/0000-0002-9231-3156; Andersson, Georg/0000-0002-9669-6895; Yourstone, Johanna/0000-0002-5667-1538; Hederström, Veronica/0000-0002-9231-3156; Rundlöf, Maj/0000-0003-3014-1544; Bommarco, Riccardo/0000-0001-8888-0476; Klatt, Bjorn/0000-0001-8241-6445	Swedish Civil Contingencies Agency; Carl Tryggers Foundation for Scientific Research; Royal Physiographic Society; Swedish Research Council [330-2014-6439]; Formas	Swedish Civil Contingencies Agency; Carl Tryggers Foundation for Scientific Research; Royal Physiographic Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); Formas(Swedish Research Council Formas)	We thank the farmers for collaboration, the project group for feedback, A. Gunnarson for farmer contacts and seeds, M. Ahlstrom Olsson and Lindesro AB for bumblebee colonies, A. Andersson and C. Du Rietz for examining bumblebee colonies, B. Andreasson, T. Carling and A. Andersson for producing and assessing honeybee colonies, J. Kreuger for discussions on pesticide quantification, and M. Stjernman for extracting land use information. Funding was provided by the Swedish Civil Contingencies Agency to R.B., I.F., T.R.P. and H.G.S., by the Carl Tryggers Foundation for Scientific Research, the Royal Physiographic Society, and the Swedish Research Council (330-2014-6439) to M.R, and by Formas to H.G.S. and R.B.	[Anonymous], 2003, Bulletin OEPP, V33, P113, DOI 10.1046/j.1365-2338.2003.00618.x; [Anonymous], 2006, SAS MIXED MODELS; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Cresswell JE, 2014, PEST MANAG SCI, V70, P332, DOI 10.1002/ps.3569; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Dicks L, 2013, NATURE, V494, P283, DOI 10.1038/494283a; Douwes P., 2004, INSEKTER FALTHANDBOK; Dupont YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025172; [EFSA PPR] European Food Safety Authority Plant Protection Products and Their Residues Panel, 2010, EFSA J, V8, P1821, DOI DOI 10.2903/J.EFSA.2010.1821; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3594; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3295; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Forbes VE, 2012, ENVIRON TOXICOL CHEM, V31, P2663, DOI 10.1002/etc.2009; Franklin MT, 2004, J ECON ENTOMOL, V97, P369, DOI 10.1603/0022-0493-97.2.369; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garthwaite D. G., 2013, 250 PEST US SURV DEP; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Gunnarson A., 2013, SVENSK FROTIDNING, V2, P9; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Holmstrom G., 2007, HUMLOR SVERIGES ARTE; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Hughes J., 2014, The Dundee Conference. Crop Protection in Northern Britain 2014, Dundee, UK, 25-26 February 2014, P21; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Imdorf A., 2001, COURSE DETERMINATION; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Jonsson O, 2013, MICROSAMPLING PHARM, P68; Jonsson O, 2012, BIOANALYSIS, V4, P1989, DOI [10.4155/BIO.12.177, 10.4155/bio.12.177]; Jonsson O, 2012, BIOANALYSIS, V4, P661, DOI [10.4155/BIO.12.25, 10.4155/bio.12.25]; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Lodhi A., 2000, PAK J BIOL SCI, V3, P104; Meier U. E., 2001, ENTWICKLUNGSSTADIEN; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Mossberg B., 2012, HUMLOR SVERIGE 40 AR; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; RAW A, 1972, T ROY ENT SOC LONDON, V124, P213; Rundlof M, 2014, BIOL CONSERV, V172, P138, DOI 10.1016/j.biocon.2014.02.027; Scott-Dupree CD, 2009, J ECON ENTOMOL, V102, P177, DOI 10.1603/029.102.0125; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Steffan-Dewenter I, 2008, ECOLOGY, V89, P1375, DOI 10.1890/06-1323.1; The Centre for Ecology and Hydrology, 2014, LARG SCAL FIELD EXPT; TORCHIO PF, 1984, J KANSAS ENTOMOL SOC, V57, P517; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	56	626	647	47	1050	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					77	U162		10.1038/nature14420	http://dx.doi.org/10.1038/nature14420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25901681				2022-12-24	WOS:000354040900036
J	Nojima, T; Gomes, T; Grosso, AR; Kimura, H; Dye, MJ; Dhir, S; Carmo-Fonseca, M; Proudfoot, NJ				Nojima, Takayuki; Gomes, Tomas; Fialho Grosso, Ana Rita; Kimura, Hiroshi; Dye, Michael J.; Dhir, Somdutta; Carmo-Fonseca, Maria; Proudfoot, Nicholas J.			Mammalian NET-Seq Reveals Genome-wide Nascent Transcription Coupled to RNA Processing	CELL			English	Article							PRE-MESSENGER-RNA; POLYMERASE-II CTD; TERMINAL DOMAIN; POLYADENYLATION; END; CLEAVAGE; SITES; PHOSPHORYLATION; INITIATION; PROMOTERS	Transcription is a highly dynamic process. Consequently, we have developed native elongating transcript sequencing technology for mammalian chromatin (mNET-seq), which generates single-nucleotide resolution, nascent transcription profiles. Nascent RNA was detected in the active site of RNA polymerase II (Pol II) along with associated RNA processing intermediates. In particular, we detected 5'splice site cleavage by the spliceosome, showing that cleaved upstream exon transcripts are associated with Pol II CTD phosphorylated on the serine 5 position (S5P), which is accumulated over downstream exons. Also, depletion of termination factors substantially reduces Pol II pausing at gene ends, leading to termination defects. Notably, termination factors play an additional promoter role by restricting non-productive RNA synthesis in a Pol II CTD S2P-specific manner. Our results suggest that CTD phosphorylation patterns established for yeast transcription are significantly different in mammals. Taken together, mNET-seq provides dynamic and detailed snapshots of the complex events underlying transcription in mammals.	[Nojima, Takayuki; Dye, Michael J.; Dhir, Somdutta; Proudfoot, Nicholas J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Gomes, Tomas; Fialho Grosso, Ana Rita; Carmo-Fonseca, Maria] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal; [Kimura, Hiroshi] Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	University of Oxford; Universidade de Lisboa; Tokyo Institute of Technology	Carmo-Fonseca, M (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.	carmo.fonseca@medicina.ulisboa.pt; nicholas.proudfoot@path.ox.ac.uk	Kimura, Hiroshi/B-9524-2015; Grosso, Ana Rita/I-6656-2013	Kimura, Hiroshi/0000-0003-0854-083X; Grosso, Ana Rita/0000-0001-6974-4209; Gomes, Tomas/0000-0003-1333-0191; Nojima, Takayuki/0000-0003-1236-4162; Proudfoot, Nicholas/0000-0001-8646-3222; Carmo-Fonseca, Maria/0000-0002-3402-7143	KANAE foundation; JSPS KAKENHI; JST CREST; Wellcome Trust Programme [091805/Z/10/Z]; ERC Advanced Grants [339270]; Fundacao Ciencia e Tecnologia, Portugal	KANAE foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Wellcome Trust Programme(Wellcome Trust); ERC Advanced Grants; Fundacao Ciencia e Tecnologia, Portugal	We thank the N.J.P. lab and Dr. M. Dienstbier for critical discussion. T.N. was supported by the KANAE foundation. H.K. was supported by JSPS KAKENHI and JST CREST. This work was supported by funding to N.J.P. (Wellcome Trust Programme [091805/Z/10/Z] and ERC Advanced [339270] Grants) and to M.C.-F. (Fundacao Ciencia e Tecnologia, Portugal).	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Conrad T, 2014, CELL REP, V9, P542, DOI 10.1016/j.celrep.2014.09.007; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Davidson L, 2012, EMBO J, V31, P2566, DOI 10.1038/emboj.2012.101; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Grosso AR, 2012, GENOME RES, V22, P1447, DOI 10.1101/gr.138057.112; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253; Nojima T, 2013, CELL REP, V3, P1080, DOI 10.1016/j.celrep.2013.03.012; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pawlicki JM, 2008, J CELL BIOL, V182, P61, DOI 10.1083/jcb.200803111; Perez-Lluch S, 2011, NUCLEIC ACIDS RES, V39, P4628, DOI 10.1093/nar/gkq1322; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109	58	311	312	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					526	540		10.1016/j.cell.2015.03.027	http://dx.doi.org/10.1016/j.cell.2015.03.027			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910207	Green Published, hybrid			2022-12-24	WOS:000353553600013
J	Kamerow, D				Kamerow, Douglas			Teenagers, smoking, and vaping	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Arrozola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Dennis B., 2015, WASHINGTON POST; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2083; Tierney PA, 2016, TOB CONTROL, V25, pE10, DOI 10.1136/tobaccocontrol-2014-052175; US Department of Health and Human Services, 2012, PREV TOB US YOUTH YO, P708	5	0	0	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2015	350								h2110	10.1136/bmj.h2110	http://dx.doi.org/10.1136/bmj.h2110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8QX	25900140				2022-12-24	WOS:000353576300016
J	Creager, RL; Li, YL; MacAlpine, DM				Creager, Rachel L.; Li, Yulong; MacAlpine, David M.			SnapShot: Origins of DNA Replication	CELL			English	Editorial Material							PROGRAM		[Creager, Rachel L.; Li, Yulong; MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Creager, RL (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.				NCI NIH HHS [T-32 CA059365] Funding Source: Medline; NIGMS NIH HHS [R01 GM104097] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA059365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104097] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Ding QY, 2011, CRIT REV BIOCHEM MOL, V46, P165, DOI 10.3109/10409238.2011.560139; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Mechali M, 2013, CURR OPIN GENET DEV, V23, P124, DOI 10.1016/j.gde.2013.02.010; Yoshida K, 2014, MOL CELL, V54, P691, DOI 10.1016/j.molcel.2014.04.032	9	6	8	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					418	+		10.1016/j.cell.2015.03.043	http://dx.doi.org/10.1016/j.cell.2015.03.043			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860614	Bronze			2022-12-24	WOS:000352708300032
J	Schmiedel, JM; Klemm, SL; Zheng, YN; Sahay, A; Bluthgen, N; Marks, DS; van Oudenaarden, A				Schmiedel, Joern M.; Klemm, Sandy L.; Zheng, Yannan; Sahay, Apratim; Bluethgen, Nils; Marks, Debora S.; van Oudenaarden, Alexander			MicroRNA control of protein expression noise	SCIENCE			English	Article							MAMMALIAN MICRORNAS; GENE-EXPRESSION; ENCODES; IMPACT	MicroRNAs (miRNAs) repress the expression of many genes in metazoans by accelerating messenger RNA degradation and inhibiting translation, thereby reducing the level of protein. However, miRNAs only slightly reduce the mean expression of most targeted proteins, leading to speculation about their role in the variability, or noise, of protein expression. We used mathematical modeling and single-cell reporter assays to show that miRNAs, in conjunction with increased transcription, decrease protein expression noise for lowly expressed genes but increase noise for highly expressed genes. Genes that are regulated by multiple miRNAs show more-pronounced noise reduction. We estimate that hundreds of (lowly expressed) genes in mouse embryonic stem cells have reduced noise due to substantial miRNA regulation. Our findings suggest that miRNAs confer precision to protein expression and thus offer plausible explanations for the commonly observed combinatorial targeting of endogenous genes by multiple miRNAs, as well as the preferential targeting of lowly expressed genes.	[Schmiedel, Joern M.; Bluethgen, Nils] Humboldt Univ, Integrat Res Inst Life Sci, D-10115 Berlin, Germany; [Schmiedel, Joern M.; Bluethgen, Nils] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Schmiedel, Joern M.; Bluethgen, Nils] Charite, Inst Pathol, D-10117 Berlin, Germany; [Schmiedel, Joern M.; Zheng, Yannan; Sahay, Apratim; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Klemm, Sandy L.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Marks, Debora S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Humboldt University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Bluthgen, N (corresponding author), Humboldt Univ, Integrat Res Inst Life Sci, D-10115 Berlin, Germany.	nils.bluethgen@charite.de; debbie@hms.harvard.edu; a.vanoudenaarden@hubrecht.eu	Schmiedel, Jörn/K-6833-2017; Bluthgen, Nils/A-1711-2011; van Oudenaarden, Alexander/AAA-1705-2019	Schmiedel, Jörn/0000-0002-6842-9837; Bluthgen, Nils/0000-0002-0171-7447; 	European Molecular Biology Organization; Koch Institute for Integrative Cancer Research; Deutsche Forschungsgemeinschaft [GK1772, SPP1395]; Bundesministerium fur Bildung und Forschung (FORSYS) [BCCN A5]; Harvard Medical School institutional support; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); European Research Council [ERC-AdG 294325-GeneNoiseControl]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Koch Institute for Integrative Cancer Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (FORSYS)(Federal Ministry of Education & Research (BMBF)); Harvard Medical School institutional support; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	We thank M. Ebert, S. Mukherji, D. Moojiman, L. Kester, D. Grun, M. Muraro, and R. Ward for discussions and help; the Boyer lab for mESC line V19; the Cuppen lab for sequencing; and S. van der Elst for help with FACS. Support was provided by the European Molecular Biology Organization (Short-Term Fellowship, J.M.S.), the Koch Institute for Integrative Cancer Research (Graduate Fellowship, S.L.K.), the Deutsche Forschungsgemeinschaft (GK1772, SPP1395, N.B.), the Bundesministerium fur Bildung und Forschung (FORSYS, BCCN A5, N.B.), Harvard Medical School institutional support (D.S.M.), the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (Vici award, A.v.O.), and the European Research Council (grant ERC-AdG 294325-GeneNoiseControl, A.v.O.).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Enright AJ, 2004, GENOME BIOL, V5; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Noorbakhsh J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072676; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	29	239	252	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					128	132		10.1126/science.aaa1738	http://dx.doi.org/10.1126/science.aaa1738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838385				2022-12-24	WOS:000352079500042
J	Sharma, G; Askari, R				Sharma, Gaurav; Askari, Reza			Transdiaphragmatic Intercostal Herniation of the Gallbladder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sharma, Gaurav; Askari, Reza] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Sharma, G (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	gsharma1@partners.org							0	1	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2015	372	14							e19	10.1056/NEJMicm1406566	http://dx.doi.org/10.1056/NEJMicm1406566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NL	25830442				2022-12-24	WOS:000352028500012
J	Bourzac, K				Bourzac, Katherine			SPIDERS Web of intrigue	NATURE			English	Editorial Material							SILK											Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921; Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847; Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120	6	22	23	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S4	S6		10.1038/519S4a	http://dx.doi.org/10.1038/519S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806496	Bronze			2022-12-24	WOS:000351602800001
J	Spence, C				Spence, Charles			Multisensory Flavor Perception	CELL			English	Review							RETRONASAL OLFACTORY STIMULI; CROSSMODAL CORRESPONDENCES; PERCEIVED CRISPNESS; SUBTHRESHOLD TASTE; COLOR CUES; FOOD; INTEGRATION; ORTHONASAL; ILLUSION; TEXTURE	The perception of flavor is perhaps the most multisensory of our everyday experiences. The latest research by psychologists and cognitive neuroscientists increasingly reveals the complex multisensory interactions that give rise to the flavor experiences we all know and love, demonstrating how they rely on the integration of cues from all of the human senses. This Perspective explores the contributions of distinct senses to our perception of food and the growing realization that the same rules of multisensory integration that have been thoroughly explored in interactions between audition, vision, and touch may also explain the combination of the (admittedly harder to study) flavor senses. Academic advances are now spilling out into the real world, with chefs and food industry increasingly taking the latest scientific findings on board in their food design.	Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford OX1 3UD, England	University of Oxford	Spence, C (corresponding author), Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, S Parks Rd, Oxford OX1 3UD, England.	charles.spence@psy.ox.ac.uk			AHRC Rethinking [AH/L007053/1]; Arts and Humanities Research Council [AH/L007053/1] Funding Source: researchfish; AHRC [AH/L007053/1] Funding Source: UKRI	AHRC Rethinking(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	The author would like to acknowledge the AHRC Rethinking the Senses grant (AH/L007053/1).	[Anonymous], 2010, WORLD FINE WINE; Barnett-Cowan M, 2010, PERCEPTION, V39, P1684, DOI 10.1068/p6784; Barros-Loscertales A, 2012, CEREB CORTEX, V22, P2554, DOI 10.1093/cercor/bhr324; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Blumenthal H., 2008, BIG FAT DUCK COOKBOO; Bremner A. J., 2012, MULTISENSORY DEV; Breslin PAS, 2001, CHEM SENSES, V26, P105, DOI 10.1093/chemse/26.2.105; Bult JHF, 2007, NEUROSCI LETT, V411, P6, DOI 10.1016/j.neulet.2006.09.036; Calvert G., 2004, HDB MULTISENSORY PRO; Chartier F., 2012, TASTE BUDS MOL ART S; Dalton P, 2000, NAT NEUROSCI, V3, P431, DOI 10.1038/74797; de Araujo IE, 2004, J NEUROSCI, V24, P3086, DOI 10.1523/JNEUROSCI.0130-04.2004; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; De Graaf C, 1997, APPETITE, V29, P305, DOI 10.1006/appe.1997.0097; Delwiche J., 2005, J SENS STUD, V20, P137, DOI DOI 10.1111/J.1745-459X.2005.00047.X; Dematte ML, 2014, FOOD QUAL PREFER, V38, P58, DOI 10.1016/j.foodqual.2014.05.009; Deroy O., 2014, FLAVOUR, V3, P6, DOI DOI 10.1186/2044-7248-3-6; Eldeghaidy S, 2011, J NEUROPHYSIOL, V105, P2572, DOI 10.1152/jn.00927.2010; Garneau NL, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00033; Grabenhorst F, 2008, CEREB CORTEX, V18, P1549, DOI 10.1093/cercor/bhm185; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Harrar V, 2011, EXP BRAIN RES, V214, P351, DOI 10.1007/s00221-011-2833-6; Hayes JE, 2012, AM J ENOL VITICULT, V63, P80, DOI 10.5344/ajev.2011.11050; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Knoferle K, 2012, PSYCHON B REV, V19, P992, DOI 10.3758/s13423-012-0321-z; Knoeferle KM, 2015, PSYCHOL MARKET, V32, P107, DOI 10.1002/mar.20766; Koza BJ, 2005, CHEM SENSES, V30, P643, DOI 10.1093/chemse/bji057; Lyman B., 1989, PSYCHOL FOOD MORE MA; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Michel C., 2014, FLAVOUR, V3, P7; Michel C, 2015, APPETITE, V90, P45, DOI 10.1016/j.appet.2015.02.030; Michel C, 2014, PERCEPTION, V43, P818, DOI 10.1068/p7733; Moir HC, 1936, J CHEM TECHNOL BIOT, V55, P145, DOI [DOI 10.1002/JCTB.5000550803, 10.1002/jctb.5000550803]; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; MURPHY C, 1977, SENS PROCESS, V1, P204; Oberfeld D, 2009, J SENS STUD, V24, P797, DOI 10.1111/j.1745-459X.2009.00239.x; Osterbauer RA, 2005, J NEUROPHYSIOL, V93, P3434, DOI 10.1152/jn.00555.2004; Parr W. V., 2003, Journal of Wine Research, V14, P79, DOI 10.1080/09571260410001677969; Pfeiffer JC, 2005, CHEM SENSES, V30, P539, DOI 10.1093/chemse/bji047; Piqueras-Fiszman B, 2015, FOOD QUAL PREFER, V40, P165, DOI 10.1016/j.foodqual.2014.09.013; Piqueras-Fiszman B, 2012, J SENS STUD, V27, P324, DOI 10.1111/j.1745-459X.2012.00397.x; Piqueras-Fiszman B, 2012, APPETITE, V58, P559, DOI 10.1016/j.appet.2011.12.021; Piqueras-Fiszman B, 2012, FOOD QUAL PREFER, V24, P205, DOI 10.1016/j.foodqual.2011.08.011; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Roudnitzky N, 2011, BEHAV BRAIN RES, V216, P109, DOI 10.1016/j.bbr.2010.07.019; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Shankar M, 2010, ATTEN PERCEPT PSYCHO, V72, P1981, DOI 10.3758/APP.72.7.1981; Shepherd G.M., 2012, NEUROGASTRONOMY BRAI; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Small DM, 2004, J NEUROPHYSIOL, V92, P1892, DOI 10.1152/jn.00050.2004; Spence C., 2012, Food oral processing: fundamentals of eating and sensory perception, P203; Spence C., 2015, PERCEPTION ITS MODAL, P247; Spence C., 2015, FLAVOUR, V4, p1, DOI [10.1186/2044-7248-4-3, DOI 10.1186/2044-7248-4-3]; Spence C., 2014, PERFECT MEAL MULTISE; Spence C., 2014, FLAVOUR, V3, P4, DOI DOI 10.1186/2044-7248-3-4; Spence C., 2013, FLAVOUR, V2, P1, DOI [10.1186/2044-7248-2-21., DOI 10.1186/2044-7248-2-21]; Spence C., 2014, FLAVOUR, V3, P1, DOI [10.1186/2044-7248-3-8, DOI 10.1186/2044-7248-3-8]; Spence C., 2014, FLAVOUR, DOI [10.1186/2044-7248-3-9, DOI 10.1186/2044-7248-3-9]; Spence C, 2010, CHEMOSENS PERCEPT, V3, P68, DOI 10.1007/s12078-010-9067-z; Stein BE, 2012, NEW HDB MULTISENSORY; STEVENS JC, 1991, APPETITE, V16, P129, DOI 10.1016/0195-6663(91)90038-T; Stevenson R.J., 2004, HDB MULTISENSORY PRO, P69; Stevenson R. J., 2009, PSYCHOL FLAVOUR; Stevenson R. J., 2012, PSYCHOL BULL, V140, P487; Stevenson RJ, 2007, PSYCHOL BULL, V133, P294, DOI 10.1037/0033-2909.133.2.294; Stewart P.C., 2013, FLAVOUR, V2, P1, DOI DOI 10.1186/2044-7248-2-27; Stuckey B., 2012, TASTE WHAT YOURE MIS; TODRANK J, 1991, PHYSIOL BEHAV, V50, P1027, DOI 10.1016/0031-9384(91)90432-N; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Triplett T., 1994, MARKETING NEWS, V28, P1; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Velasco C., 2013, FLAVOUR, P1, DOI [DOI 10.1186/2044-7248-2-23, 10.1186/2044-7248-2-23]; Velasco C, 2015, FOOD QUAL PREFER, V41, P151, DOI 10.1016/j.foodqual.2014.11.010; Wan X., 2014, FLAVOUR, V3, P3, DOI DOI 10.1186/2044-7248-3-3; Wan XA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01365; Yeomans MR, 2008, FOOD QUAL PREFER, V19, P565, DOI 10.1016/j.foodqual.2008.02.009; Young J. Z., 1968, BIOL MOUTH, P21; Zampini M, 2005, FOOD QUAL PREFER, V16, P632, DOI 10.1016/j.foodqual.2004.11.004; Zampini M, 2004, J SENS STUD, V19, P347, DOI 10.1111/j.1745-459x.2004.080403.x; Zampini M, 2008, FOOD QUAL PREFER, V19, P335, DOI 10.1016/j.foodqual.2007.11.001; Zampini M, 2007, FOOD QUAL PREFER, V18, P975, DOI 10.1016/j.foodqual.2007.04.001; Zellner DA, 2004, AM J PSYCHOL, V117, P363, DOI 10.2307/4149006; Zellner DA, 2014, APPETITE, V77, P31, DOI 10.1016/j.appet.2014.02.009	87	207	216	11	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					24	35		10.1016/j.cell.2015.03.007	http://dx.doi.org/10.1016/j.cell.2015.03.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815982	Bronze			2022-12-24	WOS:000351952200005
J	Doshi, P				Doshi, Peter			ANTIBIOTICS Speeding new antibiotics to market: a fake fix?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; DOUBLE-BLIND; TIGECYCLINE					pdoshi@bmj.com			UK National Institute for Health Research; American Association of Colleges of Pharmacy	UK National Institute for Health Research(National Institute for Health Research (NIHR)); American Association of Colleges of Pharmacy	I have read and understood BMJ policy on declaration of interests and declare I know and consider some of the people interviewed in this article as colleagues. I was a corecipient of a UK National Institute for Health Research grant (for the HTA Update and amalgamation of two Cochrane reviews of neuraminidase inhibitors). In addition, I received support from the European Respiratory Society for travel to give a talk at the society's 2012 annual congress in Vienna. I also received a 2015 new investigator award from the American Association of Colleges of Pharmacy to fund a PhD student to work on research on how the potential harms of statins are conveyed in drug labeling and pharmacy leaflets.	Bennet, 2015, HATCH REINTR PATH AC; Cerexa, 2014, INTR CEFT AV CAZ AV; Davies SC, 2013, LANCET, V381, P1606, DOI 10.1016/S0140-6736(13)60604-2; Davies SC, 2013, ANNUAL REPORT CHIEF; Duong M, 2010, ANN EMERG MED, V55, P401, DOI 10.1016/j.annemergmed.2009.03.014; Florescu I, 2008, J ANTIMICROB CHEMOTH, V62, pI17, DOI 10.1093/jac/dkn250; Food and Drug Administration, 2010, GUID IND NON CLIN TR; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Janssen Therapeutics, 2014, PRESCR INF SIRT BED; Komo S, 2012, ANTIINFECTIVE DRUGS; Murray BE, 2014, WRITTEN STATEMENT BA; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Obama B, 2014, COMBATING ANTIBIOTIC; Podolsky SH, 2015, ANTIBIOTIC ERA: REFORM, RESISTANCE, AND THE PURSUIT OF A RATIONAL THERAPEUTICS, P1; Prasad P, 2012, CLIN INFECT DIS, V54, P1699, DOI 10.1093/cid/cis270; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07; Schmitz GR, 2010, ANN EMERG MED, V56, P283, DOI 10.1016/j.annemergmed.2010.03.002; Sherman RE, 2013, NEW ENGL J MED, V369, P1877, DOI 10.1056/NEJMp1311439; Theravance, 2013, PRESCR INF VIB TEL; US Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; US Government Accountability Office, 2010, GAO 10 798 NEW DRUG; Walsh F, 2014, BBC NEWS; Woodcock J., 2014, 21 CENTURY CURES EXA; World Health Organization, ANT RES GLOB REP SUR; Yaw LK, 2014, LANCET INFECT DIS, V14, P967, DOI 10.1016/S1473-3099(14)70876-X	25	19	19	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2015	350								h1453	10.1136/bmj.h1453	http://dx.doi.org/10.1136/bmj.h1453			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE7NV	25814536				2022-12-24	WOS:000352029500001
J	Li, Y; Klena, NT; Gabriel, GC; Liu, XQ; Kim, AJ; Lemke, K; Chen, Y; Chatterjee, B; Devine, W; Damerla, RR; Chang, CF; Yagi, H; San Agustin, JT; Thahir, M; Anderton, S; Lawhead, C; Vescovi, A; Pratt, H; Morgan, J; Haynes, L; Smith, CL; Eppig, JT; Reinholdt, L; Francis, R; Leatherbury, L; Ganapathiraju, MK; Tobita, K; Pazour, GJ; Lo, CW				Li, You; Klena, Nikolai T.; Gabriel, George C.; Liu, Xiaoqin; Kim, Andrew J.; Lemke, Kristi; Chen, Yu; Chatterjee, Bishwanath; Devine, William; Damerla, Rama Rao; Chang, Chienfu; Yagi, Hisato; San Agustin, Jovenal T.; Thahir, Mohamed; Anderton, Shane; Lawhead, Caroline; Vescovi, Anita; Pratt, Herbert; Morgan, Judy; Haynes, Leslie; Smith, Cynthia L.; Eppig, Janan T.; Reinholdt, Laura; Francis, Richard; Leatherbury, Linda; Ganapathiraju, Madhavi K.; Tobita, Kimimasa; Pazour, Gregory J.; Lo, Cecilia W.			Global genetic analysis in mice unveils central role for cilia in congenital heart disease	NATURE			English	Article							FETAL ECHOCARDIOGRAPHY; HETEROTAXY SYNDROME; DEFECTS; MOUSE; DIAGNOSIS; MUTATIONS; SPECTRUM; ACCURACY; PROTEIN; SCREEN	Congenital heart disease (CHD) is the most prevalent birth defect, affecting nearly 1% of live births(1); the incidence of CHD is up to tenfold higher inhumanfetuses(2,3). Agenetic contributionis strongly suggested by the association of CHD with chromosome abnormalities and high recurrence risk(4). Here we report findings from a recessive forward genetic screen in fetal mice, showing that cilia and ciliatransduced cell signalling have important roles in the pathogenesis of CHD. The cilium is an evolutionarily conserved organelle projecting from the cell surface with essential roles in diverse cellular processes. Using echocardiography, we ultrasound scanned 87,355 chemically mutagenized C57BL/6J fetal mice and recovered 218 CHD mouse models. Whole-exome sequencing identified 91 recessive CHD mutations in 61 genes. This included 34 cilia-related genes, 16 genes involved in cilia-transduced cell signalling, and 10 genes regulating vesicular trafficking, a pathway important for ciliogenesis and cell signalling. Surprisingly, many CHD genes encoded interacting proteins, suggesting that an interactome protein network may provide a larger genomic context for CHD pathogenesis. These findings provide novel insights into the potential Mendelian genetic contribution to CHD in the fetal population, a segment of the human population not well studied. We note that the pathways identified show overlap with CHD candidate genes recovered in CHD patients(5), suggesting that they may have relevance to the more complex genetics of CHD overall. These CHD mouse models and >8,000 incidental mutations have been sperm archived, creating a rich public resource for human disease modelling.	[Li, You; Klena, Nikolai T.; Gabriel, George C.; Liu, Xiaoqin; Kim, Andrew J.; Lemke, Kristi; Chen, Yu; Chatterjee, Bishwanath; Damerla, Rama Rao; Chang, Chienfu; Yagi, Hisato; Anderton, Shane; Lawhead, Caroline; Vescovi, Anita; Francis, Richard; Tobita, Kimimasa; Lo, Cecilia W.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15201 USA; [Devine, William] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [San Agustin, Jovenal T.; Pazour, Gregory J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Thahir, Mohamed; Ganapathiraju, Madhavi K.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15206 USA; [Thahir, Mohamed; Ganapathiraju, Madhavi K.] Univ Pittsburgh, Sch Arts & Sci, Intelligent Syst Program, Pittsburgh, PA 16260 USA; [Pratt, Herbert; Morgan, Judy; Haynes, Leslie; Smith, Cynthia L.; Eppig, Janan T.; Reinholdt, Laura] Jackson Lab, Bar Harbor, ME 04609 USA; [Leatherbury, Linda] Childrens Natl Med Ctr, Ctr Heart, Washington, DC 20010 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jackson Laboratory; Children's National Health System	Lo, CW (corresponding author), Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15201 USA.	cel36@pitt.edu	Smith, Cynthia/AAY-6219-2020; Smith, Cynthia L/A-5646-2009; Francis, Richard/P-2524-2015	Smith, Cynthia/0000-0003-3691-0324; Smith, Cynthia L/0000-0003-3691-0324; Francis, Richard/0000-0002-4401-1946; Kim, Andrew/0000-0002-4923-6343; Tobita, Kimimasa/0000-0001-5435-8436; Klena, Nikolai/0000-0002-2631-2294; Pazour, Gregory/0000-0002-6285-8796; Gabriel, George/0000-0003-3250-2518; Yagi, Hisato/0000-0003-1460-4043; Damerla, Rama Rao/0000-0001-6815-0097; Ganapathiraju, Madhavi/0000-0002-3825-0924; Pratt, Herb/0000-0002-4964-8292	National Heart, Lung, and Blood Institute [U01HL098180, U01HL098188]; National Institute of Mental Health [R01MH094564]; National Human Genome Research Institute [HG000330]; University of Pittsburgh School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098180, U01HL098188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG000330, P01HG000330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094564] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Ramirez for early assistance with the mutagenesis breeding pipeline, R. Subramanian and D. Farkas for early assistance with necropsy and pathology examination of mutants, A. Srinivasan for early assistance with exome sequencing, S. Fatakia for assistance with sequencing data maintenance, M. Wong and C. Krise for assistance with mouse curation, B. Beutler for advice on mapping mutations using intercrosses with the C57BL/10J strain and whole-mouse exome sequencing analysis, D. Weeks and Y. Shan for assistance in statistical modelling of target gene size estimates, E. Goldmuntz for helpful discussions and critical review of the manuscript, and the New England Research Institutes (NERI) for constructing the CHD Mouse Mutation Database. The project was supported by award numbers U01HL098180 (to C.W.L.) and U01HL098188 (to NERI) from the National Heart, Lung, and Blood Institute, R01MH094564 (to M.K.G.) from the National Institute of Mental Health, and HG000330 (to J.E.) from the National Human Genome Research Institute. Funding was also provided by the University of Pittsburgh School of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Human Genome Research Institute or the National Institutes of Health.	Atkinson DE, 1998, AM J CARDIOL, V82, P1147, DOI 10.1016/S0002-9149(98)00574-8; Berg C, 2003, ULTRASOUND OBST GYN, V22, P451, DOI 10.1002/uog.904; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Damerla RR, 2014, MAMM GENOME, V25, P120, DOI 10.1007/s00335-013-9494-7; Donoso M, 2009, MOL BIOL CELL, V20, P481, DOI 10.1091/mbc.E08-08-0805; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P103, DOI 10.1007/BF00801907; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kim AJ, 2013, CIRC-CARDIOVASC IMAG, V6, P551, DOI 10.1161/CIRCIMAGING.113.000279; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Liu XQ, 2014, CIRC-CARDIOVASC IMAG, V7, P31, DOI 10.1161/CIRCIMAGING.113.000451; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Oyen N, 2009, CIRCULATION, V120, P295, DOI 10.1161/CIRCULATIONAHA.109.857987; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Shen Y, 2005, PHYSIOL GENOMICS, V24, P23, DOI 10.1152/physiolgenomics.00129.2005; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Stagner EE, 2009, BIOCHEM BIOPH RES CO, V383, P16, DOI 10.1016/j.bbrc.2009.03.113; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Taketazu M, 2006, AM J CARDIOL, V97, P720, DOI 10.1016/j.amjcard.2005.09.119; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; Tennstedt C, 1999, HEART, V82, P34, DOI 10.1136/hrt.82.1.34; Ware Stephanie M, 2011, Proc Am Thorac Soc, V8, P444, DOI 10.1513/pats.201103-025SD; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	30	257	260	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					520	U224		10.1038/nature14269	http://dx.doi.org/10.1038/nature14269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25807483	Green Accepted			2022-12-24	WOS:000355286600043
J	Snyder, EL; Stramer, SL; Benjamin, RJ				Snyder, Edward L.; Stramer, Susan L.; Benjamin, Richard J.			The Safety of the Blood Supply - Time to Raise the Bar	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSMISSION; TRANSFUSION; DONORS; VIRUS		[Snyder, Edward L.] Yale Univ, New Haven, CT 06520 USA; [Stramer, Susan L.; Benjamin, Richard J.] Amer Red Cross, Blood Serv, Rockville, MD USA	Yale University; American Red Cross	Snyder, EL (corresponding author), Yale Univ, New Haven, CT 06520 USA.							Bracey AW, 2008, ADVISORY COMMITTEE B; Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880; Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x; Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x; Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x	5	50	51	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1882	1885		10.1056/NEJMp1500154	http://dx.doi.org/10.1056/NEJMp1500154			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1HB	25902384				2022-12-24	WOS:000354493300003
J	Xu, X; Zheng, XT; Sullivan, C; Wang, XL; Xing, LD; Wang, Y; Zhang, XM; O'Connor, JK; Zhang, FC; Pan, YH				Xu, Xing; Zheng, Xiaoting; Sullivan, Corwin; Wang, Xiaoli; Xing, Lida; Wang, Yan; Zhang, Xiaomei; O'Connor, Jingmai K.; Zhang, Fucheng; Pan, Yanhong			A bizarre Jurassic maniraptoran theropod with preserved evidence of membranous wings	NATURE			English	Article							EVOLUTION; CHINA; DINOSAURS	The wings of birds and their closest theropod relatives share a uniform fundamental architecture, with pinnate flight feathers as the key component(1-3). Here we report a new scansoriopterygid theropod, Yi qi gen. et sp. nov., based on a new specimen from the Middle-Upper Jurassic period Tiaojishan Formation of Hebei Province, China(4). Yi is nested phylogenetically among winged theropods but has large stiff filamentous feathers of an unusual type on both the forelimb and hindlimb. However, the filamentous feathers of Yi resemble pinnate feathers in bearing morphologically diverse melanosomes(5). Most surprisingly, Yi has a long rod-like bone extending from each wrist, and patches of membranous tissue preserved between the rod-like bones and the manual digits. Analogous features are unknown in any dinosaur but occur in various flying and gliding tetrapods(6-10), suggesting the intriguing possibility that Yi had membranous aerodynamic surfaces totally different from the archetypal feathered wings of birds and their closest relatives. Documentation of the unique forelimbs of Yi greatly increases the morphological disparity known to exist among dinosaurs, and highlights the extraordinary breadth and richness of the evolutionary experimentation that took place close to the origin of birds.	[Xu, Xing; Zheng, Xiaoting; Wang, Xiaoli; Wang, Yan] Linyi Univ, Inst Geol & Paleontol, Linyi 276005, Shandong, Peoples R China; [Xu, Xing; Sullivan, Corwin; O'Connor, Jingmai K.; Zhang, Fucheng] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Zheng, Xiaoting; Zhang, Xiaomei] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [Xing, Lida] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Pan, Yanhong] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Key Lab Econ Stratig & Palaeogeog, Nanjing 210008, Jiangsu, Peoples R China	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; China University of Geosciences; Chinese Academy of Sciences	Xu, X (corresponding author), Linyi Univ, Inst Geol & Paleontol, Linyi 276005, Shandong, Peoples R China.	xingxu@vip.sina.com; ty4291666@163.com	Xiaoli, Wang/H-1079-2014	Sullivan, Corwin/0000-0002-5488-6797	National Natural Science Foundation of China [41372014, 41472023, 41120124002, 41125008]; Major Basic Research Projects of the Ministry of Science and Technology, China [2012CB821900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Projects of the Ministry of Science and Technology, China	We thank Z. Zhou, R. Dudley, J. Clarke and T. Stidham for discussion, X. Ding for specimen preparation, Y. Liu and Y. Han for providing illustrations, Z. Zhang for assistance with the EDS analysis, and Y. Hou for CT scanning the specimen. This research was funded by the National Natural Science Foundation of China (41372014, 41472023, 41120124002 and 41125008) and Major Basic Research Projects of the Ministry of Science and Technology, China (2012CB821900).	Bennett SC, 2007, J VERTEBR PALEONTOL, V27, P881, DOI 10.1671/0272-4634(2007)27[881:AAFOTP]2.0.CO;2; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P63; Czerkas SA, 2014, J ORNITHOL, V155, P841, DOI 10.1007/s10336-014-1098-9; Feduccia A, 2013, AUK, V130, P1, DOI 10.1525/auk.2013.130.1.1; Foth C, 2014, NATURE, V511, P79, DOI 10.1038/nature13467; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jackson SM, 2000, MAMMAL REV, V30, P9, DOI 10.1046/j.1365-2907.2000.00056.x; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; JOHNSONMURRAY JL, 1977, J MAMMAL, V58, P374, DOI 10.2307/1379336; Li QG, 2014, NATURE, V507, P350, DOI 10.1038/nature12973; Moyer AE, 2014, SCI REP-UK, V4, DOI [10.1038/srep04233, 10.1038/srep06191]; O'Connor Jingmai K., 2014, Vertebrata Palasiatica, V52, P3; Schutt William A. Jr., 1998, Journal of Mammalian Evolution, V5, P1; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Storch G, 1996, NATURE, V379, P439, DOI 10.1038/379439a0; Sullivan C, 2014, J VERTEBR PALEONTOL, V34, P243, DOI 10.1080/02724634.2013.787316; Thorington RW, 1998, J MAMMAL, V79, P245, DOI 10.2307/1382860; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Xu K., 2003, JURASSIC SYSTEM N CH, VVII; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	24	103	108	5	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					70	U131		10.1038/nature14423	http://dx.doi.org/10.1038/nature14423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924069				2022-12-24	WOS:000354040900034
J	Finnegan, S; Anderson, SC; Harnik, PG; Simpson, C; Tittensor, DP; Byrnes, JE; Finkel, ZV; Lindberg, DR; Liow, LH; Lockwood, R; Lotze, HK; McClain, CR; McGuire, JL; O'Dea, A; Pandolfi, JM				Finnegan, Seth; Anderson, Sean C.; Harnik, Paul G.; Simpson, Carl; Tittensor, Derek P.; Byrnes, Jarrett E.; Finkel, Zoe V.; Lindberg, David R.; Liow, Lee Hsiang; Lockwood, Rowan; Lotze, Heike K.; McClain, Craig R.; McGuire, Jenny L.; O'Dea, Aaron; Pandolfi, John M.			Paleontological baselines for evaluating extinction risk in the modern oceans	SCIENCE			English	Article							MARINE BIODIVERSITY; SPECIES RICHNESS; GLOBAL PATTERNS; DIVERSITY; HOTSPOTS; VULNERABILITY; CONSERVATION; PREDICTORS; DRIVERS; CLIMATE	Marine taxa are threatened by anthropogenic impacts, but knowledge of their extinction vulnerabilities is limited. The fossil record provides rich information on past extinctions that can help predict biotic responses. We show that over 23 million years, taxonomic membership and geographic range size consistently explain a large proportion of extinction risk variation in six major taxonomic groups. We assess intrinsic risk-extinction risk predicted by paleontologically calibrated models-for modern genera in these groups. Mapping the geographic distribution of these genera identifies coastal biogeographic provinces where fauna with high intrinsic risk are strongly affected by human activity or climate change. Such regions are disproportionately in the tropics, raising the possibility that these ecosystems may be particularly vulnerable to future extinctions. Intrinsic risk provides a prehuman baseline for considering current threats to marine biodiversity.	[Finnegan, Seth; Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Anderson, Sean C.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Harnik, Paul G.] Franklin & Marshall Coll, Dept Earth & Environm, Lancaster, PA 17604 USA; [Simpson, Carl] Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Tittensor, Derek P.] United Nations Environm Programme World Conservat, Cambridge CB3 0DL, England; [Tittensor, Derek P.] Microsoft Res, Sci Computat Lab, Cambridge CB1 2FB, England; [Tittensor, Derek P.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Byrnes, Jarrett E.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA; [Finkel, Zoe V.] Mt Allison Univ, Environm Sci Program, Sackville, NB E4L 1A5, Canada; [Liow, Lee Hsiang] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Lockwood, Rowan] Coll William & Mary, Dept Geol, Williamsburg, VA 23187 USA; [McClain, Craig R.] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; [McGuire, Jenny L.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [O'Dea, Aaron] Smithsonian Trop Res Inst, Balboa 084303092, Panama; [Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Coral Reef Studies, St Lucia, Qld 4072, Australia	University of California System; University of California Berkeley; Simon Fraser University; Franklin & Marshall College; Smithsonian Institution; Smithsonian National Museum of Natural History; Microsoft; Dalhousie University; University of Massachusetts System; University of Massachusetts Boston; Mount Allison University; University of Oslo; William & Mary; The National Evolutionary Synthesis Center; University of Washington; University of Washington Seattle; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Queensland	Finnegan, S (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	sethf@berkeley.edu	Liow, Lee Hsiang/E-3481-2010; Anderson, Sean C./AFN-3267-2022; McGuire, Jenny L./G-8819-2011; Pandolfi, John M/A-3121-2009; Tittensor, Derek P./AAV-1117-2021; Lindberg, David R/D-8138-2011; Finkel, Zoe/B-9626-2008	Liow, Lee Hsiang/0000-0002-3732-6069; Anderson, Sean C./0000-0001-9563-1937; McGuire, Jenny L./0000-0002-0663-6902; Pandolfi, John M/0000-0003-3047-6694; Tittensor, Derek P./0000-0002-9550-3123; McClain, Craig/0000-0003-0574-428X; Lotze, Heike/0000-0001-6258-1304; Harnik, Paul/0000-0001-6931-9931; O'Dea, Aaron/0000-0001-5495-4764; Simpson, Carl/0000-0003-0719-4437; Byrnes, Jarrett/0000-0002-9791-9472; Finkel, Zoe/0000-0003-4212-3917	National Evolutionary Synthesis Center (NSF) [EF-0905606]; Natural Sciences and Engineering Research Council of Canada; National System of Investigators of the National Secretariat for Science, Technology and Innovation of Panama; Australian Research Council Centre of Excellence for Coral Reef Studies; Deutsche Forschungsgemeinschaft [KI 806/7-1]; Directorate For Geosciences [1325379] Funding Source: National Science Foundation	National Evolutionary Synthesis Center (NSF); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National System of Investigators of the National Secretariat for Science, Technology and Innovation of Panama; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is a product of the Determinants of Extinction in Ancient and Modern Seas Working Group supported by the National Evolutionary Synthesis Center (NSF grant EF-0905606). Additional support was provided by the Natural Sciences and Engineering Research Council of Canada (to H.K.L., S.C.A., and Z.V.F.); the National System of Investigators of the National Secretariat for Science, Technology and Innovation of Panama (to A.O.); the Australian Research Council Centre of Excellence for Coral Reef Studies (to J.M.P.); and the Deutsche Forschungsgemeinschaft (grant KI 806/7-1 to C.S.). We thank the contributors to the Paleobiology Database and to OBIS. We also thank four anonymous reviewers for insightful comments that substantially improved the quality of the manuscript. This article is Paleobiology Database contribution no. 227. All scripts and data used to conduct analyses are available at https://github.com/seananderson/paleobaselines	Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Bromham L, 2012, P ROY SOC B-BIOL SCI, V279, P4024, DOI 10.1098/rspb.2012.1437; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; CBIS, DAT OC BIOG INF SYST; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Clarke A, 2008, J EXP MAR BIOL ECOL, V366, P48, DOI 10.1016/j.jembe.2008.07.008; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy Nicholas K., 2009, P129; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Foote M, 2008, PALEOBIOLOGY, V34, P421, DOI 10.1666/08023.1; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harnik PG, 2012, P ROY SOC B-BIOL SCI, V279, P4969, DOI 10.1098/rspb.2012.1902; Harnik PG, 2012, TRENDS ECOL EVOL, V27, P608, DOI 10.1016/j.tree.2012.07.010; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Lucifora LO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019356; Lyle M, 2007, GEOLOGY, V35, P691, DOI 10.1130/G23806A.1; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; Mora C, 2005, ECOLOGY, V86, P1771, DOI 10.1890/04-0883; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parravicini V, 2014, ECOL LETT, V17, P1101, DOI 10.1111/ele.12316; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; Purvis A., 2005, PHYLOGENY CONSERVATI; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Ronov A.B., 1982, INT GEOL REV, V24, P509, DOI [DOI 10.1080/10643389.2012.728825, 10.1080/00206818209451555]; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Valentine JW, 2013, PALEOBIOLOGY, V39, P1, DOI 10.1666/0094-8373-39.1.1; Vilhena DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074470; Wang SC, 2008, PALEOBIOLOGY, V34, P434, DOI 10.1666/07060.1; Webb TJ, 2015, CURR BIOL, V25, P506, DOI 10.1016/j.cub.2014.12.023	43	82	82	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					567	570		10.1126/science.aaa6635	http://dx.doi.org/10.1126/science.aaa6635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931558				2022-12-24	WOS:000353778100040
J	Doerschuk, CM				Doerschuk, Claire M.			Pulmonary Alveolar Proteinosis and Macrophage Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THERAPY		Univ N Carolina, Dept Med, Marsico Lung Inst, Div Pulm Dis & Crit Care Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Doerschuk, CM (corresponding author), Univ N Carolina, Dept Med, Marsico Lung Inst, Div Pulm Dis & Crit Care Med, Chapel Hill, NC 27515 USA.							Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Kleff V, 2008, MOL THER, V16, P757, DOI 10.1038/mt.2008.7; Lachmann N, 2014, AM J RESP CRIT CARE, V189, P167, DOI 10.1164/rccm.201306-1012OC; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108	5	14	16	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2015	372	18					1762	1764		10.1056/NEJMcibr1413035	http://dx.doi.org/10.1056/NEJMcibr1413035			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG9RF	25923557	Green Published			2022-12-24	WOS:000353655000013
J	Nelson, CP; Hamby, SE; Saleheen, D; Hopewell, JC; Zeng, L; Assimes, TL; Kanoni, S; Willenborg, C; Burgess, S; Amouyel, P; Anand, S; Blankenberg, S; Boehm, BO; Clarke, RJ; Collins, R; Dedoussis, G; Farrall, M; Franks, PW; Groop, L; Hall, AS; Hamsten, A; Hengstenberg, C; Hovingh, GK; Ingelsson, E; Kathiresan, S; Kee, F; Konig, IR; Kooner, J; Lehtimaki, T; Marz, W; McPherson, R; Metspalu, A; Nieminen, MS; O'Donnell, CJ; Palmer, CNA; Peters, A; Perola, M; Reilly, MP; Ripatti, S; Roberts, R; Salomaa, V; Shah, SH; Schreiber, S; Siegbahn, A; Thorsteinsdottir, U; Veronesi, G; Wareham, N; Willer, CJ; Zalloua, PA; Erdmann, J; Deloukas, P; Watkins, H; Schunkert, H; Danesh, J; Thompson, JR; Samani, NJ				Nelson, C. P.; Hamby, S. E.; Saleheen, D.; Hopewell, J. C.; Zeng, L.; Assimes, T. L.; Kanoni, S.; Willenborg, C.; Burgess, S.; Amouyel, P.; Anand, S.; Blankenberg, S.; Boehm, B. O.; Clarke, R. J.; Collins, R.; Dedoussis, G.; Farrall, M.; Franks, P. W.; Groop, L.; Hall, A. S.; Hamsten, A.; Hengstenberg, C.; Hovingh, G. Kees; Ingelsson, E.; Kathiresan, S.; Kee, F.; Koenig, I. R.; Kooner, J.; Lehtimaeki, T.; Maerz, W.; McPherson, R.; Metspalu, A.; Nieminen, M. S.; O'Donnell, C. J.; Palmer, C. N. A.; Peters, A.; Perola, M.; Reilly, M. P.; Ripatti, S.; Roberts, R.; Salomaa, V.; Shah, S. H.; Schreiber, S.; Siegbahn, A.; Thorsteinsdottir, U.; Veronesi, G.; Wareham, N.; Willer, C. J.; Zalloua, P. A.; Erdmann, J.; Deloukas, P.; Watkins, H.; Schunkert, H.; Danesh, J.; Thompson, J. R.; Samani, N. J.		CARDIoGRAM C4D Consortium	Genetically Determined Height and Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; ASSOCIATION; LOCI; ATHEROSCLEROSIS; VARIANTS; IGF-1	BACKGROUND The nature and underlying mechanisms of an inverse association between adult height and the risk of coronary artery disease (CAD) are unclear. METHODS We used a genetic approach to investigate the association between height and CAD, using 180 height-associated genetic variants. We tested the association between a change in genetically determined height of 1 SD (6.5 cm) with the risk of CAD in 65,066 cases and 128,383 controls. Using individual-level genotype data from 18,249 persons, we also examined the risk of CAD associated with the presence of various numbers of height-associated alleles. To identify putative mechanisms, we analyzed whether genetically determined height was associated with known cardiovascular risk factors and performed a pathway analysis of the height-associated genes. RESULTS We observed a relative increase of 13.5% (95% confidence interval [CI], 5.4 to 22.1; P<0.001) in the risk of CAD per 1-SD decrease in genetically determined height. There was a graded relationship between the presence of an increased number of height-raising variants and a reduced risk of CAD (odds ratio for height quar-tile 4 versus quartile 1, 0.74; 95% CI, 0.68 to 0.84; P<0.001). Of the 12 risk factors that we studied, we observed significant associations only with levels of low-density lipoprotein cholesterol and triglycerides (accounting for approximately 30% of the association). We identified several overlapping pathways involving genes associated with both development and atherosclerosis. CONCLUSIONS There is a primary association between a genetically determined shorter height and an increased risk of CAD, a link that is partly explained by the association between shorter height and an adverse lipid profile. Shared biologic processes that determine achieved height and the development of atherosclerosis may explain some of the association.	[Nelson, C. P.; Hamby, S. E.; Samani, N. J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Thompson, J. R.] Univ Leicester, Dept Hlth Sci, Leicester LE3 9QP, Leics, England; [Nelson, C. P.; Hamby, S. E.; Samani, N. J.] Natl Inst Hlth Res Leicester, Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Saleheen, D.; Burgess, S.; Danesh, J.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Ripatti, S.; Deloukas, P.] Wellcome Trust Sanger Inst, Cambridge, England; [Wareham, N.] Addenbrookes Hosp, Inst Metab Sci, Med Res Council Epidemiol Unit, Cambridge, England; [Hopewell, J. C.; Clarke, R. J.; Collins, R.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Hopewell, J. C.; Clarke, R. J.; Collins, R.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Farrall, M.; Watkins, H.] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Farrall, M.; Watkins, H.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kanoni, S.; Deloukas, P.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Boehm, B. O.] Univ London Imperial Coll Sci Technol & Med, London, England; [Kooner, J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Hall, A. S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Kee, F.] Queens Univ Belfast, Clin Res Collaborat Ctr Excellence Publ Hlth Nort, Belfast, Antrim, North Ireland; [Palmer, C. N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Saleheen, D.] Ctr Noncommunicable Dis, Karachi, Pakistan; [Saleheen, D.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Reilly, M. P.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Zeng, L.; Clarke, R. J.; Collins, R.; Hengstenberg, C.; Schunkert, H.] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Zeng, L.; Clarke, R. J.; Collins, R.; Hengstenberg, C.; Schunkert, H.] Partner Site Munich Heart Alliance, Deutsch Zentrum Herz Kreislauf Forsch, Munich, Germany; [Peters, A.] German Ctr Cardiovasc Res Partner Site Munich, Munich, Germany; [Willenborg, C.; Erdmann, J.] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23538 Lubeck, Germany; [Willenborg, C.; Erdmann, J.] Partner Site Hamburg Lubeck Kiel, German Ctr Cardiovasc Res, Lubeck, Germany; [Koenig, I. R.] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Blankenberg, S.] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, Hamburg, Germany; [Boehm, B. O.] Univ Ulm, Med Ctr, Dept Internal Med 1, D-89069 Ulm, Germany; [Maerz, W.] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, W.] Heidelberg Univ, Mannheim Med Fac, Med Clin 5, Synlab Acad,Synlab Serv, Mannheim, Germany; [Peters, A.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Schreiber, S.] Univ Kiel, Inst Klin Mol Biol, Kiel, Germany; [Assimes, T. L.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Amouyel, P.] Univ Lille Nord France, INSERM, U744, Inst Pasteur Lille, Lille, France; [Anand, S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [McPherson, R.; Roberts, R.] Univ Ottawa Heart Inst, John & Jennifer Ruddy Canadian Cardiovasc Genet C, Ottawa, ON, Canada; [McPherson, R.; Roberts, R.] Univ Ottawa Heart Inst, Atherogen Lab, Ottawa, ON, Canada; [Boehm, B. O.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Dedoussis, G.] Harokopio Univ, Dept Dietet Nutr, Athens, Greece; [Franks, P. W.] Lund Univ, Ctr Diabet, Skane Univ Hosp, Genet & Mol Epidemiol Unit,Dept Clin Sci, Malmo, Sweden; [Groop, L.] Lund Univ, Univ Hosp Malmo, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Franks, P. W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Hamsten, A.] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Ingelsson, E.] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Siegbahn, A.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Franks, P. W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Kathiresan, S.] Massachusetts Gen Hosp, Div Cardiol, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, S.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, S.] Harvard Univ, Sch Med, Boston, MA USA; [Kathiresan, S.] Broad Inst Harvard & MIT, Cambridge, MA USA; [O'Donnell, C. J.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Lehtimaeki, T.] Univ Tampere, Fimlab Labs, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaeki, T.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Nieminen, M. S.] Univ Helsinki, Cent Hosp, Dept Med, Div Cardiol, Helsinki, Finland; [Perola, M.; Salomaa, V.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Ripatti, S.] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Ripatti, S.] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Metspalu, A.; Perola, M.] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Shah, S. H.] Duke Univ, Dept Med, Div Cardiol, Duke Mol Physiol Inst, Durham, NC USA; [Thorsteinsdottir, U.] deCODE Genet, Reykjavik, Iceland; [Veronesi, G.] Univ Insubria, Dept Clin & Expt Med, Res Ctr Epidemiol & Prevent Med, Varese, Italy; [Willer, C. J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Willer, C. J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Willer, C. J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Zalloua, P. A.] Lebanese Amer Univ, Beirut, Lebanon; [Deloukas, P.] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	University of Leicester; University of Leicester; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of London; Queen Mary University London; Imperial College London; Imperial College London; University of Leeds; Queens University Belfast; University of Dundee; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; German Centre for Cardiovascular Research; University of Lubeck; German Centre for Cardiovascular Research; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Medical University of Graz; Ruprecht Karls University Heidelberg; SYNLAB Group; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; McMaster University; Population Health Research Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harokopio University Athens; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Umea University; Karolinska Institutet; Uppsala University; Uppsala University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Amsterdam; Academic Medical Center Amsterdam; Tampere University; Tampere University; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Tartu; Duke University; University of Insubria; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lebanese American University; King Abdulaziz University	Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, BHF Cardiovasc Res Ctr, Groby Rd, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk	Erdmann, Jeanette/P-7513-2014; Lehtimäki, Terho/AAD-1094-2022; Hall, Alistair/K-1953-2019; Veronesi, Giovanni/E-3859-2010; Cazier, Jean-Baptiste/GLR-2949-2022; Boehm, Bernhard Otto/F-8750-2015; Peters, Annette/A-6117-2011; Kessler, Thorsten/O-7426-2015; Willenborg, Christina/D-2668-2012; Franks, Paul/AAA-3300-2020; Hengstenberg, Christian/U-5485-2019; Kanoni, Stavroula/AAN-7161-2021; Lyytikäinen, Leo-Pekka/C-8544-2016; Gudnason, Vilmundur/K-6885-2015; Gauguier, Dominique/G-2190-2016; Dedoussis, George/AAN-7252-2021; Assimes, Themistocles Leonard/D-9696-2015; König, Inke R/A-4544-2009; Study, GoDARTS/K-9448-2016; Tregouet, David-Alexandre/E-3961-2016; Trégouët, David-Alexandre/P-9210-2019; Langenberg, Claudia/ABG-9067-2021; Erdmann, Jeanette/A-4417-2009; Palmer, Colin NA/C-7053-2008; Veronesi, Giovanni/O-5678-2019; Müller-Nurasyid, Martina/I-8735-2018; Deloukas, Panos/B-2922-2013; Ripatti, Samuli/H-9446-2014; Strawbridge, Rona/H-5422-2012	Erdmann, Jeanette/0000-0002-4486-6231; Lehtimäki, Terho/0000-0002-2555-4427; Veronesi, Giovanni/0000-0002-4119-6615; Cazier, Jean-Baptiste/0000-0001-7581-9051; Peters, Annette/0000-0001-6645-0985; Willenborg, Christina/0000-0001-5217-6882; Kanoni, Stavroula/0000-0002-1691-9615; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Gudnason, Vilmundur/0000-0001-5696-0084; Gauguier, Dominique/0000-0001-6156-9530; Dedoussis, George/0000-0002-7798-6221; Assimes, Themistocles Leonard/0000-0003-2349-0009; König, Inke R/0000-0003-0504-6465; Trégouët, David-Alexandre/0000-0001-9084-7800; Langenberg, Claudia/0000-0002-5017-7344; Palmer, Colin NA/0000-0002-6415-6560; Veronesi, Giovanni/0000-0002-4119-6615; Müller-Nurasyid, Martina/0000-0003-3793-5910; Deloukas, Panos/0000-0001-9251-070X; Ripatti, Samuli/0000-0002-0504-1202; Gigante, Bruna/0000-0003-4508-7990; Ouwehand, Willem/0000-0002-7744-1790; Nikus, Kjell/0000-0002-9345-9851; Shungin, Dmitry/0000-0001-7900-5856; Reilly, Muredach/0000-0002-3035-9386; Eriksson, Per/0000-0002-5635-2692; Strawbridge, Rona/0000-0001-8506-3585; Kleber, Marcus/0000-0003-0663-7275; Hopewell, Jemma/0000-0002-3870-8018; Hall, Alistair/0000-0003-0306-7887; Watkins, Hugh/0000-0002-5287-9016; Wild, Philipp/0000-0003-4413-9752; Franks, Paul/0000-0002-0520-7604; Esko, Tonu/0000-0003-1982-6569; Melander, Olle/0000-0002-2581-484X; Kristiansson, Kati/0000-0003-4688-107X; zalloua, pierre/0000-0002-8494-5081; Kuulasmaa, Kari/0000-0003-2165-1411; Ferrario, Marco M/0000-0003-2741-7124; Barroso, Ines/0000-0001-5800-4520; Kessler, Thorsten/0000-0003-3326-1621; Nelson, Christopher/0000-0001-8025-2897; Amouyel, Philippe/0000-0001-9088-234X; Burgess, Stephen/0000-0001-5365-8760	British Heart Foundation; MRC [MR/L003120/1, MR/L01629X/1, G0601463, MC_UU_12015/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, FS/14/55/30806] Funding Source: researchfish; Medical Research Council [MR/L01629X/1, MC_UU_12015/1, G0601463, MC_CF023241, MC_U106179471, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, NF-SI-0611-10170, NF-SI-0508-10235, NF-SI-0512-10135] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006173, ZIAHL006175, ZIAHL006002] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the British Heart Foundation and others.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Di Angelantonio E, 2012, JAMA-J AM MED ASSOC, V307, P2499, DOI 10.1001/jama.2012.6571; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Higashi Y, 2010, TRENDS ENDOCRIN MET, V21, P245, DOI 10.1016/j.tem.2009.12.005; Lieb W, 2013, HYPERTENSION, V61, P995, DOI 10.1161/HYPERTENSIONAHA.111.00275; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; OConnor NJ, 1996, CIRCULATION, V93, P652, DOI 10.1161/01.CIR.93.4.652; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toma I, 2012, CELL TISSUE RES, V347, P155, DOI 10.1007/s00441-011-1189-3; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; von der Thusen JH, 2011, AM J PATHOL, V178, P924, DOI 10.1016/j.ajpath.2010.10.007; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wanschel A, 2013, ARTERIOSCL THROM VAS, V33, P886, DOI 10.1161/ATVBAHA.112.300941; Wormser D, 2012, INT J EPIDEMIOL, V41, P1419, DOI 10.1093/ije/dys086; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	27	166	168	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1608	1618		10.1056/NEJMoa1404881	http://dx.doi.org/10.1056/NEJMoa1404881			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25853659	Green Published, Green Accepted			2022-12-24	WOS:000353294000006
J	Yu, M; Selvaraj, SK; Liang-Chu, MMY; Aghajani, S; Busse, M; Yuan, J; Lee, G; Peale, F; Klijn, C; Bourgon, R; Kaminker, JS; Neve, RM				Yu, Mamie; Selvaraj, Suresh K.; Liang-Chu, May M. Y.; Aghajani, Sahar; Busse, Matthew; Yuan, Jean; Lee, Genee; Peale, Franklin; Klijn, Christiaan; Bourgon, Richard; Kaminker, Joshua S.; Neve, Richard M.			A resource for cell line authentication, annotation and quality control	NATURE			English	Article							SPECIES IDENTIFICATION; CROSS-CONTAMINATION; CANCER	Cell line misidentification, contamination and poor annotation affect scientific reproducibility. Here we outline simple measures to detect or avoid cross-contamination, present a framework for cell line annotation linked to short tandem repeat and single nucleotide polymorphism profiles, and provide a catalogue of synonymous cell lines. This resource will enable our community to eradicate the use of misidentified lines and generate credible cell-based data.	[Yu, Mamie; Selvaraj, Suresh K.; Liang-Chu, May M. Y.; Lee, Genee; Neve, Richard M.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Aghajani, Sahar; Busse, Matthew; Yuan, Jean; Klijn, Christiaan; Bourgon, Richard; Kaminker, Joshua S.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Peale, Franklin] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Neve, RM (corresponding author), Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA.	neve.richard@gene.com		Klijn, Christiaan/0000-0003-0878-4121; Bourgon, Richard/0000-0002-5890-4374				[Anonymous], 2013, NATURE, V496, P398, DOI 10.1038/496398a; [Anonymous], 2009, NATURE, V457, P935, DOI 10.1038/457935b; Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Buehring GC, 2004, IN VITRO CELL DEV-AN, V40, P211; Capes-Davis A, 2013, INT J CANCER, V132, P2510, DOI 10.1002/ijc.27931; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Centers for Disease Control and Prevention, INT CLASSIFICATION D; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Didion JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-847; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; ICLAC, 2014, DAT CROSS CONT MIS C; ICLAC, 2014, NAM CELL LIN; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Lorsch JR, 2014, SCIENCE, V346, P1452, DOI 10.1126/science.1259110; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; Masters JR, 2012, NATURE, V492, P186, DOI 10.1038/492186a; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Much M, 2014, HUM PATHOL, V45, P549, DOI 10.1016/j.humpath.2013.10.022; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; Parodi B, 2002, BIOTECHNIQUES, V32, P432, DOI 10.2144/02322rr05; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Sarntivijai S, 2008, BIOINFORMATICS, V24, P2760, DOI 10.1093/bioinformatics/btn502; Steube KG, 2003, IN VITRO CELL DEV-AN, V39, P468; TANABE H, 1999, TISSUE CULT RES COMM, V18, P329, DOI DOI 10.11418/JTCA1981.18.4_329; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561; Wellcome Trust Sanger Institute, 2015, CELL LIN PROJ; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	35	141	144	3	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					307	+		10.1038/nature14397	http://dx.doi.org/10.1038/nature14397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877200				2022-12-24	WOS:000352974200029
J	Hawkes, N				Hawkes, Nigel			BMJ AWARDS 2015 Imaging team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2015	350								h1747	10.1136/bmj.h1747	http://dx.doi.org/10.1136/bmj.h1747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SR	25854263				2022-12-24	WOS:000352907500001
J	Cohen, D				Cohen, Deborah			DRUG REGULATION Attacks on publicly funded trials: what happens when industry does not want to know the answer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com						Ball D., 2014, WALL ST J       0529; Cohen D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2006; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2	5	2	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1701	10.1136/bmj.h1701	http://dx.doi.org/10.1136/bmj.h1701			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25834025				2022-12-24	WOS:000352439300011
J	Savage, N				Savage, Neil			SYNTHETIC COATINGS Super surfaces	NATURE			English	Editorial Material																		Bird JC, 2013, NATURE, V503, P385, DOI 10.1038/nature12740; Bixler GD, 2014, J COLLOID INTERF SCI, V419, P114, DOI 10.1016/j.jcis.2013.12.019; Huang YJ, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-3; Sileika TS, 2013, ANGEW CHEM INT EDIT, V52, P10766, DOI 10.1002/anie.201304922; Zhang MJ, 2009, J BIOMED NANOTECHNOL, V5, P294, DOI 10.1166/jbn.2009.1034	5	23	25	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S7	S9		10.1038/519S7a	http://dx.doi.org/10.1038/519S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806497				2022-12-24	WOS:000351602800002
J	Mohrin, M; Shin, JY; Liu, YF; Brown, K; Luo, HZ; Xi, YN; Haynes, CM; Chen, D				Mohrin, Mary; Shin, Jiyung; Liu, Yufei; Brown, Katharine; Luo, Hanzhi; Xi, Yannan; Haynes, Cole M.; Chen, Danica			A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging	SCIENCE			English	Article							STRESS; GROWTH; HOMEOSTASIS; MECHANISMS; DISEASE	Deterioration of adult stem cells accounts for much of aging-associated compromised tissue maintenance. How stem cells maintain metabolic homeostasis remains elusive. Here, we identified a regulatory branch of the mitochondrial unfolded protein response (UPRmt), which is mediated by the interplay of SIRT7 and NRF1 and is coupled to cellular energy metabolism and proliferation. SIRT7 inactivation caused reduced quiescence, increased mitochondrial protein folding stress (PFSmt), and compromised regenerative capacity of hematopoietic stem cells (HSCs). SIRT7 expression was reduced in aged HSCs, and SIRT7 up-regulation improved the regenerative capacity of aged HSCs. These findings define the deregulation of a UPRmt-mediated metabolic checkpoint as a reversible contributing factor for HSC aging.	[Mohrin, Mary; Shin, Jiyung; Brown, Katharine; Luo, Hanzhi; Xi, Yannan; Chen, Danica] Univ Calif Berkeley, Program Metab Biol Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Liu, Yufei] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Haynes, Cole M.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Haynes, Cole M.] Weill Cornell Med Coll, Biochem Cell & Mol Biol Allied Program, New York, NY USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center; Cornell University	Chen, D (corresponding author), Univ Calif Berkeley, Program Metab Biol Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	danicac@berkeley.edu		Liu, Yufei/0000-0003-3501-5790	NIH [R01 AG040990, R01AG040061, T32 AG000266]; Ellison Medical Foundation; Glenn Foundation; NSF Graduate Research Fellowship Program; Siebel Stem Cell Institute; NATIONAL INSTITUTE ON AGING [T32AG000266, R01AG040061, R01AG040990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Siebel Stem Cell Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Nolla, A. Valeros, and K. Heydari for cell sorting; R. Zalpuri for electron microscopy; U. Andersen for mass spectrometry; J. Kim for technical assistance; the Chua laboratory for SIRT7 antibody and constructs; and the Hoogenraad laboratory for OTC constructs. This work was supported by NIH R01 AG040990 (D.C.), R01AG040061 (C.M.H.), T32 AG000266 (M.M.), Ellison Medical Foundation (D.C.), Glenn Foundation (D.C.), NSF Graduate Research Fellowship Program (J.S.), and Siebel Stem Cell Institute (D.C. and M.M.). The supplementary materials contain additional data.	Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu J. Y., 2009, ACTA ACAD MED SINICA, V31, P724; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Vakhrusheva O, 2008, J PHYSIOL PHARMACOL, V59, P201; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Webb AE, 2013, CELL REP, V4, P477, DOI 10.1016/j.celrep.2013.06.035; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	25	308	319	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1374	1377		10.1126/science.aaa2361	http://dx.doi.org/10.1126/science.aaa2361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6SM	25792330	Green Accepted			2022-12-24	WOS:000351219600045
J	Berkley, S				Berkley, Seth			Share the risks of Ebola vaccine development	NATURE			English	Editorial Material									Gavi, Geneva, Switzerland		Berkley, S (corresponding author), Gavi, Geneva, Switzerland.	sberkley@gavi.org							0	2	2	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					263	263		10.1038/519263a	http://dx.doi.org/10.1038/519263a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788059	Bronze			2022-12-24	WOS:000351171900004
J	Lansky, Z; Braun, M; Ludecke, A; Schlierf, M; ten Wolde, PR; Janson, ME; Diez, S				Lansky, Zdenek; Braun, Marcus; Luedecke, Annemarie; Schlierf, Michael; ten Wolde, Pieter Rein; Janson, Marcel E.; Diez, Stefan			Diffusible Crosslinkers Generate Directed Forces in Microtubule Networks	CELL			English	Article							FISSION YEAST; OVERLAPPING MICROTUBULES; KINESIN MOTORS; CELL-DIVISION; PROTEIN; ASE1P; FRICTION; COMPLEX; CYTOKINESIS; TRANSPORT	Cytoskeletal remodeling is essential to eukaryotic cell division and morphogenesis. The mechanical forces driving the restructuring are attributed to the action of molecular motors and the dynamics of cytoskeletal filaments, which both consume chemical energy. By contrast, non-enzymatic filament cross-linkers are regarded as mere friction-generating entities. Here, we experimentally demonstrate that diffusible microtubule crosslinkers of the Ase1/PRC1/Map65 family generate directed microtubule sliding when confined between partially overlapping microtubules. The Ase1-generated forces, directly measured by optical tweezers to be in the piconewton-range, were sufficient to antagonize motor-protein driven microtubule sliding. Force generation is quantitatively explained by the entropic expansion of confined Ase1 molecules diffusing within the microtubule overlaps. The thermal motion of crosslinkers is thus harnessed to generate mechanical work analogous to compressed gas propelling a piston in a cylinder. As confinement of diffusible proteins is ubiquitous in cells, the associated entropic forces are likely of importance for cellular mechanics beyond cytoskeletal networks.	[Lansky, Zdenek; Braun, Marcus; Luedecke, Annemarie; Schlierf, Michael; Diez, Stefan] Tech Univ Dresden, CUBE Ctr Mol Bioengn B, D-01307 Dresden, Germany; [Lansky, Zdenek; Braun, Marcus; Diez, Stefan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [ten Wolde, Pieter Rein] AMOLF, NL-1098 XG Amsterdam, Netherlands; [Janson, Marcel E.] Wageningen Univ, Lab Cell Biol, NL-6708 PB Wageningen, Netherlands	Technische Universitat Dresden; Max Planck Society; AMOLF; Wageningen University & Research	ten Wolde, PR (corresponding author), AMOLF, NL-1098 XG Amsterdam, Netherlands.	tenwolde@amolf.nl; marcel.janson@wur.nl; diez@bcube-dresden.de	Braun, Marcus/L-8931-2018; Schlierf, Michael/F-5343-2012; Lansky, Zdenek/M-4548-2014; Wolde, Pieter Rein Ten/U-4433-2019; Diez, Stefan/E-8172-2010	Braun, Marcus/0000-0003-2026-2238; Schlierf, Michael/0000-0002-6209-2364; Lansky, Zdenek/0000-0001-8474-053X; Wolde, Pieter Rein Ten/0000-0001-9933-4016; Diez, Stefan/0000-0002-0750-8515	European Research Council (ERC) [242933]; Deutsche Forschungsgemeinschaft [DI 1226/4]; Deutsche Forschungsgemeinschaft (research unit SFG 877) [DI 1226/4]; Dresden International Graduate School for Biomedicine and Bioengineering; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [03Z2EN11]; Foundation for Fundamental Research on Matter (FOM) part of the Netherlands Organisation for Scientific Research (NWO); Division for Earth and Life Sciences (ALW) part of the Netherlands Organisation for Scientific Research (NWO) [834.09.005]	European Research Council (ERC)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (research unit SFG 877); Dresden International Graduate School for Biomedicine and Bioengineering; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Foundation for Fundamental Research on Matter (FOM) part of the Netherlands Organisation for Scientific Research (NWO); Division for Earth and Life Sciences (ALW) part of the Netherlands Organisation for Scientific Research (NWO)	We thank Stephan Grill, Joe Howard, Tim Mitchison, Francois Nedelec, Friedrich Schwarz, Antoine van Oijen, and Klaus Kroy for discussions, as well as Gijsje Koenderink and Marileen Dogterom for comments on an earlier version of the manuscript. M.B., Z.L., A.L., and S.D. acknowledge support from the European Research Council (ERC starting grant 242933 to S.D.), the Deutsche Forschungsgemeinschaft (Heisenberg programme grant DI 1226/4 and research unit SFG 877 grant DI 1226/4), and the Dresden International Graduate School for Biomedicine and Bioengineering (stipend to A.L.); M.S. from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung grant 03Z2EN11); and M.E.J., and P.R.t.W. from the Foundation for Fundamental Research on Matter (FOM) and the Division for Earth and Life Sciences (ALW grant 834.09.005), which are part of the Netherlands Organisation for Scientific Research (NWO).	Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Civelekoglu-Scholey G, 2010, CELL MOL LIFE SCI, V67, P2231, DOI 10.1007/s00018-010-0326-6; Compton DA, 1998, J CELL SCI, V111, P1477; Einstein A, 1906, ANN PHYS-BERLIN, V19, P371; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Forth S, 2014, CELL, V157, P420, DOI 10.1016/j.cell.2014.02.018; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Ma XF, 2012, P NATL ACAD SCI USA, V109, P4509, DOI 10.1073/pnas.1116268109; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE3986, DOI 10.1073/pnas.1406535111; Neujahr R, 1997, J CELL SCI, V110, P123; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Sun SX, 2010, CURR BIOL, V20, pR649, DOI 10.1016/j.cub.2010.07.004; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Volkov VA, 2013, P NATL ACAD SCI USA, V110, P7708, DOI 10.1073/pnas.1305821110; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zandi R, 2003, P NATL ACAD SCI USA, V100, P8649, DOI 10.1073/pnas.1533334100	41	95	96	2	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1159	1168		10.1016/j.cell.2015.01.051	http://dx.doi.org/10.1016/j.cell.2015.01.051			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25748652	Green Submitted, Bronze			2022-12-24	WOS:000351951800015
J	Holmes, DR; Brennan, JM; Rumsfeld, JS; Dai, D; O'Brien, SM; Vemulapalli, S; Edwards, FH; Carroll, J; Shahian, D; Grover, F; Tuzcu, EM; Peterson, ED; Brindis, RG; Mack, MJ				Holmes, David R., Jr.; Brennan, J. Matthew; Rumsfeld, John S.; Dai, David; O'Brien, Sean M.; Vemulapalli, Sreekanth; Edwards, Fred H.; Carroll, John; Shahian, David; Grover, Fred; Tuzcu, E. Murat; Peterson, Eric D.; Brindis, Ralph G.; Mack, Michael J.		STS ACC TVT Registry	Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							END-POINT DEFINITIONS; HIGH-RISK PATIENTS; EDWARDS SAPIEN; PREDICT OUTCOMES; EUROSCORE II; IMPLANTATION; REGISTRY; MORTALITY; STENOSIS; DEVICES	IMPORTANCE Introducing new medical devices into routine practice raises concerns because patients and outcomesmay differ from those in randomized trials. OBJECTIVE To update the previous report of 30-day outcomes and present 1-year outcomes following transcatheter aortic valve replacement (TAVR) in the United States. DESIGN, SETTING, AND PARTICIPANTS Data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) Transcatheter Valve Therapies Registry were linked with patient-specific Centers for Medicare & Medicaid Services (CMS) administrative claims data. At 299 US hospitals, 12 182 patients linked with CMS data underwent TAVR procedures performed from November 2011 through June 30, 2013, and the end of the follow-up period was June 30, 2014. EXPOSURE Transcatheter aortic valve replacement. MAIN OUTCOMES AND MEASURES One-year outcomes including mortality, stroke, and rehospitalization were evaluated using multivariate modeling. RESULTS The median age of patients was 84 years and 52% were women, with a median STS Predicted Risk of Operative Mortality (STS PROM) score of 7.1%. Following the TAVR procedure, 59.8% were discharged to home and the 30-day mortality was 7.0% (95% CI, 6.5%-7.4%) (n = 847 deaths). In the first year after TAVR, patients were alive and out of the hospital for a median of 353 days (interquartile range, 312-359 days); 24.4%(n = 2074) of survivors were rehospitalized once and 12.5%(n = 1525) were rehospitalized twice. By 1 year, the overall mortality rate was 23.7%(95% CI, 22.8%-24.5%) (n = 2450 deaths), the stroke rate was 4.1%(95% CI, 3.7%-4.5%) (n = 455 stroke events), and the rate of the composite outcome of mortality and stroke was 26.0%(25.1%-26.8%) (n = 2719 events). Characteristics significantly associated with 1-year mortality included advanced age (hazard ratio [HR] for >= 95 vs <75 years, 1.61 [95% CI, 1.24-2.09]; HR for 85-94 years vs <75 years, 1.35 [95% CI, 1.18-1.55]; and HR for 75-84 years vs < 75 years, 1.23 [95% CI, 1.08-1.41]), male sex (HR, 1.21; 95% CI, 1.12-1.31), end-stage renal disease (HR, 1.66; 95% CI, 1.41-1.95), severe chronic obstructive pulmonary disease (HR, 1.39; 95% CI, 1.25-1.55), nontransfemoral access (HR, 1.37; 95% CI, 1.27-1.48), STS PROM score greater than 15% vs less than 8%(HR, 1.82; 95% CI, 1.60-2.06), and preoperative atrial fibrillation/flutter (HR, 1.37; 95% CI, 1.27-1.48). Compared with men, women had a higher risk of stroke (HR, 1.40; 95% CI, 1.15-1.71). CONCLUSIONS AND RELEVANCE Among patients undergoing TAVR in US clinical practice, at 1-year follow-up, overall mortality was 23.7%, the stroke rate was 4.1%, and the rate of the composite outcome of death and stroke was 26.0%. These findings should be helpful in discussions with patients undergoing TAVR.	[Holmes, David R., Jr.] Mayo Clin, Rochester, MN 55905 USA; [Brennan, J. Matthew; Dai, David; O'Brien, Sean M.; Vemulapalli, Sreekanth] Duke Clin Res Inst, Durham, NC USA; [Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO USA; [Edwards, Fred H.] Univ Florida, Jacksonville, FL USA; [Carroll, John; Grover, Fred] Univ Colorado, Denver, CO 80202 USA; [Shahian, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tuzcu, E. Murat] Cleveland Clin, Cleveland, OH 44106 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Durham, NC USA; [Brindis, Ralph G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mack, Michael J.] Baylor Scott & White Hlth, Plano, TX USA	Mayo Clinic; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Denver; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation; Duke University; University of California System; University of California San Francisco; Baylor Health Care System	Holmes, DR (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	holmes.david@mayo.edu	Peterson, Eric David/ABF-5033-2021; Doğan, Ali/AAN-5331-2020		American College of Cardiology Foundation's National Cardiovascular Data Registry; Society of Thoracic Surgeons	American College of Cardiology Foundation's National Cardiovascular Data Registry; Society of Thoracic Surgeons	The STS/ACC TVT Registry is an initiative of the Society of Thoracic Surgeons and the American College of Cardiology Foundation. This research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry and the Society of Thoracic Surgeons.	Adams DH, 2014, NEW ENGL J MED, V371, P967, DOI 10.1056/NEJMc1408396; Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Centers for Medicare and Medicaid Services, NAT COV DET NCD TRAN; Chieffo A, 2013, J AM COLL CARDIOL, V61, P830, DOI 10.1016/j.jacc.2012.11.050; cmprsk Gray B, SUBDISTRIBUTION ANAL; D'Ascenzo F, 2013, J CARDIOVASC MED, V14, P894, DOI 10.2459/JCM.0b013e3283638e26; Dewey TM, 2008, J THORAC CARDIOV SUR, V135, P180, DOI 10.1016/j.jtcvs.2007.09.011; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hamm CW, 2014, EUR HEART J, V35, P1588, DOI 10.1093/eurheartj/eht381; Holmes DR, 2012, J AM COLL CARDIOL, V59, P1200, DOI 10.1016/j.jacc.2012.01.001; Iturra SA, 2014, J THORAC CARDIOV SUR, V147, P127, DOI 10.1016/j.jtcvs.2013.08.036; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Kohl M, 2013, PSHREG SAS MACRO PRO; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2013, JAMA-J AM MED ASSOC, V310, P2069, DOI 10.1001/jama.2013.282043; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mylotte D, 2013, J AM COLL CARDIOL, V62, P210, DOI 10.1016/j.jacc.2013.03.074; Nombela-Franco L, 2013, AM J CARDIOL, V111, P1026, DOI 10.1016/j.amjcard.2012.11.063; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stahli BE, 2013, CARDIOLOGY, V126, P15, DOI 10.1159/000351438; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Unbehaun A, 2012, J AM COLL CARDIOL, V59, P211, DOI 10.1016/j.jacc.2011.10.857; Van Mieghem NM, 2014, EUROINTERVENTION, V9, P1317, DOI 10.4244/EIJV9I11A222; Vanhuyse F, 2013, J HEART VALVE DIS, V22, P517; Watanabe Y, 2013, CATHETER CARDIO INTE, V81, P1053, DOI 10.1002/ccd.24702	33	344	346	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1019	1028		10.1001/jama.2015.1474	http://dx.doi.org/10.1001/jama.2015.1474			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756438	Bronze			2022-12-24	WOS:000350643100017
J	Farris, G				Farris, Grace			The library card	LANCET			English	Editorial Material									Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Farris, G (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	gfarris@bidmc.harvard.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					766	767		10.1016/S0140-6736(15)60426-3	http://dx.doi.org/10.1016/S0140-6736(15)60426-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25752166				2022-12-24	WOS:000350051700017
J	Gagliani, N; Vesely, MCA; Iseppon, A; Brockmann, L; Xu, H; Palm, NW; de Zoete, MR; Licona-Limon, P; Paiva, RS; Ching, T; Weaver, C; Zi, XY; Pan, XH; Fan, R; Garmire, LX; Cotton, MJ; Drier, Y; Bernstein, B; Geginat, J; Stockinger, B; Esplugues, E; Huber, S; Flavell, RA				Gagliani, Nicola; Vesely, Maria Carolina Amezcua; Iseppon, Andrea; Brockmann, Leonie; Xu, Hao; Palm, Noah W.; de Zoete, Marcel R.; Licona-Limon, Paula; Paiva, Ricardo S.; Ching, Travers; Weaver, Casey; Zi, Xiaoyuan; Pan, Xinghua; Fan, Rong; Garmire, Lana X.; Cotton, Matthew J.; Drier, Yotam; Bernstein, Bradley; Geginat, Jens; Stockinger, Brigitta; Esplugues, Enric; Huber, Samuel; Flavell, Richard A.			TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation	NATURE			English	Article							T(H)17 CELLS; TGF-BETA; DIFFERENTIATION; INTERLEUKIN-10; FOXP3(+); RECEPTOR; ABSENCE; IL-10; GAMMA	Inflammation is a beneficial host response to infection but can contribute to inflammatory disease if unregulated. The TH17 lineage of T helper (TH) cells can cause severe human inflammatory diseases. These cells exhibit both instability (they can cease to express their signature cytokine, IL-17A)(1) and plasticity (they can start expressing cytokines typical of other lineages)(1,2) upon in vitro re-stimulation. However, technical limitations have prevented the transcriptional profiling of pre- and post-conversion TH17 cells ex vivo during immune responses. Thus, it is unknown whether TH17 cell plasticity merely reflects change in expression of a few cytokines, or if TH17 cells physiologically undergo global genetic reprogramming driving their conversion from one T helper cell type to another, a process known as transdifferentiation(3,4). Furthermore, although TH17 cell instability/plasticity has been associated with pathogenicity(1,2,5), it is unknown whether this could present a therapeutic opportunity, whereby formerly pathogenic TH17 cells could adopt an anti-inflammatory fate. Here we used two new fate-mapping mouse models to track TH17 cells during immune responses to show that CD4(+) T cells that formerly expressed IL-17A go on to acquire an anti-inflammatory phenotype. The transdifferentiation of TH17 into regulatory T cells was illustrated by a change in their signature transcriptional profile and the acquisition of potent regulatory capacity. Comparisons of the transcriptional profiles of pre-and post-conversion TH17 cells also revealed a role for canonical TGF-beta signalling and consequently for the aryl hydrocarbon receptor (AhR) in conversion. Thus, TH17 cells transdifferentiate into regulatory cells, and contribute to the resolution of inflammation. Our data suggest that TH17 cell instability and plasticity is a therapeutic opportunity for inflammatory diseases.	[Gagliani, Nicola; Vesely, Maria Carolina Amezcua; Iseppon, Andrea; Xu, Hao; Palm, Noah W.; de Zoete, Marcel R.; Licona-Limon, Paula; Paiva, Ricardo S.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Brockmann, Leonie; Huber, Samuel] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin, D-20246 Hamburg, Germany; [de Zoete, Marcel R.; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Ching, Travers; Garmire, Lana X.] Univ Hawaii, Ctr Canc, Manoa, HI 96813 USA; [Weaver, Casey] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zi, Xiaoyuan; Fan, Rong] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Pan, Xinghua] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Cotton, Matthew J.; Drier, Yotam; Bernstein, Bradley] Howard Hughes Med Inst, Boston, MA 02114 USA; [Cotton, Matthew J.; Drier, Yotam; Bernstein, Bradley] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cotton, Matthew J.; Drier, Yotam; Bernstein, Bradley] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Geginat, Jens] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, I-20122 Milan, Italy; [Stockinger, Brigitta] MRCNat Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Esplugues, Enric] Icahn Sch Med Mt Sinai, Mt Sinai Sch Med, Immunol Inst, New York, NY 10029 USA	Yale University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Howard Hughes Medical Institute; Yale University; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Alabama System; University of Alabama Birmingham; Yale University; Yale University; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	s.huber@uke.de; richard.flavell@yale.edu	de Zoete, Marcel R/O-3012-2014; Drier, Yotam/K-5208-2012; Geginat, Jens/AAA-5818-2019; de Zoete, Marcel/ABA-7918-2021; Esplugues, Enric/AAD-4245-2020	Drier, Yotam/0000-0003-1725-2995; Geginat, Jens/0000-0003-4813-0384; Ching, Travers/0000-0002-5577-3516; Stockinger, Brigitta/0000-0001-8781-336X; Esplugues, Enric/0000-0002-8130-0413; de Zoete, Marcel/0000-0002-6561-5810; Gagliani, Nicola/0000-0001-8514-1395; Palm, Noah/0000-0001-7262-9455; AMEZCUA VESELY, MARIA CAROLINA/0000-0001-9631-1249; Pan, Xinghua (Victor)/0000-0002-7421-8155; de Sousa e Paiva, Ricardo/0000-0001-5898-0126; Huber, Samuel/0000-0001-9325-8227	NIH/BD2K [K01ES025434]; NIH/NIGMS [P20 COBRE GM103457]; DFG [EXC 257 NeuroCure, SFB633, HU1714/3]; Crohn's & Colitis Foundation of America [311143]; Dr. Keith Landesman Memorial Fellowship of the Cancer Research Institute; Ernst Jung-Stiftung Hamburg; Howard Hughes Medical Institute; Cariplo foundation [2013-0937]; AbbVie-Yale Collaboration; Francis Crick Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES025434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER; Medical Research Council [MC_U117512792] Funding Source: researchfish; The Francis Crick Institute [10159] Funding Source: researchfish; MRC [MC_U117512792] Funding Source: UKRI	NIH/BD2K; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DFG(German Research Foundation (DFG)); Crohn's & Colitis Foundation of America; Dr. Keith Landesman Memorial Fellowship of the Cancer Research Institute; Ernst Jung-Stiftung Hamburg; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cariplo foundation(Fondazione Cariplo); AbbVie-Yale Collaboration(AbbVie); Francis Crick Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank C. Lieber, P. Musco, E. Hughes-Picard and J. Alderman for expert administrative assistance. J. Stein, L. Evangelisti and C. Hughes for generating the IL-17A IRES-eGFP-CRE-ERT2 constructs, embryonic stem cells and chimaeric mice, respectively. We thank E. Baiocchi for remote key support. LXG is supported by grants K01ES025434 from NIH/BD2K and P20 COBRE GM103457 from NIH/NIGMS. E. E. was supported by the DFG (EXC 257 NeuroCure and SFB633) and by the Crohn's & Colitis Foundation of America (#311143). N.G. is supported by the Dr. Keith Landesman Memorial Fellowship of the Cancer Research Institute. S.H. is supported by the DFG (HU1714/3) and by Ernst Jung-Stiftung Hamburg and has an endowed Hofschneider-Professorship from the Stiftung Experimentelle Biomedizin. This work was supported, by the Howard Hughes Medical Institute, by Cariplo foundation (2013-0937 to J.G. and R.A.F.), by the AbbVie-Yale Collaboration (R.A.F.) and by the Francis Crick Institute (B.S.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; Heinemann C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4770; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huber S, 2012, EUR J IMMUNOL, V42, P2238, DOI 10.1002/eji.201242619; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Okamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7329; Pan XH, 2013, P NATL ACAD SCI USA, V110, P594, DOI 10.1073/pnas.1217322109; Panzer M, 2012, J IMMUNOL, V188, P615, DOI 10.4049/jimmunol.1101164; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	38	503	529	5	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					221	U225		10.1038/nature14452	http://dx.doi.org/10.1038/nature14452			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	25924064	Green Accepted			2022-12-24	WOS:000357695900037
J	Hepworth, MR; Fung, TC; Masur, SH; Kelsen, JR; McConnell, FM; Dubrot, J; Withers, DR; Hugues, S; Farrar, MA; Reith, W; Eberl, G; Baldassano, RN; Laufer, TM; Elson, CO; Sonnenberg, GF				Hepworth, Matthew R.; Fung, Thomas C.; Masur, Samuel H.; Kelsen, Judith R.; McConnell, Fiona M.; Dubrot, Juan; Withers, David R.; Hugues, Stephanie; Farrar, Michael A.; Reith, Walter; Eberl, Gerard; Baldassano, Robert N.; Laufer, Terri M.; Elson, Charles O.; Sonnenberg, Gregory F.			Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CLASS-II EXPRESSION; NEGATIVE SELECTION; PROMOTER-IV; MICROBIOTA; HOMEOSTASIS; APOPTOSIS; THYMUS; REPERTOIRE; RESPONSES	Inflammatory CD4(+) T cell responses to self or commensal bacteria underlie the pathogenesis of autoimmunity and inflammatory bowel disease (IBD), respectively. Although selection of self-specific T cells in the thymus limits responses to mammalian tissue antigens, the mechanisms that control selection of commensal bacteria-specific T cells remain poorly understood. Here, we demonstrate that group 3 innate lymphoid cell (ILC3)-intrinsic expression of major histocompatibility complex class II (MHCII) is regulated similarly to thymic epithelial cells and that MHCII+ ILC3s directly induce cell death of activated commensal bacteria-specific T cells. Further, MHCII on colonic ILC3s was reduced in pediatric IBD patients. Collectively, these results define a selection pathway for commensal bacteria-specific CD4(+) T cells in the intestine and suggest that this process is dysregulated in human IBD.	[Hepworth, Matthew R.; Fung, Thomas C.; Sonnenberg, Gregory F.] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Div Gastroenterol, New York, NY 10021 USA; [Hepworth, Matthew R.; Fung, Thomas C.; Sonnenberg, Gregory F.] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10021 USA; [Fung, Thomas C.; Laufer, Terri M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Masur, Samuel H.; Kelsen, Judith R.; Baldassano, Robert N.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [McConnell, Fiona M.; Withers, David R.] Univ Birmingham, MRC, Coll Med & Dent Sci, Ctr Immune Regulat, Birmingham, W Midlands, England; [Hugues, Stephanie; Reith, Walter] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Farrar, Michael A.] Univ Minnesota, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, Paris, France; [Laufer, Terri M.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Elson, Charles O.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Cornell University; Cornell University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Birmingham; University of Geneva; University of Minnesota System; University of Minnesota Twin Cities; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sonnenberg, GF (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Div Gastroenterol, New York, NY 10021 USA.	gfsonnenberg@med.cornell.edu	Withers, David/C-7055-2015; Eberl, Gerard/A-1160-2013; Dubrot, Juan/ABI-1676-2020; Farrar, Michael A/M-7802-2013	Withers, David/0000-0003-3757-7594; Dubrot, Juan/0000-0002-8093-2208; Farrar, Michael/0000-0002-5569-0366; hugues, stephanie/0000-0002-1031-5909; Hepworth, Matthew/0000-0002-9613-7858; Eberl, Gerard/0000-0002-1119-5638	National Institutes of Health [DP5OD012116, DK071176]; National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity; Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (from the U.S. National Center for Research Resources) [UL1-RR024134]; Crohn's and Colitis Foundation of America (CCFA) [297365]; Cancer Research Institute Student Training and Research in Tumor immunology (STaRT) grant; Wellcome Trust Research Career Development Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity; Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (from the U.S. National Center for Research Resources); Crohn's and Colitis Foundation of America (CCFA); Cancer Research Institute Student Training and Research in Tumor immunology (STaRT) grant; Wellcome Trust Research Career Development Fellowship(Wellcome Trust); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank members of the Sonnenberg laboratory for discussions and critical reading of the manuscript. We thank C. Hunter and S. Wagage (University of Pennsylvania) for the Ahr-deficient mice; I. Brodsky (University of Pennsylvania) for the Caspase 1/11-deficient mice; and M. Jenkins, J. Walter, and T. Dileepan (University of Minnesota) for tetramer reagents and protocols. Data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Microarray data are accessible at Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) via accession number GSE67076. CBir1 Tg mice are available from University of Alabama, Rorc(gamma t)-Gfp<SUP>TG</SUP> and Rorc<SUP>Cre</SUP> mice are available from Institut Pasteur, STAT5-CA mice are available from University of Minnesota, IAbbSTOP<SUP>fl/fl</SUP> mice and CD11c Tg mice are available from University of Pennsylvania, and Il23a deficient mice are available from Janssen Research and Development LLC, all under Material Transfer Agreement. Research in the Sonnenberg laboratory is supported by the National Institutes of Health (DP5OD012116), the National Institute of Allergy and Infectious Diseases Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity, and the Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (UL1-RR024134 from the U.S. National Center for Research Resources). M.R.H. is supported by a research fellowship from the Crohn's and Colitis Foundation of America (CCFA, no. 297365). T.C.F. is supported by a Cancer Research Institute Student Training and Research in Tumor immunology (STaRT) grant. D.R.W. is supported by a Wellcome Trust Research Career Development Fellowship. C.O.E. is supported by the National Institutes of Health (DK071176).	Ai TL, 2014, IMMUNOL REV, V259, P60, DOI 10.1111/imr.12171; Archambault AS, 2013, J IMMUNOL, V191, P545, DOI 10.4049/jimmunol.1201598; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; Bollrath J, 2013, SEMIN IMMUNOL, V25, P352, DOI 10.1016/j.smim.2013.09.002; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Eberl G, 2010, MUCOSAL IMMUNOL, V3, P450, DOI 10.1038/mi.2010.20; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Laufer TM, 1999, SEMIN IMMUNOL, V11, P65, DOI 10.1006/smim.1998.9997; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2009, SEMIN IMMUNOPATHOL, V31, P145, DOI 10.1007/s00281-009-0174-3; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Neurath MF, 2001, TRENDS IMMUNOL, V22, P21, DOI 10.1016/S1471-4906(00)01798-1; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sprent J, 2002, IMMUNOL REV, V185, P126, DOI 10.1034/j.1600-065X.2002.18512.x; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Waldburger JM, 2003, BLOOD, V101, P3550, DOI 10.1182/blood-2002-06-1855; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	41	294	316	2	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1031	1035		10.1126/science.aaa4812	http://dx.doi.org/10.1126/science.aaa4812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	25908663	Green Accepted			2022-12-24	WOS:000355276600048
J	Benazzi, S; Slon, V; Talamo, S; Negrino, F; Peresani, M; Bailey, SE; Sawyer, S; Panetta, D; Vicino, G; Starnini, E; Mannino, MA; Salvadori, PA; Meyer, M; Paabo, S; Hublin, JJ				Benazzi, S.; Slon, V.; Talamo, S.; Negrino, F.; Peresani, M.; Bailey, S. E.; Sawyer, S.; Panetta, D.; Vicino, G.; Starnini, E.; Mannino, M. A.; Salvadori, P. A.; Meyer, M.; Paeaebo, S.; Hublin, J. -J.			The makers of the Protoaurignacian and implications for Neandertal extinction	SCIENCE			English	Article							HUMAN-CLIMATE INTERACTION; MODERN HUMANS; PROTO-AURIGNACIAN; GENOME SEQUENCE; ADAPTIVE SHIFT; HYPOTHESIS; DISPERSAL; REMAINS; GROTTE; RENNE	The Protoaurignacian culture is pivotal to the debate about the timing of the arrival of modern humans in western Europe and the demise of Neandertals. However, which group is responsible for this culture remains uncertain. We investigated dental remains associated with the Protoaurignacian. The lower deciduous incisor from Riparo Bombrini is modern human, based on its morphology. The upper deciduous incisor from Grotta di Fumane contains ancient mitochondrial DNA of a modern human type. These teeth are the oldest human remains in an Aurignacian-related archaeological context, confirming that by 41,000 calendar years before the present, modern humans bearing Protoaurignacian culture spread into southern Europe. Because the last Neandertals date to 41,030 to 39,260 calendar years before the present, we suggest that the Protoaurignacian triggered the demise of Neandertals in this area.	[Benazzi, S.] Univ Bologna, Dept Cultural Heritage, I-48121 Ravenna, Italy; [Benazzi, S.; Talamo, S.; Bailey, S. E.; Mannino, M. A.; Hublin, J. -J.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Slon, V.; Sawyer, S.; Meyer, M.; Paeaebo, S.] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Negrino, F.] Univ Genoa, Dipartimento Antichita Filosofia Storia & Geog, I-16126 Genoa, Italy; [Peresani, M.] Univ Ferrara, Dipartimento Studi Umanist, Sez Sci Preistor & Antropol, I-44100 Ferrara, Italy; [Bailey, S. E.] NYU, Ctr Study Human Origins, Dept Anthropol, New York, NY 10003 USA; [Panetta, D.; Salvadori, P. A.] CNR, CNR Inst Clin Physiol, I-56124 Pisa, Italy; [Vicino, G.] Museo Archeol Finale, I-17024 Finale Ligure Borgo, Italy; [Starnini, E.] Univ Turin, Dipartimento Studi Stor, Scuola Sci Umanist, I-10124 Turin, Italy; [Starnini, E.] Museo Preistor Nazl Balzi Rossi, I-18039 Ventimiglia, Italy	University of Bologna; Max Planck Society; Max Planck Society; University of Genoa; University of Ferrara; New York University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Turin	Benazzi, S (corresponding author), Univ Bologna, Dept Cultural Heritage, Via Ariani 1, I-48121 Ravenna, Italy.	stefano.benazzi@unibo.it	Talamo, Sahra/AAD-1774-2022; Starnini, Elisabetta/AAN-8466-2020; Starnini, Elisabetta/N-3651-2017; Panetta, Daniele/A-8580-2013; Peresani, Marco/X-1343-2019; Salvadori, Piero A/B-2342-2012; Benazzi, Stefano/AAH-3923-2020	Talamo, Sahra/0000-0002-2406-3132; Starnini, Elisabetta/0000-0002-3933-0854; Starnini, Elisabetta/0000-0002-3933-0854; Panetta, Daniele/0000-0002-4184-0175; Salvadori, Piero A/0000-0001-6114-1059; Negrino, Fabio/0000-0001-7539-2959; Sawyer, Susanna/0000-0002-8477-6089; Peresani, Marco/0000-0001-6562-6336; Bailey, Shara/0000-0002-4626-9262; Benazzi, Stefano/0000-0003-4305-6920	Ministry of Culture-Veneto Archaeological Superintendency; Lessinia Mountain Community Regional Natural Park; Fumane Municipality; Veneto Region Department for Cultural Heritage; Max Planck Society	Ministry of Culture-Veneto Archaeological Superintendency; Lessinia Mountain Community Regional Natural Park; Fumane Municipality; Veneto Region Department for Cultural Heritage(Regione Veneto); Max Planck Society(Max Planck SocietyFoundation CELLEX)	The authors are grateful to H. Temming for technical support. Research at Fumane is coordinated by Ferrara University in the framework of a project supported by the Ministry of Culture-Veneto Archaeological Superintendency; public institutions (Lessinia Mountain Community Regional Natural Park, Fumane Municipality, and the Veneto Region Department for Cultural Heritage); and private associations and companies. We are indebted for technical assistance to L. Radisch and S. Steinbrenner of the Department of Human Evolution at the Max Planck Institute for Evolutionary Anthropology. We thank A. Hubner and C. Barbieri for their input on the phylogenetic analyses. The data described in the paper are archived in the supplementary materials. The sequence data for the Fumane 2 specimen have been submitted to GenBank and are available under accession number KP718913. The Bombrini tooth is housed at the Museo Preistorico Nazionale dei Balzi Rossi (Ventimiglia, Italy); the Fumane 2 is temporarily housed at the Dipartimento di Studi Umanistici, Universita di Ferrara (Ferrara, Italy). This research is supported by the Max Planck Society. S.B., F.N., M.P., M.A.M., and J.-J.H. initiated and organized the project. S.B. collected the fossil and modern human comparative samples for enamel thickness analysis. D.P. and P.A.S. carried out the microCT scan of the teeth and reconstructed the digital models. S.B. and S.E.B. provided the morphological description of the fossil sample. S.B. carried out the digital morphometric analysis of the teeth. V.S., M.M., and S.S. carried out ancient DNA analysis. S.B., J.-J.H., V.S., S.S., M.M., and S.P. analyzed the data. S.T. initiated and performed the radiocarbon dating project at Riparo Bombrini. S.B., V.S., S.T., F.N., M.P., S.E.B., G.V., M.A.M., M.M., S.P., and J.-J.H. discussed the results. S.B., V.S., S.T., F.N., M.P., S.E.B., D.P., E.S., M.A.M., M.M., S.P., and J.-J.H. wrote and edited the manuscript.	Bailey SE, 2006, J HUM EVOL, V50, P485, DOI 10.1016/j.jhevol.2005.11.008; Banks WE, 2013, J HUM EVOL, V64, P39, DOI 10.1016/j.jhevol.2012.10.001; Bar-Yosef O., 2003, MORE MEETS EYE STUDI, P265; BARTOLOMEI G, 1992, PREISTORIA ALPINA, V28, P131; Beckouche S., 1981, PIAGE SITE PREHISTOR, P159; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P305, DOI 10.1002/ajpa.22421; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bordes J.-G., 2003, TRABALHOS ARQUEOLOGI, V33, P223; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Conard NJ, 2004, NATURE, V430, P198, DOI 10.1038/nature02690; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; Fleitmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040050; Formicola V., 1989, RIV ANTROPOL, V67, P287; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; Hublin J-J., 2014, QUAT SCI REV; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Ronchitelli A, 2014, J HUM EVOL, V73, P107, DOI 10.1016/j.jhevol.2013.12.010; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stringer C., 1989, PALEORIENT, V15, P99, DOI DOI 10.3406/paleo.1989.4512; White M, 2012, EUR J ARCHAEOL, V15, P392, DOI 10.1179/1461957112Y.0000000019	35	118	125	1	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					793	796		10.1126/science.aaa2773	http://dx.doi.org/10.1126/science.aaa2773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI0LN	25908660	Green Published			2022-12-24	WOS:000354428700042
J	Behrmann, E; Loerke, J; Budkevich, TV; Yamamoto, K; Schmidt, A; Penczek, PA; Vos, MR; Burger, J; Mielke, T; Scheerer, P; Spahn, CMT				Behrmann, Elmar; Loerke, Justus; Budkevich, Tatyana V.; Yamamoto, Kaori; Schmidt, Andrea; Penczek, Pawel A.; Vos, Matthijn R.; Buerger, Joerg; Mielke, Thorsten; Scheerer, Patrick; Spahn, Christian M. T.			Structural Snapshots of Actively Translating Human Ribosomes	CELL			English	Article							AMINOACYL-TRANSFER-RNA; CRYSTAL-STRUCTURE; MESSENGER-RNA; 70S RIBOSOME; E-SITE; EF-TU; MECHANISM; DYNAMICS; SUBUNIT; COMPLEX	Macromolecular machines, such as the ribosome, undergo large-scale conformational changes during their functional cycles. Although their mode of action is often compared to that of mechanical machines, a crucial difference is that, at the molecular dimension, thermodynamic effects dominate functional cycles, with proteins fluctuating stochastically between functional states defined by energetic minima on an energy landscape. Here, we have used cryo-electron microscopy to image ex-vivo-derived human polysomes as a source of actively translating ribosomes. Multiparticle refinement and 3D variability analysis allowed us to visualize a variety of native translation intermediates. Significantly populated states include not only elongation cycle intermediates in pre- and post-translocational states, but also eEF1A-containing decoding and termination/recycling complexes. Focusing on the post-translocational state, we extended this assessment to the single-residue level, uncovering striking details of ribosome-ligand interactions and identifying both static and functionally important dynamic elements.	[Behrmann, Elmar; Loerke, Justus; Budkevich, Tatyana V.; Yamamoto, Kaori; Schmidt, Andrea; Buerger, Joerg; Mielke, Thorsten; Scheerer, Patrick; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Schmidt, Andrea; Scheerer, Patrick] Charite, Inst Med Phys & Biophys, AG Prot X Ray Crystallog, D-10117 Berlin, Germany; [Penczek, Pawel A.] Univ Texas Med Sch, Dept Biochem & Mol Biol, Houston, TX 77054 USA; [Vos, Matthijn R.] FEI Co, Nanoport Europe, NL-5651 GG Eindhoven, Netherlands; [Mielke, Thorsten] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Texas System; University of Texas Health Science Center Houston; Thermo Fisher Scientific; FEI Company; Max Planck Society	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, Charite Pl 1, D-10117 Berlin, Germany.	christian.spahn@charite.de	Behrmann, Elmar/I-5808-2015	Behrmann, Elmar/0000-0001-6794-3669; Burger, Jorg/0000-0002-4326-5047; Scheerer, Patrick/0000-0001-5028-2075; Yamamoto, Kaori/0000-0001-8441-841X; Loerke, Justus/0000-0002-3424-8536	Deutsche Forschungsgemeinschaft DFG [SFB 740, SFB 1078]; DFG Cluster of Excellence "Unifying Concepts in Catalysis'' [D3/E3-1]; HSFP; Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum), Charite; NIH [R01 GM60635]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); DFG Cluster of Excellence "Unifying Concepts in Catalysis''(German Research Foundation (DFG)); HSFP; Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum), Charite; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Helena Seibel and Brian Bauer for technical support during sample preparation and Alina Bretfeld and Mathias Brunner for initial structural work. The present work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SFB 740 to C.M.T.S., P.S., and T.M.; SFB 1078 to P.S), DFG Cluster of Excellence "Unifying Concepts in Catalysis'' (Research Field D3/E3-1) to P.S., HSFP and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum), Charite (Rahel-Hirsch stipend to T.V.B.), and by the NIH (R01 GM60635) to P.A.P. E.B. holds a Freigeist-Fellowship from the Volkswagen Foundation. The authors acknowledge the North-German Supercomputing Alliance (HLRN) and the Texas Advanced Computing Center (TACC) at the University of Texas at Austin for providing high-performance computing resources that have contributed to the research results reported in this paper.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Brandt F, 2010, MOL CELL, V39, P560, DOI 10.1016/j.molcel.2010.08.003; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Burnett BJ, 2014, J BIOL CHEM, V289, P23917, DOI 10.1074/jbc.M114.583385; Burnett BJ, 2013, J BIOL CHEM, V288, P13917, DOI 10.1074/jbc.M113.460014; Caulfield T, 2012, PROTEINS, V80, P2489, DOI 10.1002/prot.24131; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; des Georges A, 2014, NUCLEIC ACIDS RES, V42, P3409, DOI 10.1093/nar/gkt1279; Dunkle JA, 2010, ANNU REV BIOPHYS, V39, P227, DOI 10.1146/annurev.biophys.37.032807.125954; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, REP PROG PHYS, V69, P1383, DOI 10.1088/0034-4885/69/5/R03; Frank J, 2013, BIOPOLYMERS, V99, P832, DOI 10.1002/bip.22274; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; Korostelev A, 2008, CURR OPIN CHEM BIOL, V12, P674, DOI 10.1016/j.cbpa.2008.08.037; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Moore PB, 2012, ANNU REV BIOPHYS, V41, P1, DOI 10.1146/annurev-biophys-050511-102314; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Myasnikov AG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6294; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009; Petrov A, 2011, CURR OPIN STRUC BIOL, V21, P137, DOI 10.1016/j.sbi.2010.11.007; Preis A, 2014, CELL REP, V8, P59, DOI 10.1016/j.celrep.2014.04.058; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rhodin MHJ, 2010, NUCLEIC ACIDS RES, V38, P8377, DOI 10.1093/nar/gkq711; RICH A, 1963, COLD SPRING HARB SYM, V28, P269, DOI 10.1101/SQB.1963.028.01.043; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1053, DOI 10.1016/j.biochi.2006.06.012; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stephens S, 2007, THEATER HEUTE, P47; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4	57	111	121	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					845	857		10.1016/j.cell.2015.03.052	http://dx.doi.org/10.1016/j.cell.2015.03.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957688	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000354175200017
J	Gozalo, P; Plotzke, M; Mor, V; Miller, SC; Teno, JM				Gozalo, Pedro; Plotzke, Michael; Mor, Vincent; Miller, Susan C.; Teno, Joan M.			Changes in Medicare Costs with the Growth of Hospice Care in Nursing Homes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE; END; EXPENDITURES; RESIDENTS; DEMENTIA; QUALITY; PROGRAM; IMPROVE	BACKGROUND Nursing home residents' use of hospice has substantially increased. Whether this increase in hospice use reduces end-of-life expenditures is unknown. METHODS The expansion of hospice between 2004 and 2009 created a natural experiment, allowing us to conduct a difference-in-differences matched analysis to examine changes in Medicare expenditures in the last year of life that were associated with this expansion. We also assessed intensive care unit (ICU) use in the last 30 days of life and, for patients with advanced dementia, feeding-tube use and hospital transfers within the last 90 days of life. We compared a subset of hospice users from 2009, whose use of hospice was attributed to hospice expansion, with a matched subset of non-hospice users from 2004, who were considered likely to have used hospice had they died in 2009. RESULTS Of 786,328 nursing home decedents, 27.6% in 2004 and 39.8% in 2009 elected to use hospice. The 2004 and 2009 matched hospice and nonhospice cohorts were similar (mean age, 85 years; 35% male; 25% with cancer). The increase in hospice use was associated with significant decreases in the rates of hospital transfers (2.4 percentage-point reduction), feeding-tube use (1.2 percentage-point reduction), and ICU use (7.1 percentage-point reduction). The mean length of stay in hospice increased from 72.1 days in 2004 to 92.6 days in 2009. Between 2004 and 2009, the expansion of hospice was associated with a mean net increase in Medicare expenditures of $6,761 (95% confidence interval, 6,335 to 7,186), reflecting greater additional spending on hospice care ($10,191) than reduced spending on hospital and other care ($3,430). CONCLUSIONS The growth in hospice care for nursing home residents was associated with less aggressive care near death but at an overall increase in Medicare expenditures. (Funded by the Centers for Medicare and Medicaid Services and the National Institute on Aging.)	[Gozalo, Pedro; Mor, Vincent; Miller, Susan C.; Teno, Joan M.] Brown Univ, Sch Publ Hlth, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Gozalo, Pedro; Mor, Vincent; Miller, Susan C.; Teno, Joan M.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Mor, Vincent] Providence Vet Affairs Med Ctr, Hlth Serv Res, Providence, RI USA; [Plotzke, Michael] Abt Associates Inc, Cambridge, MA USA	Brown University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; ABT Associates	Gozalo, P (corresponding author), Brown Univ, Sch Publ Hlth, Ctr Gerontol & Hlth Care Res, Box G-S121-6, Providence, RI 02912 USA.	pedro_gozalo@brown.edu			Centers for Medicare and Medicaid Services; National Institute on Aging; NATIONAL INSTITUTE ON AGING [P01AG027296] Funding Source: NIH RePORTER	Centers for Medicare and Medicaid Services; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the Centers for Medicare and Medicaid Services and the National Institute on Aging.	[Anonymous], 2011, MED HOSP FOC NURS FA; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baer WM, 2000, J AM GERIATR SOC, V48, P879, DOI 10.1111/j.1532-5415.2000.tb06883.x; Banaszak-Holl J, 1996, Hosp J, V11, P1, DOI 10.1300/J011v11n03_01; Bureau of Labor Statistics, 2013, CONS PRIC IND MED CA; Campbell DE, 2004, ANN INTERN MED, V140, P269, DOI 10.7326/0003-4819-140-4-200402170-00009; Centers for Medicare Medicaid Services, PROV SERV CURR FIL; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Emanuel EJ, 1996, JAMA-J AM MED ASSOC, V275, P1907, DOI 10.1001/jama.275.24.1907; FRIES JF, 1993, NEW ENGL J MED, V329, P321, DOI 10.1056/NEJM199307293290506; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Gozalo PL, 2008, HEALTH SERV RES, V43, P134, DOI 10.1111/j.1475-6773.2007.00746.x; Kelley AS, 2013, HEALTH AFFAIR, V32, P552, DOI 10.1377/hlthaff.2012.0851; Medicare Payment Advisory Commission, 2008, REP C REF DEL SYST; Medicare Payment Advisory Committee, 2014, REP C MED PAYM POL; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Miller SC, 2010, J AM GERIATR SOC, V58, P1481, DOI 10.1111/j.1532-5415.2010.02968.x; Mitchell SL, 2010, JAMA-J AM MED ASSOC, V304, P1929, DOI 10.1001/jama.2010.1572; Newhouse J P, 1989, Health Care Financ Rev, V10, P41; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Plotzke M, 2014, MEDICARE HOSPICE PAY; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; SINGER PA, 1992, ARCH INTERN MED, V152, P478, DOI 10.1001/archinte.152.3.478; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Teno JM, 2011, J AM GERIATR SOC, V59, P1531, DOI 10.1111/j.1532-5415.2011.03505.x	25	63	63	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2015	372	19					1823	1831		10.1056/NEJMsa1408705	http://dx.doi.org/10.1056/NEJMsa1408705			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH4BB	25946281	Green Accepted, Bronze			2022-12-24	WOS:000353974700007
J	Walther, DM; Kasturi, P; Zheng, M; Pinkert, S; Vecchi, G; Ciryam, P; Morimoto, RI; Dobson, CM; Vendruscolo, M; Mann, M; Hartl, FU				Walther, Dirk M.; Kasturi, Prasad; Zheng, Min; Pinkert, Stefan; Vecchi, Giulia; Ciryam, Prajwal; Morimoto, Richard I.; Dobson, Christopher M.; Vendruscolo, Michele; Mann, Matthias; Hartl, F. Ulrich			Widespread Proteome Remodeling and Aggregation in Aging C-elegans	CELL			English	Article							HEAT-SHOCK PROTEINS; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; MISFOLDED PROTEINS; PROTEOTOXIC STRESS; GENE-EXPRESSION; AMINO-ACIDS; LIFE-SPAN; PROTEOSTASIS; LONGEVITY	Aging has been associated with a progressive decline of proteostasis, but how this process affects proteome composition remains largely unexplored. Here, we profiled more than 5,000 proteins along the lifespan of the nematode C. elegans. We find that one-third of proteins change in abundance at least 2-fold during aging, resulting in a severe proteome imbalance. These changes are reduced in the long-lived daf-2 mutant but are enhanced in the short-lived daf-16 mutant. While ribosomal proteins decline and lose normal stoichiometry, proteasome complexes increase. Proteome imbalance is accompanied by widespread protein aggregation, with abundant proteins that exceed solubility contributing most to aggregate load. Notably, the properties by which proteins are selected for aggregation differ in the daf-2 mutant, and an increased formation of aggregates associated with small heat-shock proteins is observed. We suggest that sequestering proteins into chaperone-enriched aggregates is a protective strategy to slow proteostasis decline during nematode aging.	[Walther, Dirk M.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Kasturi, Prasad; Zheng, Min; Pinkert, Stefan; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Vecchi, Giulia; Ciryam, Prajwal; Dobson, Christopher M.; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Ciryam, Prajwal; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA	Max Planck Society; Max Planck Society; University of Cambridge; Northwestern University	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Kasturi, Prasad/GLT-6507-2022; Hartl, F. Ulrich/Y-8206-2019; Vendruscolo, Michele/F-5901-2012	Kasturi, Prasad/0000-0002-3611-5489; Vendruscolo, Michele/0000-0002-3616-1610	European Commission [ERC-2012-SyG_318987]; Wellcome Trust [094425/Z/10/Z]; Center for Integrated Protein Science Munich (CIPSM); Munich Cluster for Systems Neurology (SyNergy); NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152, R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026647, R01AG026647] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Center for Integrated Protein Science Munich (CIPSM); Munich Cluster for Systems Neurology (SyNergy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Caenorhabditis Genetics Center for providing most of the strains used in this study. hsp-16.1:: gfp transgenic worms were provided by Dr. Junho Lee, Seoul National University. This work was supported by the European Commission under FP7 GA number ERC-2012-SyG_318987-Toxic Protein Aggregation in Neurodegeneration (ToPAG), the Wellcome Trust (094425/Z/10/Z), the Center for Integrated Protein Science Munich (CIPSM), and the Munich Cluster for Systems Neurology (SyNergy). We would further like to thank Igor Paron and Korbinian Mayr for excellent technical assistance with MS instrumentation, as well as Daniel Hornburg, Manajit Hayer-Hartl, and members of the Hartl laboratory for critically reading this manuscript.	Andersson V, 2013, AGING-US, V5, P802, DOI 10.18632/aging.100613; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jiao WW, 2005, BIOCHEM BIOPH RES CO, V335, P227, DOI 10.1016/j.bbrc.2005.07.065; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Larance M, 2011, NAT METHODS, V8, P849, DOI [10.1038/NMETH.1679, 10.1038/nmeth.1679]; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Sormanni P, 2015, J MOL BIOL, V427, P982, DOI 10.1016/j.jmb.2014.12.007; Sormanni P, 2015, J MOL BIOL, V427, P478, DOI 10.1016/j.jmb.2014.09.026; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Vendruscolo M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a010454; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	61	326	331	1	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					919	932		10.1016/j.cell.2015.03.032	http://dx.doi.org/10.1016/j.cell.2015.03.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957690	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000354175200023
J	Viatte, S; Plant, D; Han, B; Fu, B; Yarwood, A; Thomson, W; Symmons, DPM; Worthington, J; Young, A; Hyrich, KL; Morgan, AW; Wilson, AG; Isaacs, JD; Raychaudhuri, S; Barton, A				Viatte, Sebastien; Plant, Darren; Han, Buhm; Fu, Bo; Yarwood, Annie; Thomson, Wendy; Symmons, Deborah P. M.; Worthington, Jane; Young, Adam; Hyrich, Kimme L.; Morgan, Ann W.; Wilson, Anthony G.; Isaacs, John D.; Raychaudhuri, Soumya; Barton, Anne			Association of HLA-DRB1 Haplotypes With Rheumatoid Arthritis Severity, Mortality, and Treatment Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETIC SUSCEPTIBILITY MARKERS; INFLAMMATORY POLYARTHRITIS; VARIABLE MODELS; DISEASE; PREDICTORS; CRITERIA; DAMAGE	IMPORTANCE Advances have been made in identifying genetic susceptibility loci for autoimmune diseases, but evidence is needed regarding their association with prognosis and treatment response. OBJECTIVE To assess whether specific HLA-DRB1 haplotypes associated with rheumatoid arthritis (RA) susceptibility are also associated with radiological severity, mortality, and response to tumor necrosis factor (TNF) inhibitor drugs. DESIGN, SETTING, AND PARTICIPANTS The Norfolk Arthritis Register (NOAR; 1691 patients and 2811 radiographs; recruitment: 1989-2008; 2008 as final follow-up) was used as a discovery cohort and the Early Rheumatoid Arthritis Study (421 patients and 3758 radiographs; recruitment: 1986-1999; 2005 as final follow-up) as an independent replication cohort for studies of radiographic outcome. Mortality studies were performed in the NOAR cohort (2432 patients; recruitment: 1990-2007; 2011 as final follow-up) and studies of treatment response in the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort (1846 patients enrolled at initiation of TNF inhibitor; recruitment: 2006-2010; 2011 as final follow-up). Longitudinal statistical modeling was performed to integrate multiple radiograph records per patient over time. All patients were from the United Kingdom and had self-reported white ancestry. EXPOSURES Sixteen HLA-DRB1 haplotypes defined by amino acids at positions 11, 71, and 74. MAIN OUTCOMES AND MEASURES Radiological outcome using the Larsen score (range: 0 [none] to 200 [severe joint damage]) and erosions of the hands and feet on radiographs, all-cause mortality, and treatment response measured by change in Disease Activity Score based on 28 joint counts and European League Against Rheumatism (EULAR) response. RESULTS Patients with RA and valine at position 11 of HLA-DRB1 had the strongest association with radiological damage (OR, 1.75 [95% CI, 1.51-2.05], P = 4.6E-13). By year 5, the percentages of patients with erosions of the hands and feet were 48% of noncarriers (150/314) of valine at position 11, 61% of heterozygote carriers (130/213), and 74% of homozygote carriers (43/58). Valine at position 11 also was associated with higher all-cause mortality in patients with inflammatory polyarthritis (hazard ratio, 1.16 [95% CI, 1.03-1.31], P = .01) (noncarriers: 319 deaths in 1398 patients over 17 196 person-years, mortality rate of 1.9% per year; carriers: 324 deaths in 1116 patients in 13 208 person-years, mortality rate of 2.5% per year) and with better EULAR response to TNF inhibitor therapy (OR, 1.14 [95% CI, 1.01-1.30], P = .04) (noncarriers: 78% [439/561 patients] with moderate or good EULAR response; heterozygote carriers: 81% [698/866]; and homozygote carriers: 86%[277/322]). The risk hierarchy defined by HLA-DRB1 haplotypes was correlated between disease susceptibility, severity, and mortality, but inversely correlated with TNF inhibitor treatment response. CONCLUSIONS AND RELEVANCE Among patients with RA, the HLA-DRB1 locus, which is associated with disease susceptibility, was also associated with radiological severity, mortality, and treatment response. Replication of these findings in other cohorts is needed as a next step in evaluating the role of HLA-DRB1 haplotype analysis for management of RA.	[Viatte, Sebastien; Plant, Darren; Fu, Bo; Yarwood, Annie; Thomson, Wendy; Worthington, Jane; Raychaudhuri, Soumya; Barton, Anne] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res, Manchester M13 9PT, Lancs, England; [Plant, Darren; Thomson, Wendy; Symmons, Deborah P. M.; Worthington, Jane; Barton, Anne] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England; [Han, Buhm; Raychaudhuri, Soumya] Broad Inst Massachusetts Inst Technol & Harvard U, Program Med & Populat Genet, Cambridge, MA USA; [Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol & Genet, Boston, MA 02115 USA; [Han, Buhm; Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Fu, Bo] Univ Manchester, Ctr Biostat, Inst Populat Hlth, Manchester M13 9PT, Lancs, England; [Symmons, Deborah P. M.; Hyrich, Kimme L.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol, Ctr Musculoskeletal Res, Manchester M13 9PT, Lancs, England; [Young, Adam] St Albans Hosp, St Albans, England; [Young, Adam] Univ Hertfordshire, Hlth & Human Sci Res Inst, Hatfield AL10 9AB, Herts, England; [Morgan, Ann W.] Leeds Teaching Hosp NHS Trust, Chapel Allerton Hosp, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Morgan, Ann W.] Univ Leeds, Sch Med, Leeds Inst Rheumat & Musculoskeletal Med, St Jamess Univ Hosp, Leeds LS2 9JT, W Yorkshire, England; [Wilson, Anthony G.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Isaacs, John D.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Biomed Res Ctr, Natl Inst Hlth Res, Newcastle Upon Tyne, Tyne & Wear, England; [Isaacs, John D.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Manchester; University of Manchester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; University of Manchester; University of Manchester; University of Hertfordshire; Chapel Allerton Hospital; Leeds Biomedical Research Centre; University of Leeds; Saint James's University Hospital; University of Leeds; University College Dublin; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Barton, A (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Genet & Genom, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anne.barton@manchester.ac.uk	Han, Buhm/AAQ-9672-2020; Viatte, Sebastien/B-4253-2015; Barton, Anne/N-2053-2014	Viatte, Sebastien/0000-0001-6471-3358; Morgan, Ann/0000-0003-1109-624X; Hyrich, Kimme/0000-0001-8242-9262; Barton, Anne/0000-0003-3316-2527; Isaacs, John/0000-0002-6103-7056; Symmons, Deborah/0000-0002-8625-1200; Raychaudhuri, Soumya/0000-0002-1901-8265; Thomson, Wendy/0000-0002-9022-5179	Arthritis Research UK [20385]; National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit; Innovative Medicines Initiative Be The Cure [115142-2]; Swiss Foundation for Medical-Biological Scholarships [PASMP3_134380]; Novartis; Arthritis Foundation; Doris Duke Foundation; National Institutes of Health [1RO1AR063759-O1A1, 1RO1ARO62886-O1, 5UO1GMO92691]; Medical Research Council [MR/L01629X/1, G1001518] Funding Source: researchfish; National Institute for Health Research [IS-BRC-0211-10046, NF-SI-0510-10211] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH121055, BH120307, BH142386] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759, R01AR062886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; MRC [G1001518, MR/L01629X/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit; Innovative Medicines Initiative Be The Cure; Swiss Foundation for Medical-Biological Scholarships; Novartis(Novartis); Arthritis Foundation; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by core programme grant 20385 from Arthritis Research UK, by the National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit, and by the Innovative Medicines Initiative Be The Cure (contract 115142-2). At the start of this project, Dr Viatte was supported by research grant PASMP3_134380 from the Swiss Foundation for Medical-Biological Scholarships, managed by the Swiss National Science Foundation. That grant is financed by a donation from Novartis to the Swiss Foundation for Medical-Biological Scholarships. Dr Raychaudhuri is supported by the Arthritis Foundation, the Doris Duke Foundation, and National Institutes of Health grants 1RO1AR063759-O1A1, 1RO1ARO62886-O1, and 5UO1GMO92691.	Ajeganova S, 2013, J RHEUMATOL, V40, P1958, DOI 10.3899/jrheum.130365; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barra L, 2009, J RHEUMATOL, V36, P1421, DOI 10.3899/jrheum.081122; Bruynesteyn K, 2002, ARTHRITIS RHEUM-US, V46, P913, DOI 10.1002/art.10190; Bukhari M, 2007, ARTHRITIS RHEUM-US, V56, P2929, DOI 10.1002/art.22868; Criswell LA, 2004, ARTHRITIS RHEUM-US, V50, P2750, DOI 10.1002/art.20469; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Farragher TM, 2008, ARTHRITIS RHEUM-US, V58, P359, DOI 10.1002/art.23149; Farragher TM, 2010, ARTHRIT CARE RES, V62, P676, DOI 10.1002/acr.20208; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Ibrahim I, 2014, ANN RHEUM DIS, V73, P787, DOI 10.1136/annrheumdis-2013-204330; James D, 2004, RHEUMATOLOGY, V43, P369, DOI 10.1093/rheumatology/keh059; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Karlson EW, 2010, ANN RHEUM DIS, V69, P1077, DOI 10.1136/ard.2009.120170; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Norton S, 2013, RHEUMATOLOGY, V52, P2016, DOI 10.1093/rheumatology/ket253; Plant D, 2014, NAT REV RHEUMATOL, V10, P329, DOI 10.1038/nrrheum.2014.16; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Plant D, 2011, RHEUMATOLOGY, V50, P78, DOI 10.1093/rheumatology/keq032; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Rabe-Hesketh S, 2004, PSYCHOMETRIKA, V69, P167, DOI 10.1007/BF02295939; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rabe-Hesketh S, 2008, STAT METHODS MED RES, V17, P5, DOI 10.1177/0962280207081236; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Solymossy C, 1999, RHEUMATOLOGY, V38, P1127, DOI 10.1093/rheumatology/38.11.1127; Symmons DPM, 2003, CLIN EXP RHEUMATOL, V21, pS94; Thomson W, 1999, ARTHRITIS RHEUM, V42, P757, DOI 10.1002/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Viatte S, 2012, EUR MUSCULOSKELETAL, V7, P102; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Viatte S, 2013, J RHEUMATOL, V40, P144, DOI 10.3899/jrheum.121034; Viatte S, 2012, ANN RHEUM DIS, V71, P1984, DOI 10.1136/annrheumdis-2011-201225; Yarwood A, 2015, ANN RHEUM DIS, V74, P170, DOI 10.1136/annrheumdis-2013-204133	37	101	103	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1645	1656		10.1001/jama.2015.3435	http://dx.doi.org/10.1001/jama.2015.3435			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919528	Bronze, Green Accepted			2022-12-24	WOS:000353595200015
J	Beyrer, C; Bekker, LG; Pozniak, A; Barre-Sinoussi, F				Beyrer, Chris; Bekker, Linda-Gail; Pozniak, Anton; Barre-Sinoussi, Francoise			Pre-exposure prophylaxis works-it's time to deliver	LANCET			English	Editorial Material							ANTIRETROVIRAL PROPHYLAXIS; HIV; WOMEN; MEN		[Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Pozniak, Anton] Chelsea & Westminster NHS Fdn Trust, London, England; [Barre-Sinoussi, Francoise] Inst Pasteur, Paris, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; Imperial College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	cbeyrer@jhu.edu	Bekker, Linda-Gail/AAZ-8929-2020	BEKKER, LINDA-GAIL/0000-0002-0755-4386				AVAC, 2015, PREV LIN AVA C REP 2; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bukusi, 2015, C RETR OPP INF 2015; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Joint United Nations Programme for HIV/ AIDS (UNAIDS), 2014, THE GAP REP 2014; McCormack SDD, 2015, C RETR OPP INF 2015; Molina JMCC., 2015, C RETR OPP INF 2015; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; US Public Health Service, 2014, PREEXP PROPH PREV HI; World Health Organization, ANT THER ART COV ALL	12	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1482	1484		10.1016/S0140-6736(15)60724-3	http://dx.doi.org/10.1016/S0140-6736(15)60724-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25933264				2022-12-24	WOS:000353220000006
J	Chan, HK; Zhang, HR; Yang, F; Fischer, G				Chan, Hon-Ki; Zhang, Huarong; Yang, Feng; Fischer, Gunter			Improve customs systems to monitor global wildlife trade	SCIENCE			English	Editorial Material									[Chan, Hon-Ki; Zhang, Huarong; Yang, Feng; Fischer, Gunter] Kadoorie Farm & Bot Garden, Tai Po, Hong Kong, Peoples R China		Chan, HK (corresponding author), Kadoorie Farm & Bot Garden, Tai Po, Hong Kong, Peoples R China.	honkichan@gmail.com	Chan, Ki/AAA-8944-2021	Chan, Ki/0000-0003-0864-0451				Bannon I, 2003, NATURAL RESOURCES VI; Clarke S, 2004, FISH FISH, V5, P53, DOI 10.1111/j.1467-2960.2004.00137.x; FAO, 2012, SUPP MAT FAO REV PRO, P1; Flavia, 2020, LIFEGATE; Fragoso G, 2008, CONSERV BIOL, V22, P1648, DOI 10.1111/j.1523-1739.2008.01094.x; Gerson H, 2008, CONSERV BIOL, V22, P1651, DOI 10.1111/j.1523-1739.2008.01095.x; Goetzl A., 2005, ITTO Tropical Forest Update, V15, P8; Gratwicke B, 2010, FRONT ECOL ENVIRON, V8, P438, DOI 10.1890/090111; O'Rourke D, 2014, SCIENCE, V344, P1124, DOI 10.1126/science.1248526; OECD, 2012, ILL TRAD ENV SENS GO; WCO, 2015, WILDL TRAFF TARG SOL	11	34	35	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					291	292		10.1126/science.aaa3141	http://dx.doi.org/10.1126/science.aaa3141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG0YC	25883346				2022-12-24	WOS:000352999000025
J	Chen, CC; Wang, L; Plikus, MV; Jiang, TX; Murray, PJ; Ramos, R; Guerrero-Juarez, CF; Hughes, MW; Lee, OK; Shi, ST; Widelitz, RB; Lander, AD; Chuong, CM				Chen, Chih-Chiang; Wang, Lei; Plikus, Maksim V.; Jiang, Ting Xin; Murray, Philip J.; Ramos, Raul; Guerrero-Juarez, Christian F.; Hughes, Michael W.; Lee, Oscar K.; Shi, Songtao; Widelitz, Randall B.; Lander, Arthur D.; Chuong, Cheng Ming			Organ-Level Quorum Sensing Directs Regeneration in Hair Stem Cell Populations	CELL			English	Article							MORPHOGEN GRADIENT; SKIN; ACTIVATION; FOLLICLE; GROWTH; NICHE; ESTABLISHMENT; MACROPHAGES; CHEMOKINES; BACTERIA	Coordinated organ behavior is crucial for an effective response to environmental stimuli. By studying regeneration of hair follicles in response to patterned hair plucking, we demonstrate that organ-level quorum sensing allows coordinated responses to skin injury. Plucking hair at different densities leads to a regeneration of up to five times more neighboring, unplucked resting hairs, indicating activation of a collective decision-making process. Through data modeling, the range of the quorum signal was estimated to be on the order of 1 mm, greater than expected for a diffusible molecular cue. Molecular and genetic analysis uncovered a two-step mechanism, where release of CCL2 from injured hairs leads to recruitment of TNF-alpha-secreting macrophages, which accumulate and signal to both plucked and unplucked follicles. By coupling immune response with regeneration, this mechanism allows skin to respond predictively to distress, disregarding mild injury, while meeting stronger injury with full-scale cooperative activation of stem cells.	[Chen, Chih-Chiang; Jiang, Ting Xin; Widelitz, Randall B.; Chuong, Cheng Ming] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Chen, Chih-Chiang] Taipei Vet Gen Hosp, Dept Dermatol, Taipei 112, Taiwan; [Chen, Chih-Chiang; Chuong, Cheng Ming] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chih-Chiang; Chuong, Cheng Ming] Natl Yang Ming Univ, Dept Dermatol, Taipei 112, Taiwan; [Wang, Lei] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi, Peoples R China; [Plikus, Maksim V.; Ramos, Raul; Guerrero-Juarez, Christian F.; Lander, Arthur D.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Plikus, Maksim V.; Ramos, Raul; Guerrero-Juarez, Christian F.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Plikus, Maksim V.; Ramos, Raul; Guerrero-Juarez, Christian F.; Lander, Arthur D.] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Murray, Philip J.] Univ Dundee, Div Math, Dundee DD1 4HN, Scotland; [Hughes, Michael W.] Natl Cheng Kung Univ, Int Lab Wound Repair & Regenerat, Tainan 701, Taiwan; [Hughes, Michael W.] Natl Cheng Kung Univ, Inst Clin Med, Tainan 701, Taiwan; [Lee, Oscar K.] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Taipei & Ctr Stem Cell Res, Dept Orthopaed & Traumatol, Taipei 112, Taiwan; [Lee, Oscar K.] Vet Gen Hosp, Taipei 112, Taiwan; [Shi, Songtao] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Lander, Arthur D.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Chuong, Cheng Ming] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10617, Taiwan	University of Southern California; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Air Force Military Medical University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Dundee; National Cheng Kung University; National Cheng Kung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; University of Pennsylvania; University of California System; University of California Irvine; National Taiwan University	Chuong, CM (corresponding author), Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu	Lander, Arthur D/C-9008-2011; Lander, Arthur/L-2827-2019	Lander, Arthur D/0000-0002-4380-5525; Lander, Arthur/0000-0002-4380-5525; Hughes, Michael W./0000-0002-8899-9773; Plikus, Maksim/0000-0002-8845-2559; Murray, Philip/0000-0003-0332-5356	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [RO1-AR42177, AR 47364, AR60306]; NSC [100-2314-B-075-044, 101-2314-B-075-008-MY3]; Taipei Veterans General Hospital [VN103-12, V103C-010, V102B-009, R-1100403]; NIGMS [P50-GM076516]; NIH [R01DE17449]; National Natural Science Foundation of China [81270015]; NIAMS [R01-AR067273]; Edward Mallinckrodt Jr. Foundation grant; California Institute of Regenerative Medicine (CIRM) [TG2-01152]; National Science Foundation Graduate Research Fellowship Program [DGE-1321846]; Northern Research Parternship (NRP); Top Notch University plan of CKU, Taiwan; University of Southern California [D2014-0054, 2014-255]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067273, R01AR042177, R01AR047364, R01AR060306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NSC(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Edward Mallinckrodt Jr. Foundation grant; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Northern Research Parternship (NRP); Top Notch University plan of CKU, Taiwan; University of Southern California; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.M.C., T.X.J., and R.B.W. are supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) RO1-AR42177, AR 47364, and AR60306. C.C.C. is supported by NSC 100-2314-B-075-044, NSC 101-2314-B-075-008-MY3, and the Taipei Veterans General Hospital (VN103-12, V103C-010, V102B-009, R-1100403). A.D.L. is supported by NIGMS P50-GM076516. S.S. is supported by NIH R01DE17449. L.W. is supported by the National Natural Science Foundation of China (81270015). M.V.P. is supported by NIAMS R01-AR067273 and Edward Mallinckrodt Jr. Foundation grant. R.R. is supported by a California Institute of Regenerative Medicine (CIRM) training grant (TG2-01152). C.F.G.-J. is supported by the National Science Foundation Graduate Research Fellowship Program (DGE-1321846). P.J.M. is supported by a post-doctoral and early career researcher exchange fellowship from the Northern Research Parternship (NRP). M.W.H. is supported by Top Notch University plan of CKU, Taiwan. We thank Drs. Jaw-Ching Wu, Han-Nan Liu, and Yun-Ting Chang of National Yang Ming University/Taipei Veterans General hospital for their support. Invention number 2014-255 "Enhance hair growth via plucking'' (D2014-0054) was disclosed to University of Southern California.	Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bischoff M, 2013, NAT CELL BIOL, V15, P1269, DOI 10.1038/ncb2856; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chen CC, 2012, J DERMATOL SCI, V66, P3, DOI 10.1016/j.jdermsci.2012.02.007; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; Collins HH, 1918, J EXP ZOOL, V27, P73, DOI 10.1002/jez.1400270106; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Fessing MY, 2006, AM J PATHOL, V169, P2075, DOI 10.2353/ajpath.2006.060227; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821; Ito M, 2002, J INVEST DERMATOL, V119, P1310, DOI 10.1046/j.1523-1747.2002.19644.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jahoda CAB, 2011, CELL, V146, P678, DOI 10.1016/j.cell.2011.08.020; Jiang S, 2010, J DERMATOL SCI, V60, P143, DOI 10.1016/j.jdermsci.2010.10.008; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Murray PJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002804; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Nagao K, 2012, STEM CELLS, V30, P1781, DOI 10.1002/stem.1153; Osaka N, 2007, J CELL BIOL, V176, P903, DOI 10.1083/jcb.200611015; Paus R, 1998, J INVEST DERMATOL, V111, P7, DOI 10.1046/j.1523-1747.1998.00243.x; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; SILVER AF, 1970, DEV BIOL, V21, P440, DOI 10.1016/0012-1606(70)90134-X; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P9680, DOI 10.1073/pnas.1731184100; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782	41	142	149	5	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					277	290		10.1016/j.cell.2015.02.016	http://dx.doi.org/10.1016/j.cell.2015.02.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860610	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000352708300021
J	Kowalik, KM; Shimada, Y; Flury, V; Stadler, MB; Batki, J; Buhler, M				Kowalik, Katarzyna Maria; Shimada, Yukiko; Flury, Valentin; Stadler, Michael Beda; Batki, Julia; Buehler, Marc			The Paf1 complex represses small-RNA-mediated epigenetic gene silencing	NATURE			English	Article							DOUBLE-STRANDED-RNA; POLYMERASE-II; HUMAN-CELLS; FISSION YEAST; HISTONE H3; HETEROCHROMATIN; TRANSCRIPTION; METHYLATION; RITS; INTERFERENCE	RNA interference (RNAi) refers to the ability of exogenously introduced double-stranded RNA to silence expression of homologous sequences. Silencing is initiated when the enzyme Dicer processes the double-stranded RNA into small interfering RNAs (siRNAs). Small RNA molecules are incorporated into Argonaute-protein-containing effector complexes, which they guide to complementary targets to mediate different types of gene silencing, specifically post-transcriptional gene silencing and chromatin-dependent gene silencing(1). Although endogenous small RNAs have crucial roles in chromatin-mediated processes across kingdoms, efforts to initiate chromatin modifications in trans by using siRNAs have been inherently difficult to achieve in all eukaryotic cells. Using fission yeast, here we show that RNAi-directed heterochromatin formation is negatively controlled by the highly conserved RNA polymerase-associated factor 1 complex (Paf1C). Temporary expression of a synthetic hairpin RNA in Paf1C mutants triggers stable heterochromatin formation at homologous loci, effectively silencing genes in trans. This repressed state is propagated across generations by the continual production of secondary siRNAs, independently of the synthetic hairpin RNA. Our data support a model in which Paf1C prevents targeting of nascent transcripts by the siRNA-containing RNA-induced transcriptional silencing complex and thereby epigenetic gene silencing, by promoting efficient transcription termination and rapid release of the RNA from the site of transcription. We show that although compromised transcription termination is sufficient to initiate the formation of bi-stable heterochromatin by trans-acting siRNAs, impairment of both transcription termination and nascent transcript release is imperative to confer stability to the repressed state. Our work uncovers a novel mechanism for small-RNA-mediated epigenome regulation and highlights fundamental roles for Paf1C and the RNAi machinery in building epigenetic memory.	[Kowalik, Katarzyna Maria; Shimada, Yukiko; Flury, Valentin; Stadler, Michael Beda; Buehler, Marc] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Kowalik, Katarzyna Maria; Shimada, Yukiko; Flury, Valentin; Stadler, Michael Beda; Buehler, Marc] Univ Basel, CH-4003 Basel, Switzerland; [Stadler, Michael Beda] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Batki, Julia] Eotvos Lorand Univ, Fac Sci, Inst Chem, H-1117 Budapest, Hungary	Friedrich Miescher Institute for Biomedical Research; University of Basel; Swiss Institute of Bioinformatics; Eotvos Lorand University; Hungarian Academy of Sciences	Buhler, M (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	marc.buehler@fmi.ch	Buehler, Marc/S-5866-2019	Buehler, Marc/0000-0001-6661-9795; Flury, Valentin/0000-0003-0476-4940	Swiss National Science Foundation; European Research Council; Boehringer Ingelheim Fonds; Novartis Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Novartis Research Foundation	We thank T. Iida for providing the plasmid encoding the ade6-hp construct, N. Laschet and R. Tsuji for technical assistance, S. Thiry for hybridizing tiling arrays, K. Jacobeit and S. Dessus-Babus for small RNA sequencing, T. Roloff for archiving data sets, M. Kirschmann for developing the Matlab script for colony counting, and A. Tuck for comments on the manuscript. This work was supported by funds from the Swiss National Science Foundation, the European Research Council, and the Boehringer Ingelheim Fonds. The Friedrich Miescher Institute for Biomedical Research is supported by the Novartis Research Foundation.	Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Chandler VL, 2010, SCIENCE, V330, P628, DOI 10.1126/science.1191044; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Luteijn MJ, 2012, EMBO J, V31, P3422, DOI 10.1038/emboj.2012.213; Mbogning J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004029; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Ponnusamy MP, 2009, STEM CELLS, V27, P3001, DOI 10.1002/stem.237; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Simmer F, 2010, EMBO REP, V11, P112, DOI 10.1038/embor.2009.273; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014	41	64	66	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					248	U294		10.1038/nature14337	http://dx.doi.org/10.1038/nature14337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25807481	Green Accepted			2022-12-24	WOS:000352454600045
J	Renati, S; Cukras, A; Bigby, M				Renati, Sruthi; Cukras, Anthony; Bigby, Michael			Pityriasis versicolor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TINEA VERSICOLOR		[Renati, Sruthi] Harvard Univ, Sch Med, Boston, MA USA; [Cukras, Anthony; Bigby, Michael] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02215 USA; [Cukras, Anthony; Bigby, Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Bigby, M (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02215 USA.	mbigby@bidmc.harvard.edu						Faergemann J, 2002, ARCH DERMATOL, V138, P69, DOI 10.1001/archderm.138.1.69; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gupta AK, 2014, J CUTAN MED SURG, V18, P79, DOI 10.2310/7750.2013.13062; Han A, 2009, ARCH DERMATOL, V145, P1078, DOI 10.1001/archdermatol.2009.203; HELLGREN L, 1983, J MED MICROBIOL, V16, P501, DOI 10.1099/00222615-16-4-501; Hu SW, 2010, ARCH DERMATOL, V146, P1132, DOI 10.1001/archdermatol.2010.259; Kaymak Yesim, 2008, Dermatol Nurs, V20, P367; Kyriakis KP, 2006, MYCOSES, V49, P517, DOI 10.1111/j.1439-0507.2006.01285.x; Schwartz RA, 2004, LANCET, V364, P1173, DOI 10.1016/S0140-6736(04)17107-9; Szepietowski JC, 2000, KOREAN J MED MYCOL, V5, P108; US Food and Drug Administration, 2013, DRUG SAF COMM FDA LI	11	20	21	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2015	350								h1394	10.1136/bmj.h1394	http://dx.doi.org/10.1136/bmj.h1394			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9SM	25852089				2022-12-24	WOS:000352906900001
J	Simpson, SJ; Le Couteur, DG; Raubenheimer, D				Simpson, Stephen J.; Le Couteur, David G.; Raubenheimer, David			Putting the Balance Back in Diet	CELL			English	Article							HIGH-PROTEIN-DIET; ENERGY-INTAKE; LIFE-SPAN; CALORIC RESTRICTION; LEVERAGE HYPOTHESIS; SWEDISH WOMEN; COHORT; POPULATION; MORTALITY; OBESITY	The notion of dietary balance is fundamental to health yet is not captured by focusing on the intake of energy or single nutrients. Advances in nutritional geometry have begun to unravel and integrate the interactive effects of multiple nutrients on health, lifespan, aging, and reproduction.	[Simpson, Stephen J.; Le Couteur, David G.; Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Simpson, Stephen J.; Raubenheimer, David] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Le Couteur, David G.] Univ Sydney, Concord Hosp, Ageing & Alzheimers Inst, Sydney, NSW 2139, Australia; [Le Couteur, David G.] Univ Sydney, Concord Hosp, Ctr Educ & Res Aging, Sydney, NSW 2139, Australia; [Le Couteur, David G.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2139, Australia; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney	Simpson, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	stephen.simpson@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016	Raubenheimer, David/0000-0001-9050-1447; Simpson, Stephen J./0000-0003-0256-7687; Le Couteur, David/0000-0002-4227-5817	National Health and Medical Research Council; Australian Research Council, Gravida; Ageing and Alzheimers Institute	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council, Gravida(Australian Research Council); Ageing and Alzheimers Institute	We acknowledge funding support from the National Health and Medical Research Council, Australian Research Council, Gravida (The National Research Centre for Growth and Development, New Zealand), and the Ageing and Alzheimers Institute for supporting the fruit fly and mice studies discussed in this essay. We also thank our colleagues who contributed to these studies.	[Anonymous], CELL METAB, V19, P418; Austin GL, 2013, J NUTR, V143, P1651, DOI 10.3945/jn.113.180067; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Blumfield M, 2012, NUTRIENTS, V4, P1958, DOI 10.3390/nu4121958; Box GE., 1978, STAT EXPT; Curtis J, 2013, METHODS MOL BIOL, V1077, P303, DOI 10.1007/978-1-62703-637-5_20; Everitt AV, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P1, DOI 10.1007/978-90-481-8556-6; Feinman RD, 2011, CURR DIABETES REP, V11, P128, DOI 10.1007/s11892-011-0178-y; Fung TT, 2010, ANN INTERN MED, V153, P289, DOI 10.7326/0003-4819-153-5-201009070-00003; Gosby AK, 2014, OBES REV, V15, P183, DOI 10.1111/obr.12131; Gosby AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025929; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Griffioen-Roose S, 2014, AM J CLIN NUTR, V100, P113, DOI 10.3945/ajcn.113.079392; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Lagiou P, 2007, J INTERN MED, V261, P366, DOI 10.1111/j.1365-2796.2007.01774.x; Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026; Le Couteur DG, 2012, J GERONTOL A-BIOL, V67, P168, DOI 10.1093/gerona/glr095; LeCouteur D.G., 2014, J GERONTOL A; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Lihoreau M, 2014, J INSECT PHYSIOL, V69, P2, DOI 10.1016/j.jinsphys.2014.03.004; Martens EA, 2014, AM J CLIN NUTR, V99, P1397, DOI 10.3945/ajcn.113.078774; Martens EA, 2013, AM J CLIN NUTR, V97, P86, DOI 10.3945/ajcn.112.046540; Martinez-Cordero C, 2012, APPETITE, V59, P312, DOI 10.1016/j.appet.2012.05.013; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005; Noto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055030; Pedersen AN, 2013, FOOD NUTR RES, V57, P1, DOI [10.3402/fnr.v57i0.21245, 10.3402/fnrv57i0.21245]; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2015, BRIT J NUTR, V113, pS26, DOI 10.1017/S0007114514002323; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Ruohonen K, 2004, AQUACULT NUTR, V10, P145, DOI 10.1111/j.1365-2095.2004.00277.x; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; Simpson SJ, 2012, NATURE NUTR UNIFYING; Simpson SJ, 2014, NATURE, V508, pS66, DOI 10.1038/508S66a; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Speakman JR, 2014, PHYSIOLOGY, V29, P88, DOI 10.1152/physiol.00053.2013; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Tatar M, 2011, EXP GERONTOL, V46, P363, DOI 10.1016/j.exger.2010.12.002; Trichopoulou A, 2007, EUR J CLIN NUTR, V61, P575, DOI 10.1038/sj.ejcn.1602557; Wells JCK, 2006, BIOL REV, V81, P183, DOI 10.1017/S1464793105006974; Willett WC, 2011, J AM DIET ASSOC, V111, P660, DOI 10.1016/j.jada.2011.03.029	46	120	125	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					18	23		10.1016/j.cell.2015.02.033	http://dx.doi.org/10.1016/j.cell.2015.02.033			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815981	Bronze			2022-12-24	WOS:000351952200004
J	Yeeles, JTP; Deegan, TD; Janska, A; Early, A; Diffley, JFX				Yeeles, Joseph T. P.; Deegan, Tom D.; Janska, Agnieszka; Early, Anne; Diffley, John F. X.			Regulated eukaryotic DNA replication origin firing with purified proteins	NATURE			English	Article							CDK-DEPENDENT PHOSPHORYLATION; BUDDING YEAST; IN-VITRO; CRYSTAL-STRUCTURE; POLYMERASE ALPHA; MCM2-7 HELICASE; S-PHASE; KINASES; REPLISOME; COMPLEX	Eukaryotic cells initiate DNA replication from multiple origins, which must be tightly regulated to promote precise genome duplication in every cell cycle. To accomplish this, initiation is partitioned into two temporally discrete steps: a double hexameric minichromosome maintenance (MCM) complex is first loaded at replication origins during G1 phase, and then converted to the active CMG (Cdc45-MCM-GINS) helicase during S phase. Here we describe the reconstitution of budding yeast DNA replication initiation with 16 purified replication factors, made from 42 polypeptides. Origin-dependent initiation recapitulates regulation seen in vivo. Cyclin-dependent kinase (CDK) inhibits MCM loading by phosphorylating the origin recognition complex (ORC) and promotes CMG formation by phosphorylating Sld2 and Sld3. Dbf4-dependent kinase (DDK) promotes replication by phosphorylating MCM, and can act either before or after CDK. These experiments define the minimum complement of proteins, protein kinase substrates and co-factors required for regulated eukaryotic DNA replication.	[Yeeles, Joseph T. P.; Deegan, Tom D.; Janska, Agnieszka; Early, Anne; Diffley, John F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk		Yeeles, Joseph/0000-0002-2255-2119; Diffley, John/0000-0001-5184-7680	Cancer Research UK; FEBS; Boehringer Ingelheim; ERC [249883 - EUKDNAREP]; Cancer Research UK [15669] Funding Source: researchfish; Wellcome Trust [106252/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10273, 10066] Funding Source: researchfish; Worldwide Cancer Research [10-0270] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); FEBS; Boehringer Ingelheim(Boehringer Ingelheim); ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; Worldwide Cancer Research	We are grateful to B. Pfander and M. Douglas for the Mcm10 expression plasmid and advice on purification, C. Kurat for construction of plasmids used to generate ARS1 linear templates, K. On and D. Boos for Sic1 and A-Cdk2 and K. Labib for Psf1 antibodies and the E. coli GINS expression strain. We thank A. Alidoust and N. Patel for growing yeast cultures. This work was supported by Cancer Research UK, a FEBS Return-to-Europe fellowship to J.T.P.Y., a Boehringer Ingelheim Fonds PhD fellowship to A.J. and an ERC grant (249883 - EUKDNAREP) to J.F.X.D.	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Clausen A. R., 2015, NATURE STRUCT MOL BI; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Georgescu RE, 2014, NAT STRUCT MOL BIOL, V21, P664, DOI 10.1038/nsmb.2851; Gros J, 2014, EMBO J, V33, P621, DOI 10.1002/embj.201387278; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Itou H, 2014, STRUCTURE, V22, P1341, DOI 10.1016/j.str.2014.07.001; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rowles A, 1999, J CELL SCI, V112, P2011; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Yu CH, 2014, MOL CELL, V56, P551, DOI 10.1016/j.molcel.2014.09.017; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	34	303	308	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					431	+		10.1038/nature14285	http://dx.doi.org/10.1038/nature14285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25739503	Bronze, Green Accepted			2022-12-24	WOS:000351602800047
J	Park, SE; Kim, JM; Seok, OH; Cho, H; Wadas, B; Kim, SY; Varshavsky, A; Hwang, CS				Park, Sang-Eun; Kim, Jeong-Mok; Seok, Ok-Hee; Cho, Hanna; Wadas, Brandon; Kim, Seon-Young; Varshavsky, Alexander; Hwang, Cheol-Sang			Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathway	SCIENCE			English	Article							UBIQUITIN LIGASE; CELLULAR-PROTEINS; DEGRADATION; RGS2; REGULATORS; TEB4	Rgs2, a regulator of G proteins, lowers blood pressure by decreasing signaling through G alpha(q). Human patients expressing Met-Leu-Rgs2 (ML-Rgs2) or Met-Arg-Rgs2 (MR-Rgs2) are hypertensive relative to people expressing wild-type Met-Gln-Rgs2 (MQ-Rgs2). We found that wild-type MQ-Rgs2 and its mutant, MR-Rgs2, were destroyed by the Ac/N-end rule pathway, which recognizes N-alpha-terminally acetylated (Nt-acetylated) proteins. The shortest-lived mutant, ML-Rgs2, was targeted by both the Ac/N-end rule and Arg/N-end rule pathways. The latter pathway recognizes unacetylated N-terminal residues. Thus, the Nt-acetylated Ac-MX-Rgs2 (X = Arg, Gln, Leu) proteins are specific substrates of the mammalian Ac/N-end rule pathway. Furthermore, the Ac/N-degron of Ac-MQ-Rgs2 was conditional, and Teb4, an endoplasmic reticulum (ER) membrane-embedded ubiquitin ligase, was able to regulate G protein signaling by targeting Ac-MX-Rgs2 proteins for degradation through their N-alpha-terminal acetyl group.	[Park, Sang-Eun; Kim, Jeong-Mok; Seok, Ok-Hee; Cho, Hanna; Hwang, Cheol-Sang] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Gyeongbuk, South Korea; [Wadas, Brandon; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Kim, Seon-Young] KRIBB, Med Genom Res Ctr, Taejon, South Korea; [Kim, Seon-Young] Univ Sci & Technol, Dept Funct Genom, Taejon, South Korea	Pohang University of Science & Technology (POSTECH); California Institute of Technology; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu; cshwang@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; Kim, Jeong-Mok/0000-0002-7223-248X; cho, Hanna/0000-0002-5339-2541; Wadas, Brandon/0000-0003-2796-2384	National Research Foundation of the Korea government (MSIP) [NRF-2011-0021975, NRF-2012R1A4A1028200, NRF-2013R1A1A2012529]; BK21 Plus Program; NIH [DK039520, GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520, R56DK039520, R37DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Research Foundation of the Korea government (MSIP); BK21 Plus Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Neubig, M. Mulvihill, and E. Wiertz for gifts of plasmids, and K. Piatkov for helpful suggestions. Supported by grants from the National Research Foundation of the Korea government (MSIP) (NRF-2011-0021975, NRF-2012R1A4A1028200, NRF-2013R1A1A2012529) and BK21 Plus Program (C.-S.H.), and by NIH grants DK039520 and GM031530 (A.V.).	Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Chidiac P, 2014, CELL SIGNAL, V26, P1226, DOI 10.1016/j.cellsig.2014.02.006; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim JM, 2014, CELL CYCLE, V13, P1366, DOI 10.4161/cc.28751; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Matsuo M, 2013, FEBS LETT, V587, P1392, DOI 10.1016/j.febslet.2013.03.016; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13	26	97	98	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1249	1252		10.1126/science.aaa3844	http://dx.doi.org/10.1126/science.aaa3844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766235	Green Accepted			2022-12-24	WOS:000350824300038
J	Newman, CB; Tobert, JA				Newman, Connie B.; Tobert, Jonathan A.			Statin Intolerance Reconciling Clinical Trials and Clinical Experience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Newman, Connie B.] NYU, Sch Med, New York, NY 10016 USA	New York University	Newman, CB (corresponding author), NYU, Dept Med, Sch Med, 550 First Ave, New York, NY 10016 USA.	connie.newman@nyumc.org	Tobert, Jonathan/AAD-2155-2020; Tobert, Jonathan/J-4294-2019	Tobert, Jonathan/0000-0001-7105-299X; Newman, Connie/0000-0001-9144-056X				Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Maningat P, 2011, NEW ENGL J MED, V365, P2250, DOI 10.1056/NEJMp1112023; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	7	48	48	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1011	1012		10.1001/jama.2015.1335	http://dx.doi.org/10.1001/jama.2015.1335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756433				2022-12-24	WOS:000350643100012
J	Stuwe, T; Correia, AR; Lin, DH; Paduch, M; Lu, VT; Kossiakoff, AA; Hoelz, A				Stuwe, Tobias; Correia, Ana R.; Lin, Daniel H.; Paduch, Marcin; Lu, Vincent T.; Kossiakoff, Anthony A.; Hoelz, Andre			Architecture of the nuclear pore complex coat	SCIENCE			English	Article							NUP84 COMPLEX; VESICLE COATS; MEMBRANE; PROTEINS; REVEALS; STATES; MODULE	The nuclear pore complex (NPC) constitutes the sole gateway for bidirectional nucleocytoplasmic transport. Despite half a century of structural characterization, the architecture of the NPC remains unknown. Here we present the crystal structure of a reconstituted similar to 400-kilodalton coat nucleoporin complex (CNC) from Saccharomyces cerevisiae at a 7.4 angstrom resolution. The crystal structure revealed a curved Y-shaped architecture and the molecular details of the coat nucleoporin interactions forming the central "triskelion" of the Y. A structural comparison of the yeast CNC with an electron microscopy reconstruction of its human counterpart suggested the evolutionary conservation of the elucidated architecture. Moreover, 32 copies of the CNC crystal structure docked readily into a cryoelectron tomographic reconstruction of the fully assembled human NPC, thereby accounting for similar to 16 megadalton of its mass.	[Stuwe, Tobias; Correia, Ana R.; Lin, Daniel H.; Hoelz, Andre] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Paduch, Marcin; Lu, Vincent T.; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	California Institute of Technology; University of Chicago	Hoelz, A (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	hoelz@caltech.edu	Hoelz, Andre/AAB-6978-2021		Gordon and Betty Moore Foundation; Beckman Institute; Sanofi-Aventis Bioengineering Research Program; U.S. Department of Energy; National Institues of Health (NIH); National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; Postdoctoral Fellowship of the Deutsche Forschungsgemeinschaft; NIH Research Service Award [5 T32 GM07616]; NIH [U01 GM094588, U54 GM087519]; Searle Funds at The Chicago Community Trust; Caltech startup funds; Albert Wyrick V Scholar Award of the V Foundation for Cancer Research; 54th Mallinckrodt Scholar Award of the Edward Mallinckrodt Jr. Foundation; Kimmel Scholar Award of the Sidney Kimmel Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117360, U54GM087519, T32GM007616, U01GM094588] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Sanofi-Aventis Bioengineering Research Program; U.S. Department of Energy(United States Department of Energy (DOE)); National Institues of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Postdoctoral Fellowship of the Deutsche Forschungsgemeinschaft; NIH Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Funds at The Chicago Community Trust; Caltech startup funds; Albert Wyrick V Scholar Award of the V Foundation for Cancer Research; 54th Mallinckrodt Scholar Award of the Edward Mallinckrodt Jr. Foundation; Kimmel Scholar Award of the Sidney Kimmel Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. J. Bley, W. M. Clemons, A. M. Davenport, O. Dreesen, A. Patke, D. C. Rees, S. O. Shan, P. Stravropoulos, and K. Thierbach for critical reading of the manuscript: K. Kato and K. Kato for their contributions at the initial stages of this project; L. N. Collins for technical support; D. King for mass spectrometry analysis; E. Hurt and P. Loppnau for material; S. Koide for providing the phage display library; S. Graskind for the pSFV4 vector; P. Afoninc for advice regarding structure refinement in PHENIX; and J. Kaiser and the scientific staff of Stanford Synchrotron Radiation Laboratory (SSRL) Beamline 12-2 and the National Institue of General Medical Sciences and National Cancer Institue Structural Biology Facility (GM/CA) at the Advanced Photon Source (APS) for their support with x-ray diffraction measurements. We acknowledge the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program for their support of the Molecular Observatory at the California Institute of Technology (Caltech). The operations at the SSRL and APS are supported by the U.S. Department of Energy and the National Institues of Health (NIH). GM/CA has been funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). T.S. was supported by a Postdoctoral Fellowship of the Deutsche Forschungsgemeinschaft. D.H.L. was supported by a NIH Research Service Award (5 T32 GM07616). A.A.K was supported by NIH awards U01 GM094588 and U54 GM087519 and by Searle Funds at The Chicago Community Trust. A.H. was supported by Caltech startup funds, the Albert Wyrick V Scholar Award of the V Foundation for Cancer Research, the 54th Mallinckrodt Scholar Award of the Edward Mallinckrodt Jr. Foundation and a Kimmel Scholar Award of the Sidney Kimmel Foundation for Cancer Research. The coordinates and structure factors have Seen deposited with the Protein Data Bank with accession codes 4XMM and 4XMN. The authors declare no financial conflicts of interest.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Debler EW, 2010, NUCLEUS-PHILA, V1, P150, DOI 10.4161/nucl.1.2.11120; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Harrison SC, 2010, NATURE, V466, P1048, DOI 10.1038/4661048a; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Seo HS, 2009, P NATL ACAD SCI USA, V106, P14281, DOI 10.1073/pnas.0907453106; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Thierbach K, 2013, STRUCTURE, V21, P1672, DOI 10.1016/j.str.2013.07.004	17	73	75	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1148	1152		10.1126/science.aaa4136	http://dx.doi.org/10.1126/science.aaa4136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745173	Green Accepted, Green Submitted			2022-12-24	WOS:000350354200056
J	Angell, SY; De Cock, KM; Frieden, TR				Angell, Sonia Y.; De Cock, Kevin M.; Frieden, Thomas R.			A public health approach to global management of hypertension	LANCET			English	Editorial Material							COUNTRIES; DISEASE		[Angell, Sonia Y.; De Cock, Kevin M.; Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], GLOB ACT PLAN PREV C; [Anonymous], 2014, LANCET, V383, P1861; [Anonymous], 2013, JAMA-J AM MED ASSOC; [Anonymous], 2015, BLOOD PRESSURE MED 5; [Anonymous], 2015, GLOB STAND HYP TREAT; [Anonymous], 2015, COUNT PROBL FALS SUB; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Bloom DE, 2011, GLOBAL EC BURDEN NON; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Ford N, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-33; Frieden TR, 2014, JAMA-J AM MED ASSOC, V311, P21, DOI 10.1001/jama.2013.282615; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Ikeda N, 2014, B WORLD HEALTH ORGAN, V92, P10, DOI 10.2471/BLT.13.121954; Khader A, 2012, TROP MED INT HEALTH, V17, P1163, DOI 10.1111/j.1365-3156.2012.03048.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; UNAIDS, 2014, GAP REP; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; World Health Organisation, 2014, TUBERCULOSIS; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2015, GLOB STAT REP NONC D	21	51	54	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					825	827		10.1016/S0140-6736(14)62256-X	http://dx.doi.org/10.1016/S0140-6736(14)62256-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25752181	Green Accepted			2022-12-24	WOS:000350051700037
J	Gabel, HW; Kinde, B; Stroud, H; Gilbert, CS; Harmin, DA; Kastan, NR; Hemberg, M; Ebert, DH; Greenberg, ME				Gabel, Harrison W.; Kinde, Benyam; Stroud, Hume; Gilbert, Caitlin S.; Harmin, David A.; Kastan, Nathaniel R.; Hemberg, Martin; Ebert, Daniel H.; Greenberg, Michael E.			Disruption of DNA-methylation-dependent long gene repression in Rett syndrome	NATURE			English	Article							BDNF TRANSCRIPTION; EXPRESSION CHANGES; BINDING DOMAIN; MESSENGER-RNAS; MOUSE MODELS; MECP2; PHOSPHORYLATION; PURIFICATION; DUPLICATION; CHROMATIN	Disruption of the MECP2 gene leads to Rett syndrome (RTT), a severe neurological disorder with features of autism(1). MECP2 encodes a methyl-DNA-binding protein(2) that has been proposed to function as a transcriptional repressor, but despite numerous mouse studies examining neuronal gene expression in Mecp2 mutants, no clear model has emerged for how MeCP2 protein regulates transcription(3-9). Here we identify a genome-wide length-dependent increase in gene expression in MeCP2 mutant mouse models and human RTT brains. We present evidence that MeCP2 represses gene expression by binding to methylated CA sites within long genes, and that in neurons lacking MeCP2, decreasing the expression of long genes attenuates RTT-associated cellular deficits. In addition, we find that long genes as a population are enriched for neuronal functions and selectively expressed in the brain. These findings suggest that mutations in MeCP2 may cause neurological dysfunction by specifically disrupting long gene expression in the brain.	[Gabel, Harrison W.; Kinde, Benyam; Stroud, Hume; Gilbert, Caitlin S.; Harmin, David A.; Kastan, Nathaniel R.; Ebert, Daniel H.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Hemberg, Martin] Harvard Univ, Ctr Brain Sci, Childrens Hosp Boston, Dept Ophthalmol, Boston, MA 02115 USA; [Hemberg, Martin] Harvard Univ, Swartz Ctr Theoret Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	Stroud, Hume/ABF-1325-2021		Rett Syndrome Research Trust; National Institutes of Health (NIH) [1RO1NS048276]; Damon Runyon Cancer Research Foundation [DRG-2048-10]; William Randolf Hearst fund; NIH [T32GM007753]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	Rett Syndrome Research Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; William Randolf Hearst fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Griffith and members of the Greenberg laboratory, A. Bird, G. Mandel and members of their laboratories, and M. Coenraads for discussions, M. Goodell for providing the Dnmt3a mice, N. Sharma and F. DiBiase for experimental support, and M. Mistry of the HSPH Bioinformatics Core, Harvard School of Public Health for assistance with gene expression analysis. This work was supported by grants from the Rett Syndrome Research Trust and the National Institutes of Health (NIH) (1RO1NS048276) to M.E.G., fellowships from the Damon Runyon Cancer Research Foundation (DRG-2048-10) and the William Randolf Hearst fund to H.W.G., as well as NIH grant T32GM007753, and the HHMI Gilliam fellowship to B.K., H.S. is a HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG-2194-14).	Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ebert DH, 2013, NATURE, V499, P341, DOI 10.1038/nature12348; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Khrapunov S, 2014, BIOCHEMISTRY-US, V53, P3379, DOI 10.1021/bi500424z; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagy G, 2013, IMMUNOBIOLOGY, V218, P1416, DOI 10.1016/j.imbio.2013.07.006; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Samaco RC, 2012, NAT GENET, V44, P206, DOI 10.1038/ng.1066; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wu YJ, 2006, BIOMETRICS, V62, P877, DOI 10.1111/j.1541-0420.2006.00533.x; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Zhao YT, 2013, NEUROBIOL DIS, V59, P257, DOI 10.1016/j.nbd.2013.08.001; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	53	338	340	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					89	U221		10.1038/nature14319	http://dx.doi.org/10.1038/nature14319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25762136	Green Submitted, Green Accepted			2022-12-24	WOS:000355543400035
J	Barisic, M; Sousa, RSE; Tripathy, SK; Magiera, MM; Zaytsev, AV; Pereira, AL; Janke, C; Grishchuk, EL; Maiato, H				Barisic, Marin; Silva e Sousa, Ricardo; Tripathy, Suvranta K.; Magiera, Maria M.; Zaytsev, Anatoly V.; Pereira, Ana L.; Janke, Carsten; Grishchuk, Ekaterina L.; Maiato, Helder			Microtubule detyrosination guides chromosomes during mitosis	SCIENCE			English	Article							NONTYROSINATED ALPHA-TUBULIN; KINESIN CENP-E; CONGRESSION; MOTOR; CODE; TYROSINATION; MECHANISMS; TRANSPORT; SPINDLE	Before chromosomes segregate into daughter cells, they align at the mitotic spindle equator, a process known as chromosome congression. Centromere-associated protein E (CENP-E)/Kinesin-7 is a microtubule plus-end-directed kinetochore motor required for congression of pole-proximal chromosomes. Because the plus-ends of many astral microtubules in the spindle point to the cell cortex, it remains unknown how CENP-E guides pole-proximal chromosomes specifically toward the equator. We found that congression of pole-proximal chromosomes depended on specific posttranslational detyrosination of spindle microtubules that point to the equator. In vitro reconstitution experiments demonstrated that CENP-E-dependent transport was strongly enhanced on detyrosinated microtubules. Blocking tubulin tyrosination in cells caused ubiquitous detyrosination of spindle microtubules, and CENP-E transported chromosomes away from spindle poles in random directions. Thus, CENP-E-driven chromosome congression is guided by microtubule detyrosination.	[Barisic, Marin; Pereira, Ana L.; Maiato, Helder] Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, P-4150180 Oporto, Portugal; [Barisic, Marin; Pereira, Ana L.; Maiato, Helder] Univ Porto, I3S, P-4150180 Oporto, Portugal; [Silva e Sousa, Ricardo; Tripathy, Suvranta K.; Zaytsev, Anatoly V.; Grishchuk, Ekaterina L.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Magiera, Maria M.; Janke, Carsten] Inst Curie, F-91405 Orsay, France; [Magiera, Maria M.; Janke, Carsten] Paris Sci & Lettres PSL Res Univ, F-75005 Paris, France; [Magiera, Maria M.; Janke, Carsten] CNRS, UMR 3348, F-91405 Orsay, France; [Zaytsev, Anatoly V.] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Zaytsev, Anatoly V.] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4200319 Oporto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Universidade do Porto	Grishchuk, EL (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	gekate@mail.med.upenn.edu; maiato@ibmc.up.pt	Tripathy, Suvranta/ABB-5152-2020; Magiera, Maria M./Y-8754-2019; Zaytsev, Anatoly/R-9422-2016; Janke, Carsten/A-7279-2011; Barisic, Marin/K-2301-2013; Maiato, Helder/J-9466-2013	Magiera, Maria M./0000-0003-4847-3053; Janke, Carsten/0000-0001-7053-2000; Barisic, Marin/0000-0001-7587-3867; Maiato, Helder/0000-0002-6200-9997; Tripathy, Suvranta/0000-0002-6658-1691	National Institutes of Health [R01-GM098389]; American Cancer Society [RSG-14-018-01-CCG]; Institut Curie; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; L'Agence Nationale de la Recherche (ANR) [ANR-12-BSV2-0007, INCA_6517, ANR-10-LBX-0038, ANR-10-IDEX-0001-02 PSL]; L'Agence Nationale de la Recherche (ANR) part of the IDEX Idex PSL; Fundacao Luso-Americana para o Desenvolvimento (FLAD) Life Science; PRECISE grant from the European Research Council; RAS Presidium; Russian Fund for Basic Research [12-04-00111-a, 13-00-40188]; Programa Graduado em Areas da Biologia Basica e Aplicada (GABBA) PhD program from the University of Porto; Fundacao para a Ciencia e a Tecnologia of Portugal [SFRH/BPD/66707/2009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Institut Curie; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); L'Agence Nationale de la Recherche (ANR) part of the IDEX Idex PSL(French National Research Agency (ANR)); Fundacao Luso-Americana para o Desenvolvimento (FLAD) Life Science; PRECISE grant from the European Research Council; RAS Presidium(Russian Academy of Sciences); Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Programa Graduado em Areas da Biologia Basica e Aplicada (GABBA) PhD program from the University of Porto; Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. I. Ataullakhanov for help with the laser trap and data analysis; A. Kiyatkin, V. Mustyatsa, M. Molodtsov, A. Gautreau, G. Lakisic, and M. Barisic for technical assistance; and members of our laboratories for stimulating discussions. This work was supported by National Institutes of Health grant R01-GM098389 and RSG-14-018-01-CCG from the American Cancer Society to E.L.G.; by the Institut Curie, the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the L'Agence Nationale de la Recherche (ANR) award ANR-12-BSV2-0007, INCA_6517, ANR-10-LBX-0038, part of the IDEX Idex PSL, ANR-10-IDEX-0001-02 PSL to C.J.; and Fundacao Luso-Americana para o Desenvolvimento (FLAD) Life Science 2020 and PRECISE grant from the European Research Council to H.M. A.V.Z. is supported by the RAS Presidium Grants "Mechanisms of the Molecular Systems Integration," " Molecular and Cell Biology programs," and Russian Fund for Basic Research Grant 12-04-00111-a and 13-00-40188. R.S.S. is supported by a fellowship from the Programa Graduado em Areas da Biologia Basica e Aplicada (GABBA) PhD program from the University of Porto. A.L.P. is supported by fellowship SFRH/BPD/66707/2009 from Fundacao para a Ciencia e a Tecnologia of Portugal. M.B., R.S.S., S.K.T., M.M.M., C.J., E.L.G., and H.M. designed the experiments; M.B. performed all experiments in cells; M. M. M. established and performed the tubulin purification protocol from HeLa cells; R.S.S. performed single-molecule experiments; S.K.T. performed force measurements; A.L.P. provided reagents; all authors analyzed data; H.M., E.L.G., and M.B. wrote the paper, with contributions from all authors; H.M. conceived and coordinated the project. Data described can be found in the main figures and supplementary materials. The authors declare no conflict of interests.	Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Fonrose X, 2007, CANCER RES, V67, P3371, DOI 10.1158/0008-5472.CAN-06-3732; Gudimchuk N, 2013, NAT CELL BIOL, V15, P1079, DOI 10.1038/ncb2831; GUNDERSEN GG, 1986, J CELL BIOL, V102, P1118, DOI 10.1083/jcb.102.3.1118; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; WILSON PJ, 1989, CELL MOTIL CYTOSKEL, V14, P237, DOI 10.1002/cm.970140210; Yardimci H, 2008, P NATL ACAD SCI USA, V105, P6016, DOI 10.1073/pnas.0711314105; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	26	142	147	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2015	348	6236					799	803		10.1126/science.aaa5175	http://dx.doi.org/10.1126/science.aaa5175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI0LN	25908662	Green Accepted, Green Submitted			2022-12-24	WOS:000354428700044
J	Perrillo, RP; Martin, P; Lok, AS				Perrillo, Robert P.; Martin, Paul; Lok, Anna S.			Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS REACTIVATION; INFECTION PRIOR; RECOMMENDATIONS; CHEMOTHERAPY; LAMIVUDINE; LYMPHOMA; AGENTS		[Perrillo, Robert P.] Baylor Univ, Med Ctr, Hepatol Div, Dallas, TX USA; [Martin, Paul] Univ Miami, Div Hepatol, Miami, FL USA; [Lok, Anna S.] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA	Baylor University; Baylor University Medical Center; University of Miami; University of Michigan System; University of Michigan	Lok, AS (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, 1500 E Med Ctr Dr,3912 Taubman Ctr,SPC 5362, Ann Arbor, MI 48109 USA.	aslok@umich.edu						Di Bisceglie AM, 2015, HEPATOLOGY, V61, P703, DOI 10.1002/hep.27609; HUANG H, 2014, JAMA, V312, P2521; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; Motaparthi K, 2014, J AM ACAD DERMATOL, V70, P178, DOI 10.1016/j.jaad.2013.08.049; Perrillo RP, 2015, GASTROENTEROLOGY, V148, P221, DOI 10.1053/j.gastro.2014.10.038; Seto WK, 2014, J CLIN ONCOL, V32, P3736, DOI 10.1200/JCO.2014.56.7081; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Stine JG, 2010, ARTHRIT CARE RES, V62, P704, DOI 10.1002/acr.20209; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699	10	48	48	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1617	1618		10.1001/jama.2015.2571	http://dx.doi.org/10.1001/jama.2015.2571			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25790287				2022-12-24	WOS:000353595200008
J	Mayer, A; di Iulio, J; Maleri, S; Eser, U; Vierstra, J; Reynolds, A; Sandstrom, R; Stamatoyannopoulos, JA; Churchman, LS				Mayer, Andreas; di Iulio, Julia; Maleri, Seth; Eser, Umut; Vierstra, Jeff; Reynolds, Alex; Sandstrom, Richard; Stamatoyannopoulos, John A.; Churchman, L. Stirling			Native Elongating Transcript Sequencing Reveals Human Transcriptional Activity at Nucleotide Resolution	CELL			English	Article							RNA-POLYMERASE-II; DIVERGENT TRANSCRIPTION; P-TEFB; DROSOPHILA-MELANOGASTER; BIDIRECTIONAL PROMOTERS; DNA-METHYLATION; START SITES; IN-VITRO; GENE; INITIATION	Major features of transcription by human RNA polymerase II (Pol II) remain poorly defined due to a lack of quantitative approaches for visualizing Pol II progress at nucleotide resolution. We developed a simple and powerful approach for performing native elongating transcript sequencing (NET-seq) in human cells that globally maps strand-specific Pol II density at nucleotide resolution. NET-seq exposes a mode of antisense transcription that originates downstream and converges on transcription from the canonical promoter. Convergent transcription is associated with a distinctive chromatin configuration and is characteristic of lower-expressed genes. Integration of NET-seq with genomic footprinting data reveals stereotypic Pol II pausing coincident with transcription factor occupancy. Finally, exons retained in mature transcripts display Pol II pausing signatures that differ markedly from skipped exons, indicating an intrinsic capacity for Pol II to recognize exons with different processing fates. Together, human NET-seq exposes the topography and regulatory complexity of human gene expression.	[Mayer, Andreas; di Iulio, Julia; Maleri, Seth; Eser, Umut; Churchman, L. Stirling] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Vierstra, Jeff; Reynolds, Alex; Sandstrom, Richard; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98104 USA; [Stamatoyannopoulos, John A.] Univ Washington, Div Oncol, Dept Med, Seattle, WA 98104 USA	Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Churchman, LS (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	churchman@genetics.med.harvard.edu	Mayer, Andreas/AAA-5173-2021	DI IULIO, JULIA/0000-0001-9343-127X; Sandstrom, Richard/0000-0002-3356-1547; Mayer, Andreas/0000-0002-4532-9382; Vierstra, Jeff/0000-0001-6406-8563	US National Institutes of Health NHGRI [R01HG007173, U54HG007010]; Damon Runyon Dale F. Frey Award; Burroughs Wellcome Fund Career Award; Long-Term Postdoctoral Fellowships of the Human Frontier Science Program [LT000314/2013-L]; EMBO [ALTF858-2012]; Swiss National Science Foundation Postdoc Mobility Fellowship; US National Science Foundation Graduate Research Fellowship [DGE-071824]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007173, U54HG007010] Funding Source: NIH RePORTER	US National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Damon Runyon Dale F. Frey Award; Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Long-Term Postdoctoral Fellowships of the Human Frontier Science Program; EMBO(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation Postdoc Mobility Fellowship; US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank F. Winston, J. Gray, M. Couvillion, S. Doris, and E. Feinberg for critical comments on the manuscript. We thank J. Gray and A. Snavely for help with eRNA analysis. We thank F. Winston, K. Struhl, S. Buratowski, A. Ciuffi, and A. Regev for advice and discussions. We thank M. Gebremeskel for tissue culture support; K. Waraska at the HMS Biopolymers Facility and Z. Herbert at the DFCI Molecular Biology Core Facilities for sequencing; and N. Pho and B.D. Kim at HMS Research Computing for computing support. This work was supported by US National Institutes of Health NHGRI grants R01HG007173 to L.S.C. and U54HG007010 to J.A.S.; a Damon Runyon Dale F. Frey Award for Breakthrough Scientists (to L.S.C.); and a Burroughs Wellcome Fund Career Award at the Scientific Interface (to L.S.C). A.M. was supported by Long-Term Postdoctoral Fellowships of the Human Frontier Science Program (LT000314/2013-L) and EMBO (ALTF858-2012). J.d.I. was supported by the Swiss National Science Foundation Postdoc Mobility Fellowship. J.V. was supported by US National Science Foundation Graduate Research Fellowship under grant DGE-071824.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; CAI H, 1987, J BIOL CHEM, V262, P298; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Churchman L Stirling, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0414s98; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Davis-Turak JC, 2015, NUCLEIC ACIDS RES, V43, P699, DOI 10.1093/nar/gku1338; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; DeGennaro CM, 2013, MOL CELL BIOL, V33, P4779, DOI 10.1128/MCB.01068-13; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dujardin G, 2014, MOL CELL, V54, P683, DOI 10.1016/j.molcel.2014.03.044; Dujardin G, 2013, BBA-GENE REGUL MECH, V1829, P134, DOI 10.1016/j.bbagrm.2012.08.005; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrari F, 2013, CELL REP, V5, P629, DOI 10.1016/j.celrep.2013.09.037; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gullerova M, 2012, NAT STRUCT MOL BIOL, V19, P1193, DOI 10.1038/nsmb.2392; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Lis JT, 2000, GENE DEV, V14, P792; MAIZELS NM, 1973, P NATL ACAD SCI USA, V70, P3585, DOI 10.1073/pnas.70.12.3585; Marquardt S, 2014, CELL, V157, P1712, DOI 10.1016/j.cell.2014.04.036; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Skene PJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02042; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/NMETH.2713, 10.1038/nmeth.2713]; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wozniak GG, 2014, BBA-GENE REGUL MECH, V1839, P1353, DOI 10.1016/j.bbagrm.2014.03.002; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	81	211	213	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					541	554		10.1016/j.cell.2015.03.010	http://dx.doi.org/10.1016/j.cell.2015.03.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910208	Green Accepted, Bronze			2022-12-24	WOS:000353553600014
J	Parker, IM; Saunders, M; Bontrager, M; Weitz, AP; Hendricks, R; Magarey, R; Suiter, K; Gilbert, GS				Parker, Ingrid M.; Saunders, Megan; Bontrager, Megan; Weitz, Andrew P.; Hendricks, Rebecca; Magarey, Roger; Suiter, Karl; Gilbert, Gregory S.			Phylogenetic structure and host abundance drive disease pressure in communities	NATURE			English	Article							INFECTIOUS-DISEASES; TROPICAL FOREST; PLANT-DISEASE; BIODIVERSITY; PATHOGENS; ECOLOGY; HERBIVORES; EMERGENCE; ESCAPE; SIGNAL	Pathogens play an important part in shaping the structure and dynamics of natural communities, because species are not affected by them equally(1,2). A shared goal of ecology and epidemiology is to predict when a species is most vulnerable to disease. A leading hypothesis asserts that the impact of disease should increase with host abundance, producing a 'rare-species advantage'(3-5). However, the impact of a pathogen may be decoupled from host abundance, because most pathogens infect more than one species, leading to pathogen spillover onto closely related species(6,7). Here we show that the phylogenetic and ecological structure of the surrounding community can be important predictors of disease pressure. We found that the amount of tissue lost to disease increased with the relative abundance of a species across a grassland plant community, and that this rare-species advantage had an additional phylogenetic component: disease pressure was stronger on species with many close relatives. We used a global model of pathogen sharing as a function of relatedness between hosts, which provided a robust predictor of relative disease pressure at the local scale. In our grassland, the total amount of disease was most accurately explained not by the abundance of the focal host alone, but by the abundance of all species in the community weighted by their phylogenetic distance to the host. Furthermore, the model strongly predicted observed disease pressure for 44 novel host species we introduced experimentally to our study site, providing evidence for a mechanism to explain why phylogenetically rare species are more likely to become invasive when introduced(8,9). Our results demonstrate how the phylogenetic and ecological structure of communities can have a key role in disease dynamics, with implications for the maintenance of biodiversity, biotic resistance against introduced weeds, and the success of managed plants in agriculture and forestry.	[Parker, Ingrid M.; Bontrager, Megan; Weitz, Andrew P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Parker, Ingrid M.; Gilbert, Gregory S.] Smithsonian Trop Res Inst, Balboa, Panama; [Saunders, Megan; Hendricks, Rebecca; Gilbert, Gregory S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Magarey, Roger; Suiter, Karl] N Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27606 USA	University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Santa Cruz; University of North Carolina; North Carolina State University	Parker, IM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	imparker@ucsc.edu	Parker, Ingrid M./ABH-2014-2020	Parker, Ingrid M./0000-0002-4847-1827; Weitz, Andrew/0000-0001-9799-5574; Magarey, Roger/0000-0002-5651-5965	National Science Foundation [DEB-0842059, DEB-1136626]; G.S.G. [14-8130-1472-CA]; US Department of Agriculture APHIS-PPQ-CPHST PERAL [14-8130-1472-CA]; Direct For Biological Sciences [1136626] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); G.S.G.; US Department of Agriculture APHIS-PPQ-CPHST PERAL; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. Webb for development of the methods of phylogenetic ecology. We thank J. Velzy for greenhouse support and the many undergraduates and volunteers who helped with fieldwork and disease assessments from scanned leaves. Editorial comments were provided by M. Kilpatrick, B. Lyon, C. Fresquez, D. Gordon, S. Grove, S. Gulamhussein, J. Harrower, C. Ray, K. Ross and M. Shu; K. Tanner revised Fig. 1. This research was funded by National Science Foundation grants DEB-0842059 and DEB-1136626, and by a Cooperative Agreement 14-8130-1472-CA between G.S.G. and US Department of Agriculture APHIS-PPQ-CPHST PERAL funded from Section 10201 of the Farm Bill.	Alexander HM, 2010, PLANT DIS, V94, P492, DOI 10.1094/PDIS-94-5-0492; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 2008, ASSESS 2 0 IMAGE ANA; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Baldwin B.G., 2012, JEPSON MANUAL VASCUL; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; CONNELL J H, 1971, P298; Duncan RP, 2002, NATURE, V417, P608, DOI 10.1038/417608a; Elton C. S., 1958, ECOLOGY INVASIONS AN; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gilbert GS, 2012, EVOL APPL, V5, P869, DOI 10.1111/j.1752-4571.2012.00265.x; Gilbert GS, 2010, EVOL APPL, V3, P144, DOI 10.1111/j.1752-4571.2009.00107.x; GILLETT J. B., 1962, SYST ASS PUBLICATION, V4, P37; Goodell K, 2000, INCORPORATING SCIENCE ECONOMICS AND SOCIOLOGY IN DEVELOPING SANITARY AND PHYTOSANITARY STANDARDS IN INTERNATIONAL TRADE: PROCEEDINGS OF A CONFENENCE, P87; Haff TM, 2008, NATURAL HIST UC SANT; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Mack R. N., 1996, Proceedings of the 9th international symposium on biological control of weeds, Stellenbosch, South Africa, 19-26 January 1996., P39; Mack R. N., 1989, BIOL INVASIONS GLOBA, P155; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; WAPSHERE AJ, 1974, ANN APPL BIOL, V77, P201, DOI 10.1111/j.1744-7348.1974.tb06886.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1; Yguel B, 2011, ECOL LETT, V14, P1117, DOI 10.1111/j.1461-0248.2011.01680.x	37	193	199	14	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					542	+		10.1038/nature14372	http://dx.doi.org/10.1038/nature14372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903634	Green Published			2022-12-24	WOS:000353334500043
J	Odden, MC; Pletcher, MJ; Coxson, PG; Thekkethala, D; Guzman, D; Heller, D; Goldman, L; Bibbins-Domingo, K				Odden, Michelle C.; Pletcher, Mark J.; Coxson, Pamela G.; Thekkethala, Divya; Guzman, David; Heller, David; Goldman, Lee; Bibbins-Domingo, Kirsten			Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; ALL-CAUSE MORTALITY; GLOBAL BURDEN; STROKE INCIDENCE; PREDICTIVE-VALUE; ISCHEMIC-STROKE; RISK; CHOLESTEROL; THERAPY	Background: Evidence to guide primary prevention in adults aged 75 years or older is limited. Objective: To project the population impact and cost-effectiveness of statin therapy in adults aged 75 years or older. Design: Forecasting study using the Cardiovascular Disease Policy Model, a Markov model. Data Sources: Trial, cohort, and nationally representative data sources. Target Population: U.S. adults aged 75 to 94 years. Time Horizon: 10 years. Perspective: Health care system. Intervention: Statins for primary prevention based on low-density lipoprotein cholesterol threshold of 4.91 mmol/L (190 mg/dL), 4.14 mmol/L (160 mg/dL), or 3.36 mmol/L (130 mg/dL); presence of diabetes; or 10-year risk score of at least 7.5%. Outcome Measures: Myocardial infarction (MI), coronary heart disease (CHD) death, disability-adjusted life-years, and costs. Results of Base-Case Analysis: All adults aged 75 years or older in the National Health and Nutrition Examination Survey have a 10-year risk score greater than 7.5%. If statins had no effect on functional limitation or cognitive impairment, all primary prevention strategies would prevent MIs and CHD deaths and be cost-effective. Treatment of all adults aged 75 to 94 years would result in 8 million additional users and prevent 105 000 (4.3%) incident MIs and 68 000 (2.3%) CHD deaths at an incremental cost per disability-adjusted life-year of $25 200. Results of Sensitivity Analysis: An increased relative risk for functional limitation or mild cognitive impairment of 1.10 to 1.29 could offset the cardiovascular benefits. Limitation: Limited trial evidence targeting primary prevention in adults aged 75 years or older. Conclusion: At effectiveness similar to that in trials, statins are projected to be cost-effective for primary prevention; however, even a small increase in geriatric-specific adverse effects could offset the cardiovascular benefit. Improved data on the potential benefits and harms of statins are needed to inform decision making.	[Odden, Michelle C.] Oregon State Univ, Corvallis, OR 97331 USA; [Pletcher, Mark J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; Columbia Univ, New York, NY USA	Oregon State University; University of California System; University of California San Francisco; Columbia University	Odden, MC (corresponding author), Oregon State Univ, 141B Milam Hall, Corvallis, OR 97331 USA.			Heller, David/0000-0003-0060-8393	American Heart Association Western States Affiliate; National Institute on Aging; National Institute for Diabetes on Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK103992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG039387] Funding Source: NIH RePORTER	American Heart Association Western States Affiliate(American Heart Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Diabetes on Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	American Heart Association Western States Affiliate, National Institute on Aging, and the National Institute for Diabetes on Digestive and Kidney Diseases.	Agency for Healthcare Research and Quality, 2014, MED EXP PAN SURV PUB; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Anderson JL, 2014, CIRCULATION, V129, P2329, DOI 10.1161/CIR.0000000000000042; [Anonymous], 2000, CAL PAT DISCH DAT JA; Appelros P, 2011, ACTA NEUROL SCAND, V124, P383, DOI 10.1111/j.1600-0404.2011.01500.x; Average Cost to Community Hospitals per Patient, 1998, STAT ANSTR US BUR CE, P136; BEHAR S, 1991, AM J MED, V91, P45, DOI 10.1016/0002-9343(91)90072-6; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Bureau of Labor Statistics: U.S. Department of Labor, 2014, CONS PRIC IND; California Office of Statewide Health Planning and Development, 2008, ANN FIN DAT; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Centers for Disease Control and Prevention (CDC), 2021, NATL HLTH NUTR EXAMI; Centers for Medicare & Medicaid Services, 2015, NAT PHYS FEE SCHED 2; Centers for Medicare & Medicaid Services, 2014, NAT AV DRUG ACQ COST; Centers for Medicare & Medicaid Services, 2000, PERS HLTH CAR SPEND; Centers for Medicare & Medicaid Services, 2014, CLIN LAB FEE SCHED 2; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dawber TR., 1980, FRAMINGHAM STUDY EPI, DOI DOI 10.4159/HARVARD.9780674492097; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Ford ES, 2003, ETHNIC DIS, V13, P85; Freedman VA, 2013, DEMOGRAPHY, V50, P661, DOI 10.1007/s13524-012-0167-z; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Groeneveld PW, 2003, CIRCULATION, V108, P286, DOI 10.1161/01.CIR.0000079164.95019.5A; Gross R, 1996, Public Health Rev, V24, P167; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Lakshminarayan K, 2011, STROKE, V42, P1556, DOI 10.1161/STROKEAHA.110.605600; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Lee DSH, 2014, JAMA INTERN MED, V174, P1263, DOI 10.1001/jamainternmed.2014.2266; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lo-Ciganic WH, 2013, ANN PHARMACOTHER, V47, P984, DOI 10.1345/aph.1S050; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Center for Health Statistics, 2012, CDC WONDER DAT; National Center for Health Statistics, 2012, NAT HLTH INT SURV 20; National Center for Health Statistics, 2010, NAT HOSP DISCH SURV; National Center for Health Statistics, 2004, ICD 10 COD; Packer M, 1999, AM J CARDIOL, V83, p1A; Padala KP, 2010, J AM GERIATR SOC, V58, P1214, DOI 10.1111/j.1532-5415.2010.02889.x; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Pletcher MJ, 2014, CIRC-CARDIOVASC QUAL, V7, P276, DOI 10.1161/CIRCOUTCOMES.113.000799; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Prosser J, 2007, STROKE, V38, P2295, DOI 10.1161/STROKEAHA.106.471813; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Rieves D, 2000, AM J CARDIOL, V85, P147, DOI 10.1016/S0002-9149(99)00652-9; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sathasivam S, 2012, EUR J INTERN MED, V23, P317, DOI 10.1016/j.ejim.2012.01.004; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Schiattarella Gabriele Giacomo, 2012, Aging Clin Exp Res, V24, P47; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Society for Post-Acute and Long-Term Care Medicine, 2013, 5 THINGS PHYS PAT SH; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33; U.S. Census Bureau, 2011, MONTH RES POP SINGL; U.S. Census Bureau, 2012, PROJ POP SINGL YEAR; U.S. Census Bureau, 2012, METH ASS 2012 NAT PR; Vaccarino V, 2009, ARCH INTERN MED, V169, P1767, DOI 10.1001/archinternmed.2009.332; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006	80	82	82	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					533	+		10.7326/M14-1430	http://dx.doi.org/10.7326/M14-1430			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG4GT	25894023	Green Accepted			2022-12-24	WOS:000353244300013
J	Gupta, V; Sugg, N; Butners, M; Allen-White, G; Molnar, A				Gupta, Vin; Sugg, Nancy; Butners, Marite; Allen-White, Gillian; Molnar, Alexandra			Tuberculosis among the Homeless - Preventing Another Outbreak through Community Action	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION		[Gupta, Vin] Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; [Gupta, Vin; Sugg, Nancy; Molnar, Alexandra] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA; [Butners, Marite] Butners Consulting Serv, Seattle, WA USA; [Allen-White, Gillian] Grand Cent Bakery, Seattle, WA USA	Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle	Gupta, V (corresponding author), Brigham & Womens Hosp, Dept Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.			Molnar, Alexandra/0000-0003-3258-6782				Centers for Disease Control and Prevention, 2012, TB NOTES NEWSL; Centers for Disease Control and Prevention, 2014, REP TUB US; Dye C, 2011, NEW ENGL J MED, V365, P2230, DOI 10.1056/NEJMe1111859; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875	5	17	18	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2015	372	16					1483	1485		10.1056/NEJMp1501316	http://dx.doi.org/10.1056/NEJMp1501316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF9BL	25875254	Bronze			2022-12-24	WOS:000352856500002
J	Hoenen, T; Safronetz, D; Groseth, A; Wollenberg, KR; Koita, OA; Diarra, B; Fall, IS; Haidara, FC; Diallo, F; Sanogo, M; Sarro, YS; Kone, A; Togo, ACG; Traore, A; Kodio, M; Dosseh, A; Rosenke, K; de Wit, E; Feldmann, F; Ebihara, H; Munster, VJ; Zoon, KC; Feldmann, H; Sow, S				Hoenen, T.; Safronetz, D.; Groseth, A.; Wollenberg, K. R.; Koita, O. A.; Diarra, B.; Fall, I. S.; Haidara, F. C.; Diallo, F.; Sanogo, M.; Sarro, Y. S.; Kone, A.; Togo, A. C. G.; Traore, A.; Kodio, M.; Dosseh, A.; Rosenke, K.; de Wit, E.; Feldmann, F.; Ebihara, H.; Munster, V. J.; Zoon, K. C.; Feldmann, H.; Sow, S.			Mutation rate and genotype variation of Ebola virus from Mali case sequences	SCIENCE			English	Article							OUTBREAK; TRANSMISSION; CONGO	The occurrence of Ebola virus (EBOV) in West Africa during 2013-2015 is unprecedented. Early reports suggested that in this outbreak EBOV is mutating twice as fast as previously observed, which indicates the potential for changes in transmissibility and virulence and could render current molecular diagnostics and countermeasures ineffective. We have determined additional full-length sequences from two clusters of imported EBOV infections into Mali, and we show that the nucleotide substitution rate (9.6 x 10(-4) substitutions per site per year) is consistent with rates observed in Central African outbreaks. In addition, overall variation among all genotypes observed remains low. Thus, our data indicate that EBOV is not undergoing rapid evolution in humans during the current outbreak. This finding has important implications for outbreak response and public health decisions and should alleviate several previously raised concerns.	[Hoenen, T.; Safronetz, D.; Groseth, A.; Rosenke, K.; de Wit, E.; Ebihara, H.; Munster, V. J.; Feldmann, H.] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Wollenberg, K. R.] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Koita, O. A.; Diarra, B.; Sanogo, M.; Sarro, Y. S.; Kone, A.; Togo, A. C. G.] Univ Sci Tech & Technol Bamako, Ctr Res & Training HIV & TB, Bamako, Mali; [Fall, I. S.] World Hlth Org Off, Bamako, Mali; [Haidara, F. C.; Diallo, F.; Traore, A.; Kodio, M.; Sow, S.] Minist Sante & Hyg Publ, Ctr Natl Appui Lutte Maladie, Ctr Dev Vaccins CVD Mali, Ctr Operat Urgence, Bamako, Mali; [Dosseh, A.] WHO, Inter Country Support Team, Ouagadougou, Burkina Faso; [Feldmann, F.] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Zoon, K. C.] NIAID, Off Sci Director, NIH, Bethesda, MD 20895 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Science & Technology of Bamako; World Health Organization; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Feldmann, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA.	feldmannh@niaid.nih.gov; ssow@medicine.umaryland.edu	Groseth, Allison/AAJ-9076-2020; Munster, Vincent/I-7607-2018; Hoenen, Thomas/H-8990-2019; de Wit, Emmie/A-1549-2019	Groseth, Allison/0000-0001-9528-5130; Munster, Vincent/0000-0002-2288-3196; Hoenen, Thomas/0000-0002-5829-6305; de Wit, Emmie/0000-0002-9763-7758; Diarra, Bassirou/0000-0002-1795-9379	Intramural Research Program of the NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001190, ZIAAI001089, ZIAAI001136, ZIAAI001179] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Nichol and U. Stroher (U. S. Centers for Disease Control and Prevention); T. Schwan, R. Sakai, M. Niang, and M. Pineda (NIH, NIAID); and S. Diop, S. Tounkara, and F. Daou Centre de Recherche et de Formation sur le VIH/TB SEREFO for helpful discussion and help with logistics and sample preparation. We also thank the Research Technology Branch at the Rocky Mountain Laboratories, particularly S. Kramer, K. Barbian, and S. Porcella, for sequencing services. This study made use of the high-performance computational capabilities of the Biowulf Linux cluster at the NIH, Bethesda, MD (http://biowulf.nih.gov), and the Office of Cyber Infrastructure and Computational Biology High-Performance Computing cluster at the NIAID, Bethesda, MD. This work was supported in part by the Intramural Research Program of the NIH, NIAID. The full-length sequences of the Malian EBOVs were deposited at GenBank under the accession numbers KP260799.1, KP260800.1, KP260801.1, and KP260802.1 (Ebola virus/H.sapiens-wt/MLI/2014/Makona-Mali-DPR1 to 4). There are no conflicts of interest, material transfer agreements, patents, or patent applications that apply to reagents, methods, or data in the paper for any of the authors.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Dowall SD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0540-x; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Grolla A, 2012, ZOONOSES PUBLIC HLTH, V59, P151, DOI 10.1111/j.1863-2378.2012.01477.x; Groseth A, 2005, J VIROL, V79, P4425, DOI 10.1128/JVI.79.7.4425-4433.2005; Groseth A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002847; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371	14	101	105	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					117	119		10.1126/science.aaa5646	http://dx.doi.org/10.1126/science.aaa5646			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25814067				2022-12-24	WOS:000352079500039
J	Byrne, JM; Klueglein, N; Pearce, C; Rosso, KM; Appel, E; Kappler, A				Byrne, James M.; Klueglein, Nicole; Pearce, Carolyn; Rosso, Kevin M.; Appel, Erwin; Kappler, Andreas			Redox cycling of Fe(II) and Fe(III) in magnetite by Fe-metabolizing bacteria	SCIENCE			English	Article							PALUSTRIS STRAIN TIE-1; NANOPARTICULATE MAGNETITE; FE3-XTIXO4 NANOPARTICLES; ELECTRON-TRANSFER; REDUCTION; OXIDATION; IRON; STOICHIOMETRY; OXIDE	Microorganisms are a primary control on the redox-induced cycling of iron in the environment. Despite the ability of bacteria to grow using both Fe(II) and Fe(III) bound in solid-phase iron minerals, it is currently unknown whether changing environmental conditions enable the sharing of electrons in mixed-valent iron oxides between bacteria with different metabolisms. We show through magnetic and spectroscopic measurements that the phototrophic Fe(II)-oxidizing bacterium Rhodopseudomonas palustris TIE-1 oxidizes magnetite (Fe3O4) nanoparticles using light energy. This process is reversible in co-cultures by the anaerobic Fe(III)-reducing bacterium Geobacter sulfurreducens. These results demonstrate that Fe ions bound in the highly crystalline mineral magnetite are bioavailable as electron sinks and electron sources under varying environmental conditions, effectively rendering magnetite a naturally occurring battery.	[Byrne, James M.; Klueglein, Nicole; Kappler, Andreas] Univ Tubingen, Ctr Appl Geosci, Geomicrobiol, D-72076 Tubingen, Germany; [Pearce, Carolyn] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Pearce, Carolyn; Rosso, Kevin M.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Appel, Erwin] Univ Tubingen, Ctr Appl Geosci, Geophys, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; University of Manchester; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Eberhard Karls University of Tubingen	Byrne, JM (corresponding author), Univ Tubingen, Ctr Appl Geosci, Geomicrobiol, Sigwartstr 10, D-72076 Tubingen, Germany.	James.Byrne@uni-tuebingen.de	Rosso, Kevin/AAQ-1561-2021; Kappler, Andreas/G-7221-2016; Byrne, James/L-4860-2016	Byrne, James/0000-0002-4399-7336; Kappler, Andreas/0000-0002-3558-9500	Deutsche Forschungsgemeinschaft; Pacific Northwest National Laboratory Science Focus Area, the Subsurface Biogeochemical Research program of the U.S. Department of Energy Office of Biological and Environmental Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Pacific Northwest National Laboratory Science Focus Area, the Subsurface Biogeochemical Research program of the U.S. Department of Energy Office of Biological and Environmental Research	We thank G. Ojha for help with kappa-T measurements and C. Berthold for advice on mu-XRD. This work was funded by the Deutsche Forschungsgemeinschaft. Part of this work was funded by the Pacific Northwest National Laboratory Science Focus Area, the Subsurface Biogeochemical Research program of the U.S. Department of Energy Office of Biological and Environmental Research. We thank J. Liu (Peking University) for providing TEM images, which were taken in the Environmental Molecular Science Laboratory (EMSL), a national user facility supported by the OBER and located at PNNL. All data associated with this publication are available at www.pangaea.de.	Berkowitz AE, 1999, J MAGN MAGN MATER, V196, P591, DOI 10.1016/S0304-8853(98)00845-2; Bird LJ, 2011, TRENDS MICROBIOL, V19, P330, DOI 10.1016/j.tim.2011.05.001; Bose A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4391; COEY JMD, 1971, PHYS REV LETT, V27, P1140, DOI 10.1103/PhysRevLett.27.1140; Cutting RS, 2009, GEOCHIM COSMOCHIM AC, V73, P4004, DOI 10.1016/j.gca.2009.04.009; Dong HL, 2000, CHEM GEOL, V169, P299, DOI 10.1016/S0009-2541(00)00210-2; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Evans M.E., 2003, ENV MAGNETISM PRINCI; Gorski CA, 2010, AM MINERAL, V95, P1017, DOI 10.2138/am.2010.3435; Gorski CA, 2009, ENVIRON SCI TECHNOL, V43, P3675, DOI 10.1021/es803613a; Jiao YYQ, 2005, APPL ENVIRON MICROB, V71, P4487, DOI 10.1128/AEM.71.8.4487-4496.2005; JOLIVET JP, 1988, J COLLOID INTERF SCI, V125, P688, DOI 10.1016/0021-9797(88)90036-7; Kato S, 2012, P NATL ACAD SCI USA, V109, P10042, DOI 10.1073/pnas.1117592109; Liu J, 2013, J AM CHEM SOC, V135, P8896, DOI 10.1021/ja4015343; LOVLEY DR, 1989, APPL ENVIRON MICROB, V55, P700, DOI 10.1128/AEM.55.3.700-706.1989; Maher BA, 2009, ELEMENTS, V5, P229, DOI 10.2113/gselements.5.4.229; Melton ED, 2014, GEOMICROBIOL J, V31, P835, DOI 10.1080/01490451.2014.901439; Melton ED, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00197; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; OZDEMIR O, 1993, GEOPHYS RES LETT, V20, P1671, DOI 10.1029/93GL01483; Pearce CI, 2012, J COLLOID INTERF SCI, V387, P24, DOI 10.1016/j.jcis.2012.06.092; Porsch K, 2010, ENVIRON SCI TECHNOL, V44, P3846, DOI 10.1021/es903954u; Rebodos RL, 2010, LANGMUIR, V26, P16745, DOI 10.1021/la102461z; Smith JA, 2013, APPL ENVIRON MICROB, V79, P901, DOI 10.1128/AEM.02954-12; Vikesland PJ, 2007, ENVIRON SCI TECHNOL, V41, P5277, DOI 10.1021/es062082i	25	179	188	53	624	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1473	1476		10.1126/science.aaa4834	http://dx.doi.org/10.1126/science.aaa4834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814583				2022-12-24	WOS:000352136400040
J	Atkins, KE; Wenzel, NS; Ndeffo-Mbah, M; Altice, FL; Townsend, JP; Galvani, AP				Atkins, Katherine E.; Wenzel, Natasha S.; Ndeffo-Mbah, Martial; Altice, Frederick L.; Townsend, Jeffrey P.; Galvani, Alison P.			Under-reporting and case fatality estimates for emerging epidemics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EBOLA-VIRUS DISEASE; INFECTION		[Atkins, Katherine E.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Atkins, Katherine E.; Wenzel, Natasha S.; Ndeffo-Mbah, Martial; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA; [Altice, Frederick L.] Yale Univ, Dept Med, Infect Dis Sect, New Haven, CT 06520 USA; [Townsend, Jeffrey P.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA	University of London; London School of Hygiene & Tropical Medicine; Yale University; Yale University; Yale University	Atkins, KE (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	katherine.atkins@lshtm.ac.uk	Townsend, Jeffrey/H-2747-2019	Townsend, Jeffrey/0000-0002-9890-3907; Altice, Frederick/0000-0002-7860-693X; Ndeffo Mbah, Martial/0000-0003-4158-7613	National Institutes of Health [NIH U01 GM087719, U01 GM105627, K24 DA017072]; National Science Foundation [NSF RAPID 1514673]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England (PHE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM105627, U01GM087719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA017072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England (PHE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All authors have completed the unified competing interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare the work was supported by the National Institutes of Health (NIH U01 GM087719, U01 GM105627, and K24 DA017072), and the National Science Foundation (NSF RAPID 1514673). This research was partly funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE). The views expressed are those of the authors and not necessarily those of the NIH, NSF, NHS, NIHR, the Department of Health or Public Health England.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bellan SE, 2014, LANCET, V384, P1499, DOI 10.1016/S0140-6736(14)61839-0; Centers for Disease Control, 2014, OUTBR CHRON EB HEM F; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Kucharski AJ, 2014, LANCET, V384, P1260, DOI 10.1016/S0140-6736(14)61706-2; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; World Health Organization, 2014, WHO GLOB AL RESP; World Health Organization, 2014, WHY EB OUTBR HAS BEE	10	28	28	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2015	350								h1115	10.1136/bmj.h1115	http://dx.doi.org/10.1136/bmj.h1115			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KM	25779635	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000351570500002
J	Takahashi, S; Metcalf, CJE; Ferrari, MJ; Moss, WJ; Truelove, SA; Tatem, AJ; Grenfell, BT; Lessler, J				Takahashi, Saki; Metcalf, C. Jessica E.; Ferrari, Matthew J.; Moss, William J.; Truelove, Shaun A.; Tatem, Andrew J.; Grenfell, Bryan T.; Lessler, Justin			Reduced vaccination and the risk of measles and other childhood infections post-Ebola	SCIENCE			English	Article							MORTALITY	The Ebola epidemic in West Africa has caused substantial morbidity and mortality. The outbreak has also disrupted health care services, including childhood vaccinations, creating a second public health crisis. We project that after 6 to 18 months of disruptions, a large connected cluster of children unvaccinated for measles will accumulate across Guinea, Liberia, and Sierra Leone. This pool of susceptibility increases the expected size of a regional measles outbreak from 127,000 to 227,000 cases after 18 months, resulting in 2000 to 16,000 additional deaths (comparable to the numbers of Ebola deaths reported thus far). There is a clear path to avoiding outbreaks of childhood vaccine-preventable diseases once the threat of Ebola begins to recede: an aggressive regional vaccination campaign aimed at age groups left unprotected because of health care disruptions.	[Takahashi, Saki; Metcalf, C. Jessica E.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Metcalf, C. Jessica E.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Ferrari, Matthew J.] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16801 USA; [Moss, William J.; Truelove, Shaun A.; Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton SO17 1BJ, Hants, England; [Tatem, Andrew J.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Tatem, Andrew J.] Flowminder Fdn, S-17177 Stockholm, Sweden	Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Southampton; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	justin@jhu.edu	Truelove, Shaun/D-4187-2018	Truelove, Shaun/0000-0003-0538-0607; Lessler, Justin/0000-0002-9741-8109; Takahashi, Saki/0000-0001-5413-5507; Tatem, Andrew/0000-0002-7270-941X	Bill & Melinda Gates Foundation [OPP1094793, OPP1106427, 1032350]; U.S. Department of Homeland Security Science & Technology Directorate [HSHQDC-12-C-00058]; RAPIDD program of the Department of Homeland Security Science & Technology Directorate; NIH Fogarty International Center; National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI102939, U19AI089674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102939, U19AI089674] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); U.S. Department of Homeland Security Science & Technology Directorate(United States Department of Homeland Security (DHS)); RAPIDD program of the Department of Homeland Security Science & Technology Directorate; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Bill & Melinda Gates Foundation grant OPP1094793 and U.S. Department of Homeland Security Science & Technology Directorate contract HSHQDC-12-C-00058 (B.T.G., C.J.E.M.); the RAPIDD program of the Department of Homeland Security Science & Technology Directorate and the NIH Fogarty International Center (C.J.E.M., B.T.G., A.J.T.); National Institute of Allergy and Infectious Diseases (NIAID) grant R01 AI102939 (J.L.); and NIAID grant U19AI089674 and Bill & Melinda Gates Foundation grants OPP1106427 and 1032350 (A.J.T.). We thank M. Hanson for helping to organize the assessment of the impact of Ebola on measles vaccination and for motivating this work, and W. Hao for helpful discussion in preparation of the manuscript. Demographic and Health Surveys data are made freely available to those filing a request (22). WorldPop project demographic data may be obtained from www.worldpop.org.uk. Data on measles incidence, routine vaccination coverage, and SIAs are available at www.who.int/immunization/monitoring_surveillance/data/en/. Ebola incidence data were extracted from publicly available situation reports (23-25).	Ambassade de France a Conakry, EBOLA POINT DE SITUA; Bolkan Hakon Angell, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0307d588df619f9c9447f8ead5b72b2d; Epicentre, 2014, MEDECINS SANS FRONTI; Garcia AJ, 2015, MIGR STUD, V3, P89, DOI 10.1093/migration/mnu036; ICF International, DEMOGRAPHIC AND HEAL; Liberian Ministry of Health, LIBERIA EBOLA DAILY; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mancini S, 2014, CONFL HEALTH, V8, P9, DOI [DOI 10.1186/1752-1505-8-9, 10.1186/1752-1505-8-9]; McFerron W., 2014, BLOOMBERG NEWS; Medecins Sans Frontieres, 2015, MSF BEGINS MALARIA P; Nyenswah TG, 2014, MMWR-MORBID MORTAL W, V63, P1; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; Sharara SL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004438; Sierra Leone National Ebola Response Centre (NERC), EBOLA OUTBREAK UPDAT; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; SURMIEDA M R S, 1992, Morbidity and Mortality Weekly Report, V41, P9; Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2; UNICEF, SANCTIONS CHILDREN H; Wesolowski A, 2014, PLOS CURR, V6; who, WHO RECOMMENDATIONS; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224; World Health Organization, 2015, IMMUNIZATION VACCINE; World Health Organization, 2013, GLOB VACC ACT PLAN M; World Health Organization, 2015, EBOLA SITUATION REPO	25	127	132	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1240	1242		10.1126/science.aaa3438	http://dx.doi.org/10.1126/science.aaa3438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766232	Green Accepted			2022-12-24	WOS:000350824300035
J	Theodoris, CV; Li, ML; White, MP; Liu, L; He, D; Pollard, KS; Bruneau, BG; Srivastava, D				Theodoris, Christina V.; Li, Molong; White, Mark P.; Liu, Lei; He, Daniel; Pollard, Katherine S.; Bruneau, Benoit G.; Srivastava, Deepak			Human Disease Modeling Reveals Integrated Transcriptional and Epigenetic Mechanisms of NOTCH1 Haploinsufficiency	CELL			English	Article							REGULATORY NETWORKS; GENE-EXPRESSION; CALCIFICATION; BINDING; CELLS; DIFFERENTIATION; MUTATIONS; ALIGNMENT; LEUKEMIA; RECEPTOR	The mechanisms by which transcription factor haploinsufficiency alters the epigenetic and transcriptional landscape in human cells to cause disease are unknown. Here, we utilized human induced pluripotent stem cell (iPSC)-derived endothelial cells (ECs) to show that heterozygous nonsense mutations in NOTCH1 that cause aortic valve calcification disrupt the epigenetic architecture, resulting in derepression of latent pro-osteogenic and -inflammatory gene networks. Hemodynamic shear stress, which protects valves from calcification in vivo, activated anti-osteogenic and anti-inflammatory networks in NOTCH1(+/+), but not NOTCH1(+/-), iPSC-derived ECs. NOTCH1 haploinsufficiency altered H3K27ac at NOTCH1-bound enhancers, dysregulating downstream transcription of more than 1,000 genes involved in osteogenesis, inflammation, and oxidative stress. Computational predictions of the disrupted NOTCH1-dependent gene network revealed regulatory nodes that, when modulated, restored the network toward the NOTCH1(+/+) state. Our results highlight how alterations in transcription factor dosage affect gene networks leading to human disease and reveal nodes for potential therapeutic intervention.	[Theodoris, Christina V.; Li, Molong; White, Mark P.; Liu, Lei; He, Daniel; Pollard, Katherine S.; Bruneau, Benoit G.; Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Theodoris, Christina V.; Li, Molong; White, Mark P.; Liu, Lei; He, Daniel; Bruneau, Benoit G.; Srivastava, Deepak] Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA; [Theodoris, Christina V.; Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Program Dev & Stem Cell Biol, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Srivastava, D (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	Theodoris, Christina/N-4403-2016	Theodoris, Christina/0000-0003-1658-1447; Srivastava, Deepak/0000-0002-3480-5953	NIH/NHLBI [U01 HL098179, U01 HL100406, HL089707]; L.K. Whittier Foundation; William H. Younger Family Foundation; Eugene Roddenberry Foundation; California Institute for Regenerative Medicine; Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association (AHA) Established Investigator Award; California Institute for Regenerative Medicine [RB4-05901]; AHA; UCSF; Roddenberry Fellowship; Winslow Fellowship; UCSF Core Exploratory Award; Developmental and Stem Cell Biology Graduate Program [NIH T32HD007470]; Medical Scientist Training Program [NIH T32GM007618]; Sarnoff Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, U01HL098179, U01HL100406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); L.K. Whittier Foundation; William H. Younger Family Foundation; Eugene Roddenberry Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association (AHA) Established Investigator Award; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); AHA(American Heart Association); UCSF; Roddenberry Fellowship; Winslow Fellowship; UCSF Core Exploratory Award; Developmental and Stem Cell Biology Graduate Program; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sarnoff Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Srivastava Lab and Gladstone/UCSF community for helpful scientific discussions. We thank the Gladstone Genomics, Histology, and Stem Cell Cores and UCSF ESC Targeting Core for their technical expertise. We thank G. Howard and B. Taylor for their editorial help and K. Ivey and C. Gifford for critical comments. This work was supported by NIH/NHLBI grants U01 HL098179 (B. G. B., K.S.P., and D.S.) and U01 HL100406 (B. G. B. and D.S.). D.S. was supported by the L.K. Whittier, William H. Younger Family, and Eugene Roddenberry Foundations and the California Institute for Regenerative Medicine. B. G. B. was supported by the Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association (AHA) Established Investigator Award, William H. Younger Family Foundation, and a grant from the California Institute for Regenerative Medicine (RB4-05901). K.S.P. was supported by a grant from NIH/NHLBI (HL089707). C.V.T. was supported by the AHA Predoctoral, UCSF Discovery, Roddenberry, and Winslow Fellowships and the UCSF Core Exploratory Award, Developmental and Stem Cell Biology Graduate Program (NIH T32HD007470), and Medical Scientist Training Program (NIH T32GM007618). M.P.W. was supported by the AHA Predoctoral and Winslow Fellowship, and M.L. was supported by a Sarnoff Fellowship.	Alatalo SL, 2000, CLIN CHEM, V46, P1751; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Conway DE, 2009, CARDIOVASC RES, V81, P669, DOI 10.1093/cvr/cvn360; Del Bianco C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015034; Deleuze V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040484; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; Engelholm LH, 2001, LAB INVEST, V81, P1403, DOI 10.1038/labinvest.3780354; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Foffa I, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-44; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goettsch C, 2013, CIRC RES, V112, P1073, DOI 10.1161/CIRCRESAHA.113.300937; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hofmann JJ, 2012, DEVELOPMENT, V139, P4449, DOI 10.1242/dev.084871; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOSTKA D, 2014, ARXIV14020042; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kwa MQ, 2014, J BIOL CHEM, V289, P19758, DOI 10.1074/jbc.M114.584540; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li HL, 2013, STEM CELL RES, V10, P313, DOI 10.1016/j.scr.2012.11.007; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007780; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; VANDERLAAN MJ, 2001, J STAT PLAN INFEREN, V117, P275; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Weinberg EJ, 2010, CARDIOVASC ENG, V10, P5, DOI 10.1007/s10558-009-9089-9; White MP, 2013, STEM CELLS, V31, P92, DOI 10.1002/stem.1267; Wu J, 2014, J BIOL CHEM, V289, P12168, DOI 10.1074/jbc.M114.553859; Yamashiro T, 2004, J BONE MINER RES, V19, P1671, DOI 10.1359/JBMR.040801; Yashiro-Ohtani Y, 2014, P NATL ACAD SCI USA, V111, pE4946, DOI 10.1073/pnas.1407079111; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	66	131	132	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1072	1086		10.1016/j.cell.2015.02.035	http://dx.doi.org/10.1016/j.cell.2015.02.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768904	Bronze, Green Accepted			2022-12-24	WOS:000351951800008
J	Garnham, CP; Vemu, A; Wilson-Kubalek, EM; Yu, I; Szyk, A; Lander, GC; Milligan, RA; Roll-Mecak, A				Garnham, Christopher P.; Vemu, Annapurna; Wilson-Kubalek, Elizabeth M.; Yu, Ian; Szyk, Agnieszka; Lander, Gabriel C.; Milligan, Ronald A.; Roll-Mecak, Antonina			Multivalent Microtubule Recognition by Tubulin Tyrosine Ligase-like Family Glutamylases	CELL			English	Article							ALPHA-BETA-TUBULIN; STRUCTURAL BASIS; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; POLYGLUTAMYLATION; PROTEIN; MOTILITY; BINDING; RESOLUTION; BRAIN	Glutamylation, the most prevalent tubulin posttranslational modification, marks stable microtubules and regulates recruitment and activity of microtubule-interacting proteins. Nine enzymes of the tubulin tyrosine ligase-like (TTLL) family catalyze glutamylation. TTLL7, the most abundant neuronal glutamylase, adds glutamates preferentially to the beta-tubulin tail. Coupled with ensemble and single-molecule biochemistry, our hybrid X-ray and cryo-electron microscopy structure of TTLL7 bound to the microtubule delineates a tripartite microtubule recognition strategy. The enzyme uses its core to engage the disordered anionic tails of alpha-and beta-tubulin, and a flexible cationic domain to bind the microtubule and position itself for beta-tail modification. Furthermore, we demonstrate that all single-chain TTLLs with known glutamylase activity utilize a cationic microtubule-binding domain analogous to that of TTLL7. Therefore, our work reveals the combined use of folded and intrinsically disordered substrate recognition elements as the molecular basis for specificity among the enzymes primarily responsible for chemically diversifying cellular microtubules.	[Garnham, Christopher P.; Vemu, Annapurna; Yu, Ian; Szyk, Agnieszka; Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; [Wilson-Kubalek, Elizabeth M.; Lander, Gabriel C.; Milligan, Ronald A.] Scripps Res Inst, La Jolla, CA 92037 USA; [Roll-Mecak, Antonina] NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA.	antonina@mail.nih.gov		Lander, Gabriel C./0000-0003-4921-1135; Roll-Mecak, Antonina/0000-0003-2621-7307	NIGMS [P41 GM103310]; NINDS postdoctoral fellowship; Damon Runyon Cancer Research Foundation (DFS) [07-13]; Pew Scholars program; Searle Scholars program; NIH [DP2 EB020402, GM-052468, GM095573]; Searle Scholar program; National Institute of Neurological Disorders and Stroke; National Heart, Lung and Blood Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB020402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, R37GM052468, R01GM095573, R01GM052468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS postdoctoral fellowship; Damon Runyon Cancer Research Foundation (DFS); Pew Scholars program; Searle Scholars program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank staff at beamlines 24-ID (Advanced Photon Source) and 5.0.1 and 5.0.2 (Advanced Light Source) for support, D.-Y. Lee for access to mass spectrometers, and A. Ferre-D'Amare, E. Giniger, and S. Gottesman for critical reading of the manuscript. TEM studies were conducted at the National Resource for Automated Molecular Microscopy, supported by NIGMS (P41 GM103310). C.P.G. is supported by an NINDS postdoctoral fellowship. G.C.L. is supported by the Damon Runyon Cancer Research Foundation (DFS-#07-13), the Pew Scholars program, the Searle Scholars program, and NIH (DP2 EB020402). R.A.M. is supported by NIH (GM-052468). E.M.W.-K is partly supported by NIH (GM095573). A.R.-M. is supported by the Searle Scholar program and the intramural programs of the National Institute of Neurological Disorders and Stroke and National Heart, Lung and Blood Institute.	ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; AUDEBERT S, 1994, J CELL SCI, V107, P2313; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.3.CO;2-3; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; Bulinski JC, 1997, J CELL SCI, V110, P3055; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Geimer S, 1997, CELL MOTIL CYTOSKEL, V37, P72; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kubo T, 2014, MOL BIOL CELL, V25, P107, DOI 10.1091/mbc.E13-07-0424; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mukai M, 2009, BIOCHEMISTRY-US, V48, P1084, DOI 10.1021/bi802047y; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; RAYBIN D, 1975, BIOCHEM BIOPH RES CO, V65, P1088, DOI 10.1016/S0006-291X(75)80497-9; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2015, SEMIN CELL DEV BIOL, V37, P11, DOI 10.1016/j.semcdb.2014.09.026; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; RUDIGER M, 1994, EUR J BIOCHEM, V220, P309, DOI 10.1111/j.1432-1033.1994.tb18627.x; Schneider A, 1998, FEBS LETT, V429, P399, DOI 10.1016/S0014-5793(98)00644-9; Sergouniotis PI, 2014, AM J HUM GENET, V94, P760, DOI 10.1016/j.ajhg.2014.04.003; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Szyk A, 2013, J MOL BIOL, V425, P2412, DOI 10.1016/j.jmb.2013.04.017; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Tomita K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00036; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vemu A, 2014, METHOD ENZYMOL, V540, P149, DOI 10.1016/B978-0-12-397924-7.00009-1; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19	53	56	61	4	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1112	1123		10.1016/j.cell.2015.04.003	http://dx.doi.org/10.1016/j.cell.2015.04.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25959773	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000355152600018
J	Smith, CD; Levinson, WS				Smith, Cynthia D.; Levinson, Wendy S.		Internal Med HVC Advisory Board	A Commitment to High-Value Care Education From the Internal Medicine Community	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIANS; COST	The Alliance for Academic Internal Medicine, American Board of Internal Medicine (ABIM), ABIM Foundation, and American College of Physicians are collaborating to enhance the education of physicians in high-value care (HVC) and make its practice an essential competency in undergraduate and postgraduate education by 2017. This article serves as the organizations' formal commitment to providing a foundation of HVC education on which others may build. The 5 key targets for HVC education are experiential learning and curriculum, environment and culture, clinical support, regulatory requirements, and sustainability. The goal is to train future health care professionals for whom HVC is part of normal practice, thus providing patients with improved clinical outcomes at a lower cost.	[Smith, Cynthia D.] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Toronto, Toronto, ON, Canada	American College of Physicians; University of Toronto	Smith, CD (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.			Lang, Valerie J/0000-0003-1119-5029				Asch DA, 2014, ACAD MED, V89, P24, DOI 10.1097/ACM.0000000000000067; CUMMINGS KM, 1982, MED CARE, V20, P293, DOI 10.1097/00005650-198203000-00006; Dine C Jessica, 2010, J Grad Med Educ, V2, P175, DOI 10.4300/JGME-D-10-00021.1; Levy AE, 2014, ACAD MED, V89, P1440, DOI 10.1097/ACM.0000000000000496; Ryskina KL, 2014, ANN INTERN MED, V161, P733, DOI 10.7326/M14-0444; Sirovich BE, 2006, ANN INTERN MED, V144, P641, DOI 10.7326/0003-4819-144-9-200605020-00007; Stiefel MN K., 2012, GUIDE MEASURING TRIP; Weinberger SE, 2014, ANN INTERN MED, V161, P73, DOI 10.7326/M13-2993; Weinberger SE, 2011, ANN INTERN MED, V155, P386, DOI 10.7326/0003-4819-155-6-201109200-00007; Young P., 2010, HEALTHC IMP LOW COST	10	14	16	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					639	U233		10.7326/M14-2610	http://dx.doi.org/10.7326/M14-2610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25938993				2022-12-24	WOS:000354119100008
J	Liu, YH; Zhang, XN; Han, C; Wan, GH; Huang, XX; Ivan, C; Jiang, DH; Rodriguez-Aguayo, C; Lopez-Berestein, G; Rao, PH; Maru, DM; Pahl, A; He, XM; Sood, AK; Ellis, LM; Anderl, J; Lu, XB				Liu, Yunhua; Zhang, Xinna; Han, Cecil; Wan, Guohui; Huang, Xingxu; Ivan, Cristina; Jiang, Dahai; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Rao, Pulivarthi H.; Maru, Dipen M.; Pahl, Andreas; He, Xiaoming; Sood, Anil K.; Ellis, Lee M.; Anderl, Jan; Lu, Xiongbin			TP53 loss creates therapeutic vulnerability in colorectal cancer	NATURE			English	Article							CRISPR-CAS9 SYSTEM; P53 PATHWAY; HUMAN-CELLS; AMANITIN; INHIBITION; PHENOTYPE	TP53, a well-known tumour suppressor gene that encodes p53, is frequently inactivated by mutation or deletion in most human tumours'''. A tremendous effort has been made to restore p53 activity in cancer therapies'''. However, no effective p53-based therapy has been successfully translated into clinical cancer treatment owing to the complexity of p53 signalling. Here we demonstrate that genomic deletion of TP53 frequently encompasses essential neighbouring genes, rendering cancer cells with hemizygous TP53 deletion vulnerable to further suppression of such genes. POLR2A is identified as such a gene that is almost always co-deleted with TP53 in human cancers. It encodes the largest and catalytic subunit of the RNA polymerase II complex, which is specifically inhibited by a-amanitin". Our analysis of The Cancer Genome Atlas (TCGA) and Cancer Cell Line Encyclopedia (CCLE) databases reveals that POLR2A expression levels are tightly correlated with its gene copy numbers in human colorectal cancer. Suppression of POLR2A with alpha-amanitin or small interfering RNAs selectively inhibits the proliferation, survival and tumorigenic potential of colorectal cancer cells with hemizygous TP53 loss in a p53-independent manner. Previous clinical applications of a-amanitin have been limited owing to its liver toxicity'. However, we found that alpha-amanitin-based antibody-drug conjugates are highly effective therapeutic agents with reduced toxicity". Here we show that low doses of alpha-amanitin-conjugated anti-epithelial cell adhesion molecule (EpCAM) antibody lead to complete tumour regression in mouse models of human colorectal cancer with hemizygous deletion of POLR2A. We anticipate that inhibiting POLR2A will be a new therapeutic approach for human cancers containing such common genomic alterations.	[Liu, Yunhua; Han, Cecil; Wan, Guohui; Sood, Anil K.; Lu, Xiongbin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Zhang, Xinna; Ivan, Cristina; Jiang, Dahai; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynaecol Oncol & Reprod Med, Houston, TX 77030 USA; [Zhang, Xinna; Ivan, Cristina; Jiang, Dahai; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Sood, Anil K.; Lu, Xiongbin] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Huang, Xingxu] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Rao, Pulivarthi H.] Baylor Coll Med, Dept Paediat, Houston, TX 77030 USA; [Maru, Dipen M.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Pahl, Andreas; Anderl, Jan] Heidelberg Pharma GmbH, D-68526 Ladenburg, Germany; [He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; ShanghaiTech University; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Lu, XB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	xlu2@mdanderson.org	Sood, Anoop Kumar/A-7344-2013; Wan, Guohui/G-3904-2011; He, Xiaoming/C-5499-2008; Liu, Yunhua/I-8149-2015	Sood, Anoop Kumar/0000-0001-5702-4108; Wan, Guohui/0000-0001-5170-7282; He, Xiaoming/0000-0003-0125-6086; huang, xingxu/0000-0001-8934-1247; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Ivan, Cristina/0000-0002-4848-0168	National Institutes of Health (NIH), MD Anderson Moon Shots Program [R01 CA136549]; NIH [U54 CA151668]; NATIONAL CANCER INSTITUTE [R21CA185742, U54CA151668, R01CA136549, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH), MD Anderson Moon Shots Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank F. Zhang and I. J. Fidler for technical support in orthotopic tumour experiments. We thank L. Huang and M. Bar-Eli for lentivirus production. This work was supported by grants to X.L. (National Institutes of Health (NIH) R01 CA136549, MD Anderson Moon Shots Program) and to A.K.S. (NIH U54 CA151668).	Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; FAULSTICH H, 1985, METHOD ENZYMOL, V112, P225, DOI 10.1016/S0076-6879(85)12019-7; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Haupt S, 2004, SEMIN CANCER BIOL, V14, P244, DOI 10.1016/j.semcancer.2004.04.003; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Letschert K, 2006, TOXICOL SCI, V91, P140, DOI 10.1093/toxsci/kfj141; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu YH, 2012, J VIROL, V86, P1372, DOI 10.1128/JVI.06245-11; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Moldenhauer G, 2012, JNCI-J NATL CANCER I, V104, P622, DOI 10.1093/jnci/djs140; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Pecot CV, 2014, MOL CANCER THER, V13, P2876, DOI 10.1158/1535-7163.MCT-14-0074; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026	28	150	158	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					697	U286		10.1038/nature14418	http://dx.doi.org/10.1038/nature14418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25901683	Green Accepted			2022-12-24	WOS:000353689700054
J	Rungta, RL; Choi, HB; Tyson, JR; Malik, A; Dissing-Olesen, L; Lin, PJC; Cain, SM; Cullis, PR; Snutch, TP; MacVicar, BA				Rungta, Ravi L.; Choi, Hyun B.; Tyson, John R.; Malik, Aqsa; Dissing-Olesen, Lasse; Lin, Paulo J. C.; Cain, Stuart M.; Cullis, Pieter R.; Snutch, Terrance P.; MacVicar, Brian A.			The Cellular Mechanisms of Neuronal Swelling Underlying Cytotoxic Edema	CELL			English	Article							SPREADING DEPRESSION; CHLORIDE TRANSPORTER; ANION-EXCHANGERS; BRAIN; EXPRESSION; SLC26A11; RELEASE; CALCIUM; SODIUM; NMDA	Cytotoxic brain edema triggered by neuronal swelling is the chief cause of mortality following brain trauma and cerebral infarct. Using fluorescence lifetime imaging to analyze contributions of intracellular ionic changes in brain slices, we find that intense Na+ entry triggers a secondary increase in intracellular Cl- that is required for neuronal swelling and death. Pharmacological and siRNA-mediated knockdown screening identified the ion exchanger SLC26A11 unexpectedly acting as a voltage-gated Cl- channel that is activated upon neuronal depolarization to membrane potentials lower than -20 mV. Blockade of SLC26A11 activity attenuates both neuronal swelling and cell death. Therefore cytotoxic neuronal edema occurs when sufficient Na+ influx and depolarization is followed by Cl- entry via SLC26A11. The resultant NaCl accumulation causes subsequent neuronal swelling leading to neuronal death. These findings shed light on unique elements of volume control in excitable cells and lay the ground for the development of specific treatments for brain edema.	[Rungta, Ravi L.; Choi, Hyun B.; Tyson, John R.; Malik, Aqsa; Dissing-Olesen, Lasse; Cain, Stuart M.; Snutch, Terrance P.; MacVicar, Brian A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 2B5, Canada; [Tyson, John R.; Cain, Stuart M.; Snutch, Terrance P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Lin, Paulo J. C.; Cullis, Pieter R.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	MacVicar, BA (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC V6T 2B5, Canada.	bmacvicar@brain.ubc.ca	MacVicar, Brian/P-1553-2015; MacVicar, Brian/AAI-7729-2020; Snutch, Terrance P/L-3464-2019	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Snutch, Terrance P/0000-0001-5182-1296; Rungta, Ravi/0000-0003-3505-2743	Canadian Institutes of Health Research (CIHR); BC Epilepsy Society; CIHR [10677, 8545, 115121]; Canada Research Chair (CRC) in Biotechnology and Genomics-Neurobiology; CIHR Emerging Team Grant: Personalized siRNA-Based Nanomedicines [FRN:111627]; CRC in Neuroscience; Fondation Leducq; MIRI grant from Brain Canada; Genome British Columbia; Michael Smith Foundation for Health Research; Koerner Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Epilepsy Society; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (CRC) in Biotechnology and Genomics-Neurobiology; CIHR Emerging Team Grant: Personalized siRNA-Based Nanomedicines; CRC in Neuroscience; Fondation Leducq(Leducq Foundation); MIRI grant from Brain Canada; Genome British Columbia; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Koerner Foundation	R.L.R. was supported by a studentship from the Canadian Institutes of Health Research (CIHR), S.L.C. by a fellowship from the BC Epilepsy Society, T.P.S. by an operating grant from the CIHR (# 10677) and a Canada Research Chair (CRC) in Biotechnology and Genomics-Neurobiology, P.R.C. by a CIHR Emerging Team Grant: Personalized siRNA-Based Nanomedicines (FRN:111627) and B.A.M. by a CRC in Neuroscience and CIHR operating grants (# 8545 and # 115121) and the Fondation Leducq. We thank Dr. Xiling Zhou and Dr. Anne Marie Craig for supplying neuronal cultures and Jeff LeDue for assistance with establishing the FLIM methodology. We thank Kate Campbell for illustrations. The work was also supported by a MIRI grant from Brain Canada, Genome British Columbia, the Michael Smith Foundation for Health Research, and the Koerner Foundation. P.R.C. has greater than 5% ownership of Precision Nanosystems Inc. that makes the systems to formulate the lipid nanoparticles.	Allen NJ, 2004, J NEUROSCI, V24, P3837, DOI 10.1523/JNEUROSCI.5539-03.2004; Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; AlvarezLeefmans FJ, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P1; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beierlein M, 2004, J NEUROPHYSIOL, V92, P591, DOI 10.1152/jn.00057.2004; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; CHOI DW, 1987, J NEUROSCI, V7, P369; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Gagnon M, 2013, NAT MED, V19, P1524, DOI 10.1038/nm.3356; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kajta M, 2005, DEV BRAIN RES, V160, P40, DOI 10.1016/j.devbrainres.2005.08.002; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lee HJ, 2012, OTOL NEUROTOL, V33, P1664, DOI 10.1097/MAO.0b013e31826bf3d3; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; Miles R., 2012, JASPERS BASIC MECH E; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Rahmati N, 2013, PFLUG ARCH EUR J PHY, V465, P1583, DOI 10.1007/s00424-013-1300-6; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Rungta RL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.65; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SMITH RL, 1995, J NEUROSCI, V15, P4057; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stewart AK, 2011, AM J PHYSIOL-CELL PH, V301, pC289, DOI 10.1152/ajpcell.00089.2011; Svichar N, 2009, J NEUROSCI, V29, P3252, DOI 10.1523/JNEUROSCI.0036-09.2009; THOMPSON SM, 1988, J NEUROPHYSIOL, V60, P105, DOI 10.1152/jn.1988.60.1.105; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; VERKMAN AS, 1989, ANAL BIOCHEM, V178, P355, DOI 10.1016/0003-2697(89)90652-0; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Xu J, 2011, KIDNEY INT, V80, P926, DOI 10.1038/ki.2011.196; Zeuthen T, 2010, J MEMBRANE BIOL, V234, P57, DOI 10.1007/s00232-009-9216-y; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	49	129	129	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					610	621		10.1016/j.cell.2015.03.029	http://dx.doi.org/10.1016/j.cell.2015.03.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910210	Bronze, Green Submitted			2022-12-24	WOS:000353553600019
J	Jain, A; Marshall, J; Buikema, A; Bancroft, T; Kelly, JP; Newschaffer, CJ				Jain, Anjali; Marshall, Jaclyn; Buikema, Ami; Bancroft, Tim; Kelly, Jonathan P.; Newschaffer, Craig J.			Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPECTRUM DISORDERS; SAFETY CONCERNS; MEASLES; RECURRENCE; MUMPS; RISK	IMPORTANCE Despite research showing no link between the measles-mumps-rubella (MMR) vaccine and autism spectrum disorders (ASD), beliefs that the vaccine causes autism persist, leading to lower vaccination levels. Parents who already have a child with ASD may be especially wary of vaccinations. OBJECTIVE To report ASD occurrence by MMR vaccine status in a large sample of US children who have older siblings with and without ASD. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort study using an administrative claims database associated with a large commercial health plan. Participants included children continuously enrolled in the health plan from birth to at least 5 years of age during 2001-2012 who also had an older sibling continuously enrolled for at least 6 months between 1997 and 2012. EXPOSURES MMR vaccine receipt (0, 1, 2 doses) between birth and 5 years of age. MAIN OUTCOMES AND MEASURES ASD status defined as 2 claims with a diagnosis code in any position for autistic disorder or other specified pervasive developmental disorder (PDD) including Asperger syndrome, or unspecified PDD (International Classification of Diseases, Ninth Revision, Clinical Modification 299.0x, 299.8x, 299.9x). RESULTS Of 95 727 children with older siblings, 994 (1.04%) were diagnosed with ASD and 1929 (2.01%) had an older sibling with ASD. Of those with older siblings with ASD, 134 (6.9%) had ASD, vs 860 (0.9%) children with unaffected siblings (P < .001). MMR vaccination rates (>= 1 dose) were 84%(n = 78 564) at age 2 years and 92%(n = 86 063) at age 5 years for children with unaffected older siblings, vs 73%(n = 1409) at age 2 years and 86%(n = 1660) at age 5 years for children with affected siblings. MMR vaccine receipt was not associated with an increased risk of ASD at any age. For children with older siblings with ASD, at age 2, the adjusted relative risk (RR) of ASD for 1 dose of MMR vaccine vs no vaccine was 0.76 (95% CI, 0.49-1.18; P = .22), and at age 5, the RR of ASD for 2 doses compared with no vaccine was 0.56 (95% CI, 0.31-1.01; P = .052). For children whose older siblings did not have ASD, at age 2, the adjusted RR of ASD for 1 dose was 0.91 (95% CI, 0.67-1.20; P = .50) and at age 5, the RR of ASD for 2 doses was 1.12 (95% CI, 0.78-1.59; P = .55). CONCLUSIONS AND RELEVANCE In this large sample of privately insured children with older siblings, receipt of the MMR vaccine was not associated with increased risk of ASD, regardless of whether older siblings had ASD. These findings indicate no harmful association between MMR vaccine receipt and ASD even among children already at higher risk for ASD.	[Jain, Anjali; Marshall, Jaclyn; Kelly, Jonathan P.] Lewin Grp, Falls Church, VA 22042 USA; [Buikema, Ami; Bancroft, Tim] Optum, Eden Prairie, MN USA; [Newschaffer, Craig J.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA	Optum; Drexel University	Jain, A (corresponding author), Lewin Grp, 3130 Fairview Pk Dr,Ste SOO, Falls Church, VA 22042 USA.	anjali.jain@lewin.com		Buikema, Ami/0000-0002-2481-4872	National Institute of Mental Health, National Institutes of Health; US Department of Health and Human Services [HHSN-271-2010-00033-C]	National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US Department of Health and Human Services	This project was funded by the National Institute of Mental Health, National Institutes of Health, and the US Department of Health and Human Services under contract HHSN-271-2010-00033-C.	Abu Kuwaik G, 2014, AUTISM, V18, P148, DOI 10.1177/1362361312459111; Burke JP, 2014, AUTISM, V18, P321, DOI 10.1177/1362361312467709; Centers for Disease Control and Prevention, 2011, EPIDEMIOLOGY PREVENT, V60, P40; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; DeFrank Jessica T, 2007, Prev Chronic Dis, V4, pA60; Demicheli V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub3; Doja A, 2006, CAN J NEUROL SCI, V33, P341, DOI 10.1017/S031716710000528X; Feudtner C, 2000, PEDIATRICS, V106, P205; Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962; Gastanaduy PA, 2014, MMWR-MORBID MORTAL W, V63, P496; Gronborg TK, 2013, JAMA PEDIATR, V167, P947, DOI 10.1001/jamapediatrics.2013.2259; Gust DA, 2004, PEDIATRICS, V114, pE16, DOI 10.1542/peds.114.1.e16; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Harrington JW, 2006, J DEV BEHAV PEDIATR, V27, pS156, DOI 10.1097/00004703-200604002-00014; Lash TL, 2009, APPL QUANTITATIVE BI; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Mandell DS, 2009, AM J PUBLIC HEALTH, V99, P493, DOI 10.2105/AJPH.2007.131243; Mercer L, 2006, J Genet Couns, V15, P41, DOI 10.1007/s10897-005-9002-7; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Rosenberg RE, 2013, CLIN PEDIATR, V52, P871, DOI 10.1177/0009922812438435; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; The Lewin Group, 2012, STUD HLTH OUTC CHILD; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; US Census Bureau, 2015, STAT COUNT QUICKF DA; Wingate M, 2014, MMWR SURVEILL SUMM, V63	27	101	106	1	250	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1534	1540		10.1001/jama.2015.3077	http://dx.doi.org/10.1001/jama.2015.3077			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3SA	25898051				2022-12-24	WOS:000353198700018
J	Moin, T; Li, JN; Duru, OK; Ettner, S; Turk, N; Keckhafer, A; Ho, S; Mangione, CM				Moin, Tannaz; Li, Jinnan; Duru, O. Kenrik; Ettner, Susan; Turk, Norman; Keckhafer, Abigail; Ho, Sam; Mangione, Carol M.			Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012 A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-STYLE INTERVENTIONS; IMPAIRED GLUCOSE-TOLERANCE; DIABETES PREVENTION; FOLLOW-UP; REDUCTION; INDUCTION; OVULATION	Background: Prediabetes affects 1 in 3 Americans. Both intensive lifestyle intervention and metformin can prevent or delay progression to diabetes. Over the past decade, lifestyle interventions have been translated across various settings, but little is known about the translation of evidence surrounding metformin use. Objective: To examine metformin prescription for diabetes prevention and patient characteristics that may affect metformin prescription. Design: Retrospective cohort analysis over a 3-year period. Setting: Employer groups that purchased health plans from the nation's largest private insurer. Participants: A national sample of 17 352 working-age adults with prediabetes insured for 3 continuous years between 2010 and 2012. Measurements: Percentage of health plan enrollees with prediabetes who were prescribed metformin. Results: Only 3.7% of patients with prediabetes were prescribed metformin over the 3-year study window. After adjust-ment for age, income, and education, the predicted probability of metformin prescription was almost 2 times higher among women and obese patients and more than 1.5 times higher among patients with 2 or more comorbid conditions. Limitation: Missing data on lifestyle interventions, possible misclassification of prediabetes and metformin use, and inability to define eligible patients exactly as defined in the American Diabetes Association guidelines. Conclusion: Evidence shows that metformin is rarely prescribed for diabetes prevention in working-age adults. Future studies are needed to understand potential barriers to wider adoption of this safe, tolerable, evidence-based, and cost-effective prediabetes therapy.	Vet Affairs Hlth Serv Res & Dev Serv, Vet Affairs Greater Angeles Hlth Syst, Washington, DC USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; UnitedHealthcare, Minneapolis, MN USA	University of California System; University of California Los Angeles	Moin, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, 911 Broxton Ave, Los Angeles, CA 90024 USA.	tmoin@mednet.ucla.edu			Centers for Disease Control and Prevention (Division of Diabetes Translation); National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (Division of Diabetes Translation)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Centers for Disease Control and Prevention (Division of Diabetes Translation) and the National Institute of Diabetes and Digestive and Kidney Diseases.	Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Baran S, 2010, ARCH GYNECOL OBSTET, V282, P439, DOI 10.1007/s00404-010-1497-y; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Cardona-Morrell M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-653; Centers for Disease Control and Prevention, 2014, PRED COULD IT BE YOU; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Crandall J, 2006, J GERONTOL A-BIOL, V61, P1075; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Duru OK, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120150; Fradkin JE, 2012, NEW ENGL J MED, V367, P1177, DOI 10.1056/NEJMp1208169; Heilbrunn E, 2013, TOP HLTH INSURANCE C; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Kahn R, 2014, DIABETES CARE, V37, P943, DOI 10.2337/dc13-1954; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Mathur R, 2008, AM J OBSTET GYNECOL, V199, P596, DOI 10.1016/j.ajog.2008.09.010; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Schmittdiel JA, 2014, DIABETES CARE, V37, P565, DOI 10.2337/dc13-1223; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Xiao JS, 2012, GYNECOL ENDOCRINOL, V28, P956, DOI 10.3109/09513590.2012.705368	30	61	61	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					542	+		10.7326/M14-1773	http://dx.doi.org/10.7326/M14-1773			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25894024	Green Published, Green Accepted			2022-12-24	WOS:000353244300014
J	Ryu, JK; Min, D; Rah, SH; Kim, SJ; Park, Y; Kim, H; Hyeon, C; Kim, HM; Jahn, R; Yoon, TY				Ryu, Je-Kyung; Min, Duyoung; Rah, Sang-Hyun; Kim, Soo Jin; Park, Yongsoo; Kim, Haesoo; Hyeon, Changbong; Kim, Ho Min; Jahn, Reinhard; Yoon, Tae-Young			Spring-loaded unraveling of a single SNARE complex by NSF in one round of ATP turnover	SCIENCE			English	Article							CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ALPHA-SNAP; PROTEIN; DOMAIN; TRANSPORT; VANADATE	During intracellular membrane trafficking, N-ethylmaleimide-sensitive factor (NSF) and alpha-soluble NSF attachment protein (alpha-SNAP) disassemble the soluble NSF attachment protein receptor (SNARE) complex for recycling of the SNARE proteins. The molecular mechanism by which NSF disassembles the SNARE complex is largely unknown. Using single-molecule fluorescence spectroscopy and magnetic tweezers, we found that NSF disassembled a single SNARE complex in only one round of adenosine triphosphate (ATP) turnover. Upon ATP cleavage, the NSF hexamer developed internal tension with dissociation of phosphate ions. After latent time measuring tens of seconds, NSF released the built-up tension in a burst within 20 milliseconds, resulting in disassembly followed by immediate release of the SNARE proteins. Thus, NSF appears to use a "spring-loaded" mechanism to couple ATP hydrolysis and unfolding of substrate proteins.	[Ryu, Je-Kyung; Min, Duyoung; Rah, Sang-Hyun; Yoon, Tae-Young] Korea Adv Inst Sci & Technol KAIST, Natl Creat Res Initiat Ctr Single Mol Syst Biol, Taejon 305701, South Korea; [Ryu, Je-Kyung; Min, Duyoung; Rah, Sang-Hyun; Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Kim, Soo Jin; Kim, Haesoo; Kim, Ho Min] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Park, Yongsoo; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Hyeon, Changbong] Korea Inst Adv Study, Seoul 130722, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Max Planck Society; Korea Institute for Advanced Study (KIAS)	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de; tyyoon@kaist.ac.kr	Park, Yongsoo/G-9285-2014; Yoon, Tae-Young/C-1687-2011; Kim, Ho Min/G-2712-2011; Hyeon, Changbong/AAU-7862-2021; Min, Duyoung/AAA-5205-2019; Hyeon, Changbong/H-3295-2011	Park, Yongsoo/0000-0001-8336-8051; Yoon, Tae-Young/0000-0002-5184-7725; Min, Duyoung/0000-0002-2856-8082; Hyeon, Changbong/0000-0002-4844-7237; Jahn, Reinhard/0000-0003-1542-3498; Ryu, Je-Kyung/0000-0002-0545-9502; Rah, Sang-Hyun/0000-0002-9480-7731	National Creative Research Initiative Program (Center for Single-Molecule Systems Biology); National Research Foundation of Korea (NRF) - Korean government [NRF-2012R1A1A1010456]; National Institutes of Health [3P01GM072694-05S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Creative Research Initiative Program (Center for Single-Molecule Systems Biology); National Research Foundation of Korea (NRF) - Korean government; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jo and B. Choi for help with preparing illustrations and S. E. Lee for help with single-molecule analysis. This work was supported by the National Creative Research Initiative Program (Center for Single-Molecule Systems Biology to T.-Y.Y.) and a grant (NRF-2012R1A1A1010456 to H.M.K.) through the National Research Foundation of Korea (NRF) funded by the Korean government. Funding was also generously provided by the National Institutes of Health (3P01GM072694-05S1 to R.J.).	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; De Vlaminck I, 2012, ANNU REV BIOPHYS, V41, P453, DOI 10.1146/annurev-biophys-122311-100544; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Park Y, 2014, J BIOL CHEM, V289, P16326, DOI 10.1074/jbc.M114.556803; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; SHIMIZU T, 1983, J BIOL CHEM, V258, P3833; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	31	59	60	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1485	1489		10.1126/science.aaa5267	http://dx.doi.org/10.1126/science.aaa5267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814585	Green Accepted			2022-12-24	WOS:000352136400043
J	Brenner, MP; Sorensen, PM				Brenner, Michael P.; Soerensen, Pia M.			Biophysics of Molecular Gastronomy	CELL			English	Editorial Material								Chefs and scientists exploring biophysical processes have given rise to molecular gastronomy. In this Commentary, we describe how a scientific understanding of recipes and techniques facilitates the development of new textures and expands the flavor palette. The new dishes that result engage our senses in unexpected ways.	[Brenner, Michael P.; Soerensen, Pia M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University	Brenner, MP (corresponding author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St, Cambridge, MA 02138 USA.	brenner@seas.harvard.edu		Sorensen, Pia M./0000-0001-7433-0844				Blumenthal H., 2009, FAT DUCK COOKBOOK; Maxime B., 2011, MODERNIST CUISINE AR; MCGEE H, 1984, FOOD COOKING SCI LOR	3	8	8	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					5	8		10.1016/j.cell.2015.03.002	http://dx.doi.org/10.1016/j.cell.2015.03.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815978	Bronze			2022-12-24	WOS:000351952200001
J	Mateja, A; Paduch, M; Chang, HY; Szydlowska, A; Kossiakoff, AA; Hegde, RS; Keenan, RJ				Mateja, Agnieszka; Paduch, Marcin; Chang, Hsin-Yang; Szydlowska, Anna; Kossiakoff, Anthony A.; Hegde, Ramanujan S.; Keenan, Robert J.			Structure of the Get3 targeting factor in complex with its membrane protein cargo	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; TAIL-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; ER MEMBRANE; INSERTION; MECHANISM; BINDING; CHAPERONE	Tail-anchored (TA) proteins are a physiologically important class of membrane proteins targeted to the endoplasmic reticulum by the conserved guided-entry of TA proteins (GET) pathway. During transit, their hydrophobic transmembrane domains (TMDs) are chaperoned by the cytosolic targeting factor Get3, but the molecular nature of the functional Get3-TA protein targeting complex remains unknown. We reconstituted the physiologic assembly pathway for a functional targeting complex and showed that it comprises a TA protein bound to a Get3 homodimer. Crystal structures of Get3 bound to different TA proteins showed an alpha-helical TMD occupying a hydrophobic groove that spans the Get3 homodimer. Our data elucidate the mechanism of TA protein recognition and shielding by Get3 and suggest general principles of hydrophobic domain chaperoning by cellular targeting factors.	[Mateja, Agnieszka; Paduch, Marcin; Chang, Hsin-Yang; Szydlowska, Anna; Kossiakoff, Anthony A.; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Hegde, Ramanujan S.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	University of Chicago; MRC Laboratory Molecular Biology	Hegde, RS (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk; bkeenan@uchicago.edu		Hegde, Ramanujan/0000-0001-8338-852X; Keenan, Robert/0000-0003-1466-0889	NIH [P41 GM103403, U01 GM094588, U54 GM087519, R01 GM086487]; U.S. Department of Energy [DE-AC02-06CH11357]; UK Medical Research Council [MC_UP_A022_1007]; Searle Funds at The Chicago Community trust for the Chicago Biomedical Consortium; MRC [MC_UP_A022_1007] Funding Source: UKRI; Medical Research Council [MC_UP_A022_1007] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086487, P41GM103403, U01GM094588, U54GM087519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Searle Funds at The Chicago Community trust for the Chicago Biomedical Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Shao tor help with assay development; S. Koide for the phage library; S. Sidhu for the sAB expression vector; M. Kivlen for plasmids; F. Bezanilla, E. Perozo and J. Piccirilli for instrumentation; members of the Keenan, Hegde, and Kossiakoff labs tor support; and the NE CAT (24-ID-C) beamline staff at Advanced Photon Source for technical assistance. NE-CAT is supported by NIH grant P41 GM103403 and U.S. Department of Energy contract DE-AC02-06CH11357. Additional support was from the UK Medical Research Council (MC_UP_A022_1007 to R.S.H.), the NIH (U01 GM094588 and U54 GM087519 to A.A.K.: R01 GM086487 to R.J.K.), and the Searle Funds at The Chicago Community trust for the Chicago Biomedical Consortium (to A.A.K. and R.J.K.). The Protein Data Bank (PDB) accession codes are 4XTR (Pep12), 4XVU (Nyv1), and 4XWO (Sec22).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Denic V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013334; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Gristick HB, 2014, NAT STRUCT MOL BIOL, V21, P437, DOI 10.1038/nsmb.2813; Hainzl T, 2011, NAT STRUCT MOL BIOL, V18, P389, DOI 10.1038/nsmb.1994; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Rome ME, 2014, P NATL ACAD SCI USA, V111, pE4929, DOI 10.1073/pnas.1411284111; Rome ME, 2013, P NATL ACAD SCI USA, V110, P7666, DOI 10.1073/pnas.1222054110; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Voth W, 2014, MOL CELL, V56, P116, DOI 10.1016/j.molcel.2014.08.017; Wang F, 2014, NATURE, V512, P441, DOI 10.1038/nature13471; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	29	76	76	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1152	1155		10.1126/science.1261671	http://dx.doi.org/10.1126/science.1261671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745174	Green Accepted			2022-12-24	WOS:000350354200057
J	Ashley, EA				Ashley, Euan A.			The Precision Medicine Initiative A New National Effort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ashley, Euan A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ashley, Euan A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Ashley, EA (corresponding author), Stanford Univ, Falk CVRB, Dept Med, 870 Quarry Rd, Stanford, CA 94305 USA.	euan@stanford.edu						Altman RB, 2007, NAT GENET, V39, P426, DOI 10.1038/ng0407-426; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Basile Jan, 2009, Ther Adv Cardiovasc Dis, V3, P157, DOI 10.1177/1753944708101552; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Nherera L, 2011, HEART, V97, P1175, DOI 10.1136/hrt.2010.213975; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ross JS, 2015, JAMA ONCOL, V1, P40, DOI 10.1001/jamaoncol.2014.216	8	323	345	2	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2119	2120		10.1001/jama.2015.3595	http://dx.doi.org/10.1001/jama.2015.3595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	25928209				2022-12-24	WOS:000355430900006
J	Xu, GT; Chapman, JR; Brandsma, I; Yuan, JS; Mistrik, M; Bouwman, P; Bartkova, J; Gogola, E; Warmerdam, D; Barazas, M; Jaspers, JE; Watanabe, K; Pieterse, M; Kersbergen, A; Sol, W; Celie, PHN; Schouten, PC; van den Broek, B; Salman, A; Nieuwland, M; de Rink, I; de Ronde, J; Jalink, K; Boulton, SJ; Chen, JJ; van Gent, DC; Bartek, J; Jonkers, J; Borst, P; Rottenberg, S				Xu, Guotai; Chapman, J. Ross; Brandsma, Inger; Yuan, Jingsong; Mistrik, Martin; Bouwman, Peter; Bartkova, Jirina; Gogola, Ewa; Warmerdam, Daniel; Barazas, Marco; Jaspers, Janneke E.; Watanabe, Kenji; Pieterse, Mark; Kersbergen, Ariena; Sol, Wendy; Celie, Patrick H. N.; Schouten, Philip C.; van den Broek, Bram; Salman, Ahmed; Nieuwland, Marja; de Rink, Iris; de Ronde, Jorma; Jalink, Kees; Boulton, Simon J.; Chen, Junjie; van Gent, Dik C.; Bartek, Jiri; Jonkers, Jos; Borst, Piet; Rottenberg, Sven			REV7 counteracts DNA double-strand break resection and affects PARP inhibition	NATURE			English	Article							CLASS SWITCH RECOMBINATION; POLYMERASE-ZETA; POL-ZETA; REPAIR; 53BP1; DAMAGE; CELLS; RESISTANCE; COMPLEX	Error-free repair of DNA double-strand breaks (DSBs) is achieved by homologous recombination (HR), and BRCA1 is an important factor for this repair pathway(1). In the absence of BRCA1-mediated HR, the administration of PARP inhibitors induces synthetic lethality of tumour cells of patients with breast or ovarian cancers(2,3). Despite the benefit of this tailored therapy, drug resistance can occur by HR restoration(4). Genetic reversion of BRCA1-inactivating mutations can be the underlying mechanism of drug resistance, but this does not explain resistance in all cases(5). In particular, little is known about BRCA1-independent restoration of HR. Here we show that loss of REV7 (also known as MAD2L2) in mouse and human cell lines re-establishes CTIP-dependent endresection of DSBs in BRCA1 deficient cells, leading to HR restoration and PARP inhibitor resistance, which is reversed by ATM kinase inhibition. REV7 is recruited to DSBs in a manner dependent on the H2AX-MDC1-RNF8-RNF168-53BP1 chromatin pathway, and seems to block HR and promote end joining in addition to its regulatory role in DNA damage tolerance(6). Finally, we establish that REV7 blocks DSB resection to promote non-homologous end-joining during immunoglobulin class switch recombination. Our results reveal an unexpected crucial function of REV7 downstream of 53BP1 in coordinating pathological DSB repair pathway choices in BRCA1-deficient cells.	[Xu, Guotai; Gogola, Ewa; Barazas, Marco; Jaspers, Janneke E.; Kersbergen, Ariena; Sol, Wendy; Borst, Piet; Rottenberg, Sven] Netherlands Canc Inst, Div Mol Oncol, NL-1066 CX Amsterdam, Netherlands; [Chapman, J. Ross; Salman, Ahmed] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Brandsma, Inger; van Gent, Dik C.] Erasmus, Univ Med Ctr, Dept Genet, NL-3000 CA Rotterdam, Netherlands; [Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Mistrik, Martin; Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77900, Czech Republic; [Bouwman, Peter; Pieterse, Mark; Schouten, Philip C.; Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands; [Bartkova, Jirina; Watanabe, Kenji; Bartek, Jiri] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Warmerdam, Daniel; van den Broek, Bram; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Celie, Patrick H. N.] Netherlands Canc Inst, Prot Facil, NL-1066 CX Amsterdam, Netherlands; [Nieuwland, Marja; de Rink, Iris] Netherlands Canc Inst, Deep Sequencing Core Facil, NL-1066 CX Amsterdam, Netherlands; [de Ronde, Jorma] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, South Mimms EN6 3LD, Herts, England; [Rottenberg, Sven] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, CH-3012 Bern, Switzerland	Netherlands Cancer Institute; University of Oxford; Wellcome Centre for Human Genetics; Erasmus University Rotterdam; University of Texas System; UTMD Anderson Cancer Center; Palacky University Olomouc; Netherlands Cancer Institute; Danish Cancer Society; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Cancer Research UK; University of Bern	Rottenberg, S (corresponding author), Netherlands Canc Inst, Div Mol Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sven.rottenberg@vetsuisse.unibe.ch	Bouwman, Peter/AAO-7813-2021; Jonkers, Jos/AAG-3246-2019; Chapman, Ross/GYD-7815-2022; Celie, Patrick/AAY-9559-2021	Bouwman, Peter/0000-0002-9252-5896; Jonkers, Jos/0000-0002-9264-9792; Chapman, Ross/0000-0002-6477-4254; van den Broek, Bram/0000-0003-1037-907X; Barazas, Marco/0000-0002-4497-6000; Warmerdam, Daniel/0000-0003-1606-7448; Xu, Guotai/0000-0001-5265-3407; /0000-0003-1850-1340; Gogola, Ewa/0000-0002-5733-770X; Salman, Ahmed/0000-0003-4300-2033; salman, ahmed/0000-0002-5634-2726; van Gent, Dik C./0000-0003-1473-8148; Jalink, Kees/0000-0001-7019-3440; Rottenberg, Sven/0000-0003-2044-9844; Mistrik, Martin/0000-0002-2321-0348	Netherlands Organization for Scientific Research (NWO-Toptalent); Netherlands Organization for Scientific Research (NWO-VIDI); Dutch Cancer Society; CTMM Breast Care; Swiss National Science Foundation; European Union (EU); Wellcome Trust; Danish Cancer Society; Danish Council for Independent Research; Lundbeck Foundation; Czech National Program of Sustainability; Cancer Research UK; ERC; Royal Society; Cancer Research UK [11581] Funding Source: researchfish; Medical Research Council [MR/M009971/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002290] Funding Source: researchfish; Wellcome Trust [104558/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10267, 10048] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; MRC [MR/M009971/1] Funding Source: UKRI	Netherlands Organization for Scientific Research (NWO-Toptalent)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); CTMM Breast Care; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union (EU)(CGIAREuropean Commission); Wellcome Trust(Wellcome Trust); Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Czech National Program of Sustainability; Cancer Research UK(Cancer Research UK); ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Gerritsen, P. Halonen, B. Morris, T. Halazonetis and O. Kallioniemi for advice on the DDR shRNA library, A. Gasparini and G. Borst for their assistance with the cone beam micro-irradiator, R. Kanaar for his RAD51 antibody, J. Jacobs for the pMSCV-GFP vector, and M. O'Connor for olaparib and AZD2461. This work was supported by the Netherlands Organization for Scientific Research (NWO-Toptalent to J.E.J. and NWO-VIDI to S.R.), the Dutch Cancer Society, CTMM Breast Care, the Swiss National Science Foundation, and the European Union (EU) FP6 Integrated Project CHEMORES and FP7 Project DDResponse. Work in J.R.C.'s group is funded by the Wellcome Trust. The work in the J.B.'s laboratories was funded by the Danish Cancer Society, the Danish Council for Independent Research, the Lundbeck Foundation and the Czech National Program of Sustainability. S.J.B. is funded by Cancer Research UK and an ERC Advanced Investigator Grant (RecMitMei) and is a Royal Society Wolfson Research Merit Award Holder.	Ang JE, 2013, CLIN CANCER RES, V19, P5485, DOI 10.1158/1078-0432.CCR-13-1262; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chun ACS, 2013, CELL CYCLE, V12, P365, DOI 10.4161/cc.23214; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Khalaj M, 2014, J BIOL CHEM, V289, P3811, DOI 10.1074/jbc.M113.514752; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; Lee JM, 2014, ANN ONCOL, V25, P32, DOI 10.1093/annonc/mdt384; Listovsky T, 2013, J CELL BIOL, V203, P87, DOI 10.1083/jcb.201302060; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schenten D, 2009, J EXP MED, V206, P477, DOI 10.1084/jem.20080669; Stap J, 2008, NAT METHODS, V5, P261, DOI [10.1038/nmeth.f.206, 10.1038/NMETH.f.206]; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	30	385	390	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					541	U308		10.1038/nature14328	http://dx.doi.org/10.1038/nature14328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25799992	Green Accepted			2022-12-24	WOS:000355286600048
J	Barry, C				Barry, Clifton			More than just bugs in spit	SCIENCE			English	Editorial Material							TREHALOSE ANALOGS; TUBERCULOSIS; MOXIFLOXACIN; LESIONS		[Barry, Clifton] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA; [Barry, Clifton] Univ Cape Town, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Barry, Clifton] Univ Stellenbosch, Dept Mol Biol & Human Genet, ZA-7600 Stellenbosch, South Africa	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; Stellenbosch University	Barry, C (corresponding author), NIAID, TB Res Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@niaid.nih.gov	Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000734] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AI001214-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; Chen RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009501; Coleman MT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009500; Dartois V, 2014, NAT REV MICROBIOL, V12, P159, DOI 10.1038/nrmicro3200; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Mahapatra S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-53; McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Urbanek BL, 2014, CHEMBIOCHEM, V15, P2066, DOI 10.1002/cbic.201402288; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960	12	2	2	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					633	634		10.1126/science.aaa2886	http://dx.doi.org/10.1126/science.aaa2886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25953992	Green Accepted			2022-12-24	WOS:000354045700026
J	Mina, MJ; Metcalf, CJE; de Swart, RL; Osterhaus, ADME; Grenfell, BT				Mina, Michael J.; Metcalf, C. Jessica E.; de Swart, Rik L.; Osterhaus, A. D. M. E.; Grenfell, Bryan T.			Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality	SCIENCE			English	Article							CELL-MEDIATED-IMMUNITY; GUINEA-BISSAU; RURAL BANGLADESH; EXCESS MORTALITY; T-CELLS; VACCINATION; VIRUS; MEMORY; COMMUNITY; REDUCTION	Immunosuppression after measles is known to predispose people to opportunistic infections for a period of several weeks to months. Using population-level data, we show that measles has a more prolonged effect on host resistance, extending over 2 to 3 years. We find that nonmeasles infectious disease mortality in high-income countries is tightly coupled to measles incidence at this lag, in both the pre- and post-vaccine eras. We conclude that long-term immunologic sequelae of measles drive interannual fluctuations in nonmeasles deaths. This is consistent with recent experimental work that attributes the immunosuppressive effects of measles to depletion of B and T lymphocytes. Our data provide an explanation for the long-term benefits of measles vaccination in preventing all-cause infectious disease. By preventing measles-associated immune memory loss, vaccination protects polymicrobial herd immunity.	[Mina, Michael J.; Metcalf, C. Jessica E.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Mina, Michael J.] Emory Univ, Sch Med, Med Scientist Training Program, Atlanta, GA USA; [Metcalf, C. Jessica E.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [de Swart, Rik L.; Osterhaus, A. D. M. E.] Erasmus Univ, Med Ctr, Dept Virosci, Rotterdam, Netherlands	Princeton University; Emory University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Erasmus University Rotterdam; Erasmus MC	Mina, MJ (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	michael.j.mina@gmail.com	de Swart, Rik L./E-6508-2011	de Swart, Rik L./0000-0003-3599-8969; Mina, Michael/0000-0002-0674-5762	Bill and Melinda Gates Foundation; Science and Technology Directorate of the Department of Homeland Security [HSHQDC-12-C-00058]; RAPIDD program of the Science and Technology Directorate of the Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Science and Technology Directorate of the Department of Homeland Security(United States Department of Homeland Security (DHS)); RAPIDD program of the Science and Technology Directorate of the Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for analyses regarding England and Wales were retrieved from the Office of Population Censuses and Surveys and the Office for National Statistics (www.ons.gov.uk). We thank P. Rohani for supplying us with historical data on pertussis, as originally described in (34). Data for U.S. analyses were retrieved from the U.S. Centers for Disease Control and Prevention, National Center for Health Statistics (www.cdc.gov/nchs). Data for Denmark was retrieved from Statistics Denmark (www.statbank.dk) and WHO (www.apps.who.int). This work is funded by the Bill and Melinda Gates Foundation, the Science and Technology Directorate of the Department of Homeland Security [contract HSHQDC-12-C-00058 (B.T.G. and C.J.E.M.)], and the RAPIDD program of the Science and Technology Directorate of the Department of Homeland Security and the Fogarty International Center, National Institutes of Health (C.J.E.M. and B.T.G).	AABY P, 1990, AM J EPIDEMIOL, V132, P211, DOI 10.1093/oxfordjournals.aje.a115650; Aaby P, 2003, INT J EPIDEMIOL, V32, P106, DOI 10.1093/ije/dyg005; Aaby P, 1996, AM J EPIDEMIOL, V143, P1035, DOI 10.1093/oxfordjournals.aje.a008667; Aaby P, 1996, PEDIATR INFECT DIS J, V15, P39, DOI 10.1097/00006454-199601000-00009; AABY P, 1984, J INFECTION, V8, P13, DOI 10.1016/S0163-4453(84)93192-X; Aaby P, 2014, NAT IMMUNOL, V15, P895, DOI 10.1038/ni.2961; CLARKSON JA, 1985, INT J EPIDEMIOL, V14, P153, DOI 10.1093/ije/14.1.153; CLEMENS JD, 1988, AM J EPIDEMIOL, V128, P1330, DOI 10.1093/oxfordjournals.aje.a115086; de Vries RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004482; de Vries RD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002885; DULOU AD, 1995, AM J EPIDEMIOL, V142, P643, DOI 10.1093/oxfordjournals.aje.a117688; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Flanagan KL, 2013, CLIN INFECT DIS, V57, P283, DOI 10.1093/cid/cit209; Hahm B, 2009, CURR TOP MICROBIOL, V330, P271; Hinman AR, 2004, J INFECT DIS, V189, pS17, DOI 10.1086/377694; HOLT EA, 1990, PEDIATRICS, V85, P188; HORWITZ O, 1974, AM J EPIDEMIOL, V100, P136, DOI 10.1093/oxfordjournals.aje.a112016; Kabir Z, 2003, B WORLD HEALTH ORGAN, V81, P244; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; Kim SK, 2004, J IMMUNOL, V172, P3139, DOI 10.4049/jimmunol.172.5.3139; Kim SK, 2002, J IMMUNOL, V169, P90, DOI 10.4049/jimmunol.169.1.90; Kipps A., 1996, S AFR MED J, V86, P104; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; KOENIG MA, 1990, B WORLD HEALTH ORGAN, V68, P441; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lin WHW, 2012, P NATL ACAD SCI USA, V109, P14989, DOI 10.1073/pnas.1211138109; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Peacock CD, 2003, J IMMUNOL, V171, P655, DOI 10.4049/jimmunol.171.2.655; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P103; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schneider-Schaulies S, 2009, CURR TOP MICROBIOL, V330, P243; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shaheen SO, 1996, BRIT MED J, V313, P969, DOI 10.1136/bmj.313.7063.969; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; WHO, 2011, GLOB REV DISTR PNEUM; WHO, 2014, STST REV NONSP EFF B	40	215	221	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					694	699		10.1126/science.aaa3662	http://dx.doi.org/10.1126/science.aaa3662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954009	Green Accepted			2022-12-24	WOS:000354045700046
J	Fu, Y; Luo, GZ; Chen, K; Deng, X; Yu, M; Han, DL; Hao, ZY; Liu, JZ; Lu, XY; Dore, LC; Weng, XC; Ji, QJ; Mets, L; He, C				Fu, Ye; Luo, Guan-Zheng; Chen, Kai; Deng, Xin; Yu, Miao; Han, Dali; Hao, Ziyang; Liu, Jianzhao; Lu, Xingyu; Dore, Louis C.; Weng, Xiaocheng; Ji, Quanjiang; Mets, Laurens; He, Chuan			N-6-Methyldeoxyadenosine Marks Active Transcription Start Sites in Chlamydomonas	CELL			English	Article							DNA METHYLATION; ADENINE METHYLATION; GENE-EXPRESSION; RNA; WIDE; RESTRICTION; METHYLOMES; REVEALS; PLANTS; ROLES	N-6-methyldeoxyadenosine (6mA or m(6)A) is a DNA modification preserved in prokaryotes to eukaryotes. It is widespread in bacteria and functions in DNA mismatch repair, chromosome segregation, and virulence regulation. In contrast, the distribution and function of 6mA in eukaryotes have been unclear. Here, we present a comprehensive analysis of the 6mA landscape in the genome of Chlamydomonas using new sequencing approaches. We identified the 6mA modification in 84% of genes in Chlamydomonas. We found that 6mA mainly locates at ApT dinucleotides around transcription start sites (TSS) with a bimodal distribution and appears to mark active genes. A periodic pattern of 6mA deposition was also observed at base resolution, which is associated with nucleosome distribution near the TSS, suggesting a possible role in nucleosome positioning. The new genome-wide mapping of 6mA and its unique distribution in the Chlamydomonas genome suggest potential regulatory roles of 6mA in gene expression in eukaryotic organisms.	[Fu, Ye; Luo, Guan-Zheng; Chen, Kai; Deng, Xin; Yu, Miao; Han, Dali; Hao, Ziyang; Liu, Jianzhao; Lu, Xingyu; Dore, Louis C.; Weng, Xiaocheng; Ji, Quanjiang; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Fu, Ye; Luo, Guan-Zheng; Chen, Kai; Deng, Xin; Yu, Miao; Han, Dali; Hao, Ziyang; Liu, Jianzhao; Lu, Xingyu; Dore, Louis C.; Weng, Xiaocheng; Ji, Quanjiang; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Fu, Ye; Luo, Guan-Zheng; Chen, Kai; Deng, Xin; Yu, Miao; Han, Dali; Hao, Ziyang; Liu, Jianzhao; Lu, Xingyu; Dore, Louis C.; Weng, Xiaocheng; Ji, Quanjiang; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Mets, Laurens] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Dore, Louis/A-5689-2009; Han, Dali/I-4145-2016; Ji, Quanjiang/AAZ-9793-2020; Liu, Jianzhao/AAO-2359-2020; Liu, Jianzhao/E-9165-2011; Ji, Quanjiang/AAP-9111-2020	Dore, Louis/0000-0002-7837-5887; Ji, Quanjiang/0000-0002-2321-8462; Liu, Jianzhao/0000-0001-9465-6075; Liu, Jianzhao/0000-0001-9465-6075; Ji, Quanjiang/0000-0002-2321-8462; Fu, Ye/0000-0003-4434-6014; Fu, Ye/0000-0002-3807-9717	National Institutes of Health [R01 HG006827]; National Science Foundation [CHE-1048528]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Dr. Q. Jin for help with HPLC-QQQ-MS/MS and Dr. Pieter W. Faber for help with high-throughput sequencing. This work is partially supported by National Institutes of Health (R01 HG006827 to C.H.), and C.H. is a Howard Hughes Medical Institute investigator. The Mass Spectrometry Facility of the University of Chicago is funded by National Science Foundation (CHE-1048528). S.F. Reichard, MA edited the manuscript.	Babinger P, 2001, NUCLEIC ACIDS RES, V29, P1261, DOI 10.1093/nar/29.6.1261; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bisova K, 2005, PLANT PHYSIOL, V137, P475, DOI 10.1104/pp.104.054155; Cerutti H, 1997, PLANT CELL, V9, P925, DOI 10.1105/tpc.9.6.925; Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; CUMMINGS DJ, 1974, BIOCHIM BIOPHYS ACTA, V374, P1, DOI 10.1016/0005-2787(74)90194-4; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Ehrlich M., 1990, J CHROMATOGRAPHY LIB, pB327; Eichler-Stahlberg A, 2009, PLANTA, V229, P873, DOI 10.1007/s00425-008-0879-x; ENGEL JD, 1978, J BIOL CHEM, V253, P927; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; HATTMAN S, 1978, J BACTERIOL, V135, P1156, DOI 10.1128/JB.135.3.1156-1157.1978; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MESSER W, 1988, CELL, V54, P735, DOI 10.1016/S0092-8674(88)90911-7; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; RAE PMM, 1978, P NATL ACAD SCI USA, V75, P4992, DOI 10.1073/pnas.75.10.4992; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Rhee H. S., 2012, CURR PROTOC MOL BIOL; ROGERS JC, 1995, PLANT J, V7, P221, DOI 10.1046/j.1365-313X.1995.7020221.x; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; STERNBERG N, 1985, J BACTERIOL, V164, P490, DOI 10.1128/JB.164.1.490-493.1985; VOVIS GF, 1977, J MOL BIOL, V115, P525, DOI 10.1016/0022-2836(77)90169-3; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZHANG YP, 1992, NUCLEIC ACIDS RES, V20, P5351, DOI 10.1093/nar/20.20.5351	39	310	325	7	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					879	892		10.1016/j.cell.2015.04.010	http://dx.doi.org/10.1016/j.cell.2015.04.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25936837	Bronze, Green Accepted			2022-12-24	WOS:000354175200020
J	Namburi, P; Beyeler, A; Yorozu, S; Calhoon, GG; Halbert, SA; Wichmann, R; Holden, SS; Mertens, KL; Anahtar, M; Felix-Ortiz, AC; Wickersham, IR; Gray, JM; Tye, KM				Namburi, Praneeth; Beyeler, Anna; Yorozu, Suzuko; Calhoon, Gwendolyn G.; Halbert, Sarah A.; Wichmann, Romy; Holden, Stephanie S.; Mertens, Kim L.; Anahtar, Melodi; Felix-Ortiz, Ada C.; Wickersham, Ian R.; Gray, Jesse M.; Tye, Kay M.			A circuit mechanism for differentiating positive and negative associations	NATURE			English	Article							BASOLATERAL AMYGDALA; CONDITIONED FEAR; REWARD-SEEKING; NEURONS; MEMORY; NUCLEUS; MICROCIRCUIT; POTENTIATION; EXPRESSION; PLASTICITY	The ability to differentiate stimuli predicting positive or negative outcomes is critical for survival, and perturbations of emotional processing underlie many psychiatric disease states. Synaptic plasticity in the basolateral amygdala complex (BLA) mediates the acquisition of associative memories, both positive(1'2) and negative'. Different populations of BLA neurons may encode fearful or rewarding associations'', but the identifying features of these populations and the synaptic mechanisms of differentiating positive and negative emotional valence have remained unknown. Here we show that BLA neurons projecting to the nucleus accumbens (NAc projectors) or the centromedial amygdala (CeM projectors) undergo opposing synaptic changes following fear or reward conditioning. We find that photostimulation of NAc projectors supports positive reinforcement while photostimulation of CeM projectors mediates negative reinforcement. Photoinhibition of CeM projectors impairs fear conditioning and enhances reward conditioning. We characterize these functionally distinct neuronal populations by comparing their electrophysiological, morphological and genetic features. Overall, we provide a mechanistic explanation for the representation of positive and negative associations within the amygdala.	[Namburi, Praneeth; Beyeler, Anna; Calhoon, Gwendolyn G.; Halbert, Sarah A.; Wichmann, Romy; Holden, Stephanie S.; Mertens, Kim L.; Anahtar, Melodi; Felix-Ortiz, Ada C.; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Namburi, Praneeth; Felix-Ortiz, Ada C.] MIT, Neurosci Grad Program, Cambridge, MA 02139 USA; [Yorozu, Suzuko; Gray, Jesse M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Halbert, Sarah A.] Wellesley Coll, Undergrad Program Neurosci, Wellesley, MA 02481 USA; [Holden, Stephanie S.; Anahtar, Melodi] MIT, Undergrad Program Neurosci, Cambridge, MA 02139 USA; [Mertens, Kim L.] Univ Amsterdam, Masters Program Biomed Sci, NL-1098 XH Amsterdam, Netherlands; [Wickersham, Ian R.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Wellesley College; Massachusetts Institute of Technology (MIT); University of Amsterdam; Massachusetts Institute of Technology (MIT)	Tye, KM (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	kaytye@mit.edu	Core, Vector/CAF-4832-2022; Beyeler, Anna/V-9934-2019	/0000-0003-2371-5706	NIMH [R01-MH102441-01, R01-MH101528-01]; NIDDK [DP2-DK-102256-01]; JPB Foundation (PIIF); JPB Foundation (PNDRF); NARSAD Foundation; Klingenstein Foundation; Whitehall Foundation; Sloan Foundation; Singleton fellowship; Leventhal fellowship; Whitaker fellowship; Swiss National Science Foundation; Simons Center for the Social Brain; Netherlands Organization for Scientific Research (NWO) RUBICON fellowship program; McGovern Institute for Brain Research; Picower Institute for Learning and Memory; MIT Department of Brain and Cognitive Sciences; BRAIN Initiative award from NIMH [U01-MH106018, U01-N5090473]; BRAIN Initiative award from NINDS [U01-MH106018, U01-N5090473]; NSF [IOS-1451202]; BRAIN Initiative award from NEI [U01-MH106018, U01-N5090473]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH104785, R01MH101528, R01MH102441, U01MH106018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090473] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JPB Foundation (PIIF); JPB Foundation (PNDRF); NARSAD Foundation(NARSAD); Klingenstein Foundation(Klingenstein Philanthropies); Whitehall Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Singleton fellowship; Leventhal fellowship; Whitaker fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Simons Center for the Social Brain; Netherlands Organization for Scientific Research (NWO) RUBICON fellowship program(Netherlands Organization for Scientific Research (NWO)); McGovern Institute for Brain Research; Picower Institute for Learning and Memory; MIT Department of Brain and Cognitive Sciences; BRAIN Initiative award from NIMH; BRAIN Initiative award from NINDS; NSF(National Science Foundation (NSF)); BRAIN Initiative award from NEI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Wildes, G. Glober, R. Luck and G. F. Conyers for technical assistance. We thank the entire Tye laboratory, B. Okaty, U. Eser, J. di lulio and A. Pfenning for helpful discussion. We thank E. J. Kremer for providing the CAV2-Cre virus, R. Neve for the HSV virus carrying Cre recombinase and mCherry, and the UNC vector core for the AAV viruses carrying double floxed constructs. K.M.T. is a New York Stem Cell Foundation Robertson Investigator and holds a Whitehead Career Development Chair. This work was supported by funds from NIMH (R01-MH102441-01), NIDDK (DP2-DK-102256-01), the JPB Foundation (PIIF and PNDRF), NARSAD, Klingenstein, Whitehall and Sloan Foundations (K.M.T.). Additionally, S.Y. and J.G. were supported by NIMH (R01-MH101528-01), P.N. was supported by Singleton, Leventhal and Whitaker fellowships, and A.B. was supported by a fellowship from the Swiss National Science Foundation. R.W. was supported by post-doctoral fellowships from the Simons Center for the Social Brain and the Netherlands Organization for Scientific Research (NWO) RUBICON fellowship program. I.R.W. was supported by seed grants from the McGovern Institute for Brain Research, the Picower Institute for Learning and Memory, the MIT Department of Brain and Cognitive Sciences, and the Simons Center for the Social Brain, as well as by BRAIN Initiative awards from NIMH, NEI, and NINDS (U01-MH106018 and U01-N5090473) and NSF (IOS-1451202).	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fontanini A, 2009, J NEUROSCI, V29, P2486, DOI 10.1523/JNEUROSCI.3898-08.2009; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jimenez SA, 2009, LEARN MEMORY, V16, P766, DOI 10.1101/lm.1607109; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Novak P, 2006, ANN BIOMED ENG, V34, P1201, DOI 10.1007/s10439-006-9140-6; PARE D, 1995, NEUROSCIENCE, V69, P567, DOI 10.1016/0306-4522(95)00272-K; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pitkanen A., 2000, AMYGDALA FUNCTIONAL; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; SHOLL DA, 1953, J ANAT, V87, P387; Soudais C, 2001, MOL THER, V3, P631, DOI 10.1006/mthe.2001.0263; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248	37	319	322	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					675	U208		10.1038/nature14366	http://dx.doi.org/10.1038/nature14366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25925480	Green Accepted, Green Submitted			2022-12-24	WOS:000353689700049
J	Guidotti, LG; Inverso, D; Sironi, L; Di Lucia, P; Fioravanti, J; Ganzer, L; Fiocchi, A; Vacca, M; Aiolfi, R; Sammicheli, S; Mainetti, M; Cataudella, T; Raimondi, A; Gonzalez-Aseguinolaza, G; Protzer, U; Ruggeri, ZM; Chisari, FV; Isogawa, M; Sitia, G; Iannacone, M				Guidotti, Luca G.; Inverso, Donato; Sironi, Laura; Di Lucia, Pietro; Fioravanti, Jessica; Ganzer, Lucia; Fiocchi, Amleto; Vacca, Maurizio; Aiolfi, Roberto; Sammicheli, Stefano; Mainetti, Marta; Cataudella, Tiziana; Raimondi, Andrea; Gonzalez-Aseguinolaza, Gloria; Protzer, Ulrike; Ruggeri, Zaverio M.; Chisari, Francis V.; Isogawa, Masanori; Sitia, Giovanni; Iannacone, Matteo			Immunosurveillance of the Liver by Intravascular Effector CD8(+) T Cells	CELL			English	Article							VIRUS; PLATELETS; MIGRATION; HYALURONAN; GENERATION; CLEARANCE; NETWORKS; DYNAMICS; ENTRY; CD44	Effector CD8(+) T cells (CD8 T-E) play a key role during hepatotropic viral infections. Here, we used advanced imaging in mouse models of hepatitis B virus (HBV) pathogenesis to understand the mechanisms whereby these cells home to the liver, recognize antigens, and deploy effector functions. We show that circulating CD8 T-E arrest within liver sinusoids by docking onto platelets previously adhered to sinusoidal hyaluronan via CD44. After the initial arrest, CD8 T-E actively crawl along liver sinusoids and probe sub-sinusoidal hepatocytes for the presence of antigens by extending cytoplasmic protrusions through endothelial fenestrae. Hepatocellular antigen recognition triggers effector functions in a diapedesis-independent manner and is inhibited by the processes of sinusoidal defenestration and capillarization that characterize liver fibrosis. These findings reveal the dynamic behavior whereby CD8 T-E control hepatotropic pathogens and suggest how liver fibrosis might reduce CD8 T-E immune surveillance toward infected or transformed hepatocytes.	[Guidotti, Luca G.; Inverso, Donato; Sironi, Laura; Di Lucia, Pietro; Fioravanti, Jessica; Ganzer, Lucia; Fiocchi, Amleto; Vacca, Maurizio; Aiolfi, Roberto; Sammicheli, Stefano; Mainetti, Marta; Cataudella, Tiziana; Sitia, Giovanni; Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Guidotti, Luca G.; Chisari, Francis V.; Isogawa, Masanori] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Inverso, Donato; Aiolfi, Roberto; Iannacone, Matteo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Sironi, Laura; Ganzer, Lucia] Univ Milano Bicocca, Dept Phys, I-20126 Milan, Italy; [Raimondi, Andrea; Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, I-20132 Milan, Italy; [Gonzalez-Aseguinolaza, Gloria] Ctr Appl Med Res, Gene Therapy & Gene Regulat Program, Pamplona 31008, Spain; [Protzer, Ulrike] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Ruggeri, Zaverio M.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Scripps Research Institute; Vita-Salute San Raffaele University; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Navarra; Technical University of Munich; Scripps Research Institute	Guidotti, LG (corresponding author), IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy.	guidotti.luca@hsr.it; iannacone.matteo@hsr.it	Aiolfi, Roberto/H-2290-2019; Protzer, Ulrike/D-5915-2015; Sironi, Laura/AAA-5384-2022; Sitia, Giovanni/K-1036-2016; Guidotti, Luca G. G/I-8542-2018; Inverso, Donato/AAA-5387-2022; Fioravanti, Jessica/AAS-1245-2020; Sitia, Giovanni/U-2114-2019; Gonzalez-Aseguinolaza, Gloria/H-9928-2015; Raimondi, Andrea/AAN-2475-2020; Isogawa, Masanori/AAN-8969-2021; Iannacone, Matteo/I-8507-2018	Aiolfi, Roberto/0000-0003-2066-4536; Protzer, Ulrike/0000-0002-9421-1911; Sitia, Giovanni/0000-0003-1024-9128; Guidotti, Luca G. G/0000-0002-0205-2678; Fioravanti, Jessica/0000-0001-6263-4306; Sitia, Giovanni/0000-0003-1024-9128; Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562; Isogawa, Masanori/0000-0001-8730-4303; Iannacone, Matteo/0000-0002-9370-2671; Di Lucia, Pietro/0000-0002-0726-1532; Chisari, Francis/0000-0002-4832-1044; Inverso, Donato/0000-0003-0987-3345; SIRONI, LAURA/0000-0002-6638-7709; Raimondi, Andrea/0000-0002-4563-386X	European Research Council (ERC) [250219, 281648]; NIH RO1 grant [AI40696, HL-42846]; Italian Association for Cancer Research (AIRC) grant [9965]; Career Development Award from the Giovanni Armenise-Harvard Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042846, R01HL042846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040696] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research (AIRC) grant(Fondazione AIRC per la ricerca sul cancro); Career Development Award from the Giovanni Armenise-Harvard Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Raso for technical support; R. Serra for secretarial assistance; S. Jalkanen for providing anti-VAP-1 Abs; S. Wieland for providing pCMV-beta-gal; M. Bader for providing TPH-1<SUP>-/-</SUP> mice; J. Egen for advice on the liver surgical preparation for the inverted microscope setup; C. Tacchetti for advice on correlative microscopy; L. Suarez-Amaran for help with the generation of recombinant adeno-associated viruses; P. Dellabona and R. Pardi for critical reading of the manuscript and the members of the M. Iannacone and L.G.G. laboratories for helpful discussions. We would like to acknowledge the PhD program in Basic and Applied Immunology at San Raffaele University, as D.I. conducted this study as partial fulfillment of his PhD in Molecular Medicine within that program. This work was supported by European Research Council (ERC) grants 250219 (to L.G.G.) and 281648 (to M. Iannacone); NIH RO1 grant AI40696 (to L.G.G.) and HL-42846 (to Z.M.R.); Italian Association for Cancer Research (AIRC) grant 9965 (to M. Iannacone); and a Career Development Award from the Giovanni Armenise-Harvard Foundation (to M. Iannacone).	ANDO K, 1994, J IMMUNOL, V153, P482; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benseler V, 2011, P NATL ACAD SCI USA, V108, P16735, DOI 10.1073/pnas.1112251108; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; GUIDOTTI LG, 1994, J VIROL, V68, P5469, DOI 10.1128/JVI.68.9.5469-5475.1994; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guidotti LG, 1999, J EXP MED, V189, P1555, DOI 10.1084/jem.189.10.1555; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Isogawa M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003490; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Ji CH, 2012, HEPATOLOGY, V56, P2027, DOI 10.1002/hep.25875; Johnsson C, 1999, TRANSPLANT INT, V12, P235, DOI 10.1007/s001470050216; Lee WY, 2008, J HEPATOL, V48, P504, DOI 10.1016/j.jhep.2007.12.005; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Mueller SN, 2013, IMMUNOL CELL BIOL, V91, P290, DOI 10.1038/icb.2012.75; Sironi L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07341; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Straub AC, 2007, HEPATOLOGY, V45, P205, DOI 10.1002/hep.21444; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; ZHENG Z, 1995, J CELL BIOL, V130, P485, DOI 10.1083/jcb.130.2.485	34	191	204	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					486	500		10.1016/j.cell.2015.03.005	http://dx.doi.org/10.1016/j.cell.2015.03.005			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892224	Green Published, Bronze			2022-12-24	WOS:000353553600010
J	Roberts, RG; Lian, OB				Roberts, Richard G.; Lian, Olav B.			DATING TECHNIQUES Illuminating the past	NATURE			English	Editorial Material							OPTICALLY STIMULATED LUMINESCENCE; MIDDLE STONE-AGE; HUMAN-BEHAVIOR; SOUTH-AFRICA; SEDIMENTS; AUSTRALIA; PROGRESS; SINGLE; QUARTZ	The technique of optical dating was first reported 30 years ago, and has since revolutionized studies of events that occurred during the past 500,000 years. Here, two practitioners of optical dating assess its impact and consider its future.	[Roberts, Richard G.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Lian, Olav B.] Univ Fraser Valley, Dept Geog & Environm, Abbotsford, BC V2S 7M8, Canada	University of Wollongong; University of Fraser Valley	Roberts, RG (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	rgrob@uow.edu.au; olav.lian@ufv.ca	Roberts, Richard Graham/B-8245-2013	Roberts, Richard Graham/0000-0002-0128-4119				Aitken M.J., 1998, INTRO OPTICAL DATING; Botter-Jensen L., 2003, OPTICALLY STIMULATED; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Herman F, 2010, EARTH PLANET SC LETT, V297, P183, DOI 10.1016/j.epsl.2010.06.019; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; HUTT G, 1988, QUATERNARY SCI REV, V7, P381, DOI 10.1016/0277-3791(88)90033-9; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Kalchgruber R, 2007, PLANET SPACE SCI, V55, P2203, DOI 10.1016/j.pss.2007.09.002; Lian OB, 2006, QUATERNARY SCI REV, V25, P2449, DOI 10.1016/j.quascirev.2005.11.013; Liritzis I., 2013, LUMINESCENCE DATING; Murray AS, 1998, RADIAT MEAS, V29, P503, DOI 10.1016/S1350-4487(98)00044-4; Prescott JR, 2008, AUST J EARTH SCI, V55, P997, DOI 10.1080/08120090802097468; Rhodes EJ, 2011, ANNU REV EARTH PL SC, V39, P461, DOI [10.1146/annurev-earth-040610-133425, 10.1146/annurev-earth-040610-13425]; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Roberts RG, 2015, J ARCHAEOL SCI, V56, P41, DOI 10.1016/j.jas.2015.02.028; SMITH BW, 1986, RADIAT PROT DOSIM, V17, P229; WINTLE AG, 1979, NATURE, V279, P710, DOI 10.1038/279710a0	20	20	22	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					438	439		10.1038/520438a	http://dx.doi.org/10.1038/520438a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903619				2022-12-24	WOS:000353334500021
J	Katajisto, P; Dohla, J; Chaffer, CL; Pentinmikko, N; Marjanovic, N; Iqbal, S; Zoncu, R; Chen, W; Weinberg, RA; Sabatini, DM				Katajisto, Pekka; Doehla, Julia; Chaffer, Christine L.; Pentinmikko, Nalle; Marjanovic, Nemanja; Iqbal, Sharif; Zoncu, Roberto; Chen, Walter; Weinberg, Robert A.; Sabatini, David M.			Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness	SCIENCE			English	Article							BUDDING YEAST; DAMAGED PROTEINS; QUALITY-CONTROL; LIFE-SPAN; IN-VITRO; DIVISION; INHERITANCE; PLURIPOTENCY; MITOPHAGY; REVEALS	By dividing asymmetrically, stem cells can generate two daughter cells with distinct fates. However, evidence is limited in mammalian systems for the selective apportioning of subcellular contents between daughters. We followed the fates of old and young organelles during the division of human mammary stemlike cells and found that such cells apportion aged mitochondria asymmetrically between daughter cells. Daughter cells that received fewer old mitochondria maintained stem cell traits. Inhibition of mitochondrial fission disrupted both the age-dependent subcellular localization and segregation of mitochondria and caused loss of stem cell properties in the progeny cells. Hence, mechanisms exist for mammalian stemlike cells to asymmetrically sort aged and young mitochondria, and these are important for maintaining stemness properties.	[Katajisto, Pekka; Chaffer, Christine L.; Marjanovic, Nemanja; Zoncu, Roberto; Chen, Walter; Weinberg, Robert A.; Sabatini, David M.] Whitehead Inst Biomed Res, Boston, MA 02142 USA; [Katajisto, Pekka; Marjanovic, Nemanja; Zoncu, Roberto; Chen, Walter; Weinberg, Robert A.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Katajisto, Pekka; Zoncu, Roberto; Chen, Walter; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Katajisto, Pekka; Doehla, Julia; Pentinmikko, Nalle; Iqbal, Sharif] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Katajisto, P (corresponding author), Whitehead Inst Biomed Res, Boston, MA 02142 USA.	pekka.katajisto@helsinki.fi; sabatini@wi.mit.edu	Pentinmikko, Nalle/ABB-8148-2021	Pentinmikko, Nalle/0000-0003-3578-1073; Katajisto, Pekka/0000-0002-3033-4189; IQBAL, MD SHARIF/0000-0002-0366-2080; Chen, Walter/0000-0002-7752-9581; /0000-0002-1446-7256	U.S. National Institutes of Health [R01 CA103866, R01 CA129105, R37 AI047389]; Foundations' Post Doc Pool; Academy of Finland; Juselius Foundation; NATIONAL CANCER INSTITUTE [R01CA129105, P30CA014051, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundations' Post Doc Pool; Academy of Finland(Academy of Finland); Juselius Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Sabatini and Katajisto laboratories-especially A. Efeyan, W. Comb, Y. Chudnovsky, and L. Schweitzer-for comments on this manuscript; K. Birsoy and E. Salminen for help and reagents; and K. Ottina for RNAi reagents. This work was supported by the U.S. National Institutes of Health (R01 CA103866, R01 CA129105, and R37 AI047389) (D.M.S.), Foundations' Post Doc Pool (P.K.), Academy of Finland (P.K.), Juselius Foundation (P.K.) and Marie Curie Actions (P.K.). D.M.S. is an Investigator of the Howard Hughes Medical Institute.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Charruyer A, 2012, J INVEST DERMATOL, V132, P2522, DOI 10.1038/jid.2012.196; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hernebring M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01381; Higuchi R, 2013, CURR BIOL, V23, P2417, DOI 10.1016/j.cub.2013.10.022; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lai CY, 2002, GENETICS, V162, P73; Lee GM, 2002, IN VITRO CELL DEV-AN, V38, P90; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Vazquez-Martin A, 2012, AGING-US, V4, P393, DOI 10.18632/aging.100465; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107	31	326	330	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					340	343		10.1126/science.1260384	http://dx.doi.org/10.1126/science.1260384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25837514	Green Accepted, Green Submitted			2022-12-24	WOS:000352999000046
J	Rinkevich, Y; Walmsley, GG; Hu, MS; Maan, ZN; Newman, AM; Drukker, M; Januszyk, M; Krampitz, GW; Gurtner, GC; Lorenz, HP; Weissman, IL; Longaker, MT				Rinkevich, Yuval; Walmsley, Graham G.; Hu, Michael S.; Maan, Zeshaan N.; Newman, Aaron M.; Drukker, Micha; Januszyk, Michael; Krampitz, Geoffrey W.; Gurtner, Geoffrey C.; Lorenz, H. Peter; Weissman, Irving L.; Longaker, Michael T.			Identification and isolation of a dermal lineage with intrinsic fibrogenic potential	SCIENCE			English	Article							STROMAL CELLS; CIRCULATING FIBROCYTES; BREAST FIBROBLASTS; PROTEIN-ALPHA; HOST-CELLS; SKIN; MYOFIBROBLASTS; EXPRESSION; FIBROSIS; CANCER	Dermal fibroblasts represent a heterogeneous population of cells with diverse features that remain largely undefined. We reveal the presence of at least two fibroblast lineages in murine dorsal skin. Lineage tracing and transplantation assays demonstrate that a single fibroblast lineage is responsible for the bulk of connective tissue deposition during embryonic development, cutaneous wound healing, radiation fibrosis, and cancer stroma formation. Lineage-specific cell ablation leads to diminished connective tissue deposition in wounds and reduces melanoma growth. Using flow cytometry, we identify CD26/DPP4 as a surface marker that allows isolation of this lineage. Small molecule-based inhibition of CD26/DPP4 enzymatic activity during wound healing results in diminished cutaneous scarring. Identification and isolation of these lineages hold promise for translational medicine aimed at in vivo modulation of fibrogenic behavior.	[Rinkevich, Yuval; Walmsley, Graham G.; Hu, Michael S.; Newman, Aaron M.; Drukker, Micha; Krampitz, Geoffrey W.; Weissman, Irving L.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Rinkevich, Yuval; Walmsley, Graham G.; Hu, Michael S.; Newman, Aaron M.; Drukker, Micha; Krampitz, Geoffrey W.; Weissman, Irving L.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, Stanford, CA 94305 USA; [Walmsley, Graham G.; Hu, Michael S.; Maan, Zeshaan N.; Januszyk, Michael; Gurtner, Geoffrey C.; Lorenz, H. Peter; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Sch Med, Dept Surg Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Ludwig Ctr Canc Stem Cell Biol & Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Rinkevich, Y (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA.	ryuval@stanford.edu; irv@stanford.edu; longaker@stanford.edu	Rinkevich, Yuval/B-7854-2018; Newman, Aaron M/ABE-1620-2021; Rinkevich, Yuval/B-7647-2018	Rinkevich, Yuval/0000-0001-6290-7271; Newman, Aaron M/0000-0002-1857-8172; Rinkevich, Yuval/0000-0002-9022-7668; Drukker, Micha/0000-0002-4279-1125; Maan, Zeshaan/0000-0002-7683-1914	NIH [R01 GM087609, U01 HL099776, U01 HL099999]; California Institute of Regenerative Medicine [RC1 00354]; Smith Family Trust; Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Gunn/Olivier fund; Stanford School of Medicine; Stanford Medical Scientist Training Program; National Institute of General Medical Sciences [GM07365]; Human Frontier Science Program (HFSP) Long Term Fellowship; Machiah Foundation Fellowship; Siebel Scholarship; California Institute for Regenerative Medicine [TG2-01159]; Plastic Surgery Foundation [114288]; Translational Research and Applied Medicine program pilot grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776, U01HL099999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087609, T32GM007365] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Smith Family Trust; Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Gunn/Olivier fund; Stanford School of Medicine; Stanford Medical Scientist Training Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontier Science Program (HFSP) Long Term Fellowship; Machiah Foundation Fellowship; Siebel Scholarship; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Plastic Surgery Foundation; Translational Research and Applied Medicine program pilot grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank D. T. Montoro and S. D. Morrison for their early contribution to developing the live fibroblast harvest protocol. This work was supported in part by NIH grant R01 GM087609 (to H.P.L.), a gift from Ingrid Lai and Bill Shu in honor of Anthony Shu (to H.P.L.), the California Institute of Regenerative Medicine (RC1 00354 to I.L.W.), the Smith Family Trust (to I.L.W.), the Hagey Laboratory for Pediatric Regenerative Medicine and The Oak Foundation (to M.T.L., H.P.L., and G.C.G.), NIH grants U01 HL099776 (to M.T.L.) and U01 HL099999 (to I.L.W.), the Virginia and D. K. Ludwig Fund for Cancer Research (to I.L.W.), and the Gunn/Olivier fund (to M.T.L. and I.L.W.). G.G.W. was supported by the Stanford School of Medicine, the Stanford Medical Scientist Training Program, and National Institute of General Medical Sciences training grant GM07365. Y.R. was supported by the Human Frontier Science Program (HFSP) Long Term Fellowship, the Machiah Foundation Fellowship, and the Siebel Scholarship. M.S.H. was supported by the California Institute for Regenerative Medicine Clinical Fellow training grant TG2-01159. Z.N.M. was supported by the Plastic Surgery Foundation Research Fellowship grant 114288 and the Translational Research and Applied Medicine program pilot grant. Microarray data are available at the Gene Expression Omnibus (GEO) at www.ncbi.nlm.nih.gov/geo, under accession number GSE65402. Author contributions: Y.R. and G.G.W. conceived, designed, and oversaw the experiments, with suggestions from I.L.W. and M.T.L. Y.R., G.G.W., M.S.H., and Z.N.M. performed the experiments and analyzed the data. A.M.N. and M.J. assisted with collection and analysis of data. M.D. assisted with microarray preparations, and A.M.N. analyzed the microarray data. Y.R., G.G.W., M.S.H., and Z.N.M. wrote the manuscript, with helpful suggestions from G.C.G., H.P.L., I.L.W., and M.T.L. The authors have no competing interests.	Ahren B, 2007, BEST PRACT RES CL EN, V21, P517, DOI 10.1016/j.beem.2007.07.005; Arwert EN, 2012, ONCOGENE, V31, P992, DOI 10.1038/onc.2011.298; ATHERTON AJ, 1992, INT J CANCER, V50, P15, DOI 10.1002/ijc.2910500105; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Dumont N, 2013, NEOPLASIA, V15, P249, DOI 10.1593/neo.121950; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Glotzbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021211; Gottlober P, 2001, INT J RADIAT ONCOL, V50, P159, DOI 10.1016/S0360-3016(00)01542-X; HANSEN LS, 1984, ANAT REC, V210, P569, DOI 10.1002/ar.1092100404; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hiramatsu H, 2004, BIOL CHEM, V385, P561, DOI 10.1515/BC.2004.068; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Januszyk M, 2014, DIABETES, V63, P3047, DOI 10.2337/db13-1366; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Labrousse AL, 2004, CRIT REV ONCOL HEMAT, V49, P269, DOI 10.1016/j.critrevonc.2003.10.007; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levi B, 2011, J BIOL CHEM, V286, P39497, DOI 10.1074/jbc.M111.256529; MOORE K, 1977, INT J CANCER, V19, P803, DOI 10.1002/ijc.2910190610; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Tripathi M, 2012, CELL ADHES MIGR, V6, P231, DOI 10.4161/cam.20419; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; WEBER L, 1984, J INVEST DERMATOL, V82, P156, DOI 10.1111/1523-1747.ep12259720; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	43	379	387	8	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232							aaa2151	10.1126/science.aaa2151	http://dx.doi.org/10.1126/science.aaa2151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883361	Green Accepted			2022-12-24	WOS:000352999000034
J	Gates, B				Gates, Bill			The Next Epidemic - Lessons from Ebola	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Gates, B (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.							[Anonymous], PAND RISK ON HLTH; Myhrvold N., 2013, STRATEGIC TERRORISM	2	156	161	0	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2015	372	15					1381	1384		10.1056/NEJMp1502918	http://dx.doi.org/10.1056/NEJMp1502918			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF2ZV	25853741	Bronze			2022-12-24	WOS:000352417900001
J	Mugnier, MR; Cross, GAM; Papavasiliou, FN				Mugnier, Monica R.; Cross, George A. M.; Papavasiliou, F. Nina			The in vivo dynamics of antigenic variation in Trypanosoma brucei	SCIENCE			English	Article							CLONES; GENES; POPULATIONS	Trypanosoma brucei, a causative agent of African Sleeping Sickness, constantly changes its dense variant surface glycoprotein (VSG) coat to avoid elimination by the immune system of its mammalian host, using an extensive repertoire of dedicated genes. However, the dynamics of VSG expression in T. brucei during an infection are poorly understood. We have developed a method, based on de novo assembly of VSGs, for quantitatively examining the diversity of expressed VSGs in any population of trypanosomes and monitored VSG population dynamics in vivo. Our experiments revealed unexpected diversity within parasite populations and a mechanism for diversifying the genome-encoded VSG repertoire. The interaction between T. brucei and its host is substantially more dynamic and nuanced than previously expected.	[Mugnier, Monica R.; Cross, George A. M.; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; [Mugnier, Monica R.; Cross, George A. M.; Papavasiliou, F. Nina] Rockefeller Univ, Lab Mol Parasitol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Papavasiliou, FN (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA.	papavasiliou@rockefeller.edu	; Cross, George/B-7444-2011	Mugnier, Monica/0000-0002-1535-2530; Cross, George/0000-0003-1374-6955	NIH/National Institute of Allergy and Infectious Diseases [AI085973]; NSF Graduate Research Fellowship [DGE-1325261]; Rockefeller University Women in Science Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097127, R01AI085973] Funding Source: NIH RePORTER	NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Rockefeller University Women in Science Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Ivens, K. Matthews, K. Gunasekera, and I. Roditi for generously sharing their independently assembled genome sequences and J. Scott for help with early optimization experiments. The work presented has been supported in part by the NIH/National Institute of Allergy and Infectious Diseases (AI085973) to F.N.P., by an NSF Graduate Research Fellowship (DGE-1325261) to M.R.M., and by a Rockefeller University Women in Science Fellowship to M.R.M. All raw data has been deposited to the National Center for Biotechnology Information's Sequence Read Archive under accession number SRP051697, along with all the methods used to generate the figures.	Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Claes F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000486; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Eyford BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071463; Frank SA, 1999, P ROY SOC B-BIOL SCI, V266, P1397, DOI 10.1098/rspb.1999.0793; Gjini E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2129; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRAY AR, 1965, J GEN MICROBIOL, V41, P195, DOI 10.1099/00221287-41-2-195; Hall JPJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003502; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; KAMPER SM, 1992, MOL BIOCHEM PARASIT, V53, P33, DOI 10.1016/0166-6851(92)90004-4; LIU AYC, 1985, J MOL BIOL, V182, P383, DOI 10.1016/0022-2836(85)90198-6; Lu J, 2014, MOL IMMUNOL, V57, P274, DOI 10.1016/j.molimm.2013.09.008; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; MacGregor P, 2011, CELL HOST MICROBE, V9, P310, DOI 10.1016/j.chom.2011.03.013; Marcello L, 2007, J EUKARYOT MICROBIOL, V54, P14, DOI 10.1111/j.1550-7408.2006.00227.x; MILLER EN, 1981, PARASITOLOGY, V82, P63, DOI 10.1017/S0031182000041871; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; MYLER PJ, 1985, INFECT IMMUN, V47, P684, DOI 10.1128/IAI.47.3.684-690.1985; Ross R, 1910, P R SOC LOND B-CONTA, V82, P411, DOI 10.1098/rspb.1910.0035; ROTH C, 1989, P NATL ACAD SCI USA, V86, P9375, DOI 10.1073/pnas.86.23.9375; SEED JR, 1978, J PROTOZOOL, V25, P526, DOI 10.1111/j.1550-7408.1978.tb04179.x; Turner CMR, 1997, FEMS MICROBIOL LETT, V153, P227, DOI 10.1111/j.1574-6968.1997.tb10486.x; TURNER CMR, 1989, PARASITOLOGY, V99, P67, DOI 10.1017/S0031182000061035; van Meirvenne N., 1975, Annales Soc belge Med trop, V55, P1	25	92	92	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1470	1473		10.1126/science.aaa4502	http://dx.doi.org/10.1126/science.aaa4502			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AT	25814582	Green Accepted			2022-12-24	WOS:000352136400039
J	Ben-Zvi, D; Melton, DA				Ben-Zvi, Danny; Melton, Douglas A.			Modeling Human Nutrition Using Human Embryonic Stem Cells	CELL			English	Article							WEIGHT-LOSS DIETS; GUT MICROBIOTA; IN-VITRO; DISEASE; HEALTH; DIFFERENTIATION; MECHANISMS; GENERATION	Nutrition presents unanswered scientific questions of high public health importance. We envision model systems composed of interacting gastrointestinal and metabolic tissues derived from human embryonic stem cells, populated by gut microbiota. The culture will be embedded in 3D scaffolds, creating a controlled experimental system that enables tissue sampling and imaging.	[Ben-Zvi, Danny; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Ben-Zvi, D (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, 7 Divinity Ave, Cambridge, MA 02138 USA.	benzvi@fas.harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Ben-Zvi, Danny/0000-0002-8697-9744	Human Frontiers in Science post-doctoral fellowship	Human Frontiers in Science post-doctoral fellowship	D.B.-Z. is supported by the Human Frontiers in Science post-doctoral fellowship. D.A.M. is an Investigator of the Howard Hughes Medical Institute. We thank Dr. Jonathan Schneidermann and Dr. Sagi Levy for critical reading of this manuscript.	[Anonymous], 2014, NATURE, V511, P264, DOI 10.1038/511264a; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; Baranski M, 2014, BRIT J NUTR, V112, P794, DOI 10.1017/S0007114514001366; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Cuaranta-Monroy I, 2014, STEM CELL RES, V13, P88, DOI 10.1016/j.scr.2014.04.015; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Feinman RD, 2015, NUTRITION, V31, P1, DOI 10.1016/j.nut.2014.06.011; Figueiredo JC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004228; Gardner C, 2012, DIABETES CARE, V35, P1798, DOI 10.2337/dc12-9002; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Malik VS, 2007, NAT CLIN PRACT CARD, V4, P34, DOI 10.1038/ncpcardio0726; Matarese LE, 2014, NUTR CLIN PRACT, V29, P759, DOI 10.1177/0884533614550251; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Parfrey LW, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/j.1469-0691.2012.03861.x; Psichas A, 2015, J CLIN INVEST, V125, P908, DOI 10.1172/JCI76309; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; van der Meer AD, 2013, LAB CHIP, V13, P3562, DOI 10.1039/c3lc50435b; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034	38	8	9	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					12	17		10.1016/j.cell.2015.02.039	http://dx.doi.org/10.1016/j.cell.2015.02.039			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815980	Bronze			2022-12-24	WOS:000351952200003
J	Van Roy, P; Daley, AC; Briggs, DEG				Van Roy, Peter; Daley, Allison C.; Briggs, Derek E. G.			Anomalocaridid trunk limb homology revealed by a giant filter-feeder with paired flaps	NATURE			English	Article							BURGESS SHALE; APPENDAGES; MORPHOLOGY; EVOLUTION; OPABINIA; AFFINITY; BRAIN	Exceptionally preserved fossils from the Palaeozoic era provide crucial insights into arthropod evolution, with recent discoveries bringing phylogeny and character homology into sharp focus(1-4). Integral to such studies are anomalocaridids, a clade of stem arthropods whose remarkable morphology illuminates early arthropod relationships(5,6) and Cambrian ecology(7-9). Although recent work has focused on the anomalocaridid head(6-10), the nature of their trunk has been debated widely(5,11-18). Here we describe new anomalocaridid(17) specimens from the Early Ordovician Fezouata Biota of Morocco(19), which not only show well-preserved head appendages providing key ecological data, but also elucidate the nature of anomalocaridid trunk flaps, resolving their homology with arthropod trunk limbs. The new material shows that each trunk segment bears a separate dorsal and ventral pair of flaps, with a series of setal blades attached at the base of the dorsal flaps. Comparisons with other stem lineage arthropods(16,20-22) indicate that anomalocaridid ventral flaps are homologous with lobopodous walking limbs and the endopod of the euarthropod biramous limb, whereas the dorsal flaps and associated setal blades are homologous with the flaps of gilled lobopodians (for example, Kerygmachela kierkegaardi, Pambdelurion whittingtoni) and exites of the 'Cambrian biramous limb'(23). This evidence shows that anomalocaridids represent a stage before the fusion of exite and endopod into the 'Cambrian biramous limb'(5,16,23), confirming their basal placement in the euarthropod stem(4-6), rather than in the arthropod crown(24) or with cycloneuralian worms(14). Unlike other anomalocaridids, the Fezouata taxon combines head appendages convergently(9) adapted for filter-feeding with an unprecedented body length exceeding 2 m, indicating a new direction in the feeding ecology of the clade. The evolution of giant filter-feeding anomalocaridids may reflect the establishment of highly developed planktic ecosystems during the Great Ordovician Biodiversification Event(25).	[Van Roy, Peter; Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Van Roy, Peter] Univ Ghent, Dept Geol & Soil Sci, Res Unit Palaeontol, B-9000 Ghent, Belgium; [Daley, Allison C.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Daley, Allison C.] Oxford Univ Museum Nat Hist, Oxford OX1 3PW, England; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA	Yale University; Ghent University; University of Oxford; University of Oxford; Yale University	Van Roy, P (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.	peter.vanroy@yale.edu	Daley, Allison/A-3117-2015	Daley, Allison/0000-0001-5369-5879; Van Roy, Peter/0000-0001-5330-8402	Biology Commission of the Research Foundation - Flanders (FWO); Swedish Research Council (Vetenskapsradet); Oxford University Museum of Natural History; National Science Foundation [EAR-1053247]; Division of Invertebrate Paleontology, YPM; Division Of Earth Sciences [1053247] Funding Source: National Science Foundation	Biology Commission of the Research Foundation - Flanders (FWO)(FWO); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Oxford University Museum of Natural History; National Science Foundation(National Science Foundation (NSF)); Division of Invertebrate Paleontology, YPM; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	M. and B. 'Ou Said' Ben Moula discovered the specimens and provided support in the field. S. Beardmore, D. Field, A. Little, R. Racicot and O. E. Tetlie assisted with fieldwork in 2011. L. Ben Moula and B. Tahiri provided practical assistance. J.-B. Caron loaned specimens of Hurdia from ROM collections. S. Butts and J. Utrup, K. Hollis and D. Erwin curated specimens and facilitated access to the collections at the YPM and USNM respectively. N. Utrup built custom cradles to support the articulated specimens. J. Vinther and P. Hull discussed filter-feeding and gigantism, and J. Lamsdell eurypterid book gills and phylogenetic methodology. E. Martin made available precise biostratigraphical data for the localities. G. Edgecombe provided unpublished observations on Cucumericrus. M. Collins discussed appendage function and prepared the digital reconstruction (Fig. 3). M. Fox advised on preparation and consolidation techniques and provided equipment. C. Graham and J. Slawski provided support and access to digital imaging facilities. The initial part of the research was done while P.V.R. was at Ghent University and in receipt of a mobility grant from the Biology Commission of the Research Foundation - Flanders (FWO). A.C.D. was financially supported by the Swedish Research Council (Vetenskapsradet) and the Oxford University Museum of Natural History. The research was supported by National Science Foundation Grant EAR-1053247 and by the Division of Invertebrate Paleontology, YPM.	BERGSTROM J, 1986, LETHAIA, V19, P241, DOI 10.1111/j.1502-3931.1986.tb00738.x; Braddy SJ, 2008, BIOL LETTERS, V4, P106, DOI 10.1098/rsbl.2007.0491; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Budd GE, 2012, LETHAIA, V45, P83, DOI 10.1111/j.1502-3931.2011.00264.x; CHEN JY, 1994, SCIENCE, V264, P1304, DOI 10.1126/science.264.5163.1304; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Cong PY, 2014, NATURE, V513, P538, DOI 10.1038/nature13486; Daley AC, 2014, J PALEONTOL, V88, P68, DOI 10.1666/13-067; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2010, PALAEONTOLOGY, V53, P721, DOI 10.1111/j.1475-4983.2010.00955.x; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Schneider Jorg W., 1998, Veroeffentlichungen Naturhistorisches Museum Schloss Bertholdsburg Schleusingen, V13, P19; Servais T, 2010, PALAEOGEOGR PALAEOCL, V294, P99, DOI 10.1016/j.palaeo.2010.05.031; Tanaka G, 2013, NATURE, V502, P364, DOI 10.1038/nature12520; Van Roy P, 2011, NATURE, V473, P510, DOI 10.1038/nature09920; Van Roy P, 2010, NATURE, V465, P215, DOI 10.1038/nature09038; Vinther J, 2014, NATURE, V507, P496, DOI 10.1038/nature13010; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096; Wolff C, 2008, P ROY SOC B-BIOL SCI, V275, P1023, DOI 10.1098/rspb.2007.1327; Yang J, 2013, NATURE, V494, P468, DOI 10.1038/nature11874; Zhang XL, 2007, LETHAIA, V40, P161, DOI 10.1111/j.1502-3931.2007.00013.x	30	106	106	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					77	U178		10.1038/nature14256	http://dx.doi.org/10.1038/nature14256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	25762145				2022-12-24	WOS:000355543400032
J	Suding, K; Higgs, E; Palmer, M; Callicott, JB; Anderson, CB; Baker, M; Gutrich, JJ; Hondula, KL; LaFevor, MC; Larson, BMH; Randall, A; Ruhl, JB; Schwartz, KZS				Suding, Katharine; Higgs, Eric; Palmer, Margaret; Callicott, J. Baird; Anderson, Christopher B.; Baker, Matthew; Gutrich, John J.; Hondula, Kelly L.; LaFevor, Matthew C.; Larson, Brendon M. H.; Randall, Alan; Ruhl, J. B.; Schwartz, Katrina Z. S.			Committing to ecological restoration	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BENEFITS		[Suding, Katharine] Univ Colorado, Boulder, CO 80309 USA; [Higgs, Eric] Univ Victoria, Victoria, BC V8W 2Y2, Canada; [Palmer, Margaret] Univ Maryland, College Pk, MD 20742 USA; [Callicott, J. Baird] Univ N Texas, Denton, TX 76203 USA; [Anderson, Christopher B.] Consejo Nacl Invest Cient & Tecn, RA-9410 Ushuaia, Tdf, Argentina; [Anderson, Christopher B.] Natl Univ Tierra del Fuego, RA-9410 Ushuaia, Tdf, Argentina; [Baker, Matthew] Univ Maryland Baltimore Cty, Baltimore, MD 21250 USA; [Gutrich, John J.] Southern Oregon Univ, Ashland, OR 97520 USA; [Hondula, Kelly L.; LaFevor, Matthew C.] Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA; [Larson, Brendon M. H.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Randall, Alan] Ohio State Univ, Columbus, OH 43210 USA; [Randall, Alan] Univ Sydney, Sydney, NSW 2006, Australia; [Ruhl, J. B.] Vanderbilt Univ, Sch Law, Nashville, TN 37203 USA; [Schwartz, Katrina Z. S.] Woodrow Wilson Int Ctr Scholars, Washington, DC 20004 USA	University of Colorado System; University of Colorado Boulder; University of Victoria; University System of Maryland; University of Maryland College Park; University of North Texas System; University of North Texas Denton; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University System of Maryland; University of Maryland Baltimore County; University of Waterloo; University System of Ohio; Ohio State University; University of Sydney; Vanderbilt University	Suding, K (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	suding@colorado.edu	Anderson, Christopher/V-4882-2019; Suding, Katharine/O-6290-2017; Palmer, Margaret A/F-9648-2013; Randall, Alan/N-4153-2019; Callicott, Joseph/C-9102-2009	Anderson, Christopher/0000-0001-8120-5689; Suding, Katharine/0000-0002-5357-0176; Palmer, Margaret A/0000-0003-1468-7993; Callicott, Joseph/0000-0003-1298-3334; LaFevor, Matthew/0000-0002-0988-4768; Hondula, Kelly/0000-0002-1928-1442; Ruhl, J.B./0000-0003-3866-733X; Randall, Alan/0000-0003-1028-5903	National Socio-Environmental Synthesis Center (SESYNC) under U.S. National Science Foundation [DBI-1052875]; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	National Socio-Environmental Synthesis Center (SESYNC) under U.S. National Science Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank anonymous reviewers, N. Barger, R. Hobbs, and S. Murphy for comments. This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the U.S. National Science Foundation DBI-1052875.	[Anonymous], 2014, ECONOMIST; Balaguer L, 2014, BIOL CONSERV, V176, P12, DOI 10.1016/j.biocon.2014.05.007; Biron C., 2014, INTERPRESS SERV 1003; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Callicott J. B., 2006, PRINCIPLES CONSERVAT; Chazdon R., 2014, 2 GROWTH PROMISE TRO, DOI DOI 10.1017/CB09781107415324.004; Ciccarese L, 2012, NEW FOREST, V43, P543, DOI 10.1007/s11056-012-9350-8; Craig RK, 2010, HARVARD ENVIRON LAW, V34, P9; De Groot RS, 2013, CONSERV BIOL, V27, P1286, DOI 10.1111/cobi.12158; Falk D. A., 2007, FDN RESTORATION ECOL; Hallett LM, 2013, RESTOR ECOL, V21, P312, DOI 10.1111/rec.12007; Higgs E., 2003, NATURE DESIGN; Higgs E, 2014, FRONT ECOL ENVIRON, V12, P499, DOI 10.1890/110267; Hobbs RJ, 2011, BIOSCIENCE, V61, P442, DOI 10.1525/bio.2011.61.6.6; Keeneleyside KA., 2012, ECOLOGICAL RESTORATI, DOI [10.25607/OBP-171, DOI 10.25607/OBP-171]; Lin BB, 2013, BIOSCIENCE, V63, P793, DOI 10.1525/bio.2013.63.10.6; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Palmer MA, 2014, ENVIRON SCI TECHNOL, V48, P10552, DOI 10.1021/es503052f; Palmer MA, 2014, ECOL ENG, V65, P62, DOI 10.1016/j.ecoleng.2013.07.059; Salzman J, 2000, STANFORD LAW REV, V53, P607, DOI 10.2307/1229470; Science and Policy Working Group Society for Ecological Restoration, 2004, SER INT PRIM EC REST; Shackelford N, 2013, RESTOR ECOL, V21, P297, DOI 10.1111/rec.12012; Suckling K., 2012, TIME TARGET ENDANGER; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Telesetsky A., 2013, VERMONT J ENV LAW, V14, P494; Temperton VM, 2014, RESTOR ECOL, V22, P271, DOI 10.1111/rec.12095; Veldman JW, 2015, SCIENCE, V347, P484, DOI 10.1126/science.347.6221.484-c	27	313	326	19	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					638	640		10.1126/science.aaa4216	http://dx.doi.org/10.1126/science.aaa4216			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH5AI	25953995				2022-12-24	WOS:000354045700029
J	Omand, MM; D'Asaro, EA; Lee, CM; Perry, MJ; Briggs, N; Cetinic, I; Mahadevan, A				Omand, Melissa M.; D'Asaro, Eric A.; Lee, Craig M.; Perry, Mary Jane; Briggs, Nathan; Cetinic, Ivona; Mahadevan, Amala			Eddy-driven subduction exports particulate organic carbon from the spring bloom	SCIENCE			English	Article							SUBPOLAR NORTH-ATLANTIC; OCEANS TWILIGHT ZONE; PHYTOPLANKTON BLOOMS; SUBTROPICAL GYRE; VERTICAL MOTION; HIGH-RESOLUTION; PARTICLE-FLUX; DIATOM BLOOM; FRONTS; PUMP	The export of particulate organic carbon (POC) from the surface ocean to depth is traditionally ascribed to sinking. Here, we show that a dynamic eddying flow field subducts surface water with high concentrations of nonsinking POC. Autonomous observations made by gliders during the North Atlantic spring bloom reveal anomalous features at depths of 100 to 350 meters with elevated POC, chlorophyll, oxygen, and temperature-salinity characteristics of surface water. High-resolution modeling reveals that during the spring transition, intrusions of POC-rich surface water descend as coherent, 1- to 10-kilometer-scale filamentous features, often along the perimeter of eddies. Such a submesoscale eddy-driven flux of POC is unresolved in global carbon cycle models but can contribute as much as half of the total springtime export of POC from the highly productive subpolar oceans.	[Omand, Melissa M.; Mahadevan, Amala] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [D'Asaro, Eric A.; Lee, Craig M.] Univ Washington, Appl Ocean Phys Lab, Seattle, WA 98195 USA; [Perry, Mary Jane; Briggs, Nathan; Cetinic, Ivona] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	Woods Hole Oceanographic Institution; University of Washington; University of Washington Seattle; University of Maine System; University of Maine Orono	Mahadevan, A (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	amala@whoi.edu	Cetinic, Ivona/I-7252-2012; Cetinic, Ivona/GSI-5613-2022; Cetinic, Ivona/Q-6281-2019		National Science Foundation (NSF) [OCE 1260080, 1434788]; Office of Naval Research; Radcliffe Institute for Advanced Study; NSF [OCE-0628107, OCE-0628379]; NASA [NNX-08AL92G]; Division Of Ocean Sciences [1434512] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Radcliffe Institute for Advanced Study; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	M.M.O. and A.M. were supported by the National Science Foundation (NSF OCE 1260080, 1434788), the Office of Naval Research, and a fellowship to A.M. from the Radcliffe Institute for Advanced Study. The NAB08 field experiment was supported by NSF OCE-0628107 and OCE-0628379 and NASA NNX-08AL92G. Data from NAB08 is publicly available at the Biological and Chemical Oceanography Data Management Office: http://osprey.bcodmo.org/project.cfm?flag=view&id=102&sortby=project.	Alkire MB, 2012, DEEP-SEA RES PT I, V64, P157, DOI 10.1016/j.dsr.2012.01.012; Bagniewski W, 2011, BIOGEOSCIENCES, V8, P1291, DOI 10.5194/bg-8-1291-2011; Barth JA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000956; Briggs N, 2011, DEEP-SEA RES PT I, V58, P1031, DOI 10.1016/j.dsr.2011.07.007; BUESSELER KO, 1992, DEEP-SEA RES, V39, P1115, DOI 10.1016/0198-0149(92)90060-7; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; Dall'Olmo G, 2014, GEOPHYS RES LETT, V41, P2921, DOI 10.1002/2014GL059244; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P1, DOI 10.1016/0967-0645(93)90003-6; Fielding S, 2001, J MARINE SYST, V30, P287, DOI 10.1016/S0924-7963(01)00063-X; Follows MJ, 1996, J MAR RES, V54, P605, DOI 10.1357/0022240963213682; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; GARDNER WD, 1995, DEEP-SEA RES PT II, V42, P757, DOI 10.1016/0967-0645(95)00037-Q; Giering SLC, 2014, NATURE, V507, P480, DOI 10.1038/nature13123; Held IM, 1999, J ATMOS SCI, V56, P1688, DOI 10.1175/1520-0469(1999)056<1688:TSBOTZ>2.0.CO;2; Johnston TMS, 2009, DEEP-SEA RES PT II, V56, P246, DOI 10.1016/j.dsr2.2008.08.006; Karleskind P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006446; Kortzinger A, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004347; Lee MM, 2012, J PHYS OCEANOGR, V42, P1762, DOI 10.1175/JPO-D-11-0219.1; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Mahadevan A, 1996, J PHYS OCEANOGR, V26, P1868, DOI 10.1175/1520-0485(1996)026<1868:ANMOMP>2.0.CO;2; Mahadevan A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005203; Mahadevan A, 2006, OCEAN MODEL, V14, P241, DOI 10.1016/j.ocemod.2006.05.006; Mahadevan A, 2006, OCEAN MODEL, V14, P222, DOI 10.1016/j.ocemod.2006.05.005; Mahadevan A, 2012, SCIENCE, V337, P54, DOI 10.1126/science.1218740; Martin P, 2011, DEEP-SEA RES PT I, V58, P338, DOI 10.1016/j.dsr.2011.01.006; McWilliams JC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039402; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; POLLARD RT, 1990, NATURE, V348, P227, DOI 10.1038/348227a0; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Rynearson TA, 2013, DEEP-SEA RES PT I, V82, P60, DOI 10.1016/j.dsr.2013.07.013; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sallee JB, 2012, NAT GEOSCI, V5, P579, DOI [10.1038/ngeo1523, 10.1038/NGEO1523]; Sanders R, 2014, PROG OCEANOGR, V129, P200, DOI 10.1016/j.pocean.2014.05.005; Siegel DA, 2014, GLOBAL BIOGEOCHEM CY, V28, P181, DOI 10.1002/2013GB004743; SPALL MA, 1995, J GEOPHYS RES-OCEANS, V100, P2543, DOI 10.1029/94JC02860; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Taylor JR, 2011, LIMNOL OCEANOGR, V56, P2293, DOI 10.4319/lo.2011.56.6.2293	38	200	204	10	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231					222	225		10.1126/science.1260062	http://dx.doi.org/10.1126/science.1260062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25814062	Green Accepted			2022-12-24	WOS:000352613700042
J	Cichon, J; Gan, WB				Cichon, Joseph; Gan, Wen-Biao			Branch-specific dendritic Ca2+ spikes cause persistent synaptic plasticity	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; LONG-TERM POTENTIATION; BARREL CORTEX; IN-VIVO; CALCIUM SIGNALS; TRANSGENIC MICE; INTEGRATION; CELLS; MEMORY; SPINES	The brain has an extraordinary capacity for memory storage, but how it or new information without disrupting previously acquired memories remains unknown. Here we show that different motor learning tasks induce dendritic Ca2+ spikes on different apical tuft branches of individual layer V pyramidal neurons in the mouse motor cortex . These ask-related, branch-specific Ca2+ spikes cause long-lasting potentiation of postsynaptic dendritic spines active at the time of spike generation. When somatostatin-expressing interneurons are inactivated, different motor tasks frequently induce Ca2+ spikes on the same branches. On those branches, spines potentiated during one task are depotentiated when they are active seconds before Ca2+ spikes induced by another task. Concomitantly, increased neuronal activity and performance improvement after learning one task are disrupted when another task is learned. These findings indicate that dendritic-branch-specific generation of Ca2+ spikes is crucial for establishing long-lasting synaptic plasticity, thereby facilitating information storage associated with different learning experiences	[Cichon, Joseph; Gan, Wen-Biao] NYU, Sch Med, Skirball Inst, Dept Neurosci & Physiol, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Skirball Inst, Dept Neurosci & Physiol, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	Core, Vector/CAF-4832-2022		National Institutes of Health [R01 NS047325, P01 NS074972]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074972, R01NS047325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health R01 NS047325 and P01 NS074972 to W.-B.G. We thank L. Looger, G. Chen and members of the Gan laboratory for their comments on the manuscript. We thank the Genetically-Encoded Neuronal Indicator and Effector (GENIE) Project and the Janelia Farm Research Campus of the Howard Hughes Medical Institute for sharing GCaMP6 constructs.	Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Grienberger C, 2014, NEURON, V81, P1274, DOI 10.1016/j.neuron.2014.01.014; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harnett MT, 2013, NEURON, V79, P516, DOI 10.1016/j.neuron.2013.06.005; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Humeau Y, 2007, NEUROPHARMACOLOGY, V52, P234, DOI 10.1016/j.neuropharm.2006.07.010; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Palmer LM, 2014, NAT NEUROSCI, V17, P383, DOI 10.1038/nn.3646; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Yang Guang, 2013, Methods Mol Biol, V1010, P35, DOI 10.1007/978-1-62703-411-1_3; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	47	273	276	6	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					180	U80		10.1038/nature14251	http://dx.doi.org/10.1038/nature14251			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25822789	Green Accepted			2022-12-24	WOS:000352454600030
J	Reddy, U; Mallepaddi, NR; Chevassut, TJ				Reddy, Udaya; Mallepaddi, Nageswara Rao; Chevassut, Timothy J.			10-MINUTE CONSULTATION High INR on warfarin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTICOAGULATION		[Reddy, Udaya] Worthing Dist Hosp, Dept Gastroenterol, Worthing BN11 2DH, England; [Mallepaddi, Nageswara Rao] Roslyn Rd Surg, Stoke On Trent, Staffs, England; [Chevassut, Timothy J.] Univ Sussex, Sussex Med Sch, Brighton, E Sussex, England; [Chevassut, Timothy J.] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England	University of Brighton; University of Sussex; University of Brighton	Reddy, U (corresponding author), Worthing Dist Hosp, Dept Gastroenterol, Worthing BN11 2DH, England.	udaya.reddy@nhs.net						Baglin T, 2013, BRIT J HAEMATOL, V163, P160, DOI 10.1111/bjh.12502; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Medicines and Healthcare Products Regulatory Agency, 2009, WARF CHNAG PROD SAF, P11; National Institute for Health and Care Excellence, 2007, HEAD INJ CLIN GUID C; National Institute for Health and Care Excellence, 2012, VEN THROMB DIS MAN V, VCG144; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x	6	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2015	350								h1282	10.1136/bmj.h1282	http://dx.doi.org/10.1136/bmj.h1282			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF9VG	25858914	Green Accepted			2022-12-24	WOS:000352914700003
J	Amunts, A; Brown, A; Toots, J; Scheres, SHW; Ramakrishnan, V				Amunts, Alexey; Brown, Alan; Toots, Jaan; Scheres, Sjors H. W.; Ramakrishnan, V.			The structure of the human mitochondrial ribosome	SCIENCE			English	Article							MESSENGER-RNA; STRANDED-RNA; PROTEIN S1; SUBUNIT; INITIATION; BINDING; TRANSLOCATION; TRANSLATION; SEQUENCES; COMPLEX	The highly divergent ribosomes of human mitochondria (mitoribosomes) synthesize 13 essential proteins of oxidative phosphorylation complexes. We have determined the structure of the intact mitoribosome to 3.5 angstrom resolution by means of single-particle electron cryogenic microscopy. It reveals 80 extensively interconnected proteins, 36 of which are specific to mitochondria, and three ribosomal RNA molecules. The head domain of the small subunit, particularly the messenger (mRNA) channel, is highly remodeled. Many intersubunit bridges are specific to the mitoribosome, which adopts conformations involving ratcheting or rolling of the small subunit that are distinct from those seen in bacteria or eukaryotes. An intrinsic guanosine triphosphatase mediates a contact between the head and central protuberance. The structure provides a reference for analysis of mutations that cause severe pathologies and for future drug design.	[Amunts, Alexey; Brown, Alan; Toots, Jaan; Scheres, Sjors H. W.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Amunts, A./AAZ-2279-2020; Scheres, Sjors H.W./AAY-2265-2021; Brown, Alan/I-1473-2019	Amunts, A./0000-0002-5302-1740; Scheres, Sjors H.W./0000-0002-0462-6540; Brown, Alan/0000-0002-0021-0476; Ramakrishnan, V/0000-0002-4699-2194	UK MRC [MC_U105184332, MC_UP_A025_1013]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; MRC [MC_UP_A025_1013]; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1013, MC_U105184332] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank S. Peak-Chew and M. Skehel for mass spectrometry; G. McMullan, S. Chen, and C. Savva for help with data collection; J. Grimmett and T. Darling for help with computing; A. Pulk and J. Cate for scripts to visualize conformational changes; R. Nicholls for help with the structure comparison features of ProSmart; and P. Emsley for help with ligand analysis in Coot. This work was funded by grants from the UK MRC (MC_U105184332 to V.R. and MC_UP_A025_1013 to S.H.W.S.), a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation (V.R.). J. T. was funded by a MRC summer studentship (MC_UP_A025_1013). Cryo-EM density maps have been deposited with the Electron Microscopy Data Bank (accession numbers EMD-2876, EMD-2877, EMD-2878, EMD-2879, EMD-2880, and EMD-2881), and coordinates have been deposited with the Protein Data Bank (entry code 3J9M). A. A. dedicates his share of the work to his mentor N. Nelson.	Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Budkevich TV, 2014, CELL, V158, P121, DOI 10.1016/j.cell.2014.04.044; Byrgazov K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032702; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Heublein M, 2014, MOL BIOL CELL, V25, P3342, DOI 10.1091/mbc.E14-07-1178; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Kim HR, 2007, FASEB J, V21, P188, DOI 10.1096/fj.06-6283com; Manavski N, 2012, PLANT CELL, V24, P3087, DOI 10.1105/tpc.112.099051; Mohan S, 2014, P NATL ACAD SCI USA, V111, P13325, DOI 10.1073/pnas.1413731111; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Qu XH, 2012, P NATL ACAD SCI USA, V109, P14458, DOI 10.1073/pnas.1208950109; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Selimoglu E, 2007, CURR PHARM DESIGN, V13, P119, DOI 10.2174/138161207779313731; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Soriano A, 2005, NEW ENGL J MED, V353, P2305, DOI 10.1056/NEJM200511243532123; Takeshita D, 2014, NUCLEIC ACIDS RES, V42, P10809, DOI 10.1093/nar/gku745; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	35	310	369	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					95	98		10.1126/science.aaa1193	http://dx.doi.org/10.1126/science.aaa1193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838379	Green Accepted			2022-12-24	WOS:000352079500033
J	Deng, WW; Gowen, BG; Zhang, L; Wang, L; Lau, S; Iannello, A; Xu, JF; Rovis, TL; Xiong, N; Raulet, DH				Deng, Weiwen; Gowen, Benjamin G.; Zhang, Li; Wang, Lin; Lau, Stephanie; Iannello, Alexandre; Xu, Jianfeng; Rovis, Tihana L.; Xiong, Na; Raulet, David H.			A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection	SCIENCE			English	Article							IN-VIVO; EXPRESSION; NK; CYTOTOXICITY; RESPONSES; RECEPTOR; MOLECULES; EXOSOMES; RELEASE; NKP46	Immune cells, including natural killer (NK) cells, recognize transformed cells and eliminate them in a process termed immunosurveillance. It is thought that tumor cells evade immunosurveillance by shedding membrane ligands that bind to the NKG2D-activating receptor on NK cells and/or T cells, and desensitize these cells. In contrast, we show that in mice, a shed form of MULT1, a high-affinity NKG2D ligand, causes NK cell activation and tumor rejection. Recombinant soluble MULT1 stimulated tumor rejection in mice. Soluble MULT1 functions, at least in part, by competitively reversing a global desensitization of NK cells imposed by engagement of membrane NKG2D ligands on tumor-associated cells, such as myeloid cells. The results overturn conventional wisdom that soluble ligands are always inhibitory and suggest a new approach for cancer immunotherapy.	[Deng, Weiwen; Gowen, Benjamin G.; Zhang, Li; Wang, Lin; Lau, Stephanie; Iannello, Alexandre; Xu, Jianfeng; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Deng, Weiwen; Gowen, Benjamin G.; Zhang, Li; Wang, Lin; Lau, Stephanie; Iannello, Alexandre; Xu, Jianfeng; Raulet, David H.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Rovis, Tihana L.] Univ Rijeka, Fac Med, Ctr Prote, Rijeka 51000, Croatia; [Xiong, Na] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Rijeka; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@berkeley.edu	wang, lin/GSE-3040-2022; lenac rovis, tihana/C-5857-2018; wang, lili/HDL-7210-2022; wang, lin/HHM-2225-2022; Lenac Rovis, Tihana/ABB-7451-2021; Gowen, Benjamin/E-2977-2015	lenac rovis, tihana/0000-0002-3299-1334; Lenac Rovis, Tihana/0000-0002-3299-1334; Raulet, David/0000-0002-1257-8649; Gowen, Benjamin/0000-0002-1111-3284; Lau, Stephanie/0000-0003-1352-8923	Cancer Research Institute postdoctoral fellowship; National Science Foundation Graduate Research Fellowship; Hirth Chair Graduate Fellowship of University of California, Berkeley; Leukemia and Lymphoma Society Fellowships; NIH-Initiative for Maximizing Student Development grant; NIH [R01 CA093678]; NATIONAL CANCER INSTITUTE [R01CA093678] Funding Source: NIH RePORTER	Cancer Research Institute postdoctoral fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Hirth Chair Graduate Fellowship of University of California, Berkeley; Leukemia and Lymphoma Society Fellowships; NIH-Initiative for Maximizing Student Development grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Nolla and A. Valeros for help with cell sorting; C. Kang for targeting eggs for creating the Raet1 knockout mice; Q. Yan for assistance with Biacore assays; and T. Trevino, L. Bai, S. Li for technical assistance. We thank Raulet Lab members and R. Vance for useful discussion and comments on the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. D.H.R. is an inventor on a patent (U.S. 6821522) filed by University of California, Berkeley describing the use of soluble ligands for immunotherapy of cancer. W.D. was supported by a Cancer Research Institute postdoctoral fellowship. B.G.G. was supported by a National Science Foundation Graduate Research Fellowship and the Hirth Chair Graduate Fellowship of University of California, Berkeley. L.W. and A.I. were supported by Leukemia and Lymphoma Society Fellowships, and S. L. was supported by a NIH-Initiative for Maximizing Student Development grant. This work was supported by NIH grant R01 CA093678 to D.H.R.	Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Chitadze G, 2013, SCAND J IMMUNOL, V78, P120, DOI 10.1111/sji.12072; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Crane CA, 2014, P NATL ACAD SCI USA, V111, P12823, DOI 10.1073/pnas.1413933111; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Eagle RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004503; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Marten A, 2006, INT J CANCER, V119, P2359, DOI 10.1002/ijc.22186; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Nausch N, 2008, BLOOD, V112, P4080, DOI 10.1182/blood-2008-03-143776; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Sheppard S, 2013, BLOOD, V121, P5025, DOI 10.1182/blood-2012-12-471607; Song H, 2006, CELL IMMUNOL, V239, P22, DOI 10.1016/j.cellimm.2006.03.002; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; von Lilienfeld-Toal M, 2010, CANCER IMMUNOL IMMUN, V59, P829, DOI 10.1007/s00262-009-0807-3; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Xia MC, 2011, CIRCULATION, V124, P2933, DOI 10.1161/CIRCULATIONAHA.111.034850; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017	28	172	184	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					136	139		10.1126/science.1258867	http://dx.doi.org/10.1126/science.1258867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25745066	Green Accepted			2022-12-24	WOS:000352079500044
J	Sugimoto, Y; Vigilante, A; Darbo, E; Zirra, A; Militti, C; D'Ambrogio, A; Luscombe, NM; Ule, J				Sugimoto, Yoichiro; Vigilante, Alessandra; Darbo, Elodie; Zirra, Alexandra; Militti, Cristina; D'Ambrogio, Andrea; Luscombe, Nicholas M.; Ule, Jernej			hiCLIP reveals the in vivo atlas of mRNA secondary structures recognized by Staufen 1	NATURE			English	Article							ROUGH ENDOPLASMIC-RETICULUM; INTEGRATIVE GENOMICS VIEWER; THROUGHPUT SEQUENCE DATA; EMBRYONIC STEM-CELLS; BINDING PROTEIN; NUCLEOTIDE RESOLUTION; CROSS-LINKING; WIDE ANALYSIS; ALU ELEMENTS; RIBOSOME	The structure of messenger RNA is important for post-transcriptional regulation, mainly because it affects binding of trans-acting factors(1). However, little is known about the in vivo structure of full-length mRNAs. Here we present hiCLIP, a biochemical technique for transcriptome-wide identification of RNA secondary structures interacting with RNA-binding proteins (RBPs). Using this technique to investigate RNA structures bound by Staufen 1 (STAU1) in human cells, we uncover a dominance of intra-molecular RNA duplexes, a depletion of duplexes from coding regions of highly translated mRNAs, an unexpected prevalence of long-range duplexes in 39 untranslated regions (UTRs), and a decreased incidence of single nucleotide polymorphisms in duplex-forming regions. We also discover a duplex spanning 858 nucleotides in the 39 UTR of the X-box binding protein 1 (XBP1) mRNA that regulates its cytoplasmic splicing and stability. Our study reveals the fundamental role of mRNA secondary structures in gene expression and introduce shiCLIPas a widely applicable method for discovering new, especially long-range, RNA duplexes.	[Sugimoto, Yoichiro; D'Ambrogio, Andrea; Ule, Jernej] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Zirra, Alexandra; Militti, Cristina; D'Ambrogio, Andrea; Ule, Jernej] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Vigilante, Alessandra; Darbo, Elodie; Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England; [Vigilante, Alessandra; Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	MRC Laboratory Molecular Biology; University of London; University College London; Cancer Research UK; University of London; University College London; Okinawa Institute of Science & Technology Graduate University	Ule, J (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	nicholas.luscombe@ucl.ac.uk; j.ule@ucl.ac.uk	D'Ambrogio, Andrea/AAN-9429-2021; Ule, Jernej/C-6315-2013	Ule, Jernej/0000-0002-2452-4277; Sugimoto, Yoichiro/0000-0003-1646-7679; Vigilante, Alessandra/0000-0002-8768-8287	Human Frontier Science Program [RGP0024/2008-C]; European Research Council [206726-CLIP, 617837-Translate]; Medical Research Council [U105185858]; Cancer Research UK; UCL; Wellcome Trust [103760/Z/14/Z]; Nakajima Foundation; MRC; Cancer Research UK [16358] Funding Source: researchfish; Medical Research Council [MC_U105185858] Funding Source: researchfish; The Francis Crick Institute [10110, 10111] Funding Source: researchfish; MRC [MC_U105185858] Funding Source: UKRI	Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); UCL; Wellcome Trust(Wellcome Trust); Nakajima Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank S. Granneman and C. Sibley for discussions on the development of hiCLIP protocol; K. Zarnack, N. Haberman, C. Ravarani and B. Lang for assistance with bioinformatic analyses; D. Daujotyte and P. Lukavsky for sharing the STAU1 plasmid and helping in setting up the project; L. Maquat for sharing the ARF1 SBS plasmid; the genomic team at the Cancer Research UK Cambridge Institute for Illumina HiSeq sequencing, and M. Babu Mohan and Ule group members for support and comments on the manuscript. This work was supported by funding from Human Frontier Science Program (RGP0024/2008-C), European Research Council (206726-CLIP and 617837-Translate) and Medical Research Council (U105185858) to J.U., Cancer Research UK and UCL to N.M.L., a Wellcome Trust Joint Investigator Award to N.M.L. and J.U. (103760/Z/14/Z), the Nakajima Foundation fellowship and MRC Centenary Early Career Award to Y.S.	Aboyoun P., PLOS COMPUTATIONAL B, V9; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Bartonicek N, 2010, BIOINFORMATICS, V26, P2900, DOI 10.1093/bioinformatics/btq545; Boulay K, 2014, NUCLEIC ACIDS RES, V42, P7867, DOI 10.1093/nar/gku506; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Day DS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r69; de Lucas S, 2014, NUCLEIC ACIDS RES, V42, P4516, DOI 10.1093/nar/gku073; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Goodarzi H, 2014, NATURE, V513, P256, DOI 10.1038/nature13466; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heraud-Farlow JE, 2014, TRENDS NEUROSCI, V37, P470, DOI 10.1016/j.tins.2014.05.009; Heraud-Farlow JE, 2013, CELL REP, V5, P1511, DOI 10.1016/j.celrep.2013.11.039; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laver JD, 2013, NUCLEIC ACIDS RES, V41, P9438, DOI 10.1093/nar/gkt702; LeGendre JB, 2013, J BIOL CHEM, V288, P2532, DOI 10.1074/jbc.M112.397349; Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Luo M, 2002, BIOCHEM J, V365, P817, DOI 10.1042/BJ20020263; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2012, LANG ENV STAT COMP; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ricci EP, 2014, NAT STRUCT MOL BIOL, V21, P26, DOI 10.1038/nsmb.2739; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; The Bioconductor Dev Team, BSGENOME HS UCSC HG1; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023	59	187	192	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					491	+		10.1038/nature14280	http://dx.doi.org/10.1038/nature14280			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799984	Green Accepted			2022-12-24	WOS:000351602800060
J	Ngo, TTM; Zhang, QC; Zhou, RB; Yodh, JG; Ha, T				Ngo, Thuy T. M.; Zhang, Qiucen; Zhou, Ruobo; Yodh, Jaya G.; Ha, Taekjip			Asymmetric Unwrapping of Nucleosomes under Tension Directed by DNA Local Flexibility	CELL			English	Article							SINGLE-MOLECULE FRET; RNA-POLYMERASE-II; CORE PARTICLE; PAIR FRET; TRANSCRIPTION; CHROMATIN; DYNAMICS; FORCE; SEQUENCE; STABILITY	Dynamics of the nucleosome and exposure of nucleosomal DNA play key roles in many nuclear processes, but local dynamics of the nucleosome and its modulation by DNA sequence are poorly understood. Using single-molecule assays, we observed that the nucleosome can unwrap asymmetrically and directionally under force. The relative DNA flexibility of the inner quarters of nucleosomal DNA controls the unwrapping direction such that the nucleosome unwraps from the stiffer side. If the DNA flexibility is similar on two sides, it stochastically unwraps from either side. The two ends of the nucleosome are orchestrated such that the opening of one end helps to stabilize the other end, providing a mechanism to amplify even small differences in flexibility to a large asymmetry in nucleosome stability. Our discovery of DNA flexibility as a critical factor for nucleosome dynamics and mechanical stability suggests a novel mechanism of gene regulation by DNA sequence and modifications.	[Ngo, Thuy T. M.; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Zhang, Qiucen; Zhou, Ruobo; Yodh, Jaya G.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Yodh, JG (corresponding author), Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA.	jyodh@illinois.edu; tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Zhou, Ruobo/0000-0001-8628-0282	NIH [GM065367]; National Science Foundation Physics Frontiers Center program [PHY 0822613, PHY 1430124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1430124] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Physics Frontiers Center program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NIH (GM065367) and by the National Science Foundation Physics Frontiers Center program (PHY 0822613 and PHY 1430124). We thank A.J. Spakowitz for providing the energy function used for Monte Carlo simulations. T.H. is an investigator with the Howard Hughes Medical Institute.	Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Bintu L, 2011, NAT STRUCT MOL BIOL, V18, P1394, DOI 10.1038/nsmb.2164; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Koopmans WJA, 2007, J FLUORESC, V17, P785, DOI 10.1007/s10895-007-0218-9; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kruithof M, 2009, BIOPHYS J, V96, P3708, DOI [10.1016/j.bpj.2009.01.048, 10.1016/j.bpj.2009.01.04X]; Kulaeva OI, 2013, MOL BIOL+, V47, P655, DOI 10.1134/S0026893313050099; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mack AH, 2012, J MOL BIOL, V423, P687, DOI 10.1016/j.jmb.2012.08.021; Maffeo C, 2014, J CHEM THEORY COMPUT, V10, P2891, DOI 10.1021/ct500193u; Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Mirsaidov U, 2009, BIOPHYS J, V96, pL32, DOI 10.1016/j.bpj.2008.12.3760; Mollazadeh-Beidokhti L, 2012, BIOPHYS J, V102, P2235, DOI 10.1016/j.bpj.2012.04.012; Nag R, 2009, MUTAT RES-REV MUTAT, V682, P13, DOI 10.1016/j.mrrev.2009.01.002; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Richard P, 2013, NAT STRUCT MOL BIOL, V20, P1022, DOI 10.1038/nsmb.2657; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Severin PMD, 2011, NUCLEIC ACIDS RES, V39, P8740, DOI 10.1093/nar/gkr578; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Sudhanshu B, 2011, P NATL ACAD SCI USA, V108, P1885, DOI 10.1073/pnas.1010047108; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Toth K, 2013, CYTOM PART A, V83, P839, DOI 10.1002/cyto.a.22320; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Yen KY, 2013, CELL, V154, P1246, DOI 10.1016/j.cell.2013.08.043; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036; Zhou RB, 2010, METHOD ENZYMOL, V475, P405, DOI 10.1016/S0076-6879(10)75016-3	54	173	179	3	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1135	1144		10.1016/j.cell.2015.02.001	http://dx.doi.org/10.1016/j.cell.2015.02.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768909	Green Accepted, Bronze			2022-12-24	WOS:000351951800013
J	Shi, FZ; Zhang, Q; Wang, PF; Sun, HB; Wang, JR; Rong, X; Chen, M; Ju, CY; Reinhard, F; Chen, HW; Wrachtrup, J; Wang, JF; Du, JF				Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Sun, Hongbin; Wang, Jiarong; Rong, Xing; Chen, Ming; Ju, Chenyong; Reinhard, Friedemann; Chen, Hongwei; Wrachtrup, Joerg; Wang, Junfeng; Du, Jiangfeng			Single-protein spin resonance spectroscopy under ambient conditions	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SITE-DIRECTED SPIN; ELECTRON-SPIN; COHERENCE TIME; DIAMOND; RESOLUTION; SENSITIVITY	Magnetic resonance is essential in revealing the structure and dynamics of biomolecules. However, measuring the magnetic resonance spectrum of single biomolecules has remained an elusive goal. We demonstrate the detection of the electron spin resonance signal from a single spin-labeled protein under ambient conditions. As a sensor, we use a single nitrogen vacancy center in bulk diamond in close proximity to the protein. We measure the orientation of the spin label at the protein and detect the impact of protein motion on the spin label dynamics. In addition, we coherently drive the spin at the protein, which is a prerequisite for studies involving polarization of nuclear spins of the protein or detailed structure analysis of the protein itself.	[Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Rong, Xing; Chen, Ming; Ju, Chenyong; Du, Jiangfeng] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Rong, Xing; Chen, Ming; Ju, Chenyong; Du, Jiangfeng] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Rong, Xing; Chen, Ming; Ju, Chenyong; Du, Jiangfeng] Univ Sci & Technol China, Inst Biophys, Joint Lab Quantum Biophys, Hefei 230026, Peoples R China; [Shi, Fazhan; Zhang, Qi; Wang, Pengfei; Rong, Xing; Chen, Ming; Ju, Chenyong; Du, Jiangfeng] Chinese Acad Sci, Hefei 230000, Peoples R China; [Shi, Fazhan; Wang, Pengfei; Rong, Xing; Ju, Chenyong; Du, Jiangfeng] Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Hefei 230026, Peoples R China; [Sun, Hongbin; Wang, Jiarong; Chen, Hongwei; Wang, Junfeng] Chinese Acad Sci, High Magnet Field Lab, Hefei 230000, Peoples R China; [Reinhard, Friedemann; Wrachtrup, Joerg] Univ Stuttgart, Phys & Integrated Quantum Sci & Technol IQST 3, D-70569 Stuttgart, Germany	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; University of Stuttgart	Du, JF (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	djf@ustc.edu.cn	Sun, Hongbin/C-9721-2015; rong, xing/N-3145-2015; rong, xing/T-2896-2019	Sun, Hongbin/0000-0002-7712-0655; rong, xing/0000-0001-8788-0896; rong, xing/0000-0001-8788-0896; Zhang, Qi/0000-0001-8889-2039; Wang, Pengfei/0000-0001-5112-0502; Reinhard, Friedemann/0000-0001-6273-7399	973 Program [2013CB921800, 2012CB917202]; National Natural Science Foundation of China [11227901, 91021005, 31470835, 11275183, 21103199]; Chinese Academy of Sciences; Max Planck Society; European Union (via the ERC grant SQUTEC); European Union (via the ERC grant DIADEMS); Baden-Wurttemberg Stiftung	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union (via the ERC grant SQUTEC); European Union (via the ERC grant DIADEMS); Baden-Wurttemberg Stiftung	We thank F. Jelezko for helpful discussions. Supported by 973 Program grants 2013CB921800 and 2012CB917202, National Natural Science Foundation of China grants 11227901, 91021005, 31470835, 11275183, and 21103199, and the Chinese Academy of Sciences. J.W. was supported by the Max Planck Society and the European Union (via the ERC grants SQUTEC and DIADEMS) and by the Baden-Wurttemberg Stiftung.	Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Bar-Gill N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2771; Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773; Borbat PP, 2001, SCIENCE, V291, P266, DOI 10.1126/science.291.5502.266; Chen CC, 2013, NATURE, V496, P74, DOI 10.1038/nature12009; Doherty MW, 2013, PHYS REP, V528, P1, DOI 10.1016/j.physrep.2013.02.001; Gaponenko V, 2000, PROTEIN SCI, V9, P302; Grinolds MS, 2014, NAT NANOTECHNOL, V9, P279, DOI [10.1038/NNANO.2014.30, 10.1038/nnano.2014.30]; Grinolds MS, 2013, NAT PHYS, V9, P215, DOI [10.1038/NPHYS2543, 10.1038/nphys2543]; Grotz B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/055004; Hemminga M. A., 2007, ESR SPECTROSCOPY MEM, P133; Jacobsen K, 2005, BIOPHYS J, V88, P4351, DOI 10.1529/biophysj.105.059725; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; MANASSEN Y, 1989, PHYS REV LETT, V62, P2531, DOI 10.1103/PhysRevLett.62.2531; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Muller C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5703; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Schaffry M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.207210; Shi FZ, 2014, NAT PHYS, V10, P21, DOI [10.1038/NPHYS2814, 10.1038/nphys2814]; Shi FZ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195414; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Sushkov AO, 2014, NANO LETT, V14, P6443, DOI 10.1021/nl502988n; Sushkov AO, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.197601; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Weil J. A., 2007, ELECT PARAMAGNETIC R, P316; Xiao M, 2004, NATURE, V430, P435, DOI 10.1038/nature02727	31	223	237	18	387	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1135	1138		10.1126/science.aaa2253	http://dx.doi.org/10.1126/science.aaa2253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745170				2022-12-24	WOS:000350354200052
J	Coffelt, SB; Kersten, K; Doornebal, CW; Weiden, J; Vrijland, K; Hau, CS; Verstegen, NJM; Ciampricotti, M; Hawinkels, LJAC; Jonkers, J; de Visser, KE				Coffelt, Seth B.; Kersten, Kelly; Doornebal, Chris W.; Weiden, Jorieke; Vrijland, Kim; Hau, Cheei-Sing; Verstegen, Niels J. M.; Ciampricotti, Metamia; Hawinkels, Lukas J. A. C.; Jonkers, Jos; de Visser, Karin E.			IL-17-producing gamma delta T cells and neutrophils conspire to promote breast cancer metastasis	NATURE			English	Article							COLONY-STIMULATING FACTOR; MAMMARY-CARCINOMA; MOUSE MODEL; TUMOR; PROGRESSION; BETA; INFLAMMATION; RECRUITMENT; SUPPRESSION; INDUCTION	Metastatic disease remains the primary cause of death for patients with breast cancer. The different steps of the metastatic cascade rely on reciprocal interactions between cancer cells and their microenvironment. Within this local microenvironment and in distant organs, immune cells and their mediators are known to facilitate metastasis formation(1,2). However, theprecisecontributionof tumour-induced systemic inflammation to metastasis and the mechanisms regulating systemic inflammation are poorly understood. Here we show that tumours maximize their chance of metastasizing by evoking a systemic inflammatory cascade in mouse models of spontaneous breast cancer metastasis. We mechanistically demonstrate that interleukin (IL)-1 beta elicits IL-17 expression from gamma delta (gamma delta) T cells, resulting in systemic, granulocyte colony-stimulating factor (G-CSF)-dependent expansion and polarization of neutrophils in mice bearing mammary tumours. Tumour-induced neutrophils acquire the ability to suppress cytotoxic T lymphocytes carrying the CD8 antigen, which limit the establishment of metastases. Neutralization of IL-17 or G-CSF and absence of gamma delta T cells prevents neutrophil accumulation and downregulates the T-cell-suppressive phenotype of neutrophils. Moreover, the absence of gamma delta T cells or neutrophils profoundly reduces pulmonary and lymph node metastases without influencing primary tumour progression. Our data indicate that targeting this novel cancer-cell-initiated domino effect within the immune system-the gamma delta T cell/IL-17/neutrophil axis-represents a new strategy to inhibit metastatic disease.	[Coffelt, Seth B.; Kersten, Kelly; Doornebal, Chris W.; Weiden, Jorieke; Vrijland, Kim; Hau, Cheei-Sing; Verstegen, Niels J. M.; Ciampricotti, Metamia; de Visser, Karin E.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Hawinkels, Lukas J. A. C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Hawinkels, Lukas J. A. C.] Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands; [Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	de Visser, KE (corresponding author), Netherlands Canc Inst, Div Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	k.d.visser@nki.nl	Coffelt, Seth/O-9929-2019; Jonkers, Jos/AAG-3246-2019; Hawinkels, Lukas/Q-5098-2019; Weiden, Jorieke/M-5843-2015	Coffelt, Seth/0000-0003-2257-2862; Jonkers, Jos/0000-0002-9264-9792; Hawinkels, Lukas/0000-0002-2274-9325; Weiden, Jorieke/0000-0002-2485-0590; Verstegen, Niels/0000-0001-5732-4979; ciampricotti, metamia/0000-0001-5382-0481; de Visser, Karin/0000-0002-0293-868X	Marie Curie Intra-European Fellowship [BMDCMET 275610]; European Research Council [INFLAMET 615300]; Dutch Cancer Society [2011-5004]; Worldwide Cancer Research [AICR 11-0677]; Netherlands Organization for Scientific Research NWO VIDI [917.96.307]; Dutch Cancer Society/Bas Mulder Award [UL2011-5051]; Worldwide Cancer Research [11-0677] Funding Source: researchfish	Marie Curie Intra-European Fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission); Dutch Cancer Society(KWF Kankerbestrijding); Worldwide Cancer Research; Netherlands Organization for Scientific Research NWO VIDI(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society/Bas Mulder Award; Worldwide Cancer Research	This work was supported by a Marie Curie Intra-European Fellowship to S.B.C. (BMDCMET 275610); a European Research Council Consolidator award (INFLAMET 615300) to K.E.dV; grants from the Dutch Cancer Society to K.E.dV and J.J. (2011-5004); Worldwide Cancer Research (AICR 11-0677) to K.E.dV; the Netherlands Organization for Scientific Research NWO VIDI (917.96.307) to K.E.dV; and a Dutch Cancer Society/Bas Mulder Award to L.J.A.C.H. (UL2011-5051). We thank J. Borst, T. Schumacher and J. Coquet for discussions. We thank the core facilities at the Netherlands Cancer Institute. We thank L. Coussens for Rag1<SUP>-/-</SUP> mice and A. Hayday for Tcrd<SUP>-/-</SUP> mice. We thank C. Ries and K. Wartha for technical assistance.	Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chen WC, 2013, HISTOPATHOLOGY, V63, P225, DOI 10.1111/his.12156; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Ciampricotti M, 2012, NAT MED, V18, P344, DOI 10.1038/nm.2652; Ciampricotti M, 2011, J PATHOL, V224, P56, DOI 10.1002/path.2837; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Doornebal CW, 2013, CANCER RES, V73, P353, DOI 10.1158/0008-5472.CAN-11-4208; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Han YW, 2012, BREAST CANCER RES TR, V131, P483, DOI 10.1007/s10549-011-1799-1; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kuonen F, 2012, CLIN CANCER RES, V18, P4365, DOI 10.1158/1078-0432.CCR-11-3028; LEJEUNE P, 1994, J IMMUNOL, V152, P5077; Ma CL, 2012, J IMMUNOL, V189, P5029, DOI 10.4049/jimmunol.1201892; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Mei JJ, 2012, J CLIN INVEST, V122, P974, DOI 10.1172/JCI60588; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Novitskiy SV, 2011, CANCER DISCOV, V1, P430, DOI 10.1158/2159-8290.CD-11-0100; Pillay J, 2013, CELL MOL LIFE SCI, V70, P3813, DOI 10.1007/s00018-013-1286-4; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Young MRI, 1996, J IMMUNOL, V156, P1916	34	954	992	10	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					345	+		10.1038/nature14282	http://dx.doi.org/10.1038/nature14282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25822788	Green Accepted			2022-12-24	WOS:000356425400054
J	Okun, M; Steinmetz, NA; Cossell, L; Iacaruso, MF; Ko, H; Bartho, P; Moore, T; Hofer, SB; Mrsic-Flogel, TD; Carandini, M; Harris, KD				Okun, Michael; Steinmetz, Nicholas A.; Cossell, Lee; Iacaruso, M. Florencia; Ko, Ho; Bartho, Peter; Moore, Tirin; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Carandini, Matteo; Harris, Kenneth D.			Diverse coupling of neurons to populations in sensory cortex	NATURE			English	Article							PRIMARY VISUAL-CORTEX; FUNCTIONAL-ORGANIZATION; PROJECTION NEURONS; IN-VIVO; DYNAMICS; RECORDINGS; RESPONSES; STATE	A large population of neurons can, in principle, produce an astronomical number of distinct firing patterns. In cortex, however, these patterns lie in a space of lower dimension(1-4), as if individual neurons were "obedientmembers of a huge orchestra''(5). Here we use recordings from the visual cortex of mouse (Mus musculus) and monkey (Macaca mulatta) to investigate the relationship between individual neurons and the population, and to establish the underlying circuit mechanisms. We show that neighbouring neurons can differ in their coupling to the overall firing of the population, ranging from strongly coupled 'choristers' to weakly coupled 'soloists'. Population coupling is largely independent of sensory preferences, and it is a fixed cellular attribute, invariant to stimulus conditions. Neurons with high population coupling are more strongly affected by non-sensory behavioural variables such as motor intention. Population coupling reflects a causal relationship, predicting the response of a neuron to optogenetically driven increases in local activity. Moreover, population coupling indicates synaptic connectivity; the population coupling of a neuron, measured in vivo, predicted subsequent in vitro estimates of the number of synapses received from its neighbours. Finally, population coupling provides a compact summary of population activity; knowledge of the population couplings of n neurons predicts a substantial portion of their n(2) pairwise correlations. Population coupling therefore represents a novel, simple measure that characterizes the relationship of each neuron to a larger population, explaining seemingly complex network firing patterns in terms of basic circuit variables.	[Okun, Michael; Steinmetz, Nicholas A.; Harris, Kenneth D.] UCL, UCL Inst Neurol, London WC1N 3BG, England; [Okun, Michael; Steinmetz, Nicholas A.; Cossell, Lee; Iacaruso, M. Florencia; Ko, Ho; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.; Harris, Kenneth D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England; [Okun, Michael; Steinmetz, Nicholas A.; Carandini, Matteo] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Steinmetz, Nicholas A.; Moore, Tirin] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Steinmetz, Nicholas A.; Moore, Tirin] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Cossell, Lee; Iacaruso, M. Florencia; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Bartho, Peter; Harris, Kenneth D.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	University of London; University College London; University of London; University College London; University of London; University College London; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Basel; Rutgers State University Newark; Rutgers State University New Brunswick	Okun, M (corresponding author), UCL, UCL Inst Neurol, London WC1N 3BG, England.	m.okun@ucl.ac.uk; kenneth.harris@ucl.ac.uk	Steinmetz, Nick/B-8555-2018; Carandini, Matteo/ABD-8296-2021; Ko, Ho/AAH-2755-2020; Ko, Ho/I-7513-2016	Steinmetz, Nick/0000-0001-7029-2908; Carandini, Matteo/0000-0003-4880-7682; Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274; Hofer, Sonja/0000-0003-4921-8521; Harris, Kenneth/0000-0002-5930-6456; Okun, Michael/0000-0002-7795-5513; Mrsic-Flogel, Tom/0000-0002-8947-408X	Wellcome Trust; Engineering and Physical Sciences Research Council; European Research Council; Medical Research Council; National Institutes of Health [EY014924]; Simons Foundation; EPSRC [EP/I005102/1, EP/K015141/1, EP/I005102/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K015141/1, EP/I005102/1, EP/I005102/2] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY014924, R56EY014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Buesing for advice on latent variable analysis, C. Reddy and T. Sato for technical assistance, and M. Hausser for advice on the manuscript. This work was supported by the Wellcome Trust (S.B.H., T.D.M.-F., M.C., K.D.H.), Engineering and Physical Sciences Research Council (K.D.H.), the European Research Council (T.D.M.-F.), the Medical Research Council (L.C.), National Institutes of Health (EY014924, N.A.S. and T.M.) and the Simons Foundation (M.C. and K.D.H.). M.C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Dorn JD, 2003, J NEUROPHYSIOL, V89, P2271, DOI 10.1152/jn.000889.2002; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Gulati T, 2014, NAT NEUROSCI, V17, P1107, DOI 10.1038/nn.3759; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Kenet T., 2006, 23 PROBLEMS SYSTEMS; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2013, J NEUROSCI, V33, P1684, DOI 10.1523/JNEUROSCI.2928-12.2013; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Macke Jakob H, 2012, ADV NEURAL INFORM PR, V24, P1350; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Martin KAC, 2013, J NEUROSCI, V33, P7325, DOI 10.1523/JNEUROSCI.4071-12.2013; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Okun M, 2012, J NEUROSCI, V32, P17108, DOI 10.1523/JNEUROSCI.1831-12.2012; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Paninski L., 2013, ADV NEURAL INF PROCE, V26, P2391; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Steinmetz NA, 2014, NEURON, V83, P496, DOI 10.1016/j.neuron.2014.06.014; Tkacik G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003408; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Yamashita T, 2013, NEURON, V80, P1477, DOI 10.1016/j.neuron.2013.10.059; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008; Zagha E, 2013, NEURON, V79, P567, DOI 10.1016/j.neuron.2013.06.008	42	211	214	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					511	U189		10.1038/nature14273	http://dx.doi.org/10.1038/nature14273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25849776	Green Submitted, Green Accepted			2022-12-24	WOS:000355286600041
J	Lujan, E; Zunder, ER; Ng, YH; Goronzy, IN; Nolan, GP; Wernig, M				Lujan, Ernesto; Zunder, Eli R.; Ng, Yi Han; Goronzy, Isabel N.; Nolan, Garry P.; Wernig, Marius			Early reprogramming regulators identified by prospective isolation and mass cytometry	NATURE			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; MOLECULAR ROADMAP; FIBROBLASTS; EXPRESSION; INDUCTION; MARKERS	In the context of most induced pluripotent stem(iPS) cell reprogramming methods, heterogeneous populations of non-productive and staggered productive intermediates arise at different reprogramming time points(1-11). Despite recent reports claiming substantially increased reprogramming efficiencies using genetically modified donor cells(12,13), prospectively isolating distinct reprogramming intermediates remains an important goal to decipher reprogramming mechanisms. Previous attempts to identify surface markers of intermediate cell populations were based on the assumption that, during reprogramming, cells progressively lose donor cell identity and gradually acquire iPS cell properties(1,2,7,8,10). Here we report that iPS cell and epithelial markers, such as SSEA1 and EpCAM, respectively, are not predictive of reprogramming during early phases. Instead, in a systematic functional surface marker screen, we find that early reprogramming-prone cells express a unique set of surface markers, including CD73, CD49d and CD200, that are absent in both fibroblasts and iPS cells. Single-cell mass cytometry and prospective isolation show that these distinct intermediates are transient and bridge the gap between donor cell silencing and pluripotency marker acquisition during the early, presumably stochastic, reprogramming phase(2). Expression profiling reveals early upregulation of the transcriptional regulators Nr0b1 and Etv5 in this reprogramming state, preceding activation of key pluripotency regulators such asRex1 (also known as Zfp42), Dppa2, Nanog and Sox2. Both factors are required for the generation of the early intermediate state and fully reprogrammed iPS cells, and thus represent some of the earliest known regulators of iPS cell induction. Our study deconvolutes the first steps in a hierarchical series of events that lead to pluripotency acquisition.	[Lujan, Ernesto; Ng, Yi Han; Goronzy, Isabel N.; Wernig, Marius] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lujan, Ernesto] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lujan, Ernesto; Ng, Yi Han; Goronzy, Isabel N.; Wernig, Marius] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Zunder, Eli R.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Ng, Yi Han] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Wernig, M (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	wernig@stanford.edu	Nolan, Garry/AAE-7903-2019	Zunder, Eli/0000-0002-0356-1685; Nolan, Garry/0000-0002-8862-9043	California Institute of Regenerative Medicine [RB2-01592]; Institute for Stem Cell Biology and Regenerative Medicine at Stanford; New York Stem Cell Foundation-Robertson Investigator Award; California Institute for Regenerative Medicine Predoctoral Fellowship [TG2-01159]; National Science Foundation Graduate Research Fellowship [DGE-114747]; National Institutes of Health National Research Service Award [F32 GM093508-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Institute for Stem Cell Biology and Regenerative Medicine at Stanford; New York Stem Cell Foundation-Robertson Investigator Award; California Institute for Regenerative Medicine Predoctoral Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Lovelace, R. Finck, K. M. Loh, K. Tanabe and S. Marro for advice. We thank J. Hanna for his the secondary Mbd3<SUP>fl/-</SUP> MEFs. We also thank S. Knobel for them EF-SK4 antibody. This work was supported by the California Institute of Regenerative Medicine grant RB2-01592 (to G.P.N.), the Institute for Stem Cell Biology and Regenerative Medicine at Stanford, and a New York Stem Cell Foundation-Robertson Investigator Award. E.L. was supported by the California Institute for Regenerative Medicine Predoctoral Fellowship TG2-01159 and National Science Foundation Graduate Research Fellowship DGE-114747. E.R.Z. was supported by National Institutes of Health National Research Service Award F32 GM093508-01. M.W. is a New York Stem Cell Foundation-Robertson Investigator and a Tashia and John Morgridge Faculty Scholar at the Child Health Research Institute at Stanford.	Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Linderman MD, 2012, BIOINFORMATICS, V28, P2400, DOI 10.1093/bioinformatics/bts425; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhang JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6042; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	31	69	71	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					352	+		10.1038/nature14274	http://dx.doi.org/10.1038/nature14274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25830878	Green Accepted			2022-12-24	WOS:000354816500056
J	Falk, SJ; Guo, LY; Sekulic, N; Smoak, EM; Mani, T; Logsdon, GA; Gupta, K; Jansen, LET; Van Duyne, GD; Vinogradov, SA; Lampson, MA; Black, BE				Falk, Samantha J.; Guo, Lucie Y.; Sekulic, Nikolina; Smoak, Evan M.; Mani, Tomoyasu; Logsdon, Glennis A.; Gupta, Kushol; Jansen, Lars E. T.; Van Duyne, Gregory D.; Vinogradov, Sergei A.; Lampson, Michael A.; Black, Ben E.			CENP-C reshapes and stabilizes CENP-A nucleosomes at the centromere	SCIENCE			English	Article							CRYSTAL-STRUCTURE; CHROMATIN; PROPAGATION; RECOGNITION; MECHANISM; FEATURES; REVEALS; OCTAMER	Inheritance of each chromosome depends upon its centromere. A histone H3 variant, centromere protein A (CENP-A), is essential for epigenetically marking centromere location. We find that CENP-A is quantitatively retained at the centromere upon which it is initially assembled. CENP-C binds to CENP-A nucleosomes and is a prime candidate to stabilize centromeric chromatin. Using purified components, we find that CENP-C reshapes the octameric histone core of CENP-A nucleosomes, rigidifies both surface and internal nucleosome structure, and modulates terminal DNA to match the loose wrap that is found on native CENP-A nucleosomes at functional human centromeres. Thus, CENP-C affects nucleosome shape and dynamics in a manner analogous to allosteric regulation of enzymes. CENP-C depletion leads to rapid removal of CENP-A from centromeres, indicating their collaboration in maintaining centromere identity.	[Falk, Samantha J.; Guo, Lucie Y.; Sekulic, Nikolina; Smoak, Evan M.; Mani, Tomoyasu; Logsdon, Glennis A.; Gupta, Kushol; Van Duyne, Gregory D.; Vinogradov, Sergei A.; Black, Ben E.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Falk, Samantha J.; Lampson, Michael A.; Black, Ben E.] Univ Penn, Grad Program Cell & Mol Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Guo, Lucie Y.; Smoak, Evan M.; Mani, Tomoyasu; Logsdon, Glennis A.; Van Duyne, Gregory D.; Vinogradov, Sergei A.; Lampson, Michael A.; Black, Ben E.] Univ Penn, Grad Program Biochem & Mol Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smoak, Evan M.; Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Jansen, Lars E. T.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Instituto Gulbenkian de Ciencia	Black, BE (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA.	blackbe@mail.med.upenn.edu	Mani, Tomoyasu/B-2241-2012; Sekulic, Nikolina/N-5550-2016; Gupta, Kushol/GOE-5620-2022; MANI, TOMOYASU/AAS-5058-2021	Mani, Tomoyasu/0000-0002-4125-5195; Sekulic, Nikolina/0000-0001-7555-3222; Gupta, Kushol/0000-0002-7006-2667; MANI, TOMOYASU/0000-0002-4125-5195; Logsdon, Glennis/0000-0003-2396-0656; Jansen, Lars/0000-0002-2158-0345	NIH [GM082989, CA186430, GM008275, GM008216, GM007229]; European Research Council [ERC-2013-CoG-615638]; American Heart Association; American Cancer Society; NSF [DMR-0944772]; NATIONAL CANCER INSTITUTE [F30CA186430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229, T32GM008216, T32GM008275, R01GM082989, S06GM008216, R01GM083988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our University of Pennsylvania colleagues (J. Bell, C. Bialas, J. DeNizio, Y. Goldman, W. Hu, L. Lippert, L. Mayne, T. Panchenko, B. Turegun, and Z. Zhao) and S. Krueger and K. Sarachan [National Institute of Standards and Technology (NIST)] for assistance and advice with experiments; A. Straight (Stanford) for reagents and advice; and D. Cleveland (University of California, San Diego), J. Lippincott-Schwartz (NIH), K. Luger (Colorado State University), and E. Makeyev (Nanyang Technical University) for reagents. This work was supported by NIH grant GM082989 (B. E. B.), European Research Council grant ERC-2013-CoG-615638 (L. E. T. J.), predoctoral fellowships from the American Heart Association (E.M.S.) and NIH (CA186430, L.Y.G.), and a postdoctoral fellowship from the American Cancer Society (N.S.). We acknowledge support from NIH grants GM008275 (UPenn Structural Biology Training Grant, L.Y.G. and E.M.S), GM008216 (UPenn Genetics Training Grant, S.J.F.), and GM007229 (UPenn Cell and Molecular Biology Training Grant, G.A.L.). This work used facilities supported in part by NSF (agreement DMR-0944772). We acknowledge the support of NIST in providing the neutron research facilities used in this work.	Bassett EA, 2012, DEV CELL, V22, P749, DOI 10.1016/j.devcel.2012.02.001; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bodor DL, 2013, MOL BIOL CELL, V24, P923, DOI 10.1091/mbc.E13-01-0034; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Harp JM, 1996, ACTA CRYSTALLOGR D, V52, P283, DOI 10.1107/S0907444995009139; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258	16	135	136	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					699	703		10.1126/science.1259308	http://dx.doi.org/10.1126/science.1259308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954010	Green Accepted, Green Submitted			2022-12-24	WOS:000354045700047
J	Zhang, CX; Chen, CH; Dong, HX; Shen, JR; Dau, H; Zhao, JQ				Zhang, Chunxi; Chen, Changhui; Dong, Hongxing; Shen, Jian-Ren; Dau, Holger; Zhao, Jingquan			A synthetic Mn4Ca-cluster mimicking the oxygen-evolving center of photosynthesis	SCIENCE			English	Article							PHOTOSYSTEM-II; SPECTROSCOPIC PROPERTIES; ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURE; PROTON-TRANSFER; WATER; COMPLEX; BINDING; CLUSTER; MODELS	Photosynthetic splitting of water into oxygen by plants, algae, and cyanobacteria is catalyzed by the oxygen-evolving center (OEC). Synthetic mimics of the OEC, which is composed of an asymmetric manganese-calcium-oxygen cluster bound to protein groups, may promote insight into the structural and chemical determinants of biological water oxidation and lead to development of superior catalysts for artificial photosynthesis. We synthesized a Mn4Ca-cluster similar to the native OEC in both the metal-oxygen core and the binding protein groups. Like the native OEC, the synthetic cluster can undergo four redox transitions and shows two magnetic resonance signals assignable to redox and structural isomerism. Comparison with previously synthesized Mn3CaO4-cubane clusters suggests that the fourth Mn ion determines redox potentials and magnetic properties of the native OEC.	[Zhang, Chunxi; Zhao, Jingquan] Chinese Acad Sci, Inst Chem, Lab Photochem, Beijing 100190, Peoples R China; [Chen, Changhui; Dong, Hongxing] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Harbin 150001, Peoples R China; [Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Photosynth Res Ctr, Okayama 7008530, Japan; [Dau, Holger] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany	Chinese Academy of Sciences; Institute of Chemistry, CAS; Harbin Engineering University; Okayama University; Free University of Berlin	Zhang, CX (corresponding author), Chinese Acad Sci, Inst Chem, Lab Photochem, Beijing 100190, Peoples R China.	chunxizhang@iccas.ac.cn; dhongxing@hrbeu.edu.cn; holger.dau@fu-berlin.de	Zhang, Chunxi/H-9435-2017; zhao, jing/B-3868-2019; Shen, Jian-Ren/B-2558-2011	Zhang, Chunxi/0000-0002-8483-6897; Dau, Holger/0000-0001-6482-7494; Chen, Changhui/0000-0001-5703-5894	National Natural Science Foundation of China [20973186, 31070216, 21076049, 91427303]; Chinese Academy of Sciences [KJCX2-YW-W25]; Japan Society for the Promotion of Science [24000018/Shen]; Deutsche Forschungsgemeinschaft [CRC 1078, A4/Dau]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the National Natural Science Foundation of China (nos. 20973186, 31070216, 21076049, and 91427303), Chinese Academy of Sciences (KJCX2-YW-W25), Japan Society for the Promotion of Science (no. 24000018/Shen), and by the Deutsche Forschungsgemeinschaft (CRC 1078, A4/Dau). We thank A. Zouni and W. Junge for their suggestions. Crystallographic data have been deposited at the Cambridge Crystallographic Database Centre, and the deposition numbers are 1042697(I), 1042515 (II), and 1042514 (III).	Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Boussac A, 2000, BBA-BIOENERGETICS, V1457, P145, DOI 10.1016/S0005-2728(00)00073-6; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; Dismukes GC, 2009, ACCOUNTS CHEM RES, V42, P1935, DOI 10.1021/ar900249x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Junge W, 2002, PHILOS T ROY SOC B, V357, P1407, DOI 10.1098/rstb.2002.1137; Kanady JS, 2014, J AM CHEM SOC, V136, P14373, DOI 10.1021/ja508160x; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; Krewald V, 2013, J AM CHEM SOC, V135, P5726, DOI 10.1021/ja312552f; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Mullins CS, 2008, COORDIN CHEM REV, V252, P416, DOI 10.1016/j.ccr.2007.07.021; Navarro MP, 2013, P NATL ACAD SCI USA, V110, P15561, DOI 10.1073/pnas.1304334110; Nilsson H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5305; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Sproviero EM, 2008, J AM CHEM SOC, V130, P3428, DOI 10.1021/ja076130q; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Tsui EY, 2013, P NATL ACAD SCI USA, V110, P10084, DOI 10.1073/pnas.1302677110; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VASS I, 1991, BIOCHEMISTRY-US, V30, P830, DOI 10.1021/bi00217a037; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	347	358	31	744	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					690	693		10.1126/science.aaa6550	http://dx.doi.org/10.1126/science.aaa6550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954008				2022-12-24	WOS:000354045700045
J	Carmi, Y; Spitzer, MH; Linde, IL; Burt, BM; Prestwood, TR; Perlman, N; Davidson, MG; Kenkel, JA; Segal, E; Pusapati, GV; Bhattacharya, N; Engleman, EG				Carmi, Yaron; Spitzer, Matthew H.; Linde, Ian L.; Burt, Bryan M.; Prestwood, Tyler R.; Perlman, Nicola; Davidson, Matthew G.; Kenkel, Justin A.; Segal, Ehud; Pusapati, Ganesh V.; Bhattacharya, Nupur; Engleman, Edgar G.			Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity	NATURE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; CHRONIC INFLAMMATION; METASTATIC MELANOMA; PANCREATIC-CANCER; TUMOR-REGRESSION; ANTIBODIES; HOST; IMMUNOGLOBULIN; IMMUNOTHERAPY; RECEPTORS	Whereas cancers grow within host tissues and evade host immunity through immune-editing and immunosuppression(1-5), tumours are rarely transmissible between individuals. Much like transplanted allogeneic organs, allogeneic tumours are reliably rejected by host T cells, even when the tumour and host share the same major histocompatibility complex alleles, the most potent determinants of transplant rejection(6-10). How such tumour-eradicating immunity is initiated remains unknown, although elucidating this process could provide the basis for inducing similar responses against naturally arising tumours. Here we find that allogeneic tumour rejection is initiated in mice by naturally occurring tumour-binding IgG antibodies, which enable dendritic cells (DCs) to internalize tumour antigens and subsequently activate tumour-reactive T cells. We exploited this mechanism to treat autologous and autochthonous tumours successfully. Either systemic administration of DCs loaded with allogeneic-IgG-coated tumour cells or intratumoral injection of allogeneic IgG in combination with DC stimuli induced potent T-cell-mediated antitumour immune responses, resulting in tumour eradication in mouse models of melanoma, pancreas, lung and breast cancer. Moreover, this strategy led to eradication of distant tumours and metastases, as well as the injected primary tumours. To assess the clinical relevance of these findings, we studied antibodies and cells from patients with lung cancer. T cells from these patients responded vigorously to autologous tumour antigens after culture with allogeneic-IgG-loaded DCs, recapitulating our findings in mice. These results reveal that tumour-binding allogeneic IgG can induce powerful antitumour immunity that can be exploited for cancer immunotherapy.	[Carmi, Yaron; Spitzer, Matthew H.; Linde, Ian L.; Prestwood, Tyler R.; Perlman, Nicola; Davidson, Matthew G.; Kenkel, Justin A.; Segal, Ehud; Bhattacharya, Nupur; Engleman, Edgar G.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Spitzer, Matthew H.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Palo Alto, CA 94305 USA; [Burt, Bryan M.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Palo Alto, CA 94305 USA; [Pusapati, Ganesh V.] Stanford Univ, Sch Med, Dept Biochem, Palo Alto, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Engleman, EG (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	ycarmi76@stanford.edu; edengleman@stanford.edu		Linde, Ian/0000-0002-6077-7466; Spitzer, Matthew/0000-0002-5291-3819; Pusapati, Ganesh/0000-0002-1406-2566	NIH [U01 CA141468, 5T32AI007290-27]; NIH NRSA [F31CA189331]; Smith Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE [F31CA189331, U01CA141468, P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. C. Grumet and N. E. Reticker-Flynn for helpful discussion. We also thank J. Sonnenburg for providing gnotobiotic mice. This work was supported by NIH grants U01 CA141468 and 5T32AI007290-27. M.H.S. is supported by NIH NRSA F31CA189331. I.L.L. is supported by a Smith Stanford Graduate Fellowship.	Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Appelbaum FR, 2001, NATURE, V411, P385, DOI 10.1038/35077251; Bishop MR, 2004, J CLIN ONCOL, V22, P3886, DOI 10.1200/JCO.2004.01.127; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DiLillo DJ, 2010, J IMMUNOL, V184, P4006, DOI 10.4049/jimmunol.0903009; FERRARA J, 1986, J INVEST DERMATOL, V86, P371, DOI 10.1111/1523-1747.ep12285612; Fishman P, 2002, INT J ONCOL, V21, P875; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Goulmy E, 2004, CANCER J, V10, P1, DOI 10.1097/00130404-200401000-00001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gumus E, 2004, INT J UROL, V11, P1070, DOI 10.1111/j.1442-2042.2004.00948.x; Hamanaka Y, 2003, INT J CANCER, V103, P97, DOI 10.1002/ijc.10801; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Kurtenkov O, 2007, ACTA ONCOL, V46, P316, DOI 10.1080/02841860601055441; Li Q, 2011, CLIN CANCER RES, V17, P4987, DOI 10.1158/1078-0432.CCR-11-0207; Manning TC, 1997, J IMMUNOL, V159, P4665; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Rafiq K, 2002, J CLIN INVEST, V110, P71, DOI 10.1172/JCI200215640; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Schachter J, 2007, ANN NY ACAD SCI, V1110, P305, DOI 10.1196/annals.1423.032; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Soussi T, 2000, CANCER RES, V60, P1777; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016	31	136	146	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					99	U254		10.1038/nature14424	http://dx.doi.org/10.1038/nature14424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924063	Green Accepted			2022-12-24	WOS:000354040900041
J	Benzon, HT; Huntoon, MA; Rathmell, JP				Benzon, Honorio T.; Huntoon, Marc A.; Rathmell, James P.			Improving the Safety of Epidural Steroid Injections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Benzon, Honorio T.] Northwestern Univ, Dept Anesthesiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Huntoon, Marc A.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Rathmell, James P.] Massachusetts Gen Hosp, Dept Anesthesiol, Boston, MA 02114 USA; [Rathmell, James P.] Harvard Univ, Sch Med, Boston, MA USA	Northwestern University; Feinberg School of Medicine; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Benzon, HT (corresponding author), Northwestern Univ, Dept Anesthesiol, Feinberg Sch Med, 251 E Huron St,Feinberg Pavil,Ste 5-704, Chicago, IL 60611 USA.	h-benzon@northwestern.edu	Rathmell, James/GQZ-1503-2022					[Anonymous], SUMM MIN AN AN DRUG; Benzon HT, 2007, ANESTHESIOLOGY, V106, P331, DOI 10.1097/00000542-200702000-00022; Dawley JD, 2009, SPINE, V34, P1638, DOI 10.1097/BRS.0b013e3181ac0018; Huntoon MA, 2005, PAIN, V117, P104, DOI 10.1016/j.pain.2005.05.030; Karasek M, 2004, PAIN MED, V5, P202, DOI 10.1111/j.1526-4637.2004.04028.x; Kennedy DJ, 2014, PAIN MED, V15, P548, DOI 10.1111/pme.12325; Malani AN, 2013, JAMA-J AM MED ASSOC, V309, P2465, DOI 10.1001/jama.2013.6293; Manchikanti L, 2013, PAIN PHYSICIAN, V16, pE349; Rathmell JP, 2015, ANESTHESIOLOGY, V122, P974, DOI 10.1097/ALN.0000000000000614	9	20	21	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2015	313	17					1713	1714		10.1001/jama.2015.2912	http://dx.doi.org/10.1001/jama.2015.2912			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3HQ	25822848	Bronze			2022-12-24	WOS:000353921000014
J	Urban, MC				Urban, Mark C.			Accelerating extinction risk from climate change	SCIENCE			English	Article							ECOLOGICAL RESPONSES; WESTERN-HEMISPHERE; BIODIVERSITY	Current predictions of extinction risks from climate change vary widely depending on the specific assumptions and geographic and taxonomic focus of each study. I synthesized published studies in order to estimate a global mean extinction rate and determine which factors contribute the greatest uncertainty to climate change-induced extinction risks. Results suggest that extinction risks will accelerate with future global temperatures, threatening up to one in six species under current policies. Extinction risks were highest in South America, Australia, and New Zealand, and risks did not vary by taxonomic group. Realistic assumptions about extinction debt and dispersal capacity substantially increased extinction risks. We urgently need to adopt strategies that limit further climate change if we are to avoid an acceleration of global extinctions.	Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Urban, MC (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, 75 North Eagleville Rd,Unit 3043, Storrs, CT 06269 USA.	mark.urban@uconn.edu	Urban, Mark Christopher/Y-2430-2019		NSF [DEB-1119877, PLR-1417754]; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation	The data reported in this paper are tabulated in the supplementary materials. Research was supported by NSF DEB-1119877 and PLR-1417754 and the James S. McDonnell Foundation. I thank M. Tingley, J. Urban, and all the authors of the studies who made this meta-analysis possible.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; HANSEN J, 1981, SCIENCE, V213, P957, DOI 10.1126/science.213.4511.957; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Stanton JC, 2015, GLOBAL CHANGE BIOL, V21, P1066, DOI 10.1111/gcb.12721; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Warren R, 2011, CLIMATIC CHANGE, V106, P141, DOI 10.1007/s10584-010-9923-5; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464	27	1054	1100	84	843	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					571	573		10.1126/science.aaa4984	http://dx.doi.org/10.1126/science.aaa4984			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH1JR	25931559	Green Submitted			2022-12-24	WOS:000353778100041
J	Rubin, MA				Rubin, Mark A.			Make precision medicine work for cancer care	NATURE			English	Editorial Material							INHIBITION		[Rubin, Mark A.] Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA; [Rubin, Mark A.] New York Presbyterian Hosp, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital	Rubin, MA (corresponding author), Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA.	rubinma@med.cornell.edu		Rubin, Mark/0000-0002-8321-9950				Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Kaushal R, 2014, J AM MED INFORM ASSN, V21, P587, DOI 10.1136/amiajnl-2014-002764; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Massard C, 2015, ANN ONCOL, V26, P4, DOI 10.1093/annonc/mdv081.7; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Ramos P., 2014, ONCOGENE; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769	10	46	54	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					290	291		10.1038/520290a	http://dx.doi.org/10.1038/520290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25877189	Bronze			2022-12-24	WOS:000352974200015
J	Stonington, SD				Stonington, Scott D.			The art of medicine On the (f)utility of pain	LANCET			English	Editorial Material									[Stonington, Scott D.] Brigham & Womens Hosp, Internal Med, Boston, MA 02115 USA; [Stonington, Scott D.] Harvard Univ, Sch Med, Global Hlth & Social Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Stonington, SD (corresponding author), Brigham & Womens Hosp, Internal Med, Boston, MA 02115 USA.	scott.stonington@stanfordalumni.org		Stonington, Scott/0000-0002-0472-3885					0	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1388	1389		10.1016/S0140-6736(15)60708-5	http://dx.doi.org/10.1016/S0140-6736(15)60708-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF7EU	25890410				2022-12-24	WOS:000352719800015
J	Lipsitch, M; Eyal, N; Halloran, ME; Hernan, MA; Longini, IM; Perencevich, EN; Grais, RF				Lipsitch, Marc; Eyal, Nir; Halloran, M. Elizabeth; Hernan, Miguel A.; Longini, Ira M.; Perencevich, Eli N.; Grais, Rebecca F.			Ebola and beyond	SCIENCE			English	Editorial Material									[Lipsitch, Marc; Hernan, Miguel A.] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc; Hernan, Miguel A.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Eyal, Nir] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Eyal, Nir] Harvard Univ, Sch Med, Ctr Bioeth, Boston, MA 02115 USA; [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Ctr Inference & Dynam Infect Dis, Seattle, WA 98104 USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98105 USA; [Hernan, Miguel A.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [Longini, Ira M.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Ctr Inference & Dynam Infect Dis, Gainesville, FL USA; [Longini, Ira M.] Univ Florida, Coll Med, Gainesville, FL USA; [Perencevich, Eli N.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Perencevich, Eli N.] Iowa Vet Affairs Hlth Care Syst, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA USA; [Grais, Rebecca F.] Epicentre, Paris, France	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Lipsitch, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	mlipsitc@hsph.harvard.edu; Rebecca.grais@epicentre.msf.org		Freeman Grais, Rebecca/0000-0002-5037-8218; Perencevich, Eli/0000-0002-3721-3355; Hernan, Miguel/0000-0003-1619-8456	NIAID NIH HHS [R37 AI032042] Funding Source: Medline; NIGMS NIH HHS [U54GM111274, U54GM088558, U54 GM111274, U54 GM088558] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558, U54GM111274] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; Branswell H., 2014, IMPROVED EBOLA SITUA; Fleck F, 2015, B WORLD HEALTH ORGAN, V93, P7, DOI 10.2471/BLT.15.020115; Giahyue J. H., 2015, REUTERS; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Jennison C, 2000, GROUP SEQUENTIAL MET; King G, 2007, J POLICY ANAL MANAG, V26, P479, DOI 10.1002/pam.20279; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; Maxmen A., 2015, AL JAZEERA AM   0311; NIAID, 2015, PREVAIL PHAS 2 3 CLI; SAGE Working Group on Vaccination in Acute Humanitarian Emergencies, 2013, VACC AC HUM EM FRAM; WHO/MSF/NIPH, 2015, EB VACC EFF TRIAL RE; World Health Organization, 2014, EXP EB VACC SIT REP; World Health Organization, 2014, WHO HIGH LEV M EB VA	15	14	14	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					46	48		10.1126/science.aaa3178	http://dx.doi.org/10.1126/science.aaa3178			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838371	Green Accepted			2022-12-24	WOS:000352079500023
J	Bateman, BT; Hernandez-Diaz, S; Fischer, MA; Seely, EW; Ecker, JL; Franklin, JM; Desai, RJ; Allen-Coleman, C; Mogun, H; Avorn, J; Huybrechts, KF				Bateman, Brian T.; Hernandez-Diaz, Sonia; Fischer, Michael A.; Seely, Ellen W.; Ecker, Jeffrey L.; Franklin, Jessica M.; Desai, Rishi J.; Allen-Coleman, Cora; Mogun, Helen; Avorn, Jerry; Huybrechts, Krista F.			Statins and congenital malformations: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL EXPOSURE; RISK; PREGNANCY; OUTCOMES; SURVEILLANCE; SIMVASTATIN; PRAVASTATIN; ANOMALIES; SYSTEM; WOMEN	OBJECTIVE To examine the teratogenic potential of statins. DESIGN Cohort study. SETTING United States. PARTICIPANTS A cohort of 886 996 completed pregnancies linked to liveborn infants of women enrolled in Medicaid from 2000 to 2007. METHODS We examined the risk of major congenital malformations and organ specific malformations in offspring associated with maternal use of a statin in the first trimester. Propensity score based methods were used to control for potential confounders, including maternal demographic characteristics, obstetric and medical conditions, and use of other drugs. RESULTS 1152 (0.13%) women used a statin during the first trimester. In unadjusted analyses, the prevalence of malformations in the offspring of these women was 6.34% compared with 3.55% in those of women who did not use a statin in the first trimester (relative risk 1.79, 95% confidence interval 1.43 to 2.23). Controlling for confounders, particularly pre-existing diabetes, accounted for this increase in risk (1.07, 0.85 to 1.37). There were also no statistically significant increases in any of the organ specific malformations assessed after accounting for confounders. Results were similar across a range of sensitivity analyses. CONCLUSIONS Our analysis did not find a significant teratogenic effect from maternal use of statins in the first trimester. However, these findings need to be replicated in other large studies, and the long term effects of in utero exposure to statins needs to be assessed, before use of statins in pregnancy can be considered safe.	[Bateman, Brian T.; Fischer, Michael A.; Franklin, Jessica M.; Desai, Rishi J.; Allen-Coleman, Cora; Mogun, Helen; Avorn, Jerry; Huybrechts, Krista F.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Bateman, Brian T.; Fischer, Michael A.; Franklin, Jessica M.; Desai, Rishi J.; Allen-Coleman, Cora; Mogun, Helen; Avorn, Jerry; Huybrechts, Krista F.] Harvard Univ, Sch Med, Boston, MA USA; [Bateman, Brian T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Obstet Anesthesia,Dept Anesthesia Crit Care &, Boston, MA USA; [Hernandez-Diaz, Sonia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Seely, Ellen W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Metab,Dept Med, Boston, MA 02115 USA; [Ecker, Jeffrey L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Bateman, BT (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	bbateman@partners.org	Desai, Rishi/AAH-8988-2021		Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (Bethesda, MD) [K08HD075831]; National Heart Lung and Blood Institute of the NIH [K24HL096141]; National Institute of Mental Health of the NIH [K01MH099141]; Agency for Healthcare Research and Quality (AHRQ) [R01HS018533]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018533] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083806, K24HL096141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (Bethesda, MD); National Heart Lung and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health of the NIH; Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (Bethesda, MD) under award No K08HD075831 (BTB), the National Heart Lung and Blood Institute of the NIH under award No K24HL096141 (EWS), and the National Institute of Mental Health of the NIH under award No K01MH099141 (KFH). Medicaid Analytic eXtract pregnancy cohort creation was supported by the Agency for Healthcare Research and Quality (AHRQ) (grant R01HS018533). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrade SE, 2008, PHARMACOEPIDEM DR S, V17, P240, DOI 10.1002/pds.1550; Briggs GG., 2017, DRUGS PREGNANCY LACT; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Edison RJ, 2005, NEW ENGL J MED, V352, P2759, DOI 10.1056/NEJM200506303522622; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Edison RJ, 2004, NEW ENGL J MED, V350, P1579, DOI 10.1056/NEJM200404083501524; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Garcia G, 2014, MAT CHILD HLTH MCH U; Godfrey LM, 2012, ANN PHARMACOTHER, V46, P1419, DOI 10.1345/aph.1R202; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Hayes DK, 2011, PREV CHRONIC DIS, V8; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; KHOURY MJ, 1989, AM J EPIDEMIOL, V130, P361, DOI 10.1093/oxfordjournals.aje.a115342; Manson JM, 1996, REPROD TOXICOL, V10, P439, DOI 10.1016/S0890-6238(96)00130-X; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; Ofori B, 2007, BRIT J CLIN PHARMACO, V64, P496, DOI 10.1111/j.1365-2125.2007.02905.x; Palmsten K, 2014, PHARMACOEPIDEM DR S, V23, P646, DOI 10.1002/pds.3627; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Patel C, 2006, J FAM PRACTICE, V55, P75; Petersen EE, 2008, AM J MED GENET A, V146A, P2701, DOI 10.1002/ajmg.a.32493; Pollack PS, 2005, BIRTH DEFECTS RES A, V73, P888, DOI 10.1002/bdra.20181; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taguchi N, 2008, REPROD TOXICOL, V26, P175, DOI 10.1016/j.reprotox.2008.06.009; Vaughan CJ, 2004, CIRCULATION, V110, P886, DOI 10.1161/01.CIR.0000139312.10076.BA; Winterfeld U, 2013, BJOG-INT J OBSTET GY, V120, P463, DOI 10.1111/1471-0528.12066; Zarek J, 2013, PLACENTA, V34, P719, DOI 10.1016/j.placenta.2013.05.002; Zarek J, 2014, J OBSTET GYNAECOL CA, V36, P506, DOI 10.1016/S1701-2163(15)30565-X	31	135	144	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2015	350								h1035	10.1136/bmj.h1035	http://dx.doi.org/10.1136/bmj.h1035			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE1KO	25784688	hybrid, Green Published			2022-12-24	WOS:000351570700001
J	Dong, YY; Pike, ACW; Mackenzie, A; McClenaghan, C; Aryal, P; Dong, L; Quigley, A; Grieben, M; Goubin, S; Mukhopadhyay, S; Ruda, GF; Clausen, MV; Cao, LS; Brennan, PE; Burgess-Brown, NA; Sansom, MSP; Tucker, SJ; Carpenter, EP				Dong, Yin Yao; Pike, Ashley C. W.; Mackenzie, Alexandra; McClenaghan, Conor; Aryal, Prafulla; Dong, Liang; Quigley, Andrew; Grieben, Mariana; Goubin, Solenne; Mukhopadhyay, Shubhashish; Ruda, Gian Filippo; Clausen, Michael V.; Cao, Lishuang; Brennan, Paul E.; Burgess-Brown, Nicola A.; Sansom, Mark S. P.; Tucker, Stephen J.; Carpenter, Elisabeth P.			K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac	SCIENCE			English	Article							DOMAIN POTASSIUM CHANNEL; HYDROPHOBIC BARRIER; CRYSTAL-STRUCTURE; TRAAK; MEMBRANE; PORE; ACTIVATION; FLUOXETINE; GATE	TREK-2 (KCNK10/K2P10), a two-pore domain potassium (K2P) channel, is gated by multiple stimuli such as stretch, fatty acids, and pH and by several drugs. However, the mechanisms that control channel gating are unclear. Here we present crystal structures of the human TREK-2 channel (up to 3.4 angstrom resolution) in two conformations and in complex with norfluoxetine, the active metabolite of fluoxetine (Prozac) and a state-dependent blocker of TREK channels. Norfluoxetine binds within intramembrane fenestrations found in only one of these two conformations. Channel activation by arachidonic acid and mechanical stretch involves conversion between these states through movement of the pore-lining helices. These results provide an explanation for TREK channel mechanosensitivity, regulation by diverse stimuli, and possible off-target effects of the serotonin reuptake inhibitor Prozac.	[Dong, Yin Yao; Pike, Ashley C. W.; Mackenzie, Alexandra; Dong, Liang; Quigley, Andrew; Grieben, Mariana; Goubin, Solenne; Mukhopadhyay, Shubhashish; Ruda, Gian Filippo; Brennan, Paul E.; Burgess-Brown, Nicola A.; Carpenter, Elisabeth P.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Mackenzie, Alexandra; McClenaghan, Conor; Aryal, Prafulla; Clausen, Michael V.; Tucker, Stephen J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [McClenaghan, Conor; Aryal, Prafulla; Sansom, Mark S. P.; Tucker, Stephen J.; Carpenter, Elisabeth P.] Univ Oxford, OXION Initiat Ian Channels & Dis, Oxford OX1 3PN, England; [Aryal, Prafulla; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Ruda, Gian Filippo; Brennan, Paul E.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford OX3 7FZ, England; [Cao, Lishuang] Pfizer Neusentis, Cambridge CB21 6GS, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Pfizer	Tucker, SJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	stephen.tucker@physics.ox.ac.uk; liz.carpenter@sge.ox.ac.uk	Tucker, Stephen J./ABE-6741-2020; Tucker, Stephen J./ABE-7468-2020	Tucker, Stephen J./0000-0001-8996-2000; Tucker, Stephen J./0000-0001-8996-2000; Brennan, Paul/0000-0002-8950-7646; McClenaghan, Conor/0000-0002-0859-3854; Quigley, Andrew/0000-0002-5022-9845; Dong, Yin/0000-0001-8600-6988; Voldsgaard Clausen, Michael/0000-0002-7176-5524; Mukhopadhyay, Shubhashish M M/0000-0003-1430-5529; Pike, Ashley/0000-0001-9661-2607; Ruda, Gian Filippo/0000-0001-6150-2715; Carpenter, Liz/0000-0001-9138-2937	AbbVie [1097737]; Bayer; Boehringer Ingelheim; Genome Canada through Ontario Genomics Institute [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; UK Biotechnology and Biological Sciences Research Council; Wellcome Trust; BBSRC [BB/J00037X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J00037X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1104933] Funding Source: researchfish	AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Structural Genomics Consortium is a registered charity (no. 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, Genome Canada through Ontario Genomics Institute grant OGI-055, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and Wellcome Trust grant 092809/Z/10/Z. M.S.P.S. and S.J.T. are supported by the UK Biotechnology and Biological Sciences Research Council and the Wellcome Trust. Atomic coordinates and structure factors have been deposited with the Protein Data Bank under accession codes 4XDJ (down state), 4BW5 (up state), 4XDL (Br-fluoxetine complex), and 4XDK (norfluoxetine complex). We declare no competing financial interests.	Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Aryal P, 2015, CHANNELS, V9, P44, DOI 10.4161/19336950.2014.981987; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Chemin J, 2007, PFLUG ARCH EUR J PHY, V455, P97, DOI 10.1007/s00424-007-0250-2; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Es-Salah-Lamoureux Z, 2010, TRENDS PHARMACOL SCI, V31, P587, DOI 10.1016/j.tips.2010.09.001; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Henry ME, 2005, NEUROPSYCHOPHARMACOL, V30, P1576, DOI 10.1038/sj.npp.1300749; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Teng JF, 2015, PFLUG ARCH EUR J PHY, V467, P27, DOI 10.1007/s00424-014-1530-2; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	28	188	188	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1256	1259		10.1126/science.1261512	http://dx.doi.org/10.1126/science.1261512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766236	Green Accepted, Green Submitted			2022-12-24	WOS:000350824300040
J	Gill, S; Le, HD; Melkani, GC; Panda, S				Gill, Shubhroz; Le, Hiep D.; Melkani, Girish C.; Panda, Satchidananda			Time-restricted feeding attenuates age-related cardiac decline in Drosophila	SCIENCE			English	Article							HEART FUNCTION; DYSFUNCTION; PATHWAY; SLEEP	Circadian clocks orchestrate periods of rest or activity and feeding or fasting over the course of a 24-hour day and maintain homeostasis. To assess whether a consolidated 24-hour cycle of feeding and fasting can sustain health, we explored the effect of time-restricted feeding (TRF; food access limited to daytime 12 hours every day) on neural, peripheral, and cardiovascular physiology in Drosophila melanogaster. We detected improved sleep, prevention of body weight gain, and deceleration of cardiac aging under TRF, even when caloric intake and activity were unchanged. We used temporal gene expression profiling and validation through classical genetics to identify the TCP-1 ring complex (TRiC) chaperonin, the mitochondrial electron transport chain complexes, and the circadian clock as pathways mediating the benefits of TRF.	[Gill, Shubhroz; Le, Hiep D.; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Gill, Shubhroz] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA; [Melkani, Girish C.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Melkani, Girish C.] San Diego State Univ, Dept Mol Biol, San Diego, CA 92182 USA; [Melkani, Girish C.] San Diego State Univ, Inst Heart, San Diego, CA 92182 USA	Salk Institute; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Melkani, GC (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	gmelkani@mail.sdsu.edu; satchin@salk.edu		Melkani, Girish/0000-0003-0353-4633	NIH [DK091618, EY016807, NS066457, RR032100, P30 CA014195, P30 EY019005]; American Federation for Aging Research [M14322]; American Heart Association [13BGIA17260057]; H.A. and Mary K. Chapman Trust; Aginsky Research Scholar Award; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Glenn Center for Aging; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR032100] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY019005, R01EY016807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066457] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; American Heart Association(American Heart Association); H.A. and Mary K. Chapman Trust; Aginsky Research Scholar Award; Leona M. and Harry B. Helmsley Charitable Trust; Glenn Center for Aging; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Vienna Drosophila RNAi Center, Bloomington Stock Center, and P. Hardin for fly strains; R. Bodmer and K. Ocorr for use of Drosophila heart analysis setup; S. Bernstein for use of the lab facility; and M. Ku and C. Benner for RNA sequencing and bioinformatics. This work was partially supported by NIH grants DK091618, EY016807, and NS066457 and American Federation for Aging Research grant M14322 to S. P. and by NIH grant RR032100 and American Heart Association grant 13BGIA17260057 to G.C.M. S.G. was supported by the H.A. and Mary K. Chapman Trust, an Aginsky Research Scholar Award, and Leona M. and Harry B. Helmsley Charitable Trust grant 2012-PG-MED002. Additional support came from NIH P30 CA014195, P30 EY019005, and the Glenn Center for Aging. We declare no conflicting interests.	Antosh M, 2011, CELL CYCLE, V10, P904, DOI 10.4161/cc.10.6.14912; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Birse RT, 2011, CRIT REV BIOCHEM MOL, V46, P376, DOI 10.3109/10409238.2011.599830; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; Farhadian SF, 2012, PHYSIOL BEHAV, V105, P544, DOI 10.1016/j.physbeh.2011.09.007; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476	13	160	160	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1265	1269		10.1126/science.1256682	http://dx.doi.org/10.1126/science.1256682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD1GZ	25766238	Green Accepted			2022-12-24	WOS:000350824300042
J	Chen, SD; Sanjana, NE; Zheng, KJ; Shalem, O; Lee, K; Shi, X; Scott, DA; Song, J; Pan, JQ; Weissleder, R; Lee, H; Zhang, F; Sharp, PA				Chen, Sidi; Sanjana, Neville E.; Zheng, Kaijie; Shalem, Ophir; Lee, Kyungheon; Shi, Xi; Scott, David A.; Song, Jun; Pan, Jen Q.; Weissleder, Ralph; Lee, Hakho; Zhang, Feng; Sharp, Phillip A.			Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis	CELL			English	Article							CANCER; CELLS; RNA; IMMUNITY; PROVIDES; PROLIFERATION; METHYLATION; PROGRESSION; SUPPRESSES; MICRORNA	Genetic screens are powerful tools for identifying genes responsible for diverse phenotypes. Here we describe a genome-wide CRISPR/Cas9-mediated loss-of-function screen in tumor growth and metastasis. We mutagenized a non-metastatic mouse cancer cell line using a genome-scale library with 67,405 single-guide RNAs (sgRNAs). The mutant cell pool rapidly generates metastases when transplanted into immunocompromised mice. Enriched sgRNAs in lung metastases and late-stage primary tumors were found to target a small set of genes, suggesting that specific loss-of-function mutations drive tumor growth and metastasis. Individual sgRNAs and a small pool of 624 sgRNAs targeting the top-scoring genes from the primary screen dramatically accelerate metastasis. In all of these experiments, the effect of mutations on primary tumor growth positively correlates with the development of metastases. Our study demonstrates Cas9-based screening as a robust method to systematically assay gene phenotypes in cancer evolution in vivo.	[Chen, Sidi; Sharp, Phillip A.] David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Sidi; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Chen, Sidi; Sanjana, Neville E.; Zheng, Kaijie; Shalem, Ophir; Shi, Xi; Scott, David A.; Pan, Jen Q.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sanjana, Neville E.; Zheng, Kaijie; Shalem, Ophir; Shi, Xi; Scott, David A.; Pan, Jen Q.; Zhang, Feng] Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Sanjana, Neville E.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Sanjana, Neville E.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Sanjana, Neville E.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lee, Kyungheon; Song, Jun; Weissleder, Ralph; Lee, Hakho] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	zhang@broadinstitute.org; sharppa@mit.edu	CHEN, SIDI/D-8284-2016; Lee, Kyungheon/E-3863-2013; Macrae, Rhiannon/AAX-1536-2020	CHEN, SIDI/0000-0002-3819-5005; Shalem, Ophir/0000-0002-2267-0801; Sanjana, Neville/0000-0002-1504-0027; /0000-0003-0828-4143	United States Public Health Service from the NIH [R01-CA133404]; MIT-Harvard Center for Cancer Nanotechnology Excellence from the National Cancer Institute [U54 CA151884]; Skolkovo Foundation; Koch Institute from the National Cancer Institute [P30-CA14051]; NIH through NIMH [5DP1-MH100706]; NIDDK [5R01-DK097768]; National Science Foundation; Keck foundation; New York Stem Cell foundation; Damon Runyon foundation; Searle Scholars foundation; Merkin foundation; Vallee foundation; Bob Metcalfe; Dale Frey Award for Breakthrough Scientists; Simons Center for the Social Brain Postdoctoral Fellowship; NIH NHGRI [K99-HG008171]; NIH [U54 CA151884]; NSF; Department of Defense [OCRP W81XWH-14-1-0279]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA133404, P01CA042063, U54CA151884] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG008171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	United States Public Health Service from the NIH; MIT-Harvard Center for Cancer Nanotechnology Excellence from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skolkovo Foundation; Koch Institute from the National Cancer Institute; NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); Keck foundation(W.M. Keck Foundation); New York Stem Cell foundation; Damon Runyon foundation; Searle Scholars foundation; Merkin foundation; Vallee foundation; Bob Metcalfe; Dale Frey Award for Breakthrough Scientists; Simons Center for the Social Brain Postdoctoral Fellowship; NIH NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Weinberg and R. Kerbel for critically reading the manuscript; the entire P.A.S. lab and F.Z. lab, L. Cong, T. Kelly, X. Ni, M. Nobel, J. Boehm, A. Tsherniak, S. Levine, M. Cornwall-Brady, S. Malstrom, M. Jennings, E. Vasile, C. Whittaker, K. Cormier, R. Bronson, and colleagues at the Koch Institute, Broad Institute, McGovern Institute, and Department of Biology for technical assistance and/or discussion; the Swanson Biotechnology Center for technical support (Genomics, Animal Imaging and Preclinical Testing, Bioinformatics and Computing, Microscopy, Flow Cytometry, Microscopy, and Histology, in particular). This work is supported by grants to P.A.S., including a United States Public Health Service grant R01-CA133404 from the NIH, an MIT-Harvard Center for Cancer Nanotechnology Excellence Grant U54 CA151884 from the National Cancer Institute, a generous gift from the Marie D. and Pierre Casimir-Lambert Fund, an SkTech/MIT Initiative Grant from the Skolkovo Foundation, and the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. F.Z. is supported by the NIH through NIMH grant 5DP1-MH100706) and NIDDK grant 5R01-DK097768; a Waterman Award from the National Science Foundation; the Keck, New York Stem Cell, Damon Runyon, Searle Scholars, Merkin, and Vallee foundations; and Bob Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. S. C. is a Damon Runyon Cancer Research Fellow (DRG-2117-12) and also supported by the Dale Frey Award for Breakthrough Scientists. N.E.S. is supported by a Simons Center for the Social Brain Postdoctoral Fellowship and NIH NHGRI award K99-HG008171. O.S. is a fellow of the Klarman Cell Observatory. R.W. is supported by NIH grant U54 CA151884. D. A. S. is supported by a NSF Graduate Research Fellowship. H.L. is supported by Department of Defense grant OCRP W81XWH-14-1-0279. CRISPR reagents (plasmids and libraries) are available to the academic community through Addgene. F.Z. is a co-founder of Editas Medicine and a scientific advisor for Editas Medicine and Horizon Discovery.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen SD, 2014, GENE DEV, V28, P1054, DOI 10.1101/gad.239681.114; Cheng ZS, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.51; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heimann R, 1998, J CLIN ONCOL, V16, P2686, DOI 10.1200/JCO.1998.16.8.2686; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jesien-Lewandowicz E, 2009, CANCER GENET CYTOGEN, V188, P77, DOI 10.1016/j.cancergencyto.2008.09.015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaczmarczyk G, 2012, WSPOLCZESNA ONKOL, V16, P322, DOI 10.5114/wo.2012.30061; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; KORCZAK B, 1988, MOL CELL BIOL, V8, P3143, DOI 10.1128/MCB.8.8.3143; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schiano C, 2014, BBA-REV CANCER, V1845, P66, DOI 10.1016/j.bbcan.2013.12.001; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Tang JT, 2011, CARCINOGENESIS, V32, P1207, DOI 10.1093/carcin/bgr114; TANO K, 1990, P NATL ACAD SCI USA, V87, P686, DOI 10.1073/pnas.87.2.686; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; WAGHORNE C, 1988, CANCER RES, V48, P6109; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weinberg R, 2007, BIOL CANC GARLAND SC; Yokota J, 2003, CLIN EXP METASTAS, V20, P189, DOI 10.1023/A:1022978932215; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	51	514	624	20	325	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1246	1260		10.1016/j.cell.2015.02.038	http://dx.doi.org/10.1016/j.cell.2015.02.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25748654	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000351951800022
J	Baker, S				Baker, Stephen			A return to the pre-antimicrobial era?	SCIENCE			English	Editorial Material							ENTERICA SEROVAR TYPHI; FLUOROQUINOLONES		[Baker, Stephen] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen] Univ Oxford, Ctr Trop Med, Oxford, England; [Baker, Stephen] London Sch Hyg & Trop Med, London WC1, England	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Baker, S (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	sbaker@oucru.org		Baker, Stephen/0000-0003-1308-5755	Wellcome Trust [100087/Z/12/Z, 100087, 089276] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CDC, 2013, ANTIBIOTIC RESISTANC; Chang H., 2015, EMBO MOL MED, DOI 10.15252/emmm.201404767; Department of Health and Department of Environment Food and Rural Affairs, 2013, UK 5 YEAR ANT RES ST; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; Ingram-Sieber K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002610; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Koirala KD, 2012, ANTIMICROB AGENTS CH, V56, P2761, DOI 10.1128/AAC.06414-11; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Parry CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001163; Perros M, 2015, SCIENCE, V347, P1062, DOI 10.1126/science.aaa3048; Robertson MN, 2014, PARASITOLOGY, V141, P148, DOI 10.1017/S0031182013001121; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; World Health Organization, 2014, ANT RES GLOB REP SUR	15	62	65	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1064	1066		10.1126/science.aaa2868	http://dx.doi.org/10.1126/science.aaa2868			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745145				2022-12-24	WOS:000350354200017
J	Yusuf, S; Wood, D; Ralston, J; Reddy, KS				Yusuf, Salim; Wood, David; Ralston, Johanna; Reddy, K. Srinath			The World Heart Federation's vision for worldwide cardiovascular disease prevention	LANCET			English	Editorial Material							RISK-FACTORS; GLOBAL BURDEN; INTERVENTIONS; INTERHEART; MORTALITY; COUNTRIES; REGIONS; MIDDLE		[Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Wood, David] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Ralston, Johanna] World Heart Federat, Geneva, Switzerland; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	McMaster University; Population Health Research Institute; McMaster University; Imperial College London; Public Health Foundation of India	Yusuf, S (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Reddy, K Srinath/0000-0003-3416-3548; Yusuf, Salim/0000-0003-4776-5601				Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Dalen JE, 2014, AM J MED, V127, P807, DOI 10.1016/j.amjmed.2014.04.015; ELLIOTT P, 1988, BRIT MED J, V297, P319; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Huff man MD, GLOBAL HEAR IN PRESS; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Kamath DY, 2014, AM HEART J, V168, P690, DOI 10.1016/j.ahj.2014.07.029; Khatib R., 2014, THESIS MCMASTER U; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; United Nations General Assembly, 2011, A66L1 UN GEN ASS; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; World Bank, 2014, WORLD DEV IND HLTH S; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2014, GLOB PROGR REP IMPL; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2014, EUR HEART J, V35, P353, DOI 10.1093/eurheartj/eht407	28	94	102	2	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					399	402		10.1016/S0140-6736(15)60265-3	http://dx.doi.org/10.1016/S0140-6736(15)60265-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN5CX	25892680				2022-12-24	WOS:000358448400029
J	Najm, FJ; Madhavan, M; Zaremba, A; Shick, E; Karl, RT; Factor, DC; Miller, TE; Nevin, ZS; Kantor, C; Sargent, A; Quick, KL; Schlatzer, DM; Tang, H; Papoian, R; Brimacombe, KR; Shen, M; Boxer, MB; Jadhav, A; Robinson, AP; Podojil, JR; Miller, SD; Miller, RH; Tesar, PJ				Najm, Fadi J.; Madhavan, Mayur; Zaremba, Anita; Shick, Elizabeth; Karl, Robert T.; Factor, Daniel C.; Miller, Tyler E.; Nevin, Zachary S.; Kantor, Christopher; Sargent, Alex; Quick, Kevin L.; Schlatzer, Daniela M.; Tang, Hong; Papoian, Ruben; Brimacombe, Kyle R.; Shen, Min; Boxer, Matthew B.; Jadhav, Ajit; Robinson, Andrew P.; Podojil, Joseph R.; Miller, Stephen D.; Miller, Robert H.; Tesar, Paul J.			Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo	NATURE			English	Article							OLIGODENDROCYTE PROGENITOR CELLS; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; SPINAL-CORD; RNA-SEQ; DIFFERENTIATION; GLUCOCORTICOIDS; LYSOLECITHIN; TRANSCRIPTS	Multiple sclerosis involves an aberrant autoimmune response and progressive failure of remyelination in the central nervous system. Prevention of neural degeneration and subsequent disability requires remyelination through the generation of new oligodendrocytes, but current treatments exclusively target the immune system. Oligodendrocyte progenitor cells are stem cells in the central nervous system and the principal source of myelinating oligodendrocytes(1). These cells are abundant in demyelinated regions of patients with multiple sclerosis, yet fail to differentiate, thereby representing a cellular target for pharmacological intervention(2). To discover therapeutic compounds for enhancing myelination from endogenous oligodendrocyte progenitor cells, we screened a library of bioactive small molecules on mouse pluripotent epiblast stem-cell-derived oligodendrocyte progenitor cells(3-5). Here we show seven drugs function at nanomolar doses selectively to enhance the generation of mature oligodendrocytes from progenitor cells in vitro. Two drugs, miconazole and clobetasol, are effective in promoting precocious myelination in organotypic cerebellar slice cultures, and in vivo in early postnatal mouse pups. Systemic delivery of each of the two drugs significantly increases the number of new oligodendrocytes and enhances remyelination in a lysolecithin-induced mouse model of focal demyelination. Administering each of the two drugs at the peak of disease in an experimental autoimmune encephalomyelitis mouse model of chronic progressive multiple sclerosis results in striking reversal of disease severity. Immune response assays show that miconazole functions directly as a remyelinating drug with no effect on the immune system, whereas clobetasol is a potent immunosuppressant as well as a remyelinating agent. Mechanistic studies show that miconazole and clobetasol function in oligodendrocyte progenitor cells through mitogen-activated protein kinase and glucocorticoid receptor signalling, respectively. Furthermore, both drugs enhance the generation of human oligodendrocytes from human oligodendrocyte progenitor cells in vitro. Collectively, our results provide a rationale for testing miconazole and clobetasol, or structurally modified derivatives, to enhance remyelination in patients.	[Najm, Fadi J.; Madhavan, Mayur; Shick, Elizabeth; Karl, Robert T.; Factor, Daniel C.; Miller, Tyler E.; Nevin, Zachary S.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Zaremba, Anita; Kantor, Christopher; Sargent, Alex; Miller, Robert H.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Miller, Tyler E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Miller, Tyler E.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Quick, Kevin L.] PerkinElmer, Waltham, MA 02451 USA; [Schlatzer, Daniela M.] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Tang, Hong; Papoian, Ruben] Univ Cincinnati, Coll Med, Ctr Drug Discovery, Cincinnati, OH 45237 USA; [Brimacombe, Kyle R.; Shen, Min; Boxer, Matthew B.; Jadhav, Ajit] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA; [Robinson, Andrew P.; Podojil, Joseph R.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Robinson, Andrew P.; Podojil, Joseph R.; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Interdept Immunobiol Ctr, Chicago, IL 60611 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Tesar, PJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	rhm3@gwu.edu; paul.tesar@case.edu	Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022; Robinson, Andrew/AAA-9162-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155; Robinson, Andrew/0000-0002-1867-5634; Miller, Tyler E/0000-0002-1269-1895; Factor, Daniel/0000-0002-3200-7560; Jadhav, Ajit/0000-0001-7955-1451; Nevin, Zachary/0000-0003-4987-924X	US NIH [NS085246, NS030800, NS026543]; NewYork Stem Cell Foundation; Myelin Repair Foundation; Mt. Sinai Health Care Foundation; NIH [T32GM008056, F30CA183510]; Cytometry & Imaging Microscopy, Proteomics, and Genomics core facilities of the Case Comprehensive Cancer Center [P30CA043703]; CWRU Council; NATIONAL CANCER INSTITUTE [F30CA183510, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000120, UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056, T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085246, R01NS030800, R01NS026543] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NewYork Stem Cell Foundation; Myelin Repair Foundation; Mt. Sinai Health Care Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry & Imaging Microscopy, Proteomics, and Genomics core facilities of the Case Comprehensive Cancer Center; CWRU Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the US NIH NS085246 (P.J.T. and R.H.M.), NS030800 (R.H.M.), and NS026543 (S.D.M.); NewYork Stem Cell Foundation (P.J.T.); Myelin Repair Foundation (P.J.T., R.H.M., and S.D.M.); Mt. Sinai Health Care Foundation (P.J.T.); and NIH predoctoral training grants T32GM008056 (R.T.K.) and F30CA183510 (T.E.M). Additional support was provided by the Cytometry & Imaging Microscopy, Proteomics, and Genomics core facilities of the Case Comprehensive Cancer Center (P30CA043703), the CWRU Council to Advance Human Health, and philanthropic support from the Goodman, Long, and Geller families. P.J.T. is a New York Stem Cell Foundation-Robertson Investigator. We are grateful to M. Hitomi, W. Harte, D. Adams, W. Seibel, M. Haag, P. Scacheri, J. Wanta, C. Fang, H. Olsen, T. LaFramboise, J. Song, F. Van den Akker, and M. Shoham for technical assistance and discussion, A. Lager and M. Elitt for comments on the manuscript, B. Trapp for the PLP1 antibody, and B. Barres and B. Zuchero for RNA from in vivo isolated OPCs.	Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fyffe-Maricich SL, 2013, J NEUROSCI, V33, P18402, DOI 10.1523/JNEUROSCI.2381-13.2013; Goldman SA, 2012, SCIENCE, V338, P491, DOI 10.1126/science.1218071; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Ishii A, 2012, J NEUROSCI, V32, P8855, DOI 10.1523/JNEUROSCI.0137-12.2012; JEFFERY ND, 1995, J NEUROCYTOL, V24, P775, DOI 10.1007/BF01191213; KUMAR S, 1989, P NATL ACAD SCI USA, V86, P6807, DOI 10.1073/pnas.86.17.6807; Mei F, 2014, NAT MED, V20, P954, DOI 10.1038/nm.3618; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; Morisaki S, 2010, GLIA, V58, P954, DOI 10.1002/glia.20977; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Najm FJ, 2011, NAT METHODS, V8, P957, DOI [10.1038/NMETH.1712, 10.1038/nmeth.1712]; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Woodruff RH, 1998, J NEUROCYTOL, V27, P683, DOI 10.1023/A:1006972316697; Woodruff RH, 1999, NEUROPATH APPL NEURO, V25, P226	30	266	279	5	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					216	+		10.1038/nature14335	http://dx.doi.org/10.1038/nature14335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25896324	Green Accepted			2022-12-24	WOS:000356016700039
J	Cusanovich, DA; Daza, R; Adey, A; Pliner, HA; Christiansen, L; Gunderson, KL; Steemers, FJ; Trapnell, C; Shendure, J				Cusanovich, Darren A.; Daza, Riza; Adey, Andrew; Pliner, Hannah A.; Christiansen, Lena; Gunderson, Kevin L.; Steemers, Frank J.; Trapnell, Cole; Shendure, Jay			Multiplex single-cell profiling of chromatin accessibility by combinatorial cellular indexing	SCIENCE			English	Article							RNA-SEQ; HUMAN GENOME; IN-VITRO; TRANSPOSITION; CONTIGUITY; EXPRESSION; FATE	Technical advances have enabled the collection of genome and transcriptome data sets with single-cell resolution. However, single-cell characterization of the epigenome has remained challenging. Furthermore, because cells must be physically separated before biochemical processing, conventional single-cell preparatory methods scale linearly. We applied combinatorial cellular indexing to measure chromatin accessibility in thousands of single cells per assay, circumventing the need for compartmentalization of individual cells. We report chromatin accessibility profiles from more than 15,000 single cells and use these data to cluster cells on the basis of chromatin accessibility landscapes. We identify modules of coordinately regulated chromatin accessibility at the level of single cells both between and within cell types, with a scalable method that may accelerate progress toward a human cell atlas.	[Cusanovich, Darren A.; Daza, Riza; Pliner, Hannah A.; Trapnell, Cole; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Adey, Andrew] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Christiansen, Lena; Gunderson, Kevin L.; Steemers, Frank J.] Illumina Inc, Adv Res Grp, San Diego, CA USA	University of Washington; University of Washington Seattle; Oregon Health & Science University; Illumina	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu	Daza, Riza M./HCH-4047-2022; Shendure, Jay/AAU-3684-2021; Horwitz, Marshall/AAE-8376-2021; wang, edwin/G-5372-2010; Pliner, Hannah Andersen/F-3608-2015	Cusanovich, Darren/0000-0001-6889-0095; Pliner, Hannah Andersen/0000-0003-1484-6501	NIH [1DP1HG007811]; Paul G. Allen Family Foundation; Damon Runyon Cancer Research Foundation (DFS) [10-14]; Illumina, Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811, R01HG006283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Family Foundation; Damon Runyon Cancer Research Foundation (DFS); Illumina, Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Trapnell and Shendure laboratories, particularly R. Hause, C. Lee, V. Ramani, R. Qiu, Z. Duan, and J. Kitzman, for helpful discussions; D. Prunkard, J. Fredrickson, and L. Gitari in the Rabinovitch laboratory for their exceptional assistance in flow sorting; and C. Disteche for the Patski cell line. This work was funded by an NIH Director's Pioneer Award (1DP1HG007811 to J.S.) and a grant from the Paul G. Allen Family Foundation (J.S.). C.T. is supported in part by the Damon Runyon Cancer Research Foundation (DFS-#10-14). All sequencing data are available from the NIH National Center for Biotechnology Information Gene Expression Omnibus (accession number GSE68103). L.C., K.L.G., and F.J.S. declare competing financial interests in the form of stock ownership and paid employment by Illumina, Inc. One or more embodiments of one or more patents and patent applications filed by Illumina may encompass the methods, reagents, and data disclosed in this manuscript. All methods for making the transposase complexes are described in (18); however, Illumina will provide transposase complexes in response to reasonable requests from the scientific community subject to a material transfer agreement. Some work in this study is related to technology described in patent applications WO2014142850, 2014/0194324, 2010/0120098, 2011/0287435, 2013/0196860, and 2012/0208705.	Adey A, 2014, GENOME RES, V24, P2041, DOI 10.1101/gr.178319.114; Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Gole J, 2013, NAT BIOTECHNOL, V31, P1126, DOI 10.1038/nbt.2720; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Pan Xinghua, 2014, Single Cell Biol, V3; Regev A., THE HUMAN CELL ATLAS; Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109	22	590	654	8	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					910	914		10.1126/science.aab1601	http://dx.doi.org/10.1126/science.aab1601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25953818	Green Accepted			2022-12-24	WOS:000354877900044
J	Metzger, BPH; Yuan, DC; Gruber, JD; Duveau, F; Wittkopp, PJ				Metzger, Brian P. H.; Yuan, David C.; Gruber, Jonathan D.; Duveau, Fabien; Wittkopp, Patricia J.			Selection on noise constrains variation in a eukaryotic promoter	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; BIOCONDUCTOR PACKAGE; REGULATORY ELEMENTS; SEQUENCE; CIS; MUTATION; DISSECTION; EVOLUTION; ENHANCERS	Genetic variation segregating within a species reflects the combined activities of mutation, selection, and genetic drift. In the absence of selection, polymorphisms are expected to be a randomsubset of new mutations; thus, comparing the effects of polymorphisms and new mutations provides a test for selection(1-4). When evidence of selection exists, such comparisons can identify properties of mutations that are most likely to persist in natural populations(2). Here we investigate how mutation and selection have shaped variation in a cis-regulatory sequence controlling gene expression by empirically determining the effects of polymorphisms segregating in the TDH3 promoter among 85 strains of Saccharomyces cerevisiae and comparing their effects to a distribution of mutational effects defined by 236 point mutations in the same promoter. Surprisingly, we find that selection on expression noise (that is, variability in expression among genetically identical cells(5)) appears to have had a greater impact on sequence variation in the TDH3 promoter than selection on mean expression level. This is not necessarily because variation in expression noise impacts fitness more than variation in mean expression level, but rather because of differences in the distributions of mutational effects for these two phenotypes. This study shows how systematically examining the effects of new mutations can enrich our understanding of evolutionary mechanisms. It also provides rare empirical evidence of selection acting on expression noise.	[Metzger, Brian P. H.; Gruber, Jonathan D.; Duveau, Fabien; Wittkopp, Patricia J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Yuan, David C.; Wittkopp, Patricia J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wittkopp, PJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	wittkopp@umich.edu	Metzger, Brian/ABE-2059-2020; Metzger, Brian P H/AAX-9217-2021; Duveau, Fabien/AAC-5596-2019	Metzger, Brian P H/0000-0003-4878-2913; Duveau, Fabien/0000-0003-4784-0640	March of Dimes [5-FY07-181]; Alfred P. Sloan Research Foundation; National Science Foundation [MCB-1021398]; National Institutes of Health [1R01 GM108826]; University of Michigan; University of Michigan Rackham Graduate School, Ecology and Evolutionary Biology Department; National Institutes of Health Genome Sciences training grant [T32 HG000040]; National Institutes of Health Genetics training grant [T32 GM007544]; National Institutes of Health National Research Service Award (NRSA) postdoctoral fellowship [1 F32 GM083513-0]; European Molecular Biology Organization postdoctoral fellowship [EMBO ALTF 1114-2012]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108826, T32GM007544, F32GM083513] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); Alfred P. Sloan Research Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); University of Michigan Rackham Graduate School, Ecology and Evolutionary Biology Department; National Institutes of Health Genome Sciences training grant; National Institutes of Health Genetics training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service Award (NRSA) postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization postdoctoral fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Maclean, J. Zhang, and C. Hittinger for strains, the University of Michigan Center for Chemical Genomics for technical assistance with flow cytometry, and J. Coolon, R. Lusk, K. Stevenson, A. Hodgins-Davis, J. Lachowiec, C. Maclean, J. Yang, C. Landry, J. Townsend, and D. Petrov for comments on the manuscript. Funding for this work was provided to P.J.W. by the March of Dimes (5-FY07-181), Alfred P. Sloan Research Foundation, National Science Foundation (MCB-1021398), National Institutes of Health (1R01 GM108826) and the University of Michigan. Additional support was provided by the University of Michigan Rackham Graduate School, Ecology and Evolutionary Biology Department, and the National Institutes of Health Genome Sciences training grant (T32 HG000040) to B.P.H.M.; by a National Institutes of Health Genetics training grant (T32 GM007544) to D.C.Y.; by a National Institutes of Health National Research Service Award (NRSA) postdoctoral fellowship (1 F32 GM083513-0) to J.D.G.; and by a European Molecular Biology Organization postdoctoral fellowship (EMBO ALTF 1114-2012) to F.D.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De Vries H., 1905, SPECIES VARIETIES TH, P825; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; FONTANA W, 1994, B MATH BIOL, V56, P1; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gruber JD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002497; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hittinger CT, 2013, TRENDS GENET, V29, P309, DOI 10.1016/j.tig.2013.01.002; Hornung G, 2012, GENOME RES, V22, P2409, DOI 10.1101/gr.139378.112; HUIE MA, 1992, MOL CELL BIOL, V12, P2690, DOI 10.1128/MCB.12.6.2690; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Lehner B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.11; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Liti G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-69; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lo K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-145; Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; MCALISTER L, 1985, J BIOL CHEM, V260, P5019; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; R Core Team, 2021, R LANG ENV STAT COMP; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rice DP, 2012, GENETICS, V190, P1533, DOI 10.1534/genetics.111.137075; Ringel AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003871; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Smith JD, 2013, MOL BIOL EVOL, V30, P2509, DOI 10.1093/molbev/mst134; Stoltzfus A, 2009, J HERED, V100, P637, DOI 10.1093/jhered/esp048; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang QM, 2012, MOL ECOL, V21, P5404, DOI 10.1111/j.1365-294X.2012.05732.x; Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108; Wittkopp PJ, 2011, METHODS MOL BIOL, V772, P297, DOI 10.1007/978-1-61779-228-1_18; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; YAGI S, 1994, J VET MED SCI, V56, P235, DOI 10.1292/jvms.56.235; Zhang ZH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.58	46	88	89	1	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					344	+		10.1038/nature14244	http://dx.doi.org/10.1038/nature14244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25778704	Green Accepted			2022-12-24	WOS:000354816500054
J	Frakt, AB; Bagley, N				Frakt, Austin B.; Bagley, Nicholas			Protection or Harm? Suppressing Substance-Use Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							USE DISORDERS; HEALTH-CARE		[Frakt, Austin B.] Vet Affairs Boston Healthcare Syst, Dept Vet Affairs, Boston, MA 02114 USA; [Frakt, Austin B.] Boston Univ, Boston, MA 02215 USA; [Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Bagley, Nicholas] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Frakt, AB (corresponding author), Vet Affairs Boston Healthcare Syst, Dept Vet Affairs, Boston, MA 02114 USA.			Frakt, Austin/0000-0002-0795-5462				Brennan PL, 2001, MED CARE, V39, P39, DOI 10.1097/00005650-200101000-00006; Frakt AB, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-79; Hensley S, 2015, POLL MOST AM WOULD S; Petersen LA, 2010, HEALTH SERV RES, V45, P762, DOI 10.1111/j.1475-6773.2010.01107.x	4	28	28	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2015	372	20					1879	1881		10.1056/NEJMp1501362	http://dx.doi.org/10.1056/NEJMp1501362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1HB	25875196				2022-12-24	WOS:000354493300002
J	Kato, HE; Inoue, K; Abe-Yoshizumi, R; Kato, Y; Ono, H; Konno, M; Hososhima, S; Ishizuka, T; Hoque, MR; Kunitomo, H; Ito, J; Yoshizawa, S; Yamashita, K; Takemoto, M; Nishizawa, T; Taniguchi, R; Kogure, K; Maturana, AD; Iino, Y; Yawo, H; Ishitani, R; Kandori, H; Nureki, O				Kato, Hideaki E.; Inoue, Keiichi; Abe-Yoshizumi, Rei; Kato, Yoshitaka; Ono, Hikaru; Konno, Masae; Hososhima, Shoko; Ishizuka, Toru; Hoque, Mohammad Razuanul; Kunitomo, Hirofumi; Ito, Jumpei; Yoshizawa, Susumu; Yamashita, Keitaro; Takemoto, Mizuki; Nishizawa, Tomohiro; Taniguchi, Reiya; Kogure, Kazuhiro; Maturana, Andres D.; Iino, Yuichi; Yawo, Hiromu; Ishitani, Ryuichiro; Kandori, Hideki; Nureki, Osamu			Structural basis for Na+ transport mechanism by a light-driven Na+ pump	NATURE			English	Article							CHLORIDE PUMP; PROTON PUMP; C-ELEGANS; CHANNELRHODOPSIN; RHODOPSIN; BACTERIORHODOPSIN; XANTHORHODOPSIN; HALORHODOPSIN; ACTIVATION; MEMBRANE	Krokinobacter eikastus rhodopsin 2 (KR2) is the first light-driven Na+ pump discovered, and is viewed as a potential next-generation optogenetics tool. Since the positively charged Schiff base proton, located within the ion-conducting pathway of all light-driven ion pumps, was thought to prohibit the transport of a non-proton cation, the discovery of KR2 raised the question of how it achieves Na+ transport. Here we present crystal structures of KR2 under neutral and acidic conditions, which represent the resting and M-like intermediate states, respectively. Structural and spectroscopic analyses revealed the gating mechanism, whereby the flipping of Asp116 sequesters the Schiff base proton from the conducting pathway to facilitate Na+ transport. Together with the structure-based engineering of the first light-driven K1 pumps, electrophysiological assays in mammalian neurons and behavioural assays in a nematode, our studies reveal the molecular basis for light-driven non-proton cation pumps and thus provide a framework that may advance the development of next-generation optogenetics.	[Kato, Hideaki E.; Kunitomo, Hirofumi; Takemoto, Mizuki; Nishizawa, Tomohiro; Taniguchi, Reiya; Iino, Yuichi; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Inoue, Keiichi; Abe-Yoshizumi, Rei; Kato, Yoshitaka; Ono, Hikaru; Konno, Masae; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hososhima, Shoko; Ishizuka, Toru; Hoque, Mohammad Razuanul; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan; [Hososhima, Shoko; Ishizuka, Toru; Hoque, Mohammad Razuanul; Iino, Yuichi; Yawo, Hiromu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Ito, Jumpei] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yoshizawa, Susumu; Kogure, Kazuhiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Yamashita, Keitaro] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan	University of Tokyo; Nagoya Institute of Technology; Nagoya Institute of Technology; Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST); Nagoya University; University of Tokyo; RIKEN	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	kandori@nitech.ac.jp; nureki@bs.s.u-tokyo.ac.jp	Inoue, Keiichi/AEO-3337-2022; Yawo, Hiromu/I-4871-2015; NUREKI, OSAMU/G-4960-2014; Konno, Masae/C-1066-2009; Kato, Hideaki/AAQ-4323-2020; KUNITOMO, HIROFUMI/G-4963-2014; Ishizuka, Toru/L-8191-2017	Inoue, Keiichi/0000-0002-6898-4347; Yawo, Hiromu/0000-0002-4299-3288; Konno, Masae/0000-0002-0605-1816; Kato, Hideaki/0000-0002-1941-5535; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Ishizuka, Toru/0000-0003-4405-8792; Ito, Jumpei/0000-0001-5149-9962; Takemoto, Mizuki/0000-0002-6339-6431; Yamashita, Keitaro/0000-0002-5442-7582; yoshizawa, susumu/0000-0001-9667-6010	Platform for Drug Discovery, Informatics and Structural Life Science, of the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [11J06643, 24115508, 24655009, 25104009, 24681003, 24227004, 25291011]; FIRST program, PRESTO, CREST, JST; Grants-in-Aid for Scientific Research [25115010, 15K15025, 25620011, 14J40214, 15H01413] Funding Source: KAKEN	Platform for Drug Discovery, Informatics and Structural Life Science, of the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FIRST program, PRESTO, CREST, JST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Hattori and H. Nishimasu for useful discussions and critical comments on the manuscript; A. Kurabayashi, N. Sahara, and J. Sasaki for technical assistance; and S. Doki, K. Hirata and the beam-line staff members at BL32XU of SPring-8 for assistance in data collection. The synchrotron radiation experiments were performed at BL32XU of SPring-8, with approval from RIKEN. This work was supported by the Platform for Drug Discovery, Informatics and Structural Life Science, of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by JSPS KAKENHI (grant nos. 11J06643, 24115508, 24655009, 25104009, 24681003, 24227004, and 25291011), by the FIRST program, PRESTO, CREST, JST, and by a Grant-in-Aid for JSPS Fellows.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aston-Jones G, 2013, BRAIN RES, V1511, P1, DOI 10.1016/j.brainres.2013.01.026; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; BRENNER S, 1974, GENETICS, V77, P71; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grote M, 2011, FEMS MICROBIOL REV, V35, P1082, DOI 10.1111/j.1574-6976.2011.00281.x; Gushchin I, 2011, J MOL BIOL, V412, P591, DOI 10.1016/j.jmb.2011.07.022; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kandori H, 2004, BBA-BIOENERGETICS, V1658, P72, DOI 10.1016/j.bbabio.2004.03.015; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1458, DOI 10.1039/c0pp00236d; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Li TB, 2014, J BIOL CHEM, V289, P15441, DOI 10.1074/jbc.M114.550012; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Okumura H, 2005, J MOL BIOL, V351, P481, DOI 10.1016/j.jmb.2005.06.026; Ono H, 2014, J PHYS CHEM B, V118, P4784, DOI 10.1021/jp500756f; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Shinkai Y, 2011, J NEUROSCI, V31, P3007, DOI 10.1523/JNEUROSCI.4691-10.2011; Spudich JL, 2014, BBA-BIOENERGETICS, V1837, P546, DOI 10.1016/j.bbabio.2013.06.006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	48	153	157	3	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					48	U347		10.1038/nature14322	http://dx.doi.org/10.1038/nature14322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25849775				2022-12-24	WOS:000354040900029
J	Davis, D; Brayne, C				Davis, Daniel; Brayne, Carol			Ageing, health, and social care: reframing the discussion	LANCET			English	Editorial Material									[Davis, Daniel] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Brayne, Carol] Univ Cambridge, Sch Clin Med, Cambridge Inst Publ Hlth, Cambridge CB2 0SR, England	University of London; University College London; University of Cambridge	Brayne, C (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge Inst Publ Hlth, Cambridge Biomed Campus, Cambridge CB2 0SR, England.	cb105@medschl.cam.ac.uk	Brayne, Carol/AAA-4285-2020; Davis, Daniel/F-9995-2012	Brayne, Carol/0000-0001-5307-663X; Davis, Daniel/0000-0002-1560-1955	Medical Research Council [MC_UU_12019/1] Funding Source: Medline; MRC [MC_UU_12019/1] Funding Source: UKRI; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Beard JR, 2015, LANCET, V385, P658, DOI 10.1016/S0140-6736(14)61461-6; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; British Geriatrics Society, 2015, CALL BRIT GER SOC IN; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Hastings G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5124; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; NHS England Care Quality Commission Public Health England Monitor NHS Trust Development Authority Health Education England, 2014, NHS 5 YEAR FORW VIEW; Oliver D., 2014, MAKING OUR HLTH CARE; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Pollock AM, 2015, LANCET, V385, P1171; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368; YUDKIN JS, 2014, BMJ-BRIT MED J, V349, pNIL11, DOI [10.1136/bmj.g4485, DOI 10.1136/BMJ.G4485]	14	6	6	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1699	1700		10.1016/S0140-6736(15)60466-4	http://dx.doi.org/10.1016/S0140-6736(15)60466-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH0PZ	25943920	Green Accepted			2022-12-24	WOS:000353726000004
J	Fouda, GG; Cunningham, CK; Permar, SR				Fouda, Genevieve G.; Cunningham, Coleen K.; Permar, Sallie R.			Infant HIV-1 Vaccines Supplementing Strategies to Reduce Maternal-Child Transmission	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VACCINATION; RESPONSES; MOTHERS; TRIAL; BORN		[Fouda, Genevieve G.; Cunningham, Coleen K.; Permar, Sallie R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Fouda, Genevieve G.; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University	Permar, SR (corresponding author), Duke Univ, Med Ctr, Human Vaccine Inst, POB 103020, Durham, NC 27710 USA.	sallie.permar@duke.edu	Fouda, Genevieve/AAY-8099-2020; Fouda, Genevieve/AAR-9720-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD072796] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115, UL1TR001117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106716, P01AI117915, UM1AI068616, UM1AI068632, P30AI064518] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR001115, UL1 TR001117, KL2TR001115] Funding Source: Medline; NIAID NIH HHS [UM1 AI068632, UM1 AI106716, 5P30 AI064518, UM1AI068632, UM1AI106716, P30 AI064518, UM1 AI068616, UM1AI068616, P01 AI117915] Funding Source: Medline; NICHD NIH HHS [R03 HD072796] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cunningham CK, 2001, CLIN INFECT DIS, V32, P801, DOI 10.1086/319215; Fouda GG, 2015, J INFECT DIS, V211, P508, DOI 10.1093/infdis/jiu444; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Kintu K, 2013, JAIDS-J ACQ IMM DEF, V63, P1, DOI 10.1097/QAI.0b013e31827f1c2d; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45; Njuguna IN, 2014, VACCINE, V32, P5801, DOI 10.1016/j.vaccine.2014.08.034; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	10	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1513	1514		10.1001/jama.2015.1382	http://dx.doi.org/10.1001/jama.2015.1382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898044	Green Accepted			2022-12-24	WOS:000353198700011
J	Gordus, A; Pokala, N; Levy, S; Flavell, SW; Bargmann, CI				Gordus, Andrew; Pokala, Navin; Levy, Sagi; Flavell, Steven W.; Bargmann, Cornelia I.			Feedback from Network States Generates Variability in a Probabilistic Olfactory Circuit	CELL			English	Article							CAENORHABDITIS-ELEGANS; NEURONAL-ACTIVITY; C-ELEGANS; NEURAL CIRCUITS; IN-VIVO; SENSITIVITY; PERFORMANCE; PATTERNS; BEHAVIOR; SYSTEMS	Variability is a prominent feature of behavior and is an active element of certain behavioral strategies. To understand how neuronal circuits control variability, we examined the propagation of sensory information in a chemotaxis circuit of C. elegans where discrete sensory inputs can drive a probabilistic behavioral response. Olfactory neurons respond to odor stimuli with rapid and reliable changes in activity, but downstream AIB interneurons respond with a probabilistic delay. The interneuron response to odor depends on the collective activity of multiple neurons-AIB, RIM, and AVA-when the odor stimulus arrives. Certain activity states of the network correlate with reliable responses to odor stimuli. Artificially generating these activity states by modifying neuronal activity increases the reliability of odor responses in interneurons and the reliability of the behavioral response to odor. The integration of sensory information with network states may represent a general mechanism for generating variability in behavior.	[Gordus, Andrew; Pokala, Navin; Levy, Sagi; Flavell, Steven W.; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Gordus, Andrew; Pokala, Navin; Levy, Sagi; Flavell, Steven W.; Bargmann, Cornelia I.] Rockefeller Univ, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	cori@rockefeller.edu	Pokala, Navin/AAH-5719-2019; Levy, Sagi/AAG-1593-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618; Flavell, Steven/0000-0001-9464-1877	Marie-Josee and Henry Kravis Postdoctoral Fellowship; Human Frontiers Science Program Fellowship; G. Harold and Leila Y. Mathers Charitable Foundation; Howard Hughes Medical Institute	Marie-Josee and Henry Kravis Postdoctoral Fellowship; Human Frontiers Science Program Fellowship(Human Frontier Science Program); G. Harold and Leila Y. Mathers Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank L. Looger for GCaMP constructs, D. Albrecht and J. Larsch for advice with arena imaging, and S. Kato, M. Lockard, D. Ventimiglia, and other members of our laboratory for helpful discussions. This work was supported by a Marie-Josee and Henry Kravis Postdoctoral Fellowship to A.G., a Human Frontiers Science Program Fellowship to S. L., the G. Harold and Leila Y. Mathers Charitable Foundation, and the Howard Hughes Medical Institute. C.I.B. is a Howard Hughes Medical Institute investigator.	Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; Barlow H B, 1971, Vision Res, VSuppl 3, P87; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BRENNER S, 1974, GENETICS, V77, P71; Chaisanguanthum KS, 2014, J NEUROSCI, V34, P12071, DOI 10.1523/JNEUROSCI.3001-13.2014; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Faumont S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024666; Frederick DE, 2011, BEHAV NEUROSCI, V125, P588, DOI 10.1037/a0024371; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; Harsanyi J. C., 1973, International Journal of Game Theory, V2, P1, DOI 10.1007/BF01737554; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Larsch J, 2013, P NATL ACAD SCI USA, V110, pE4266, DOI 10.1073/pnas.1318325110; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LILLYWHITE PG, 1979, NATURE, V277, P569, DOI 10.1038/277569a0; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mellem JE, 2008, NAT NEUROSCI, V11, P865, DOI 10.1038/nn.2131; Mitsutake Ayori, 2013, Methods Mol Biol, V924, P153, DOI 10.1007/978-1-62703-017-5_7; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; Press WH., 2002, NUMERICAL RECIPES C, V2; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Rajan K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011903; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schrodel T, 2013, NAT METHODS, V10, P1013, DOI [10.1038/NMETH.2637, 10.1038/nmeth.2637]; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Thrun S.B., 1992, EFFICIENT EXPLORATIO; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	53	111	113	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					215	227		10.1016/j.cell.2015.02.018	http://dx.doi.org/10.1016/j.cell.2015.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25772698	Bronze, Green Accepted			2022-12-24	WOS:000352708300016
J	Ragunathan, K; Jih, G; Moazed, D				Ragunathan, Kaushik; Jih, Gloria; Moazed, Danesh			Epigenetic inheritance uncoupled from sequence-specific recruitment	SCIENCE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; LYSINE-9 METHYLATION; CHROMODOMAIN PROTEIN; CHROMATIN-STRUCTURE; BYPASSES RNAI; HISTONE CODE; HETEROCHROMATIN; MAINTENANCE; COMPLEX	Changes in histone posttranslational modifications are associated with epigenetic states that define distinct patterns of gene expression. It remains unclear whether epigenetic information can be transmitted through histone modifications independently of specific DNA sequence, DNA methylation, or RNA interference. Here we show that, in the fission yeast Schizosaccharomyces pombe, ectopically induced domains of histone H3 lysine 9 methylation (H3K9me), a conserved marker of heterochromatin, are inherited through several mitotic and meiotic cell divisions after removal of the sequence-specific initiator. The putative JmjC domain H3K9 demethylase, Epe1, and the chromodomain of the H3K9 methyltransferase, Clr4/Suv39h, play opposing roles in maintaining silent H3K9me domains. These results demonstrate how a direct "read-write" mechanism involving Clr4 propagates histone modifications and allows histones to act as carriers of epigenetic information.	[Ragunathan, Kaushik; Jih, Gloria; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	danesh@hms.harvard.edu			Leukemia and Lymphoma Society [CDP-5025-14]; NIH [GM072805, T32 GM007226]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226, R01GM072805] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Shetty for help with tetrad dissections; D. Shea for help in data processing; DNA 2.0 (Menlo Park, CA) for synthesis of the plasmid containing tetO binding sites; D. Landgraf for the gift of a yeast codon-optimized GFP plasmid; T. Hattori and S. Koide for the gift of a H3K9me3 recombinant antibody; and members of the Moazed lab for helpful discussions and comments-particularly E. Egan, N. Iglesias, and J. Xiol for providing valuable experimental help and advice and R. Behrouzi for advice and help with FACS analysis. The raw and processed ChIP-seq data are publicly available at the National Center for Biotechnology Information Gene Expression Omnibus under accession number GSE63304. This work was supported by a postdoctoral fellowship from the Leukemia and Lymphoma Society (CDP-5025-14 to K.R.) and a grant from the NIH (GM072805 to D.M.). G.J. was supported partly by an NIH training grant (T32 GM007226). D.M. is an investigator of the Howard Hughes Medical Institute.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; Busturia A, 1997, DEVELOPMENT, V124, P4343; Cheng TH, 2000, GENE DEV, V14, P452; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; Egan ED, 2014, RNA, V20, P867, DOI 10.1261/rna.044479.114; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomez EB, 2005, MOL CELL BIOL, V25, P8887, DOI 10.1128/MCB.25.20.8887-8903.2005; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hattori T, 2013, NAT METHODS, V10, P992, DOI 10.1038/nmeth.2605; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; JACKSON V, 1974, BIOCHEMISTRY-US, V13, P3952, DOI 10.1021/bi00716a021; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Reyes-Turcu FE, 2011, NAT STRUCT MOL BIOL, V18, P1132, DOI 10.1038/nsmb.2122; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tadeo X, 2013, GENE DEV, V27, P2489, DOI 10.1101/gad.226118.113; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wheeler BS, 2012, GENETICS, V190, P549, DOI 10.1534/genetics.111.137083; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhong XH, 2014, CELL, V157, P1050, DOI 10.1016/j.cell.2014.03.056	57	176	176	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230							1258699	10.1126/science.1258699	http://dx.doi.org/10.1126/science.1258699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25831549	Green Accepted			2022-12-24	WOS:000352079500031
J	Cohen, D				Cohen, Deborah			BANNER Why have UK doctors been deterred from prescribing Avastin?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com						Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6867; Lock D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1377; Martin DF, 2010, NEW ENGL J MED, V363, P105, DOI 10.1056/NEJMp1001201; Moja L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011230.pub2	4	25	25	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2015	350								h1654	10.1136/bmj.h1654	http://dx.doi.org/10.1136/bmj.h1654			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF3HO	25834024				2022-12-24	WOS:000352439300008
J	Sandler, O; Mizrahi, SP; Weiss, N; Agam, O; Simon, I; Balaban, NQ				Sandler, Oded; Mizrahi, Sivan Pearl; Weiss, Noga; Agam, Oded; Simon, Itamar; Balaban, Nathalie Q.			Lineage correlations of single cell division time as a probe of cell-cycle dynamics	NATURE			English	Article							GENE-EXPRESSION; GENERATION TIMES; MODEL; NOISE; VARIABILITY; BACTERIA; SERIES	Stochastic processes in cells are associated with fluctuations in mRNA(1), protein production and degradation(2,3), noisy partition of cellular components at division(4), and other cell processes. Variability within a clonal population of cells originates from such stochastic processes, which may be amplified or reduced by deterministic factors(5). Cell-to-cell variability, such as that seen in the heterogeneous response of bacteria to antibiotics, or of cancer cells to treatment, is understood as the inevitable consequence of stochasticity. Variability in cell-cycle duration was observed long ago; however, its sources are still unknown. A central question is whether the variance of the observed distribution originates from stochastic processes, or whether it arises mostly from a deterministic process that only appears to be random. A surprising feature of cell-cycle-duration inheritance is that it seems to be lost within one generation but to be still present in the next generation, generating poor correlation between mother and daughter cells but high correlation between cousin cells(6). This observation suggests the existence of underlying deterministic factors that determine the main part of cell-to-cell variability. We developed an experimental system that precisely measures the cell-cycle duration of thousands of mammalian cells along several generations and a mathematical framework that allows discrimination between stochastic and deterministic processes in lineages of cells. We show that the inter-and intra-generation correlations reveal complex inheritance of the cell-cycle duration. Finally, we build a deterministic nonlinear toy model for cell-cycle inheritance that reproduces the main features of our data. Our approach constitutes a general method to identify deterministic variability in lineages of cells or organisms, which may help to predict and, eventually, reduce cell-to-cell heterogeneity in various systems, such as cancer cells under treatment.	[Sandler, Oded; Mizrahi, Sivan Pearl; Simon, Itamar] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Sandler, Oded; Mizrahi, Sivan Pearl; Weiss, Noga; Agam, Oded; Balaban, Nathalie Q.] Hebrew Univ Jerusalem, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Balaban, NQ (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	agam@phys.huji.ac.il; itamarsi@ekmd.huji.ac.il; nathalieqb@phys.huji.ac.il	Pearl, Sivan/GQG-8887-2022; Balaban, Nathalie/AGI-1487-2022; Balaban, Nathalie/AAH-1004-2019	Pearl, Sivan/0000-0001-5093-8361; Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766; Agam, Oded/0000-0002-4118-8586; Simon, Itamar/0000-0002-8517-1903	ISF [592/10, 567/10, 9/09, 302/14]; ERC [281306, 260871]; Chief Scientist Office of the Israel Ministry of Health; Weinkselbaum family medical research fund; Clore Foundation	ISF(Israel Science Foundation); ERC(European Research Council (ERC)European Commission); Chief Scientist Office of the Israel Ministry of Health; Weinkselbaum family medical research fund; Clore Foundation	We thank H. Miyoshi at the Riken Tsukuba for the Fucci markers, N. Barkai, N. Shoresh, J. Theiler, S. Kadener, L. Glass, G. Asher, A. W. Murray and J. Paulsson for discussions, and M. Gorfine and R. Heller for advice on statistical analysis. We thank Q. Yang and A. van Oudenaarden for the Cyanobacteria data sets, and the authors of ref. 24 for making their published data available online. This work was supported by the ISF (grants no. 592/10 (N.Q.B.); no. 567/10(I.S.); and no. 9/09, 302/14 (O.A.)) and the ERC Starting Grant no. 281306 (I.S.), no. 260871 (N.Q.B.), the Chief Scientist Office of the Israel Ministry of Health and the Weinkselbaum family medical research fund(I.S.). I.S. thanks the USAID's ASHA Program for the upgrading of the FACS laboratory. S.P.M. is supported by the Clore Foundation.	Altinok A, 2011, INTERFACE FOCUS, V1, P36, DOI 10.1098/rsfs.2010.0009; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; COWAN R, 1986, BIOMETRICS, V42, P769, DOI 10.2307/2530692; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; FROESE G, 1964, EXP CELL RES, V35, P415, DOI 10.1016/0014-4827(64)90108-9; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; GLASS L, 1993, MED PROG TECHNOL, V19, P115; GRASMAN J, 1990, B MATH BIOL, V52, P535, DOI 10.1016/S0092-8240(05)80361-1; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; HEJBLUM G, 1988, J THEOR BIOL, V131, P255, DOI 10.1016/S0022-5193(88)80242-X; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; KUCZEK T, 1986, MATH BIOSCI, V79, P87, DOI 10.1016/0025-5564(86)90018-0; LLOYD D, 1992, BIOSYSTEMS, V27, P17, DOI 10.1016/0303-2647(92)90043-X; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; NURSE P, 1980, NATURE, V286, P9, DOI 10.1038/286009a0; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; POWELL EO, 1955, BIOMETRIKA, V42, P16, DOI 10.1093/biomet/42.1-2.16; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; SHIELDS R, 1977, NATURE, V267, P704, DOI 10.1038/267704a0; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Skinner J., 1994, NAT BIOTECHNOL, V12, P596; STAUDTE RG, 1984, J THEOR BIOL, V109, P127, DOI 10.1016/S0022-5193(84)80115-0; THEILER J, 1995, PHYS LETT A, V196, P335, DOI 10.1016/0375-9601(94)00856-K; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759	31	86	86	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					468	+		10.1038/nature14318	http://dx.doi.org/10.1038/nature14318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8BH	25762143				2022-12-24	WOS:000371581400002
J	Bleichert, F; Botchan, MR; Berger, JM				Bleichert, Franziska; Botchan, Michael R.; Berger, James M.			Crystal structure of the eukaryotic origin recognition complex	NATURE			English	Article							DNA-REPLICATION; CONFORMATIONAL-CHANGES; ORC6 PROTEIN; ATP-HYDROLYSIS; BINDING; SEQUENCE; DOMAIN; CLAMP; INITIATORS; HOMOLOGY	Initiation of cellular DNA replication is tightly controlled to sustain genomic integrity. In eukaryotes, the heterohexameric origin recognition complex (ORC) is essential for coordinating replication onset. Here we describe the crystal structure of Drosophila ORC at 3.5 angstrom resolution, showing that the 270 kiloclalton initiator core complex comprises a two-layered notched ring in which a collar of winged-helix domains from the Orcl-5 subunits sits atop a layer of AAA+ (ATPases associated with a variety of cellular activities) folds. Although canonical inter-AAA+ domain interactions exist between four of the six ORC subunits, unanticipated features are also evident. These include highly interdigitated domain-swapping interactions between the winged-helix folds and AAA+ modules of neighbouring protomers, and a quasi-spiral arrange. ment of DNA binding elements that circumnavigate an approximately 20 A wide channel in the centre of the complex. Comparative analyses indicate that ORC encircles DNA, using its winged-helix domain face to engage the mini-chromosome maintenance 2-7 (MCM2-7) complex during replicative helicase loading; however, an observed out-of-plane rotation of more than 900 for the Orc1 AAA+ domain disrupts interactions with catalytic amino acids in Orc4, narrowing and sealing off entry into the central channel. Prima facie, our data indicate that Drosophila ORC can switch between active and autoinhibited conformations, suggesting a novel means for cell cycle and/or developmental control of ORC functions.	[Bleichert, Franziska; Berger, James M.] Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Botchan, Michael R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Berkeley	Berger, JM (corresponding author), Johns Hopkins Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	mbotchan@berkeley.edu; jberge29@jhmi.edu			National Institutes of Health [GM071747, CA R37-30490]; UC Berkeley Miller Institute for Basic Research in Science; NATIONAL CANCER INSTITUTE [R37CA030490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Berkeley Miller Institute for Basic Research in Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline scientists at beamlines 8.3.1 of the Advanced Light Source (Berkeley Lawrence National Laboratory), 23-ID-B of the Advanced Photon Source (Argonne National Laboratory) and X25 of the National Synchrotron Light Source (Brookhaven National Laboratory) for technical support with X-ray diffraction data collection, and the Nogales laboratory (University of California, Berkeley) for EM support. We also thank A. Fisher and Y. Li for assistance with insect cell cultures. This work was supported by the National Institutes of Health (GM071747 to J.M.B. and CA R37-30490 to M.R.B.) and by a fellowship from the UC Berkeley Miller Institute for Basic Research in Science (to F.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bell SP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010124; Bleichert F, 2013, ELIFE, V2, DOI 10.7554/eLife.00882; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZQ, 2008, P NATL ACAD SCI USA, V105, P10326, DOI 10.1073/pnas.0803829105; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Dueber EC, 2011, NUCLEIC ACIDS RES, V39, P3621, DOI 10.1093/nar/gkq1308; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Gaczynska M, 2004, P NATL ACAD SCI USA, V101, P17952, DOI 10.1073/pnas.0408369102; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Houchens CR, 2008, J BIOL CHEM, V283, P30216, DOI 10.1074/jbc.M802649200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Liu SX, 2011, P NATL ACAD SCI USA, V108, P7373, DOI 10.1073/pnas.1013676108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller P, 2010, GENE DEV, V24, P1418, DOI 10.1101/gad.1906410; Neuwald AF, 1999, GENOME RES, V9, P27; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Singleton MR, 2004, J MOL BIOL, V343, P547, DOI 10.1016/j.jmb.2004.08.044; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Sun JC, 2012, STRUCTURE, V20, P534, DOI 10.1016/j.str.2012.01.011; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yardimci H, 2014, NAT STRUCT MOL BIOL, V21, P20, DOI 10.1038/nsmb.2738	68	84	86	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					321	+		10.1038/nature14239	http://dx.doi.org/10.1038/nature14239			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25762138	Green Accepted			2022-12-24	WOS:000351171900034
J	Elmore, JG; Longton, GM; Carney, PA; Geller, BM; Onega, T; Tosteson, ANA; Nelson, HD; Pepe, MS; Allison, KH; Schnitt, SJ; O'Malley, FP; Weaver, DL				Elmore, Joann G.; Longton, Gary M.; Carney, Patricia A.; Geller, Berta M.; Onega, Tracy; Tosteson, Anna N. A.; Nelson, Heidi D.; Pepe, Margaret S.; Allison, Kimberly H.; Schnitt, Stuart J.; O'Malley, Frances P.; Weaver, Donald L.			Diagnostic Concordance Among Pathologists interpreting Breast Biopsy Specimens	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAMMOGRAPHIC DENSITY; CANCER; AGREEMENT; RISK; WOMEN; VARIABILITY; DISEASE; LESIONS; MANAGEMENT; OUTCOMES	IMPORTANCE A breast pathology diagnosis provides the basis for clinical treatment and management decisions; however, its accuracy is inadequately understood. 0BJECTIVES To quantify the magnitude of diagnostic disagreement among pathologists compared with a consensus panel reference diagnosis and to evaluate associated patient and pathologist characteristics. PARTICIPANTS Study of pathologists who interpret breast biopsies in clinical practices in 8 US states. EXPOSURES Participants independently interpreted slides between November 2011 and May 2014 from test sets of 60 breast biopsies (240 total cases, 1 slide per case), including 23 cases of invasive breast cancer, 73 ductal carcinoma in situ (DCIS), 72 with atypical hyperplasia (atypia), and 72 benign cases without atypia. Participants were blinded to the interpretations of other study pathologists and consensus panel members. Among the 3 consensus panel members, unanimous agreement of their independent diagnoses was 75%, and concordance with the consensus-derived reference diagnoses was 90.3%. MAIN OUTCOMES AND MEASURES The proportions of diagnoses overinterpreted and underinterpreted relative to the consensus-derived reference diagnoses were assessed. RESULTS Sixty-five percent of invited, responding pathologists were eligible and consented to participate. Of these, 91% (N = 115) completed the study, providing 6900 individual case diagnoses. Compared with the consensus-derived reference diagnosis, the overall concordance rate of diagnostic interpretations of participating pathologists was 75.3% (95% Cl, 73.4%-77.0%; 5194 of 6900 interpretations). [GRAPHICS] Disagreement with the reference diagnosis was statistically significantly higher among biopsies from women with higher (n = 122) vs lower (n = 118) breast density on prior mammograms (overall concordance rate, 73% [95% Cl, 71%-75%] for higher vs 77% [95% Cl, 75%-80%] for lower, P < .001), and among pathologists who interpreted lower weekly case volumes (P < .001) or worked in smaller practices (P = .034) or nonacademic settings (P = .007). CONCLUSIONS AND RELEVANCE In this study of pathologists, in which diagnostic interpretation was based on a single breast biopsy slide, overall agreement between the individual pathologists' interpretations and the expert consensus-derived reference diagnoses was 75.3%, with the highest level of concordance for invasive carcinoma and lower levels of concordance for DCIS and atypia. Further research is needed to understand the relationship of these findings with patient management.	[Elmore, Joann G.] Univ Washington, Dept Med, Sch Med, Seattle, WA 98104 USA; [Longton, Gary M.; Pepe, Margaret S.] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Geller, Berta M.] Univ Vermont, Family Med, Vineyard Haven, MA USA; [Onega, Tracy; Tosteson, Anna N. A.] Norris Cotton Canc Ctr, Dept Community & Family Med, Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, Lebanon, NH USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Nelson, Heidi D.] Providence Hlth & Serv Oregon, Providence Canc Ctr, Portland, OR USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Dept Clin Epidemiol & Med, Portland, OR 97201 USA; [Allison, Kimberly H.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Schnitt, Stuart J.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Schnitt, Stuart J.] Harvard Univ, Sch Med, Boston, MA USA; [O'Malley, Frances P.] Li Ka Shing Knowledge Inst, Dept Lab Med, Toronto, ON, Canada; [O'Malley, Frances P.] Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [O'Malley, Frances P.] St Michaels Hosp, Toronto, ON, Canada; [O'Malley, Frances P.] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Weaver, Donald L.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Weaver, Donald L.] Univ Vermont, Ctr Canc, Burlington, VT 05405 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Oregon Health & Science University; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Oregon Health & Science University; Oregon Health & Science University; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Vermont; University of Vermont	Elmore, JG (corresponding author), Univ Washington, Dept Med, 325 Ninth Ave,POB 359780, Seattle, WA 98104 USA.	jelmore@u.washington.edu			National Cancer Institute [R01CA140560, R01CA172343, K05CA104699, U01CA70013, HHSN261201100031C]; NATIONAL CANCER INSTITUTE [P30CA023108, K05CA104699, U01CA070013, R01CA172343, R01CA140560] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (R01CA140560, R01CA172343, and K05CA104699) and by the National Cancer Institute-funded Breast Cancer Surveillance Consortium (U01CA70013 and HHSN261201100031C). The collection of cancerand vital status data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of sources, visit http://www.breastscreening.cancer.gov/work /acknowledgement.html. The American Medical Association (AMA) is the source for the raw physician data; statistics, tables, or tabulations were prepared by the authors using AMA Physician Masterfile data. The AMA Physician Masterfile data on pathologist age, sex, level of direct medical care, and proportion working in a population of 250 000 or more were used in comparing characteristics of participants and nonparticipants.	Allison KH, 2014, HISTOPATHOLOGY, V65, P240, DOI 10.1111/his.12387; American Medical Association, PHYS; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Carney PA, 1998, J COMMUN HEALTH, V23, P85, DOI 10.1023/A:1018779022971; Collins LC, 2004, AM J SURG PATHOL, V28, P126, DOI 10.1097/00000478-200401000-00015; DellaMea V, 1997, MODERN PATHOL, V10, P636; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; ELMORE JG, 1992, J CLIN EPIDEMIOL, V45, P567, DOI 10.1016/0895-4356(92)90128-A; FEINSTEIN AR, 1985, J CHRON DIS, V38, P619, DOI 10.1016/0021-9681(85)90016-5; Feng S, 2014, ARCH PATHOL LAB MED, V138, P955, DOI 10.5858/arpa.2013-0263-OA; Ginsburg OM, 2008, BRIT J CANCER, V99, P1369, DOI 10.1038/sj.bjc.6604635; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Haas JS, 2000, J GEN INTERN MED, V15, P321, DOI 10.1046/j.1525-1497.2000.08030.x; Hall FM, 2010, RADIOLOGY, V254, P655, DOI 10.1148/radiol.09092100; Harris JR, 2014, DIS BREAST; Hartmann LC, 2015, NEW ENGL J MED, V372, P78, DOI 10.1056/NEJMsr1407164; Helmer O, SYSTEMATIC USE EXPER; Lee CI, 2012, RADIOLOGY, V264, P632, DOI 10.1148/radiol.12120184; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; National Cancer Institute, BREAST CANC SURV CON; O'Malley FP, 2011, BREAST PATHOLOGY; Oster NV, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-3; Rakovitch E, 2004, BREAST CANCER RES TR, V87, P265, DOI 10.1007/s10549-004-9454-8; ROSAI J, 1991, AM J SURG PATHOL, V15, P209, DOI 10.1097/00000478-199103000-00001; RUBIN E, 1988, CANCER, V61, P2077, DOI 10.1002/1097-0142(19880515)61:10<2077::AID-CNCR2820611024>3.0.CO;2-M; Saul S, 2010, NY TIMES; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Schnitt SJ, 2009, BIOPSY INTERPRETATIO; Shaw EC, 2012, J CLIN PATHOL, V65, P403, DOI 10.1136/jclinpath-2011-200369; Silverstein M, 2009, J AM COLL SURGEONS, V208, P78, DOI 10.1016/j.jamcollsurg.2008.09.022; Silverstein Melvin J, 2009, J Am Coll Surg, V209, P504, DOI 10.1016/j.jamcollsurg.2009.07.006; Stang A, 2011, HISTOPATHOLOGY, V59, P939, DOI 10.1111/j.1365-2559.2011.04032.x; Trocchi P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-554; Weaver DL, 2006, CANCER, V106, P732, DOI 10.1002/cncr.21652; Wells WA, 1998, J NATL CANCER I, V90, P142, DOI 10.1093/jnci/90.2.142; Willis GB, 2005, COGNITIVE INTERVIEWI; Zahl PH, 2013, BRIT J CANCER, V109, P2014, DOI 10.1038/bjc.2013.427	39	177	188	4	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2015	313	11					1122	1132		10.1001/jama.2015.1405	http://dx.doi.org/10.1001/jama.2015.1405			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD5BP	25781441	Green Accepted, Bronze			2022-12-24	WOS:000351102500014
J	Kramer, DB; Kesselheim, AS				Kramer, Daniel B.; Kesselheim, Aaron S.			The Watchman Saga - Closure at Last?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LEFT ATRIAL APPENDAGE; WARFARIN THERAPY; FIBRILLATION; PREVENTION; STROKE		[Kramer, Daniel B.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02163 USA; [Kramer, Daniel B.] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Kramer, Daniel B.] Hebrew SeniorLife Inst Aging Res, Boston, MA USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Hebrew SeniorLife; Harvard University; Brigham & Women's Hospital	Kramer, DB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02163 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	NATIONAL INSTITUTE ON AGING [K23AG045963] Funding Source: NIH RePORTER; NIA NIH HHS [K23 AG045963] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Kramer DB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001519; Maisel WH, 2009, NEW ENGL J MED, V360, P2601, DOI 10.1056/NEJMp0903763; Sick PB, 2007, J AM COLL CARDIOL, V49, P1490, DOI 10.1016/j.jacc.2007.02.035	5	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2015	372	11					994	995		10.1056/NEJMp1415738	http://dx.doi.org/10.1056/NEJMp1415738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD0XK	25760353	Green Accepted			2022-12-24	WOS:000350797300003
J	Cuthbertson, JD; MacMillan, DWC				Cuthbertson, James D.; MacMillan, David W. C.			The direct arylation of allylic sp(3) C-H bonds via organic and photoredox catalysis	NATURE			English	Article							ALDEHYDES; ACTIVATION; ORGANOCATALYSIS; PHOTOCHEMISTRY; OXIDATION; OLEFINS; ACIDS; ALKYL	The direct functionalization of unactivated sp(3) C-H bonds is still one of the most challenging problems facing synthetic organic chemists. The appeal of such transformations derives from their capacity to facilitate the construction of complex organic molecules via the coupling of simple and otherwise inert building blocks, without introducing extraneous functional groups. Despite notable recent efforts', the establishment of general and mild strategies for the engagement of sp(3) C-H bonds in C-C bond forming reactions has proved difficult. Within this context, the discovery of chemical transformations that are able to directly functionalize allylic methyl, methylene and methine carbons in a catalytic manner is a priority. Although protocols for direct oxidation and amination of allylic C-H bonds (that is, C-H bonds where an adjacent carbon is involved in a C=C bond) have become widely established(2,3), the engagement of allylic substrates in C-C bond forming reactions has thus far required the use of pre-functionalized coupling partners'. In particular, the direct arylation of non-functionalized allylic systems would enable access to a series of known pharmacophores (molecular features responsible for a drug's action), though a general solution to this long-standing challenge remains elusive. Here we report the use of both photoredox and organic catalysis to accomplish a mild, broadly effective direct allylic C-H arylation. This C-C bond forming reaction readily accommodates abroad range of alkene and electron-deficient arene reactants, and has been used in the direct arylation of benzylic C-H bonds.	[Cuthbertson, James D.; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Cuthbertson, James/0000-0003-3820-6816	NIHGMS [R01 GM103558-03]; Merck; Amgen; Marie Curie Actions; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103558] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Merck(Merck & Company); Amgen(Amgen); Marie Curie Actions(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by NIHGMS (R01 GM103558-03), and we also thank Merck and Amgen for funding. J.D.C. thanks Marie Curie Actions for an International Outgoing Fellowship.	BORG RM, 1984, CAN J CHEM, V62, P1785, DOI 10.1139/v84-306; Denisov E, 2009, INT J CHEM KINET, V41, P284, DOI 10.1002/kin.20404; Eames J, 2001, ANGEW CHEM INT EDIT, V40, P3567, DOI 10.1002/1521-3773(20011001)40:19<3567::AID-ANIE3567>3.0.CO;2-C; Flamigni L, 2007, TOP CURR CHEM, V281, P143, DOI 10.1007/128_2007_131; He J, 2014, SCIENCE, V343, P1216, DOI 10.1126/science.1249198; Hoshikawa T, 2013, CHEM SCI, V4, P3118, DOI 10.1039/c3sc51080h; JENCKS WP, 1971, J AM CHEM SOC, V93, P4433, DOI 10.1021/ja00747a016; Johannsen M, 1998, CHEM REV, V98, P1689, DOI 10.1021/cr970343o; Khursan SL, 1997, REACT KINET CATAL L, V61, P91, DOI 10.1007/BF02477518; MCMILLEN DF, 1982, ANNU REV PHYS CHEM, V33, P493, DOI 10.1146/annurev.pc.33.100182.002425; Mori Y, 2000, J PHYS CHEM A, V104, P4896, DOI 10.1021/jp0007437; Nagib DA, 2009, J AM CHEM SOC, V131, P10875, DOI 10.1021/ja9053338; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Ogawa KA, 2014, ORG LETT, V16, P1928, DOI 10.1021/ol500459x; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qvortrup K, 2014, J AM CHEM SOC, V136, P626, DOI 10.1021/ja411596q; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Sekine M, 2013, ORG LETT, V15, P714, DOI 10.1021/ol400056z; Trost BM, 1996, CHEM REV, V96, P395, DOI 10.1021/cr9409804	21	321	320	14	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					74	77		10.1038/nature14255	http://dx.doi.org/10.1038/nature14255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739630	Green Submitted, Green Accepted			2022-12-24	WOS:000350304000038
J	Spoor, F; Gunz, P; Neubauer, S; Stelzer, S; Scott, N; Kwekason, A; Dean, MC				Spoor, Fred; Gunz, Philipp; Neubauer, Simon; Stelzer, Stefanie; Scott, Nadia; Kwekason, Amandus; Dean, M. Christopher			Reconstructed Homo habilis type OH 7 suggests deep-rooted species diversity in early Homo	NATURE			English	Article							OLDUVAI-GORGE; KOOBI FORA; ENDOCRANIAL VOLUMES; CRANIAL CAPACITY; LIFE-HISTORY; FOSSILS; EVOLUTION; PRIMATE; GROWTH; SAMPLE	Besides Homo erectus (sensu lato), the eastern African fossil record of early Homo has been interpreted as representing either a single variable species, Homo habilis(1), or two species(2-6). In the latter case, however, there is no consensus over the respective groupings, and which of the two includes OH 7, the 1.8-million-year-old H. habilis holotype(7). This partial skull and hand from Olduvai Gorge remains pivotal to evaluating the early evolution of the Homo lineage, and by priority names one or other of the two taxa. However, the distorted preservation of the diagnostically important OH 7 mandible has hindered attempts to compare this specimen with other fossils(8,9). Here we present a virtual reconstruction of the OH 7 mandible, and compare it to other early Homo fossils. The reconstructed mandible is remarkably primitive, with a long and narrow dental arcade more similar to Australopithecus afarensis than to the derived parabolic arcades of Homo sapiens or H. erectus. We find that this shape variability is not consistent with a single species of early Homo. Importantly, the jaw morphology of OH 7 is incompatible with fossils assigned to Homo rudolfensiss(8) and with the A.L. 666-1 Homo maxilla. The latter is morphologically more derived than OH 7 but 500,000 years older(10), suggesting that the H. habilis lineage originated before 2.3 million years ago, thus marking deep-rooted species diversity in the genus Homo. We also reconstructed the parietal bones of OH 7 and estimated its endocranial volume. At between 729 and 824 ml it is larger than any previously published value, and emphasizes the near-complete overlap in brain size among species of early Homo. Our results clarify the H. habilis hypodigm, but raise questions about its phylogenetic relationships. Differences between species of early Homo appear to be characterized more by gnathic diversity than by differences in brain size, which was highly variable within all taxa.	[Spoor, Fred; Gunz, Philipp; Neubauer, Simon; Stelzer, Stefanie; Scott, Nadia] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Spoor, Fred; Dean, M. Christopher] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Kwekason, Amandus] Natl Museum Tanzania, Museum & House Culture, Dar Es Salaam, Tanzania	Max Planck Society; University of London; University College London	Spoor, F (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany.	f.spoor@ucl.ac.uk; gunz@eva.mpg.de	Gunz, Philipp/C-7748-2009; Neubauer, Simon/D-1317-2010	Gunz, Philipp/0000-0002-2350-4450; Neubauer, Simon/0000-0001-9113-5063; Stelzer, Stefanie/0000-0003-2408-7211	Max Planck Society	Max Planck Society(Max Planck Society)	We thank the National Museum of Tanzania, the Tanzania Commission for Science and Technology and the National Museums of Kenya for giving access to fossils in their care, and the Imaging Plus Medical Centre, Dar es Salaam, for CT scanning facilities. We are grateful to M. Leakey, L. Leakey, J.-J. Hublin and S. Anton for support and encouragement, and to R. Blumenschine, P. Corujo, R. David, P. Gokarn, W. Kimbel, K. Kupczik, R. Leakey, J. Lewis, E. Mbua, R. McCarthy, M. Meyer, P. Mitteroecker, P. Msemwa, J. Njau, D. Reinhardt, L. Schroeder, M. Skinner, A. Stoessel, A. Strauss, H. Temming and B. Wood for help with aspects of this study. Research was supported by the Max Planck Society.	Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Brown P., 2014, AUSTR ASIAN PALAEOAN; Clarke R. J., 2012, J HUM EVOL; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; HOLLOWAY RL, 1973, NATURE, V243, P97, DOI 10.1038/243097a0; HOLLOWAY RL, 1980, AM J PHYS ANTHROPOL, V53, P267, DOI 10.1002/ajpa.1330530211; HOLLOWAY RL, 1983, AM J PHYS ANTHROPOL, V60, P505, DOI 10.1002/ajpa.1330600413; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jimenez-Arenas JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406507; Joordens JCA, 2013, J HUM EVOL, V65, P731, DOI 10.1016/j.jhevol.2013.09.002; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 2010, PHILOS T R SOC B, V365, P3365, DOI 10.1098/rstb.2010.0070; LEAKEY LSB, 1961, NATURE, V189, P649, DOI 10.1038/189649a0; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; Leigh SR, 2012, EVOL BIOL, V39, P587, DOI 10.1007/s11692-012-9168-5; Leonard WR, 2007, ANNU REV NUTR, V27, P311, DOI 10.1146/annurev.nutr.27.061406.093659; Lewis JE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001071; LIEBERMAN DE, 1988, J HUM EVOL, V17, P503, DOI 10.1016/0047-2484(88)90039-5; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Marchand F., 1902, HIRNGEWICHT MENSCHEN; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Neubauer S, 2012, J HUM EVOL, V62, P498, DOI 10.1016/j.jhevol.2012.01.005; Neubauer S, 2012, AM J PHYS ANTHROPOL, V147, P319, DOI 10.1002/ajpa.21641; Neubauer S, 2010, J HUM EVOL, V59, P555, DOI 10.1016/j.jhevol.2010.06.011; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Schwartz J. H., 2003, HUMAN FOSSIL RECORD, V2; Scott N, 2014, EVOL BIOL, V41, P572, DOI 10.1007/s11692-014-9290-7; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Stringer C.B., 1986, P266; TOBIAS P. V., 1968, S AFR J SCI, V64, P81; Tobias PV, 1991, OLDUVAI GORGE, V4; VAISNYS JR, 1984, AM J PHYS ANTHROPOL, V65, P71, DOI 10.1002/ajpa.1330650110; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; WOLPOFF MH, 1981, AM J PHYS ANTHROPOL, V56, P297, DOI 10.1002/ajpa.1330560310; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Zuckerman S, 1928, P ZOOL SOC LOND, V1928, P1	50	101	104	0	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					83	U157		10.1038/nature14224	http://dx.doi.org/10.1038/nature14224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739632				2022-12-24	WOS:000350304000040
J	Uplekar, M; Weil, D; Lonnroth, K; Jaramillo, E; Lienhardt, C; Dias, HM; Falzon, D; Floyd, K; Gargioni, G; Getahun, H; Gilpin, C; Glaziou, P; Grzemska, M; Mirzayev, F; Nakatani, H; Raviglione, M				Uplekar, Mukund; Weil, Diana; Lonnroth, Knut; Jaramillo, Ernesto; Lienhardt, Christian; Dias, Hannah Monica; Falzon, Dennis; Floyd, Katherine; Gargioni, Giuliano; Getahun, Haileyesus; Gilpin, Christopher; Glaziou, Philippe; Grzemska, Malgorzata; Mirzayev, Fuad; Nakatani, Hiroki; Raviglione, Mario		WHO's Global TB Programme	WHO's new End TB Strategy	LANCET			English	Editorial Material							TUBERCULOSIS; COUNTRIES; TARGETS		[Uplekar, Mukund; Weil, Diana; Lonnroth, Knut; Jaramillo, Ernesto; Lienhardt, Christian; Dias, Hannah Monica; Falzon, Dennis; Floyd, Katherine; Gargioni, Giuliano; Getahun, Haileyesus; Gilpin, Christopher; Glaziou, Philippe; Grzemska, Malgorzata; Mirzayev, Fuad; Nakatani, Hiroki; Raviglione, Mario] WHO, Global TB Programme, CH-1211 Geneva, Switzerland	World Health Organization	Uplekar, M (corresponding author), WHO, Global TB Programme, CH-1211 Geneva, Switzerland.	uplekarm@who.int	Lienhardt, Christian/AAU-4969-2021; Lonnroth, Knut/H-5470-2017; Getahun, Haileyesus/ABC-5181-2020; Lönnroth, Knut/L-2339-2014	Lienhardt, Christian/0000-0003-0233-893X; Lonnroth, Knut/0000-0001-6944-0256; Lönnroth, Knut/0000-0001-5054-8240; Yesudian DIAS, Hannah Monica/0000-0003-0114-5757; RAVIGLIONE, Mario/0000-0002-9331-2067; Mirzayev, Fuad/0000-0001-6658-0325; Glaziou, Philippe/0000-0002-0649-1272	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Floyd K, 2013, LANCET GLOB HEALTH, V1, pE105, DOI 10.1016/S2214-109X(13)70032-9; Lonnroth K, 2014, ANN INTERN MED, V161, P670, DOI 10.7326/M14-1888; Lonnroth K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001693; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Raviglione M, 2014, LANCET GLOB HEALTH, V2, pE71, DOI 10.1016/S2214-109X(13)70166-9; Raviglione MC, 2013, NAT MED, V19, P263, DOI 10.1038/nm.3129; United Nations, OP WORK GROUP PROP S; WHO, 2011, INT ROADM TUB RES WO; WHO, 2013, WHOHTMTB201304; WHO, DOC WORLD HLTH ASS 6; World Health Organization, WHOHTMTB201316; World Health Organization Geneva, 2014, GLOB TUB CONTR WHO R; World Health Organization (WHO), 2015, GUIDELINES MANAGEMEN	14	609	630	2	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2015	385	9979					1799	1801		10.1016/S0140-6736(15)60570-0	http://dx.doi.org/10.1016/S0140-6736(15)60570-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH0PZ	25814376				2022-12-24	WOS:000353726000036
J	Stockman, MI				Stockman, Mark I.			Nanoplasmonic sensing and detection	SCIENCE			English	Editorial Material									[Stockman, Mark I.] Georgia State Univ, Ctr Nanoopt CeNO, Atlanta, GA 30302 USA; [Stockman, Mark I.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Stockman, MI (corresponding author), Georgia State Univ, Ctr Nanoopt CeNO, 29 Peachtree Ctr Ave, Atlanta, GA 30302 USA.	mstockman@gsu.edu						Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; Dantham VR, 2013, NANO LETT, V13, P3347, DOI 10.1021/nl401633y; De Angelis F, 2011, NAT PHOTONICS, V5, P683, DOI [10.1038/NPHOTON.2011.222, 10.1038/nphoton.2011.222]; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Hoa XD, 2007, BIOSENS BIOELECTRON, V23, P151, DOI 10.1016/j.bios.2007.07.001; Li N, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.107; Ma RM, 2014, NAT NANOTECHNOL, V9, P600, DOI [10.1038/nnano.2014.135, 10.1038/NNANO.2014.135]; Malmqvist Magnus, 1994, Journal of Molecular Recognition, V7, P1, DOI 10.1002/jmr.300070102; Novotny L., 2012, PRINCIPLES NANOOPTIC; Saha K, 2003, ANAL CHEM, V75, P835, DOI 10.1021/ac0204911; Stockman MI, 2011, OPT EXPRESS, V19, P22029, DOI 10.1364/OE.19.022029; Stockman MI, 2011, PHYS TODAY, V64, P39, DOI 10.1063/1.3554315; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; Wong WR, 2014, ANAL CHEM, V86, P1735, DOI 10.1021/ac403539k; Yanik AA, 2010, NANO LETT, V10, P4962, DOI 10.1021/nl103025u	15	126	130	5	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					287	288		10.1126/science.aaa6805	http://dx.doi.org/10.1126/science.aaa6805			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883343				2022-12-24	WOS:000352999000022
J	Chu, C; Zhang, QFC; da Rocha, ST; Flynn, RA; Bharadwaj, M; Calabrese, JM; Magnuson, T; Heard, E; Chang, HY				Chu, Ci; Zhang, Qiangfeng Cliff; da Rocha, Simao Teixeira; Flynn, Ryan A.; Bharadwaj, Maheetha; Calabrese, J. Mauro; Magnuson, Terry; Heard, Edith; Chang, Howard Y.			Systematic Discovery of Xist RNA Binding Proteins	CELL			English	Article							X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; LONG NONCODING RNAS; U1 SNRNP; CRYSTAL-STRUCTURE; PRC2 RECRUITMENT; HISTONE H2A; POLYCOMB; MOUSE; PLURIPOTENCY	Noncoding RNAs (ncRNAs) function with associated proteins to effect complex structural and regulatory outcomes. To reveal the composition and dynamics of specific noncoding RNA-protein complexes (RNPs) in vivo, we developed comprehensive identification of RNA binding proteins by mass spectrometry (ChIRP-MS). ChIRP-MS analysis of four ncRNAs captures key protein interactors, including a U1-specific link to the 3' RNA processing machinery. Xist, an essential lncRNA for X chromosome inactivation (XCI), interacts with 81 proteins from chromatin modification, nuclear matrix, and RNA remodeling pathways. The Xist RNA-protein particle assembles in two steps coupled with the transition from pluripotency to differentiation. Specific interactors include HnrnpK, which participates in Xist-mediated gene silencing and histone modifications but not Xist localization, and Drosophila Split ends homolog Spen, which interacts via the A-repeat domain of Xist and is required for gene silencing. Thus, Xist lncRNA engages with proteins in a modular and developmentally controlled manner to coordinate chromatin spreading and silencing.	[Chu, Ci; Zhang, Qiangfeng Cliff; Flynn, Ryan A.; Bharadwaj, Maheetha; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Chu, Ci; Zhang, Qiangfeng Cliff; Flynn, Ryan A.; Bharadwaj, Maheetha; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Chu, Ci] Genome Inst Singapore, Singapore 138672, Singapore; [da Rocha, Simao Teixeira; Heard, Edith] Inst Curie, CNRS UMR3215, INSERM U934, F-75248 Paris, France; [Calabrese, J. Mauro] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Calabrese, J. Mauro; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu	da Rocha, Simão Teixeira/ABG-4589-2020; Zhang, Qiangfeng/C-2902-2011; Heard, Edith/D-7197-2017	da Rocha, Simão Teixeira/0000-0002-9683-7942; Heard, Edith/0000-0001-8052-7117; Flynn, Ryan/0000-0001-5013-0442	NIH [NS069375, P50-HG007735]; California Institute for Regenerative Medicine; Equipe labellisee "La Ligue Contre Le Cancer" (Equipe Labellise); Labex DEEP, IDEX Idex PSL [ANR-11-LBX-0044, ANR-10-IDEX-000102 PSL]; EpiGeneSys Network of Excellence [FP7 257082]; ERC [250367]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Equipe labellisee "La Ligue Contre Le Cancer" (Equipe Labellise); Labex DEEP, IDEX Idex PSL; EpiGeneSys Network of Excellence; ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Wutz (ETH), A. Surani, J. Zylicz (University of Cambridge), A. Smith (University of Cambridge), and A. Gillich (Stanford) for reagents and advice; W. Lane and R. Robinson (Harvard) for MS analysis; A. Olson for assistance with confocal microscopy (Stanford Neuroscience Microscopy Service supported by NIH NS069375); and P. Walker (Stanford PAN facility) for ChIRP oligo synthesis. This work was supported by NIH P50-HG007735 and California Institute for Regenerative Medicine. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. E.H. is supported as an Equipe labellisee "La Ligue Contre Le Cancer" (Equipe Labellise to E.H.) and by Labex DEEP (ANR-11-LBX-0044) part of the IDEX Idex PSL (ANR-10-IDEX-000102 PSL), as well as the EpiGeneSys FP7 257082 Network of Excellence and ERC Advanced Investigator award 250367. H.Y.C. is a founder of Epinomics, Inc. and is a member of the Scientific Advisory Board of RaNA Therapeutics.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Arieti F, 2014, NUCLEIC ACIDS RES, V42, P6742, DOI 10.1093/nar/gku277; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BUZIN CH, 1994, DEVELOPMENT, V120, P3529; Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; Chu C, 2015, NAT STRUCT MOL BIOL, V22, P29, DOI 10.1038/nsmb.2921; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Gendrel AV, 2011, DEVELOPMENT, V138, P5049, DOI 10.1242/dev.068320; Gesteland RF., 1993, RNA WORLD NATURE MOD; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Riley KJ, 2013, MOL CELL, V49, P601, DOI 10.1016/j.molcel.2013.01.030; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Song J, 2012, MOL CELL PROTEOMICS, V11, P1036, DOI 10.1074/mcp.M111.011114; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	55	634	657	12	175	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					404	416		10.1016/j.cell.2015.03.025	http://dx.doi.org/10.1016/j.cell.2015.03.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25843628	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000352708300030
J	Yano, JM; Yu, K; Donaldson, GP; Shastri, GG; Ann, P; Ma, L; Nagler, CR; Ismagilov, RF; Mazmanian, SK; Hsiao, EY				Yano, Jessica M.; Yu, Kristie; Donaldson, Gregory P.; Shastri, Gauri G.; Ann, Phoebe; Ma, Liang; Nagler, Cathryn R.; Ismagilov, Rustem F.; Mazmanian, Sarkis K.; Hsiao, Elaine Y.			Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis	CELL			English	Article							VITAMIN-E; GASTROINTESTINAL MOTILITY; PERIPHERAL SEROTONIN; MAJOR DEPRESSION; SP NOV.; ACID; MICROFLORA; MICE; LIFE; TRANSPORTER	The gastrointestinal (GI) tract contains much of the body's serotonin (5-hydroxytryptamine, 5-HT), but mechanisms controlling the metabolism of gut-derived 5-HT remain unclear. Here, we demonstrate that the microbiota plays a critical role in regulating host 5-HT. Indigenous spore-forming bacteria (Sp) from the mouse and human microbiota promote 5-HT biosynthesis from colonic enterochromaffin cells (ECs), which supply 5-HT to the mucosa, lumen, and circulating platelets. Importantly, microbiota-dependent effects on gut 5-HT significantly impact host physiology, modulating GI motility and platelet function. We identify select fecal metabolites that are increased by Sp and that elevate 5-HT in chromaffin cell cultures, suggesting direct metabolic signaling of gut microbes to ECs. Furthermore, elevating luminal concentrations of particular microbial metabolites increases colonic and blood 5-HT in germ-free mice. Altogether, these findings demonstrate that Sp are important modulators of host 5-HT and further highlight a key role for host-microbiota interactions in regulating fundamental 5-HT-related biological processes.	[Yano, Jessica M.; Yu, Kristie; Donaldson, Gregory P.; Shastri, Gauri G.; Ann, Phoebe; Mazmanian, Sarkis K.; Hsiao, Elaine Y.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Ma, Liang; Ismagilov, Rustem F.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Nagler, Cathryn R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Nagler, Cathryn R.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	California Institute of Technology; California Institute of Technology; University of Chicago; University of Chicago	Hsiao, EY (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	ehsiao@caltech.edu		Yu, Kristie/0000-0001-6735-3968; Donaldson, Gregory/0000-0002-8551-374X	NIH [5DP5OD017924]; Caltech Center for Environmental Microbial Interactions Award; National Science Foundatio (NSF) Emerging Frontiers in Research and Innovation Award [EFRI-1137089]; National Human Genome Research Institute (NHGRI) grant [R01HG005826]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant [DK078938]; National Institute of Mental Health (NIMH) grant [MH100556]; National Institute of Allergy and Infectious Diseases (NIAID) grant [AI106302]; Food Allergy Research and Education (FARE); University of Chicago Digestive Diseases Center Core Grant [P30DK42086]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, R01DK078938, R56DK078938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Center for Environmental Microbial Interactions Award; National Science Foundatio (NSF) Emerging Frontiers in Research and Innovation Award(National Science Foundation (NSF)); National Human Genome Research Institute (NHGRI) grant; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant; National Institute of Mental Health (NIMH) grant; National Institute of Allergy and Infectious Diseases (NIAID) grant; Food Allergy Research and Education (FARE); University of Chicago Digestive Diseases Center Core Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the assistance of Andrew Stefka and Taylor Feehley (University of Chicago) for contributing pilot serum and fecal samples, Taren Thron, Sara McBride, and Alyssa Maskell for caring for the animals, Drs. Nathan Dalleska and Jesse Allen (Caltech) for conducting pilot LC/MS experiments, Said Bogatyrev (Caltech) for helpful advice, Natasha Shelby (Caltech) for editing the manuscript, and the late Dr. Paul H. Patterson for his valuable support. This work was supported by the NIH Director's Early Independence Award (5DP5OD017924 to E.Y.H.), Caltech Center for Environmental Microbial Interactions Award (to E.Y.H.), National Science Foundatio (NSF) Emerging Frontiers in Research and Innovation Award (EFRI-1137089 to R.F.I. and S.K.M.), National Human Genome Research Institute (NHGRI) grant (R01HG005826 to R.F.I.), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant (DK078938 to S.K.M.) and National Institute of Mental Health (NIMH) grant (MH100556 to S.K.M.), National Institute of Allergy and Infectious Diseases (NIAID) grant (AI106302 to C.R.N.), and Food Allergy Research and Education (FARE) and University of Chicago Digestive Diseases Center Core Grant (P30DK42086 to C.R.N.).	Abdala-Valencia H, 2012, AM J PHYSIOL-LUNG C, V303, pL642, DOI 10.1152/ajplung.00406.2011; Alemi F, 2013, GASTROENTEROLOGY, V144, P145, DOI 10.1053/j.gastro.2012.09.055; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Baganz NL, 2013, ACS CHEM NEUROSCI, V4, P48, DOI 10.1021/cn300186b; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Brigelius-Flohe R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; de Crecy-Lagard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-245; De Cuyper IM, 2013, BLOOD, V121, pE70, DOI 10.1182/blood-2012-06-437723; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Ducy P, 2010, J CELL BIOL, V191, P7, DOI 10.1083/jcb.201006123; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HIRANO S, 1981, APPL ENVIRON MICROB, V41, P737, DOI 10.1128/AEM.41.3.737-745.1981; Hoffman JM, 2012, GASTROENTEROLOGY, V142, P844, DOI 10.1053/j.gastro.2011.12.041; Kitahara M, 2000, INT J SYST EVOL MICR, V50, P971, DOI 10.1099/00207713-50-3-971; Kitahara M, 2001, INT J SYST EVOL MICR, V51, P39, DOI 10.1099/00207713-51-1-39; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Liu QY, 2008, J PHARMACOL EXP THER, V325, P47, DOI 10.1124/jpet.107.132670; Liu Yang, 2012, World J Exp Med, V2, P30, DOI 10.5493/wjem.v2.i2.30; Lobato KR, 2010, BEHAV BRAIN RES, V209, P249, DOI 10.1016/j.bbr.2010.02.002; Ma L, 2014, P NATL ACAD SCI USA, V111, P9768, DOI 10.1073/pnas.1404753111; Maes M, 2000, J AFFECT DISORDERS, V58, P241, DOI 10.1016/S0165-0327(99)00121-4; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; Marcobal A, 2012, CRIT REV FOOD SCI, V52, P448, DOI 10.1080/10408398.2010.500545; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Narushima S, 2006, LIPIDS, V41, P835, DOI 10.1007/s11745-006-5038-1; Neufeld KAM, 2013, NEUROGASTROENT MOTIL, V25, P183, DOI 10.1111/nmo.12049; Nieswandt Bernhard, 2004, Methods Mol Biol, V272, P255; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; ODELL TT, 1961, P SOC EXP BIOL MED, V106, P107; Oleskin A. V., 1998, Mikrobiologiya, V67, P305; Owen AJ, 2005, EUR J CLIN NUTR, V59, P304, DOI 10.1038/sj.ejcn.1602072; Quigley EMM, 2011, J NEUROGASTROENTEROL, V17, P140, DOI 10.5056/jnm.2011.17.2.140; Ramage AG, 2008, TRENDS PHARMACOL SCI, V29, P472, DOI 10.1016/j.tips.2008.06.009; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Roshchina VV, 2010, MICROBIAL ENDOCRINOLOGY: INTERKINGDOM SIGNALING IN INFECTIOUS DISEASE AND HEALTH, P17, DOI 10.1007/978-1-4419-5576-0_2; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shimizu T, 2003, AM J RESP CRIT CARE, V168, P581, DOI 10.1164/rccm.200212-1437OC; Sjogren K, 2012, BONE, V50, pS91, DOI [10.1016/j.bone.2012.02.272, 10.1002/jbmr.1588]; Stasi C, 2014, TECH COLOPROCTOL, V18, P613, DOI 10.1007/s10151-013-1106-8; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P229, DOI 10.1134/S000368380603001X; URIBE A, 1994, GASTROENTEROLOGY, V107, P1259, DOI 10.1016/0016-5085(94)90526-6; Wade PR, 1996, J NEUROSCI, V16, P2352; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; WESTPHAL JF, 1994, J ANTIMICROB CHEMOTH, V33, P387, DOI 10.1093/jac/33.3.387; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhao Y, 2010, J AGR FOOD CHEM, V58, P4844, DOI 10.1021/jf904464u; Ziu E, 2012, J MOL CELL CARDIOL, V52, P1112, DOI 10.1016/j.yjmcc.2012.02.004	72	1534	1668	60	598	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					264	276		10.1016/j.cell.2015.02.047	http://dx.doi.org/10.1016/j.cell.2015.02.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860609	Green Accepted, Bronze			2022-12-24	WOS:000352708300020
J	Alarcon, CR; Lee, H; Goodarzi, H; Halberg, N; Tavazoie, SF				Alarcon, Claudio R.; Lee, Hyeseung; Goodarzi, Hani; Halberg, Nils; Tavazoie, Sohail F.			N-6-methyladenosine marks primary microRNAs for processing	NATURE			English	Article							RNA; PLATFORM; SUBUNIT; COMPLEX; REGION	The first step in the biogenesis of microRNAs is the processing of primary microRNAs (pri-miRNAs) by the microprocessor complex, composed of the RNA-binding protein DGCR8 and the type III RNase DROSHA(1-4). This initial event requires recognition of the junction between the stem and the flanking single-stranded RNA of the pri-miRNA hairpin by DGCR8 followed by recruitment of DROSHA, which cleaves the RNA duplex to yield the pre-miRNA product(5). While the mechanisms underlying pri-miRNA processing have been determined, the mechanism by which DGCR8 recognizes and binds pri-miRNAs, as opposed to other secondary structures present in transcripts, is not understood. Here we find in mammalian cells that methyltransferase-like 3(METTL3) methylates pri-miRNAs, marking them for recognition and processing by DGCR8. Consistent with this, METTL3 depletion reduced the binding of DGCR8 to pri-miRNAs and resulted in the global reduction of mature miRNAs and concomitant accumulation of unprocessed pri-miRNAs. In vitro processing reactions confirmed the sufficiency of the N6-methyladenosine (m(6)A) mark in promoting pri-miRNA processing. Finally, gain-of-function experiments revealed that METTL3 is sufficient to enhance miRNA maturation in a global and non-cell-type-specific manner. Our findings reveal that the m(6)A mark acts as a key post-transcriptional modification that promotes the initiation of miRNA biogenesis.	[Alarcon, Claudio R.; Lee, Hyeseung; Goodarzi, Hani; Halberg, Nils; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA	Rockefeller University	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA.	stavazoie@rockefeller.edu	Halberg, Nils/AAF-8153-2019	Halberg, Nils/0000-0002-2943-3147; Goodarzi, Hani/0000-0002-9648-8949	Era of Hope Department of Defense Award; Department of Defense	Era of Hope Department of Defense Award; Department of Defense(United States Department of Defense)	We thank members of the Tavazoie laboratory as well as S. Kurdistani for comments on previous versions of this manuscript. We thank D. Bartel for suggestions about conservation analysis. We thank L. Fish for technical advice. We thank C. Zhao and C. Lai of the Rockefeller Genomics Resource Center for assistance with next-generation RNA-seq. We thank H. Molina of the Rockefeller Proteomics Center for his input in proteomics analysis. We thank C. Eicken of LC Sciences for assistance with microarray analysis. We thank H. Chang and P. Batista for providing targeted embryonic stem cells. C.R.A. was an Anderson Cancer Center Fellow at Rockefeller University. This work was supported by an Era of Hope Department of Defense Award to S.F.T. S.F.T. is a Department of Defense Breast Cancer Collaborative Scholars and Innovators Award recipient.	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bokar JA, 1997, RNA, V3, P1233; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	26	742	782	16	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					482	+		10.1038/nature14281	http://dx.doi.org/10.1038/nature14281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799998	Green Accepted			2022-12-24	WOS:000351602800058
J	Dolgin, E				Dolgin, Elie			TEXTILES Fabrics of life	NATURE			English	Editorial Material							HYDRODYNAMIC FUNCTION; SHARK SKIN											Oeffner J, 2012, J EXP BIOL, V215, P785, DOI 10.1242/jeb.063040; Phan L., 2015, J MAT CHEM; Shillingford C, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014019; Wen L, 2014, J EXP BIOL, V217, P1656, DOI 10.1242/jeb.097097; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Yu CJ, 2014, P NATL ACAD SCI USA, V111, P12998, DOI 10.1073/pnas.1410494111	6	5	5	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S10	S11		10.1038/519S10a	http://dx.doi.org/10.1038/519S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806490				2022-12-24	WOS:000351602800003
J	Naeem, S; Ingram, JC; Varga, A; Agardy, T; Barten, P; Bennett, G; Bloomgarden, E; Bremer, LL; Burkill, P; Cattau, M; Ching, C; Colby, M; Cook, DC; Costanza, R; DeClerck, F; Freund, C; Gartner, T; Benner, RG; Gunderson, J; Jarrett, D; Kinzig, AP; Kiss, A; Koontz, A; Kumar, P; Lasky, JR; Masozera, M; Meyers, D; Milano, F; Naughton-Treves, L; Nichols, E; Olander, L; Olmsted, P; Perge, E; Perrings, C; Polasky, S; Potent, J; Prager, C; Quetier, F; Redford, K; Saterson, K; Thoumi, G; Vargas, MT; Vickerman, S; Weisser, W; Wilkie, D; Wunder, S				Naeem, S.; Ingram, J. C.; Varga, A.; Agardy, T.; Barten, P.; Bennett, G.; Bloomgarden, E.; Bremer, L. L.; Burkill, P.; Cattau, M.; Ching, C.; Colby, M.; Cook, D. C.; Costanza, R.; DeClerck, F.; Freund, C.; Gartner, T.; Benner, R. Goldman; Gunderson, J.; Jarrett, D.; Kinzig, A. P.; Kiss, A.; Koontz, A.; Kumar, P.; Lasky, J. R.; Masozera, M.; Meyers, D.; Milano, F.; Naughton-Treves, L.; Nichols, E.; Olander, L.; Olmsted, P.; Perge, E.; Perrings, C.; Polasky, S.; Potent, J.; Prager, C.; Quetier, F.; Redford, K.; Saterson, K.; Thoumi, G.; Vargas, M. T.; Vickerman, S.; Weisser, W.; Wilkie, D.; Wunder, S.			Get the science right when paying for nature's services	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIODIVERSITY CONSERVATION; ENVIRONMENTAL SERVICES; PAYMENTS; PROGRAMS; MONEY					sn2121@columbia.edu	Costanza, Robert/A-4912-2008; Wunder, Sven/ABE-7773-2020; Nichols, Elizabeth/L-7484-2013; Freund, Cathryn A./AAI-7805-2020; Weisser, Wolfgang W/B-9718-2014; Polasky, Stephen/AAC-5341-2019; Cook, David C/C-1064-2009; Costanza, Robert/AAJ-3546-2021; Quetier, Fabien/K-6872-2015	Costanza, Robert/0000-0001-6348-8734; Wunder, Sven/0000-0002-9422-0260; Nichols, Elizabeth/0000-0002-4960-6842; Freund, Cathryn A./0000-0002-1570-5519; Weisser, Wolfgang W/0000-0002-2757-8959; Cook, David C/0000-0002-2954-7697; Cattau, Megan/0000-0003-2164-3809; Quetier, Fabien/0000-0002-3767-0353; Jarrett, David/0000-0001-7600-5447; Bremer, Leah/0000-0003-3791-4482	U.S. Agency for International Development TRANSLINKS program [EPP-A-00-06-00014-00]; National Academies Keck Futures Initiative	U.S. Agency for International Development TRANSLINKS program(United States Agency for International Development (USAID)); National Academies Keck Futures Initiative	This work has been supported by the U.S. Agency for International Development TRANSLINKS program (EPP-A-00-06-00014-00) and the National Academies Keck Futures Initiative.	Clements T, 2010, ECOL ECON, V69, P1283, DOI 10.1016/j.ecolecon.2009.11.010; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Ellison K, 2009, FRONT ECOL ENVIRON, V7, P60, DOI 10.1890/1540-9295-7.1.60; Farley J, 2010, ECOL ECON, V69, P2060, DOI 10.1016/j.ecolecon.2010.06.010; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Grolleau G, 2012, ECOL ECON, V76, P87, DOI 10.1016/j.ecolecon.2012.02.006; Ina P., 2013, PAYMENTS ENV SERVICE; Ingram JC, 2014, ECOSYST SERV, V7, P10, DOI 10.1016/j.ecoser.2013.12.003; Kareiva P, 2008, SCIENCE, V321, P1638, DOI 10.1126/science.1162756; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Muradian R, 2010, ECOL ECON, V69, P1202, DOI 10.1016/j.ecolecon.2009.11.006; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Pirard R, 2014, ECOSYST SERV, V9, P106, DOI 10.1016/j.ecoser.2014.06.005; Sutherland WJ, 2014, ORYX, V48, P1, DOI 10.1017/S0030605313001543; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Wunder S, 2013, CONSERV LETT, V6, P230, DOI 10.1111/conl.12034; Yin RS, 2013, FOREST POLICY ECON, V35, P66, DOI 10.1016/j.forpol.2013.06.010	18	180	186	11	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1206	1207		10.1126/science.aaa1403	http://dx.doi.org/10.1126/science.aaa1403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD1GZ	25766222				2022-12-24	WOS:000350824300023
J	Booth, B; Bellouin, N				Booth, Ben; Bellouin, Nicolas			CLIMATE CHANGE Black carbon and atmospheric feedbacks	NATURE			English	Editorial Material									[Booth, Ben] Met Off, Hadley Ctr, Exeter EX1 3PB, Devon, England; [Bellouin, Nicolas] Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England	Met Office - UK; Hadley Centre; University of Reading	Booth, B (corresponding author), Met Off, Hadley Ctr, Exeter EX1 3PB, Devon, England.	ben.booth@metoffice.gov.uk; n.bellouin@reading.ac.uk		Bellouin, Nicolas/0000-0003-2109-9559				Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Sand M., 2015, J CLIM; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026	3	37	37	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					167	168		10.1038/519167a	http://dx.doi.org/10.1038/519167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25762278				2022-12-24	WOS:000350770500025
J	Knaul, FM; Farmer, PE; Bhadelia, A; Berman, P; Horton, R				Knaul, Felicia M.; Farmer, Paul E.; Bhadelia, Afsan; Berman, Philippa; Horton, Richard			Closing the divide: the Harvard Global Equity Initiative-Lancet Commission on global access to pain control and palliative care	LANCET			English	Editorial Material									[Knaul, Felicia M.; Bhadelia, Afsan] Harvard Global Equ Initiat, Boston, MA 02115 USA; [Farmer, Paul E.] Harvard Univ, Sch Med, Boston, MA USA; [Berman, Philippa; Horton, Richard] The Lancet, London, England	Harvard University; Harvard Medical School	Knaul, FM (corresponding author), Harvard Global Equ Initiat, Boston, MA 02115 USA.	felicia_knaul@harvard.edu		Knaul, Felicia/0000-0002-0512-4788				Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Callahan D., 2002, THICAL DIMENSIONS HL, P3; Cohen J., 2012, APPLYING PUBLIC HLTH, P3, DOI [10.1093/acprof:oso/9780199599400.003.0010, DOI 10.1093/ACPROF:OSO/9780199599400.003.0010]; de Lima L., LEY NACL CUIDADOS PA; European Association of Palliative Care, 2014, ALB PASS 1 PALL CAR; Gawande A., 2014, MED WHAT MATTERS END; Harvard Global Equity Initiative, HGEI LANC COMM GLOB; Human Rights Watch, 2009, PLEAS DO NOT MAK US; International Association for Hospice and Palliative Care, VIS AND MISS; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kmietowicz Z., 2014, BMJ-BRIT MED J, V348, pg1744; Knaul FM, 2012, CLOSING CANC DIVIDE, P96; Knaul FM., 2012, CLOSING CANC DIVIDE, P29; Krakauer EL, 2007, ETHNOG STUD SUBJ, V7, P381; Krakauer EL, 2008, J PAIN SYMPTOM MANAG, V36, P505, DOI 10.1016/j.jpainsymman.2007.11.015; Liberman J, 2010, LANCET, V376, P856, DOI 10.1016/S0140-6736(10)60880-X; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Merriman Anne, 2010, Philos Ethics Humanit Med, V5, P10, DOI 10.1186/1747-5341-5-10; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ntizimira C., 2014, INTEGRATION PALLIATI; Pastrana T, 2014, PALLIATIVE MED, V28, P1; Paudel BD, 2015, J PAIN SYMPTOM MANAG, V49, P111, DOI 10.1016/j.jpainsymman.2014.02.011; Powell RA, 2015, LANCET ONCOL, V16, P131, DOI 10.1016/S1470-2045(15)70002-1; Secretaria de gobernacio: Diario Oficial De La Federacion, DIARIO OFICIAL FEDER; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Steedman MR, 2014, HEALTH AFFAIR, V33, P1612, DOI 10.1377/hlthaff.2014.0379; Worldwide Palliative Care Alliance World Health Organization, 2014, GLOB ATL PALL CAR EN	28	39	40	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					722	724		10.1016/S0140-6736(15)60289-6	http://dx.doi.org/10.1016/S0140-6736(15)60289-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	25762055	Bronze			2022-12-24	WOS:000360287900008
J	Arie, S				Arie, Sophie			VACCINES Ebola: a game changer for vaccines, or a scare that will soon be forgotten?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com							0	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2015	350								h1938	10.1136/bmj.h1938	http://dx.doi.org/10.1136/bmj.h1938			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GD	25948574				2022-12-24	WOS:000354414000003
J	Costanzo, P; Cleland, JGF; Pellicori, P; Clark, AL; Hepburn, D; Kilpatrick, ES; Perrone-Filardi, P; Zhang, JF; Atkin, SL				Costanzo, Pierluigi; Cleland, John G. F.; Pellicori, Pierpaolo; Clark, Andrew L.; Hepburn, David; Kilpatrick, Eric S.; Perrone-Filardi, Pasquale; Zhang, Jufen; Atkin, Stephen L.			The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; CARDIORESPIRATORY FITNESS; TRANSLATING RESEARCH; INSULIN-RESISTANCE; VASCULAR-DISEASE; MORTALITY; WEIGHT; PREDICTORS; OVERWEIGHT	Background: Whether obesity is associated with a better prognosis in patients with type 2 diabetes mellitus is controversial. Objective: To investigate the association between body weight and prognosis in a large cohort of patients with type 2 diabetes followed for a prolonged period. Design: Prospective cohort. Setting: National Health Service, England. Patients: Patients with diabetes. Measurements: The relationship between body mass index (BMI) and prognosis in patients with type 2 diabetes without known cardiovascular disease at baseline was investigated. Information on all-cause mortality and cardiovascular morbidity (such as the acute coronary syndrome, cerebrovascular accidents, and heart failure) was collected. Cox regression survival analysis, corrected for potential modifiers, including cardiovascular risk factors and comorbid conditions (such as cancer, chronic kidney disease, and lung disease), was done. Results: 10 568 patients were followed for a median of 10.6 years (interquartile range, 7.8 to 13.4). Median age was 63 years (interquartile range, 55 to 71), and 54% of patients were men. Overweight or obese patients (BMI >25 kg/m(2)) had a higher rate of cardiac events (such as the acute coronary syndrome and heart failure) than those of normal weight (BMI, 18.5 to 24.9 kg/m(2)). However, being overweight (BMI, 25 to 29.9 kg/m2) was associated with a lower mortality risk, whereas obese patients (BMI >30 kg/m(2)) had a mortality risk similar to that of normal-weight persons. Patients with low body weight had the worst prognosis. Limitation: Data about cause of death were not available. Conclusion: In this cohort, patients with type 2 diabetes who were overweight or obese were more likely to be hospitalized for cardiovascular reasons. Being overweight was associated with a lower mortality risk, but being obese was not.	Univ Hull, York Med Sch, Kingston Upon Hull, Yorks, England; Castle Hill Hosp, Cottingham, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; Univ Naples Federico II, Naples, Italy	University of Hull; University of Hull; Imperial College London; University of Naples Federico II	Costanzo, P (corresponding author), Univ Hull, Acad Cardiol Unit, Hull York Med Sch, Castle Hill Hosp, Cottingham HU16 5JQ, England.	pierluigicostanzo83@gmail.com	Cleland, John G./AAZ-4185-2020; Pellicori, Pierpaolo/N-1880-2013; Perrone Filardi, Pasquale/AAC-7590-2022; Atkin, stephen/ABE-7047-2020; Atkin, Stephen/D-7400-2014	Cleland, John G./0000-0002-1471-7016; Pellicori, Pierpaolo/0000-0001-7175-0464; Atkin, Stephen/0000-0002-5887-7257	National Institute for Health Research; University of Hull; National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); University of Hull; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research and University of Hull.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; BALKAU B, 1993, BRIT MED J, V307, P295, DOI 10.1136/bmj.307.6899.295; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; CHATURVEDI N, 1995, DIABETES CARE, V18, P766, DOI 10.2337/diacare.18.6.766; Church TS, 2005, ARCH INTERN MED, V165, P2114, DOI 10.1001/archinte.165.18.2114; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Czernichow S, 2011, EUR J CARDIOV PREV R, V18, P312, DOI 10.1097/HJR.0b013e32833c1aa3; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; Dorner TE, 2012, INT J CARDIOL, V155, P56, DOI 10.1016/j.ijcard.2011.01.076; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FORD ES, 1991, AM J EPIDEMIOL, V133, P1220, DOI 10.1093/oxfordjournals.aje.a115834; Futter JE, 2011, EUR J HEART FAIL, V13, P207, DOI 10.1093/eurjhf/hfq218; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Jackson CL, 2014, J GEN INTERN MED, V29, P25, DOI 10.1007/s11606-013-2553-7; Jahangir E, 2014, PROG CARDIOVASC DIS, V57, P127, DOI 10.1016/j.pcad.2014.01.001; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Khalangot M, 2009, HEART, V95, P454, DOI 10.1136/hrt.2008.150524; Knowler WC, 2014, LANCET DIABETES ENDO, V2, P801, DOI 10.1016/S2213-8587(14)70156-1; Lavie CJ, 2014, J AM COLL CARDIOL, V63, P1345, DOI 10.1016/j.jacc.2014.01.022; Logue J, 2013, DIABETES CARE, V36, P887, DOI 10.2337/dc12-0944; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; McAuley PA, 2007, DIABETES CARE, V30, P1539, DOI 10.2337/dc06-2397; McEwen LN, 2007, DIABETES CARE, V30, P1736, DOI 10.2337/dc07-0305; McEwen LN, 2012, DIABETES CARE, V35, P1301, DOI 10.2337/dc11-2281; MORRISH NJ, 1990, DIABETOLOGIA, V33, P538, DOI 10.1007/BF00404141; Morse SA, 2010, CURR HYPERTENS REP, V12, P120, DOI 10.1007/s11906-010-0099-1; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Oreopoulos A, 2009, CLIN GERIATR MED, V25, P643, DOI 10.1016/j.cger.2009.07.005; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; PETTITT DJ, 1982, AM J EPIDEMIOL, V115, P359, DOI 10.1093/oxfordjournals.aje.a113313; Public Health England, 2015, INT COMP; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; ROSENGREN A, 1989, BRIT MED J, V299, P1127, DOI 10.1136/bmj.299.6708.1127; Ross C, 1997, DIABETES CARE, V20, P650, DOI 10.2337/diacare.20.4.650; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; SASAKI A, 1989, DIABETES RES CLIN PR, V7, P33, DOI 10.1016/0168-8227(89)90042-9; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; Vittinghoff E, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b138825; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Zoppini G, 2003, INT J OBESITY, V27, P281, DOI 10.1038/sj.ijo.802199	51	118	121	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					610	U208		10.7326/M14-1551	http://dx.doi.org/10.7326/M14-1551			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25938991				2022-12-24	WOS:000354119100005
J	Ohyama, T; Schneider-Mizell, CM; Fetter, RD; Aleman, JV; Franconville, R; Rivera-Alba, M; Mensh, BD; Branson, KM; Simpson, JH; Truman, JW; Cardona, A; Zlatic, M				Ohyama, Tomoko; Schneider-Mizell, Casey M.; Fetter, Richard D.; Aleman, Javier Valdes; Franconville, Romain; Rivera-Alba, Marta; Mensh, Brett D.; Branson, Kristin M.; Simpson, Julie H.; Truman, James W.; Cardona, Albert; Zlatic, Marta			A multilevel multimodal circuit enhances action selection in Drosophila	NATURE			English	Article							MULTISENSORY INTEGRATION; DIRECTION-SELECTIVITY; NOCICEPTIVE NEURONS; WIRING SPECIFICITY; GENE-EXPRESSION; NERVOUS-SYSTEM; UNIT RESPONSES; NOMPC; ORGANIZATION; PROJECTIONS	Natural events present multiple types of sensory cues each detected by a specialized sensory modality. Combining information from several modalities is essential for the selection of appropriate actions. Key to understanding multimodal computations is determining the structural patterns of multimodal convergence and how these patterns contribute to behaviour. Modalities could converge early, late or at multiple levels in the sensory processing hierarchy. Here we show that combining rnechanosensory and nociceptive cues synergistically enhances the selection of the fastest mode of escape locomotion in Drosophila larvae. In an electron microscopy volume that spans the entire insect nervous system, we reconstructed the multisensory circuit supporting the synergy, spanning multiple levels of the sensory processing hierarchy. The wiring diagram revealed a complex multilevel rnultimorlal convergence architecture. Using behavioural and physiological studies, we identified functionally connected circuit nodes that trigger the fastest locomotor mode, and others that facilitate it, and we provide evidence that multiple levels of multimodal integration contribute to escape mode selection. We propose that the multilevel rnultimoclal convergence architecture may be a general feature of multisensory circuits enabling complex input-output functions and selective tuning to ecologically relevant combinations of cues.	[Ohyama, Tomoko; Schneider-Mizell, Casey M.; Fetter, Richard D.; Aleman, Javier Valdes; Franconville, Romain; Rivera-Alba, Marta; Mensh, Brett D.; Branson, Kristin M.; Simpson, Julie H.; Truman, James W.; Cardona, Albert; Zlatic, Marta] Howard Hughes Med Inst Janelia Res Campus, Ashburn, VA 20147 USA		Cardona, A (corresponding author), Howard Hughes Med Inst Janelia Res Campus, 19700 Helix Dr, Ashburn, VA 20147 USA.	cardonaa@hhmi.org; zlaticm@hhmi.org	Franconville, Romain/P-7177-2014	Franconville, Romain/0000-0002-4440-7297; Schneider-Mizell, Casey/0000-0001-9477-3853; Rivera-Alba, Marta/0000-0002-8069-385X; Cardona, Albert/0000-0003-4941-6536; Zlatic, Marta/0000-0002-3149-2250; Ohyama, Tomoko/0000-0003-1697-1138; Simpson, Julie/0000-0002-6793-7100; Valdes-Aleman, Javier/0000-0002-1577-1057	Janelia HHMI; Institute of Neuroinformatics of the University of Zurich; ETH Zurich; SNSF [31003A_132969]; Universitat Zurich Forschungskredit; HHMI Visiting Scientist program at Janelia	Janelia HHMI; Institute of Neuroinformatics of the University of Zurich; ETH Zurich(ETH Zurich); SNSF(Swiss National Science Foundation (SNSF)); Universitat Zurich Forschungskredit; HHMI Visiting Scientist program at Janelia	We thank G. Rubin and the Janelia Fly EM Project for the gift of the comprehensive image dataset of the larval nervous system; S. Lauchie and A. Brothers for assistance with EM imaging; B. Arruda and T. Dang for assistance with behavioural screens; L. Herren, I. Andrade, K. Floria and A. Berthold van der Bourg for assistance with neuronal reconstruction; G. Rubin, H. Dionne and B. Pfeiffer for GAL4 and Split GAL4 lines; A. Nern and G. Rubin for the single cell FLP-out stocks; J.-M. Knapp for Tsh-LexA stock; H.-H. Li and Janelia Fly Light Project Team for images of neuronal lines; K. Hibbard, M. Mercer, T. Laverty and the rest of Janelia Fly Core for stock construction and fly crosses; G. Denisov for the roll and crawl detection LARA software; E. Trautman, R. Svirskas, C. Weaver and D. Olbris for data analysis pipelines; Y. Park, C. Priebe, D. Naiman and J.-B. Masson for advice on statistical analysis; V. Jayaraman for input on calcium imaging; and W. Den k, B. Dickson, S. Druckmann, B. Gerber, K. Svoboda and C. Zuker for helpful comments on the manuscript We thank Janelia HHMI for funding. A.C. and C.M.S.-M. were also funded by the Institute of Neuroinformatics of the University of Zurich and ETH Zurich, the SNSF grant 31003A_132969, the Universitat Zurich Forschungskredit and the HHMI Visiting Scientist program at Janelia. The EM image data is available via the Open Connectome Project (http://www.openconnectomeproject.org).	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bastian M., 2009, P 3 INT C WEBLOGS SO, DOI DOI 10.13140/2.1.1341.1520; Basura GJ, 2012, BRAIN RES, V1485, P95, DOI 10.1016/j.brainres.2012.08.037; BATE M, 1981, J NEUROSCI, V1, P103, DOI 10.1523/JNEUROSCI.01-01-00103.1981; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Dayan P., 2001, THEORETICAL NEUROSCI; Duda R.O., 2006, PATTERN CLASSIFICATI; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jain R, 2006, NEUROSCI LETT, V395, P71, DOI 10.1016/j.neulet.2005.10.077; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kenshalo DR, 2000, J NEUROPHYSIOL, V84, P719, DOI 10.1152/jn.2000.84.2.719; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Li HH, 2014, CELL REP, V8, P897, DOI 10.1016/j.celrep.2014.06.065; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; MEREDITH MA, 1985, SCIENCE, V227, P657, DOI 10.1126/science.3969558; MILDE JJ, 1990, J COMP NEUROL, V294, P59, DOI 10.1002/cne.902940106; Mu LY, 2014, J EXP BIOL, V217, P2121, DOI 10.1242/jeb.099135; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Ohyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071706; Olcese U, 2013, NEURON, V79, P579, DOI 10.1016/j.neuron.2013.06.010; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Robertson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078704; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Saalfeld S, 2009, BIOINFORMATICS, V25, P1984, DOI 10.1093/bioinformatics/btp266; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrader S, 2000, J COMP NEUROL, V425, P34; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein E. B., 1993, MERGING SENSES; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tsubouchi A, 2012, CURR BIOL, V22, P2124, DOI 10.1016/j.cub.2012.09.019; van Atteveldt N, 2014, NEURON, V81, P1240, DOI 10.1016/j.neuron.2014.02.044; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Vogelstein JT, 2014, SCIENCE, V344, P386, DOI 10.1126/science.1250298; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zhang W, 2013, P NATL ACAD SCI USA, V110, P13612, DOI 10.1073/pnas.1312477110; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	78	240	240	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2015	520	7549					633	U107		10.1038/nature14297	http://dx.doi.org/10.1038/nature14297			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH0DQ	25896325				2022-12-24	WOS:000353689700041
J	Chou, CM; Nelson, C; Tarle, SA; Pribila, JT; Bardakjian, T; Woods, S; Schneider, A; Glaser, T				Chou, Christopher M.; Nelson, Christine; Tarle, Susan A.; Pribila, Jonathan T.; Bardakjian, Tanya; Woods, Sean; Schneider, Adele; Glaser, Tom			Biochemical Basis for Dominant Inheritance, Variable Penetrance, and Maternal Effects in RBP4 Congenital Eye Disease	CELL			English	Article							RETINOL-BINDING-PROTEIN; VITAMIN-A-DEFICIENCY; HUMAN PLASMA; HEART-DEFECTS; YOLK-SAC; MUTATIONS; ANOPHTHALMIA; ACID; TRANSTHYRETIN; RECEPTOR	Gestational vitamin A (retinol) deficiency poses a risk for ocular birth defects and blindness. We identified missense mutations in RBP4, encoding serum retinol binding protein, in three families with eye malformations of differing severity, including bilateral anophthalmia. The mutant phenotypes exhibit dominant inheritance, but incomplete penetrance. Maternal transmission significantly increases the probability of phenotypic expression. RBP normally delivers retinol from hepatic stores to peripheral tissues, including the placenta and fetal eye. The disease mutations greatly reduce retinol binding to RBP, yet paradoxically increase the affinity of RBP for its cell surface receptor, STRA6. By occupying STRA6 nonproductively, the dominant-negative proteins disrupt vitamin A delivery from wild-type proteins within the fetus, but also, in the case of maternal transmission, at the placenta. These findings establish a previously uncharacterized mode of maternal inheritance, distinct from imprinting and oocyte-derived mRNA, and define a group of hereditary disorders plausibly modulated by dietary vitamin A.	[Chou, Christopher M.; Tarle, Susan A.; Glaser, Tom] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Chou, Christopher M.; Tarle, Susan A.; Glaser, Tom] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nelson, Christine; Pribila, Jonathan T.] Univ Michigan, Sch Med, Kellogg Eye Ctr, Dept Ophthalmol, Ann Arbor, MI 48109 USA; [Bardakjian, Tanya; Schneider, Adele] Albert Einstein Med Ctr, Div Genet, Philadelphia, PA 19141 USA; [Woods, Sean] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Congenital Eye Dis Study Grp, Davis, CA 95616 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yeshiva University; University of California System; University of California Davis	Glaser, T (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	tmglaser@ucdavis.edu			NIH [EY19497]; Midwest Eye Bank and Transplantation Center; UM Center for Rare Disease; UM Center for Genetics in Health and Medicine; NIH T32 grants [GM07544, HD07505]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Eye Bank and Transplantation Center; UM Center for Rare Disease; UM Center for Genetics in Health and Medicine; NIH T32 grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for technical support from Bob Lyons and Susan Dagenais (DNA sequencing), Philip Gafken (MS), Peter Hwang and Andrew Hill (SPR), and Paul Kirchoff (molecular modeling). We thank Catherine Downs and Kari Branham for help with genetic counseling; Ed Pugh for quantitative analysis of binding kinetics; Noor Ghiasvand and Hui Sun for valuable discussions; Friedhelm Hildebrandt and Edgar Otto for advice on library construction; Tony Antonellis for sharing control DNAs; James Doss and Sarah Oelrich for clinical data; Ed Pugh, Ala Moshiri, and Zach Farrow for careful reading of the manuscript; and Dellaney Rudolph and Nathan Vale for technical assistance. We are profoundly grateful to subject families for participating in the study. This research was funded by grants from the NIH (EY19497), Midwest Eye Bank and Transplantation Center, the UM Center for Rare Disease, and the UM Center for Genetics in Health and Medicine. C.M.C. was supported by NIH T32 grants GM07544 and HD07505.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Bellenguez C, 2009, GENET EPIDEMIOL, V33, P207, DOI 10.1002/gepi.20371; BERR F, 1992, J LIPID RES, V33, P915; Biesalski HK, 1999, AM J CLIN NUTR, V69, P931; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; Bychkova VE, 1998, FOLD DES, V3, P285, DOI 10.1016/S1359-0278(98)00039-X; Calderone V, 2003, J MOL BIOL, V329, P841, DOI 10.1016/S0022-2836(03)00468-6; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Cukras C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050205; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; Drager U. C., 2000, P73; Duester G, 2009, CHEM-BIOL INTERACT, V178, P178, DOI 10.1016/j.cbi.2008.09.004; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; Flower DR, 1996, BIOCHEM J, V318, P1; Folli C, 2005, BIOCHEM BIOPH RES CO, V336, P1017, DOI 10.1016/j.bbrc.2005.08.227; Folli C, 2010, METHODS MOL BIOL, V652, P189, DOI 10.1007/978-1-60327-325-1_11; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; GOODMAN DS, 1965, J LIPID RES, V6, P390; Greene LH, 2006, BIOCHEMISTRY-US, V45, P9475, DOI 10.1021/bi060229c; Hale F, 1933, J HERED, V24, P105, DOI 10.1093/oxfordjournals.jhered.a103720; HELLER J, 1974, J BIOL CHEM, V249, P5933; Hornby Stella J, 2003, Med Sci Monit, V9, pHY23; Johansson S, 1997, ANAT EMBRYOL, V195, P483, DOI 10.1007/s004290050067; Johansson S, 1999, PLACENTA, V20, P459, DOI 10.1053/plac.1999.0397; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Lahti JL, 2011, FEBS LETT, V585, P1135, DOI 10.1016/j.febslet.2011.03.044; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lengyel CSE, 2007, J BIOL CHEM, V282, P30658, DOI 10.1074/jbc.M704513200; Malpeli G, 1996, BBA-PROTEIN STRUCT M, V1294, P48, DOI 10.1016/0167-4838(95)00264-2; MELHUS H, 1992, J BIOL CHEM, V267, P12036; Mondul AM, 2011, HUM MOL GENET, V20, P4724, DOI 10.1093/hmg/ddr387; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; MUTO Y, 1972, J BIOL CHEM, V247, P2542; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; NORA JJ, 1987, AM J CARDIOL, V59, P459, DOI 10.1016/0002-9149(87)90956-8; Onwochei BC, 2000, SURV OPHTHALMOL, V45, P175, DOI 10.1016/S0039-6257(00)00151-X; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; PETERSON PA, 1971, J BIOL CHEM, V246, P44; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Raila J, 2005, J NUTR, V135, P2512, DOI 10.1093/jn/135.11.2512; RAZ A, 1970, J BIOL CHEM, V245, P1903; Sapin V, 1997, DEV DYNAM, V208, P199, DOI 10.1002/(SICI)1097-0177(199702)208:2<199::AID-AJA7>3.0.CO;2-D; See AWM, 2009, DEV BIOL, V325, P94, DOI 10.1016/j.ydbio.2008.09.030; Selvaraj SR, 2008, MOL BIOL CELL, V19, P5579, DOI 10.1091/mbc.E08-01-0026; Soprano Dianne Robert, 1994, P257; SOPRANO DR, 1986, P NATL ACAD SCI USA, V83, P7330, DOI 10.1073/pnas.83.19.7330; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Ward SJ, 1997, BIOL REPROD, V57, P751, DOI 10.1095/biolreprod57.4.751; WARKANY J, 1946, ARCH OPHTHALMOL-CHIC, V35, P150, DOI 10.1001/archopht.1946.00890200155008; Wassef L, 2011, J BIOL CHEM, V286, P32198, DOI 10.1074/jbc.M111.253070; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Williamson KA, 2014, EUR J MED GENET, V57, P369, DOI 10.1016/j.ejmg.2014.05.002; ZANOTTI G, 1993, J MOL BIOL, V230, P613, DOI 10.1006/jmbi.1993.1173	67	42	44	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					634	646		10.1016/j.cell.2015.03.006	http://dx.doi.org/10.1016/j.cell.2015.03.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910211	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000353553600021
J	Dajani, R				Dajani, Rana			Why I teach evolution to Muslim students	NATURE			English	Editorial Material									[Dajani, Rana] Hashemite Univ, Mol Biol, Zarqa, Jordan	Hashemite University	Dajani, R (corresponding author), Univ Cambridge, Faraday Inst, Cambridge CB2 1TN, England.	rdajani@hu.edu.jo	Dajani, Rana/C-3466-2014	Dajani, Rana/0000-0002-4355-9977					0	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					409	409		10.1038/520409a	http://dx.doi.org/10.1038/520409a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25903591	Bronze			2022-12-24	WOS:000353334500004
J	Kaukonen, KM; Bailey, M; Pilcher, D; Cooper, DJ; Bellomo, R				Kaukonen, Kirsi-Maija; Bailey, Michael; Pilcher, David; Cooper, D. Jamie; Bellomo, Rinaldo			Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GOAL-DIRECTED RESUSCITATION; NEW-ZEALAND RISK; MORTALITY; ADULTS; PREDICTION; THERAPY; TIME; SIRS	BACKGROUND The consensus definition of severe sepsis requires suspected or proven infection, organ failure, and signs that meet two or more criteria for the systemic inflammatory response syndrome (SIRS). We aimed to test the sensitivity, face validity, and construct validity of this approach. METHODS We studied data from patients from 172 intensive care units in Australia and New Zealand from 2000 through 2013. We identified patients with infection and organ failure and categorized them according to whether they had signs meeting two or more SIRS criteria (SIRS-positive severe sepsis) or less than two SIRS criteria (SIRS-negative severe sepsis). We compared their characteristics and outcomes and assessed them for the presence of a step increase in the risk of death at a threshold of two SIRS criteria. RESULTS Of 1,171,797 patients, a total of 109,663 had infection and organ failure. Among these, 96,385 patients (87.9%) had SIRS-positive severe sepsis and 13,278 (12.1%) had SIRS-negative severe sepsis. Over a period of 14 years, these groups had similar characteristics and changes in mortality (SIRS-positive group: from 36.1% [829 of 2296 patients] to 18.3% [2037 of 11,119], P<0.001; SIRS-negative group: from 27.7% [100 of 361] to 9.3% [122 of 1315], P<0.001). Moreover, this pattern remained similar after adjustment for baseline characteristics (odds ratio in the SIRS-positive group, 0.96; 95% confidence interval [CI], 0.96 to 0.97; odds ratio in the SIRS-negative group, 0.96; 95% CI, 0.94 to 0.98; P = 0.12 for between-group difference). In the adjusted analysis, mortality increased linearly with each additional SIRS criterion (odds ratio for each additional criterion, 1.13; 95% CI, 1.11 to 1.15; P<0.001) without any transitional increase in risk at a threshold of two SIRS criteria. CONCLUSIONS The need for two or more SIRS criteria to define severe sepsis excluded one in eight otherwise similar patients with infection, organ failure, and substantial mortality and failed to define a transition point in the risk of death.	[Kaukonen, Kirsi-Maija; Bailey, Michael; Pilcher, David; Cooper, D. Jamie; Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Pilcher, David] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Melbourne, Vic, Australia; [Pilcher, David] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Austin Hlth, Intens Care Unit, Heidelberg, Vic, Australia; [Kaukonen, Kirsi-Maija] Univ Helsinki, Cent Hosp, Dept Anesthesiol Intens Care & Pain Med, Neurosurg Unit, Helsinki, Finland	Monash University; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Helsinki; Helsinki University Central Hospital	Bellomo, R (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Alfred Ctr, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.	rinaldo.bellomo@austin.org.au	Bailey, Michael J/A-4499-2012; Cooper, D. James/G-7961-2013	Bailey, Michael J/0000-0002-5551-1401; Cooper, D. James/0000-0002-5872-9051; Pilcher, David/0000-0002-8939-7985; Bellomo, Rinaldo/0000-0002-1650-8939	Australian and New Zealand Intensive Care Research Centre	Australian and New Zealand Intensive Care Research Centre	Funded by the Australian and New Zealand Intensive Care Research Centre.	Alberti C, 2005, AM J RESP CRIT CARE, V171, P461, DOI 10.1164/rccm.200403-324OC; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P1698; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Karlsson S, 2007, INTENS CARE MED, V33, P435, DOI 10.1007/s00134-006-0504-z; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Liao MM, 2014, AM J EMERG MED, V32, P1319, DOI 10.1016/j.ajem.2014.07.035; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Paul E, 2012, ANAESTH INTENS CARE, V40, P980, DOI 10.1177/0310057X1204000609; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Pilcher D, 2014, CRIT CARE RESUSC, V16, P3; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Sprung CL, 2006, INTENS CARE MED, V32, P421, DOI 10.1007/s00134-005-0039-8; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 1997, CRIT CARE MED, V25, P372, DOI 10.1097/00003246-199702000-00029	27	646	711	6	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2015	372	17					1629	1638		10.1056/NEJMoa1415236	http://dx.doi.org/10.1056/NEJMoa1415236			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4XX	25776936				2022-12-24	WOS:000353294000008
J	Samuel, M; Winston, A; Peters, B				Samuel, Miriam; Winston, Alan; Peters, Barry			Drug treatment for adults with HIV infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIRETROVIRAL TREATMENT; ASSOCIATION GUIDELINES; TREATMENT-NAIVE; EFAVIRENZ; THERAPY; TRIAL; LIPODYSTROPHY; MANAGEMENT; MORTALITY; IMPACT		[Samuel, Miriam; Peters, Barry] St Thomas Hosp, London SE1 7EH, England; [Winston, Alan] Imperial Coll London, Dept Med, Sect Infect Dis, London, England; [Peters, Barry] Kings Coll London, Dept Infect Dis, London, England	Guy's & St Thomas' NHS Foundation Trust; Imperial College London; University of London; King's College London	Samuel, M (corresponding author), St Thomas Hosp, London SE1 7EH, England.	Miriam.Samuel@nhs.net	Winston, Alan/AGZ-3015-2022	Winston, Alan/0000-0002-5847-8416				Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Bavinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059551; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bolland MJ, 2015, LANCET DIABETES ENDO, V3, P63, DOI 10.1016/S2213-8587(13)70181-5; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Chaponda M, 2011, BRIT J CLIN PHARMACO, V71, P659, DOI 10.1111/j.1365-2125.2010.03784.x; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Department of Health and Human Services, 2014, GUIDELINES USE ANTIR; Gazzard B, 2011, AIDS, V25, P2249, DOI 10.1097/QAD.0b013e32834c4c06; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Guaraldi G, 2013, DRUGS, V73, P1431, DOI 10.1007/s40265-013-0108-1; Keiser O, 2007, ANTIVIR THER, V12, P1157; Levy A, 2010, PHARMACOECONOMICS, V28, P35, DOI 10.2165/11587430-000000000-00000; Maggiolo F, 2009, J ANTIMICROB CHEMOTH, V64, P910, DOI 10.1093/jac/dkp334; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Mills AM, 2013, HIV MED, V14, P391, DOI 10.1111/hiv.12012; Mohanna K, 2011, TEACHING MADE EASY M; Mollan KR, 2014, ANN INTERN MED, V161, P1, DOI 10.7326/M14-0293; Peters BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078048; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sabin CA, 2009, CURR OPIN INFECT DIS, V22, P191, DOI 10.1097/QCO.0b013e328326cd34; Taylor GP, 2012, HIV MED, V13, P87, DOI [10.1111/j.1468-1293.2012.01030.x, 10.1111/j.1468-1293.2012.01030_2.x]; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; WHO, 2010, PRINC REC INF FEED C; Williams I, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12119; World Health Organization, 2016, CONS GUID US ANT DRU	28	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2015	350								h1555	10.1136/bmj.h1555	http://dx.doi.org/10.1136/bmj.h1555			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8RA	25908648				2022-12-24	WOS:000353576800001
J	Searchinger, T; Edwards, R; Mulligan, D; Heimlich, R; Plevin, R				Searchinger, T.; Edwards, R.; Mulligan, D.; Heimlich, R.; Plevin, R.			Do biofuel policies seek to cut emissions by cutting food?	SCIENCE			English	Editorial Material									[Searchinger, T.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Edwards, R.; Mulligan, D.] Commiss European Communities, Joint Res Ctr, I-21027 Ispra, Italy; [Heimlich, R.] Agr Conservat Econ, Laurel, MD 20723 USA; [Plevin, R.] Univ Calif Davis, Inst Transportat Studies, Davis, CA 95616 USA	Princeton University; European Commission Joint Research Centre; EC JRC ISPRA Site; University of California System; University of California Davis	Searchinger, T (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	tsearchi@princeton.edu; robert.edwards@jrc.it						Berry S., 2011, BIOFUEL POLICY EMPIR; CARB, 2009, PROPOSED REGULATION, VI; Decara S.A., 2012, LAND USE CHANGE ENV; Dorward A, 2012, FOOD SECUR, V4, P633, DOI 10.1007/s12571-012-0210-3; Edwards R, 2010, INDIRECT LAND USE CH, DOI 10.2788/54137; Filipski M., 2010, AGR POLICIES POVERTY; Finkbeiner M, 2014, BIOMASS BIOENERG, V62, P218, DOI 10.1016/j.biombioe.2014.01.024; Food and Agricultural Policy Research Institute, EL DAT; High Level Panel on Food Security, 2011, PRIC VOL FOOD SEC; High Level Panel on Food Security, 2013, BIOF FOOD SEC; Hochman G, 2014, BIOMASS BIOENERG, V68, P106, DOI 10.1016/j.biombioe.2014.06.012; Laborde D., 2011, ASSESSING LAND USE C; National Research Council, 2011, REN FUEL STAND POT E; Plevin RJ, 2014, J IND ECOL, V18, P73, DOI 10.1111/jiec.12074; Roberts MJ, 2013, AM ECON REV, V103, P2265, DOI 10.1257/aer.103.6.2265; Searchinger TD, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024007; Searchinger TD, 2009, SCIENCE, V326, P527, DOI 10.1126/science.1178797; U.S. Environmental Protection Agency, 2010, REN FUEL STAND PROGR; UK Renewable Fuels Agency, 2008, GALL REV IND EFF BIO; Zilberman D., 2010, AGBIOL FORUM, V13, P11	20	62	62	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2015	347	6229					1420	1422		10.1126/science.1261221	http://dx.doi.org/10.1126/science.1261221			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9AT	25814570				2022-12-24	WOS:000352136400023
J	Liu, YC; Posey, DL; Cetron, MS; Painter, JA				Liu, Yecai; Posey, Drew L.; Cetron, Martin S.; Painter, John A.			Effect of a Culture-Based Screening Algorithm on Tuberculosis Incidence in Immigrants and Refugees Bound for the United States A Population-Based Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTION; IMPLEMENTATION; RIFAPENTINE	Background: Before 2007, immigrants and refugees bound for the United States were screened for tuberculosis (TB) by a smear-based algorithm that could not diagnose smear-negative/culture-positive TB. In 2007, the Centers for Disease Control and Prevention implemented a culture-based algorithm. Objective: To evaluate the effect of the culture-based algorithm on preventing the importation of TB to the United States by immigrants and refugees from foreign countries. Design: Population-based, cross-sectional study. Setting: Panel physician sites for overseas medical examination. Patients: Immigrants and refugees with TB. Measurements: Comparison of the increase of smear-negative/culture-positive TB cases diagnosed overseas among immigrants and refugees by the culture-based algorithm with the decline of reported cases among foreign-born persons within 1 year after arrival in the United States from 2007 to 2012. Results: Of the 3 212 421 arrivals of immigrants and refugees from 2007 to 2012, a total of 1 650 961 (51.4%) were screened by the smear-based algorithm and 1 561 460 (48.6%) were screened by the culture-based algorithm. Among the 4032 TB cases diagnosed by the culture-based algorithm, 2195 (54.4%) were smear-negative/culture-positive. Before implementation (2002 to 2006), the annual number of reported cases among foreign-born persons within 1 year after arrival was relatively constant (range, 1424 to 1626 cases; mean, 1504 cases) but decreased from 1511 to 940 cases during implementation (2007 to 2012). During the same period, the annual number of smearnegative/culture-positive TB cases diagnosed overseas among immigrants and refugees bound for the United States by the culture-based algorithm increased from 4 to 629. Limitation: This analysis did not control for the decline in new arrivals of nonimmigrant visitors to the United States and the decrease of incidence of TB in their countries of origin. Conclusion: Implementation of the culture-based algorithm may have substantially reduced the incidence of TB among newly arrived, foreign-born persons in the United States.	[Liu, Yecai; Posey, Drew L.; Cetron, Martin S.; Painter, John A.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Liu, YC (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, 1600 Clifton Rd,MS-E03, Atlanta, GA 30333 USA.	yliu@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Alami NN, 2014, MMWR-MORBID MORTAL W, V63, P229; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; [Anonymous], 2010, TUB SCREEN TREATM TE; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Barr M, 2008, ANN FLOW REPORT NONI; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; Binkin NJ, 1996, CLIN INFECT DIS, V23, P1226, DOI 10.1093/clinids/23.6.1226; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Centers for Disease Control and Prevention, 2012, REP SURG GEN PREV TO, P1; Centers for Disease Control and Prevention, 2013, ONL TUB INF SYST; Centers for Disease Control and Prevention, 1991, TECHN INSTR PAN PHYS; Centers for Disease Control and Prevention, 2008, MMWR MORB MORTAL WKL, V57, P292; Dara M, 2013, EXPERT REV ANTI-INFE, V11, P137, DOI [10.1586/eri.12.168, 10.1586/ERI.12.168]; Jereb John A., 2011, Morbidity and Mortality Weekly Report, V60, P1650; Liu Y, 2012, ENCY IMMIGRANT HLTH, P1171; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Lowenthal P, 2011, INT J TUBERC LUNG D, V15, P761, DOI 10.5588/ijtld.10.0370; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Monger R, 2010, ANN FLOW REPORT NONI; Monger R, 2011, ANN FLOW REPORT NONI; Monger R, 2012, ANN FLOW REPORT NONI; Monger R, 2013, ANN FLOW REPORT NONI; Monger R, 2009, ANN FLOW REPORT NONI; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Oeltmann JE, 2008, EMERG INFECT DIS, V14, P1715, DOI 10.3201/eid1411.071629; Posey DL, 2014, MMWR-MORBID MORTAL W, V63, P234; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Sciortino S, 1999, INT J TUBERC LUNG D, V3, P778; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Emerging and Zoonotic Infectious Diseases, 2007, CDC IMM REQ TECHN IN; U.S. Department of Homeland Security, 2007, ANN FLOW REP TEMP AD; WHO, 2007, WHOHTMTB2007376	34	47	47	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					420	U150		10.7326/M14-2082	http://dx.doi.org/10.7326/M14-2082			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775314	Green Accepted			2022-12-24	WOS:000351279600015
J	Shroff, GR				Shroff, Gautam R.			Acute Myocardial Infarction: What's in a Name?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shroff, Gautam R.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Shroff, Gautam R.] Univ Minnesota, Minneapolis, MN USA	Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Shroff, GR (corresponding author), Hennepin Cty Med Ctr, Div Cardiovasc, 701 Pk Ave, Minneapolis, MN 55415 USA.	shrof010@umn.edu	Shroff, Gautam/H-7687-2019	Shroff, Gautam/0000-0002-7614-9560				Bandstein N, 2014, J AM COLL CARDIOL, V63, P2569, DOI 10.1016/j.jacc.2014.03.017; Braunwald E, 2013, CIRCULATION, V127, P2452, DOI 10.1161/CIRCULATIONAHA.113.001258; de Lemos JA, 2013, JAMA-J AM MED ASSOC, V309, P2262, DOI 10.1001/jama.2013.5809; Saaby L, 2014, AM J MED, V127, P295, DOI 10.1016/j.amjmed.2013.12.020; Saaby L, 2013, AM J MED, V126, P789, DOI 10.1016/j.amjmed.2013.02.029; Sandoval Y, 2014, J AM COLL CARDIOL, V63, P2079, DOI 10.1016/j.jacc.2014.02.541; Shroff GR, 2015, INT J CARDIOL, V182, P412, DOI 10.1016/j.ijcard.2014.12.141; Shroff GR, 2014, JAMA INTERN MED, V174, P1689, DOI 10.1001/jamainternmed.2014.3446; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	9	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					448	U95		10.7326/M14-2259	http://dx.doi.org/10.7326/M14-2259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25775318				2022-12-24	WOS:000351279600018
J	Doncic, A; Atay, O; Valk, E; Grande, A; Bush, A; Vasen, G; Colman-Lerner, A; Loog, M; Skotheim, JM				Doncic, Andreas; Atay, Oguzhan; Valk, Ervin; Grande, Alicia; Bush, Alan; Vasen, Gustavo; Colman-Lerner, Alejandro; Loog, Mart; Skotheim, Jan M.			Compartmentalization of a Bistable Switch Enables Memory to Cross a Feedback-Driven Transition	CELL			English	Article							SCAFFOLD PROTEIN STE5; SIGNAL-TRANSDUCTION PATHWAY; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; DEPENDENT PHOSPHORYLATION; NEGATIVE FEEDBACK; POSITIVE FEEDBACK; KINASE CASCADE; MESSENGER-RNA	Cells make accurate decisions in the face of molecular noise and environmental fluctuations by relying not only on present pathway activity, but also on their memory of past signaling dynamics. Once a decision is made, cellular transitions are often rapid and switch-like due to positive feedback loops in the regulatory network. While positive feedback loops are good at promoting switch-like transitions, they are not expected to retain information to inform subsequent decisions. However, this expectation is based on our current understanding of network motifs that accounts for temporal, but not spatial, dynamics. Here, we show how spatial organization of the feedback-driven yeast G1/S switch enables the transmission of memory of past pheromone exposure across this transition. We expect this to be one of many examples where the exquisite spatial organization of the eukaryotic cell enables previously well-characterized network motifs to perform new and unexpected signal processing functions.	[Doncic, Andreas; Atay, Oguzhan; Skotheim, Jan M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Valk, Ervin; Loog, Mart] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Grande, Alicia; Bush, Alan; Vasen, Gustavo; Colman-Lerner, Alejandro] IFIBYNE UBA CONICET, Buenos Aires, DF, Argentina; [Grande, Alicia; Bush, Alan; Vasen, Gustavo; Colman-Lerner, Alejandro] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Stanford University; University of Tartu; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Skotheim, JM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	skotheim@stanford.edu	Bush, Alan/L-5098-2019; Colman-Lerner, Alejandro/ABC-3808-2020; Skotheim, Jan/C-3238-2015	Bush, Alan/0000-0002-0407-5750; Colman-Lerner, Alejandro/0000-0002-2557-8883; Skotheim, Jan/0000-0001-8420-6820; Atay, Oguzhan/0000-0002-7203-9575; Vasen, Gustavo/0000-0002-5968-2312	Burroughs Wellcome Fund (CASI); NIH [GM092925, GM097479]; Argentine Agency of Research and Technology (ANPCyT) [PICT2010-2248]; Estonian Science Agency [IUT2-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, R01GM097479, R01GM092925] Funding Source: NIH RePORTER	Burroughs Wellcome Fund (CASI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Argentine Agency of Research and Technology (ANPCyT); Estonian Science Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the Skotheim laboratory was supported by the Burroughs Wellcome Fund (CASI) and the NIH (GM092925). The Colman-Lerner laboratory was supported by grant PICT2010-2248 from the Argentine Agency of Research and Technology (ANPCyT) and the NIH (GM097479), while the Loog laboratory was supported by Estonian Science Agency Grant IUT2-21.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Behar M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000197; Blackwell E, 2003, MOL CELL BIOL, V23, P1135, DOI 10.1128/MCB.23.4.1135-1150.2003; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Blondel M, 1999, GENE DEV, V13, P2284, DOI 10.1101/gad.13.17.2284; Cai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084630; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Doncic A, 2013, MOL CELL, V50, P856, DOI 10.1016/j.molcel.2013.04.014; Doncic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057970; Doncic A, 2011, MOL CELL, V43, P528, DOI 10.1016/j.molcel.2011.06.025; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Gari E, 2001, GENE DEV, V15, P2803; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Holmes KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084060; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Laabs TL, 2003, P NATL ACAD SCI USA, V100, P10275, DOI 10.1073/pnas.1833999100; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; MCKINNEY JD, 1993, GENE DEV, V7, P833, DOI 10.1101/gad.7.5.833; MOORE SA, 1984, J BIOL CHEM, V259, P1004; Nagiec MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002437; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Oehlen LJWM, 1998, MOL GEN GENET, V258, P183, DOI 10.1007/s004380050722; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Pope P. A., 2014, CURR BIOL; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Qi MS, 2005, J CELL SCI, V118, P2837, DOI 10.1242/jcs.02418; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Santos SDM, 2012, CELL, V149, P1500, DOI 10.1016/j.cell.2012.05.028; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Torres MP, 2011, J BIOL CHEM, V286, P20208, DOI 10.1074/jbc.M111.239343; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; VALTZ N, 1995, J CELL BIOL, V131, P863, DOI 10.1083/jcb.131.4.863; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	58	29	29	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1182	1195		10.1016/j.cell.2015.02.032	http://dx.doi.org/10.1016/j.cell.2015.02.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768911	Green Accepted, Bronze			2022-12-24	WOS:000351951800017
J	Besseling, J; Kastelein, JJP; Defesche, JC; Hutten, BA; Hovingh, GK				Besseling, Joost; Kastelein, John J. P.; Defesche, Joep C.; Hutten, Barbara A.; Hovingh, G. Kees			Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; INSULIN-SECRETION; HEART-DISEASE; ABCA1; RISK; CHOLESTEROL; MUTATIONS; PATHOPHYSIOLOGY; METAANALYSIS	IMPORTANCE Familial hypercholesterolemia is characterized by impaired uptake of cholesterol in peripheral tissues, including the liver and the pancreas. In contrast, statins increase the cellular cholesterol uptake and are associated with increased risk for type 2 diabetes mellitus. We hypothesize that transmembrane cholesterol transport is linked to the development of type 2 diabetes. OBJECTIVE To assess the association between type 2 diabetes prevalence and familial hypercholesterolemia. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study in all individuals (n = 63 320) who underwent DNA testing for familial hypercholesterolemia in the national Dutch screening program between 1994 and 2014. EXPOSURES Deleteriousness and nondeleteriousness of familial hypercholesterolemia mutations were based on literature or laboratory function testing. Low-density lipoprotein (LDL) receptor mutations were considered more severe than apolipoprotein B gene (APOB) mutations, and receptor-negative LDL receptor mutations were considered more severe than receptor-deficient mutations. MAIN OUTCOMES AND MEASURES Prevalence of type 2 diabetes. RESULTS The prevalence of type 2 diabetes was 1.75% in familial hypercholesterolemia patients (n = 440/25 137) vs 2.93% in unaffected relatives (n = 1119/38 183) (P <.001; odds ratio [OR], 0.62 [95% CI, 0.55-0.69]). The adjusted prevalence of type 2 diabetes in familial hypercholesterolemia, determined using multivariable regression models, was 1.44% (difference, 1.49% [95% CI, 1.24%-1.71%]) (OR, 0.49 [95% CI, 0.41-0.58]; P <.001). The adjusted prevalence of type 2 diabetes by APOB vs LDL receptor gene was 1.91% vs 1.33% (OR, 0.65 [95% CI, 0.48-0.87] vs OR, 0.45 [95% CI, 0.38-0.54]), and the prevalence for receptor-deficient vs receptor-negative mutation carriers was 1.44% vs 1.12%(OR, 0.49 [95% CI, 0.40-0.60] vs OR, 0.38 [95% CI, 0.29-0.49]), respectively (P for trend <. 001 in both comparisons). CONCLUSIONS AND RELEVANCE In a cross-sectional analysis in the Netherlands, the prevalence of type 2 diabetes among patients with familial hypercholesterolemia was significantly lower than among unaffected relatives, with variability by mutation type. If this finding is confirmed in longitudinal analysis, it would raise the possibility of a causal relationship between LDL receptor-mediated transmembrane cholesterol transport and type 2 diabetes.	[Besseling, Joost; Kastelein, John J. P.; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Defesche, Joep C.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Hutten, Barbara A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,Room F4-280, NL-1105 AZ Amsterdam, Netherlands.	j.j.kastelein@amc.nl	Kastelein, John/AAF-7950-2020		Netherlands Organisation for Scientific Research (NWO) [91612122]; CardioVascular Research Initiative [CVON2011-19]; European Union (TransCard) [FP7-603091-2]; Amgen; Pfizer; Roche; Sanofi; AstraZeneca; Netherland Heart Foundation (NHS) [2010T082]; Aegerion; Boehringer Ingelheim; Cerenis; Eli Lilly; Genzyme; JSiS; MSD; Novartis; Regeneron	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CardioVascular Research Initiative; European Union (TransCard); Amgen(Amgen); Pfizer(Pfizer); Roche(Roche Holding); Sanofi; AstraZeneca(AstraZeneca); Netherland Heart Foundation (NHS); Aegerion; Boehringer Ingelheim(Boehringer Ingelheim); Cerenis; Eli Lilly(Eli Lilly); Genzyme(Sanofi-AventisGenzyme Corporation); JSiS; MSD; Novartis(Novartis); Regeneron(Regeneron)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kastelein reports receipt of a VENI grant from the Netherlands Organisation for Scientific Research (NWO, project number 91612122) and support by grants from the CardioVascular Research Initiative (CVON2011-19; Genius) and the European Union (TransCard, FP7-603091-2); receipt of lecture fees for Dr Hovingh from Amgen, Pfizer, Roche, and Sanofi; and a research grant from AstraZeneca. Dr Kastelein reports being a recipient of the Lifetime Achievement Award of the Netherland Heart Foundation (NHS, project number 2010T082) and receipt of lecture grants from Aegerion, AstraZeneca, Boehringer Ingelheim, Cerenis, Eli Lilly, Genzyme, JSiS, MSD, Novartis, Pfizer, Regeneron, Roche, and Sanofi. No other disclosures were reported.	Alonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024; Axsom K, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0299-z; Bertolini S, 2000, ARTERIOSCLER THROMB, V20, P41; Bertolini S, 2013, ATHEROSCLEROSIS, V227, P342, DOI 10.1016/j.atherosclerosis.2013.01.007; Besseling J, 2014, ATHEROSCLEROSIS, V233, P219, DOI 10.1016/j.atherosclerosis.2013.12.020; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cnop M, 2002, ENDOCRINOLOGY, V143, P3449, DOI 10.1210/en.2002-220273; COBBAERT C, 1994, EUR J CLIN CHEM CLIN, V32, P391; Costi M, 2010, ACTA DIABETOL, V47, pS169, DOI 10.1007/s00592-009-0158-8; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Harvey J. N., 2002, Journal of Epidemiology and Community Health, V56, P18, DOI 10.1136/jech.56.1.18; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Hovingh GK, 2013, EUR HEART J, V34, P962, DOI 10.1093/eurheartj/eht015; Humphries SE, 2006, J MOL MED, V84, P203, DOI 10.1007/s00109-005-0019-z; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Lombardi MP, 2000, CLIN GENET, V57, P116, DOI 10.1034/j.1399-0004.2000.570205.x; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Oram JF, 2001, J LIPID RES, V42, P1173; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Rutti S, 2009, ENDOCRINOLOGY, V150, P4521, DOI 10.1210/en.2009-0252; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Santos Carlos Antonio S T, 2008, BMC Med Res Methodol, V8, P80, DOI 10.1186/1471-2288-8-80; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; SIRTORI CR, 1990, PHARMACOL RES, V22, P555, DOI 10.1016/S1043-6618(05)80047-7; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Van de Lisdonk E, 2008, DIS CLIN GEN PRACTIT; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; Vohl MC, 1997, EUR J CLIN INVEST, V27, P366, DOI 10.1046/j.1365-2362.1997.1250669.x; Wijesekara N, 2012, DIABETES, V61, P653, DOI 10.2337/db11-0944	37	256	260	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2015	313	10					1029	1036		10.1001/jama.2015.1206	http://dx.doi.org/10.1001/jama.2015.1206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8UE	25756439	Bronze			2022-12-24	WOS:000350643100018
J	Luzzatto, L; Hollak, CEM; Cox, TM; Schieppati, A; Licht, C; Kaariainen, H; Merlini, G; Schaefer, F; Simoens, S; Pani, L; Garattini, S; Remuzzi, G				Luzzatto, Lucio; Hollak, Carla E. M.; Cox, Timothy M.; Schieppati, Arrigo; Licht, Christoph; Kaariainen, Helena; Merlini, Giampaolo; Schaefer, Franz; Simoens, Steven; Pani, Luca; Garattini, Silvio; Remuzzi, Giuseppe			Rare diseases and effective treatments: are we delivering?	LANCET			English	Editorial Material							ORPHAN DRUGS; ECULIZUMAB		[Luzzatto, Lucio] Ist Toscano Tumori, Florence, Italy; [Hollak, Carla E. M.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Cox, Timothy M.] Univ Cambridge, Univ Dept Med, Cambridge, England; [Schieppati, Arrigo; Garattini, Silvio; Remuzzi, Giuseppe] Ist Ric Farmacol Mario Negri, IRCCS, I-24126 Bergamo, Italy; [Schieppati, Arrigo] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Licht, Christoph] Hosp Sick Children, Div Nephrol, Toronto, ON M5G 1X8, Canada; [Kaariainen, Helena] European Platform Patients Org Sci & Ind, Brussels, Belgium; [Merlini, Giampaolo] Univ Pavia, Dept Mol Med, Amyloidosis Res & Treatment Ctr, I-27100 Pavia, Italy; [Schaefer, Franz] Heidelberg Univ, Ctr Pediat & Adolescent Med, Pediat Nephrol Div, Heidelberg, Germany; [Simoens, Steven] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Pani, Luca] AIFA Italian Med Agcy, Rome, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Amsterdam; Academic Medical Center Amsterdam; University of Cambridge; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pavia; Ruprecht Karls University Heidelberg; KU Leuven	Remuzzi, G (corresponding author), Ist Ric Farmacol Mario Negri, IRCCS, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Merlini, Giampaolo/A-3817-2008; Garattini, Silvio/AAA-6390-2020; Pani, Luca/AAM-9467-2020; Remuzzi, Giuseppe/V-9766-2017	Merlini, Giampaolo/0000-0001-7680-3254; Garattini, Silvio/0000-0003-0647-9297; Pani, Luca/0000-0001-9273-2839; Simoens, Steven/0000-0002-9512-2005; Hollak, Carla/0000-0003-0464-1078; Remuzzi, Giuseppe/0000-0002-6194-3446				Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Hyry HI, 2014, QJM-INT J MED, V107, P241, DOI 10.1093/qjmed/hcu016; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; O'Sullivan BP, 2013, JAMA-J AM MED ASSOC, V310, P1343, DOI 10.1001/jama.2013.278129; Parker C, 2009, LANCET, V373, P759, DOI 10.1016/S0140-6736(09)60001-5; Picavet E, 2012, J CLIN PHARM THER, V37, P664, DOI 10.1111/j.1365-2710.2012.01364.x; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7	7	34	38	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					750	752		10.1016/S0140-6736(15)60297-5	http://dx.doi.org/10.1016/S0140-6736(15)60297-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25752159				2022-12-24	WOS:000350051700009
J	Johnston, AM; Memon, AA				Johnston, AM; Memon, AA			A medical mystery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland; Southport & Formby Dist Gen Hosp, Southport PR8 6PN, Merseyside, England	University of Aberdeen	Johnston, AM (corresponding author), Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland.		Johnston, Andy/GOK-2428-2022	Johnston, Andrew McDonald/0000-0002-0220-0589					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	1999	340	13					1011	1011		10.1056/NEJM199904013401305	http://dx.doi.org/10.1056/NEJM199904013401305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GA	25859579				2022-12-24	WOS:000079489800005
J	Wall, SP; Plunkett, C; Caplan, A				Wall, Stephen P.; Plunkett, Carolyn; Caplan, Arthur			A Potential Solution to the Shortage of Solid Organs for Transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DONATION		[Wall, Stephen P.] NYU, Ronald O Perelman Dept Emergency Med, Bellevue Hosp Center, Sch Med, New York, NY 10016 USA; [Plunkett, Carolyn; Caplan, Arthur] NYU, Div Med Eth, Sch Med, New York, NY 10016 USA; [Plunkett, Carolyn] CUNY, Grad Ctr, Philosophy Program, New York, NY USA	New York University; New York University; City University of New York (CUNY) System	Wall, SP (corresponding author), NYU, Ronald O Perelman Dept Emergency Med, Bellevue Hosp Center, Sch Med, OBV Ste 345A, New York, NY 10016 USA.	Stephen.Wall@nyumc.org		Wall, Stephen/0000-0003-3965-5074	OSTLTS CDC HHS [R38OT08761] Funding Source: Medline	OSTLTS CDC HHS		*CDC, INJ PREV CONTR DAT S; Childress JF., 2006, ORGAN DONATION OPPOR; Organ Procurement and Transplantation Network (OPTN), 2015, ORG PROC TRANSPL DAT; Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x; Rudge C, 2012, BRIT J ANAESTH, V108, pI48, DOI 10.1093/bja/aer399; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Wall SR, 2014, ANN EMERG MED, V63, P392, DOI 10.1016/j.annemergmed.2013.10.014	7	17	17	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2015	313	23					2321	2322		10.1001/jama.2015.5328	http://dx.doi.org/10.1001/jama.2015.5328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK5XE	25961717	Bronze			2022-12-24	WOS:000356300200013
J	Rosenblatt, M; Kuhlik, B				Rosenblatt, Michael; Kuhlik, Bruce			Principles and Challenges in Access to Experimental Medicines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rosenblatt, Michael; Kuhlik, Bruce] Merck & Co Inc, Kenilworth, NJ 07033 USA	Merck & Company	Rosenblatt, M (corresponding author), Merck & Co Inc, 2000 Galloping Hill Rd,K1-4118B, Kenilworth, NJ 07033 USA.	michael.rosenblatt@merck.com						Darrow JJ, 2015, NEW ENGL J MED, V372, P279, DOI 10.1056/NEJMhle1409465; Leonard Kimberley, 2014, US NEWS; Lieu CH, J CLIN ONCOL, DOI [10.1200/JCO.2014.60.6004, DOI 10.1200/JC0.2014.60.6004]; Sanghavi D, 2014, HLTH POLICY ISSUE BR; Turkewitzjan J., 2015, NY TIMES	5	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2023	2024		10.1001/jama.2015.4135	http://dx.doi.org/10.1001/jama.2015.4135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	25906392				2022-12-24	WOS:000355142400012
J	Thi, EP; Mire, CE; Lee, ACH; Geisbert, JB; Zhou, JZ; Agans, KN; Snead, NM; Deer, DJ; Barnard, TR; Fenton, KA; MacLachlan, I; Geisbert, TW				Thi, Emily P.; Mire, Chad E.; Lee, Amy C. H.; Geisbert, Joan B.; Zhou, Joy Z.; Agans, Krystle N.; Snead, Nicholas M.; Deer, Daniel J.; Barnard, Trisha R.; Fenton, Karla A.; MacLachlan, Ian; Geisbert, Thomas W.			Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates	NATURE			English	Article							HEPATITIS-C VIRUS; HAIRPIN RNAS; DISEASE; MICE	The current outbreak of Ebola virus in West Africa is unprecedented, causing more cases and fatalities than all previous outbreaks combined, and has yet to be controlled(1). Several post-exposure interventions have been employed under compassionate use to treat patients repatriated to Europe and the United States(2). However, the in vivo efficacy of these interventions against the new outbreak strain of Ebola virus is unknown. Here we show that lipid-nanoparticle-encapsulated short interfering RNAs (siRNAs) rapidly adapted to target the Makona outbreak strain of Ebola virus are able to protect 100% of rhesus monkeys against lethal challenge when treatment was initiated at 3 days after exposure while animals were viraemic and clinically ill. Although all infected animals showed evidence of advanced disease including abnormal haematology, blood chemistry and coagulopathy, siRNA-treated animals had milder clinical features and fully recovered, while the untreated control animals succumbed to the disease. These results represent the first, to our knowledge, successful demonstration of therapeutic anti-Ebola virus efficacy against the new outbreak strain in nonhuman primates and highlight the rapid development of lipid-nanoparticle-delivered siRNA as a countermeasure against this highly lethal human disease.	[Thi, Emily P.; Lee, Amy C. H.; Zhou, Joy Z.; Snead, Nicholas M.; Barnard, Trisha R.; MacLachlan, Ian] Tekmira Pharmaceut, Burnaby, BC V5J 5J8, Canada; [Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Deer, Daniel J.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77550 USA; [Mire, Chad E.; Geisbert, Joan B.; Agans, Krystle N.; Deer, Daniel J.; Fenton, Karla A.; Geisbert, Thomas W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77550 USA.	twgeisbe@utmb.edu	Mire, Chad/Z-6338-2019	Mire, Chad/0000-0001-7596-1808	Department of Health and Human Services, National Institutes of Health [U19AI109711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109711] Funding Source: NIH RePORTER	Department of Health and Human Services, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Borisevich for assistance with clinical pathology assays performed in the GNL BSL-4 laboratory. We also thank S. Klassen for his assistance with siRNA-LNP preparation. This study was supported by the Department of Health and Human Services, National Institutes of Health grant U19AI109711 to T.W.G. and I.M.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227; Dallas A, 2014, J VIROL, V88, P4647, DOI 10.1128/JVI.00105-14; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Hirschberg R, 2014, VIRUSES-BASEL, V6, P2673, DOI 10.3390/v6072673; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Ma H, 2014, GASTROENTEROLOGY, V146, P63, DOI 10.1053/j.gastro.2013.09.049; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Trefry C., 2015, ASM BIOD EM DIS RES; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; World Health Organization, 2015, EB DAT STAT	21	185	192	0	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2015	521	7552					362	+		10.1038/nature14442	http://dx.doi.org/10.1038/nature14442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI5RM	25901685	Green Accepted			2022-12-24	WOS:000354816500058
J	Egan, ES; Jiang, RHY; Moechtar, MA; Barteneva, NS; Weekes, MP; Nobre, LV; Gygi, SP; Paulo, JA; Frantzreb, C; Tani, Y; Takahashi, J; Watanabe, S; Goldberg, J; Paul, AS; Brugnara, C; Root, DE; Wiegand, RC; Doench, JG; Duraisingh, MT				Egan, Elizabeth S.; Jiang, Rays H. Y.; Moechtar, Mischka A.; Barteneva, Natasha S.; Weekes, Michael P.; Nobre, Luis V.; Gygi, Steven P.; Paulo, Joao A.; Frantzreb, Charles; Tani, Yoshihiko; Takahashi, Junko; Watanabe, Seishi; Goldberg, Jonathan; Paul, Aditya S.; Brugnara, Carlo; Root, David E.; Wiegand, Roger C.; Doench, John G.; Duraisingh, Manoj T.			A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion	SCIENCE			English	Article							RED-BLOOD-CELLS; GROUP-A STREPTOCOCCUS; RESISTANCE LOCI; INAB PHENOTYPE; GENOME-WIDE; MALARIA; RECEPTOR; ASSOCIATION; ATTACHMENT; PARASITES	Efforts to identify host determinants for malaria have been hindered by the absence of a nucleus in erythrocytes, which precludes genetic manipulation in the cell in which the parasite replicates. We used cultured red blood cells derived from hematopoietic stem cells to carry out a forward genetic screen for Plasmodium falciparum host determinants. We found that CD55 is an essential host factor for P. falciparum invasion. CD55-null erythrocytes were refractory to invasion by all isolates of P. falciparum because parasites failed to attach properly to the erythrocyte surface. Thus, CD55 is an attractive target for the development of malaria therapeutics. Hematopoietic stem cell-based forward genetic screens may be valuable for the identification of additional host determinants of malaria pathogenesis.	[Egan, Elizabeth S.; Jiang, Rays H. Y.; Moechtar, Mischka A.; Frantzreb, Charles; Goldberg, Jonathan; Paul, Aditya S.; Duraisingh, Manoj T.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Egan, Elizabeth S.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Jiang, Rays H. Y.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [Jiang, Rays H. Y.] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA; [Barteneva, Natasha S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Barteneva, Natasha S.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Weekes, Michael P.; Nobre, Luis V.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Gygi, Steven P.; Paulo, Joao A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Tani, Yoshihiko; Takahashi, Junko] Japanese Red Cross Kinki Block Blood Ctr, Osaka, Japan; [Watanabe, Seishi] Japanese Red Cross Kyushu Block Blood Ctr, Fukuoka, Japan; [Brugnara, Carlo] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Brugnara, Carlo] Harvard Univ, Sch Med, Boston, MA USA; [Root, David E.; Wiegand, Roger C.; Doench, John G.; Duraisingh, Manoj T.] Broad Inst Harvard & Massachussetts Insititute Te, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Cambridge; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Duraisingh, MT (corresponding author), Broad Inst Harvard & Massachussetts Insititute Te, Cambridge, MA 02142 USA.	mduraisi@hsph.harvard.edu	Doench, John/ABE-6251-2020; Doench, John G/HCI-9570-2022; Paulo, Joao/AAO-3981-2020; Barteneva, Natalie/V-3826-2019; Barteneva, Natasha/B-9094-2017	Doench, John/0000-0002-3707-9889; Doench, John G/0000-0002-3707-9889; Paulo, Joao/0000-0002-4291-413X; Barteneva, Natalie/0000-0002-8109-1754; Weekes, Michael/0000-0003-3196-5545; Nobre, Luis/0000-0003-0467-8989	Foundation Grand Challenges Exploration Award [OPP1035276]; NIH [R01AI091787, K08 1K08AI103034-01A1, K01DK098285]; Pediatric Scientist Development Program Fellowship from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12-HD000850]; Boston Children's Hospital Faculty Development Award; Cambridge Biomedical Research Center, UK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI103034, R01AI091787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER	Foundation Grand Challenges Exploration Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Scientist Development Program Fellowship from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; Boston Children's Hospital Faculty Development Award; Cambridge Biomedical Research Center, UK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Wirth, M. Ganter, A. Nicholson-Weller, M. Waldor, S. Lux, R. Husson, B. Burleigh, and members of the Duraisingh Laboratory for helpful discussions and reading of the manuscript. We thank C. Westhoff and C. Lomas-Francis of the New York Blood Center for gift of the second Inab sample. We thank U. Kanjee for technical assistance and D. Ndiaye, S. Mboup, and S. Volkman for P. falciparum clinical isolates from Senegal. This work was supported by a Gates Foundation Grand Challenges Exploration Award OPP1035276 (M.T.D.), NIH grant R01AI091787 (M.T.D.), a Pediatric Scientist Development Program Fellowship from the Eunice Kennedy Shriver National Institute of Child Health and Human Development K12-HD000850 (E.S.E), NIH grant K08 1K08AI103034-01A1 (E.S.E.), Boston Children's Hospital Faculty Development Award (E.S.E.), NIH grant K01DK098285 (J.A.P.), and the Cambridge Biomedical Research Center, UK (M.P.W. and L.V.N.). Additional data can be found in the supplementary materials.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Fairhurst RM, 2010, PRINCIPLES PRACTICE, V2, P3437; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gwamaka M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-386; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Hue-Roye K, 2005, Immunohematology, V21, P53; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; MERRY AH, 1989, BRIT J HAEMATOL, V73, P248, DOI 10.1111/j.1365-2141.1989.tb00260.x; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NOWICKI B, 1988, AM J PATHOL, V133, P1; O'Brien DP, 2008, J BIOL CHEM, V283, P23922, DOI 10.1074/jbc.M801144200; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; REID ME, 1991, BLOOD, V78, P3291; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Storry J R, 2010, Immunohematology, V26, P109; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Takahashi J., 2008, JAPAN J TRANSF CELL, V54, P359; Tamez PA, 2009, BLOOD, V114, P3652, DOI 10.1182/blood-2009-07-231894; Taylor SM, 2014, CURR OPIN HEMATOL, V21, P193, DOI 10.1097/MOH.0000000000000039; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715	35	76	76	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					711	714		10.1126/science.aaa3526	http://dx.doi.org/10.1126/science.aaa3526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25954012	Green Accepted			2022-12-24	WOS:000354045700050
J	Gutsche, I; Desfosses, A; Effantin, G; Ling, WL; Haupt, M; Ruigrok, RWH; Sachse, C; Schoehn, G				Gutsche, Irina; Desfosses, Ambroise; Effantin, Gregory; Ling, Wai Li; Haupt, Melina; Ruigrok, Rob W. H.; Sachse, Carsten; Schoehn, Guy			Near-atomic cryo-EM structure of the helical measles virus nucleocapsid	SCIENCE			English	Article							NUCLEOPROTEIN-RNA COMPLEX; RESPIRATORY SYNCYTIAL VIRUS; VESICULAR STOMATITIS-VIRUS; CRYSTAL-STRUCTURE; RECONSTRUCTION; PHOSPHOPROTEIN; BINDING; DOMAIN	Measles is a highly contagious human disease. We used cryo-electron microscopy and single particle-based helical image analysis to determine the structure of the helical nucleocapsid formed by the folded domain of the measles virus nucleoprotein encapsidating an RNA at a resolution of 4.3 angstroms. The resulting pseudoatomic model of the measles virus nucleocapsid offers important insights into the mechanism of the helical polymerization of nucleocapsids of negative-strand RNA viruses, in particular via the exchange subdomains of the nucleoprotein. The structure reveals the mode of the nucleoprotein-RNA interaction and explains why each nucleoprotein of measles virus binds six nucleotides, whereas the respiratory syncytial virus nucleoprotein binds seven. It provides a rational basis for further analysis of measles virus replication and transcription, and reveals potential targets for drug design.	[Gutsche, Irina; Effantin, Gregory; Ruigrok, Rob W. H.; Schoehn, Guy] CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Gutsche, Irina; Effantin, Gregory; Ruigrok, Rob W. H.; Schoehn, Guy] Univ Grenoble Alpes, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Desfosses, Ambroise; Sachse, Carsten] European Mol Biol Lab, Struct & Computat Biol Unit, D-69917 Heidelberg, Germany; [Ling, Wai Li; Schoehn, Guy] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Ling, Wai Li; Schoehn, Guy] CNRS, IBS, F-38044 Grenoble, France; [Ling, Wai Li; Schoehn, Guy] CEA, IBS, F-38044 Grenoble, France; [Haupt, Melina] Inst Max Von Laue Paul Langevin, F-38000 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Laue-Langevin (ILL)	Gutsche, I (corresponding author), CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble, France.	gutsche@embl.fr	Sachse, Carsten/AAY-9384-2020; Ling, Wai Li W/F-9823-2012; Sachse, Carsten/H-2727-2012	Sachse, Carsten/0000-0002-1168-5143; Ling, Wai Li W/0000-0002-4264-5750; Sachse, Carsten/0000-0002-1168-5143; Schoehn, Guy/0000-0002-1459-3201; Desfosses, Ambroise/0000-0002-6525-5042	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]; EMBL Interdisciplinary Postdoc (EIPOD) fellowships under Marie Curie Actions [PCOFUND-GA-2008-229597]	FRISBI; GRAL; EMBL Interdisciplinary Postdoc (EIPOD) fellowships under Marie Curie Actions	We thank A. Jakobi for assistance in real-space coordinate refinement using PHENIX, and M. Jamin for discussions and comments on the manuscript. This work used the platforms of the Grenoble Instruct Center (ISBG: UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB); the electron microscope facility is supported by the Rhone-Alpes Region and by the Fondation pour la Recherche Medicale. A.D. received support from EMBL Interdisciplinary Postdoc (EIPOD) fellowships under Marie Curie Actions (PCOFUND-GA-2008-229597). The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. The cryo-EM map of the helical MeV Ncore-RNA nucleocapsid and the atomic model are deposited in the Electron Microscopy Data Bank and in the Protein Data Bank with accession codes EMDB-2867 and 4uft. The authors declare no competing financial interests. I.G., R.W.H.R., and G.S. designed the study; M.H. purified biological material; I.G., A.D., W.L.L., C.S., and G.S. performed research and analyzed data; R.W.H.R. and G.E. contributed to data interpretation; and I.G. wrote the paper with input from G.E.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; BUCKLAND R, 1989, J GEN VIROL, V70, P435, DOI 10.1099/0022-1317-70-2-435; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Cox R, 2014, P NATL ACAD SCI USA, V111, P15208, DOI 10.1073/pnas.1413268111; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Desfosses A, 2011, J VIROL, V85, P1391, DOI 10.1128/JVI.01459-10; EGELMAN EH, 1989, J VIROL, V63, P2233, DOI 10.1128/JVI.63.5.2233-2243.1989; Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766; Green TJ, 2014, J VIROL, V88, P3766, DOI 10.1128/JVI.03483-13; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Iseni F, 2002, RNA, V8, P1056, DOI 10.1017/S1355838202029977; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; Kingston RL, 2004, J VIROL, V78, P8630, DOI 10.1128/JVI.78.16.8630-8640.2004; Krumm SA, 2013, J BIOL CHEM, V288, P29943, DOI 10.1074/jbc.M113.503862; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Yabukarsi F, 2014, NAT STRUCT MOL BIOL, V21, P754, DOI 10.1038/nsmb.2868	21	96	99	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2015	348	6235					704	707		10.1126/science.aaa5137	http://dx.doi.org/10.1126/science.aaa5137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH5AI	25883315				2022-12-24	WOS:000354045700048
J	Zhang, GQ; Huang, H; Liu, D; Cheng, Y; Liu, XL; Zhang, WX; Yin, RC; Zhang, DP; Zhang, P; Liu, JZ; Li, CY; Liu, BD; Luo, YW; Zhu, YX; Zhang, N; He, SM; He, C; Wang, HL; Chen, DH				Zhang, Guoqiang; Huang, Hua; Liu, Di; Cheng, Ying; Liu, Xiaoling; Zhang, Wenxin; Yin, Ruichuan; Zhang, Dapeng; Zhang, Peng; Liu, Jianzhao; Li, Chaoyi; Liu, Baodong; Luo, Yuewan; Zhu, Yuanxiang; Zhang, Ning; He, Shunmin; He, Chuan; Wang, Hailin; Chen, Dahua			N-6-Methyladenine DNA Modification in Drosophila	CELL			English	Article							STEM-CELL NICHE; ADAPTIVE RESPONSE; MAMMALIAN DNA; METHYLATION; 5-METHYLCYTOSINE; DEMETHYLATION; 5-CARBOXYLCYTOSINE; BASE; 5-HYDROXYMETHYLCYTOSINE; METHYLTRANSFERASE	DNA N-6-methyladenine (6mA) modification is commonly found in microbial genomes and plays important functions in regulating numerous biological processes in bacteria. However, whether 6mA occurs and what its potential roles are in higher-eukaryote cells remain unknown. Here, we show that 6mA is present in Drosophila genome and that the 6mA modification is dynamic and is regulated by the Drosophila Tet homolog, DNA 6mA demethylase ( DMAD), during embryogenesis. Importantly, our biochemical assays demonstrate that DMAD directly catalyzes 6mA demethylation in vitro. Further genetic and sequencing analyses reveal that DMAD is essential for development and that DMAD removes 6mA primarily from transposon regions, which correlates with transposon suppression in Drosophila ovary. Collectively, we uncover a DNA modification in Drosophila and describe a potential role of the DMAD-6mA regulatory axis in controlling development in higher eukaryotes.	[Zhang, Guoqiang; Cheng, Ying; Zhang, Wenxin; Li, Chaoyi; Luo, Yuewan; Zhu, Yuanxiang; Chen, Dahua] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Huang, Hua; Liu, Di; Liu, Xiaoling; Yin, Ruichuan; Zhang, Dapeng; Liu, Baodong; Zhang, Ning; Wang, Hailin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China; [Zhang, Peng; He, Shunmin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Liu, Jianzhao; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Dept Chem, Chicago, IL 60637 USA; [Liu, Jianzhao; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, Chicago, IL 60637 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Zoology, CAS; Howard Hughes Medical Institute; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Chen, DH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	hlwang@rcees.ac.cn; chendh@ioz.ac.cn	Cheng, Ying/GOK-0705-2022; Liu, Jianzhao/AAO-2359-2020; Yin, Ruichuan/Q-7045-2016; Liu, Xiaoling/HGD-3566-2022; He, Shunmin/B-8037-2011; Liu, Jianzhao/E-9165-2011; Yin, Ruichuan/AAZ-4569-2021	Liu, Jianzhao/0000-0001-9465-6075; Yin, Ruichuan/0000-0001-8478-7100; He, Shunmin/0000-0002-7294-0865; Liu, Jianzhao/0000-0001-9465-6075; Yin, Ruichuan/0000-0001-8478-7100; Luo, Yuewan/0000-0002-8964-5301; Cheng, Ying/0000-0002-4233-5330; Zhang, Peng/0000-0001-9303-1639; huang, hua/0000-0002-9881-4197	National Basic Research Program of China [2013CB945002]; Natural Science Foundation of China [31130036, 21125523, 21327006, 91019022]; Chinese Academy of Sciences [XDB14030200, XDA01010306, YSW2013A01]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is supported by the National Basic Research Program of China (2013CB945002), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB14030200 and XDA01010306), Natural Science Foundation of China (31130036, 21125523, 21327006, and 91019022), and the Chinese Academy of Sciences (YSW2013A01).	Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang HD, 2014, J CELL BIOL, V206, P217, DOI 10.1083/jcb.201401002; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LAWLEY PD, 1972, BIOCHEM J, V128, P133, DOI 10.1042/bj1280133; Li DY, 2012, J AM CHEM SOC, V134, P8896, DOI 10.1021/ja3010094; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Reisenauer A, 1999, J BACTERIOL, V181, P5135, DOI 10.1128/JB.181.17.5135-5139.1999; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	350	373	13	209	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					893	906		10.1016/j.cell.2015.04.018	http://dx.doi.org/10.1016/j.cell.2015.04.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25936838	Bronze			2022-12-24	WOS:000354175200021
J	Halsey, NA; Salmon, DA				Halsey, Neal A.; Salmon, Daniel A.			Measles at Disneyland, a Problem for All Ages	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Halsey, Neal A.; Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Halsey, NA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St,Room w5041, Baltimore, MD 21205 USA.	nhalsey1@jhu.edu		salmon, daniel/0000-0002-1035-4422				[Anonymous], WHIT PAP US IN PRESS; [Anonymous], VACCINES AND AUTISM; Centers for Disease Control and Prevention, MEASL CAS OUTBR; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P1099, DOI 10.1001/jama.2015.1518; Institute of Medicine, 2013, CHILDH IMM SCHED SAF; Mnookin S., 2012, PANIC VIRUS TRUE STO; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Omer SB, 2013, NEW ENGL J MED, V368, P1374, DOI 10.1056/NEJMp1300765; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712	9	23	23	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2015	162	9					655	U253		10.7326/M15-0447	http://dx.doi.org/10.7326/M15-0447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH6AZ	25751746				2022-12-24	WOS:000354119100012
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What are the odds?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P., 2012, BMJ-BRIT MED J, V345, P5613; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4488; Sedgwick P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6859; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4960; Sheehan SR, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4661	5	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2015	350								h2327	10.1136/bmj.h2327	http://dx.doi.org/10.1136/bmj.h2327			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH3UX	25934660				2022-12-24	WOS:000353957100004
J	Stettler, N; McKiernan, CM; Melin, CQ; Adejoro, OO; Walczak, NB				Stettler, Nicolas; McKiernan, Colleen M.; Melin, Court Q.; Adejoro, Oluwakayode O.; Walczak, Nancy B.			Proportion of Adults With Sickle Cell Anemia and Pain Crises Receiving Hydroxyurea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Stettler, Nicolas; McKiernan, Colleen M.; Melin, Court Q.; Adejoro, Oluwakayode O.; Walczak, Nancy B.] Lewin Grp, Falls Church, VA 22042 USA		Stettler, N (corresponding author), Lewin Grp, 3130 Fairview Pk Dr, Falls Church, VA 22042 USA.	nicolas.stettler@lewin.com						Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Brawley OW, 2008, ANN INTERN MED, V148, P932, DOI 10.7326/0003-4819-148-12-200806170-00220; Burke JP, 2014, AUTISM, V18, P321, DOI 10.1177/1362361312467709; Lanzkron S, 2008, ANN INTERN MED, V148, P939, DOI 10.7326/0003-4819-148-12-200806170-00221; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	5	42	43	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1671	1672		10.1001/jama.2015.3075	http://dx.doi.org/10.1001/jama.2015.3075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919532	Bronze			2022-12-24	WOS:000353595200019
J	Raghupathy, R; Anilkumar, AA; Polley, A; Singh, PP; Yadav, M; Johnson, C; Suryawanshi, S; Saikam, V; Sawant, SD; Panda, A; Guo, Z; Vishwakarma, RA; Rao, M; Mayor, S				Raghupathy, Riya; Anilkumar, Anupama Ambika; Polley, Anirban; Singh, Parvinder Pal; Yadav, Mahipal; Johnson, Charles; Suryawanshi, Sharad; Saikam, Varma; Sawant, Sanghapal D.; Panda, Aniruddha; Guo, Zhongwu; Vishwakarma, Ram A.; Rao, Madan; Mayor, Satyajit			Transbilayer Lipid Interactions Mediate Nanoclustering of Lipid-Anchored Proteins	CELL			English	Article							CELL-SURFACE MOLECULES; PLASMA-MEMBRANE; NANOSCALE ORGANIZATION; INDEPENDENT ENDOCYTOSIS; PHOSPHOLIPASE-C; PHOSPHATIDYLSERINE; RECEPTOR; DOMAINS; BIOSYNTHESIS; VESICLES	Understanding how functional lipid domains in live cell membranes are generated has posed a challenge. Here, we show that transbilayer interactions are necessary for the generation of cholesterol-dependent nanoclusters of GPI-anchored proteins mediated by membrane-adjacent dynamic actin filaments. We find that long saturated acyl-chains are required for forming GPI-anchor nanoclusters. Simultaneously, at the inner leaflet, long acyl-chain-containing phosphatidylserine (PS) is necessary for transbilayer coupling. All-atom molecular dynamics simulations of asymmetric multicomponent-membrane bilayers in a mixed phase provide evidence that immobilization of long saturated acyl-chain lipids at either leaflet stabilizes cholesterol-dependent transbilayer interactions forming local domains with characteristics similar to a liquid-ordered (lo) phase. This is verified by experiments wherein immobilization of long acyl-chain lipids at one leaflet effects transbilayer interactions of corresponding lipids at the opposite leaflet. This suggests a general mechanism for the generation and stabilization of nanoscale cholesterol-dependent and actin-mediated lipid clusters in live cell membranes.	[Raghupathy, Riya; Anilkumar, Anupama Ambika; Panda, Aniruddha; Rao, Madan; Mayor, Satyajit] Natl Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India; [Polley, Anirban; Rao, Madan] Raman Res Inst, Bangalore 560080, Karnataka, India; [Raghupathy, Riya; Anilkumar, Anupama Ambika] Shanmugha Arts Sci Technol & Res Acad, Thanjavur 613401, India; [Mayor, Satyajit] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India; [Johnson, Charles; Suryawanshi, Sharad; Guo, Zhongwu] Wayne State Univ, Detroit, MI 48202 USA; [Singh, Parvinder Pal; Yadav, Mahipal; Saikam, Varma; Sawant, Sanghapal D.; Vishwakarma, Ram A.] Indian Inst Integrat Med CSIR, Jammu 180001, India; [Panda, Aniruddha] Manipal Univ, Manipal 576104, Karnataka, India; [Polley, Anirban] Tampere Univ Technol, Tampere 33720, Finland	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Science & Technology (India); Raman Research Institute (RRI); Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Wayne State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Manipal Academy of Higher Education (MAHE); Tampere University	Rao, M (corresponding author), Natl Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	madan@ncbs.res.in; mayor@ncbs.res.in	Saikam, Varma/AAW-9765-2020; Yadav, Mahipal/AAD-1896-2021; Sawant, Sanghapal/GOE-6804-2022; Rao, Madan/E-2927-2012; Polley, Anirban/X-8050-2018	Saikam, Varma/0000-0003-2500-9717; Yadav, Mahipal/0000-0003-4394-9737; Sawant, Sanghapal/0000-0002-6224-3214; Polley, Anirban/0000-0001-9425-8835; Panda, Aniruddha/0000-0002-9447-9547	DST (Government of India); HFSP [RGP0027/2012]; CSIR; Simons Foundation; NSF [CHE-1053848]; NIH [GM090270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090270] Funding Source: NIH RePORTER; Division Of Chemistry [1053848] Funding Source: National Science Foundation	DST (Government of India)(Department of Science & Technology (India)); HFSP(Human Frontier Science Program); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Simons Foundation; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Suvrajit Saha for help with FCS measurements and MEM analysis; Balaji for Matlab codes to analyze the anisotropy data; Kabir Husain for help with the correlation analysis; Joseph Jose Thottacherry and Darius Koester for FRAP measurement and analysis; Taroh Kinoshita, Tomohiko Taguchi, Tobias Meyer, and Antonio S. Sechi for their generous gifts of various reagents (as indicated in the Supplemental Information); Max Planck-NCBS lipid centre; Dominik Schwudke and Sudarkodi Sukumar for mass spectrometry; and H. Krishnamurthy and Manoj Mathew at the Central Imaging and Flow Facility (NCBS). R.R. acknowledges Vytas A. Bankaitis for suggestions with lipid incorporation methods. We thank Tampere University of Technology for help with the longer run simulations and all SM lab members for their critical comments on the manuscript. S.M. acknowledges JC Bose Fellowship from DST (Government of India) and a grant from HFSP RGP0027/2012. A. A. A. acknowledges pre-doctoral fellowship from CSIR. M.R. acknowledges a grant from Simons Foundation. Z.G. acknowledges NSF CHE-1053848 and NIH GM090270 for providing financial support.	An XL, 2004, BLOOD CELL MOL DIS, V32, P430, DOI 10.1016/j.bcmd.2004.02.001; Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Ariotti N, 2014, J CELL BIOL, V204, P777, DOI 10.1083/jcb.201307055; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brodsky RA, 2000, AM J CLIN PATHOL, V114, P459, DOI 10.1093/ajcp/114.3.459; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chaudhuri A, 2011, P NATL ACAD SCI USA, V108, P14825, DOI 10.1073/pnas.1100007108; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; ITO S, 1983, J BIOL CHEM, V258, P4626; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kobayashi T, 1996, JPN J MED SCI BIOL, V49, P103, DOI 10.7883/yoken1952.49.103; Koivusalo M, 2007, MOL BIOL CELL, V18, P5113, DOI 10.1091/mbc.E07-04-0330; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Makuch R, 1997, BIOPHYS J, V73, P1607, DOI 10.1016/S0006-3495(97)78192-X; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mazerik JN, 2012, J BIOL CHEM, V287, P13104, DOI 10.1074/jbc.M111.336313; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MUGURUMA M, 1995, J BIOCHEM-TOKYO, V117, P1036, DOI 10.1093/oxfordjournals.jbchem.a124803; Murakami H, 2012, BIOCHEM BIOPH RES CO, V417, P1235, DOI 10.1016/j.bbrc.2011.12.116; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; PERCY AK, 1983, ARCH BIOCHEM BIOPHYS, V223, P484, DOI 10.1016/0003-9861(83)90613-6; Pick H, 2005, J AM CHEM SOC, V127, P2908, DOI 10.1021/ja044605x; Polley A, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4892087; Polley A, 2012, J PHYS CHEM B, V116, P13403, DOI 10.1021/jp3032868; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Raucher D, 2001, J CELL SCI, V114, P3759; Saha S, 2015, METHODS MOL BIOL, V1251, P151, DOI 10.1007/978-1-4939-2080-8_9; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Swamy MJ, 2006, BIOPHYS J, V90, P4452, DOI 10.1529/biophysj.105.070839; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Wolf AA, 1998, J CELL BIOL, V141, P917, DOI 10.1083/jcb.141.4.917; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	52	215	215	2	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					581	594		10.1016/j.cell.2015.03.048	http://dx.doi.org/10.1016/j.cell.2015.03.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910209	Bronze, Green Accepted			2022-12-24	WOS:000353553600017
J	Comstock, MJ; Whitley, KD; Jia, HF; Sokoloski, J; Lohman, TM; Ha, T; Chemla, YR				Comstock, Matthew J.; Whitley, Kevin D.; Jia, Haifeng; Sokoloski, Joshua; Lohman, Timothy M.; Ha, Taekjip; Chemla, Yann R.			Direct observation of structure-function relationship in a nucleic acid-processing enzyme	SCIENCE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI UVRD; HELICASE-II; CRYSTAL-STRUCTURES; MECHANISM; TRANSLOCATION; MONOMER; ATP; COMPLEXES	The relationship between protein three-dimensional structure and function is essential for mechanism determination. Unfortunately, most techniques do not provide a direct measurement of this relationship. Structural data are typically limited to static pictures, and function must be inferred. Conversely, functional assays usually provide little information on structural conformation. We developed a single-molecule technique combining optical tweezers and fluorescence microscopy that allows for both measurements simultaneously. Here we present measurements of UvrD, a DNA repair helicase, that directly and unambiguously reveal the connection between its structure and function. Our data reveal that UvrD exhibits two distinct types of unwinding activity regulated by its stoichiometry. Furthermore, two UvrD conformational states, termed "closed" and "open," correlate with movement toward or away from the DNA fork.	[Comstock, Matthew J.; Whitley, Kevin D.; Ha, Taekjip; Chemla, Yann R.] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Comstock, Matthew J.; Whitley, Kevin D.; Ha, Taekjip; Chemla, Yann R.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Jia, Haifeng; Sokoloski, Joshua; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Chemla, YR (corresponding author), Univ Illinois, Dept Phys, Ctr Phys Living Cells, 1110 W Green St, Urbana, IL 61801 USA.	ychemla@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Chemla, Yann/0000-0001-9167-0234; Whitley, Kevin/0000-0001-9719-6916	NSF [MCB-0952442, PHY-1430124]; NIH [R21 RR025341, R01 GM065367, R01 GM045948]; Alfred P. Sloan Research Fellowship; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM045948] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1430124] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0952442] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank members of the Chemla (including Z. Qi), Ha (including K.-S. Lee), and Lohman (including E. Tomko) laboratories for scientific discussion and assistance in the experimental design. Funding was provided by NSF grants MCB-0952442 (CAREER to Y.R.C.) and PHY-1430124 (Center for the Physics of Living Cells to Y.R.C. and T.H.); NIH grants R21 RR025341 (to Y.R.C. and T.H.), R01 GM065367 (to T.H.), and R01 GM045948 (to T.M.L.); and the Alfred P. Sloan Research Fellowship (to Y.R.C.). T.H. is an investigator with the Howard Hughes Medical Institute.	Arslan S, 2015, SCIENCE, V348, P344, DOI 10.1126/science.aaa0445; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Comstock MJ, 2011, NAT METHODS, V8, P335, DOI 10.1038/NMETH.1574; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Kisker C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012591; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lee KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2882; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1986, J BIOL CHEM, V261, P169; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Qi Z, 2013, ELIFE, V2, DOI 10.7554/eLife.00334; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Tomko EJ, 2012, J MOL BIOL, V418, P32, DOI 10.1016/j.jmb.2012.02.013; Tomko EJ, 2010, EMBO J, V29, P3826, DOI 10.1038/emboj.2010.242; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; Yokota H, 2013, BIOPHYS J, V104, P924, DOI 10.1016/j.bpj.2013.01.014	29	126	126	6	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					352	354		10.1126/science.aaa0130	http://dx.doi.org/10.1126/science.aaa0130			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883359	Green Accepted			2022-12-24	WOS:000352999000049
J	Obenauf, AC; Zou, YL; Ji, AL; Vanharanta, S; Shu, WP; Shi, HB; Kong, XJ; Bosenberg, MC; Wiesner, T; Rosen, N; Lo, RS; Massague, J				Obenauf, Anna C.; Zou, Yilong; Ji, Andrew L.; Vanharanta, Sakari; Shu, Weiping; Shi, Hubing; Kong, Xiangju; Bosenberg, Marcus C.; Wiesner, Thomas; Rosen, Neal; Lo, Roger S.; Massague, Joan			Therapy-induced tumour secretomes promote resistance and tumour progression	NATURE			English	Article							TRANSLATIONAL PROFILING APPROACH; ACQUIRED-RESISTANCE; DRUG-RESISTANCE; RAF INHIBITORS; MELANOMA; SURVIVAL; EVOLUTION	Drug resistance invariably limits the clinical efficacy of targeted therapy with kinase inhibitors against cancer(1,2). Here we show that targeted therapy with BRAF, ALK or EGFR kinase inhibitors induces a complex network of secreted signals in drug-stressed human and mouse melanoma and human lung adenocarcinoma cells. This therapy-induced secretome stimulates the outgrowth, dissemination and metastasis of drug-resistant cancer cell clones and supports the survival of drug-sensitive cancer cells, contributing to incomplete tumour regression. The tumour-promoting secretome of melanoma cells treated with the kinase inhibitor vemurafenib is driven by down-regulation of the transcription factor FRA1. In situ transcriptome analysis of drug-resistant melanoma cells responding to the regressing tumour microenvironment revealed hyperactivation of several signalling pathways, most prominently the AKT pathway. Dual inhibition of RAF and the PI(3) K/AKT/mTOR intracellular signalling pathways blunted the outgrowth of the drug-resistant cell population in BRAF mutant human melanoma, suggesting this combination therapy as a strategy against tumour relapse. Thus, therapeutic inhibition of oncogenic drivers induces vast secretome changes in drug-sensitive cancer cells, paradoxically establishing a tumour microenvironment that supports the expansion of drug-resistant clones, but is susceptible to combination therapy.	[Obenauf, Anna C.; Zou, Yilong; Ji, Andrew L.; Vanharanta, Sakari; Shu, Weiping; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Zou, Yilong] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Sch Biomed Sci, New York, NY 10065 USA; [Vanharanta, Sakari] Univ Cambridge, MRC Canc Unit, Cambridge CB2 0XZ, England; [Shi, Hubing; Kong, Xiangju; Lo, Roger S.] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Shi, Hubing; Kong, Xiangju; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Bosenberg, Marcus C.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Bosenberg, Marcus C.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Wiesner, Thomas] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Cambridge; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org	Rosen, Neal/ABF-2677-2020	Obenauf, Anna/0000-0002-9556-5914; Wiesner, Thomas/0000-0001-5877-2992; Ji, Andrew/0000-0001-9688-5680; Shi, Hubing/0000-0002-2926-3440; Zou, Yilong/0000-0001-8198-6067; Massague, Joan/0000-0001-9324-8408	AACR [SU2C]; MSK Metastasis Research Center; NIH [CA163167, CA129243]; Congressionally Directed Medical Research Program of the Department of Defense; Howard Hughes Medical Institute; Cancer Center [P30 CA008748]; Erwin Schroedinger Fellowship (FWF, Austrian Science Fund) [J3013]; Medical Research Council; NATIONAL CANCER INSTITUTE [R01CA176111, P01CA094060, P01CA129243, P30CA008748, P30CA016042, U54CA163167] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1101/4, MC_UU_12022/7] Funding Source: researchfish; MRC [MC_UU_12022/7] Funding Source: UKRI	AACR; MSK Metastasis Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Program of the Department of Defense; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Center; Erwin Schroedinger Fellowship (FWF, Austrian Science Fund); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Massague laboratory for discussions; L. Sevenich and L. Akkari for technical advice. This work was supported by grants from the AACR (SU2C) to R.S.L., the MSK Metastasis Research Center, the NIH (CA163167 and CA129243), the Congressionally Directed Medical Research Program of the Department of Defense, the Howard Hughes Medical Institute, and the Cancer Center Support Grant P30 CA008748 to J.M., A.C.O. was an Erwin Schroedinger Fellowship awardee (J3013, FWF, Austrian Science Fund). A.L.J. was a Medical Research Fellow of the Howard Hughes Medical Institute. S.V. is supported by the Medical Research Council.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shaw AT, 2013, J CLIN ONCOL, V31, P1105, DOI 10.1200/JCO.2012.44.5353; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shi HB, 2014, CANCER DISCOV, V4, P69, DOI 10.1158/2159-8290.CD-13-0279; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Villanueva J, 2008, CURR ONCOL REP, V10, P439, DOI 10.1007/s11912-008-0067-y; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	38	315	337	3	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					368	+		10.1038/nature14336	http://dx.doi.org/10.1038/nature14336			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25807485	Green Accepted, Green Submitted			2022-12-24	WOS:000352974200043
J	Husain, I; Spence, D				Husain, Iltifat; Spence, Des			HEAD TO HEAD Can healthy people benefit from health apps?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WEIGHT-LOSS; TECHNOLOGY		[Husain, Iltifat] Wake Forest Sch Med, Emergency Med, Winston Salem, NC 27157 USA	Wake Forest University	Husain, I (corresponding author), Wake Forest Sch Med, Emergency Med, Winston Salem, NC 27157 USA.	ihusain@wakehealth.edu; destwo@yahoo.co.uk						[Anonymous], 2010, SEV ANX OV BLOOD PRE; Brookings Institution, 2013, MOD HLTH CAR MOB TEC; Burke LE, 2012, AM J PREV MED, V43, P20, DOI 10.1016/j.amepre.2012.03.016; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; DiFilippo KN, 2015, J TELEMED TELECARE, V21, P243, DOI 10.1177/1357633X15572203; Dolan B, 2014, MOBI HLTH NEWS  0107; Gates A, 2014, PROFILES MED OUTREAC; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; Medicines and Healthcare Products Regulatory Agency, 2014, MED DEV SOFTW APPL A; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; NHS Choices, HLTH APPS LIB; Nielsen, 2014, HACKING HLTH CONSUME; Odosoft, FET DOPPL UNB IT PRE; RAVEN R J, 1988, American Museum Novitates, P1; Spring B, 2013, JAMA INTERN MED, V173, P105, DOI 10.1001/jamainternmed.2013.1221; US Food and Drug Administration, MOB MED APPL	16	38	39	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2015	350								h1887	10.1136/bmj.h1887	http://dx.doi.org/10.1136/bmj.h1887			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG5JL	25873345				2022-12-24	WOS:000353327500006
J	Audergon, PNCB; Catania, S; Kagansky, A; Tong, P; Shukla, M; Pidoux, AL; Allshire, RC				Audergon, Pauline N. C. B.; Catania, Sandra; Kagansky, Alexander; Tong, Pin; Shukla, Manu; Pidoux, Alison L.; Allshire, Robin C.			Restricted epigenetic inheritance of H3K9 methylation	SCIENCE			English	Article							JMJC DOMAIN PROTEIN; FISSION YEAST; HETEROCHROMATIN NUCLEATION; HISTONE DEMETHYLATION; RNA INTERFERENCE; LYSINE 9; MAINTENANCE; TRANSCRIPTION; ROLES; REPLICATION	Posttranslational histone modifications are believed to allow the epigenetic transmission of distinct chromatin states, independently of associated DNA sequences. Histone H3 lysine 9 (H3K9) methylation is essential for heterochromatin formation; however, a demonstration of its epigenetic heritability is lacking. Fission yeast has a single H3K9 methyltransferase, Clr4, that directs all H3K9 methylation and heterochromatin. Using releasable tethered Clr4 reveals that an active process rapidly erases H3K9 methylation from tethering sites in wild-type cells. However, inactivation of the putative histone demethylase Epe1 allows H3K9 methylation and silent chromatin maintenance at the tethering site through many mitotic divisions, and transgenerationally throughmeiosis, after release of tethered Clr4. Thus, H3K9 methylation is a heritable epigenetic mark whose transmission is usually countered by its active removal, which prevents the unauthorized inheritance of heterochromatin.	[Allshire, Robin C.] Univ Edinburgh, Max Born Crescent, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; Univ Edinburgh, Max Born Crescent, Inst Cell Biol, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Allshire, RC (corresponding author), Univ Edinburgh, Max Born Crescent, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Kagansky, Alexander/B-3137-2011	Kagansky, Alexander/0000-0002-6219-6892; Allshire, Robin/0000-0002-8005-3625	Wellcome Trust 4 Year PhD program in Cell Biology [093852]; Wellcome Trust Principal Research Fellowship [095021]; EC-NOE-EpiGeneSys [HEALTH-F4-2010-257082]; Wellcome Trust Centre for Cell Biology [092076]	Wellcome Trust 4 Year PhD program in Cell Biology; Wellcome Trust Principal Research Fellowship(Wellcome Trust); EC-NOE-EpiGeneSys; Wellcome Trust Centre for Cell Biology(Wellcome Trust)	We thank I. Stancheva and the Allshire lab for valuable discussions; E. S. Choi for RNA-seq data; and S. Grewal, F. van Leeuwen, L. Bayne, Y. Shi, H. D. Madhani, T. Urano, and H. Watanabe for providing strains and materials. P.N.C.B.A. was supported by the Wellcome Trust 4 Year PhD program in Cell Biology (grant 093852). R.C.A. is supported by a Wellcome Trust Principal Research Fellowship (grant 095021), the EC-NOE-EpiGeneSys (grant HEALTH-F4-2010-257082), and core funding to the Wellcome Trust Centre for Cell Biology (grant 092076). RNA-seq data have been deposited with the National Center for Biotechnology Information Gene Expression Omnibus under accession code SRX689922.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Almouzni G, 2011, NUCLEUS-PHILA, V2, P332, DOI 10.4161/nucl.2.5.17707; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Buscaino A, 2013, EMBO J, V32, P1250, DOI 10.1038/emboj.2013.72; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Cheng XD, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018747; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Rivera C, 2014, BBA-GENE REGUL MECH, V1839, P1433, DOI 10.1016/j.bbagrm.2014.03.009; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052977; Wheeler BS, 2012, GENETICS, V190, P549, DOI 10.1534/genetics.111.137083; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	30	158	161	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					132	135		10.1126/science.1260638	http://dx.doi.org/10.1126/science.1260638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8GJ	25838386	Green Accepted, Green Submitted			2022-12-24	WOS:000352079500043
J	Victor, DG				Victor, David G.			Embed the social sciences in climate policy	NATURE			English	Editorial Material							POLITICAL-SCIENCE		[Victor, David G.] Univ Calif San Diego, Int Relat, San Diego, CA 92103 USA; [Victor, David G.] Univ Calif San Diego, Lab Int Law & Regulat, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Victor, DG (corresponding author), Univ Calif San Diego, Int Relat, San Diego, CA 92103 USA.							Committee to Review the Intergovernmental Panel on Climate Change, 2010, CLIM CHNAG ASS REV P; Hafner-Burton EM, 2012, AM J INT LAW, V106, P47, DOI 10.5305/amerjintelaw.106.1.0047; Hulme M, 2009, WHY WE DISAGREE ABOUT CLIMATE CHANGE: UNDERSTANDING CONTROVERSY, INACTION AND OPPORTUNITY, P1; Hulme M, 2010, NATURE, V463, P730, DOI 10.1038/463730a; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Intergovernmental Panel on Climate Change (IPCC), 2015, FUT WORK IPCC CHAIRM; Keohane RO, 2015, PS-POLIT SCI POLIT, V48, P19, DOI 10.1017/S1049096514001541; Victor DG, 2014, NATURE, V514, P30, DOI 10.1038/514030a; Victor DG, 2014, SCIENCE, V345, P34, DOI 10.1126/science.1255302	9	130	131	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					27	29		10.1038/520027a	http://dx.doi.org/10.1038/520027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE7NE	25832390	Bronze			2022-12-24	WOS:000352027700020
J	Subramanian, S; Blanton, LV; Frese, SA; Charbonneau, M; Mills, DA; Gordon, JI				Subramanian, Sathish; Blanton, Laura V.; Frese, Steven A.; Charbonneau, Mark; Mills, David A.; Gordon, Jeffrey I.			Cultivating Healthy Growth and Nutrition through the Gut Microbiota	CELL			English	Review							HUMAN-MILK OLIGOSACCHARIDES; SECRETORY IMMUNOGLOBULIN-A; MAL-ED COHORT; BOVINE-MILK; INTESTINAL INFLAMMATION; FECAL BIFIDOBACTERIA; BREAST-MILK; N-GLYCANS; PRETERM; INFANTS	Microbiota assembly is perturbed in children with undernutrition, resulting in persistent microbiota immaturity that is not rescued by current nutritional interventions. Evidence is accumulating that this immaturity is causally related to the pathogenesis of undernutrition and its lingering sequelae. Preclinical models in which human gut communities are replicated in gnotobiotic mice have provided an opportunity to identify and predict the effects of different dietary ingredients on microbiota structure, expressed functions, and host biology. This capacity sets the stage for proof-of-concept tests designed to deliberately shape the developmental trajectory and configurations of microbiota in children representing different geographies, cultural traditions, and states of health. Developing these capabilities for microbial stewardship is timely given the global health burden of childhood undernutrition, the effects of changing eating practices brought about by globalization, and the realization that affordable nutritious foods need to be developed to enhance our capacity to cultivate healthier microbiota in populations at risk for poor nutrition.	[Subramanian, Sathish; Blanton, Laura V.; Charbonneau, Mark; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Subramanian, Sathish; Blanton, Laura V.; Charbonneau, Mark; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Gut Microbiome & Nutr Res, St Louis, MO 63108 USA; [Frese, Steven A.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Frese, Steven A.; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; University of California System; University of California Davis	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Mills, David Andrew/G-2282-2011; Frese, Steven/GNH-1991-2022; Mills, David/GXF-1821-2022	Mills, David Andrew/0000-0003-1913-9865; 	Bill & Melinda Gates Foundation (BMGF); NIH [DK078669, DK30292, DK70977]; National Center for Complementary & Integrative Health [R01AT007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, R01DK070977, R01DK030292, R37DK030292] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work cited from the authors' labs was supported in part by grants from the Bill & Melinda Gates Foundation (BMGF) and the NIH (DK078669, DK30292, and DK70977). We thank our colleagues in the BMGF-sponsored Breast Milk, Gut Microbiome, and Immunity Project, Tahmeed Ahmed and other members of our collaboration with the International Center for Diarrheal Disease Research, Bangladesh (ICDDR, B), Michael Barratt, Jeanette Gehrig, Siddarth Venkatesh and other members of our laboratories, plus William Petri and Andrew Serazin for their insights and inspiration. J.I.G. is a co-founder of Matatu, Inc., a company characterizing the role of diet-by-microbiota interactions in animal health. D.A.M. is a co-founder and President of Evolve Biosystems, Inc., a company focused on diet-based manipulation of the gut microbiota.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Aldredge DL, 2013, GLYCOBIOLOGY, V23, P664, DOI 10.1093/glycob/cwt007; Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Arslanoglu S, 2009, J PERINATOL, V29, P489, DOI 10.1038/jp.2009.50; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Boehm G, 2002, ARCH DIS CHILD-FETAL, V86, P178, DOI 10.1136/fn.86.3.F178; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Castellote C, 2011, J NUTR, V141, P1181, DOI 10.3945/jn.110.133652; Caulfield LE, 2014, CLIN INFECT DIS, V59, pS248, DOI 10.1093/cid/ciu421; Chichlowski M, 2012, J PEDIATR GASTR NUTR, V55, P321, DOI 10.1097/MPG.0b013e31824fb899; COPPA GV, 1993, PEDIATRICS, V91, P637; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; De Leoz MLA, 2015, J PROTEOME RES, V14, P491, DOI 10.1021/pr500759e; De Leoz MLA, 2012, J PROTEOME RES, V11, P4662, DOI 10.1021/pr3004979; Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Dogra S, 2015, MBIO, V6, DOI 10.1128/mBio.02419-14; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Drewnowski A, 2010, AM J CLIN NUTR, V91, p1095S, DOI 10.3945/ajcn.2010.28450D; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Gaayeb L, 2014, AM J TROP MED HYG, V90, P566, DOI 10.4269/ajtmh.12-0657; Gabrielli O, 2011, PEDIATRICS, V128, pE1520, DOI 10.1542/peds.2011-1206; Galler JR, 2012, PEDIATRICS, V130, pE1, DOI 10.1542/peds.2012-0073; Garrido D, 2013, MICROBIOL-SGM, V159, P649, DOI 10.1099/mic.0.064113-0; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020; Gronlund MM, 2011, GUT MICROBES, V2, P227, DOI 10.4161/gmic.2.4.16799; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; HENNART PF, 1991, AM J CLIN NUTR, V53, P32, DOI 10.1093/ajcn/53.1.32; Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jantscher-Krenn E, 2012, BRIT J NUTR, V108, P1839, DOI 10.1017/S0007114511007392; Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics, 2001, HLTH NUTR PROP PROB, P1; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Kleinman RE, 2000, PEDIATRICS, V106, P1274; Knol J, 2005, ACTA PAEDIATR, V94, P31, DOI 10.1080/08035320510043529; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Korpe PS, 2013, CLIN INFECT DIS, V56, P988, DOI 10.1093/cid/cis1044; Kosek M, 2014, CLIN INFECT DIS, V59, pS239, DOI 10.1093/cid/ciu457; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kramer M. S., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003517; KRAMER MS, 1992, AM J EPIDEMIOL, V136, P574, DOI 10.1093/oxfordjournals.aje.a116535; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; LEMONS JA, 1982, PEDIATR RES, V16, P113, DOI 10.1203/00006450-198202000-00007; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Muthana S, 2009, CURR OPIN CHEM BIOL, V13, P573, DOI 10.1016/j.cbpa.2009.09.013; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Platts-Mills JA, 2014, CLIN INFECT DIS, V59, pS233, DOI 10.1093/cid/ciu408; Richard SA, 2014, CLIN INFECT DIS, V59, pS255, DOI 10.1093/cid/ciu436; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Smilowitz JT, 2013, J NUTR, V143, P1906, DOI 10.3945/jn.113.180695; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang M, 2015, J PEDIAT GASTROENTER; Weber A, 2001, ACTA PAEDIATR, V90, P772, DOI 10.1080/080352501750315681; Weng MQ, 2014, AM J PHYSIOL-GASTR L, V306, pG779, DOI 10.1152/ajpgi.00183.2013; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053; Zivkovic AM, 2011, ADV NUTR, V2, P284, DOI 10.3945/an.111.000455	78	100	108	0	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1					36	48		10.1016/j.cell.2015.03.013	http://dx.doi.org/10.1016/j.cell.2015.03.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815983	Bronze, Green Accepted			2022-12-24	WOS:000351952200006
J	Vitorino, P; Yeung, S; Crow, A; Bakke, J; Smyczek, T; West, K; McNamara, E; Eastham-Anderson, J; Gould, S; Harris, SF; Ndubaku, C; Ye, WL				Vitorino, Philip; Yeung, Stacey; Crow, Ailey; Bakke, Jesse; Smyczek, Tanya; West, Kristina; McNamara, Erin; Eastham-Anderson, Jeffrey; Gould, Stephen; Harris, Seth F.; Ndubaku, Chudi; Ye, Weilan			MAP4K4 regulates integrin-FERM binding to control endothelial cell motility	NATURE			English	Article							SIGNALING PATHWAY; ADHESION DYNAMICS; KINASE MISSHAPEN; MATRIX ADHESIONS; LUMEN FORMATION; ERM PROTEINS; ANGIOGENESIS; MIGRATION; POLARITY; GROWTH	Cell migration is a stepwise process that coordinates multiple molecular machineries. Using in vitro angiogenesis screens with short interfering RNA and chemical inhibitors, we define here a MAP4K4-moesin-talin-beta 1-integrin molecular pathway that promotes efficient plasma membrane retraction during endothelial cell migration. Loss of MAP4K4 decreased membrane dynamics, slowed endothelial cell migration, and impaired angiogenesis in vitro and in vivo. In migrating endothelial cells, MAP4K4 phosphorylates moesin in retracting membranes at sites of focal adhesion disassembly. Epistasis analyses indicated that moesin functions downstream of MAP4K4 to inactivate integrin by competing with talin for binding to beta 1-integrin intracellular domain. Consequently, loss of moesin (encoded by the MSN gene) or MAP4K4 reduced adhesion disassembly rate in endothelial cells. Additionally, alpha 5 beta 1-integrin blockade reversed the membrane retraction defects associated with loss of Map4k4 in vitro and in vivo. Our study uncovers a novel aspect of endothelial cell migration. Finally, loss of MAP4K4 function suppressed pathological angiogenesis in disease models, identifying MAP4K4 as a potential therapeutic target.	[Vitorino, Philip; Yeung, Stacey; Crow, Ailey; Smyczek, Tanya; Ye, Weilan] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Bakke, Jesse] St Jude Childrens Res Hosp, Chem Biol & Therapeut Dept, Memphis, TN 38105 USA; [West, Kristina; McNamara, Erin; Gould, Stephen] Genentech Inc, Translat Oncol Dept, San Francisco, CA 94080 USA; [Eastham-Anderson, Jeffrey] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Harris, Seth F.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Ndubaku, Chudi] Genentech Inc, Discovery Chem Dept, San Francisco, CA 94080 USA	Roche Holding; Genentech; St Jude Children's Research Hospital; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ye, WL (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	loni@gene.com		Bakke, Jesse/0000-0003-0305-5165; Ndubaku, Chudi/0000-0003-4183-0417; Ye, Weilan/0000-0002-6219-3982				AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bhatt A, 2002, J CELL SCI, V115, P3415; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Bridgewater RE, 2012, J CELL SCI, V125, P3695, DOI 10.1242/jcs.095810; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gatto CL, 2007, J CELL PHYSIOL, V210, P122, DOI 10.1002/jcp.20844; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaneko S, 2011, P NATL ACAD SCI USA, V108, P11127, DOI 10.1073/pnas.1104128108; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lewellyn L, 2013, J CELL BIOL, V200, P721, DOI 10.1083/jcb.201209129; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Poinat P, 2002, CURR BIOL, V12, P622, DOI 10.1016/S0960-9822(02)00764-9; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Teuliere J, 2011, DEVELOPMENT, V138, P4475, DOI 10.1242/dev.061952; Wilson CW, 2013, BLOOD, V122, P3678, DOI 10.1182/blood-2013-02-483156; Xue YZ, 2001, DEVELOPMENT, V128, P1559; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	42	82	84	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					425	+		10.1038/nature14323	http://dx.doi.org/10.1038/nature14323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25799996				2022-12-24	WOS:000351602800046
J	Kay, RF				Kay, Richard F.			New World monkey origins	SCIENCE			English	Editorial Material							BIOGEOGRAPHY		[Kay, Richard F.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Kay, Richard F.] Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA	Duke University; Duke University	Kay, RF (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	richard.kay@duke.edu						Antoine PO, 2012, P ROY SOC B-BIOL SCI, V279, P1319, DOI 10.1098/rspb.2011.1732; Bertrand OC, 2012, AM MUS NOVIT, P1; Bond M, 2015, NATURE, V520, P538, DOI 10.1038/nature14120; Frailey Carl David, 2004, Natural History Museum of Los Angeles County Science Series, V40, P71; Kay RF, 2001, ADV PRIMATO, P339; Kay RF, 1998, J VERTEBR PALEONTOL, V18, P189, DOI 10.1080/02724634.1998.10011043; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; Kay RF, 2012, EARLY MIOCENE PALEOBIOLOGY IN PATAGONIA: HIGH-LATITUDE PALEOCOMMUNITIES OF THE SANTA CRUZ FORMATION, P306; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Seiffert ER, 2005, SCIENCE, V310, P300, DOI 10.1126/science.1116569; Seiffert ER, 2012, EVOL ANTHROPOL, V21, P239, DOI 10.1002/evan.21335; Takai M, 2000, AM J PHYS ANTHROPOL, V111, P263, DOI 10.1002/(SICI)1096-8644(200002)111:2<263::AID-AJPA10>3.3.CO;2-Y; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; Wildman DE, 2009, MOL PHYLOGENET EVOL, V53, P694, DOI 10.1016/j.ympev.2009.07.019	14	21	22	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1068	1069		10.1126/science.aaa9217	http://dx.doi.org/10.1126/science.aaa9217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745147				2022-12-24	WOS:000350354200019
J	Schnabel, RB; Yin, XY; Gona, P; Larson, MG; Beiser, AS; McManus, DD; Newton-Cheh, C; Lubitz, SA; Magnani, JW; Ellinor, PT; Seshadri, S; Wolf, PA; Vasan, RS; Benjamin, EJ; Levy, D				Schnabel, Renate B.; Yin, Xiaoyan; Gona, Philimon; Larson, Martin G.; Beiser, Alexa S.; McManus, David D.; Newton-Cheh, Christopher; Lubitz, Steven A.; Magnani, Jared W.; Ellinor, Patrick T.; Seshadri, Sudha; Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.; Levy, Daniel			50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study	LANCET			English	Article							LEFT-VENTRICULAR HYPERTROPHY; MEDICARE BENEFICIARIES; US; ANTICOAGULATION; HYPERTENSION; SURVIVAL; DISEASE	Background Comprehensive long-term data on atrial fibrillation trends in men and women are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 years. Methods We investigated trends in incidence, prevalence, and risk factors for atrial fibrillation and its association with stroke and mortality after onset in 9511 participants enrolled in the Framingham Heart Study between 1958 and 2007. We analysed trends within 10 year groups (1958-67, 1968-77, 1978-87, 1988-97, and 1998-2007), stratified by sex. Findings During 50 years of observation (202 417 person-years), 1544 cases of new-onset atrial fibrillation occurred (of whom 723 [47%] were women). Between 1958-67 and 1998-2007, age-adjusted prevalence of atrial fibrillation quadrupled from 20.4 to 96.2 cases per 1000 person-years in men and from 13.7 to 49.4 cases per 1000 person-years in women; age-adjusted incidence increased from 3.7 to 13.4 new cases per 1000 person-years in men and from 2.5 to 8.6 new cases per 1000 person-years in women (p(trend) < 0.0001 for all comparisons). For atrial fibrillation diagnosed by electrocardiograph (ECG) during routine Framingham examinations, age-adjusted prevalence per 1000 person-years increased (12.6 in 1958-67 to 25.7 in 1998-2007 in men, p(trend) = 0.0007; 8.1 to 11.8 in women, p(trend) = 0.009). However, age-adjusted incidence of atrial fibrillation by Framingham Heart Study ECGs did not change significantly with time. Although the prevalence of most risk factors changed over time, their associated hazards for atrial fibrillation changed little. Multivariable-adjusted proportional hazards models revealed a 74% (95% CI 50-86%) decrease in stroke (hazards ratio [HR] 3.77, 95% CI 1.98-7.20 in 1958-1967 compared with 1998-2007; p(trend) = 0.0001) and a 25% (95% CI -3-46%) decrease in mortality (HR 1.34, 95% CI 0.97-1.86 in 1958-1967 compared with 1998-2007; p(trend) = 0.003) in 20 years following atrial fibrillation onset. Interpretation Trends of increased incidence and prevalence of atrial fibrillation in the community were probably partly due to enhanced surveillance. Measures are needed to enhance early detection of atrial fibrillation, through increased awareness coupled with targeted screening programmes and risk factor-specific prevention.	[Schnabel, Renate B.; Yin, Xiaoyan; Gona, Philimon; Larson, Martin G.; Beiser, Alexa S.; Newton-Cheh, Christopher; Seshadri, Sudha; Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.; Levy, Daniel] Natl Heart Lung & Blood Inst Framingham Study, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Larson, Martin G.; Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Evans Mem Med Dept, Boston, MA 02118 USA; [Magnani, Jared W.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Beiser, Alexa S.; Seshadri, Sudha; Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.; Levy, Daniel] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA; [McManus, David D.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiol, Boston, MA 02125 USA; [Gona, Philimon] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Div Biostat & Hlth Serv Res, Boston, MA 02125 USA; [Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Newton-Cheh, Christopher; Ellinor, Patrick T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [Newton-Cheh, Christopher] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Newton-Cheh, Christopher; Lubitz, Steven A.; Ellinor, Patrick T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Newton-Cheh, Christopher; Ellinor, Patrick T.] Broad Inst Harvard & MIT, Program Med Populat Genet, Cambridge, MA USA; [Schnabel, Renate B.] Deutsch Zentrum Herz Kreislauf Forsch, Univ Heart Ctr, Dept Gen & Intervent Cardiol, Hamburg, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schnabel, RB (corresponding author), Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, D-20246 Hamburg, Germany.	r.schnabel@uke.de	Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Gona, Philimon/K-1477-2019; Schnabel, Renate B/ABE-6668-2021	Benjamin, Emelia/0000-0003-4076-2336; Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Schnabel, Renate B/0000-0001-7170-9509; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Ellinor, Patrick/0000-0002-2067-0533	NIH; NHLBI; NINDS; Deutsche Forschungsgemeinschaft; NIH/NHLBI [N01-HC-25195, 1K23HL114724]; NIH [1RC1HL101056, HL102214, AG028321, 2R01HL092577, 1R01HL092577, 1R01HL102214, 1R01AG028321, R01HL104156, 1K24HL105780, HL080124, HL077477, HL71039, HL093328, 6RO1-NS-17950, HL080025, 1U01HL105268-01, KL2RR031981]; Fondation Leducq [14CVD01]; American Heart Association [13EIA14220013]; Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHN 1149/3-2]; Doris Duke Charitable Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL105780, U01HL105268, K23HL080025, ZIAHL006001, R01HL104156, R01HL080124, K23HL114724, RC1HL099452, R01HL092577, R01HL102214, RC1HL101056, R01HL093328, R01HL071039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321, R01AG008122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH, NHLBI, NINDS, Deutsche Forschungsgemeinschaft.; EJB was supported by NIH/NHLBI contract N01-HC-25195 and NIH grants 1RC1HL101056, HL102214, and AG028321. EJB and PTE were supported by NIH grant 2R01HL092577. PTE was supported by Fondation Leducq (14CVD01) and NIH grants 1R01HL092577, 1RC1HL101056, 1R01HL102214, 1R01AG028321, R01HL104156, and 1K24HL105780 and received the American Heart Association Established Investigator Award 13EIA14220013. RSV was supported by NIH grants HL080124, HL077477, HL71039, and HL093328. PAW, SS, and ASB were supported by NIH grant 6RO1-NS-17950. RBS was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program SCHN 1149/3-2. CNC was supported by the NIH grant HL080025 and received the Doris Duke Charitable Foundation Clinical Scientist Development Award and the Burroughs Wellcome Fund Career Award for Medical Scientists. SAL was supported by the NIH/NHLBI grant 1K23HL114724. DDM received additional partial salary support by NIH grants 1U01HL105268-01 and KL2RR031981.	Abbott RD, 1987, FRAMINGHAM STUDY EPI; Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Friberg L, 2007, EUR HEART J, V28, P2346, DOI 10.1093/eurheartj/ehm308; Frost L, 2005, INT J CARDIOL, V103, P78, DOI 10.1016/j.ijcard.2004.08.024; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; Koton S, 2014, JAMA-J AM MED ASSOC; Krijthe BP, 2013, EUR HEART J, V34, P2746, DOI 10.1093/eurheartj/eht280; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Miyasaka Y, 1980, SECULAR TRENDS INCID; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Okin PM, 2006, JAMA-J AM MED ASSOC, V296, P1242, DOI 10.1001/jama.296.10.1242; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Rowan SB, 2007, J AM COLL CARDIOL, V49, P1561, DOI 10.1016/j.jacc.2006.11.045; Stefansdottir H, 2011, EUROPACE, V13, P1110, DOI 10.1093/europace/eur132; Wattigney WA, 2002, AM J EPIDEMIOL, V155, P819, DOI 10.1093/aje/155.9.819	30	755	796	14	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 11	2015	386	9989					154	162		10.1016/S0140-6736(14)61774-8	http://dx.doi.org/10.1016/S0140-6736(14)61774-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM5QC	25960110	Green Accepted			2022-12-24	WOS:000357742200032
J	Berkovits, BD; Mayr, C				Berkovits, Binyamin D.; Mayr, Christine			Alternative 3 ' UTRs act as scaffolds to regulate membrane protein localization	NATURE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; IN-VIVO; GTP-BINDING; SET PROTEIN; CELL; HUR; CD47; SITES; IMMUNOPRECIPITATION	About half of human genes use alternative cleavage and polyadenylation (ApA) to generate messenger RNA transcripts that differ in the length of their 3' untranslated regions (3' UTRs) while producing the same protein(1-3). Here we show in human cell lines that alternative 3' UTRs differentially regulate the localization of membrane proteins. The long 3' UTR of CD47 enables efficient cell surface expression of CD47 protein, whereas the short 3' UTR primarily localizes CD47 protein to the endoplasmic reticulum. CD47 protein localization occurs post-translationally and independently of RNA localization. In our model of 3' UTR-dependent protein localization, the long 3' UTR of CD47 acts as a scaffold to recruit a protein complex containing the RNA-binding protein HuR (also known as ELAVL1) and SET4 to the site of translation. This facilitates interaction of SET with the newly translated cytoplasmic domains of CD47 and results in subsequent translocation of CD47 to the plasma membrane via activated RAC1 (ref. 5). We also show that CD47 protein has different functions depending on whether it was generated by the short or long 3' UTR isoforms. Thus, ApA contributes to the functional diversity of the proteome without changing the amino acid sequence. 3' UTR-dependent protein localization has the potential to be a widespread trafficking mechanism for membrane proteins because HuR binds to thousands of mRNAs(6-9), and we show that the long 3' UTRs of CD44, ITGA1 and TNFRSF13C, which are bound by HuR, increase surface protein expression compared to their corresponding short 3' UTRs. We propose that during translation the scaffold function of 3' UTRs facilitates binding of proteins to nascent proteins to direct their transport or function-and this role of 3' UTRs can be regulated by ApA.	[Berkovits, Binyamin D.; Mayr, Christine] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Mayr, C (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10065 USA.	mayrc@mskcc.org			Damon Runyon-Rachleff Cancer Foundation; Island Outreach Foundation [DRR-24-13]; National Institutes of Health [U01-CA164190];  [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, U01CA164190] Funding Source: NIH RePORTER	Damon Runyon-Rachleff Cancer Foundation; Island Outreach Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Innovator Award of the Damon Runyon-Rachleff Cancer Foundation and the Island Outreach Foundation (DRR-24-13) and National Institutes of Health grant U01-CA164190. We thank N. Patel for help with cloning of the constructs and the members of the Mayr laboratory, specifically S.-H. Lee and E. Kallin, as well as N. Rajewsky and A. Ventura, for helpful discussions. We also thank J. Joyce, C. Haynes, A. Hall and R. Benezra for critical reading of the manuscript. The N17RAC1 construct was provided by A. Hall and the JinB8 cells by W.A. Frazier and D. D. Roberts. We thank the Molecular Cytology Core Facility (Memorial Sloan Kettering Cancer Center) for help with the confocal microscopy (funded by P30 CA008748).	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Avet C, 2013, J BIOL CHEM, V288, P2641, DOI 10.1074/jbc.M112.388876; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Frazier W. A., 2010, UCSD NATURE MOL PAGE; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isenberg JS, 2008, AM J PATHOL, V173, P1100, DOI 10.2353/ajpath.2008.080237; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Lamy L, 2003, J BIOL CHEM, V278, P23915, DOI 10.1074/jbc.M301869200; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; REINHOLD MI, 1995, J CELL SCI, V108, P3419; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710; Soto-Pantoja D., 2011, J GENET SYNDR GENE T, V2, DOI 10.4172/2157-7412.1000105; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	40	255	266	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					363	+		10.1038/nature14321	http://dx.doi.org/10.1038/nature14321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	25896326	Green Accepted			2022-12-24	WOS:000356425400058
J	Sarpatwari, A; Avorn, J; Kesselheim, AS				Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.			Progress and Hurdles for Follow-on Biologics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sarpatwari, Ameet] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				*FOOD DRUG ADM, 2010, GEN COMP DRUG PRIC; Gleason PP, 2009, J MANAGE CARE PHARM, V15, P648, DOI 10.18553/jmcp.2009.15.8.648; Hunt D, 2014, NEW ENGL J MED, V370, P1270, DOI 10.1056/NEJMc1316118; IMS Institute for Healthcare Informatics, 2014, ASS BIOS UPT COMP EU	4	39	42	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2380	2382		10.1056/NEJMp1504672	http://dx.doi.org/10.1056/NEJMp1504672			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK6RF	25946143				2022-12-24	WOS:000356354600003
J	Lupianez, DG; Kraft, K; Heinrich, V; Krawitz, P; Brancati, F; Klopocki, E; Hom, D; Kayserili, H; Opitz, JM; Laxova, R; Santos-Simarro, F; Gilbert-Dussardier, B; Wittler, L; Borschiwer, M; Haas, SA; Osterwalder, M; Franke, M; Timmermann, B; Hecht, J; Spielmann, M; Visel, A; Mundlos, S				Lupianez, Dario G.; Kraft, Katerina; Heinrich, Verena; Krawitz, Peter; Brancati, Francesco; Klopocki, Eva; Hom, Denise; Kayserili, Hulya; Opitz, John M.; Laxova, Renata; Santos-Simarro, Fernando; Gilbert-Dussardier, Brigitte; Wittler, Lars; Borschiwer, Marina; Haas, Stefan A.; Osterwalder, Marco; Franke, Martin; Timmermann, Bernd; Hecht, Jochen; Spielmann, Malte; Visel, Axel; Mundlos, Stefan			Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions	CELL			English	Article							HUMAN GENOME; REGULATORY LANDSCAPE; SPECIFICITY; EXPRESSION; PRINCIPLES; VARIANTS; CIS; MAP	Mammalian genomes are organized into megabase-scale topologically associated domains (TADs). We demonstrate that disruption of TADs can rewire long-range regulatory architecture and result in pathogenic phenotypes. We show that distinct human limb malformations are caused by deletions, inversions, or duplications altering the structure of the TAD-spanning WNT6/IHH/EPHA4/PAX3 locus. Using CRISPR/Cas genome editing, we generated mice with corresponding rearrangements. Both in mouse limb tissue and patient-derived fibroblasts, disease-relevant structural changes cause ectopic interactions between promoters and non-coding DNA, and a cluster of limb enhancers normally associated with Epha4 is misplaced relative to TAD boundaries and drives ectopic limb expression of another gene in the locus. This rewiring occurred only if the variant disrupted a CTCF-associated boundary domain. Our results demonstrate the functional importance of TADs for orchestrating gene expression via genome architecture and indicate criteria for predicting the pathogenicity of human structural variants, particularly in non-coding regions of the human genome.	[Lupianez, Dario G.; Kraft, Katerina; Krawitz, Peter; Borschiwer, Marina; Franke, Martin; Hecht, Jochen; Spielmann, Malte; Mundlos, Stefan] Max Planck Inst Mol Genet, RG Dev & Dis, D-14195 Berlin, Germany; [Lupianez, Dario G.; Kraft, Katerina; Heinrich, Verena; Krawitz, Peter; Hom, Denise; Franke, Martin; Spielmann, Malte; Mundlos, Stefan] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Brancati, Francesco] Policlin Tor Vergata Univ Hosp, Med Genet Unit, I-00133 Rome, Italy; [Klopocki, Eva] Univ Wurzburg, Inst Human Genet, Biozentrum, D-97070 Wurzburg, Germany; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Istanbul, Turkey; [Opitz, John M.; Laxova, Renata] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84108 USA; [Santos-Simarro, Fernando] Hosp Univ La Paz, IdiPAZ, Inst Genet Med Mol INGEMM, Madrid 28046, Spain; [Santos-Simarro, Fernando] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades, U753, Madrid 28046, Spain; [Gilbert-Dussardier, Brigitte] CHU Poitiers, F-86021 Poitiers, France; [Wittler, Lars] Max Planck Inst Mol Genet, Dept Dev Genet, D-14195 Berlin, Germany; [Haas, Stefan A.] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Osterwalder, Marco; Visel, Axel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, MS 84 171, Berkeley, CA 94720 USA; [Timmermann, Bernd] Max Planck Inst Mol Genet, Sequencing Core Facil, D-14195 Berlin, Germany; [Hecht, Jochen; Spielmann, Malte; Mundlos, Stefan] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Visel, Axel] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rome Tor Vergata; Policlin Tor Vergata; University of Wurzburg; Istanbul University; Utah System of Higher Education; University of Utah; Hospital Universitario La Paz; Instituto de Salud Carlos III; CHU Poitiers; Universite de Poitiers; Max Planck Society; Max Planck Society; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced	Mundlos, S (corresponding author), Max Planck Inst Mol Genet, RG Dev & Dis, D-14195 Berlin, Germany.	mundlos@molgen.mpg.de	Brancati, Francesco/AAC-3778-2022; Krawitz, Peter M/F-3142-2012; Spielmann, Malte/H-2230-2018; Kayserili, Hülya/AAA-5593-2021; Visel, Axel/A-9398-2009; Klopocki, Eva/B-6823-2017; Mundlos, Stefan/ABH-9585-2020; Franke, Martin/AAX-6027-2021; Lupiáñez, Darío G./AAH-3405-2019; Osterwalder, Marco/AAU-4478-2021; Franke, Martin/O-8986-2017; Kayserili, Hülya/M-3791-2015; Santos-Simarro, Fernando/L-3063-2014; Osterwalder, Marco/T-1817-2018	Brancati, Francesco/0000-0003-3624-2354; Krawitz, Peter M/0000-0002-3194-8625; Spielmann, Malte/0000-0002-0583-4683; Kayserili, Hülya/0000-0003-0376-499X; Visel, Axel/0000-0002-4130-7784; Klopocki, Eva/0000-0003-1438-2081; Franke, Martin/0000-0002-4626-3290; Lupiáñez, Darío G./0000-0002-3165-036X; Franke, Martin/0000-0002-4626-3290; Kraft, Katerina/0000-0002-2011-6946; Kulik, Marina/0000-0003-4885-4059; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Haas, Stefan/0000-0003-3418-3688; Santos-Simarro, Fernando/0000-0002-1201-9118; Mundlos, Stefan/0000-0002-9788-3166; Osterwalder, Marco/0000-0002-1969-2313	Fundacion Alfonso Martin Escudero; Deutsche Forschungsgemeinschaft; Berlin Institute for Health; Max Planck Foundation; Swiss National Science Foundation (SNSF) fellowship; NIH [R01HG003988, U54HG006997, U01DE024427]; Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988, U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE024427] Funding Source: NIH RePORTER	Fundacion Alfonso Martin Escudero; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berlin Institute for Health; Max Planck Foundation(Foundation CELLEX); Swiss National Science Foundation (SNSF) fellowship(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	D.G.L. is supported by the Fundacion Alfonso Martin Escudero. This research was supported by grants from the Deutsche Forschungsgemeinschaft, from the Berlin Institute for Health, and the Max Planck Foundation to S.M. M.O. was supported by a Swiss National Science Foundation (SNSF) fellowship. A.V. was supported by NIH grants R01HG003988, U54HG006997, and U01DE024427. Research conducted at the E.O. Lawrence Berkeley National Laboratory was performed under Department of Energy Contract DE-AC02-05CH11231, University of California. We thank Daniel Ibrahim and Guillaume Andrey for comments on the manuscript. We also thank Nicole Rosener, Asita Stiege, Karol Macura, Nadine Lehmann, Anne Hess, and Christin Franke for technical support.	Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Babbs C, 2008, MECH DEVELOP, V125, P517, DOI 10.1016/j.mod.2008.01.001; CAMERA G, 1995, AM J MED GENET, V57, P472, DOI 10.1002/ajmg.1320570322; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Geetha-Loganathan P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-32; GOULDING M, 1994, DEVELOPMENT, V120, P957; GROSSE F R, 1969, Birth Defects Original Article Series, V5, P48; Haraksingh RR, 2013, J MOL BIOL, V425, P3970, DOI 10.1016/j.jmb.2013.07.015; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Montavon T, 2012, P NATL ACAD SCI USA, V109, P20204, DOI 10.1073/pnas.1217659109; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Spielmann M, 2013, BIOESSAYS, V35, P533, DOI 10.1002/bies.201200178; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Thiele H, 2004, J MED GENET, V41, P213, DOI 10.1136/jmg.2003.014894; Tsujimura T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004897; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yuksel-Apak M, 2012, EUR J HUM GENET, V20, P639, DOI 10.1038/ejhg.2011.250; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994	34	922	942	5	137	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1012	1025		10.1016/j.cell.2015.04.004	http://dx.doi.org/10.1016/j.cell.2015.04.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25959774	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-24	WOS:000355152600010
J	Raine, NE; Gill, RJ				Raine, Nigel E.; Gill, Richard J.			ECOLOGY Tasteless pesticides affect bees in the field	NATURE			English	Editorial Material							SEED-TREATED CANOLA; EXPOSURE; POLLINATORS; NEONICOTINOIDS; IMPACT		[Raine, Nigel E.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Gill, Richard J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	University of Guelph; Imperial College London	Raine, NE (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	nraine@uoguelph.ca; r.gill@imperial.ac.uk	Raine, Nigel/AAK-6425-2020	Raine, Nigel/0000-0001-6343-2829; Gill, Richard/0000-0001-9389-1284	BBSRC [BB/I000178/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000178/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, ECOTOXICOLOGY, V23, P1755, DOI 10.1007/s10646-014-1340-5; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; FERA (The Food and Environment Research Agency), 2013, EFF NEON SEED TREATM; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goulson D, 2015, PEERJ, V3, DOI 10.7717/peerj.854; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Nieto A, 2014, EUROPEAN RED LIST BE; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	20	28	31	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					38	40		10.1038/nature14391	http://dx.doi.org/10.1038/nature14391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25901679				2022-12-24	WOS:000354040900025
J	Steinert, EM; Schenkel, JM; Fraser, KA; Beura, LK; Manlove, LS; Igyarto, BZ; Southern, PJ; Masopust, D				Steinert, Elizabeth M.; Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Manlove, Luke S.; Igyarto, Botond Z.; Southern, Peter J.; Masopust, David			Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance	CELL			English	Article							RESIDENT MEMORY; NONLYMPHOID TISSUE; VIRUS-INFECTION; CUTTING EDGE; LYMPHOCYTES; MIGRATION; DIFFERENTIATION; MICE; GUT; IMMUNITY	Memory CD8 T cells protect against intracellular pathogens by scanning host cell surfaces; thus, infection detection rates depend on memory cell number and distribution. Population analyses rely on cell isolation from whole organs, and interpretation is predicated on presumptions of near complete cell recovery. Paradigmatically, memory is parsed into central, effector, and resident subsets, ostensibly defined by immunosurveillance patterns but in practice identified by phenotypic markers. Because isolation methods ultimately inform models of memory T cell differentiation, protection, and vaccine translation, we tested their validity via parabiosis and quantitative immunofluorescence microscopy of a mouse memory CD8 T cell population. We report three major findings: lymphocyte isolation fails to recover most cells and biases against certain subsets, residents greatly outnumber recirculating cells within non-lymphoid tissues, and memory subset homing to inflammation does not conform to previously hypothesized migration patterns. These results indicate that most host cells are surveyed for reinfection by segregated residents rather than by recirculating cells that migrate throughout the blood and body.	[Steinert, Elizabeth M.; Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Southern, Peter J.; Masopust, David] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Steinert, Elizabeth M.; Schenkel, Jason M.; Fraser, Kathryn A.; Beura, Lalit K.; Manlove, Luke S.; Igyarto, Botond Z.; Masopust, David] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Manlove, Luke S.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Igyarto, Botond Z.] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	masopust, david/B-5027-2008; Beura, Lalit/W-6281-2019; Schenkel, Jason/AAV-8184-2020	Schenkel, Jason/0000-0003-4641-6872; Igyarto, Botond/0000-0002-9770-800X; Steinert, Elizabeth/0000-0002-6947-2271	NIH [R01-AI084913, R01-AI111671, T32-AI083196, F30-DK100159-02, F31-CA183226]; NATIONAL CANCER INSTITUTE [F31CA183226, P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084913, R01AI111671, T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK100159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (R01-AI084913 and R01-AI111671 to D.M., T32-AI083196 to E.M.S., F30-DK100159-02 to J.M.S., and F31-CA183226 to L.S.M.).	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P405, DOI 10.1085/jgp.89.3.405; Doctor RB, 2010, NEPHROL DIAL TRANSPL, V25, P3496, DOI 10.1093/ndt/gfq195; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Horbul JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022638; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; NUTTER RL, 1980, ANAT REC, V197, P363, DOI 10.1002/ar.1091970310; Peaudecerf L, 2011, IMMUNOL LETT, V140, P1, DOI 10.1016/j.imlet.2011.05.009; Pires MD, 2001, ANAL QUANT CYTOL, V23, P427; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; SELBY WS, 1984, GUT, V25, P32, DOI 10.1136/gut.25.1.32; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Suvas PK, 2007, J IMMUNOL, V179, P8122, DOI 10.4049/jimmunol.179.12.8122; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180	44	433	439	2	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 7	2015	161	4					737	749		10.1016/j.cell.2015.03.031	http://dx.doi.org/10.1016/j.cell.2015.03.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH6VT	25957682	Green Accepted, Bronze			2022-12-24	WOS:000354175200009
J	Gerdts, J; Brace, EJ; Sasaki, Y; DiAntonio, A; Milbrandt, J				Gerdts, Josiah; Brace, E. J.; Sasaki, Yo; DiAntonio, Aaron; Milbrandt, Jeffrey			SARM1 activation triggers axon degeneration locally via NAD(+) destruction	SCIENCE			English	Article							CELL-DEATH; WALLERIAN DEGENERATION; PROTEIN; BIOSYNTHESIS; MITOCHONDRIA; PROTECTION; REQUIRES; NEURONS; PATHWAY; DISEASE	Axon degeneration is an intrinsic self-destruction program that underlies axon loss during injury and disease. Sterile alpha and TIR motif-containing 1 (SARM1) protein is an essential mediator of axon degeneration. We report that SARM1 initiates a local destruction program involving rapid breakdown of nicotinamide adenine dinucleotide (NAD(+)) after injury. We used an engineered protease-sensitized SARM1 to demonstrate that SARM1 activity is required after axon injury to induce axon degeneration. Dimerization of the Toll-interleukin receptor (TIR) domain of SARM1 alone was sufficient to induce locally mediated axon degeneration. Formation of the SARM1 TIR dimer triggered rapid breakdown of NAD(+), whereas SARM1-induced axon destruction could be counteracted by increased NAD(+) synthesis. SARM1-induced depletion of NAD(+) may explain the potent axon protection in Wallerian degeneration slow (Wld(s)) mutant mice.	[Gerdts, Josiah; Sasaki, Yo; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Brace, E. J.; DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [DiAntonio, Aaron; Milbrandt, Jeffrey] Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	National Institutes of Health [RO1DA020812, RO1AG013730, RO1NS065053, RO1NS087632, RO1NS078007, F31NS074517]; Vertex Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078007, F31NS074517, R01NS065053, R01NS087632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vertex Pharmaceuticals(Vertex Pharmaceuticals); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by National Institutes of Health grants RO1DA020812 (A.D.), RO1AG013730 (J.M.), RO1NS065053, RO1NS087632, and RO1NS078007 (J.M. and A.D.), and F31NS074517 (J.G.); and a grant from Vertex Pharmaceuticals. We thank ChromaDex (Irvine, California) for providing nicotinamide riboside; A. Strickland, T. Farhner, and N. Panchenko for technical assistance; and members of the Milbrandt and DiAntonio labs for fruitful discussions.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; ELIA MC, 1991, ANAL BIOCHEM, V192, P329, DOI 10.1016/0003-2697(91)90544-4; Fegan A, 2010, CHEM REV, V110, P3315, DOI 10.1021/cr8002888; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Panneerselvam P, 2013, CELL DEATH DIFFER, V20, P478, DOI 10.1038/cdd.2012.144; Sasaki Y, 2010, J BIOL CHEM, V285, P41211, DOI 10.1074/jbc.C110.193904; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967	23	303	310	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					453	457		10.1126/science.1258366	http://dx.doi.org/10.1126/science.1258366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908823	Green Accepted			2022-12-24	WOS:000353338000039
J	Lee, DC; Sohn, HA; Park, ZY; Oh, SH; Kang, YK; Lee, KM; Kang, MH; Jang, YJ; Yang, SJ; Hong, YK; Noh, H; Kim, JA; Kim, DJ; Bae, KH; Kim, DM; Chung, SJ; Yoo, HS; Yu, DY; Park, KC; Yeom, YI				Lee, Dong Chul; Sohn, Hyun Ahm; Park, Zee-Yong; Oh, Sangho; Kang, Yun Kyung; Lee, Kyoung-min; Kang, Minho; Jang, Ye Jin; Yang, Suk-Jin; Hong, Young Ki; Noh, Hanmi; Kim, Jung-Ae; Kim, Dong Joon; Bae, Kwang-Hee; Kim, Dong Min; Chung, Sang J.; Yoo, Hyang Sook; Yu, Dae-Yeul; Park, Kyung Chan; Yeom, Young Il			A Lactate-Induced Response to Hypoxia	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; CANCER; HIF-1; HIF-1-ALPHA; INHIBITION; EXPRESSION; PATHWAYS; THERAPY; FAMILY	Organisms must be able to respond to low oxygen in a number of homeostatic and pathological contexts. Regulation of hypoxic responses via the hypoxia-inducible factor (HIF) is well established, but evidence indicates that other, HIF-independent mechanisms are also involved. Here, we report a hypoxic response that depends on the accumulation of lactate, a metabolite whose production increases in hypoxic conditions. We find that the NDRG3 protein is degraded in a PHD2/VHL-dependent manner in normoxia but is protected from destruction by binding to lactate that accumulates under hypoxia. The stabilized NDRG3 protein binds c-Raf to mediate hypoxia-induced activation of Raf-ERK pathway, promoting angiogenesis and cell growth. Inhibiting cellular lactate production abolishes the NDRG3-mediated hypoxia responses. Our study, therefore, elucidates the molecular basis for lactate-induced hypoxia signaling, which can be exploited for the development of therapies targeting hypoxia-induced diseases.	[Lee, Dong Chul; Sohn, Hyun Ahm; Kang, Minho; Jang, Ye Jin; Yang, Suk-Jin; Hong, Young Ki; Noh, Hanmi; Kim, Jung-Ae; Kim, Dong Joon; Kim, Dong Min; Chung, Sang J.; Yoo, Hyang Sook; Yu, Dae-Yeul; Park, Kyung Chan; Yeom, Young Il] Korea Res Inst Biosci & Biotechnol KRIBB, Med Genom Res Ctr, Taejon 305806, South Korea; [Yeom, Young Il] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang Branch Inst, Taejon 305806, South Korea; [Oh, Sangho] Korea Res Inst Biosci & Biotechnol KRIBB, Korean Bioinformat Ctr, Taejon 305806, South Korea; [Bae, Kwang-Hee] Korea Res Inst Biosci & Biotechnol KRIBB, Res Ctr Integrat Cellul, Taejon 305806, South Korea; [Park, Zee-Yong; Lee, Kyoung-min] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Kang, Yun Kyung] Inje Univ, Seoul Paik Hosp, Dept Pathol, Seoul 100032, South Korea; [Noh, Hanmi; Kim, Jung-Ae; Bae, Kwang-Hee; Yeom, Young Il] Korea Univ Sci & Technol, Dept Funct Genom, Taejon 305350, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Gwangju Institute of Science & Technology (GIST); Inje University	Park, KC (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Med Genom Res Ctr, Taejon 305806, South Korea.	kpark@kribb.re.kr; yeomyi@kribb.re.kr	Kim, Dong Joon/AAL-8967-2020	Bae, Kwang-Hee/0000-0002-5868-2556	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2010-0030020, NRF-2011-0028171, NRF-2013M3A9B5076422, NRF-2006-2006799]; KRIBB Research Initiative Program	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; KRIBB Research Initiative Program	We thank Chul-Ho Lee (KRIBB) and MoonKyung Kang (Inje University) for the helps with animal studies and viral particles preparation, respectively. This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2010-0030020, NRF-2011-0028171, NRF-2013M3A9B5076422, NRF-2006-2006799) and by KRIBB Research Initiative Program.	Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cassavaugh J, 2011, J CELL BIOCHEM, V112, P735, DOI 10.1002/jcb.22956; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hopfl G, 2002, CANCER RES, V62, P2962; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Maher ER, 2011, EUR J HUM GENET, V19, P617, DOI 10.1038/ejhg.2010.175; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Mizukami Y, 2004, CANCER RES, V64, P1765, DOI 10.1158/0008-5472.CAN-03-3017; Mizukami Y, 2007, CLIN CANCER RES, V13, P5670, DOI 10.1158/1078-0432.CCR-07-0111; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Rapisarda A, 2009, CELL CYCLE, V8, P4040, DOI 10.4161/cc.8.24.10145; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SETA KA, 2002, SCI STKE, pRE11	22	247	258	10	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					595	609		10.1016/j.cell.2015.03.011	http://dx.doi.org/10.1016/j.cell.2015.03.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25892225	Bronze			2022-12-24	WOS:000353553600018
J	Bailey, DB; Gehtland, L				Bailey, Donald B., Jr.; Gehtland, Lisa			Newborn Screening Evolving Challenges in an Era of Rapid Discovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Bailey, Donald B., Jr.; Gehtland, Lisa] RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Bailey, DB (corresponding author), RTI Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	dbailey@rti.org		Bailey, Donald/0000-0002-0513-9330	NCATS NIH HHS [1UL1TR001111, UL1 TR002489, UL1 TR001111] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Duffner PK, 2009, PEDIATR NEUROL, V40, P245, DOI 10.1016/j.pediatrneurol.2008.11.010; Goldenberg AJ, 2012, JAMA-J AM MED ASSOC, V307, P461, DOI 10.1001/jama.2012.68; Grosse SD, 2006, PEDIATRICS, V117, P923, DOI 10.1542/peds.2005-0553; Kemper AR, 2014, GENET MED, V16, P183, DOI 10.1038/gim.2013.98; *PRES COUNC BIOETH, CHANG MOR FOC NEWB S; Ross LF, 2010, KENNEDY INST ETHIC J, V20, P299; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad	7	26	26	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1511	1512		10.1001/jama.2014.17488	http://dx.doi.org/10.1001/jama.2014.17488			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898043	Green Accepted			2022-12-24	WOS:000353198700010
J	Arslan, S; Khafizov, R; Thomas, CD; Chemla, YR; Ha, T				Arslan, Sinan; Khafizov, Rustem; Thomas, Christopher D.; Chemla, Yann R.; Ha, Taekjip			Engineering of a superhelicase through conformational control	SCIENCE			English	Article							ESCHERICHIA-COLI UVRD; INITIATOR PROTEIN REPD; SINGLE-STRANDED-DNA; HELICASE IN-VITRO; PCRA HELICASE; CRYSTAL-STRUCTURES; PROCESSIVITY; COMPLEXES; MECHANISM; MONOMER	Conformational control of biomolecular activities can reveal functional insights and enable the engineering of novel activities. Here we show that conformational control through intramolecular cross-linking of a helicase monomer with undetectable unwinding activity converts it into a superhelicase that can unwind thousands of base pairs processively, even against a large opposing force. A natural partner that enhances the helicase activity is shown to achieve its stimulating role also by selectively stabilizing the active conformation. Our work provides insight into the regulation of nucleic acid unwinding activity and introduces a monomeric superhelicase without nuclease activities, which may be useful for biotechnological applications.	[Arslan, Sinan; Khafizov, Rustem; Chemla, Yann R.; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Arslan, Sinan; Khafizov, Rustem; Chemla, Yann R.; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Thomas, Christopher D.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Leeds; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@illinois.edu	Thomas, Christopher D./E-1236-2015; Ha, Taekjip/B-9506-2009	Thomas, Christopher D./0000-0003-0316-6391; Ha, Taekjip/0000-0003-2195-6258; Chemla, Yann/0000-0001-9167-0234	NIH [GM065367]; NSF (Physics Frontier Center) [0822613, MCB 09-52442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; Division Of Physics [1430124] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0952442] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF (Physics Frontier Center)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Park and M. Schlierf for experimental help and R. Zhou, H. Balci, K. Lee, J. Yodh, T. Ngo, B. Leslie, M. Comstock, P. Jena, and A. Jain for helpful discussions. This work was supported by the NIH (grant GM065367) and the NSF (Physics Frontier Center grant PHY 0822613 and CAREER award MCB 09-52442 to Y. R. C.). T. H. and S. A. have filed a patent application (62/079,183) that relates to superhelicases.	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Choi B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.078102; Comstock MJ, 2015, SCIENCE, V348, P352, DOI 10.1126/science.aaa0130; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee G, 2012, SCIENCE, V336, P1726, DOI 10.1126/science.1216848; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Machon C, 2010, NUCLEIC ACIDS RES, V38, P1874, DOI 10.1093/nar/gkp1153; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; Zhang WK, 2007, J MOL BIOL, V371, P336, DOI 10.1016/j.jmb.2007.05.050	27	65	72	5	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2015	348	6232					344	347		10.1126/science.aaa0445	http://dx.doi.org/10.1126/science.aaa0445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0YC	25883358	Green Accepted			2022-12-24	WOS:000352999000047
J	Benanti, EL; Nguyen, CM; Welch, MD				Benanti, Erin L.; Nguyen, Catherine M.; Welch, Matthew D.			Virulent Burkholderia Species Mimic Host Actin Polymerases to Drive Actin-Based Motility	CELL			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; TRIMERIC AUTOTRANSPORTER ADHESINS; BARBED-END ASSOCIATION; III SECRETION SYSTEM; FILAMENT NUCLEATION; ENA/VASP PROTEINS; ARP2/3 COMPLEX; VI SECRETION; MOLECULAR-MECHANISM; CAPPING PROTEIN	Burkholderia pseudomallei and B. mallei are bacterial pathogens that cause melioidosis and glanders, whereas their close relative B. thailandensis is nonpathogenic. All use the trimeric autotransporter BimA to facilitate actin-based motility, host cell fusion, and dissemination. Here, we show that BimA orthologs mimic different host actin-polymerizing proteins. B. thailandensis BimA activates the host Arp2/3 complex. In contrast, B. pseudomallei and B. mallei BimA mimic host Ena/VASP actin polymerases in their ability to nucleate, elongate, and bundle filaments by associating with barbed ends, as well as in their use of WH2 motifs and oligomerization for activity. Mechanistic differences among BimA orthologs resulted in distinct actin filament organization and motility parameters, which affected the efficiency of cell fusion during infection. Our results identify bacterial Ena/VASP mimics and reveal that pathogens imitate the full spectrum of host actin-polymerizing pathways, suggesting that mimicry of different polymerization mechanisms influences key parameters of infection.	[Benanti, Erin L.; Nguyen, Catherine M.; Welch, Matthew D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Benanti, EL (corresponding author), Aduro Biotech, 626 Bancroft Way 3C, Berkeley, CA 94710 USA.	ebenanti@aduro.com; welch@berkeley.edu			NIH/NIGMS NRSA [F32 GM093652]; NIH/NIGMS [R01 GM059609]; NIH/NIAID [R01 AI109044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109044, R21AI109270, R21AI119743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609, F32GM093652] Funding Source: NIH RePORTER	NIH/NIGMS NRSA; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Peggy Cotter, Jeffrey Iwig, and Rebecca Lamason for comments on the manuscript and Tiago Barros for expertise in model design. We are grateful to Melissa Anderson, Erin Garcia, Peggy Cotter, Todd French, and Jeff F. Miller for reagents and technical advice and to Taro Ohkawa for imaging assistance. E.L.B. was supported by NIH/NIGMS NRSA F32 GM093652. M.D.W. is supported by NIH/NIGMS R01 GM059609 and NIH/NIAID R01 AI109044.	Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Hartmann MD, 2012, P NATL ACAD SCI USA, V109, P20907, DOI 10.1073/pnas.1211872110; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; MACK D, 1994, MED MICROBIOL IMMUN, V183, P217; Madasu Y, 2013, P NATL ACAD SCI USA, V110, pE2677, DOI 10.1073/pnas.1307235110; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pernier J, 2013, NAT STRUCT MOL BIOL, V20, P1069, DOI 10.1038/nsmb.2639; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Reed SCO, 2014, CURR BIOL, V24, P98, DOI 10.1016/j.cub.2013.11.025; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Schwarz S, 2014, INFECT IMMUN, V82, P1445, DOI 10.1128/IAI.01368-13; Sitthidet C, 2011, J BACTERIOL, V193, P1901, DOI 10.1128/JB.01455-10; Sitthidet C, 2010, J BACTERIOL, V192, P5249, DOI 10.1128/JB.00608-10; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Toesca IJ, 2014, INFECT IMMUN, V82, P1436, DOI 10.1128/IAI.01367-13; Truong D, 2014, BIOESSAYS, V36, P687, DOI 10.1002/bies.201400038; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; West T Eoin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS119, DOI 10.1016/S0035-9203(08)70028-2; WILKINSON L, 1981, MED HIST, V25, P363, DOI 10.1017/S0025727300034876; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110	55	71	73	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					348	360		10.1016/j.cell.2015.02.044	http://dx.doi.org/10.1016/j.cell.2015.02.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25860613	Green Accepted, Bronze			2022-12-24	WOS:000352708300026
J	Schulkey, CE; Regmi, SD; Magnan, RA; Danzo, MT; Luther, H; Hutchinson, AK; Panzer, AA; Grady, MM; Wilson, DB; Jay, PY				Schulkey, Claire E.; Regmi, Suk D.; Magnan, Rachel A.; Danzo, Megan T.; Luther, Herman; Hutchinson, Alayna K.; Panzer, Adam A.; Grady, Mary M.; Wilson, David B.; Jay, Patrick Y.			The maternal-age-associated risk of congenital heart disease is modifiable	NATURE			English	Article							CHROMOSOME SUBSTITUTION STRAINS; CARDIOVASCULAR DEFECTS; BIRTH-DEFECTS; MALFORMATIONS; MICE; EPIDEMIOLOGY; POPULATION; METABOLOME; MUTATIONS; COUNCIL	Maternal age is a risk factor for congenital heart disease even in the absence of any chromosomal abnormality in the newborn(1-7). Whether the basis of this risk resides with the mother or oocyte is unknown. The impact of maternal age on congenital heart disease can be modelled in mouse pups that harbour a mutation of the cardiac transcription factor gene Nkx2-5 (ref. 8). Here, reciprocal ovarian transplants between young and old mothers establish a maternal basis for the age-associated risk in mice. A high-fat diet does not accelerate the effect of maternal ageing, so hyperglycaemia and obesity do not simply explain the mechanism. The age-associated risk varies with the mother's strain background, making it a quantitative genetic trait. Most remarkably, voluntary exercise, whether begun by mothers at a young age or later in life, can mitigate the risk when they are older. Thus, even when the offspring carry a causal mutation, an intervention aimed at the mother can meaningfully reduce their risk of congenital heart disease.	[Schulkey, Claire E.; Regmi, Suk D.; Magnan, Rachel A.; Danzo, Megan T.; Luther, Herman; Hutchinson, Alayna K.; Panzer, Adam A.; Grady, Mary M.; Wilson, David B.; Jay, Patrick Y.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wilson, David B.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Jay, Patrick Y.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Jay, PY (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	jay_p@kids.wustl.edu	Wilson, David/K-7433-2014	Wilson, David/0000-0002-1826-7745	Ruth L. Kirschstein National Research Service Award from the Developmental Cardiology and Pulmonary Training Program (National Institutes ofHealth (NIH)) [T32HL007873]; Children's Discovery Institute of Washington University; St Louis Children's Hospital, the Children's Heart Foundation; NIH [R01 HL105857, P30 DK52574, P30 DK020579]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105857, T32HL007873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, P30DK020579] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award from the Developmental Cardiology and Pulmonary Training Program (National Institutes ofHealth (NIH)); Children's Discovery Institute of Washington University; St Louis Children's Hospital, the Children's Heart Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	C.E.S. was supported by a Ruth L. Kirschstein National Research Service Award from the Developmental Cardiology and Pulmonary Training Program (National Institutes ofHealth (NIH) T32HL007873). P.Y.J. isan Established Investigator of the American Heart Association and the Lawrence J. & Florence A. DeGeorge Charitable Trust. This work was supported by the Children's Discovery Institute of Washington University and St Louis Children's Hospital, the Children's Heart Foundation, and the NIH (R01 HL105857). The Washington University Digestive Diseases Research Core Center provided histology services and is supported by the NIH (P30 DK52574). MRI studies were performed in the Washington University Diabetes Research Center, which is supported by the NIH (P30 DK020579). We thank J. Magee, J. Rubin, D. Rudnick and A. Schwartz for comments.	Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; BAIRD PA, 1991, LANCET, V337, P527, DOI 10.1016/0140-6736(91)91306-F; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Burrage LC, 2010, MAMM GENOME, V21, P115, DOI 10.1007/s00335-010-9247-9; Bye A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042330; Chorell E, 2012, MOL BIOSYST, V8, P1187, DOI 10.1039/c2mb05428k; Forrester MB, 2004, PAEDIATR PERINAT EP, V18, P415, DOI 10.1111/j.1365-3016.2004.00594.x; Hollier LM, 2000, OBSTET GYNECOL, V96, P701, DOI 10.1016/S0029-7844(00)01019-X; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; KIDD SA, 1993, J PAEDIATR CHILD H, V29, P344, DOI 10.1111/j.1440-1754.1993.tb00531.x; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li M, 2014, GENET EPIDEMIOL, V38, P198, DOI 10.1002/gepi.21793; Loane M, 2009, BJOG-INT J OBSTET GY, V116, P1111, DOI 10.1111/j.1471-0528.2009.02227.x; Lustgarten MS, 2013, EUR J APPL PHYSIOL, V113, P1311, DOI 10.1007/s00421-012-2555-x; Materna-Kiryluk A, 2009, PAEDIATR PERINAT EP, V23, P29, DOI 10.1111/j.1365-3016.2008.00979.x; Miller A, 2011, AM J MED GENET A, V155A, P2137, DOI 10.1002/ajmg.a.34130; Mukherjee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092031; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Pradat P, 2003, PEDIATR CARDIOL, V24, P195, DOI 10.1007/s00246-002-9401-6; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Tanaka M, 1999, DEVELOPMENT, V126, P1269; WALD N, 1991, LANCET, V338, P131; Winston JB, 2012, CIRC-CARDIOVASC GENE, V5, P293, DOI 10.1161/CIRCGENETICS.111.961136; Winston JB, 2010, CIRCULATION, V121, P1313, DOI 10.1161/CIRCULATIONAHA.109.887687	27	57	59	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					230	U225		10.1038/nature14361	http://dx.doi.org/10.1038/nature14361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25830876	Green Accepted			2022-12-24	WOS:000352454600041
J	McGrath, PS; Wells, JM				McGrath, Patrick S.; Wells, James M.			SnapShot: GI Tract Development	CELL			English	Editorial Material								The endoderm germ layer contributes to the respiratory and gastrointestinal (GI) lineages during development, giving rise to an array of specialized epithelial cell types lining organs, including the thyroid, thymus, lungs, liver, biliary system, pancreas, and intestines. This SnapShot timelines and summarizes key stages following gastrulation, including endoderm patterning, organ specification, and organogenesis. A lineage tree of the developing endocrine pancreas is outlined to further illustrate this process.	[McGrath, Patrick S.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	McGrath, PS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.			McGrath, Patrick/0000-0002-1498-371X				Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	4	6	7	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 26	2015	161	1							176.e1	10.1016/j.cell.2015.03.014	http://dx.doi.org/10.1016/j.cell.2015.03.014			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MW	25815994	Bronze			2022-12-24	WOS:000351952200018
J	Traverso, G; Langer, R				Traverso, Giovanni; Langer, Robert			PERSPECTIVE Special delivery for the gut	NATURE			English	Editorial Material									[Traverso, Giovanni] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Traverso, Giovanni] Harvard Univ, Sch Med, Boston, MA USA; [Langer, Robert] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Traverso, G (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	ctraverso@partners.org; rlanger@mit.edu	Traverso, Carlo Giovanni/ABC-9065-2020	Traverso, Carlo Giovanni/0000-0001-7851-4077				CARGILL R, 1988, PHARM RES-DORDR, V5, P533, DOI 10.1023/A:1015981627525; Ereqat S, 2011, LANCET INFECT DIS, V11, P662, DOI 10.1016/S1473-3099(11)70227-4; Fallon SC, 2013, J PEDIATR SURG, V48, P830, DOI 10.1016/j.jpedsurg.2012.07.046; Gordi T, 2008, CLIN THER, V30, P909, DOI 10.1016/j.clinthera.2008.05.008; Kethu SR, 2012, GASTROINTEST ENDOSC, V76, P1, DOI 10.1016/j.gie.2012.02.020; Lam PL, 2014, J CONTROL RELEASE, V178, P25, DOI 10.1016/j.jconrel.2013.12.028; World Health Organisation, 2003, ADHERENCE LONG TERM	7	48	53	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S19	S19		10.1038/519S19a	http://dx.doi.org/10.1038/519S19a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25806494	Bronze			2022-12-24	WOS:000351602800007
J	Gennarino, VA; Singh, RK; White, JJ; De Maio, A; Han, K; Kim, JY; Jafar-Nejad, P; di Ronza, A; Kang, H; Sayegh, LS; Cooper, TA; Orr, HT; Sillitoe, RV; Zoghbi, HY				Gennarino, Vincenzo A.; Singh, Ravi K.; White, Joshua J.; De Maio, Antonia; Han, Kihoon; Kim, Ji-Yoen; Jafar-Nejad, Paymaan; di Ronza, Alberto; Kang, Hyojin; Sayegh, Layal S.; Cooper, Thomas A.; Orr, Harry T.; Sillitoe, Roy V.; Zoghbi, Huda Y.			Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels	CELL			English	Article							FAMILIAL PARKINSONS-DISEASE; RNA-BINDING PROTEINS; SPINOCEREBELLAR ATAXIA; EXPRESSION ANALYSIS; MESSENGER-RNAS; PUF FAMILY; LOCUS DUPLICATION; SCA1; IDENTIFICATION; AGGREGATION	Spinocerebellar ataxia type 1 (SCA1) is a paradigmatic neurodegenerative proteinopathy, in which a mutant protein (in this case, ATAXIN1) accumulates in neurons and exerts toxicity; in SCA1, this process causes progressive deterioration of motor coordination. Seeking to understand how post-translational modification of ATAXIN1 levels influences disease, we discovered that the RNA-binding protein PUMILIO1 (PUM1) not only directly regulates ATAXIN1 but also plays an unexpectedly important role in neuronal function. Loss of Pum1 caused progressive motor dysfunction and SCA1-like neurodegeneration with motor impairment, primarily by increasing Ataxin1 levels. Breeding Pum1(+/-) mice to SCA1 mice (Atxn(1154Q/+)) exacerbated disease progression, whereas breeding them to Atxn1(+/-) mice normalized Ataxin1 levels and largely rescued the Pum1(+/-) phenotype. Thus, both increased wildtype ATAXIN1 levels and PUM1 haploinsufficiency could contribute to human neurodegeneration. These results demonstrate the importance of studying post-transcriptional regulation of disease-driving proteins to reveal factors underlying neurodegenerative disease.	[Gennarino, Vincenzo A.; Han, Kihoon; Kim, Ji-Yoen; Jafar-Nejad, Paymaan; di Ronza, Alberto; Kang, Hyojin; Sayegh, Layal S.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Singh, Ravi K.; White, Joshua J.; Cooper, Thomas A.; Sillitoe, Roy V.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [White, Joshua J.; Sillitoe, Roy V.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [De Maio, Antonia; Cooper, Thomas A.; Sillitoe, Roy V.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Han, Kihoon; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Gennarino, Vincenzo A.; White, Joshua J.; De Maio, Antonia; Han, Kihoon; Kim, Ji-Yoen; Jafar-Nejad, Paymaan; di Ronza, Alberto; Kang, Hyojin; Sayegh, Layal S.; Sillitoe, Roy V.; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu	Gennarino, Vincenzo A./H-3306-2019; White, Joshua/AAU-7461-2020; Han, Kihoon/AAE-8919-2019; White, Joshua/AAP-9445-2021	Gennarino, Vincenzo A./0000-0002-3312-6991; White, Joshua/0000-0002-6218-623X; Han, Kihoon/0000-0002-5925-2152; White, Joshua/0000-0002-6218-623X; Zoghbi, Huda/0000-0002-0700-3349; De Maio, Antonia/0000-0002-5667-5141; Singh, Ravi/0000-0002-2524-6109; Orr, Harry/0000-0001-6118-741X	RNA In Situ Hybridization, Confocal and Mouse Behavioral Cores at the BCM Intellectual and Developmental Disabilities Research Center (IDDRC) [NIH/NICHHDP30-HD024064, 1R01NS089664-01];  [R01NS02769926]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD083092] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R01NS089664, R01NS027600] Funding Source: NIH RePORTER	RNA In Situ Hybridization, Confocal and Mouse Behavioral Cores at the BCM Intellectual and Developmental Disabilities Research Center (IDDRC); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Haifan Lin (Yale Stem Cell Center and Department of Cell Biology, Yale University School of Medicine) for sharing the Pum1 mutant mice; A. McCall for helpful suggestions on analysis; X. Liu for genotyping; C. Spencer for behavioral training; C. Ljungberg for ISH analysis; D. Yu for confocal microscopy training; and members of the H.Y.Z. laboratory for helpful discussions. We also thank A. Ballabio, T. Klisch, S. Yamamoto, M. Rousseaux, M. Sardiello, C. Schaaf, C. Alcott, and V. Brandt for helpful suggestions and critical reading of the manuscript. This research was supported by R01NS02769926 (to H.Y.Z.) and the RNA In Situ Hybridization, Confocal and Mouse Behavioral Cores at the BCM Intellectual and Developmental Disabilities Research Center (IDDRC; NIH/NICHHDP30-HD024064) and 1R01NS089664-01 (to R.V.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Banfi S, 1996, HUM MOL GENET, V5, P33, DOI 10.1093/hmg/5.1.33; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen D, 2012, CURR BIOL, V22, P420, DOI 10.1016/j.cub.2012.01.039; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Gennarino VA, 2011, GENE, V480, P51, DOI 10.1016/j.gene.2011.03.005; Glorian V, 2011, CELL DEATH DIFFER, V18, P1692, DOI 10.1038/cdd.2011.35; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kundu P, 2012, NUCLEIC ACIDS RES, V40, P5088, DOI 10.1093/nar/gks148; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	49	97	100	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1087	1098		10.1016/j.cell.2015.02.012	http://dx.doi.org/10.1016/j.cell.2015.02.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768905	Bronze, Green Accepted			2022-12-24	WOS:000351951800009
J	Presnyak, V; Alhusaini, N; Chen, YH; Martin, S; Morris, N; Kline, N; Olson, S; Weinberg, D; Baker, KE; Graveley, BR; Coller, J				Presnyak, Vladimir; Alhusaini, Najwa; Chen, Ying-Hsin; Martin, Sophie; Morris, Nathan; Kline, Nicholas; Olson, Sara; Weinberg, David; Baker, Kristian E.; Graveley, Brenton R.; Coller, Jeff			Codon Optimality Is a Major Determinant of mRNA Stability	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST; TRANSLATION; PROTEIN; USAGE; DECAY; TRANSCRIPT; DIFFERENTIATION; DEADENYLATION	mRNA degradation represents a critical regulated step in gene expression. Although the major pathways in turnover have been identified, accounting for disparate half-lives has been elusive. We show that codon optimality is one feature that contributes greatly to mRNA stability. Genome-wide RNA decay analysis revealed that stable mRNAs are enriched in codons designated optimal, whereas unstable mRNAs contain predominately non-optimal codons. Substitution of optimal codons with synonymous, non-optimal codons results in dramatic mRNA destabilization, whereas the converse substitution significantly increases stability. Further, we demonstrate that codon optimality impacts ribosome translocation, connecting the processes of translation elongation and decay through codon optimality. Finally, we show that optimal codon content accounts for the similar stabilities observed in mRNAs encoding proteins with coordinated physiological function. This work demonstrates that codon optimization exists as a mechanism to finely tune levels of mRNAs and, ultimately, proteins.	[Presnyak, Vladimir; Alhusaini, Najwa; Chen, Ying-Hsin; Martin, Sophie; Kline, Nicholas; Baker, Kristian E.; Coller, Jeff] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Morris, Nathan] Case Western Reserve Univ, Ctr Clin Invest, Stat Sci Core, Cleveland, OH 44106 USA; [Weinberg, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA USA; [Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, Farmington, CT 06030 USA	Case Western Reserve University; Case Western Reserve University; University of California System; University of California San Francisco; University of Connecticut	Coller, J (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	jmc71@case.edu	Graveley, Brenton R/C-3108-2013	Martin, Sophie/0000-0002-4458-7582; Morris, Nathan/0000-0001-7989-5764; Kline, Nicholas/0000-0002-7616-834X; Graveley, Brenton/0000-0001-5777-5892; Presnyak, Vladimir/0000-0001-6695-7102; Coller, Jeff/0000-0001-5662-8110	NIH [GM095621, GM080465]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056, R01GM080465, R01GM095296, R01GM095621] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors express their appreciation to Dr. Tim Nilsen for his suggestions and critical evaluation of the manuscript and Dr. Beth Grayhack (University of Rochester) for helpful discussion. We thank the members of the Coller and Baker labs for their input into this work. This work was funded by NIH grant GM095621 to K.E.B. and GM080465 to J.C.K.E.B. and J.C. are inventors on a patent that has been filed related to this work.	AKASHI H, 1994, GENETICS, V136, P927; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Geisberg JV, 2014, CELL, V156, P812, DOI 10.1016/j.cell.2013.12.026; Ghosh S, 2010, WIRES RNA, V1, P351, DOI 10.1002/wrna.25; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HOEKEMA A, 1987, MOL CELL BIOL, V7, P2914, DOI 10.1128/MCB.7.8.2914; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Krisko A, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r44; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Lee SR, 2013, TRENDS CELL BIOL, V23, P504, DOI 10.1016/j.tcb.2013.05.001; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Sweet T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001342; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	29	462	480	9	116	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1111	1124		10.1016/j.cell.2015.02.029	http://dx.doi.org/10.1016/j.cell.2015.02.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768907	Green Accepted, Bronze			2022-12-24	WOS:000351951800011
J	Horton, R; Berman, P				Horton, Richard; Berman, Philippa			Eliminating acute kidney injury by 2025: an achievable goal	LANCET			English	Editorial Material									[Horton, Richard; Berman, Philippa] The Lancet, London EC2Y 5AS, England		Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.							Mehta RL, 2015, LANCET; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Remuzzi G, 2013, LANCET, V382, P353, DOI 10.1016/S0140-6736(13)60438-9	3	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 27	2015	385	9987					2551	2552		10.1016/S0140-6736(15)60269-0	http://dx.doi.org/10.1016/S0140-6736(15)60269-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL4NQ	25777660				2022-12-24	WOS:000356930000005
J	Grow, EJ; Flynn, RA; Chavez, SL; Bayless, NL; Wossidlo, M; Wesche, DJ; Martin, L; Ware, CB; Blish, CA; Chang, HY; Pera, RAR; Wysocka, J				Grow, Edward J.; Flynn, Ryan A.; Chavez, Shawn L.; Bayless, Nicholas L.; Wossidlo, Mark; Wesche, Daniel J.; Martin, Lance; Ware, Carol B.; Blish, Catherine A.; Chang, Howard Y.; Pera, Renee A. Reijo; Wysocka, Joanna			Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells	NATURE			English	Article							HERV-K; REGULATORY CIRCUITRY; IDENTIFICATION; ELEMENTS; PROTEIN; FAMILY; HERV-K(HML-2); EXPRESSION; INDUCTION; DYNAMICS	Endogenous retroviruses (ERVs) are remnants of ancient retroviral infections, and comprise nearly 8% of the human genome(1). The most recently acquired human ERV is HERVK(HML-2), which repeatedly infected the primate lineage both before and after the divergence of the human and chimpanzee common ancestor(2,3). Unlike most other human ERVs, HERVK retained multiple copies of intact open reading frames encoding retroviral proteins(4). However, HERVK is transcriptionally silenced by the host, with the exception of in certain pathological contexts such as germ-cell tumours, melanoma or human immunodeficiency virus (HIV) infection(5-7). Here we demonstrate that DNA hypomethylation at long terminal repeat elements representing the most recent genomic integrations, together with transactivation by OCT4 (also known as POU5F1), synergistically facilitate HERVK expression. Consequently, HERVK is transcribed during normal human embryogenesis, beginning with embryonic genome activation at the eight-cell stage, continuing through the emergence of epiblast cells in preimplantation blastocysts, and ceasing during human embryonic stem cell derivation from blastocyst outgrowths. Remarkably, we detected HERVK viral-like particles and Gag proteins in human blastocysts, indicating that early human development proceeds in the presence of retroviral products. We further show that overexpression of one such product, the HERVK accessory protein Rec, in a pluripotent cell line is sufficient to increase IFITM1 levels on the cell surface and inhibit viral infection, suggesting at least one mechanism through which HERVK can induce viral restriction pathways in early embryonic cells. Moreover, Rec directly binds a subset of cellular RNAs and modulates their ribosome occupancy, indicating that complex interactions between retroviral proteins and host factors can fine-tune pathways of early human development.	[Grow, Edward J.; Wossidlo, Mark; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Flynn, Ryan A.; Martin, Lance; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Flynn, Ryan A.; Martin, Lance; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Chavez, Shawn L.; Wossidlo, Mark; Wesche, Daniel J.; Pera, Renee A. Reijo; Wysocka, Joanna] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Chavez, Shawn L.; Wossidlo, Mark; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Chavez, Shawn L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Bayless, Nicholas L.] Stanford Univ, Sch Med, Stanford Immunol, Stanford, CA 94305 USA; [Ware, Carol B.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Blish, Catherine A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Pera, Renee A. Reijo] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Oregon Health & Science University; Oregon National Primate Research Center; Stanford University; University of Washington; University of Washington Seattle; Stanford University; Montana State University System; Montana State University Bozeman; Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	wysocka@stanford.edu	Chavez, Shawn L./ABF-6125-2021; Wossidlo, Mark/M-9690-2019	Chavez, Shawn L./0000-0002-8285-0222; Wossidlo, Mark/0000-0002-3184-0753; Flynn, Ryan/0000-0001-5013-0442; Blish, Catherine/0000-0001-6946-7627; Reijo Pera, Renee/0000-0002-6487-1329	National Institutes of Health (NIH) [P01GM099130, R01 GM112720]; Stanford Genome Sciences Training Program; National Science Foundation Graduate Research Fellowship Program; NIH [1F30CA189514-01, DP2AI11219301, P50-HG007735, 1S10RR02933801, 1S10RR02678001]; Smith Family Stanford Graduate Fellowship; CIRM [RB4-05763, RB3-02209]; March of Dimes [6-FY10-351, U01 HL100397]; NATIONAL CANCER INSTITUTE [F30CA189514, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI112193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130, R01GM112720] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Genome Sciences Training Program; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Stanford Graduate Fellowship; CIRM(California Institute for Regenerative Medicine); March of Dimes(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Bieniasz for the HERVK-con plasmid, P. Lovelace for assistance with FACS, M. Teruel for recombinant Giardia DICER, J. Perrino for TEM assistance, T. Swigut for ideas and input on data analysis, B. Gu for assistance with bisulfite sequencing, A. Moore for assistance with influenza experiments, J. Skowronski and members of the Wysocka laboratory for invaluable comments on the manuscript. This work was supported by the National Institutes of Health (NIH) P01GM099130 and R01 GM112720 (J.W.); Stanford Genome Sciences Training Program and National Science Foundation Graduate Research Fellowship Program (E.J.G.); NIH F30 (1F30CA189514-01) (R.A.F.); NIH DP2AI11219301 (C.A.B.); Smith Family Stanford Graduate Fellowship (N.L.B.); CIRM RB4-05763 and NIH P50-HG007735 (H.Y.C.); CIRM RB3-02209, March of Dimes 6-FY10-351 and U01 HL100397 (R.A.R.P.) grants and NIH equipment grants 1S10RR02933801 (Institute for Stem Cell Biology and Regenerative Medicine FACS core) and 1S10RR02678001 (electronmicroscopy core facility).	Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Bieda K, 2001, J GEN VIROL, V82, P591, DOI 10.1099/0022-1317-82-3-591; BOLLER K, 1993, VIROLOGY, V196, P349, DOI 10.1006/viro.1993.1487; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chavez SL, 2008, STEM CELLS DEV, V17, P535, DOI 10.1089/scd.2007.0216; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Hanke K, 2013, J VIROL, V87, P11019, DOI 10.1128/JVI.03031-12; Herbst H, 1996, AM J PATHOL, V149, P1727; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; LOWER R, 1995, J VIROL, V69, P141; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Magin-Lachmann C, 2001, J VIROL, V75, P10359, DOI 10.1128/JVI.75.21.10359-10371.2001; Muster T, 2003, CANCER RES, V63, P8735; Myers JW, 2005, METH MOL B, V309, P93; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Shin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060605; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wong C, 2013, REPROD BIOMED ONLINE, V26, P120, DOI 10.1016/j.rbmo.2012.11.003; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660	41	340	351	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					221	+		10.1038/nature14308	http://dx.doi.org/10.1038/nature14308			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	25896322	Green Accepted			2022-12-24	WOS:000356016700040
J	Mayer, KH				Mayer, Kenneth H.			Antiretroviral chemoprophylaxis: new successes and questions	LANCET			English	Editorial Material							PHARMACOKINETICS; INFECTION		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Fenway Hlth, Boston, MA 02215 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mayer, KH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Fenway Hlth, Boston, MA 02215 USA.	khmayer@gmail.com			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069412, UM1AI069412] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AVAC, 2015, GLOB ADV HIV PREV DA; Baeten J, 2015, C RETR OPP INF CROI; Bekker L-G, 2015, C RETR OPP INF CROI; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Graham BS, 2014, HIV RES PREVENTION 2; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S., 2015, TOPICS ANTIVIRAL MED, V23, P9, DOI 10.1016/S0140-6736(15)00056-2; Molina J.-M., 2015, C RETR OPP INF; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Rees H, 2015, C RETR OPP INF CROI; Spreen W, 2014, JAIDS-J ACQ IMM DEF, V67, P487, DOI 10.1097/QAI.0000000000000365; Trezza CR, 2014, CLIN PHARMACOKINET, V53, P611, DOI 10.1007/s40262-014-0148-z; UNAIDS, 2014, THE GAP REPP	16	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2236	2237		10.1016/S0140-6736(15)60494-9	http://dx.doi.org/10.1016/S0140-6736(15)60494-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25769358				2022-12-24	WOS:000355943500010
J	Klomp, J; Athy, D; Kwan, CW; Bloch, NI; Sandmann, T; Lemke, S; Schmidt-Ott, U				Klomp, Jeff; Athy, Derek; Kwan, Chun Wai; Bloch, Natasha I.; Sandmann, Thomas; Lemke, Steffen; Schmidt-Ott, Urs			A cysteine-clamp gene drives embryo polarity in the midge Chironomus	SCIENCE			English	Article							EARLY DROSOPHILA EMBRYO; BICOID PROTEIN; ANTERIOR; ORTHODENTICLE; MORPHOGEN; TRIBOLIUM; POSTERIOR; TAILLESS; PATTERN; EGG	In the fruit fly Drosophila, head formation is driven by a single gene, bicoid, which generates head-to-tail polarity of the main embryonic axis. Bicoid deficiency results in embryos with tail-to-tail polarity and no head. However, most insects lack bicoid, and the molecular mechanism for establishing head-to-tail polarity is poorly understood. We have identified a gene that establishes head-to-tail polarity of the mosquito-like midge, Chironomus riparius. This gene, named panish, encodes a cysteine-clamp DNA binding domain and operates through a different mechanism than bicoid. This finding, combined with the observation that the phylogenetic distributions of panish and bicoid are limited to specific families of flies, reveals frequent evolutionary changes of body axis determinants and a remarkable opportunity to study gene regulatory network evolution.	[Klomp, Jeff; Athy, Derek; Kwan, Chun Wai; Bloch, Natasha I.; Lemke, Steffen; Schmidt-Ott, Urs] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Sandmann, Thomas] German Canc Res Ctr, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany	University of Chicago; Helmholtz Association; German Cancer Research Center (DKFZ)	Schmidt-Ott, U (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	uschmid@uchicago.edu	Lemke, Steffen/A-2463-2017	Sandmann, Thomas/0000-0002-6601-8890; Schmidt-Ott, Urs/0000-0002-1351-9472; Klomp, Jeffrey/0000-0002-5243-6987; Bloch, Natasha I/0000-0002-4769-1027	Cell Networks Cluster of Excellence grant [EXC81]; NIH [1R03HD67700-01A1]; NSF [IOS-1121211, IOS-1355057]; University of Chicago; Division Of Integrative Organismal Systems [1121211, 1355057] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD067700] Funding Source: NIH RePORTER	Cell Networks Cluster of Excellence grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Chicago(University of Chicago); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Transcriptomic data are available at the National Center for Biotechnology Information Sequence Read Archive (PRJNA229141). We thank G. K. Bergtrom for Chironomus culture and equipment; T. Hankeln, F. Ripp, L. Wieslander, and N. Visa for chironomid sequence data; J. E. Klomp for technical advice and discussions; M. Ludwig, S. Lott, M. Kim, C. Avila, A. Barnett, E. Davydova, T. Uchanski, C. Martinez, and Y. Yoon for technical help; J. Reinitz, M. Long, P. Rice, P. Faber, A. Ruthenberg, and C. Martinez for discussions; and C. Ferguson and M. Feder for laboratory equipment. Supported by Cell Networks Cluster of Excellence grant EXC81 (T. S.), NIH grant 1R03HD67700-01A1, NSF grants IOS-1121211 and IOS-1355057, and the University of Chicago.	Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; Brent AE, 2007, SCIENCE, V315, P1841, DOI 10.1126/science.1137528; BRONNER G, 1994, NATURE, V369, P664, DOI 10.1038/369664a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1990, DEVELOPMENT, V109, P811; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; DRIEVER W, 1993, DEV DROSOPHILA MELAN, V1, P301; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Fu JP, 2012, P NATL ACAD SCI USA, V109, P7782, DOI 10.1073/pnas.1116641109; KALTHOFF K, 1971, DEV BIOL, V25, P119, DOI 10.1016/0012-1606(71)90022-4; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kotkamp K, 2010, DEVELOPMENT, V137, P1853, DOI 10.1242/dev.047043; Lemke S, 2010, DEVELOPMENT, V137, P1709, DOI 10.1242/dev.046649; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Moran E, 2006, MOL CELL BIOL, V26, P3446, DOI 10.1128/MCB.26.9.3446-3454.2006; Rosenberg MI, 2009, BBA-GENE REGUL MECH, V1789, P333, DOI 10.1016/j.bbagrm.2008.09.007; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Stauber M, 2002, P NATL ACAD SCI USA, V99, P274, DOI 10.1073/pnas.012292899; STRECKER TR, 1988, DEVELOPMENT, V102, P721; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; YAJIMA H, 1964, J EMBRYOL EXP MORPH, V12, P89	22	28	29	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1040	1042		10.1126/science.aaa7105	http://dx.doi.org/10.1126/science.aaa7105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	25953821	Green Accepted			2022-12-24	WOS:000355276600050
J	Iwasaki, S; Sasaki, HM; Sakaguchi, Y; Suzuki, T; Tadakuma, H; Tomari, Y				Iwasaki, Shintaro; Sasaki, Hiroshi M.; Sakaguchi, Yuriko; Suzuki, Tsutomu; Tadakuma, Hisashi; Tomari, Yukihide			Defining fundamental steps in the assembly of the Drosophila RNAi enzyme complex	NATURE			English	Article							RISC; ARGONAUTE; HSP90; DICER; SIRNA; INTERFERENCE; CLEAVES; MIRNAS; STRAND; C3PO	SmallRNAs suchas small interfering RNAs(siRNAs) and microRNAs (miRNAs) silence the expression of their complementary target messenger RNAs1,2 via the formation of effector RNA-induced silencing complexes (RISCs), which contain Argonaute (Ago) family proteins at their core. Although loading of siRNA duplexes into Drosophila Ago2 requires the Dicer-2-R2D2 heterodimer(3-5) and the Hsc70/Hsp90 (Hsp90 also known as Hsp83) chaperone machinery6-8, the details of RISC assembly remain unclear. Here we reconstitute RISC assembly using only Ago2, Dicer-2, R2D2, Hsc70, Hsp90, Hop, Droj2 (an Hsp40 homologue) and p23. By following the assembly of single RISC molecules, we find that, in the absence of the chaperone machinery, an siRNA bound to Dicer-2-R2D2 associates with Ago2 only transiently. The chaperone machinery extends the dwell time of the Dicer-2-R2D2-siRNA complex on Ago2, in a manner dependent on recognition of the 59-phosphate on the siRNA guide strand. We propose that the chaperone machinery supports a productive state of Ago2, allowing it to load siRNA duplexes from Dicer-2-R2D2 and thereby assemble RISC.	[Iwasaki, Shintaro; Sasaki, Hiroshi M.; Tomari, Yukihide] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Sakaguchi, Yuriko; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1130033, Japan; [Tadakuma, Hisashi; Tomari, Yukihide] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Tomari, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	tadakuma@k.u-tokyo.ac.jp; tomari@iam.u-tokyo.ac.jp	Tomari, Yukihide/A-8009-2009; Iwasaki, Shintaro/D-1472-2017; Iwasaki, Shintaro/AAO-7743-2021; Suzuki, Tsutomu/J-1776-2015	Tomari, Yukihide/0000-0001-8442-0851; Iwasaki, Shintaro/0000-0001-7724-3754; Iwasaki, Shintaro/0000-0001-7724-3754; Suzuki, Tsutomu/0000-0002-9731-1731; Sasaki, Hiroshi/0000-0001-9201-8766	Ministry of Education, Culture, Sports, Science and Technology in Japan; Grants-in-Aid for Scientific Research [26113007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Q. Liu for providing vectors for Dicer-2 and R2D2 expression, M. Horwich and P. D. Zamore for Ago2 cDNA, and H. Siomi and M. C. Siomi for anti-Ago2 antibody and ago2<SUP>414</SUP> flies. We are also grateful to P. B. Kwak and A. Tsutsumi for assistance with plasmid constructions, S. Katsuma for support for Dicer-2-R2D2 preparation, and A. Yamashita for advice on protein purification. We thank H. Taguchi and T. Ueda for fruitful discussions and P. D. Zamore, H. Seitz and the members of the Tomari laboratory for critical comments on the manuscript. This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas ('Functional machinery for non-coding RNAs' and 'Non-coding RNA neo-taxonomy'), a Grant-in-Aid for Young Scientists (A) (to H.T. and Y.T.), a Grant-in-Aid for Research Activity start-up (to S.I.), and Grants-in-Aid for challenging Exploratory Research (to H.M.S.) from The Ministry of Education, Culture, Sports, Science and Technology in Japan.	Betancur JG, 2012, RNA, V18, P24, DOI 10.1261/rna.029785.111; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawamata T, 2011, METHODS MOL BIOL, V725, P91, DOI 10.1007/978-1-61779-046-1_7; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kim Y, 2014, CELL REP, V9, P1061, DOI 10.1016/j.celrep.2014.09.039; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Miyazono Y, 2010, EMBO J, V29, P93, DOI 10.1038/emboj.2009.319; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Miyoshi T, 2010, NAT STRUCT MOL BIOL, V17, P1024, DOI 10.1038/nsmb.1875; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhou ZP, 2011, J BIOCHEM, V149, P609, DOI 10.1093/jb/mvr010	42	85	88	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					533	U274		10.1038/nature14254	http://dx.doi.org/10.1038/nature14254			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	25822791				2022-12-24	WOS:000355286600046
J	Schmidt, AG; Therkelsen, MD; Stewart, S; Kepler, TB; Liao, HX; Moody, MA; Haynes, BF; Harrison, SC				Schmidt, Aaron G.; Therkelsen, Matthew D.; Stewart, Shaun; Kepler, Thomas B.; Liao, Hua-Xin; Moody, M. Anthony; Haynes, Barton F.; Harrison, Stephen C.			Viral Receptor-Binding Site Antibodies with Diverse Germline Origins	CELL			English	Article							MONOCLONAL-ANTIBODIES; INFLUENZA-VIRUSES; GLOBULAR HEAD; H1N1 VIRUS; HIV-1; NEUTRALIZATION; RECOGNITION; BROAD; VACCINE; DESIGN	Vaccines for rapidly evolving pathogens will confer lasting immunity if they elicit antibodies recognizing conserved epitopes, such as a receptor-binding site (RBS). From characteristics of an influenza-virus RBS-directed antibody, we devised a signature motif to search for similar antibodies. We identified, from three vaccinees, over 100 candidates encoded by 11 different V-H genes. Crystal structures show that antibodies in this class engage the hemagglutinin RBS and mimic binding of the receptor, sialic acid, by supplying a critical dipeptide on their projecting, heavy-chain third complementarity determining region. They share contacts with conserved, receptor-binding residues but contact different residues on the RBS periphery, limiting the likelihood of viral escape when several such antibodies are present. These data show that related modes of RBS recognition can arise from different germline origins and mature through diverse affinity maturation pathways. Immunogens focused on an RBS-directed response will thus have a broad range of B cell targets.	[Schmidt, Aaron G.; Therkelsen, Matthew D.; Harrison, Stephen C.] Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, Boston, MA 02115 USA; [Stewart, Shaun] Novartis Vaccines & Diagnost, Cambridge, MA USA; [Kepler, Thomas B.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Liao, Hua-Xin; Moody, M. Anthony; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Novartis; Boston University; Duke University; Howard Hughes Medical Institute	Harrison, SC (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Mol Med Lab, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Moody, M/AAB-6947-2020	Moody, M/0000-0002-3890-5855	NIH [P01AI089618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Harrison Laboratory for discussions. We thank the beamline staff at Advanced Light Source 8.2.2 and Advanced Photon Source NE-CAT ID-24E. The work at Harvard Medical School and Boston Children's Hospital was supported by NIH Grant P01AI089618. S.C.H. is an investigator of the Howard Hughes Medical Institute. The authors note that S.C.H., A.G.S., B.F.H., H.X.L., M.A.M., and T.B.K. hold a patent on CH65 lineage antibodies.	BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Okada J, 2011, J GEN VIROL, V92, P326, DOI 10.1099/vir.0.026419-0; Okada J, 2010, VIROLOGY, V397, P322, DOI 10.1016/j.virol.2009.11.025; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu HF, 2015, PROTEINS, V83, P771, DOI 10.1002/prot.24745; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500	37	105	105	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1026	1034		10.1016/j.cell.2015.04.028	http://dx.doi.org/10.1016/j.cell.2015.04.028			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	25959776	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000355152600011
J	Betley, JN; Xu, SJ; Cao, ZFH; Gong, R; Magnus, CJ; Yu, Y; Sternson, SM				Betley, J. Nicholas; Xu, Shengjin; Cao, Zhen Fang Huang; Gong, Rong; Magnus, Christopher J.; Yu, Yang; Sternson, Scott M.			Neurons for hunger and thirst transmit a negative-valence teaching signal	NATURE			English	Article							LATERAL HYPOTHALAMUS; CIRCUIT; FOOD; AGRP; ACTIVATION; DEPRESSION; NUCLEUS; SWITCH; WATER	Homeostasis is a biological principle for regulation of essential physiological parameters within a set range. Behavioural responses due to deviation from homeostasis are critical for survival, but motivational processes engaged by physiological need states are incompletely understood. We examined motivational characteristics of two separate neuron populations that regulate energy and fluid homeostasis by using cell-type-specific activity manipulations in mice. We found that starvation-sensitive AGRP neurons exhibit properties consistent with a negative-valence teaching signal. Mice avoided activation of AGRP neurons, indicating that AGRP neuron activity has negative valence. AGRP neuron inhibition conditioned preference for flavours and places. Correspondingly, deep-brain calcium imaging revealed that AGRP neuron activity rapidly reduced in response to food-related cues. Complementary experiments activating thirst-promoting neurons also conditioned avoidance. Therefore, these need-sensing neurons condition preference for environmental cues associated with nutrient or water ingestion, which is learned through reduction of negative-valence signals during restoration of homeostasis.	[Betley, J. Nicholas; Xu, Shengjin; Cao, Zhen Fang Huang; Gong, Rong; Magnus, Christopher J.; Yu, Yang; Sternson, Scott M.] Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Janelia Res Campus, Howard Hughes Med Inst, 19700 Helix Dr, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org	Core, Vector/CAF-4832-2022; Xu, Shengjin/G-2594-2016; Yu, Yang/D-4071-2015; Gong, Rong/A-6358-2017	Yu, Yang/0000-0002-4340-430X; Gong, Rong/0000-0002-9775-118X; Sternson, Scott/0000-0002-0835-444X	Howard Hughes Medical Institute; HHMI Janelia Farm Graduate Scholar program	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HHMI Janelia Farm Graduate Scholar program	This research was funded by the Howard Hughes Medical Institute. Z.F.H.C. was funded by the HHMI Janelia Farm Graduate Scholar program. We thank B. Balleine, M. Schnitzer, N. Ji, A. Lee, Z. Guo for suggestions on experimental design; H. Su for molecular biology; J. Rouchard, S. Lindo, K. Morris, M. McManus for mouse breeding and procedures; M. Copeland for histology; J. Osborne and C. Werner for apparatus design; K. Branson for automated mouse tracking software (Ctrax); J. Dudman, S. Eddy, H. Grill, N. Geary, U. Heberlein for comments on the manuscript.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; CRAVENS RW, 1969, J EXP PSYCHOL, V81, P312, DOI 10.1037/h0027777; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Hagan MM, 2000, AM J PHYSIOL-REG I, V279, pR47, DOI 10.1152/ajpregu.2000.279.1.R47; Hull C., 1943, PRINCIPLES BEHAV; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Johnson RF, 2003, AM J PHYSIOL-REG I, V285, pR394, DOI 10.1152/ajpregu.00130.2003; Keys A, 1950, BIOL HUMAN STARVATIO, V2, DOI DOI 10.1017/S1352465801003010; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mackintosh N. J, 1983, CONDITIONING ASS LEA; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Navratilova E, 2012, P NATL ACAD SCI USA, V109, P20709, DOI 10.1073/pnas.1214605109; Oka Y, 2015, NATURE, V520, P349, DOI 10.1038/nature14108; Olds J., 1973, BRAIN STIMULATION MO, P81; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; Robinson MJF, 2013, CURR BIOL, V23, P282, DOI 10.1016/j.cub.2013.01.016; ROLLS BJ, 1980, AM J PHYSIOL, V239, pR476, DOI 10.1152/ajpregu.1980.239.5.R476; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; SIDMAN M, 1953, SCIENCE, V118, P157, DOI 10.1126/science.118.3058.157; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; STUNKARD AJ, 1974, ANN INTERN MED, V81, P526, DOI 10.7326/0003-4819-81-4-526; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; WADDEN TA, 1986, J CONSULT CLIN PSYCH, V54, P869, DOI 10.1037/0022-006X.54.6.869; Wang Q, 2014, MOL METAB, V3, P64, DOI 10.1016/j.molmet.2013.10.001; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yiin YM, 2005, PHYSIOL BEHAV, V84, P217, DOI 10.1016/j.physbeh.2004.11.008	47	365	371	5	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	2015	521	7551					180	+		10.1038/nature14416	http://dx.doi.org/10.1038/nature14416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH9SY	25915020	Green Accepted			2022-12-24	WOS:000354377800050
J	Heymann, DL; Rodier, GR; Ryan, MJ				Heymann, David L.; Rodier, Guenael R.; Ryan, Michael J.			Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out	LANCET			English	Editorial Material							HEMORRHAGIC-FEVER; CONGO		[Heymann, David L.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Heymann, David L.] Royal Inst Int Affairs, Ctr Global Hlth Secur, London, England; [Rodier, Guenael R.] WHO Reg Off Europe, Copenhagen, Denmark; [Ryan, Michael J.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University College Dublin	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	david.heymann@lshtm.ac.uk			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 1978, Bull World Health Organ, V56, P271; Cassels FJ., 2012, SEVERE ACUTE RESP SY, P98; GAVI Vaccine Alliance, 2014, GAV COMM PURCH EB VA; Heymann D, 1999, J INFECT DIS, V142, P372; Jezek Z, 1999, J INFECT DIS, V179, pS60, DOI 10.1086/514295; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Lamunu M, 2004, INT J INFECT DIS, V8, P27, DOI 10.1016/j.ijid.2003.04.001; Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099; van Alken WG, 2004, WHO TECH REP SER, V926, P1; Wellcome Trust and the Center for Infectious Disease Research and Policy (CIDRAP) University of Minnesota, 2015, REC ACC DEV EB VACC; WHO, 2015, WHO EB R D EFF VACC	11	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 9	2015	385	9980					1913	1915		10.1016/S0140-6736(15)60645-6	http://dx.doi.org/10.1016/S0140-6736(15)60645-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CH6ZE	25843891	Green Published, Bronze			2022-12-24	WOS:000354184500035
J	Geden, O				Geden, Oliver			Climate advisers must maintain integrity	NATURE			English	Editorial Material									German Inst Int & Secur Affairs, EU Res Div, Berlin, Germany		Geden, O (corresponding author), German Inst Int & Secur Affairs, EU Res Div, Berlin, Germany.	oliver.geden@swp-berlin.org						Brunsson N., 2007, CONSEQUENCES DECISIO; Edenhofer O, 2015, ENVIRON SCI POLICY, V51, P56, DOI 10.1016/j.envsci.2015.03.017; Fuss S, 2014, NAT CLIM CHANGE, V4, P850, DOI 10.1038/nclimate2392; Geden O., 2013, MODIFYING 2 C TARGET; Geden O, 2014, NAT CLIM CHANGE, V4, P747, DOI 10.1038/nclimate2309; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Lentsch J., 2011, POLITICS SCI ADVICE, P3; Pielke R.A.J., 2007, HONEST BROKER MAKING; Tavoni M, 2013, CLIMATIC CHANGE, V118, P1, DOI 10.1007/s10584-013-0757-9; Victor DG, 2014, NAT CLIM CHANGE, V4, P853, DOI 10.1038/nclimate2396	10	65	66	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					27	28		10.1038/521027a	http://dx.doi.org/10.1038/521027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH4YS	25951268	Bronze			2022-12-24	WOS:000354040900013
J	Insel, TR; Cuthbert, BN				Insel, Thomas R.; Cuthbert, Bruce N.			Brain disorders? Precisely	SCIENCE			English	Editorial Material							RESEARCH DOMAIN CRITERIA; MENTAL-DISORDERS; MEDICINE; HEALTH		[Insel, Thomas R.; Cuthbert, Bruce N.] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Insel, TR (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	tinsel@mail.nih.gov						Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Crocker LD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00261; Dichter GS, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-19; Goodkind M., 2015, JAMA PSYCHIAT, DOI [10.1001/jamapsychiatry.2014.2206, DOI 10.1001/JAMAPSYCHIATRY.2014.2206]; Hall BS, 2015, NEUROBIOL STRESS, V1, P174, DOI 10.1016/j.ynstr.2014.10.008; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Karalunas SL, 2014, JAMA PSYCHIAT, V71, P1015, DOI 10.1001/jamapsychiatry.2014.763; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; McCoy TH, 2015, AM J PSYCHIAT, V172, P316, DOI 10.1176/appi.ajp.2014.14091177; Rosa MA, 2012, NEUROPSYCHOPHARMACOL, V37, P102, DOI 10.1038/npp.2011.225; Schumann G, 2014, EUR NEUROPSYCHOPHARM, V24, P5, DOI 10.1016/j.euroneuro.2013.09.010; Tamminga CA, 2014, SCHIZOPHRENIA BULL, V40, pS131, DOI 10.1093/schbul/sbt179; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Health Organisation, 2014, PREV SUIC PREV SUIC	15	385	392	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2015	348	6234					499	500		10.1126/science.aab2358	http://dx.doi.org/10.1126/science.aab2358			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CH1JR	25931539				2022-12-24	WOS:000353778100020
J	Wilson, KD; Wu, JC				Wilson, Kitchener D.; Wu, Joseph C.			Induced Pluripotent Stem Cells	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wilson, Kitchener D.; Wu, Joseph C.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Wilson, Kitchener D.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Wu, JC (corresponding author), Stanford Univ, Lorry Lokey Stem Cell Bldg,265 Campus Dr, Stanford, CA 94305 USA.	joewu@stanford.edu	Wilson, Kitchener/A-7146-2016; Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113006, U01HL107393, R24HL117756] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG000044] Funding Source: Medline; NHLBI NIH HHS [R01 HL113006, R24 HL117756, U01 HL107393] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Marx V, 2015, NAT METHODS, V12, P111, DOI 10.1038/nmeth.3263; McKernan R, 2013, NAT BIOTECHNOL, V31, P875, DOI 10.1038/nbt.2710; Reardon S, 2014, NATURE, V513, P287, DOI 10.1038/513287a; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	8	35	35	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2015	313	16					1613	1614		10.1001/jama.2015.1846	http://dx.doi.org/10.1001/jama.2015.1846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG8WD	25919522				2022-12-24	WOS:000353595200006
J	Gantz, VM; Bier, E				Gantz, Valentino M.; Bier, Ethan			The mutagenic chain reaction: A method for converting heterozygous to homozygous mutations	SCIENCE			English	Article							DROSOPHILA	An organism with a single recessive loss-of-function allele will typically have a wild-type phenotype, whereas individuals homozygous for two copies of the allele will display a mutant phenotype. We have developed a method called the mutagenic chain reaction (MCR), which is based on the CRISPR/Cas9 genome-editing system for generating autocatalytic mutations, to produce homozygous loss-of-function mutations. In Drosophila, we found that MCR mutations efficiently spread from their chromosome of origin to the homologous chromosome, thereby converting heterozygous mutations to homozygosity in the vast majority of somatic and germline cells. MCR technology should have broad applications in diverse organisms.	[Gantz, Valentino M.; Bier, Ethan] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92095 USA	University of California System; University of California San Diego	Gantz, VM (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92095 USA.	vgantz@ucsd.edu; ebier@ucsd.edu		Gantz, Valentino/0000-0003-2453-0711	NIH [R01 GM067247, R56 NS029870]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110713, R01AI070654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS029870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Yanofsky, W. McGinnis, S. Wasserman, R. Kolodner, H. Bellen, and members of the Bier lab for helpful discussions and comments on the manuscript; M. Harrison, K. O'Connor-Giles, J. Wildonger, and S. Bullock for providing CRISPR/Cas9 reagents and information; and J. Vinetz and A. Lubar for granting us access to their BSL2 Insectary. Supported by NIH grants R01 GM067247 and R56 NS029870 and by a generous gift from S. Sandell and M. Marshall. E.B. and V.M.G. are authors on a patent applied for by the University of California, San Diego (provisional patent application number 62075534) that relates to the mutagenic chain reaction. MCR fly stocks and DNA constructs are available from E.B. under a material transfer agreement from UCSD. This protocol for use and containment of our MCR stocks in a BSL2 barrier insectary also used for containment of malaria-infected mosquitos was reviewed and approved by the UCSD Institutional Biosafety Committee (BUA R461).	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	7	352	369	5	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233					442	444		10.1126/science.aaa5945	http://dx.doi.org/10.1126/science.aaa5945			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25908821	Green Accepted			2022-12-24	WOS:000353338000036
J	Maiuri, P; Rupprecht, JF; Wieser, S; Ruprecht, V; Benichou, O; Carpi, N; Coppey, M; De Beco, S; Gov, N; Heisenberg, CP; Crespo, CL; Lautenschlaeger, F; Le Berre, M; Lennon-Dumenil, AM; Raab, M; Thiam, HR; Piel, M; Sixt, M; Voituriez, R				Maiuri, Paolo; Rupprecht, Jean-Francois; Wieser, Stefan; Ruprecht, Verena; Benichou, Olivier; Carpi, Nicolas; Coppey, Mathieu; De Beco, Simon; Gov, Nir; Heisenberg, Carl-Philipp; Crespo, Carolina Lage; Lautenschlaeger, Franziska; Le Berre, Maeil; Lennon-Dumenil, Ana-Maria; Raab, Matthew; Thiam, Hawa-Racine; Piel, Matthieu; Sixt, Michael; Voituriez, Raphael			Actin Flows Mediate a Universal Coupling between Cell Speed and Cell Persistence	CELL			English	Article							MYOSIN-II; PAR PROTEINS; MIGRATION; DYNAMICS; CONTRACTILITY; MECHANISMS; MOTILITY; ADHESION; POLARITY; SYSTEM	Cell movement has essential functions in development, immunity, and cancer. Various cell migration patterns have been reported, but no general rule has emerged so far. Here, we show on the basis of experimental data in vitro and in vivo that cell persistence, which quantifies the straightness of trajectories, is robustly coupled to cell migration speed. We suggest that this universal coupling constitutes a generic law of cell migration, which originates in the advection of polarity cues by an actin cytoskeleton undergoing flows at the cellular scale. Our analysis relies on a theoretical model that we validate by measuring the persistence of cells upon modulation of actin flow speeds and upon optogenetic manipulation of the binding of an actin regulator to actin filaments. Beyond the quantitative prediction of the coupling, the model yields a generic phase diagram of cellular trajectories, which recapitulates the full range of observed migration patterns.	[Maiuri, Paolo; Carpi, Nicolas; Lautenschlaeger, Franziska; Le Berre, Maeil; Raab, Matthew; Thiam, Hawa-Racine; Piel, Matthieu] CNRS UMR 144, Inst Curie, F-75005 Paris, France; [Rupprecht, Jean-Francois; Benichou, Olivier; Voituriez, Raphael] UPMC, UMR CNRS 7600, Lab Phys Theor Mat Condensee, F-75255 Paris, France; [Wieser, Stefan; Ruprecht, Verena; Heisenberg, Carl-Philipp; Sixt, Michael] IST Austria, A-3400 Klosterneuburg, Austria; [Coppey, Mathieu; De Beco, Simon] CNRS UMR 168, Inst Curie, F-75005 Paris, France; [Gov, Nir] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Crespo, Carolina Lage] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Lennon-Dumenil, Ana-Maria] Inst Curie, U653, INSERM, F-75248 Paris 05, France; [Voituriez, Raphael] UPMC, UMR CNRS 8237, Lab Jean Perrin, F-75255 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Institute of Science & Technology - Austria; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Weizmann Institute of Science; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite	Piel, M (corresponding author), CNRS UMR 144, Inst Curie, 26 Rue Ulm, F-75005 Paris, France.	matthieu.piel@curie.fr; sixt@ist.ac.at; voiturie@lptmc.jussieu.fr	Coppey, Mathieu/AAR-3207-2020; Le Berre, Maël/E-3538-2010; voituriez, raphael/V-3418-2017; Lennon-Dumenil, Ana-Maria/I-6716-2016; wieser, stefan/ABH-4102-2020; Thiam, Hawa Racine/AAY-4658-2021; Ruprecht, Verena/H-7563-2017; Thiam, Hawa Racine/AAQ-2006-2020; Crespo, Carolina L/M-3546-2017; Lautenschläger, Franziska/L-3484-2016; GOV, NIR/K-1415-2012	Coppey, Mathieu/0000-0001-8924-3233; Le Berre, Maël/0000-0002-2293-3659; wieser, stefan/0000-0002-2670-2217; Thiam, Hawa Racine/0000-0002-2381-1442; Ruprecht, Verena/0000-0003-4088-8633; Crespo, Carolina L/0000-0001-8659-648X; Lautenschläger, Franziska/0000-0001-8263-3386; Sixt, Michael/0000-0002-6620-9179; voituriez, raphael/0000-0001-8746-5713; Rupprecht, Jean-Francois/0000-0001-8904-5878; de Beco, Simon/0000-0003-1730-3000; CARPI, Nicolas/0000-0002-7494-5555; Maiuri, Paolo/0000-0001-5079-445X; Heisenberg, Carl-Philipp/0000-0002-0912-4566; GOV, NIR/0000-0001-7774-1139	Fondation pour la Recherche Medicale; Austrian Science Fund (FWF) [T560-B17]; AIRC-IG; PRIN; EMBO ALTF [1163-2010]; ANR [ANR-09-PIRI-0027]; InNaBioSant; ERC [311205-PROMICO, 281556_Leukocyte Forces]; HFSP Program Grant; Austrian Science Fund (FWF) [T 560] Funding Source: researchfish	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); AIRC-IG(Fondazione AIRC per la ricerca sul cancro); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); EMBO ALTF; ANR(French National Research Agency (ANR)); InNaBioSant; ERC(European Research Council (ERC)European Commission); HFSP Program Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge J. Wittbrodt for providing the medaka fish transgenic line and D. Riveline and J.F. Joanny for discussions and comments on the manuscript. The authors greatly acknowledge Lucie Sengmanivong from the Nikon Imaging Centre at Institut Curie-CNRS and Vincent Fraisier from the PICT-IBiSA Lhomond Imaging facility of Institut Curie for their help on microscopy. P.M. was supported by a "Fondation pour la Recherche Medicale" fellowship. V.R. was supported by the Austrian Science Fund (FWF) T560-B17. C.L.C. was supported by grant AIRC-IG and PRIN 2010-2011 to Ruggero Pardi. F.L. was supported by EMBO ALTF 1163-2010. O.B., R.V., and M.P. were supported by ANR (ANR-09-PIRI-0027) and InNaBioSant. M.P. was supported by ERC (311205-PROMICO). M.S. was supported by ERC (281556_Leukocyte Forces) and a HFSP Program Grant.	Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Callan-Jones AC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025022; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gardiner C W, 2004, HDB STOCHASTIC METHO; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Gole L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026901; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Hawkins RJ, 2011, BIOPHYS J, V101, P1041, DOI 10.1016/j.bpj.2011.07.038; Heuze ML, 2013, IMMUNOL REV, V256, P240, DOI 10.1111/imr.12108; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kondo T, 2011, BIOCHEM J, V435, P569, DOI 10.1042/BJ20100837; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Mallick K, 2004, EUR PHYS J B, V38, P99, DOI 10.1140/epjb/e2004-00104-3; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Miyoshi H, 2003, PROTOPLASMA, V222, P175, DOI 10.1007/s00709-003-0013-7; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Romanczuk P, 2012, EUR PHYS J-SPEC TOP, V202, P1, DOI 10.1140/epjst/e2012-01529-y; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Selmeczi D, 2008, EUR PHYS J-SPEC TOP, V157, P1, DOI 10.1140/epjst/e2008-00626-x; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tejedor V, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.088103; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; Vedel S, 2013, P NATL ACAD SCI USA, V110, P129, DOI 10.1073/pnas.1204291110; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Zhang J, 2014, P NATL ACAD SCI USA, V111, P16383, DOI 10.1073/pnas.1410533111	43	231	234	1	91	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					374	386		10.1016/j.cell.2015.01.056	http://dx.doi.org/10.1016/j.cell.2015.01.056			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	25799384	Bronze			2022-12-24	WOS:000352708300028
J	Ashrafian, H				Ashrafian, Hutan			Intelligent robots must uphold human rights	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Ashrafian, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	h.ashrafian@imperial.ac.uk							0	9	9	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					391	391		10.1038/519391a	http://dx.doi.org/10.1038/519391a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25810170	Bronze			2022-12-24	WOS:000351602800020
J	DiMaggio, EN; Campisano, CJ; Rowan, J; Dupont-Nivet, G; Deino, AL; Bibi, F; Lewis, ME; Souron, A; Garello, D; Werdelin, L; Reed, KE; Arrowsmith, JR				DiMaggio, Erin N.; Campisano, Christopher J.; Rowan, John; Dupont-Nivet, Guillaume; Deino, Alan L.; Bibi, Faysal; Lewis, Margaret E.; Souron, Antoine; Garello, Dominique; Werdelin, Lars; Reed, Kaye E.; Arrowsmith, J. Ramon			Late Pliocene fossiliferous sedimentary record and the environmental context of early Homo from Afar, Ethiopia	SCIENCE			English	Article							HADAR FORMATION; EVOLUTION; PLIOPLEISTOCENE; AFRICA; RIFT; DEPRESSION; GONA; SITE; MA	Sedimentary basins in eastern Africa preserve a record of continental rifting and contain important fossil assemblages for interpreting hominin evolution. However, the record of hominin evolution between 3 and 2.5 million years ago (Ma) is poorly documented in surface outcrops, particularly in Afar, Ethiopia. Here we present the discovery of a 2.84- to 2.58-million-year-old fossil and hominin-bearing sediments in the Ledi-Geraru research area of Afar, Ethiopia, that have produced the earliest record of the genus Homo. Vertebrate fossils record a faunal turnover indicative of more open and probably arid habitats than those reconstructed earlier in this region, which is in broad agreement with hypotheses addressing the role of environmental forcing in hominin evolution at this time. Geological analyses constrain depositional and structural models of Afar and date the LD 350-1 Homo mandible to 2.80 to 2.75 Ma.	[DiMaggio, Erin N.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Campisano, Christopher J.; Rowan, John; Reed, Kaye E.] Arizona State Univ, Inst Human Origins, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Dupont-Nivet, Guillaume] CNRS Geosci Rennes, F-35042 Rennes, France; [Deino, Alan L.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Bibi, Faysal] Museum Nat Kunde, Leibniz Inst Evolut & Biodivers Sci, D-10115 Berlin, Germany; [Lewis, Margaret E.] Stockton Univ, Biol Program, Galloway, NJ 08205 USA; [Souron, Antoine] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [Garello, Dominique; Arrowsmith, J. Ramon] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Werdelin, Lars] Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); Berkeley Geochronolgy Center; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of California System; University of California Berkeley; Arizona State University; Arizona State University-Tempe; Swedish Museum of Natural History	DiMaggio, EN (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	dimaggio@psu.edu; kreed@asu.edu	Bibi, Faysal/AAZ-9917-2021; DUPONT-NIVET, Guillaume/HII-9066-2022; Lewis, Margaret E/P-8243-2016	Bibi, Faysal/0000-0002-9414-5547; Lewis, Margaret E/0000-0002-2661-1489; Campisano, Christopher/0000-0001-9530-6130; Dupont-Nivet, Guillaume/0000-0001-9905-9739; DiMaggio, Erin/0000-0002-3157-5160	NSF [BCS-1157351, BCS-1322017]; Institute of Human Origins and School of Human Evolution and Social Change at ASU; American Association of Petroleum Geologists, Society for Sedimentary Geology; Geological Society of America; Philanthropic Education Organization; Marie Curie Actions; Alexander von Humbolt Foundation; Fyssen Foundation; Human Evolution Research Center/University of California Berkeley; Direct For Social, Behav & Economic Scie [1157351] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Institute of Human Origins and School of Human Evolution and Social Change at ASU; American Association of Petroleum Geologists, Society for Sedimentary Geology; Geological Society of America; Philanthropic Education Organization; Marie Curie Actions(European Commission); Alexander von Humbolt Foundation(Alexander von Humboldt Foundation); Fyssen Foundation; Human Evolution Research Center/University of California Berkeley; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the Ethiopian Authority for Research and Conservation of Cultural Heritage, especially Y. Desta, D. Abebaw, G. Senishaw, T. Getachew, T. Assefa, and Y. Assefa. We also thank our Afar representative, M. Ahamedin, and our field crew and Afar friends, especially M. Mekonnen Bekele, and M. Jungers for field assistance. The Arizona State University (ASU) LeRoy Eyring Center for Solid State Studies and NG<SUP>3</SUP>L laboratory personnel provided laboratory support. J. Kalb and E. B. Oswald generously shared their geological and paleontological data. Discussions with C. Ebinger, W. Kimbel, and D. Feary, and comments from two anonymous reviewers, have greatly improved this manuscript. This research was funded by NSF (grants BCS-1157351 and BCS-1322017); the Institute of Human Origins and School of Human Evolution and Social Change at ASU; grants to E.N.D. from American Association of Petroleum Geologists, Society for Sedimentary Geology, Geological Society of America, and the Philanthropic Education Organization; to G.D.-N. from the Marie Curie Actions and Alexander von Humbolt Foundation; and to A.S. from the Fyssen Foundation and Human Evolution Research Center/University of California Berkeley. Supporting data for this paper are presented in the supplementary materials.	ARONSON JL, 1981, HOMINID SITES THEIR, P165; Bibi F, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0890; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Campisano CJ, 2012, J HUM EVOL, V62, P338, DOI 10.1016/j.jhevol.2011.05.002; Campisano CJ, 2008, GEOL SOC AM SPEC PAP, V446, P179, DOI 10.1130/2008.2446(08); Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; DiMaggio E., 2013, THESIS ARIZONE STATE; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hayward NJ, 1996, TECTONICS, V15, P244, DOI 10.1029/95TC02292; KALB JE, 1995, PALAEOGEOGR PALAEOCL, V114, P357, DOI 10.1016/0031-0182(94)00088-P; Kidane T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000645; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Kingston John D., 1999, P69; Lahitte P, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001689; Levin NE, 2011, PALAEOGEOGR PALAEOCL, V307, P75, DOI 10.1016/j.palaeo.2011.04.026; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; Quade J, 2008, GEOL SOC AM SPEC PAP, V446, P1, DOI 10.1130/2008.2446(01); Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Reed KE, 2008, J HUM EVOL, V54, P743, DOI 10.1016/j.jhevol.2007.08.013; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Wolfenden E, 2004, EARTH PLANET SC LETT, V224, P213, DOI 10.1016/j.epsl.2004.04.022; Wynn J. G., 2008, SPEC PAP GEOL SOC AM, V446, P87; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317	27	48	48	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1355	1359		10.1126/science.aaa1415	http://dx.doi.org/10.1126/science.aaa1415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25739409				2022-12-24	WOS:000351219600040
J	Villmoare, B; Kimbel, WH; Seyoum, C; Campisano, CJ; DiMaggio, EN; Rowan, J; Braun, DR; Arrowsmith, JR; Reed, KE				Villmoare, Brian; Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; DiMaggio, Erin N.; Rowan, John; Braun, David R.; Arrowsmith, J. Ramon; Reed, Kaye E.			Early Homo at 2.8 Ma from Ledi-Geraru, Afar, Ethiopia	SCIENCE			English	Article							EARLY HOMINID; KOOBI FORA; GENUS HOMO; OMO GROUP; EVOLUTION; KENYA; PLEISTOCENE; DIVERSITY; POSITION; CLIMATE	Our understanding of the origin of the genus Homo has been hampered by a limited fossil record in eastern Africa between 2.0 and 3.0 million years ago (Ma). Here we report the discovery of a partial hominin mandible with teeth from the Ledi-Geraru research area, Afar Regional State, Ethiopia, that establishes the presence of Homo at 2.80 to 2.75 Ma. This specimen combines primitive traits seen in early Australopithecus with derived morphology observed in later Homo, confirming that dentognathic departures from the australopith pattern occurred early in the Homo lineage. The Ledi-Geraru discovery has implications for hypotheses about the timing and place of origin of the genus Homo.	[Villmoare, Brian] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; Rowan, John; Reed, Kaye E.] Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA; [Kimbel, William H.; Seyoum, Chalachew; Campisano, Christopher J.; Rowan, John; Reed, Kaye E.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [DiMaggio, Erin N.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Villmoare, Brian; Braun, David R.] George Washington Univ, Ctr Adv Study Hominin Paleobiol, Washington, DC 20052 USA; [Arrowsmith, J. Ramon] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA; [Villmoare, Brian] UCL, Dept Anthropol, London WC1H 0BW, England; [Seyoum, Chalachew] Author Res & Conservat Cultural Heritage, Addis Ababa, Ethiopia	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Washington University; Arizona State University; Arizona State University-Tempe; University of London; University College London	Villmoare, B (corresponding author), Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA.	brian.villmoare@unlv.edu; wkimbel.iho@asu.edu	Villmoare, Brian/W-4391-2019	Campisano, Christopher/0000-0001-9530-6130; DiMaggio, Erin/0000-0002-3157-5160	National Science Foundation (NSF) [BCS-1157351]; Institute of Human Origins at Arizona State University; NSF [BCS-0725122 HOMINID]; George Washington University Selective Excellence Program; Direct For Social, Behav & Economic Scie [1302067] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1157351] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Institute of Human Origins at Arizona State University; NSF(National Science Foundation (NSF)); George Washington University Selective Excellence Program; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the Authority for Research and Conservation of Cultural Heritage, Ethiopian Ministry of Culture and Tourism, for permission to conduct field work at Ledi-Geraru and laboratory research in the National Museum of Ethiopia, Addis Ababa, in which the LD 350-1 mandible is housed. Research funding provided by the National Science Foundation (NSF) (grant no. BCS-1157351), and the Institute of Human Origins at Arizona State University is gratefully acknowledged. B.A.V. also thanks NSF (BCS-0725122 HOMINID grant) and the George Washington University Selective Excellence Program for support during this research project. We thank Z. Alemseged, B. Asfaw, L. Berger, F. Brown, C. Feibel, D. Johanson, F. Spoor, G. Suwa, C. Ward, T. White, and B. Wood for discussion, assistance, and/or permission to examine fossils. Constructive comments by F. Spoor, B. Wood, and three anonymous referees substantially improved the manuscript. Supporting data for this paper are presented in the supplementary materials.	Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Boisserie JR, 2008, CR PALEVOL, V7, P429, DOI 10.1016/j.crpv.2008.07.010; Campisano CJ, 2007, J HUM EVOL, V53, P515, DOI 10.1016/j.jhevol.2007.05.015; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; DiMaggio EN, 2015, SCIENCE, V347, P1355, DOI 10.1126/science.aaa1415; Guatelli-Steinberg D, 2005, AM J PHYS ANTHROPOL, V128, P477, DOI 10.1002/ajpa.20194; Herries Andy I.R., 2013, P21; Kimbel W. H., 2004, HUMAN EVOLUTION SERI; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; LEAKEY REF, 1985, AM J PHYS ANTHROPOL, V67, P135, DOI 10.1002/ajpa.1330670209; McDougall I, 2012, J GEOL SOC LONDON, V169, P213, DOI 10.1144/0016-76492010-188; Montagu MFA, 1954, AM J PHYS ANTHROP-NE, V12, P503, DOI 10.1002/ajpa.1330120404; Potts R, 2013, QUATERNARY SCI REV, V73, P1, DOI 10.1016/j.quascirev.2013.04.003; Spoor F, 2015, NATURE, V519, P83, DOI 10.1038/nature14224; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; SUWA G, 1994, AM J PHYS ANTHROPOL, V93, P407, DOI 10.1002/ajpa.1330930402; Suwa G., 1990, THESIS U CALIFORNIA; Tobias PV, 1991, OLDUVAI GORGE, V4; Vrba E.S., 1988, P405; Weidenreich F., 1936, Palaeontologia Sinica, VD7, P1; WHITE TD, 1981, S AFR J SCI, V77, P445; WHITE TD, 1977, THESIS U MICHIGAN AN; White Tim D., 2005, Transactions of the Royal Society of South Africa, V60, P79; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1986, AM J PHYS ANTHROPOL, V69, P117, DOI 10.1002/ajpa.1330690113; Wood B, 2011, ANNU REV ECOL EVOL S, V42, P47, DOI 10.1146/annurev-ecolsys-102209-144653	33	213	221	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2015	347	6228					1352	1355		10.1126/science.aaa1343	http://dx.doi.org/10.1126/science.aaa1343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6SM	25739410				2022-12-24	WOS:000351219600039
J	Conn, SJ; Pillman, KA; Toubia, J; Conn, VM; Salmanidis, M; Phillips, CA; Roslan, S; Schreiber, AW; Gregory, PA; Goodall, GJ				Conn, Simon J.; Pillman, Katherine A.; Toubia, John; Conn, Vanessa M.; Salmanidis, Marika; Phillips, Caroline A.; Roslan, Suraya; Schreiber, Andreas W.; Gregory, Philip A.; Goodall, Gregory J.			The RNA Binding Protein Quaking Regulates Formation of circRNAs	CELL			English	Article							CIRCULAR RNAS; MESSENGER-RNA; MESENCHYMAL TRANSITION; FAMILY; IDENTIFICATION; TRANSCRIPTS; MECHANISMS; GENE	Circular RNAs (circRNAs), formed by non-sequential back-splicing of pre-mRNA transcripts, are a widespread form of non-coding RNA in animal cells. However, it is unclear whether the majority of circRNAs represent splicing by-products without function or are produced in a regulated manner to carry out specific cellular functions. We show that hundreds of circRNAs are regulated during human epithelial-mesenchymal transition (EMT) and find that the production of over one-third of abundant circRNAs is dynamically regulated by the alternative splicing factor, Quaking (QKI), which itself is regulated during EMT. Furthermore, by modulating QKI levels, we show the effect on circRNA abundance is dependent on intronic QKI binding motifs. Critically, the addition of QKI motifs is sufficient to induce de novo circRNA formation from transcripts that are normally linearly spliced. These findings demonstrate circRNAs are both purposefully synthesized and regulated by cell-type specific mechanisms, suggesting they play specific biological roles in EMT.	[Conn, Simon J.; Pillman, Katherine A.; Toubia, John; Conn, Vanessa M.; Salmanidis, Marika; Phillips, Caroline A.; Roslan, Suraya; Schreiber, Andreas W.; Gregory, Philip A.; Goodall, Gregory J.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Conn, Simon J.; Pillman, Katherine A.; Toubia, John; Conn, Vanessa M.; Salmanidis, Marika; Phillips, Caroline A.; Roslan, Suraya; Schreiber, Andreas W.; Gregory, Philip A.; Goodall, Gregory J.] Univ S Australia, Adelaide, SA 5000, Australia; [Pillman, Katherine A.; Toubia, John; Schreiber, Andreas W.] SA Pathol, ACRF Canc Genom Facil, Adelaide, SA 5000, Australia; [Phillips, Caroline A.; Schreiber, Andreas W.; Goodall, Gregory J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Gregory, Philip A.; Goodall, Gregory J.] Univ Adelaide, Dept Med, Adelaide, SA 5005, Australia	Centre for Cancer Biology; SA Pathology; University of South Australia; SA Pathology; University of Adelaide; University of Adelaide	Goodall, GJ (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia.	greg.goodall@health.sa.gov.au	SAUB, ROSLAN/B-9608-2010; Gregory, Philip/F-4089-2013; Pillman, Katherine A/M-5723-2019	Gregory, Philip/0000-0002-0999-0632; Pillman, Katherine A/0000-0002-5869-889X; Conn, Vanessa/0000-0002-8850-8209; Phillips, Caroline/0000-0002-4471-9768; Conn, Simon/0000-0002-1376-4515; Goodall, Gregory/0000-0003-1294-0692; Toubia, John/0000-0002-5135-6504; Schreiber, Andreas/0000-0002-9081-3405	Royal Adelaide Hospital Research Fund; National Health and Medical Research Council [GNT1089167, GNT1068773]; EMPathy Breast Cancer Network, a National Breast Cancer Foundation (Australia); Cancer Council SA Beat Cancer Fellowship; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	Royal Adelaide Hospital Research Fund; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); EMPathy Breast Cancer Network, a National Breast Cancer Foundation (Australia); Cancer Council SA Beat Cancer Fellowship(Cancer Council South Australia); National Breast Cancer Foundation	We thank all members of the Goodall Laboratory for valuable discussion. We thank David Lawrence of the CCB ACRF Cancer Genomics Facility for valuable discussion and for establishing sequencing analysis pipelines. Funding for this research was obtained from the Royal Adelaide Hospital Research Fund in the form of a Florey Postdoctoral Fellowship to S.J.C.; from the National Health and Medical Research Council project grants GNT1089167 to G.J.G. and S.J.C.; GNT1068773 to G.J.G. and P.A.G.; and from the EMPathy Breast Cancer Network, a National Breast Cancer Foundation (Australia)-funded National Collaborative Research Program. P.A.G. is supported by a Cancer Council SA Beat Cancer Fellowship.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Gadea G, 2014, EUR J CELL BIOL, V93, P466, DOI 10.1016/j.ejcb.2014.06.003; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Gualandi F, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e100; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; Teplova M, 2013, GENE DEV, V27, P928, DOI 10.1101/gad.216531.113; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001	41	1275	1362	10	240	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 12	2015	160	6					1125	1134		10.1016/j.cell.2015.02.014	http://dx.doi.org/10.1016/j.cell.2015.02.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CE6MT	25768908	Bronze			2022-12-24	WOS:000351951800012
J	Gulland, A				Gulland, Anne			Can GPs do more to help patients with facial disfigurement?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk						Hodson H., 2012, TELEGRAPH; Julian D, 2007, FACE EQUALITY CAMPAI; Palacio RJ, 2013, WONDER	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2015	350								h1160	10.1136/bmj.h1160	http://dx.doi.org/10.1136/bmj.h1160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD6EH	25758246				2022-12-24	WOS:000351181800003
J	Perros, M				Perros, Manos			A sustainable model for antibiotics	SCIENCE			English	Editorial Material							GRAM-NEGATIVE BACILLI; RESISTANCE; PATHOGENS; DRUGS		AstraZeneca Innovat Med & Early Dev, Waltham, MA 02451 USA		Perros, M (corresponding author), AstraZeneca Innovat Med & Early Dev, Gatehouse Dr, Waltham, MA 02451 USA.	manos.perros@astrazeneca.com						Baker S, 2015, SCIENCE, V347, P1064, DOI 10.1126/science.aaa2868; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Karaiskos I, 2014, EXPERT OPIN PHARMACO, V15, P1351, DOI 10.1517/14656566.2014.914172; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012; Mylonakis E, 2015, CLIN INFECT DIS, V60, P892, DOI 10.1093/cid/ciu959; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Spellberg B, 2013, NAT REV DRUG DISCOV, V12, P963, DOI 10.1038/nrd3957-c1; Tenover FC, 2013, J CLIN MICROBIOL, V51, P3780, DOI 10.1128/JCM.01092-13	15	36	39	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1062	1064		10.1126/science.aaa3048	http://dx.doi.org/10.1126/science.aaa3048			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25745144				2022-12-24	WOS:000350354200016
J	Hou, X; Hu, YH; Grinthal, A; Khan, M; Aizenberg, J				Hou, Xu; Hu, Yuhang; Grinthal, Alison; Khan, Mughees; Aizenberg, Joanna			Liquid-based gating mechanism with tunable multiphase selectivity and antifouling behaviour	NATURE			English	Article							MEMBRANES; WATER; PERMEATION; NANOPORES	Living organisms make extensive use of micro- and nanometre-sized pores as gatekeepers for controlling the movement of fluids, vapours and solids between complex environments. The ability of such pores to coordinate multiphase transport, in a highly selective and subtly triggered fashion and without clogging, has inspired interest in synthetic gated pores for applications ranging from fluid processing to 3D printing and lab-on-chip systems(1-10). But although specific gating and transport behaviours have been realized by precisely tailoring pore surface chemistries and pore geometries(6,11-17), a single system capable of controlling complex, selective multiphase transport has remained a distant prospect, and fouling is nearly inevitable(11,12). Here we introduce a gating mechanism that uses a capillary-stabilized liquid as a reversible, reconfigurable gate that fills and seals pores in the closed state, and creates a non-fouling, liquid-lined pore in the open state. Theoretical modelling and experiments demonstrate that for each transport substance, the gating threshold-the pressure needed to open the pores-can be rationally tuned over a wide pressure range. This enables us to realize in one system differential response profiles for a variety of liquids and gases, even letting liquids flow through the pore while preventing gas from escaping. These capabilities allow us to dynamically modulate gas-liquid sorting in a microfluidic flow and to separate a three-phase air-water-oil mixture, with the liquid lining ensuring sustained antifouling behaviour. Because the liquid gating strategy enables efficient long-term operation and can be applied to a variety of pore structures and membrane materials, and to micro- as well as macroscale fluid systems, we expect it to prove useful in a wide range of applications.	[Hou, Xu; Hu, Yuhang; Grinthal, Alison; Aizenberg, Joanna] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Hou, Xu; Khan, Mughees; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Aizenberg, J (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	jaiz@seas.harvard.edu	Hu, Yuhang/E-5378-2010	Hu, Yuhang/0000-0002-2274-4903; Hou, Xu/0000-0002-9615-9547	Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy [DE-AR0000326]	Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy(United States Department of Energy (DOE))	This work was supported in part by the Advanced Research Projects Agency-Energy (ARPA-E), US Department of Energy, under award number DE-AR0000326. We thank M. Aizenberg, R. T. Blough and X. Y. Chen for discussions; A. B. Tesler for assistance with the scanning electron microscopy; and T. S. Wong, B. D. Hatton and R. A. Belisle for assistance with antifouling experiments.	Adrus N, 2012, J MATER CHEM, V22, P3088, DOI 10.1039/c2jm15022k; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Chen PC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02776; Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868; Faulkner-Jones A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015013; Germic L, 1997, J MEMBRANE SCI, V132, P131, DOI 10.1016/S0376-7388(97)00058-6; Holt JK, 2004, 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY, P110; Kargov A, 2005, INT C REHAB ROBOT, P182; Karlsson JM, 2013, LAB CHIP, V13, P4366, DOI 10.1039/c3lc50778e; Kralj JG, 2007, LAB CHIP, V7, P256, DOI 10.1039/b610888a; Lin NH, 2010, J MATER CHEM, V20, P4642, DOI 10.1039/b926918e; Liu CC, 2011, LAB CHIP, V11, P1688, DOI 10.1039/c1lc20089e; MiettonPeuchot M, 1997, J MEMBRANE SCI, V133, P73, DOI 10.1016/S0376-7388(97)00091-4; MOHNS J, 1995, ANAL CHIM ACTA, V305, P241, DOI 10.1016/0003-2670(94)00608-O; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Namati E, 2008, AM J RESP CELL MOL, V38, P572, DOI 10.1165/rcmb.2007-0120OC; Oh KW, 2006, J MICROMECH MICROENG, V16, pR13, DOI 10.1088/0960-1317/16/5/R01; Paven M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3512; Peleg O, 2010, BIOL CHEM, V391, P719, DOI 10.1515/BC.2010.092; Peng XS, 2009, NAT NANOTECHNOL, V4, P353, DOI [10.1038/NNANO.2009.90, 10.1038/nnano.2009.90]; Powell MR, 2011, NAT NANOTECHNOL, V6, P798, DOI [10.1038/NNANO.2011.189, 10.1038/nnano.2011.189]; PURCELL WR, 1949, T AM I MIN MET ENG, V186, P39; Stroock AD, 2014, ANNU REV FLUID MECH, V46, P615, DOI 10.1146/annurev-fluid-010313-141411; Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084; Wen YQ, 2012, CHEM COMMUN, V48, P8410, DOI 10.1039/c2cc34501c; Winther-Jensen B, 2008, SCIENCE, V321, P671, DOI 10.1126/science.1159267; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Yameen B, 2009, SMALL, V5, P1287, DOI 10.1002/smll.200801318; Yusko EC, 2011, NAT NANOTECHNOL, V6, P253, DOI 10.1038/nnano.2011.12; Zhang CY, 2011, ENERG FUEL, V25, P3493, DOI 10.1021/ef101732k	30	317	323	45	942	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					70	73		10.1038/nature14253	http://dx.doi.org/10.1038/nature14253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25739629	Green Submitted			2022-12-24	WOS:000350304000037
J	Kahn, MW				Kahn, Michael W.			On Taking Notice - Learning Mindfulness from (Boston) Brahmins	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kahn, Michael W.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kahn, Michael W.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kahn, MW (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Kabat-Zinn J., 1994, WHEREVER YOU GO THER	1	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					901	903		10.1056/NEJMp1410397	http://dx.doi.org/10.1056/NEJMp1410397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC4EU	25738665				2022-12-24	WOS:000350304500005
J	Blaikie, AJ; Dutton, GN				Blaikie, Andrew J.; Dutton, Gordon N.			PRACTICE POINTER How to assess eyes and vision in infants and preschool children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMBLYOPIA		[Blaikie, Andrew J.] Fife Acute Hosp Trust, Queen Margaret Hosp, Dept Ophthalmol, Paediat Serv, Dunfermline KY12 0SU, Fife, Scotland; [Dutton, Gordon N.] Glasgow Caledonian Univ, Visual Sci, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Dutton, GN (corresponding author), Glasgow Caledonian Univ, Visual Sci, Glasgow G4 0BA, Lanark, Scotland.	dutton@duttonhome.com		Blaikie, Andrew/0000-0001-7913-6872; Dutton, Gordon N/0000-0003-2516-5795				Anna, 2017, PEDIAT OPHTHALMOLOGY, P746; Atkinson J., 2000, OXFORD PSYCHOL SERIE, V32, P44; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Bowman R, 2010, BRIT J OPHTHALMOL, V94, P882, DOI 10.1136/bjo.2009.162750; Goddard AG, 1999, BRIT J OPHTHALMOL, V83, P1320, DOI 10.1136/bjo.83.12.1320; Horwood A, 2003, BRIT J OPHTHALMOL, V87, P1146, DOI 10.1136/bjo.87.9.1146; Papageorgiou E, 2014, PEDIATR NEONATOL, V55, P341, DOI 10.1016/j.pedneo.2014.02.007; Russell HC, 2010, J PEDIATR OPHTHALMOL, V1, P1; Salt A, 2014, ARCH DIS CHILD, V99, P1163, DOI 10.1136/archdischild-2013-305267; Stein A, 2014, J PEDIATR-US, V165, P820, DOI 10.1016/j.jpeds.2014.06.053; Zihl J, 2014, CEREBRAL VISUAL IMPA	11	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2015	350								h1716	10.1136/bmj.h1716	http://dx.doi.org/10.1136/bmj.h1716			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI0GJ	25952683				2022-12-24	WOS:000354414800001
J	Chawla, DS				Chawla, Dalmeet Singh			'Living figures' make their debut	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					112	112		10.1038/521112a	http://dx.doi.org/10.1038/521112a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25951287				2022-12-24	WOS:000354040900045
J	Zitvogel, L; Kroemer, G				Zitvogel, Laurence; Kroemer, Guido			CANCER Antibodies regulate antitumour immunity	NATURE			English	Editorial Material							DEATH		[Zitvogel, Laurence] Gustave Roussy Comprehens Canc Ctr, F-94805 Villejuif, France; [Kroemer, Guido] Univ Paris 05, Cordeliers Res Ctr, F-75006 Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, Pole Biol, Paris, France	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), Gustave Roussy Comprehens Canc Ctr, F-94805 Villejuif, France.	kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998				Carmi Y, 2015, NATURE, V521, P99, DOI 10.1038/nature14424; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Galluzzi L, 2014, ONCOTARGET, V5, P12472, DOI 10.18632/oncotarget.2998; Gerdes CA, 2013, CLIN CANCER RES, V19, P1126, DOI 10.1158/1078-0432.CCR-12-0989; Hannani D, 2014, CELL DEATH DIFFER, V21, P50, DOI 10.1038/cdd.2013.60; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	10	27	28	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2015	521	7550					35	37		10.1038/nature14388	http://dx.doi.org/10.1038/nature14388			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH4YS	25924066				2022-12-24	WOS:000354040900023
J	Chen, KH; Boettiger, AN; Moffitt, JR; Wang, SY; Zhuang, XW				Chen, Kok Hao; Boettiger, Alistair N.; Moffitt, Jeffrey R.; Wang, Siyuan; Zhuang, Xiaowei			Spatially resolved, highly multiplexed RNA profiling in single cells	SCIENCE			English	Article							GENE-EXPRESSION; MOLECULE FLUORESCENCE; MESSENGER-RNAS; DESIGN; VISUALIZATION; TRANSLOCATION; LOCALIZATION; MECHANISMS; REVEALS; TOOL	Knowledge of the expression profile and spatial landscape of the transcriptome in individual cells is essential for understanding the rich repertoire of cellular behaviors. Here, we report multiplexed error-robust fluorescence in situ hybridization (MERFISH), a single-molecule imaging approach that allows the copy numbers and spatial localizations of thousands of RNA species to be determined in single cells. Using error-robust encoding schemes to combat single-molecule labeling and detection errors, we demonstrated the imaging of 100 to 1000 distinct RNA species in hundreds of individual cells. Correlation analysis of the similar to 10(4) to 10(6) pairs of genes allowed us to constrain gene regulatory networks, predict novel functions for many unannotated genes, and identify distinct spatial distribution patterns of RNAs that correlate with properties of the encoded proteins.	[Chen, Kok Hao; Boettiger, Alistair N.; Moffitt, Jeffrey R.; Wang, Siyuan; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	, 周一珉/AAQ-9453-2020	Boettiger, Alistair/0000-0002-3554-5196; Wang, Siyuan (Steven)/0000-0001-6550-4064	National Institutes of Health; Agency for Science, Technology and Research of Singapore; Damon Runyon Foundation; Helen Hay Whitney Foundation; Jane Coffins Child Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450, R01GM105637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Damon Runyon Foundation; Helen Hay Whitney Foundation; Jane Coffins Child Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Babcock for technical advice and help with instrumentation and B. Bintu for aid in error analysis. This work was in part supported by the National Institutes of Health. K.H.C. acknowledges a National Science Scholarship from the Agency for Science, Technology and Research of Singapore. A.N.B. acknowledges support by the Damon Runyon Foundation postdoctoral fellowship. J.R.M. acknowledges support from the Helen Hay Whitney Foundation postdoctoral fellowship. S.W. acknowledges support from Jane Coffins Child Foundation postdoctoral fellowship. X.Z. is a Howard Hughes Medical Institute investigator. RNA-seq data were deposited under the accession number GSE67685. MERFISH data are available at http://zhuang.harvard.edu/merfish. X.Z., K.H.C., A.N.B., J.R.M., and S.W. are inventors on a patent applied for by Harvard University that covers the MERFISH method described here; X.Z., J.R.M., and A.N.B. are inventors on a patent applied for by Harvard University that covers the probe synthesis method described here.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babcock Hazen, 2012, Opt Nanoscopy, V1, DOI 10.1186/2192-2853-1-6; Babcock HP, 2013, OPT EXPRESS, V21, P28583, DOI 10.1364/OE.21.028583; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Batish M, 2011, METHODS MOL BIOL, V714, P3, DOI 10.1007/978-1-61779-005-8_1; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Dolinski K, 2005, GENOME RES, V15, P1611, DOI 10.1101/gr.3727505; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Gregor T, 2014, TRENDS GENET, V30, P364, DOI 10.1016/j.tig.2014.06.002; Ha T, 2014, NAT METHODS, V11, P1015, DOI 10.1038/nmeth.3107; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/nmeth.2069, 10.1038/NMETH.2069]; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Moon TK, 2005, ERROR CORRECTION CODING: MATHEMATICAL METHODS AND ALGORITHMS, P1, DOI 10.1002/0471739219; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murgha YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094752; Padovan-Merhar O, 2013, WIRES SYST BIOL MED, V5, P751, DOI 10.1002/wsbm.1243; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Rodriguez AJ, 2008, CURR OPIN CELL BIOL, V20, P144, DOI 10.1016/j.ceb.2008.02.004; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Shi XH, 2010, ANAL CHEM, V82, P6132, DOI 10.1021/ac1008749; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Xu QK, 2009, P NATL ACAD SCI USA, V106, P2289, DOI 10.1073/pnas.0812506106; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	51	914	951	39	315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2015	348	6233							aaa6090	10.1126/science.aaa6090	http://dx.doi.org/10.1126/science.aaa6090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5NF	25858977	Green Accepted, Green Published			2022-12-24	WOS:000353338000027
J	Zimmerman, K; Yoder, BK				Zimmerman, Kurt; Yoder, Bradley K.			SnapShot: Sensing and Signaling by Cilia	CELL			English	Editorial Material									[Zimmerman, Kurt; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Zimmerman, K (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038, R01DK065655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088010] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007051] Funding Source: Medline; NIDDK NIH HHS [P30 DK074038, DK065655, R01 DK065655] Funding Source: Medline; NIGMS NIH HHS [2K12GM088010-06, K12 GM088010] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Ibraghimov-Beskrovnaya O, 2011, TRENDS MOL MED, V17, P625, DOI 10.1016/j.molmed.2011.06.003; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Praetorius HA, 2015, AM J PHYSIOL-CELL PH, V308, pC198, DOI 10.1152/ajpcell.00336.2014; Takao D, 2013, DEV BIOL, V376, P23, DOI 10.1016/j.ydbio.2013.01.018; Welmbs T., 2013, JAK STAT, V2; Yildiz O, 2012, VISION RES, V75, P112, DOI 10.1016/j.visres.2012.08.007; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	9	26	30	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 23	2015	161	3					692	692		10.1016/j.cell.2015.04.015	http://dx.doi.org/10.1016/j.cell.2015.04.015			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CG8JN	25910215	Green Accepted, Bronze			2022-12-24	WOS:000353553600026
J	Psaty, BM; Platt, R; Altman, RB				Psaty, Bruce M.; Platt, Richard; Altman, Russ B.			Neurotoxicity of Generic Anesthesia Agents in Infants and Children An Orphan Research Question in Search of a Sponsor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEURODEGENERATION; EXPOSURE		[Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Platt, Richard] Harvard Univ, Sch Med, Boston, MA USA; [Platt, Richard] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Dept Genet & Med, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Stanford University; Stanford University	Psaty, BM (corresponding author), Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu		Altman, Russ/0000-0003-3859-2905	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078888, R01HL103612, R01HL105756] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL078888, HL103612, R01 HL103612, HL105756] Funding Source: Medline; NIGMS NIH HHS [GM61374] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andropoulos DB, FDA PUBLIC SESSION R; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Hays SR, 2013, J UROLOGY, V189, P1222, DOI 10.1016/j.juro.2012.11.090; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; US Food and Drug Administration, SIGN EX NONCL CLIN D; US Food and Drug Administration, CLIN INV POT EFF AN; Yu CK, 2013, F1000RESEARCH, V2, P166, DOI [DOI 10.12688/F1000RESEARCH.2-166.V1, 10.12688/f1000research.2-166.v2]	10	39	39	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2015	313	15					1515	1516		10.1001/jama.2015.1149	http://dx.doi.org/10.1001/jama.2015.1149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3SA	25898045				2022-12-24	WOS:000353198700012
J	Lu, Y; Lee, BH; King, RW; Finley, D; Kirschner, MW				Lu, Ying; Lee, Byung-hoon; King, Randall W.; Finley, Daniel; Kirschner, Marc W.			Substrate degradation by the proteasome: A single-molecule kinetic analysis	SCIENCE			English	Article							UBIQUITINATED PROTEINS ACTIVATE; 26S PROTEASOME; CYCLIN B1; RECOGNITION; DEUBIQUITINATION; INITIATION; RECEPTORS; BINDING; SIGNAL; MULTIUBIQUITINATION	To address how the configuration of conjugated ubiquitins determines the recognition of substrates by the proteasome, we analyzed the degradation kinetics of substrates with chemically defined ubiquitin configurations. Contrary to the view that a tetraubiquitin chain is the minimal signal for efficient degradation, we find that distributing the ubiquitins as diubiquitin chains provides a more efficient signal. To understand how the proteasome actually discriminates among ubiquitin configurations, we developed single-molecule assays that distinguished intermediate steps of degradation kinetically. The level of ubiquitin on a substrate drives proteasome-substrate interaction, whereas the chain structure of ubiquitin affects translocation into the axial channel on the proteasome. Together these two features largely determine the susceptibility of substrates for proteasomal degradation.	[Lu, Ying; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Lee, Byung-hoon; King, Randall W.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	marc@hms.harvard.edu		Lee, Byung-Hoon/0000-0002-7101-0471	Damon Runyon Research Fellowship; NIH [GM43601, GM66492]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066492, R01GM066492, R01GM039023, R01GM043601, R37GM043601] Funding Source: NIH RePORTER	Damon Runyon Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Bai and W. Ma for commenting on the manuscript. We thank the Nikon Imaging Center at Harvard Medical School for providing instruments. Y.L. is supported by a Damon Runyon Research Fellowship and is a Lallage Feazel Wall Fellow. This work was supported in part by NIH grants GM43601 (to D.F.) and GM66492 (to R.W.K.)	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1194; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Imamura S, 2012, J BIOL CHEM, V287, P23047, DOI 10.1074/jbc.M111.332882; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1248737; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722	54	132	133	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2015	348	6231							1250834	10.1126/science.1250834	http://dx.doi.org/10.1126/science.1250834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5RD	25859050	Green Accepted			2022-12-24	WOS:000352613700036
J	Stahl, AE; Feigenson, L				Stahl, Aimee E.; Feigenson, Lisa			Observing the unexpected enhances infants' learning and exploration	SCIENCE			English	Article							OBJECT PERMANENCE; EXPLANATION; LOCATION; BEHAVIOR; ORIGINS	Given the overwhelming quantity of information available from the environment, how do young learners know what to learn about and what to ignore? We found that 11-month-old infants (N = 110) used violations of prior expectations as special opportunities for learning. The infants were shown events that violated expectations about object behavior or events that were nearly identical but did not violate expectations. The sight of an object that violated expectations enhanced learning and promoted information-seeking behaviors; specifically, infants learned more effectively about objects that committed violations, explored those objects more, and engaged in hypothesis-testing behaviors that reflected the particular kind of violation seen. Thus, early in life, expectancy violations offer a wedge into the problem of what to learn.	[Stahl, Aimee E.; Feigenson, Lisa] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA	Johns Hopkins University	Stahl, AE (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	astahl4@jhu.edu			NSF [DGE-1232825]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD077407] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NSF Graduate Research Fellowship DGE-1232825 (A.E.S.). We thank J. Halberda for comments; J. Taggart, S. Folsom, M. Santoru, C. Veazey, G. Lisandrelli, and K. Grubb for assistance with data collection and coding; and J. Garmon for construction of the experimental apparatus. Data can be found on the Harvard Institute for Quantitative Social Sciences dataverse (DOI: 10.7910/DVN/29315).	BAILLARGEON R, 1986, COGNITION, V23, P21, DOI 10.1016/0010-0277(86)90052-1; Berger A, 2006, P NATL ACAD SCI USA, V103, P12649, DOI 10.1073/pnas.0605350103; Bonawitz EB, 2012, COGNITIVE PSYCHOL, V64, P215, DOI 10.1016/j.cogpsych.2011.12.002; Camras LA, 2002, EMOTION, V2, P179, DOI 10.1037//1528-3542.2.2.179; Chiandetti C, 2010, ANIM COGN, V13, P463, DOI 10.1007/s10071-009-0297-x; Chomsky N., 1980, LANGUAGE LEARNING DE, P393; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Dehaene S, 2006, SCIENCE, V311, P381, DOI 10.1126/science.1121739; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jaswal VK, 2010, COGNITIVE PSYCHOL, V61, P248, DOI 10.1016/j.cogpsych.2010.06.002; KUHL PK, 1984, INFANT BEHAV DEV, V7, P361, DOI 10.1016/S0163-6383(84)80050-8; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; McCrink K, 2004, PSYCHOL SCI, V15, P776, DOI 10.1111/j.0956-7976.2004.00755.x; NEEDHAM A, 1993, COGNITION, V47, P121, DOI 10.1016/0010-0277(93)90002-D; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; REGOLIN L, 1995, PERCEPT PSYCHOPHYS, V57, P971, DOI 10.3758/BF03205456; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schulz L, 2012, TRENDS COGN SCI, V16, P382, DOI 10.1016/j.tics.2012.06.004; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; SPELKE ES, 1995, BRIT J DEV PSYCHOL, V13, P113, DOI 10.1111/j.2044-835X.1995.tb00669.x; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Wilcox T, 1996, INFANT BEHAV DEV, V19, P309, DOI 10.1016/S0163-6383(96)90031-4; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551	29	227	228	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2015	348	6230					91	94		10.1126/science.aaa3799	http://dx.doi.org/10.1126/science.aaa3799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8GJ	25838378	Green Accepted			2022-12-24	WOS:000352079500032
J	Lanphier, E; Urnov, F; Haecker, SE; Werner, M; Smolenski, J				Lanphier, Edward; Urnov, Fyodor; Haecker, Sarah Ehlen; Werner, Michael; Smolenski, Joanna			Don't edit the human germ line	NATURE			English	Editorial Material							RATS		[Lanphier, Edward; Urnov, Fyodor] Sangamo BioSci, Richmond, CA 94804 USA; [Lanphier, Edward; Werner, Michael] Alliance Regenerat Med, Washington, DC USA; [Haecker, Sarah Ehlen] Alliance Regenerat Med, Technol Sect, Washington, DC USA; [Smolenski, Joanna] CUNY, Grad Ctr, Philosophy, New York, NY USA	Sangamo Therapeutics, Inc.; City University of New York (CUNY) System	Lanphier, E (corresponding author), Sangamo BioSci, Richmond, CA 94804 USA.	lanphier@sangamo.com		Smolenski, Joanna/0000-0002-1652-770X				Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Han HB, 2014, FRONT AGRIC SCI ENG, V1, P2, DOI 10.15302/J-FASE-2014007; Heo YT, 2015, STEM CELLS DEV, V24, P393, DOI 10.1089/scd.2014.0278; Kang Q., 2014, P 10 WORLD C GEN APP; Regalado A., 2015, MIT TECH REV; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240	9	318	342	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					410	411		10.1038/519410a	http://dx.doi.org/10.1038/519410a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE1WF	25810189	Bronze			2022-12-24	WOS:000351602800031
J	Brienen, RJW; Phillips, OL; Feldpausch, TR; Gloor, E; Baker, TR; Lloyd, J; Lopez-Gonzalez, G; Monteagudo-Mendoza, A; Malhi, Y; Lewis, SL; Martinez, RV; Alexiades, M; Davila, EA; Alvarez-Loayza, P; Andrade, A; Aragao, LEOC; Araujo-Murakami, A; Arets, EJMM; Arroyo, L; Aymard, GA; Banki, OS; Baraloto, C; Barroso, J; Bonal, D; Boot, RGA; Camargo, JLC; Castilho, CV; Chama, V; Chao, KJ; Chave, J; Comiskey, JA; Valverde, FC; da Costa, L; de Oliveira, EA; Di Fiore, A; Erwin, TL; Fauset, S; Forsthofer, M; Galbraith, DR; Grahame, ES; Groot, N; Herault, B; Higuchi, N; Coronado, ENH; Keeling, H; Killeen, TJ; Laurance, WF; Laurance, S; Licona, J; Magnussen, WE; Marimon, BS; Marimon, BH; Mendoza, C; Neill, DA; Nogueira, EM; Nunez, P; Camacho, NCP; Parada, A; Pardo-Molina, G; Peacock, J; Pena-Claros, M; Pickavance, GC; Pitman, NCA; Poorter, L; Prieto, A; Quesada, CA; Ramirez, F; Ramirez-Angulo, H; Restrepo, Z; Roopsind, A; Rudas, A; Salomao, RP; Schwarz, M; Silva, N; Silva-Espejo, JE; Silveira, M; Stropp, J; Talbot, J; ter Steege, H; Teran-Aguilar, J; Terborgh, J; Thomas-Caesar, R; Toledo, M; Torello-Raventos, M; Umetsu, RK; Van der Heijden, GMF; Van der Hout, P; Vieira, ICG; Vieira, SA; Vilanova, E; Vos, VA; Zagt, RJ				Brienen, R. J. W.; Phillips, O. L.; Feldpausch, T. R.; Gloor, E.; Baker, T. R.; Lloyd, J.; Lopez-Gonzalez, G.; Monteagudo-Mendoza, A.; Malhi, Y.; Lewis, S. L.; Vasquez Martinez, R.; Alexiades, M.; Alvarez Davila, E.; Alvarez-Loayza, P.; Andrade, A.; Aragao, L. E. O. C.; Araujo-Murakami, A.; Arets, E. J. M. M.; Arroyo, L.; Aymard C, G. A.; Banki, O. S.; Baraloto, C.; Barroso, J.; Bonal, D.; Boot, R. G. A.; Camargo, J. L. C.; Castilho, C. V.; Chama, V.; Chao, K. J.; Chave, J.; Comiskey, J. A.; Cornejo Valverde, F.; da Costa, L.; de Oliveira, E. A.; Di Fiore, A.; Erwin, T. L.; Fauset, S.; Forsthofer, M.; Galbraith, D. R.; Grahame, E. S.; Groot, N.; Herault, B.; Higuchi, N.; Coronado, E. N. Honorio; Keeling, H.; Killeen, T. J.; Laurance, W. F.; Laurance, S.; Licona, J.; Magnussen, W. E.; Marimon, B. S.; Marimon-Junior, B. H.; Mendoza, C.; Neill, D. A.; Nogueira, E. M.; Nunez, P.; Pallqui Camacho, N. C.; Parada, A.; Pardo-Molina, G.; Peacock, J.; Pena-Claros, M.; Pickavance, G. C.; Pitman, N. C. A.; Poorter, L.; Prieto, A.; Quesada, C. A.; Ramirez, F.; Ramirez-Angulo, H.; Restrepo, Z.; Roopsind, A.; Rudas, A.; Salomao, R. P.; Schwarz, M.; Silva, N.; Silva-Espejo, J. E.; Silveira, M.; Stropp, J.; Talbot, J.; ter Steege, H.; Teran-Aguilar, J.; Terborgh, J.; Thomas-Caesar, R.; Toledo, M.; Torello-Raventos, M.; Umetsu, R. K.; Van der Heijden, G. M. F.; Van der Hout, P.; Vieira, I. C. Guimaraes; Vieira, S. A.; Vilanova, E.; Vos, V. A.; Zagt, R. J.			Long-term decline of the Amazon carbon sink	NATURE			English	Article							TROPICAL FOREST; EXPERIMENTAL DROUGHT; WOOD PRODUCTIVITY; TREE MORTALITY; TURNOVER RATES; SENSITIVITY; GROWTH; RECRUITMENT; DISTURBANCE; DYNAMICS	Atmospheric carbon dioxide records indicate that the land surface has acted as a strong global carbon sink over recent decades(1,2), with a substantial fraction of this sink probably located in the tropics', particularly in the Amazon(4). Nevertheless, it is unclear how the terrestrial carbon sink will evolve as climate and atmospheric composition continue to change. Here we analyse the historical evolution of the biomass dynamics of the Amazon rainforest over three decades using a distributed network of 321 plots. While this analysis confirms that Amazon forests have acted as a long-term net biomass sink, we find a long-term decreasing trend of carbon accumulation. Rates of net increase in above-ground biomass declined by one-third during the past decade compared to the 1990s. This is a consequence of growth rate increases levelling off recently, while biomass mortality persistently increased throughout, leading to a shortening of carbon residence times. Potential drivers for the mortality increase include greater climate variability, and feedbacks of faster growth on mortality, resulting in shortened tree longevity(5). The observed decline of the Amazon sink diverges markedly from the recent increase in terrestrial carbon uptake at the global scale", and is contrary to expectations based on models(6).	[Brienen, R. J. W.; Phillips, O. L.; Feldpausch, T. R.; Gloor, E.; Baker, T. R.; Lopez-Gonzalez, G.; Lewis, S. L.; Chao, K. J.; Fauset, S.; Galbraith, D. R.; Grahame, E. S.; Groot, N.; Coronado, E. N. Honorio; Keeling, H.; Peacock, J.; Pickavance, G. C.; Schwarz, M.; Talbot, J.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Feldpausch, T. R.; Aragao, L. E. O. C.] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter EX4 4RJ, Devon, England; [Lloyd, J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Lloyd, J.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4870, Australia; [Monteagudo-Mendoza, A.; Vasquez Martinez, R.] Prolongac Bolognesi Mze, Jardin Bot Missouri, Oxapampa, Pasco, Peru; [Malhi, Y.] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford OX1 3QK, England; [Lewis, S. L.] UCL, Dept Geog, London WC1E 6BT, England; [Alexiades, M.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT1 3EH, Kent, England; [Alvarez Davila, E.; Restrepo, Z.] Jardin Bot Medellin, Serv Ecosistemicosy Cambio Climat, Medellin 050010, Colombia; [Alvarez-Loayza, P.; Pitman, N. C. A.; Terborgh, J.] Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA; [Andrade, A.; Camargo, J. L. C.; Higuchi, N.] INPA, Biol Dynam Forest Fragment Project, BR-69011970 Manaus, Amazonas, Brazil; [Andrade, A.; Camargo, J. L. C.; Higuchi, N.] STRI, BR-69011970 Manaus, Amazonas, Brazil; [Aragao, L. E. O. C.] Natl Inst Space Res INPE, BR-12227010 Sao Paulo, Brazil; [Araujo-Murakami, A.; Arroyo, L.; Parada, A.] Univ Autonoma Gabriel Rene Moreno, Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [Arets, E. J. M. M.] Univ Wageningen & Res Ctr, Alterra, NL-6700 AA Wageningen, Netherlands; [Aymard C, G. A.] Herbario Univ PORT, Programa Cienclas Agro & Mar, UNELLEZ Guanare, Mesa De Cavacas 3350, Estado Portugue, Venezuela; [Banki, O. S.] Univ Amsterdam, Biodiversiteit Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands; [Baraloto, C.] INRA, UMR EcoFoG, F-97310 Kourou, French Guiana; [Baraloto, C.] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Barroso, J.] Univ Fed Acre, Rio Branco, Brazil; [Bonal, D.] INRA, UMR Ecol & Ecophysiol Forestiere 1137, F-54280 Seichamps, France; [Boot, R. G. A.; Zagt, R. J.] Tropenbos Int, NL-6700 AE Wageningen, Netherlands; [Castilho, C. V.] Embrapa Roraima, BR-69301970 Bio Vista, RR, Brazil; [Chama, V.; Nunez, P.; Pallqui Camacho, N. C.; Silva-Espejo, J. E.] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Chao, K. J.] Natl Chung Hsing Univ, Coll Agr & Nat Resources, Int Master Program Agr, Taichung 40227, Taiwan; [Chave, J.] Univ Toulouse 3, CNRS, UMR Evolut & Divers Biol 5174, F-31062 Toulouse, France; [Comiskey, J. A.] Natl Pk Serv, Northeast Reg Inventory & Monitoring Program, Fredericksburg, VA 22405 USA; [Cornejo Valverde, F.] Andes toAmazon Biodivers Program, Madre De Dios, Peru; [da Costa, L.] Fed Univ Para, Ctr Geociencias, BR-66017970 Belem, Para, Brazil; [de Oliveira, E. A.; Forsthofer, M.; Marimon, B. S.; Marimon-Junior, B. H.; Umetsu, R. K.] Univ Estado Mato Grosso, BR-78690000 Nova Xavantina, MT, Brazil; [Di Fiore, A.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Erwin, T. L.] Smithsonian Inst, Dept Entomol, Washington, DC 20013 USA; [Herault, B.] Cirad, UMR Ecol Forets Guyane, F-97310 Kourou, French Guiana; [Coronado, E. N. Honorio] Inst Invest Amazonia Peruana, Iquitos, Peru; [Killeen, T. J.] World Wildlife Fund, Washington, DC 20037 USA; [Laurance, W. F.; Laurance, S.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia; [Laurance, W. F.; Laurance, S.] James Cook Univ, Sch Marine & Environm Sci, Cairns, Qld 4878, Australia; [Licona, J.; Pena-Claros, M.; Toledo, M.] Inst Boliviano Invest Forestal, Santa Cruz 6201, Bolivia; [Magnussen, W. E.] Natl Inst Res Amazonia INPA, BR-69011970 Manaus, Amazonas, Brazil; [Mendoza, C.] FOMABO, Manejo Forestal Tierras Trop Bolivia, Sacta, Bolivia; [Mendoza, C.] UMSS, Escuela Ciencias Forestales ESFOR, Sacta, Bolivia; [Neill, D. A.] Univ Estatal Amazon, Fac Ingn Ambiental, Puyo, Pastaza, Ecuador; [Nogueira, E. M.; Quesada, C. A.] Natl Inst Res Amazonia INPA, BR-69080971 Manaus, Amazonas, Brazil; [Pardo-Molina, G.; Vos, V. A.] Univ Autonoma Beni, Riberalta, Beni, Bolivia; [Pena-Claros, M.; Poorter, L.] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AA Wageningen, Netherlands; [Pitman, N. C. A.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Prieto, A.; Ramirez, F.] Univ Nacl Amazonia Peruana, Iquitos, Loreto, Peru; [Ramirez-Angulo, H.; Vilanova, E.] Univ Los Andes, Inst Invest Desarrollo Forestal INDEFOR, Fac Cienclas Forestales & Ambientales, Merida 5101, Venezuela; [Roopsind, A.] Iwokrama Int Ctr Rainforest Conservat & Dev, Georgetown, Guyana; [Rudas, A.] Univ Nacl Colombia, Inst Ciencias Nat, Bogota 111321, Colombia; [Salomao, R. P.; Vieira, I. C. Guimaraes] Museu Paraense Emilio Goeldi, BR-66040170 Belem, Para, Brazil; [Silva, N.; Thomas-Caesar, R.] Univ Fed Rural Amazonia, BR-66077901 Belem, Para, Brazil; [Silveira, M.] Univ Fed Acre, Museu Univ, BR-69910900 Rio Branco, AC, Brazil; [Stropp, J.] Commiss European Communities, DG Joint Res Ctr, Inst Environm & Sustainabil, I-21010 Ispra, Italy; [ter Steege, H.] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [ter Steege, H.] Univ Utrecht, Ecol & Biodivers Grp, NL-3508 TB Utrecht, Netherlands; [Teran-Aguilar, J.] Museo Hist Nat Alcide DOrbigny, Cochabamba, Bolivia; [Torello-Raventos, M.] James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld 4870, Australia; [Torello-Raventos, M.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia; [Torello-Raventos, M.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia; [Van der Heijden, G. M. F.] Northumbria Univ, Sch Geog, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Van der Heijden, G. M. F.] Univ Wisconsin, Milwaukee, WI 53202 USA; [Van der Heijden, G. M. F.] Smithsonian Trop Res Inst, Panama City, Panama; [Van der Hout, P.] Van der Hout Forestry Consulting, NL-3078 HP Rotterdam, Netherlands; [Vieira, S. A.] Univ Estadual Campinas, NEPAM, BR-13083867 Sao Paulo, Brazil; [Vos, V. A.] Ctr Invest & Promoc Campesinado, Reg Norte Amazon, Riberalta, Bolivia	University of Leeds; University of Exeter; Imperial College London; James Cook University; University of Oxford; University of London; University College London; University of Kent; Duke University; Institute Nacional de Pesquisas da Amazonia; Instituto Nacional de Pesquisas Espaciais (INPE); Wageningen University & Research; University of Amsterdam; INRAE; State University System of Florida; Florida International University; Universidade Federal do Acre (UFAC); INRAE; Universite de Lorraine; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidad Nacional de San Antonio Abad del Cusco; National Chung Hsing University; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); United States Department of the Interior; Universidade Federal do Para; Universidade do Estado de Mato Grosso; University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; CIRAD; World Wildlife Fund; James Cook University; James Cook University; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Field Museum of Natural History (Chicago); Universidad Nacional de la Amazonia Peruana; University of Los Andes Venezuela; Universidad Nacional de Colombia; Museu Paraense Emilio Goeldi; Universidade Federal Rural da Amazonia (UFRA); European Commission Joint Research Centre; EC JRC ISPRA Site; Naturalis Biodiversity Center; Utrecht University; James Cook University; James Cook University; James Cook University; Northumbria University; University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidade Estadual de Campinas	Brienen, RJW (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	r.brienen@leeds.ac.uk	Vieira, Ima C.G./H-6897-2012; aragao, luiz eoc/G-8387-2012; Lloyd, Jonathan J/F-8893-2010; Vos, Vincent/ABA-1492-2020; Alvarez-Davila, Esteban/AAP-4231-2020; Vilanova, Emilio/AAG-9543-2020; Vos, Vincent Antoine/I-7209-2019; Higuchi, Niro/ABC-8890-2020; Brienen, Roel/AAU-9959-2020; Camargo, José Luís C/C-3137-2015; Feldpausch, Ted/ABH-3123-2020; Higuchi, Niro/J-1287-2016; Coronado, Eurídice Nora Honorio/K-3412-2015; Pitman, Nigel C A/A-7681-2008; Vieira, Sabrina Nunes/X-1702-2018; Marimon, Beatriz/J-6389-2012; Laurance, Susan/G-6021-2011; SALOMÃO, RAFAEL/AAU-1306-2020; Umetsu, Ricardo Keichi/AAG-9014-2019; Noojipady, Praveen/B-2511-2010; Silveira, Marcos/H-7906-2013; Arets, Eric/C-1050-2008; Baraloto, Christopher/ABG-2500-2020; Junior, Ben Hur Marimon/AAT-9354-2020; Galbraith, David/AAE-8162-2019; Feldpausch, Ted/D-3436-2009; de Castilho, Carolina Volkmer/I-6618-2019; Junior, Ben Hur Marimon/E-7330-2013; Vieira, Simone/H-1225-2011; Phillips, Oliver/A-1523-2011; Laurance, William F/B-2709-2012; Barroso, Jorcely G./H-5852-2017; Hérault, Bruno/B-2765-2011; Higuchi, Niro/ABC-9134-2020; Steege, Hans ter/B-5866-2011; Stropp, Juliana/AAF-7946-2020; Pallqui Camacho, Nadir Carolina/G-2529-2017; Aymard, Gerardo/ABE-9203-2020; van der Heijden, Geertje/AAB-4102-2019; Poorter, Lourens/AAL-1709-2021; Silva Espejo, Javier Eduardo/U-2962-2017; Ramirez, Fredy/R-1522-2016	Vieira, Ima C.G./0000-0003-1233-318X; aragao, luiz eoc/0000-0002-4134-6708; Lloyd, Jonathan J/0000-0002-5458-9960; Vos, Vincent/0000-0002-0388-8530; Alvarez-Davila, Esteban/0000-0001-9032-0099; Vilanova, Emilio/0000-0001-6289-5127; Vos, Vincent Antoine/0000-0002-0388-8530; Brienen, Roel/0000-0002-5397-5755; Feldpausch, Ted/0000-0002-6631-7962; Higuchi, Niro/0000-0002-1203-4502; Coronado, Eurídice Nora Honorio/0000-0003-2314-590X; Pitman, Nigel C A/0000-0002-9211-2880; Marimon, Beatriz/0000-0003-3105-2914; Laurance, Susan/0000-0002-2831-2933; SALOMÃO, RAFAEL/0000-0003-0947-0132; Umetsu, Ricardo Keichi/0000-0002-0345-269X; Silveira, Marcos/0000-0003-0485-7872; Arets, Eric/0000-0001-7209-9028; Baraloto, Christopher/0000-0001-7322-8581; Feldpausch, Ted/0000-0002-6631-7962; de Castilho, Carolina Volkmer/0000-0002-1064-2758; Vieira, Simone/0000-0002-0129-4181; Phillips, Oliver/0000-0002-8993-6168; Laurance, William F/0000-0003-4430-9408; Barroso, Jorcely G./0000-0003-3017-9462; Hérault, Bruno/0000-0002-6950-7286; Higuchi, Niro/0000-0002-1203-4502; Steege, Hans ter/0000-0002-8738-2659; Stropp, Juliana/0000-0002-2831-4066; Pallqui Camacho, Nadir Carolina/0000-0003-4596-0905; Aymard, Gerardo/0000-0001-9405-0508; van der Heijden, Geertje/0000-0002-2110-5173; Neill, David Alan/0000-0002-5143-9430; Marimon Junior, Ben Hur/0000-0002-6359-6281; Poorter, Lourens/0000-0003-1391-4875; Silva Espejo, Javier Eduardo/0000-0003-1954-3817; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Fauset, Sophie/0000-0003-4246-1828; Campana Camargo, Jose Luis/0000-0003-0370-9878; Galbraith, David/0000-0002-5555-4823; Alvarez-Loayza, Patricia/0000-0002-0090-4013; Talbot, Joey/0000-0002-6520-4560; Lewis, Simon/0000-0002-8066-6851; Ramirez, Fredy/0000-0003-2441-9984; Banki, Olaf/0000-0001-6197-9951; Groot, Nikee/0000-0003-3594-4311; Pena-Claros, Marielos/0000-0001-9134-6733; Comiskey, James/0000-0001-6710-1269; Chama Moscoso, Victor/0000-0002-4455-0157	Natural Environment Research Council [NE/B503384/1, NE/D01025X/1, NE/I02982X/1, NE/F005806/1, NE/D005590/1, NE/I028122/1]; Gordon and Betty Moore Foundation; EU Seventh Framework Programme [GEOCARBON-283080, AMAZALERT-282664]; NERC Research Fellowship [NE/I021160/1]; ERC Advanced Grant; Royal Society-Wolfson Research Merit Award; Investissement d'Avenir grants of the French ANR [CEBA: ANR-10-LABX-0025, TULIP: ANR-10-LABX-0041]; Conservation International; Missouri Botanical Garden; Smithsonian Institution; Wildlife Conservation Society; Natural Environment Research Council [NE/I021160/1, NE/B504630/1, NE/D010306/1] Funding Source: researchfish; NERC [NE/D01025X/1, NE/D010306/1, NE/I021160/1, NE/F005806/1, NE/D005590/1, NE/I028122/1, NE/I02982X/1, NE/F005776/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); EU Seventh Framework Programme; NERC Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC Advanced Grant(European Research Council (ERC)); Royal Society-Wolfson Research Merit Award(Royal Society of London); Investissement d'Avenir grants of the French ANR(French National Research Agency (ANR)); Conservation International; Missouri Botanical Garden; Smithsonian Institution(Smithsonian Institution); Wildlife Conservation Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The RAINFOR forest monitoring network has been supported principally by the Natural Environment Research Council (grants NE/B503384/1, NE/D01025X/1, NE/I02982X/1, NE/F005806/1, NE/D005590/1 and NE/I028122/1), the Gordon and Betty Moore Foundation, and by the EU Seventh Framework Programme (GEOCARBON-283080 and AMAZALERT-282664). R.J.W.B. is funded by NERC Research Fellowship NE/I021160/1. O.P. is supported by an ERC Advanced Grant and is a Royal Society-Wolfson Research Merit Award holder. Additional data were supported by Investissement d'Avenir grants of the French ANR (CEBA: ANR-10-LABX-0025; TULIP: ANR-10-LABX-0041), and contributed by the Tropical Ecology Assessment and Monitoring (TEAM) Network, funded by Conservation International, the Missouri Botanical Garden, the Smithsonian Institution, the Wildlife Conservation Society and the Gordon and Betty Moore Foundation. This paper is 656 in the Technical Series of the Biological Dynamics of Forest Fragments Project (BDFFP-INPA/STRI). The field data summarized here involve vital contributions from many field assistants and rural communities in Bolivia, Brazil, Colombia, Ecuador, French Guiana, Guyana, Peru and Venezuela, most of whom have been specifically acknowledged elsewhere<SUP>4</SUP>. We additionally thank A. Alarcon, I. Amaral, P. P. Barbosa Camargo, I. F. Brown, L. Blanc, B. Burban, N. Cardozo, J. Engel, M. A. de Freitas, A. de Oliveira, T. S. Fredericksen, L. Ferreira, N. T. Hinojosa, E. Jimenez, E. Lenza, C. Mendoza, I. Mendoza Polo, A. Pena Cruz, M. C. Penuela, P. Petronelli, J. Singh, P. Maquirino, J. Serano, A. Sota,C. Oliveira dos Santos, J. Ybarnegaray and J. Ricardo for contributions. CNPq (Brazil), MCT (Brazil), Ministerio del Medio Ambiente, Vivienda y Desarrollo Territorial (Colombia), Ministerio de Ambiente (Ecuador), the Forestry Commission (Guyana), INRENA (Peru), SERNANP (Peru), and Ministerio del Ambiente para el Poder Popular (Venezuela) granted research permissions. We thank our deceased colleagues and friends, A. H. Gentry, J. P. Veillon, S. Almeida and S. Patino for invaluable contributions to this work; their pioneering efforts to understand neotropical forests continue to inspire South American ecologists.	[Anonymous], [No title captured]; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bigler C, 2009, OIKOS, V118, P1130, DOI 10.1111/j.1600-0706.2009.17592.x; Booth BBB, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024002; Bugmann H, 2011, OECOLOGIA, V165, P533, DOI 10.1007/s00442-010-1837-4; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Condit R, 1997, TRENDS ECOL EVOL, V12, P249, DOI 10.1016/S0169-5347(97)01095-1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Di Filippo A, 2012, GLOBAL CHANGE BIOL, V18, P960, DOI 10.1111/j.1365-2486.2011.02617.x; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Friend AD, 2014, P NATL ACAD SCI USA, V111, P3280, DOI 10.1073/pnas.1222477110; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; Huntingford C, 2013, NAT GEOSCI, V6, P268, DOI [10.1038/ngeo1741, 10.1038/NGEO1741]; Jimenez-Munoz JC, 2013, J GEOPHYS RES-ATMOS, V118, P5204, DOI 10.1002/jgrd.50456; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; Lewis SL, 2004, J ECOL, V92, P929, DOI 10.1111/j.0022-0477.2004.00923.x; LIEBERMAN D, 1985, J ECOL, V73, P915, DOI 10.2307/2260157; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Manusch C, 2012, ECOL MODEL, V243, P101, DOI 10.1016/j.ecolmodel.2012.06.008; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Muller-Landau H. C., 2014, FORESTS GLOBAL CHANG, P462; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; R Core Team, 2016, R FDN STAT COMP; Ryan MG, 2006, PLANT CELL ENVIRON, V29, P367, DOI 10.1111/j.1365-3040.2005.01478.x; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Sheil D, 1996, J ECOL, V84, P91, DOI 10.2307/2261703; Talbot J, 2014, FOREST ECOL MANAG, V320, P30, DOI 10.1016/j.foreco.2014.02.021; Thomas SC, 2011, TREE PHYSIOL-NETH, V4, P33, DOI 10.1007/978-94-007-1242-3_2; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; Wood S, 2011, GEN ADDITIVE MIXED M	45	619	631	57	810	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					344	+		10.1038/nature14283	http://dx.doi.org/10.1038/nature14283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788097	Green Accepted			2022-12-24	WOS:000351171900039
J	Leslie, S; Winney, B; Hellenthal, G; Davison, D; Boumertit, A; Day, T; Hutnik, K; Royrvik, EC; Cunliffe, B; Lawson, DJ; Falush, D; Freeman, C; Pirinen, M; Myers, S; Robinson, M; Donnelly, P; Bodmer, W				Leslie, Stephen; Winney, Bruce; Hellenthal, Garrett; Davison, Dan; Boumertit, Abdelhamid; Day, Tammy; Hutnik, Katarzyna; Royrvik, Ellen C.; Cunliffe, Barry; Lawson, Daniel J.; Falush, Daniel; Freeman, Colin; Pirinen, Matti; Myers, Simon; Robinson, Mark; Donnelly, Peter; Bodmer, Walter		Wellcome Trust Case Control; Int Multiple Sclerosis Genetics	The fine-scale genetic structure of the British population	NATURE			English	Article							LINKAGE DISEQUILIBRIUM; INFERENCE; ADMIXTURE; ANCESTRY; AFRICA; MODEL	Fine-scale genetic variation between human Populations is interesting as a signature of historical demographic events and because of its potential for confounding disease studies. We use haplotype-based statistical methods to analyse genome-wide single nucleotide polymorphism (SNP) data from a carefully chosen geographically diverse sample of 2,039 individuals from the United Kingdom. This reveals a rich and detailed pattern of genetic differentiation with remarkable concordance between genetic clusters and geography. The regional genetic differentiation and differing patterns of shared ancestry with 6,209 individuals from across Europe carry clear signals of historical demographic events. We estimate the genetic contribution to southeastern England from Anglo-Saxon migrations to be under half, and identify the regions not carrying genetic material from these migrations. We suggest significant pre-Roman but post-Mesolithic movement into southeastern England from continental Europe, and show that in non-Saxon parts of the United Kingdom, there exist genetically differentiated subgroups rather than a general 'Celtic' population.	[Leslie, Stephen] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Leslie, Stephen] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia; [Leslie, Stephen; Winney, Bruce; Boumertit, Abdelhamid; Day, Tammy; Hutnik, Katarzyna; Royrvik, Ellen C.; Bodmer, Walter] Univ Oxford, Dept Oncol, Oxford OX3 7DQ, England; [Hellenthal, Garrett] Univ Coll London Genet Inst, London WC1E 6BT, England; [Davison, Dan] Counsyl, San Francisco, CA 94080 USA; [Cunliffe, Barry] Univ Oxford, Inst Archaeol, Oxford OX1 2PG, England; [Lawson, Daniel J.] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; [Falush, Daniel] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Freeman, Colin; Donnelly, Peter] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Pirinen, Matti] Univ Helsinki, FI-00014 Helsinki, Finland; [Myers, Simon; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Robinson, Mark] Univ Oxford, Univ Museum Nat Hist, Oxford OX1 3PW, England	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Oxford; University of London; University College London; University of Oxford; University of Bristol; Swansea University; University of Oxford; Wellcome Centre for Human Genetics; University of Helsinki; University of Oxford; University of Oxford	Donnelly, P (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	donnelly@well.ox.ac.uk	Myers, Simon R/A-6792-2015; Brown, Matthew A/E-5749-2010; Lawson, Daniel/A-8550-2011	Myers, Simon R/0000-0002-2585-9626; Brown, Matthew A/0000-0003-0538-8211; Bodmer, Walter/0000-0001-6244-9792; Pirinen, Matti/0000-0002-1664-1350; Lawson, Daniel/0000-0002-5311-6213	Wellcome Trust [072974/Z/03/Z, 088262/Z/09/Z, 075491/Z/04/Z, 075491/Z/04/A, 075491/Z/04/B, 090532/Z/09/Z, 084818/Z/08/Z, 095552/Z/11/Z, 085475/Z/08/Z, 098387/Z/12/Z, 098386/Z/12/Z]; Academy of Finland [257654]; Australian National Health and Medical Research Council [APP1053756]; Wolfson-Royal Society Merit Award; AHRC [AH/K002600/1] Funding Source: UKRI; MRC [MC_UU_12013/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/K002600/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1, MR/M501608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wolfson-Royal Society Merit Award(Royal Society of London); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Cheshire for his advice. We thank the UK Office for National Statistics, the National Records of Scotland, and the Northern Ireland Statistics and Research Agency for providing the boundaries used for the UK maps. We note that census output is Crown copyright and is reproduced with the permission of the Controller of HMSO and the Queen's Printer for Scotland. We further acknowledge the provision of maps from Eurostat, which are copyright EuroGeographics for the administrative boundaries. We acknowledge support from the Wellcome Trust (072974/Z/03/Z, 088262/Z/09/Z, 075491/Z/04/Z, 075491/Z/04/A, 075491/Z/04/B, 090532/Z/09/Z, 084818/Z/08/Z, 095552/Z/11/Z, 085475/Z/08/Z, 098387/Z/12/Z, 098386/Z/12/Z), the Academy of Finland (257654) and the Australian National Health and Medical Research Council (APP1053756). P.D. was supported in part by a Wolfson-Royal Society Merit Award.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bodmer JG, 1980, POPULATION STRUCTURE, P211; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Falush D, 2003, GENETICS, V164, P1567; Goodacre S, 2005, HEREDITY, V95, P129, DOI 10.1038/sj.hdy.6800661; Hellenthal G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000078; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Lawson CL, 1995, SOLVING LEAST SQUARE; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; National Records of Scotland, 2011, 2011 CENS DIG BOUND; Northern Ireland Statistics and Research Agency, 2011 CENS DIG BOUND; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; Office for National Statistics, 2011, 2011 CENS DIG BOUND; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; ROUSSET F, 2004, GENETIC STRUCTURE SE; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127; Wright S, 1943, GENETICS, V28, P114	38	237	238	4	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					309	+		10.1038/nature14230	http://dx.doi.org/10.1038/nature14230			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25788095	Green Submitted, Green Accepted			2022-12-24	WOS:000351171900032
J	Gould, J				Gould, Julie			LEARNING FROM NATURE'S BEST	NATURE			English	Editorial Material																			0	21	21	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					S3	S4		10.1098/rsif.2014.06	http://dx.doi.org/10.1098/rsif.2014.06			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VC0LI	25806495				2022-12-24	WOS:000426172400001
